UNII	IIG-ID	Route	Strength	IIG-URL
1S66E28KXA	POLOXAMER 124:ORAL:SUSPENSION:MG/1ML	ORAL	0.09MG/1ML ORAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
1S66E28KXA	POLOXAMER 124:TOPICAL:GEL:%W/W	TOPICAL	0.2%W/W TOPICAL GEL	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
1S66E28KXA	POLOXAMER 124:TOPICAL:LOTION:%W/W	TOPICAL	0.2%W/W TOPICAL LOTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
QX10HYY4QV	SESAME OIL:IM - SC:INJECTABLE:NA	IM - SC	IM - SC INJECTABLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
QX10HYY4QV	SESAME OIL:IM - SC:INJECTION:NA	IM - SC	IM - SC INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
QX10HYY4QV	SESAME OIL:IM - SC:INJECTION, SUSTAINED ACTION:NA	IM - SC	IM - SC INJECTION, SUSTAINED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
QX10HYY4QV	SESAME OIL:INTRAMUSCULAR:INJECTABLE:NA	INTRAMUSCULAR	INTRAMUSCULAR INJECTABLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
QX10HYY4QV	SESAME OIL:INTRAMUSCULAR:INJECTION:%V/V	INTRAMUSCULAR	70%V/V INTRAMUSCULAR INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
QX10HYY4QV	SESAME OIL:INTRAMUSCULAR:SOLUTION, INJECTION:NA	INTRAMUSCULAR	INTRAMUSCULAR SOLUTION, INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
QX10HYY4QV	SESAME OIL:ORAL:CAPSULE:MG	ORAL	162.5MG ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
QX10HYY4QV	SESAME OIL:ORAL:CAPSULE, SOFT GELATIN:MG	ORAL	44.4MG ORAL CAPSULE, SOFT GELATIN	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
QX10HYY4QV	SESAME OIL:ORAL:CONCENTRATE:NA	ORAL	ORAL CONCENTRATE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
QX10HYY4QV	SESAME OIL:ORAL:EMULSION:NA	ORAL	ORAL EMULSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
QX10HYY4QV	SESAME OIL:ORAL:SOLUTION:QS	ORAL	QS ORAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
QX10HYY4QV	SESAME OIL:ORAL:TABLET, COATED:NA	ORAL	ORAL TABLET, COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
QX10HYY4QV	SESAME OIL:SUBCUTANEOUS:INJECTION:QS	SUBCUTANEOUS	QS SUBCUTANEOUS INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
1Q73Q2JULR	SODIUM CITRATE:INTRAVENOUS:INJECTION:%	INTRAVENOUS	0.37% INTRAVENOUS INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
1Q73Q2JULR	SODIUM CITRATE:ORAL:LIQUID:mg/10mL	ORAL	12.5mg/10mL ORAL LIQUID	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
1Q73Q2JULR	SODIUM CITRATE:ORAL:SUSPENSION:mg/1mL	ORAL	21.91mg/1mL ORAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
1Q73Q2JULR	SODIUM CITRATE, UNSPECIFIED FORM:AN,INFILTRATION:INJECTION:%	AN,INFILTRATION	0.04% AN,INFILTRATION INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
1Q73Q2JULR	SODIUM CITRATE, UNSPECIFIED FORM:AURICULAR (OTIC):SOLUTION:%	AURICULAR (OTIC)	2% AURICULAR (OTIC) SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
1Q73Q2JULR	SODIUM CITRATE, UNSPECIFIED FORM:AURICULAR (OTIC):SUSPENSION:NA	AURICULAR (OTIC)	AURICULAR (OTIC) SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
1Q73Q2JULR	SODIUM CITRATE, UNSPECIFIED FORM:EPIDURAL:INJECTION:%	EPIDURAL	2.2% EPIDURAL INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
1Q73Q2JULR	SODIUM CITRATE, UNSPECIFIED FORM:IM - IV:INJECTABLE:%	IM - IV	1.35% IM - IV INJECTABLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
1Q73Q2JULR	SODIUM CITRATE, UNSPECIFIED FORM:IM - IV:INJECTION:%	IM - IV	40% IM - IV INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
1Q73Q2JULR	SODIUM CITRATE, UNSPECIFIED FORM:IM - IV:POWDER, FOR INJECTION SOLUTION:%	IM - IV	3.5% IM - IV POWDER, FOR INJECTION SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
1Q73Q2JULR	SODIUM CITRATE, UNSPECIFIED FORM:IM - IV:SOLUTION:%	IM - IV	0.025% IM - IV SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
1Q73Q2JULR	SODIUM CITRATE, UNSPECIFIED FORM:IM - IV - SC:INJECTABLE:%	IM - IV - SC	0.23% IM - IV - SC INJECTABLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
1Q73Q2JULR	SODIUM CITRATE, UNSPECIFIED FORM:IM - IV - SC:INJECTION:%	IM - IV - SC	0.94% IM - IV - SC INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
1Q73Q2JULR	SODIUM CITRATE, UNSPECIFIED FORM:IM - SC:INJECTION:%	IM - SC	0.23% IM - SC INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
1Q73Q2JULR	SODIUM CITRATE, UNSPECIFIED FORM:INHALATION:INHALANT:NA	INHALATION	INHALATION INHALANT	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
1Q73Q2JULR	SODIUM CITRATE, UNSPECIFIED FORM:INHALATION:SOLUTION:%	INHALATION	0.6% INHALATION SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
1Q73Q2JULR	SODIUM CITRATE, UNSPECIFIED FORM:INHALATION:SUSPENSION, FOR INHALATION:%	INHALATION	0.05% INHALATION SUSPENSION, FOR INHALATION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
1Q73Q2JULR	SODIUM CITRATE, UNSPECIFIED FORM:INTRA-ARTERIAL:INJECTION:%	INTRA-ARTERIAL	0.3% INTRA-ARTERIAL INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
1Q73Q2JULR	SODIUM CITRATE, UNSPECIFIED FORM:INTRA-ARTICULAR:INJECTION:%	INTRA-ARTICULAR	2.2% INTRA-ARTICULAR INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
1Q73Q2JULR	SODIUM CITRATE, UNSPECIFIED FORM:INTRACARDIAC:INJECTION:%	INTRACARDIAC	0.8% INTRACARDIAC INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
1Q73Q2JULR	SODIUM CITRATE, UNSPECIFIED FORM:INTRACAVITARY:INJECTION:%	INTRACAVITARY	0.15% INTRACAVITARY INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
1Q73Q2JULR	SODIUM CITRATE, UNSPECIFIED FORM:INTRACAVITARY:POWDER, FOR INJECTION SOLUTION, LYOPHILIZED:%	INTRACAVITARY	0.005% INTRACAVITARY POWDER, FOR INJECTION SOLUTION, LYOPHILIZED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
1Q73Q2JULR	SODIUM CITRATE, UNSPECIFIED FORM:INTRALESIONAL:INJECTION:%	INTRALESIONAL	1% INTRALESIONAL INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
1Q73Q2JULR	SODIUM CITRATE, UNSPECIFIED FORM:INTRAMUSCULAR:INJECTABLE:%	INTRAMUSCULAR	0.435% INTRAMUSCULAR INJECTABLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
1Q73Q2JULR	SODIUM CITRATE, UNSPECIFIED FORM:INTRAMUSCULAR:INJECTION:%	INTRAMUSCULAR	4% INTRAMUSCULAR INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
1Q73Q2JULR	SODIUM CITRATE, UNSPECIFIED FORM:INTRAMUSCULAR:POWDER, FOR INJECTION SOLUTION:%	INTRAMUSCULAR	4.62% INTRAMUSCULAR POWDER, FOR INJECTION SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
1Q73Q2JULR	SODIUM CITRATE, UNSPECIFIED FORM:INTRAMUSCULAR:POWDER, FOR INJECTION SOLUTION, LYOPHILIZED:%	INTRAMUSCULAR	0.74% INTRAMUSCULAR POWDER, FOR INJECTION SOLUTION, LYOPHILIZED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
1Q73Q2JULR	SODIUM CITRATE, UNSPECIFIED FORM:INTRAMUSCULAR:SOLUTION, INJECTION:%	INTRAMUSCULAR	1.47% INTRAMUSCULAR SOLUTION, INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
1Q73Q2JULR	SODIUM CITRATE, UNSPECIFIED FORM:INTRAOCULAR:SOLUTION:%	INTRAOCULAR	0.4% INTRAOCULAR SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
1Q73Q2JULR	SODIUM CITRATE, UNSPECIFIED FORM:INTRAPERITONEAL:INJECTION:%	INTRAPERITONEAL	2.2% INTRAPERITONEAL INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
1Q73Q2JULR	SODIUM CITRATE, UNSPECIFIED FORM:INTRAPLEURAL:INJECTION:ADJ PH	INTRAPLEURAL	ADJ PH INTRAPLEURAL INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
1Q73Q2JULR	SODIUM CITRATE, UNSPECIFIED FORM:INTRAPLEURAL:POWDER, FOR INJECTION SOLUTION:%	INTRAPLEURAL	4.62% INTRAPLEURAL POWDER, FOR INJECTION SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
1Q73Q2JULR	SODIUM CITRATE, UNSPECIFIED FORM:INTRASYNOVIAL:INJECTION:%	INTRASYNOVIAL	1% INTRASYNOVIAL INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
1Q73Q2JULR	SODIUM CITRATE, UNSPECIFIED FORM:INTRATHECAL:INJECTION:ADJ PH	INTRATHECAL	ADJ PH INTRATHECAL INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
1Q73Q2JULR	SODIUM CITRATE, UNSPECIFIED FORM:INTRATHECAL:POWDER, FOR INJECTION SOLUTION:%	INTRATHECAL	4.62% INTRATHECAL POWDER, FOR INJECTION SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
1Q73Q2JULR	SODIUM CITRATE, UNSPECIFIED FORM:INTRATRACHEAL:SUSPENSION:NA	INTRATRACHEAL	INTRATRACHEAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
1Q73Q2JULR	SODIUM CITRATE, UNSPECIFIED FORM:INTRAUTERINE:SOLUTION:%	INTRAUTERINE	0.32% INTRAUTERINE SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
1Q73Q2JULR	SODIUM CITRATE, UNSPECIFIED FORM:INTRAVASCULAR:INJECTION:%	INTRAVASCULAR	0.32% INTRAVASCULAR INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
1Q73Q2JULR	SODIUM CITRATE, UNSPECIFIED FORM:INTRAVENOUS:INFUSION:ADJ PH	INTRAVENOUS	ADJ PH INTRAVENOUS INFUSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
1Q73Q2JULR	SODIUM CITRATE, UNSPECIFIED FORM:INTRAVENOUS:INJECTABLE:%	INTRAVENOUS	20% INTRAVENOUS INJECTABLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
1Q73Q2JULR	SODIUM CITRATE, UNSPECIFIED FORM:INTRAVENOUS:INJECTION:MG/1ML	INTRAVENOUS	1.64MG/1ML INTRAVENOUS INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
1Q73Q2JULR	SODIUM CITRATE, UNSPECIFIED FORM:INTRAVENOUS:INJECTION:%	INTRAVENOUS	0.6% INTRAVENOUS INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
1Q73Q2JULR	SODIUM CITRATE, UNSPECIFIED FORM:INTRAVENOUS:POWDER, FOR INJECTION SOLUTION:%	INTRAVENOUS	0.16% INTRAVENOUS POWDER, FOR INJECTION SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
1Q73Q2JULR	SODIUM CITRATE, UNSPECIFIED FORM:INTRAVENOUS:POWDER, FOR INJECTION SOLUTION, LYOPHILIZED:%	INTRAVENOUS	16.35% INTRAVENOUS POWDER, FOR INJECTION SOLUTION, LYOPHILIZED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
1Q73Q2JULR	SODIUM CITRATE, UNSPECIFIED FORM:INTRAVENOUS:SOLUTION:%	INTRAVENOUS	0.83% INTRAVENOUS SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
1Q73Q2JULR	SODIUM CITRATE, UNSPECIFIED FORM:IONTOPHORESIS:DRUG DELIVERY SYSTEM:MG	IONTOPHORESIS	2.2MG IONTOPHORESIS DRUG DELIVERY SYSTEM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
1Q73Q2JULR	SODIUM CITRATE, UNSPECIFIED FORM:IRRIGATION:INJECTION:%	IRRIGATION	2.2% IRRIGATION INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
1Q73Q2JULR	SODIUM CITRATE, UNSPECIFIED FORM:IV(INFUSION):INJECTABLE:%	IV(INFUSION)	0.547% IV(INFUSION) INJECTABLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
1Q73Q2JULR	SODIUM CITRATE, UNSPECIFIED FORM:IV(INFUSION):INJECTION:%	IV(INFUSION)	40% IV(INFUSION) INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
1Q73Q2JULR	SODIUM CITRATE, UNSPECIFIED FORM:IV(INFUSION):INJECTION:MG/100ML	IV(INFUSION)	30MG/100ML IV(INFUSION) INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
1Q73Q2JULR	SODIUM CITRATE, UNSPECIFIED FORM:IV(INFUSION):POWDER, FOR INJECTION SOLUTION:%	IV(INFUSION)	8% IV(INFUSION) POWDER, FOR INJECTION SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
1Q73Q2JULR	SODIUM CITRATE, UNSPECIFIED FORM:IV(INFUSION):POWDER, FOR INJECTION SOLUTION, LYOPHILIZED:%	IV(INFUSION)	14% IV(INFUSION) POWDER, FOR INJECTION SOLUTION, LYOPHILIZED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
1Q73Q2JULR	SODIUM CITRATE, UNSPECIFIED FORM:IV(INFUSION):SOLUTION, CONCENTRATE:%	IV(INFUSION)	2.4% IV(INFUSION) SOLUTION, CONCENTRATE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
1Q73Q2JULR	SODIUM CITRATE, UNSPECIFIED FORM:IV(INFUSION):SOLUTION, INJECTION:%	IV(INFUSION)	0.6% IV(INFUSION) SOLUTION, INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
1Q73Q2JULR	SODIUM CITRATE, UNSPECIFIED FORM:NASAL:GEL:NA	NASAL	NASAL GEL	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
1Q73Q2JULR	SODIUM CITRATE, UNSPECIFIED FORM:NASAL:SOLUTION:%	NASAL	0.7% NASAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
1Q73Q2JULR	SODIUM CITRATE, UNSPECIFIED FORM:NASAL:SPRAY:%	NASAL	44% NASAL SPRAY	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
1Q73Q2JULR	SODIUM CITRATE, UNSPECIFIED FORM:NASAL:SPRAY, METERED:UG/SPRAY	NASAL	95.9UG/SPRAY NASAL SPRAY, METERED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
1Q73Q2JULR	SODIUM CITRATE, UNSPECIFIED FORM:NERVE BLOCK:INJECTION:%	NERVE BLOCK	0.04% NERVE BLOCK INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
1Q73Q2JULR	SODIUM CITRATE, UNSPECIFIED FORM:OPHTHALMIC:POWDER, FOR SOLUTION:%	OPHTHALMIC	0.17% OPHTHALMIC POWDER, FOR SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
1Q73Q2JULR	SODIUM CITRATE, UNSPECIFIED FORM:OPHTHALMIC:SOLUTION:%	OPHTHALMIC	2.2% OPHTHALMIC SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
1Q73Q2JULR	SODIUM CITRATE, UNSPECIFIED FORM:OPHTHALMIC:SOLUTION, DROPS:%	OPHTHALMIC	2% OPHTHALMIC SOLUTION, DROPS	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
1Q73Q2JULR	SODIUM CITRATE, UNSPECIFIED FORM:OPHTHALMIC:SUSPENSION:%	OPHTHALMIC	0.3% OPHTHALMIC SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
1Q73Q2JULR	SODIUM CITRATE, UNSPECIFIED FORM:OPHTHALMIC:SUSPENSION, DROPS:%	OPHTHALMIC	0.45% OPHTHALMIC SUSPENSION, DROPS	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
1Q73Q2JULR	SODIUM CITRATE, UNSPECIFIED FORM:ORAL:CAPSULE:MG	ORAL	1MG ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
1Q73Q2JULR	SODIUM CITRATE, UNSPECIFIED FORM:ORAL:CONCENTRATE:MG/1ML	ORAL	5.07MG/1ML ORAL CONCENTRATE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
1Q73Q2JULR	SODIUM CITRATE, UNSPECIFIED FORM:ORAL:DROPS:MG/5ML	ORAL	100MG/5ML ORAL DROPS	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
1Q73Q2JULR	SODIUM CITRATE, UNSPECIFIED FORM:ORAL:EMULSION:NA	ORAL	ORAL EMULSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
1Q73Q2JULR	SODIUM CITRATE, UNSPECIFIED FORM:ORAL:GRANULE:MG/5ML	ORAL	210.63MG/5ML ORAL GRANULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
1Q73Q2JULR	SODIUM CITRATE, UNSPECIFIED FORM:ORAL:GRANULE, FOR RECONSTITUTION:MG	ORAL	0.7MG ORAL GRANULE, FOR RECONSTITUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
1Q73Q2JULR	SODIUM CITRATE, UNSPECIFIED FORM:ORAL:GRANULE, FOR SUSPENSION:MG	ORAL	15MG ORAL GRANULE, FOR SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
1Q73Q2JULR	SODIUM CITRATE, UNSPECIFIED FORM:ORAL:LIQUID:ADJ PH	ORAL	ADJ PH ORAL LIQUID	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
1Q73Q2JULR	SODIUM CITRATE, UNSPECIFIED FORM:ORAL:POWDER, FOR ORAL SUSPENSION:MG/5ML	ORAL	40MG/5ML ORAL POWDER, FOR ORAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
1Q73Q2JULR	SODIUM CITRATE, UNSPECIFIED FORM:ORAL:POWDER, FOR RECONSTITUTION:MG/5ML	ORAL	2MG/5ML ORAL POWDER, FOR RECONSTITUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
1Q73Q2JULR	SODIUM CITRATE, UNSPECIFIED FORM:ORAL:POWDER, FOR SOLUTION:MG/PACKET	ORAL	2942MG/PACKET ORAL POWDER, FOR SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
1Q73Q2JULR	SODIUM CITRATE, UNSPECIFIED FORM:ORAL:POWDER, FOR SUSPENSION:MG/5ML	ORAL	37.5MG/5ML ORAL POWDER, FOR SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
1Q73Q2JULR	SODIUM CITRATE, UNSPECIFIED FORM:ORAL:SOLUTION:MG/75ML	ORAL	1567.5MG/75ML ORAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
1Q73Q2JULR	SODIUM CITRATE, UNSPECIFIED FORM:ORAL:SOLUTION:ADJ PH	ORAL	ADJ PH ORAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
1Q73Q2JULR	SODIUM CITRATE, UNSPECIFIED FORM:ORAL:SOLUTION, CONCENTRATE:MG/1ML	ORAL	0.5MG/1ML ORAL SOLUTION, CONCENTRATE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
1Q73Q2JULR	SODIUM CITRATE, UNSPECIFIED FORM:ORAL:SOLUTION, ELIXIR:MG/5ML	ORAL	22.5MG/5ML ORAL SOLUTION, ELIXIR	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
1Q73Q2JULR	SODIUM CITRATE, UNSPECIFIED FORM:ORAL:SOLUTION, LIQUID:MG/1ML	ORAL	7.09MG/1ML ORAL SOLUTION, LIQUID	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
1Q73Q2JULR	SODIUM CITRATE, UNSPECIFIED FORM:ORAL:SUSPENSION:MG/5ML	ORAL	7800MG/5ML ORAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
1Q73Q2JULR	SODIUM CITRATE, UNSPECIFIED FORM:ORAL:SUSPENSION, EXTENDED RELEASE:MG/5ML	ORAL	13MG/5ML ORAL SUSPENSION, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
1Q73Q2JULR	SODIUM CITRATE, UNSPECIFIED FORM:ORAL:SUSPENSION, LIQUID:MG/5ML	ORAL	0.9MG/5ML ORAL SUSPENSION, LIQUID	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
1Q73Q2JULR	SODIUM CITRATE, UNSPECIFIED FORM:ORAL:SUSPENSION, SUSTAINED ACTION:MG/1PKT	ORAL	23.5MG/1PKT ORAL SUSPENSION, SUSTAINED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
1Q73Q2JULR	SODIUM CITRATE, UNSPECIFIED FORM:ORAL:SYRUP:MG/5ML	ORAL	25MG/5ML ORAL SYRUP	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
1Q73Q2JULR	SODIUM CITRATE, UNSPECIFIED FORM:ORAL:TABLET:MG	ORAL	275MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
1Q73Q2JULR	SODIUM CITRATE, UNSPECIFIED FORM:ORAL:TABLET (IMMED./COMP. RELEASE), UNCOATED, CHEWABLE:MG	ORAL	300MG ORAL TABLET (IMMED./COMP. RELEASE), UNCOATED, CHEWABLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
1Q73Q2JULR	SODIUM CITRATE, UNSPECIFIED FORM:ORAL:TABLET, COATED:MG	ORAL	19MG ORAL TABLET, COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
1Q73Q2JULR	SODIUM CITRATE, UNSPECIFIED FORM:ORAL:TABLET, DELAYED ACTION, ENTERIC COATED:MG	ORAL	82MG ORAL TABLET, DELAYED ACTION, ENTERIC COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
1Q73Q2JULR	SODIUM CITRATE, UNSPECIFIED FORM:ORAL:TABLET, EXTENDED RELEASE:MG	ORAL	110MG ORAL TABLET, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
1Q73Q2JULR	SODIUM CITRATE, UNSPECIFIED FORM:ORAL:TABLET, FILM COATED:MG	ORAL	200MG ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
1Q73Q2JULR	SODIUM CITRATE, UNSPECIFIED FORM:RECTAL:SOLUTION:NA	RECTAL	RECTAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
1Q73Q2JULR	SODIUM CITRATE, UNSPECIFIED FORM:RESPIRATORY (INHALATION):POWDER, FOR INHALATION:%	RESPIRATORY (INHALATION)	0.14% RESPIRATORY (INHALATION) POWDER, FOR INHALATION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
1Q73Q2JULR	SODIUM CITRATE, UNSPECIFIED FORM:RESPIRATORY (INHALATION):SUSPENSION, FOR INHALATION:MG/2ML	RESPIRATORY (INHALATION)	1MG/2ML RESPIRATORY (INHALATION) SUSPENSION, FOR INHALATION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
1Q73Q2JULR	SODIUM CITRATE, UNSPECIFIED FORM:SOFT TISSUE:INJECTION:%	SOFT TISSUE	1% SOFT TISSUE INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
1Q73Q2JULR	SODIUM CITRATE, UNSPECIFIED FORM:SUBCUTANEOUS:POWDER, FOR INJECTION SOLUTION, LYOPHILIZED:%	SUBCUTANEOUS	0.74% SUBCUTANEOUS POWDER, FOR INJECTION SOLUTION, LYOPHILIZED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
1Q73Q2JULR	SODIUM CITRATE, UNSPECIFIED FORM:SUBCUTANEOUS:SOLUTION, INJECTION:%	SUBCUTANEOUS	1.47% SUBCUTANEOUS SOLUTION, INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
1Q73Q2JULR	SODIUM CITRATE, UNSPECIFIED FORM:SUBLINGUAL:TABLET (IMMED./COMP. RELEASE), UNCOATED, BUCCAL:MG	SUBLINGUAL	3.52MG SUBLINGUAL TABLET (IMMED./COMP. RELEASE), UNCOATED, BUCCAL	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
1Q73Q2JULR	SODIUM CITRATE, UNSPECIFIED FORM:TOPICAL:CREAM:%W/W 	TOPICAL	0.12%W/W  TOPICAL CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
1Q73Q2JULR	SODIUM CITRATE, UNSPECIFIED FORM:TOPICAL:EMULSION, CREAM:%W/W	TOPICAL	0.25%W/W TOPICAL EMULSION, CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
1Q73Q2JULR	SODIUM CITRATE, UNSPECIFIED FORM:TOPICAL:EMULSION, LOTION:%W/W	TOPICAL	0.08%W/W TOPICAL EMULSION, LOTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
1Q73Q2JULR	SODIUM CITRATE, UNSPECIFIED FORM:TOPICAL:LOTION:%W/W 	TOPICAL	0.32%W/W  TOPICAL LOTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
1Q73Q2JULR	SODIUM CITRATE, UNSPECIFIED FORM:TOPICAL:SHAMPOO:%W/W	TOPICAL	2.6%W/W TOPICAL SHAMPOO	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
1Q73Q2JULR	SODIUM CITRATE, UNSPECIFIED FORM:TOPICAL:SOLUTION:MG/1ML	TOPICAL	1MG/1ML TOPICAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
1Q73Q2JULR	SODIUM CITRATE, UNSPECIFIED FORM:TOPICAL:SOLUTION:%W/V	TOPICAL	0.1%W/V TOPICAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
1Q73Q2JULR	SODIUM CITRATE, UNSPECIFIED FORM:TOPICAL:SOLUTION, DROPS:%W/V	TOPICAL	0.29%W/V TOPICAL SOLUTION, DROPS	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
1Q73Q2JULR	SODIUM CITRATE, UNSPECIFIED FORM:TRANSDERMAL:DRUG DELIVERY SYSTEM:MG	TRANSDERMAL	2.2MG TRANSDERMAL DRUG DELIVERY SYSTEM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
1Q73Q2JULR	SODIUM CITRATE, UNSPECIFIED FORM:URETERAL:SOLUTION:NA	URETERAL	URETERAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
1Q73Q2JULR	SODIUM CITRATE, UNSPECIFIED FORM:VAGINAL:SPONGE:MG	VAGINAL	7.6MG VAGINAL SPONGE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
O3L624621X	NAPHTHA:ORAL:CAPSULE, SOFT GELATIN LIQUID-FILLED:NA	ORAL	ORAL CAPSULE, SOFT GELATIN LIQUID-FILLED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=N
O3L624621X	NAPHTHA:ORAL:TABLET:MG	ORAL	0.99MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=N
O3L624621X	NAPHTHA:ORAL:TABLET, COATED:NA	ORAL	ORAL TABLET, COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=N
WE369X5600	POLY(DL-LACTIC-CO-GLYCOLIC ACID), (50:50; 12000 MW):INTRAVITREAL:IMPLANT:MG	INTRAVITREAL	116MG INTRAVITREAL IMPLANT	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
WE369X5600	POLY(DL-LACTIC-CO-GLYCOLIC ACID), (50:50; 12000 MW):INTRAVITREAL:INJECTABLE:%	INTRAVITREAL	11.6% INTRAVITREAL INJECTABLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
WE369X5600	POLY(DL-LACTIC-CO-GLYCOLIC ACID), (50:50; 12000 MW):NASAL:IMPLANT:UG	NASAL	1350UG NASAL IMPLANT	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
WE369X5600	POLY(DL-LACTIC-CO-GLYCOLIC ACID), (50:50; 12000 MW):SUBCUTANEOUS:INJECTION, SUSPENSION, EXTENDED RELEASE:MG/0.85 ML	SUBCUTANEOUS	37.2MG/0.85 ML SUBCUTANEOUS INJECTION, SUSPENSION, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
WE369X5600	POLY(DL-LACTIC-CO-GLYCOLIC ACID), (50:50; 12000 MW):SUBCUTANEOUS:SOLUTION, INJECTION:MG/1.5 mL	SUBCUTANEOUS	533MG/1.5 mL SUBCUTANEOUS SOLUTION, INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
K4XZD9W99K	D&C RED NO. 6 BARIUM LAKE:ORAL:TABLET:MG	ORAL	0.38MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
O7TSZ97GEP	CALCIUM PHOSPHATE, DIBASIC, DIHYDRATE:ORAL:CAPSULE:mg	ORAL	55.87mg ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
O7TSZ97GEP	CALCIUM PHOSPHATE, DIBASIC, DIHYDRATE:ORAL:TABLET:mg	ORAL	99.9mg ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
O7TSZ97GEP	DIBASIC CALCIUM PHOSPHATE DIHYDRATE:ORAL:CAPSULE:MG	ORAL	400MG ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
O7TSZ97GEP	DIBASIC CALCIUM PHOSPHATE DIHYDRATE:ORAL:CAPSULE, EXTENDED RELEASE:MG	ORAL	50.6MG ORAL CAPSULE, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
O7TSZ97GEP	DIBASIC CALCIUM PHOSPHATE DIHYDRATE:ORAL:TABLET:MG	ORAL	603.48MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
O7TSZ97GEP	DIBASIC CALCIUM PHOSPHATE DIHYDRATE:ORAL:TABLET (IMMED./COMP. RELEASE), FILM COATED:MG	ORAL	336.96MG ORAL TABLET (IMMED./COMP. RELEASE), FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
O7TSZ97GEP	DIBASIC CALCIUM PHOSPHATE DIHYDRATE:ORAL:TABLET, CHEWABLE:MG	ORAL	53MG ORAL TABLET, CHEWABLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
O7TSZ97GEP	DIBASIC CALCIUM PHOSPHATE DIHYDRATE:ORAL:TABLET, COATED:MG	ORAL	488.7MG ORAL TABLET, COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
O7TSZ97GEP	DIBASIC CALCIUM PHOSPHATE DIHYDRATE:ORAL:TABLET, DELAYED RELEASE:MG	ORAL	236.3MG ORAL TABLET, DELAYED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
O7TSZ97GEP	DIBASIC CALCIUM PHOSPHATE DIHYDRATE:ORAL:TABLET, EXTENDED RELEASE:MG	ORAL	518.2MG ORAL TABLET, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
O7TSZ97GEP	DIBASIC CALCIUM PHOSPHATE DIHYDRATE:ORAL:TABLET, FILM COATED:MG	ORAL	635.5MG ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
O7TSZ97GEP	DIBASIC CALCIUM PHOSPHATE DIHYDRATE:ORAL:TABLET, SUSTAINED ACTION:MG	ORAL	189MG ORAL TABLET, SUSTAINED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
3VRD35U26C	AMMONIUM GLYCYRRHIZATE:ORAL:FILM, SOLUBLE:MG	ORAL	0.3MG ORAL FILM, SOLUBLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
3VRD35U26C	AMMONIUM GLYCYRRHIZATE:ORAL:GRANULE:MG	ORAL	3.13MG ORAL GRANULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
3VRD35U26C	AMMONIUM GLYCYRRHIZATE:ORAL:GRANULE, FOR ORAL SUSPENSION:MG	ORAL	2.33MG ORAL GRANULE, FOR ORAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
3VRD35U26C	AMMONIUM GLYCYRRHIZATE:ORAL:GRANULE, FOR SUSPENSION:MG	ORAL	60MG ORAL GRANULE, FOR SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
3VRD35U26C	AMMONIUM GLYCYRRHIZATE:ORAL:POWDER:MG/1PKT	ORAL	200MG/1PKT ORAL POWDER	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
3VRD35U26C	AMMONIUM GLYCYRRHIZATE:ORAL:POWDER:MG/1SCP	ORAL	200MG/1SCP ORAL POWDER	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
3VRD35U26C	AMMONIUM GLYCYRRHIZATE:ORAL:POWDER, FOR RECONSTITUTION:MG/1BOT	ORAL	270MG/1BOT ORAL POWDER, FOR RECONSTITUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
3VRD35U26C	AMMONIUM GLYCYRRHIZATE:ORAL:POWDER, FOR SOLUTION:MG/1BOT	ORAL	531.9MG/1BOT ORAL POWDER, FOR SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
3VRD35U26C	AMMONIUM GLYCYRRHIZATE:ORAL:SOLUTION:MG/5ML	ORAL	125MG/5ML ORAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
3VRD35U26C	AMMONIUM GLYCYRRHIZATE:ORAL:SOLUTION, LIQUID:MG/1ML	ORAL	1.5MG/1ML ORAL SOLUTION, LIQUID	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
3VRD35U26C	AMMONIUM GLYCYRRHIZATE:ORAL:SUSPENSION:MG/5ML	ORAL	0.6MG/5ML ORAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
3VRD35U26C	AMMONIUM GLYCYRRHIZATE:ORAL:SYRUP:MG/5ML	ORAL	1.25MG/5ML ORAL SYRUP	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
3VRD35U26C	AMMONIUM GLYCYRRHIZATE:ORAL:TABLET:MG	ORAL	4.67MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
3VRD35U26C	AMMONIUM GLYCYRRHIZATE:ORAL:TABLET (IMMED./COMP. RELEASE), UNCOATED, CHEWABLE:MG	ORAL	11.5MG ORAL TABLET (IMMED./COMP. RELEASE), UNCOATED, CHEWABLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
3VRD35U26C	AMMONIUM GLYCYRRHIZATE:ORAL:TABLET, ORALLY DISINTEGRATING:MG	ORAL	1.4MG ORAL TABLET, ORALLY DISINTEGRATING	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
5KV86114PT	MONOETHANOLAMINE:ORAL:TABLET, DELAYED ACTION:MG	ORAL	1MG ORAL TABLET, DELAYED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
5KV86114PT	MONOETHANOLAMINE:ORAL:TABLET, DELAYED RELEASE:mg	ORAL	1mg ORAL TABLET, DELAYED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
339NCG44TV	PHENOL:IM - IV:INJECTION:%	IM - IV	0.5% IM - IV INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
339NCG44TV	PHENOL:IM - IV - SC:INJECTION:%	IM - IV - SC	0.45% IM - IV - SC INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
339NCG44TV	PHENOL:IM - SC:INJECTION:%	IM - SC	0.5% IM - SC INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
339NCG44TV	PHENOL:IM - SC:INJECTION, SUSTAINED ACTION:%	IM - SC	0.5% IM - SC INJECTION, SUSTAINED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
339NCG44TV	PHENOL:INTRA-ARTICULAR:INJECTION:%	INTRA-ARTICULAR	0.5% INTRA-ARTICULAR INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
339NCG44TV	PHENOL:INTRADERMAL:INJECTION:%	INTRADERMAL	0.25% INTRADERMAL INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
339NCG44TV	PHENOL:INTRALESIONAL:INJECTION:%	INTRALESIONAL	0.5% INTRALESIONAL INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
339NCG44TV	PHENOL:INTRAMUSCULAR:INJECTABLE:%W/V	INTRAMUSCULAR	0.5%W/V INTRAMUSCULAR INJECTABLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
339NCG44TV	PHENOL:INTRAMUSCULAR:INJECTION:%W/V	INTRAMUSCULAR	1.33%W/V INTRAMUSCULAR INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
339NCG44TV	PHENOL:INTRAMUSCULAR:INJECTION, SUSTAINED ACTION:%	INTRAMUSCULAR	0.5% INTRAMUSCULAR INJECTION, SUSTAINED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
339NCG44TV	PHENOL:INTRAMUSCULAR:POWDER, FOR INJECTION SOLUTION:NA	INTRAMUSCULAR	INTRAMUSCULAR POWDER, FOR INJECTION SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
339NCG44TV	PHENOL:INTRAMUSCULAR:SOLUTION, INJECTION:%W/V	INTRAMUSCULAR	0.5%W/V INTRAMUSCULAR SOLUTION, INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
339NCG44TV	PHENOL:INTRASYNOVIAL:INJECTION:%	INTRASYNOVIAL	0.5% INTRASYNOVIAL INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
339NCG44TV	PHENOL:INTRAVENOUS:INJECTABLE:%	INTRAVENOUS	0.5% INTRAVENOUS INJECTABLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
339NCG44TV	PHENOL:INTRAVENOUS:INJECTION:%	INTRAVENOUS	0.5% INTRAVENOUS INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
339NCG44TV	PHENOL:INTRAVENOUS:INJECTION, SOLUTION:MG/1ML	INTRAVENOUS	4.5MG/1ML INTRAVENOUS INJECTION, SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
339NCG44TV	PHENOL:INTRAVENOUS:SOLUTION:mg/1mL	INTRAVENOUS	4.5mg/1mL INTRAVENOUS SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
339NCG44TV	PHENOL:INTRAVENOUS:SOLUTION, INJECTION:%	INTRAVENOUS	0.5% INTRAVENOUS SOLUTION, INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
339NCG44TV	PHENOL:IV - SC:INJECTION:NA	IV - SC	IV - SC INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
339NCG44TV	PHENOL:IV - SC:INJECTION, SOLUTION:MG/1ML	IV - SC	1.5MG/1ML IV - SC INJECTION, SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
339NCG44TV	PHENOL:IV - SC:INJECTION, SOLUTION:%	IV - SC	0.5% IV - SC INJECTION, SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
339NCG44TV	PHENOL:IV(INFUSION):INJECTABLE:%	IV(INFUSION)	0.5% IV(INFUSION) INJECTABLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
339NCG44TV	PHENOL:IV(INFUSION):INJECTION:%	IV(INFUSION)	0.5% IV(INFUSION) INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
339NCG44TV	PHENOL:IV(INFUSION):SOLUTION, INJECTION:%	IV(INFUSION)	0.5% IV(INFUSION) SOLUTION, INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
339NCG44TV	PHENOL:SOFT TISSUE:INJECTION:NA	SOFT TISSUE	SOFT TISSUE INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
339NCG44TV	PHENOL:SUBCUTANEOUS:INJECTABLE:%	SUBCUTANEOUS	0.5% SUBCUTANEOUS INJECTABLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
339NCG44TV	PHENOL:SUBCUTANEOUS:INJECTION:%	SUBCUTANEOUS	0.57% SUBCUTANEOUS INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
339NCG44TV	PHENOL:SUBCUTANEOUS:INJECTION, SOLUTION:MG/1ML	SUBCUTANEOUS	5.5MG/1ML SUBCUTANEOUS INJECTION, SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
339NCG44TV	PHENOL:SUBCUTANEOUS:SOLUTION, INJECTION:%	SUBCUTANEOUS	0.25% SUBCUTANEOUS SOLUTION, INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
339NCG44TV	PHENOL:SUBCUTANEOUS:SUSPENSION:%	SUBCUTANEOUS	0.08% SUBCUTANEOUS SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
339NCG44TV	PHENOL:SUBCUTANEOUS:SUSPENSION, INJECTION:%	SUBCUTANEOUS	0.15% SUBCUTANEOUS SUSPENSION, INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
I4807BK602	SACCHARIN SODIUM ANHYDROUS:IM - IV:INJECTION:%	IM - IV	0.09% IM - IV INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
I4807BK602	SACCHARIN SODIUM ANHYDROUS:INTRAMUSCULAR:INJECTION:NA	INTRAMUSCULAR	INTRAMUSCULAR INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
I4807BK602	SACCHARIN SODIUM ANHYDROUS:IV(INFUSION):INJECTION:%	IV(INFUSION)	0.09% IV(INFUSION) INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
I4807BK602	SACCHARIN SODIUM ANHYDROUS:ORAL:EMULSION:%	ORAL	0.04% ORAL EMULSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
I4807BK602	SACCHARIN SODIUM ANHYDROUS:ORAL:LIQUID:MG/120ML	ORAL	50MG/120ML ORAL LIQUID	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
I4807BK602	SACCHARIN SODIUM ANHYDROUS:ORAL:POWDER:NA	ORAL	ORAL POWDER	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
I4807BK602	SACCHARIN SODIUM ANHYDROUS:ORAL:POWDER, FOR SOLUTION:NA	ORAL	ORAL POWDER, FOR SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
I4807BK602	SACCHARIN SODIUM ANHYDROUS:ORAL:POWDER, FOR SUSPENSION:MG/5ML	ORAL	18.75MG/5ML ORAL POWDER, FOR SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
I4807BK602	SACCHARIN SODIUM ANHYDROUS:ORAL:SOLUTION:MG	ORAL	20MG ORAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
I4807BK602	SACCHARIN SODIUM ANHYDROUS:ORAL:SOLUTION, ELIXIR:NA	ORAL	ORAL SOLUTION, ELIXIR	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
I4807BK602	SACCHARIN SODIUM ANHYDROUS:ORAL:SUSPENSION:MG/5ML	ORAL	16.65MG/5ML ORAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
I4807BK602	SACCHARIN SODIUM ANHYDROUS:ORAL:SYRUP:MG/5ML	ORAL	3.96MG/5ML ORAL SYRUP	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
I4807BK602	SACCHARIN SODIUM ANHYDROUS:ORAL:TABLET:MG	ORAL	2.08MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
I4807BK602	SACCHARIN SODIUM ANHYDROUS:ORAL:TABLET (IMMED./COMP. RELEASE), UNCOATED, CHEWABLE:MG	ORAL	7.5MG ORAL TABLET (IMMED./COMP. RELEASE), UNCOATED, CHEWABLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
I4807BK602	SACCHARIN SODIUM ANHYDROUS:ORAL:TABLET, FILM COATED:MG	ORAL	0.32MG ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
I4807BK602	SACCHARIN SODIUM ANHYDROUS:ORAL:WAFER:MG	ORAL	2.75MG ORAL WAFER	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
I4807BK602	SACCHARIN SODIUM ANHYDROUS:RECTAL:LIQUID:%	RECTAL	0.042% RECTAL LIQUID	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
I4807BK602	SACCHARIN SODIUM ANHYDROUS:RECTAL:SOLUTION:%	RECTAL	0.67% RECTAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
3T8H1794QW	EUGENOL:ORAL:SOLUTION, ELIXIR:NA	ORAL	ORAL SOLUTION, ELIXIR	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
I7T908772F	ALUMINUM SULFATE ANHYDROUS:AURICULAR (OTIC):SOLUTION:%	AURICULAR (OTIC)	0.79% AURICULAR (OTIC) SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
I7T908772F	ALUMINUM SULFATE ANHYDROUS:TOPICAL:EMULSION, CREAM:%W/W	TOPICAL	0.13%W/W TOPICAL EMULSION, CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
I7T908772F	ALUMINUM SULFATE ANHYDROUS:TOPICAL:LOTION:NA	TOPICAL	TOPICAL LOTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
DJN2FGG8Z3	BUTYL METHACRYLATE AND METHYL METHACRYLATE COPOLYMER (3:1; 150000 MW):TRANSDERMAL:PATCH:mg	TRANSDERMAL	18mg TRANSDERMAL PATCH	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
AYI8EX34EU	CREATININE:AURICULAR (OTIC):SOLUTION:%	AURICULAR (OTIC)	0.5% AURICULAR (OTIC) SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
AYI8EX34EU	CREATININE:IM - IV:INJECTION:%	IM - IV	0.8% IM - IV INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
AYI8EX34EU	CREATININE:IM - IV - SC:INJECTION:NA	IM - IV - SC	IM - IV - SC INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
AYI8EX34EU	CREATININE:INTRA-ARTICULAR:INJECTION:%	INTRA-ARTICULAR	0.8% INTRA-ARTICULAR INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
AYI8EX34EU	CREATININE:INTRA-ARTICULAR:INJECTION, SUSTAINED ACTION:NA	INTRA-ARTICULAR	INTRA-ARTICULAR INJECTION, SUSTAINED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
AYI8EX34EU	CREATININE:INTRABURSAL:INJECTION:NA	INTRABURSAL	INTRABURSAL INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
AYI8EX34EU	CREATININE:INTRADERMAL:INJECTION, SUSTAINED ACTION:NA	INTRADERMAL	INTRADERMAL INJECTION, SUSTAINED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
AYI8EX34EU	CREATININE:INTRALESIONAL:INJECTION:%	INTRALESIONAL	0.8% INTRALESIONAL INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
AYI8EX34EU	CREATININE:INTRALESIONAL:INJECTION, SUSTAINED ACTION:NA	INTRALESIONAL	INTRALESIONAL INJECTION, SUSTAINED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
AYI8EX34EU	CREATININE:INTRAMUSCULAR:INJECTION:%W/V	INTRAMUSCULAR	0.5%W/V INTRAMUSCULAR INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
AYI8EX34EU	CREATININE:INTRAMUSCULAR:INJECTION, SUSTAINED ACTION:NA	INTRAMUSCULAR	INTRAMUSCULAR INJECTION, SUSTAINED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
AYI8EX34EU	CREATININE:INTRASYNOVIAL:INJECTION:%	INTRASYNOVIAL	0.8% INTRASYNOVIAL INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
AYI8EX34EU	CREATININE:INTRASYNOVIAL:INJECTION, SUSTAINED ACTION:NA	INTRASYNOVIAL	INTRASYNOVIAL INJECTION, SUSTAINED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
AYI8EX34EU	CREATININE:OPHTHALMIC:SOLUTION:%	OPHTHALMIC	0.5% OPHTHALMIC SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
AYI8EX34EU	CREATININE:OPHTHALMIC:SOLUTION, DROPS:%	OPHTHALMIC	0.2% OPHTHALMIC SOLUTION, DROPS	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
AYI8EX34EU	CREATININE:SOFT TISSUE:INJECTION:%	SOFT TISSUE	0.8% SOFT TISSUE INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
AYI8EX34EU	CREATININE:TOPICAL:EMULSION, CREAM:NA	TOPICAL	TOPICAL EMULSION, CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
1212Z7S33A	POLYETHYLENE GLYCOL 1500:DENTAL:GEL:%	DENTAL	5% DENTAL GEL	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
1212Z7S33A	POLYETHYLENE GLYCOL 1500:DENTAL:PASTE:NA	DENTAL	DENTAL PASTE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
1212Z7S33A	POLYETHYLENE GLYCOL 1500:ORAL:SOLUTION:MG/1BOT	ORAL	33.64MG/1BOT ORAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
1212Z7S33A	POLYETHYLENE GLYCOL 1500:ORAL:TABLET:MG	ORAL	1.2MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
1212Z7S33A	POLYETHYLENE GLYCOL 1500:ORAL:TABLET, COATED:NA	ORAL	ORAL TABLET, COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
1212Z7S33A	POLYETHYLENE GLYCOL 1500:RECTAL:SUPPOSITORY:NA	RECTAL	RECTAL SUPPOSITORY	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
1212Z7S33A	POLYETHYLENE GLYCOL 1500:TOPICAL:OINTMENT:NA	TOPICAL	TOPICAL OINTMENT	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
1212Z7S33A	POLYETHYLENE GLYCOL 1500:TOPICAL:SOLUTION:%W/W	TOPICAL	29.7%W/W TOPICAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
P7E6YFV72X	DIISOPROPYL ADIPATE:TOPICAL:EMULSION, AEROSOL FOAM:%W/W	TOPICAL	5%W/W TOPICAL EMULSION, AEROSOL FOAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
P7E6YFV72X	DIISOPROPYL ADIPATE:TOPICAL:LOTION:%W/W	TOPICAL	20%W/W TOPICAL LOTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
P7E6YFV72X	DIISOPROPYL ADIPATE:TOPICAL:SOLUTION:%W/W	TOPICAL	12%W/W TOPICAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
P7E6YFV72X	DIISOPROPYL ADIPATE:TOPICAL:SPRAY:%W/W	TOPICAL	12%W/W TOPICAL SPRAY	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
P7E6YFV72X	DIISOPROPYL ADIPATE:TRANSDERMAL:GEL:%	TRANSDERMAL	1.5% TRANSDERMAL GEL	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
R75537T0T4	HYPROMELLOSE 2910 (5 MPA.S):OPHTHALMIC:SOLUTION:%	OPHTHALMIC	0.1% OPHTHALMIC SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
R75537T0T4	HYPROMELLOSE 2910 (5 MPA.S):ORAL:CAPSULE:MG	ORAL	150MG ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
R75537T0T4	HYPROMELLOSE 2910 (5 MPA.S):ORAL:CAPSULE, DELAYED ACTION:MG	ORAL	20.82MG ORAL CAPSULE, DELAYED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
R75537T0T4	HYPROMELLOSE 2910 (5 MPA.S):ORAL:CAPSULE, DELAYED RELEASE:MG	ORAL	19.91MG ORAL CAPSULE, DELAYED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
R75537T0T4	HYPROMELLOSE 2910 (5 MPA.S):ORAL:CAPSULE, EXTENDED RELEASE:MG	ORAL	41.85MG ORAL CAPSULE, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
R75537T0T4	HYPROMELLOSE 2910 (5 MPA.S):ORAL:CAPSULE, HARD GELATIN:MG	ORAL	4MG ORAL CAPSULE, HARD GELATIN	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
R75537T0T4	HYPROMELLOSE 2910 (5 MPA.S):ORAL:SUSPENSION:MG/5ML	ORAL	25MG/5ML ORAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
R75537T0T4	HYPROMELLOSE 2910 (5 MPA.S):ORAL:TABLET:MG	ORAL	300MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
R75537T0T4	HYPROMELLOSE 2910 (5 MPA.S):ORAL:TABLET (IMMED./COMP. RELEASE), FILM COATED:MG	ORAL	7MG ORAL TABLET (IMMED./COMP. RELEASE), FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
R75537T0T4	HYPROMELLOSE 2910 (5 MPA.S):ORAL:TABLET, CONTROLLED RELEASE:MG	ORAL	4.25MG ORAL TABLET, CONTROLLED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
R75537T0T4	HYPROMELLOSE 2910 (5 MPA.S):ORAL:TABLET, DELAYED ACTION:MG	ORAL	10.31MG ORAL TABLET, DELAYED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
R75537T0T4	HYPROMELLOSE 2910 (5 MPA.S):ORAL:TABLET, DELAYED RELEASE:MG	ORAL	19.94MG ORAL TABLET, DELAYED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
R75537T0T4	HYPROMELLOSE 2910 (5 MPA.S):ORAL:TABLET, EXTENDED RELEASE:mg	ORAL	110.82mg ORAL TABLET, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
R75537T0T4	HYPROMELLOSE 2910 (5 MPA.S):ORAL:TABLET, FILM COATED:MG	ORAL	22MG ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
R75537T0T4	HYPROMELLOSE 2910 (5 MPA.S):ORAL-20:TABLET:mg	ORAL-20	4mg ORAL-20 TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
R75537T0T4	HYPROMELLOSE 2910 (5 MPA.S):SUBLINGUAL:FILM:MG/STRIP	SUBLINGUAL	2.34MG/STRIP SUBLINGUAL FILM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
JFH385Y744	COFFEE BEAN:ORAL:POWDER:MG/TBSP	ORAL	11.3MG/TBSP ORAL POWDER	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
2YZU14UIFP	SODIUM 1,2-ETHANEDISULFONATE:ORAL:SOLUTION:MG/5ML	ORAL	1MG/5ML ORAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
2YZU14UIFP	SODIUM 1,2-ETHANEDISULFONATE:ORAL:TABLET:NA	ORAL	ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
E89I1637KE	GUAR GUM:BUCCAL/SUBLINGUAL:TABLET:MG	BUCCAL/SUBLINGUAL	1.1MG BUCCAL/SUBLINGUAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
E89I1637KE	GUAR GUM:OPHTHALMIC:SUSPENSION:%	OPHTHALMIC	0.2% OPHTHALMIC SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
E89I1637KE	GUAR GUM:ORAL:BAR, CHEWABLE:NA	ORAL	ORAL BAR, CHEWABLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
E89I1637KE	GUAR GUM:ORAL:CAPSULE:MG	ORAL	3.3MG ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
E89I1637KE	GUAR GUM:ORAL:FOR SUSPENSION:MG/5ML	ORAL	10MG/5ML ORAL FOR SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
E89I1637KE	GUAR GUM:ORAL:POWDER, FOR ORAL SUSPENSION:MG/5ML	ORAL	12.5MG/5ML ORAL POWDER, FOR ORAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
E89I1637KE	GUAR GUM:ORAL:POWDER, FOR SUSPENSION:MG/5ML	ORAL	10MG/5ML ORAL POWDER, FOR SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
E89I1637KE	GUAR GUM:ORAL:SUSPENSION:MG/5ML	ORAL	4.93MG/5ML ORAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
E89I1637KE	GUAR GUM:ORAL:TABLET:MG	ORAL	40MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
E89I1637KE	GUAR GUM:ORAL:TABLET, CHEWABLE:MG	ORAL	24MG ORAL TABLET, CHEWABLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
E89I1637KE	GUAR GUM:ORAL:TABLET, FILM COATED:MG	ORAL	35.4MG ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
E89I1637KE	GUAR GUM:ORAL:TABLET, ORALLY DISINTEGRATING:MG	ORAL	5.94MG ORAL TABLET, ORALLY DISINTEGRATING	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
E89I1637KE	GUAR GUM:ORAL:TABLET, SUSTAINED ACTION:MG	ORAL	5.04MG ORAL TABLET, SUSTAINED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
E89I1637KE	GUAR GUM:TOPICAL:LOTION:NA	TOPICAL	TOPICAL LOTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
E89I1637KE	GUAR GUM:VAGINAL:TABLET:MG	VAGINAL	2.76MG VAGINAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
89T13OHQ2B	AGAR, UNSPECIFIED:ORAL:TABLET:MG	ORAL	0.2MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
5WKN5KL2O8	POLYETHYLENE GLYCOL 20000:ORAL:CAPSULE:MG	ORAL	18MG ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
5WKN5KL2O8	POLYETHYLENE GLYCOL 20000:ORAL:CAPSULE, HARD GELATIN:MG	ORAL	13.5MG ORAL CAPSULE, HARD GELATIN	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
5WKN5KL2O8	POLYETHYLENE GLYCOL 20000:ORAL:TABLET:MG	ORAL	0.86MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
5WKN5KL2O8	POLYETHYLENE GLYCOL 20000:ORAL:TABLET, DELAYED ACTION, ENTERIC COATED:MG	ORAL	0.008MG ORAL TABLET, DELAYED ACTION, ENTERIC COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
8DUH1N11BX	TRYPTOPHAN:IV(INFUSION):INJECTION:%	IV(INFUSION)	15.2% IV(INFUSION) INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
8DUH1N11BX	TRYPTOPHAN:IV(INFUSION):SOLUTION, INJECTION:%	IV(INFUSION)	0.046% IV(INFUSION) SOLUTION, INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
25IH6R4SGF	EDETATE CALCIUM DISODIUM:AN,INFILTRATION:INJECTION:NA	AN,INFILTRATION	AN,INFILTRATION INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
25IH6R4SGF	EDETATE CALCIUM DISODIUM:CAUDAL BLOCK:INJECTION:NA	CAUDAL BLOCK	CAUDAL BLOCK INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
25IH6R4SGF	EDETATE CALCIUM DISODIUM:EPIDURAL:INJECTION:NA	EPIDURAL	EPIDURAL INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
25IH6R4SGF	EDETATE CALCIUM DISODIUM:IM - IV:INJECTION:NA	IM - IV	IM - IV INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
25IH6R4SGF	EDETATE CALCIUM DISODIUM:INTRA-ARTERIAL:INJECTION:%	INTRA-ARTERIAL	0.048% INTRA-ARTERIAL INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
25IH6R4SGF	EDETATE CALCIUM DISODIUM:INTRA-ARTERIAL:SOLUTION, INJECTION:MG/ML	INTRA-ARTERIAL	0.1MG/ML INTRA-ARTERIAL SOLUTION, INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
25IH6R4SGF	EDETATE CALCIUM DISODIUM:INTRA-ARTICULAR:INJECTION:NA	INTRA-ARTICULAR	INTRA-ARTICULAR INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
25IH6R4SGF	EDETATE CALCIUM DISODIUM:INTRACARDIAC:INJECTION:NA	INTRACARDIAC	INTRACARDIAC INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
25IH6R4SGF	EDETATE CALCIUM DISODIUM:INTRADISCAL:INJECTION:NA	INTRADISCAL	INTRADISCAL INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
25IH6R4SGF	EDETATE CALCIUM DISODIUM:INTRAMUSCULAR:INJECTION:%W/V	INTRAMUSCULAR	0.048%W/V INTRAMUSCULAR INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
25IH6R4SGF	EDETATE CALCIUM DISODIUM:INTRAMUSCULAR:POWDER, FOR INJECTION SOLUTION:%	INTRAMUSCULAR	0.005% INTRAMUSCULAR POWDER, FOR INJECTION SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
25IH6R4SGF	EDETATE CALCIUM DISODIUM:INTRAPERITONEAL:POWDER, FOR INJECTION SOLUTION:%	INTRAPERITONEAL	0.005% INTRAPERITONEAL POWDER, FOR INJECTION SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
25IH6R4SGF	EDETATE CALCIUM DISODIUM:INTRATHECAL:INJECTABLE:NA	INTRATHECAL	INTRATHECAL INJECTABLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
25IH6R4SGF	EDETATE CALCIUM DISODIUM:INTRATHECAL:INJECTION:%	INTRATHECAL	0.22% INTRATHECAL INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
25IH6R4SGF	EDETATE CALCIUM DISODIUM:INTRATHECAL:SOLUTION:MG/ML	INTRATHECAL	0.1MG/ML INTRATHECAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
25IH6R4SGF	EDETATE CALCIUM DISODIUM:INTRAUTERINE:INJECTION:NA	INTRAUTERINE	INTRAUTERINE INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
25IH6R4SGF	EDETATE CALCIUM DISODIUM:INTRAUTERINE:SOLUTION:NA	INTRAUTERINE	INTRAUTERINE SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
25IH6R4SGF	EDETATE CALCIUM DISODIUM:INTRAVASCULAR:INJECTION:%	INTRAVASCULAR	10% INTRAVASCULAR INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
25IH6R4SGF	EDETATE CALCIUM DISODIUM:INTRAVASCULAR:SOLUTION:MG/ML	INTRAVASCULAR	0.1MG/ML INTRAVASCULAR SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
25IH6R4SGF	EDETATE CALCIUM DISODIUM:INTRAVASCULAR:SOLUTION, INJECTION:MG/ML	INTRAVASCULAR	0.1MG/ML INTRAVASCULAR SOLUTION, INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
25IH6R4SGF	EDETATE CALCIUM DISODIUM:INTRAVENOUS:INJECTION:%	INTRAVENOUS	0.48% INTRAVENOUS INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
25IH6R4SGF	EDETATE CALCIUM DISODIUM:INTRAVENOUS:SOLUTION:NA	INTRAVENOUS	INTRAVENOUS SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
25IH6R4SGF	EDETATE CALCIUM DISODIUM:INTRAVENOUS:SOLUTION, INJECTION:MG/ML	INTRAVENOUS	0.1MG/ML INTRAVENOUS SOLUTION, INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
25IH6R4SGF	EDETATE CALCIUM DISODIUM:INTRAVESICAL:SOLUTION:MG	INTRAVESICAL	0.11MG INTRAVESICAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
25IH6R4SGF	EDETATE CALCIUM DISODIUM:IV(INFUSION):INJECTION:%	IV(INFUSION)	0.005% IV(INFUSION) INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
25IH6R4SGF	EDETATE CALCIUM DISODIUM:IV(INFUSION):POWDER, FOR INJECTION SOLUTION:%	IV(INFUSION)	0.005% IV(INFUSION) POWDER, FOR INJECTION SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
25IH6R4SGF	EDETATE CALCIUM DISODIUM:IV(INFUSION):SOLUTION:MG/ML	IV(INFUSION)	0.1MG/ML IV(INFUSION) SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
25IH6R4SGF	EDETATE CALCIUM DISODIUM:NERVE BLOCK:INJECTION:NA	NERVE BLOCK	NERVE BLOCK INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
25IH6R4SGF	EDETATE CALCIUM DISODIUM:NERVE BLOCK:SOLUTION, INJECTION:%	NERVE BLOCK	0.01% NERVE BLOCK SOLUTION, INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
25IH6R4SGF	EDETATE CALCIUM DISODIUM:ORAL:CAPSULE:MG	ORAL	0.27MG ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
25IH6R4SGF	EDETATE CALCIUM DISODIUM:ORAL:CAPSULE, SUSTAINED ACTION:NA	ORAL	ORAL CAPSULE, SUSTAINED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
25IH6R4SGF	EDETATE CALCIUM DISODIUM:ORAL:CONCENTRATE:MG/1ML	ORAL	0.25MG/1ML ORAL CONCENTRATE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
25IH6R4SGF	EDETATE CALCIUM DISODIUM:ORAL:DROPS:NA	ORAL	ORAL DROPS	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
25IH6R4SGF	EDETATE CALCIUM DISODIUM:ORAL:POWDER, FOR SOLUTION:%	ORAL	0.004% ORAL POWDER, FOR SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
25IH6R4SGF	EDETATE CALCIUM DISODIUM:ORAL:POWDER, FOR SUSPENSION:NA	ORAL	ORAL POWDER, FOR SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
25IH6R4SGF	EDETATE CALCIUM DISODIUM:ORAL:SOLUTION:MG/ML	ORAL	0.1MG/ML ORAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
25IH6R4SGF	EDETATE CALCIUM DISODIUM:ORAL:SOLUTION, ELIXIR:MG/5ML	ORAL	5MG/5ML ORAL SOLUTION, ELIXIR	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
25IH6R4SGF	EDETATE CALCIUM DISODIUM:ORAL:SUSPENSION:NA	ORAL	ORAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
25IH6R4SGF	EDETATE CALCIUM DISODIUM:ORAL:SYRUP:NA	ORAL	ORAL SYRUP	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
25IH6R4SGF	EDETATE CALCIUM DISODIUM:ORAL:TABLET:MG	ORAL	4MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
25IH6R4SGF	EDETATE CALCIUM DISODIUM:ORAL:TABLET, FILM COATED:MG	ORAL	0.4MG ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
25IH6R4SGF	EDETATE CALCIUM DISODIUM:ORAL:TABLET, ORALLY DISINTEGRATING:MG	ORAL	0.78MG ORAL TABLET, ORALLY DISINTEGRATING	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
25IH6R4SGF	EDETATE CALCIUM DISODIUM:PERIARTICULAR:INJECTION:NA	PERIARTICULAR	PERIARTICULAR INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
25IH6R4SGF	EDETATE CALCIUM DISODIUM:RECTAL:SOLUTION:MG/ML	RECTAL	0.1MG/ML RECTAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
25IH6R4SGF	EDETATE CALCIUM DISODIUM:SUBCUTANEOUS:INJECTION:%	SUBCUTANEOUS	0.34% SUBCUTANEOUS INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
25IH6R4SGF	EDETATE CALCIUM DISODIUM:SUBCUTANEOUS:SOLUTION, INJECTION:%	SUBCUTANEOUS	0.06% SUBCUTANEOUS SOLUTION, INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
25IH6R4SGF	EDETATE CALCIUM DISODIUM:TOPICAL:SOLUTION:%W/W	TOPICAL	0.007%W/W TOPICAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
25IH6R4SGF	EDETATE CALCIUM DISODIUM:URETERAL:SOLUTION:%	URETERAL	0.01% URETERAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
25IH6R4SGF	EDETATE CALCIUM DISODIUM:URETHRAL:INJECTION:NA	URETHRAL	URETHRAL INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
25IH6R4SGF	EDETATE CALCIUM DISODIUM:URETHRAL:SOLUTION:%	URETHRAL	0.01% URETHRAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
4R4HFI6D95	POLYETHYLENE GLYCOL 4000:AURICULAR (OTIC):SUSPENSION:NA	AURICULAR (OTIC)	AURICULAR (OTIC) SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
4R4HFI6D95	POLYETHYLENE GLYCOL 4000:DENTAL:OINTMENT:NA	DENTAL	DENTAL OINTMENT	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
4R4HFI6D95	POLYETHYLENE GLYCOL 4000:INTRA-ARTICULAR:INJECTION:%	INTRA-ARTICULAR	3% INTRA-ARTICULAR INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
4R4HFI6D95	POLYETHYLENE GLYCOL 4000:INTRALESIONAL:INJECTION:%	INTRALESIONAL	3% INTRALESIONAL INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
4R4HFI6D95	POLYETHYLENE GLYCOL 4000:INTRAMUSCULAR:INJECTION:%	INTRAMUSCULAR	3% INTRAMUSCULAR INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
4R4HFI6D95	POLYETHYLENE GLYCOL 4000:INTRAMUSCULAR:SUSPENSION:%	INTRAMUSCULAR	3% INTRAMUSCULAR SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
4R4HFI6D95	POLYETHYLENE GLYCOL 4000:INTRAMUSCULAR:SUSPENSION, EXTENDED RELEASE:%	INTRAMUSCULAR	7.5% INTRAMUSCULAR SUSPENSION, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
4R4HFI6D95	POLYETHYLENE GLYCOL 4000:INTRAMUSCULAR:SUSPENSION, INJECTION:%W/V	INTRAMUSCULAR	4.5%W/V INTRAMUSCULAR SUSPENSION, INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
4R4HFI6D95	POLYETHYLENE GLYCOL 4000:INTRASYNOVIAL:INJECTION:%	INTRASYNOVIAL	3% INTRASYNOVIAL INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
4R4HFI6D95	POLYETHYLENE GLYCOL 4000:INTRAVENOUS:INJECTION, SUSPENSION:%	INTRAVENOUS	0.49% INTRAVENOUS INJECTION, SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
4R4HFI6D95	POLYETHYLENE GLYCOL 4000:OPHTHALMIC:SUSPENSION:NA	OPHTHALMIC	OPHTHALMIC SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
4R4HFI6D95	POLYETHYLENE GLYCOL 4000:ORAL:CAPSULE:MG	ORAL	380.5MG ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
4R4HFI6D95	POLYETHYLENE GLYCOL 4000:ORAL:CAPSULE, DELAYED ACTION:MG	ORAL	2.55MG ORAL CAPSULE, DELAYED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
4R4HFI6D95	POLYETHYLENE GLYCOL 4000:ORAL:CAPSULE, DELAYED RELEASE:MG	ORAL	1.28MG ORAL CAPSULE, DELAYED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
4R4HFI6D95	POLYETHYLENE GLYCOL 4000:ORAL:CAPSULE, ENTERIC COATED PELLETS:MG	ORAL	96.19MG ORAL CAPSULE, ENTERIC COATED PELLETS	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
4R4HFI6D95	POLYETHYLENE GLYCOL 4000:ORAL:CAPSULE, EXTENDED RELEASE:MG	ORAL	10.72MG ORAL CAPSULE, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
4R4HFI6D95	POLYETHYLENE GLYCOL 4000:ORAL:CAPSULE, SOFT GELATIN:MG	ORAL	15MG ORAL CAPSULE, SOFT GELATIN	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
4R4HFI6D95	POLYETHYLENE GLYCOL 4000:ORAL:GRANULE:MG/1PKT	ORAL	83MG/1PKT ORAL GRANULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
4R4HFI6D95	POLYETHYLENE GLYCOL 4000:ORAL:SOLUTION:MG/1ML	ORAL	66.67MG/1ML ORAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
4R4HFI6D95	POLYETHYLENE GLYCOL 4000:ORAL:TABLET:MG	ORAL	15MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
4R4HFI6D95	POLYETHYLENE GLYCOL 4000:ORAL:TABLET (IMMED./COMP. RELEASE), FILM COATED:MG	ORAL	1.5MG ORAL TABLET (IMMED./COMP. RELEASE), FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
4R4HFI6D95	POLYETHYLENE GLYCOL 4000:ORAL:TABLET, COATED:MG	ORAL	2MG ORAL TABLET, COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
4R4HFI6D95	POLYETHYLENE GLYCOL 4000:ORAL:TABLET, DELAYED ACTION:MG	ORAL	1.05MG ORAL TABLET, DELAYED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
4R4HFI6D95	POLYETHYLENE GLYCOL 4000:ORAL:TABLET, DELAYED ACTION, ENTERIC COATED:MG	ORAL	0.96MG ORAL TABLET, DELAYED ACTION, ENTERIC COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
4R4HFI6D95	POLYETHYLENE GLYCOL 4000:ORAL:TABLET, EXTENDED RELEASE:MG	ORAL	216.5MG ORAL TABLET, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
4R4HFI6D95	POLYETHYLENE GLYCOL 4000:ORAL:TABLET, FILM COATED:MG	ORAL	4.2MG ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
4R4HFI6D95	POLYETHYLENE GLYCOL 4000:ORAL:TABLET, MULTILAYER, EXTENDED RELEASE:MG	ORAL	2.8MG ORAL TABLET, MULTILAYER, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
4R4HFI6D95	POLYETHYLENE GLYCOL 4000:ORAL:TABLET, SUSTAINED ACTION:MG	ORAL	454MG ORAL TABLET, SUSTAINED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
4R4HFI6D95	POLYETHYLENE GLYCOL 4000:ORAL:TABLET, SUSTAINED ACTION, FILM COATED:MG	ORAL	1.8MG ORAL TABLET, SUSTAINED ACTION, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
4R4HFI6D95	POLYETHYLENE GLYCOL 4000:RECTAL:SUPPOSITORY:MG	RECTAL	1269MG RECTAL SUPPOSITORY	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
4R4HFI6D95	POLYETHYLENE GLYCOL 4000:SOFT TISSUE:INJECTION:NA	SOFT TISSUE	SOFT TISSUE INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
4R4HFI6D95	POLYETHYLENE GLYCOL 4000:SUBLINGUAL:TABLET:MG	SUBLINGUAL	2.5MG SUBLINGUAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
4R4HFI6D95	POLYETHYLENE GLYCOL 4000:TOPICAL:EMULSION, CREAM:NA	TOPICAL	TOPICAL EMULSION, CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
4R4HFI6D95	POLYETHYLENE GLYCOL 4000:TOPICAL:OINTMENT:%W/W	TOPICAL	45%W/W TOPICAL OINTMENT	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
4R4HFI6D95	POLYETHYLENE GLYCOL 4000:TOPICAL:SOLUTION:NA	TOPICAL	TOPICAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
4R4HFI6D95	POLYETHYLENE GLYCOL 4000:VAGINAL:EMULSION, CREAM:%	VAGINAL	0.5% VAGINAL EMULSION, CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
4R4HFI6D95	POLYETHYLENE GLYCOL 4000:VAGINAL:SUPPOSITORY:NA	VAGINAL	VAGINAL SUPPOSITORY	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
16P9295IIL	POLYETHYLENE GLYCOL 900000:SUBLINGUAL:FILM:MG	SUBLINGUAL	6MG SUBLINGUAL FILM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
16P9295IIL	POLYETHYLENE OXIDE 900000:ORAL:TABLET, EXTENDED RELEASE:MG	ORAL	321.75MG ORAL TABLET, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
KH7I04HPUU	SODIUM PHOSPHATE, MONOBASIC, ANHYDROUS:AURICULAR (OTIC):SOLUTION:%	AURICULAR (OTIC)	0.13% AURICULAR (OTIC) SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
KH7I04HPUU	SODIUM PHOSPHATE, MONOBASIC, ANHYDROUS:AURICULAR (OTIC):SUSPENSION:NA	AURICULAR (OTIC)	AURICULAR (OTIC) SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
KH7I04HPUU	SODIUM PHOSPHATE, MONOBASIC, ANHYDROUS:BUCCAL:FILM:MG	BUCCAL	1.09MG BUCCAL FILM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
KH7I04HPUU	SODIUM PHOSPHATE, MONOBASIC, ANHYDROUS:IM - IV:INJECTABLE:%	IM - IV	0.16% IM - IV INJECTABLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
KH7I04HPUU	SODIUM PHOSPHATE, MONOBASIC, ANHYDROUS:IM - IV:INJECTION:%	IM - IV	1.28% IM - IV INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
KH7I04HPUU	SODIUM PHOSPHATE, MONOBASIC, ANHYDROUS:IM - IV:POWDER, FOR INJECTION SOLUTION:%	IM - IV	1.28% IM - IV POWDER, FOR INJECTION SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
KH7I04HPUU	SODIUM PHOSPHATE, MONOBASIC, ANHYDROUS:IM - IV:SOLUTION, INJECTION:%	IM - IV	0.62% IM - IV SOLUTION, INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
KH7I04HPUU	SODIUM PHOSPHATE, MONOBASIC, ANHYDROUS:INTRA-ARTERIAL:SUSPENSION, INJECTION:mg/1mL	INTRA-ARTERIAL	6.8mg/1mL INTRA-ARTERIAL SUSPENSION, INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
KH7I04HPUU	SODIUM PHOSPHATE, MONOBASIC, ANHYDROUS:INTRA-ARTICULAR:INJECTION:NA	INTRA-ARTICULAR	INTRA-ARTICULAR INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
KH7I04HPUU	SODIUM PHOSPHATE, MONOBASIC, ANHYDROUS:INTRA-ARTICULAR:SUSPENSION:%	INTRA-ARTICULAR	0.28% INTRA-ARTICULAR SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
KH7I04HPUU	SODIUM PHOSPHATE, MONOBASIC, ANHYDROUS:INTRABURSAL:INJECTION:NA	INTRABURSAL	INTRABURSAL INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
KH7I04HPUU	SODIUM PHOSPHATE, MONOBASIC, ANHYDROUS:INTRADERMAL:INJECTION:NA	INTRADERMAL	INTRADERMAL INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
KH7I04HPUU	SODIUM PHOSPHATE, MONOBASIC, ANHYDROUS:INTRALESIONAL:INJECTION:NA	INTRALESIONAL	INTRALESIONAL INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
KH7I04HPUU	SODIUM PHOSPHATE, MONOBASIC, ANHYDROUS:INTRALESIONAL:INJECTION, SUSTAINED ACTION:MG/ML	INTRALESIONAL	6.59MG/ML INTRALESIONAL INJECTION, SUSTAINED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
KH7I04HPUU	SODIUM PHOSPHATE, MONOBASIC, ANHYDROUS:INTRAMUSCULAR:INJECTION:%W/V	INTRAMUSCULAR	0.5%W/V INTRAMUSCULAR INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
KH7I04HPUU	SODIUM PHOSPHATE, MONOBASIC, ANHYDROUS:INTRAMUSCULAR:INJECTION, SUSPENSION, EXTENDED RELEASE:%	INTRAMUSCULAR	0.17% INTRAMUSCULAR INJECTION, SUSPENSION, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
KH7I04HPUU	SODIUM PHOSPHATE, MONOBASIC, ANHYDROUS:INTRAMUSCULAR:INJECTION, SUSTAINED ACTION:MG/ML	INTRAMUSCULAR	6.59MG/ML INTRAMUSCULAR INJECTION, SUSTAINED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
KH7I04HPUU	SODIUM PHOSPHATE, MONOBASIC, ANHYDROUS:INTRAMUSCULAR:POWDER, FOR INJECTION SOLUTION:%	INTRAMUSCULAR	0.5% INTRAMUSCULAR POWDER, FOR INJECTION SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
KH7I04HPUU	SODIUM PHOSPHATE, MONOBASIC, ANHYDROUS:INTRAMUSCULAR:POWDER, FOR INJECTION SOLUTION, LYOPHILIZED:%	INTRAMUSCULAR	1.2% INTRAMUSCULAR POWDER, FOR INJECTION SOLUTION, LYOPHILIZED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
KH7I04HPUU	SODIUM PHOSPHATE, MONOBASIC, ANHYDROUS:INTRAMUSCULAR:SOLUTION, INJECTION:NA	INTRAMUSCULAR	INTRAMUSCULAR SOLUTION, INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
KH7I04HPUU	SODIUM PHOSPHATE, MONOBASIC, ANHYDROUS:INTRAMUSCULAR:SUSPENSION:%	INTRAMUSCULAR	0.28% INTRAMUSCULAR SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
KH7I04HPUU	SODIUM PHOSPHATE, MONOBASIC, ANHYDROUS:INTRAMUSCULAR:SUSPENSION, INJECTION:%	INTRAMUSCULAR	0.75% INTRAMUSCULAR SUSPENSION, INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
KH7I04HPUU	SODIUM PHOSPHATE, MONOBASIC, ANHYDROUS:INTRAOCULAR:INSERT:%	INTRAOCULAR	1.08% INTRAOCULAR INSERT	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
KH7I04HPUU	SODIUM PHOSPHATE, MONOBASIC, ANHYDROUS:INTRASYNOVIAL:INJECTION, SUSTAINED ACTION:MG/ML	INTRASYNOVIAL	6.59MG/ML INTRASYNOVIAL INJECTION, SUSTAINED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
KH7I04HPUU	SODIUM PHOSPHATE, MONOBASIC, ANHYDROUS:INTRAVASCULAR:INJECTION:%	INTRAVASCULAR	0.013% INTRAVASCULAR INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
KH7I04HPUU	SODIUM PHOSPHATE, MONOBASIC, ANHYDROUS:INTRAVENOUS:INJECTION:%	INTRAVENOUS	0.5% INTRAVENOUS INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
KH7I04HPUU	SODIUM PHOSPHATE, MONOBASIC, ANHYDROUS:INTRAVENOUS:POWDER, FOR INJECTION SOLUTION:%	INTRAVENOUS	0.71% INTRAVENOUS POWDER, FOR INJECTION SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
KH7I04HPUU	SODIUM PHOSPHATE, MONOBASIC, ANHYDROUS:INTRAVENOUS:SOLUTION:%	INTRAVENOUS	4% INTRAVENOUS SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
KH7I04HPUU	SODIUM PHOSPHATE, MONOBASIC, ANHYDROUS:INTRAVESICAL:SOLUTION:MG	INTRAVESICAL	0.115MG INTRAVESICAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
KH7I04HPUU	SODIUM PHOSPHATE, MONOBASIC, ANHYDROUS:IV(INFUSION):INJECTION:%	IV(INFUSION)	0.5% IV(INFUSION) INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
KH7I04HPUU	SODIUM PHOSPHATE, MONOBASIC, ANHYDROUS:IV(INFUSION):POWDER, FOR INJECTION SOLUTION:%	IV(INFUSION)	1.28% IV(INFUSION) POWDER, FOR INJECTION SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
KH7I04HPUU	SODIUM PHOSPHATE, MONOBASIC, ANHYDROUS:NASAL:SPRAY, METERED:%	NASAL	0.019% NASAL SPRAY, METERED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
KH7I04HPUU	SODIUM PHOSPHATE, MONOBASIC, ANHYDROUS:OPHTHALMIC:DROPS:%	OPHTHALMIC	0.35% OPHTHALMIC DROPS	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
KH7I04HPUU	SODIUM PHOSPHATE, MONOBASIC, ANHYDROUS:OPHTHALMIC:SOLUTION:%	OPHTHALMIC	0.78% OPHTHALMIC SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
KH7I04HPUU	SODIUM PHOSPHATE, MONOBASIC, ANHYDROUS:OPHTHALMIC:SOLUTION, DROPS:%	OPHTHALMIC	0.72% OPHTHALMIC SOLUTION, DROPS	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
KH7I04HPUU	SODIUM PHOSPHATE, MONOBASIC, ANHYDROUS:OPHTHALMIC:SUSPENSION:%	OPHTHALMIC	0.65% OPHTHALMIC SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
KH7I04HPUU	SODIUM PHOSPHATE, MONOBASIC, ANHYDROUS:OPHTHALMIC:SUSPENSION, DROPS:%	OPHTHALMIC	0.056% OPHTHALMIC SUSPENSION, DROPS	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
KH7I04HPUU	SODIUM PHOSPHATE, MONOBASIC, ANHYDROUS:ORAL:CONCENTRATE:NA	ORAL	ORAL CONCENTRATE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
KH7I04HPUU	SODIUM PHOSPHATE, MONOBASIC, ANHYDROUS:ORAL:SOLUTION:MG	ORAL	40MG ORAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
KH7I04HPUU	SODIUM PHOSPHATE, MONOBASIC, ANHYDROUS:ORAL:SUSPENSION:MG/5ML	ORAL	32.5MG/5ML ORAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
KH7I04HPUU	SODIUM PHOSPHATE, MONOBASIC, ANHYDROUS:ORAL:SYRUP:%	ORAL	0.07% ORAL SYRUP	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
KH7I04HPUU	SODIUM PHOSPHATE, MONOBASIC, ANHYDROUS:ORAL:TABLET:MG	ORAL	4.18MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
KH7I04HPUU	SODIUM PHOSPHATE, MONOBASIC, ANHYDROUS:ORAL:TABLET, DELAYED ACTION, ENTERIC COATED:MG	ORAL	23.4MG ORAL TABLET, DELAYED ACTION, ENTERIC COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
KH7I04HPUU	SODIUM PHOSPHATE, MONOBASIC, ANHYDROUS:ORAL:TABLET, SUSTAINED ACTION, FILM COATED:MG	ORAL	30.97MG ORAL TABLET, SUSTAINED ACTION, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
KH7I04HPUU	SODIUM PHOSPHATE, MONOBASIC, ANHYDROUS:SOFT TISSUE:INJECTION, SUSTAINED ACTION:MG/ML	SOFT TISSUE	6.59MG/ML SOFT TISSUE INJECTION, SUSTAINED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
KH7I04HPUU	SODIUM PHOSPHATE, MONOBASIC, ANHYDROUS:SUBCUTANEOUS:INJECTION:%	SUBCUTANEOUS	3.31% SUBCUTANEOUS INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
KH7I04HPUU	SODIUM PHOSPHATE, MONOBASIC, ANHYDROUS:SUBCUTANEOUS:POWDER, FOR INJECTION SOLUTION:%	SUBCUTANEOUS	0.08% SUBCUTANEOUS POWDER, FOR INJECTION SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
KH7I04HPUU	SODIUM PHOSPHATE, MONOBASIC, ANHYDROUS:SUBCUTANEOUS:POWDER, FOR INJECTION SOLUTION, LYOPHILIZED:%	SUBCUTANEOUS	0.11% SUBCUTANEOUS POWDER, FOR INJECTION SOLUTION, LYOPHILIZED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
KH7I04HPUU	SODIUM PHOSPHATE, MONOBASIC, ANHYDROUS:SUBCUTANEOUS:SOLUTION, INJECTION:%	SUBCUTANEOUS	0.2% SUBCUTANEOUS SOLUTION, INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
KH7I04HPUU	SODIUM PHOSPHATE, MONOBASIC, ANHYDROUS:TOPICAL:EMULSION, CREAM:%W/W	TOPICAL	0.3%W/W TOPICAL EMULSION, CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
KH7I04HPUU	SODIUM PHOSPHATE, MONOBASIC, ANHYDROUS:TOPICAL:GEL:%W/W	TOPICAL	0.3%W/W TOPICAL GEL	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
KH7I04HPUU	SODIUM PHOSPHATE, MONOBASIC, ANHYDROUS:TOPICAL:LOTION:%W/W 	TOPICAL	0.2%W/W  TOPICAL LOTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
KH7I04HPUU	SODIUM PHOSPHATE, MONOBASIC, ANHYDROUS:TOPICAL:SHAMPOO, SUSPENSION:%W/V	TOPICAL	1%W/V TOPICAL SHAMPOO, SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
KH7I04HPUU	SODIUM PHOSPHATE, MONOBASIC, ANHYDROUS:TOPICAL:SOLUTION:%W/V	TOPICAL	0.47%W/V TOPICAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
KH7I04HPUU	SODIUM PHOSPHATE, MONOBASIC, ANHYDROUS:VAGINAL:EMULSION, CREAM:ADJ PH	VAGINAL	ADJ PH VAGINAL EMULSION, CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
3DYK7UYZ62	ETHYLCELLULOSE (10 MPA.S):ORAL:CAPSULE:mg	ORAL	39.39mg ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
3DYK7UYZ62	ETHYLCELLULOSE (10 MPA.S):ORAL:CAPSULE, DELAYED ACTION:MG	ORAL	25.1MG ORAL CAPSULE, DELAYED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
3DYK7UYZ62	ETHYLCELLULOSE (10 MPA.S):ORAL:CAPSULE, EXTENDED RELEASE:mg	ORAL	175.4mg ORAL CAPSULE, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
3DYK7UYZ62	ETHYLCELLULOSE (10 MPA.S):ORAL:SUSPENSION, EXTENDED RELEASE:MG/ML	ORAL	4.17MG/ML ORAL SUSPENSION, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
3DYK7UYZ62	ETHYLCELLULOSE (10 MPA.S):ORAL:TABLET:MG	ORAL	100MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
3DYK7UYZ62	ETHYLCELLULOSE (10 MPA.S):ORAL:TABLET, EXTENDED RELEASE:MG	ORAL	99MG ORAL TABLET, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
6OZP39ZG8H	POLYSORBATE 80:AURICULAR (OTIC):SOLUTION:%	AURICULAR (OTIC)	0.2% AURICULAR (OTIC) SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
6OZP39ZG8H	POLYSORBATE 80:AURICULAR (OTIC):SOLUTION, DROPS:%	AURICULAR (OTIC)	2.5% AURICULAR (OTIC) SOLUTION, DROPS	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
6OZP39ZG8H	POLYSORBATE 80:AURICULAR (OTIC):SUSPENSION:%	AURICULAR (OTIC)	5% AURICULAR (OTIC) SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
6OZP39ZG8H	POLYSORBATE 80:IM - IV:INJECTION:NA	IM - IV	IM - IV INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
6OZP39ZG8H	POLYSORBATE 80:INHALATION:AEROSOL:ug	INHALATION	0.02ug INHALATION AEROSOL	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
6OZP39ZG8H	POLYSORBATE 80:INHALATION:POWDER:MG	INHALATION	0.22MG INHALATION POWDER	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
6OZP39ZG8H	POLYSORBATE 80:INHALATION:SUSPENSION:mg/2mL	INHALATION	0.37mg/2mL INHALATION SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
6OZP39ZG8H	POLYSORBATE 80:INHALATION:SUSPENSION, FOR INHALATION:%	INHALATION	0.02% INHALATION SUSPENSION, FOR INHALATION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
6OZP39ZG8H	POLYSORBATE 80:INTRA-ARTERIAL:SUSPENSION, INJECTION:mg/1mL	INTRA-ARTERIAL	1.94mg/1mL INTRA-ARTERIAL SUSPENSION, INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
6OZP39ZG8H	POLYSORBATE 80:INTRA-ARTICULAR:INJECTABLE:%	INTRA-ARTICULAR	0.04% INTRA-ARTICULAR INJECTABLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
6OZP39ZG8H	POLYSORBATE 80:INTRA-ARTICULAR:INJECTION:%	INTRA-ARTICULAR	0.4% INTRA-ARTICULAR INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
6OZP39ZG8H	POLYSORBATE 80:INTRA-ARTICULAR:INJECTION, SUSPENSION, EXTENDED RELEASE:MG	INTRA-ARTICULAR	5MG INTRA-ARTICULAR INJECTION, SUSPENSION, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
6OZP39ZG8H	POLYSORBATE 80:INTRA-ARTICULAR:INJECTION, SUSTAINED ACTION:NA	INTRA-ARTICULAR	INTRA-ARTICULAR INJECTION, SUSTAINED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
6OZP39ZG8H	POLYSORBATE 80:INTRABURSAL:INJECTION:%	INTRABURSAL	0.04% INTRABURSAL INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
6OZP39ZG8H	POLYSORBATE 80:INTRADERMAL:INJECTION:NA	INTRADERMAL	INTRADERMAL INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
6OZP39ZG8H	POLYSORBATE 80:INTRADERMAL:INJECTION, SUSTAINED ACTION:NA	INTRADERMAL	INTRADERMAL INJECTION, SUSTAINED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
6OZP39ZG8H	POLYSORBATE 80:INTRALESIONAL:INJECTABLE:%	INTRALESIONAL	0.19% INTRALESIONAL INJECTABLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
6OZP39ZG8H	POLYSORBATE 80:INTRALESIONAL:INJECTION:%	INTRALESIONAL	0.2% INTRALESIONAL INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
6OZP39ZG8H	POLYSORBATE 80:INTRALESIONAL:INJECTION, SUSTAINED ACTION:NA	INTRALESIONAL	INTRALESIONAL INJECTION, SUSTAINED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
6OZP39ZG8H	POLYSORBATE 80:INTRALESIONAL:SUSPENSION, INJECTION:%	INTRALESIONAL	0.19% INTRALESIONAL SUSPENSION, INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
6OZP39ZG8H	POLYSORBATE 80:INTRAMUSCULAR:INJECTABLE:%W/V	INTRAMUSCULAR	0.19%W/V INTRAMUSCULAR INJECTABLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
6OZP39ZG8H	POLYSORBATE 80:INTRAMUSCULAR:INJECTION:%	INTRAMUSCULAR	12% INTRAMUSCULAR INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
6OZP39ZG8H	POLYSORBATE 80:INTRAMUSCULAR:INJECTION:mg	INTRAMUSCULAR	3.8mg INTRAMUSCULAR INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
6OZP39ZG8H	POLYSORBATE 80:INTRAMUSCULAR:INJECTION:MG/1ML	INTRAMUSCULAR	0.4MG/1ML INTRAMUSCULAR INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
6OZP39ZG8H	POLYSORBATE 80:INTRAMUSCULAR:INJECTION, MICROSPHERES:%	INTRAMUSCULAR	0.1% INTRAMUSCULAR INJECTION, MICROSPHERES	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
6OZP39ZG8H	POLYSORBATE 80:INTRAMUSCULAR:INJECTION, SUSTAINED ACTION:NA	INTRAMUSCULAR	INTRAMUSCULAR INJECTION, SUSTAINED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
6OZP39ZG8H	POLYSORBATE 80:INTRAMUSCULAR:POWDER, FOR INJECTION SOLUTION:NA	INTRAMUSCULAR	INTRAMUSCULAR POWDER, FOR INJECTION SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
6OZP39ZG8H	POLYSORBATE 80:INTRAMUSCULAR:POWDER, FOR INJECTION SOLUTION, LYOPHILIZED:%	INTRAMUSCULAR	0.2% INTRAMUSCULAR POWDER, FOR INJECTION SOLUTION, LYOPHILIZED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
6OZP39ZG8H	POLYSORBATE 80:INTRAMUSCULAR:SOLUTION, INJECTION:%W/V	INTRAMUSCULAR	5%W/V INTRAMUSCULAR SOLUTION, INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
6OZP39ZG8H	POLYSORBATE 80:INTRAMUSCULAR:SUSPENSION:%	INTRAMUSCULAR	0.02% INTRAMUSCULAR SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
6OZP39ZG8H	POLYSORBATE 80:INTRAMUSCULAR:SUSPENSION, INJECTION:%W/V	INTRAMUSCULAR	0.24%W/V INTRAMUSCULAR SUSPENSION, INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
6OZP39ZG8H	POLYSORBATE 80:INTRASYNOVIAL:INJECTABLE:%	INTRASYNOVIAL	0.19% INTRASYNOVIAL INJECTABLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
6OZP39ZG8H	POLYSORBATE 80:INTRASYNOVIAL:INJECTION:%	INTRASYNOVIAL	0.2% INTRASYNOVIAL INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
6OZP39ZG8H	POLYSORBATE 80:INTRASYNOVIAL:INJECTION, SUSTAINED ACTION:NA	INTRASYNOVIAL	INTRASYNOVIAL INJECTION, SUSTAINED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
6OZP39ZG8H	POLYSORBATE 80:INTRASYNOVIAL:SUSPENSION, INJECTION:%	INTRASYNOVIAL	0.19% INTRASYNOVIAL SUSPENSION, INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
6OZP39ZG8H	POLYSORBATE 80:INTRA-SYNOVIAL:SUSPENSION, INJECTION:mg	INTRA-SYNOVIAL	9.7mg INTRA-SYNOVIAL SUSPENSION, INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
6OZP39ZG8H	POLYSORBATE 80:INTRAVENOUS:INFUSION:NA	INTRAVENOUS	INTRAVENOUS INFUSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
6OZP39ZG8H	POLYSORBATE 80:INTRAVENOUS:INJECTABLE:%	INTRAVENOUS	63% INTRAVENOUS INJECTABLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
6OZP39ZG8H	POLYSORBATE 80:INTRAVENOUS:INJECTION:%W/V	INTRAVENOUS	26%W/V INTRAVENOUS INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
6OZP39ZG8H	POLYSORBATE 80:INTRAVENOUS:INJECTION, SOLUTION:%W/V	INTRAVENOUS	26%W/V INTRAVENOUS INJECTION, SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
6OZP39ZG8H	POLYSORBATE 80:INTRAVENOUS:INJECTION, SUSPENSION:%	INTRAVENOUS	0.5% INTRAVENOUS INJECTION, SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
6OZP39ZG8H	POLYSORBATE 80:INTRAVENOUS:LIQUID:MG/5ML	INTRAVENOUS	400MG/5ML INTRAVENOUS LIQUID	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
6OZP39ZG8H	POLYSORBATE 80:INTRAVENOUS:POWDER, FOR INJECTION SOLUTION, LYOPHILIZED:%	INTRAVENOUS	12% INTRAVENOUS POWDER, FOR INJECTION SOLUTION, LYOPHILIZED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
6OZP39ZG8H	POLYSORBATE 80:INTRAVENOUS:SOLUTION, INJECTION:%	INTRAVENOUS	52% INTRAVENOUS SOLUTION, INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
6OZP39ZG8H	POLYSORBATE 80:INTRAVENOUS:SOLUTION, LIQUID:ug/1mL	INTRAVENOUS	100ug/1mL INTRAVENOUS SOLUTION, LIQUID	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
6OZP39ZG8H	POLYSORBATE 80:INTRAVENOUS INFUSION:INJECTION:mg/1mL	INTRAVENOUS INFUSION	260mg/1mL INTRAVENOUS INFUSION INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
6OZP39ZG8H	POLYSORBATE 80:INTRAVITREAL:SUSPENSION, INJECTION:%	INTRAVITREAL	0.015% INTRAVITREAL SUSPENSION, INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
6OZP39ZG8H	POLYSORBATE 80:IV(INFUSION):INJECTABLE:%	IV(INFUSION)	52% IV(INFUSION) INJECTABLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
6OZP39ZG8H	POLYSORBATE 80:IV(INFUSION):INJECTION, SOLUTION:%	IV(INFUSION)	54% IV(INFUSION) INJECTION, SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
6OZP39ZG8H	POLYSORBATE 80:IV(INFUSION):POWDER, FOR INJECTION SOLUTION:%	IV(INFUSION)	5.3% IV(INFUSION) POWDER, FOR INJECTION SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
6OZP39ZG8H	POLYSORBATE 80:IV(INFUSION):POWDER, FOR INJECTION SOLUTION, LYOPHILIZED:%	IV(INFUSION)	12.5% IV(INFUSION) POWDER, FOR INJECTION SOLUTION, LYOPHILIZED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
6OZP39ZG8H	POLYSORBATE 80:IV(INFUSION):SOLUTION:%	IV(INFUSION)	10% IV(INFUSION) SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
6OZP39ZG8H	POLYSORBATE 80:IV(INFUSION):SOLUTION, CONCENTRATE:%W/V	IV(INFUSION)	26%W/V IV(INFUSION) SOLUTION, CONCENTRATE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
6OZP39ZG8H	POLYSORBATE 80:IV(INFUSION):SOLUTION, INJECTION:%	IV(INFUSION)	58.5% IV(INFUSION) SOLUTION, INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
6OZP39ZG8H	POLYSORBATE 80:NASAL:SPRAY:%	NASAL	0.5% NASAL SPRAY	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
6OZP39ZG8H	POLYSORBATE 80:NASAL:SPRAY, METERED:%	NASAL	10% NASAL SPRAY, METERED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
6OZP39ZG8H	POLYSORBATE 80:NASAL:SUSPENSION:NA	NASAL	NASAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
6OZP39ZG8H	POLYSORBATE 80:OPHTHALMIC:DROPS:%	OPHTHALMIC	0.1% OPHTHALMIC DROPS	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
6OZP39ZG8H	POLYSORBATE 80:OPHTHALMIC:EMULSION:%	OPHTHALMIC	4% OPHTHALMIC EMULSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
6OZP39ZG8H	POLYSORBATE 80:OPHTHALMIC:SOLUTION:%W/W	OPHTHALMIC	0.25%W/W OPHTHALMIC SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
6OZP39ZG8H	POLYSORBATE 80:OPHTHALMIC:SOLUTION, DROPS:%	OPHTHALMIC	1% OPHTHALMIC SOLUTION, DROPS	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
6OZP39ZG8H	POLYSORBATE 80:OPHTHALMIC:SOLUTION, GEL FORMING, EXTENDED RELEASE:%	OPHTHALMIC	0.05% OPHTHALMIC SOLUTION, GEL FORMING, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
6OZP39ZG8H	POLYSORBATE 80:OPHTHALMIC:SUSPENSION:%	OPHTHALMIC	0.1% OPHTHALMIC SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
6OZP39ZG8H	POLYSORBATE 80:OPHTHALMIC:SUSPENSION, DROPS:%	OPHTHALMIC	0.1% OPHTHALMIC SUSPENSION, DROPS	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
6OZP39ZG8H	POLYSORBATE 80:ORAL:CAPSULE:MG	ORAL	418.37MG ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
6OZP39ZG8H	POLYSORBATE 80:ORAL:CAPSULE, COATED PELLETS:MG	ORAL	0.053MG ORAL CAPSULE, COATED PELLETS	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
6OZP39ZG8H	POLYSORBATE 80:ORAL:CAPSULE, DELAYED ACTION:MG	ORAL	3.05MG ORAL CAPSULE, DELAYED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
6OZP39ZG8H	POLYSORBATE 80:ORAL:CAPSULE, DELAYED RELEASE:MG	ORAL	3.82MG ORAL CAPSULE, DELAYED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
6OZP39ZG8H	POLYSORBATE 80:ORAL:CAPSULE, ENTERIC COATED PELLETS:MG	ORAL	2MG ORAL CAPSULE, ENTERIC COATED PELLETS	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
6OZP39ZG8H	POLYSORBATE 80:ORAL:CAPSULE, EXTENDED RELEASE:MG	ORAL	1.56MG ORAL CAPSULE, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
6OZP39ZG8H	POLYSORBATE 80:ORAL:CAPSULE, HARD GELATIN:NA	ORAL	ORAL CAPSULE, HARD GELATIN	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
6OZP39ZG8H	POLYSORBATE 80:ORAL:CAPSULE, SOFT GELATIN:MG	ORAL	80.56MG ORAL CAPSULE, SOFT GELATIN	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
6OZP39ZG8H	POLYSORBATE 80:ORAL:CAPSULE, SOFT GELATIN LIQUID-FILLED:MG	ORAL	6MG ORAL CAPSULE, SOFT GELATIN LIQUID-FILLED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
6OZP39ZG8H	POLYSORBATE 80:ORAL:CAPSULE, SUSTAINED ACTION:MG	ORAL	2.6MG ORAL CAPSULE, SUSTAINED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
6OZP39ZG8H	POLYSORBATE 80:ORAL:CONCENTRATE:MG/1ML	ORAL	1MG/1ML ORAL CONCENTRATE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
6OZP39ZG8H	POLYSORBATE 80:ORAL:DROPS:MG/1ML	ORAL	2MG/1ML ORAL DROPS	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
6OZP39ZG8H	POLYSORBATE 80:ORAL:GRANULE:MG	ORAL	20MG ORAL GRANULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
6OZP39ZG8H	POLYSORBATE 80:ORAL:GRANULE, FOR ORAL SUSPENSION:MG	ORAL	5MG ORAL GRANULE, FOR ORAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
6OZP39ZG8H	POLYSORBATE 80:ORAL:LIQUID:NA	ORAL	ORAL LIQUID	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
6OZP39ZG8H	POLYSORBATE 80:ORAL:PELLET:MG	ORAL	1.1MG ORAL PELLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
6OZP39ZG8H	POLYSORBATE 80:ORAL:POWDER:MG/1PKT	ORAL	66MG/1PKT ORAL POWDER	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
6OZP39ZG8H	POLYSORBATE 80:ORAL:POWDER, FOR ORAL SUSPENSION:MG/5ML	ORAL	5MG/5ML ORAL POWDER, FOR ORAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
6OZP39ZG8H	POLYSORBATE 80:ORAL:POWDER, FOR SOLUTION:NA	ORAL	ORAL POWDER, FOR SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
6OZP39ZG8H	POLYSORBATE 80:ORAL:POWDER, FOR SUSPENSION:MG/5ML	ORAL	5MG/5ML ORAL POWDER, FOR SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
6OZP39ZG8H	POLYSORBATE 80:ORAL:SOLUTION:MG/1ML	ORAL	126MG/1ML ORAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
6OZP39ZG8H	POLYSORBATE 80:ORAL:SOLUTION, ELIXIR:MG/15ML	ORAL	2.5MG/15ML ORAL SOLUTION, ELIXIR	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
6OZP39ZG8H	POLYSORBATE 80:ORAL:SUSPENSION:MG/5ML	ORAL	125MG/5ML ORAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
6OZP39ZG8H	POLYSORBATE 80:ORAL:SUSPENSION, DROPS:MG/2.5ML	ORAL	7.5MG/2.5ML ORAL SUSPENSION, DROPS	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
6OZP39ZG8H	POLYSORBATE 80:ORAL:SUSPENSION, EXTENDED RELEASE:MG/5ML	ORAL	10MG/5ML ORAL SUSPENSION, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
6OZP39ZG8H	POLYSORBATE 80:ORAL:SUSPENSION, FOR INHALATION:MG/2 ML	ORAL	0.4MG/2 ML ORAL SUSPENSION, FOR INHALATION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
6OZP39ZG8H	POLYSORBATE 80:ORAL:SUSPENSION, LIQUID:MG/5ML	ORAL	5MG/5ML ORAL SUSPENSION, LIQUID	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
6OZP39ZG8H	POLYSORBATE 80:ORAL:SUSPENSION, SUSTAINED ACTION:MG	ORAL	5MG ORAL SUSPENSION, SUSTAINED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
6OZP39ZG8H	POLYSORBATE 80:ORAL:SUSPENSION, SYRUP, SUSTAINED ACTION:%	ORAL	0.06% ORAL SUSPENSION, SYRUP, SUSTAINED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
6OZP39ZG8H	POLYSORBATE 80:ORAL:TABLET:MG	ORAL	21.25MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
6OZP39ZG8H	POLYSORBATE 80:ORAL:TABLET (IMMED./COMP. RELEASE), COATED:MG	ORAL	0.5MG ORAL TABLET (IMMED./COMP. RELEASE), COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
6OZP39ZG8H	POLYSORBATE 80:ORAL:TABLET (IMMED./COMP. RELEASE), FILM COATED:MG	ORAL	24MG ORAL TABLET (IMMED./COMP. RELEASE), FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
6OZP39ZG8H	POLYSORBATE 80:ORAL:TABLET, COATED:MG	ORAL	2.2MG ORAL TABLET, COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
6OZP39ZG8H	POLYSORBATE 80:ORAL:TABLET, CONTROLLED RELEASE:mg	ORAL	1.635mg ORAL TABLET, CONTROLLED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
6OZP39ZG8H	POLYSORBATE 80:ORAL:TABLET, DELAYED ACTION:MG	ORAL	1.15MG ORAL TABLET, DELAYED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
6OZP39ZG8H	POLYSORBATE 80:ORAL:TABLET, DELAYED ACTION, ENTERIC COATED:MG	ORAL	0.17MG ORAL TABLET, DELAYED ACTION, ENTERIC COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
6OZP39ZG8H	POLYSORBATE 80:ORAL:TABLET, DELAYED RELEASE:MG	ORAL	0.62MG ORAL TABLET, DELAYED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
6OZP39ZG8H	POLYSORBATE 80:ORAL:TABLET, EXTENDED RELEASE:MG	ORAL	8MG ORAL TABLET, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
6OZP39ZG8H	POLYSORBATE 80:ORAL:TABLET, FILM COATED:MG	ORAL	14.8MG ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
6OZP39ZG8H	POLYSORBATE 80:ORAL:TABLET, FILM COATED, EXTENDED RELEASE:MG	ORAL	0.12MG ORAL TABLET, FILM COATED, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
6OZP39ZG8H	POLYSORBATE 80:ORAL:TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE:mg	ORAL	5.68mg ORAL TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
6OZP39ZG8H	POLYSORBATE 80:ORAL:TABLET, SUSTAINED ACTION:MG	ORAL	0.12MG ORAL TABLET, SUSTAINED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
6OZP39ZG8H	POLYSORBATE 80:ORAL:TABLET, SUSTAINED ACTION, COATED:MG	ORAL	8MG ORAL TABLET, SUSTAINED ACTION, COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
6OZP39ZG8H	POLYSORBATE 80:ORAL:TABLET, SUSTAINED ACTION, FILM COATED:MG	ORAL	0.2MG ORAL TABLET, SUSTAINED ACTION, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
6OZP39ZG8H	POLYSORBATE 80:RECTAL:ENEMA:%	RECTAL	0.35% RECTAL ENEMA	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
6OZP39ZG8H	POLYSORBATE 80:RECTAL:LIQUID:NA	RECTAL	RECTAL LIQUID	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
6OZP39ZG8H	POLYSORBATE 80:RECTAL:POWDER, FOR SOLUTION:NA	RECTAL	RECTAL POWDER, FOR SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
6OZP39ZG8H	POLYSORBATE 80:RECTAL:SOLUTION:%	RECTAL	0.75% RECTAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
6OZP39ZG8H	POLYSORBATE 80:RECTAL:SUPPOSITORY:MG	RECTAL	72.15MG RECTAL SUPPOSITORY	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
6OZP39ZG8H	POLYSORBATE 80:RESPIRATORY (INHALATION):SUSPENSION, FOR INHALATION:%	RESPIRATORY (INHALATION)	0.04% RESPIRATORY (INHALATION) SUSPENSION, FOR INHALATION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
6OZP39ZG8H	POLYSORBATE 80:SOFT TISSUE:INJECTABLE:%	SOFT TISSUE	0.04% SOFT TISSUE INJECTABLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
6OZP39ZG8H	POLYSORBATE 80:SOFT TISSUE:INJECTION:%	SOFT TISSUE	0.2% SOFT TISSUE INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
6OZP39ZG8H	POLYSORBATE 80:SOFT TISSUE:INJECTION, SUSTAINED ACTION:NA	SOFT TISSUE	SOFT TISSUE INJECTION, SUSTAINED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
6OZP39ZG8H	POLYSORBATE 80:SOFT TISSUE:SUSPENSION, INJECTION:%	SOFT TISSUE	0.19% SOFT TISSUE SUSPENSION, INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
6OZP39ZG8H	POLYSORBATE 80:SUBCUTANEOUS:INJECTION:NA	SUBCUTANEOUS	SUBCUTANEOUS INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
6OZP39ZG8H	POLYSORBATE 80:SUBCUTANEOUS:SUSPENSION, INJECTION:%	SUBCUTANEOUS	0.46% SUBCUTANEOUS SUSPENSION, INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
6OZP39ZG8H	POLYSORBATE 80:SUBLINGUAL:TABLET:MG	SUBLINGUAL	0.075MG SUBLINGUAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
6OZP39ZG8H	POLYSORBATE 80:TOPICAL:CREAM, AUGMENTED:%W/W	TOPICAL	15%W/W TOPICAL CREAM, AUGMENTED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
6OZP39ZG8H	POLYSORBATE 80:TOPICAL:CREAM, EMULSION, SUSTAINED RELEASE:%W/W	TOPICAL	5%W/W TOPICAL CREAM, EMULSION, SUSTAINED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
6OZP39ZG8H	POLYSORBATE 80:TOPICAL:DROPS:NA	TOPICAL	TOPICAL DROPS	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
6OZP39ZG8H	POLYSORBATE 80:TOPICAL:EMULSION:%W/W	TOPICAL	2.5%W/W TOPICAL EMULSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
6OZP39ZG8H	POLYSORBATE 80:TOPICAL:EMULSION, AEROSOL FOAM:%W/W	TOPICAL	0.98%W/W TOPICAL EMULSION, AEROSOL FOAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
6OZP39ZG8H	POLYSORBATE 80:TOPICAL:EMULSION, CREAM:%W/W	TOPICAL	4.5%W/W TOPICAL EMULSION, CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
6OZP39ZG8H	POLYSORBATE 80:TOPICAL:GEL:%W/W	TOPICAL	8.5%W/W TOPICAL GEL	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
6OZP39ZG8H	POLYSORBATE 80:TOPICAL:LOTION:%W/W	TOPICAL	2.5%W/W TOPICAL LOTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
6OZP39ZG8H	POLYSORBATE 80:TOPICAL:OINTMENT:%W/W	TOPICAL	0.1%W/W TOPICAL OINTMENT	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
6OZP39ZG8H	POLYSORBATE 80:TOPICAL:PATCH, CONTROLLED RELEASE:NA	TOPICAL	TOPICAL PATCH, CONTROLLED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
6OZP39ZG8H	POLYSORBATE 80:VAGINAL:CREAM:%W/W	VAGINAL	0.001%W/W VAGINAL CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
6OZP39ZG8H	POLYSORBATE 80:VAGINAL:EMULSION, CREAM:%	VAGINAL	0.4% VAGINAL EMULSION, CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
6OZP39ZG8H	POLYSORBATE 80:VAGINAL:SUPPOSITORY:MG	VAGINAL	28MG VAGINAL SUPPOSITORY	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
2E48G1QI9Q	ACETIC ANHYDRIDE:INTRAVENOUS:INJECTION:NA	INTRAVENOUS	INTRAVENOUS INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
2E48G1QI9Q	ACETIC ANHYDRIDE:ORAL:TABLET, SUSTAINED ACTION:MG	ORAL	0.11MG ORAL TABLET, SUSTAINED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
04Y7590D77	ISOLEUCINE:IV(INFUSION):INJECTION:%	IV(INFUSION)	40.6% IV(INFUSION) INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=I
04Y7590D77	ISOLEUCINE:IV(INFUSION):SOLUTION, INJECTION:%	IV(INFUSION)	0.21% IV(INFUSION) SOLUTION, INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=I
2A1Q1Q3557	SODIUM CARBONATE MONOHYDRATE:INTRA-ARTERIAL:INJECTION:ADJ PH	INTRA-ARTERIAL	ADJ PH INTRA-ARTERIAL INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
2A1Q1Q3557	SODIUM CARBONATE MONOHYDRATE:INTRACARDIAC:INJECTION:ADJ PH	INTRACARDIAC	ADJ PH INTRACARDIAC INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
2A1Q1Q3557	SODIUM CARBONATE MONOHYDRATE:INTRAVENOUS:INJECTION:ADJ PH	INTRAVENOUS	ADJ PH INTRAVENOUS INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
2A1Q1Q3557	SODIUM CARBONATE MONOHYDRATE:OPHTHALMIC:SOLUTION:ADJ PH	OPHTHALMIC	ADJ PH OPHTHALMIC SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
2A1Q1Q3557	SODIUM CARBONATE MONOHYDRATE:ORAL:POWDER, FOR ORAL SUSPENSION:MG/5ML	ORAL	30MG/5ML ORAL POWDER, FOR ORAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
2A1Q1Q3557	SODIUM CARBONATE MONOHYDRATE:ORAL:TABLET:MG	ORAL	30MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
2A1Q1Q3557	SODIUM CARBONATE MONOHYDRATE:ORAL:TABLET, FILM COATED:mg	ORAL	104mg ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
905HNO1SIH	DIMETHYLAMINOETHYL METHACRYLATE - BUTYL METHACRYLATE - METHYL METHACRYLATE COPOLYMER:ORAL:CAPSULE:MG	ORAL	4.52MG ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
905HNO1SIH	DIMETHYLAMINOETHYL METHACRYLATE - BUTYL METHACRYLATE - METHYL METHACRYLATE COPOLYMER:ORAL:CAPSULE, EXTENDED RELEASE:MG	ORAL	33.69MG ORAL CAPSULE, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
905HNO1SIH	DIMETHYLAMINOETHYL METHACRYLATE - BUTYL METHACRYLATE - METHYL METHACRYLATE COPOLYMER:ORAL:CAPSULE, SUSTAINED ACTION:MG	ORAL	1.63MG ORAL CAPSULE, SUSTAINED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
905HNO1SIH	DIMETHYLAMINOETHYL METHACRYLATE - BUTYL METHACRYLATE - METHYL METHACRYLATE COPOLYMER:ORAL:PELLET:MG	ORAL	4.2MG ORAL PELLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
905HNO1SIH	DIMETHYLAMINOETHYL METHACRYLATE - BUTYL METHACRYLATE - METHYL METHACRYLATE COPOLYMER:ORAL:SUSPENSION:MG/5ML	ORAL	85MG/5ML ORAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
905HNO1SIH	DIMETHYLAMINOETHYL METHACRYLATE - BUTYL METHACRYLATE - METHYL METHACRYLATE COPOLYMER:ORAL:TABLET:MG	ORAL	12.9MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
905HNO1SIH	DIMETHYLAMINOETHYL METHACRYLATE - BUTYL METHACRYLATE - METHYL METHACRYLATE COPOLYMER:ORAL:TABLET (IMMED./COMP. RELEASE), FILM COATED:MG	ORAL	100MG ORAL TABLET (IMMED./COMP. RELEASE), FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
905HNO1SIH	DIMETHYLAMINOETHYL METHACRYLATE - BUTYL METHACRYLATE - METHYL METHACRYLATE COPOLYMER:ORAL:TABLET (IMMED./COMP. RELEASE), UNCOATED, CHEWABLE:MG	ORAL	4.57MG ORAL TABLET (IMMED./COMP. RELEASE), UNCOATED, CHEWABLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
905HNO1SIH	DIMETHYLAMINOETHYL METHACRYLATE - BUTYL METHACRYLATE - METHYL METHACRYLATE COPOLYMER:ORAL:TABLET, COATED:NA	ORAL	ORAL TABLET, COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
905HNO1SIH	DIMETHYLAMINOETHYL METHACRYLATE - BUTYL METHACRYLATE - METHYL METHACRYLATE COPOLYMER:ORAL:TABLET, DELAYED ACTION:MG	ORAL	2.16MG ORAL TABLET, DELAYED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
905HNO1SIH	DIMETHYLAMINOETHYL METHACRYLATE - BUTYL METHACRYLATE - METHYL METHACRYLATE COPOLYMER:ORAL:TABLET, EXTENDED RELEASE:MG	ORAL	28MG ORAL TABLET, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
905HNO1SIH	DIMETHYLAMINOETHYL METHACRYLATE - BUTYL METHACRYLATE - METHYL METHACRYLATE COPOLYMER:ORAL:TABLET, FILM COATED:MG	ORAL	7.2MG ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
905HNO1SIH	DIMETHYLAMINOETHYL METHACRYLATE - BUTYL METHACRYLATE - METHYL METHACRYLATE COPOLYMER:ORAL:TABLET, ORALLY DISINTEGRATING:MG	ORAL	214.28MG ORAL TABLET, ORALLY DISINTEGRATING	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
905HNO1SIH	DIMETHYLAMINOETHYL METHACRYLATE - BUTYL METHACRYLATE - METHYL METHACRYLATE COPOLYMER:ORAL:TABLET, SUSTAINED ACTION:MG	ORAL	3.96MG ORAL TABLET, SUSTAINED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
905HNO1SIH	DIMETHYLAMINOETHYL METHACRYLATE - BUTYL METHACRYLATE - METHYL METHACRYLATE COPOLYMER:TRANSDERMAL:FILM, CONTROLLED RELEASE:NA	TRANSDERMAL	TRANSDERMAL FILM, CONTROLLED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
905HNO1SIH	DIMETHYLAMINOETHYL METHACRYLATE - BUTYL METHACRYLATE - METHYL METHACRYLATE COPOLYMER:TRANSDERMAL:PATCH:NA	TRANSDERMAL	TRANSDERMAL PATCH	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
905HNO1SIH	DIMETHYLAMINOETHYL METHACRYLATE - BUTYL METHACRYLATE - METHYL METHACRYLATE COPOLYMER:TRANSDERMAL:PATCH, ELECTRICALLY CONTROLLED:MG	TRANSDERMAL	10MG TRANSDERMAL PATCH, ELECTRICALLY CONTROLLED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
9XZ8H6N6OH	HYDROXYPROPYL CELLULOSE, UNSPECIFIED:ORAL:CAPSULE:MG	ORAL	3MG ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
9XZ8H6N6OH	HYDROXYPROPYL CELLULOSE, UNSPECIFIED:ORAL:TABLET:MG	ORAL	95MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
9XZ8H6N6OH	HYDROXYPROPYL CELLULOSE, UNSPECIFIED:ORAL:TABLET, EXTENDED RELEASE:MG	ORAL	140MG ORAL TABLET, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
36SFW2JZ0W	HYPROMELLOSE 2910 (15 MPA.S):ORAL:CAPSULE:mg	ORAL	35.2mg ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
36SFW2JZ0W	HYPROMELLOSE 2910 (15 MPA.S):ORAL:CAPSULE, DELAYED ACTION:MG	ORAL	54.4MG ORAL CAPSULE, DELAYED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
36SFW2JZ0W	HYPROMELLOSE 2910 (15 MPA.S):ORAL:CAPSULE, DELAYED RELEASE:MG	ORAL	13MG ORAL CAPSULE, DELAYED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
36SFW2JZ0W	HYPROMELLOSE 2910 (15 MPA.S):ORAL:CAPSULE, EXTENDED RELEASE:mg	ORAL	35.348mg ORAL CAPSULE, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
36SFW2JZ0W	HYPROMELLOSE 2910 (15 MPA.S):ORAL:CAPSULE, HARD GELATIN:MG	ORAL	3MG ORAL CAPSULE, HARD GELATIN	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
36SFW2JZ0W	HYPROMELLOSE 2910 (15 MPA.S):ORAL:FILM, SOLUBLE:MG	ORAL	15.53MG ORAL FILM, SOLUBLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
36SFW2JZ0W	HYPROMELLOSE 2910 (15 MPA.S):ORAL:TABLET:MG	ORAL	52.5MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
36SFW2JZ0W	HYPROMELLOSE 2910 (15 MPA.S):ORAL:TABLET, DELAYED RELEASE:mg	ORAL	30mg ORAL TABLET, DELAYED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
36SFW2JZ0W	HYPROMELLOSE 2910 (15 MPA.S):ORAL:TABLET, EXTENDED RELEASE:mg	ORAL	255.85mg ORAL TABLET, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
36SFW2JZ0W	HYPROMELLOSE 2910 (15 MPA.S):ORAL:TABLET, FILM COATED:MG	ORAL	19.68MG ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
36SFW2JZ0W	HYPROMELLOSE 2910 (15 MPA.S):ORAL:TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE:mg	ORAL	9mg ORAL TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
36SFW2JZ0W	HYPROMELLOSE 2910 (15 MPA.S):SUBLINGUAL:FILM:mg	SUBLINGUAL	3.42mg SUBLINGUAL FILM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
36SFW2JZ0W	HYPROMELLOSE 2910 (15 MPA.S):VAGINAL:INSERT:MG	VAGINAL	36.76MG VAGINAL INSERT	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
36SFW2JZ0W	HYPROMELLOSE 2910 (15 MPA.S):VAGINAL:TABLET:mg	VAGINAL	53.35mg VAGINAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
2PP9364507	BETADEX SULFOBUTYL ETHER SODIUM:INTRAMUSCULAR:POWDER, FOR INJECTION SOLUTION, LYOPHILIZED, WITH ADDITIVES:%W/V	INTRAMUSCULAR	44.15%W/V INTRAMUSCULAR POWDER, FOR INJECTION SOLUTION, LYOPHILIZED, WITH ADDITIVES	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
2PP9364507	BETADEX SULFOBUTYL ETHER SODIUM:INTRAVENOUS:INJECTION:%	INTRAVENOUS	25% INTRAVENOUS INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
2PP9364507	BETADEX SULFOBUTYL ETHER SODIUM:INTRAVENOUS:POWDER:%	INTRAVENOUS	27% INTRAVENOUS POWDER	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
2PP9364507	BETADEX SULFOBUTYL ETHER SODIUM:INTRAVENOUS:POWDER, FOR INJECTION SOLUTION:%	INTRAVENOUS	94.1% INTRAVENOUS POWDER, FOR INJECTION SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
2PP9364507	BETADEX SULFOBUTYL ETHER SODIUM:INTRAVENOUS:POWDER, FOR INJECTION SOLUTION, LYOPHILIZED:%	INTRAVENOUS	96.23% INTRAVENOUS POWDER, FOR INJECTION SOLUTION, LYOPHILIZED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
2PP9364507	BETADEX SULFOBUTYL ETHER SODIUM:IV - SC:SOLUTION, INJECTION:MG/ML	IV - SC	400MG/ML IV - SC SOLUTION, INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
2PP9364507	BETADEX SULFOBUTYL ETHER SODIUM:IV(INFUSION):POWDER, FOR INJECTION SOLUTION, LYOPHILIZED:%	IV(INFUSION)	16% IV(INFUSION) POWDER, FOR INJECTION SOLUTION, LYOPHILIZED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
J41CSQ7QDS	ZINC:IV - SC:INJECTION, SOLUTION:UG/1ML	IV - SC	19.6UG/1ML IV - SC INJECTION, SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=Z
J41CSQ7QDS	ZINC:SUBCUTANEOUS:INJECTABLE:%	SUBCUTANEOUS	0.0065% SUBCUTANEOUS INJECTABLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=Z
J41CSQ7QDS	ZINC:SUBCUTANEOUS:INJECTION:%	SUBCUTANEOUS	0.0055% SUBCUTANEOUS INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=Z
J41CSQ7QDS	ZINC:SUBCUTANEOUS:SOLUTION, INJECTION:%	SUBCUTANEOUS	0.007% SUBCUTANEOUS SOLUTION, INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=Z
J41CSQ7QDS	ZINC:SUBCUTANEOUS:SUSPENSION, INJECTION:%	SUBCUTANEOUS	1.09% SUBCUTANEOUS SUSPENSION, INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=Z
2ZA36H0S2V	YELLOW WAX:INTRAMUSCULAR:INJECTION, SUSTAINED ACTION:%	INTRAMUSCULAR	4.8% INTRAMUSCULAR INJECTION, SUSTAINED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=Y
2ZA36H0S2V	YELLOW WAX:ORAL:CAPSULE:MG	ORAL	10MG ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=Y
2ZA36H0S2V	YELLOW WAX:ORAL:CAPSULE, EXTENDED RELEASE:MG	ORAL	80.67MG ORAL CAPSULE, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=Y
2ZA36H0S2V	YELLOW WAX:ORAL:CAPSULE, SOFT GELATIN:MG	ORAL	16.8MG ORAL CAPSULE, SOFT GELATIN	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=Y
2ZA36H0S2V	YELLOW WAX:ORAL:CAPSULE, SOFT GELATIN LIQUID-FILLED:MG	ORAL	2.09MG ORAL CAPSULE, SOFT GELATIN LIQUID-FILLED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=Y
2ZA36H0S2V	YELLOW WAX:ORAL:CAPSULE, SUSTAINED ACTION:MG	ORAL	15.79MG ORAL CAPSULE, SUSTAINED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=Y
2ZA36H0S2V	YELLOW WAX:ORAL:TABLET:MG	ORAL	3.22MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=Y
2ZA36H0S2V	YELLOW WAX:ORAL:TABLET, COATED:MG	ORAL	0.65MG ORAL TABLET, COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=Y
2ZA36H0S2V	YELLOW WAX:ORAL:TABLET, DELAYED ACTION, ENTERIC COATED:MG	ORAL	0.1MG ORAL TABLET, DELAYED ACTION, ENTERIC COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=Y
2ZA36H0S2V	YELLOW WAX:TOPICAL:EMULSION, CREAM:%W/W	TOPICAL	5%W/W TOPICAL EMULSION, CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=Y
2ZA36H0S2V	YELLOW WAX:TOPICAL:OINTMENT:%W/W	TOPICAL	20%W/W TOPICAL OINTMENT	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=Y
2ZA36H0S2V	YELLOW WAX:VAGINAL:CREAM, EMULSION, SUSTAINED RELEASE:MG/GM	VAGINAL	10MG/GM VAGINAL CREAM, EMULSION, SUSTAINED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=Y
3G6A5W338E	CAFFEINE:NASAL:SPRAY, METERED:%	NASAL	1% NASAL SPRAY, METERED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
3G6A5W338E	CAFFEINE:OPHTHALMIC:SOLUTION:%	OPHTHALMIC	2% OPHTHALMIC SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
554127163Y	SODIUM DODECYLBENZENESULFONATE:TOPICAL:SHAMPOO, SUSPENSION:NA	TOPICAL	TOPICAL SHAMPOO, SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
8I089SAH3T	STARCH, POTATO:ORAL:TABLET:MG	ORAL	80.59MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
8I089SAH3T	STARCH, POTATO:ORAL:TABLET, COATED:MG	ORAL	2.1MG ORAL TABLET, COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
8I089SAH3T	STARCH, POTATO:ORAL:TABLET, EXTENDED RELEASE:NA	ORAL	ORAL TABLET, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
9M64UO4C25	CETEARYL ETHYLHEXANOATE:TOPICAL:CREAM:%W/W	TOPICAL	1%W/W TOPICAL CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
9M64UO4C25	CETEARYL ETHYLHEXANOATE:TOPICAL:EMULSION, CREAM:%W/W	TOPICAL	3%W/W TOPICAL EMULSION, CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
11628IH70O	POLYETHYLENE GLYCOL 200000:SUBLINGUAL:FILM:MG	SUBLINGUAL	13.5MG SUBLINGUAL FILM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
11628IH70O	POLYETHYLENE OXIDE 200000:ORAL:TABLET, CONTROLLED RELEASE:MG	ORAL	149.39MG ORAL TABLET, CONTROLLED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
11628IH70O	POLYETHYLENE OXIDE 200000:ORAL:TABLET, EXTENDED RELEASE:MG	ORAL	345MG ORAL TABLET, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
11628IH70O	POLYETHYLENE OXIDE 200000:SUBLINGUAL:FILM:mg	SUBLINGUAL	27.1mg SUBLINGUAL FILM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
5K3991GVWI	POLYETHYLENE OXIDE 2000000:ORAL:TABLET, CONTROLLED RELEASE:MG	ORAL	54.66MG ORAL TABLET, CONTROLLED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
5K3991GVWI	POLYETHYLENE OXIDE 2000000:ORAL:TABLET, EXTENDED RELEASE:MG	ORAL	70MG ORAL TABLET, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
6JS9U5611X	STANNOUS TARTRATE:INTRAVENOUS:INJECTION:%	INTRAVENOUS	0.008% INTRAVENOUS INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
7A314HQM0I	PENTETIC ACID:INTRATHECAL:INJECTABLE:NA	INTRATHECAL	INTRATHECAL INJECTABLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
7A314HQM0I	PENTETIC ACID:INTRAVENOUS:INJECTION:%	INTRAVENOUS	0.2% INTRAVENOUS INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
O03S90U1F2	TOCOPHERSOLAN:OPHTHALMIC:SOLUTION:%	OPHTHALMIC	0.5% OPHTHALMIC SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
O03S90U1F2	TOCOPHERSOLAN:ORAL:CAPSULE:MG	ORAL	300MG ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
O03S90U1F2	TOCOPHERSOLAN:ORAL:CAPSULE, SOFT GELATIN:MG	ORAL	282MG ORAL CAPSULE, SOFT GELATIN	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
O03S90U1F2	TOCOPHERSOLAN:ORAL:SOLUTION:MG/1ML	ORAL	120MG/1ML ORAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
O03S90U1F2	TOCOPHERSOLAN:ORAL:TABLET:MG	ORAL	42.5MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
O03S90U1F2	TOCOPHERSOLAN:ORAL:TABLET, FILM COATED:MG	ORAL	28.33MG ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
O03S90U1F2	TOCOPHERSOLAN:TOPICAL:SOLUTION:NA	TOPICAL	TOPICAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
00BT03FSO2	PEG-8 CAPRYLIC/CAPRIC GLYCERIDES:ORAL:CAPSULE, SOFT GELATIN:MG	ORAL	70MG ORAL CAPSULE, SOFT GELATIN	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
00BT03FSO2	PEG-8 CAPRYLIC/CAPRIC GLYCERIDES:ORAL:SOLUTION:MG/1ML	ORAL	61.2MG/1ML ORAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
N0MWT4C7WH	METHYL GLUCETH-10:TOPICAL:CREAM, AUGMENTED:%W/W	TOPICAL	5%W/W TOPICAL CREAM, AUGMENTED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
4V4H07OJB9	STEARIC DIETHANOLAMIDE:ORAL:TABLET:NA	ORAL	ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
4V4H07OJB9	STEARIC DIETHANOLAMIDE:TOPICAL:EMULSION, CREAM:NA	TOPICAL	TOPICAL EMULSION, CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
7EV65EAW6H	LANOLIN:OPHTHALMIC:OINTMENT:%	OPHTHALMIC	3% OPHTHALMIC OINTMENT	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
7EV65EAW6H	LANOLIN:RECTAL:OINTMENT:%	RECTAL	14% RECTAL OINTMENT	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
7EV65EAW6H	LANOLIN:TOPICAL:EMULSION, CREAM:%W/W	TOPICAL	2%W/W TOPICAL EMULSION, CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
7EV65EAW6H	LANOLIN:TOPICAL:LOTION:%W/W	TOPICAL	1.5%W/W TOPICAL LOTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
7EV65EAW6H	LANOLIN:TOPICAL:OINTMENT:NA	TOPICAL	TOPICAL OINTMENT	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
7EV65EAW6H	LANOLIN:TRANSDERMAL:OINTMENT:%	TRANSDERMAL	35% TRANSDERMAL OINTMENT	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
7EV65EAW6H	LANOLIN:VAGINAL:EMULSION, CREAM:%	VAGINAL	2% VAGINAL EMULSION, CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
0W44HYL8T5	DIISOPROPANOLAMINE:TOPICAL:CREAM:%W/W	TOPICAL	0.12%W/W TOPICAL CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
0W44HYL8T5	DIISOPROPANOLAMINE:TOPICAL:CREAM, EMULSION, SUSTAINED RELEASE:%W/W	TOPICAL	0.12%W/W TOPICAL CREAM, EMULSION, SUSTAINED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
0W44HYL8T5	DIISOPROPANOLAMINE:TOPICAL:EMULSION, CREAM:%W/W	TOPICAL	0.12%W/W TOPICAL EMULSION, CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
0W44HYL8T5	DIISOPROPANOLAMINE:TOPICAL:GEL:%W/W	TOPICAL	1.5%W/W TOPICAL GEL	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
0W44HYL8T5	DIISOPROPANOLAMINE:TOPICAL:SOLUTION:NA	TOPICAL	TOPICAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
5655G9Y8AQ	POLYETHYLENE GLYCOL 300:IM - IV:INJECTION:%	IM - IV	50% IM - IV INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
5655G9Y8AQ	POLYETHYLENE GLYCOL 300:IM, IV:INJECTION:ML	IM, IV	0.5ML IM, IV INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
5655G9Y8AQ	POLYETHYLENE GLYCOL 300:INTRAMUSCULAR:INJECTION:%W/V	INTRAMUSCULAR	55%W/V INTRAMUSCULAR INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
5655G9Y8AQ	POLYETHYLENE GLYCOL 300:INTRAVENOUS:INJECTION:%	INTRAVENOUS	65% INTRAVENOUS INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
5655G9Y8AQ	POLYETHYLENE GLYCOL 300:INTRAVENOUS:LIQUID:MG/5ML	INTRAVENOUS	3250MG/5ML INTRAVENOUS LIQUID	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
5655G9Y8AQ	POLYETHYLENE GLYCOL 300:INTRAVENOUS:SOLUTION, INJECTION:%	INTRAVENOUS	4.42% INTRAVENOUS SOLUTION, INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
5655G9Y8AQ	POLYETHYLENE GLYCOL 300:INTRAVENOUS INFUSION:INJECTION:QS	INTRAVENOUS INFUSION	QS INTRAVENOUS INFUSION INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
5655G9Y8AQ	POLYETHYLENE GLYCOL 300:IV(INFUSION):INJECTABLE:%	IV(INFUSION)	13.5% IV(INFUSION) INJECTABLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
5655G9Y8AQ	POLYETHYLENE GLYCOL 300:IV(INFUSION):INJECTION:%	IV(INFUSION)	65% IV(INFUSION) INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
5655G9Y8AQ	POLYETHYLENE GLYCOL 300:IV(INFUSION):SOLUTION, INJECTION:%	IV(INFUSION)	44.22% IV(INFUSION) SOLUTION, INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
5655G9Y8AQ	POLYETHYLENE GLYCOL 300:OPHTHALMIC:OINTMENT:NA	OPHTHALMIC	OPHTHALMIC OINTMENT	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
5655G9Y8AQ	POLYETHYLENE GLYCOL 300:OPHTHALMIC:SOLUTION:NA	OPHTHALMIC	OPHTHALMIC SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
5655G9Y8AQ	POLYETHYLENE GLYCOL 300:ORAL:TABLET:MG	ORAL	1.5MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
5655G9Y8AQ	POLYETHYLENE GLYCOL 300:ORAL:TABLET, FILM COATED:MG	ORAL	1.5MG ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
5655G9Y8AQ	POLYETHYLENE GLYCOL 300:TOPICAL:LOTION:%W/W	TOPICAL	2%W/W TOPICAL LOTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
5655G9Y8AQ	POLYETHYLENE GLYCOL 300:TOPICAL:OINTMENT:%W/W	TOPICAL	57%W/W TOPICAL OINTMENT	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
5655G9Y8AQ	POLYETHYLENE GLYCOL 300:TOPICAL:SOLUTION:%W/W	TOPICAL	29.7%W/W TOPICAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
ZT934N0X4W	CYSTEINE HYDROCHLORIDE:INTRAVENOUS:INJECTION:%	INTRAVENOUS	0.2% INTRAVENOUS INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
ZT934N0X4W	CYSTEINE HYDROCHLORIDE:INTRAVENOUS:POWDER, FOR INJECTION SOLUTION:%	INTRAVENOUS	0.1% INTRAVENOUS POWDER, FOR INJECTION SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
ZT934N0X4W	CYSTEINE HYDROCHLORIDE:INTRAVENOUS:POWDER, FOR INJECTION SOLUTION, LYOPHILIZED:%	INTRAVENOUS	0.38% INTRAVENOUS POWDER, FOR INJECTION SOLUTION, LYOPHILIZED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
ZT934N0X4W	CYSTEINE HYDROCHLORIDE:IV(INFUSION):INFUSION:%	IV(INFUSION)	0.025% IV(INFUSION) INFUSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
ZT934N0X4W	CYSTEINE HYDROCHLORIDE:IV(INFUSION):INJECTION:%	IV(INFUSION)	0.025% IV(INFUSION) INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
ZT934N0X4W	CYSTEINE HYDROCHLORIDE:IV(INFUSION):POWDER, FOR INJECTION SOLUTION, LYOPHILIZED:%	IV(INFUSION)	0.1% IV(INFUSION) POWDER, FOR INJECTION SOLUTION, LYOPHILIZED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
ZT934N0X4W	CYSTEINE HYDROCHLORIDE:IV(INFUSION):SOLUTION:%	IV(INFUSION)	0.025% IV(INFUSION) SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
ZT934N0X4W	CYSTEINE HYDROCHLORIDE:ORAL:CAPSULE:NA	ORAL	ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
ZT934N0X4W	CYSTEINE HYDROCHLORIDE:ORAL:TABLET, EXTENDED RELEASE:MG	ORAL	16MG ORAL TABLET, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
ZT934N0X4W	CYSTEINE HYDROCHLORIDE:ORAL:TABLET, FILM COATED, EXTENDED RELEASE:MG	ORAL	12MG ORAL TABLET, FILM COATED, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
ZT934N0X4W	CYSTEINE HYDROCHLORIDE:ORAL:TABLET, SUSTAINED ACTION, FILM COATED:MG	ORAL	16.2MG ORAL TABLET, SUSTAINED ACTION, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
N863NB338G	BENZYL BENZOATE:INTRAMUSCULAR:INJECTABLE:%V/V	INTRAMUSCULAR	46%V/V INTRAMUSCULAR INJECTABLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
N863NB338G	BENZYL BENZOATE:INTRAMUSCULAR:INJECTION:%W/V	INTRAMUSCULAR	50%W/V INTRAMUSCULAR INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
N863NB338G	BENZYL BENZOATE:INTRAMUSCULAR:INJECTION, SOLUTION:%V/V	INTRAMUSCULAR	46%V/V INTRAMUSCULAR INJECTION, SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
N863NB338G	BENZYL BENZOATE:INTRAMUSCULAR:SOLUTION:%W/V	INTRAMUSCULAR	44.7%W/V INTRAMUSCULAR SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
N863NB338G	BENZYL BENZOATE:INTRAMUSCULAR:SOLUTION, INJECTION:%W/V	INTRAMUSCULAR	15%W/V INTRAMUSCULAR SOLUTION, INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
N863NB338G	BENZYL BENZOATE:ORAL:CAPSULE:NA	ORAL	ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
UZH29XGA8G	LIME OIL:ORAL:SOLUTION, ELIXIR:NA	ORAL	ORAL SOLUTION, ELIXIR	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
UZH29XGA8G	LIME OIL:SUBLINGUAL:TABLET:MG	SUBLINGUAL	0.001MG SUBLINGUAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
K0KQV10C35	POVIDONE K25:ORAL:CAPSULE:mg	ORAL	30mg ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
K0KQV10C35	POVIDONE K25:ORAL:CAPSULE, EXTENDED RELEASE:MG	ORAL	21.36MG ORAL CAPSULE, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
K0KQV10C35	POVIDONE K25:ORAL:CAPSULE, SUSTAINED ACTION:MG	ORAL	17.79MG ORAL CAPSULE, SUSTAINED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
K0KQV10C35	POVIDONE K25:ORAL:CAPSULE, SUSTAINED ACTION, HARD GELATIN:MG	ORAL	12.6MG ORAL CAPSULE, SUSTAINED ACTION, HARD GELATIN	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
K0KQV10C35	POVIDONE K25:ORAL:GRANULE, FOR ORAL SUSPENSION:MG	ORAL	0.27MG ORAL GRANULE, FOR ORAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
K0KQV10C35	POVIDONE K25:ORAL:SOLUTION:MG/5ML	ORAL	500MG/5ML ORAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
K0KQV10C35	POVIDONE K25:ORAL:SUSPENSION, SUSTAINED ACTION:MG/206.84 MG	ORAL	0.27MG/206.84 MG ORAL SUSPENSION, SUSTAINED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
K0KQV10C35	POVIDONE K25:ORAL:TABLET:MG	ORAL	52MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
K0KQV10C35	POVIDONE K25:ORAL:TABLET (IMMED./COMP. RELEASE), FILM COATED:MG	ORAL	54.47MG ORAL TABLET (IMMED./COMP. RELEASE), FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
K0KQV10C35	POVIDONE K25:ORAL:TABLET, CHEWABLE:MG	ORAL	0.45MG ORAL TABLET, CHEWABLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
K0KQV10C35	POVIDONE K25:ORAL:TABLET, COATED:MG	ORAL	40MG ORAL TABLET, COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
K0KQV10C35	POVIDONE K25:ORAL:TABLET, DELAYED ACTION:MG	ORAL	12.3MG ORAL TABLET, DELAYED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
K0KQV10C35	POVIDONE K25:ORAL:TABLET, DELAYED ACTION, ENTERIC COATED:MG	ORAL	20MG ORAL TABLET, DELAYED ACTION, ENTERIC COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
K0KQV10C35	POVIDONE K25:ORAL:TABLET, DELAYED RELEASE:MG	ORAL	0.4MG ORAL TABLET, DELAYED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
K0KQV10C35	POVIDONE K25:ORAL:TABLET, EXTENDED RELEASE:MG	ORAL	5MG ORAL TABLET, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
K0KQV10C35	POVIDONE K25:ORAL:TABLET, FILM COATED:MG	ORAL	22.5MG ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
K0KQV10C35	POVIDONE K25:ORAL:TABLET, MULTILAYER, EXTENDED RELEASE:MG	ORAL	1.8MG ORAL TABLET, MULTILAYER, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
K0KQV10C35	POVIDONE K25:ORAL:TABLET, SUSTAINED ACTION, COATED:NA	ORAL	ORAL TABLET, SUSTAINED ACTION, COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
CZ1032CEKR	DISODIUM CITRATE SESQUIHYDRATE:INTRAVENOUS:INJECTION:%	INTRAVENOUS	0.18% INTRAVENOUS INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
TUF2IVW3M2	POLOXAMER 407:INTRATYMPANIC:SUSPENSION:%W/W	INTRATYMPANIC	15.1%W/W INTRATYMPANIC SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
TUF2IVW3M2	POLOXAMER 407:OPHTHALMIC:SOLUTION:%	OPHTHALMIC	0.2% OPHTHALMIC SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
TUF2IVW3M2	POLOXAMER 407:OPHTHALMIC:SUSPENSION, DROPS:%	OPHTHALMIC	0.1% OPHTHALMIC SUSPENSION, DROPS	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
TUF2IVW3M2	POLOXAMER 407:ORAL:CAPSULE:MG	ORAL	30MG ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
TUF2IVW3M2	POLOXAMER 407:ORAL:CAPSULE (IMMED./COMP. RELEASE):MG	ORAL	1MG ORAL CAPSULE (IMMED./COMP. RELEASE)	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
TUF2IVW3M2	POLOXAMER 407:ORAL:CAPSULE, DELAYED ACTION:MG	ORAL	40MG ORAL CAPSULE, DELAYED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
TUF2IVW3M2	POLOXAMER 407:ORAL:CAPSULE, ENTERIC COATED PELLETS:MG	ORAL	5MG ORAL CAPSULE, ENTERIC COATED PELLETS	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
TUF2IVW3M2	POLOXAMER 407:ORAL:CAPSULE, EXTENDED RELEASE:MG	ORAL	8.96MG ORAL CAPSULE, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
TUF2IVW3M2	POLOXAMER 407:ORAL:POWDER, FOR ORAL SUSPENSION:MG/25.169GM	ORAL	126MG/25.169GM ORAL POWDER, FOR ORAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
TUF2IVW3M2	POLOXAMER 407:ORAL:SOLUTION:MG/5ML	ORAL	50MG/5ML ORAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
TUF2IVW3M2	POLOXAMER 407:ORAL:SUSPENSION:MG/5ML	ORAL	2.5MG/5ML ORAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
TUF2IVW3M2	POLOXAMER 407:ORAL:TABLET:MG	ORAL	110MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
TUF2IVW3M2	POLOXAMER 407:ORAL:TABLET, FILM COATED:MG	ORAL	106.7MG ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
TUF2IVW3M2	POLOXAMER 407:PERIODONTAL:GEL:%	PERIODONTAL	15.5% PERIODONTAL GEL	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
TUF2IVW3M2	POLOXAMER 407:TOPICAL:CREAM:%W/W	TOPICAL	1%W/W TOPICAL CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
TUF2IVW3M2	POLOXAMER 407:TOPICAL:EMULSION, CREAM:%W/W	TOPICAL	1%W/W TOPICAL EMULSION, CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
TUF2IVW3M2	POLOXAMER 407:TOPICAL:GEL:%W/W	TOPICAL	0.2%W/W TOPICAL GEL	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
TUF2IVW3M2	POLOXAMER 407:TOPICAL:LOTION:%W/W	TOPICAL	1%W/W TOPICAL LOTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
TUF2IVW3M2	POLOXAMER 407:TOPICAL:OPHTHALMIC SUSPENSION DOSAGE FORM:%W/V	TOPICAL	0.5%W/V TOPICAL OPHTHALMIC SUSPENSION DOSAGE FORM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
TUF2IVW3M2	POLOXAMER 407:TOPICAL:SOLUTION:%W/W	TOPICAL	0.2%W/W TOPICAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
TUF2IVW3M2	POLOXAMER 407:TOPICAL:SUSPENSION, DROPS:%W/W	TOPICAL	0.1%W/W TOPICAL SUSPENSION, DROPS	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
BJ169U4NLG	CEDAR LEAF OIL:TOPICAL:SHAMPOO:%W/W	TOPICAL	30%W/W TOPICAL SHAMPOO	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
990TYB331R	TRICHLOROMONOFLUOROMETHANE:INHALATION:AEROSOL, SPRAY:%	INHALATION	24.4% INHALATION AEROSOL, SPRAY	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
990TYB331R	TRICHLOROMONOFLUOROMETHANE:NASAL:AEROSOL, METERED:%	NASAL	2.37% NASAL AEROSOL, METERED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
990TYB331R	TRICHLOROMONOFLUOROMETHANE:ORAL:AEROSOL:%	ORAL	65% ORAL AEROSOL	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
990TYB331R	TRICHLOROMONOFLUOROMETHANE:TOPICAL:AEROSOL:NA	TOPICAL	TOPICAL AEROSOL	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
990TYB331R	TRICHLOROMONOFLUOROMETHANE:TOPICAL:AEROSOL, SPRAY:NA	TOPICAL	TOPICAL AEROSOL, SPRAY	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
5QB0T2IUN0	ALUMINUM HYDROXIDE:ORAL:CAPSULE:NA	ORAL	ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
5QB0T2IUN0	ALUMINUM HYDROXIDE:ORAL:TABLET:MG	ORAL	15MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
5QB0T2IUN0	ALUMINUM HYDROXIDE:TOPICAL:CREAM:%W/W	TOPICAL	0.25%W/W TOPICAL CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
5QB0T2IUN0	ALUMINUM HYDROXIDE:TOPICAL:EMULSION, CREAM:%W/W	TOPICAL	5%W/W TOPICAL EMULSION, CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
5QB0T2IUN0	ALUMINUM HYDROXIDE:TOPICAL:OINTMENT:NA	TOPICAL	TOPICAL OINTMENT	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
5EYA69XGAT	HYPROMELLOSE 2906 (4000 MPA.S):BUCCAL:GUM, CHEWING:MG	BUCCAL	14MG BUCCAL GUM, CHEWING	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
5EYA69XGAT	HYPROMELLOSE 2906 (4000 MPA.S):BUCCAL:TABLET:MG	BUCCAL	2.25MG BUCCAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
5EYA69XGAT	HYPROMELLOSE 2906 (4000 MPA.S):OPHTHALMIC:SOLUTION:%	OPHTHALMIC	0.5% OPHTHALMIC SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
5EYA69XGAT	HYPROMELLOSE 2906 (4000 MPA.S):ORAL:CAPSULE:MG	ORAL	3.5MG ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
5EYA69XGAT	HYPROMELLOSE 2906 (4000 MPA.S):ORAL:GRANULE, ENTERIC COATED:MG	ORAL	33.2MG ORAL GRANULE, ENTERIC COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
5EYA69XGAT	HYPROMELLOSE 2906 (4000 MPA.S):ORAL:TABLET:MG	ORAL	50MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
5EYA69XGAT	HYPROMELLOSE 2906 (4000 MPA.S):ORAL:TABLET, EXTENDED RELEASE:MG	ORAL	17MG ORAL TABLET, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
5EYA69XGAT	HYPROMELLOSE 2906 (4000 MPA.S):ORAL:TABLET, FILM COATED:NA	ORAL	ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
6B5VVT93AR	DICHLOROTETRAFLUOROETHANE:INHALATION:AEROSOL, METERED:%	INHALATION	51.12% INHALATION AEROSOL, METERED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
6B5VVT93AR	DICHLOROTETRAFLUOROETHANE:INHALATION:AEROSOL, SPRAY:%	INHALATION	53.28% INHALATION AEROSOL, SPRAY	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
6B5VVT93AR	DICHLOROTETRAFLUOROETHANE:NASAL:AEROSOL:NA	NASAL	NASAL AEROSOL	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
6B5VVT93AR	DICHLOROTETRAFLUOROETHANE:NASAL:AEROSOL, METERED:%	NASAL	0.86% NASAL AEROSOL, METERED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
6B5VVT93AR	DICHLOROTETRAFLUOROETHANE:RECTAL:AEROSOL, METERED:%	RECTAL	9% RECTAL AEROSOL, METERED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
6B5VVT93AR	DICHLOROTETRAFLUOROETHANE:SUBLINGUAL:AEROSOL:NA	SUBLINGUAL	SUBLINGUAL AEROSOL	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
6B5VVT93AR	DICHLOROTETRAFLUOROETHANE:TOPICAL:AEROSOL:NA	TOPICAL	TOPICAL AEROSOL	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
6B5VVT93AR	DICHLOROTETRAFLUOROETHANE:TOPICAL:AEROSOL, METERED:NA	TOPICAL	TOPICAL AEROSOL, METERED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
6B5VVT93AR	DICHLOROTETRAFLUOROETHANE:TOPICAL:EMULSION, AEROSOL FOAM:NA	TOPICAL	TOPICAL EMULSION, AEROSOL FOAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
6B5VVT93AR	DICHLOROTETRAFLUOROETHANE:VAGINAL:EMULSION, AEROSOL FOAM:%	VAGINAL	80% VAGINAL EMULSION, AEROSOL FOAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
UH2K6W1Y64	LACTITOL MONOHYDRATE:ORAL:CAPSULE:MG	ORAL	235MG ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
FST467XS7D	SACCHARIN:INHALATION:AEROSOL, METERED:%	INHALATION	0.11% INHALATION AEROSOL, METERED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
FST467XS7D	SACCHARIN:INHALATION:AEROSOL, SPRAY:%	INHALATION	0.045% INHALATION AEROSOL, SPRAY	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
FST467XS7D	SACCHARIN:INHALATION:SOLUTION:NA	INHALATION	INHALATION SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
FST467XS7D	SACCHARIN:ORAL:AEROSOL:NA	ORAL	ORAL AEROSOL	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
FST467XS7D	SACCHARIN:ORAL:GRANULE, FOR SUSPENSION:MG	ORAL	16MG ORAL GRANULE, FOR SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
FST467XS7D	SACCHARIN:ORAL:POWDER, FOR SOLUTION:NA	ORAL	ORAL POWDER, FOR SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
FST467XS7D	SACCHARIN:ORAL:SOLUTION:MG/1ML	ORAL	10MG/1ML ORAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
FST467XS7D	SACCHARIN:ORAL:SOLUTION, ELIXIR:NA	ORAL	ORAL SOLUTION, ELIXIR	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
FST467XS7D	SACCHARIN:ORAL:SUSPENSION:MG/5ML	ORAL	12.5MG/5ML ORAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
FST467XS7D	SACCHARIN:ORAL:SYRUP:MG/5ML	ORAL	3.5MG/5ML ORAL SYRUP	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
FST467XS7D	SACCHARIN:ORAL:TABLET:MG	ORAL	1.6MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
FST467XS7D	SACCHARIN:ORAL:TABLET (IMMED./COMP. RELEASE), UNCOATED, CHEWABLE:NA	ORAL	ORAL TABLET (IMMED./COMP. RELEASE), UNCOATED, CHEWABLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
FST467XS7D	SACCHARIN:ORAL:TABLET, EXTENDED RELEASE:MG	ORAL	8MG ORAL TABLET, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
FST467XS7D	SACCHARIN:SUBLINGUAL:TABLET:MG	SUBLINGUAL	0.2MG SUBLINGUAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
FST467XS7D	SACCHARIN:TOPICAL:OINTMENT:%W/W	TOPICAL	0.5%W/W TOPICAL OINTMENT	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
FST467XS7D	SACCHARIN:TOPICAL:SOLUTION:NA	TOPICAL	TOPICAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
LAV5U5022Y	METHYL SALICYLATE:ORAL:CAPSULE:MG	ORAL	16MG ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
LAV5U5022Y	METHYL SALICYLATE:ORAL:SOLUTION:NA	ORAL	ORAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
LAV5U5022Y	METHYL SALICYLATE:TOPICAL:GEL:%W/W	TOPICAL	0.05%W/W TOPICAL GEL	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
PJL7EVT77G	GENTISIC ACID ETHANOLAMINE:INTRAVENOUS:INJECTION:%	INTRAVENOUS	2% INTRAVENOUS INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
PJL7EVT77G	GENTISIC ACID ETHANOLAMINE:IV(INFUSION):INJECTION:%	IV(INFUSION)	2% IV(INFUSION) INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
7CV7WJK4UI	SODIUM STEARYL FUMARATE:ORAL:CAPSULE:MG	ORAL	15MG ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
7CV7WJK4UI	SODIUM STEARYL FUMARATE:ORAL:CAPSULE, DELAYED ACTION:MG	ORAL	4.92MG ORAL CAPSULE, DELAYED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
7CV7WJK4UI	SODIUM STEARYL FUMARATE:ORAL:CAPSULE, DELAYED RELEASE:mg	ORAL	2.713mg ORAL CAPSULE, DELAYED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
7CV7WJK4UI	SODIUM STEARYL FUMARATE:ORAL:CAPSULE, EXTENDED RELEASE:MG	ORAL	7MG ORAL CAPSULE, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
7CV7WJK4UI	SODIUM STEARYL FUMARATE:ORAL:CAPSULE, GELATIN COATED:MG	ORAL	3MG ORAL CAPSULE, GELATIN COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
7CV7WJK4UI	SODIUM STEARYL FUMARATE:ORAL:CAPSULE, HARD GELATIN:MG	ORAL	2.7MG ORAL CAPSULE, HARD GELATIN	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
7CV7WJK4UI	SODIUM STEARYL FUMARATE:ORAL:GRANULE, FOR ORAL SOLUTION:MG/SACHET	ORAL	18.2MG/SACHET ORAL GRANULE, FOR ORAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
7CV7WJK4UI	SODIUM STEARYL FUMARATE:ORAL:POWDER, FOR ORAL SUSPENSION:MG/5ML	ORAL	3.74MG/5ML ORAL POWDER, FOR ORAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
7CV7WJK4UI	SODIUM STEARYL FUMARATE:ORAL:TABLET:MG	ORAL	29.3MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
7CV7WJK4UI	SODIUM STEARYL FUMARATE:ORAL:TABLET (IMMED./COMP. RELEASE), FILM COATED:MG	ORAL	12MG ORAL TABLET (IMMED./COMP. RELEASE), FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
7CV7WJK4UI	SODIUM STEARYL FUMARATE:ORAL:TABLET (IMMED./COMP. RELEASE), UNCOATED, CHEWABLE:MG	ORAL	6.3MG ORAL TABLET (IMMED./COMP. RELEASE), UNCOATED, CHEWABLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
7CV7WJK4UI	SODIUM STEARYL FUMARATE:ORAL:TABLET, COATED:MG	ORAL	1.18MG ORAL TABLET, COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
7CV7WJK4UI	SODIUM STEARYL FUMARATE:ORAL:TABLET, CONTROLLED RELEASE:MG	ORAL	2MG ORAL TABLET, CONTROLLED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
7CV7WJK4UI	SODIUM STEARYL FUMARATE:ORAL:TABLET, DELAYED ACTION:MG	ORAL	7MG ORAL TABLET, DELAYED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
7CV7WJK4UI	SODIUM STEARYL FUMARATE:ORAL:TABLET, DELAYED ACTION, ENTERIC COATED:MG	ORAL	27MG ORAL TABLET, DELAYED ACTION, ENTERIC COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
7CV7WJK4UI	SODIUM STEARYL FUMARATE:ORAL:TABLET, DELAYED RELEASE:mg	ORAL	9mg ORAL TABLET, DELAYED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
7CV7WJK4UI	SODIUM STEARYL FUMARATE:ORAL:TABLET, EXTENDED RELEASE:MG	ORAL	20MG ORAL TABLET, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
7CV7WJK4UI	SODIUM STEARYL FUMARATE:ORAL:TABLET, FILM COATED:MG	ORAL	26MG ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
7CV7WJK4UI	SODIUM STEARYL FUMARATE:ORAL:TABLET, ORALLY DISINTEGRATING:MG	ORAL	17.1MG ORAL TABLET, ORALLY DISINTEGRATING	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
7CV7WJK4UI	SODIUM STEARYL FUMARATE:ORAL:TABLET, SUSTAINED ACTION:MG	ORAL	8.9MG ORAL TABLET, SUSTAINED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
7CV7WJK4UI	SODIUM STEARYL FUMARATE:ORAL:TABLET, SUSTAINED ACTION, COATED:MG	ORAL	4MG ORAL TABLET, SUSTAINED ACTION, COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
7CV7WJK4UI	SODIUM STEARYL FUMARATE:ORAL:TABLET, SUSTAINED ACTION, FILM COATED:MG	ORAL	16MG ORAL TABLET, SUSTAINED ACTION, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
7CV7WJK4UI	SODIUM STEARYL FUMARATE:SUBLINGUAL:TABLET:MG	SUBLINGUAL	10MG SUBLINGUAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
4HI65O1DUA	ENTSUFON:TOPICAL:EMULSION:NA	TOPICAL	TOPICAL EMULSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
4HI65O1DUA	ENTSUFON:TOPICAL:SPONGE:NA	TOPICAL	TOPICAL SPONGE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
03J11K103C	ALGELDRATE:ORAL:TABLET:MG	ORAL	85MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
03J11K103C	ALGELDRATE:TOPICAL:EMULSION, CREAM:%W/W	TOPICAL	5%W/W TOPICAL EMULSION, CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
2944357O2O	TRAGACANTH:BUCCAL/SUBLINGUAL:TABLET:MG	BUCCAL/SUBLINGUAL	5MG BUCCAL/SUBLINGUAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
2944357O2O	TRAGACANTH:ORAL:POWDER, FOR SUSPENSION:MG/1ML	ORAL	60MG/1ML ORAL POWDER, FOR SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
2944357O2O	TRAGACANTH:ORAL:SUSPENSION:MG/5ML	ORAL	17MG/5ML ORAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
2944357O2O	TRAGACANTH:ORAL:SUSPENSION, EXTENDED RELEASE:MG/5ML	ORAL	17.5MG/5ML ORAL SUSPENSION, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
2944357O2O	TRAGACANTH:ORAL:SUSPENSION, SUSTAINED ACTION:MG/5ML	ORAL	22.5MG/5ML ORAL SUSPENSION, SUSTAINED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
2944357O2O	TRAGACANTH:ORAL:SYRUP:NA	ORAL	ORAL SYRUP	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
2944357O2O	TRAGACANTH:ORAL:TABLET:MG	ORAL	5MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
2944357O2O	TRAGACANTH:ORAL:TABLET, COATED:MG	ORAL	7.5MG ORAL TABLET, COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
2944357O2O	TRAGACANTH:ORAL:TABLET, DELAYED ACTION, ENTERIC COATED:NA	ORAL	ORAL TABLET, DELAYED ACTION, ENTERIC COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
R12CBM0EIZ	CARNAUBA WAX:BUCCAL:GUM, CHEWING:MG	BUCCAL	0.55MG BUCCAL GUM, CHEWING	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
R12CBM0EIZ	CARNAUBA WAX:ORAL:CAPSULE, EXTENDED RELEASE:MG	ORAL	80.67MG ORAL CAPSULE, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
R12CBM0EIZ	CARNAUBA WAX:ORAL:CAPSULE, SUSTAINED ACTION:MG	ORAL	0.75MG ORAL CAPSULE, SUSTAINED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
R12CBM0EIZ	CARNAUBA WAX:ORAL:SOLUTION:NA	ORAL	ORAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
R12CBM0EIZ	CARNAUBA WAX:ORAL:TABLET:MG	ORAL	167.8MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
R12CBM0EIZ	CARNAUBA WAX:ORAL:TABLET (IMMED./COMP. RELEASE), FILM COATED:NA	ORAL	ORAL TABLET (IMMED./COMP. RELEASE), FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
R12CBM0EIZ	CARNAUBA WAX:ORAL:TABLET (IMMED./COMP. RELEASE), UNCOATED, CHEWABLE:MG	ORAL	31.13MG ORAL TABLET (IMMED./COMP. RELEASE), UNCOATED, CHEWABLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
R12CBM0EIZ	CARNAUBA WAX:ORAL:TABLET, COATED:MG	ORAL	0.92MG ORAL TABLET, COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
R12CBM0EIZ	CARNAUBA WAX:ORAL:TABLET, CONTROLLED RELEASE:NA	ORAL	ORAL TABLET, CONTROLLED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
R12CBM0EIZ	CARNAUBA WAX:ORAL:TABLET, DELAYED ACTION:MG	ORAL	5MG ORAL TABLET, DELAYED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
R12CBM0EIZ	CARNAUBA WAX:ORAL:TABLET, DELAYED ACTION, ENTERIC COATED:MG	ORAL	230MG ORAL TABLET, DELAYED ACTION, ENTERIC COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
R12CBM0EIZ	CARNAUBA WAX:ORAL:TABLET, DELAYED RELEASE:MG	ORAL	0.43MG ORAL TABLET, DELAYED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
R12CBM0EIZ	CARNAUBA WAX:ORAL:TABLET, EXTENDED RELEASE:MG	ORAL	290MG ORAL TABLET, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
R12CBM0EIZ	CARNAUBA WAX:ORAL:TABLET, FILM COATED:MG	ORAL	5MG ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
R12CBM0EIZ	CARNAUBA WAX:ORAL:TABLET, MULTILAYER, EXTENDED RELEASE:MG	ORAL	0.11MG ORAL TABLET, MULTILAYER, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
R12CBM0EIZ	CARNAUBA WAX:ORAL:TABLET, REPEAT ACTION:MG	ORAL	0.046MG ORAL TABLET, REPEAT ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
R12CBM0EIZ	CARNAUBA WAX:ORAL:TABLET, SUGAR COATED:MG	ORAL	0.09MG ORAL TABLET, SUGAR COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
R12CBM0EIZ	CARNAUBA WAX:ORAL:TABLET, SUSTAINED ACTION:MG	ORAL	300MG ORAL TABLET, SUSTAINED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
R12CBM0EIZ	CARNAUBA WAX:ORAL:TABLET, SUSTAINED ACTION, COATED:MG	ORAL	140MG ORAL TABLET, SUSTAINED ACTION, COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
R12CBM0EIZ	CARNAUBA WAX:ORAL:TABLET, SUSTAINED ACTION, FILM COATED:MG	ORAL	0.25MG ORAL TABLET, SUSTAINED ACTION, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
TTL6G7LIWZ	LYSINE ACETATE:IV(INFUSION):INJECTION:%	IV(INFUSION)	0.76% IV(INFUSION) INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
TTL6G7LIWZ	LYSINE ACETATE:IV(INFUSION):SOLUTION, INJECTION:%	IV(INFUSION)	0.31% IV(INFUSION) SOLUTION, INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
DK6Y9P42IN	SODIUM PROPIONATE:ORAL:CAPSULE:MG	ORAL	0.36MG ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
DK6Y9P42IN	SODIUM PROPIONATE:ORAL:CAPSULE, SUSTAINED ACTION:NA	ORAL	ORAL CAPSULE, SUSTAINED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
DK6Y9P42IN	SODIUM PROPIONATE:ORAL:CONCENTRATE:NA	ORAL	ORAL CONCENTRATE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
DK6Y9P42IN	SODIUM PROPIONATE:ORAL:POWDER, FOR RECONSTITUTION:NA	ORAL	ORAL POWDER, FOR RECONSTITUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
DK6Y9P42IN	SODIUM PROPIONATE:ORAL:POWDER, FOR SOLUTION:NA	ORAL	ORAL POWDER, FOR SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
DK6Y9P42IN	SODIUM PROPIONATE:ORAL:POWDER, FOR SUSPENSION:MG/5ML	ORAL	12.5MG/5ML ORAL POWDER, FOR SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
DK6Y9P42IN	SODIUM PROPIONATE:ORAL:SOLUTION:MG/5ML	ORAL	5MG/5ML ORAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
DK6Y9P42IN	SODIUM PROPIONATE:ORAL:SUSPENSION:NA	ORAL	ORAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
DK6Y9P42IN	SODIUM PROPIONATE:ORAL:SYRUP:MG/5ML	ORAL	10MG/5ML ORAL SYRUP	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
DK6Y9P42IN	SODIUM PROPIONATE:ORAL:TABLET, SUSTAINED ACTION, COATED:NA	ORAL	ORAL TABLET, SUSTAINED ACTION, COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
UEP843BRCQ	POLYETHYLENE GLYCOL 900:TOPICAL:OINTMENT:NA	TOPICAL	TOPICAL OINTMENT	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
UEP843BRCQ	POLYETHYLENE GLYCOL 900:TOPICAL:SOLUTION:%W/W	TOPICAL	0.95%W/W TOPICAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
J7I2T6IV1N	SPEARMINT:ORAL:SOLUTION:%	ORAL	0.7% ORAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
J7I2T6IV1N	SPEARMINT:ORAL:TABLET (IMMED./COMP. RELEASE), UNCOATED, CHEWABLE:MG	ORAL	2.1MG ORAL TABLET (IMMED./COMP. RELEASE), UNCOATED, CHEWABLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
J7I2T6IV1N	SPEARMINT:ORAL:TABLET, ORALLY DISINTEGRATING:MG	ORAL	0.063MG ORAL TABLET, ORALLY DISINTEGRATING	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
BBX060AN9V	HYDROGEN PEROXIDE:ORAL:TABLET, DELAYED ACTION:NA	ORAL	ORAL TABLET, DELAYED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
BBX060AN9V	HYDROGEN PEROXIDE:TOPICAL:SOLUTION:%W/W	TOPICAL	0.16%W/W TOPICAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
BBX060AN9V	HYDROGEN PEROXIDE:TOPICAL:SPONGE:NA	TOPICAL	TOPICAL SPONGE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
EWQ57Q8I5X	LACTOSE MONOHYDRATE:BUCCAL:TABLET:MG	BUCCAL	21.38MG BUCCAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
EWQ57Q8I5X	LACTOSE MONOHYDRATE:IM - IV:INJECTABLE:%	IM - IV	2.5% IM - IV INJECTABLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
EWQ57Q8I5X	LACTOSE MONOHYDRATE:IM - IV:INJECTION:%	IM - IV	2.5% IM - IV INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
EWQ57Q8I5X	LACTOSE MONOHYDRATE:IM - IV:POWDER:%	IM - IV	2.75% IM - IV POWDER	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
EWQ57Q8I5X	LACTOSE MONOHYDRATE:IM - IV:POWDER, FOR INJECTION SOLUTION:%	IM - IV	2.5% IM - IV POWDER, FOR INJECTION SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
EWQ57Q8I5X	LACTOSE MONOHYDRATE:IM - IV - SC:POWDER, FOR INJECTION SOLUTION, LYOPHILIZED:%	IM - IV - SC	10.7% IM - IV - SC POWDER, FOR INJECTION SOLUTION, LYOPHILIZED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
EWQ57Q8I5X	LACTOSE MONOHYDRATE:IM - SC:INJECTION:%	IM - SC	2.1% IM - SC INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
EWQ57Q8I5X	LACTOSE MONOHYDRATE:INHALATION:POWDER:MG	INHALATION	24.95MG INHALATION POWDER	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
EWQ57Q8I5X	LACTOSE MONOHYDRATE:INHALATION:POWDER:%	INHALATION	2.5% INHALATION POWDER	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
EWQ57Q8I5X	LACTOSE MONOHYDRATE:INHALATION:POWDER, FOR INHALATION:MG/INH	INHALATION	2.2MG/INH INHALATION POWDER, FOR INHALATION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
EWQ57Q8I5X	LACTOSE MONOHYDRATE:INTRACAVITARY:POWDER, FOR INJECTION SOLUTION, LYOPHILIZED:%	INTRACAVITARY	4.54% INTRACAVITARY POWDER, FOR INJECTION SOLUTION, LYOPHILIZED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
EWQ57Q8I5X	LACTOSE MONOHYDRATE:INTRAMUSCULAR:INJECTION:%	INTRAMUSCULAR	5% INTRAMUSCULAR INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
EWQ57Q8I5X	LACTOSE MONOHYDRATE:INTRAMUSCULAR:POWDER, FOR INJECTION SOLUTION:%	INTRAMUSCULAR	10.7% INTRAMUSCULAR POWDER, FOR INJECTION SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
EWQ57Q8I5X	LACTOSE MONOHYDRATE:INTRAMUSCULAR:POWDER, FOR INJECTION SOLUTION, LYOPHILIZED:%	INTRAMUSCULAR	5% INTRAMUSCULAR POWDER, FOR INJECTION SOLUTION, LYOPHILIZED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
EWQ57Q8I5X	LACTOSE MONOHYDRATE:INTRAVENOUS:INJECTION:%	INTRAVENOUS	4.5% INTRAVENOUS INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
EWQ57Q8I5X	LACTOSE MONOHYDRATE:INTRAVENOUS:POWDER, FOR INJECTION SOLUTION:%	INTRAVENOUS	10.7% INTRAVENOUS POWDER, FOR INJECTION SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
EWQ57Q8I5X	LACTOSE MONOHYDRATE:INTRAVENOUS:POWDER, FOR INJECTION SOLUTION, LYOPHILIZED:%	INTRAVENOUS	69% INTRAVENOUS POWDER, FOR INJECTION SOLUTION, LYOPHILIZED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
EWQ57Q8I5X	LACTOSE MONOHYDRATE:INTRAVENOUS INFUSION:INJECTION:%W/W	INTRAVENOUS INFUSION	66.67%W/W INTRAVENOUS INFUSION INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
EWQ57Q8I5X	LACTOSE MONOHYDRATE:IV - SC:INJECTION:%	IV - SC	4.9% IV - SC INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
EWQ57Q8I5X	LACTOSE MONOHYDRATE:IV(INFUSION):INJECTABLE:%	IV(INFUSION)	4.5% IV(INFUSION) INJECTABLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
EWQ57Q8I5X	LACTOSE MONOHYDRATE:IV(INFUSION):POWDER, FOR INJECTION SOLUTION:%	IV(INFUSION)	20% IV(INFUSION) POWDER, FOR INJECTION SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
EWQ57Q8I5X	LACTOSE MONOHYDRATE:IV(INFUSION):POWDER, FOR INJECTION SOLUTION, LYOPHILIZED:MG/Vial	IV(INFUSION)	394.9MG/Vial IV(INFUSION) POWDER, FOR INJECTION SOLUTION, LYOPHILIZED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
EWQ57Q8I5X	LACTOSE MONOHYDRATE:IV(INFUSION):POWDER, FOR INJECTION SUSPENSION, LYOPHILIZED:%W/V	IV(INFUSION)	9.5%W/V IV(INFUSION) POWDER, FOR INJECTION SUSPENSION, LYOPHILIZED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
EWQ57Q8I5X	LACTOSE MONOHYDRATE:ORAL:CAPSULE:MG	ORAL	430.42MG ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
EWQ57Q8I5X	LACTOSE MONOHYDRATE:ORAL:CAPSULE (IMMED./COMP. RELEASE):MG	ORAL	112MG ORAL CAPSULE (IMMED./COMP. RELEASE)	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
EWQ57Q8I5X	LACTOSE MONOHYDRATE:ORAL:CAPSULE (IMMED./COMP. RELEASE), HARD GELATIN:MG	ORAL	166.77MG ORAL CAPSULE (IMMED./COMP. RELEASE), HARD GELATIN	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
EWQ57Q8I5X	LACTOSE MONOHYDRATE:ORAL:CAPSULE, COATED:MG	ORAL	99.5MG ORAL CAPSULE, COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
EWQ57Q8I5X	LACTOSE MONOHYDRATE:ORAL:CAPSULE, COATED PELLETS:MG	ORAL	33.09MG ORAL CAPSULE, COATED PELLETS	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
EWQ57Q8I5X	LACTOSE MONOHYDRATE:ORAL:CAPSULE, COATED, HARD GELATIN:MG	ORAL	85MG ORAL CAPSULE, COATED, HARD GELATIN	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
EWQ57Q8I5X	LACTOSE MONOHYDRATE:ORAL:CAPSULE, COATED, SOFT GELATIN:MG	ORAL	178.91MG ORAL CAPSULE, COATED, SOFT GELATIN	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
EWQ57Q8I5X	LACTOSE MONOHYDRATE:ORAL:CAPSULE, DELAYED ACTION:MG	ORAL	125.09MG ORAL CAPSULE, DELAYED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
EWQ57Q8I5X	LACTOSE MONOHYDRATE:ORAL:CAPSULE, DELAYED ACTION, COATED:mg	ORAL	16mg ORAL CAPSULE, DELAYED ACTION, COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
EWQ57Q8I5X	LACTOSE MONOHYDRATE:ORAL:CAPSULE, DELAYED RELEASE:MG	ORAL	76.4MG ORAL CAPSULE, DELAYED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
EWQ57Q8I5X	LACTOSE MONOHYDRATE:ORAL:CAPSULE, ENTERIC COATED PELLETS:MG	ORAL	100MG ORAL CAPSULE, ENTERIC COATED PELLETS	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
EWQ57Q8I5X	LACTOSE MONOHYDRATE:ORAL:CAPSULE, EXTENDED RELEASE:MG	ORAL	536.4MG ORAL CAPSULE, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
EWQ57Q8I5X	LACTOSE MONOHYDRATE:ORAL:CAPSULE, HARD GELATIN:MG	ORAL	199.5MG ORAL CAPSULE, HARD GELATIN	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
EWQ57Q8I5X	LACTOSE MONOHYDRATE:ORAL:CAPSULE, SUSTAINED ACTION:MG	ORAL	147.6MG ORAL CAPSULE, SUSTAINED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
EWQ57Q8I5X	LACTOSE MONOHYDRATE:ORAL:CAPSULE, SUSTAINED ACTION, HARD GELATIN:MG	ORAL	18.8MG ORAL CAPSULE, SUSTAINED ACTION, HARD GELATIN	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
EWQ57Q8I5X	LACTOSE MONOHYDRATE:ORAL:DISPERSIBLE TABLET:MG	ORAL	543.6MG ORAL DISPERSIBLE TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
EWQ57Q8I5X	LACTOSE MONOHYDRATE:ORAL:GRANULE:MG	ORAL	109.8MG ORAL GRANULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
EWQ57Q8I5X	LACTOSE MONOHYDRATE:ORAL:GRANULE, FOR ORAL SOLUTION:MG/SACHET	ORAL	1691.8MG/SACHET ORAL GRANULE, FOR ORAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
EWQ57Q8I5X	LACTOSE MONOHYDRATE:ORAL:GRANULE, FOR SUSPENSION:NA	ORAL	ORAL GRANULE, FOR SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
EWQ57Q8I5X	LACTOSE MONOHYDRATE:ORAL:POWDER, FOR SUSPENSION:NA	ORAL	ORAL POWDER, FOR SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
EWQ57Q8I5X	LACTOSE MONOHYDRATE:ORAL:TABLET:MG	ORAL	708.9MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
EWQ57Q8I5X	LACTOSE MONOHYDRATE:ORAL:TABLET (IMMED./COMP. RELEASE), COATED:MG	ORAL	254MG ORAL TABLET (IMMED./COMP. RELEASE), COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
EWQ57Q8I5X	LACTOSE MONOHYDRATE:ORAL:TABLET (IMMED./COMP. RELEASE), FILM COATED:MG	ORAL	269.8MG ORAL TABLET (IMMED./COMP. RELEASE), FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
EWQ57Q8I5X	LACTOSE MONOHYDRATE:ORAL:TABLET (IMMED./COMP. RELEASE), UNCOATED, CHEWABLE:MG	ORAL	100MG ORAL TABLET (IMMED./COMP. RELEASE), UNCOATED, CHEWABLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
EWQ57Q8I5X	LACTOSE MONOHYDRATE:ORAL:TABLET, CHEWABLE:MG	ORAL	126.1MG ORAL TABLET, CHEWABLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
EWQ57Q8I5X	LACTOSE MONOHYDRATE:ORAL:TABLET, COATED:MG	ORAL	346.5MG ORAL TABLET, COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
EWQ57Q8I5X	LACTOSE MONOHYDRATE:ORAL:TABLET, CONTROLLED RELEASE:MG	ORAL	152.75MG ORAL TABLET, CONTROLLED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
EWQ57Q8I5X	LACTOSE MONOHYDRATE:ORAL:TABLET, DELAYED ACTION:MG	ORAL	385.55MG ORAL TABLET, DELAYED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
EWQ57Q8I5X	LACTOSE MONOHYDRATE:ORAL:TABLET, DELAYED ACTION, ENTERIC COATED:MG	ORAL	157.95MG ORAL TABLET, DELAYED ACTION, ENTERIC COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
EWQ57Q8I5X	LACTOSE MONOHYDRATE:ORAL:TABLET, DELAYED RELEASE:mg	ORAL	245mg ORAL TABLET, DELAYED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
EWQ57Q8I5X	LACTOSE MONOHYDRATE:ORAL:TABLET, ENTERIC COATED PARTICLES:MG	ORAL	150MG ORAL TABLET, ENTERIC COATED PARTICLES	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
EWQ57Q8I5X	LACTOSE MONOHYDRATE:ORAL:TABLET, EXTENDED RELEASE:MG	ORAL	538MG ORAL TABLET, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
EWQ57Q8I5X	LACTOSE MONOHYDRATE:ORAL:TABLET, FILM COATED:MG	ORAL	587.44MG ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
EWQ57Q8I5X	LACTOSE MONOHYDRATE:ORAL:TABLET, FILM COATED, EXTENDED RELEASE:MG	ORAL	72.14MG ORAL TABLET, FILM COATED, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
EWQ57Q8I5X	LACTOSE MONOHYDRATE:ORAL:TABLET, FOR SUSPENSION:MG	ORAL	4.9MG ORAL TABLET, FOR SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
EWQ57Q8I5X	LACTOSE MONOHYDRATE:ORAL:TABLET, MULTILAYER, COATED:MG	ORAL	22.7MG ORAL TABLET, MULTILAYER, COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
EWQ57Q8I5X	LACTOSE MONOHYDRATE:ORAL:TABLET, ORALLY DISINTEGRATING:MG	ORAL	29.75MG ORAL TABLET, ORALLY DISINTEGRATING	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
EWQ57Q8I5X	LACTOSE MONOHYDRATE:ORAL:TABLET, REPEAT ACTION:MG	ORAL	155.28MG ORAL TABLET, REPEAT ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
EWQ57Q8I5X	LACTOSE MONOHYDRATE:ORAL:TABLET, SUSTAINED ACTION:MG	ORAL	299.2MG ORAL TABLET, SUSTAINED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
EWQ57Q8I5X	LACTOSE MONOHYDRATE:ORAL:TABLET, SUSTAINED ACTION, FILM COATED:MG	ORAL	260MG ORAL TABLET, SUSTAINED ACTION, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
EWQ57Q8I5X	LACTOSE MONOHYDRATE:ORAL:TABLET, SUSTAINED RELEASE, FILM COATED:MG	ORAL	81.9MG ORAL TABLET, SUSTAINED RELEASE, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
EWQ57Q8I5X	LACTOSE MONOHYDRATE:ORAL-20:TABLET:mg	ORAL-20	288.75mg ORAL-20 TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
EWQ57Q8I5X	LACTOSE MONOHYDRATE:RESPIRATORY (INHALATION):POWDER:MG	RESPIRATORY (INHALATION)	12.327MG RESPIRATORY (INHALATION) POWDER	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
EWQ57Q8I5X	LACTOSE MONOHYDRATE:RESPIRATORY (INHALATION):POWDER, FOR INHALATION:%	RESPIRATORY (INHALATION)	2% RESPIRATORY (INHALATION) POWDER, FOR INHALATION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
EWQ57Q8I5X	LACTOSE MONOHYDRATE:SUBCUTANEOUS:POWDER, FOR INJECTION SOLUTION:%	SUBCUTANEOUS	10.7% SUBCUTANEOUS POWDER, FOR INJECTION SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
EWQ57Q8I5X	LACTOSE MONOHYDRATE:SUBLINGUAL:TABLET:MG	SUBLINGUAL	191.76MG SUBLINGUAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
EWQ57Q8I5X	LACTOSE MONOHYDRATE:SUBLINGUAL:TABLET (IMMED./COMP. RELEASE), UNCOATED, BUCCAL:MG	SUBLINGUAL	160.4MG SUBLINGUAL TABLET (IMMED./COMP. RELEASE), UNCOATED, BUCCAL	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
EWQ57Q8I5X	LACTOSE MONOHYDRATE:VAGINAL:EMULSION, CREAM:NA	VAGINAL	VAGINAL EMULSION, CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
EWQ57Q8I5X	LACTOSE MONOHYDRATE:VAGINAL:INSERT:MG	VAGINAL	210MG VAGINAL INSERT	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
EWQ57Q8I5X	LACTOSE MONOHYDRATE:VAGINAL:TABLET:MG	VAGINAL	596MG VAGINAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
EWQ57Q8I5X	LACTOSE MONOHYDRATE:VAGINAL:TABLET, FILM COATED:MG	VAGINAL	17.9MG VAGINAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
R0ZB2556P8	TOCOPHEROL:INTRAVENOUS:EMULSION, INJECTION:MG/1000ML	INTRAVENOUS	225MG/1000ML INTRAVENOUS EMULSION, INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
R0ZB2556P8	TOCOPHEROL:ORAL:CAPSULE:NA	ORAL	ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
R0ZB2556P8	TOCOPHEROL:ORAL:TABLET:MG	ORAL	0.08MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
R0ZB2556P8	TOCOPHEROL:TOPICAL:OINTMENT:NA	TOPICAL	TOPICAL OINTMENT	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
AZE05TDV2V	DIETHANOLAMINE:IV(INFUSION):INJECTION:%W/V	IV(INFUSION)	0.3%W/V IV(INFUSION) INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
AZE05TDV2V	DIETHANOLAMINE:OPHTHALMIC:SOLUTION:NA	OPHTHALMIC	OPHTHALMIC SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
AZE05TDV2V	DIETHANOLAMINE:TOPICAL:EMULSION, CREAM:%W/W	TOPICAL	0.3%W/W TOPICAL EMULSION, CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
257THB963H	HYDROGENATED PALM OIL:RECTAL:SUPPOSITORY:NA	RECTAL	RECTAL SUPPOSITORY	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
257THB963H	HYDROGENATED PALM OIL:VAGINAL:GEL:%	VAGINAL	1.13% VAGINAL GEL	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
4AQJ3LG584	FD&C BLUE NO. 2--ALUMINUM LAKE:ORAL:CAPSULE:MG	ORAL	0.22MG ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
4AQJ3LG584	FD&C BLUE NO. 2--ALUMINUM LAKE:ORAL:CAPSULE, DELAYED ACTION, ENTERIC COATED:NA	ORAL	ORAL CAPSULE, DELAYED ACTION, ENTERIC COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
4AQJ3LG584	FD&C BLUE NO. 2--ALUMINUM LAKE:ORAL:CAPSULE, ENTERIC COATED PELLETS:MG	ORAL	3.5MG ORAL CAPSULE, ENTERIC COATED PELLETS	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
4AQJ3LG584	FD&C BLUE NO. 2--ALUMINUM LAKE:ORAL:CAPSULE, SUSTAINED ACTION:NA	ORAL	ORAL CAPSULE, SUSTAINED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
4AQJ3LG584	FD&C BLUE NO. 2--ALUMINUM LAKE:ORAL:TABLET:MG	ORAL	9MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
4AQJ3LG584	FD&C BLUE NO. 2--ALUMINUM LAKE:ORAL:TABLET (IMMED./COMP. RELEASE), FILM COATED:MG	ORAL	1.81MG ORAL TABLET (IMMED./COMP. RELEASE), FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
4AQJ3LG584	FD&C BLUE NO. 2--ALUMINUM LAKE:ORAL:TABLET (IMMED./COMP. RELEASE), UNCOATED, CHEWABLE:MG	ORAL	1.25MG ORAL TABLET (IMMED./COMP. RELEASE), UNCOATED, CHEWABLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
4AQJ3LG584	FD&C BLUE NO. 2--ALUMINUM LAKE:ORAL:TABLET, COATED:MG	ORAL	0.75MG ORAL TABLET, COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
4AQJ3LG584	FD&C BLUE NO. 2--ALUMINUM LAKE:ORAL:TABLET, CONTROLLED RELEASE:MG	ORAL	0.55MG ORAL TABLET, CONTROLLED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
4AQJ3LG584	FD&C BLUE NO. 2--ALUMINUM LAKE:ORAL:TABLET, DELAYED ACTION:MG	ORAL	0.2MG ORAL TABLET, DELAYED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
4AQJ3LG584	FD&C BLUE NO. 2--ALUMINUM LAKE:ORAL:TABLET, DELAYED ACTION, ENTERIC COATED:MG	ORAL	0.05MG ORAL TABLET, DELAYED ACTION, ENTERIC COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
4AQJ3LG584	FD&C BLUE NO. 2--ALUMINUM LAKE:ORAL:TABLET, DELAYED RELEASE:MG	ORAL	0.19MG ORAL TABLET, DELAYED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
4AQJ3LG584	FD&C BLUE NO. 2--ALUMINUM LAKE:ORAL:TABLET, EXTENDED RELEASE:mg	ORAL	2mg ORAL TABLET, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
4AQJ3LG584	FD&C BLUE NO. 2--ALUMINUM LAKE:ORAL:TABLET, FILM COATED:MG	ORAL	1.25MG ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
4AQJ3LG584	FD&C BLUE NO. 2--ALUMINUM LAKE:ORAL:TABLET, ORALLY DISINTEGRATING:MG	ORAL	4.7MG ORAL TABLET, ORALLY DISINTEGRATING	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
4AQJ3LG584	FD&C BLUE NO. 2--ALUMINUM LAKE:ORAL:TABLET, SUSTAINED ACTION:MG	ORAL	7MG ORAL TABLET, SUSTAINED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
4AQJ3LG584	FD&C BLUE NO. 2--ALUMINUM LAKE:ORAL:TABLET, SUSTAINED ACTION, FILM COATED:NA	ORAL	ORAL TABLET, SUSTAINED ACTION, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
4AQJ3LG584	FD&C BLUE NO. 2--ALUMINUM LAKE:ORAL:TABLET, UNCOATED, TROCHE:NA	ORAL	ORAL TABLET, UNCOATED, TROCHE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
4AQJ3LG584	FD&C BLUE NO. 2--ALUMINUM LAKE:SUBLINGUAL:TABLET:mg	SUBLINGUAL	0.07mg SUBLINGUAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
QN83US2B0N	ASCORBYL PALMITATE:ORAL:CAPSULE:MG	ORAL	12MG ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
QN83US2B0N	ASCORBYL PALMITATE:ORAL:TABLET:MG	ORAL	0.52MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
QN83US2B0N	ASCORBYL PALMITATE:RECTAL:SUPPOSITORY:MG	RECTAL	5.6MG RECTAL SUPPOSITORY	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
QN83US2B0N	ASCORBYL PALMITATE:TOPICAL:EMULSION, CREAM:%W/W	TOPICAL	0.02%W/W TOPICAL EMULSION, CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
QN83US2B0N	ASCORBYL PALMITATE:TOPICAL:PATCH:MG	TOPICAL	0.04MG TOPICAL PATCH	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
QN83US2B0N	ASCORBYL PALMITATE:TOPICAL:SOLUTION:%W/W	TOPICAL	0.004%W/W TOPICAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
ZF94AP8MEY	HYDROGENATED CASTOR OIL:ORAL:CAPSULE:MG	ORAL	10MG ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
ZF94AP8MEY	HYDROGENATED CASTOR OIL:ORAL:CAPSULE, EXTENDED RELEASE:MG	ORAL	24MG ORAL CAPSULE, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
ZF94AP8MEY	HYDROGENATED CASTOR OIL:ORAL:CAPSULE, SUSTAINED ACTION:MG	ORAL	410.82MG ORAL CAPSULE, SUSTAINED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
ZF94AP8MEY	HYDROGENATED CASTOR OIL:ORAL:TABLET:MG	ORAL	40MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
ZF94AP8MEY	HYDROGENATED CASTOR OIL:ORAL:TABLET, DELAYED ACTION:MG	ORAL	3MG ORAL TABLET, DELAYED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
ZF94AP8MEY	HYDROGENATED CASTOR OIL:ORAL:TABLET, DELAYED ACTION, ENTERIC COATED:MG	ORAL	1.3MG ORAL TABLET, DELAYED ACTION, ENTERIC COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
ZF94AP8MEY	HYDROGENATED CASTOR OIL:ORAL:TABLET, DELAYED RELEASE:MG	ORAL	111.4MG ORAL TABLET, DELAYED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
ZF94AP8MEY	HYDROGENATED CASTOR OIL:ORAL:TABLET, EXTENDED RELEASE:MG	ORAL	232MG ORAL TABLET, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
ZF94AP8MEY	HYDROGENATED CASTOR OIL:ORAL:TABLET, FILM COATED:MG	ORAL	16.8MG ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
ZF94AP8MEY	HYDROGENATED CASTOR OIL:ORAL:TABLET, SUSTAINED ACTION:MG	ORAL	295MG ORAL TABLET, SUSTAINED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
ZF94AP8MEY	HYDROGENATED CASTOR OIL:ORAL:TABLET, SUSTAINED ACTION, COATED:MG	ORAL	5MG ORAL TABLET, SUSTAINED ACTION, COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
ZF94AP8MEY	HYDROGENATED CASTOR OIL:SUBLINGUAL:TABLET:MG	SUBLINGUAL	1.6MG SUBLINGUAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
ZF94AP8MEY	HYDROGENATED CASTOR OIL:TOPICAL:EMULSION, CREAM:NA	TOPICAL	TOPICAL EMULSION, CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
ZF94AP8MEY	HYDROGENATED CASTOR OIL:TOPICAL:LIQUID:%W/W	TOPICAL	1%W/W TOPICAL LIQUID	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
ZF94AP8MEY	HYDROGENATED CASTOR OIL:TOPICAL:SUSPENSION:%W/W	TOPICAL	2%W/W TOPICAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
L6Q8K29L05	ETHYL MALTOL:ORAL:POWDER, FOR SUSPENSION:MG/140ML	ORAL	10MG/140ML ORAL POWDER, FOR SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
L6Q8K29L05	ETHYL MALTOL:ORAL:SOLUTION:MG/15ML	ORAL	15MG/15ML ORAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
L6Q8K29L05	ETHYL MALTOL:ORAL:SOLUTION, ELIXIR:MG/15ML	ORAL	0.6MG/15ML ORAL SOLUTION, ELIXIR	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
L6Q8K29L05	ETHYL MALTOL:ORAL:SUSPENSION, EXTENDED RELEASE:MG/5ML	ORAL	5MG/5ML ORAL SUSPENSION, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
L6Q8K29L05	ETHYL MALTOL:ORAL:SYRUP:MG/5ML	ORAL	30.5MG/5ML ORAL SYRUP	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
22ADO53M6F	SODIUM PHOSPHATE, DIBASIC, ANHYDROUS:BUCCAL:FILM:MG	BUCCAL	0.35MG BUCCAL FILM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
22ADO53M6F	SODIUM PHOSPHATE, DIBASIC, ANHYDROUS:IM - IV:INJECTABLE:%	IM - IV	1.75% IM - IV INJECTABLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
22ADO53M6F	SODIUM PHOSPHATE, DIBASIC, ANHYDROUS:IM - IV:INJECTION:%	IM - IV	13.92% IM - IV INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
22ADO53M6F	SODIUM PHOSPHATE, DIBASIC, ANHYDROUS:IM - IV:POWDER, FOR INJECTION SOLUTION:%	IM - IV	13.92% IM - IV POWDER, FOR INJECTION SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
22ADO53M6F	SODIUM PHOSPHATE, DIBASIC, ANHYDROUS:INTRA-ARTERIAL:SUSPENSION, INJECTION:mg/1mL	INTRA-ARTERIAL	1.42mg/1mL INTRA-ARTERIAL SUSPENSION, INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
22ADO53M6F	SODIUM PHOSPHATE, DIBASIC, ANHYDROUS:INTRA-ARTICULAR:INJECTABLE:%	INTRA-ARTICULAR	0.71% INTRA-ARTICULAR INJECTABLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
22ADO53M6F	SODIUM PHOSPHATE, DIBASIC, ANHYDROUS:INTRALESIONAL:INJECTABLE:%	INTRALESIONAL	0.71% INTRALESIONAL INJECTABLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
22ADO53M6F	SODIUM PHOSPHATE, DIBASIC, ANHYDROUS:INTRALESIONAL:SUSPENSION, INJECTION:mg/1mL	INTRALESIONAL	1.42mg/1mL INTRALESIONAL SUSPENSION, INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
22ADO53M6F	SODIUM PHOSPHATE, DIBASIC, ANHYDROUS:INTRAMUSCULAR:INJECTABLE:%	INTRAMUSCULAR	0.71% INTRAMUSCULAR INJECTABLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
22ADO53M6F	SODIUM PHOSPHATE, DIBASIC, ANHYDROUS:INTRAMUSCULAR:INJECTION:%	INTRAMUSCULAR	27.8% INTRAMUSCULAR INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
22ADO53M6F	SODIUM PHOSPHATE, DIBASIC, ANHYDROUS:INTRAMUSCULAR:INJECTION, SUSPENSION, EXTENDED RELEASE:%	INTRAMUSCULAR	0.2% INTRAMUSCULAR INJECTION, SUSPENSION, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
22ADO53M6F	SODIUM PHOSPHATE, DIBASIC, ANHYDROUS:INTRAMUSCULAR:POWDER, FOR INJECTION SOLUTION:NA	INTRAMUSCULAR	INTRAMUSCULAR POWDER, FOR INJECTION SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
22ADO53M6F	SODIUM PHOSPHATE, DIBASIC, ANHYDROUS:INTRAMUSCULAR:POWDER, FOR INJECTION SOLUTION, LYOPHILIZED:%	INTRAMUSCULAR	0.03% INTRAMUSCULAR POWDER, FOR INJECTION SOLUTION, LYOPHILIZED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
22ADO53M6F	SODIUM PHOSPHATE, DIBASIC, ANHYDROUS:INTRAMUSCULAR:SUSPENSION, INJECTION:mg/1mL	INTRAMUSCULAR	1.42mg/1mL INTRAMUSCULAR SUSPENSION, INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
22ADO53M6F	SODIUM PHOSPHATE, DIBASIC, ANHYDROUS:INTRAOCULAR:INSERT:%	INTRAOCULAR	2.88% INTRAOCULAR INSERT	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
22ADO53M6F	SODIUM PHOSPHATE, DIBASIC, ANHYDROUS:INTRA-SYNOVIAL:SUSPENSION, INJECTION:mg/1mL	INTRA-SYNOVIAL	1.42mg/1mL INTRA-SYNOVIAL SUSPENSION, INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
22ADO53M6F	SODIUM PHOSPHATE, DIBASIC, ANHYDROUS:INTRAVENOUS:INJECTABLE:%	INTRAVENOUS	0.24% INTRAVENOUS INJECTABLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
22ADO53M6F	SODIUM PHOSPHATE, DIBASIC, ANHYDROUS:INTRAVENOUS:INJECTION:MG/VIAL	INTRAVENOUS	40MG/VIAL INTRAVENOUS INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
22ADO53M6F	SODIUM PHOSPHATE, DIBASIC, ANHYDROUS:INTRAVENOUS:INJECTION:%	INTRAVENOUS	27.8% INTRAVENOUS INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
22ADO53M6F	SODIUM PHOSPHATE, DIBASIC, ANHYDROUS:INTRAVENOUS:INJECTION, EMULSION:MG/ML	INTRAVENOUS	2.8MG/ML INTRAVENOUS INJECTION, EMULSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
22ADO53M6F	SODIUM PHOSPHATE, DIBASIC, ANHYDROUS:INTRAVENOUS:POWDER, FOR INJECTION SOLUTION:%	INTRAVENOUS	3.25% INTRAVENOUS POWDER, FOR INJECTION SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
22ADO53M6F	SODIUM PHOSPHATE, DIBASIC, ANHYDROUS:INTRAVENOUS:POWDER, FOR INJECTION SOLUTION, LYOPHILIZED:%	INTRAVENOUS	1.5% INTRAVENOUS POWDER, FOR INJECTION SOLUTION, LYOPHILIZED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
22ADO53M6F	SODIUM PHOSPHATE, DIBASIC, ANHYDROUS:INTRAVENOUS:SOLUTION:%	INTRAVENOUS	0.048% INTRAVENOUS SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
22ADO53M6F	SODIUM PHOSPHATE, DIBASIC, ANHYDROUS:INTRAVENOUS:SOLUTION, INJECTION:%	INTRAVENOUS	0.01% INTRAVENOUS SOLUTION, INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
22ADO53M6F	SODIUM PHOSPHATE, DIBASIC, ANHYDROUS:INTRAVESICAL:SOLUTION, INJECTION:%	INTRAVESICAL	3.83% INTRAVESICAL SOLUTION, INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
22ADO53M6F	SODIUM PHOSPHATE, DIBASIC, ANHYDROUS:IV(INFUSION):INFUSION:%	IV(INFUSION)	0.01% IV(INFUSION) INFUSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
22ADO53M6F	SODIUM PHOSPHATE, DIBASIC, ANHYDROUS:IV(INFUSION):INJECTABLE:%	IV(INFUSION)	0.012% IV(INFUSION) INJECTABLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
22ADO53M6F	SODIUM PHOSPHATE, DIBASIC, ANHYDROUS:IV(INFUSION):INJECTION:%	IV(INFUSION)	4% IV(INFUSION) INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
22ADO53M6F	SODIUM PHOSPHATE, DIBASIC, ANHYDROUS:IV(INFUSION):LIQUID:MG/ML	IV(INFUSION)	0.476MG/ML IV(INFUSION) LIQUID	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
22ADO53M6F	SODIUM PHOSPHATE, DIBASIC, ANHYDROUS:IV(INFUSION):POWDER, FOR INJECTION SOLUTION:%	IV(INFUSION)	13.92% IV(INFUSION) POWDER, FOR INJECTION SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
22ADO53M6F	SODIUM PHOSPHATE, DIBASIC, ANHYDROUS:IV(INFUSION):SOLUTION, INJECTION:%	IV(INFUSION)	0.012% IV(INFUSION) SOLUTION, INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
22ADO53M6F	SODIUM PHOSPHATE, DIBASIC, ANHYDROUS:NASAL:SOLUTION:%	NASAL	0.5% NASAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
22ADO53M6F	SODIUM PHOSPHATE, DIBASIC, ANHYDROUS:NASAL:SPRAY:%	NASAL	0.011% NASAL SPRAY	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
22ADO53M6F	SODIUM PHOSPHATE, DIBASIC, ANHYDROUS:NASAL:SPRAY, METERED:MCG/SPRAY 	NASAL	887.76MCG/SPRAY  NASAL SPRAY, METERED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
22ADO53M6F	SODIUM PHOSPHATE, DIBASIC, ANHYDROUS:NASAL:SPRAY, METERED:%	NASAL	0.5% NASAL SPRAY, METERED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
22ADO53M6F	SODIUM PHOSPHATE, DIBASIC, ANHYDROUS:OPHTHALMIC:SOLUTION:MG/1ML	OPHTHALMIC	5MG/1ML OPHTHALMIC SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
22ADO53M6F	SODIUM PHOSPHATE, DIBASIC, ANHYDROUS:OPHTHALMIC:SOLUTION:%	OPHTHALMIC	1.28% OPHTHALMIC SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
22ADO53M6F	SODIUM PHOSPHATE, DIBASIC, ANHYDROUS:OPHTHALMIC:SOLUTION:%W/V	OPHTHALMIC	0.47%W/V OPHTHALMIC SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
22ADO53M6F	SODIUM PHOSPHATE, DIBASIC, ANHYDROUS:OPHTHALMIC:SOLUTION, DROPS:MG/ML	OPHTHALMIC	5MG/ML OPHTHALMIC SOLUTION, DROPS	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
22ADO53M6F	SODIUM PHOSPHATE, DIBASIC, ANHYDROUS:OPHTHALMIC:SOLUTION, DROPS:%	OPHTHALMIC	1.4% OPHTHALMIC SOLUTION, DROPS	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
22ADO53M6F	SODIUM PHOSPHATE, DIBASIC, ANHYDROUS:OPHTHALMIC:SOLUTION, DROPS:%W/V	OPHTHALMIC	0.5%W/V OPHTHALMIC SOLUTION, DROPS	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
22ADO53M6F	SODIUM PHOSPHATE, DIBASIC, ANHYDROUS:OPHTHALMIC:SUSPENSION:%	OPHTHALMIC	0.25% OPHTHALMIC SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
22ADO53M6F	SODIUM PHOSPHATE, DIBASIC, ANHYDROUS:ORAL:CAPSULE:MG	ORAL	300MG ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
22ADO53M6F	SODIUM PHOSPHATE, DIBASIC, ANHYDROUS:ORAL:CAPSULE, DELAYED RELEASE:MG	ORAL	4.8MG ORAL CAPSULE, DELAYED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
22ADO53M6F	SODIUM PHOSPHATE, DIBASIC, ANHYDROUS:ORAL:CAPSULE, ENTERIC COATED PELLETS:MG	ORAL	2MG ORAL CAPSULE, ENTERIC COATED PELLETS	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
22ADO53M6F	SODIUM PHOSPHATE, DIBASIC, ANHYDROUS:ORAL:FILM, SOLUBLE:MG	ORAL	0.054MG ORAL FILM, SOLUBLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
22ADO53M6F	SODIUM PHOSPHATE, DIBASIC, ANHYDROUS:ORAL:SOLUTION:MG	ORAL	300MG ORAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
22ADO53M6F	SODIUM PHOSPHATE, DIBASIC, ANHYDROUS:ORAL:SOLUTION, SYRUP:MG/1ML	ORAL	17.5MG/1ML ORAL SOLUTION, SYRUP	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
22ADO53M6F	SODIUM PHOSPHATE, DIBASIC, ANHYDROUS:ORAL:SUSPENSION:MG/5ML	ORAL	33MG/5ML ORAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
22ADO53M6F	SODIUM PHOSPHATE, DIBASIC, ANHYDROUS:ORAL:SUSPENSION:mg/1mL	ORAL	6.59mg/1mL ORAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
22ADO53M6F	SODIUM PHOSPHATE, DIBASIC, ANHYDROUS:ORAL:SYRUP:MG/1ML	ORAL	3.5MG/1ML ORAL SYRUP	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
22ADO53M6F	SODIUM PHOSPHATE, DIBASIC, ANHYDROUS:ORAL:TABLET:MG	ORAL	96MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
22ADO53M6F	SODIUM PHOSPHATE, DIBASIC, ANHYDROUS:ORAL:TABLET, EXTENDED RELEASE:MG	ORAL	105MG ORAL TABLET, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
22ADO53M6F	SODIUM PHOSPHATE, DIBASIC, ANHYDROUS:ORAL:TABLET, FILM COATED:MG	ORAL	0.015MG ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
22ADO53M6F	SODIUM PHOSPHATE, DIBASIC, ANHYDROUS:ORAL:TABLET, SUSTAINED ACTION:MG	ORAL	110MG ORAL TABLET, SUSTAINED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
22ADO53M6F	SODIUM PHOSPHATE, DIBASIC, ANHYDROUS:ORAL:TABLET, UNCOATED, LOZENGE:MG	ORAL	31MG ORAL TABLET, UNCOATED, LOZENGE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
22ADO53M6F	SODIUM PHOSPHATE, DIBASIC, ANHYDROUS:ORAL:TABLET, UNCOATED, TROCHE:MG	ORAL	28MG ORAL TABLET, UNCOATED, TROCHE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
22ADO53M6F	SODIUM PHOSPHATE, DIBASIC, ANHYDROUS:SOFT TISSUE:SUSPENSION, INJECTION:mg/1mL	SOFT TISSUE	1.42mg/1mL SOFT TISSUE SUSPENSION, INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
22ADO53M6F	SODIUM PHOSPHATE, DIBASIC, ANHYDROUS:SUBCUTANEOUS:INJECTABLE:%	SUBCUTANEOUS	0.1% SUBCUTANEOUS INJECTABLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
22ADO53M6F	SODIUM PHOSPHATE, DIBASIC, ANHYDROUS:SUBCUTANEOUS:INJECTION:%W/V	SUBCUTANEOUS	0.66%W/V SUBCUTANEOUS INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
22ADO53M6F	SODIUM PHOSPHATE, DIBASIC, ANHYDROUS:SUBCUTANEOUS:POWDER, FOR INJECTION SOLUTION, LYOPHILIZED:%	SUBCUTANEOUS	0.03% SUBCUTANEOUS POWDER, FOR INJECTION SOLUTION, LYOPHILIZED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
22ADO53M6F	SODIUM PHOSPHATE, DIBASIC, ANHYDROUS:SUBCUTANEOUS:SOLUTION, INJECTION:%	SUBCUTANEOUS	0.012% SUBCUTANEOUS SOLUTION, INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
22ADO53M6F	SODIUM PHOSPHATE, DIBASIC, ANHYDROUS:SUBLINGUAL:FILM:mg	SUBLINGUAL	4.066mg SUBLINGUAL FILM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
22ADO53M6F	SODIUM PHOSPHATE, DIBASIC, ANHYDROUS:TOPICAL:EMULSION, AEROSOL FOAM:%W/W	TOPICAL	0.09%W/W TOPICAL EMULSION, AEROSOL FOAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
22ADO53M6F	SODIUM PHOSPHATE, DIBASIC, ANHYDROUS:TOPICAL:EMULSION, CREAM:%W/W	TOPICAL	0.36%W/W TOPICAL EMULSION, CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
22ADO53M6F	SODIUM PHOSPHATE, DIBASIC, ANHYDROUS:TOPICAL:GEL:NA	TOPICAL	TOPICAL GEL	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
22ADO53M6F	SODIUM PHOSPHATE, DIBASIC, ANHYDROUS:TOPICAL:LOTION:NA	TOPICAL	TOPICAL LOTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
22ADO53M6F	SODIUM PHOSPHATE, DIBASIC, ANHYDROUS:TOPICAL:OINTMENT:NA	TOPICAL	TOPICAL OINTMENT	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
22ADO53M6F	SODIUM PHOSPHATE, DIBASIC, ANHYDROUS:TOPICAL:SOLUTION:%W/V	TOPICAL	0.47%W/V TOPICAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
22ADO53M6F	SODIUM PHOSPHATE, DIBASIC, ANHYDROUS:TOPICAL:SOLUTION, DROPS:%W/V	TOPICAL	0.45%W/V TOPICAL SOLUTION, DROPS	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
22ADO53M6F	SODIUM PHOSPHATE, DIBASIC, ANHYDROUS:VAGINAL:CREAM, EMULSION, SUSTAINED RELEASE:%	VAGINAL	0.09% VAGINAL CREAM, EMULSION, SUSTAINED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
ED959S6ACY	INVERT SUGAR:ORAL:CAPSULE:NA	ORAL	ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=I
ED959S6ACY	INVERT SUGAR:ORAL:SOLUTION:%	ORAL	61.2% ORAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=I
ED959S6ACY	INVERT SUGAR:ORAL:SYRUP:%	ORAL	77% ORAL SYRUP	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=I
867H4YOZ8Z	CETEARETH-15:TOPICAL:EMULSION, CREAM:%W/W	TOPICAL	1.25%W/W TOPICAL EMULSION, CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
KEH0A3F75J	HEXYLENE GLYCOL:TOPICAL:EMULSION, CREAM:%W/W	TOPICAL	12%W/W TOPICAL EMULSION, CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
KEH0A3F75J	HEXYLENE GLYCOL:TOPICAL:GEL:%W/W	TOPICAL	2%W/W TOPICAL GEL	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
KEH0A3F75J	HEXYLENE GLYCOL:TOPICAL:OINTMENT:%W/W	TOPICAL	12%W/W TOPICAL OINTMENT	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
KEH0A3F75J	HEXYLENE GLYCOL:TOPICAL:SOLUTION:%W/W	TOPICAL	0.3%W/W TOPICAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
L11K75P92J	ANHYDROUS DIBASIC CALCIUM PHOSPHATE:ORAL:CAPSULE:MG	ORAL	401MG ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
L11K75P92J	ANHYDROUS DIBASIC CALCIUM PHOSPHATE:ORAL:CAPSULE, DELAYED RELEASE:MG	ORAL	381MG ORAL CAPSULE, DELAYED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
L11K75P92J	ANHYDROUS DIBASIC CALCIUM PHOSPHATE:ORAL:CAPSULE, SUSTAINED ACTION:MG	ORAL	301.7MG ORAL CAPSULE, SUSTAINED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
L11K75P92J	ANHYDROUS DIBASIC CALCIUM PHOSPHATE:ORAL:PASTILLE:NA	ORAL	ORAL PASTILLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
L11K75P92J	ANHYDROUS DIBASIC CALCIUM PHOSPHATE:ORAL:SYRUP:NA	ORAL	ORAL SYRUP	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
L11K75P92J	ANHYDROUS DIBASIC CALCIUM PHOSPHATE:ORAL:TABLET:MG	ORAL	850MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
L11K75P92J	ANHYDROUS DIBASIC CALCIUM PHOSPHATE:ORAL:TABLET (IMMED./COMP. RELEASE), FILM COATED:MG	ORAL	138.84MG ORAL TABLET (IMMED./COMP. RELEASE), FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
L11K75P92J	ANHYDROUS DIBASIC CALCIUM PHOSPHATE:ORAL:TABLET, COATED:MG	ORAL	333.3MG ORAL TABLET, COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
L11K75P92J	ANHYDROUS DIBASIC CALCIUM PHOSPHATE:ORAL:TABLET, DELAYED ACTION, ENTERIC COATED:MG	ORAL	55.16MG ORAL TABLET, DELAYED ACTION, ENTERIC COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
L11K75P92J	ANHYDROUS DIBASIC CALCIUM PHOSPHATE:ORAL:TABLET, DELAYED RELEASE:MG	ORAL	11MG ORAL TABLET, DELAYED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
L11K75P92J	ANHYDROUS DIBASIC CALCIUM PHOSPHATE:ORAL:TABLET, EXTENDED RELEASE:MG	ORAL	125.9MG ORAL TABLET, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
L11K75P92J	ANHYDROUS DIBASIC CALCIUM PHOSPHATE:ORAL:TABLET, FILM COATED:MG	ORAL	525.56MG ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
L11K75P92J	ANHYDROUS DIBASIC CALCIUM PHOSPHATE:ORAL:TABLET, FOR SUSPENSION:MG	ORAL	101.5MG ORAL TABLET, FOR SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
L11K75P92J	ANHYDROUS DIBASIC CALCIUM PHOSPHATE:ORAL:TABLET, SUSTAINED ACTION:MG	ORAL	335MG ORAL TABLET, SUSTAINED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
L11K75P92J	ANHYDROUS DIBASIC CALCIUM PHOSPHATE:TOPICAL:SHAMPOO:NA	TOPICAL	TOPICAL SHAMPOO	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
L11K75P92J	CALCIUM PHOSPHATE, DIBASIC, ANHYDROUS:ORAL:TABLET:mg	ORAL	298.16mg ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
L11K75P92J	CALCIUM PHOSPHATE, DIBASIC, ANHYDROUS:ORAL:TABLET, FILM COATED:mg	ORAL	147.31mg ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
L11K75P92J	CALCIUM PHOSPHATE, DIBASIC, ANHYDROUS:ORAL-20:TABLET:mg	ORAL-20	210.6mg ORAL-20 TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
L11K75P92J	CALCIUM PHOSPHATE, DIBASIC, ANHYDROUS:SUBLINGUAL:TABLET:mg	SUBLINGUAL	1.18mg SUBLINGUAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
77CBG3UN78	MAGNESIUM NITRATE:TOPICAL:EMULSION, CREAM:NA	TOPICAL	TOPICAL EMULSION, CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
77CBG3UN78	MAGNESIUM NITRATE:TOPICAL:LOTION:NA	TOPICAL	TOPICAL LOTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
6HQ855798J	LAURETH-4:TOPICAL:EMULSION, CREAM:%W/W	TOPICAL	1.1%W/W TOPICAL EMULSION, CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
6HQ855798J	LAURETH-4:TOPICAL:GEL:%W/W	TOPICAL	3%W/W TOPICAL GEL	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
6HQ855798J	LAURETH-4:TOPICAL:LOTION:%W/W	TOPICAL	1.3%W/W TOPICAL LOTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
6HQ855798J	LAURETH-4:TOPICAL:SOLUTION:%W/V	TOPICAL	5.22%W/V TOPICAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
E4GA8884NN	PHOSPHORIC ACID:IM - IV:INJECTION:ADJ PH	IM - IV	ADJ PH IM - IV INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
E4GA8884NN	PHOSPHORIC ACID:IM - IV - SC:INJECTION:ADJ PH	IM - IV - SC	ADJ PH IM - IV - SC INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
E4GA8884NN	PHOSPHORIC ACID:IM - SC:INJECTION:ADJ PH	IM - SC	ADJ PH IM - SC INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
E4GA8884NN	PHOSPHORIC ACID:IM - SC:POWDER, FOR INJECTION SOLUTION:ADJ PH	IM - SC	ADJ PH IM - SC POWDER, FOR INJECTION SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
E4GA8884NN	PHOSPHORIC ACID:INFILTRATION:INJECTION, LIPOSOMAL:NA	INFILTRATION	INFILTRATION INJECTION, LIPOSOMAL	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
E4GA8884NN	PHOSPHORIC ACID:INTRA-ARTICULAR:INJECTION:ADJ PH	INTRA-ARTICULAR	ADJ PH INTRA-ARTICULAR INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
E4GA8884NN	PHOSPHORIC ACID:INTRALESIONAL:INJECTION:ADJ PH	INTRALESIONAL	ADJ PH INTRALESIONAL INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
E4GA8884NN	PHOSPHORIC ACID:INTRAMUSCULAR:POWDER, FOR INJECTION SOLUTION:ADJ PH	INTRAMUSCULAR	ADJ PH INTRAMUSCULAR POWDER, FOR INJECTION SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
E4GA8884NN	PHOSPHORIC ACID:INTRAMUSCULAR:POWDER, FOR INJECTION SOLUTION, LYOPHILIZED:%	INTRAMUSCULAR	0.23% INTRAMUSCULAR POWDER, FOR INJECTION SOLUTION, LYOPHILIZED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
E4GA8884NN	PHOSPHORIC ACID:INTRAVENOUS:INJECTABLE:ADJ PH	INTRAVENOUS	ADJ PH INTRAVENOUS INJECTABLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
E4GA8884NN	PHOSPHORIC ACID:INTRAVENOUS:INJECTION:%	INTRAVENOUS	5% INTRAVENOUS INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
E4GA8884NN	PHOSPHORIC ACID:INTRAVENOUS:POWDER, FOR INJECTION SOLUTION:ADJ PH	INTRAVENOUS	ADJ PH INTRAVENOUS POWDER, FOR INJECTION SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
E4GA8884NN	PHOSPHORIC ACID:INTRAVENOUS:POWDER, FOR INJECTION SOLUTION, LYOPHILIZED:NA	INTRAVENOUS	INTRAVENOUS POWDER, FOR INJECTION SOLUTION, LYOPHILIZED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
E4GA8884NN	PHOSPHORIC ACID:INTRAVENOUS:SOLUTION:NA	INTRAVENOUS	INTRAVENOUS SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
E4GA8884NN	PHOSPHORIC ACID:INTRAVENOUS:SOLUTION, INJECTION:ADJ PH	INTRAVENOUS	ADJ PH INTRAVENOUS SOLUTION, INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
E4GA8884NN	PHOSPHORIC ACID:IV - SC:INJECTION:ADJ PH	IV - SC	ADJ PH IV - SC INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
E4GA8884NN	PHOSPHORIC ACID:IV(INFUSION):INJECTION:%	IV(INFUSION)	0.12% IV(INFUSION) INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
E4GA8884NN	PHOSPHORIC ACID:IV(INFUSION):POWDER, FOR INJECTION SOLUTION:ADJ PH	IV(INFUSION)	ADJ PH IV(INFUSION) POWDER, FOR INJECTION SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
E4GA8884NN	PHOSPHORIC ACID:IV(INFUSION):POWDER, FOR INJECTION SOLUTION, LYOPHILIZED:ADJ PH	IV(INFUSION)	ADJ PH IV(INFUSION) POWDER, FOR INJECTION SOLUTION, LYOPHILIZED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
E4GA8884NN	PHOSPHORIC ACID:IV(INFUSION):SOLUTION, INJECTION:ADJ PH	IV(INFUSION)	ADJ PH IV(INFUSION) SOLUTION, INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
E4GA8884NN	PHOSPHORIC ACID:OPHTHALMIC:SOLUTION:ADJ PH	OPHTHALMIC	ADJ PH OPHTHALMIC SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
E4GA8884NN	PHOSPHORIC ACID:ORAL:LIQUID:%	ORAL	0.14% ORAL LIQUID	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
E4GA8884NN	PHOSPHORIC ACID:ORAL:ORAL SOLUTION DOSAGE FORM:mg/5mL	ORAL	9.35mg/5mL ORAL ORAL SOLUTION DOSAGE FORM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
E4GA8884NN	PHOSPHORIC ACID:ORAL:SOLUTION:MG/5ML	ORAL	6.41MG/5ML ORAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
E4GA8884NN	PHOSPHORIC ACID:ORAL:TABLET:MG	ORAL	0.044MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
E4GA8884NN	PHOSPHORIC ACID:ORAL:TABLET, CONTROLLED RELEASE:NA	ORAL	ORAL TABLET, CONTROLLED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
E4GA8884NN	PHOSPHORIC ACID:ORAL:TABLET, EXTENDED RELEASE:NA	ORAL	ORAL TABLET, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
E4GA8884NN	PHOSPHORIC ACID:ORAL:TABLET, ORALLY DISINTEGRATING:MG	ORAL	1MG ORAL TABLET, ORALLY DISINTEGRATING	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
E4GA8884NN	PHOSPHORIC ACID:ORAL:TABLET, SUSTAINED ACTION, FILM COATED:MG	ORAL	2.98MG ORAL TABLET, SUSTAINED ACTION, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
E4GA8884NN	PHOSPHORIC ACID:SOFT TISSUE:INJECTION:ADJ PH	SOFT TISSUE	ADJ PH SOFT TISSUE INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
E4GA8884NN	PHOSPHORIC ACID:SUBCUTANEOUS:INJECTION:%	SUBCUTANEOUS	0.21% SUBCUTANEOUS INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
E4GA8884NN	PHOSPHORIC ACID:SUBCUTANEOUS:POWDER, FOR INJECTION SOLUTION:ADJ PH	SUBCUTANEOUS	ADJ PH SUBCUTANEOUS POWDER, FOR INJECTION SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
E4GA8884NN	PHOSPHORIC ACID:SUBCUTANEOUS:POWDER, FOR INJECTION SOLUTION, LYOPHILIZED:%	SUBCUTANEOUS	0.28% SUBCUTANEOUS POWDER, FOR INJECTION SOLUTION, LYOPHILIZED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
E4GA8884NN	PHOSPHORIC ACID:SUBCUTANEOUS:POWDER, FOR INJECTION SOLUTION, LYOPHILIZED, WITH ADDITIVES:%	SUBCUTANEOUS	0.14% SUBCUTANEOUS POWDER, FOR INJECTION SOLUTION, LYOPHILIZED, WITH ADDITIVES	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
E4GA8884NN	PHOSPHORIC ACID:TOPICAL:CREAM:%W/W	TOPICAL	0.4%W/W TOPICAL CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
E4GA8884NN	PHOSPHORIC ACID:TOPICAL:CREAM, AUGMENTED:%W/W	TOPICAL	0.02%W/W TOPICAL CREAM, AUGMENTED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
E4GA8884NN	PHOSPHORIC ACID:TOPICAL:CREAM, EMULSION, SUSTAINED RELEASE:%W/W	TOPICAL	0.002%W/W TOPICAL CREAM, EMULSION, SUSTAINED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
E4GA8884NN	PHOSPHORIC ACID:TOPICAL:EMULSION, CREAM:%W/W	TOPICAL	0.1%W/W TOPICAL EMULSION, CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
E4GA8884NN	PHOSPHORIC ACID:TOPICAL:LOTION:%W/W	TOPICAL	0.1%W/W TOPICAL LOTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
E4GA8884NN	PHOSPHORIC ACID:TOPICAL:LOTION, AUGMENTED:%W/W	TOPICAL	0.012%W/W TOPICAL LOTION, AUGMENTED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
E4GA8884NN	PHOSPHORIC ACID:TOPICAL:OINTMENT:%W/W	TOPICAL	0.004%W/W TOPICAL OINTMENT	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
E4GA8884NN	PHOSPHORIC ACID:TOPICAL:SOLUTION:%W/W	TOPICAL	0.23%W/W TOPICAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
E4GA8884NN	PHOSPHORIC ACID:TOPICAL:SPONGE:NA	TOPICAL	TOPICAL SPONGE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
E4GA8884NN	PHOSPHORIC ACID:VAGINAL:EMULSION, AEROSOL FOAM:NA	VAGINAL	VAGINAL EMULSION, AEROSOL FOAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
E4GA8884NN	PHOSPHORIC ACID:VAGINAL:EMULSION, CREAM:%	VAGINAL	0.8% VAGINAL EMULSION, CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
U72Q2I8C85	GLYCERYL CAPRYLOCAPRATE:ORAL:CAPSULE:MG	ORAL	369.47MG ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
U72Q2I8C85	GLYCERYL CAPRYLOCAPRATE:ORAL:CAPSULE, COATED, SOFT GELATIN:MG	ORAL	349.47MG ORAL CAPSULE, COATED, SOFT GELATIN	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
U72Q2I8C85	GLYCERYL CAPRYLOCAPRATE:ORAL:CAPSULE, DELAYED ACTION:MG	ORAL	4.07MG ORAL CAPSULE, DELAYED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
U72Q2I8C85	GLYCERYL CAPRYLOCAPRATE:ORAL:CAPSULE, SOFT GELATIN:MG	ORAL	765MG ORAL CAPSULE, SOFT GELATIN	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
U72Q2I8C85	GLYCERYL CAPRYLOCAPRATE:ORAL:CAPSULE, SOFT GELATIN LIQUID-FILLED:MG	ORAL	139MG ORAL CAPSULE, SOFT GELATIN LIQUID-FILLED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
U72Q2I8C85	GLYCERYL CAPRYLOCAPRATE:ORAL:SOFT CAPSULE DOSAGE FORM:mg	ORAL	349.47mg ORAL SOFT CAPSULE DOSAGE FORM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
U72Q2I8C85	GLYCERYL MONO AND DICAPRYLOCAPRATE:ORAL:CAPSULE:mg	ORAL	196.5mg ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
21C2F5E8RE	ANISE:ORAL:SOLUTION:MG/5ML	ORAL	5MG/5ML ORAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
21C2F5E8RE	ANISE:ORAL:SOLUTION, ELIXIR:%	ORAL	0.009% ORAL SOLUTION, ELIXIR	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
B1QE5P712K	HYPROMELLOSE 2208 (100 MPA.S):BUCCAL:TABLET:MG	BUCCAL	20.5MG BUCCAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
B1QE5P712K	HYPROMELLOSE 2208 (100 MPA.S):BUCCAL:TABLET, EXTENDED RELEASE:MG	BUCCAL	17.25MG BUCCAL TABLET, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
B1QE5P712K	HYPROMELLOSE 2208 (100 MPA.S):ORAL:CAPSULE, EXTENDED RELEASE:MG	ORAL	3MG ORAL CAPSULE, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
B1QE5P712K	HYPROMELLOSE 2208 (100 MPA.S):ORAL:POWDER, FOR SUSPENSION:g/236mL	ORAL	0.25g/236mL ORAL POWDER, FOR SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
B1QE5P712K	HYPROMELLOSE 2208 (100 MPA.S):ORAL:SUSPENSION:MG/5ML	ORAL	50MG/5ML ORAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
B1QE5P712K	HYPROMELLOSE 2208 (100 MPA.S):ORAL:SYRUP:MG/5ML	ORAL	12.5MG/5ML ORAL SYRUP	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
B1QE5P712K	HYPROMELLOSE 2208 (100 MPA.S):ORAL:TABLET, CONTROLLED RELEASE:MG	ORAL	86MG ORAL TABLET, CONTROLLED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
B1QE5P712K	HYPROMELLOSE 2208 (100 MPA.S):ORAL:TABLET, DELAYED RELEASE:MG	ORAL	90MG ORAL TABLET, DELAYED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
B1QE5P712K	HYPROMELLOSE 2208 (100 MPA.S):ORAL:TABLET, EXTENDED RELEASE:MG	ORAL	405MG ORAL TABLET, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
B1QE5P712K	HYPROMELLOSE 2208 (100 MPA.S):VAGINAL:INSERT:MG	VAGINAL	15.36MG VAGINAL INSERT	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
Z1LH97KTRM	ALFADEX:INTRACAVITARY:POWDER, FOR INJECTION SOLUTION, LYOPHILIZED:%	INTRACAVITARY	0.13% INTRACAVITARY POWDER, FOR INJECTION SOLUTION, LYOPHILIZED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
15FIX9V2JP	TITANIUM DIOXIDE:BUCCAL:FILM:MG	BUCCAL	1.66MG BUCCAL FILM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
15FIX9V2JP	TITANIUM DIOXIDE:BUCCAL:FILM, SOLUBLE:MG	BUCCAL	2.78MG BUCCAL FILM, SOLUBLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
15FIX9V2JP	TITANIUM DIOXIDE:BUCCAL:GUM:MG	BUCCAL	7.58MG BUCCAL GUM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
15FIX9V2JP	TITANIUM DIOXIDE:BUCCAL:GUM, CHEWING:MG	BUCCAL	7.58MG BUCCAL GUM, CHEWING	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
15FIX9V2JP	TITANIUM DIOXIDE:DENTAL:PASTE:NA	DENTAL	DENTAL PASTE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
15FIX9V2JP	TITANIUM DIOXIDE:INHALATION:POWDER:MG	INHALATION	2MG INHALATION POWDER	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
15FIX9V2JP	TITANIUM DIOXIDE:INTRAUTERINE:SUPPOSITORY, INSERT, CONTROLLED RELEASE:MG	INTRAUTERINE	1MG INTRAUTERINE SUPPOSITORY, INSERT, CONTROLLED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
15FIX9V2JP	TITANIUM DIOXIDE:OPHTHALMIC:SUPPOSITORY, INSERT, CONTROLLED RELEASE:MG	OPHTHALMIC	0.4MG OPHTHALMIC SUPPOSITORY, INSERT, CONTROLLED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
15FIX9V2JP	TITANIUM DIOXIDE:ORAL:CAPSULE:mg	ORAL	5.681mg ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
15FIX9V2JP	TITANIUM DIOXIDE:ORAL:CAPSULE (IMMED./COMP. RELEASE):MG	ORAL	0.97MG ORAL CAPSULE (IMMED./COMP. RELEASE)	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
15FIX9V2JP	TITANIUM DIOXIDE:ORAL:CAPSULE (IMMED./COMP. RELEASE), HARD GELATIN:MG	ORAL	0.96MG ORAL CAPSULE (IMMED./COMP. RELEASE), HARD GELATIN	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
15FIX9V2JP	TITANIUM DIOXIDE:ORAL:CAPSULE (IMMED./COMP. RELEASE), SOFT GELATIN:MG	ORAL	5.15MG ORAL CAPSULE (IMMED./COMP. RELEASE), SOFT GELATIN	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
15FIX9V2JP	TITANIUM DIOXIDE:ORAL:CAPSULE, COATED:MG	ORAL	5.5224MG ORAL CAPSULE, COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
15FIX9V2JP	TITANIUM DIOXIDE:ORAL:CAPSULE, COATED PELLETS:NA	ORAL	ORAL CAPSULE, COATED PELLETS	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
15FIX9V2JP	TITANIUM DIOXIDE:ORAL:CAPSULE, COATED, SOFT GELATIN:MG	ORAL	0.8MG ORAL CAPSULE, COATED, SOFT GELATIN	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
15FIX9V2JP	TITANIUM DIOXIDE:ORAL:CAPSULE, DELAYED ACTION:MG	ORAL	16.82MG ORAL CAPSULE, DELAYED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
15FIX9V2JP	TITANIUM DIOXIDE:ORAL:CAPSULE, DELAYED ACTION, COATED:mg	ORAL	5.616mg ORAL CAPSULE, DELAYED ACTION, COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
15FIX9V2JP	TITANIUM DIOXIDE:ORAL:CAPSULE, DELAYED ACTION, ENTERIC COATED:NA	ORAL	ORAL CAPSULE, DELAYED ACTION, ENTERIC COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
15FIX9V2JP	TITANIUM DIOXIDE:ORAL:CAPSULE, DELAYED RELEASE:MG	ORAL	8.53MG ORAL CAPSULE, DELAYED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
15FIX9V2JP	TITANIUM DIOXIDE:ORAL:CAPSULE, ENTERIC COATED PELLETS:MG	ORAL	4.4MG ORAL CAPSULE, ENTERIC COATED PELLETS	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
15FIX9V2JP	TITANIUM DIOXIDE:ORAL:CAPSULE, EXTENDED RELEASE:mg	ORAL	3.29mg ORAL CAPSULE, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
15FIX9V2JP	TITANIUM DIOXIDE:ORAL:CAPSULE, HARD GELATIN:MG	ORAL	1.62MG ORAL CAPSULE, HARD GELATIN	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
15FIX9V2JP	TITANIUM DIOXIDE:ORAL:CAPSULE, SOFT GELATIN:MG	ORAL	17.93MG ORAL CAPSULE, SOFT GELATIN	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
15FIX9V2JP	TITANIUM DIOXIDE:ORAL:CAPSULE, SOFT GELATIN LIQUID-FILLED:NA	ORAL	ORAL CAPSULE, SOFT GELATIN LIQUID-FILLED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
15FIX9V2JP	TITANIUM DIOXIDE:ORAL:CAPSULE, SUSTAINED ACTION:MG	ORAL	5.1MG ORAL CAPSULE, SUSTAINED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
15FIX9V2JP	TITANIUM DIOXIDE:ORAL:DROPS:NA	ORAL	ORAL DROPS	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
15FIX9V2JP	TITANIUM DIOXIDE:ORAL:FILM, SOLUBLE:MG	ORAL	0.6MG ORAL FILM, SOLUBLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
15FIX9V2JP	TITANIUM DIOXIDE:ORAL:GRANULE, FOR ORAL SUSPENSION:MG	ORAL	0.37MG ORAL GRANULE, FOR ORAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
15FIX9V2JP	TITANIUM DIOXIDE:ORAL:GRANULE, FOR SUSPENSION:MG	ORAL	35.7MG ORAL GRANULE, FOR SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
15FIX9V2JP	TITANIUM DIOXIDE:ORAL:POWDER:MG	ORAL	0.04MG ORAL POWDER	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
15FIX9V2JP	TITANIUM DIOXIDE:ORAL:POWDER, FOR ORAL SUSPENSION:MG/25.169GM	ORAL	400MG/25.169GM ORAL POWDER, FOR ORAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
15FIX9V2JP	TITANIUM DIOXIDE:ORAL:POWDER, FOR SUSPENSION:MG/5ML	ORAL	90MG/5ML ORAL POWDER, FOR SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
15FIX9V2JP	TITANIUM DIOXIDE:ORAL:SOFT CAPSULE DOSAGE FORM:mg	ORAL	1.543mg ORAL SOFT CAPSULE DOSAGE FORM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
15FIX9V2JP	TITANIUM DIOXIDE:ORAL:SUSPENSION:%W/W	ORAL	0.37%W/W ORAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
15FIX9V2JP	TITANIUM DIOXIDE:ORAL:SUSPENSION, SUSTAINED ACTION:MG/206.84 MG	ORAL	0.37MG/206.84 MG ORAL SUSPENSION, SUSTAINED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
15FIX9V2JP	TITANIUM DIOXIDE:ORAL:TABLET:mg	ORAL	13.39mg ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
15FIX9V2JP	TITANIUM DIOXIDE:ORAL:TABLET (IMMED./COMP. RELEASE), FILM COATED:MG	ORAL	11.91MG ORAL TABLET (IMMED./COMP. RELEASE), FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
15FIX9V2JP	TITANIUM DIOXIDE:ORAL:TABLET, COATED:MG	ORAL	10.57MG ORAL TABLET, COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
15FIX9V2JP	TITANIUM DIOXIDE:ORAL:TABLET, CONTROLLED RELEASE:MG	ORAL	2.46MG ORAL TABLET, CONTROLLED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
15FIX9V2JP	TITANIUM DIOXIDE:ORAL:TABLET, DELAYED ACTION:MG	ORAL	7.8MG ORAL TABLET, DELAYED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
15FIX9V2JP	TITANIUM DIOXIDE:ORAL:TABLET, DELAYED ACTION, ENTERIC COATED:MG	ORAL	6MG ORAL TABLET, DELAYED ACTION, ENTERIC COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
15FIX9V2JP	TITANIUM DIOXIDE:ORAL:TABLET, DELAYED RELEASE:MG	ORAL	8.14MG ORAL TABLET, DELAYED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
15FIX9V2JP	TITANIUM DIOXIDE:ORAL:TABLET, ENTERIC COATED PARTICLES:MG	ORAL	15MG ORAL TABLET, ENTERIC COATED PARTICLES	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
15FIX9V2JP	TITANIUM DIOXIDE:ORAL:TABLET, EXTENDED RELEASE:MG	ORAL	49.27MG ORAL TABLET, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
15FIX9V2JP	TITANIUM DIOXIDE:ORAL:TABLET, FILM COATED:MG	ORAL	24.23MG ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
15FIX9V2JP	TITANIUM DIOXIDE:ORAL:TABLET, FILM COATED, EXTENDED RELEASE:MG	ORAL	5.563MG ORAL TABLET, FILM COATED, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
15FIX9V2JP	TITANIUM DIOXIDE:ORAL:TABLET, MULTILAYER, EXTENDED RELEASE:MG	ORAL	18MG ORAL TABLET, MULTILAYER, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
15FIX9V2JP	TITANIUM DIOXIDE:ORAL:TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE:MG	ORAL	7MG ORAL TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
15FIX9V2JP	TITANIUM DIOXIDE:ORAL:TABLET, SUSTAINED ACTION:MG	ORAL	10MG ORAL TABLET, SUSTAINED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
15FIX9V2JP	TITANIUM DIOXIDE:ORAL:TABLET, SUSTAINED ACTION, COATED:MG	ORAL	4.17MG ORAL TABLET, SUSTAINED ACTION, COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
15FIX9V2JP	TITANIUM DIOXIDE:ORAL:TABLET, SUSTAINED ACTION, FILM COATED:MG	ORAL	3MG ORAL TABLET, SUSTAINED ACTION, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
15FIX9V2JP	TITANIUM DIOXIDE:ORAL:TABLET, SUSTAINED RELEASE, FILM COATED:MG	ORAL	4.72MG ORAL TABLET, SUSTAINED RELEASE, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
15FIX9V2JP	TITANIUM DIOXIDE:RESPIRATORY (INHALATION):POWDER, FOR INHALATION:%	RESPIRATORY (INHALATION)	0.2% RESPIRATORY (INHALATION) POWDER, FOR INHALATION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
15FIX9V2JP	TITANIUM DIOXIDE:TOPICAL:CREAM:%W/W	TOPICAL	1%W/W TOPICAL CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
15FIX9V2JP	TITANIUM DIOXIDE:TOPICAL:EMULSION, CREAM:%W/W	TOPICAL	2%W/W TOPICAL EMULSION, CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
15FIX9V2JP	TITANIUM DIOXIDE:TOPICAL:GEL:%W/W	TOPICAL	0.063%W/W TOPICAL GEL	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
15FIX9V2JP	TITANIUM DIOXIDE:TOPICAL:LOTION:NA	TOPICAL	TOPICAL LOTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
15FIX9V2JP	TITANIUM DIOXIDE:TOPICAL:OINTMENT:%W/W	TOPICAL	5%W/W TOPICAL OINTMENT	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
15FIX9V2JP	TITANIUM DIOXIDE:TOPICAL:PATCH, CONTROLLED RELEASE:NA	TOPICAL	TOPICAL PATCH, CONTROLLED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
15FIX9V2JP	TITANIUM DIOXIDE:TOPICAL:SHAMPOO, SUSPENSION:%W/V	TOPICAL	3%W/V TOPICAL SHAMPOO, SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
15FIX9V2JP	TITANIUM DIOXIDE:TOPICAL:SUPPOSITORY, INSERT:NA	TOPICAL	TOPICAL SUPPOSITORY, INSERT	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
15FIX9V2JP	TITANIUM DIOXIDE:TRANSDERMAL:FILM, CONTROLLED RELEASE:NA	TRANSDERMAL	TRANSDERMAL FILM, CONTROLLED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
V4716MY704	LOCUST BEAN GUM:ORAL:BAR, CHEWABLE:NA	ORAL	ORAL BAR, CHEWABLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
V4716MY704	LOCUST BEAN GUM:ORAL:TABLET, EXTENDED RELEASE:MG	ORAL	74.25MG ORAL TABLET, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
I9GRO824LL	LEMON OIL:ORAL:CAPSULE:MG	ORAL	5MG ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
I9GRO824LL	LEMON OIL:ORAL:CAPSULE, SOFT GELATIN:MG	ORAL	8.5MG ORAL CAPSULE, SOFT GELATIN	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
I9GRO824LL	LEMON OIL:ORAL:SUSPENSION:MG/10ML	ORAL	1MG/10ML ORAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
I9GRO824LL	LEMON OIL:ORAL:TABLET:NA	ORAL	ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
I9GRO824LL	LEMON OIL:TOPICAL:GEL:%W/W	TOPICAL	0.05%W/W TOPICAL GEL	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
9E8X80D2L0	.ALPHA.-TOCOPHEROL ACETATE:BUCCAL:FILM:MG	BUCCAL	0.088MG BUCCAL FILM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
9E8X80D2L0	.ALPHA.-TOCOPHEROL ACETATE:ORAL:CAPSULE:MG	ORAL	2MG ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
9E8X80D2L0	.ALPHA.-TOCOPHEROL ACETATE:ORAL:TABLET:MG	ORAL	0.5MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
RCZ785HI7S	POLACRILIN:IONTOPHORESIS:DRUG DELIVERY SYSTEM:MG	IONTOPHORESIS	1.1MG IONTOPHORESIS DRUG DELIVERY SYSTEM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
RCZ785HI7S	POLACRILIN:ORAL:SUSPENSION, EXTENDED RELEASE:MG/ML	ORAL	14.9MG/ML ORAL SUSPENSION, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
RCZ785HI7S	POLACRILIN:ORAL:TABLET, CHEWABLE:MG	ORAL	20MG ORAL TABLET, CHEWABLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
RCZ785HI7S	POLACRILIN:ORAL:TABLET, ORALLY DISINTEGRATING:MG	ORAL	24MG ORAL TABLET, ORALLY DISINTEGRATING	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
RCZ785HI7S	POLACRILIN:TRANSDERMAL:DRUG DELIVERY SYSTEM:MG	TRANSDERMAL	1.1MG TRANSDERMAL DRUG DELIVERY SYSTEM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
L8B7EWV9I7	ORANGE OIL TERPENELESS:ORAL:SUSPENSION:%	ORAL	0.26% ORAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
L8B7EWV9I7	ORANGE OIL TERPENELESS:ORAL:SYRUP:%	ORAL	0.001% ORAL SYRUP	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
625NNB0G9N	PROPYLPARABEN SODIUM:ORAL:CAPSULE:MG	ORAL	0.072MG ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
625NNB0G9N	PROPYLPARABEN SODIUM:ORAL:CAPSULE, SOFT GELATIN:MG	ORAL	0.35MG ORAL CAPSULE, SOFT GELATIN	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
625NNB0G9N	PROPYLPARABEN SODIUM:ORAL:POWDER, FOR ORAL SUSPENSION:MG/5ML	ORAL	1MG/5ML ORAL POWDER, FOR ORAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
625NNB0G9N	PROPYLPARABEN SODIUM:ORAL:POWDER, FOR SUSPENSION:%	ORAL	0.02% ORAL POWDER, FOR SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
625NNB0G9N	PROPYLPARABEN SODIUM:ORAL:SOLUTION:MG/75ML	ORAL	16.88MG/75ML ORAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
625NNB0G9N	PROPYLPARABEN SODIUM:ORAL:SUSPENSION:MG/1ML	ORAL	0.2MG/1ML ORAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
625NNB0G9N	PROPYLPARABEN SODIUM:ORAL:TABLET:MG	ORAL	0.063MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
625NNB0G9N	PROPYLPARABEN SODIUM:ORAL:TABLET, ORALLY DISINTEGRATING:MG	ORAL	0.1MG ORAL TABLET, ORALLY DISINTEGRATING	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
71DD5V995L	CARBOMER COPOLYMER TYPE A (ALLYL PENTAERYTHRITOL CROSSLINKED):OPHTHALMIC:EMULSION:%W/W	OPHTHALMIC	0.05%W/W OPHTHALMIC EMULSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
71DD5V995L	CARBOMER COPOLYMER TYPE A (ALLYL PENTAERYTHRITOL CROSSLINKED):TOPICAL:CREAM:%W/W	TOPICAL	0.2%W/W TOPICAL CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
71DD5V995L	CARBOMER COPOLYMER TYPE A (ALLYL PENTAERYTHRITOL CROSSLINKED):TOPICAL:LOTION:%W/W	TOPICAL	0.6%W/W TOPICAL LOTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
6LV4FOR43R	BUTANE:RECTAL:EMULSION, AEROSOL FOAM:%	RECTAL	0.45% RECTAL EMULSION, AEROSOL FOAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
6LV4FOR43R	BUTANE:SUBLINGUAL:AEROSOL, METERED:%	SUBLINGUAL	2.2% SUBLINGUAL AEROSOL, METERED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
6LV4FOR43R	BUTANE:TOPICAL:AEROSOL:NA	TOPICAL	TOPICAL AEROSOL	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
6LV4FOR43R	BUTANE:TOPICAL:EMULSION, AEROSOL FOAM:NA	TOPICAL	TOPICAL EMULSION, AEROSOL FOAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
JV039JZZ3A	BETADEX:ORAL:TABLET:MG	ORAL	133.33MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
JV039JZZ3A	BETADEX:ORAL:TABLET, FILM COATED:MG	ORAL	82.5MG ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
JV039JZZ3A	BETADEX:TOPICAL:GEL:%W/W	TOPICAL	1%W/W TOPICAL GEL	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
G263MI44RU	DEXTRATES:ORAL:POWDER:MG	ORAL	855.6MG ORAL POWDER	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
G263MI44RU	DEXTRATES:ORAL:TABLET:MG	ORAL	218.7MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
G263MI44RU	DEXTRATES:ORAL:TABLET (IMMED./COMP. RELEASE), UNCOATED, CHEWABLE:MG	ORAL	2494MG ORAL TABLET (IMMED./COMP. RELEASE), UNCOATED, CHEWABLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
G263MI44RU	DEXTRATES:ORAL:TABLET, CHEWABLE:MG	ORAL	867.5MG ORAL TABLET, CHEWABLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
G263MI44RU	DEXTRATES:ORAL:TABLET, EXTENDED RELEASE:MG	ORAL	109.1MG ORAL TABLET, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
G263MI44RU	DEXTRATES:ORAL:TABLET, ORALLY DISINTEGRATING:MG	ORAL	77.76MG ORAL TABLET, ORALLY DISINTEGRATING	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
G263MI44RU	DEXTRATES:ORAL:TABLET, SUSTAINED ACTION:MG	ORAL	108.5MG ORAL TABLET, SUSTAINED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
G263MI44RU	DEXTRATES:ORAL:TABLET, UNCOATED, LOZENGE:MG	ORAL	598.8MG ORAL TABLET, UNCOATED, LOZENGE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
G263MI44RU	DEXTRATES:TRANSMUCOSAL:TABLET, UNCOATED, LOZENGE:MG	TRANSMUCOSAL	1840MG TRANSMUCOSAL TABLET, UNCOATED, LOZENGE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
C1MS7RRZ6L	POLYVINYL ALCOHOL (94000 MW):ORAL:TABLET:mg	ORAL	9.97mg ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
C1MS7RRZ6L	POLYVINYL ALCOHOL (94000 MW):ORAL:TABLET, EXTENDED RELEASE:MG	ORAL	9.26MG ORAL TABLET, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
O8232NY3SJ	STARCH 1500, PREGELATINIZED:ORAL:CAPSULE:MG	ORAL	282.75MG ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
O8232NY3SJ	STARCH 1500, PREGELATINIZED:ORAL:TABLET:MG	ORAL	150MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
O8232NY3SJ	STARCH 1500, PREGELATINIZED:ORAL:TABLET, DELAYED RELEASE:MG	ORAL	60MG ORAL TABLET, DELAYED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
O8232NY3SJ	STARCH 1500, PREGELATINIZED:ORAL:TABLET, FILM COATED:mg	ORAL	68.4mg ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
O8232NY3SJ	STARCH, CORN:BUCCAL:TABLET:MG	BUCCAL	16.6MG BUCCAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
O8232NY3SJ	STARCH, CORN:ORAL:CAPSULE:MG	ORAL	600MG ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
O8232NY3SJ	STARCH, CORN:ORAL:CAPSULE (IMMED./COMP. RELEASE):MG	ORAL	110MG ORAL CAPSULE (IMMED./COMP. RELEASE)	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
O8232NY3SJ	STARCH, CORN:ORAL:CAPSULE, COATED, SOFT GELATIN:MG	ORAL	27.75MG ORAL CAPSULE, COATED, SOFT GELATIN	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
O8232NY3SJ	STARCH, CORN:ORAL:CAPSULE, DELAYED ACTION:MG	ORAL	36.4MG ORAL CAPSULE, DELAYED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
O8232NY3SJ	STARCH, CORN:ORAL:CAPSULE, DELAYED RELEASE:MG	ORAL	36MG ORAL CAPSULE, DELAYED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
O8232NY3SJ	STARCH, CORN:ORAL:CAPSULE, EXTENDED RELEASE:MG	ORAL	95.85MG ORAL CAPSULE, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
O8232NY3SJ	STARCH, CORN:ORAL:CAPSULE, HARD GELATIN:MG	ORAL	289.2MG ORAL CAPSULE, HARD GELATIN	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
O8232NY3SJ	STARCH, CORN:ORAL:CAPSULE, SUSTAINED ACTION:MG	ORAL	27MG ORAL CAPSULE, SUSTAINED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
O8232NY3SJ	STARCH, CORN:ORAL:CONCENTRATE:NA	ORAL	ORAL CONCENTRATE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
O8232NY3SJ	STARCH, CORN:ORAL:DROPS:NA	ORAL	ORAL DROPS	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
O8232NY3SJ	STARCH, CORN:ORAL:PASTILLE:NA	ORAL	ORAL PASTILLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
O8232NY3SJ	STARCH, CORN:ORAL:POWDER, FOR ORAL SUSPENSION:MG/5ML	ORAL	16.85MG/5ML ORAL POWDER, FOR ORAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
O8232NY3SJ	STARCH, CORN:ORAL:POWDER, FOR SUSPENSION:NA	ORAL	ORAL POWDER, FOR SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
O8232NY3SJ	STARCH, CORN:ORAL:SUSPENSION:MG/5ML	ORAL	72.5MG/5ML ORAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
O8232NY3SJ	STARCH, CORN:ORAL:SUSPENSION, DROPS:NA	ORAL	ORAL SUSPENSION, DROPS	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
O8232NY3SJ	STARCH, CORN:ORAL:SUSPENSION, EXTENDED RELEASE:MG/ML	ORAL	9.38MG/ML ORAL SUSPENSION, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
O8232NY3SJ	STARCH, CORN:ORAL:TABLET:MG	ORAL	482MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
O8232NY3SJ	STARCH, CORN:ORAL:TABLET (IMMED./COMP. RELEASE), COATED:MG	ORAL	28MG ORAL TABLET (IMMED./COMP. RELEASE), COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
O8232NY3SJ	STARCH, CORN:ORAL:TABLET (IMMED./COMP. RELEASE), FILM COATED:MG	ORAL	24MG ORAL TABLET (IMMED./COMP. RELEASE), FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
O8232NY3SJ	STARCH, CORN:ORAL:TABLET (IMMED./COMP. RELEASE), UNCOATED, CHEWABLE:MG	ORAL	170MG ORAL TABLET (IMMED./COMP. RELEASE), UNCOATED, CHEWABLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
O8232NY3SJ	STARCH, CORN:ORAL:TABLET, CHEWABLE:MG	ORAL	30MG ORAL TABLET, CHEWABLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
O8232NY3SJ	STARCH, CORN:ORAL:TABLET, COATED:MG	ORAL	285MG ORAL TABLET, COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
O8232NY3SJ	STARCH, CORN:ORAL:TABLET, DELAYED ACTION:MG	ORAL	101.8MG ORAL TABLET, DELAYED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
O8232NY3SJ	STARCH, CORN:ORAL:TABLET, DELAYED ACTION, ENTERIC COATED:MG	ORAL	54MG ORAL TABLET, DELAYED ACTION, ENTERIC COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
O8232NY3SJ	STARCH, CORN:ORAL:TABLET, DELAYED RELEASE:MG	ORAL	15MG ORAL TABLET, DELAYED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
O8232NY3SJ	STARCH, CORN:ORAL:TABLET, EXTENDED RELEASE:MG	ORAL	250MG ORAL TABLET, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
O8232NY3SJ	STARCH, CORN:ORAL:TABLET, FILM COATED:MG	ORAL	232MG ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
O8232NY3SJ	STARCH, CORN:ORAL:TABLET, MULTILAYER, EXTENDED RELEASE:MG	ORAL	10MG ORAL TABLET, MULTILAYER, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
O8232NY3SJ	STARCH, CORN:ORAL:TABLET, ORALLY DISINTEGRATING:MG	ORAL	45MG ORAL TABLET, ORALLY DISINTEGRATING	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
O8232NY3SJ	STARCH, CORN:ORAL:TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE:mg	ORAL	3.48mg ORAL TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
O8232NY3SJ	STARCH, CORN:ORAL:TABLET, REPEAT ACTION:MG	ORAL	32MG ORAL TABLET, REPEAT ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
O8232NY3SJ	STARCH, CORN:ORAL:TABLET, SUSTAINED ACTION:MG	ORAL	92MG ORAL TABLET, SUSTAINED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
O8232NY3SJ	STARCH, CORN:ORAL:TABLET, SUSTAINED ACTION, COATED:NA	ORAL	ORAL TABLET, SUSTAINED ACTION, COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
O8232NY3SJ	STARCH, CORN:ORAL:TABLET, SUSTAINED ACTION, FILM COATED:MG	ORAL	74.3MG ORAL TABLET, SUSTAINED ACTION, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
O8232NY3SJ	STARCH, CORN:SUBLINGUAL:TABLET:MG	SUBLINGUAL	136.44MG SUBLINGUAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
O8232NY3SJ	STARCH, CORN:SUBLINGUAL:TABLET (IMMED./COMP. RELEASE), UNCOATED, BUCCAL:MG	SUBLINGUAL	32MG SUBLINGUAL TABLET (IMMED./COMP. RELEASE), UNCOATED, BUCCAL	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
O8232NY3SJ	STARCH, CORN:VAGINAL:TABLET:MG	VAGINAL	210MG VAGINAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
O8232NY3SJ	STARCH, CORN:VAGINAL:TABLET, FILM COATED:MG	VAGINAL	8MG VAGINAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
O8232NY3SJ	STARCH, PREGELATINIZED CORN:ORAL:TABLET:mg	ORAL	106.72mg ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
PF5DZW74VN	CALCIUM HYDROXIDE:INTRAVENOUS:INJECTION:%	INTRAVENOUS	0.37% INTRAVENOUS INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
PF5DZW74VN	CALCIUM HYDROXIDE:IV - SC:INJECTION:ADJ PH	IV - SC	ADJ PH IV - SC INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
PF5DZW74VN	CALCIUM HYDROXIDE:ORAL:CAPSULE, DELAYED ACTION:MG	ORAL	13.56MG ORAL CAPSULE, DELAYED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
PF5DZW74VN	CALCIUM HYDROXIDE:ORAL:SUSPENSION:ADJ PH	ORAL	ADJ PH ORAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
PF5DZW74VN	CALCIUM HYDROXIDE:ORAL:TABLET:MG	ORAL	35MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
PF5DZW74VN	CALCIUM HYDROXIDE:TOPICAL:EMULSION, CREAM:NA	TOPICAL	TOPICAL EMULSION, CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
W6Z28A9YWO	2-ETHYL-1,6-HEXANEDIOL:TOPICAL:SOLUTION:%W/W	TOPICAL	0.25%W/W TOPICAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=2
668Z5835Z3	PROPYLENE GLYCOL MONOLAURATE:ORAL:TABLET:MG	ORAL	10MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
668Z5835Z3	PROPYLENE GLYCOL MONOLAURATE:ORAL:TABLET, FILM COATED:MG	ORAL	6.67MG ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
668Z5835Z3	PROPYLENE GLYCOL MONOLAURATE:TRANSDERMAL:FILM, CONTROLLED RELEASE:NA	TRANSDERMAL	TRANSDERMAL FILM, CONTROLLED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
09179OX7TB	PEG-75 LANOLIN:TOPICAL:AEROSOL:%W/W	TOPICAL	1.5%W/W TOPICAL AEROSOL	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
09179OX7TB	PEG-75 LANOLIN:TOPICAL:EMULSION:%W/W	TOPICAL	1.5%W/W TOPICAL EMULSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
09179OX7TB	PEG-75 LANOLIN:TOPICAL:SOLUTION:%W/W	TOPICAL	1%W/W TOPICAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
47EQO8LE7H	PECTIN, CITRUS:ORAL:TABLET:MG	ORAL	0.35MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
2KAG279R6R	DEHYDROACETIC ACID:TOPICAL:LOTION:%W/W	TOPICAL	0.1%W/W TOPICAL LOTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
2KAG279R6R	DEHYDROACETIC ACID:TOPICAL:SHAMPOO:NA	TOPICAL	TOPICAL SHAMPOO	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
AJ56JP5TFP	CITRUS SINENSIS FLOWER OIL:ORAL:TABLET:NA	ORAL	ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
J1P7893F4J	SULFUROUS ACID:INTRAMUSCULAR:INJECTION:ADJ PH	INTRAMUSCULAR	ADJ PH INTRAMUSCULAR INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
CI71S98N1Z	DIBASIC POTASSIUM PHOSPHATE:INTRA-ARTICULAR:INJECTION:%	INTRA-ARTICULAR	0.6% INTRA-ARTICULAR INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
CI71S98N1Z	DIBASIC POTASSIUM PHOSPHATE:INTRAMUSCULAR:INJECTION:%W/V	INTRAMUSCULAR	0.6%W/V INTRAMUSCULAR INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
CI71S98N1Z	DIBASIC POTASSIUM PHOSPHATE:INTRAVENOUS:SOLUTION:NA	INTRAVENOUS	INTRAVENOUS SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
CI71S98N1Z	DIBASIC POTASSIUM PHOSPHATE:IV(INFUSION):INJECTION:%	IV(INFUSION)	55.2% IV(INFUSION) INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
CI71S98N1Z	DIBASIC POTASSIUM PHOSPHATE:ORAL:CAPSULE:MG	ORAL	30MG ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
CI71S98N1Z	DIBASIC POTASSIUM PHOSPHATE:ORAL:POWDER, FOR SUSPENSION:MG/1SCP	ORAL	50MG/1SCP ORAL POWDER, FOR SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
CI71S98N1Z	DIBASIC POTASSIUM PHOSPHATE:ORAL:SOLUTION:MG/5ML	ORAL	75MG/5ML ORAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
CI71S98N1Z	DIBASIC POTASSIUM PHOSPHATE:ORAL:SUSPENSION:MG/1ML	ORAL	5MG/1ML ORAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
CI71S98N1Z	DIBASIC POTASSIUM PHOSPHATE:ORAL:SYRUP:MG/5ML	ORAL	22MG/5ML ORAL SYRUP	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
CI71S98N1Z	DIBASIC POTASSIUM PHOSPHATE:ORAL:TABLET:NA	ORAL	ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
CI71S98N1Z	DIBASIC POTASSIUM PHOSPHATE:SUBCUTANEOUS:INJECTION:%	SUBCUTANEOUS	1.36% SUBCUTANEOUS INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
CI71S98N1Z	DIBASIC POTASSIUM PHOSPHATE:SUBCUTANEOUS:POWDER, FOR INJECTION SOLUTION, LYOPHILIZED:%	SUBCUTANEOUS	0.19% SUBCUTANEOUS POWDER, FOR INJECTION SOLUTION, LYOPHILIZED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
1T8387508X	GELATIN TYPE B BOVINE (160 BLOOM):ORAL:CAPSULE, SOFT GELATIN:MG	ORAL	92.25MG ORAL CAPSULE, SOFT GELATIN	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
1T8387508X	GELATIN TYPE B BOVINE (160 BLOOM):ORAL:TABLET:MG	ORAL	2MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
5QWK665956	SODIUM PHOSPHATE, MONOBASIC, DIHYDRATE:IM - IV:INJECTION:%	IM - IV	1.28% IM - IV INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
5QWK665956	SODIUM PHOSPHATE, MONOBASIC, DIHYDRATE:IM - SC:INJECTION:NA	IM - SC	IM - SC INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
5QWK665956	SODIUM PHOSPHATE, MONOBASIC, DIHYDRATE:INTRAMUSCULAR:INJECTABLE:mg/1mL	INTRAMUSCULAR	0.8mg/1mL INTRAMUSCULAR INJECTABLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
5QWK665956	SODIUM PHOSPHATE, MONOBASIC, DIHYDRATE:INTRAVENOUS:INJECTION:%	INTRAVENOUS	0.76% INTRAVENOUS INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
5QWK665956	SODIUM PHOSPHATE, MONOBASIC, DIHYDRATE:INTRAVENOUS:SOLUTION, INJECTION:%	INTRAVENOUS	0.049% INTRAVENOUS SOLUTION, INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
5QWK665956	SODIUM PHOSPHATE, MONOBASIC, DIHYDRATE:IV(INFUSION):INJECTABLE:%	IV(INFUSION)	0.3% IV(INFUSION) INJECTABLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
5QWK665956	SODIUM PHOSPHATE, MONOBASIC, DIHYDRATE:IV(INFUSION):POWDER, FOR INJECTION SOLUTION:%	IV(INFUSION)	0.16% IV(INFUSION) POWDER, FOR INJECTION SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
5QWK665956	SODIUM PHOSPHATE, MONOBASIC, DIHYDRATE:IV(INFUSION):SOLUTION, INJECTION:%	IV(INFUSION)	0.3% IV(INFUSION) SOLUTION, INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
5QWK665956	SODIUM PHOSPHATE, MONOBASIC, DIHYDRATE:NASAL:SPRAY, METERED:%	NASAL	4.2% NASAL SPRAY, METERED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
5QWK665956	SODIUM PHOSPHATE, MONOBASIC, DIHYDRATE:OPHTHALMIC:DROPS:%	OPHTHALMIC	0.2% OPHTHALMIC DROPS	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
5QWK665956	SODIUM PHOSPHATE, MONOBASIC, DIHYDRATE:OPHTHALMIC:SOLUTION:%	OPHTHALMIC	1.16% OPHTHALMIC SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
5QWK665956	SODIUM PHOSPHATE, MONOBASIC, DIHYDRATE:OPHTHALMIC:SOLUTION:%W/V	OPHTHALMIC	0.53%W/V OPHTHALMIC SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
5QWK665956	SODIUM PHOSPHATE, MONOBASIC, DIHYDRATE:OPHTHALMIC:SOLUTION, DROPS:%	OPHTHALMIC	1.15% OPHTHALMIC SOLUTION, DROPS	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
5QWK665956	SODIUM PHOSPHATE, MONOBASIC, DIHYDRATE:OPHTHALMIC:SOLUTION/DROPS:%	OPHTHALMIC	0.015% OPHTHALMIC SOLUTION/DROPS	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
5QWK665956	SODIUM PHOSPHATE, MONOBASIC, DIHYDRATE:ORAL:SOLUTION:MG/100ML	ORAL	0.63MG/100ML ORAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
5QWK665956	SODIUM PHOSPHATE, MONOBASIC, DIHYDRATE:ORAL:SUSPENSION:MG/5ML	ORAL	100MG/5ML ORAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
5QWK665956	SODIUM PHOSPHATE, MONOBASIC, DIHYDRATE:SUBCUTANEOUS:INJECTABLE:%	SUBCUTANEOUS	0.3% SUBCUTANEOUS INJECTABLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
5QWK665956	SODIUM PHOSPHATE, MONOBASIC, DIHYDRATE:SUBCUTANEOUS:INJECTION:%	SUBCUTANEOUS	0.24% SUBCUTANEOUS INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
5QWK665956	SODIUM PHOSPHATE, MONOBASIC, DIHYDRATE:SUBCUTANEOUS:POWDER, FOR INJECTION SOLUTION, LYOPHILIZED:%	SUBCUTANEOUS	0.13% SUBCUTANEOUS POWDER, FOR INJECTION SOLUTION, LYOPHILIZED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
5QWK665956	SODIUM PHOSPHATE, MONOBASIC, DIHYDRATE:SUBCUTANEOUS:SOLUTION, INJECTION:%	SUBCUTANEOUS	0.3% SUBCUTANEOUS SOLUTION, INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
5QWK665956	SODIUM PHOSPHATE, MONOBASIC, DIHYDRATE:TOPICAL:DROPS:NA	TOPICAL	TOPICAL DROPS	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
5QWK665956	SODIUM PHOSPHATE, MONOBASIC, DIHYDRATE:TOPICAL:GEL:%W/W	TOPICAL	0.022%W/W TOPICAL GEL	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
0YPR65R21J	SODIUM SULFATE:IM - IV:INJECTION:NA	IM - IV	IM - IV INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
0YPR65R21J	SODIUM SULFATE:OPHTHALMIC:SOLUTION:%	OPHTHALMIC	0.23% OPHTHALMIC SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
0YPR65R21J	SODIUM SULFATE:OPHTHALMIC:SUSPENSION:%	OPHTHALMIC	1.2% OPHTHALMIC SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
0YPR65R21J	SODIUM SULFATE:ORAL:CAPSULE:NA	ORAL	ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
0YPR65R21J	SODIUM SULFATE:ORAL:TABLET:MG	ORAL	182MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
0YPR65R21J	SODIUM SULFATE:ORAL:TABLET, DELAYED ACTION, ENTERIC COATED:MG	ORAL	16.24MG ORAL TABLET, DELAYED ACTION, ENTERIC COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
456148SDMJ	HEPTANE:INTRAUTERINE:INTRAUTERINE DEVICE:MG	INTRAUTERINE	1.04MG INTRAUTERINE INTRAUTERINE DEVICE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
456148SDMJ	HEPTANE:TRANSDERMAL:PATCH:MG	TRANSDERMAL	157.88MG TRANSDERMAL PATCH	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
XRQ165498B	POLYGLYCERYL-3 OLEATE:ORAL:CAPSULE, GELATIN COATED:MG	ORAL	0.87MG ORAL CAPSULE, GELATIN COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
XRQ165498B	POLYGLYCERYL-3 OLEATE:ORAL:CAPSULE, SOFT GELATIN:MG	ORAL	330.7MG ORAL CAPSULE, SOFT GELATIN	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
XRQ165498B	POLYGLYCERYL-3 OLEATE:ORAL:SOLUTION:MG/1ML	ORAL	310MG/1ML ORAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
XRQ165498B	POLYGLYCERYL-3 OLEATE:TOPICAL:CREAM, EMULSION, SUSTAINED RELEASE:%W/W	TOPICAL	2.7%W/W TOPICAL CREAM, EMULSION, SUSTAINED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
XRQ165498B	POLYGLYCERYL-3 OLEATE:VAGINAL:CREAM, EMULSION, SUSTAINED RELEASE:%W/W	VAGINAL	2.7%W/W VAGINAL CREAM, EMULSION, SUSTAINED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
XRQ165498B	POLYGLYCERYL-3 OLEATE:VAGINAL:EMULSION, CREAM:%	VAGINAL	2.7% VAGINAL EMULSION, CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
6YSS42VSEV	FRUCTOSE:IV(INFUSION):POWDER, FOR INJECTION SOLUTION, LYOPHILIZED:%	IV(INFUSION)	5% IV(INFUSION) POWDER, FOR INJECTION SOLUTION, LYOPHILIZED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
6YSS42VSEV	FRUCTOSE:ORAL:BAR, CHEWABLE:NA	ORAL	ORAL BAR, CHEWABLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
6YSS42VSEV	FRUCTOSE:ORAL:POWDER, FOR SUSPENSION:MG/5ML	ORAL	1376MG/5ML ORAL POWDER, FOR SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
6YSS42VSEV	FRUCTOSE:ORAL:SOLUTION:MG/5ML	ORAL	2481MG/5ML ORAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
6YSS42VSEV	FRUCTOSE:ORAL:SUSPENSION:MG/1ML	ORAL	20MG/1ML ORAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
6YSS42VSEV	FRUCTOSE:ORAL:SUSPENSION, SUSTAINED ACTION:NA	ORAL	ORAL SUSPENSION, SUSTAINED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
6YSS42VSEV	FRUCTOSE:ORAL:SYRUP:MG/5ML	ORAL	1732.5MG/5ML ORAL SYRUP	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
6YSS42VSEV	FRUCTOSE:ORAL:TABLET:MG	ORAL	64.92MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
6YSS42VSEV	FRUCTOSE:RECTAL:SOLUTION:%	RECTAL	0.67% RECTAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
C3M81465G5	SPEARMINT OIL:ORAL:SOLUTION:%	ORAL	0.01% ORAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
C3M81465G5	SPEARMINT OIL:ORAL:SUSPENSION:MG/20ML	ORAL	0.59MG/20ML ORAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
C3M81465G5	SPEARMINT OIL:ORAL:SYRUP:%	ORAL	0.4% ORAL SYRUP	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
C3M81465G5	SPEARMINT OIL:SUBLINGUAL:TABLET:MG	SUBLINGUAL	0.4MG SUBLINGUAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
C3M81465G5	SPEARMINT OIL:TOPICAL:OINTMENT:NA	TOPICAL	TOPICAL OINTMENT	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
311332OII1	ERYTHORBIC ACID:ORAL:CONCENTRATE:NA	ORAL	ORAL CONCENTRATE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
311332OII1	ERYTHORBIC ACID:ORAL:TABLET:NA	ORAL	ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
V46Y6OJ5QB	POLYETHYLENE OXIDE 100000:ORAL:TABLET:mg	ORAL	192.66mg ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
V46Y6OJ5QB	POLYETHYLENE OXIDE 100000:SUBLINGUAL:FILM:mg	SUBLINGUAL	12.04mg SUBLINGUAL FILM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
U6XF9NP8HM	ALUMINUM STEARATE:ORAL:CAPSULE, SUSTAINED ACTION:MG	ORAL	0.4MG ORAL CAPSULE, SUSTAINED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
U6XF9NP8HM	ALUMINUM STEARATE:ORAL:TABLET:MG	ORAL	2.8MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
U6XF9NP8HM	ALUMINUM STEARATE:ORAL:TABLET, SUSTAINED ACTION:MG	ORAL	105MG ORAL TABLET, SUSTAINED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
U6XF9NP8HM	ALUMINUM STEARATE:TOPICAL:EMULSION, CREAM:%W/W	TOPICAL	0.01%W/W TOPICAL EMULSION, CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
U6XF9NP8HM	ALUMINUM STEARATE:TOPICAL:OINTMENT:%W/W	TOPICAL	0.01%W/W TOPICAL OINTMENT	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
BMJ7J4127K	LOW-SUBSTITUTED HYDROXYPROPYL CELLULOSE (11% HYDROXYPROPYL; 100000 MW):ORAL:CAPSULE, DELAYED ACTION:MG	ORAL	2.5MG ORAL CAPSULE, DELAYED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
BMJ7J4127K	LOW-SUBSTITUTED HYDROXYPROPYL CELLULOSE (11% HYDROXYPROPYL; 100000 MW):ORAL:CAPSULE, DELAYED RELEASE:mg	ORAL	10.91mg ORAL CAPSULE, DELAYED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
R9QTB5E82N	HEXYLRESORCINOL:IV(INFUSION):INJECTION:NA	IV(INFUSION)	IV(INFUSION) INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
R9QTB5E82N	HEXYLRESORCINOL:NERVE BLOCK:INJECTION:NA	NERVE BLOCK	NERVE BLOCK INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
241ATL177A	SOYBEAN OIL:INTRAVENOUS:EMULSION, INJECTION:%	INTRAVENOUS	20% INTRAVENOUS EMULSION, INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
241ATL177A	SOYBEAN OIL:INTRAVENOUS:INJECTABLE:%	INTRAVENOUS	10% INTRAVENOUS INJECTABLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
241ATL177A	SOYBEAN OIL:INTRAVENOUS:INJECTION:%	INTRAVENOUS	10% INTRAVENOUS INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
241ATL177A	SOYBEAN OIL:INTRAVENOUS:INJECTION, EMULSION:MG/1ML	INTRAVENOUS	96.4MG/1ML INTRAVENOUS INJECTION, EMULSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
241ATL177A	SOYBEAN OIL:INTRAVENOUS:SOLUTION, INJECTION:%	INTRAVENOUS	2.75% INTRAVENOUS SOLUTION, INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
241ATL177A	SOYBEAN OIL:IV(INFUSION):EMULSION, INJECTION:%	IV(INFUSION)	10% IV(INFUSION) EMULSION, INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
241ATL177A	SOYBEAN OIL:IV(INFUSION):POWDER, FOR INJECTION SOLUTION, LYOPHILIZED:%	IV(INFUSION)	10% IV(INFUSION) POWDER, FOR INJECTION SOLUTION, LYOPHILIZED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
241ATL177A	SOYBEAN OIL:IV(INFUSION):SOLUTION, INJECTION:%	IV(INFUSION)	2.75% IV(INFUSION) SOLUTION, INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
241ATL177A	SOYBEAN OIL:ORAL:CAPSULE:MG	ORAL	263MG ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
241ATL177A	SOYBEAN OIL:ORAL:CAPSULE (IMMED./COMP. RELEASE), COATED, SOFT GELATIN:MG	ORAL	238.59MG ORAL CAPSULE (IMMED./COMP. RELEASE), COATED, SOFT GELATIN	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
241ATL177A	SOYBEAN OIL:ORAL:CAPSULE, SOFT GELATIN:mg	ORAL	283.53mg ORAL CAPSULE, SOFT GELATIN	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
241ATL177A	SOYBEAN OIL:ORAL:CAPSULE, SOFT GELATIN LIQUID-FILLED:MG	ORAL	129.87MG ORAL CAPSULE, SOFT GELATIN LIQUID-FILLED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
241ATL177A	SOYBEAN OIL:ORAL:TABLET (IMMED./COMP. RELEASE), UNCOATED, CHEWABLE:MG	ORAL	0.14MG ORAL TABLET (IMMED./COMP. RELEASE), UNCOATED, CHEWABLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
241ATL177A	SOYBEAN OIL:TOPICAL:LOTION:NA	TOPICAL	TOPICAL LOTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
241ATL177A	SOYBEAN OIL:TOPICAL:SOLUTION:%W/W	TOPICAL	5.82%W/W TOPICAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
H77VEI93A8	FD&C YELLOW NO. 6:INHALATION:POWDER:MG	INHALATION	0.12MG INHALATION POWDER	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
H77VEI93A8	FD&C YELLOW NO. 6:INHALATION:SOLUTION:NA	INHALATION	INHALATION SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
H77VEI93A8	FD&C YELLOW NO. 6:ORAL:CAPSULE:MG	ORAL	0.96MG ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
H77VEI93A8	FD&C YELLOW NO. 6:ORAL:CAPSULE (IMMED./COMP. RELEASE), SOFT GELATIN, PERLE:NA	ORAL	ORAL CAPSULE (IMMED./COMP. RELEASE), SOFT GELATIN, PERLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
H77VEI93A8	FD&C YELLOW NO. 6:ORAL:CAPSULE, COATED PELLETS:MG	ORAL	0.002MG ORAL CAPSULE, COATED PELLETS	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
H77VEI93A8	FD&C YELLOW NO. 6:ORAL:CAPSULE, DELAYED ACTION:MG	ORAL	0.07MG ORAL CAPSULE, DELAYED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
H77VEI93A8	FD&C YELLOW NO. 6:ORAL:CAPSULE, DELAYED ACTION, ENTERIC COATED:NA	ORAL	ORAL CAPSULE, DELAYED ACTION, ENTERIC COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
H77VEI93A8	FD&C YELLOW NO. 6:ORAL:CAPSULE, ENTERIC COATED PELLETS:MG	ORAL	0.028MG ORAL CAPSULE, ENTERIC COATED PELLETS	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
H77VEI93A8	FD&C YELLOW NO. 6:ORAL:CAPSULE, EXTENDED RELEASE:mg	ORAL	0.91mg ORAL CAPSULE, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
H77VEI93A8	FD&C YELLOW NO. 6:ORAL:CAPSULE, HARD GELATIN:MG	ORAL	0.001MG ORAL CAPSULE, HARD GELATIN	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
H77VEI93A8	FD&C YELLOW NO. 6:ORAL:CAPSULE, SOFT GELATIN:MG	ORAL	0.8MG ORAL CAPSULE, SOFT GELATIN	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
H77VEI93A8	FD&C YELLOW NO. 6:ORAL:CAPSULE, SOFT GELATIN LIQUID-FILLED:MG	ORAL	0.13MG ORAL CAPSULE, SOFT GELATIN LIQUID-FILLED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
H77VEI93A8	FD&C YELLOW NO. 6:ORAL:CAPSULE, SUSTAINED ACTION:MG	ORAL	4.59MG ORAL CAPSULE, SUSTAINED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
H77VEI93A8	FD&C YELLOW NO. 6:ORAL:CONCENTRATE:MG/5ML	ORAL	0.03MG/5ML ORAL CONCENTRATE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
H77VEI93A8	FD&C YELLOW NO. 6:ORAL:DROPS:NA	ORAL	ORAL DROPS	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
H77VEI93A8	FD&C YELLOW NO. 6:ORAL:LIQUID:MG/5ML	ORAL	0.006MG/5ML ORAL LIQUID	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
H77VEI93A8	FD&C YELLOW NO. 6:ORAL:POWDER:MG/1PKT	ORAL	20MG/1PKT ORAL POWDER	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
H77VEI93A8	FD&C YELLOW NO. 6:ORAL:POWDER, FOR ORAL SUSPENSION:MG/5ML	ORAL	0.65MG/5ML ORAL POWDER, FOR ORAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
H77VEI93A8	FD&C YELLOW NO. 6:ORAL:POWDER, FOR RECONSTITUTION:NA	ORAL	ORAL POWDER, FOR RECONSTITUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
H77VEI93A8	FD&C YELLOW NO. 6:ORAL:POWDER, FOR SOLUTION:MG	ORAL	4MG ORAL POWDER, FOR SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
H77VEI93A8	FD&C YELLOW NO. 6:ORAL:POWDER, FOR SUSPENSION:MG/5ML	ORAL	2MG/5ML ORAL POWDER, FOR SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
H77VEI93A8	FD&C YELLOW NO. 6:ORAL:SOLUTION:MG/15ML	ORAL	75.3MG/15ML ORAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
H77VEI93A8	FD&C YELLOW NO. 6:ORAL:SOLUTION, ELIXIR:%	ORAL	4% ORAL SOLUTION, ELIXIR	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
H77VEI93A8	FD&C YELLOW NO. 6:ORAL:SUSPENSION:MG/5ML	ORAL	5MG/5ML ORAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
H77VEI93A8	FD&C YELLOW NO. 6:ORAL:SUSPENSION, EXTENDED RELEASE:MG/5ML	ORAL	0.12MG/5ML ORAL SUSPENSION, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
H77VEI93A8	FD&C YELLOW NO. 6:ORAL:SUSPENSION, LIQUID:%	ORAL	0.01% ORAL SUSPENSION, LIQUID	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
H77VEI93A8	FD&C YELLOW NO. 6:ORAL:SUSPENSION, SUSTAINED ACTION:MG/5ML	ORAL	0.11MG/5ML ORAL SUSPENSION, SUSTAINED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
H77VEI93A8	FD&C YELLOW NO. 6:ORAL:SYRUP:%	ORAL	0.95% ORAL SYRUP	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
H77VEI93A8	FD&C YELLOW NO. 6:ORAL:TABLET:MG	ORAL	60.02MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
H77VEI93A8	FD&C YELLOW NO. 6:ORAL:TABLET (IMMED./COMP. RELEASE), UNCOATED, CHEWABLE:MG	ORAL	0.3MG ORAL TABLET (IMMED./COMP. RELEASE), UNCOATED, CHEWABLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
H77VEI93A8	FD&C YELLOW NO. 6:ORAL:TABLET, CHEWABLE:MG	ORAL	0.03MG ORAL TABLET, CHEWABLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
H77VEI93A8	FD&C YELLOW NO. 6:ORAL:TABLET, COATED:MG	ORAL	3.17MG ORAL TABLET, COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
H77VEI93A8	FD&C YELLOW NO. 6:ORAL:TABLET, DELAYED ACTION:mg	ORAL	1.5mg ORAL TABLET, DELAYED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
H77VEI93A8	FD&C YELLOW NO. 6:ORAL:TABLET, DELAYED ACTION, ENTERIC COATED:MG	ORAL	0.019MG ORAL TABLET, DELAYED ACTION, ENTERIC COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
H77VEI93A8	FD&C YELLOW NO. 6:ORAL:TABLET, EXTENDED RELEASE:MG	ORAL	2.87MG ORAL TABLET, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
H77VEI93A8	FD&C YELLOW NO. 6:ORAL:TABLET, FILM COATED:MG	ORAL	1MG ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
H77VEI93A8	FD&C YELLOW NO. 6:ORAL:TABLET, ORALLY DISINTEGRATING:MG	ORAL	1.36MG ORAL TABLET, ORALLY DISINTEGRATING	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
H77VEI93A8	FD&C YELLOW NO. 6:ORAL:TABLET, REPEAT ACTION:MG	ORAL	0.02MG ORAL TABLET, REPEAT ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
H77VEI93A8	FD&C YELLOW NO. 6:ORAL:TABLET, SUSTAINED ACTION:MG	ORAL	1.06MG ORAL TABLET, SUSTAINED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
H77VEI93A8	FD&C YELLOW NO. 6:RECTAL:SOLUTION:%	RECTAL	0.5% RECTAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
H77VEI93A8	FD&C YELLOW NO. 6:SUBLINGUAL:FILM:MG	SUBLINGUAL	0.02MG SUBLINGUAL FILM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
H77VEI93A8	FD&C YELLOW NO. 6:SUBLINGUAL:TABLET:MG	SUBLINGUAL	0.4MG SUBLINGUAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
H77VEI93A8	FD&C YELLOW NO. 6:TOPICAL:EMULSION, CREAM:NA	TOPICAL	TOPICAL EMULSION, CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
H77VEI93A8	FD&C YELLOW NO. 6:TOPICAL:GEL:%W/W	TOPICAL	0.001%W/W TOPICAL GEL	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
H77VEI93A8	FD&C YELLOW NO. 6:TOPICAL:LOTION:%W/W	TOPICAL	0.002%W/W TOPICAL LOTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
H77VEI93A8	FD&C YELLOW NO. 6:TOPICAL:SPONGE:NA	TOPICAL	TOPICAL SPONGE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
OP1R32D61U	MICROCRYSTALLINE CELLULOSE:BUCCAL:TABLET, EXTENDED RELEASE:MG	BUCCAL	18.04MG BUCCAL TABLET, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
OP1R32D61U	MICROCRYSTALLINE CELLULOSE:INTRA-ARTICULAR:INJECTION:%	INTRA-ARTICULAR	0.05% INTRA-ARTICULAR INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
OP1R32D61U	MICROCRYSTALLINE CELLULOSE:INTRAMUSCULAR:INJECTION:%	INTRAMUSCULAR	0.05% INTRAMUSCULAR INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
OP1R32D61U	MICROCRYSTALLINE CELLULOSE:INTRAVITREAL:IMPLANT:MG	INTRAVITREAL	1.66MG INTRAVITREAL IMPLANT	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
OP1R32D61U	MICROCRYSTALLINE CELLULOSE:NASAL:SPRAY, METERED:MG/INH	NASAL	1.5MG/INH NASAL SPRAY, METERED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
OP1R32D61U	MICROCRYSTALLINE CELLULOSE:ORAL:CAPSULE:MG	ORAL	359MG ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
OP1R32D61U	MICROCRYSTALLINE CELLULOSE:ORAL:CAPSULE (IMMED./COMP. RELEASE):MG	ORAL	139.1MG ORAL CAPSULE (IMMED./COMP. RELEASE)	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
OP1R32D61U	MICROCRYSTALLINE CELLULOSE:ORAL:CAPSULE (IMMED./COMP. RELEASE), HARD GELATIN:MG	ORAL	44.33MG ORAL CAPSULE (IMMED./COMP. RELEASE), HARD GELATIN	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
OP1R32D61U	MICROCRYSTALLINE CELLULOSE:ORAL:CAPSULE, COATED PELLETS:MG	ORAL	57.03MG ORAL CAPSULE, COATED PELLETS	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
OP1R32D61U	MICROCRYSTALLINE CELLULOSE:ORAL:CAPSULE, COATED, SOFT GELATIN:MG	ORAL	60MG ORAL CAPSULE, COATED, SOFT GELATIN	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
OP1R32D61U	MICROCRYSTALLINE CELLULOSE:ORAL:CAPSULE, DELAYED ACTION:MG	ORAL	131.6MG ORAL CAPSULE, DELAYED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
OP1R32D61U	MICROCRYSTALLINE CELLULOSE:ORAL:CAPSULE, DELAYED RELEASE:MG	ORAL	60MG ORAL CAPSULE, DELAYED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
OP1R32D61U	MICROCRYSTALLINE CELLULOSE:ORAL:CAPSULE, ENTERIC COATED PELLETS:MG	ORAL	14MG ORAL CAPSULE, ENTERIC COATED PELLETS	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
OP1R32D61U	MICROCRYSTALLINE CELLULOSE:ORAL:CAPSULE, EXTENDED RELEASE:MG	ORAL	306.8MG ORAL CAPSULE, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
OP1R32D61U	MICROCRYSTALLINE CELLULOSE:ORAL:CAPSULE, GELATIN COATED:MG	ORAL	60.15MG ORAL CAPSULE, GELATIN COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
OP1R32D61U	MICROCRYSTALLINE CELLULOSE:ORAL:CAPSULE, HARD GELATIN:MG	ORAL	172.2MG ORAL CAPSULE, HARD GELATIN	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
OP1R32D61U	MICROCRYSTALLINE CELLULOSE:ORAL:CAPSULE, SOFT GELATIN:MG	ORAL	105MG ORAL CAPSULE, SOFT GELATIN	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
OP1R32D61U	MICROCRYSTALLINE CELLULOSE:ORAL:CAPSULE, SUSTAINED ACTION:MG	ORAL	186MG ORAL CAPSULE, SUSTAINED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
OP1R32D61U	MICROCRYSTALLINE CELLULOSE:ORAL:CAPSULE, SUSTAINED ACTION, HARD GELATIN:MG	ORAL	282.6MG ORAL CAPSULE, SUSTAINED ACTION, HARD GELATIN	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
OP1R32D61U	MICROCRYSTALLINE CELLULOSE:ORAL:DISPERSIBLE TABLET:MG	ORAL	340MG ORAL DISPERSIBLE TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
OP1R32D61U	MICROCRYSTALLINE CELLULOSE:ORAL:GRANULE:mg	ORAL	81.6mg ORAL GRANULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
OP1R32D61U	MICROCRYSTALLINE CELLULOSE:ORAL:GRANULE, ENTERIC COATED:MG	ORAL	789.6MG ORAL GRANULE, ENTERIC COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
OP1R32D61U	MICROCRYSTALLINE CELLULOSE:ORAL:GRANULE, FOR ORAL SUSPENSION:MG	ORAL	27.39MG ORAL GRANULE, FOR ORAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
OP1R32D61U	MICROCRYSTALLINE CELLULOSE:ORAL:GRANULE, FOR RECONSTITUTION:MG	ORAL	25MG ORAL GRANULE, FOR RECONSTITUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
OP1R32D61U	MICROCRYSTALLINE CELLULOSE:ORAL:GRANULE, FOR SUSPENSION:NA	ORAL	ORAL GRANULE, FOR SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
OP1R32D61U	MICROCRYSTALLINE CELLULOSE:ORAL:PELLET:MG	ORAL	31.36MG ORAL PELLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
OP1R32D61U	MICROCRYSTALLINE CELLULOSE:ORAL:POWDER, FOR ORAL SOLUTION:MG	ORAL	0.75MG ORAL POWDER, FOR ORAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
OP1R32D61U	MICROCRYSTALLINE CELLULOSE:ORAL:POWDER, FOR RECONSTITUTION:MG/5ML	ORAL	50MG/5ML ORAL POWDER, FOR RECONSTITUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
OP1R32D61U	MICROCRYSTALLINE CELLULOSE:ORAL:POWDER, FOR SUSPENSION:MG/1SCP	ORAL	586.5MG/1SCP ORAL POWDER, FOR SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
OP1R32D61U	MICROCRYSTALLINE CELLULOSE:ORAL:SOLUTION:NA	ORAL	ORAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
OP1R32D61U	MICROCRYSTALLINE CELLULOSE:ORAL:SUSPENSION:MG/1ML	ORAL	20MG/1ML ORAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
OP1R32D61U	MICROCRYSTALLINE CELLULOSE:ORAL:SUSPENSION, SUSTAINED ACTION:MG/206.84 MG	ORAL	27.39MG/206.84 MG ORAL SUSPENSION, SUSTAINED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
OP1R32D61U	MICROCRYSTALLINE CELLULOSE:ORAL:TABLET:MG	ORAL	1553MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
OP1R32D61U	MICROCRYSTALLINE CELLULOSE:ORAL:TABLET (IMMED./COMP. RELEASE), COATED:MG	ORAL	182.4MG ORAL TABLET (IMMED./COMP. RELEASE), COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
OP1R32D61U	MICROCRYSTALLINE CELLULOSE:ORAL:TABLET (IMMED./COMP. RELEASE), FILM COATED:MG	ORAL	665.36MG ORAL TABLET (IMMED./COMP. RELEASE), FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
OP1R32D61U	MICROCRYSTALLINE CELLULOSE:ORAL:TABLET (IMMED./COMP. RELEASE), UNCOATED, BUCCAL:MG	ORAL	10.4MG ORAL TABLET (IMMED./COMP. RELEASE), UNCOATED, BUCCAL	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
OP1R32D61U	MICROCRYSTALLINE CELLULOSE:ORAL:TABLET (IMMED./COMP. RELEASE), UNCOATED, CHEWABLE:MG	ORAL	639MG ORAL TABLET (IMMED./COMP. RELEASE), UNCOATED, CHEWABLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
OP1R32D61U	MICROCRYSTALLINE CELLULOSE:ORAL:TABLET, CHEWABLE:MG	ORAL	154.6MG ORAL TABLET, CHEWABLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
OP1R32D61U	MICROCRYSTALLINE CELLULOSE:ORAL:TABLET, COATED:MG	ORAL	356MG ORAL TABLET, COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
OP1R32D61U	MICROCRYSTALLINE CELLULOSE:ORAL:TABLET, CONTROLLED RELEASE:MG	ORAL	152MG ORAL TABLET, CONTROLLED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
OP1R32D61U	MICROCRYSTALLINE CELLULOSE:ORAL:TABLET, DELAYED ACTION:MG	ORAL	333.25MG ORAL TABLET, DELAYED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
OP1R32D61U	MICROCRYSTALLINE CELLULOSE:ORAL:TABLET, DELAYED ACTION, COATED:MG	ORAL	289.9MG ORAL TABLET, DELAYED ACTION, COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
OP1R32D61U	MICROCRYSTALLINE CELLULOSE:ORAL:TABLET, DELAYED ACTION, ENTERIC COATED:MG	ORAL	375.26MG ORAL TABLET, DELAYED ACTION, ENTERIC COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
OP1R32D61U	MICROCRYSTALLINE CELLULOSE:ORAL:TABLET, DELAYED RELEASE:MG	ORAL	736.83MG ORAL TABLET, DELAYED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
OP1R32D61U	MICROCRYSTALLINE CELLULOSE:ORAL:TABLET, DISPERSIBLE:MG	ORAL	155.5MG ORAL TABLET, DISPERSIBLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
OP1R32D61U	MICROCRYSTALLINE CELLULOSE:ORAL:TABLET, ENTERIC COATED PARTICLES:MG	ORAL	391MG ORAL TABLET, ENTERIC COATED PARTICLES	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
OP1R32D61U	MICROCRYSTALLINE CELLULOSE:ORAL:TABLET, EXTENDED RELEASE:MG	ORAL	675.3MG ORAL TABLET, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
OP1R32D61U	MICROCRYSTALLINE CELLULOSE:ORAL:TABLET, FILM COATED:MG	ORAL	563.5MG ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
OP1R32D61U	MICROCRYSTALLINE CELLULOSE:ORAL:TABLET, FILM COATED, EXTENDED RELEASE:MG	ORAL	328.36MG ORAL TABLET, FILM COATED, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
OP1R32D61U	MICROCRYSTALLINE CELLULOSE:ORAL:TABLET, FOR SUSPENSION:MG	ORAL	156.25MG ORAL TABLET, FOR SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
OP1R32D61U	MICROCRYSTALLINE CELLULOSE:ORAL:TABLET, MULTILAYER, COATED:MG	ORAL	34MG ORAL TABLET, MULTILAYER, COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
OP1R32D61U	MICROCRYSTALLINE CELLULOSE:ORAL:TABLET, MULTILAYER, EXTENDED RELEASE:MG	ORAL	17.3MG ORAL TABLET, MULTILAYER, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
OP1R32D61U	MICROCRYSTALLINE CELLULOSE:ORAL:TABLET, ORALLY DISINTEGRATING:MG	ORAL	415.92MG ORAL TABLET, ORALLY DISINTEGRATING	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
OP1R32D61U	MICROCRYSTALLINE CELLULOSE:ORAL:TABLET, SUGAR COATED:MG	ORAL	4.64MG ORAL TABLET, SUGAR COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
OP1R32D61U	MICROCRYSTALLINE CELLULOSE:ORAL:TABLET, SUSTAINED ACTION:MG	ORAL	363.7MG ORAL TABLET, SUSTAINED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
OP1R32D61U	MICROCRYSTALLINE CELLULOSE:ORAL:TABLET, SUSTAINED ACTION, COATED:MG	ORAL	100MG ORAL TABLET, SUSTAINED ACTION, COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
OP1R32D61U	MICROCRYSTALLINE CELLULOSE:ORAL:TABLET, SUSTAINED ACTION, FILM COATED:MG	ORAL	307.52MG ORAL TABLET, SUSTAINED ACTION, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
OP1R32D61U	MICROCRYSTALLINE CELLULOSE:ORAL:TABLET, SUSTAINED RELEASE, FILM COATED:MG	ORAL	62.4MG ORAL TABLET, SUSTAINED RELEASE, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
OP1R32D61U	MICROCRYSTALLINE CELLULOSE:ORAL:TABLET, UNCOATED, TROCHE:MG	ORAL	60MG ORAL TABLET, UNCOATED, TROCHE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
OP1R32D61U	MICROCRYSTALLINE CELLULOSE:SUBLINGUAL:TABLET:MG	SUBLINGUAL	43.2MG SUBLINGUAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
OP1R32D61U	MICROCRYSTALLINE CELLULOSE:VAGINAL:TABLET:MG	VAGINAL	390MG VAGINAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
OP1R32D61U	MICROCRYSTALLINE CELLULOSE :ORAL:CAPSULE:mg	ORAL	169.5mg ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
OP1R32D61U	MICROCRYSTALLINE CELLULOSE :ORAL:CAPSULE, EXTENDED RELEASE:mg	ORAL	20mg ORAL CAPSULE, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
OP1R32D61U	MICROCRYSTALLINE CELLULOSE :ORAL:TABLET:mg	ORAL	396.53mg ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
OP1R32D61U	MICROCRYSTALLINE CELLULOSE :ORAL:TABLET, CHEWABLE:mg	ORAL	70.45mg ORAL TABLET, CHEWABLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
OP1R32D61U	MICROCRYSTALLINE CELLULOSE :ORAL:TABLET, EXTENDED RELEASE:mg	ORAL	234mg ORAL TABLET, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
R30H55TN67	STANNOUS CHLORIDE ANHYDROUS:INTRAVENOUS:INJECTION:%	INTRAVENOUS	0.005% INTRAVENOUS INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
R30H55TN67	STANNOUS CHLORIDE ANHYDROUS:IV(INFUSION):INJECTION:NA	IV(INFUSION)	IV(INFUSION) INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
VQ8ZWO78F6	HYDROXYPROPYL CELLULOSE (430000 WAMW):ORAL:TABLET:mg	ORAL	0.38mg ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
VQ8ZWO78F6	HYDROXYPROPYL CELLULOSE (430000 WAMW):ORAL:TABLET, EXTENDED RELEASE:mg	ORAL	85mg ORAL TABLET, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
7CVR7L4A2D	MALTODEXTRIN:ORAL:CAPSULE:MG	ORAL	100MG ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
7CVR7L4A2D	MALTODEXTRIN:ORAL:CAPSULE (IMMED./COMP. RELEASE):MG	ORAL	75MG ORAL CAPSULE (IMMED./COMP. RELEASE)	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
7CVR7L4A2D	MALTODEXTRIN:ORAL:FILM, SOLUBLE:MG	ORAL	3.2MG ORAL FILM, SOLUBLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
7CVR7L4A2D	MALTODEXTRIN:ORAL:GRANULE, FOR SUSPENSION:MG	ORAL	238.1MG ORAL GRANULE, FOR SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
7CVR7L4A2D	MALTODEXTRIN:ORAL:POWDER:MG/1PKT	ORAL	729MG/1PKT ORAL POWDER	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
7CVR7L4A2D	MALTODEXTRIN:ORAL:POWDER:MG/1SCP	ORAL	729MG/1SCP ORAL POWDER	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
7CVR7L4A2D	MALTODEXTRIN:ORAL:POWDER, FOR SUSPENSION:MG/1SCP	ORAL	190MG/1SCP ORAL POWDER, FOR SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
7CVR7L4A2D	MALTODEXTRIN:ORAL:SOLUTION:mg	ORAL	145.1mg ORAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
7CVR7L4A2D	MALTODEXTRIN:ORAL:SOLUTION:MG/5ML	ORAL	45MG/5ML ORAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
7CVR7L4A2D	MALTODEXTRIN:ORAL:SUSPENSION:MG/5ML	ORAL	6.25MG/5ML ORAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
7CVR7L4A2D	MALTODEXTRIN:ORAL:TABLET:MG	ORAL	102.35MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
7CVR7L4A2D	MALTODEXTRIN:ORAL:TABLET (IMMED./COMP. RELEASE), UNCOATED, CHEWABLE:MG	ORAL	292MG ORAL TABLET (IMMED./COMP. RELEASE), UNCOATED, CHEWABLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
7CVR7L4A2D	MALTODEXTRIN:ORAL:TABLET, CHEWABLE:MG	ORAL	4.2MG ORAL TABLET, CHEWABLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
7CVR7L4A2D	MALTODEXTRIN:ORAL:TABLET, COATED:MG	ORAL	5.6MG ORAL TABLET, COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
7CVR7L4A2D	MALTODEXTRIN:ORAL:TABLET, EFFERVESCENT, FOR SOLUTION:MG	ORAL	400.1MG ORAL TABLET, EFFERVESCENT, FOR SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
7CVR7L4A2D	MALTODEXTRIN:ORAL:TABLET, EXTENDED RELEASE:MG	ORAL	165.18MG ORAL TABLET, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
7CVR7L4A2D	MALTODEXTRIN:ORAL:TABLET, FILM COATED:NA	ORAL	ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
7CVR7L4A2D	MALTODEXTRIN:ORAL:TABLET, ORALLY DISINTEGRATING:MG	ORAL	1.88MG ORAL TABLET, ORALLY DISINTEGRATING	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
7CVR7L4A2D	MALTODEXTRIN:ORAL:TABLET, SUSTAINED ACTION:MG	ORAL	72.5MG ORAL TABLET, SUSTAINED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
7CVR7L4A2D	MALTODEXTRIN:ORAL:TABLET, SUSTAINED ACTION, COATED:NA	ORAL	ORAL TABLET, SUSTAINED ACTION, COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
SE337SVY37	SODIUM PHOSPHATE:IM - IV:INJECTION:%	IM - IV	0.3% IM - IV INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
SE337SVY37	SODIUM PHOSPHATE:IM - IV:POWDER, FOR INJECTION SOLUTION:%	IM - IV	2.48% IM - IV POWDER, FOR INJECTION SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
SE337SVY37	SODIUM PHOSPHATE:IM - IV:SOLUTION, INJECTION:%	IM - IV	0.17% IM - IV SOLUTION, INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
SE337SVY37	SODIUM PHOSPHATE:INTRA-ARTICULAR:INJECTION:NA	INTRA-ARTICULAR	INTRA-ARTICULAR INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
SE337SVY37	SODIUM PHOSPHATE:INTRABURSAL:INJECTION:ADJ PH	INTRABURSAL	ADJ PH INTRABURSAL INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
SE337SVY37	SODIUM PHOSPHATE:INTRADERMAL:INJECTION:%	INTRADERMAL	0.2% INTRADERMAL INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
SE337SVY37	SODIUM PHOSPHATE:INTRALESIONAL:INJECTION:NA	INTRALESIONAL	INTRALESIONAL INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
SE337SVY37	SODIUM PHOSPHATE:INTRAMUSCULAR:INJECTION:%	INTRAMUSCULAR	1.06% INTRAMUSCULAR INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
SE337SVY37	SODIUM PHOSPHATE:INTRAMUSCULAR:POWDER, FOR INJECTION SOLUTION:%	INTRAMUSCULAR	0.1% INTRAMUSCULAR POWDER, FOR INJECTION SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
SE337SVY37	SODIUM PHOSPHATE:INTRAVENOUS:INJECTION:%	INTRAVENOUS	3.2% INTRAVENOUS INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
SE337SVY37	SODIUM PHOSPHATE:INTRAVENOUS:POWDER, FOR INJECTION SOLUTION:%	INTRAVENOUS	1% INTRAVENOUS POWDER, FOR INJECTION SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
SE337SVY37	SODIUM PHOSPHATE:IV(INFUSION):INJECTION:%	IV(INFUSION)	0.048% IV(INFUSION) INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
SE337SVY37	SODIUM PHOSPHATE:IV(INFUSION):POWDER, FOR INJECTION SOLUTION:%	IV(INFUSION)	0.88% IV(INFUSION) POWDER, FOR INJECTION SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
SE337SVY37	SODIUM PHOSPHATE:NASAL:SOLUTION:%	NASAL	0.19% NASAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
SE337SVY37	SODIUM PHOSPHATE:NASAL:SPRAY:%	NASAL	0.468% NASAL SPRAY	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
SE337SVY37	SODIUM PHOSPHATE:NERVE BLOCK:INJECTION:%	NERVE BLOCK	0.02% NERVE BLOCK INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
SE337SVY37	SODIUM PHOSPHATE:OPHTHALMIC:SOLUTION, DROPS:%	OPHTHALMIC	0.29% OPHTHALMIC SOLUTION, DROPS	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
SE337SVY37	SODIUM PHOSPHATE:OPHTHALMIC:SUSPENSION:%	OPHTHALMIC	0.2% OPHTHALMIC SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
SE337SVY37	SODIUM PHOSPHATE:ORAL:CAPSULE:MG	ORAL	36MG ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
SE337SVY37	SODIUM PHOSPHATE:ORAL:CONCENTRATE:NA	ORAL	ORAL CONCENTRATE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
SE337SVY37	SODIUM PHOSPHATE:ORAL:SOLUTION:MG/5ML	ORAL	27MG/5ML ORAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
SE337SVY37	SODIUM PHOSPHATE:ORAL:SUSPENSION:NA	ORAL	ORAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
SE337SVY37	SODIUM PHOSPHATE:ORAL:SYRUP:NA	ORAL	ORAL SYRUP	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
SE337SVY37	SODIUM PHOSPHATE:ORAL:TABLET:MG	ORAL	16MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
SE337SVY37	SODIUM PHOSPHATE:SOFT TISSUE:INJECTION:NA	SOFT TISSUE	SOFT TISSUE INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
SE337SVY37	SODIUM PHOSPHATE:SUBCUTANEOUS:INJECTION:%	SUBCUTANEOUS	0.38% SUBCUTANEOUS INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
SE337SVY37	SODIUM PHOSPHATE:TOPICAL:EMULSION, CREAM:NA	TOPICAL	TOPICAL EMULSION, CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
SE337SVY37	SODIUM PHOSPHATE:TOPICAL:OINTMENT:%W/W	TOPICAL	0.15%W/W TOPICAL OINTMENT	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
SE337SVY37	SODIUM PHOSPHATE:TOPICAL:SHAMPOO:NA	TOPICAL	TOPICAL SHAMPOO	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
SE337SVY37	SODIUM PHOSPHATE:TOPICAL:SHAMPOO, SUSPENSION:NA	TOPICAL	TOPICAL SHAMPOO, SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
LRX7AJ16DT	CUPRIC SULFATE:AURICULAR (OTIC):SUSPENSION:NA	AURICULAR (OTIC)	AURICULAR (OTIC) SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
ZDN57Z154K	HYDROXYETHYL ETHYLCELLULOSE:OPHTHALMIC:SOLUTION, DROPS:%	OPHTHALMIC	0.48% OPHTHALMIC SOLUTION, DROPS	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
ZDN57Z154K	HYDROXYETHYL ETHYLCELLULOSE:ORAL:TABLET, EXTENDED RELEASE:MG	ORAL	40.63MG ORAL TABLET, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
G538EBV4VF	SODIUM CHLORITE:OPHTHALMIC:SOLUTION, DROPS:%	OPHTHALMIC	0.005% OPHTHALMIC SOLUTION, DROPS	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
225ZLC74HX	GLYCINE HYDROCHLORIDE:ORAL:TABLET:MG	ORAL	6MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
225ZLC74HX	GLYCINE HYDROCHLORIDE:SUBCUTANEOUS:SOLUTION, INJECTION:%	SUBCUTANEOUS	0.045% SUBCUTANEOUS SOLUTION, INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
B7I80BVV5E	ETHYLHEXYL HYDROXYSTEARATE:TOPICAL:CREAM, EMULSION, SUSTAINED RELEASE:%W/W	TOPICAL	12%W/W TOPICAL CREAM, EMULSION, SUSTAINED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
B7I80BVV5E	ETHYLHEXYL HYDROXYSTEARATE:TOPICAL:EMULSION, CREAM:%W/W	TOPICAL	12%W/W TOPICAL EMULSION, CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
G79YN26H5B	PENTETATE CALCIUM TRISODIUM:INTRATHECAL:INJECTION:NA	INTRATHECAL	INTRATHECAL INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
G79YN26H5B	PENTETATE CALCIUM TRISODIUM:INTRAVENOUS:INJECTION:NA	INTRAVENOUS	INTRAVENOUS INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
G79YN26H5B	PENTETATE CALCIUM TRISODIUM:IV(INFUSION):INJECTION:NA	IV(INFUSION)	IV(INFUSION) INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
660YQ98I10	POTASSIUM CHLORIDE:AN,INFILTRATION:INJECTION:%	AN,INFILTRATION	0.03% AN,INFILTRATION INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
660YQ98I10	POTASSIUM CHLORIDE:CAUDAL BLOCK:INJECTION:%	CAUDAL BLOCK	0.03% CAUDAL BLOCK INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
660YQ98I10	POTASSIUM CHLORIDE:EPIDURAL:INJECTION:%	EPIDURAL	0.03% EPIDURAL INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
660YQ98I10	POTASSIUM CHLORIDE:INHALATION:POWDER:MG	INHALATION	0.18MG INHALATION POWDER	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
660YQ98I10	POTASSIUM CHLORIDE:INTRAOCULAR:SOLUTION:%	INTRAOCULAR	0.075% INTRAOCULAR SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
660YQ98I10	POTASSIUM CHLORIDE:INTRAVENOUS:INJECTION:NA	INTRAVENOUS	INTRAVENOUS INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
660YQ98I10	POTASSIUM CHLORIDE:INTRAVENOUS:SOLUTION, INJECTION:%	INTRAVENOUS	0.44% INTRAVENOUS SOLUTION, INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
660YQ98I10	POTASSIUM CHLORIDE:INTRAVITREAL:SUSPENSION, INJECTION:%	INTRAVITREAL	0.075% INTRAVITREAL SUSPENSION, INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
660YQ98I10	POTASSIUM CHLORIDE:IRRIGATION:SOLUTION:%	IRRIGATION	0.037% IRRIGATION SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
660YQ98I10	POTASSIUM CHLORIDE:IV(INFUSION):INJECTION:NA	IV(INFUSION)	IV(INFUSION) INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
660YQ98I10	POTASSIUM CHLORIDE:NASAL:POWDER, FOR INHALATION:NA	NASAL	NASAL POWDER, FOR INHALATION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
660YQ98I10	POTASSIUM CHLORIDE:NERVE BLOCK:INJECTION:%	NERVE BLOCK	0.03% NERVE BLOCK INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
660YQ98I10	POTASSIUM CHLORIDE:OPHTHALMIC:DROPS:%	OPHTHALMIC	0.03% OPHTHALMIC DROPS	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
660YQ98I10	POTASSIUM CHLORIDE:OPHTHALMIC:POWDER, FOR SOLUTION:%	OPHTHALMIC	0.075% OPHTHALMIC POWDER, FOR SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
660YQ98I10	POTASSIUM CHLORIDE:OPHTHALMIC:SOLUTION:%	OPHTHALMIC	0.23% OPHTHALMIC SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
660YQ98I10	POTASSIUM CHLORIDE:OPHTHALMIC:SOLUTION, DROPS:%	OPHTHALMIC	0.14% OPHTHALMIC SOLUTION, DROPS	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
660YQ98I10	POTASSIUM CHLORIDE:OPHTHALMIC:SUSPENSION:NA	OPHTHALMIC	OPHTHALMIC SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
660YQ98I10	POTASSIUM CHLORIDE:ORAL:CAPSULE:MG	ORAL	62MG ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
660YQ98I10	POTASSIUM CHLORIDE:ORAL:CAPSULE, EXTENDED RELEASE:MG	ORAL	0.4MG ORAL CAPSULE, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
660YQ98I10	POTASSIUM CHLORIDE:ORAL:SUSPENSION:NA	ORAL	ORAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
660YQ98I10	POTASSIUM CHLORIDE:ORAL:TABLET:MG	ORAL	40MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
660YQ98I10	POTASSIUM CHLORIDE:ORAL:TABLET, EXTENDED RELEASE:MG	ORAL	9.9MG ORAL TABLET, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
5101OP7P2I	SACCHARIN CALCIUM:ORAL:SOLUTION:MG/5ML	ORAL	17.5MG/5ML ORAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
5101OP7P2I	SACCHARIN CALCIUM:ORAL:SYRUP:%	ORAL	0.01% ORAL SYRUP	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
1P9D0Z171K	BUTYLATED HYDROXYTOLUENE:BUCCAL:GUM, CHEWING:MG	BUCCAL	0.21MG BUCCAL GUM, CHEWING	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
1P9D0Z171K	BUTYLATED HYDROXYTOLUENE:INTRAMUSCULAR:INJECTION:%	INTRAMUSCULAR	0.03% INTRAMUSCULAR INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
1P9D0Z171K	BUTYLATED HYDROXYTOLUENE:INTRAVENOUS:INJECTABLE:mg/mL	INTRAVENOUS	0.02mg/mL INTRAVENOUS INJECTABLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
1P9D0Z171K	BUTYLATED HYDROXYTOLUENE:INTRAVENOUS:INJECTION:%	INTRAVENOUS	0.002% INTRAVENOUS INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
1P9D0Z171K	BUTYLATED HYDROXYTOLUENE:INTRAVENOUS:POWDER, FOR INJECTION SOLUTION, LYOPHILIZED:%	INTRAVENOUS	0.002% INTRAVENOUS POWDER, FOR INJECTION SOLUTION, LYOPHILIZED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
1P9D0Z171K	BUTYLATED HYDROXYTOLUENE:INTRAVENOUS:SOLUTION, INJECTION:%	INTRAVENOUS	0.002% INTRAVENOUS SOLUTION, INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
1P9D0Z171K	BUTYLATED HYDROXYTOLUENE:INTRAVENOUS INFUSION:SOLUTION, INJECTION:mg/mL	INTRAVENOUS INFUSION	0.01mg/mL INTRAVENOUS INFUSION SOLUTION, INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
1P9D0Z171K	BUTYLATED HYDROXYTOLUENE:IV(INFUSION):INJECTION:%	IV(INFUSION)	0.006% IV(INFUSION) INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
1P9D0Z171K	BUTYLATED HYDROXYTOLUENE:IV(INFUSION):POWDER, FOR INJECTION SOLUTION:NA	IV(INFUSION)	IV(INFUSION) POWDER, FOR INJECTION SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
1P9D0Z171K	BUTYLATED HYDROXYTOLUENE:NASAL:SPRAY, METERED:%	NASAL	0.01% NASAL SPRAY, METERED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
1P9D0Z171K	BUTYLATED HYDROXYTOLUENE:ORAL:CAPSULE:MG	ORAL	0.38MG ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
1P9D0Z171K	BUTYLATED HYDROXYTOLUENE:ORAL:CAPSULE, COATED, SOFT GELATIN:MG	ORAL	0.035MG ORAL CAPSULE, COATED, SOFT GELATIN	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
1P9D0Z171K	BUTYLATED HYDROXYTOLUENE:ORAL:CAPSULE, SOFT GELATIN:MG	ORAL	0.25MG ORAL CAPSULE, SOFT GELATIN	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
1P9D0Z171K	BUTYLATED HYDROXYTOLUENE:ORAL:FILM, SOLUBLE:MG	ORAL	0.06MG ORAL FILM, SOLUBLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
1P9D0Z171K	BUTYLATED HYDROXYTOLUENE:ORAL:SOLUTION:%W/V	ORAL	0.02%W/V ORAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
1P9D0Z171K	BUTYLATED HYDROXYTOLUENE:ORAL:SOLUTION, LIQUID, CONCENTRATE, ORAL:MG/1ML	ORAL	0.1MG/1ML ORAL SOLUTION, LIQUID, CONCENTRATE, ORAL	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
1P9D0Z171K	BUTYLATED HYDROXYTOLUENE:ORAL:TABLET:MG	ORAL	0.42MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
1P9D0Z171K	BUTYLATED HYDROXYTOLUENE:ORAL:TABLET (IMMED./COMP. RELEASE), FILM COATED:MG	ORAL	0.15MG ORAL TABLET (IMMED./COMP. RELEASE), FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
1P9D0Z171K	BUTYLATED HYDROXYTOLUENE:ORAL:TABLET, COATED:NA	ORAL	ORAL TABLET, COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
1P9D0Z171K	BUTYLATED HYDROXYTOLUENE:ORAL:TABLET, CONTROLLED RELEASE:MG	ORAL	0.21MG ORAL TABLET, CONTROLLED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
1P9D0Z171K	BUTYLATED HYDROXYTOLUENE:ORAL:TABLET, EXTENDED RELEASE:MG	ORAL	0.4MG ORAL TABLET, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
1P9D0Z171K	BUTYLATED HYDROXYTOLUENE:ORAL:TABLET, FILM COATED:MG	ORAL	0.36MG ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
1P9D0Z171K	BUTYLATED HYDROXYTOLUENE:ORAL:TABLET, FOR SUSPENSION:MG	ORAL	0.1MG ORAL TABLET, FOR SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
1P9D0Z171K	BUTYLATED HYDROXYTOLUENE:ORAL:TABLET, ORALLY DISINTEGRATING:MG	ORAL	0.3MG ORAL TABLET, ORALLY DISINTEGRATING	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
1P9D0Z171K	BUTYLATED HYDROXYTOLUENE:ORAL:TABLET, SUSTAINED ACTION:MG	ORAL	0.17MG ORAL TABLET, SUSTAINED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
1P9D0Z171K	BUTYLATED HYDROXYTOLUENE:ORAL:TABLET, SUSTAINED ACTION, COATED:MG	ORAL	0.24MG ORAL TABLET, SUSTAINED ACTION, COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
1P9D0Z171K	BUTYLATED HYDROXYTOLUENE:RECTAL:SUPPOSITORY:MG	RECTAL	0.21MG RECTAL SUPPOSITORY	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
1P9D0Z171K	BUTYLATED HYDROXYTOLUENE:SUBLINGUAL:TABLET:mg	SUBLINGUAL	0.13mg SUBLINGUAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
1P9D0Z171K	BUTYLATED HYDROXYTOLUENE:TOPICAL:AEROSOL:%W/W	TOPICAL	0.1%W/W TOPICAL AEROSOL	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
1P9D0Z171K	BUTYLATED HYDROXYTOLUENE:TOPICAL:AEROSOL, FOAM:%	TOPICAL	0.1% TOPICAL AEROSOL, FOAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
1P9D0Z171K	BUTYLATED HYDROXYTOLUENE:TOPICAL:CREAM:%W/W	TOPICAL	0.05%W/W TOPICAL CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
1P9D0Z171K	BUTYLATED HYDROXYTOLUENE:TOPICAL:CREAM, AUGMENTED:%W/W	TOPICAL	0.2%W/W TOPICAL CREAM, AUGMENTED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
1P9D0Z171K	BUTYLATED HYDROXYTOLUENE:TOPICAL:CREAM, EMULSION, SUSTAINED RELEASE:%W/W	TOPICAL	0.1%W/W TOPICAL CREAM, EMULSION, SUSTAINED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
1P9D0Z171K	BUTYLATED HYDROXYTOLUENE:TOPICAL:EMULSION, AEROSOL FOAM:%W/W	TOPICAL	0.1%W/W TOPICAL EMULSION, AEROSOL FOAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
1P9D0Z171K	BUTYLATED HYDROXYTOLUENE:TOPICAL:EMULSION, CREAM:%W/W	TOPICAL	0.1%W/W TOPICAL EMULSION, CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
1P9D0Z171K	BUTYLATED HYDROXYTOLUENE:TOPICAL:GEL:%W/W	TOPICAL	0.1%W/W TOPICAL GEL	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
1P9D0Z171K	BUTYLATED HYDROXYTOLUENE:TOPICAL:LOTION:%W/W 	TOPICAL	0.021%W/W  TOPICAL LOTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
1P9D0Z171K	BUTYLATED HYDROXYTOLUENE:TOPICAL:OINTMENT:NA	TOPICAL	TOPICAL OINTMENT	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
1P9D0Z171K	BUTYLATED HYDROXYTOLUENE:TOPICAL:SHAMPOO:%W/W	TOPICAL	0.1%W/W TOPICAL SHAMPOO	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
1P9D0Z171K	BUTYLATED HYDROXYTOLUENE:TOPICAL:SOLUTION:%W/W	TOPICAL	0.1%W/W TOPICAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
1P9D0Z171K	BUTYLATED HYDROXYTOLUENE:TOPICAL:SPRAY: %W/W	TOPICAL	0.1 %W/W TOPICAL SPRAY	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
1P9D0Z171K	BUTYLATED HYDROXYTOLUENE:TOPICAL:SUSPENSION:%W/W	TOPICAL	0.016%W/W TOPICAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
1P9D0Z171K	BUTYLATED HYDROXYTOLUENE:TOPICAL:SWAB:NA	TOPICAL	TOPICAL SWAB	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
1P9D0Z171K	BUTYLATED HYDROXYTOLUENE:TRANSDERMAL:GEL:%	TRANSDERMAL	0.05% TRANSDERMAL GEL	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
1P9D0Z171K	BUTYLATED HYDROXYTOLUENE:VAGINAL:EMULSION, CREAM:%	VAGINAL	0.05% VAGINAL EMULSION, CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
1P9D0Z171K	BUTYLATED HYDROXYTOLUENE:VAGINAL:SUPPOSITORY:NA	VAGINAL	VAGINAL SUPPOSITORY	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
612E703ZUQ	HYPROMELLOSE 2906 (50 MPA.S):ORAL:TABLET, EXTENDED RELEASE:MG	ORAL	88MG ORAL TABLET, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
410Q7WN1BX	SODIUM LAURETH-5 SULFATE:TOPICAL:EMULSION, CREAM:NA	TOPICAL	TOPICAL EMULSION, CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
410Q7WN1BX	SODIUM LAURETH-5 SULFATE:TOPICAL:SHAMPOO:%W/W	TOPICAL	38%W/W TOPICAL SHAMPOO	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
5138Q19F1X	AMMONIA SOLUTION:INHALATION:LIQUID:NA	INHALATION	INHALATION LIQUID	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
5138Q19F1X	AMMONIA SOLUTION:INTRAVENOUS:INJECTION:%	INTRAVENOUS	0.22% INTRAVENOUS INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
5138Q19F1X	AMMONIA SOLUTION:OPHTHALMIC:SOLUTION:ADJ PH	OPHTHALMIC	ADJ PH OPHTHALMIC SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
5138Q19F1X	AMMONIA SOLUTION:ORAL:CAPSULE:MG	ORAL	6.03MG ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
5138Q19F1X	AMMONIA SOLUTION:ORAL:CAPSULE, DELAYED ACTION:MG	ORAL	1.5MG ORAL CAPSULE, DELAYED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
5138Q19F1X	AMMONIA SOLUTION:ORAL:CAPSULE, SUSTAINED ACTION:ADJ PH	ORAL	ADJ PH ORAL CAPSULE, SUSTAINED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
5138Q19F1X	AMMONIA SOLUTION:ORAL:SUSPENSION:MG/1ML	ORAL	0.15MG/1ML ORAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
5138Q19F1X	AMMONIA SOLUTION:ORAL:TABLET:NA	ORAL	ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
5138Q19F1X	AMMONIA SOLUTION:ORAL:TABLET, DELAYED ACTION:MG	ORAL	0.005MG ORAL TABLET, DELAYED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
5138Q19F1X	AMMONIA SOLUTION:ORAL:TABLET, DELAYED ACTION, ENTERIC COATED:NA	ORAL	ORAL TABLET, DELAYED ACTION, ENTERIC COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
5138Q19F1X	AMMONIA SOLUTION:ORAL:TABLET, EXTENDED RELEASE:MG	ORAL	0.01MG ORAL TABLET, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
5138Q19F1X	AMMONIA SOLUTION:ORAL:TABLET, SUSTAINED ACTION, COATED:NA	ORAL	ORAL TABLET, SUSTAINED ACTION, COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
5138Q19F1X	AMMONIA SOLUTION:SUBCUTANEOUS:INJECTION:ADJ PH	SUBCUTANEOUS	ADJ PH SUBCUTANEOUS INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
5138Q19F1X	AMMONIA SOLUTION:SUBLINGUAL:FILM:QS	SUBLINGUAL	QS SUBLINGUAL FILM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
5138Q19F1X	AMMONIA SOLUTION:SUBLINGUAL:FILM:PNG	SUBLINGUAL	PNG SUBLINGUAL FILM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
5138Q19F1X	AMMONIA SOLUTION:TOPICAL:EMULSION, CREAM:%W/W	TOPICAL	5.72%W/W TOPICAL EMULSION, CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
5138Q19F1X	AMMONIA SOLUTION:TOPICAL:GEL:%W/W	TOPICAL	1.2%W/W TOPICAL GEL	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
5138Q19F1X	AMMONIA SOLUTION:TOPICAL:GEL:ADJ PH	TOPICAL	ADJ PH TOPICAL GEL	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
5138Q19F1X	AMMONIA SOLUTION:TOPICAL:LOTION:ADJ PH	TOPICAL	ADJ PH TOPICAL LOTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
5138Q19F1X	AMMONIUM HYDROXIDE:TOPICAL:GEL:%W/W	TOPICAL	1.2%W/W TOPICAL GEL	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
80EHD8I43D	ALUMINUM ACETATE:AURICULAR (OTIC):SOLUTION:%	AURICULAR (OTIC)	0.79% AURICULAR (OTIC) SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
80EHD8I43D	ALUMINUM ACETATE:TOPICAL:EMULSION, CREAM:%W/W	TOPICAL	0.009%W/W TOPICAL EMULSION, CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
80EHD8I43D	ALUMINUM ACETATE:TOPICAL:LOTION:NA	TOPICAL	TOPICAL LOTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
80EHD8I43D	ALUMINUM ACETATE:TOPICAL:SHAMPOO:%W/W	TOPICAL	0.1%W/W TOPICAL SHAMPOO	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
C12674942B	TERT-BUTYLHYDROQUINONE:VAGINAL:CREAM:%W/W	VAGINAL	0.02%W/W VAGINAL CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
C12674942B	TERT-BUTYLHYDROQUINONE:VAGINAL:EMULSION, CREAM:%	VAGINAL	0.02% VAGINAL EMULSION, CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
T95DR77GMR	SODIUM CHLORATE:AN,INFILTRATION:INJECTION:NA	AN,INFILTRATION	AN,INFILTRATION INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
T95DR77GMR	SODIUM CHLORATE:INTRAMUSCULAR:INJECTION:NA	INTRAMUSCULAR	INTRAMUSCULAR INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
T95DR77GMR	SODIUM CHLORATE:INTRAVENOUS:INJECTION:%	INTRAVENOUS	0.45% INTRAVENOUS INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
T95DR77GMR	SODIUM CHLORATE:IV(INFUSION):INJECTION:%	IV(INFUSION)	15.4% IV(INFUSION) INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
T95DR77GMR	SODIUM CHLORATE:NERVE BLOCK:INJECTION:NA	NERVE BLOCK	NERVE BLOCK INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
J4BY50FL78	CAPRYLIC/CAPRIC/SUCCINIC TRIGLYCERIDE:SUBLINGUAL:AEROSOL:NA	SUBLINGUAL	SUBLINGUAL AEROSOL	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
J4BY50FL78	CAPRYLIC/CAPRIC/SUCCINIC TRIGLYCERIDE:SUBLINGUAL:AEROSOL, METERED:%	SUBLINGUAL	1.04% SUBLINGUAL AEROSOL, METERED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
5Y0974F5PW	HYDROXYPROPYL CELLULOSE (110000 WAMW):BUCCAL:FILM:MG	BUCCAL	18.92MG BUCCAL FILM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
5Y0974F5PW	HYDROXYPROPYL CELLULOSE (110000 WAMW):ORAL:CAPSULE:MG	ORAL	0.2MG ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
5Y0974F5PW	HYDROXYPROPYL CELLULOSE (110000 WAMW):ORAL:CAPSULE, DELAYED ACTION:MG	ORAL	75MG ORAL CAPSULE, DELAYED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
5Y0974F5PW	HYDROXYPROPYL CELLULOSE (110000 WAMW):ORAL:CAPSULE, EXTENDED RELEASE:MG	ORAL	25.2MG ORAL CAPSULE, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
5Y0974F5PW	HYDROXYPROPYL CELLULOSE (110000 WAMW):ORAL:GRANULE:NA	ORAL	ORAL GRANULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
5Y0974F5PW	HYDROXYPROPYL CELLULOSE (110000 WAMW):ORAL:POWDER, FOR ORAL SUSPENSION:MG	ORAL	25MG ORAL POWDER, FOR ORAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
5Y0974F5PW	HYDROXYPROPYL CELLULOSE (110000 WAMW):ORAL:SUSPENSION:mg/5mL	ORAL	16.65mg/5mL ORAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
5Y0974F5PW	HYDROXYPROPYL CELLULOSE (110000 WAMW):ORAL:TABLET:mg	ORAL	30mg ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
5Y0974F5PW	HYDROXYPROPYL CELLULOSE (110000 WAMW):ORAL:TABLET (IMMED./COMP. RELEASE), FILM COATED:MG	ORAL	40MG ORAL TABLET (IMMED./COMP. RELEASE), FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
5Y0974F5PW	HYDROXYPROPYL CELLULOSE (110000 WAMW):ORAL:TABLET (IMMED./COMP. RELEASE), UNCOATED, CHEWABLE:MG	ORAL	5MG ORAL TABLET (IMMED./COMP. RELEASE), UNCOATED, CHEWABLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
5Y0974F5PW	HYDROXYPROPYL CELLULOSE (110000 WAMW):ORAL:TABLET, CHEWABLE:MG	ORAL	60MG ORAL TABLET, CHEWABLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
5Y0974F5PW	HYDROXYPROPYL CELLULOSE (110000 WAMW):ORAL:TABLET, DELAYED ACTION:MG	ORAL	3.5MG ORAL TABLET, DELAYED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
5Y0974F5PW	HYDROXYPROPYL CELLULOSE (110000 WAMW):ORAL:TABLET, DELAYED RELEASE:MG	ORAL	8.1MG ORAL TABLET, DELAYED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
5Y0974F5PW	HYDROXYPROPYL CELLULOSE (110000 WAMW):ORAL:TABLET, EXTENDED RELEASE:mg	ORAL	18mg ORAL TABLET, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
5Y0974F5PW	HYDROXYPROPYL CELLULOSE (110000 WAMW):ORAL:TABLET, FILM COATED:MG	ORAL	92MG ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
5Y0974F5PW	HYDROXYPROPYL CELLULOSE (110000 WAMW):ORAL:TABLET, MULTILAYER, EXTENDED RELEASE:MG	ORAL	28.7MG ORAL TABLET, MULTILAYER, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
5Y0974F5PW	HYDROXYPROPYL CELLULOSE (110000 WAMW):ORAL:TABLET, ORALLY DISINTEGRATING:MG	ORAL	2.25MG ORAL TABLET, ORALLY DISINTEGRATING	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
5Y0974F5PW	HYDROXYPROPYL CELLULOSE (110000 WAMW):ORAL:TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE:mg	ORAL	15mg ORAL TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
5Y0974F5PW	HYDROXYPROPYL CELLULOSE (110000WAMW):ORAL:TABLET:MG	ORAL	28MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
5Y0974F5PW	LOW-SUBSTITUTED HYDROXYPROPYL CELLULOSE (11% HYDROXYPROPYL; 100000 MW):ORAL:CAPSULE, EXTENDED RELEASE:MG	ORAL	94.29MG ORAL CAPSULE, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
5Y0974F5PW	LOW-SUBSTITUTED HYDROXYPROPYL CELLULOSE (11% HYDROXYPROPYL; 100000 MW):ORAL:TABLET, CHEWABLE:mg	ORAL	20mg ORAL TABLET, CHEWABLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
02NG325BQG	PEG-60 HYDROGENATED CASTOR OIL:IV(INFUSION):INJECTION:MG/1ML	IV(INFUSION)	200MG/1ML IV(INFUSION) INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
02NG325BQG	PEG-60 HYDROGENATED CASTOR OIL:TOPICAL:EMULSION, CREAM:%W/W	TOPICAL	1.9%W/W TOPICAL EMULSION, CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
02NG325BQG	PEG-60 HYDROGENATED CASTOR OIL:TOPICAL:GEL:%W/W	TOPICAL	1.9%W/W TOPICAL GEL	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
L7T10EIP3A	MENTHOL, UNSPECIFIED FORM:BUCCAL:GUM, CHEWING:MG	BUCCAL	21MG BUCCAL GUM, CHEWING	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
L7T10EIP3A	MENTHOL, UNSPECIFIED FORM:DENTAL:SOLUTION:NA	DENTAL	DENTAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
L7T10EIP3A	MENTHOL, UNSPECIFIED FORM:INHALATION:AEROSOL, METERED:%	INHALATION	0.05% INHALATION AEROSOL, METERED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
L7T10EIP3A	MENTHOL, UNSPECIFIED FORM:INHALATION:AEROSOL, SPRAY:%	INHALATION	0.02% INHALATION AEROSOL, SPRAY	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
L7T10EIP3A	MENTHOL, UNSPECIFIED FORM:ORAL:CAPSULE:MG	ORAL	0.87MG ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
L7T10EIP3A	MENTHOL, UNSPECIFIED FORM:ORAL:CONCENTRATE:MG/5ML	ORAL	0.05MG/5ML ORAL CONCENTRATE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
L7T10EIP3A	MENTHOL, UNSPECIFIED FORM:ORAL:POWDER, FOR SOLUTION:MG/5 ML	ORAL	0.23MG/5 ML ORAL POWDER, FOR SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
L7T10EIP3A	MENTHOL, UNSPECIFIED FORM:ORAL:SOLUTION:MG/1ML	ORAL	0.5MG/1ML ORAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
L7T10EIP3A	MENTHOL, UNSPECIFIED FORM:ORAL:SOLUTION, ELIXIR:NA	ORAL	ORAL SOLUTION, ELIXIR	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
L7T10EIP3A	MENTHOL, UNSPECIFIED FORM:ORAL:SOLUTION, LIQUID, CONCENTRATE, ORAL:MG/1ML	ORAL	0.5MG/1ML ORAL SOLUTION, LIQUID, CONCENTRATE, ORAL	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
L7T10EIP3A	MENTHOL, UNSPECIFIED FORM:ORAL:SUSPENSION:MG/5ML	ORAL	0.41MG/5ML ORAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
L7T10EIP3A	MENTHOL, UNSPECIFIED FORM:ORAL:SYRUP:%	ORAL	20% ORAL SYRUP	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
L7T10EIP3A	MENTHOL, UNSPECIFIED FORM:ORAL:TABLET:MG	ORAL	0.58MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
L7T10EIP3A	MENTHOL, UNSPECIFIED FORM:ORAL:TABLET, ORALLY DISINTEGRATING:MG	ORAL	14MG ORAL TABLET, ORALLY DISINTEGRATING	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
L7T10EIP3A	MENTHOL, UNSPECIFIED FORM:SUBLINGUAL:AEROSOL:NA	SUBLINGUAL	SUBLINGUAL AEROSOL	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
L7T10EIP3A	MENTHOL, UNSPECIFIED FORM:TOPICAL:LOTION:%W/W	TOPICAL	0.05%W/W TOPICAL LOTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
L7T10EIP3A	MENTHOL, UNSPECIFIED FORM:TOPICAL:SOLUTION:%W/V	TOPICAL	0.08%W/V TOPICAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
MA3UYZ6K1H	ACESULFAME:BUCCAL:GUM, CHEWING:MG	BUCCAL	2.4MG BUCCAL GUM, CHEWING	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
MA3UYZ6K1H	ACESULFAME:ORAL:SOLUTION:MG/1ML	ORAL	4MG/1ML ORAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
98553S1MHQ	POLYISOBUTYLENE (35000 MW):TRANSDERMAL:FILM, CONTROLLED RELEASE:MG	TRANSDERMAL	86MG TRANSDERMAL FILM, CONTROLLED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
Q662QK8M3B	POLYETHYLENE GLYCOL 8000:OPHTHALMIC:SOLUTION:%	OPHTHALMIC	2% OPHTHALMIC SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
Q662QK8M3B	POLYETHYLENE GLYCOL 8000:ORAL:CAPSULE:MG	ORAL	35MG ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
Q662QK8M3B	POLYETHYLENE GLYCOL 8000:ORAL:CAPSULE, DELAYED ACTION:MG	ORAL	1.78MG ORAL CAPSULE, DELAYED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
Q662QK8M3B	POLYETHYLENE GLYCOL 8000:ORAL:CAPSULE, EXTENDED RELEASE:MG	ORAL	9.77MG ORAL CAPSULE, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
Q662QK8M3B	POLYETHYLENE GLYCOL 8000:ORAL:CAPSULE, HARD GELATIN:MG	ORAL	27.8MG ORAL CAPSULE, HARD GELATIN	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
Q662QK8M3B	POLYETHYLENE GLYCOL 8000:ORAL:CAPSULE, SUSTAINED ACTION:MG	ORAL	1.39MG ORAL CAPSULE, SUSTAINED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
Q662QK8M3B	POLYETHYLENE GLYCOL 8000:ORAL:TABLET:mg	ORAL	400mg ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
Q662QK8M3B	POLYETHYLENE GLYCOL 8000:ORAL:TABLET (IMMED./COMP. RELEASE), FILM COATED:MG	ORAL	5.71MG ORAL TABLET (IMMED./COMP. RELEASE), FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
Q662QK8M3B	POLYETHYLENE GLYCOL 8000:ORAL:TABLET (IMMED./COMP. RELEASE), UNCOATED, CHEWABLE:MG	ORAL	6.5MG ORAL TABLET (IMMED./COMP. RELEASE), UNCOATED, CHEWABLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
Q662QK8M3B	POLYETHYLENE GLYCOL 8000:ORAL:TABLET, COATED:MG	ORAL	0.21MG ORAL TABLET, COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
Q662QK8M3B	POLYETHYLENE GLYCOL 8000:ORAL:TABLET, DELAYED ACTION:MG	ORAL	3.17MG ORAL TABLET, DELAYED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
Q662QK8M3B	POLYETHYLENE GLYCOL 8000:ORAL:TABLET, DELAYED ACTION, ENTERIC COATED:MG	ORAL	0.75MG ORAL TABLET, DELAYED ACTION, ENTERIC COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
Q662QK8M3B	POLYETHYLENE GLYCOL 8000:ORAL:TABLET, EXTENDED RELEASE:MG	ORAL	144.6MG ORAL TABLET, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
Q662QK8M3B	POLYETHYLENE GLYCOL 8000:ORAL:TABLET, FILM COATED:MG	ORAL	49MG ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
Q662QK8M3B	POLYETHYLENE GLYCOL 8000:ORAL:TABLET, MULTILAYER, EXTENDED RELEASE:MG	ORAL	4.3MG ORAL TABLET, MULTILAYER, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
Q662QK8M3B	POLYETHYLENE GLYCOL 8000:ORAL:TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE:MG	ORAL	2.55MG ORAL TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
Q662QK8M3B	POLYETHYLENE GLYCOL 8000:ORAL:TABLET, SUSTAINED ACTION:MG	ORAL	100MG ORAL TABLET, SUSTAINED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
Q662QK8M3B	POLYETHYLENE GLYCOL 8000:ORAL:TABLET, SUSTAINED ACTION, COATED:MG	ORAL	14MG ORAL TABLET, SUSTAINED ACTION, COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
Q662QK8M3B	POLYETHYLENE GLYCOL 8000:ORAL:TABLET, SUSTAINED ACTION, FILM COATED:MG	ORAL	0.18MG ORAL TABLET, SUSTAINED ACTION, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
Q662QK8M3B	POLYETHYLENE GLYCOL 8000:RECTAL:SUPPOSITORY:MG	RECTAL	52MG RECTAL SUPPOSITORY	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
Q662QK8M3B	POLYETHYLENE GLYCOL 8000:SUBLINGUAL:FILM:mg	SUBLINGUAL	12.2mg SUBLINGUAL FILM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
Q662QK8M3B	POLYETHYLENE GLYCOL 8000:TOPICAL:CREAM:%W/W	TOPICAL	4.6%W/W TOPICAL CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
Q662QK8M3B	POLYETHYLENE GLYCOL 8000:TOPICAL:CREAM, EMULSION, SUSTAINED RELEASE:%W/W	TOPICAL	4%W/W TOPICAL CREAM, EMULSION, SUSTAINED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
Q662QK8M3B	POLYETHYLENE GLYCOL 8000:TOPICAL:EMULSION, CREAM:%W/W	TOPICAL	5%W/W TOPICAL EMULSION, CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
Q662QK8M3B	POLYETHYLENE GLYCOL 8000:TOPICAL:POWDER:NA	TOPICAL	TOPICAL POWDER	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
Q662QK8M3B	POLYETHYLENE GLYCOL 8000:TOPICAL:SOLUTION:NA	TOPICAL	TOPICAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
Q662QK8M3B	POLYETHYLENE GLYCOL 8000:VAGINAL:TABLET:MG	VAGINAL	3MG VAGINAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
18L31PSR28	TRIMYRISTIN:ORAL:CAPSULE:NA	ORAL	ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
18L31PSR28	TRIMYRISTIN:ORAL:TABLET:MG	ORAL	16MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
F05Q2T2JA0	DOCUSATE SODIUM:INTRAMUSCULAR:INJECTION:%W/V	INTRAMUSCULAR	0.015%W/V INTRAMUSCULAR INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
F05Q2T2JA0	DOCUSATE SODIUM:ORAL:CAPSULE:MG	ORAL	8.2MG ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
F05Q2T2JA0	DOCUSATE SODIUM:ORAL:CAPSULE, HARD GELATIN:MG	ORAL	0.64MG ORAL CAPSULE, HARD GELATIN	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
F05Q2T2JA0	DOCUSATE SODIUM:ORAL:CAPSULE, SUSTAINED ACTION:MG	ORAL	0.001MG ORAL CAPSULE, SUSTAINED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
F05Q2T2JA0	DOCUSATE SODIUM:ORAL:GRANULE, FOR SUSPENSION, EXTENDED RELEASE:NA	ORAL	ORAL GRANULE, FOR SUSPENSION, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
F05Q2T2JA0	DOCUSATE SODIUM:ORAL:SUSPENSION:MG/5ML	ORAL	6MG/5ML ORAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
F05Q2T2JA0	DOCUSATE SODIUM:ORAL:SUSPENSION, SUSTAINED ACTION:MG/1PKT	ORAL	0.77MG/1PKT ORAL SUSPENSION, SUSTAINED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
F05Q2T2JA0	DOCUSATE SODIUM:ORAL:TABLET:MG	ORAL	11MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
F05Q2T2JA0	DOCUSATE SODIUM:ORAL:TABLET (IMMED./COMP. RELEASE), COATED:MG	ORAL	0.5MG ORAL TABLET (IMMED./COMP. RELEASE), COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
F05Q2T2JA0	DOCUSATE SODIUM:ORAL:TABLET, COATED:MG	ORAL	0.006MG ORAL TABLET, COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
F05Q2T2JA0	DOCUSATE SODIUM:ORAL:TABLET, FILM COATED:MG	ORAL	0.5MG ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
F05Q2T2JA0	DOCUSATE SODIUM:ORAL:TABLET, SUSTAINED ACTION, FILM COATED:MG	ORAL	0.03MG ORAL TABLET, SUSTAINED ACTION, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
F05Q2T2JA0	DOCUSATE SODIUM:TOPICAL:GEL:%W/W	TOPICAL	0.2%W/W TOPICAL GEL	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
F05Q2T2JA0	DOCUSATE SODIUM:TOPICAL:SHAMPOO:%W/W	TOPICAL	2%W/W TOPICAL SHAMPOO	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
436LS6U35Y	SODIUM DESOXYCHOLATE:IV(INFUSION):INJECTION:NA	IV(INFUSION)	IV(INFUSION) INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
436LS6U35Y	SODIUM DESOXYCHOLATE:IV(INFUSION):POWDER, FOR INJECTION SOLUTION:%	IV(INFUSION)	4.1% IV(INFUSION) POWDER, FOR INJECTION SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
762O8IWA10	PEG-8 LAURATE:TOPICAL:LOTION:%W/V	TOPICAL	0.5%W/V TOPICAL LOTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
762O8IWA10	PEG-8 LAURATE:TOPICAL:SUSPENSION:%W/W	TOPICAL	0.63%W/W TOPICAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
4Q93RCW27E	CARBOMER 940:TOPICAL:GEL:%W/W	TOPICAL	1.1%W/W TOPICAL GEL	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
4Q93RCW27E	CARBOMER 980:TOPICAL:GEL:%W/W	TOPICAL	1.8%W/W TOPICAL GEL	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
4Q93RCW27E	CARBOMER HOMOPOLYMER TYPE C (ALLYL PENTAERYTHRITOL CROSSLINKED):OPHTHALMIC:GEL:%	OPHTHALMIC	4% OPHTHALMIC GEL	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
4Q93RCW27E	CARBOMER HOMOPOLYMER TYPE C (ALLYL PENTAERYTHRITOL CROSSLINKED):TOPICAL:CREAM:%W/W	TOPICAL	1.2%W/W TOPICAL CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
4Q93RCW27E	CARBOMER HOMOPOLYMER TYPE C (ALLYL PENTAERYTHRITOL CROSSLINKED):TOPICAL:CREAM, AUGMENTED:%W/W	TOPICAL	1%W/W TOPICAL CREAM, AUGMENTED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
4Q93RCW27E	CARBOMER HOMOPOLYMER TYPE C (ALLYL PENTAERYTHRITOL CROSSLINKED):TOPICAL:CREAM, EMULSION, SUSTAINED RELEASE:%W/W	TOPICAL	1.2%W/W TOPICAL CREAM, EMULSION, SUSTAINED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
4Q93RCW27E	CARBOMER HOMOPOLYMER TYPE C (ALLYL PENTAERYTHRITOL CROSSLINKED):TOPICAL:EMULSION:%W/W	TOPICAL	0.6%W/W TOPICAL EMULSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
4Q93RCW27E	CARBOMER HOMOPOLYMER TYPE C (ALLYL PENTAERYTHRITOL CROSSLINKED):TOPICAL:EMULSION, CREAM:%W/W	TOPICAL	1.2%W/W TOPICAL EMULSION, CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
4Q93RCW27E	CARBOMER HOMOPOLYMER TYPE C (ALLYL PENTAERYTHRITOL CROSSLINKED):TOPICAL:GEL:%W/W	TOPICAL	3.5%W/W TOPICAL GEL	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
4Q93RCW27E	CARBOMER HOMOPOLYMER TYPE C (ALLYL PENTAERYTHRITOL CROSSLINKED):TOPICAL:LOTION:%W/W	TOPICAL	0.5%W/W TOPICAL LOTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
4Q93RCW27E	CARBOMER HOMOPOLYMER TYPE C (ALLYL PENTAERYTHRITOL CROSSLINKED):TOPICAL:OINTMENT, AUGMENTED:%W/W	TOPICAL	2.25%W/W TOPICAL OINTMENT, AUGMENTED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
4Q93RCW27E	CARBOMER HOMOPOLYMER TYPE C (ALLYL PENTAERYTHRITOL CROSSLINKED):TRANSDERMAL:GEL:%W/W	TRANSDERMAL	1.5%W/W TRANSDERMAL GEL	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
4Q93RCW27E	CARBOMER HOMOPOLYMER TYPE C (ALLYL PENTAERYTHRITOL CROSSLINKED):TRANSDERMAL:GEL, METERED:%	TRANSDERMAL	1% TRANSDERMAL GEL, METERED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
D9OM4SK49P	CETYLPYRIDINIUM CHLORIDE:INHALATION:AEROSOL, METERED:NA	INHALATION	INHALATION AEROSOL, METERED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
D9OM4SK49P	CETYLPYRIDINIUM CHLORIDE:INHALATION:AEROSOL, SPRAY:NA	INHALATION	INHALATION AEROSOL, SPRAY	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
D9OM4SK49P	CETYLPYRIDINIUM CHLORIDE:IONTOPHORESIS:DRUG DELIVERY SYSTEM:MG	IONTOPHORESIS	1.2MG IONTOPHORESIS DRUG DELIVERY SYSTEM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
D9OM4SK49P	CETYLPYRIDINIUM CHLORIDE:ORAL:AEROSOL:NA	ORAL	ORAL AEROSOL	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
D9OM4SK49P	CETYLPYRIDINIUM CHLORIDE:ORAL:CAPSULE:MG	ORAL	1.5MG ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
D9OM4SK49P	CETYLPYRIDINIUM CHLORIDE:ORAL:CAPSULE, SOFT GELATIN:MG	ORAL	0.004MG ORAL CAPSULE, SOFT GELATIN	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
D9OM4SK49P	CETYLPYRIDINIUM CHLORIDE:ORAL:CAPSULE, SUSTAINED ACTION:MG	ORAL	0.02MG ORAL CAPSULE, SUSTAINED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
D9OM4SK49P	CETYLPYRIDINIUM CHLORIDE:TRANSDERMAL:DRUG DELIVERY SYSTEM:MG	TRANSDERMAL	1.2MG TRANSDERMAL DRUG DELIVERY SYSTEM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
QE6F49RPJ1	SORBITAN TRIOLEATE:INHALATION:AEROSOL, METERED:%	INHALATION	0.069% INHALATION AEROSOL, METERED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
QE6F49RPJ1	SORBITAN TRIOLEATE:INHALATION:AEROSOL, SPRAY:%	INHALATION	0.86% INHALATION AEROSOL, SPRAY	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
QE6F49RPJ1	SORBITAN TRIOLEATE:NASAL:AEROSOL, METERED:%	NASAL	0.018% NASAL AEROSOL, METERED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
QE6F49RPJ1	SORBITAN TRIOLEATE:ORAL:CAPSULE:NA	ORAL	ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
QE6F49RPJ1	SORBITAN TRIOLEATE:ORAL:DROPS:NA	ORAL	ORAL DROPS	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
QE6F49RPJ1	SORBITAN TRIOLEATE:ORAL:POWDER, FOR ORAL SUSPENSION:MG/5ML	ORAL	1.5MG/5ML ORAL POWDER, FOR ORAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
QE6F49RPJ1	SORBITAN TRIOLEATE:ORAL:SOLUTION:NA	ORAL	ORAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
QE6F49RPJ1	SORBITAN TRIOLEATE:ORAL:SYRUP:NA	ORAL	ORAL SYRUP	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
QE6F49RPJ1	SORBITAN TRIOLEATE:ORAL:TABLET:NA	ORAL	ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
K414AX1M5S	LIGHT GREEN CF YELLOWISH:ORAL:CAPSULE:MG	ORAL	40MG ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
LX22YL083G	DEXTROSE MONOHYDRATE:INTRAVENOUS:INJECTABLE:%	INTRAVENOUS	5% INTRAVENOUS INJECTABLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
LX22YL083G	DEXTROSE MONOHYDRATE:INTRAVENOUS:INJECTION:%	INTRAVENOUS	5.05% INTRAVENOUS INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
LX22YL083G	DEXTROSE MONOHYDRATE:INTRAVENOUS:INJECTION, SOLUTION:%	INTRAVENOUS	5.02% INTRAVENOUS INJECTION, SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
LX22YL083G	DEXTROSE MONOHYDRATE:INTRAVENOUS:SOLUTION, INJECTION:%	INTRAVENOUS	5.02% INTRAVENOUS SOLUTION, INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
LX22YL083G	DEXTROSE MONOHYDRATE:IV(INFUSION):INJECTION:%	IV(INFUSION)	5.02% IV(INFUSION) INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
LX22YL083G	DEXTROSE MONOHYDRATE:NASAL:SPRAY, METERED:%	NASAL	5.5% NASAL SPRAY, METERED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
LX22YL083G	DEXTROSE MONOHYDRATE:NASAL:SUSPENSION:NA	NASAL	NASAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
LX22YL083G	DEXTROSE MONOHYDRATE:ORAL:TABLET:MG	ORAL	5.32MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
LX22YL083G	DEXTROSE MONOHYDRATE:ORAL:TABLET, EXTENDED RELEASE:MG	ORAL	46.2MG ORAL TABLET, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
BQN1B9B9HA	POTASSIUM CARBONATE:ORAL:CAPSULE:MG	ORAL	27.69MG ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
BQN1B9B9HA	POTASSIUM CARBONATE:ORAL:SOLUTION:MG/1ML	ORAL	6.2MG/1ML ORAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
BQN1B9B9HA	POTASSIUM CARBONATE:ORAL:TABLET:MG	ORAL	25MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
BQN1B9B9HA	POTASSIUM CARBONATE:TOPICAL:SOLUTION:%W/W	TOPICAL	15%W/W TOPICAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
AV092KU4JH	PEPPERMINT OIL:BUCCAL:FILM:MG	BUCCAL	0.51MG BUCCAL FILM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
AV092KU4JH	PEPPERMINT OIL:BUCCAL:FILM, SOLUBLE:MG	BUCCAL	0.85MG BUCCAL FILM, SOLUBLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
AV092KU4JH	PEPPERMINT OIL:BUCCAL:GUM, CHEWING:MG	BUCCAL	31MG BUCCAL GUM, CHEWING	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
AV092KU4JH	PEPPERMINT OIL:DENTAL:SOLUTION:%	DENTAL	0.035% DENTAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
AV092KU4JH	PEPPERMINT OIL:ORAL:CAPSULE:MG	ORAL	3MG ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
AV092KU4JH	PEPPERMINT OIL:ORAL:CAPSULE (IMMED./COMP. RELEASE), SOFT GELATIN:MG	ORAL	0.6MG ORAL CAPSULE (IMMED./COMP. RELEASE), SOFT GELATIN	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
AV092KU4JH	PEPPERMINT OIL:ORAL:CAPSULE, SOFT GELATIN:MG	ORAL	1.02MG ORAL CAPSULE, SOFT GELATIN	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
AV092KU4JH	PEPPERMINT OIL:ORAL:CONCENTRATE:%	ORAL	0.005% ORAL CONCENTRATE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
AV092KU4JH	PEPPERMINT OIL:ORAL:GUM, CHEWING:MG	ORAL	15MG ORAL GUM, CHEWING	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
AV092KU4JH	PEPPERMINT OIL:ORAL:SOLUTION:MG/1ML	ORAL	3.5MG/1ML ORAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
AV092KU4JH	PEPPERMINT OIL:ORAL:SOLUTION, ELIXIR:NA	ORAL	ORAL SOLUTION, ELIXIR	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
AV092KU4JH	PEPPERMINT OIL:ORAL:SUSPENSION:MG/1ML	ORAL	100MG/1ML ORAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
AV092KU4JH	PEPPERMINT OIL:ORAL:SYRUP:%	ORAL	12% ORAL SYRUP	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
AV092KU4JH	PEPPERMINT OIL:ORAL:TABLET:MG	ORAL	1908MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
AV092KU4JH	PEPPERMINT OIL:ORAL:TABLET, ORALLY DISINTEGRATING:MG	ORAL	0.72MG ORAL TABLET, ORALLY DISINTEGRATING	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
AV092KU4JH	PEPPERMINT OIL:SUBLINGUAL:AEROSOL:NA	SUBLINGUAL	SUBLINGUAL AEROSOL	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
AV092KU4JH	PEPPERMINT OIL:SUBLINGUAL:AEROSOL, METERED:%	SUBLINGUAL	0.022% SUBLINGUAL AEROSOL, METERED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
AV092KU4JH	PEPPERMINT OIL:SUBLINGUAL:SPRAY:%	SUBLINGUAL	0.034% SUBLINGUAL SPRAY	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
AV092KU4JH	PEPPERMINT OIL:SUBLINGUAL:SPRAY, METERED:%	SUBLINGUAL	0.035% SUBLINGUAL SPRAY, METERED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
AV092KU4JH	PEPPERMINT OIL:SUBLINGUAL:TABLET:MG	SUBLINGUAL	0.15MG SUBLINGUAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
AV092KU4JH	PEPPERMINT OIL:TOPICAL:OINTMENT:%W/W	TOPICAL	0.2%W/W TOPICAL OINTMENT	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
NPT6P8P3UU	POTASSIUM BITARTRATE:ORAL:TABLET, CONTROLLED RELEASE:MG	ORAL	10MG ORAL TABLET, CONTROLLED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
NPT6P8P3UU	POTASSIUM BITARTRATE:ORAL:TABLET, EXTENDED RELEASE:MG	ORAL	9.5MG ORAL TABLET, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
G7036X8B5H	FERROUS OXIDE:ORAL:TABLET:NA	ORAL	ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
G7036X8B5H	FERROUS OXIDE:ORAL:TABLET, DELAYED ACTION, ENTERIC COATED:NA	ORAL	ORAL TABLET, DELAYED ACTION, ENTERIC COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
G7036X8B5H	FERROUS OXIDE:ORAL:TABLET, SUSTAINED ACTION:NA	ORAL	ORAL TABLET, SUSTAINED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
4DGK8B7I3S	STARCH, RICE:ORAL:TABLET, SUSTAINED ACTION:MG	ORAL	301MG ORAL TABLET, SUSTAINED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
X4ZGP7K714	SODIUM FORMALDEHYDE SULFOXYLATE:IM - IV:INJECTION:%	IM - IV	0.1% IM - IV INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
X4ZGP7K714	SODIUM FORMALDEHYDE SULFOXYLATE:IM - SC:INJECTION:%	IM - SC	0.1% IM - SC INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
X4ZGP7K714	SODIUM FORMALDEHYDE SULFOXYLATE:INTRAMUSCULAR:INJECTION:%	INTRAMUSCULAR	0.2% INTRAMUSCULAR INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
X4ZGP7K714	SODIUM FORMALDEHYDE SULFOXYLATE:INTRAVENOUS:INJECTION:%	INTRAVENOUS	1% INTRAVENOUS INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
X4ZGP7K714	SODIUM FORMALDEHYDE SULFOXYLATE:INTRAVENOUS:POWDER, FOR INJECTION SOLUTION:%	INTRAVENOUS	1% INTRAVENOUS POWDER, FOR INJECTION SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
X4ZGP7K714	SODIUM FORMALDEHYDE SULFOXYLATE:INTRAVENOUS:POWDER, FOR INJECTION SOLUTION, LYOPHILIZED:%	INTRAVENOUS	1.05% INTRAVENOUS POWDER, FOR INJECTION SOLUTION, LYOPHILIZED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
X4ZGP7K714	SODIUM FORMALDEHYDE SULFOXYLATE:IV(INFUSION):INJECTION:%	IV(INFUSION)	1.1% IV(INFUSION) INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
X4ZGP7K714	SODIUM FORMALDEHYDE SULFOXYLATE:IV(INFUSION):POWDER, FOR INJECTION SOLUTION, LYOPHILIZED:%	IV(INFUSION)	1% IV(INFUSION) POWDER, FOR INJECTION SOLUTION, LYOPHILIZED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
X4ZGP7K714	SODIUM FORMALDEHYDE SULFOXYLATE:TOPICAL:EMULSION, CREAM:NA	TOPICAL	TOPICAL EMULSION, CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
411VRN1TV4	NITRIC ACID:INHALATION:AEROSOL, METERED:%	INHALATION	1.67% INHALATION AEROSOL, METERED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=N
411VRN1TV4	NITRIC ACID:INHALATION:AEROSOL, SPRAY:%	INHALATION	0.8% INHALATION AEROSOL, SPRAY	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=N
411VRN1TV4	NITRIC ACID:IV(INFUSION):INJECTION:ADJ PH	IV(INFUSION)	ADJ PH IV(INFUSION) INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=N
411VRN1TV4	NITRIC ACID:OPHTHALMIC:SOLUTION:NA	OPHTHALMIC	OPHTHALMIC SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=N
411VRN1TV4	NITRIC ACID:TOPICAL:EMULSION, CREAM:NA	TOPICAL	TOPICAL EMULSION, CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=N
411VRN1TV4	NITRIC ACID:TOPICAL:SOLUTION:NA	TOPICAL	TOPICAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=N
411VRN1TV4	NITRIC ACID:VAGINAL:EMULSION, CREAM:ADJ PH	VAGINAL	ADJ PH VAGINAL EMULSION, CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=N
461N1O614Y	OCTYLDODECANOL:TOPICAL:EMULSION, CREAM:%W/W	TOPICAL	12%W/W TOPICAL EMULSION, CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
461N1O614Y	OCTYLDODECANOL:TOPICAL:GEL:%W/W	TOPICAL	10%W/W TOPICAL GEL	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
461N1O614Y	OCTYLDODECANOL:TOPICAL:LOTION:%W/W	TOPICAL	10%W/W TOPICAL LOTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
461N1O614Y	OCTYLDODECANOL:TOPICAL:OINTMENT:NA	TOPICAL	TOPICAL OINTMENT	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
461N1O614Y	OCTYLDODECANOL:TOPICAL:SUPPOSITORY, INSERT:NA	TOPICAL	TOPICAL SUPPOSITORY, INSERT	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
461N1O614Y	OCTYLDODECANOL:TOPICAL:SUSPENSION:%W/W	TOPICAL	2.01%W/W TOPICAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
461N1O614Y	OCTYLDODECANOL:TOPICAL:TABLET:NA	TOPICAL	TOPICAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
461N1O614Y	OCTYLDODECANOL:TRANSDERMAL:FILM:MG	TRANSDERMAL	32.44MG TRANSDERMAL FILM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
461N1O614Y	OCTYLDODECANOL:TRANSDERMAL:FILM, CONTROLLED RELEASE:MG	TRANSDERMAL	253.4MG TRANSDERMAL FILM, CONTROLLED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
461N1O614Y	OCTYLDODECANOL:VAGINAL:CREAM, AUGMENTED:%	VAGINAL	13.5% VAGINAL CREAM, AUGMENTED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
461N1O614Y	OCTYLDODECANOL:VAGINAL:EMULSION, CREAM:%	VAGINAL	13.5% VAGINAL EMULSION, CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
461N1O614Y	OCTYLDODECANOL:VAGINAL:SUPPOSITORY, INSERT:NA	VAGINAL	VAGINAL SUPPOSITORY, INSERT	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
461N1O614Y	OCTYLDODECANOL:VAGINAL:TABLET:NA	VAGINAL	VAGINAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
3J50XA376E	THYMOL:INHALATION:AEROSOL:ug	INHALATION	0.01ug INHALATION AEROSOL	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
3J50XA376E	THYMOL:INHALATION:LIQUID:%	INHALATION	0.01% INHALATION LIQUID	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
3J50XA376E	THYMOL:ORAL:POWDER, FOR SOLUTION:MG/5 ML	ORAL	0.6MG/5 ML ORAL POWDER, FOR SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
GSY51O183C	GLYCERYL PALMITOSTEARATE:INTRADERMAL:INJECTION:%	INTRADERMAL	1.6% INTRADERMAL INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
GSY51O183C	GLYCERYL PALMITOSTEARATE:ORAL:SUSPENSION:MG/5ML	ORAL	150MG/5ML ORAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
GSY51O183C	GLYCERYL PALMITOSTEARATE:ORAL:TABLET:MG	ORAL	18MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
DEL7T5QRPN	METHYLCHLOROISOTHIAZOLINONE:TOPICAL:EMULSION, CREAM:NA	TOPICAL	TOPICAL EMULSION, CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
DEL7T5QRPN	METHYLCHLOROISOTHIAZOLINONE:TOPICAL:LOTION:NA	TOPICAL	TOPICAL LOTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
W4888I119H	TARTARIC ACID:INTRAMUSCULAR:INJECTION:%	INTRAMUSCULAR	0.35% INTRAMUSCULAR INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
W4888I119H	TARTARIC ACID:INTRAMUSCULAR:POWDER, FOR INJECTION SOLUTION, LYOPHILIZED:%	INTRAMUSCULAR	0.35% INTRAMUSCULAR POWDER, FOR INJECTION SOLUTION, LYOPHILIZED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
W4888I119H	TARTARIC ACID:INTRAMUSCULAR:SOLUTION, INJECTION:%W/V	INTRAMUSCULAR	0.23%W/V INTRAMUSCULAR SOLUTION, INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
W4888I119H	TARTARIC ACID:INTRAVENOUS:INJECTABLE:%	INTRAVENOUS	0.5% INTRAVENOUS INJECTABLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
W4888I119H	TARTARIC ACID:INTRAVENOUS:INJECTION:%	INTRAVENOUS	2% INTRAVENOUS INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
W4888I119H	TARTARIC ACID:INTRAVENOUS:INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION:%	INTRAVENOUS	2% INTRAVENOUS INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
W4888I119H	TARTARIC ACID:INTRAVENOUS:POWDER, FOR INJECTION SOLUTION, LYOPHILIZED:%	INTRAVENOUS	2% INTRAVENOUS POWDER, FOR INJECTION SOLUTION, LYOPHILIZED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
W4888I119H	TARTARIC ACID:INTRAVENOUS:SOLUTION, CONCENTRATE:%	INTRAVENOUS	0.5% INTRAVENOUS SOLUTION, CONCENTRATE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
W4888I119H	TARTARIC ACID:INTRAVENOUS:SOLUTION, INJECTION:%	INTRAVENOUS	0.5% INTRAVENOUS SOLUTION, INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
W4888I119H	TARTARIC ACID:IV(INFUSION):INJECTION:%	IV(INFUSION)	2% IV(INFUSION) INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
W4888I119H	TARTARIC ACID:IV(INFUSION):POWDER, FOR INJECTION SOLUTION, LYOPHILIZED:%	IV(INFUSION)	2% IV(INFUSION) POWDER, FOR INJECTION SOLUTION, LYOPHILIZED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
W4888I119H	TARTARIC ACID:ORAL:CAPSULE:mg	ORAL	230mg ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
W4888I119H	TARTARIC ACID:ORAL:CAPSULE, EXTENDED RELEASE:MG	ORAL	260MG ORAL CAPSULE, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
W4888I119H	TARTARIC ACID:ORAL:CAPSULE, SUSTAINED ACTION:MG	ORAL	215.1MG ORAL CAPSULE, SUSTAINED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
W4888I119H	TARTARIC ACID:ORAL:POWDER, FOR SOLUTION:MG/1ML	ORAL	15MG/1ML ORAL POWDER, FOR SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
W4888I119H	TARTARIC ACID:ORAL:SOLUTION:%W/W	ORAL	0.75%W/W ORAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
W4888I119H	TARTARIC ACID:ORAL:SUSPENSION:MG/5ML	ORAL	10MG/5ML ORAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
W4888I119H	TARTARIC ACID:ORAL:TABLET:MG	ORAL	40MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
W4888I119H	TARTARIC ACID:ORAL:TABLET, COATED:MG	ORAL	10MG ORAL TABLET, COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
W4888I119H	TARTARIC ACID:ORAL:TABLET, EXTENDED RELEASE:MG	ORAL	75MG ORAL TABLET, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
W4888I119H	TARTARIC ACID:ORAL:TABLET, FILM COATED:MG	ORAL	30MG ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
W4888I119H	TARTARIC ACID:ORAL:TABLET, FOR SUSPENSION:MG	ORAL	7MG ORAL TABLET, FOR SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
W4888I119H	TARTARIC ACID:ORAL:TABLET, ORALLY DISINTEGRATING:MG	ORAL	45MG ORAL TABLET, ORALLY DISINTEGRATING	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
W4888I119H	TARTARIC ACID:ORAL:TABLET, SUSTAINED ACTION:MG	ORAL	29.2MG ORAL TABLET, SUSTAINED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
W4888I119H	TARTARIC ACID:RECTAL:SUPPOSITORY:MG	RECTAL	21.5MG RECTAL SUPPOSITORY	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
W4888I119H	TARTARIC ACID:SUBCUTANEOUS:SOLUTION, INJECTION:%	SUBCUTANEOUS	0.23% SUBCUTANEOUS SOLUTION, INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
W4888I119H	TARTARIC ACID:SUBLINGUAL:TABLET:MG	SUBLINGUAL	1.5MG SUBLINGUAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
W4888I119H	TARTARIC ACID:TOPICAL:FILM, CONTROLLED RELEASE:ADJ PH	TOPICAL	ADJ PH TOPICAL FILM, CONTROLLED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
W4888I119H	TARTARIC ACID:TOPICAL:PATCH:MG	TOPICAL	67MG TOPICAL PATCH	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
W4888I119H	TARTARIC ACID:TOPICAL:PATCH, CONTROLLED RELEASE:NA	TOPICAL	TOPICAL PATCH, CONTROLLED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
0A6MDS9SLT	TRIMETHYLSILYL TREATED DIMETHICONOL/TRIMETHYLSILOXYSILICATE CROSSPOLYMER (35/65 W/W; 50000000 PA.S):PERCUTANEOUS:PATCH, CONTROLLED RELEASE:MG	PERCUTANEOUS	220MG PERCUTANEOUS PATCH, CONTROLLED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
0A6MDS9SLT	TRIMETHYLSILYL TREATED DIMETHICONOL/TRIMETHYLSILOXYSILICATE CROSSPOLYMER (35/65 W/W; 50000000 PA.S):TRANSDERMAL:FILM, CONTROLLED RELEASE:MG	TRANSDERMAL	171.17MG TRANSDERMAL FILM, CONTROLLED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
0A6MDS9SLT	TRIMETHYLSILYL TREATED DIMETHICONOL/TRIMETHYLSILOXYSILICATE CROSSPOLYMER (35/65 W/W; 50000000 PA.S):TRANSDERMAL:PATCH:MG	TRANSDERMAL	59.34MG TRANSDERMAL PATCH	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
GGO4Y809LO	METACRESOL:IM - IV - SC:INJECTION:%	IM - IV - SC	0.1% IM - IV - SC INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
GGO4Y809LO	METACRESOL:IM - SC:INJECTION:%	IM - SC	0.25% IM - SC INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
GGO4Y809LO	METACRESOL:INTRADERMAL:INJECTION:%	INTRADERMAL	0.16% INTRADERMAL INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
GGO4Y809LO	METACRESOL:INTRAMUSCULAR:POWDER, FOR INJECTION SOLUTION, LYOPHILIZED:%	INTRAMUSCULAR	0.3% INTRAMUSCULAR POWDER, FOR INJECTION SOLUTION, LYOPHILIZED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
GGO4Y809LO	METACRESOL:INTRAVENOUS:INJECTION:MG/1ML	INTRAVENOUS	3MG/1ML INTRAVENOUS INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
GGO4Y809LO	METACRESOL:INTRAVENOUS:SOLUTION, INJECTION:MG/1ML	INTRAVENOUS	3.15MG/1ML INTRAVENOUS SOLUTION, INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
GGO4Y809LO	METACRESOL:IV - SC:INJECTION, SOLUTION:MG/1ML	IV - SC	1.72MG/1ML IV - SC INJECTION, SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
GGO4Y809LO	METACRESOL:IV(INFUSION):INJECTION:%	IV(INFUSION)	0.1% IV(INFUSION) INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
GGO4Y809LO	METACRESOL:SUBCUTANEOUS:INJECTABLE:%	SUBCUTANEOUS	0.32% SUBCUTANEOUS INJECTABLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
GGO4Y809LO	METACRESOL:SUBCUTANEOUS:INJECTION:%	SUBCUTANEOUS	0.32% SUBCUTANEOUS INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
GGO4Y809LO	METACRESOL:SUBCUTANEOUS:INJECTION, SOLUTION:%	SUBCUTANEOUS	0.27% SUBCUTANEOUS INJECTION, SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
GGO4Y809LO	METACRESOL:SUBCUTANEOUS:POWDER, FOR INJECTION SOLUTION, LYOPHILIZED:%	SUBCUTANEOUS	0.3% SUBCUTANEOUS POWDER, FOR INJECTION SOLUTION, LYOPHILIZED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
GGO4Y809LO	METACRESOL:SUBCUTANEOUS:SOLUTION:%	SUBCUTANEOUS	0.083% SUBCUTANEOUS SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
GGO4Y809LO	METACRESOL:SUBCUTANEOUS:SOLUTION, INJECTION:%	SUBCUTANEOUS	0.27% SUBCUTANEOUS SOLUTION, INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
GGO4Y809LO	METACRESOL:SUBCUTANEOUS:SUSPENSION:%	SUBCUTANEOUS	0.18% SUBCUTANEOUS SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
GGO4Y809LO	METACRESOL:SUBCUTANEOUS:SUSPENSION, INJECTION:%	SUBCUTANEOUS	0.22% SUBCUTANEOUS SUSPENSION, INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
MJ9J2BSO5V	CAPRYLOCAPROYL POLYOXYLGLYCERIDES:ORAL:CAPSULE, SOFT GELATIN:MG	ORAL	905.81MG ORAL CAPSULE, SOFT GELATIN	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
4ELV7Z65AP	STEARIC ACID:BUCCAL:TABLET:MG	BUCCAL	5MG BUCCAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
4ELV7Z65AP	STEARIC ACID:BUCCAL/SUBLINGUAL:TABLET:MG	BUCCAL/SUBLINGUAL	6MG BUCCAL/SUBLINGUAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
4ELV7Z65AP	STEARIC ACID:IMPLANTATION:PELLET:MG	IMPLANTATION	0.2MG IMPLANTATION PELLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
4ELV7Z65AP	STEARIC ACID:ORAL:CAPSULE:MG	ORAL	52MG ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
4ELV7Z65AP	STEARIC ACID:ORAL:CAPSULE, COATED, SOFT GELATIN:MG	ORAL	3MG ORAL CAPSULE, COATED, SOFT GELATIN	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
4ELV7Z65AP	STEARIC ACID:ORAL:CAPSULE, DELAYED ACTION:MG	ORAL	3MG ORAL CAPSULE, DELAYED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
4ELV7Z65AP	STEARIC ACID:ORAL:CAPSULE, EXTENDED RELEASE:MG	ORAL	3.23MG ORAL CAPSULE, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
4ELV7Z65AP	STEARIC ACID:ORAL:CAPSULE, HARD GELATIN:MG	ORAL	15MG ORAL CAPSULE, HARD GELATIN	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
4ELV7Z65AP	STEARIC ACID:ORAL:CAPSULE, SUSTAINED ACTION:MG	ORAL	21MG ORAL CAPSULE, SUSTAINED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
4ELV7Z65AP	STEARIC ACID:ORAL:POWDER, FOR SUSPENSION:MG/5ML	ORAL	1203MG/5ML ORAL POWDER, FOR SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
4ELV7Z65AP	STEARIC ACID:ORAL:SYRUP:NA	ORAL	ORAL SYRUP	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
4ELV7Z65AP	STEARIC ACID:ORAL:TABLET:MG	ORAL	72MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
4ELV7Z65AP	STEARIC ACID:ORAL:TABLET (IMMED./COMP. RELEASE), COATED:MG	ORAL	5.3MG ORAL TABLET (IMMED./COMP. RELEASE), COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
4ELV7Z65AP	STEARIC ACID:ORAL:TABLET (IMMED./COMP. RELEASE), UNCOATED, CHEWABLE:MG	ORAL	15MG ORAL TABLET (IMMED./COMP. RELEASE), UNCOATED, CHEWABLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
4ELV7Z65AP	STEARIC ACID:ORAL:TABLET, CHEWABLE:MG	ORAL	10MG ORAL TABLET, CHEWABLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
4ELV7Z65AP	STEARIC ACID:ORAL:TABLET, COATED:MG	ORAL	42.4MG ORAL TABLET, COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
4ELV7Z65AP	STEARIC ACID:ORAL:TABLET, CONTROLLED RELEASE:MG	ORAL	1.6MG ORAL TABLET, CONTROLLED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
4ELV7Z65AP	STEARIC ACID:ORAL:TABLET, DELAYED ACTION:mg	ORAL	20mg ORAL TABLET, DELAYED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
4ELV7Z65AP	STEARIC ACID:ORAL:TABLET, DELAYED ACTION, ENTERIC COATED:MG	ORAL	16MG ORAL TABLET, DELAYED ACTION, ENTERIC COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
4ELV7Z65AP	STEARIC ACID:ORAL:TABLET, DELAYED RELEASE:mg	ORAL	20mg ORAL TABLET, DELAYED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
4ELV7Z65AP	STEARIC ACID:ORAL:TABLET, ENTERIC COATED PARTICLES:MG	ORAL	5MG ORAL TABLET, ENTERIC COATED PARTICLES	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
4ELV7Z65AP	STEARIC ACID:ORAL:TABLET, EXTENDED RELEASE:MG	ORAL	180MG ORAL TABLET, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
4ELV7Z65AP	STEARIC ACID:ORAL:TABLET, FILM COATED:MG	ORAL	22MG ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
4ELV7Z65AP	STEARIC ACID:ORAL:TABLET, ORALLY DISINTEGRATING:MG	ORAL	10MG ORAL TABLET, ORALLY DISINTEGRATING	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
4ELV7Z65AP	STEARIC ACID:ORAL:TABLET, SUGAR COATED:MG	ORAL	0.9MG ORAL TABLET, SUGAR COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
4ELV7Z65AP	STEARIC ACID:ORAL:TABLET, SUSTAINED ACTION:MG	ORAL	187.5MG ORAL TABLET, SUSTAINED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
4ELV7Z65AP	STEARIC ACID:ORAL:TABLET, SUSTAINED RELEASE, FILM COATED:MG	ORAL	9MG ORAL TABLET, SUSTAINED RELEASE, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
4ELV7Z65AP	STEARIC ACID:SUBCUTANEOUS:IMPLANT:MG	SUBCUTANEOUS	1.04MG SUBCUTANEOUS IMPLANT	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
4ELV7Z65AP	STEARIC ACID:SUBLINGUAL:TABLET:MG	SUBLINGUAL	5.05MG SUBLINGUAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
4ELV7Z65AP	STEARIC ACID:TOPICAL:CREAM:%W/W 	TOPICAL	17%W/W  TOPICAL CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
4ELV7Z65AP	STEARIC ACID:TOPICAL:CREAM, AUGMENTED:%W/W	TOPICAL	3%W/W TOPICAL CREAM, AUGMENTED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
4ELV7Z65AP	STEARIC ACID:TOPICAL:CREAM, EMULSION, SUSTAINED RELEASE:%W/W	TOPICAL	16%W/W TOPICAL CREAM, EMULSION, SUSTAINED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
4ELV7Z65AP	STEARIC ACID:TOPICAL:EMULSION, AEROSOL FOAM:%W/W	TOPICAL	8%W/W TOPICAL EMULSION, AEROSOL FOAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
4ELV7Z65AP	STEARIC ACID:TOPICAL:EMULSION, CREAM:%W/W	TOPICAL	22.5%W/W TOPICAL EMULSION, CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
4ELV7Z65AP	STEARIC ACID:TOPICAL:LOTION:%W/W	TOPICAL	2%W/W TOPICAL LOTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
4ELV7Z65AP	STEARIC ACID:TOPICAL:OINTMENT:%W/W	TOPICAL	15%W/W TOPICAL OINTMENT	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
4ELV7Z65AP	STEARIC ACID:TOPICAL:SOLUTION:NA	TOPICAL	TOPICAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
4ELV7Z65AP	STEARIC ACID:TOPICAL:SUSPENSION:%W/W	TOPICAL	1.75%W/W TOPICAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
4ELV7Z65AP	STEARIC ACID:VAGINAL:EMULSION, AEROSOL FOAM:%	VAGINAL	4% VAGINAL EMULSION, AEROSOL FOAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
4ELV7Z65AP	STEARIC ACID:VAGINAL:EMULSION, CREAM:%	VAGINAL	14% VAGINAL EMULSION, CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
4ELV7Z65AP	STEARIC ACID:VAGINAL:TABLET:MG	VAGINAL	60MG VAGINAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
5SL0G7R0OK	ANHYDROUS DEXTROSE:IM - IV:INJECTABLE:%	IM - IV	5% IM - IV INJECTABLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
5SL0G7R0OK	ANHYDROUS DEXTROSE:IM - IV:POWDER, FOR INJECTION SOLUTION:%	IM - IV	3.9% IM - IV POWDER, FOR INJECTION SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
5SL0G7R0OK	ANHYDROUS DEXTROSE:IM - SC:INJECTION:%	IM - SC	7.5% IM - SC INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
5SL0G7R0OK	ANHYDROUS DEXTROSE:INTRAMUSCULAR:INJECTION:%W/V	INTRAMUSCULAR	5%W/V INTRAMUSCULAR INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
5SL0G7R0OK	ANHYDROUS DEXTROSE:INTRAVENOUS:INJECTION:%	INTRAVENOUS	5% INTRAVENOUS INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
5SL0G7R0OK	ANHYDROUS DEXTROSE:INTRAVENOUS:SOLUTION, INJECTION:%	INTRAVENOUS	5% INTRAVENOUS SOLUTION, INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
5SL0G7R0OK	ANHYDROUS DEXTROSE:IV(INFUSION):INJECTION:%	IV(INFUSION)	5.43% IV(INFUSION) INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
5SL0G7R0OK	ANHYDROUS DEXTROSE:IV(INFUSION):POWDER, FOR INJECTION SOLUTION:%	IV(INFUSION)	3.9% IV(INFUSION) POWDER, FOR INJECTION SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
5SL0G7R0OK	ANHYDROUS DEXTROSE:NASAL:SPRAY:%	NASAL	0.28% NASAL SPRAY	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
5SL0G7R0OK	ANHYDROUS DEXTROSE:NASAL:SPRAY, METERED:%	NASAL	0.5% NASAL SPRAY, METERED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
5SL0G7R0OK	ANHYDROUS DEXTROSE:ORAL:GRANULE, FOR ORAL SUSPENSION:MG	ORAL	2813MG ORAL GRANULE, FOR ORAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
5SL0G7R0OK	ANHYDROUS DEXTROSE:ORAL:TABLET, EXTENDED RELEASE:MG	ORAL	15MG ORAL TABLET, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
5SL0G7R0OK	ANHYDROUS DEXTROSE:SPINAL:INJECTABLE:%	SPINAL	8.25% SPINAL INJECTABLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
5SL0G7R0OK	ANHYDROUS DEXTROSE:SPINAL:INJECTION:%	SPINAL	8.25% SPINAL INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
GR686LBA74	SODIUM PHOSPHATE, DIBASIC:ORAL:SUSPENSION:mg/1mL	ORAL	8mg/1mL ORAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
GR686LBA74	SODIUM PHOSPHATE, DIBASIC, UNSPECIFIED FORM:IM - IV:INJECTABLE:%	IM - IV	4% IM - IV INJECTABLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
GR686LBA74	SODIUM PHOSPHATE, DIBASIC, UNSPECIFIED FORM:IM - IV:INJECTION:ADJ PH	IM - IV	ADJ PH IM - IV INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
GR686LBA74	SODIUM PHOSPHATE, DIBASIC, UNSPECIFIED FORM:IM - IV:POWDER, FOR INJECTION SOLUTION:%	IM - IV	4% IM - IV POWDER, FOR INJECTION SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
GR686LBA74	SODIUM PHOSPHATE, DIBASIC, UNSPECIFIED FORM:INTRADERMAL:INJECTION:%	INTRADERMAL	0.2% INTRADERMAL INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
GR686LBA74	SODIUM PHOSPHATE, DIBASIC, UNSPECIFIED FORM:INTRALESIONAL:SUSPENSION, INJECTION:%	INTRALESIONAL	0.14% INTRALESIONAL SUSPENSION, INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
GR686LBA74	SODIUM PHOSPHATE, DIBASIC, UNSPECIFIED FORM:INTRAMUSCULAR:INJECTABLE:%	INTRAMUSCULAR	4% INTRAMUSCULAR INJECTABLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
GR686LBA74	SODIUM PHOSPHATE, DIBASIC, UNSPECIFIED FORM:INTRAMUSCULAR:INJECTION:%W/V	INTRAMUSCULAR	0.48%W/V INTRAMUSCULAR INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
GR686LBA74	SODIUM PHOSPHATE, DIBASIC, UNSPECIFIED FORM:INTRAMUSCULAR:POWDER, FOR INJECTION SOLUTION:%W/V	INTRAMUSCULAR	1.75%W/V INTRAMUSCULAR POWDER, FOR INJECTION SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
GR686LBA74	SODIUM PHOSPHATE, DIBASIC, UNSPECIFIED FORM:INTRAMUSCULAR:SUSPENSION, INJECTION:%W/V	INTRAMUSCULAR	0.14%W/V INTRAMUSCULAR SUSPENSION, INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
GR686LBA74	SODIUM PHOSPHATE, DIBASIC, UNSPECIFIED FORM:INTRASYNOVIAL:SUSPENSION, INJECTION:%	INTRASYNOVIAL	0.14% INTRASYNOVIAL SUSPENSION, INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
GR686LBA74	SODIUM PHOSPHATE, DIBASIC, UNSPECIFIED FORM:INTRAVENOUS:INJECTABLE:MG/1VIAL	INTRAVENOUS	200MG/1VIAL INTRAVENOUS INJECTABLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
GR686LBA74	SODIUM PHOSPHATE, DIBASIC, UNSPECIFIED FORM:INTRAVENOUS:INJECTABLE:%	INTRAVENOUS	4% INTRAVENOUS INJECTABLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
GR686LBA74	SODIUM PHOSPHATE, DIBASIC, UNSPECIFIED FORM:INTRAVENOUS:INJECTION:%	INTRAVENOUS	0.76% INTRAVENOUS INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
GR686LBA74	SODIUM PHOSPHATE, DIBASIC, UNSPECIFIED FORM:INTRAVENOUS:POWDER, FOR INJECTION SOLUTION:%	INTRAVENOUS	1.75% INTRAVENOUS POWDER, FOR INJECTION SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
GR686LBA74	SODIUM PHOSPHATE, DIBASIC, UNSPECIFIED FORM:INTRAVENOUS:POWDER, FOR INJECTION SOLUTION, LYOPHILIZED:%	INTRAVENOUS	3.25% INTRAVENOUS POWDER, FOR INJECTION SOLUTION, LYOPHILIZED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
GR686LBA74	SODIUM PHOSPHATE, DIBASIC, UNSPECIFIED FORM:INTRAVENOUS:SOLUTION, INJECTION:MG/1ML	INTRAVENOUS	1.88MG/1ML INTRAVENOUS SOLUTION, INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
GR686LBA74	SODIUM PHOSPHATE, DIBASIC, UNSPECIFIED FORM:INTRAVENOUS:SOLUTION, INJECTION:%	INTRAVENOUS	0.11% INTRAVENOUS SOLUTION, INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
GR686LBA74	SODIUM PHOSPHATE, DIBASIC, UNSPECIFIED FORM:IV(INFUSION):INJECTION:NA	IV(INFUSION)	IV(INFUSION) INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
GR686LBA74	SODIUM PHOSPHATE, DIBASIC, UNSPECIFIED FORM:IV(INFUSION):POWDER, FOR INJECTION SOLUTION:%	IV(INFUSION)	4% IV(INFUSION) POWDER, FOR INJECTION SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
GR686LBA74	SODIUM PHOSPHATE, DIBASIC, UNSPECIFIED FORM:IV(INFUSION):POWDER, FOR INJECTION SOLUTION, LYOPHILIZED:%	IV(INFUSION)	0.38% IV(INFUSION) POWDER, FOR INJECTION SOLUTION, LYOPHILIZED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
GR686LBA74	SODIUM PHOSPHATE, DIBASIC, UNSPECIFIED FORM:IV(INFUSION):SOLUTION:%	IV(INFUSION)	0.013% IV(INFUSION) SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
GR686LBA74	SODIUM PHOSPHATE, DIBASIC, UNSPECIFIED FORM:NASAL:SOLUTION, SPRAY:%	NASAL	0.65% NASAL SOLUTION, SPRAY	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
GR686LBA74	SODIUM PHOSPHATE, DIBASIC, UNSPECIFIED FORM:NASAL:SPRAY:%W/V	NASAL	0.26%W/V NASAL SPRAY	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
GR686LBA74	SODIUM PHOSPHATE, DIBASIC, UNSPECIFIED FORM:NASAL:SPRAY, METERED:%	NASAL	0.3% NASAL SPRAY, METERED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
GR686LBA74	SODIUM PHOSPHATE, DIBASIC, UNSPECIFIED FORM:OPHTHALMIC:SOLUTION:%	OPHTHALMIC	0.51% OPHTHALMIC SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
GR686LBA74	SODIUM PHOSPHATE, DIBASIC, UNSPECIFIED FORM:OPHTHALMIC:SUSPENSION:%	OPHTHALMIC	0.43% OPHTHALMIC SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
GR686LBA74	SODIUM PHOSPHATE, DIBASIC, UNSPECIFIED FORM:ORAL:CONCENTRATE:MG/5ML	ORAL	17MG/5ML ORAL CONCENTRATE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
GR686LBA74	SODIUM PHOSPHATE, DIBASIC, UNSPECIFIED FORM:ORAL:SOLUTION:MG/5ML	ORAL	140MG/5ML ORAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
GR686LBA74	SODIUM PHOSPHATE, DIBASIC, UNSPECIFIED FORM:ORAL:SOLUTION, LIQUID:MG/1ML	ORAL	1.5MG/1ML ORAL SOLUTION, LIQUID	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
GR686LBA74	SODIUM PHOSPHATE, DIBASIC, UNSPECIFIED FORM:ORAL:SUSPENSION:MG/1ML	ORAL	4.5MG/1ML ORAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
GR686LBA74	SODIUM PHOSPHATE, DIBASIC, UNSPECIFIED FORM:ORAL:SYRUP:MG/1GM	ORAL	3.5MG/1GM ORAL SYRUP	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
GR686LBA74	SODIUM PHOSPHATE, DIBASIC, UNSPECIFIED FORM:ORAL:TABLET, EXTENDED RELEASE:MG	ORAL	71.5MG ORAL TABLET, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
GR686LBA74	SODIUM PHOSPHATE, DIBASIC, UNSPECIFIED FORM:ORAL:TABLET, UNCOATED, LOZENGE:MG	ORAL	31MG ORAL TABLET, UNCOATED, LOZENGE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
GR686LBA74	SODIUM PHOSPHATE, DIBASIC, UNSPECIFIED FORM:SOFT TISSUE:SUSPENSION, INJECTION:%	SOFT TISSUE	0.14% SOFT TISSUE SUSPENSION, INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
GR686LBA74	SODIUM PHOSPHATE, DIBASIC, UNSPECIFIED FORM:SUBCUTANEOUS:INJECTION:%	SUBCUTANEOUS	0.66% SUBCUTANEOUS INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
GR686LBA74	SODIUM PHOSPHATE, DIBASIC, UNSPECIFIED FORM:SUBCUTANEOUS:POWDER, FOR INJECTION SOLUTION, LYOPHILIZED:%	SUBCUTANEOUS	0.3% SUBCUTANEOUS POWDER, FOR INJECTION SOLUTION, LYOPHILIZED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
GR686LBA74	SODIUM PHOSPHATE, DIBASIC, UNSPECIFIED FORM:SUBCUTANEOUS:SUSPENSION, INJECTION:%	SUBCUTANEOUS	0.09% SUBCUTANEOUS SUSPENSION, INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
GR686LBA74	SODIUM PHOSPHATE, DIBASIC, UNSPECIFIED FORM:TOPICAL:EMULSION, CREAM:%W/W	TOPICAL	0.1%W/W TOPICAL EMULSION, CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
GR686LBA74	SODIUM PHOSPHATE, DIBASIC, UNSPECIFIED FORM:TOPICAL:OINTMENT:%W/W	TOPICAL	0.026%W/W TOPICAL OINTMENT	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
GR686LBA74	SODIUM PHOSPHATE, DIBASIC, UNSPECIFIED FORM:TOPICAL:SOLUTION:%W/V	TOPICAL	0.51%W/V TOPICAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
GR686LBA74	SODIUM PHOSPHATE, DIBASIC, UNSPECIFIED FORM:TRANSMUCOSAL:TABLET, UNCOATED, LOZENGE:MG	TRANSMUCOSAL	28MG TRANSMUCOSAL TABLET, UNCOATED, LOZENGE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
UF064M00AF	DIETHYL PHTHALATE:ORAL:CAPSULE:MG	ORAL	20.52MG ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
UF064M00AF	DIETHYL PHTHALATE:ORAL:CAPSULE, DELAYED ACTION, COATED, HARD GELATIN:MG	ORAL	15.1MG ORAL CAPSULE, DELAYED ACTION, COATED, HARD GELATIN	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
UF064M00AF	DIETHYL PHTHALATE:ORAL:CAPSULE, ENTERIC COATED PELLETS:MG	ORAL	12MG ORAL CAPSULE, ENTERIC COATED PELLETS	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
UF064M00AF	DIETHYL PHTHALATE:ORAL:CAPSULE, EXTENDED RELEASE:MG	ORAL	9.13MG ORAL CAPSULE, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
UF064M00AF	DIETHYL PHTHALATE:ORAL:CAPSULE, SUSTAINED ACTION:MG	ORAL	9.47MG ORAL CAPSULE, SUSTAINED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
UF064M00AF	DIETHYL PHTHALATE:ORAL:TABLET (IMMED./COMP. RELEASE), UNCOATED, CHEWABLE:MG	ORAL	0.5MG ORAL TABLET (IMMED./COMP. RELEASE), UNCOATED, CHEWABLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
UF064M00AF	DIETHYL PHTHALATE:ORAL:TABLET, COATED:MG	ORAL	1.25MG ORAL TABLET, COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
UF064M00AF	DIETHYL PHTHALATE:ORAL:TABLET, DELAYED ACTION, ENTERIC COATED:MG	ORAL	16.8MG ORAL TABLET, DELAYED ACTION, ENTERIC COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
UF064M00AF	DIETHYL PHTHALATE:ORAL:TABLET, DELAYED RELEASE:MG	ORAL	1.58MG ORAL TABLET, DELAYED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
UF064M00AF	DIETHYL PHTHALATE:ORAL:TABLET, EXTENDED RELEASE:MG	ORAL	6.63MG ORAL TABLET, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
UF064M00AF	DIETHYL PHTHALATE:ORAL:TABLET, FILM COATED:MG	ORAL	2.3MG ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
UF064M00AF	DIETHYL PHTHALATE:ORAL:TABLET, SUSTAINED ACTION:MG	ORAL	12MG ORAL TABLET, SUSTAINED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
Q613OCQ44Y	ISOSTEARYL ALCOHOL:TOPICAL:EMULSION, CREAM:%W/W	TOPICAL	3%W/W TOPICAL EMULSION, CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=I
Q613OCQ44Y	ISOSTEARYL ALCOHOL:TOPICAL:LOTION:%W/W	TOPICAL	2.5%W/W TOPICAL LOTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=I
Q613OCQ44Y	ISOSTEARYL ALCOHOL:TOPICAL:OINTMENT:NA	TOPICAL	TOPICAL OINTMENT	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=I
Q613OCQ44Y	ISOSTEARYL ALCOHOL:TOPICAL:SUSPENSION:%W/W	TOPICAL	2.5%W/W TOPICAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=I
0345752X7U	PEG-20 METHYL GLUCOSE SESQUISTEARATE:TOPICAL:CREAM, AUGMENTED:%W/W	TOPICAL	3.5%W/W TOPICAL CREAM, AUGMENTED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
0345752X7U	PEG-20 METHYL GLUCOSE SESQUISTEARATE:TOPICAL:EMULSION, CREAM:%W/W	TOPICAL	3.5%W/W TOPICAL EMULSION, CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
0345752X7U	PEG-20 METHYL GLUCOSE SESQUISTEARATE:TOPICAL:LOTION:%W/W	TOPICAL	3%W/W TOPICAL LOTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
SA6A6V432S	DIMETHYL ISOSORBIDE:TOPICAL:EMULSION, AEROSOL FOAM:%W/W	TOPICAL	5.44%W/W TOPICAL EMULSION, AEROSOL FOAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
SA6A6V432S	DIMETHYL ISOSORBIDE:TOPICAL:EMULSION, CREAM:%W/W	TOPICAL	15%W/W TOPICAL EMULSION, CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
SZT789770M	NAPHTHOL BLUE BLACK:ORAL:TABLET:MG	ORAL	0.08MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=N
MLM29U2X85	CALCIUM CITRATE:ORAL:POWDER:MG/1PKT	ORAL	429MG/1PKT ORAL POWDER	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
MLM29U2X85	CALCIUM CITRATE:ORAL:TABLET:MG	ORAL	98.95MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
5C69YCD2YJ	CARRAGEENAN:DENTAL:PASTE:NA	DENTAL	DENTAL PASTE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
5C69YCD2YJ	CARRAGEENAN:INHALATION:POWDER:MG	INHALATION	0.42MG INHALATION POWDER	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
5C69YCD2YJ	CARRAGEENAN:NASAL:POWDER, FOR INHALATION:NA	NASAL	NASAL POWDER, FOR INHALATION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
5C69YCD2YJ	CARRAGEENAN:ORAL:CAPSULE:MG	ORAL	2.54MG ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
5C69YCD2YJ	CARRAGEENAN:ORAL:CAPSULE, EXTENDED RELEASE:MG	ORAL	0.3MG ORAL CAPSULE, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
5C69YCD2YJ	CARRAGEENAN:ORAL:GRANULE, FOR RECONSTITUTION:MG	ORAL	6MG ORAL GRANULE, FOR RECONSTITUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
5C69YCD2YJ	CARRAGEENAN:ORAL:GRANULE, FOR SUSPENSION:MG	ORAL	20.15MG ORAL GRANULE, FOR SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
5C69YCD2YJ	CARRAGEENAN:ORAL:POWDER, FOR SUSPENSION:%	ORAL	1.5% ORAL POWDER, FOR SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
5C69YCD2YJ	CARRAGEENAN:ORAL:SYRUP:NA	ORAL	ORAL SYRUP	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
5C69YCD2YJ	CARRAGEENAN:ORAL:TABLET:MG	ORAL	15MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
5C69YCD2YJ	CARRAGEENAN:TOPICAL:LOTION:%W/W	TOPICAL	0.5%W/W TOPICAL LOTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
5C69YCD2YJ	CARRAGEENAN:TRANSDERMAL:FILM, CONTROLLED RELEASE:MG	TRANSDERMAL	33MG TRANSDERMAL FILM, CONTROLLED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
65R938S4DV	LACTOBIONIC ACID:INTRAVENOUS:INJECTABLE:%	INTRAVENOUS	0.004% INTRAVENOUS INJECTABLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
65R938S4DV	LACTOBIONIC ACID:IV(INFUSION):POWDER, FOR INJECTION SOLUTION:ADJ PH	IV(INFUSION)	ADJ PH IV(INFUSION) POWDER, FOR INJECTION SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
578389D6D0	CLOVE OIL:ORAL:SOLUTION:NA	ORAL	ORAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
578389D6D0	CLOVE OIL:ORAL:SOLUTION, ELIXIR:%	ORAL	8% ORAL SOLUTION, ELIXIR	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
578389D6D0	CLOVE OIL:ORAL:SUSPENSION:MG/5ML	ORAL	0.1MG/5ML ORAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
0324G66D0E	GLYCOL STEARATE:TOPICAL:CREAM:%W/W	TOPICAL	1%W/W TOPICAL CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
0324G66D0E	GLYCOL STEARATE:TOPICAL:EMULSION, CREAM:%W/W	TOPICAL	1%W/W TOPICAL EMULSION, CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
0324G66D0E	GLYCOL STEARATE:TOPICAL:SHAMPOO:NA	TOPICAL	TOPICAL SHAMPOO	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
0324G66D0E	GLYCOL STEARATE:TOPICAL:SHAMPOO, SUSPENSION:NA	TOPICAL	TOPICAL SHAMPOO, SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
L7HT8F1ZOD	SOYBEAN:TOPICAL:EMULSION:%W/W	TOPICAL	3%W/W TOPICAL EMULSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
70KO0R01RY	POLYSTYRENE SULFONIC ACID:ORAL:CAPSULE:MG	ORAL	12MG ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
70KO0R01RY	POLYSTYRENE SULFONIC ACID:ORAL:CAPSULE, SUSTAINED ACTION:MG	ORAL	32MG ORAL CAPSULE, SUSTAINED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
70KO0R01RY	POLYSTYRENE SULFONIC ACID:ORAL:TABLET:MG	ORAL	43.75MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
AG9B65PV6B	SODIUM STARCH GLYCOLATE TYPE A CORN:ORAL:CAPSULE:MG	ORAL	6MG ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
AG9B65PV6B	SODIUM STARCH GLYCOLATE TYPE A CORN:ORAL:TABLET:MG	ORAL	72MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
AG9B65PV6B	SODIUM STARCH GLYCOLATE TYPE A CORN:ORAL:TABLET (IMMED./COMP. RELEASE), COATED:MG	ORAL	6MG ORAL TABLET (IMMED./COMP. RELEASE), COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
AG9B65PV6B	SODIUM STARCH GLYCOLATE TYPE A CORN:ORAL:TABLET, DELAYED ACTION:MG	ORAL	8MG ORAL TABLET, DELAYED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
AG9B65PV6B	SODIUM STARCH GLYCOLATE TYPE A CORN:ORAL:TABLET, DELAYED RELEASE:MG	ORAL	10MG ORAL TABLET, DELAYED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
HG18B9YRS7	VALINE:IV(INFUSION):INJECTION:%	IV(INFUSION)	39% IV(INFUSION) INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=V
HG18B9YRS7	VALINE:IV(INFUSION):SOLUTION, INJECTION:%	IV(INFUSION)	0.2% IV(INFUSION) SOLUTION, INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=V
161H3B14U2	AMMONIO METHACRYLATE COPOLYMER TYPE B:ORAL:CAPSULE:MG	ORAL	109.56MG ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
161H3B14U2	AMMONIO METHACRYLATE COPOLYMER TYPE B:ORAL:CAPSULE, DELAYED ACTION:MG	ORAL	35.85MG ORAL CAPSULE, DELAYED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
161H3B14U2	AMMONIO METHACRYLATE COPOLYMER TYPE B:ORAL:CAPSULE, EXTENDED RELEASE:MG	ORAL	89.17MG ORAL CAPSULE, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
161H3B14U2	AMMONIO METHACRYLATE COPOLYMER TYPE B:ORAL:CAPSULE, HARD GELATIN:MG	ORAL	38.51MG ORAL CAPSULE, HARD GELATIN	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
161H3B14U2	AMMONIO METHACRYLATE COPOLYMER TYPE B:ORAL:CAPSULE, SUSTAINED ACTION:MG	ORAL	91.88MG ORAL CAPSULE, SUSTAINED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
161H3B14U2	AMMONIO METHACRYLATE COPOLYMER TYPE B:ORAL:TABLET:mg	ORAL	150mg ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
161H3B14U2	AMMONIO METHACRYLATE COPOLYMER TYPE B:ORAL:TABLET (IMMED./COMP. RELEASE), UNCOATED, CHEWABLE:MG	ORAL	16.67MG ORAL TABLET (IMMED./COMP. RELEASE), UNCOATED, CHEWABLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
161H3B14U2	AMMONIO METHACRYLATE COPOLYMER TYPE B:ORAL:TABLET, CONTROLLED RELEASE:MG	ORAL	97.5MG ORAL TABLET, CONTROLLED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
161H3B14U2	AMMONIO METHACRYLATE COPOLYMER TYPE B:ORAL:TABLET, EXTENDED RELEASE:MG	ORAL	114MG ORAL TABLET, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
161H3B14U2	AMMONIO METHACRYLATE COPOLYMER TYPE B:ORAL:TABLET, FILM COATED:MG	ORAL	8MG ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
161H3B14U2	AMMONIO METHACRYLATE COPOLYMER TYPE B:ORAL:TABLET, SUSTAINED ACTION:MG	ORAL	81.6MG ORAL TABLET, SUSTAINED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
161H3B14U2	EUDRAGIT RS 30 D:ORAL:CAPSULE, EXTENDED RELEASE:MG	ORAL	72.36MG ORAL CAPSULE, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
S34RY76LK6	KOLLIDON SR:ORAL:TABLET, EXTENDED RELEASE:mg	ORAL	371.25mg ORAL TABLET, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=K
0HO1H52958	HYPROMELLOSE 2910 (10000 MPA.S):ORAL:TABLET:mg	ORAL	3.125mg ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
0HO1H52958	HYPROMELLOSE 2910 (10000 MPA.S):ORAL:TABLET, EXTENDED RELEASE:MG	ORAL	262MG ORAL TABLET, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
2G86QN327L	GELATIN:ORAL:CAPSULE:MG	ORAL	304.04MG ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
2G86QN327L	GELATIN:ORAL:CAPSULE, DELAYED RELEASE:MG	ORAL	64.04MG ORAL CAPSULE, DELAYED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
2G86QN327L	GELATIN:ORAL:CAPSULE, EXTENDED RELEASE:mg	ORAL	117.2mg ORAL CAPSULE, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
2G86QN327L	GELATIN:ORAL:CAPSULE, SOFT GELATIN:mg	ORAL	95.73mg ORAL CAPSULE, SOFT GELATIN	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
2G86QN327L	GELATIN:ORAL:TABLET:mg	ORAL	12mg ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
2G86QN327L	GELATIN, UNSPECIFIED:BUCCAL:GUM, CHEWING:MG	BUCCAL	4.27MG BUCCAL GUM, CHEWING	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
2G86QN327L	GELATIN, UNSPECIFIED:DENTAL:PASTE:MG	DENTAL	180MG DENTAL PASTE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
2G86QN327L	GELATIN, UNSPECIFIED:IM - IV - SC:INJECTION:%	IM - IV - SC	16% IM - IV - SC INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
2G86QN327L	GELATIN, UNSPECIFIED:IM - IV - SC:POWDER, FOR INJECTION SOLUTION:%	IM - IV - SC	1.4% IM - IV - SC POWDER, FOR INJECTION SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
2G86QN327L	GELATIN, UNSPECIFIED:IM - SC:INJECTION:%	IM - SC	16% IM - SC INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
2G86QN327L	GELATIN, UNSPECIFIED:IM - SC:INJECTION, SUSTAINED ACTION:%	IM - SC	16% IM - SC INJECTION, SUSTAINED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
2G86QN327L	GELATIN, UNSPECIFIED:INHALATION:POWDER:MG	INHALATION	100MG INHALATION POWDER	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
2G86QN327L	GELATIN, UNSPECIFIED:INTRA-ARTICULAR:SUSPENSION:%	INTRA-ARTICULAR	0.03% INTRA-ARTICULAR SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
2G86QN327L	GELATIN, UNSPECIFIED:INTRAMUSCULAR:INJECTION:%	INTRAMUSCULAR	0.26% INTRAMUSCULAR INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
2G86QN327L	GELATIN, UNSPECIFIED:INTRAMUSCULAR:INJECTION, MICROSPHERES:%	INTRAMUSCULAR	0.13% INTRAMUSCULAR INJECTION, MICROSPHERES	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
2G86QN327L	GELATIN, UNSPECIFIED:INTRAMUSCULAR:SUSPENSION:%	INTRAMUSCULAR	0.03% INTRAMUSCULAR SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
2G86QN327L	GELATIN, UNSPECIFIED:INTRAVENOUS:SOLUTION:%	INTRAVENOUS	3.48% INTRAVENOUS SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
2G86QN327L	GELATIN, UNSPECIFIED:IV(INFUSION):INJECTION:%	IV(INFUSION)	2% IV(INFUSION) INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
2G86QN327L	GELATIN, UNSPECIFIED:ORAL:BAR, CHEWABLE:NA	ORAL	ORAL BAR, CHEWABLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
2G86QN327L	GELATIN, UNSPECIFIED:ORAL:CAPSULE:MG	ORAL	657MG ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
2G86QN327L	GELATIN, UNSPECIFIED:ORAL:CAPSULE (IMMED./COMP. RELEASE):MG	ORAL	50.86MG ORAL CAPSULE (IMMED./COMP. RELEASE)	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
2G86QN327L	GELATIN, UNSPECIFIED:ORAL:CAPSULE (IMMED./COMP. RELEASE), COATED, SOFT GELATIN:MG	ORAL	88.97MG ORAL CAPSULE (IMMED./COMP. RELEASE), COATED, SOFT GELATIN	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
2G86QN327L	GELATIN, UNSPECIFIED:ORAL:CAPSULE (IMMED./COMP. RELEASE), HARD GELATIN:MG	ORAL	94.87MG ORAL CAPSULE (IMMED./COMP. RELEASE), HARD GELATIN	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
2G86QN327L	GELATIN, UNSPECIFIED:ORAL:CAPSULE (IMMED./COMP. RELEASE), SOFT GELATIN:MG	ORAL	260.85MG ORAL CAPSULE (IMMED./COMP. RELEASE), SOFT GELATIN	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
2G86QN327L	GELATIN, UNSPECIFIED:ORAL:CAPSULE (IMMED./COMP. RELEASE), SOFT GELATIN, PERLE:MG	ORAL	95.21MG ORAL CAPSULE (IMMED./COMP. RELEASE), SOFT GELATIN, PERLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
2G86QN327L	GELATIN, UNSPECIFIED:ORAL:CAPSULE, COATED PELLETS:MG	ORAL	65MG ORAL CAPSULE, COATED PELLETS	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
2G86QN327L	GELATIN, UNSPECIFIED:ORAL:CAPSULE, COATED, SOFT GELATIN:MG	ORAL	153.7MG ORAL CAPSULE, COATED, SOFT GELATIN	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
2G86QN327L	GELATIN, UNSPECIFIED:ORAL:CAPSULE, DELAYED ACTION:MG	ORAL	116.23MG ORAL CAPSULE, DELAYED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
2G86QN327L	GELATIN, UNSPECIFIED:ORAL:CAPSULE, DELAYED ACTION, ENTERIC COATED:NA	ORAL	ORAL CAPSULE, DELAYED ACTION, ENTERIC COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
2G86QN327L	GELATIN, UNSPECIFIED:ORAL:CAPSULE, DELAYED RELEASE:MG	ORAL	78.64MG ORAL CAPSULE, DELAYED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
2G86QN327L	GELATIN, UNSPECIFIED:ORAL:CAPSULE, ENTERIC COATED PELLETS:MG	ORAL	84.6MG ORAL CAPSULE, ENTERIC COATED PELLETS	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
2G86QN327L	GELATIN, UNSPECIFIED:ORAL:CAPSULE, EXTENDED RELEASE:MG	ORAL	122.87MG ORAL CAPSULE, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
2G86QN327L	GELATIN, UNSPECIFIED:ORAL:CAPSULE, FILM COATED, EXTENDED RELEASE:MG	ORAL	93.48MG ORAL CAPSULE, FILM COATED, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
2G86QN327L	GELATIN, UNSPECIFIED:ORAL:CAPSULE, HARD GELATIN:MG	ORAL	52.75MG ORAL CAPSULE, HARD GELATIN	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
2G86QN327L	GELATIN, UNSPECIFIED:ORAL:CAPSULE, SOFT GELATIN:MG	ORAL	733MG ORAL CAPSULE, SOFT GELATIN	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
2G86QN327L	GELATIN, UNSPECIFIED:ORAL:CAPSULE, SOFT GELATIN LIQUID-FILLED:MG	ORAL	194MG ORAL CAPSULE, SOFT GELATIN LIQUID-FILLED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
2G86QN327L	GELATIN, UNSPECIFIED:ORAL:CAPSULE, SUSTAINED ACTION:MG	ORAL	217.86MG ORAL CAPSULE, SUSTAINED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
2G86QN327L	GELATIN, UNSPECIFIED:ORAL:CAPSULE, SUSTAINED ACTION, HARD GELATIN:MG	ORAL	107MG ORAL CAPSULE, SUSTAINED ACTION, HARD GELATIN	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
2G86QN327L	GELATIN, UNSPECIFIED:ORAL:DROPS:NA	ORAL	ORAL DROPS	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
2G86QN327L	GELATIN, UNSPECIFIED:ORAL:PASTILLE:MG	ORAL	143MG ORAL PASTILLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
2G86QN327L	GELATIN, UNSPECIFIED:ORAL:POWDER, FOR SUSPENSION:NA	ORAL	ORAL POWDER, FOR SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
2G86QN327L	GELATIN, UNSPECIFIED:ORAL:SOFT CAPSULE DOSAGE FORM:mg	ORAL	129.64mg ORAL SOFT CAPSULE DOSAGE FORM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
2G86QN327L	GELATIN, UNSPECIFIED:ORAL:SOLUTION:MG	ORAL	34.8MG ORAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
2G86QN327L	GELATIN, UNSPECIFIED:ORAL:SOLUTION, ELIXIR:NA	ORAL	ORAL SOLUTION, ELIXIR	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
2G86QN327L	GELATIN, UNSPECIFIED:ORAL:SYRUP:NA	ORAL	ORAL SYRUP	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
2G86QN327L	GELATIN, UNSPECIFIED:ORAL:TABLET:MG	ORAL	7.8MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
2G86QN327L	GELATIN, UNSPECIFIED:ORAL:TABLET (IMMED./COMP. RELEASE), UNCOATED, CHEWABLE:MG	ORAL	2MG ORAL TABLET (IMMED./COMP. RELEASE), UNCOATED, CHEWABLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
2G86QN327L	GELATIN, UNSPECIFIED:ORAL:TABLET, COATED:MG	ORAL	42.12MG ORAL TABLET, COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
2G86QN327L	GELATIN, UNSPECIFIED:ORAL:TABLET, DELAYED ACTION, ENTERIC COATED:MG	ORAL	15MG ORAL TABLET, DELAYED ACTION, ENTERIC COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
2G86QN327L	GELATIN, UNSPECIFIED:ORAL:TABLET, DELAYED RELEASE:NA	ORAL	ORAL TABLET, DELAYED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
2G86QN327L	GELATIN, UNSPECIFIED:ORAL:TABLET, FILM COATED:MG	ORAL	28.35MG ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
2G86QN327L	GELATIN, UNSPECIFIED:ORAL:TABLET, ORALLY DISINTEGRATING:MG	ORAL	23.75MG ORAL TABLET, ORALLY DISINTEGRATING	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
2G86QN327L	GELATIN, UNSPECIFIED:ORAL:TABLET, REPEAT ACTION:MG	ORAL	1.61MG ORAL TABLET, REPEAT ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
2G86QN327L	GELATIN, UNSPECIFIED:ORAL:TABLET, SUSTAINED ACTION:MG	ORAL	40MG ORAL TABLET, SUSTAINED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
2G86QN327L	GELATIN, UNSPECIFIED:ORAL:TABLET, SUSTAINED ACTION, COATED:NA	ORAL	ORAL TABLET, SUSTAINED ACTION, COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
2G86QN327L	GELATIN, UNSPECIFIED:ORAL:WAFER:NA	ORAL	ORAL WAFER	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
2G86QN327L	GELATIN, UNSPECIFIED:RESPIRATORY (INHALATION):POWDER, FOR INHALATION:%	RESPIRATORY (INHALATION)	10% RESPIRATORY (INHALATION) POWDER, FOR INHALATION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
2G86QN327L	GELATIN, UNSPECIFIED:SUBLINGUAL:TABLET:MG	SUBLINGUAL	10MG SUBLINGUAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
2G86QN327L	GELATIN, UNSPECIFIED:SUBLINGUAL:TABLET, ORALLY DISINTEGRATING:mg	SUBLINGUAL	12.5mg SUBLINGUAL TABLET, ORALLY DISINTEGRATING	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
2G86QN327L	GELATIN, UNSPECIFIED:TOPICAL:EMULSION, CREAM:NA	TOPICAL	TOPICAL EMULSION, CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
2G86QN327L	GELATIN, UNSPECIFIED:TOPICAL:FILM, CONTROLLED RELEASE:NA	TOPICAL	TOPICAL FILM, CONTROLLED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
2G86QN327L	GELATIN, UNSPECIFIED:TOPICAL:PASTE:NA	TOPICAL	TOPICAL PASTE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
2G86QN327L	GELATIN, UNSPECIFIED:TOPICAL:PASTE, DENTIFRICE:NA	TOPICAL	TOPICAL PASTE, DENTIFRICE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
2G86QN327L	GELATIN, UNSPECIFIED:TOPICAL:PATCH:MG	TOPICAL	210MG TOPICAL PATCH	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
2G86QN327L	GELATIN, UNSPECIFIED:TOPICAL:PATCH, CONTROLLED RELEASE:NA	TOPICAL	TOPICAL PATCH, CONTROLLED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
2G86QN327L	GELATIN, UNSPECIFIED:TOPICAL:SUPPOSITORY, INSERT:NA	TOPICAL	TOPICAL SUPPOSITORY, INSERT	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
2G86QN327L	GELATIN, UNSPECIFIED:VAGINAL:SUPPOSITORY:NA	VAGINAL	VAGINAL SUPPOSITORY	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
142M471B3J	CARBON DIOXIDE:AN,INFILTRATION:INJECTION:NA	AN,INFILTRATION	AN,INFILTRATION INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
142M471B3J	CARBON DIOXIDE:EXTRACORPOREAL:SOLUTION:ADJ PH	EXTRACORPOREAL	ADJ PH EXTRACORPOREAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
142M471B3J	CARBON DIOXIDE:IM - IV:INJECTION:NA	IM - IV	IM - IV INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
142M471B3J	CARBON DIOXIDE:INHALATION:GAS:MG/ING	INHALATION	950MG/ING INHALATION GAS	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
142M471B3J	CARBON DIOXIDE:INTRA-ARTERIAL:SOLUTION, INJECTION:ADJ PH	INTRA-ARTERIAL	ADJ PH INTRA-ARTERIAL SOLUTION, INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
142M471B3J	CARBON DIOXIDE:INTRACARDIAC:INJECTION:NA	INTRACARDIAC	INTRACARDIAC INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
142M471B3J	CARBON DIOXIDE:INTRAMUSCULAR:INJECTION:NA	INTRAMUSCULAR	INTRAMUSCULAR INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
142M471B3J	CARBON DIOXIDE:INTRATHECAL:INJECTABLE:ADJ PH	INTRATHECAL	ADJ PH INTRATHECAL INJECTABLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
142M471B3J	CARBON DIOXIDE:INTRATHECAL:INJECTION:NA	INTRATHECAL	INTRATHECAL INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
142M471B3J	CARBON DIOXIDE:INTRAVASCULAR:SOLUTION, INJECTION:ADJ PH	INTRAVASCULAR	ADJ PH INTRAVASCULAR SOLUTION, INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
142M471B3J	CARBON DIOXIDE:INTRAVENOUS:INJECTABLE:ADJ PH	INTRAVENOUS	ADJ PH INTRAVENOUS INJECTABLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
142M471B3J	CARBON DIOXIDE:INTRAVENOUS:INJECTION:NA	INTRAVENOUS	INTRAVENOUS INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
142M471B3J	CARBON DIOXIDE:INTRAVENOUS:SOLUTION:ADJ PH	INTRAVENOUS	ADJ PH INTRAVENOUS SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
142M471B3J	CARBON DIOXIDE:INTRAVENOUS:SOLUTION, INJECTION:ADJ PH	INTRAVENOUS	ADJ PH INTRAVENOUS SOLUTION, INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
142M471B3J	CARBON DIOXIDE:IV(INFUSION):POWDER, FOR INJECTION SOLUTION:ADJ PH	IV(INFUSION)	ADJ PH IV(INFUSION) POWDER, FOR INJECTION SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
142M471B3J	CARBON DIOXIDE:NERVE BLOCK:INJECTION:NA	NERVE BLOCK	NERVE BLOCK INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
8W8T17847W	UREA:INTRAMUSCULAR:INJECTION:NA	INTRAMUSCULAR	INTRAMUSCULAR INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=U
8W8T17847W	UREA:ORAL:TABLET, COATED:MG	ORAL	0.018MG ORAL TABLET, COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=U
8W8T17847W	UREA:ORAL:TABLET, SUSTAINED ACTION:MG	ORAL	0.01MG ORAL TABLET, SUSTAINED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=U
8W8T17847W	UREA:TOPICAL:PATCH:MG	TOPICAL	280MG TOPICAL PATCH	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=U
8W8T17847W	UREA:VAGINAL:EMULSION, CREAM:%	VAGINAL	0.64% VAGINAL EMULSION, CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=U
8W8T17847W	UREA:VAGINAL:TABLET:MG	VAGINAL	50MG VAGINAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=U
JC2Q67KRW7	DETOSU/TRIETHYLENE GLYCOL/TRIETHYLENE GLYCOL POLYGLYCOLIDE COPOLYMER:SUBCUTANEOUS:INJECTION:mg/0.4ML	SUBCUTANEOUS	392mg/0.4ML SUBCUTANEOUS INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
QTT17582CB	HYDROCHLORIC ACID:AN,CNBLK INTRATHECAL:INJECTION:ADJ PH	AN,CNBLK INTRATHECAL	ADJ PH AN,CNBLK INTRATHECAL INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
QTT17582CB	HYDROCHLORIC ACID:AN,INFILTRATION:INJECTABLE:ADJ PH	AN,INFILTRATION	ADJ PH AN,INFILTRATION INJECTABLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
QTT17582CB	HYDROCHLORIC ACID:AN,INFILTRATION:INJECTION:%	AN,INFILTRATION	1.36% AN,INFILTRATION INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
QTT17582CB	HYDROCHLORIC ACID:AN,SYMPATHETIC NBLK:INJECTION:ADJ PH	AN,SYMPATHETIC NBLK	ADJ PH AN,SYMPATHETIC NBLK INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
QTT17582CB	HYDROCHLORIC ACID:AURICULAR (OTIC):SOLUTION:%	AURICULAR (OTIC)	0.37% AURICULAR (OTIC) SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
QTT17582CB	HYDROCHLORIC ACID:AURICULAR (OTIC):SUSPENSION:%	AURICULAR (OTIC)	0.044% AURICULAR (OTIC) SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
QTT17582CB	HYDROCHLORIC ACID:CAUDAL BLOCK:INJECTABLE:ADJ PH	CAUDAL BLOCK	ADJ PH CAUDAL BLOCK INJECTABLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
QTT17582CB	HYDROCHLORIC ACID:CAUDAL BLOCK:INJECTION:ADJ PH	CAUDAL BLOCK	ADJ PH CAUDAL BLOCK INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
QTT17582CB	HYDROCHLORIC ACID:DENTAL:INJECTABLE:ADJ PH	DENTAL	ADJ PH DENTAL INJECTABLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
QTT17582CB	HYDROCHLORIC ACID:DENTAL:SOLUTION:ADJ PH	DENTAL	ADJ PH DENTAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
QTT17582CB	HYDROCHLORIC ACID:EPIDURAL:INJECTION:ADJ PH	EPIDURAL	ADJ PH EPIDURAL INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
QTT17582CB	HYDROCHLORIC ACID:EPIDURAL:INJECTION, SOLUTION:ADJ PH	EPIDURAL	ADJ PH EPIDURAL INJECTION, SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
QTT17582CB	HYDROCHLORIC ACID:EPIDURAL:LIQUID, WATER, STERILE, FOR INJECTION:ADJ PH	EPIDURAL	ADJ PH EPIDURAL LIQUID, WATER, STERILE, FOR INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
QTT17582CB	HYDROCHLORIC ACID:EPIDURAL:SOLUTION:ADJ PH	EPIDURAL	ADJ PH EPIDURAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
QTT17582CB	HYDROCHLORIC ACID:EPIDURAL:SOLUTION, INJECTION:ADJ PH	EPIDURAL	ADJ PH EPIDURAL SOLUTION, INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
QTT17582CB	HYDROCHLORIC ACID:EXTRACORPOREAL:INJECTION:ADJ PH	EXTRACORPOREAL	ADJ PH EXTRACORPOREAL INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
QTT17582CB	HYDROCHLORIC ACID:EXTRACORPOREAL:SOLUTION:ADJ PH	EXTRACORPOREAL	ADJ PH EXTRACORPOREAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
QTT17582CB	HYDROCHLORIC ACID:IM - IV:INJECTABLE:%	IM - IV	0.025% IM - IV INJECTABLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
QTT17582CB	HYDROCHLORIC ACID:IM - IV:INJECTION:%	IM - IV	3.06% IM - IV INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
QTT17582CB	HYDROCHLORIC ACID:IM - IV:INJECTION:ADJ PH	IM - IV	ADJ PH IM - IV INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
QTT17582CB	HYDROCHLORIC ACID:IM - IV:INJECTION, SOLUTION:ADJ PH	IM - IV	ADJ PH IM - IV INJECTION, SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
QTT17582CB	HYDROCHLORIC ACID:IM - IV:LIQUID, WATER, STERILE, FOR INJECTION:NA	IM - IV	IM - IV LIQUID, WATER, STERILE, FOR INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
QTT17582CB	HYDROCHLORIC ACID:IM - IV:POWDER, FOR INJECTION SOLUTION:ADJ PH	IM - IV	ADJ PH IM - IV POWDER, FOR INJECTION SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
QTT17582CB	HYDROCHLORIC ACID:IM - IV:POWDER, FOR INJECTION SOLUTION, LYOPHILIZED:ADJ PH	IM - IV	ADJ PH IM - IV POWDER, FOR INJECTION SOLUTION, LYOPHILIZED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
QTT17582CB	HYDROCHLORIC ACID:IM - IV:SOLUTION, INJECTION:ADJ PH	IM - IV	ADJ PH IM - IV SOLUTION, INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
QTT17582CB	HYDROCHLORIC ACID:IM - IV - SC:INJECTION:ADJ PH	IM - IV - SC	ADJ PH IM - IV - SC INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
QTT17582CB	HYDROCHLORIC ACID:IM - IV - SC:POWDER, FOR INJECTION SOLUTION:ADJ PH	IM - IV - SC	ADJ PH IM - IV - SC POWDER, FOR INJECTION SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
QTT17582CB	HYDROCHLORIC ACID:IM - IV - SC:POWDER, FOR INJECTION SOLUTION, LYOPHILIZED:ADJ PH	IM - IV - SC	ADJ PH IM - IV - SC POWDER, FOR INJECTION SOLUTION, LYOPHILIZED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
QTT17582CB	HYDROCHLORIC ACID:IM - IV - SC:SOLUTION, INJECTION:ADJ PH	IM - IV - SC	ADJ PH IM - IV - SC SOLUTION, INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
QTT17582CB	HYDROCHLORIC ACID:IM - SC:INJECTION:ADJ PH	IM - SC	ADJ PH IM - SC INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
QTT17582CB	HYDROCHLORIC ACID:IM - SC:INJECTION, SUSTAINED ACTION:NA	IM - SC	IM - SC INJECTION, SUSTAINED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
QTT17582CB	HYDROCHLORIC ACID:IM - SC:POWDER, FOR INJECTION SOLUTION:ADJ PH	IM - SC	ADJ PH IM - SC POWDER, FOR INJECTION SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
QTT17582CB	HYDROCHLORIC ACID:INFILTRATION:INJECTION:%	INFILTRATION	0.37% INFILTRATION INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
QTT17582CB	HYDROCHLORIC ACID:INFILTRATION:INJECTION, SOLUTION:ADJ PH	INFILTRATION	ADJ PH INFILTRATION INJECTION, SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
QTT17582CB	HYDROCHLORIC ACID:INFILTRATION:SOLUTION, INJECTION:ADJ PH	INFILTRATION	ADJ PH INFILTRATION SOLUTION, INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
QTT17582CB	HYDROCHLORIC ACID:INHALATION:AEROSOL, METERED:%	INHALATION	1.72% INHALATION AEROSOL, METERED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
QTT17582CB	HYDROCHLORIC ACID:INHALATION:AEROSOL, SPRAY:%	INHALATION	1.5% INHALATION AEROSOL, SPRAY	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
QTT17582CB	HYDROCHLORIC ACID:INHALATION:SOLUTION:%	INHALATION	3.5% INHALATION SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
QTT17582CB	HYDROCHLORIC ACID:INHALATION:SOLUTION:ADJ PH	INHALATION	ADJ PH INHALATION SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
QTT17582CB	HYDROCHLORIC ACID:INHALATION:SOLUTION, FOR INHALATION:ADJ PH	INHALATION	ADJ PH INHALATION SOLUTION, FOR INHALATION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
QTT17582CB	HYDROCHLORIC ACID:INHALATION:SPRAY:ADJ PH	INHALATION	ADJ PH INHALATION SPRAY	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
QTT17582CB	HYDROCHLORIC ACID:INJECTION:INJECTION:ADJ PH	INJECTION	ADJ PH INJECTION INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
QTT17582CB	HYDROCHLORIC ACID:INJECTION:INJECTION, SOLUTION:ADJ PH	INJECTION	ADJ PH INJECTION INJECTION, SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
QTT17582CB	HYDROCHLORIC ACID:INTERSTITIAL:INJECTION:ADJ PH	INTERSTITIAL	ADJ PH INTERSTITIAL INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
QTT17582CB	HYDROCHLORIC ACID:INTRA-AMNIOTIC:INJECTION:ADJ PH	INTRA-AMNIOTIC	ADJ PH INTRA-AMNIOTIC INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
QTT17582CB	HYDROCHLORIC ACID:INTRA-ARTERIAL:INJECTABLE:ADJ PH	INTRA-ARTERIAL	ADJ PH INTRA-ARTERIAL INJECTABLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
QTT17582CB	HYDROCHLORIC ACID:INTRA-ARTERIAL:INJECTION:ADJ PH	INTRA-ARTERIAL	ADJ PH INTRA-ARTERIAL INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
QTT17582CB	HYDROCHLORIC ACID:INTRA-ARTERIAL:POWDER, FOR INJECTION SOLUTION:ADJ PH	INTRA-ARTERIAL	ADJ PH INTRA-ARTERIAL POWDER, FOR INJECTION SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
QTT17582CB	HYDROCHLORIC ACID:INTRA-ARTERIAL:POWDER, FOR INJECTION SOLUTION, LYOPHILIZED:ADJ PH	INTRA-ARTERIAL	ADJ PH INTRA-ARTERIAL POWDER, FOR INJECTION SOLUTION, LYOPHILIZED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
QTT17582CB	HYDROCHLORIC ACID:INTRA-ARTERIAL:SOLUTION, INJECTION:ADJ PH	INTRA-ARTERIAL	ADJ PH INTRA-ARTERIAL SOLUTION, INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
QTT17582CB	HYDROCHLORIC ACID:INTRA-ARTERIAL:SUSPENSION, INJECTION:ADJ PH	INTRA-ARTERIAL	ADJ PH INTRA-ARTERIAL SUSPENSION, INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
QTT17582CB	HYDROCHLORIC ACID:INTRA-ARTICULAR:INJECTABLE:ADJ PH	INTRA-ARTICULAR	ADJ PH INTRA-ARTICULAR INJECTABLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
QTT17582CB	HYDROCHLORIC ACID:INTRA-ARTICULAR:INJECTION:ADJ PH	INTRA-ARTICULAR	ADJ PH INTRA-ARTICULAR INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
QTT17582CB	HYDROCHLORIC ACID:INTRABURSAL:INJECTION:ADJ PH	INTRABURSAL	ADJ PH INTRABURSAL INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
QTT17582CB	HYDROCHLORIC ACID:INTRACARDIAC:INJECTION:ADJ PH	INTRACARDIAC	ADJ PH INTRACARDIAC INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
QTT17582CB	HYDROCHLORIC ACID:INTRACARDIAC:SOLUTION, INJECTION:ADJ PH	INTRACARDIAC	ADJ PH INTRACARDIAC SOLUTION, INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
QTT17582CB	HYDROCHLORIC ACID:INTRACAUDAL:INJECTION:NA	INTRACAUDAL	INTRACAUDAL INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
QTT17582CB	HYDROCHLORIC ACID:INTRACAUDAL:INJECTION, SOLUTION:ADJ PH	INTRACAUDAL	ADJ PH INTRACAUDAL INJECTION, SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
QTT17582CB	HYDROCHLORIC ACID:INTRACAVITARY:INJECTION:ADJ PH	INTRACAVITARY	ADJ PH INTRACAVITARY INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
QTT17582CB	HYDROCHLORIC ACID:INTRACAVITARY:POWDER, FOR INJECTION SOLUTION, LYOPHILIZED:ADJ PH	INTRACAVITARY	ADJ PH INTRACAVITARY POWDER, FOR INJECTION SOLUTION, LYOPHILIZED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
QTT17582CB	HYDROCHLORIC ACID:INTRADERMAL:INJECTION:ADJ PH	INTRADERMAL	ADJ PH INTRADERMAL INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
QTT17582CB	HYDROCHLORIC ACID:INTRADERMAL:POWDER, FOR INJECTION SOLUTION:ADJ PH	INTRADERMAL	ADJ PH INTRADERMAL POWDER, FOR INJECTION SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
QTT17582CB	HYDROCHLORIC ACID:INTRALESIONAL:INJECTABLE:ADJ PH	INTRALESIONAL	ADJ PH INTRALESIONAL INJECTABLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
QTT17582CB	HYDROCHLORIC ACID:INTRALESIONAL:INJECTION:ADJ PH	INTRALESIONAL	ADJ PH INTRALESIONAL INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
QTT17582CB	HYDROCHLORIC ACID:INTRALESIONAL:INJECTION, SUSTAINED ACTION:ADJ PH	INTRALESIONAL	ADJ PH INTRALESIONAL INJECTION, SUSTAINED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
QTT17582CB	HYDROCHLORIC ACID:INTRALESIONAL:SUSPENSION, INJECTION:ADJ PH	INTRALESIONAL	ADJ PH INTRALESIONAL SUSPENSION, INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
QTT17582CB	HYDROCHLORIC ACID:INTRAMUSCULAR:INJECTABLE:%V/V	INTRAMUSCULAR	8%V/V INTRAMUSCULAR INJECTABLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
QTT17582CB	HYDROCHLORIC ACID:INTRAMUSCULAR:INJECTION:ADJ PH	INTRAMUSCULAR	ADJ PH INTRAMUSCULAR INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
QTT17582CB	HYDROCHLORIC ACID:INTRAMUSCULAR:INJECTION, SOLUTION:ADJ PH	INTRAMUSCULAR	ADJ PH INTRAMUSCULAR INJECTION, SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
QTT17582CB	HYDROCHLORIC ACID:INTRAMUSCULAR:INJECTION, SUSPENSION:ADJ PH	INTRAMUSCULAR	ADJ PH INTRAMUSCULAR INJECTION, SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
QTT17582CB	HYDROCHLORIC ACID:INTRAMUSCULAR:INJECTION, SUSTAINED ACTION:ADJ PH	INTRAMUSCULAR	ADJ PH INTRAMUSCULAR INJECTION, SUSTAINED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
QTT17582CB	HYDROCHLORIC ACID:INTRAMUSCULAR:LIQUID:NA	INTRAMUSCULAR	INTRAMUSCULAR LIQUID	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
QTT17582CB	HYDROCHLORIC ACID:INTRAMUSCULAR:POWDER, FOR INJECTION SOLUTION:ADJ PH	INTRAMUSCULAR	ADJ PH INTRAMUSCULAR POWDER, FOR INJECTION SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
QTT17582CB	HYDROCHLORIC ACID:INTRAMUSCULAR:POWDER, FOR INJECTION SOLUTION, LYOPHILIZED:ADJ PH	INTRAMUSCULAR	ADJ PH INTRAMUSCULAR POWDER, FOR INJECTION SOLUTION, LYOPHILIZED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
QTT17582CB	HYDROCHLORIC ACID:INTRAMUSCULAR:SOLUTION:ADJ PH	INTRAMUSCULAR	ADJ PH INTRAMUSCULAR SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
QTT17582CB	HYDROCHLORIC ACID:INTRAMUSCULAR:SOLUTION, INJECTION:%W/V	INTRAMUSCULAR	0.61%W/V INTRAMUSCULAR SOLUTION, INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
QTT17582CB	HYDROCHLORIC ACID:INTRAMUSCULAR:SUSPENSION, INJECTION:ADJ PH	INTRAMUSCULAR	ADJ PH INTRAMUSCULAR SUSPENSION, INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
QTT17582CB	HYDROCHLORIC ACID:INTRAOCULAR:SOLUTION:ADJ PH	INTRAOCULAR	ADJ PH INTRAOCULAR SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
QTT17582CB	HYDROCHLORIC ACID:INTRAPERITONEAL:INJECTION:ADJ PH	INTRAPERITONEAL	ADJ PH INTRAPERITONEAL INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
QTT17582CB	HYDROCHLORIC ACID:INTRAPERITONEAL:SOLUTION:ADJ PH	INTRAPERITONEAL	ADJ PH INTRAPERITONEAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
QTT17582CB	HYDROCHLORIC ACID:INTRAPLEURAL:INJECTION:ADJ PH	INTRAPLEURAL	ADJ PH INTRAPLEURAL INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
QTT17582CB	HYDROCHLORIC ACID:INTRASPINAL:INJECTION:ADJ PH	INTRASPINAL	ADJ PH INTRASPINAL INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
QTT17582CB	HYDROCHLORIC ACID:INTRASYNOVIAL:INJECTABLE:ADJ PH	INTRASYNOVIAL	ADJ PH INTRASYNOVIAL INJECTABLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
QTT17582CB	HYDROCHLORIC ACID:INTRASYNOVIAL:INJECTION:ADJ PH	INTRASYNOVIAL	ADJ PH INTRASYNOVIAL INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
QTT17582CB	HYDROCHLORIC ACID:INTRASYNOVIAL:INJECTION, SUSTAINED ACTION:ADJ PH	INTRASYNOVIAL	ADJ PH INTRASYNOVIAL INJECTION, SUSTAINED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
QTT17582CB	HYDROCHLORIC ACID:INTRASYNOVIAL:SUSPENSION, INJECTION:ADJ PH	INTRASYNOVIAL	ADJ PH INTRASYNOVIAL SUSPENSION, INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
QTT17582CB	HYDROCHLORIC ACID:INTRATHECAL:INJECTABLE:ADJ PH	INTRATHECAL	ADJ PH INTRATHECAL INJECTABLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
QTT17582CB	HYDROCHLORIC ACID:INTRATHECAL:INJECTION:ADJ PH	INTRATHECAL	ADJ PH INTRATHECAL INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
QTT17582CB	HYDROCHLORIC ACID:INTRATHECAL:POWDER, FOR INJECTION SOLUTION:ADJ PH	INTRATHECAL	ADJ PH INTRATHECAL POWDER, FOR INJECTION SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
QTT17582CB	HYDROCHLORIC ACID:INTRATHECAL:POWDER, FOR INJECTION SOLUTION, LYOPHILIZED:ADJ PH	INTRATHECAL	ADJ PH INTRATHECAL POWDER, FOR INJECTION SOLUTION, LYOPHILIZED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
QTT17582CB	HYDROCHLORIC ACID:INTRATHECAL:SOLUTION:ADJ PH	INTRATHECAL	ADJ PH INTRATHECAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
QTT17582CB	HYDROCHLORIC ACID:INTRATHECAL:SOLUTION, INJECTION:ADJ PH	INTRATHECAL	ADJ PH INTRATHECAL SOLUTION, INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
QTT17582CB	HYDROCHLORIC ACID:INTRATRACHEAL:POWDER, FOR SUSPENSION:ADJ PH	INTRATRACHEAL	ADJ PH INTRATRACHEAL POWDER, FOR SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
QTT17582CB	HYDROCHLORIC ACID:INTRATRACHEAL:SUSPENSION:ADJ PH	INTRATRACHEAL	ADJ PH INTRATRACHEAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
QTT17582CB	HYDROCHLORIC ACID:INTRATUMOR:INJECTABLE:ADJ PH	INTRATUMOR	ADJ PH INTRATUMOR INJECTABLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
QTT17582CB	HYDROCHLORIC ACID:INTRATUMOR:INJECTION:ADJ PH	INTRATUMOR	ADJ PH INTRATUMOR INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
QTT17582CB	HYDROCHLORIC ACID:INTRATUMOR:POWDER, FOR INJECTION SOLUTION:ADJ PH	INTRATUMOR	ADJ PH INTRATUMOR POWDER, FOR INJECTION SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
QTT17582CB	HYDROCHLORIC ACID:INTRATYMPANIC:SUSPENSION:%W/W	INTRATYMPANIC	0.14%W/W INTRATYMPANIC SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
QTT17582CB	HYDROCHLORIC ACID:INTRAVASCULAR:INJECTION:ADJ PH	INTRAVASCULAR	ADJ PH INTRAVASCULAR INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
QTT17582CB	HYDROCHLORIC ACID:INTRAVASCULAR:SOLUTION:ADJ PH	INTRAVASCULAR	ADJ PH INTRAVASCULAR SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
QTT17582CB	HYDROCHLORIC ACID:INTRAVENOUS:INJECTABLE:%	INTRAVENOUS	8% INTRAVENOUS INJECTABLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
QTT17582CB	HYDROCHLORIC ACID:INTRAVENOUS:INJECTION:MG/1ML	INTRAVENOUS	14.87MG/1ML INTRAVENOUS INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
QTT17582CB	HYDROCHLORIC ACID:INTRAVENOUS:INJECTION:ADJ PH	INTRAVENOUS	ADJ PH INTRAVENOUS INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
QTT17582CB	HYDROCHLORIC ACID:INTRAVENOUS:INJECTION, POWDER, LYOPHILIZED, FOR LIPOSOMAL SUSPENSION:ADJ PH	INTRAVENOUS	ADJ PH INTRAVENOUS INJECTION, POWDER, LYOPHILIZED, FOR LIPOSOMAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
QTT17582CB	HYDROCHLORIC ACID:INTRAVENOUS:INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION:%	INTRAVENOUS	0.85% INTRAVENOUS INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
QTT17582CB	HYDROCHLORIC ACID:INTRAVENOUS:INJECTION, SOLUTION:ADJ PH	INTRAVENOUS	ADJ PH INTRAVENOUS INJECTION, SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
QTT17582CB	HYDROCHLORIC ACID:INTRAVENOUS:INJECTION, SOLUTION:NA	INTRAVENOUS	INTRAVENOUS INJECTION, SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
QTT17582CB	HYDROCHLORIC ACID:INTRAVENOUS:INJECTION, SUSPENSION:ADJ PH	INTRAVENOUS	ADJ PH INTRAVENOUS INJECTION, SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
QTT17582CB	HYDROCHLORIC ACID:INTRAVENOUS:INJECTION, SUSPENSION, LIPOSOMAL:ADJ PH	INTRAVENOUS	ADJ PH INTRAVENOUS INJECTION, SUSPENSION, LIPOSOMAL	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
QTT17582CB	HYDROCHLORIC ACID:INTRAVENOUS:LIQUID:ADJ PH	INTRAVENOUS	ADJ PH INTRAVENOUS LIQUID	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
QTT17582CB	HYDROCHLORIC ACID:INTRAVENOUS:POWDER:ADJ PH	INTRAVENOUS	ADJ PH INTRAVENOUS POWDER	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
QTT17582CB	HYDROCHLORIC ACID:INTRAVENOUS:POWDER FOR INJECTION DOSAGE FORM:ADJ PH	INTRAVENOUS	ADJ PH INTRAVENOUS POWDER FOR INJECTION DOSAGE FORM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
QTT17582CB	HYDROCHLORIC ACID:INTRAVENOUS:POWDER, FOR INJECTION SOLUTION:ADJ PH	INTRAVENOUS	ADJ PH INTRAVENOUS POWDER, FOR INJECTION SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
QTT17582CB	HYDROCHLORIC ACID:INTRAVENOUS:POWDER, FOR INJECTION SOLUTION, LYOPHILIZED:%	INTRAVENOUS	16% INTRAVENOUS POWDER, FOR INJECTION SOLUTION, LYOPHILIZED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
QTT17582CB	HYDROCHLORIC ACID:INTRAVENOUS:SOLUTION:%	INTRAVENOUS	1.83% INTRAVENOUS SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
QTT17582CB	HYDROCHLORIC ACID:INTRAVENOUS:SOLUTION, CONCENTRATE:ADJ PH	INTRAVENOUS	ADJ PH INTRAVENOUS SOLUTION, CONCENTRATE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
QTT17582CB	HYDROCHLORIC ACID:INTRAVENOUS:SOLUTION, INJECTION:ADJ PH	INTRAVENOUS	ADJ PH INTRAVENOUS SOLUTION, INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
QTT17582CB	HYDROCHLORIC ACID:INTRAVENOUS:SOLUTION, LIQUID:ADJ PH	INTRAVENOUS	ADJ PH INTRAVENOUS SOLUTION, LIQUID	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
QTT17582CB	HYDROCHLORIC ACID:INTRAVENOUS INFUSION:INJECTION:ADJ PH	INTRAVENOUS INFUSION	ADJ PH INTRAVENOUS INFUSION INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
QTT17582CB	HYDROCHLORIC ACID:INTRAVENOUS INFUSION:POWDER:ADJ PH	INTRAVENOUS INFUSION	ADJ PH INTRAVENOUS INFUSION POWDER	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
QTT17582CB	HYDROCHLORIC ACID:INTRAVESICAL:SOLUTION, INJECTION:%	INTRAVESICAL	15.7% INTRAVESICAL SOLUTION, INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
QTT17582CB	HYDROCHLORIC ACID:INTRAVITREAL:INJECTABLE:ADJ PH	INTRAVITREAL	ADJ PH INTRAVITREAL INJECTABLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
QTT17582CB	HYDROCHLORIC ACID:INTRAVITREAL:INJECTION:ADJ PH	INTRAVITREAL	ADJ PH INTRAVITREAL INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
QTT17582CB	HYDROCHLORIC ACID:INTRAVITREAL:SUSPENSION, INJECTION:ADJ PH	INTRAVITREAL	ADJ PH INTRAVITREAL SUSPENSION, INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
QTT17582CB	HYDROCHLORIC ACID:IONTOPHORESIS:SOLUTION:ADJ PH	IONTOPHORESIS	ADJ PH IONTOPHORESIS SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
QTT17582CB	HYDROCHLORIC ACID:IRRIGATION:SOLUTION:ADJ PH	IRRIGATION	ADJ PH IRRIGATION SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
QTT17582CB	HYDROCHLORIC ACID:IV - SC:INJECTION:ADJ PH	IV - SC	ADJ PH IV - SC INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
QTT17582CB	HYDROCHLORIC ACID:IV - SC:POWDER, FOR INJECTION SOLUTION:ADJ PH	IV - SC	ADJ PH IV - SC POWDER, FOR INJECTION SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
QTT17582CB	HYDROCHLORIC ACID:IV - SC:SOLUTION, INJECTION:ADJ PH	IV - SC	ADJ PH IV - SC SOLUTION, INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
QTT17582CB	HYDROCHLORIC ACID:IV(INFUSION):INFUSION:ADJ PH	IV(INFUSION)	ADJ PH IV(INFUSION) INFUSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
QTT17582CB	HYDROCHLORIC ACID:IV(INFUSION):INJECTABLE:NA	IV(INFUSION)	IV(INFUSION) INJECTABLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
QTT17582CB	HYDROCHLORIC ACID:IV(INFUSION):INJECTION:ADJ PH	IV(INFUSION)	ADJ PH IV(INFUSION) INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
QTT17582CB	HYDROCHLORIC ACID:IV(INFUSION):INJECTION, LIPOSOMAL:ADJ PH	IV(INFUSION)	ADJ PH IV(INFUSION) INJECTION, LIPOSOMAL	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
QTT17582CB	HYDROCHLORIC ACID:IV(INFUSION):LIQUID:ADJ PH	IV(INFUSION)	ADJ PH IV(INFUSION) LIQUID	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
QTT17582CB	HYDROCHLORIC ACID:IV(INFUSION):LIQUID, WATER, STERILE, FOR INJECTION:ADJ PH	IV(INFUSION)	ADJ PH IV(INFUSION) LIQUID, WATER, STERILE, FOR INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
QTT17582CB	HYDROCHLORIC ACID:IV(INFUSION):POWDER, FOR INJECTION SOLUTION:ADJ PH	IV(INFUSION)	ADJ PH IV(INFUSION) POWDER, FOR INJECTION SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
QTT17582CB	HYDROCHLORIC ACID:IV(INFUSION):POWDER, FOR INJECTION SOLUTION, LYOPHILIZED:ADJ PH	IV(INFUSION)	ADJ PH IV(INFUSION) POWDER, FOR INJECTION SOLUTION, LYOPHILIZED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
QTT17582CB	HYDROCHLORIC ACID:IV(INFUSION):POWDER, FOR INJECTION SUSPENSION, LYOPHILIZED:%	IV(INFUSION)	0.42% IV(INFUSION) POWDER, FOR INJECTION SUSPENSION, LYOPHILIZED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
QTT17582CB	HYDROCHLORIC ACID:IV(INFUSION):SOLUTION:ADJ PH	IV(INFUSION)	ADJ PH IV(INFUSION) SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
QTT17582CB	HYDROCHLORIC ACID:IV(INFUSION):SOLUTION, INJECTION:%	IV(INFUSION)	12.7% IV(INFUSION) SOLUTION, INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
QTT17582CB	HYDROCHLORIC ACID:NASAL:SOLUTION:%	NASAL	0.25% NASAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
QTT17582CB	HYDROCHLORIC ACID:NASAL:SOLUTION, SPRAY:ADJ PH	NASAL	ADJ PH NASAL SOLUTION, SPRAY	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
QTT17582CB	HYDROCHLORIC ACID:NASAL:SPRAY:ADJ PH	NASAL	ADJ PH NASAL SPRAY	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
QTT17582CB	HYDROCHLORIC ACID:NASAL:SPRAY, METERED:ADJ PH	NASAL	ADJ PH NASAL SPRAY, METERED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
QTT17582CB	HYDROCHLORIC ACID:NERVE BLOCK:INJECTABLE:ADJ PH	NERVE BLOCK	ADJ PH NERVE BLOCK INJECTABLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
QTT17582CB	HYDROCHLORIC ACID:NERVE BLOCK:INJECTION:%	NERVE BLOCK	1.36% NERVE BLOCK INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
QTT17582CB	HYDROCHLORIC ACID:NERVE BLOCK:SOLUTION, INJECTION:ADJ PH	NERVE BLOCK	ADJ PH NERVE BLOCK SOLUTION, INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
QTT17582CB	HYDROCHLORIC ACID:OPHTHALMIC:EMULSION:ADJ PH	OPHTHALMIC	ADJ PH OPHTHALMIC EMULSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
QTT17582CB	HYDROCHLORIC ACID:OPHTHALMIC:GEL:ADJ PH	OPHTHALMIC	ADJ PH OPHTHALMIC GEL	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
QTT17582CB	HYDROCHLORIC ACID:OPHTHALMIC:POWDER, FOR SOLUTION:ADJ PH	OPHTHALMIC	ADJ PH OPHTHALMIC POWDER, FOR SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
QTT17582CB	HYDROCHLORIC ACID:OPHTHALMIC:SOLUTION:%	OPHTHALMIC	1.06% OPHTHALMIC SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
QTT17582CB	HYDROCHLORIC ACID:OPHTHALMIC:SOLUTION, DROPS:ADJ PH	OPHTHALMIC	ADJ PH OPHTHALMIC SOLUTION, DROPS	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
QTT17582CB	HYDROCHLORIC ACID:OPHTHALMIC:SOLUTION, IRRIGATION:ADJ PH	OPHTHALMIC	ADJ PH OPHTHALMIC SOLUTION, IRRIGATION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
QTT17582CB	HYDROCHLORIC ACID:OPHTHALMIC:SOLUTION/ DROPS:ADJ PH	OPHTHALMIC	ADJ PH OPHTHALMIC SOLUTION/ DROPS	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
QTT17582CB	HYDROCHLORIC ACID:OPHTHALMIC:SOLUTION/DROPS:ADJ PH	OPHTHALMIC	ADJ PH OPHTHALMIC SOLUTION/DROPS	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
QTT17582CB	HYDROCHLORIC ACID:OPHTHALMIC:SUSPENSION:ADJ PH	OPHTHALMIC	ADJ PH OPHTHALMIC SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
QTT17582CB	HYDROCHLORIC ACID:OPHTHALMIC:SUSPENSION, DROPS:ADJ PH	OPHTHALMIC	ADJ PH OPHTHALMIC SUSPENSION, DROPS	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
QTT17582CB	HYDROCHLORIC ACID:ORAL:CAPSULE, SOFT GELATIN LIQUID-FILLED:ADJ PH	ORAL	ADJ PH ORAL CAPSULE, SOFT GELATIN LIQUID-FILLED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
QTT17582CB	HYDROCHLORIC ACID:ORAL:CONCENTRATE:%	ORAL	0.62% ORAL CONCENTRATE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
QTT17582CB	HYDROCHLORIC ACID:ORAL:LIQUID:ML/ML	ORAL	0.00375ML/ML ORAL LIQUID	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
QTT17582CB	HYDROCHLORIC ACID:ORAL:LIQUID:MG/5ML	ORAL	0.002MG/5ML ORAL LIQUID	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
QTT17582CB	HYDROCHLORIC ACID:ORAL:POWDER, FOR SUSPENSION:g/236mL	ORAL	0.125g/236mL ORAL POWDER, FOR SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
QTT17582CB	HYDROCHLORIC ACID:ORAL:SOLUTION:%	ORAL	9.51% ORAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
QTT17582CB	HYDROCHLORIC ACID:ORAL:SOLUTION:ML/1ML	ORAL	0.0004ML/1ML ORAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
QTT17582CB	HYDROCHLORIC ACID:ORAL:SOLUTION:ADJ PH	ORAL	ADJ PH ORAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
QTT17582CB	HYDROCHLORIC ACID:ORAL:SOLUTION, FOR INHALATION:ADJ PH	ORAL	ADJ PH ORAL SOLUTION, FOR INHALATION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
QTT17582CB	HYDROCHLORIC ACID:ORAL:SPRAY:MG/1SPR	ORAL	2.49MG/1SPR ORAL SPRAY	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
QTT17582CB	HYDROCHLORIC ACID:ORAL:SUSPENSION:%	ORAL	2% ORAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
QTT17582CB	HYDROCHLORIC ACID:ORAL:SUSPENSION, EXTENDED RELEASE:ADJ PH	ORAL	ADJ PH ORAL SUSPENSION, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
QTT17582CB	HYDROCHLORIC ACID:ORAL:SYRUP:MG/1ML	ORAL	2.03MG/1ML ORAL SYRUP	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
QTT17582CB	HYDROCHLORIC ACID:ORAL:TABLET:ADJ PH	ORAL	ADJ PH ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
QTT17582CB	HYDROCHLORIC ACID:ORAL:TABLET, EXTENDED RELEASE:MG	ORAL	1.33MG ORAL TABLET, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
QTT17582CB	HYDROCHLORIC ACID:ORAL:TABLET, FILM COATED:ADJ PH	ORAL	ADJ PH ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
QTT17582CB	HYDROCHLORIC ACID:OTIC:SUSPENSION:ADJ PH	OTIC	ADJ PH OTIC SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
QTT17582CB	HYDROCHLORIC ACID:PARENTERAL:INJECTION:ADJ PH	PARENTERAL	ADJ PH PARENTERAL INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
QTT17582CB	HYDROCHLORIC ACID:PARENTERAL:KIT:ADJ PH	PARENTERAL	ADJ PH PARENTERAL KIT	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
QTT17582CB	HYDROCHLORIC ACID:PARENTERAL:LIQUID, WATER, STERILE, FOR INJECTION:ADJ PH	PARENTERAL	ADJ PH PARENTERAL LIQUID, WATER, STERILE, FOR INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
QTT17582CB	HYDROCHLORIC ACID:PARENTERAL:POWDER, FOR INJECTION SOLUTION:ADJ PH	PARENTERAL	ADJ PH PARENTERAL POWDER, FOR INJECTION SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
QTT17582CB	HYDROCHLORIC ACID:PERFUSION, CARDIAC:SOLUTION:ADJ PH	PERFUSION, CARDIAC	ADJ PH PERFUSION, CARDIAC SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
QTT17582CB	HYDROCHLORIC ACID:PERIDURAL:INJECTION:ADJ PH	PERIDURAL	ADJ PH PERIDURAL INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
QTT17582CB	HYDROCHLORIC ACID:PERINEURAL:INJECTION:NA	PERINEURAL	PERINEURAL INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
QTT17582CB	HYDROCHLORIC ACID:PERIODONTAL:GEL:NA	PERIODONTAL	PERIODONTAL GEL	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
QTT17582CB	HYDROCHLORIC ACID:RECTAL:LIQUID:ADJ PH	RECTAL	ADJ PH RECTAL LIQUID	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
QTT17582CB	HYDROCHLORIC ACID:RECTAL:SOLUTION:ADJ PH	RECTAL	ADJ PH RECTAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
QTT17582CB	HYDROCHLORIC ACID:RESPIRATORY (INHALATION):SOLUTION:ADJ PH	RESPIRATORY (INHALATION)	ADJ PH RESPIRATORY (INHALATION) SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
QTT17582CB	HYDROCHLORIC ACID:RESPIRATORY (INHALATION):SOLUTION, FOR INHALATION:ADJ PH	RESPIRATORY (INHALATION)	ADJ PH RESPIRATORY (INHALATION) SOLUTION, FOR INHALATION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
QTT17582CB	HYDROCHLORIC ACID:RESPIRATORY (INHALATION):SPRAY:NA	RESPIRATORY (INHALATION)	RESPIRATORY (INHALATION) SPRAY	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
QTT17582CB	HYDROCHLORIC ACID:RETROBULBAR:INJECTION:ADJ PH	RETROBULBAR	ADJ PH RETROBULBAR INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
QTT17582CB	HYDROCHLORIC ACID:SOFT TISSUE:INJECTABLE:ADJ PH	SOFT TISSUE	ADJ PH SOFT TISSUE INJECTABLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
QTT17582CB	HYDROCHLORIC ACID:SOFT TISSUE:INJECTION:ADJ PH	SOFT TISSUE	ADJ PH SOFT TISSUE INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
QTT17582CB	HYDROCHLORIC ACID:SOFT TISSUE:INJECTION, SUSTAINED ACTION:ADJ PH	SOFT TISSUE	ADJ PH SOFT TISSUE INJECTION, SUSTAINED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
QTT17582CB	HYDROCHLORIC ACID:SOFT TISSUE:SUSPENSION, INJECTION:ADJ PH	SOFT TISSUE	ADJ PH SOFT TISSUE SUSPENSION, INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
QTT17582CB	HYDROCHLORIC ACID:SPINAL:INJECTABLE:ADJ PH	SPINAL	ADJ PH SPINAL INJECTABLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
QTT17582CB	HYDROCHLORIC ACID:SPINAL:INJECTION:ADJ PH	SPINAL	ADJ PH SPINAL INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
QTT17582CB	HYDROCHLORIC ACID:SUBARACHNOID:SOLUTION, INJECTION:ADJ PH	SUBARACHNOID	ADJ PH SUBARACHNOID SOLUTION, INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
QTT17582CB	HYDROCHLORIC ACID:SUBCONJUNCTIVAL:INJECTION:ADJ PH	SUBCONJUNCTIVAL	ADJ PH SUBCONJUNCTIVAL INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
QTT17582CB	HYDROCHLORIC ACID:SUBCUTANEOUS:INJECTABLE:ADJ PH	SUBCUTANEOUS	ADJ PH SUBCUTANEOUS INJECTABLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
QTT17582CB	HYDROCHLORIC ACID:SUBCUTANEOUS:INJECTION:%	SUBCUTANEOUS	0.17% SUBCUTANEOUS INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
QTT17582CB	HYDROCHLORIC ACID:SUBCUTANEOUS:INJECTION:ADJ PH	SUBCUTANEOUS	ADJ PH SUBCUTANEOUS INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
QTT17582CB	HYDROCHLORIC ACID:SUBCUTANEOUS:INJECTION, SOLUTION:ADJ PH	SUBCUTANEOUS	ADJ PH SUBCUTANEOUS INJECTION, SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
QTT17582CB	HYDROCHLORIC ACID:SUBCUTANEOUS:POWDER, FOR INJECTION SOLUTION:ADJ PH	SUBCUTANEOUS	ADJ PH SUBCUTANEOUS POWDER, FOR INJECTION SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
QTT17582CB	HYDROCHLORIC ACID:SUBCUTANEOUS:POWDER, FOR INJECTION SOLUTION, LYOPHILIZED:NA	SUBCUTANEOUS	SUBCUTANEOUS POWDER, FOR INJECTION SOLUTION, LYOPHILIZED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
QTT17582CB	HYDROCHLORIC ACID:SUBCUTANEOUS:SOLUTION:ADJ PH	SUBCUTANEOUS	ADJ PH SUBCUTANEOUS SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
QTT17582CB	HYDROCHLORIC ACID:SUBCUTANEOUS:SOLUTION, INJECTION:%	SUBCUTANEOUS	0.61% SUBCUTANEOUS SOLUTION, INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
QTT17582CB	HYDROCHLORIC ACID:SUBCUTANEOUS:SUSPENSION:ADJ PH	SUBCUTANEOUS	ADJ PH SUBCUTANEOUS SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
QTT17582CB	HYDROCHLORIC ACID:SUBCUTANEOUS:SUSPENSION, INJECTION:%	SUBCUTANEOUS	0.073% SUBCUTANEOUS SUSPENSION, INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
QTT17582CB	HYDROCHLORIC ACID:SUBMUCOSAL:INJECTION:ADJ PH	SUBMUCOSAL	ADJ PH SUBMUCOSAL INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
QTT17582CB	HYDROCHLORIC ACID:SUBMUCOSAL:SOLUTION, INJECTION:ADJ PH	SUBMUCOSAL	ADJ PH SUBMUCOSAL SOLUTION, INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
QTT17582CB	HYDROCHLORIC ACID:TOPICAL:CREAM:%W/W	TOPICAL	0.033%W/W TOPICAL CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
QTT17582CB	HYDROCHLORIC ACID:TOPICAL:EMULSION:NA	TOPICAL	TOPICAL EMULSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
QTT17582CB	HYDROCHLORIC ACID:TOPICAL:EMULSION, AEROSOL FOAM:NA	TOPICAL	TOPICAL EMULSION, AEROSOL FOAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
QTT17582CB	HYDROCHLORIC ACID:TOPICAL:EMULSION, CREAM:%W/W	TOPICAL	0.01%W/W TOPICAL EMULSION, CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
QTT17582CB	HYDROCHLORIC ACID:TOPICAL:GEL:%W/W	TOPICAL	0.5%W/W TOPICAL GEL	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
QTT17582CB	HYDROCHLORIC ACID:TOPICAL:JELLY:NA	TOPICAL	TOPICAL JELLY	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
QTT17582CB	HYDROCHLORIC ACID:TOPICAL:LOTION:NA	TOPICAL	TOPICAL LOTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
QTT17582CB	HYDROCHLORIC ACID:TOPICAL:OINTMENT:NA	TOPICAL	TOPICAL OINTMENT	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
QTT17582CB	HYDROCHLORIC ACID:TOPICAL:SHAMPOO:%W/W	TOPICAL	4%W/W TOPICAL SHAMPOO	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
QTT17582CB	HYDROCHLORIC ACID:TOPICAL:SOLUTION:%W/V	TOPICAL	0.31%W/V TOPICAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
QTT17582CB	HYDROCHLORIC ACID:TOPICAL:SOLUTION, DROPS:ADJ PH	TOPICAL	ADJ PH TOPICAL SOLUTION, DROPS	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
QTT17582CB	HYDROCHLORIC ACID:TOPICAL:SOLUTION/DROPS:NA	TOPICAL	TOPICAL SOLUTION/DROPS	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
QTT17582CB	HYDROCHLORIC ACID:TOPICAL:SPONGE:NA	TOPICAL	TOPICAL SPONGE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
QTT17582CB	HYDROCHLORIC ACID:TOPICAL:SUSPENSION:NA	TOPICAL	TOPICAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
QTT17582CB	HYDROCHLORIC ACID:TRANSDERMAL:GEL:%	TRANSDERMAL	0.024% TRANSDERMAL GEL	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
QTT17582CB	HYDROCHLORIC ACID:URETERAL:SOLUTION:ADJ PH	URETERAL	ADJ PH URETERAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
QTT17582CB	HYDROCHLORIC ACID:URETHRAL:INJECTION:ADJ PH	URETHRAL	ADJ PH URETHRAL INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
QTT17582CB	HYDROCHLORIC ACID:URETHRAL:SOLUTION:ADJ PH	URETHRAL	ADJ PH URETHRAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
D0Y70F2B9J	SODIUM LAURYL SULFOACETATE:TOPICAL:SHAMPOO:%W/W	TOPICAL	3%W/W TOPICAL SHAMPOO	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
6FO62KCQ7A	DISODIUM HYDROGEN CITRATE:INTRAVENOUS:INJECTION:%	INTRAVENOUS	0.094% INTRAVENOUS INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
452VLY9402	SERINE:IV(INFUSION):INJECTION:%	IV(INFUSION)	0.5% IV(INFUSION) INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
452VLY9402	SERINE:IV(INFUSION):SOLUTION, INJECTION:%	IV(INFUSION)	0.18% IV(INFUSION) SOLUTION, INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
W81N5U6R6U	MONOSODIUM GLUTAMATE:ORAL:SUSPENSION:NA	ORAL	ORAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
2S42T2808B	D&C RED NO. 30:ORAL:CAPSULE:MG	ORAL	0.1MG ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
2S42T2808B	D&C RED NO. 30:ORAL:SUSPENSION, EXTENDED RELEASE:MG/5ML	ORAL	1.8MG/5ML ORAL SUSPENSION, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
2S42T2808B	D&C RED NO. 30:ORAL:TABLET:MG	ORAL	2.21MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
2S42T2808B	D&C RED NO. 30:ORAL:TABLET (IMMED./COMP. RELEASE), UNCOATED, CHEWABLE:MG	ORAL	1.46MG ORAL TABLET (IMMED./COMP. RELEASE), UNCOATED, CHEWABLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
2S42T2808B	D&C RED NO. 30:ORAL:TABLET, CHEWABLE:MG	ORAL	0.7MG ORAL TABLET, CHEWABLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
2S42T2808B	D&C RED NO. 30:ORAL:TABLET, COATED:MG	ORAL	1.16MG ORAL TABLET, COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
2S42T2808B	D&C RED NO. 30:ORAL:TABLET, DELAYED ACTION:NA	ORAL	ORAL TABLET, DELAYED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
2S42T2808B	D&C RED NO. 30:ORAL:TABLET, EXTENDED RELEASE:MG	ORAL	0.1MG ORAL TABLET, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
2S42T2808B	D&C RED NO. 30:ORAL:TABLET, FILM COATED:MG	ORAL	290MG ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
461P5CJN6T	MODIFIED CORN STARCH (1-OCTENYL SUCCINIC ANHYDRIDE):ORAL:CAPSULE:MG	ORAL	53.3MG ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
461P5CJN6T	MODIFIED CORN STARCH (1-OCTENYL SUCCINIC ANHYDRIDE):ORAL:SUSPENSION:MG/5ML	ORAL	115MG/5ML ORAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
461P5CJN6T	MODIFIED CORN STARCH (1-OCTENYL SUCCINIC ANHYDRIDE):ORAL:TABLET, ORALLY DISINTEGRATING:MG	ORAL	0.039MG ORAL TABLET, ORALLY DISINTEGRATING	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
O352864B8Z	SODIUM PYROPHOSPHATE:INTRAVENOUS:INJECTION:%	INTRAVENOUS	1.2% INTRAVENOUS INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
O352864B8Z	SODIUM PYROPHOSPHATE:INTRAVENOUS:POWDER, FOR INJECTION SOLUTION:NA	INTRAVENOUS	INTRAVENOUS POWDER, FOR INJECTION SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
N72LMW566G	LAURETH-23:TOPICAL:AEROSOL:%W/W	TOPICAL	0.45%W/W TOPICAL AEROSOL	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
N72LMW566G	LAURETH-23:TOPICAL:EMULSION:%W/W	TOPICAL	0.45%W/W TOPICAL EMULSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
N72LMW566G	LAURETH-23:TOPICAL:EMULSION, AEROSOL FOAM:%W/W	TOPICAL	1.08%W/W TOPICAL EMULSION, AEROSOL FOAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
N72LMW566G	LAURETH-23:TOPICAL:EMULSION, CREAM:NA	TOPICAL	TOPICAL EMULSION, CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
N72LMW566G	LAURETH-23:TOPICAL:LOTION:NA	TOPICAL	TOPICAL LOTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
884C3FA9HE	LANOLIN ALCOHOLS:OPHTHALMIC:OINTMENT:%	OPHTHALMIC	10% OPHTHALMIC OINTMENT	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
884C3FA9HE	LANOLIN ALCOHOLS:TOPICAL:CREAM:%W/W	TOPICAL	6%W/W TOPICAL CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
884C3FA9HE	LANOLIN ALCOHOLS:TOPICAL:CREAM, AUGMENTED:%W/W	TOPICAL	8%W/W TOPICAL CREAM, AUGMENTED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
884C3FA9HE	LANOLIN ALCOHOLS:TOPICAL:CREAM, EMULSION, SUSTAINED RELEASE:%W/W	TOPICAL	3%W/W TOPICAL CREAM, EMULSION, SUSTAINED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
884C3FA9HE	LANOLIN ALCOHOLS:TOPICAL:EMULSION, CREAM:%W/W	TOPICAL	6%W/W TOPICAL EMULSION, CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
884C3FA9HE	LANOLIN ALCOHOLS:TOPICAL:GEL:NA	TOPICAL	TOPICAL GEL	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
884C3FA9HE	LANOLIN ALCOHOLS:TOPICAL:OINTMENT:NA	TOPICAL	TOPICAL OINTMENT	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
83D19O7250	DIMETHICONOL/TRIMETHYLSILOXYSILICATE CROSSPOLYMER (40/60 W/W; 1000000 PA.S):ORAL:TABLET, SUSTAINED ACTION:MG	ORAL	1.14MG ORAL TABLET, SUSTAINED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
83D19O7250	DIMETHICONOL/TRIMETHYLSILOXYSILICATE CROSSPOLYMER (40/60 W/W; 1000000 PA.S):TRANSDERMAL:FILM:MG	TRANSDERMAL	70.6MG TRANSDERMAL FILM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
83D19O7250	DIMETHICONOL/TRIMETHYLSILOXYSILICATE CROSSPOLYMER (40/60 W/W; 1000000 PA.S):TRANSDERMAL:FILM, CONTROLLED RELEASE:MG/PATCH	TRANSDERMAL	164MG/PATCH TRANSDERMAL FILM, CONTROLLED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
83D19O7250	DIMETHICONOL/TRIMETHYLSILOXYSILICATE CROSSPOLYMER (40/60 W/W; 1000000 PA.S):TRANSDERMAL:FILM, CONTROLLED RELEASE:MG	TRANSDERMAL	57.14MG TRANSDERMAL FILM, CONTROLLED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
83D19O7250	DIMETHICONOL/TRIMETHYLSILOXYSILICATE CROSSPOLYMER (40/60 W/W; 1000000 PA.S):TRANSDERMAL:PATCH:mg	TRANSDERMAL	61.3mg TRANSDERMAL PATCH	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
83D19O7250	SILICONE ADHESIVE 4502:TRANSDERMAL:PATCH:MG	TRANSDERMAL	47.312MG TRANSDERMAL PATCH	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
77K6Z421KU	SORBITAN MONOPALMITATE:INTRAMUSCULAR:INJECTION:NA	INTRAMUSCULAR	INTRAMUSCULAR INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
77K6Z421KU	SORBITAN MONOPALMITATE:ORAL:EMULSION:NA	ORAL	ORAL EMULSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
77K6Z421KU	SORBITAN MONOPALMITATE:TOPICAL:EMULSION, CREAM:%W/W	TOPICAL	2%W/W TOPICAL EMULSION, CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
77K6Z421KU	SORBITAN MONOPALMITATE:TOPICAL:LOTION:%W/W	TOPICAL	1.53%W/W TOPICAL LOTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
77K6Z421KU	SORBITAN MONOPALMITATE:TOPICAL:PATCH:NA	TOPICAL	TOPICAL PATCH	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
Z78RG6M2N2	HYPROMELLOSE 2208 (15000 MPA.S):ORAL:CAPSULE:MG	ORAL	80.25MG ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
Z78RG6M2N2	HYPROMELLOSE 2208 (15000 MPA.S):ORAL:CAPSULE, DELAYED ACTION:MG	ORAL	221.5MG ORAL CAPSULE, DELAYED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
Z78RG6M2N2	HYPROMELLOSE 2208 (15000 MPA.S):ORAL:CAPSULE, SUSTAINED ACTION:MG	ORAL	336MG ORAL CAPSULE, SUSTAINED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
Z78RG6M2N2	HYPROMELLOSE 2208 (15000 MPA.S):ORAL:CAPSULE, SUSTAINED ACTION, HARD GELATIN:MG	ORAL	2.77MG ORAL CAPSULE, SUSTAINED ACTION, HARD GELATIN	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
Z78RG6M2N2	HYPROMELLOSE 2208 (15000 MPA.S):ORAL:TABLET:MG	ORAL	300MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
Z78RG6M2N2	HYPROMELLOSE 2208 (15000 MPA.S):ORAL:TABLET, COATED:MG	ORAL	33MG ORAL TABLET, COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
Z78RG6M2N2	HYPROMELLOSE 2208 (15000 MPA.S):ORAL:TABLET, CONTROLLED RELEASE:MG	ORAL	7.8MG ORAL TABLET, CONTROLLED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
Z78RG6M2N2	HYPROMELLOSE 2208 (15000 MPA.S):ORAL:TABLET, EXTENDED RELEASE:MG	ORAL	456MG ORAL TABLET, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
Z78RG6M2N2	HYPROMELLOSE 2208 (15000 MPA.S):ORAL:TABLET, SUSTAINED ACTION:MG	ORAL	480MG ORAL TABLET, SUSTAINED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
Z78RG6M2N2	HYPROMELLOSE 2208 (15000 MPA.S):ORAL:TABLET, SUSTAINED ACTION, COATED:MG	ORAL	94MG ORAL TABLET, SUSTAINED ACTION, COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
Z78RG6M2N2	HYPROMELLOSE 2208 (15000 MPA.S):ORAL:TABLET, SUSTAINED ACTION, FILM COATED:MG	ORAL	200MG ORAL TABLET, SUSTAINED ACTION, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
GF3CGH8D7Z	CRESOL:SUBCUTANEOUS:INJECTION:NA	SUBCUTANEOUS	SUBCUTANEOUS INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
HM4YQM8WRC	CHLOROBUTANOL:AN,INFILTRATION:INJECTION:%	AN,INFILTRATION	0.4% AN,INFILTRATION INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
HM4YQM8WRC	CHLOROBUTANOL:AURICULAR (OTIC):DROPS:NA	AURICULAR (OTIC)	AURICULAR (OTIC) DROPS	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
HM4YQM8WRC	CHLOROBUTANOL:AURICULAR (OTIC):SOLUTION:NA	AURICULAR (OTIC)	AURICULAR (OTIC) SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
HM4YQM8WRC	CHLOROBUTANOL:IM - IV:INJECTION:%	IM - IV	0.5% IM - IV INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
HM4YQM8WRC	CHLOROBUTANOL:IM - IV - SC:INJECTION:%	IM - IV - SC	0.5% IM - IV - SC INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
HM4YQM8WRC	CHLOROBUTANOL:IM - SC:INJECTION:%	IM - SC	0.5% IM - SC INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
HM4YQM8WRC	CHLOROBUTANOL:INHALATION:INHALANT:NA	INHALATION	INHALATION INHALANT	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
HM4YQM8WRC	CHLOROBUTANOL:INHALATION:SOLUTION:%	INHALATION	0.5% INHALATION SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
HM4YQM8WRC	CHLOROBUTANOL:INJECTION:INJECTABLE:mg/1mL	INJECTION	5mg/1mL INJECTION INJECTABLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
HM4YQM8WRC	CHLOROBUTANOL:INTRAMUSCULAR:INJECTABLE:%W/V	INTRAMUSCULAR	0.53%W/V INTRAMUSCULAR INJECTABLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
HM4YQM8WRC	CHLOROBUTANOL:INTRAMUSCULAR:INJECTION:%	INTRAMUSCULAR	0.53% INTRAMUSCULAR INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
HM4YQM8WRC	CHLOROBUTANOL:INTRAMUSCULAR:INJECTION, SUSTAINED ACTION:%	INTRAMUSCULAR	0.5% INTRAMUSCULAR INJECTION, SUSTAINED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
HM4YQM8WRC	CHLOROBUTANOL:INTRAVENOUS:SOLUTION, INJECTION:NA	INTRAVENOUS	INTRAVENOUS SOLUTION, INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
HM4YQM8WRC	CHLOROBUTANOL:IV(INFUSION):INJECTABLE:mg/1mL	IV(INFUSION)	5mg/1mL IV(INFUSION) INJECTABLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
HM4YQM8WRC	CHLOROBUTANOL:IV(INFUSION):INJECTION:%	IV(INFUSION)	1% IV(INFUSION) INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
HM4YQM8WRC	CHLOROBUTANOL:NASAL:SOLUTION:%	NASAL	0.53% NASAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
HM4YQM8WRC	CHLOROBUTANOL:NASAL:SPRAY:%	NASAL	0.023% NASAL SPRAY	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
HM4YQM8WRC	CHLOROBUTANOL:NASAL:SPRAY, METERED:%	NASAL	0.5% NASAL SPRAY, METERED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
HM4YQM8WRC	CHLOROBUTANOL:NERVE BLOCK:INJECTION:%	NERVE BLOCK	0.5% NERVE BLOCK INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
HM4YQM8WRC	CHLOROBUTANOL:OPHTHALMIC:DROPS:%	OPHTHALMIC	0.5% OPHTHALMIC DROPS	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
HM4YQM8WRC	CHLOROBUTANOL:OPHTHALMIC:OINTMENT:%	OPHTHALMIC	0.65% OPHTHALMIC OINTMENT	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
HM4YQM8WRC	CHLOROBUTANOL:OPHTHALMIC:POWDER, FOR SOLUTION:%	OPHTHALMIC	0.55% OPHTHALMIC POWDER, FOR SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
HM4YQM8WRC	CHLOROBUTANOL:OPHTHALMIC:SOLUTION:%	OPHTHALMIC	0.5% OPHTHALMIC SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
HM4YQM8WRC	CHLOROBUTANOL:PARENTERAL:INJECTION:%	PARENTERAL	0.5% PARENTERAL INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
HM4YQM8WRC	CHLOROBUTANOL:SUBCUTANEOUS:INJECTION:MG/1ML	SUBCUTANEOUS	5MG/1ML SUBCUTANEOUS INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
HM4YQM8WRC	CHLOROBUTANOL:TOPICAL:SOLUTION:MG/1ML	TOPICAL	11MG/1ML TOPICAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
F9S9FFU82N	LACTIC ACID, L-:INTRAVENOUS:INJECTABLE:%	INTRAVENOUS	0.4% INTRAVENOUS INJECTABLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
F9S9FFU82N	LACTIC ACID, L-:INTRAVENOUS:INJECTION:%	INTRAVENOUS	0.3% INTRAVENOUS INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
F9S9FFU82N	LACTIC ACID, L-:ORAL:CAPSULE:MG	ORAL	44MG ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
F9S9FFU82N	LACTIC ACID, L-:SUBCUTANEOUS:INJECTION:%	SUBCUTANEOUS	0.3% SUBCUTANEOUS INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
Q1LS2UJO3A	CERESIN:TOPICAL:OINTMENT:NA	TOPICAL	TOPICAL OINTMENT	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
Q1LS2UJO3A	CERESIN:VAGINAL:CREAM:%W/W	VAGINAL	7%W/W VAGINAL CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
Q1LS2UJO3A	CERESIN:VAGINAL:EMULSION, CREAM:%	VAGINAL	7% VAGINAL EMULSION, CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
1NKX3648J9	DICHLOROBENZYL ALCOHOL:TOPICAL:CREAM, EMULSION, SUSTAINED RELEASE:%W/W	TOPICAL	0.1%W/W TOPICAL CREAM, EMULSION, SUSTAINED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
1NKX3648J9	DICHLOROBENZYL ALCOHOL:TOPICAL:EMULSION, CREAM:NA	TOPICAL	TOPICAL EMULSION, CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
6I475159RA	ETHYLCELLULOSE (50 MPA.S):ORAL:CAPSULE, EXTENDED RELEASE:MG	ORAL	32.66MG ORAL CAPSULE, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
6I475159RA	ETHYLCELLULOSE (50 MPA.S):ORAL:TABLET, EXTENDED RELEASE:MG	ORAL	78.9MG ORAL TABLET, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
WIL1404U79	GELATIN TYPE B BOVINE (230 BLOOM):ORAL:CAPSULE:mg	ORAL	222.6mg ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
TQ77WR8A02	POLYISOBUTYLENE (55000 MW):TRANSDERMAL:FILM:MG	TRANSDERMAL	238.44MG TRANSDERMAL FILM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
TQ77WR8A02	POLYISOBUTYLENE (55000 MW):TRANSDERMAL:PATCH:MG	TRANSDERMAL	28.32MG TRANSDERMAL PATCH	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
7SEV7J4R1U	TALC:BUCCAL:GUM, CHEWING:NA	BUCCAL	BUCCAL GUM, CHEWING	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
7SEV7J4R1U	TALC:BUCCAL:TABLET:MG	BUCCAL	1.5MG BUCCAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
7SEV7J4R1U	TALC:BUCCAL/SUBLINGUAL:TABLET:MG	BUCCAL/SUBLINGUAL	15MG BUCCAL/SUBLINGUAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
7SEV7J4R1U	TALC:ORAL:CAPSULE:MG	ORAL	284.38MG ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
7SEV7J4R1U	TALC:ORAL:CAPSULE (IMMED./COMP. RELEASE):MG	ORAL	0.44MG ORAL CAPSULE (IMMED./COMP. RELEASE)	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
7SEV7J4R1U	TALC:ORAL:CAPSULE, COATED:MG	ORAL	28.45MG ORAL CAPSULE, COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
7SEV7J4R1U	TALC:ORAL:CAPSULE, COATED PELLETS:MG	ORAL	0.66MG ORAL CAPSULE, COATED PELLETS	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
7SEV7J4R1U	TALC:ORAL:CAPSULE, COATED, HARD GELATIN:MG	ORAL	10MG ORAL CAPSULE, COATED, HARD GELATIN	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
7SEV7J4R1U	TALC:ORAL:CAPSULE, COATED, SOFT GELATIN:NA	ORAL	ORAL CAPSULE, COATED, SOFT GELATIN	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
7SEV7J4R1U	TALC:ORAL:CAPSULE, DELAYED ACTION:MG	ORAL	130.13MG ORAL CAPSULE, DELAYED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
7SEV7J4R1U	TALC:ORAL:CAPSULE, DELAYED ACTION, COATED:mg	ORAL	16.94mg ORAL CAPSULE, DELAYED ACTION, COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
7SEV7J4R1U	TALC:ORAL:CAPSULE, DELAYED ACTION, COATED, HARD GELATIN:MG	ORAL	14.93MG ORAL CAPSULE, DELAYED ACTION, COATED, HARD GELATIN	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
7SEV7J4R1U	TALC:ORAL:CAPSULE, DELAYED RELEASE:MG	ORAL	46.63MG ORAL CAPSULE, DELAYED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
7SEV7J4R1U	TALC:ORAL:CAPSULE, ENTERIC COATED PELLETS:MG	ORAL	28.9MG ORAL CAPSULE, ENTERIC COATED PELLETS	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
7SEV7J4R1U	TALC:ORAL:CAPSULE, EXTENDED RELEASE:MG	ORAL	157.6MG ORAL CAPSULE, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
7SEV7J4R1U	TALC:ORAL:CAPSULE, FILM COATED, EXTENDED RELEASE:MG	ORAL	6.824MG ORAL CAPSULE, FILM COATED, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
7SEV7J4R1U	TALC:ORAL:CAPSULE, HARD GELATIN:MG	ORAL	139.17MG ORAL CAPSULE, HARD GELATIN	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
7SEV7J4R1U	TALC:ORAL:CAPSULE, SOFT GELATIN:MG	ORAL	0.1MG ORAL CAPSULE, SOFT GELATIN	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
7SEV7J4R1U	TALC:ORAL:CAPSULE, SUSTAINED ACTION:MG	ORAL	122.06MG ORAL CAPSULE, SUSTAINED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
7SEV7J4R1U	TALC:ORAL:CAPSULE, SUSTAINED ACTION, HARD GELATIN:MG	ORAL	16.7MG ORAL CAPSULE, SUSTAINED ACTION, HARD GELATIN	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
7SEV7J4R1U	TALC:ORAL:DISPERSIBLE TABLET:MG	ORAL	2MG ORAL DISPERSIBLE TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
7SEV7J4R1U	TALC:ORAL:DROPS:NA	ORAL	ORAL DROPS	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
7SEV7J4R1U	TALC:ORAL:GRANULE:MG/1PKT	ORAL	321.77MG/1PKT ORAL GRANULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
7SEV7J4R1U	TALC:ORAL:GRANULE, ENTERIC COATED:MG	ORAL	215.2MG ORAL GRANULE, ENTERIC COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
7SEV7J4R1U	TALC:ORAL:GRANULE, FOR ORAL SUSPENSION:MG	ORAL	34MG ORAL GRANULE, FOR ORAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
7SEV7J4R1U	TALC:ORAL:PELLET:MG	ORAL	34MG ORAL PELLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
7SEV7J4R1U	TALC:ORAL:POWDER, FOR ORAL SUSPENSION:MG/5ML	ORAL	10MG/5ML ORAL POWDER, FOR ORAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
7SEV7J4R1U	TALC:ORAL:POWDER, FOR SUSPENSION:MG/5ML	ORAL	30MG/5ML ORAL POWDER, FOR SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
7SEV7J4R1U	TALC:ORAL:SOLUTION:NA	ORAL	ORAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
7SEV7J4R1U	TALC:ORAL:SOLUTION, ELIXIR:MG/5ML	ORAL	4.5MG/5ML ORAL SOLUTION, ELIXIR	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
7SEV7J4R1U	TALC:ORAL:SUSPENSION:MG/5ML	ORAL	12.75MG/5ML ORAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
7SEV7J4R1U	TALC:ORAL:SUSPENSION, EXTENDED RELEASE:MG/ML	ORAL	3.83MG/ML ORAL SUSPENSION, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
7SEV7J4R1U	TALC:ORAL:SUSPENSION, SUSTAINED ACTION:MG/206.84 MG	ORAL	4.14MG/206.84 MG ORAL SUSPENSION, SUSTAINED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
7SEV7J4R1U	TALC:ORAL:SYRUP:NA	ORAL	ORAL SYRUP	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
7SEV7J4R1U	TALC:ORAL:TABLET:MG	ORAL	91.2MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
7SEV7J4R1U	TALC:ORAL:TABLET (IMMED./COMP. RELEASE), COATED:MG	ORAL	3MG ORAL TABLET (IMMED./COMP. RELEASE), COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
7SEV7J4R1U	TALC:ORAL:TABLET (IMMED./COMP. RELEASE), FILM COATED:MG	ORAL	22.8MG ORAL TABLET (IMMED./COMP. RELEASE), FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
7SEV7J4R1U	TALC:ORAL:TABLET (IMMED./COMP. RELEASE), UNCOATED, BUCCAL:MG	ORAL	1.6MG ORAL TABLET (IMMED./COMP. RELEASE), UNCOATED, BUCCAL	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
7SEV7J4R1U	TALC:ORAL:TABLET (IMMED./COMP. RELEASE), UNCOATED, CHEWABLE:MG	ORAL	18MG ORAL TABLET (IMMED./COMP. RELEASE), UNCOATED, CHEWABLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
7SEV7J4R1U	TALC:ORAL:TABLET, CHEWABLE:MG	ORAL	30MG ORAL TABLET, CHEWABLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
7SEV7J4R1U	TALC:ORAL:TABLET, COATED:MG	ORAL	320.75MG ORAL TABLET, COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
7SEV7J4R1U	TALC:ORAL:TABLET, CONTROLLED RELEASE:MG	ORAL	31.61MG ORAL TABLET, CONTROLLED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
7SEV7J4R1U	TALC:ORAL:TABLET, DELAYED ACTION:MG	ORAL	28.8MG ORAL TABLET, DELAYED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
7SEV7J4R1U	TALC:ORAL:TABLET, DELAYED ACTION, COATED:MG	ORAL	27.8MG ORAL TABLET, DELAYED ACTION, COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
7SEV7J4R1U	TALC:ORAL:TABLET, DELAYED ACTION, ENTERIC COATED:MG	ORAL	110MG ORAL TABLET, DELAYED ACTION, ENTERIC COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
7SEV7J4R1U	TALC:ORAL:TABLET, DELAYED RELEASE:MG	ORAL	26.68MG ORAL TABLET, DELAYED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
7SEV7J4R1U	TALC:ORAL:TABLET, DISPERSIBLE:MG	ORAL	2MG ORAL TABLET, DISPERSIBLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
7SEV7J4R1U	TALC:ORAL:TABLET, ENTERIC COATED PARTICLES:MG	ORAL	6.5MG ORAL TABLET, ENTERIC COATED PARTICLES	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
7SEV7J4R1U	TALC:ORAL:TABLET, EXTENDED RELEASE:MG	ORAL	102.8MG ORAL TABLET, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
7SEV7J4R1U	TALC:ORAL:TABLET, FILM COATED:MG	ORAL	54.72MG ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
7SEV7J4R1U	TALC:ORAL:TABLET, MULTILAYER, EXTENDED RELEASE:MG	ORAL	26MG ORAL TABLET, MULTILAYER, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
7SEV7J4R1U	TALC:ORAL:TABLET, ORALLY DISINTEGRATING:MG	ORAL	36MG ORAL TABLET, ORALLY DISINTEGRATING	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
7SEV7J4R1U	TALC:ORAL:TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE:MG	ORAL	59.5MG ORAL TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
7SEV7J4R1U	TALC:ORAL:TABLET, REPEAT ACTION:MG	ORAL	73.93MG ORAL TABLET, REPEAT ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
7SEV7J4R1U	TALC:ORAL:TABLET, SUSTAINED ACTION:MG	ORAL	91MG ORAL TABLET, SUSTAINED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
7SEV7J4R1U	TALC:ORAL:TABLET, SUSTAINED ACTION, COATED:MG	ORAL	29.3MG ORAL TABLET, SUSTAINED ACTION, COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
7SEV7J4R1U	TALC:ORAL:TABLET, SUSTAINED ACTION, FILM COATED:MG	ORAL	30MG ORAL TABLET, SUSTAINED ACTION, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
7SEV7J4R1U	TALC:RECTAL:TABLET:MG	RECTAL	32.4MG RECTAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
7SEV7J4R1U	TALC:SUBLINGUAL:TABLET:MG	SUBLINGUAL	32.4MG SUBLINGUAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
7SEV7J4R1U	TALC:TOPICAL:LOTION:NA	TOPICAL	TOPICAL LOTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
7SEV7J4R1U	TALC:TOPICAL:OINTMENT:%W/W	TOPICAL	8.27%W/W TOPICAL OINTMENT	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
7SEV7J4R1U	TALC:TOPICAL:POWDER:%W/W	TOPICAL	98%W/W TOPICAL POWDER	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
7SEV7J4R1U	TALC:TOPICAL:SHAMPOO:NA	TOPICAL	TOPICAL SHAMPOO	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
1RTM4PAL0V	PIPERAZINE:ORAL:TABLET:MG	ORAL	0.4MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
QP3MK8Z0XS	POLYVINYL ALCOHOL (108000 MW):ORAL:TABLET:mg	ORAL	4.8mg ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
QP3MK8Z0XS	POLYVINYL ALCOHOL (108000 MW):ORAL:TABLET, EXTENDED RELEASE:mg	ORAL	11.58mg ORAL TABLET, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
YRC528SWUY	POLYOXYL 20 CETOSTEARYL ETHER:TOPICAL:AEROSOL:%W/W	TOPICAL	5.5%W/W TOPICAL AEROSOL	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
YRC528SWUY	POLYOXYL 20 CETOSTEARYL ETHER:TOPICAL:AEROSOL, FOAM:%W/W	TOPICAL	0.26%W/W TOPICAL AEROSOL, FOAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
YRC528SWUY	POLYOXYL 20 CETOSTEARYL ETHER:TOPICAL:CREAM:%W/W	TOPICAL	3%W/W TOPICAL CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
YRC528SWUY	POLYOXYL 20 CETOSTEARYL ETHER:TOPICAL:CREAM, AUGMENTED:%W/W	TOPICAL	3%W/W TOPICAL CREAM, AUGMENTED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
YRC528SWUY	POLYOXYL 20 CETOSTEARYL ETHER:TOPICAL:CREAM, EMULSION, SUSTAINED RELEASE:%W/W	TOPICAL	6%W/W TOPICAL CREAM, EMULSION, SUSTAINED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
YRC528SWUY	POLYOXYL 20 CETOSTEARYL ETHER:TOPICAL:EMULSION, AEROSOL FOAM:%W/W	TOPICAL	4.74%W/W TOPICAL EMULSION, AEROSOL FOAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
YRC528SWUY	POLYOXYL 20 CETOSTEARYL ETHER:TOPICAL:EMULSION, CREAM:%W/W	TOPICAL	2%W/W TOPICAL EMULSION, CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
YRC528SWUY	POLYOXYL 20 CETOSTEARYL ETHER:TOPICAL:GEL:%W/W	TOPICAL	2%W/W TOPICAL GEL	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
YRC528SWUY	POLYOXYL 20 CETOSTEARYL ETHER:TOPICAL:LOTION:%W/W	TOPICAL	1%W/W TOPICAL LOTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
YRC528SWUY	POLYOXYL 20 CETOSTEARYL ETHER:TOPICAL:OINTMENT:NA	TOPICAL	TOPICAL OINTMENT	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
YRC528SWUY	POLYOXYL 20 CETOSTEARYL ETHER:TOPICAL:SPRAY:%W/W	TOPICAL	2.42%W/W TOPICAL SPRAY	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
Multiple	ALCOHOL, DENATURED:DENTAL:GEL:%W/W	DENTAL	1.8%W/W DENTAL GEL	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
Multiple	ALCOHOL, DENATURED:INTRAMUSCULAR:INJECTION:	INTRAMUSCULAR	INTRAMUSCULAR INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
Multiple	ALCOHOL, DENATURED:TOPICAL:AEROSOL:%W/W	TOPICAL	68%W/W TOPICAL AEROSOL	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
Multiple	ALCOHOL, DENATURED:TOPICAL:GEL:%W/W	TOPICAL	96.94%W/W TOPICAL GEL	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
Multiple	ALCOHOL, DENATURED:TOPICAL:LOTION:%W/W	TOPICAL	25%W/W TOPICAL LOTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
Multiple	ALCOHOL, DENATURED:TOPICAL:SOLUTION:%W/W	TOPICAL	60.16%W/W TOPICAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
Multiple	ALCOHOL, DENATURED:TOPICAL:SWAB:NA	TOPICAL	TOPICAL SWAB	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
Multiple	CALCIUM ALGINATE AND AMMONIUM ALGINATE:ORAL:TABLET:MG	ORAL	20MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
Multiple	CELLULOSE MICROCRYSTALLINE/CARBOXYMETHYLCELLULOSE SODIUM:NASAL:SPRAY:%	NASAL	2% NASAL SPRAY	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
Multiple	CELLULOSE MICROCRYSTALLINE/CARBOXYMETHYLCELLULOSE SODIUM:NASAL:SPRAY, METERED:MCG/SPRAY	NASAL	2740MCG/SPRAY NASAL SPRAY, METERED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
Multiple	CELLULOSE MICROCRYSTALLINE/CARBOXYMETHYLCELLULOSE SODIUM:NASAL:SUSPENSION:NA	NASAL	NASAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
Multiple	CELLULOSE MICROCRYSTALLINE/CARBOXYMETHYLCELLULOSE SODIUM:ORAL:CAPSULE, EXTENDED RELEASE:MG	ORAL	72MG ORAL CAPSULE, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
Multiple	CELLULOSE MICROCRYSTALLINE/CARBOXYMETHYLCELLULOSE SODIUM:ORAL:GRANULE, FOR ORAL SUSPENSION:MG	ORAL	93.3MG ORAL GRANULE, FOR ORAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
Multiple	CELLULOSE MICROCRYSTALLINE/CARBOXYMETHYLCELLULOSE SODIUM:ORAL:GRANULE, FOR SUSPENSION:MG	ORAL	50MG ORAL GRANULE, FOR SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
Multiple	CELLULOSE MICROCRYSTALLINE/CARBOXYMETHYLCELLULOSE SODIUM:ORAL:POWDER, FOR ORAL SUSPENSION:MG/5ML	ORAL	125MG/5ML ORAL POWDER, FOR ORAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
Multiple	CELLULOSE MICROCRYSTALLINE/CARBOXYMETHYLCELLULOSE SODIUM:ORAL:POWDER, FOR SUSPENSION:MG/5ML	ORAL	113MG/5ML ORAL POWDER, FOR SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
Multiple	CELLULOSE MICROCRYSTALLINE/CARBOXYMETHYLCELLULOSE SODIUM:ORAL:SUSPENSION:MG/5ML	ORAL	150MG/5ML ORAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
Multiple	CELLULOSE MICROCRYSTALLINE/CARBOXYMETHYLCELLULOSE SODIUM:ORAL:SUSPENSION, DROPS:MG/1ML	ORAL	13.1MG/1ML ORAL SUSPENSION, DROPS	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
Multiple	CELLULOSE MICROCRYSTALLINE/CARBOXYMETHYLCELLULOSE SODIUM:ORAL:SUSPENSION, LIQUID:MG/5ML	ORAL	150MG/5ML ORAL SUSPENSION, LIQUID	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
Multiple	CELLULOSE MICROCRYSTALLINE/CARBOXYMETHYLCELLULOSE SODIUM:ORAL:SUSPENSION, SYRUP, SUSTAINED ACTION:%	ORAL	0.15% ORAL SUSPENSION, SYRUP, SUSTAINED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
Multiple	CELLULOSE MICROCRYSTALLINE/CARBOXYMETHYLCELLULOSE SODIUM:ORAL:TABLET:MG	ORAL	200MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
Multiple	CETEARYL ALCOHOL/CETEARETH-20:TOPICAL:CREAM:%W/W	TOPICAL	2%W/W TOPICAL CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
Multiple	CETEARYL ALCOHOL/CETEARETH-20:TOPICAL:CREAM, AUGMENTED:%W/W	TOPICAL	4.72%W/W TOPICAL CREAM, AUGMENTED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
Multiple	CETEARYL ALCOHOL/CETEARETH-20:TOPICAL:EMULSION, CREAM:%W/W	TOPICAL	8%W/W TOPICAL EMULSION, CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
Multiple	COCONUT OIL/PALM KERNEL OIL GLYCERIDES, HYDROGENATED:RECTAL:SUPPOSITORY:MG	RECTAL	1734.9MG RECTAL SUPPOSITORY	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
Multiple	COCONUT OIL/PALM KERNEL OIL GLYCERIDES, HYDROGENATED:VAGINAL:INSERT:MG	VAGINAL	1228.5MG VAGINAL INSERT	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
Multiple	COCONUT OIL/PALM KERNEL OIL GLYCERIDES, HYDROGENATED:VAGINAL:SUPPOSITORY:MG	VAGINAL	2375MG VAGINAL SUPPOSITORY	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
Multiple	COCONUT OIL/PALM KERNEL OIL GLYCERIDES, HYDROGENATED:VAGINAL:TAMPON:NA	VAGINAL	VAGINAL TAMPON	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
Multiple	D&C BLUE NO. 1--ALUMINUM LAKE:ORAL:TABLET:MG	ORAL	3.6MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
Multiple	D&C BLUE NO. 1--ALUMINUM LAKE:ORAL:TABLET, COATED:NA	ORAL	ORAL TABLET, COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
Multiple	D&C RED NO. 21--ALUMINUM LAKE:ORAL:CAPSULE:NA	ORAL	ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
Multiple	D&C RED NO. 21--ALUMINUM LAKE:ORAL:TABLET (IMMED./COMP. RELEASE), UNCOATED, CHEWABLE:NA	ORAL	ORAL TABLET (IMMED./COMP. RELEASE), UNCOATED, CHEWABLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
Multiple	D&C RED NO. 28--ALUMINUM LAKE:ORAL:CAPSULE:NA	ORAL	ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
Multiple	D&C YELLOW NO. 10-ALUMINUM LAKE:ORAL:CAPSULE, EXTENDED RELEASE:MG	ORAL	1.24MG ORAL CAPSULE, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
Multiple	D&C YELLOW NO. 10-ALUMINUM LAKE:ORAL:TABLET:MG	ORAL	2MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
Multiple	D&C YELLOW NO. 10-ALUMINUM LAKE:ORAL:TABLET, EXTENDED RELEASE:MG	ORAL	1.33MG ORAL TABLET, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
Multiple	D&C YELLOW NO. 10--ALUMINUM LAKE:BUCCAL:GUM:MG	BUCCAL	2.4MG BUCCAL GUM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
Multiple	D&C YELLOW NO. 10--ALUMINUM LAKE:BUCCAL:GUM, CHEWING:MG	BUCCAL	1.9MG BUCCAL GUM, CHEWING	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
Multiple	D&C YELLOW NO. 10--ALUMINUM LAKE:ORAL:CAPSULE:MG	ORAL	1.2MG ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
Multiple	D&C YELLOW NO. 10--ALUMINUM LAKE:ORAL:CAPSULE, DELAYED ACTION, ENTERIC COATED:NA	ORAL	ORAL CAPSULE, DELAYED ACTION, ENTERIC COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
Multiple	D&C YELLOW NO. 10--ALUMINUM LAKE:ORAL:CAPSULE, ENTERIC COATED PELLETS:MG	ORAL	0.3MG ORAL CAPSULE, ENTERIC COATED PELLETS	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
Multiple	D&C YELLOW NO. 10--ALUMINUM LAKE:ORAL:CAPSULE, SUSTAINED ACTION:MG	ORAL	0.068MG ORAL CAPSULE, SUSTAINED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
Multiple	D&C YELLOW NO. 10--ALUMINUM LAKE:ORAL:POWDER:MG/1PKT	ORAL	43MG/1PKT ORAL POWDER	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
Multiple	D&C YELLOW NO. 10--ALUMINUM LAKE:ORAL:POWDER:MG/1SCP	ORAL	43MG/1SCP ORAL POWDER	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
Multiple	D&C YELLOW NO. 10--ALUMINUM LAKE:ORAL:POWDER, FOR SUSPENSION:NA	ORAL	ORAL POWDER, FOR SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
Multiple	D&C YELLOW NO. 10--ALUMINUM LAKE:ORAL:SUSPENSION:MG/5ML	ORAL	1.8MG/5ML ORAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
Multiple	D&C YELLOW NO. 10--ALUMINUM LAKE:ORAL:TABLET:MG	ORAL	12.5MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
Multiple	D&C YELLOW NO. 10--ALUMINUM LAKE:ORAL:TABLET (IMMED./COMP. RELEASE), UNCOATED, CHEWABLE:MG	ORAL	2MG ORAL TABLET (IMMED./COMP. RELEASE), UNCOATED, CHEWABLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
Multiple	D&C YELLOW NO. 10--ALUMINUM LAKE:ORAL:TABLET, COATED:MG	ORAL	0.21MG ORAL TABLET, COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
Multiple	D&C YELLOW NO. 10--ALUMINUM LAKE:ORAL:TABLET, DELAYED ACTION, ENTERIC COATED:MG	ORAL	0.05MG ORAL TABLET, DELAYED ACTION, ENTERIC COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
Multiple	D&C YELLOW NO. 10--ALUMINUM LAKE:ORAL:TABLET, DISPERSIBLE:MG	ORAL	0.13MG ORAL TABLET, DISPERSIBLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
Multiple	D&C YELLOW NO. 10--ALUMINUM LAKE:ORAL:TABLET, EXTENDED RELEASE:MG	ORAL	2.82MG ORAL TABLET, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
Multiple	D&C YELLOW NO. 10--ALUMINUM LAKE:ORAL:TABLET, FILM COATED:mg	ORAL	3.2mg ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
Multiple	D&C YELLOW NO. 10--ALUMINUM LAKE:ORAL:TABLET, SUSTAINED ACTION:MG	ORAL	2.33MG ORAL TABLET, SUSTAINED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
Multiple	D&C YELLOW NO. 10--ALUMINUM LAKE:ORAL:TABLET, SUSTAINED ACTION, FILM COATED:MG	ORAL	0.16MG ORAL TABLET, SUSTAINED ACTION, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
Multiple	D&C YELLOW NO. 10--ALUMINUM LAKE:ORAL:TABLET, SUSTAINED RELEASE, FILM COATED:MG	ORAL	0.8MG ORAL TABLET, SUSTAINED RELEASE, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
Multiple	D&C YELLOW NO. 10--ALUMINUM LAKE:SUBLINGUAL:TABLET:MG	SUBLINGUAL	0.18MG SUBLINGUAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
Multiple	D&C YELLOW NO. 5--ALUMINUM LAKE:ORAL:TABLET:MG	ORAL	2.69MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
Multiple	D&C YELLOW NO. 5--ALUMINUM LAKE:ORAL:TABLET (IMMED./COMP. RELEASE), UNCOATED, CHEWABLE:MG	ORAL	0.29MG ORAL TABLET (IMMED./COMP. RELEASE), UNCOATED, CHEWABLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
Multiple	D&C YELLOW NO. 5--ALUMINUM LAKE:ORAL:TABLET, COATED:NA	ORAL	ORAL TABLET, COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
Multiple	D&C YELLOW NO. 5--ALUMINUM LAKE:ORAL:TABLET, FILM COATED:MG	ORAL	0.59MG ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
Multiple	DEHYDAG WAX SX:ORAL:TABLET, COATED:NA	ORAL	ORAL TABLET, COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
Multiple	DEHYDAG WAX SX:TOPICAL:EMULSION, CREAM:%W/W	TOPICAL	8.5%W/W TOPICAL EMULSION, CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
Multiple	EMULSIFYING WAX:RECTAL:AEROSOL, METERED:%	RECTAL	1.5% RECTAL AEROSOL, METERED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
Multiple	EMULSIFYING WAX:RECTAL:EMULSION, AEROSOL FOAM:%	RECTAL	1.32% RECTAL EMULSION, AEROSOL FOAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
Multiple	EMULSIFYING WAX:TOPICAL:AEROSOL, FOAM:%W/W	TOPICAL	1.05%W/W TOPICAL AEROSOL, FOAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
Multiple	EMULSIFYING WAX:TOPICAL:AEROSOL, METERED:NA	TOPICAL	TOPICAL AEROSOL, METERED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
Multiple	EMULSIFYING WAX:TOPICAL:CREAM:%W/W	TOPICAL	12.5%W/W TOPICAL CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
Multiple	EMULSIFYING WAX:TOPICAL:EMULSION, CREAM:%W/W	TOPICAL	24.8%W/W TOPICAL EMULSION, CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
Multiple	EMULSIFYING WAX:TOPICAL:LOTION:%W/W	TOPICAL	4%W/W TOPICAL LOTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
Multiple	EMULSIFYING WAX:TOPICAL:OINTMENT:%W/W	TOPICAL	1.5%W/W TOPICAL OINTMENT	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
Multiple	EUDRAGIT L 30 D:ORAL:CAPSULE:MG	ORAL	53.8MG ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
Multiple	EUDRAGIT L 30 D:ORAL:CAPSULE, ENTERIC COATED PELLETS:MG	ORAL	150MG ORAL CAPSULE, ENTERIC COATED PELLETS	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
Multiple	EUDRAGIT L 30 D:ORAL:TABLET, DELAYED ACTION:mg	ORAL	19.86mg ORAL TABLET, DELAYED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
Multiple	EUDRAGIT L 30 D:ORAL:TABLET, DELAYED RELEASE:MG	ORAL	40.44MG ORAL TABLET, DELAYED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
Multiple	FD&C RED NO. 40--ALUMINUM LAKE:ORAL:CAPSULE:MG	ORAL	0.9MG ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
Multiple	FD&C RED NO. 40--ALUMINUM LAKE:ORAL:CAPSULE, DELAYED ACTION, ENTERIC COATED:NA	ORAL	ORAL CAPSULE, DELAYED ACTION, ENTERIC COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
Multiple	FD&C RED NO. 40--ALUMINUM LAKE:ORAL:CAPSULE, SOFT GELATIN:MG	ORAL	0.5MG ORAL CAPSULE, SOFT GELATIN	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
Multiple	FD&C RED NO. 40--ALUMINUM LAKE:ORAL:CAPSULE, SUSTAINED ACTION:MG	ORAL	0.05MG ORAL CAPSULE, SUSTAINED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
Multiple	FD&C RED NO. 40--ALUMINUM LAKE:ORAL:POWDER:MG/1PKT	ORAL	1MG/1PKT ORAL POWDER	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
Multiple	FD&C RED NO. 40--ALUMINUM LAKE:ORAL:POWDER:MG/1SCP	ORAL	1MG/1SCP ORAL POWDER	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
Multiple	FD&C RED NO. 40--ALUMINUM LAKE:ORAL:POWDER, FOR ORAL SUSPENSION:MG/5ML	ORAL	0.4MG/5ML ORAL POWDER, FOR ORAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
Multiple	FD&C RED NO. 40--ALUMINUM LAKE:ORAL:POWDER, FOR SOLUTION:NA	ORAL	ORAL POWDER, FOR SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
Multiple	FD&C RED NO. 40--ALUMINUM LAKE:ORAL:POWDER, FOR SUSPENSION:MG/5ML	ORAL	0.5MG/5ML ORAL POWDER, FOR SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
Multiple	FD&C RED NO. 40--ALUMINUM LAKE:ORAL:SOLUTION:MG/5ML	ORAL	0.35MG/5ML ORAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
Multiple	FD&C RED NO. 40--ALUMINUM LAKE:ORAL:SUSPENSION:MG/5ML	ORAL	2MG/5ML ORAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
Multiple	FD&C RED NO. 40--ALUMINUM LAKE:ORAL:TABLET:MG	ORAL	21.25MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
Multiple	FD&C RED NO. 40--ALUMINUM LAKE:ORAL:TABLET (IMMED./COMP. RELEASE), UNCOATED, CHEWABLE:MG	ORAL	3.5MG ORAL TABLET (IMMED./COMP. RELEASE), UNCOATED, CHEWABLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
Multiple	FD&C RED NO. 40--ALUMINUM LAKE:ORAL:TABLET, COATED:NA	ORAL	ORAL TABLET, COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
Multiple	FD&C RED NO. 40--ALUMINUM LAKE:ORAL:TABLET, DELAYED ACTION:MG	ORAL	0.6MG ORAL TABLET, DELAYED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
Multiple	FD&C RED NO. 40--ALUMINUM LAKE:ORAL:TABLET, EXTENDED RELEASE:MG	ORAL	21.25MG ORAL TABLET, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
Multiple	FD&C RED NO. 40--ALUMINUM LAKE:ORAL:TABLET, FILM COATED:MG	ORAL	2.5MG ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
Multiple	FD&C RED NO. 40--ALUMINUM LAKE:ORAL:TABLET, SUSTAINED ACTION:MG	ORAL	0.4MG ORAL TABLET, SUSTAINED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
Multiple	FD&C RED NO. 40--ALUMINUM LAKE:ORAL:TABLET, SUSTAINED ACTION, FILM COATED:NA	ORAL	ORAL TABLET, SUSTAINED ACTION, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
Multiple	FD&C RED NO. 40--ALUMINUM LAKE:SUBLINGUAL:TABLET:MG	SUBLINGUAL	0.59MG SUBLINGUAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
Multiple	FD&C YELLOW NO. 5--ALUMINUM LAKE:ORAL:CAPSULE:MG	ORAL	0.09MG ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
Multiple	FD&C YELLOW NO. 5--ALUMINUM LAKE:ORAL:TABLET:MG	ORAL	33MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
Multiple	FD&C YELLOW NO. 5--ALUMINUM LAKE:ORAL:TABLET (IMMED./COMP. RELEASE), UNCOATED, CHEWABLE:MG	ORAL	1MG ORAL TABLET (IMMED./COMP. RELEASE), UNCOATED, CHEWABLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
Multiple	FD&C YELLOW NO. 5--ALUMINUM LAKE:ORAL:TABLET, COATED:MG	ORAL	0.14MG ORAL TABLET, COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
Multiple	FD&C YELLOW NO. 5--ALUMINUM LAKE:ORAL:TABLET, DELAYED ACTION:MG	ORAL	0.4MG ORAL TABLET, DELAYED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
Multiple	FD&C YELLOW NO. 5--ALUMINUM LAKE:ORAL:TABLET, EXTENDED RELEASE:mg	ORAL	2.75mg ORAL TABLET, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
Multiple	FD&C YELLOW NO. 5--ALUMINUM LAKE:ORAL:TABLET, FILM COATED:MG	ORAL	3.07MG ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
Multiple	FD&C YELLOW NO. 5--ALUMINUM LAKE:ORAL:TABLET, ORALLY DISINTEGRATING:MG	ORAL	1.2MG ORAL TABLET, ORALLY DISINTEGRATING	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
Multiple	FD&C YELLOW NO. 5--ALUMINUM LAKE:ORAL:TABLET, SUSTAINED ACTION:NA	ORAL	ORAL TABLET, SUSTAINED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
Multiple	FD&C YELLOW NO. 5--ALUMINUM LAKE:SUBLINGUAL:TABLET:MG	SUBLINGUAL	0.03MG SUBLINGUAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
Multiple	FD&C YELLOW NO. 6-ALUMINUM LAKE:ORAL:CAPSULE:MG	ORAL	1.38MG ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
Multiple	FD&C YELLOW NO. 6-ALUMINUM LAKE:ORAL:CAPSULE, EXTENDED RELEASE:MG	ORAL	0.3MG ORAL CAPSULE, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
Multiple	FD&C YELLOW NO. 6-ALUMINUM LAKE:ORAL:CAPSULE, SOFT GELATIN:MG	ORAL	0.1MG ORAL CAPSULE, SOFT GELATIN	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
Multiple	FD&C YELLOW NO. 6-ALUMINUM LAKE:ORAL:POWDER, FOR ORAL SUSPENSION:MG/5ML	ORAL	1.2MG/5ML ORAL POWDER, FOR ORAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
Multiple	FD&C YELLOW NO. 6-ALUMINUM LAKE:ORAL:POWDER, FOR ORAL SUSPENSION:mg	ORAL	1mg ORAL POWDER, FOR ORAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
Multiple	FD&C YELLOW NO. 6-ALUMINUM LAKE:ORAL:TABLET:mg	ORAL	4.94mg ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
Multiple	FD&C YELLOW NO. 6-ALUMINUM LAKE:ORAL:TABLET, DELAYED RELEASE:MG	ORAL	0.334MG ORAL TABLET, DELAYED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
Multiple	FD&C YELLOW NO. 6-ALUMINUM LAKE:ORAL:TABLET, EXTENDED RELEASE:MG	ORAL	2.5MG ORAL TABLET, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
Multiple	FD&C YELLOW NO. 6--ALUMINUM LAKE:BUCCAL/SUBLINGUAL:TABLET:MG	BUCCAL/SUBLINGUAL	1MG BUCCAL/SUBLINGUAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
Multiple	FD&C YELLOW NO. 6--ALUMINUM LAKE:ORAL:CAPSULE:MG	ORAL	0.8MG ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
Multiple	FD&C YELLOW NO. 6--ALUMINUM LAKE:ORAL:CAPSULE, ENTERIC COATED PELLETS:MG	ORAL	1.25MG ORAL CAPSULE, ENTERIC COATED PELLETS	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
Multiple	FD&C YELLOW NO. 6--ALUMINUM LAKE:ORAL:CAPSULE, SUSTAINED ACTION:MG	ORAL	0.18MG ORAL CAPSULE, SUSTAINED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
Multiple	FD&C YELLOW NO. 6--ALUMINUM LAKE:ORAL:POWDER:MG/1PKT	ORAL	1.3MG/1PKT ORAL POWDER	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
Multiple	FD&C YELLOW NO. 6--ALUMINUM LAKE:ORAL:POWDER:MG/1SCP	ORAL	1.3MG/1SCP ORAL POWDER	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
Multiple	FD&C YELLOW NO. 6--ALUMINUM LAKE:ORAL:POWDER, FOR ORAL SUSPENSION:MG/PKT	ORAL	0.5MG/PKT ORAL POWDER, FOR ORAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
Multiple	FD&C YELLOW NO. 6--ALUMINUM LAKE:ORAL:POWDER, FOR SUSPENSION:MG/5ML	ORAL	1.6MG/5ML ORAL POWDER, FOR SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
Multiple	FD&C YELLOW NO. 6--ALUMINUM LAKE:ORAL:TABLET:MG	ORAL	6.97MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
Multiple	FD&C YELLOW NO. 6--ALUMINUM LAKE:ORAL:TABLET (IMMED./COMP. RELEASE), UNCOATED, CHEWABLE:MG	ORAL	1.76MG ORAL TABLET (IMMED./COMP. RELEASE), UNCOATED, CHEWABLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
Multiple	FD&C YELLOW NO. 6--ALUMINUM LAKE:ORAL:TABLET, COATED:MG	ORAL	0.34MG ORAL TABLET, COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
Multiple	FD&C YELLOW NO. 6--ALUMINUM LAKE:ORAL:TABLET, DELAYED ACTION:MG	ORAL	2.1MG ORAL TABLET, DELAYED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
Multiple	FD&C YELLOW NO. 6--ALUMINUM LAKE:ORAL:TABLET, DELAYED ACTION, ENTERIC COATED:MG	ORAL	1.4MG ORAL TABLET, DELAYED ACTION, ENTERIC COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
Multiple	FD&C YELLOW NO. 6--ALUMINUM LAKE:ORAL:TABLET, DELAYED RELEASE:MG	ORAL	0.03MG ORAL TABLET, DELAYED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
Multiple	FD&C YELLOW NO. 6--ALUMINUM LAKE:ORAL:TABLET, EXTENDED RELEASE:MG	ORAL	3.3MG ORAL TABLET, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
Multiple	FD&C YELLOW NO. 6--ALUMINUM LAKE:ORAL:TABLET, FILM COATED:MG	ORAL	0.25MG ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
Multiple	FD&C YELLOW NO. 6--ALUMINUM LAKE:ORAL:TABLET, SUSTAINED ACTION:MG	ORAL	2.8MG ORAL TABLET, SUSTAINED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
Multiple	FD&C YELLOW NO. 6--ALUMINUM LAKE:SUBLINGUAL:TABLET:MG	SUBLINGUAL	1.6MG SUBLINGUAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
Multiple	GLYCERYL OLEATE/PROPYLENE GLYCOL:TOPICAL:CREAM, AUGMENTED:%W/W	TOPICAL	3%W/W TOPICAL CREAM, AUGMENTED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
Multiple	GLYCERYL OLEATE/PROPYLENE GLYCOL:TOPICAL:EMULSION, CREAM:%W/W	TOPICAL	3%W/W TOPICAL EMULSION, CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
Multiple	GLYCERYL OLEATE/PROPYLENE GLYCOL:TOPICAL:OINTMENT:NA	TOPICAL	TOPICAL OINTMENT	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
Multiple	GLYCERYL STEARATE/PEG-100 STEARATE:TOPICAL:CREAM:%W/W	TOPICAL	7.5%W/W TOPICAL CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
Multiple	GLYCERYL STEARATE/PEG-100 STEARATE:TOPICAL:CREAM, AUGMENTED:%W/W	TOPICAL	7.08%W/W TOPICAL CREAM, AUGMENTED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
Multiple	GLYCERYL STEARATE/PEG-100 STEARATE:TOPICAL:CREAM, EMULSION, SUSTAINED RELEASE:%W/W	TOPICAL	5%W/W TOPICAL CREAM, EMULSION, SUSTAINED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
Multiple	GLYCERYL STEARATE/PEG-100 STEARATE:TOPICAL:EMULSION, CREAM:%W/W	TOPICAL	7.5%W/W TOPICAL EMULSION, CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
Multiple	GLYCERYL STEARATE/PEG-100 STEARATE:TOPICAL:LOTION:%W/W	TOPICAL	6.5%W/W TOPICAL LOTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
Multiple	GLYCERYL STEARATE/PEG-40 STEARATE:RECTAL:SUPPOSITORY:MG	RECTAL	35MG RECTAL SUPPOSITORY	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
Multiple	LACTOSE MONOHYDRATE - CELLULOSE, MICROCRYSTALLINE:ORAL:TABLET:MG	ORAL	614.2MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
Multiple	LACTOSE MONOHYDRATE - CELLULOSE, MICROCRYSTALLINE:ORAL:TABLET, EXTENDED RELEASE:MG	ORAL	121.5MG ORAL TABLET, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
Multiple	LANOLIN ALCOHOL - MINERAL OIL:TOPICAL:EMULSION, CREAM:%W/W	TOPICAL	5%W/W TOPICAL EMULSION, CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
Multiple	LANOLIN ALCOHOL - MINERAL OIL:TOPICAL:LOTION:%W/W	TOPICAL	11%W/W TOPICAL LOTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
Multiple	NON-PAREIL SEEDS:ORAL:CAPSULE:MG	ORAL	429.6MG ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=N
Multiple	NON-PAREIL SEEDS:ORAL:CAPSULE, COATED PELLETS:MG	ORAL	122.19MG ORAL CAPSULE, COATED PELLETS	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=N
Multiple	NON-PAREIL SEEDS:ORAL:CAPSULE, ENTERIC COATED PELLETS:NA	ORAL	ORAL CAPSULE, ENTERIC COATED PELLETS	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=N
Multiple	NON-PAREIL SEEDS:ORAL:CAPSULE, EXTENDED RELEASE:MG	ORAL	249.9MG ORAL CAPSULE, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=N
Multiple	NON-PAREIL SEEDS:ORAL:CAPSULE, HARD GELATIN:MG	ORAL	60.3MG ORAL CAPSULE, HARD GELATIN	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=N
Multiple	NON-PAREIL SEEDS:ORAL:CAPSULE, SUSTAINED ACTION:MG	ORAL	345.45MG ORAL CAPSULE, SUSTAINED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=N
Multiple	NON-PAREIL SEEDS:ORAL:TABLET:MG	ORAL	166.36MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=N
Multiple	NON-PAREIL SEEDS:ORAL:TABLET, SUSTAINED ACTION:MG	ORAL	157.5MG ORAL TABLET, SUSTAINED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=N
Multiple	OLETH-10/OLETH-5:TOPICAL:EMULSION, CREAM:NA	TOPICAL	TOPICAL EMULSION, CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
Multiple	OLETH-10/OLETH-5:TOPICAL:SOLUTION:NA	TOPICAL	TOPICAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
Multiple	POLYOXYL 6 AND POLYOXYL 32 PALMITOSTEARATE:TOPICAL:EMULSION, CREAM:%W/W	TOPICAL	20%W/W TOPICAL EMULSION, CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
Multiple	POLYOXYL 6 AND POLYOXYL 32 PALMITOSTEARATE:TOPICAL:LOTION:%W/W	TOPICAL	5%W/W TOPICAL LOTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
Multiple	PROPYLENE GLYCOL - LECITHIN:BUCCAL:PATCH, CONTROLLED RELEASE:MG	BUCCAL	49.4MG BUCCAL PATCH, CONTROLLED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
Multiple	PROPYLENE GLYCOL - LECITHIN:ORAL:SOLUTION:MG/1ML	ORAL	993.2MG/1ML ORAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
Multiple	PROPYLENE GLYCOL/DIAZOLIDINYL UREA/METHYLPARABEN/PROPYLPARBEN:TOPICAL:AEROSOL, METERED:NA	TOPICAL	TOPICAL AEROSOL, METERED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
Multiple	SIMETHICONE:IM - IV:POWDER, FOR INJECTION SOLUTION:NA	IM - IV	IM - IV POWDER, FOR INJECTION SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
Multiple	SIMETHICONE:ORAL:CAPSULE:MG	ORAL	5.7MG ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
Multiple	SIMETHICONE:ORAL:CAPSULE, DELAYED ACTION:MG	ORAL	0.2MG ORAL CAPSULE, DELAYED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
Multiple	SIMETHICONE:ORAL:CAPSULE, DELAYED RELEASE:MG	ORAL	0.02MG ORAL CAPSULE, DELAYED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
Multiple	SIMETHICONE:ORAL:CAPSULE, ENTERIC COATED PELLETS:MG	ORAL	0.61MG ORAL CAPSULE, ENTERIC COATED PELLETS	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
Multiple	SIMETHICONE:ORAL:CAPSULE, EXTENDED RELEASE:MG	ORAL	1MG ORAL CAPSULE, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
Multiple	SIMETHICONE:ORAL:CAPSULE, SOFT GELATIN LIQUID-FILLED:MG	ORAL	0.025MG ORAL CAPSULE, SOFT GELATIN LIQUID-FILLED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
Multiple	SIMETHICONE:ORAL:CAPSULE, SUSTAINED ACTION:MG	ORAL	0.062MG ORAL CAPSULE, SUSTAINED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
Multiple	SIMETHICONE:ORAL:GRANULE:MG	ORAL	3.3MG ORAL GRANULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
Multiple	SIMETHICONE:ORAL:GRANULE, EFFERVESCENT:NA	ORAL	ORAL GRANULE, EFFERVESCENT	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
Multiple	SIMETHICONE:ORAL:GRANULE, FOR ORAL SOLUTION:MG	ORAL	3MG ORAL GRANULE, FOR ORAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
Multiple	SIMETHICONE:ORAL:PASTILLE:MG	ORAL	0.4MG ORAL PASTILLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
Multiple	SIMETHICONE:ORAL:POWDER, FOR ORAL SOLUTION:MG	ORAL	0.4MG ORAL POWDER, FOR ORAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
Multiple	SIMETHICONE:ORAL:POWDER, FOR ORAL SUSPENSION:MG/1PKT	ORAL	189MG/1PKT ORAL POWDER, FOR ORAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
Multiple	SIMETHICONE:ORAL:POWDER, FOR SUSPENSION:MG/5ML	ORAL	33.3MG/5ML ORAL POWDER, FOR SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
Multiple	SIMETHICONE:ORAL:SOLUTION:MG/5ML	ORAL	1.1MG/5ML ORAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
Multiple	SIMETHICONE:ORAL:SUSPENSION:MG/10ML	ORAL	90MG/10ML ORAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
Multiple	SIMETHICONE:ORAL:SUSPENSION, LIQUID:MG/5ML	ORAL	10MG/5ML ORAL SUSPENSION, LIQUID	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
Multiple	SIMETHICONE:ORAL:TABLET:MG	ORAL	1.5MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
Multiple	SIMETHICONE:ORAL:TABLET, DELAYED ACTION, ENTERIC COATED:MG	ORAL	0.56MG ORAL TABLET, DELAYED ACTION, ENTERIC COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
Multiple	SIMETHICONE:ORAL:TABLET, EXTENDED RELEASE:MG	ORAL	1.04MG ORAL TABLET, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
Multiple	SIMETHICONE:ORAL:TABLET, FILM COATED:MG	ORAL	0.18MG ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
Multiple	SIMETHICONE:ORAL:TABLET, ORALLY DISINTEGRATING:MG	ORAL	0.04MG ORAL TABLET, ORALLY DISINTEGRATING	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
Multiple	SIMETHICONE:ORAL:TABLET, SUSTAINED ACTION:MG	ORAL	7.5MG ORAL TABLET, SUSTAINED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
Multiple	SIMETHICONE:RECTAL:SOLUTION:NA	RECTAL	RECTAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
Multiple	SIMETHICONE:TOPICAL:EMULSION, CREAM:%W/W	TOPICAL	0.2%W/W TOPICAL EMULSION, CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
Multiple	SIMETHICONE:TOPICAL:LOTION:%W/W	TOPICAL	0.5%W/W TOPICAL LOTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
Multiple	SIMETHICONE:TOPICAL:OINTMENT:NA	TOPICAL	TOPICAL OINTMENT	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
Multiple	SIMETHICONE:TOPICAL:SUSPENSION:%W/W	TOPICAL	0.1%W/W TOPICAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
Multiple	SIMETHICONE EMULSION:ORAL:CAPSULE:MG	ORAL	14.4MG ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
Multiple	SIMETHICONE EMULSION:ORAL:CAPSULE, SUSTAINED ACTION:MG	ORAL	15.63MG ORAL CAPSULE, SUSTAINED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
Multiple	SIMETHICONE EMULSION:ORAL:POWDER, FOR ORAL SOLUTION:MG	ORAL	0.05MG ORAL POWDER, FOR ORAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
Multiple	SIMETHICONE EMULSION:ORAL:POWDER, FOR ORAL SUSPENSION:MG/5ML	ORAL	1.83MG/5ML ORAL POWDER, FOR ORAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
Multiple	SIMETHICONE EMULSION:ORAL:POWDER, FOR SUSPENSION:MG/5ML	ORAL	25MG/5ML ORAL POWDER, FOR SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
Multiple	SIMETHICONE EMULSION:ORAL:POWDER, FOR SUSPENSION:g/236mL	ORAL	0.035g/236mL ORAL POWDER, FOR SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
Multiple	SIMETHICONE EMULSION:ORAL:SOLUTION:MG/5ML	ORAL	0.08MG/5ML ORAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
Multiple	SIMETHICONE EMULSION:ORAL:SUSPENSION:mg/1mL	ORAL	5.4mg/1mL ORAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
Multiple	SIMETHICONE EMULSION:ORAL:SUSPENSION:%	ORAL	0.52% ORAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
Multiple	SIMETHICONE EMULSION:ORAL:SUSPENSION:mg/1mL	ORAL	0.033mg/1mL ORAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
Multiple	SIMETHICONE EMULSION:ORAL:SUSPENSION, LIQUID:MG/5ML	ORAL	0.5MG/5ML ORAL SUSPENSION, LIQUID	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
Multiple	SIMETHICONE EMULSION:ORAL:TABLET:MG	ORAL	0.7MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
Multiple	SIMETHICONE EMULSION:ORAL:TABLET (IMMED./COMP. RELEASE), FILM COATED:MG	ORAL	0.12MG ORAL TABLET (IMMED./COMP. RELEASE), FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
Multiple	SIMETHICONE EMULSION:ORAL:TABLET, COATED:MG	ORAL	0.009MG ORAL TABLET, COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
Multiple	SIMETHICONE EMULSION:ORAL:TABLET, DELAYED ACTION:MG	ORAL	0.38MG ORAL TABLET, DELAYED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
Multiple	SIMETHICONE EMULSION:ORAL:TABLET, DELAYED ACTION, ENTERIC COATED:MG	ORAL	0.04MG ORAL TABLET, DELAYED ACTION, ENTERIC COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
Multiple	SIMETHICONE EMULSION:ORAL:TABLET, FILM COATED:NA	ORAL	ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
Multiple	SIMETHICONE EMULSION:ORAL:TABLET, SUSTAINED ACTION:MG	ORAL	0.07MG ORAL TABLET, SUSTAINED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
Multiple	SIMETHICONE EMULSION:ORAL:TABLET, SUSTAINED ACTION, COATED:MG	ORAL	1.41MG ORAL TABLET, SUSTAINED ACTION, COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
Multiple	SIMETHICONE EMULSION:TOPICAL:CREAM:%W/W	TOPICAL	0.2%W/W TOPICAL CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
Multiple	SIMETHICONE EMULSION:TOPICAL:EMULSION, CREAM:%W/W	TOPICAL	0.2%W/W TOPICAL EMULSION, CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
Multiple	SIMETHICONE EMULSION:TOPICAL:OINTMENT:NA	TOPICAL	TOPICAL OINTMENT	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
Multiple	SUGAR LIQUID TYPE NO. 0:ORAL:CONCENTRATE:NA	ORAL	ORAL CONCENTRATE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
Multiple	SUGAR LIQUID TYPE NO. 0:ORAL:SYRUP:%	ORAL	75% ORAL SYRUP	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
Multiple	SUGAR SPHERES:ORAL:CAPSULE:MG	ORAL	314.13MG ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
Multiple	SUGAR SPHERES:ORAL:CAPSULE, COATED:MG	ORAL	218MG ORAL CAPSULE, COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
Multiple	SUGAR SPHERES:ORAL:CAPSULE, DELAYED ACTION:MG	ORAL	280.12MG ORAL CAPSULE, DELAYED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
Multiple	SUGAR SPHERES:ORAL:CAPSULE, DELAYED RELEASE:MG	ORAL	200MG ORAL CAPSULE, DELAYED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
Multiple	SUGAR SPHERES:ORAL:CAPSULE, ENTERIC COATED PELLETS:MG	ORAL	225.21MG ORAL CAPSULE, ENTERIC COATED PELLETS	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
Multiple	SUGAR SPHERES:ORAL:CAPSULE, EXTENDED RELEASE:MG	ORAL	529.49MG ORAL CAPSULE, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
Multiple	SUGAR SPHERES:ORAL:CAPSULE, FILM COATED, EXTENDED RELEASE:MG	ORAL	150MG ORAL CAPSULE, FILM COATED, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
Multiple	SUGAR SPHERES:ORAL:CAPSULE, SUSTAINED ACTION:MG	ORAL	155.94MG ORAL CAPSULE, SUSTAINED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
Multiple	SUGAR SPHERES:ORAL:CAPSULE, SUSTAINED ACTION, HARD GELATIN:MG	ORAL	100.3MG ORAL CAPSULE, SUSTAINED ACTION, HARD GELATIN	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
Multiple	SUGAR SPHERES:ORAL:GRANULE:MG/1PKT	ORAL	1880MG/1PKT ORAL GRANULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
Multiple	SUGAR SPHERES:ORAL:GRANULE, FOR ORAL SUSPENSION:MG	ORAL	30MG ORAL GRANULE, FOR ORAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
Multiple	SUGAR SPHERES:ORAL:PELLET:MG	ORAL	30MG ORAL PELLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
Multiple	SUGAR SPHERES:ORAL:TABLET:MG	ORAL	10MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
Multiple	SUGAR SPHERES:ORAL:TABLET (IMMED./COMP. RELEASE), COATED:MG	ORAL	10MG ORAL TABLET (IMMED./COMP. RELEASE), COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
Multiple	SUGAR SPHERES:ORAL:TABLET, DELAYED ACTION:MG	ORAL	22MG ORAL TABLET, DELAYED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
Multiple	SUGAR SPHERES:ORAL:TABLET, DELAYED RELEASE:MG	ORAL	28MG ORAL TABLET, DELAYED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
Multiple	SUGAR SPHERES:ORAL:TABLET, EXTENDED RELEASE:MG	ORAL	126.7MG ORAL TABLET, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
Multiple	SUGAR SPHERES:ORAL:TABLET, ORALLY DISINTEGRATING:MG	ORAL	61.57MG ORAL TABLET, ORALLY DISINTEGRATING	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
Multiple	SUGAR SPHERES:ORAL:TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE:MG	ORAL	70MG ORAL TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
Multiple	SUGAR/STARCH INSERT GRANULES:ORAL:SUSPENSION:MG/5ML	ORAL	2252.4MG/5ML ORAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
K848JZ4886	CYSTEINE:IM - SC:INJECTION, SUSTAINED ACTION:%	IM - SC	0.1% IM - SC INJECTION, SUSTAINED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
K848JZ4886	CYSTEINE:INTRAVENOUS:POWDER, FOR INJECTION SOLUTION, LYOPHILIZED:%	INTRAVENOUS	2.6% INTRAVENOUS POWDER, FOR INJECTION SOLUTION, LYOPHILIZED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
K848JZ4886	CYSTEINE:IV(INFUSION):SOLUTION:%	IV(INFUSION)	0.01% IV(INFUSION) SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
K848JZ4886	CYSTEINE:IV(INFUSION):SOLUTION, INJECTION:%	IV(INFUSION)	0.02% IV(INFUSION) SOLUTION, INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
LS505BG22I	SODIUM CARBONATE DECAHYDRATE:INTRAVENOUS:INJECTION:%	INTRAVENOUS	12.43% INTRAVENOUS INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
6PT9KLV9IO	METHYL ETHYL KETONE:ORAL:TABLET:NA	ORAL	ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
6PT9KLV9IO	METHYL ETHYL KETONE:ORAL:TABLET, DELAYED ACTION, ENTERIC COATED:MG	ORAL	61MG ORAL TABLET, DELAYED ACTION, ENTERIC COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
92005F972D	COCO DIETHANOLAMIDE:TOPICAL:AEROSOL, METERED:%W/W	TOPICAL	3%W/W TOPICAL AEROSOL, METERED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
92005F972D	COCO DIETHANOLAMIDE:TOPICAL:EMULSION, CREAM:%W/W	TOPICAL	4%W/W TOPICAL EMULSION, CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
92005F972D	COCO DIETHANOLAMIDE:TOPICAL:SHAMPOO:%W/W	TOPICAL	3.5%W/W TOPICAL SHAMPOO	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
92005F972D	COCO DIETHANOLAMIDE:TOPICAL:SOLUTION:%W/W	TOPICAL	4%W/W TOPICAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
92005F972D	COCO DIETHANOLAMIDE:TOPICAL:SPONGE:NA	TOPICAL	TOPICAL SPONGE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
92005F972D	COCO DIETHANOLAMIDE:TOPICAL:SUSPENSION:%W/W	TOPICAL	4%W/W TOPICAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
9H0AO7T794	PEG/PPG-18/18 DIMETHICONE:TOPICAL:GEL:%W/W	TOPICAL	1%W/W TOPICAL GEL	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
9H0AO7T794	PEG/PPG-18/18 DIMETHICONE:TRANSDERMAL:FILM, CONTROLLED RELEASE:NA	TRANSDERMAL	TRANSDERMAL FILM, CONTROLLED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
C5529G5JPQ	GINGER:ORAL:SOLUTION, ELIXIR:MG/5ML	ORAL	10MG/5ML ORAL SOLUTION, ELIXIR	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
C5529G5JPQ	GINGER:ORAL:SYRUP:%	ORAL	1% ORAL SYRUP	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
VCQ006KQ1E	XYLITOL:BUCCAL:GUM:MG	BUCCAL	492.01MG BUCCAL GUM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=X
VCQ006KQ1E	XYLITOL:BUCCAL:GUM, CHEWING:MG	BUCCAL	506.13MG BUCCAL GUM, CHEWING	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=X
VCQ006KQ1E	XYLITOL:ORAL:FILM, SOLUBLE:MG	ORAL	4.76MG ORAL FILM, SOLUBLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=X
VCQ006KQ1E	XYLITOL:ORAL:POWDER, FOR ORAL SUSPENSION:MG/1PKT	ORAL	2000MG/1PKT ORAL POWDER, FOR ORAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=X
VCQ006KQ1E	XYLITOL:ORAL:SOLUTION:MG/5ML	ORAL	2000MG/5ML ORAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=X
VCQ006KQ1E	XYLITOL:ORAL:SUSPENSION:MG/1ML	ORAL	333.9MG/1ML ORAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=X
VCQ006KQ1E	XYLITOL:ORAL:TABLET:MG	ORAL	85.99MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=X
VCQ006KQ1E	XYLITOL:ORAL:TABLET, EXTENDED RELEASE:MG	ORAL	72MG ORAL TABLET, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=X
VCQ006KQ1E	XYLITOL:ORAL:TABLET, ORALLY DISINTEGRATING:MG	ORAL	80MG ORAL TABLET, ORALLY DISINTEGRATING	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=X
VCQ006KQ1E	XYLITOL:SUBLINGUAL:SPRAY:%	SUBLINGUAL	0.27% SUBLINGUAL SPRAY	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=X
JCV5VDB3HY	N,N-DIMETHYLACETAMIDE:INTRAVENOUS:INJECTABLE:%	INTRAVENOUS	33% INTRAVENOUS INJECTABLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=N
JCV5VDB3HY	N,N-DIMETHYLACETAMIDE:INTRAVENOUS:INJECTION:%	INTRAVENOUS	1.8% INTRAVENOUS INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=N
JCV5VDB3HY	N,N-DIMETHYLACETAMIDE:INTRAVENOUS:SOLUTION, INJECTION:%	INTRAVENOUS	30.91% INTRAVENOUS SOLUTION, INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=N
JCV5VDB3HY	N,N-DIMETHYLACETAMIDE:INTRAVENOUS INFUSION:INJECTION:%V/V	INTRAVENOUS INFUSION	33.3%V/V INTRAVENOUS INFUSION INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=N
JCV5VDB3HY	N,N-DIMETHYLACETAMIDE:INTRAVENOUS INFUSION:SOLUTION, INJECTION:MG/ML	INTRAVENOUS INFUSION	0.33MG/ML INTRAVENOUS INFUSION SOLUTION, INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=N
1M6415C70M	CALDIAMIDE SODIUM:INTRAVENOUS:SOLUTION, INJECTION:%	INTRAVENOUS	0.024% INTRAVENOUS SOLUTION, INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
BYR0546TOW	DMDM HYDANTOIN:TOPICAL:LOTION:%W/W	TOPICAL	0.4%W/W TOPICAL LOTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
J9O85FKF29	SODIUM PHOSPHATE, TRIBASIC, MONOHYDRATE:ORAL:POWDER, FOR RECONSTITUTION:MG/5ML	ORAL	0.079MG/5ML ORAL POWDER, FOR RECONSTITUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
J9O85FKF29	SODIUM PHOSPHATE, TRIBASIC, MONOHYDRATE:ORAL:POWDER, FOR SUSPENSION:MG	ORAL	88MG ORAL POWDER, FOR SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
J9O85FKF29	SODIUM PHOSPHATE, TRIBASIC, MONOHYDRATE:ORAL:SUSPENSION:NA	ORAL	ORAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
J9O85FKF29	SODIUM PHOSPHATE, TRIBASIC, MONOHYDRATE:ORAL:TABLET:MG	ORAL	88MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
J9O85FKF29	SODIUM PHOSPHATE, TRIBASIC, MONOHYDRATE:ORAL:TABLET, DELAYED ACTION, ENTERIC COATED:MG	ORAL	24.5MG ORAL TABLET, DELAYED ACTION, ENTERIC COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
NBZ3QY004S	MAGNESIUM HYDROXIDE:ORAL:CAPSULE, ENTERIC COATED PELLETS:NA	ORAL	ORAL CAPSULE, ENTERIC COATED PELLETS	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
NBZ3QY004S	MAGNESIUM HYDROXIDE:ORAL:POWDER, FOR ORAL SUSPENSION:MG/25.169GM	ORAL	250MG/25.169GM ORAL POWDER, FOR ORAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
NBZ3QY004S	MAGNESIUM HYDROXIDE:ORAL:TABLET:MG	ORAL	60MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
NBZ3QY004S	MAGNESIUM HYDROXIDE:ORAL:TABLET (IMMED./COMP. RELEASE), UNCOATED, CHEWABLE:MG	ORAL	450MG ORAL TABLET (IMMED./COMP. RELEASE), UNCOATED, CHEWABLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
NBZ3QY004S	MAGNESIUM HYDROXIDE:ORAL:TABLET, DELAYED RELEASE:MG	ORAL	60MG ORAL TABLET, DELAYED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
NBZ3QY004S	MAGNESIUM HYDROXIDE:ORAL:TABLET, FILM COATED:MG	ORAL	43.4MG ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
9O3K93S3TK	TROLAMINE:RECTAL:AEROSOL, METERED:ADJ PH	RECTAL	ADJ PH RECTAL AEROSOL, METERED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
9O3K93S3TK	TROLAMINE:TOPICAL:AEROSOL, METERED:NA	TOPICAL	TOPICAL AEROSOL, METERED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
9O3K93S3TK	TROLAMINE:TOPICAL:CREAM, AUGMENTED:%W/W	TOPICAL	1%W/W TOPICAL CREAM, AUGMENTED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
9O3K93S3TK	TROLAMINE:TOPICAL:CREAM, EMULSION, SUSTAINED RELEASE:%W/W	TOPICAL	0.4%W/W TOPICAL CREAM, EMULSION, SUSTAINED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
9O3K93S3TK	TROLAMINE:TOPICAL:EMULSION:%W/W	TOPICAL	0.5%W/W TOPICAL EMULSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
9O3K93S3TK	TROLAMINE:TOPICAL:EMULSION, AEROSOL FOAM:%W/W	TOPICAL	2.6%W/W TOPICAL EMULSION, AEROSOL FOAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
9O3K93S3TK	TROLAMINE:TOPICAL:EMULSION, CREAM:%W/W	TOPICAL	1%W/W TOPICAL EMULSION, CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
9O3K93S3TK	TROLAMINE:TOPICAL:GEL:%W/W	TOPICAL	1%W/W TOPICAL GEL	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
9O3K93S3TK	TROLAMINE:TOPICAL:LOTION:%W/W	TOPICAL	1.8%W/W TOPICAL LOTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
9O3K93S3TK	TROLAMINE:TOPICAL:LOTION:ADJ PH	TOPICAL	ADJ PH TOPICAL LOTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
9O3K93S3TK	TROLAMINE:TOPICAL:SPONGE:%	TOPICAL	11% TOPICAL SPONGE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
9O3K93S3TK	TROLAMINE:TRANSDERMAL:GEL:%	TRANSDERMAL	0.35% TRANSDERMAL GEL	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
9O3K93S3TK	TROLAMINE:VAGINAL:EMULSION, CREAM:%	VAGINAL	0.75% VAGINAL EMULSION, CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
2P9L47VI5E	PEG-8 STEARATE:NASAL:SPRAY, METERED:MG/SPR	NASAL	150MG/SPR NASAL SPRAY, METERED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
2P9L47VI5E	PEG-8 STEARATE:ORAL:CONCENTRATE:MG/5ML	ORAL	25MG/5ML ORAL CONCENTRATE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
2P9L47VI5E	PEG-8 STEARATE:ORAL:SUSPENSION:MG/5ML	ORAL	7.5MG/5ML ORAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
2P9L47VI5E	PEG-8 STEARATE:TOPICAL:CREAM:%W/W	TOPICAL	5%W/W TOPICAL CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
2P9L47VI5E	PEG-8 STEARATE:TOPICAL:EMULSION, CREAM:%W/W	TOPICAL	6.66%W/W TOPICAL EMULSION, CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
2P9L47VI5E	PEG-8 STEARATE:TOPICAL:SPONGE:NA	TOPICAL	TOPICAL SPONGE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
PDC6A3C0OX	GLYCERIN:AURICULAR (OTIC):SOLUTION:%	AURICULAR (OTIC)	63.64% AURICULAR (OTIC) SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
PDC6A3C0OX	GLYCERIN:AURICULAR (OTIC):SOLUTION, DROPS:%	AURICULAR (OTIC)	2.5% AURICULAR (OTIC) SOLUTION, DROPS	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
PDC6A3C0OX	GLYCERIN:AURICULAR (OTIC):SUSPENSION:%	AURICULAR (OTIC)	0.05% AURICULAR (OTIC) SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
PDC6A3C0OX	GLYCERIN:BUCCAL:GUM, CHEWING:MG	BUCCAL	28.8MG BUCCAL GUM, CHEWING	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
PDC6A3C0OX	GLYCERIN:BUCCAL:PATCH, CONTROLLED RELEASE:MG	BUCCAL	66MG BUCCAL PATCH, CONTROLLED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
PDC6A3C0OX	GLYCERIN:DENTAL:PASTE:NA	DENTAL	DENTAL PASTE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
PDC6A3C0OX	GLYCERIN:DENTAL:TABLET:MG	DENTAL	0.53MG DENTAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
PDC6A3C0OX	GLYCERIN:IM - IV:INJECTION:%	IM - IV	15% IM - IV INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
PDC6A3C0OX	GLYCERIN:IM - IV - SC:INJECTION:%	IM - IV - SC	15.36% IM - IV - SC INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
PDC6A3C0OX	GLYCERIN:IM - IV - SC:POWDER, FOR INJECTION SOLUTION:%	IM - IV - SC	1.2% IM - IV - SC POWDER, FOR INJECTION SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
PDC6A3C0OX	GLYCERIN:IM - SC:INJECTION:%	IM - SC	1.6% IM - SC INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
PDC6A3C0OX	GLYCERIN:INHALATION:SOLUTION:%	INHALATION	7.3% INHALATION SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
PDC6A3C0OX	GLYCERIN:INTRADERMAL:INJECTION:%	INTRADERMAL	1.6% INTRADERMAL INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
PDC6A3C0OX	GLYCERIN:INTRAMUSCULAR:INJECTABLE:%W/V	INTRAMUSCULAR	1.78%W/V INTRAMUSCULAR INJECTABLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
PDC6A3C0OX	GLYCERIN:INTRAMUSCULAR:INJECTION:%	INTRAMUSCULAR	15% INTRAMUSCULAR INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
PDC6A3C0OX	GLYCERIN:INTRAMUSCULAR:INJECTION, SOLUTION:%	INTRAMUSCULAR	15% INTRAMUSCULAR INJECTION, SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
PDC6A3C0OX	GLYCERIN:INTRAVENOUS:EMULSION, INJECTION:%	INTRAVENOUS	2.5% INTRAVENOUS EMULSION, INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
PDC6A3C0OX	GLYCERIN:INTRAVENOUS:INJECTABLE:%	INTRAVENOUS	2.25% INTRAVENOUS INJECTABLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
PDC6A3C0OX	GLYCERIN:INTRAVENOUS:INJECTION:%	INTRAVENOUS	15% INTRAVENOUS INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
PDC6A3C0OX	GLYCERIN:INTRAVENOUS:INJECTION, EMULSION:%	INTRAVENOUS	2.5% INTRAVENOUS INJECTION, EMULSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
PDC6A3C0OX	GLYCERIN:INTRAVENOUS:INJECTION, SOLUTION:%	INTRAVENOUS	15% INTRAVENOUS INJECTION, SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
PDC6A3C0OX	GLYCERIN:INTRAVENOUS:SOLUTION, INJECTION:MG/1ML	INTRAVENOUS	18.82MG/1ML INTRAVENOUS SOLUTION, INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
PDC6A3C0OX	GLYCERIN:IONTOPHORESIS:PATCH, CONTROLLED RELEASE:MG	IONTOPHORESIS	168.1MG IONTOPHORESIS PATCH, CONTROLLED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
PDC6A3C0OX	GLYCERIN:IV - SC:INJECTION:%	IV - SC	1.2% IV - SC INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
PDC6A3C0OX	GLYCERIN:IV - SC:INJECTION, SOLUTION:MG/1ML	IV - SC	3.3MG/1ML IV - SC INJECTION, SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
PDC6A3C0OX	GLYCERIN:IV(INFUSION):EMULSION:NA	IV(INFUSION)	IV(INFUSION) EMULSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
PDC6A3C0OX	GLYCERIN:IV(INFUSION):EMULSION, INJECTION:%	IV(INFUSION)	22.5% IV(INFUSION) EMULSION, INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
PDC6A3C0OX	GLYCERIN:IV(INFUSION):POWDER, FOR INJECTION SOLUTION, LYOPHILIZED:%	IV(INFUSION)	22.5% IV(INFUSION) POWDER, FOR INJECTION SOLUTION, LYOPHILIZED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
PDC6A3C0OX	GLYCERIN:NASAL:GEL:NA	NASAL	NASAL GEL	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
PDC6A3C0OX	GLYCERIN:NASAL:SOLUTION:%	NASAL	2.5% NASAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
PDC6A3C0OX	GLYCERIN:NASAL:SPRAY:%	NASAL	2.3% NASAL SPRAY	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
PDC6A3C0OX	GLYCERIN:NASAL:SPRAY, METERED:MCG/SPRAY	NASAL	3219.5MCG/SPRAY NASAL SPRAY, METERED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
PDC6A3C0OX	GLYCERIN:OPHTHALMIC:DROPS:%	OPHTHALMIC	2.25% OPHTHALMIC DROPS	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
PDC6A3C0OX	GLYCERIN:OPHTHALMIC:EMULSION:%	OPHTHALMIC	2.2% OPHTHALMIC EMULSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
PDC6A3C0OX	GLYCERIN:OPHTHALMIC:GEL:%	OPHTHALMIC	0.88% OPHTHALMIC GEL	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
PDC6A3C0OX	GLYCERIN:OPHTHALMIC:SOLUTION, DROPS:%W/V	OPHTHALMIC	2.2%W/V OPHTHALMIC SOLUTION, DROPS	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
PDC6A3C0OX	GLYCERIN:OPHTHALMIC:SUSPENSION:%	OPHTHALMIC	2.5% OPHTHALMIC SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
PDC6A3C0OX	GLYCERIN:OPHTHALMIC:SUSPENSION, DROPS:%	OPHTHALMIC	2.5% OPHTHALMIC SUSPENSION, DROPS	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
PDC6A3C0OX	GLYCERIN:ORAL:BAR, CHEWABLE:NA	ORAL	ORAL BAR, CHEWABLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
PDC6A3C0OX	GLYCERIN:ORAL:CAPSULE:MG	ORAL	249.1MG ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
PDC6A3C0OX	GLYCERIN:ORAL:CAPSULE (IMMED./COMP. RELEASE), COATED, SOFT GELATIN:MG	ORAL	41MG ORAL CAPSULE (IMMED./COMP. RELEASE), COATED, SOFT GELATIN	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
PDC6A3C0OX	GLYCERIN:ORAL:CAPSULE (IMMED./COMP. RELEASE), SOFT GELATIN:MG	ORAL	223.52MG ORAL CAPSULE (IMMED./COMP. RELEASE), SOFT GELATIN	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
PDC6A3C0OX	GLYCERIN:ORAL:CAPSULE (IMMED./COMP. RELEASE), SOFT GELATIN, PERLE:MG	ORAL	43.85MG ORAL CAPSULE (IMMED./COMP. RELEASE), SOFT GELATIN, PERLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
PDC6A3C0OX	GLYCERIN:ORAL:CAPSULE, COATED, SOFT GELATIN:MG	ORAL	91.5MG ORAL CAPSULE, COATED, SOFT GELATIN	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
PDC6A3C0OX	GLYCERIN:ORAL:CAPSULE, DELAYED ACTION:NA	ORAL	ORAL CAPSULE, DELAYED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
PDC6A3C0OX	GLYCERIN:ORAL:CAPSULE, GELATIN COATED:MG	ORAL	3.37MG ORAL CAPSULE, GELATIN COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
PDC6A3C0OX	GLYCERIN:ORAL:CAPSULE, HARD GELATIN:NA	ORAL	ORAL CAPSULE, HARD GELATIN	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
PDC6A3C0OX	GLYCERIN:ORAL:CAPSULE, SOFT GELATIN:MG	ORAL	204.2MG ORAL CAPSULE, SOFT GELATIN	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
PDC6A3C0OX	GLYCERIN:ORAL:CAPSULE, SOFT GELATIN LIQUID-FILLED:MG	ORAL	40MG ORAL CAPSULE, SOFT GELATIN LIQUID-FILLED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
PDC6A3C0OX	GLYCERIN:ORAL:CAPSULE, SUSTAINED ACTION:MG	ORAL	132.32MG ORAL CAPSULE, SUSTAINED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
PDC6A3C0OX	GLYCERIN:ORAL:CONCENTRATE:MG/1ML	ORAL	750MG/1ML ORAL CONCENTRATE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
PDC6A3C0OX	GLYCERIN:ORAL:DROPS:MG/1ML	ORAL	100MG/1ML ORAL DROPS	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
PDC6A3C0OX	GLYCERIN:ORAL:INJECTION:MG/1ML	ORAL	25MG/1ML ORAL INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
PDC6A3C0OX	GLYCERIN:ORAL:LIQUID:MG/1ML	ORAL	885.5MG/1ML ORAL LIQUID	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
PDC6A3C0OX	GLYCERIN:ORAL:ORAL SOLUTION DOSAGE FORM:mg/5mL	ORAL	500mg/5mL ORAL ORAL SOLUTION DOSAGE FORM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
PDC6A3C0OX	GLYCERIN:ORAL:SOFT CAPSULE DOSAGE FORM:mg	ORAL	59.14mg ORAL SOFT CAPSULE DOSAGE FORM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
PDC6A3C0OX	GLYCERIN:ORAL:SOLUTION:mg/5mL	ORAL	3077mg/5mL ORAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
PDC6A3C0OX	GLYCERIN:ORAL:SOLUTION:mg/15 mL	ORAL	1500mg/15 mL ORAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
PDC6A3C0OX	GLYCERIN:ORAL:SOLUTION:%W/W	ORAL	18.64%W/W ORAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
PDC6A3C0OX	GLYCERIN:ORAL:SOLUTION, CONCENTRATE:MG/1ML	ORAL	200MG/1ML ORAL SOLUTION, CONCENTRATE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
PDC6A3C0OX	GLYCERIN:ORAL:SOLUTION, ELIXIR:MG/15ML	ORAL	3108MG/15ML ORAL SOLUTION, ELIXIR	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
PDC6A3C0OX	GLYCERIN:ORAL:SOLUTION, LIQUID:MG/1ML	ORAL	222MG/1ML ORAL SOLUTION, LIQUID	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
PDC6A3C0OX	GLYCERIN:ORAL:SOLUTION, LIQUID, CONCENTRATE, ORAL:MG/1ML	ORAL	1010.81MG/1ML ORAL SOLUTION, LIQUID, CONCENTRATE, ORAL	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
PDC6A3C0OX	GLYCERIN:ORAL:SOLUTION, SYRUP:MG/5ML	ORAL	1235MG/5ML ORAL SOLUTION, SYRUP	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
PDC6A3C0OX	GLYCERIN:ORAL:SUSPENSION:MG/5ML	ORAL	2870.55MG/5ML ORAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
PDC6A3C0OX	GLYCERIN:ORAL:SUSPENSION, DROPS:MG/2.5ML	ORAL	250MG/2.5ML ORAL SUSPENSION, DROPS	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
PDC6A3C0OX	GLYCERIN:ORAL:SUSPENSION, EXTENDED RELEASE:MG/1ML	ORAL	100MG/1ML ORAL SUSPENSION, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
PDC6A3C0OX	GLYCERIN:ORAL:SUSPENSION, LIQUID:MG/1ML	ORAL	500MG/1ML ORAL SUSPENSION, LIQUID	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
PDC6A3C0OX	GLYCERIN:ORAL:SUSPENSION, SYRUP, SUSTAINED ACTION:%	ORAL	2% ORAL SUSPENSION, SYRUP, SUSTAINED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
PDC6A3C0OX	GLYCERIN:ORAL:SYRUP:%	ORAL	65% ORAL SYRUP	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
PDC6A3C0OX	GLYCERIN:ORAL:TABLET:MG	ORAL	16MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
PDC6A3C0OX	GLYCERIN:ORAL:TABLET (IMMED./COMP. RELEASE), FILM COATED:MG	ORAL	1.4MG ORAL TABLET (IMMED./COMP. RELEASE), FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
PDC6A3C0OX	GLYCERIN:ORAL:TABLET (IMMED./COMP. RELEASE), UNCOATED, CHEWABLE:MG	ORAL	1MG ORAL TABLET (IMMED./COMP. RELEASE), UNCOATED, CHEWABLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
PDC6A3C0OX	GLYCERIN:ORAL:TABLET, COATED:MG	ORAL	0.58MG ORAL TABLET, COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
PDC6A3C0OX	GLYCERIN:ORAL:TABLET, EXTENDED RELEASE:MG	ORAL	3.64MG ORAL TABLET, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
PDC6A3C0OX	GLYCERIN:ORAL:TABLET, FILM COATED:MG	ORAL	1.55MG ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
PDC6A3C0OX	GLYCERIN:ORAL:TABLET, SUSTAINED ACTION:MG	ORAL	3.45MG ORAL TABLET, SUSTAINED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
PDC6A3C0OX	GLYCERIN:PERFUSION, BILIARY:LIQUID:%	PERFUSION, BILIARY	2.5% PERFUSION, BILIARY LIQUID	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
PDC6A3C0OX	GLYCERIN:RECTAL:SUPPOSITORY:MG	RECTAL	128MG RECTAL SUPPOSITORY	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
PDC6A3C0OX	GLYCERIN:SUBCUTANEOUS:INJECTABLE:%	SUBCUTANEOUS	2% SUBCUTANEOUS INJECTABLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
PDC6A3C0OX	GLYCERIN:SUBCUTANEOUS:INJECTION:%	SUBCUTANEOUS	32.5% SUBCUTANEOUS INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
PDC6A3C0OX	GLYCERIN:SUBCUTANEOUS:INJECTION, SOLUTION:%	SUBCUTANEOUS	15% SUBCUTANEOUS INJECTION, SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
PDC6A3C0OX	GLYCERIN:SUBCUTANEOUS:SOLUTION, INJECTION:%	SUBCUTANEOUS	1.9% SUBCUTANEOUS SOLUTION, INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
PDC6A3C0OX	GLYCERIN:SUBCUTANEOUS:SUSPENSION:%	SUBCUTANEOUS	1.6% SUBCUTANEOUS SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
PDC6A3C0OX	GLYCERIN:SUBCUTANEOUS:SUSPENSION, INJECTION:%	SUBCUTANEOUS	1.6% SUBCUTANEOUS SUSPENSION, INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
PDC6A3C0OX	GLYCERIN:TOPICAL:AEROSOL:%W/W	TOPICAL	3%W/W TOPICAL AEROSOL	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
PDC6A3C0OX	GLYCERIN:TOPICAL:CREAM:%W/W	TOPICAL	20%W/W TOPICAL CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
PDC6A3C0OX	GLYCERIN:TOPICAL:CREAM, AUGMENTED:%W/W	TOPICAL	4%W/W TOPICAL CREAM, AUGMENTED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
PDC6A3C0OX	GLYCERIN:TOPICAL:CREAM, EMULSION, SUSTAINED RELEASE:%W/W	TOPICAL	3%W/W TOPICAL CREAM, EMULSION, SUSTAINED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
PDC6A3C0OX	GLYCERIN:TOPICAL:DROPS:NA	TOPICAL	TOPICAL DROPS	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
PDC6A3C0OX	GLYCERIN:TOPICAL:EMULSION, AEROSOL FOAM:%W/W	TOPICAL	2.11%W/W TOPICAL EMULSION, AEROSOL FOAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
PDC6A3C0OX	GLYCERIN:TOPICAL:EMULSION, CREAM:%W/W	TOPICAL	20%W/W TOPICAL EMULSION, CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
PDC6A3C0OX	GLYCERIN:TOPICAL:FILM, CONTROLLED RELEASE:MG	TOPICAL	2520MG TOPICAL FILM, CONTROLLED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
PDC6A3C0OX	GLYCERIN:TOPICAL:GEL:%W/W	TOPICAL	20%W/W TOPICAL GEL	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
PDC6A3C0OX	GLYCERIN:TOPICAL:LIQUID:%W/W	TOPICAL	7.2%W/W TOPICAL LIQUID	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
PDC6A3C0OX	GLYCERIN:TOPICAL:LOTION:%W/W	TOPICAL	11.2%W/W TOPICAL LOTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
PDC6A3C0OX	GLYCERIN:TOPICAL:OINTMENT:NA	TOPICAL	TOPICAL OINTMENT	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
PDC6A3C0OX	GLYCERIN:TOPICAL:OPHTHALMIC SUSPENSION DOSAGE FORM:%W/V	TOPICAL	0.6%W/V TOPICAL OPHTHALMIC SUSPENSION DOSAGE FORM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
PDC6A3C0OX	GLYCERIN:TOPICAL:PATCH:MG	TOPICAL	2870MG TOPICAL PATCH	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
PDC6A3C0OX	GLYCERIN:TOPICAL:PATCH, CONTROLLED RELEASE:MG	TOPICAL	168.1MG TOPICAL PATCH, CONTROLLED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
PDC6A3C0OX	GLYCERIN:TOPICAL:SOLUTION:%W/W	TOPICAL	11.5%W/W TOPICAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
PDC6A3C0OX	GLYCERIN:TOPICAL:SPONGE:NA	TOPICAL	TOPICAL SPONGE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
PDC6A3C0OX	GLYCERIN:TOPICAL:SUPPOSITORY, INSERT:NA	TOPICAL	TOPICAL SUPPOSITORY, INSERT	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
PDC6A3C0OX	GLYCERIN:TOPICAL:SUSPENSION:%W/W	TOPICAL	5%W/W TOPICAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
PDC6A3C0OX	GLYCERIN:TRANSDERMAL:FILM, CONTROLLED RELEASE:MG	TRANSDERMAL	306.2MG TRANSDERMAL FILM, CONTROLLED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
PDC6A3C0OX	GLYCERIN:TRANSDERMAL:GEL:%W/W	TRANSDERMAL	5%W/W TRANSDERMAL GEL	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
PDC6A3C0OX	GLYCERIN:VAGINAL:CREAM, EMULSION, SUSTAINED RELEASE:%W/W	VAGINAL	17%W/W VAGINAL CREAM, EMULSION, SUSTAINED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
PDC6A3C0OX	GLYCERIN:VAGINAL:EMULSION, CREAM:%W/W	VAGINAL	5%W/W VAGINAL EMULSION, CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
PDC6A3C0OX	GLYCERIN:VAGINAL:GEL:%	VAGINAL	14.51% VAGINAL GEL	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
PDC6A3C0OX	GLYCERIN:VAGINAL:SUPPOSITORY:MG	VAGINAL	227.9MG VAGINAL SUPPOSITORY	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
8J6RDU8L9X	D&C GREEN NO. 5:ORAL:CAPSULE, SUSTAINED ACTION:MG	ORAL	0.003MG ORAL CAPSULE, SUSTAINED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
8J6RDU8L9X	D&C GREEN NO. 5:ORAL:SOLUTION:NA	ORAL	ORAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
8J6RDU8L9X	D&C GREEN NO. 5:ORAL:SOLUTION, ELIXIR:NA	ORAL	ORAL SOLUTION, ELIXIR	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
8J6RDU8L9X	D&C GREEN NO. 5:ORAL:TABLET:MG	ORAL	0.015MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
8J6RDU8L9X	D&C GREEN NO. 5:ORAL:TABLET, COATED:NA	ORAL	ORAL TABLET, COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
8J6RDU8L9X	D&C GREEN NO. 5:TOPICAL:EMULSION, CREAM:NA	TOPICAL	TOPICAL EMULSION, CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
8J6RDU8L9X	D&C GREEN NO. 5:TOPICAL:LOTION:NA	TOPICAL	TOPICAL LOTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
M629807ATL	IMIDUREA:TOPICAL:CREAM:%W/W	TOPICAL	0.3%W/W TOPICAL CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=I
M629807ATL	IMIDUREA:TOPICAL:EMULSION, CREAM:%W/W	TOPICAL	0.4%W/W TOPICAL EMULSION, CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=I
M629807ATL	IMIDUREA:TOPICAL:EMULSION, LOTION:%W/W	TOPICAL	0.14%W/W TOPICAL EMULSION, LOTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=I
M629807ATL	IMIDUREA:TOPICAL:LOTION:%W/W	TOPICAL	0.2%W/W TOPICAL LOTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=I
M629807ATL	IMIDUREA:TOPICAL:SHAMPOO:%W/W	TOPICAL	0.4%W/W TOPICAL SHAMPOO	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=I
XOF597Q3KY	MICROCRYSTALLINE WAX:ORAL:CAPSULE, SUSTAINED ACTION:MG	ORAL	6MG ORAL CAPSULE, SUSTAINED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
XOF597Q3KY	MICROCRYSTALLINE WAX:TOPICAL:CREAM, EMULSION, SUSTAINED RELEASE:%W/W	TOPICAL	0.45%W/W TOPICAL CREAM, EMULSION, SUSTAINED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
XOF597Q3KY	MICROCRYSTALLINE WAX:TOPICAL:GEL:NA	TOPICAL	TOPICAL GEL	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
XOF597Q3KY	MICROCRYSTALLINE WAX:TOPICAL:OINTMENT:%W/W	TOPICAL	30%W/W TOPICAL OINTMENT	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
XOF597Q3KY	MICROCRYSTALLINE WAX:VAGINAL:CREAM, EMULSION, SUSTAINED RELEASE:%W/W	VAGINAL	0.45%W/W VAGINAL CREAM, EMULSION, SUSTAINED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
XOF597Q3KY	MICROCRYSTALLINE WAX:VAGINAL:EMULSION, CREAM:%	VAGINAL	0.45% VAGINAL EMULSION, CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
481744AI4O	D&C RED NO. 6:ORAL:TABLET, COATED:NA	ORAL	ORAL TABLET, COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
481744AI4O	D&C RED NO. 6:ORAL:TABLET, EXTENDED RELEASE:MG	ORAL	0.2MG ORAL TABLET, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
E1W4N241FO	SODIUM PHOSPHATE, DIBASIC, DODECAHYDRATE:INTRAVENOUS:SOLUTION, INJECTION:%	INTRAVENOUS	0.39% INTRAVENOUS SOLUTION, INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
E1W4N241FO	SODIUM PHOSPHATE, DIBASIC, DODECAHYDRATE:NASAL:SPRAY:MG/SPR	NASAL	0.86MG/SPR NASAL SPRAY	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
E1W4N241FO	SODIUM PHOSPHATE, DIBASIC, DODECAHYDRATE:NASAL:SPRAY:%	NASAL	0.66% NASAL SPRAY	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
E1W4N241FO	SODIUM PHOSPHATE, DIBASIC, DODECAHYDRATE:NASAL:SPRAY, METERED:%	NASAL	14.3% NASAL SPRAY, METERED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
E1W4N241FO	SODIUM PHOSPHATE, DIBASIC, DODECAHYDRATE:OPHTHALMIC:SOLUTION:%	OPHTHALMIC	1.26% OPHTHALMIC SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
E1W4N241FO	SODIUM PHOSPHATE, DIBASIC, DODECAHYDRATE:OPHTHALMIC:SOLUTION, DROPS:%	OPHTHALMIC	1.67% OPHTHALMIC SOLUTION, DROPS	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
FC72KVT52F	ETHYLENE GLYCOL:TOPICAL:CREAM:%W/W	TOPICAL	0.8%W/W TOPICAL CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
FC72KVT52F	ETHYLENE GLYCOL:TOPICAL:SHAMPOO, SUSPENSION:%W/V	TOPICAL	1%W/V TOPICAL SHAMPOO, SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
8334LX7S21	HARD FAT:ORAL:CAPSULE, SOFT GELATIN:MG	ORAL	76.5MG ORAL CAPSULE, SOFT GELATIN	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
8334LX7S21	HARD FAT:RECTAL:SUPPOSITORY:MG	RECTAL	1920MG RECTAL SUPPOSITORY	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
1I96OHX6EK	HYDROXYPROPYL BETADEX:INTRAMUSCULAR:INJECTION:%W/V	INTRAMUSCULAR	33.33%W/V INTRAMUSCULAR INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
1I96OHX6EK	HYDROXYPROPYL BETADEX:INTRAVENOUS:INJECTION:%	INTRAVENOUS	94.1% INTRAVENOUS INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
1I96OHX6EK	HYDROXYPROPYL BETADEX:INTRAVENOUS:POWDER, FOR INJECTION SOLUTION, LYOPHILIZED:%	INTRAVENOUS	20% INTRAVENOUS POWDER, FOR INJECTION SOLUTION, LYOPHILIZED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
1I96OHX6EK	HYDROXYPROPYL BETADEX:IV(INFUSION):INJECTION:%	IV(INFUSION)	33.33% IV(INFUSION) INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
1I96OHX6EK	HYDROXYPROPYL BETADEX:IV(INFUSION):POWDER, FOR INJECTION SOLUTION, LYOPHILIZED:%	IV(INFUSION)	15% IV(INFUSION) POWDER, FOR INJECTION SOLUTION, LYOPHILIZED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
1I96OHX6EK	HYDROXYPROPYL BETADEX:ORAL:SOLUTION:MG/1ML	ORAL	400MG/1ML ORAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
1I96OHX6EK	HYDROXYPROPYL BETADEX:ORAL:TABLET, ORALLY DISINTEGRATING:MG	ORAL	15MG ORAL TABLET, ORALLY DISINTEGRATING	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
Z8IX2SC1OH	PROPYLPARABEN:AN,INFILTRATION:INJECTION:%	AN,INFILTRATION	0.01% AN,INFILTRATION INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
Z8IX2SC1OH	PROPYLPARABEN:AURICULAR (OTIC):SUSPENSION:%	AURICULAR (OTIC)	0.001% AURICULAR (OTIC) SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
Z8IX2SC1OH	PROPYLPARABEN:BUCCAL:FILM:MG	BUCCAL	0.22MG BUCCAL FILM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
Z8IX2SC1OH	PROPYLPARABEN:BUCCAL:FILM, SOLUBLE:MG	BUCCAL	0.18MG BUCCAL FILM, SOLUBLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
Z8IX2SC1OH	PROPYLPARABEN:IM - IV:INJECTABLE:%	IM - IV	0.015% IM - IV INJECTABLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
Z8IX2SC1OH	PROPYLPARABEN:IM - IV:INJECTION:%	IM - IV	0.2% IM - IV INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
Z8IX2SC1OH	PROPYLPARABEN:IM - IV:POWDER, FOR INJECTION SOLUTION:%	IM - IV	0.04% IM - IV POWDER, FOR INJECTION SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
Z8IX2SC1OH	PROPYLPARABEN:IM - IV:SOLUTION:%	IM - IV	0.016% IM - IV SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
Z8IX2SC1OH	PROPYLPARABEN:IM - IV - SC:INJECTION:%	IM - IV - SC	20% IM - IV - SC INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
Z8IX2SC1OH	PROPYLPARABEN:IM - SC:INJECTION:%	IM - SC	0.02% IM - SC INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
Z8IX2SC1OH	PROPYLPARABEN:INTRA-ARTERIAL:INJECTION:NA	INTRA-ARTERIAL	INTRA-ARTERIAL INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
Z8IX2SC1OH	PROPYLPARABEN:INTRA-ARTICULAR:INJECTION:%	INTRA-ARTICULAR	0.16% INTRA-ARTICULAR INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
Z8IX2SC1OH	PROPYLPARABEN:INTRABURSAL:INJECTION:%	INTRABURSAL	0.02% INTRABURSAL INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
Z8IX2SC1OH	PROPYLPARABEN:INTRALESIONAL:INJECTION:%	INTRALESIONAL	0.02% INTRALESIONAL INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
Z8IX2SC1OH	PROPYLPARABEN:INTRAMUSCULAR:INJECTABLE:%W/V	INTRAMUSCULAR	0.02%W/V INTRAMUSCULAR INJECTABLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
Z8IX2SC1OH	PROPYLPARABEN:INTRAMUSCULAR:INJECTION:%	INTRAMUSCULAR	0.16% INTRAMUSCULAR INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
Z8IX2SC1OH	PROPYLPARABEN:INTRAMUSCULAR:INJECTION, SOLUTION:MG/1ML	INTRAMUSCULAR	0.2MG/1ML INTRAMUSCULAR INJECTION, SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
Z8IX2SC1OH	PROPYLPARABEN:INTRAMUSCULAR:INJECTION, SUSPENSION:%	INTRAMUSCULAR	0.015% INTRAMUSCULAR INJECTION, SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
Z8IX2SC1OH	PROPYLPARABEN:INTRAMUSCULAR:SOLUTION, INJECTION:NA	INTRAMUSCULAR	INTRAMUSCULAR SOLUTION, INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
Z8IX2SC1OH	PROPYLPARABEN:INTRAMUSCULAR:SUSPENSION:%	INTRAMUSCULAR	0.02% INTRAMUSCULAR SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
Z8IX2SC1OH	PROPYLPARABEN:INTRAMUSCULAR:SUSPENSION, INJECTION:%W/V	INTRAMUSCULAR	0.015%W/V INTRAMUSCULAR SUSPENSION, INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
Z8IX2SC1OH	PROPYLPARABEN:INTRASYNOVIAL:INJECTION:NA	INTRASYNOVIAL	INTRASYNOVIAL INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
Z8IX2SC1OH	PROPYLPARABEN:INTRATUMOR:INJECTION:%	INTRATUMOR	0.02% INTRATUMOR INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
Z8IX2SC1OH	PROPYLPARABEN:INTRAVASCULAR:INJECTION:%	INTRAVASCULAR	0.03% INTRAVASCULAR INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
Z8IX2SC1OH	PROPYLPARABEN:INTRAVENOUS:INJECTABLE:%	INTRAVENOUS	0.08% INTRAVENOUS INJECTABLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
Z8IX2SC1OH	PROPYLPARABEN:INTRAVENOUS:INJECTION:%	INTRAVENOUS	0.1% INTRAVENOUS INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
Z8IX2SC1OH	PROPYLPARABEN:INTRAVENOUS:INJECTION, SOLUTION:MG/1ML	INTRAVENOUS	0.2MG/1ML INTRAVENOUS INJECTION, SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
Z8IX2SC1OH	PROPYLPARABEN:INTRAVENOUS:INJECTION, SOLUTION:%	INTRAVENOUS	0.02% INTRAVENOUS INJECTION, SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
Z8IX2SC1OH	PROPYLPARABEN:INTRAVENOUS:POWDER, FOR INJECTION SOLUTION:%	INTRAVENOUS	0.08% INTRAVENOUS POWDER, FOR INJECTION SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
Z8IX2SC1OH	PROPYLPARABEN:INTRAVENOUS:SOLUTION, INJECTION:%	INTRAVENOUS	0.02% INTRAVENOUS SOLUTION, INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
Z8IX2SC1OH	PROPYLPARABEN:INTRAVENOUS INFUSION:INJECTION:MG/1ML	INTRAVENOUS INFUSION	0.2MG/1ML INTRAVENOUS INFUSION INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
Z8IX2SC1OH	PROPYLPARABEN:IV - SC:INJECTION:%	IV - SC	0.02% IV - SC INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
Z8IX2SC1OH	PROPYLPARABEN:IV(INFUSION):INJECTION:%	IV(INFUSION)	0.056% IV(INFUSION) INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
Z8IX2SC1OH	PROPYLPARABEN:IV(INFUSION):POWDER, FOR INJECTION SOLUTION:%	IV(INFUSION)	0.04% IV(INFUSION) POWDER, FOR INJECTION SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
Z8IX2SC1OH	PROPYLPARABEN:NASAL:SOLUTION:%	NASAL	0.017% NASAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
Z8IX2SC1OH	PROPYLPARABEN:NASAL:SOLUTION, SPRAY:%	NASAL	0.02% NASAL SOLUTION, SPRAY	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
Z8IX2SC1OH	PROPYLPARABEN:NASAL:SPRAY, METERED:%	NASAL	0.3% NASAL SPRAY, METERED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
Z8IX2SC1OH	PROPYLPARABEN:NERVE BLOCK:INJECTION:%	NERVE BLOCK	0.035% NERVE BLOCK INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
Z8IX2SC1OH	PROPYLPARABEN:OPHTHALMIC:OINTMENT:%	OPHTHALMIC	0.01% OPHTHALMIC OINTMENT	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
Z8IX2SC1OH	PROPYLPARABEN:OPHTHALMIC:SOLUTION:%	OPHTHALMIC	0.015% OPHTHALMIC SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
Z8IX2SC1OH	PROPYLPARABEN:OPHTHALMIC:SOLUTION, DROPS:%	OPHTHALMIC	0.011% OPHTHALMIC SOLUTION, DROPS	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
Z8IX2SC1OH	PROPYLPARABEN:OPHTHALMIC:SUSPENSION:%	OPHTHALMIC	0.01% OPHTHALMIC SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
Z8IX2SC1OH	PROPYLPARABEN:OPHTHALMIC:SUSPENSION, DROPS:%	OPHTHALMIC	0.01% OPHTHALMIC SUSPENSION, DROPS	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
Z8IX2SC1OH	PROPYLPARABEN:ORAL:CAPSULE:MG	ORAL	0.21MG ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
Z8IX2SC1OH	PROPYLPARABEN:ORAL:CAPSULE (IMMED./COMP. RELEASE), SOFT GELATIN, PERLE:MG	ORAL	0.081MG ORAL CAPSULE (IMMED./COMP. RELEASE), SOFT GELATIN, PERLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
Z8IX2SC1OH	PROPYLPARABEN:ORAL:CAPSULE, COATED, SOFT GELATIN:MG	ORAL	0.053MG ORAL CAPSULE, COATED, SOFT GELATIN	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
Z8IX2SC1OH	PROPYLPARABEN:ORAL:CAPSULE, HARD GELATIN:NA	ORAL	ORAL CAPSULE, HARD GELATIN	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
Z8IX2SC1OH	PROPYLPARABEN:ORAL:CAPSULE, SOFT GELATIN:MG	ORAL	0.12MG ORAL CAPSULE, SOFT GELATIN	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
Z8IX2SC1OH	PROPYLPARABEN:ORAL:CAPSULE, SUSTAINED ACTION:MG	ORAL	0.22MG ORAL CAPSULE, SUSTAINED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
Z8IX2SC1OH	PROPYLPARABEN:ORAL:CONCENTRATE:MG/5ML	ORAL	2.5MG/5ML ORAL CONCENTRATE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
Z8IX2SC1OH	PROPYLPARABEN:ORAL:DROPS:NA	ORAL	ORAL DROPS	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
Z8IX2SC1OH	PROPYLPARABEN:ORAL:EMULSION:NA	ORAL	ORAL EMULSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
Z8IX2SC1OH	PROPYLPARABEN:ORAL:LIQUID:MG/1ML	ORAL	0.2MG/1ML ORAL LIQUID	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
Z8IX2SC1OH	PROPYLPARABEN:ORAL:POWDER:%	ORAL	0.04% ORAL POWDER	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
Z8IX2SC1OH	PROPYLPARABEN:ORAL:POWDER, FOR ORAL SOLUTION:MG	ORAL	0.15MG ORAL POWDER, FOR ORAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
Z8IX2SC1OH	PROPYLPARABEN:ORAL:POWDER, FOR ORAL SUSPENSION:%W/W	ORAL	0.08%W/W ORAL POWDER, FOR ORAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
Z8IX2SC1OH	PROPYLPARABEN:ORAL:POWDER, FOR SOLUTION:MG/1ML	ORAL	0.16MG/1ML ORAL POWDER, FOR SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
Z8IX2SC1OH	PROPYLPARABEN:ORAL:POWDER, FOR SUSPENSION:MG/5ML	ORAL	4MG/5ML ORAL POWDER, FOR SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
Z8IX2SC1OH	PROPYLPARABEN:ORAL:SOLUTION:MG	ORAL	100MG ORAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
Z8IX2SC1OH	PROPYLPARABEN:ORAL:SOLUTION:mg/15 mL	ORAL	3mg/15 mL ORAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
Z8IX2SC1OH	PROPYLPARABEN:ORAL:SOLUTION:MG/5ML	ORAL	1MG/5ML ORAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
Z8IX2SC1OH	PROPYLPARABEN:ORAL:SOLUTION:MG/1ML	ORAL	0.1MG/1ML ORAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
Z8IX2SC1OH	PROPYLPARABEN:ORAL:SOLUTION:%W/W	ORAL	0.017%W/W ORAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
Z8IX2SC1OH	PROPYLPARABEN:ORAL:SOLUTION, CONCENTRATE:MG/1ML	ORAL	0.2MG/1ML ORAL SOLUTION, CONCENTRATE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
Z8IX2SC1OH	PROPYLPARABEN:ORAL:SOLUTION, ELIXIR:MG/15ML	ORAL	3MG/15ML ORAL SOLUTION, ELIXIR	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
Z8IX2SC1OH	PROPYLPARABEN:ORAL:SOLUTION, LIQUID:MG/1ML	ORAL	0.2MG/1ML ORAL SOLUTION, LIQUID	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
Z8IX2SC1OH	PROPYLPARABEN:ORAL:SOLUTION, SYRUP:MG/1ML	ORAL	1MG/1ML ORAL SOLUTION, SYRUP	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
Z8IX2SC1OH	PROPYLPARABEN:ORAL:SUSPENSION:MG/5ML	ORAL	200MG/5ML ORAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
Z8IX2SC1OH	PROPYLPARABEN:ORAL:SUSPENSION:MG/15 ML	ORAL	1.95MG/15 ML ORAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
Z8IX2SC1OH	PROPYLPARABEN:ORAL:SUSPENSION:mg/1mL	ORAL	0.32mg/1mL ORAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
Z8IX2SC1OH	PROPYLPARABEN:ORAL:SUSPENSION, EXTENDED RELEASE:%	ORAL	20% ORAL SUSPENSION, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
Z8IX2SC1OH	PROPYLPARABEN:ORAL:SUSPENSION, LIQUID:MG/5ML	ORAL	3MG/5ML ORAL SUSPENSION, LIQUID	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
Z8IX2SC1OH	PROPYLPARABEN:ORAL:SUSPENSION, SUSTAINED ACTION:MG/5ML	ORAL	1.5MG/5ML ORAL SUSPENSION, SUSTAINED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
Z8IX2SC1OH	PROPYLPARABEN:ORAL:SYRUP:MG/5ML	ORAL	200MG/5ML ORAL SYRUP	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
Z8IX2SC1OH	PROPYLPARABEN:ORAL:TABLET:MG	ORAL	0.2MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
Z8IX2SC1OH	PROPYLPARABEN:ORAL:TABLET (IMMED./COMP. RELEASE), UNCOATED, CHEWABLE:MG	ORAL	0.14MG ORAL TABLET (IMMED./COMP. RELEASE), UNCOATED, CHEWABLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
Z8IX2SC1OH	PROPYLPARABEN:ORAL:TABLET, COATED:MG	ORAL	0.002MG ORAL TABLET, COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
Z8IX2SC1OH	PROPYLPARABEN:ORAL:TABLET, FILM COATED:MG	ORAL	0.04MG ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
Z8IX2SC1OH	PROPYLPARABEN:ORAL:TABLET, SUSTAINED ACTION:MG	ORAL	0.12MG ORAL TABLET, SUSTAINED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
Z8IX2SC1OH	PROPYLPARABEN:PARENTERAL:INJECTION:%	PARENTERAL	0.02% PARENTERAL INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
Z8IX2SC1OH	PROPYLPARABEN:RECTAL:AEROSOL, METERED:%	RECTAL	0.009% RECTAL AEROSOL, METERED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
Z8IX2SC1OH	PROPYLPARABEN:RECTAL:LIQUID:%	RECTAL	0.015% RECTAL LIQUID	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
Z8IX2SC1OH	PROPYLPARABEN:RECTAL:SOLUTION:%	RECTAL	0.015% RECTAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
Z8IX2SC1OH	PROPYLPARABEN:RECTAL:SUSPENSION:%	RECTAL	0.034% RECTAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
Z8IX2SC1OH	PROPYLPARABEN:SOFT TISSUE:INJECTION:%	SOFT TISSUE	0.02% SOFT TISSUE INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
Z8IX2SC1OH	PROPYLPARABEN:SUBCUTANEOUS:INJECTION:%	SUBCUTANEOUS	0.03% SUBCUTANEOUS INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
Z8IX2SC1OH	PROPYLPARABEN:SUBCUTANEOUS:SUSPENSION, INJECTION:%	SUBCUTANEOUS	0.023% SUBCUTANEOUS SUSPENSION, INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
Z8IX2SC1OH	PROPYLPARABEN:TOPICAL:CREAM:%W/W	TOPICAL	0.4%W/W TOPICAL CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
Z8IX2SC1OH	PROPYLPARABEN:TOPICAL:CREAM, AUGMENTED:%W/W	TOPICAL	0.1%W/W TOPICAL CREAM, AUGMENTED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
Z8IX2SC1OH	PROPYLPARABEN:TOPICAL:CREAM, EMULSION, SUSTAINED RELEASE:%W/W	TOPICAL	0.1%W/W TOPICAL CREAM, EMULSION, SUSTAINED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
Z8IX2SC1OH	PROPYLPARABEN:TOPICAL:EMULSION:%W/W	TOPICAL	0.06%W/W TOPICAL EMULSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
Z8IX2SC1OH	PROPYLPARABEN:TOPICAL:EMULSION, AEROSOL FOAM:%W/W	TOPICAL	0.011%W/W TOPICAL EMULSION, AEROSOL FOAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
Z8IX2SC1OH	PROPYLPARABEN:TOPICAL:EMULSION, CREAM:%W/W	TOPICAL	5.25%W/W TOPICAL EMULSION, CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
Z8IX2SC1OH	PROPYLPARABEN:TOPICAL:EMULSION, LOTION:%W/W	TOPICAL	0.06%W/W TOPICAL EMULSION, LOTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
Z8IX2SC1OH	PROPYLPARABEN:TOPICAL:GEL:%W/W	TOPICAL	0.05%W/W TOPICAL GEL	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
Z8IX2SC1OH	PROPYLPARABEN:TOPICAL:JELLY:%W/V	TOPICAL	0.03%W/V TOPICAL JELLY	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
Z8IX2SC1OH	PROPYLPARABEN:TOPICAL:LOTION:%W/W	TOPICAL	0.2%W/W TOPICAL LOTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
Z8IX2SC1OH	PROPYLPARABEN:TOPICAL:OINTMENT:%W/W	TOPICAL	0.2%W/W TOPICAL OINTMENT	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
Z8IX2SC1OH	PROPYLPARABEN:TOPICAL:PATCH:NA	TOPICAL	TOPICAL PATCH	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
Z8IX2SC1OH	PROPYLPARABEN:TOPICAL:PATCH, CONTROLLED RELEASE:NA	TOPICAL	TOPICAL PATCH, CONTROLLED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
Z8IX2SC1OH	PROPYLPARABEN:TOPICAL:SHAMPOO:%W/W	TOPICAL	0.03%W/W TOPICAL SHAMPOO	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
Z8IX2SC1OH	PROPYLPARABEN:TOPICAL:SOLUTION:%W/W	TOPICAL	0.033%W/W TOPICAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
Z8IX2SC1OH	PROPYLPARABEN:TOPICAL:SPRAY:%W/W	TOPICAL	0.8%W/W TOPICAL SPRAY	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
Z8IX2SC1OH	PROPYLPARABEN:URETERAL:SOLUTION:NA	URETERAL	URETERAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
Z8IX2SC1OH	PROPYLPARABEN:URETHRAL:INJECTION:%	URETHRAL	0.02% URETHRAL INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
Z8IX2SC1OH	PROPYLPARABEN:URETHRAL:JELLY:%	URETHRAL	0.03% URETHRAL JELLY	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
Z8IX2SC1OH	PROPYLPARABEN:VAGINAL:CREAM, EMULSION, SUSTAINED RELEASE:%	VAGINAL	0.05% VAGINAL CREAM, EMULSION, SUSTAINED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
Z8IX2SC1OH	PROPYLPARABEN:VAGINAL:EMULSION, CREAM:%	VAGINAL	0.1% VAGINAL EMULSION, CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
Z8IX2SC1OH	PROPYLPARABEN:VAGINAL:GEL:%	VAGINAL	0.02% VAGINAL GEL	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
Z8IX2SC1OH	PROPYLPARABEN:VAGINAL:SUPPOSITORY:NA	VAGINAL	VAGINAL SUPPOSITORY	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
30KYC7MIAI	ASPARTIC ACID:INTRAVENOUS:INJECTION:%	INTRAVENOUS	0.4% INTRAVENOUS INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
30KYC7MIAI	ASPARTIC ACID:IV(INFUSION):INJECTION:%	IV(INFUSION)	0.68% IV(INFUSION) INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
30KYC7MIAI	ASPARTIC ACID:IV(INFUSION):POWDER, FOR INJECTION SOLUTION, LYOPHILIZED, WITH ADDITIVES:NA	IV(INFUSION)	IV(INFUSION) POWDER, FOR INJECTION SOLUTION, LYOPHILIZED, WITH ADDITIVES	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
776CJK5X56	PEG-50 STEARATE:TOPICAL:EMULSION, CREAM:%W/W	TOPICAL	2%W/W TOPICAL EMULSION, CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
776CJK5X56	PEG-50 STEARATE:TOPICAL:OINTMENT:NA	TOPICAL	TOPICAL OINTMENT	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
JY81OXM1OM	HYDROGENATED COCONUT OIL:RECTAL:SUPPOSITORY:NA	RECTAL	RECTAL SUPPOSITORY	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
2K5B8F6ES1	SODIUM DITHIONITE:IM - IV - SC:INJECTION:%	IM - IV - SC	0.1% IM - IV - SC INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
2K5B8F6ES1	SODIUM DITHIONITE:IV(INFUSION):INJECTION:%	IV(INFUSION)	0.1% IV(INFUSION) INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
NMQ347994Z	CYCLOMETHICONE:TOPICAL:CREAM:%W/W	TOPICAL	5%W/W TOPICAL CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
NMQ347994Z	CYCLOMETHICONE:TOPICAL:CREAM, AUGMENTED:%W/W	TOPICAL	7.6%W/W TOPICAL CREAM, AUGMENTED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
NMQ347994Z	CYCLOMETHICONE:TOPICAL:EMULSION, AEROSOL FOAM:%W/W	TOPICAL	5.26%W/W TOPICAL EMULSION, AEROSOL FOAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
NMQ347994Z	CYCLOMETHICONE:TOPICAL:EMULSION, CREAM:%W/W	TOPICAL	13%W/W TOPICAL EMULSION, CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
NMQ347994Z	CYCLOMETHICONE:TOPICAL:LOTION:%W/W	TOPICAL	4%W/W TOPICAL LOTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
NMQ347994Z	CYCLOMETHICONE:TOPICAL:SOLUTION:%W/W	TOPICAL	13%W/W TOPICAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
FVS1AZD90Y	POLYETHYLENE GLYCOL 3500:ORAL:TABLET:MG	ORAL	3.05MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
FVS1AZD90Y	POLYETHYLENE GLYCOL 3500:ORAL:TABLET, FILM COATED:NA	ORAL	ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
7QWA1RIO01	.ALPHA.-TOCOPHEROL, DL-:INTRAVENOUS:INJECTION, EMULSION:%	INTRAVENOUS	0.03% INTRAVENOUS INJECTION, EMULSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
7QWA1RIO01	.ALPHA.-TOCOPHEROL, DL-:INTRAVENOUS:SOLUTION, CONCENTRATE:%	INTRAVENOUS	0.075% INTRAVENOUS SOLUTION, CONCENTRATE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
7QWA1RIO01	.ALPHA.-TOCOPHEROL, DL-:ORAL:CAPSULE, SOFT GELATIN:MG	ORAL	0.08MG ORAL CAPSULE, SOFT GELATIN	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
7QWA1RIO01	.ALPHA.-TOCOPHEROL, DL-:ORAL:SUSPENSION:mg/1mL	ORAL	0.01mg/1mL ORAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
7QWA1RIO01	.ALPHA.-TOCOPHEROL, DL-:ORAL:SUSPENSION:MG/5ML	ORAL	0.005MG/5ML ORAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
7QWA1RIO01	.ALPHA.-TOCOPHEROL, DL-:ORAL:TABLET:MG	ORAL	0.1MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
7QWA1RIO01	.ALPHA.-TOCOPHEROL, DL-:ORAL:TABLET, CHEWABLE:mg	ORAL	0.1mg ORAL TABLET, CHEWABLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
7QWA1RIO01	.ALPHA.-TOCOPHEROL, DL-:TOPICAL:AEROSOL, FOAM:%W/W	TOPICAL	0.002%W/W TOPICAL AEROSOL, FOAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
7QWA1RIO01	.ALPHA.-TOCOPHEROL, DL-:TOPICAL:OINTMENT:%W/W	TOPICAL	0.002%W/W TOPICAL OINTMENT	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
7QWA1RIO01	.ALPHA.-TOCOPHEROL, DL-:TRANSDERMAL:PATCH:MG	TRANSDERMAL	0.135MG TRANSDERMAL PATCH	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
4550K0SC9B	SODIUM ACETATE:AN,INFILTRATION:INJECTION:%	AN,INFILTRATION	0.38% AN,INFILTRATION INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
4550K0SC9B	SODIUM ACETATE:AURICULAR (OTIC):SOLUTION:%	AURICULAR (OTIC)	0.075% AURICULAR (OTIC) SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
4550K0SC9B	SODIUM ACETATE:AURICULAR (OTIC):SOLUTION, DROPS:%	AURICULAR (OTIC)	0.027% AURICULAR (OTIC) SOLUTION, DROPS	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
4550K0SC9B	SODIUM ACETATE:AURICULAR (OTIC):SUSPENSION:%	AURICULAR (OTIC)	0.042% AURICULAR (OTIC) SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
4550K0SC9B	SODIUM ACETATE:AURICULAR (OTIC):SUSPENSION, LIQUID:%	AURICULAR (OTIC)	0.68% AURICULAR (OTIC) SUSPENSION, LIQUID	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
4550K0SC9B	SODIUM ACETATE:EXTRACORPOREAL:SOLUTION:%	EXTRACORPOREAL	0.18% EXTRACORPOREAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
4550K0SC9B	SODIUM ACETATE:IM - IV:INJECTION:%	IM - IV	0.97% IM - IV INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
4550K0SC9B	SODIUM ACETATE:IM - IV - SC:INJECTION:%	IM - IV - SC	0.65% IM - IV - SC INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
4550K0SC9B	SODIUM ACETATE:IM - SC:INJECTION:%	IM - SC	0.2% IM - SC INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
4550K0SC9B	SODIUM ACETATE:INTERSTITIAL:INJECTION:NA	INTERSTITIAL	INTERSTITIAL INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
4550K0SC9B	SODIUM ACETATE:INTRA-ARTICULAR:INJECTION:ADJ PH	INTRA-ARTICULAR	ADJ PH INTRA-ARTICULAR INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
4550K0SC9B	SODIUM ACETATE:INTRACAVITARY:INJECTION:NA	INTRACAVITARY	INTRACAVITARY INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
4550K0SC9B	SODIUM ACETATE:INTRADERMAL:INJECTION:%	INTRADERMAL	0.16% INTRADERMAL INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
4550K0SC9B	SODIUM ACETATE:INTRALESIONAL:INJECTION:ADJ PH	INTRALESIONAL	ADJ PH INTRALESIONAL INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
4550K0SC9B	SODIUM ACETATE:INTRAMUSCULAR:INJECTION:%W/V	INTRAMUSCULAR	0.4%W/V INTRAMUSCULAR INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
4550K0SC9B	SODIUM ACETATE:INTRAOCULAR:SOLUTION:%	INTRAOCULAR	0.39% INTRAOCULAR SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
4550K0SC9B	SODIUM ACETATE:INTRAPERITONEAL:INJECTION:NA	INTRAPERITONEAL	INTRAPERITONEAL INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
4550K0SC9B	SODIUM ACETATE:INTRAPLEURAL:INJECTION:NA	INTRAPLEURAL	INTRAPLEURAL INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
4550K0SC9B	SODIUM ACETATE:INTRASYNOVIAL:INJECTION:ADJ PH	INTRASYNOVIAL	ADJ PH INTRASYNOVIAL INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
4550K0SC9B	SODIUM ACETATE:INTRAVENOUS:INJECTABLE:%	INTRAVENOUS	0.2% INTRAVENOUS INJECTABLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
4550K0SC9B	SODIUM ACETATE:INTRAVENOUS:INJECTION:%	INTRAVENOUS	12.25% INTRAVENOUS INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
4550K0SC9B	SODIUM ACETATE:INTRAVENOUS:INJECTION, SOLUTION:%	INTRAVENOUS	0.04% INTRAVENOUS INJECTION, SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
4550K0SC9B	SODIUM ACETATE:INTRAVENOUS:POWDER, FOR INJECTION SOLUTION, LYOPHILIZED:%	INTRAVENOUS	12.5% INTRAVENOUS POWDER, FOR INJECTION SOLUTION, LYOPHILIZED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
4550K0SC9B	SODIUM ACETATE:INTRAVENOUS:SOLUTION:mg/1mL	INTRAVENOUS	0.2mg/1mL INTRAVENOUS SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
4550K0SC9B	SODIUM ACETATE:INTRAVENOUS:SOLUTION, INJECTION:%	INTRAVENOUS	2% INTRAVENOUS SOLUTION, INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
4550K0SC9B	SODIUM ACETATE:INTRAVENOUS INFUSION:INJECTION, SOLUTION:%	INTRAVENOUS INFUSION	0.04% INTRAVENOUS INFUSION INJECTION, SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
4550K0SC9B	SODIUM ACETATE:INTRAVITREAL:SUSPENSION, INJECTION:%	INTRAVITREAL	0.39% INTRAVITREAL SUSPENSION, INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
4550K0SC9B	SODIUM ACETATE:IV - SC:INJECTION:%	IV - SC	0.2% IV - SC INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
4550K0SC9B	SODIUM ACETATE:IV - SC:INJECTION, SOLUTION:%	IV - SC	0.2% IV - SC INJECTION, SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
4550K0SC9B	SODIUM ACETATE:IV(INFUSION):INJECTABLE:%	IV(INFUSION)	0.16% IV(INFUSION) INJECTABLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
4550K0SC9B	SODIUM ACETATE:IV(INFUSION):INJECTION:%	IV(INFUSION)	59.4% IV(INFUSION) INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
4550K0SC9B	SODIUM ACETATE:IV(INFUSION):POWDER, FOR INJECTION SOLUTION, LYOPHILIZED:%	IV(INFUSION)	6.25% IV(INFUSION) POWDER, FOR INJECTION SOLUTION, LYOPHILIZED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
4550K0SC9B	SODIUM ACETATE:IV(INFUSION):SOLUTION, INJECTION:%	IV(INFUSION)	0.68% IV(INFUSION) SOLUTION, INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
4550K0SC9B	SODIUM ACETATE:NASAL:SOLUTION:NA	NASAL	NASAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
4550K0SC9B	SODIUM ACETATE:NERVE BLOCK:INJECTION:%	NERVE BLOCK	0.38% NERVE BLOCK INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
4550K0SC9B	SODIUM ACETATE:OPHTHALMIC:EMULSION:%	OPHTHALMIC	0.05% OPHTHALMIC EMULSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
4550K0SC9B	SODIUM ACETATE:OPHTHALMIC:POWDER, FOR SOLUTION:%	OPHTHALMIC	0.39% OPHTHALMIC POWDER, FOR SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
4550K0SC9B	SODIUM ACETATE:OPHTHALMIC:SOLUTION:%	OPHTHALMIC	1.25% OPHTHALMIC SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
4550K0SC9B	SODIUM ACETATE:OPHTHALMIC:SOLUTION, DROPS:%	OPHTHALMIC	1.28% OPHTHALMIC SOLUTION, DROPS	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
4550K0SC9B	SODIUM ACETATE:ORAL:CONCENTRATE:NA	ORAL	ORAL CONCENTRATE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
4550K0SC9B	SODIUM ACETATE:ORAL:POWDER, FOR SOLUTION:MG/1GM	ORAL	99.3MG/1GM ORAL POWDER, FOR SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
4550K0SC9B	SODIUM ACETATE:ORAL:SOLUTION:MG/1000ML	ORAL	3400MG/1000ML ORAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
4550K0SC9B	SODIUM ACETATE:ORAL:SOLUTION, INJECTION:MG/1.7ML	ORAL	1.36MG/1.7ML ORAL SOLUTION, INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
4550K0SC9B	SODIUM ACETATE:ORAL:SOLUTION, SYRUP:MG/5ML	ORAL	7.2MG/5ML ORAL SOLUTION, SYRUP	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
4550K0SC9B	SODIUM ACETATE:ORAL:SYRUP:MG/5ML	ORAL	21.45MG/5ML ORAL SYRUP	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
4550K0SC9B	SODIUM ACETATE:OTIC:SUSPENSION:%	OTIC	0.03% OTIC SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
4550K0SC9B	SODIUM ACETATE:PARENTERAL:INJECTABLE:%	PARENTERAL	0.16% PARENTERAL INJECTABLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
4550K0SC9B	SODIUM ACETATE:PARENTERAL:INJECTION:%	PARENTERAL	10.37% PARENTERAL INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
4550K0SC9B	SODIUM ACETATE:PARENTERAL:POWDER, FOR INJECTION SOLUTION:%	PARENTERAL	1.25% PARENTERAL POWDER, FOR INJECTION SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
4550K0SC9B	SODIUM ACETATE:PHOTOPHERESIS:SOLUTION:%	PHOTOPHERESIS	0.18% PHOTOPHERESIS SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
4550K0SC9B	SODIUM ACETATE:SOFT TISSUE:INJECTION:ADJ PH	SOFT TISSUE	ADJ PH SOFT TISSUE INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
4550K0SC9B	SODIUM ACETATE:SUBCUTANEOUS:INJECTABLE:%	SUBCUTANEOUS	0.2% SUBCUTANEOUS INJECTABLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
4550K0SC9B	SODIUM ACETATE:SUBCUTANEOUS:INJECTION:%	SUBCUTANEOUS	0.2% SUBCUTANEOUS INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
4550K0SC9B	SODIUM ACETATE:SUBCUTANEOUS:INJECTION:%	SUBCUTANEOUS	0.2% SUBCUTANEOUS INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
4550K0SC9B	SODIUM ACETATE:SUBCUTANEOUS:INJECTION, SOLUTION:%	SUBCUTANEOUS	0.15% SUBCUTANEOUS INJECTION, SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
4550K0SC9B	SODIUM ACETATE:SUBCUTANEOUS:SOLUTION:%	SUBCUTANEOUS	0.023% SUBCUTANEOUS SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
4550K0SC9B	SODIUM ACETATE:SUBCUTANEOUS:SOLUTION, INJECTION:%	SUBCUTANEOUS	0.35% SUBCUTANEOUS SOLUTION, INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
4550K0SC9B	SODIUM ACETATE:SUBMUCOSAL:SOLUTION, INJECTION:%	SUBMUCOSAL	0.08% SUBMUCOSAL SOLUTION, INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
4550K0SC9B	SODIUM ACETATE:TOPICAL:EMULSION, CREAM:NA	TOPICAL	TOPICAL EMULSION, CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
4550K0SC9B	SODIUM ACETATE:TOPICAL:SOLUTION:MG/1ML	TOPICAL	0.3MG/1ML TOPICAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
ML9LGA7468	PHENYLETHYL ALCOHOL:AURICULAR (OTIC):SOLUTION:%	AURICULAR (OTIC)	0.25% AURICULAR (OTIC) SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
ML9LGA7468	PHENYLETHYL ALCOHOL:INTRA-ARTICULAR:SUSPENSION:%	INTRA-ARTICULAR	0.5% INTRA-ARTICULAR SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
ML9LGA7468	PHENYLETHYL ALCOHOL:INTRAMUSCULAR:SUSPENSION:%	INTRAMUSCULAR	0.5% INTRAMUSCULAR SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
ML9LGA7468	PHENYLETHYL ALCOHOL:NASAL:SOLUTION, SPRAY:%	NASAL	0.5% NASAL SOLUTION, SPRAY	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
ML9LGA7468	PHENYLETHYL ALCOHOL:NASAL:SPRAY:MG/SPRAY	NASAL	0.25MG/SPRAY NASAL SPRAY	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
ML9LGA7468	PHENYLETHYL ALCOHOL:NASAL:SPRAY, METERED:%	NASAL	0.25% NASAL SPRAY, METERED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
ML9LGA7468	PHENYLETHYL ALCOHOL:NASAL:SUSPENSION:MG/SPR	NASAL	0.25MG/SPR NASAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
ML9LGA7468	PHENYLETHYL ALCOHOL:OPHTHALMIC:SOLUTION:%	OPHTHALMIC	0.5% OPHTHALMIC SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
ML9LGA7468	PHENYLETHYL ALCOHOL:OPHTHALMIC:SUSPENSION:NA	OPHTHALMIC	OPHTHALMIC SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
R6Q3791S76	SODIUM GLUCONATE:INTRAVENOUS:INJECTION:%	INTRAVENOUS	2.3% INTRAVENOUS INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
R6Q3791S76	SODIUM GLUCONATE:IV(INFUSION):POWDER, FOR INJECTION SOLUTION, LYOPHILIZED:%	IV(INFUSION)	0.1% IV(INFUSION) POWDER, FOR INJECTION SOLUTION, LYOPHILIZED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
R6Q3791S76	SODIUM GLUCONATE:ORAL:SOLUTION:MG/1ML	ORAL	2.5MG/1ML ORAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
R6Q3791S76	SODIUM GLUCONATE:ORAL:SYRUP:NA	ORAL	ORAL SYRUP	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
8D08K3S51E	PROPYLENE CARBONATE:TOPICAL:OINTMENT:%W/W	TOPICAL	5%W/W TOPICAL OINTMENT	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
399SL044HN	SODIUM OLEATE:INTRAVENOUS:EMULSION, INJECTION:%	INTRAVENOUS	0.03% INTRAVENOUS EMULSION, INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
399SL044HN	SODIUM OLEATE:INTRAVENOUS:INJECTION, EMULSION:MG/1ML	INTRAVENOUS	4.8MG/1ML INTRAVENOUS INJECTION, EMULSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
399SL044HN	SODIUM OLEATE:INTRAVENOUS:INJECTION, EMULSION:ADJ PH	INTRAVENOUS	ADJ PH INTRAVENOUS INJECTION, EMULSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
Y882YXF34X	CALCIUM ACETATE:ORAL:SOLUTION:MG/5ML	ORAL	3MG/5ML ORAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
Y882YXF34X	CALCIUM ACETATE:ORAL:SUSPENSION:NA	ORAL	ORAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
Y882YXF34X	CALCIUM ACETATE:ORAL:SYRUP:MG/5ML	ORAL	3MG/5ML ORAL SYRUP	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
Y882YXF34X	CALCIUM ACETATE:ORAL:TABLET (IMMED./COMP. RELEASE), FILM COATED:MG	ORAL	140MG ORAL TABLET (IMMED./COMP. RELEASE), FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
Y882YXF34X	CALCIUM ACETATE:TOPICAL:CREAM:%W/W	TOPICAL	0.002%W/W TOPICAL CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
Y882YXF34X	CALCIUM ACETATE:TOPICAL:EMULSION, CREAM:%W/W	TOPICAL	0.092%W/W TOPICAL EMULSION, CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
Y882YXF34X	CALCIUM ACETATE:TOPICAL:LOTION:NA	TOPICAL	TOPICAL LOTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
KC5472WRJK	ETHYLCELLULOSE (4 MPA.S):ORAL:CAPSULE:MG	ORAL	36.67MG ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
KC5472WRJK	ETHYLCELLULOSE (4 MPA.S):ORAL:TABLET:MG	ORAL	2MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
5Z17386USF	DIACETYLATED MONOGLYCERIDES:INTRAVENOUS:INJECTION:NA	INTRAVENOUS	INTRAVENOUS INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
5Z17386USF	DIACETYLATED MONOGLYCERIDES:ORAL:CAPSULE, ENTERIC COATED PELLETS:MG	ORAL	4MG ORAL CAPSULE, ENTERIC COATED PELLETS	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
5Z17386USF	DIACETYLATED MONOGLYCERIDES:ORAL:CAPSULE, EXTENDED RELEASE:MG	ORAL	2.37MG ORAL CAPSULE, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
5Z17386USF	DIACETYLATED MONOGLYCERIDES:ORAL:CAPSULE, SUSTAINED ACTION:MG	ORAL	0.59MG ORAL CAPSULE, SUSTAINED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
5Z17386USF	DIACETYLATED MONOGLYCERIDES:ORAL:SOLUTION:MG/1ML	ORAL	240MG/1ML ORAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
5Z17386USF	DIACETYLATED MONOGLYCERIDES:ORAL:TABLET:mg	ORAL	13.85mg ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
5Z17386USF	DIACETYLATED MONOGLYCERIDES:ORAL:TABLET, COATED:MG	ORAL	0.63MG ORAL TABLET, COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
5Z17386USF	DIACETYLATED MONOGLYCERIDES:ORAL:TABLET, DELAYED ACTION:NA	ORAL	ORAL TABLET, DELAYED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
5Z17386USF	DIACETYLATED MONOGLYCERIDES:ORAL:TABLET, DELAYED ACTION, ENTERIC COATED:MG	ORAL	5.17MG ORAL TABLET, DELAYED ACTION, ENTERIC COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
5Z17386USF	DIACETYLATED MONOGLYCERIDES:ORAL:TABLET, DELAYED RELEASE:MG	ORAL	1.84MG ORAL TABLET, DELAYED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
5Z17386USF	DIACETYLATED MONOGLYCERIDES:ORAL:TABLET, FILM COATED:MG	ORAL	2.1MG ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
5Z17386USF	DIACETYLATED MONOGLYCERIDES:ORAL:TABLET, SUSTAINED ACTION:MG	ORAL	2.48MG ORAL TABLET, SUSTAINED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
6N003M473W	HYPROMELLOSE ACETATE SUCCINATE 06081224 (3 MM2/S):ORAL:TABLET, DELAYED ACTION:MG	ORAL	29.7MG ORAL TABLET, DELAYED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
6N003M473W	HYPROMELLOSE ACETATE SUCCINATE 06081224 (3 MM2/S):ORAL:TABLET, EXTENDED RELEASE:MG	ORAL	19.83MG ORAL TABLET, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
73W9IQY50Q	KARAYA GUM:BUCCAL:PATCH, CONTROLLED RELEASE:MG	BUCCAL	68.1MG BUCCAL PATCH, CONTROLLED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=K
6LUM696811	SORBITAN TRISTEARATE:TOPICAL:CREAM, AUGMENTED:%W/W	TOPICAL	0.5%W/W TOPICAL CREAM, AUGMENTED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
M4I0D6VV5M	CALCIUM CHLORIDE:AN,INFILTRATION:INJECTION:%	AN,INFILTRATION	0.033% AN,INFILTRATION INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
M4I0D6VV5M	CALCIUM CHLORIDE:CAUDAL BLOCK:INJECTION:%	CAUDAL BLOCK	0.033% CAUDAL BLOCK INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
M4I0D6VV5M	CALCIUM CHLORIDE:EPIDURAL:INJECTION:%	EPIDURAL	0.033% EPIDURAL INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
M4I0D6VV5M	CALCIUM CHLORIDE:IM - IV:INJECTION:%	IM - IV	4% IM - IV INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
M4I0D6VV5M	CALCIUM CHLORIDE:INHALATIONPOWDER:POWDER:MG	INHALATIONPOWDER	0.4MG INHALATIONPOWDER POWDER	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
M4I0D6VV5M	CALCIUM CHLORIDE:INTRAMUSCULAR:INJECTION:%W/V	INTRAMUSCULAR	4%W/V INTRAMUSCULAR INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
M4I0D6VV5M	CALCIUM CHLORIDE:INTRAMUSCULAR:SOLUTION, INJECTION:%W/W	INTRAMUSCULAR	0.005%W/W INTRAMUSCULAR SOLUTION, INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
M4I0D6VV5M	CALCIUM CHLORIDE:INTRAOCULAR:SOLUTION:%	INTRAOCULAR	0.048% INTRAOCULAR SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
M4I0D6VV5M	CALCIUM CHLORIDE:INTRAPERITONEAL:SOLUTION:%	INTRAPERITONEAL	0.026% INTRAPERITONEAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
M4I0D6VV5M	CALCIUM CHLORIDE:INTRAVASCULAR:INJECTION:%	INTRAVASCULAR	0.007% INTRAVASCULAR INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
M4I0D6VV5M	CALCIUM CHLORIDE:INTRAVENOUS:INJECTION:%	INTRAVENOUS	0.074% INTRAVENOUS INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
M4I0D6VV5M	CALCIUM CHLORIDE:INTRAVENOUS:SOLUTION, INJECTION:%W/W	INTRAVENOUS	0.005%W/W INTRAVENOUS SOLUTION, INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
M4I0D6VV5M	CALCIUM CHLORIDE:INTRAVENOUS:SOLUTION, LIPOSOME, INJECTION:%	INTRAVENOUS	0.028% INTRAVENOUS SOLUTION, LIPOSOME, INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
M4I0D6VV5M	CALCIUM CHLORIDE:INTRAVITREAL:SUSPENSION, INJECTION:%	INTRAVITREAL	0.048% INTRAVITREAL SUSPENSION, INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
M4I0D6VV5M	CALCIUM CHLORIDE:NERVE BLOCK:INJECTION:%	NERVE BLOCK	0.033% NERVE BLOCK INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
M4I0D6VV5M	CALCIUM CHLORIDE:OPHTHALMIC:POWDER, FOR SOLUTION:%	OPHTHALMIC	0.048% OPHTHALMIC POWDER, FOR SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
M4I0D6VV5M	CALCIUM CHLORIDE:OPHTHALMIC:SOLUTION:MG/1ML	OPHTHALMIC	0.147MG/1ML OPHTHALMIC SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
M4I0D6VV5M	CALCIUM CHLORIDE:OPHTHALMIC:SOLUTION, DROPS:%	OPHTHALMIC	0.02% OPHTHALMIC SOLUTION, DROPS	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
M4I0D6VV5M	CALCIUM CHLORIDE:ORAL:CAPSULE:MG	ORAL	1.74MG ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
M4I0D6VV5M	CALCIUM CHLORIDE:ORAL:CONCENTRATE:MG/1ML	ORAL	0.08MG/1ML ORAL CONCENTRATE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
M4I0D6VV5M	CALCIUM CHLORIDE:ORAL:SUSPENSION:NA	ORAL	ORAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
M4I0D6VV5M	CALCIUM CHLORIDE:RESPIRATORY (INHALATION):POWDER, FOR INHALATION:%	RESPIRATORY (INHALATION)	0.04% RESPIRATORY (INHALATION) POWDER, FOR INHALATION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
M4I0D6VV5M	CALCIUM CHLORIDE:SUBCUTANEOUS:INJECTABLE:%	SUBCUTANEOUS	0.04% SUBCUTANEOUS INJECTABLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
M4I0D6VV5M	CALCIUM CHLORIDE:SUBCUTANEOUS:INJECTION:NA	SUBCUTANEOUS	SUBCUTANEOUS INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
M4I0D6VV5M	CALCIUM CHLORIDE:SUBCUTANEOUS:SOLUTION, INJECTION:%	SUBCUTANEOUS	0.053% SUBCUTANEOUS SOLUTION, INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
M4I0D6VV5M	CALCIUM CHLORIDE:TOPICAL:EMULSION, CREAM:NA	TOPICAL	TOPICAL EMULSION, CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
88XHZ13131	FUMARIC ACID:ORAL:CAPSULE, EXTENDED RELEASE:MG	ORAL	0.7MG ORAL CAPSULE, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
88XHZ13131	FUMARIC ACID:ORAL:CAPSULE, SUSTAINED ACTION:MG	ORAL	150MG ORAL CAPSULE, SUSTAINED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
88XHZ13131	FUMARIC ACID:ORAL:POWDER, FOR ORAL SOLUTION:MG	ORAL	200MG ORAL POWDER, FOR ORAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
88XHZ13131	FUMARIC ACID:ORAL:SUSPENSION:MG/1ML	ORAL	5MG/1ML ORAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
88XHZ13131	FUMARIC ACID:ORAL:SYRUP:MG/5ML	ORAL	0.75MG/5ML ORAL SYRUP	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
88XHZ13131	FUMARIC ACID:ORAL:TABLET:MG	ORAL	80MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
88XHZ13131	FUMARIC ACID:ORAL:TABLET (IMMED./COMP. RELEASE), UNCOATED, CHEWABLE:MG	ORAL	10MG ORAL TABLET (IMMED./COMP. RELEASE), UNCOATED, CHEWABLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
88XHZ13131	FUMARIC ACID:ORAL:TABLET, CONTROLLED RELEASE:MG	ORAL	36.5MG ORAL TABLET, CONTROLLED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
88XHZ13131	FUMARIC ACID:ORAL:TABLET, EXTENDED RELEASE:MG	ORAL	19.8MG ORAL TABLET, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
88XHZ13131	FUMARIC ACID:ORAL:TABLET, SUSTAINED ACTION:MG	ORAL	55.56MG ORAL TABLET, SUSTAINED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
HIE492ZZ3T	PHENOXYETHANOL:TOPICAL:AEROSOL:%W/W	TOPICAL	1.05%W/W TOPICAL AEROSOL	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
HIE492ZZ3T	PHENOXYETHANOL:TOPICAL:CREAM, AUGMENTED:%W/W	TOPICAL	1%W/W TOPICAL CREAM, AUGMENTED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
HIE492ZZ3T	PHENOXYETHANOL:TOPICAL:CREAM, EMULSION, SUSTAINED RELEASE:%W/W	TOPICAL	0.5%W/W TOPICAL CREAM, EMULSION, SUSTAINED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
HIE492ZZ3T	PHENOXYETHANOL:TOPICAL:EMULSION, AEROSOL FOAM:%W/W	TOPICAL	1.05%W/W TOPICAL EMULSION, AEROSOL FOAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
HIE492ZZ3T	PHENOXYETHANOL:TOPICAL:EMULSION, CREAM:%W/W	TOPICAL	0.7%W/W TOPICAL EMULSION, CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
HIE492ZZ3T	PHENOXYETHANOL:TOPICAL:GEL:%W/W	TOPICAL	0.7%W/W TOPICAL GEL	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
HIE492ZZ3T	PHENOXYETHANOL:TOPICAL:LOTION:%W/W	TOPICAL	1%W/W TOPICAL LOTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
390RMW2PEQ	POVIDONE K29/32:ORAL:CAPSULE, EXTENDED RELEASE:mg	ORAL	6.26mg ORAL CAPSULE, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
390RMW2PEQ	POVIDONE K29/32:ORAL:TABLET:mg	ORAL	35mg ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
390RMW2PEQ	POVIDONE K29/32:ORAL:TABLET, EXTENDED RELEASE:mg	ORAL	17mg ORAL TABLET, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
7YC686GQ8F	POLYOXYL 40 HYDROGENATED CASTOR OIL:DENTAL:SOLUTION:%	DENTAL	1% DENTAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
7YC686GQ8F	POLYOXYL 40 HYDROGENATED CASTOR OIL:OPHTHALMIC:SOLUTION:%W/V	OPHTHALMIC	1%W/V OPHTHALMIC SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
7YC686GQ8F	POLYOXYL 40 HYDROGENATED CASTOR OIL:OPHTHALMIC:SOLUTION, DROPS:%	OPHTHALMIC	0.53% OPHTHALMIC SOLUTION, DROPS	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
7YC686GQ8F	POLYOXYL 40 HYDROGENATED CASTOR OIL:ORAL:CAPSULE:MG	ORAL	200MG ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
7YC686GQ8F	POLYOXYL 40 HYDROGENATED CASTOR OIL:ORAL:CAPSULE, SOFT GELATIN:MG	ORAL	405MG ORAL CAPSULE, SOFT GELATIN	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
7YC686GQ8F	POLYOXYL 40 HYDROGENATED CASTOR OIL:ORAL:LIQUID:MG/1ML	ORAL	102MG/1ML ORAL LIQUID	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
7YC686GQ8F	POLYOXYL 40 HYDROGENATED CASTOR OIL:ORAL:SOLUTION:MG/1ML	ORAL	450MG/1ML ORAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
7YC686GQ8F	POLYOXYL 40 HYDROGENATED CASTOR OIL:ORAL:TABLET:MG	ORAL	25MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
7YC686GQ8F	POLYOXYL 40 HYDROGENATED CASTOR OIL:ORAL:TABLET, EXTENDED RELEASE:MG	ORAL	50MG ORAL TABLET, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
7YC686GQ8F	POLYOXYL 40 HYDROGENATED CASTOR OIL:ORAL:TABLET, SUSTAINED ACTION:MG	ORAL	25MG ORAL TABLET, SUSTAINED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
7YC686GQ8F	POLYOXYL 40 HYDROGENATED CASTOR OIL:TOPICAL:EMULSION, CREAM:%W/W	TOPICAL	1%W/W TOPICAL EMULSION, CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
7YC686GQ8F	POLYOXYL 40 HYDROGENATED CASTOR OIL:TOPICAL:SOLUTION:%W/V	TOPICAL	0.2%W/V TOPICAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
TU7HW0W0QT	SODIUM LACTATE:AN,INFILTRATION:INJECTION:NA	AN,INFILTRATION	AN,INFILTRATION INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
TU7HW0W0QT	SODIUM LACTATE:IM - IV - SC:INJECTION:NA	IM - IV - SC	IM - IV - SC INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
TU7HW0W0QT	SODIUM LACTATE:IM - IV - SC:SOLUTION, INJECTION:NA	IM - IV - SC	IM - IV - SC SOLUTION, INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
TU7HW0W0QT	SODIUM LACTATE:INTRACARDIAC:SOLUTION, INJECTION:NA	INTRACARDIAC	INTRACARDIAC SOLUTION, INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
TU7HW0W0QT	SODIUM LACTATE:INTRAPERITONEAL:SOLUTION:%	INTRAPERITONEAL	0.45% INTRAPERITONEAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
TU7HW0W0QT	SODIUM LACTATE:INTRAVENOUS:INJECTABLE:%	INTRAVENOUS	0.22% INTRAVENOUS INJECTABLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
TU7HW0W0QT	SODIUM LACTATE:INTRAVENOUS:INJECTION:%	INTRAVENOUS	0.17% INTRAVENOUS INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
TU7HW0W0QT	SODIUM LACTATE:INTRAVENOUS:POWDER, FOR INJECTION SOLUTION, LYOPHILIZED:%	INTRAVENOUS	1.87% INTRAVENOUS POWDER, FOR INJECTION SOLUTION, LYOPHILIZED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
TU7HW0W0QT	SODIUM LACTATE:IV(INFUSION):INJECTION:%	IV(INFUSION)	0.89% IV(INFUSION) INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
TU7HW0W0QT	SODIUM LACTATE:IV(INFUSION):SOLUTION, INJECTION:NA	IV(INFUSION)	IV(INFUSION) SOLUTION, INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
TU7HW0W0QT	SODIUM LACTATE:NERVE BLOCK:INJECTION:NA	NERVE BLOCK	NERVE BLOCK INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
TU7HW0W0QT	SODIUM LACTATE:NERVE BLOCK:SOLUTION, INJECTION:%	NERVE BLOCK	0.17% NERVE BLOCK SOLUTION, INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
TU7HW0W0QT	SODIUM LACTATE:ORAL:SUSPENSION:MG/1ML	ORAL	20MG/1ML ORAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
TU7HW0W0QT	SODIUM LACTATE:TOPICAL:GEL:%W/W	TOPICAL	0.77%W/W TOPICAL GEL	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
TU7HW0W0QT	SODIUM LACTATE:TOPICAL:SOLUTION:%W/W	TOPICAL	0.93%W/W TOPICAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
68401960MK	CROSPOVIDONE:ORAL:TABLET, DELAYED RELEASE:MG	ORAL	17MG ORAL TABLET, DELAYED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
68401960MK	CROSPOVIDONE:SUBLINGUAL:TABLET:mg	SUBLINGUAL	26.81mg SUBLINGUAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
25FFJ4209Z	STEARAMIDOETHYL DIETHYLAMINE:TOPICAL:EMULSION, CREAM:NA	TOPICAL	TOPICAL EMULSION, CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
25FFJ4209Z	STEARAMIDOETHYL DIETHYLAMINE:TOPICAL:OINTMENT:NA	TOPICAL	TOPICAL OINTMENT	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
25FFJ4209Z	STEARAMIDOETHYL DIETHYLAMINE:VAGINAL:EMULSION, CREAM:%	VAGINAL	2.5% VAGINAL EMULSION, CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
1HG84L3525	FORMALDEHYDE:TOPICAL:EMULSION, CREAM:%W/W	TOPICAL	0.27%W/W TOPICAL EMULSION, CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
1HG84L3525	FORMALDEHYDE:TOPICAL:SOLUTION:%W/W	TOPICAL	0.2%W/W TOPICAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
1HG84L3525	FORMALDEHYDE SOLUTION:TOPICAL:EMULSION, CREAM:%W/W	TOPICAL	0.27%W/W TOPICAL EMULSION, CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
469OTG57A2	SODIUM PYRROLIDONE CARBOXYLATE:TOPICAL:LOTION:%W/W	TOPICAL	5.2%W/W TOPICAL LOTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
HYE7O27HAO	GLYCERYL ISOSTEARATE:TOPICAL:CREAM, EMULSION, SUSTAINED RELEASE:%W/W	TOPICAL	2.7%W/W TOPICAL CREAM, EMULSION, SUSTAINED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
HYE7O27HAO	GLYCERYL ISOSTEARATE:TOPICAL:EMULSION, CREAM:%W/W	TOPICAL	2%W/W TOPICAL EMULSION, CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
HYE7O27HAO	GLYCERYL ISOSTEARATE:VAGINAL:CREAM, EMULSION, SUSTAINED RELEASE:%W/W	VAGINAL	2.7%W/W VAGINAL CREAM, EMULSION, SUSTAINED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
HYE7O27HAO	GLYCERYL ISOSTEARATE:VAGINAL:EMULSION, CREAM:%	VAGINAL	2.7% VAGINAL EMULSION, CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
YTH167I2AG	OLETH-20:TOPICAL:EMULSION, CREAM:NA	TOPICAL	TOPICAL EMULSION, CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
7V31YC746X	CHLOROFORM:ORAL:SYRUP:ML/ML	ORAL	0.001ML/ML ORAL SYRUP	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
CG8692ZN14	PHENYLMERCURIC NITRATE:INTRAMUSCULAR:POWDER, FOR INJECTION SOLUTION:NA	INTRAMUSCULAR	INTRAMUSCULAR POWDER, FOR INJECTION SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
CG8692ZN14	PHENYLMERCURIC NITRATE:OPHTHALMIC:DROPS:NA	OPHTHALMIC	OPHTHALMIC DROPS	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
CG8692ZN14	PHENYLMERCURIC NITRATE:OPHTHALMIC:OINTMENT:%	OPHTHALMIC	0.002% OPHTHALMIC OINTMENT	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
CG8692ZN14	PHENYLMERCURIC NITRATE:OPHTHALMIC:SOLUTION:%	OPHTHALMIC	0.002% OPHTHALMIC SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
6M3P64V0NC	MAGNESIUM ALUMINUM SILICATE:ORAL:CAPSULE:MG	ORAL	60MG ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
6M3P64V0NC	MAGNESIUM ALUMINUM SILICATE:ORAL:CONCENTRATE:MG/5ML	ORAL	410MG/5ML ORAL CONCENTRATE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
6M3P64V0NC	MAGNESIUM ALUMINUM SILICATE:ORAL:DROPS:MG/2.5ML	ORAL	4.15MG/2.5ML ORAL DROPS	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
6M3P64V0NC	MAGNESIUM ALUMINUM SILICATE:ORAL:GRANULE:MG	ORAL	12.5MG ORAL GRANULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
6M3P64V0NC	MAGNESIUM ALUMINUM SILICATE:ORAL:GRANULE, FOR SUSPENSION:MG	ORAL	11MG ORAL GRANULE, FOR SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
6M3P64V0NC	MAGNESIUM ALUMINUM SILICATE:ORAL:LIQUID:MG/5ML	ORAL	82MG/5ML ORAL LIQUID	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
6M3P64V0NC	MAGNESIUM ALUMINUM SILICATE:ORAL:POWDER, FOR SUSPENSION:NA	ORAL	ORAL POWDER, FOR SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
6M3P64V0NC	MAGNESIUM ALUMINUM SILICATE:ORAL:SUSPENSION:MG/5ML	ORAL	1000MG/5ML ORAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
6M3P64V0NC	MAGNESIUM ALUMINUM SILICATE:ORAL:SYRUP:%	ORAL	10% ORAL SYRUP	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
6M3P64V0NC	MAGNESIUM ALUMINUM SILICATE:ORAL:TABLET:MG	ORAL	60MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
6M3P64V0NC	MAGNESIUM ALUMINUM SILICATE:ORAL:TABLET (IMMED./COMP. RELEASE), UNCOATED, CHEWABLE:MG	ORAL	12MG ORAL TABLET (IMMED./COMP. RELEASE), UNCOATED, CHEWABLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
6M3P64V0NC	MAGNESIUM ALUMINUM SILICATE:ORAL:TABLET, EXTENDED RELEASE:MG	ORAL	70MG ORAL TABLET, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
6M3P64V0NC	MAGNESIUM ALUMINUM SILICATE:RECTAL:SUSPENSION:%	RECTAL	1.81% RECTAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
6M3P64V0NC	MAGNESIUM ALUMINUM SILICATE:TOPICAL:CREAM, AUGMENTED:%W/W	TOPICAL	3%W/W TOPICAL CREAM, AUGMENTED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
6M3P64V0NC	MAGNESIUM ALUMINUM SILICATE:TOPICAL:EMULSION, CREAM:%W/W	TOPICAL	1.5%W/W TOPICAL EMULSION, CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
6M3P64V0NC	MAGNESIUM ALUMINUM SILICATE:TOPICAL:LOTION:%W/W	TOPICAL	1.5%W/W TOPICAL LOTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
6M3P64V0NC	MAGNESIUM ALUMINUM SILICATE:TOPICAL:SHAMPOO:%W/W	TOPICAL	0.5%W/W TOPICAL SHAMPOO	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
6M3P64V0NC	MAGNESIUM ALUMINUM SILICATE:TOPICAL:SHAMPOO, SUSPENSION:NA	TOPICAL	TOPICAL SHAMPOO, SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
6M3P64V0NC	MAGNESIUM ALUMINUM SILICATE:VAGINAL:OINTMENT:%	VAGINAL	5.39% VAGINAL OINTMENT	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
05JZI7B19X	CARBOXYMETHYLCELLULOSE:BUCCAL:FILM, SOLUBLE:MG	BUCCAL	10.95MG BUCCAL FILM, SOLUBLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
05JZI7B19X	CARBOXYMETHYLCELLULOSE:INTRA-ARTICULAR:INJECTABLE:%	INTRA-ARTICULAR	0.75% INTRA-ARTICULAR INJECTABLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
05JZI7B19X	CARBOXYMETHYLCELLULOSE:INTRA-ARTICULAR:INJECTION:%	INTRA-ARTICULAR	0.2% INTRA-ARTICULAR INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
05JZI7B19X	CARBOXYMETHYLCELLULOSE:INTRABURSAL:INJECTION:NA	INTRABURSAL	INTRABURSAL INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
05JZI7B19X	CARBOXYMETHYLCELLULOSE:INTRALESIONAL:INJECTABLE:%	INTRALESIONAL	0.75% INTRALESIONAL INJECTABLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
05JZI7B19X	CARBOXYMETHYLCELLULOSE:INTRAMUSCULAR:INJECTION:%	INTRAMUSCULAR	0.9% INTRAMUSCULAR INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
05JZI7B19X	CARBOXYMETHYLCELLULOSE:ORAL:CAPSULE:MG	ORAL	4.5MG ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
05JZI7B19X	CARBOXYMETHYLCELLULOSE:ORAL:CAPSULE, DELAYED ACTION:MG	ORAL	29.36MG ORAL CAPSULE, DELAYED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
05JZI7B19X	CARBOXYMETHYLCELLULOSE:ORAL:CAPSULE, SUSTAINED ACTION:NA	ORAL	ORAL CAPSULE, SUSTAINED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
05JZI7B19X	CARBOXYMETHYLCELLULOSE:ORAL:DROPS:NA	ORAL	ORAL DROPS	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
05JZI7B19X	CARBOXYMETHYLCELLULOSE:ORAL:POWDER, FOR SUSPENSION:NA	ORAL	ORAL POWDER, FOR SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
05JZI7B19X	CARBOXYMETHYLCELLULOSE:ORAL:SUSPENSION:MG/5ML	ORAL	64MG/5ML ORAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
05JZI7B19X	CARBOXYMETHYLCELLULOSE:ORAL:TABLET:MG	ORAL	12.9MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
05JZI7B19X	CARBOXYMETHYLCELLULOSE:ORAL:TABLET, DELAYED ACTION, ENTERIC COATED:NA	ORAL	ORAL TABLET, DELAYED ACTION, ENTERIC COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
05JZI7B19X	CARBOXYMETHYLCELLULOSE:SOFT TISSUE:INJECTABLE:%	SOFT TISSUE	0.75% SOFT TISSUE INJECTABLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
05JZI7B19X	CARBOXYMETHYLCELLULOSE:TOPICAL:LOTION:NA	TOPICAL	TOPICAL LOTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
05JZI7B19X	CARBOXYMETHYLCELLULOSE:TOPICAL:PATCH:NA	TOPICAL	TOPICAL PATCH	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
91D9GV0Z28	TRIBASIC CALCIUM PHOSPHATE:BUCCAL/SUBLINGUAL:TABLET:MG	BUCCAL/SUBLINGUAL	99.2MG BUCCAL/SUBLINGUAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
91D9GV0Z28	TRIBASIC CALCIUM PHOSPHATE:ORAL:CAPSULE:MG	ORAL	11.01MG ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
91D9GV0Z28	TRIBASIC CALCIUM PHOSPHATE:ORAL:CAPSULE, SUSTAINED ACTION:MG	ORAL	32.73MG ORAL CAPSULE, SUSTAINED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
91D9GV0Z28	TRIBASIC CALCIUM PHOSPHATE:ORAL:TABLET:MG	ORAL	282MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
91D9GV0Z28	TRIBASIC CALCIUM PHOSPHATE:ORAL:TABLET (IMMED./COMP. RELEASE), FILM COATED:MG	ORAL	21.8MG ORAL TABLET (IMMED./COMP. RELEASE), FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
91D9GV0Z28	TRIBASIC CALCIUM PHOSPHATE:ORAL:TABLET (IMMED./COMP. RELEASE), UNCOATED, CHEWABLE:MG	ORAL	130MG ORAL TABLET (IMMED./COMP. RELEASE), UNCOATED, CHEWABLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
91D9GV0Z28	TRIBASIC CALCIUM PHOSPHATE:ORAL:TABLET, COATED:MG	ORAL	40MG ORAL TABLET, COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
91D9GV0Z28	TRIBASIC CALCIUM PHOSPHATE:ORAL:TABLET, DELAYED ACTION, ENTERIC COATED:MG	ORAL	333.3MG ORAL TABLET, DELAYED ACTION, ENTERIC COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
91D9GV0Z28	TRIBASIC CALCIUM PHOSPHATE:ORAL:TABLET, EXTENDED RELEASE:MG	ORAL	125MG ORAL TABLET, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
91D9GV0Z28	TRIBASIC CALCIUM PHOSPHATE:ORAL:TABLET, SUSTAINED ACTION:MG	ORAL	100MG ORAL TABLET, SUSTAINED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
88S87KL877	ROSIN:ORAL:CAPSULE:NA	ORAL	ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=R
88S87KL877	ROSIN:ORAL:TABLET:NA	ORAL	ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=R
88S87KL877	ROSIN:ORAL:TABLET, COATED:MG	ORAL	10MG ORAL TABLET, COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=R
88S87KL877	ROSIN:ORAL:TABLET, EXTENDED RELEASE:NA	ORAL	ORAL TABLET, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=R
88S87KL877	ROSIN:ORAL:TABLET, REPEAT ACTION:MG	ORAL	8.99MG ORAL TABLET, REPEAT ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=R
88S87KL877	ROSIN:ORAL:TABLET, SUSTAINED ACTION:MG	ORAL	9MG ORAL TABLET, SUSTAINED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=R
84H8Z9550J	DIHYDROXYALUMINUM SODIUM CARBONATE:ORAL:TABLET:MG	ORAL	7.2MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
84H8Z9550J	DIHYDROXYALUMINUM SODIUM CARBONATE:ORAL:TABLET (IMMED./COMP. RELEASE), UNCOATED, CHEWABLE:MG	ORAL	1350MG ORAL TABLET (IMMED./COMP. RELEASE), UNCOATED, CHEWABLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
5UE7I54O43	CHOLETH-24:TOPICAL:EMULSION:%W/W	TOPICAL	5%W/W TOPICAL EMULSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
F76354LMGR	PROPYLENE GLYCOL MONOPALMITOSTEARATE:TOPICAL:EMULSION, CREAM:%W/W	TOPICAL	9.3%W/W TOPICAL EMULSION, CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
F76354LMGR	PROPYLENE GLYCOL MONOPALMITOSTEARATE:TOPICAL:LOTION:%W/W	TOPICAL	4.69%W/W TOPICAL LOTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
F76354LMGR	PROPYLENE GLYCOL MONOPALMITOSTEARATE:TOPICAL:OINTMENT:%W/W	TOPICAL	8%W/W TOPICAL OINTMENT	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
F76354LMGR	PROPYLENE GLYCOL MONOPALMITOSTEARATE:TOPICAL:OINTMENT, AUGMENTED:%W/W	TOPICAL	2%W/W TOPICAL OINTMENT, AUGMENTED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
F76354LMGR	PROPYLENE GLYCOL MONOPALMITOSTEARATE:VAGINAL:CREAM, EMULSION, SUSTAINED RELEASE:%	VAGINAL	7% VAGINAL CREAM, EMULSION, SUSTAINED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
F76354LMGR	PROPYLENE GLYCOL MONOPALMITOSTEARATE:VAGINAL:EMULSION, CREAM:%	VAGINAL	7% VAGINAL EMULSION, CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
91XW058U2C	MALEIC ACID:INTRAMUSCULAR:INJECTION:%W/V	INTRAMUSCULAR	0.01%W/V INTRAMUSCULAR INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
91XW058U2C	MALEIC ACID:INTRAMUSCULAR:POWDER, FOR INJECTION SOLUTION:NA	INTRAMUSCULAR	INTRAMUSCULAR POWDER, FOR INJECTION SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
91XW058U2C	MALEIC ACID:INTRAVENOUS:INJECTION:%	INTRAVENOUS	0.01% INTRAVENOUS INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
91XW058U2C	MALEIC ACID:IV(INFUSION):INJECTABLE:%	IV(INFUSION)	0.01% IV(INFUSION) INJECTABLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
91XW058U2C	MALEIC ACID:IV(INFUSION):INJECTION:ADJ PH	IV(INFUSION)	ADJ PH IV(INFUSION) INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
91XW058U2C	MALEIC ACID:ORAL:CAPSULE:MG	ORAL	2MG ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
91XW058U2C	MALEIC ACID:ORAL:SYRUP:MG/5ML	ORAL	1.73MG/5ML ORAL SYRUP	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
91XW058U2C	MALEIC ACID:ORAL:TABLET:MG	ORAL	4MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
550X5X78WK	BENZYL VIOLET:ORAL:TABLET:MG	ORAL	0.4MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
550X5X78WK	BENZYL VIOLET:ORAL:TABLET, COATED:MG	ORAL	0.001MG ORAL TABLET, COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
3A3U0GI71G	MAGNESIUM OXIDE:BUCCAL:GUM:MG	BUCCAL	7.2MG BUCCAL GUM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
3A3U0GI71G	MAGNESIUM OXIDE:BUCCAL:GUM, CHEWING:MG	BUCCAL	7.2MG BUCCAL GUM, CHEWING	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
3A3U0GI71G	MAGNESIUM OXIDE:ORAL:CAPSULE:MG	ORAL	20MG ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
3A3U0GI71G	MAGNESIUM OXIDE:ORAL:CAPSULE, DELAYED ACTION:MG	ORAL	5MG ORAL CAPSULE, DELAYED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
3A3U0GI71G	MAGNESIUM OXIDE:ORAL:CAPSULE, DELAYED RELEASE:MG	ORAL	13.04MG ORAL CAPSULE, DELAYED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
3A3U0GI71G	MAGNESIUM OXIDE:ORAL:CAPSULE, ENTERIC COATED PELLETS:MG	ORAL	1.6MG ORAL CAPSULE, ENTERIC COATED PELLETS	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
3A3U0GI71G	MAGNESIUM OXIDE:ORAL:CAPSULE, EXTENDED RELEASE:MG	ORAL	7.5MG ORAL CAPSULE, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
3A3U0GI71G	MAGNESIUM OXIDE:ORAL:TABLET:MG	ORAL	63MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
3A3U0GI71G	MAGNESIUM OXIDE:ORAL:TABLET, DELAYED ACTION:MG	ORAL	5MG ORAL TABLET, DELAYED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
3A3U0GI71G	MAGNESIUM OXIDE:ORAL:TABLET, DELAYED ACTION, ENTERIC COATED:MG	ORAL	63MG ORAL TABLET, DELAYED ACTION, ENTERIC COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
3A3U0GI71G	MAGNESIUM OXIDE:ORAL:TABLET, DELAYED RELEASE:MG	ORAL	61.31MG ORAL TABLET, DELAYED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
3A3U0GI71G	MAGNESIUM OXIDE:ORAL:TABLET, EXTENDED RELEASE:MG	ORAL	1MG ORAL TABLET, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
3A3U0GI71G	MAGNESIUM OXIDE:ORAL:TABLET, FILM COATED:MG	ORAL	40MG ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
3A3U0GI71G	MAGNESIUM OXIDE:ORAL:TABLET, SUSTAINED ACTION:MG	ORAL	25.74MG ORAL TABLET, SUSTAINED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
3A3U0GI71G	MAGNESIUM OXIDE:ORAL-20:TABLET:mg	ORAL-20	26.4mg ORAL-20 TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
3A3U0GI71G	MAGNESIUM OXIDE:SUBLINGUAL:TABLET:MG	SUBLINGUAL	15MG SUBLINGUAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
R5L488RY0Q	FERROUS FUMARATE:ORAL:TABLET:MG	ORAL	75MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
R5L488RY0Q	FERROUS FUMARATE:ORAL:TABLET (IMMED./COMP. RELEASE), COATED:MG	ORAL	75MG ORAL TABLET (IMMED./COMP. RELEASE), COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
R5L488RY0Q	FERROUS FUMARATE:ORAL:TABLET, CHEWABLE:MG	ORAL	75MG ORAL TABLET, CHEWABLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
8NLQ36F6MM	EDETATE DISODIUM ANHYDROUS:INTRA-AMNIOTIC:INJECTION:NA	INTRA-AMNIOTIC	INTRA-AMNIOTIC INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
8NLQ36F6MM	EDETATE DISODIUM ANHYDROUS:INTRAMUSCULAR:INJECTION:%W/V	INTRAMUSCULAR	0.01%W/V INTRAMUSCULAR INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
8NLQ36F6MM	EDETATE DISODIUM ANHYDROUS:INTRAVENOUS:INJECTABLE:%	INTRAVENOUS	0.01% INTRAVENOUS INJECTABLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
8NLQ36F6MM	EDETATE DISODIUM ANHYDROUS:INTRAVENOUS:INJECTION:%	INTRAVENOUS	0.11% INTRAVENOUS INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
8NLQ36F6MM	EDETATE DISODIUM ANHYDROUS:IV(INFUSION):INJECTION:%	IV(INFUSION)	0.01% IV(INFUSION) INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
8NLQ36F6MM	EDETATE DISODIUM ANHYDROUS:OPHTHALMIC:SOLUTION:%	OPHTHALMIC	0.1% OPHTHALMIC SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
8NLQ36F6MM	EDETATE DISODIUM ANHYDROUS:TOPICAL:CREAM:%W/W	TOPICAL	0.02%W/W TOPICAL CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
8NLQ36F6MM	EDETATE DISODIUM ANHYDROUS:VAGINAL:CREAM:%W/W	VAGINAL	0.05%W/W VAGINAL CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
O40UQP6WCF	SULFURIC ACID:AURICULAR (OTIC):SUSPENSION:%	AURICULAR (OTIC)	0.023% AURICULAR (OTIC) SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
O40UQP6WCF	SULFURIC ACID:EPIDURAL:INJECTION:ADJ PH	EPIDURAL	ADJ PH EPIDURAL INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
O40UQP6WCF	SULFURIC ACID:EPIDURAL:INJECTION, SOLUTION:ADJ PH	EPIDURAL	ADJ PH EPIDURAL INJECTION, SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
O40UQP6WCF	SULFURIC ACID:IM - IV:INJECTION:%	IM - IV	56.6% IM - IV INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
O40UQP6WCF	SULFURIC ACID:IM - SC:INJECTION:ADJ PH	IM - SC	ADJ PH IM - SC INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
O40UQP6WCF	SULFURIC ACID:IM - SC:POWDER, FOR INJECTION SOLUTION, LYOPHILIZED, WITHOUT ADDITIVES:ADJ PH	IM - SC	ADJ PH IM - SC POWDER, FOR INJECTION SOLUTION, LYOPHILIZED, WITHOUT ADDITIVES	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
O40UQP6WCF	SULFURIC ACID:INHALATION:INHALANT SOLUTION DOSAGE FORM:ADJ PH	INHALATION	ADJ PH INHALATION INHALANT SOLUTION DOSAGE FORM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
O40UQP6WCF	SULFURIC ACID:INHALATION:POWDER:MG	INHALATION	9.8MG INHALATION POWDER	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
O40UQP6WCF	SULFURIC ACID:INHALATION:SOLUTION:%	INHALATION	12.5% INHALATION SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
O40UQP6WCF	SULFURIC ACID:INHALATION:SOLUTION, FOR INHALATION:ADJ PH	INHALATION	ADJ PH INHALATION SOLUTION, FOR INHALATION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
O40UQP6WCF	SULFURIC ACID:INTRAMUSCULAR:INJECTION:%W/V	INTRAMUSCULAR	2.1%W/V INTRAMUSCULAR INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
O40UQP6WCF	SULFURIC ACID:INTRAMUSCULAR:SOLUTION, INJECTION:%W/V	INTRAMUSCULAR	2.1%W/V INTRAMUSCULAR SOLUTION, INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
O40UQP6WCF	SULFURIC ACID:INTRAPERITONEAL:INJECTION:ADJ PH	INTRAPERITONEAL	ADJ PH INTRAPERITONEAL INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
O40UQP6WCF	SULFURIC ACID:INTRATHECAL:INJECTION:ADJ PH	INTRATHECAL	ADJ PH INTRATHECAL INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
O40UQP6WCF	SULFURIC ACID:INTRATHECAL:INJECTION, SOLUTION:ADJ PH	INTRATHECAL	ADJ PH INTRATHECAL INJECTION, SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
O40UQP6WCF	SULFURIC ACID:INTRAVENOUS:INJECTION:%	INTRAVENOUS	2.1% INTRAVENOUS INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
O40UQP6WCF	SULFURIC ACID:INTRAVENOUS:INJECTION, SOLUTION:ADJ PH	INTRAVENOUS	ADJ PH INTRAVENOUS INJECTION, SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
O40UQP6WCF	SULFURIC ACID:INTRAVENOUS:POWDER, FOR INJECTION SOLUTION:ADJ PH	INTRAVENOUS	ADJ PH INTRAVENOUS POWDER, FOR INJECTION SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
O40UQP6WCF	SULFURIC ACID:INTRAVENOUS:POWDER, FOR INJECTION SOLUTION, LYOPHILIZED:ADJ PH	INTRAVENOUS	ADJ PH INTRAVENOUS POWDER, FOR INJECTION SOLUTION, LYOPHILIZED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
O40UQP6WCF	SULFURIC ACID:INTRAVENOUS:SOLUTION:ADJ PH	INTRAVENOUS	ADJ PH INTRAVENOUS SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
O40UQP6WCF	SULFURIC ACID:INTRAVENOUS:SOLUTION, INJECTION:%	INTRAVENOUS	2.1% INTRAVENOUS SOLUTION, INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
O40UQP6WCF	SULFURIC ACID:INTRAVENOUS:SOLUTION, LIPOSOME, INJECTION:ADJ PH	INTRAVENOUS	ADJ PH INTRAVENOUS SOLUTION, LIPOSOME, INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
O40UQP6WCF	SULFURIC ACID:IRRIGATION:INJECTION:ADJ PH	IRRIGATION	ADJ PH IRRIGATION INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
O40UQP6WCF	SULFURIC ACID:IRRIGATION:SOLUTION:ADJ PH	IRRIGATION	ADJ PH IRRIGATION SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
O40UQP6WCF	SULFURIC ACID:IV(INFUSION):INJECTION:%	IV(INFUSION)	2.12% IV(INFUSION) INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
O40UQP6WCF	SULFURIC ACID:IV(INFUSION):POWDER, FOR INJECTION SOLUTION:ADJ PH	IV(INFUSION)	ADJ PH IV(INFUSION) POWDER, FOR INJECTION SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
O40UQP6WCF	SULFURIC ACID:IV(INFUSION):POWDER, FOR INJECTION SOLUTION, LYOPHILIZED, WITHOUT ADDITIVES:ADJ PH	IV(INFUSION)	ADJ PH IV(INFUSION) POWDER, FOR INJECTION SOLUTION, LYOPHILIZED, WITHOUT ADDITIVES	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
O40UQP6WCF	SULFURIC ACID:IV(INFUSION):SOLUTION, INJECTION:ADJ PH	IV(INFUSION)	ADJ PH IV(INFUSION) SOLUTION, INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
O40UQP6WCF	SULFURIC ACID:NASAL:SOLUTION, FOR INHALATION:%	NASAL	1.5% NASAL SOLUTION, FOR INHALATION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
O40UQP6WCF	SULFURIC ACID:NASAL:SPRAY:%	NASAL	0.4% NASAL SPRAY	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
O40UQP6WCF	SULFURIC ACID:OPHTHALMIC:SOLUTION:%	OPHTHALMIC	0.02% OPHTHALMIC SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
O40UQP6WCF	SULFURIC ACID:OPHTHALMIC:SOLUTION, DROPS:ADJ PH	OPHTHALMIC	ADJ PH OPHTHALMIC SOLUTION, DROPS	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
O40UQP6WCF	SULFURIC ACID:OPHTHALMIC:SUSPENSION:ADJ PH	OPHTHALMIC	ADJ PH OPHTHALMIC SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
O40UQP6WCF	SULFURIC ACID:ORAL:SOLUTION:ADJ PH	ORAL	ADJ PH ORAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
O40UQP6WCF	SULFURIC ACID:ORAL:SOLUTION, FOR INHALATION:NA	ORAL	ORAL SOLUTION, FOR INHALATION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
O40UQP6WCF	SULFURIC ACID:PARENTERAL:POWDER, FOR INJECTION SOLUTION:ADJ PH	PARENTERAL	ADJ PH PARENTERAL POWDER, FOR INJECTION SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
O40UQP6WCF	SULFURIC ACID:RESPIRATORY (INHALATION):INHALANT:ADJ PH	RESPIRATORY (INHALATION)	ADJ PH RESPIRATORY (INHALATION) INHALANT	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
O40UQP6WCF	SULFURIC ACID:RESPIRATORY (INHALATION):POWDER, FOR INHALATION:%	RESPIRATORY (INHALATION)	0.98% RESPIRATORY (INHALATION) POWDER, FOR INHALATION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
O40UQP6WCF	SULFURIC ACID:RESPIRATORY (INHALATION):SOLUTION:%	RESPIRATORY (INHALATION)	40% RESPIRATORY (INHALATION) SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
O40UQP6WCF	SULFURIC ACID:RESPIRATORY (INHALATION):SOLUTION, AEROSOL, FOR INHALATION:ADJ PH	RESPIRATORY (INHALATION)	ADJ PH RESPIRATORY (INHALATION) SOLUTION, AEROSOL, FOR INHALATION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
O40UQP6WCF	SULFURIC ACID:RESPIRATORY (INHALATION):SOLUTION, FOR INHALATION:NA	RESPIRATORY (INHALATION)	RESPIRATORY (INHALATION) SOLUTION, FOR INHALATION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
O40UQP6WCF	SULFURIC ACID:TOPICAL:EMULSION, CREAM:NA	TOPICAL	TOPICAL EMULSION, CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
6Y0AI5605C	BUTYL STEARATE:TOPICAL:EMULSION, CREAM:%W/W	TOPICAL	3.68%W/W TOPICAL EMULSION, CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
6Y0AI5605C	BUTYL STEARATE:TOPICAL:LOTION:NA	TOPICAL	TOPICAL LOTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
TVH7653921	POLYETHYLENE GLYCOL 4500:ORAL:CAPSULE, EXTENDED RELEASE:MG	ORAL	10MG ORAL CAPSULE, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
TVH7653921	POLYETHYLENE GLYCOL 4500:ORAL:TABLET, COATED:NA	ORAL	ORAL TABLET, COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
TVH7653921	POLYETHYLENE GLYCOL 4500:ORAL:TABLET, FILM COATED:MG	ORAL	0.39MG ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
Y27PUL9H56	TYLOXAPOL:AURICULAR (OTIC):SUSPENSION:%	AURICULAR (OTIC)	0.01% AURICULAR (OTIC) SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
Y27PUL9H56	TYLOXAPOL:OPHTHALMIC:GEL:%	OPHTHALMIC	0.05% OPHTHALMIC GEL	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
Y27PUL9H56	TYLOXAPOL:OPHTHALMIC:SOLUTION:%	OPHTHALMIC	0.1% OPHTHALMIC SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
Y27PUL9H56	TYLOXAPOL:OPHTHALMIC:SOLUTION, DROPS:%	OPHTHALMIC	0.1% OPHTHALMIC SOLUTION, DROPS	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
Y27PUL9H56	TYLOXAPOL:OPHTHALMIC:SUSPENSION:%	OPHTHALMIC	0.3% OPHTHALMIC SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
Y27PUL9H56	TYLOXAPOL:OPHTHALMIC:SUSPENSION, DROPS:%	OPHTHALMIC	0.3% OPHTHALMIC SUSPENSION, DROPS	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
Y27PUL9H56	TYLOXAPOL:OTIC:SUSPENSION:%	OTIC	0.05% OTIC SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
Y27PUL9H56	TYLOXAPOL:TOPICAL:SUSPENSION:%W/V	TOPICAL	0.025%W/V TOPICAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
C80684146D	COCO MONOETHANOLAMIDE:TOPICAL:SHAMPOO:NA	TOPICAL	TOPICAL SHAMPOO	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
4X49Y0596W	OCTISALATE:TOPICAL:SOLUTION:%W/W	TOPICAL	6.1%W/W TOPICAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
4X49Y0596W	OCTISALATE:TRANSDERMAL:SOLUTION:%	TRANSDERMAL	6.1% TRANSDERMAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
4X49Y0596W	OCTISALATE:TRANSDERMAL:SPRAY:%	TRANSDERMAL	8.5% TRANSDERMAL SPRAY	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
H3UP11403C	ETHYLCELLULOSE (7 MPA.S):ORAL:CAPSULE:MG	ORAL	62.13MG ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
H3UP11403C	ETHYLCELLULOSE (7 MPA.S):ORAL:CAPSULE, DELAYED ACTION:MG	ORAL	41.1MG ORAL CAPSULE, DELAYED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
H3UP11403C	ETHYLCELLULOSE (7 MPA.S):ORAL:CAPSULE, EXTENDED RELEASE:MG	ORAL	72.6MG ORAL CAPSULE, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
H3UP11403C	ETHYLCELLULOSE (7 MPA.S):ORAL:TABLET:MG	ORAL	188.8MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
H3UP11403C	ETHYLCELLULOSE (7 MPA.S):ORAL:TABLET, DELAYED RELEASE:mg	ORAL	3.614mg ORAL TABLET, DELAYED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
H3UP11403C	ETHYLCELLULOSE (7 MPA.S):ORAL:TABLET, EXTENDED RELEASE:MG	ORAL	81MG ORAL TABLET, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
K3D86KJ24N	UNDECYLENIC ACID:TOPICAL:SPRAY:%W/W	TOPICAL	0.3%W/W TOPICAL SPRAY	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=U
23OV73Q5G9	ACESULFAME POTASSIUM:BUCCAL:GUM:MG	BUCCAL	2.35MG BUCCAL GUM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
23OV73Q5G9	ACESULFAME POTASSIUM:BUCCAL:GUM, CHEWING:MG	BUCCAL	7.35MG BUCCAL GUM, CHEWING	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
23OV73Q5G9	ACESULFAME POTASSIUM:DENTAL:SOLUTION:%	DENTAL	0.12% DENTAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
23OV73Q5G9	ACESULFAME POTASSIUM:ORAL:FILM, SOLUBLE:MG	ORAL	1.6MG ORAL FILM, SOLUBLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
23OV73Q5G9	ACESULFAME POTASSIUM:ORAL:LOZENGE:mg	ORAL	6mg ORAL LOZENGE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
23OV73Q5G9	ACESULFAME POTASSIUM:ORAL:POWDER, FOR ORAL SOLUTION:MG	ORAL	117MG ORAL POWDER, FOR ORAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
23OV73Q5G9	ACESULFAME POTASSIUM:ORAL:POWDER, FOR SUSPENSION:MG/5ML	ORAL	45MG/5ML ORAL POWDER, FOR SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
23OV73Q5G9	ACESULFAME POTASSIUM:ORAL:SOLUTION:MG/1ML	ORAL	10MG/1ML ORAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
23OV73Q5G9	ACESULFAME POTASSIUM:ORAL:SOLUTION:G	ORAL	0.2G ORAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
23OV73Q5G9	ACESULFAME POTASSIUM:ORAL:SOLUTION, LIQUID:MG/1ML	ORAL	4.5MG/1ML ORAL SOLUTION, LIQUID	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
23OV73Q5G9	ACESULFAME POTASSIUM:ORAL:SUSPENSION:MG/5ML	ORAL	10MG/5ML ORAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
23OV73Q5G9	ACESULFAME POTASSIUM:ORAL:SUSPENSION, LIQUID:MG/5ML	ORAL	7.5MG/5ML ORAL SUSPENSION, LIQUID	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
23OV73Q5G9	ACESULFAME POTASSIUM:ORAL:TABLET:MG	ORAL	8MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
23OV73Q5G9	ACESULFAME POTASSIUM:ORAL:TABLET (IMMED./COMP. RELEASE), UNCOATED, CHEWABLE:MG	ORAL	3.75MG ORAL TABLET (IMMED./COMP. RELEASE), UNCOATED, CHEWABLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
23OV73Q5G9	ACESULFAME POTASSIUM:ORAL:TABLET, CHEWABLE:MG	ORAL	6MG ORAL TABLET, CHEWABLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
23OV73Q5G9	ACESULFAME POTASSIUM:ORAL:TABLET, DISPERSIBLE:MG	ORAL	1MG ORAL TABLET, DISPERSIBLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
23OV73Q5G9	ACESULFAME POTASSIUM:ORAL:TABLET, EFFERVESCENT, FOR SOLUTION:MG	ORAL	4MG ORAL TABLET, EFFERVESCENT, FOR SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
23OV73Q5G9	ACESULFAME POTASSIUM:ORAL:TABLET, FILM COATED:MG	ORAL	8.19MG ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
23OV73Q5G9	ACESULFAME POTASSIUM:ORAL:TABLET, FOR SUSPENSION:MG	ORAL	1.8MG ORAL TABLET, FOR SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
23OV73Q5G9	ACESULFAME POTASSIUM:ORAL:TABLET, ORALLY DISINTEGRATING:MG	ORAL	8MG ORAL TABLET, ORALLY DISINTEGRATING	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
23OV73Q5G9	ACESULFAME POTASSIUM:ORAL:TABLET, UNCOATED, LOZENGE:MG	ORAL	1.5MG ORAL TABLET, UNCOATED, LOZENGE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
23OV73Q5G9	ACESULFAME POTASSIUM:ORAL:TROCHE:MG	ORAL	1.7MG ORAL TROCHE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
23OV73Q5G9	ACESULFAME POTASSIUM:SUBLINGUAL:FILM:mg	SUBLINGUAL	3mg SUBLINGUAL FILM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
23OV73Q5G9	ACESULFAME POTASSIUM:SUBLINGUAL:TABLET:MG	SUBLINGUAL	4.4MG SUBLINGUAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
1VPU26JZZ4	POTASSIUM SORBATE:NASAL:SPRAY, METERED:%	NASAL	0.008% NASAL SPRAY, METERED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
1VPU26JZZ4	POTASSIUM SORBATE:OPHTHALMIC:EMULSION:%W/V	OPHTHALMIC	0.47%W/V OPHTHALMIC EMULSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
1VPU26JZZ4	POTASSIUM SORBATE:OPHTHALMIC:SOLUTION:%	OPHTHALMIC	0.47% OPHTHALMIC SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
1VPU26JZZ4	POTASSIUM SORBATE:OPHTHALMIC:SOLUTION, DROPS:%	OPHTHALMIC	0.47% OPHTHALMIC SOLUTION, DROPS	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
1VPU26JZZ4	POTASSIUM SORBATE:ORAL:CONCENTRATE:MG/1ML	ORAL	0.1MG/1ML ORAL CONCENTRATE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
1VPU26JZZ4	POTASSIUM SORBATE:ORAL:GRANULE, FOR SUSPENSION:MG	ORAL	20MG ORAL GRANULE, FOR SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
1VPU26JZZ4	POTASSIUM SORBATE:ORAL:POWDER, FOR SUSPENSION:NA	ORAL	ORAL POWDER, FOR SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
1VPU26JZZ4	POTASSIUM SORBATE:ORAL:SOLUTION:MG/15ML	ORAL	1000MG/15ML ORAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
1VPU26JZZ4	POTASSIUM SORBATE:ORAL:SUSPENSION:%	ORAL	0.21% ORAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
1VPU26JZZ4	POTASSIUM SORBATE:ORAL:SYRUP:%	ORAL	0.2% ORAL SYRUP	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
1VPU26JZZ4	POTASSIUM SORBATE:ORAL:TABLET:MG	ORAL	1.4MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
1VPU26JZZ4	POTASSIUM SORBATE:ORAL:TABLET, COATED:NA	ORAL	ORAL TABLET, COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
1VPU26JZZ4	POTASSIUM SORBATE:ORAL:TABLET, SUSTAINED RELEASE, FILM COATED:MG	ORAL	0.2MG ORAL TABLET, SUSTAINED RELEASE, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
1VPU26JZZ4	POTASSIUM SORBATE:RECTAL:SOLUTION:%	RECTAL	6.67% RECTAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
1VPU26JZZ4	POTASSIUM SORBATE:TOPICAL:CREAM:%W/W	TOPICAL	0.2%W/W TOPICAL CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
1VPU26JZZ4	POTASSIUM SORBATE:TOPICAL:EMULSION, AEROSOL FOAM:%W/W	TOPICAL	0.2%W/W TOPICAL EMULSION, AEROSOL FOAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
1VPU26JZZ4	POTASSIUM SORBATE:TOPICAL:EMULSION, CREAM:%W/W	TOPICAL	0.25%W/W TOPICAL EMULSION, CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
1VPU26JZZ4	POTASSIUM SORBATE:TOPICAL:LOTION:%W/W	TOPICAL	0.2%W/W TOPICAL LOTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
1VPU26JZZ4	POTASSIUM SORBATE:TOPICAL:SOLUTION:NA	TOPICAL	TOPICAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
4J2I0SN84Y	WHEAT:ORAL:TABLET:MG	ORAL	1.16MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=W
C67P1734QJ	POVIDONE K17:SUBCUTANEOUS:SUSPENSION, INJECTION:%	SUBCUTANEOUS	0.77% SUBCUTANEOUS SUSPENSION, INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
DO250MG0W6	DIHYDROXYALUMINUM AMINOACETATE:TOPICAL:FILM, CONTROLLED RELEASE:MG	TOPICAL	32.2MG TOPICAL FILM, CONTROLLED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
DO250MG0W6	DIHYDROXYALUMINUM AMINOACETATE:TOPICAL:PATCH:MG	TOPICAL	35MG TOPICAL PATCH	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
DO250MG0W6	DIHYDROXYALUMINUM AMINOACETATE:TOPICAL:PATCH, CONTROLLED RELEASE:NA	TOPICAL	TOPICAL PATCH, CONTROLLED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
VH2XOU12IE	POLYDEXTROSE:ORAL:TABLET:MG	ORAL	1.008MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
VH2XOU12IE	POLYDEXTROSE:ORAL:TABLET (IMMED./COMP. RELEASE), FILM COATED:NA	ORAL	ORAL TABLET (IMMED./COMP. RELEASE), FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
VH2XOU12IE	POLYDEXTROSE:ORAL:TABLET, COATED:MG	ORAL	7.67MG ORAL TABLET, COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
VH2XOU12IE	POLYDEXTROSE:ORAL:TABLET, EXTENDED RELEASE:MG	ORAL	8.18MG ORAL TABLET, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
VH2XOU12IE	POLYDEXTROSE:ORAL:TABLET, FILM COATED:MG	ORAL	3.83MG ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
VH2XOU12IE	POLYDEXTROSE:ORAL:TABLET, SUSTAINED ACTION:NA	ORAL	ORAL TABLET, SUSTAINED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
C2E1CI501T	MAGNESIUM TRISILICATE:ORAL:POWDER, FOR ORAL SUSPENSION:MG/1PKT	ORAL	24MG/1PKT ORAL POWDER, FOR ORAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
C2E1CI501T	MAGNESIUM TRISILICATE:ORAL:POWDER, FOR SUSPENSION:g/236mL	ORAL	0.07g/236mL ORAL POWDER, FOR SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
C2E1CI501T	MAGNESIUM TRISILICATE:ORAL:TABLET:MG	ORAL	76.89MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
C2E1CI501T	MAGNESIUM TRISILICATE:ORAL:TABLET (IMMED./COMP. RELEASE), FILM COATED:MG	ORAL	12MG ORAL TABLET (IMMED./COMP. RELEASE), FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
C2E1CI501T	MAGNESIUM TRISILICATE:ORAL:TABLET (IMMED./COMP. RELEASE), UNCOATED, CHEWABLE:MG	ORAL	76.89MG ORAL TABLET (IMMED./COMP. RELEASE), UNCOATED, CHEWABLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
C2E1CI501T	MAGNESIUM TRISILICATE:ORAL:TABLET, COATED:MG	ORAL	20MG ORAL TABLET, COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
C2E1CI501T	MAGNESIUM TRISILICATE:ORAL:TABLET, DELAYED ACTION:MG	ORAL	26.4MG ORAL TABLET, DELAYED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
C2E1CI501T	MAGNESIUM TRISILICATE:ORAL:TABLET, DELAYED RELEASE:MG	ORAL	19MG ORAL TABLET, DELAYED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
C2E1CI501T	MAGNESIUM TRISILICATE:ORAL:TABLET, EXTENDED RELEASE:MG	ORAL	75MG ORAL TABLET, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
M911911U02	POTASSIUM ACETATE:OPHTHALMIC:POWDER, FOR SOLUTION:%	OPHTHALMIC	4% OPHTHALMIC POWDER, FOR SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
M911911U02	POTASSIUM ACETATE:RECTAL:ENEMA:%	RECTAL	0.41% RECTAL ENEMA	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
WR1WPI7EW8	.ALPHA.-TOCOPHEROL ACETATE, DL-:TOPICAL:EMULSION, AEROSOL FOAM:%W/W	TOPICAL	0.002%W/W TOPICAL EMULSION, AEROSOL FOAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
WR1WPI7EW8	.ALPHA.-TOCOPHEROL ACETATE, DL-:TOPICAL:OINTMENT:%W/W	TOPICAL	0.002%W/W TOPICAL OINTMENT	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
IDK7C2HS09	ETHYLENE GLYCOL MONOETHYL ETHER:ORAL:CAPSULE:MG	ORAL	0.009MG ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
94ZLA3W45F	ARGININE:IM - IV:INJECTION:NA	IM - IV	IM - IV INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
94ZLA3W45F	ARGININE:IM - IV:POWDER, FOR INJECTION SOLUTION, LYOPHILIZED:%	IM - IV	78% IM - IV POWDER, FOR INJECTION SOLUTION, LYOPHILIZED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
94ZLA3W45F	ARGININE:INTRAVENOUS:INJECTABLE:%	INTRAVENOUS	5% INTRAVENOUS INJECTABLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
94ZLA3W45F	ARGININE:INTRAVENOUS:INJECTION:%	INTRAVENOUS	39.5% INTRAVENOUS INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
94ZLA3W45F	ARGININE:INTRAVENOUS:POWDER, FOR INJECTION SOLUTION:%	INTRAVENOUS	78% INTRAVENOUS POWDER, FOR INJECTION SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
94ZLA3W45F	ARGININE:INTRAVENOUS:POWDER, FOR INJECTION SOLUTION, LYOPHILIZED:%	INTRAVENOUS	14% INTRAVENOUS POWDER, FOR INJECTION SOLUTION, LYOPHILIZED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
94ZLA3W45F	ARGININE:INTRAVENOUS:POWDER, FOR SOLUTION:g	INTRAVENOUS	70.7g INTRAVENOUS POWDER, FOR SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
94ZLA3W45F	ARGININE:INTRAVENOUS:SOLUTION, INJECTION:ADJ PH	INTRAVENOUS	ADJ PH INTRAVENOUS SOLUTION, INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
94ZLA3W45F	ARGININE:INTRAVENOUS INFUSION:INJECTION:mg/1VIAL	INTRAVENOUS INFUSION	50mg/1VIAL INTRAVENOUS INFUSION INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
94ZLA3W45F	ARGININE:INTRAVENOUS INFUSION:POWDER:mg/1VIAL	INTRAVENOUS INFUSION	50mg/1VIAL INTRAVENOUS INFUSION POWDER	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
94ZLA3W45F	ARGININE:IV - SC:INJECTION, SOLUTION:MG/1ML	IV - SC	3.48MG/1ML IV - SC INJECTION, SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
94ZLA3W45F	ARGININE:IV(INFUSION):INJECTION:%	IV(INFUSION)	88% IV(INFUSION) INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
94ZLA3W45F	ARGININE:IV(INFUSION):POWDER, FOR INJECTION SOLUTION, LYOPHILIZED:%	IV(INFUSION)	8.26% IV(INFUSION) POWDER, FOR INJECTION SOLUTION, LYOPHILIZED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
94ZLA3W45F	ARGININE:IV(INFUSION):SOLUTION, INJECTION:%	IV(INFUSION)	0.29% IV(INFUSION) SOLUTION, INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
94ZLA3W45F	ARGININE:ORAL:TABLET:MG	ORAL	25MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
94ZLA3W45F	ARGININE:ORAL:TABLET, MULTILAYER, EXTENDED RELEASE:MG	ORAL	20MG ORAL TABLET, MULTILAYER, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
94ZLA3W45F	ARGININE:PARENTERAL:POWDER, FOR INJECTION SOLUTION:NA	PARENTERAL	PARENTERAL POWDER, FOR INJECTION SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
99Q3C7L77T	POLY(METHYL ACRYLATE-CO-METHYL METHACRYLATE-CO-METHACRYLIC ACID 7:3:1; 280000 MW):ORAL:CAPSULE, EXTENDED RELEASE:MG	ORAL	44.08MG ORAL CAPSULE, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
H1109Z9J4N	HYDROGENATED SOYBEAN LECITHIN:AURICULAR (OTIC):SUSPENSION, LIQUID:%	AURICULAR (OTIC)	0.15% AURICULAR (OTIC) SUSPENSION, LIQUID	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
H1109Z9J4N	HYDROGENATED SOYBEAN LECITHIN:INHALATION:AEROSOL, METERED:%	INHALATION	0.28% INHALATION AEROSOL, METERED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
H1109Z9J4N	HYDROGENATED SOYBEAN LECITHIN:INTRAVENOUS:INJECTION, POWDER, LYOPHILIZED, FOR LIPOSOMAL SUSPENSION:%	INTRAVENOUS	21.3% INTRAVENOUS INJECTION, POWDER, LYOPHILIZED, FOR LIPOSOMAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
H1109Z9J4N	HYDROGENATED SOYBEAN LECITHIN:INTRAVENOUS:INJECTION, SUSPENSION, LIPOSOMAL:%	INTRAVENOUS	0.96% INTRAVENOUS INJECTION, SUSPENSION, LIPOSOMAL	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
H1109Z9J4N	HYDROGENATED SOYBEAN LECITHIN:ORAL:TABLET:MG	ORAL	0.21MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
H1109Z9J4N	HYDROGENATED SOYBEAN LECITHIN:TOPICAL:EMULSION, CREAM:NA	TOPICAL	TOPICAL EMULSION, CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
4T6H12BN9U	PETROLATUM:AURICULAR (OTIC):OINTMENT:NA	AURICULAR (OTIC)	AURICULAR (OTIC) OINTMENT	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
4T6H12BN9U	PETROLATUM:DENTAL:PASTE:MG	DENTAL	64MG DENTAL PASTE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
4T6H12BN9U	PETROLATUM:NASAL:OINTMENT:NA	NASAL	NASAL OINTMENT	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
4T6H12BN9U	PETROLATUM:OPHTHALMIC:OINTMENT:%	OPHTHALMIC	100% OPHTHALMIC OINTMENT	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
4T6H12BN9U	PETROLATUM:ORAL:CAPSULE, SUSTAINED ACTION:MG	ORAL	0.07MG ORAL CAPSULE, SUSTAINED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
4T6H12BN9U	PETROLATUM:RECTAL:OINTMENT:%	RECTAL	75% RECTAL OINTMENT	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
4T6H12BN9U	PETROLATUM:TOPICAL:CREAM:%W/W	TOPICAL	45.93%W/W TOPICAL CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
4T6H12BN9U	PETROLATUM:TOPICAL:CREAM, AUGMENTED:%W/W	TOPICAL	26%W/W TOPICAL CREAM, AUGMENTED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
4T6H12BN9U	PETROLATUM:TOPICAL:CREAM, EMULSION, SUSTAINED RELEASE:%W/W	TOPICAL	42%W/W TOPICAL CREAM, EMULSION, SUSTAINED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
4T6H12BN9U	PETROLATUM:TOPICAL:EMULSION:%W/W	TOPICAL	5.3%W/W TOPICAL EMULSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
4T6H12BN9U	PETROLATUM:TOPICAL:EMULSION, AEROSOL FOAM:%W/W	TOPICAL	7.9%W/W TOPICAL EMULSION, AEROSOL FOAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
4T6H12BN9U	PETROLATUM:TOPICAL:EMULSION, CREAM:%W/W	TOPICAL	58.2%W/W TOPICAL EMULSION, CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
4T6H12BN9U	PETROLATUM:TOPICAL:LOTION:%W/W	TOPICAL	15%W/W TOPICAL LOTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
4T6H12BN9U	PETROLATUM:TOPICAL:OINTMENT:%W/W 	TOPICAL	99.95%W/W  TOPICAL OINTMENT	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
4T6H12BN9U	PETROLATUM:TOPICAL:OINTMENT, AUGMENTED:%W/W	TOPICAL	81.94%W/W TOPICAL OINTMENT, AUGMENTED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
4T6H12BN9U	PETROLATUM:TOPICAL:SPONGE:NA	TOPICAL	TOPICAL SPONGE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
4T6H12BN9U	PETROLATUM:TOPICAL:SUPPOSITORY, INSERT:%W/W	TOPICAL	2.7%W/W TOPICAL SUPPOSITORY, INSERT	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
4T6H12BN9U	PETROLATUM:TRANSDERMAL:OINTMENT:%	TRANSDERMAL	29% TRANSDERMAL OINTMENT	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
4T6H12BN9U	PETROLATUM:VAGINAL:EMULSION, CREAM:%	VAGINAL	2.7% VAGINAL EMULSION, CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
4T6H12BN9U	PETROLATUM:VAGINAL:OINTMENT:%	VAGINAL	88.49% VAGINAL OINTMENT	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
4T6H12BN9U	PETROLATUM:VAGINAL:SUPPOSITORY, INSERT:MG	VAGINAL	27MG VAGINAL SUPPOSITORY, INSERT	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
QTO9JB4MDD	SODIUM TARTRATE:IM - IV:INJECTION:%	IM - IV	1.2% IM - IV INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
QTO9JB4MDD	SODIUM TARTRATE:INTRAMUSCULAR:INJECTION:%W/V	INTRAMUSCULAR	1.41%W/V INTRAMUSCULAR INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
QTO9JB4MDD	SODIUM TARTRATE:INTRAVENOUS:INJECTION:%	INTRAVENOUS	1.2% INTRAVENOUS INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
QTO9JB4MDD	SODIUM TARTRATE:IV(INFUSION):INJECTION:%	IV(INFUSION)	1.2% IV(INFUSION) INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
1R9DCZ5FOX	CETEARETH-30:TOPICAL:CREAM, AUGMENTED:%W/W	TOPICAL	1%W/W TOPICAL CREAM, AUGMENTED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
1R9DCZ5FOX	CETEARETH-30:TOPICAL:CREAM, EMULSION, SUSTAINED RELEASE:%W/W	TOPICAL	3%W/W TOPICAL CREAM, EMULSION, SUSTAINED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
1R9DCZ5FOX	CETEARETH-30:TOPICAL:EMULSION, CREAM:%W/W	TOPICAL	3%W/W TOPICAL EMULSION, CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
1R9DCZ5FOX	CETEARETH-30:TOPICAL:LOTION:%W/W	TOPICAL	2.3%W/W TOPICAL LOTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
ZBP1YXW0H8	LAVENDER OIL:TOPICAL:GEL:%W/W	TOPICAL	0.1%W/W TOPICAL GEL	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
89DS0H96TB	ZINC SULFATE, UNSPECIFIED FORM:ORAL:TABLET:MG	ORAL	15MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=Z
RV6J6604TK	EUCALYPTOL:DENTAL:SOLUTION:NA	DENTAL	DENTAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
XF417D3PSL	ANHYDROUS CITRIC ACID:BUCCAL:FILM:MG	BUCCAL	1.04MG BUCCAL FILM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
XF417D3PSL	ANHYDROUS CITRIC ACID:IM - IV:INJECTION:%	IM - IV	0.33% IM - IV INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
XF417D3PSL	ANHYDROUS CITRIC ACID:INHALATION:SUSPENSION:mg/2mL	INHALATION	0.56mg/2mL INHALATION SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
XF417D3PSL	ANHYDROUS CITRIC ACID:INTRACARDIAC:INJECTION:%W/V	INTRACARDIAC	0.25%W/V INTRACARDIAC INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
XF417D3PSL	ANHYDROUS CITRIC ACID:INTRAMUSCULAR:INJECTION:%W/V	INTRAMUSCULAR	0.25%W/V INTRAMUSCULAR INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
XF417D3PSL	ANHYDROUS CITRIC ACID:INTRAMUSCULAR:INJECTION, SOLUTION:%	INTRAMUSCULAR	0.25% INTRAMUSCULAR INJECTION, SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
XF417D3PSL	ANHYDROUS CITRIC ACID:INTRAVENOUS:INJECTABLE:%	INTRAVENOUS	0.2% INTRAVENOUS INJECTABLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
XF417D3PSL	ANHYDROUS CITRIC ACID:INTRAVENOUS:INJECTION:%W/V	INTRAVENOUS	7.7%W/V INTRAVENOUS INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
XF417D3PSL	ANHYDROUS CITRIC ACID:INTRAVENOUS:INJECTION, SOLUTION:%W/V	INTRAVENOUS	0.4%W/V INTRAVENOUS INJECTION, SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
XF417D3PSL	ANHYDROUS CITRIC ACID:INTRAVENOUS:LIQUID:%	INTRAVENOUS	0.2% INTRAVENOUS LIQUID	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
XF417D3PSL	ANHYDROUS CITRIC ACID:INTRAVENOUS:POWDER, FOR INJECTION SOLUTION, LYOPHILIZED:%	INTRAVENOUS	42.19% INTRAVENOUS POWDER, FOR INJECTION SOLUTION, LYOPHILIZED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
XF417D3PSL	ANHYDROUS CITRIC ACID:INTRAVENOUS:SOLUTION, INJECTION:%	INTRAVENOUS	1% INTRAVENOUS SOLUTION, INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
XF417D3PSL	ANHYDROUS CITRIC ACID:INTRAVENOUS:SOLUTION, INJECTION:ADJ PH	INTRAVENOUS	0.14ADJ PH INTRAVENOUS SOLUTION, INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
XF417D3PSL	ANHYDROUS CITRIC ACID:INTRAVENOUS INFUSION:INJECTION:MG/1ML	INTRAVENOUS INFUSION	4MG/1ML INTRAVENOUS INFUSION INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
XF417D3PSL	ANHYDROUS CITRIC ACID:INTRAVENOUS INFUSION:SOLUTION, INJECTION:%	INTRAVENOUS INFUSION	0.53% INTRAVENOUS INFUSION SOLUTION, INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
XF417D3PSL	ANHYDROUS CITRIC ACID:IV(INFUSION):INJECTABLE:%W/V	IV(INFUSION)	7.7%W/V IV(INFUSION) INJECTABLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
XF417D3PSL	ANHYDROUS CITRIC ACID:IV(INFUSION):SOLUTION, CONCENTRATE:%	IV(INFUSION)	0.6% IV(INFUSION) SOLUTION, CONCENTRATE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
XF417D3PSL	ANHYDROUS CITRIC ACID:IV(INFUSION):SOLUTION, INJECTION:%	IV(INFUSION)	1% IV(INFUSION) SOLUTION, INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
XF417D3PSL	ANHYDROUS CITRIC ACID:NASAL:SOLUTION, SPRAY:%	NASAL	0.044% NASAL SOLUTION, SPRAY	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
XF417D3PSL	ANHYDROUS CITRIC ACID:NASAL:SPRAY:%	NASAL	0.058% NASAL SPRAY	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
XF417D3PSL	ANHYDROUS CITRIC ACID:NASAL:SPRAY, METERED:%	NASAL	0.045% NASAL SPRAY, METERED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
XF417D3PSL	ANHYDROUS CITRIC ACID:OPHTHALMIC:SOLUTION:%W/W	OPHTHALMIC	0.2%W/W OPHTHALMIC SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
XF417D3PSL	ANHYDROUS CITRIC ACID:ORAL:CAPSULE, SOFT GELATIN:MG	ORAL	1.64MG ORAL CAPSULE, SOFT GELATIN	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
XF417D3PSL	ANHYDROUS CITRIC ACID:ORAL:CAPSULE, SOFT GELATIN LIQUID-FILLED:MG	ORAL	30MG ORAL CAPSULE, SOFT GELATIN LIQUID-FILLED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
XF417D3PSL	ANHYDROUS CITRIC ACID:ORAL:GRANULE, FOR ORAL SUSPENSION:MG	ORAL	4.9MG ORAL GRANULE, FOR ORAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
XF417D3PSL	ANHYDROUS CITRIC ACID:ORAL:LIQUID:MG/1ML	ORAL	2MG/1ML ORAL LIQUID	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
XF417D3PSL	ANHYDROUS CITRIC ACID:ORAL:POWDER, FOR ORAL SOLUTION:MG	ORAL	210MG ORAL POWDER, FOR ORAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
XF417D3PSL	ANHYDROUS CITRIC ACID:ORAL:POWDER, FOR ORAL SUSPENSION:mg	ORAL	100mg ORAL POWDER, FOR ORAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
XF417D3PSL	ANHYDROUS CITRIC ACID:ORAL:POWDER, FOR SOLUTION:MG	ORAL	7.99MG ORAL POWDER, FOR SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
XF417D3PSL	ANHYDROUS CITRIC ACID:ORAL:POWDER, FOR SUSPENSION:MG/140ML	ORAL	10MG/140ML ORAL POWDER, FOR SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
XF417D3PSL	ANHYDROUS CITRIC ACID:ORAL:SOLUTION:MG/5ML	ORAL	33.18MG/5ML ORAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
XF417D3PSL	ANHYDROUS CITRIC ACID:ORAL:SOLUTION, ELIXIR:MG/5ML	ORAL	5MG/5ML ORAL SOLUTION, ELIXIR	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
XF417D3PSL	ANHYDROUS CITRIC ACID:ORAL:SOLUTION, LIQUID:MG/1ML	ORAL	0.8MG/1ML ORAL SOLUTION, LIQUID	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
XF417D3PSL	ANHYDROUS CITRIC ACID:ORAL:SUSPENSION:MG/5ML	ORAL	75MG/5ML ORAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
XF417D3PSL	ANHYDROUS CITRIC ACID:ORAL:SUSPENSION, DROPS:MG/1ML	ORAL	2.5MG/1ML ORAL SUSPENSION, DROPS	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
XF417D3PSL	ANHYDROUS CITRIC ACID:ORAL:SUSPENSION, EXTENDED RELEASE:MG/ML	ORAL	5.18MG/ML ORAL SUSPENSION, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
XF417D3PSL	ANHYDROUS CITRIC ACID:ORAL:SUSPENSION, EXTENDED RELEASE:MG/1ML	ORAL	2.25MG/1ML ORAL SUSPENSION, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
XF417D3PSL	ANHYDROUS CITRIC ACID:ORAL:SYRUP:MG/5ML	ORAL	22.32MG/5ML ORAL SYRUP	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
XF417D3PSL	ANHYDROUS CITRIC ACID:ORAL:TABLET:MG	ORAL	20.4MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
XF417D3PSL	ANHYDROUS CITRIC ACID:ORAL:TABLET, CHEWABLE:MG	ORAL	8MG ORAL TABLET, CHEWABLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
XF417D3PSL	ANHYDROUS CITRIC ACID:ORAL:TABLET, EFFERVESCENT, FOR SOLUTION:MG	ORAL	839.63MG ORAL TABLET, EFFERVESCENT, FOR SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
XF417D3PSL	ANHYDROUS CITRIC ACID:ORAL:TABLET, EXTENDED RELEASE:MG	ORAL	78MG ORAL TABLET, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
XF417D3PSL	ANHYDROUS CITRIC ACID:ORAL:TABLET, ORALLY DISINTEGRATING:MG	ORAL	30MG ORAL TABLET, ORALLY DISINTEGRATING	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
XF417D3PSL	ANHYDROUS CITRIC ACID:ORAL:TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE:mg	ORAL	8mg ORAL TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
XF417D3PSL	ANHYDROUS CITRIC ACID:ORAL:TABLET, UNCOATED, LOZENGE:MG	ORAL	9.8MG ORAL TABLET, UNCOATED, LOZENGE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
XF417D3PSL	ANHYDROUS CITRIC ACID:RECTAL:SUSPENSION:%	RECTAL	0.11% RECTAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
XF417D3PSL	ANHYDROUS CITRIC ACID:RESPIRATORY (INHALATION):SOLUTION, SPRAY:%	RESPIRATORY (INHALATION)	0.0003% RESPIRATORY (INHALATION) SOLUTION, SPRAY	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
XF417D3PSL	ANHYDROUS CITRIC ACID:RESPIRATORY (INHALATION):SUSPENSION, FOR INHALATION:%	RESPIRATORY (INHALATION)	0.027% RESPIRATORY (INHALATION) SUSPENSION, FOR INHALATION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
XF417D3PSL	ANHYDROUS CITRIC ACID:SUBCUTANEOUS:INJECTION:%W/V	SUBCUTANEOUS	0.25%W/V SUBCUTANEOUS INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
XF417D3PSL	ANHYDROUS CITRIC ACID:SUBCUTANEOUS:INJECTION, SOLUTION:%	SUBCUTANEOUS	0.25% SUBCUTANEOUS INJECTION, SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
XF417D3PSL	ANHYDROUS CITRIC ACID:SUBLINGUAL:FILM:mg	SUBLINGUAL	5.56mg SUBLINGUAL FILM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
XF417D3PSL	ANHYDROUS CITRIC ACID:SUBLINGUAL:TABLET:MG	SUBLINGUAL	10MG SUBLINGUAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
XF417D3PSL	ANHYDROUS CITRIC ACID:SUBLINGUAL:TABLET (IMMED./COMP. RELEASE), UNCOATED, BUCCAL:MG	SUBLINGUAL	6MG SUBLINGUAL TABLET (IMMED./COMP. RELEASE), UNCOATED, BUCCAL	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
XF417D3PSL	ANHYDROUS CITRIC ACID:SUBLINGUAL:TABLET, ORALLY DISINTEGRATING:ADJ PH	SUBLINGUAL	ADJ PH SUBLINGUAL TABLET, ORALLY DISINTEGRATING	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
XF417D3PSL	ANHYDROUS CITRIC ACID:TOPICAL:AEROSOL:%W/W	TOPICAL	0.01%W/W TOPICAL AEROSOL	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
XF417D3PSL	ANHYDROUS CITRIC ACID:TOPICAL:AEROSOL, FOAM:%W/W	TOPICAL	0.105%W/W TOPICAL AEROSOL, FOAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
XF417D3PSL	ANHYDROUS CITRIC ACID:TOPICAL:AEROSOL, FOAM:ADJ PH	TOPICAL	ADJ PH TOPICAL AEROSOL, FOAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
XF417D3PSL	ANHYDROUS CITRIC ACID:TOPICAL:CLOTH:%W/W	TOPICAL	0.15%W/W TOPICAL CLOTH	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
XF417D3PSL	ANHYDROUS CITRIC ACID:TOPICAL:CREAM:%W/W 	TOPICAL	0.05%W/W  TOPICAL CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
XF417D3PSL	ANHYDROUS CITRIC ACID:TOPICAL:CREAM, EMULSION, SUSTAINED RELEASE:%W/W	TOPICAL	0.18%W/W TOPICAL CREAM, EMULSION, SUSTAINED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
XF417D3PSL	ANHYDROUS CITRIC ACID:TOPICAL:EMULSION, AEROSOL FOAM:%W/W	TOPICAL	0.08%W/W TOPICAL EMULSION, AEROSOL FOAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
XF417D3PSL	ANHYDROUS CITRIC ACID:TOPICAL:EMULSION, CREAM:%W/W	TOPICAL	0.05%W/W TOPICAL EMULSION, CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
XF417D3PSL	ANHYDROUS CITRIC ACID:TOPICAL:GEL:%W/W	TOPICAL	0.14%W/W TOPICAL GEL	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
XF417D3PSL	ANHYDROUS CITRIC ACID:TOPICAL:LOTION:%W/W 	TOPICAL	0.42%W/W  TOPICAL LOTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
XF417D3PSL	ANHYDROUS CITRIC ACID:TOPICAL:OIL:%W/W 	TOPICAL	0.03%W/W  TOPICAL OIL	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
XF417D3PSL	ANHYDROUS CITRIC ACID:TOPICAL:OPHTHALMIC SUSPENSION DOSAGE FORM:%W/V	TOPICAL	0.05%W/V TOPICAL OPHTHALMIC SUSPENSION DOSAGE FORM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
XF417D3PSL	ANHYDROUS CITRIC ACID:TRANSDERMAL:PATCH, ELECTRICALLY CONTROLLED:MG	TRANSDERMAL	23MG TRANSDERMAL PATCH, ELECTRICALLY CONTROLLED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
XF417D3PSL	ANHYDROUS CITRIC ACID:TRANSMUCOSAL:TABLET, UNCOATED, LOZENGE:MG	TRANSMUCOSAL	11MG TRANSMUCOSAL TABLET, UNCOATED, LOZENGE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
DIQ16UC154	LAURYL SULFATE:ORAL:CAPSULE:MG	ORAL	0.15MG ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
DIQ16UC154	LAURYL SULFATE:ORAL:TABLET, FILM COATED:MG	ORAL	2MG ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
DIQ16UC154	LAURYL SULFATE:TOPICAL:SHAMPOO, SUSPENSION:NA	TOPICAL	TOPICAL SHAMPOO, SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
8VAB711C5E	HYDROXYPROPYL CELLULOSE (45000 WAMW):ORAL:TABLET:mg	ORAL	24mg ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
UFD2LZ005D	ETHYL BUTYRATE:ORAL:SOLUTION:MG/10ML	ORAL	1MG/10ML ORAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
UFD2LZ005D	ETHYL BUTYRATE:ORAL:SUSPENSION:MG/10ML	ORAL	1MG/10ML ORAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
4W5IH7FLNY	DIBUTYL SEBACATE:ORAL:CAPSULE:MG	ORAL	15.47MG ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
4W5IH7FLNY	DIBUTYL SEBACATE:ORAL:CAPSULE, DELAYED ACTION:MG	ORAL	6.41MG ORAL CAPSULE, DELAYED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
4W5IH7FLNY	DIBUTYL SEBACATE:ORAL:CAPSULE, DELAYED RELEASE:MG	ORAL	3.02MG ORAL CAPSULE, DELAYED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
4W5IH7FLNY	DIBUTYL SEBACATE:ORAL:CAPSULE, ENTERIC COATED PELLETS:MG	ORAL	0.89MG ORAL CAPSULE, ENTERIC COATED PELLETS	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
4W5IH7FLNY	DIBUTYL SEBACATE:ORAL:CAPSULE, EXTENDED RELEASE:MG	ORAL	10MG ORAL CAPSULE, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
4W5IH7FLNY	DIBUTYL SEBACATE:ORAL:CAPSULE, HARD GELATIN:MG	ORAL	3.83MG ORAL CAPSULE, HARD GELATIN	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
4W5IH7FLNY	DIBUTYL SEBACATE:ORAL:CAPSULE, SUSTAINED ACTION:MG	ORAL	8.82MG ORAL CAPSULE, SUSTAINED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
4W5IH7FLNY	DIBUTYL SEBACATE:ORAL:CAPSULE, SUSTAINED ACTION, HARD GELATIN:MG	ORAL	2.83MG ORAL CAPSULE, SUSTAINED ACTION, HARD GELATIN	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
4W5IH7FLNY	DIBUTYL SEBACATE:ORAL:GRANULE, ENTERIC COATED:MG	ORAL	43.2MG ORAL GRANULE, ENTERIC COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
4W5IH7FLNY	DIBUTYL SEBACATE:ORAL:PELLET:MG	ORAL	0.552MG ORAL PELLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
4W5IH7FLNY	DIBUTYL SEBACATE:ORAL:TABLET:MG	ORAL	6MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
4W5IH7FLNY	DIBUTYL SEBACATE:ORAL:TABLET, EXTENDED RELEASE:MG	ORAL	19.07MG ORAL TABLET, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
4W5IH7FLNY	DIBUTYL SEBACATE:ORAL:TABLET, SUSTAINED ACTION:MG	ORAL	1.11MG ORAL TABLET, SUSTAINED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
7L6R1SQ6M0	OLETH-2:AURICULAR (OTIC):OIL:%V/V	AURICULAR (OTIC)	3.1%V/V AURICULAR (OTIC) OIL	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
7L6R1SQ6M0	OLETH-2:TOPICAL:OIL:%W/W	TOPICAL	3.25%W/W TOPICAL OIL	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
14BGY2Y3MJ	POLYSORBATE 65:TOPICAL:OINTMENT:NA	TOPICAL	TOPICAL OINTMENT	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
M41L2IN55T	BISMUTH SUBCARBONATE:ORAL:TABLET:MG	ORAL	4.3MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
M41L2IN55T	BISMUTH SUBCARBONATE:ORAL:TABLET, COATED:NA	ORAL	ORAL TABLET, COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
M41L2IN55T	BISMUTH SUBCARBONATE:ORAL:TABLET, SUSTAINED ACTION:MG	ORAL	0.044MG ORAL TABLET, SUSTAINED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
685928Z18A	BENZENESULFONIC ACID:INTRAVENOUS:INJECTION:ADJ PH	INTRAVENOUS	ADJ PH INTRAVENOUS INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
685928Z18A	BENZENESULFONIC ACID:INTRAVENOUS:LIQUID:ADJ PH	INTRAVENOUS	ADJ PH INTRAVENOUS LIQUID	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
685928Z18A	BENZENESULFONIC ACID:INTRAVENOUS:SOLUTION, INJECTION:ADJ PH	INTRAVENOUS	ADJ PH INTRAVENOUS SOLUTION, INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
685928Z18A	BENZENESULFONIC ACID:IV(INFUSION):INJECTION:ADJ PH	IV(INFUSION)	ADJ PH IV(INFUSION) INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
WL0328HX19	CANDELILLA WAX:ORAL:TABLET:MG	ORAL	0.4MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
WL0328HX19	CANDELILLA WAX:ORAL:TABLET (IMMED./COMP. RELEASE), FILM COATED:MG	ORAL	0.32MG ORAL TABLET (IMMED./COMP. RELEASE), FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
WL0328HX19	CANDELILLA WAX:ORAL:TABLET, EXTENDED RELEASE:MG	ORAL	0.37MG ORAL TABLET, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
WL0328HX19	CANDELILLA WAX:ORAL:TABLET, FILM COATED:MG	ORAL	0.8MG ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
WL0328HX19	CANDELILLA WAX:ORAL:TABLET, SUSTAINED ACTION:MG	ORAL	0.16MG ORAL TABLET, SUSTAINED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
WL0328HX19	CANDELILLA WAX:ORAL:TABLET, SUSTAINED ACTION, COATED:MG	ORAL	0.58MG ORAL TABLET, SUSTAINED ACTION, COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
U16QOD6C4E	SODIUM SUCCINATE HEXAHYDRATE:INTRAVENOUS:INJECTION, POWDER, LYOPHILIZED, FOR LIPOSOMAL SUSPENSION:%	INTRAVENOUS	2.7% INTRAVENOUS INJECTION, POWDER, LYOPHILIZED, FOR LIPOSOMAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
U16QOD6C4E	SODIUM SUCCINATE HEXAHYDRATE:ORAL:CONCENTRATE:NA	ORAL	ORAL CONCENTRATE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
D6DH1DTN7E	DISODIUM LAURETH SULFOSUCCINATE:TOPICAL:GEL:%W/W	TOPICAL	0.04%W/W TOPICAL GEL	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
D6DH1DTN7E	DISODIUM LAURETH SULFOSUCCINATE:TOPICAL:SHAMPOO:%W/W	TOPICAL	15%W/W TOPICAL SHAMPOO	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
6I2K5U1MWS	STEARETH-40:ORAL:TABLET:NA	ORAL	ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
6I2K5U1MWS	STEARETH-40:RECTAL:AEROSOL, METERED:%	RECTAL	1.35% RECTAL AEROSOL, METERED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
6I2K5U1MWS	STEARETH-40:TOPICAL:EMULSION, AEROSOL FOAM:%W/W	TOPICAL	0.92%W/W TOPICAL EMULSION, AEROSOL FOAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
6I2K5U1MWS	STEARETH-40:TOPICAL:EMULSION, CREAM:%W/W	TOPICAL	12%W/W TOPICAL EMULSION, CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
6I2K5U1MWS	STEARETH-40:TOPICAL:OINTMENT:NA	TOPICAL	TOPICAL OINTMENT	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
OK17S3S98K	PENTADECALACTONE:TRANSDERMAL:GEL:%W/W	TRANSDERMAL	8%W/W TRANSDERMAL GEL	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
VM7F0B23ZI	HYPROMELLOSE 2208 (100000 MPA.S):ORAL:TABLET:MG	ORAL	380MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
VM7F0B23ZI	HYPROMELLOSE 2208 (100000 MPA.S):ORAL:TABLET, EXTENDED RELEASE:MG	ORAL	350MG ORAL TABLET, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
VM7F0B23ZI	HYPROMELLOSE 2208 (100000 MPA.S):ORAL:TABLET, SUSTAINED RELEASE, FILM COATED:MG	ORAL	180MG ORAL TABLET, SUSTAINED RELEASE, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
H3R47K3TBD	FD&C BLUE NO. 1:DENTAL:PASTE:NA	DENTAL	DENTAL PASTE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
H3R47K3TBD	FD&C BLUE NO. 1:DENTAL:SOLUTION:%	DENTAL	0.01% DENTAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
H3R47K3TBD	FD&C BLUE NO. 1:ORAL:BAR, CHEWABLE:NA	ORAL	ORAL BAR, CHEWABLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
H3R47K3TBD	FD&C BLUE NO. 1:ORAL:CAPSULE:MG	ORAL	4.78MG ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
H3R47K3TBD	FD&C BLUE NO. 1:ORAL:CAPSULE (IMMED./COMP. RELEASE):MG	ORAL	0.13MG ORAL CAPSULE (IMMED./COMP. RELEASE)	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
H3R47K3TBD	FD&C BLUE NO. 1:ORAL:CAPSULE (IMMED./COMP. RELEASE), COATED, SOFT GELATIN:MG	ORAL	0.2MG ORAL CAPSULE (IMMED./COMP. RELEASE), COATED, SOFT GELATIN	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
H3R47K3TBD	FD&C BLUE NO. 1:ORAL:CAPSULE, COATED, SOFT GELATIN:MG	ORAL	0.034MG ORAL CAPSULE, COATED, SOFT GELATIN	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
H3R47K3TBD	FD&C BLUE NO. 1:ORAL:CAPSULE, DELAYED ACTION:MG	ORAL	0.5MG ORAL CAPSULE, DELAYED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
H3R47K3TBD	FD&C BLUE NO. 1:ORAL:CAPSULE, DELAYED ACTION, ENTERIC COATED:NA	ORAL	ORAL CAPSULE, DELAYED ACTION, ENTERIC COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
H3R47K3TBD	FD&C BLUE NO. 1:ORAL:CAPSULE, DELAYED RELEASE:MG	ORAL	0.035MG ORAL CAPSULE, DELAYED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
H3R47K3TBD	FD&C BLUE NO. 1:ORAL:CAPSULE, ENTERIC COATED PELLETS:NA	ORAL	ORAL CAPSULE, ENTERIC COATED PELLETS	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
H3R47K3TBD	FD&C BLUE NO. 1:ORAL:CAPSULE, EXTENDED RELEASE:MG	ORAL	0.78MG ORAL CAPSULE, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
H3R47K3TBD	FD&C BLUE NO. 1:ORAL:CAPSULE, HARD GELATIN:MG	ORAL	3.71MG ORAL CAPSULE, HARD GELATIN	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
H3R47K3TBD	FD&C BLUE NO. 1:ORAL:CAPSULE, SOFT GELATIN:MG	ORAL	0.04MG ORAL CAPSULE, SOFT GELATIN	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
H3R47K3TBD	FD&C BLUE NO. 1:ORAL:CAPSULE, SOFT GELATIN LIQUID-FILLED:MG	ORAL	0.024MG ORAL CAPSULE, SOFT GELATIN LIQUID-FILLED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
H3R47K3TBD	FD&C BLUE NO. 1:ORAL:CAPSULE, SUSTAINED ACTION:MG	ORAL	0.9MG ORAL CAPSULE, SUSTAINED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
H3R47K3TBD	FD&C BLUE NO. 1:ORAL:CONCENTRATE:NA	ORAL	ORAL CONCENTRATE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
H3R47K3TBD	FD&C BLUE NO. 1:ORAL:FILM, SOLUBLE:MG	ORAL	0.036MG ORAL FILM, SOLUBLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
H3R47K3TBD	FD&C BLUE NO. 1:ORAL:LIQUID:MG/15ML	ORAL	0.016MG/15ML ORAL LIQUID	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
H3R47K3TBD	FD&C BLUE NO. 1:ORAL:POWDER:NA	ORAL	ORAL POWDER	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
H3R47K3TBD	FD&C BLUE NO. 1:ORAL:POWDER, FOR ORAL SOLUTION:NA	ORAL	ORAL POWDER, FOR ORAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
H3R47K3TBD	FD&C BLUE NO. 1:ORAL:POWDER, FOR SUSPENSION:MG/5ML	ORAL	1MG/5ML ORAL POWDER, FOR SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
H3R47K3TBD	FD&C BLUE NO. 1:ORAL:SOLUTION:MG/15ML	ORAL	1.13MG/15ML ORAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
H3R47K3TBD	FD&C BLUE NO. 1:ORAL:SOLUTION, ELIXIR:MG/5ML	ORAL	0.023MG/5ML ORAL SOLUTION, ELIXIR	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
H3R47K3TBD	FD&C BLUE NO. 1:ORAL:SUSPENSION:MG/5ML	ORAL	0.075MG/5ML ORAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
H3R47K3TBD	FD&C BLUE NO. 1:ORAL:SUSPENSION, LIQUID:MG/5ML	ORAL	0.045MG/5ML ORAL SUSPENSION, LIQUID	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
H3R47K3TBD	FD&C BLUE NO. 1:ORAL:SUSPENSION, SUSTAINED ACTION:NA	ORAL	ORAL SUSPENSION, SUSTAINED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
H3R47K3TBD	FD&C BLUE NO. 1:ORAL:SYRUP:MG/5ML	ORAL	0.043MG/5ML ORAL SYRUP	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
H3R47K3TBD	FD&C BLUE NO. 1:ORAL:TABLET:MG	ORAL	20MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
H3R47K3TBD	FD&C BLUE NO. 1:ORAL:TABLET, COATED:MG	ORAL	0.52MG ORAL TABLET, COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
H3R47K3TBD	FD&C BLUE NO. 1:ORAL:TABLET, DELAYED ACTION:MG	ORAL	0.037MG ORAL TABLET, DELAYED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
H3R47K3TBD	FD&C BLUE NO. 1:ORAL:TABLET, DELAYED ACTION, ENTERIC COATED:NA	ORAL	ORAL TABLET, DELAYED ACTION, ENTERIC COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
H3R47K3TBD	FD&C BLUE NO. 1:ORAL:TABLET, EXTENDED RELEASE:MG	ORAL	1.36MG ORAL TABLET, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
H3R47K3TBD	FD&C BLUE NO. 1:ORAL:TABLET, FILM COATED:MG	ORAL	0.16MG ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
H3R47K3TBD	FD&C BLUE NO. 1:ORAL:TABLET, SUSTAINED ACTION:NA	ORAL	ORAL TABLET, SUSTAINED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
H3R47K3TBD	FD&C BLUE NO. 1:ORAL:TABLET, SUSTAINED ACTION, COATED:NA	ORAL	ORAL TABLET, SUSTAINED ACTION, COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
H3R47K3TBD	FD&C BLUE NO. 1:RECTAL:SOLUTION:%	RECTAL	0.005% RECTAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
H3R47K3TBD	FD&C BLUE NO. 1:SUBLINGUAL:FILM:PNG	SUBLINGUAL	PNG SUBLINGUAL FILM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
H3R47K3TBD	FD&C BLUE NO. 1:SUBLINGUAL:FILM:QS	SUBLINGUAL	QS SUBLINGUAL FILM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
H3R47K3TBD	FD&C BLUE NO. 1:SUBLINGUAL:TABLET:MG	SUBLINGUAL	0.03MG SUBLINGUAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
H3R47K3TBD	FD&C BLUE NO. 1:TOPICAL:LOTION:NA	TOPICAL	TOPICAL LOTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
H3R47K3TBD	FD&C BLUE NO. 1:TOPICAL:SHAMPOO:%W/W	TOPICAL	0.004%W/W TOPICAL SHAMPOO	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
H3R47K3TBD	FD&C BLUE NO. 1:TOPICAL:SHAMPOO, SUSPENSION:NA	TOPICAL	TOPICAL SHAMPOO, SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
H3R47K3TBD	FD&C BLUE NO. 1:TOPICAL:SPONGE:%W/W	TOPICAL	0.005%W/W TOPICAL SPONGE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
H3R47K3TBD	FD&C BLUE NO. 1:TOPICAL:SWAB:NA	TOPICAL	TOPICAL SWAB	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
344S277G0Z	ALLANTOIN:TOPICAL:EMULSION, CREAM:NA	TOPICAL	TOPICAL EMULSION, CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
344S277G0Z	ALLANTOIN:TOPICAL:GEL:%W/W	TOPICAL	0.2%W/W TOPICAL GEL	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
344S277G0Z	ALLANTOIN:VAGINAL:EMULSION, CREAM:%	VAGINAL	2% VAGINAL EMULSION, CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
3IN71E75Z5	URETHANE:IM - IV - SC:INJECTION:NA	IM - IV - SC	IM - IV - SC INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=U
STI11B5A2X	POLYSORBATE 40:IM - IV:INJECTION:NA	IM - IV	IM - IV INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
STI11B5A2X	POLYSORBATE 40:INTRAMUSCULAR:INJECTION:NA	INTRAMUSCULAR	INTRAMUSCULAR INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
STI11B5A2X	POLYSORBATE 40:ORAL:SOLUTION, ELIXIR:MG/5ML	ORAL	0.05MG/5ML ORAL SOLUTION, ELIXIR	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
STI11B5A2X	POLYSORBATE 40:ORAL:SUSPENSION:%	ORAL	0.1% ORAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
STI11B5A2X	POLYSORBATE 40:ORAL:SYRUP:NA	ORAL	ORAL SYRUP	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
STI11B5A2X	POLYSORBATE 40:TOPICAL:EMULSION, CREAM:%W/W	TOPICAL	3%W/W TOPICAL EMULSION, CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
STI11B5A2X	POLYSORBATE 40:TOPICAL:GEL:%W/W	TOPICAL	0.2%W/W TOPICAL GEL	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
STI11B5A2X	POLYSORBATE 40:TOPICAL:LOTION:%W/W	TOPICAL	2%W/W TOPICAL LOTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
Z135WT9208	CARBOMER HOMOPOLYMER TYPE B (ALLYL SUCROSE CROSSLINKED):TOPICAL:LOTION:%W/W	TOPICAL	0.35%W/W TOPICAL LOTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
Z135WT9208	CARBOMER HOMOPOLYMER TYPE B (ALLYL SUCROSE CROSSLINKED):TOPICAL:SOLUTION:%W/W	TOPICAL	0.13%W/W TOPICAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
J3QD0LD11P	METHYL GLUCETH-20:TOPICAL:CREAM, EMULSION, SUSTAINED RELEASE:%W/W	TOPICAL	13.6%W/W TOPICAL CREAM, EMULSION, SUSTAINED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
J3QD0LD11P	METHYL GLUCETH-20:TOPICAL:EMULSION, CREAM:%W/W	TOPICAL	5%W/W TOPICAL EMULSION, CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
G7515SW10N	GLYCERYL MONOCAPRYLOCAPRATE:ORAL:CAPSULE, SOFT GELATIN:MG	ORAL	374.5MG ORAL CAPSULE, SOFT GELATIN	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
60V9STC53F	ETHYLENEDIAMINE:ORAL:SOLUTION:MG/5ML	ORAL	18.5MG/5ML ORAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
60V9STC53F	ETHYLENEDIAMINE:RECTAL:ENEMA:NA	RECTAL	RECTAL ENEMA	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
60V9STC53F	ETHYLENEDIAMINE:TOPICAL:EMULSION, CREAM:%W/W	TOPICAL	0.18%W/W TOPICAL EMULSION, CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
TA269SD04T	BENZALDEHYDE:ORAL:SUSPENSION:MG/1ML	ORAL	0.6MG/1ML ORAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
G624N6MSBA	TRIDECETH-10:TOPICAL:AEROSOL, METERED:%W/W	TOPICAL	4%W/W TOPICAL AEROSOL, METERED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
G624N6MSBA	TRIDECETH-10:TOPICAL:SOLUTION:%W/W	TOPICAL	4%W/W TOPICAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
FM5526K07A	ZINC ACETATE:SUBCUTANEOUS:INJECTION:NA	SUBCUTANEOUS	SUBCUTANEOUS INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=Z
FM5526K07A	ZINC ACETATE:SUBCUTANEOUS:POWDER, FOR INJECTION SUSPENSION:%	SUBCUTANEOUS	0.23% SUBCUTANEOUS POWDER, FOR INJECTION SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=Z
FM5526K07A	ZINC ACETATE:TOPICAL:LOTION:NA	TOPICAL	TOPICAL LOTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=Z
FM5526K07A	ZINC ACETATE:TOPICAL:SOLUTION:NA	TOPICAL	TOPICAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=Z
FM5526K07A	ZINC ACETATE:TOPICAL:SWAB:NA	TOPICAL	TOPICAL SWAB	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=Z
2RF6EJ0M85	DIATOMACEOUS EARTH:ORAL:CAPSULE:MG	ORAL	3.4MG ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
2RF6EJ0M85	DIATOMACEOUS EARTH:ORAL:SYRUP:NA	ORAL	ORAL SYRUP	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
2RF6EJ0M85	DIATOMACEOUS EARTH:ORAL:TABLET:MG	ORAL	5MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
2RF6EJ0M85	DIATOMACEOUS EARTH:ORAL:TABLET (IMMED./COMP. RELEASE), UNCOATED, CHEWABLE:MG	ORAL	2MG ORAL TABLET (IMMED./COMP. RELEASE), UNCOATED, CHEWABLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
2RF6EJ0M85	DIATOMACEOUS EARTH:ORAL:TABLET, COATED:MG	ORAL	7.2MG ORAL TABLET, COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
2RF6EJ0M85	DIATOMACEOUS EARTH:ORAL:TABLET, SUSTAINED ACTION:MG	ORAL	4.16MG ORAL TABLET, SUSTAINED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
1D822OC34X	MYRISTYL LACTATE:TOPICAL:LOTION:%W/W	TOPICAL	0.8%W/W TOPICAL LOTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
OE8ZA0KN9Z	D&C RED NO. 36:TOPICAL:EMULSION, CREAM:NA	TOPICAL	TOPICAL EMULSION, CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
LQA7B6G8JG	POLOXAMER 188:INTRAMUSCULAR:POWDER, FOR INJECTION SUSPENSION:%W/V	INTRAMUSCULAR	0.2%W/V INTRAMUSCULAR POWDER, FOR INJECTION SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
LQA7B6G8JG	POLOXAMER 188:INTRAVENOUS:INJECTION:%	INTRAVENOUS	0.6% INTRAVENOUS INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
LQA7B6G8JG	POLOXAMER 188:INTRAVENOUS:POWDER, FOR INJECTION SOLUTION:%	INTRAVENOUS	0.22% INTRAVENOUS POWDER, FOR INJECTION SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
LQA7B6G8JG	POLOXAMER 188:OPHTHALMIC:SOLUTION:%	OPHTHALMIC	0.1% OPHTHALMIC SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
LQA7B6G8JG	POLOXAMER 188:ORAL:CAPSULE:mg	ORAL	25.1mg ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
LQA7B6G8JG	POLOXAMER 188:ORAL:CAPSULE (IMMED./COMP. RELEASE), HARD GELATIN:MG	ORAL	3.18MG ORAL CAPSULE (IMMED./COMP. RELEASE), HARD GELATIN	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
LQA7B6G8JG	POLOXAMER 188:ORAL:CAPSULE, DELAYED ACTION:MG	ORAL	4MG ORAL CAPSULE, DELAYED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
LQA7B6G8JG	POLOXAMER 188:ORAL:CAPSULE, DELAYED RELEASE:MG	ORAL	3MG ORAL CAPSULE, DELAYED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
LQA7B6G8JG	POLOXAMER 188:ORAL:CONCENTRATE:MG/1ML	ORAL	0.25MG/1ML ORAL CONCENTRATE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
LQA7B6G8JG	POLOXAMER 188:ORAL:GRANULE:NA	ORAL	ORAL GRANULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
LQA7B6G8JG	POLOXAMER 188:ORAL:GRANULE, FOR ORAL SOLUTION:MG	ORAL	26MG ORAL GRANULE, FOR ORAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
LQA7B6G8JG	POLOXAMER 188:ORAL:POWDER, FOR ORAL SOLUTION:MG	ORAL	25MG ORAL POWDER, FOR ORAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
LQA7B6G8JG	POLOXAMER 188:ORAL:POWDER, FOR ORAL SUSPENSION:MG/5ML	ORAL	17MG/5ML ORAL POWDER, FOR ORAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
LQA7B6G8JG	POLOXAMER 188:ORAL:POWDER, FOR SOLUTION:MG/5ML	ORAL	25MG/5ML ORAL POWDER, FOR SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
LQA7B6G8JG	POLOXAMER 188:ORAL:SOLUTION:MG/1ML	ORAL	100MG/1ML ORAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
LQA7B6G8JG	POLOXAMER 188:ORAL:SUSPENSION:mg/5mL	ORAL	200mg/5mL ORAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
LQA7B6G8JG	POLOXAMER 188:ORAL:SUSPENSION, EXTENDED RELEASE:MG/ML	ORAL	0.5MG/ML ORAL SUSPENSION, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
LQA7B6G8JG	POLOXAMER 188:ORAL:SYRUP:NA	ORAL	ORAL SYRUP	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
LQA7B6G8JG	POLOXAMER 188:ORAL:TABLET:MG	ORAL	66.9MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
LQA7B6G8JG	POLOXAMER 188:ORAL:TABLET, COATED:MG	ORAL	3MG ORAL TABLET, COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
LQA7B6G8JG	POLOXAMER 188:ORAL:TABLET, CONTROLLED RELEASE:MG	ORAL	5.61MG ORAL TABLET, CONTROLLED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
LQA7B6G8JG	POLOXAMER 188:ORAL:TABLET, DELAYED ACTION:MG	ORAL	3MG ORAL TABLET, DELAYED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
LQA7B6G8JG	POLOXAMER 188:ORAL:TABLET, EXTENDED RELEASE:MG	ORAL	37MG ORAL TABLET, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
LQA7B6G8JG	POLOXAMER 188:ORAL:TABLET, FILM COATED:NA	ORAL	ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
LQA7B6G8JG	POLOXAMER 188:PERIODONTAL:GEL:%	PERIODONTAL	5.5% PERIODONTAL GEL	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
LQA7B6G8JG	POLOXAMER 188:SUBCUTANEOUS:INJECTION:%	SUBCUTANEOUS	0.3% SUBCUTANEOUS INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
LQA7B6G8JG	POLOXAMER 188:SUBCUTANEOUS:SOLUTION, INJECTION:%	SUBCUTANEOUS	0.2% SUBCUTANEOUS SOLUTION, INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
LQA7B6G8JG	POLOXAMER 188:TOPICAL:EMULSION, CREAM:%W/W	TOPICAL	1%W/W TOPICAL EMULSION, CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
M28OL1HH48	CROSCARMELLOSE SODIUM:INTRAMUSCULAR:INJECTION:%W/V	INTRAMUSCULAR	1%W/V INTRAMUSCULAR INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
M28OL1HH48	CROSCARMELLOSE SODIUM:ORAL:CAPSULE:MG	ORAL	65.6MG ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
M28OL1HH48	CROSCARMELLOSE SODIUM:ORAL:CAPSULE (IMMED./COMP. RELEASE), HARD GELATIN:MG	ORAL	30MG ORAL CAPSULE (IMMED./COMP. RELEASE), HARD GELATIN	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
M28OL1HH48	CROSCARMELLOSE SODIUM:ORAL:CAPSULE, COATED PELLETS:MG	ORAL	24.75MG ORAL CAPSULE, COATED PELLETS	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
M28OL1HH48	CROSCARMELLOSE SODIUM:ORAL:CAPSULE, DELAYED ACTION:MG	ORAL	24MG ORAL CAPSULE, DELAYED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
M28OL1HH48	CROSCARMELLOSE SODIUM:ORAL:CAPSULE, ENTERIC COATED PELLETS:MG	ORAL	20MG ORAL CAPSULE, ENTERIC COATED PELLETS	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
M28OL1HH48	CROSCARMELLOSE SODIUM:ORAL:CAPSULE, EXTENDED RELEASE:MG	ORAL	7.3MG ORAL CAPSULE, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
M28OL1HH48	CROSCARMELLOSE SODIUM:ORAL:CAPSULE, GELATIN COATED:MG	ORAL	9MG ORAL CAPSULE, GELATIN COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
M28OL1HH48	CROSCARMELLOSE SODIUM:ORAL:CAPSULE, HARD GELATIN:MG	ORAL	30MG ORAL CAPSULE, HARD GELATIN	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
M28OL1HH48	CROSCARMELLOSE SODIUM:ORAL:CAPSULE, SUSTAINED ACTION:MG	ORAL	65.6MG ORAL CAPSULE, SUSTAINED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
M28OL1HH48	CROSCARMELLOSE SODIUM:ORAL:DISPERSIBLE TABLET:MG	ORAL	8MG ORAL DISPERSIBLE TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
M28OL1HH48	CROSCARMELLOSE SODIUM:ORAL:GRANULE:MG	ORAL	16.1MG ORAL GRANULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
M28OL1HH48	CROSCARMELLOSE SODIUM:ORAL:GRANULE, FOR RECONSTITUTION:MG	ORAL	143.5MG ORAL GRANULE, FOR RECONSTITUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
M28OL1HH48	CROSCARMELLOSE SODIUM:ORAL:GRANULE, FOR SUSPENSION:MG	ORAL	35.3MG ORAL GRANULE, FOR SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
M28OL1HH48	CROSCARMELLOSE SODIUM:ORAL:POWDER, FOR SUSPENSION:MG	ORAL	11.25MG ORAL POWDER, FOR SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
M28OL1HH48	CROSCARMELLOSE SODIUM:ORAL:SOLUTION:NA	ORAL	ORAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
M28OL1HH48	CROSCARMELLOSE SODIUM:ORAL:SUSPENSION:MG/5ML	ORAL	50MG/5ML ORAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
M28OL1HH48	CROSCARMELLOSE SODIUM:ORAL:TABLET:MG	ORAL	180MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
M28OL1HH48	CROSCARMELLOSE SODIUM:ORAL:TABLET (IMMED./COMP. RELEASE), COATED:MG	ORAL	32MG ORAL TABLET (IMMED./COMP. RELEASE), COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
M28OL1HH48	CROSCARMELLOSE SODIUM:ORAL:TABLET (IMMED./COMP. RELEASE), FILM COATED:MG	ORAL	100MG ORAL TABLET (IMMED./COMP. RELEASE), FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
M28OL1HH48	CROSCARMELLOSE SODIUM:ORAL:TABLET (IMMED./COMP. RELEASE), UNCOATED, CHEWABLE:MG	ORAL	25.5MG ORAL TABLET (IMMED./COMP. RELEASE), UNCOATED, CHEWABLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
M28OL1HH48	CROSCARMELLOSE SODIUM:ORAL:TABLET, CHEWABLE:mg	ORAL	18mg ORAL TABLET, CHEWABLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
M28OL1HH48	CROSCARMELLOSE SODIUM:ORAL:TABLET, COATED:MG	ORAL	35.2MG ORAL TABLET, COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
M28OL1HH48	CROSCARMELLOSE SODIUM:ORAL:TABLET, DELAYED ACTION:MG	ORAL	51.51MG ORAL TABLET, DELAYED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
M28OL1HH48	CROSCARMELLOSE SODIUM:ORAL:TABLET, DELAYED ACTION, COATED:MG	ORAL	32MG ORAL TABLET, DELAYED ACTION, COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
M28OL1HH48	CROSCARMELLOSE SODIUM:ORAL:TABLET, DELAYED ACTION, ENTERIC COATED:MG	ORAL	32.44MG ORAL TABLET, DELAYED ACTION, ENTERIC COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
M28OL1HH48	CROSCARMELLOSE SODIUM:ORAL:TABLET, DELAYED RELEASE:MG	ORAL	45MG ORAL TABLET, DELAYED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
M28OL1HH48	CROSCARMELLOSE SODIUM:ORAL:TABLET, EXTENDED RELEASE:MG	ORAL	90MG ORAL TABLET, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
M28OL1HH48	CROSCARMELLOSE SODIUM:ORAL:TABLET, FILM COATED:MG	ORAL	165MG ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
M28OL1HH48	CROSCARMELLOSE SODIUM:ORAL:TABLET, FOR SUSPENSION:MG	ORAL	11.6MG ORAL TABLET, FOR SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
M28OL1HH48	CROSCARMELLOSE SODIUM:ORAL:TABLET, ORALLY DISINTEGRATING:MG	ORAL	48MG ORAL TABLET, ORALLY DISINTEGRATING	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
M28OL1HH48	CROSCARMELLOSE SODIUM:ORAL:TABLET, SUGAR COATED:MG	ORAL	2.5MG ORAL TABLET, SUGAR COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
M28OL1HH48	CROSCARMELLOSE SODIUM:ORAL:TABLET, SUSTAINED ACTION:MG	ORAL	28MG ORAL TABLET, SUSTAINED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
M28OL1HH48	CROSCARMELLOSE SODIUM:ORAL:TABLET, UNCOATED, TROCHE:MG	ORAL	10MG ORAL TABLET, UNCOATED, TROCHE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
M28OL1HH48	CROSCARMELLOSE SODIUM:ORAL-20:TABLET:mg	ORAL-20	80mg ORAL-20 TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
M28OL1HH48	CROSCARMELLOSE SODIUM:SUBLINGUAL:TABLET:MG	SUBLINGUAL	10MG SUBLINGUAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
3EW5AXE5X5	PEGOXOL 7 STEARATE:TOPICAL:CREAM:%W/W	TOPICAL	20%W/W TOPICAL CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
3EW5AXE5X5	PEGOXOL 7 STEARATE:TOPICAL:EMULSION, CREAM:%W/W	TOPICAL	22%W/W TOPICAL EMULSION, CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
3EW5AXE5X5	PEGOXOL 7 STEARATE:TOPICAL:LOTION:NA	TOPICAL	TOPICAL LOTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
3EW5AXE5X5	PEGOXOL 7 STEARATE:TOPICAL:SUPPOSITORY:NA	TOPICAL	TOPICAL SUPPOSITORY	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
3EW5AXE5X5	PEGOXOL 7 STEARATE:VAGINAL:EMULSION, CREAM:%	VAGINAL	20% VAGINAL EMULSION, CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
3EW5AXE5X5	PEGOXOL 7 STEARATE:VAGINAL:SUPPOSITORY:NA	VAGINAL	VAGINAL SUPPOSITORY	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
30IQX730WE	POLYETHYLENE GLYCOL 6000:BUCCAL/SUBLINGUAL:TABLET:MG	BUCCAL/SUBLINGUAL	70MG BUCCAL/SUBLINGUAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
30IQX730WE	POLYETHYLENE GLYCOL 6000:NASAL:IMPLANT:UG	NASAL	675UG NASAL IMPLANT	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
30IQX730WE	POLYETHYLENE GLYCOL 6000:ORAL:CAPSULE:MG	ORAL	462.5MG ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
30IQX730WE	POLYETHYLENE GLYCOL 6000:ORAL:CAPSULE, DELAYED ACTION:MG	ORAL	4.43MG ORAL CAPSULE, DELAYED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
30IQX730WE	POLYETHYLENE GLYCOL 6000:ORAL:CAPSULE, DELAYED RELEASE:mg	ORAL	3.471mg ORAL CAPSULE, DELAYED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
30IQX730WE	POLYETHYLENE GLYCOL 6000:ORAL:CAPSULE, EXTENDED RELEASE:MG	ORAL	18.88MG ORAL CAPSULE, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
30IQX730WE	POLYETHYLENE GLYCOL 6000:ORAL:CAPSULE, HARD GELATIN:MG	ORAL	450MG ORAL CAPSULE, HARD GELATIN	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
30IQX730WE	POLYETHYLENE GLYCOL 6000:ORAL:CAPSULE, SUSTAINED ACTION:MG	ORAL	17.46MG ORAL CAPSULE, SUSTAINED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
30IQX730WE	POLYETHYLENE GLYCOL 6000:ORAL:TABLET:MG	ORAL	250MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
30IQX730WE	POLYETHYLENE GLYCOL 6000:ORAL:TABLET (IMMED./COMP. RELEASE), FILM COATED:MG	ORAL	3MG ORAL TABLET (IMMED./COMP. RELEASE), FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
30IQX730WE	POLYETHYLENE GLYCOL 6000:ORAL:TABLET, COATED:MG	ORAL	40MG ORAL TABLET, COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
30IQX730WE	POLYETHYLENE GLYCOL 6000:ORAL:TABLET, DELAYED ACTION:MG	ORAL	2.5MG ORAL TABLET, DELAYED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
30IQX730WE	POLYETHYLENE GLYCOL 6000:ORAL:TABLET, DELAYED ACTION, ENTERIC COATED:MG	ORAL	1.14MG ORAL TABLET, DELAYED ACTION, ENTERIC COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
30IQX730WE	POLYETHYLENE GLYCOL 6000:ORAL:TABLET, DELAYED RELEASE:MG	ORAL	9MG ORAL TABLET, DELAYED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
30IQX730WE	POLYETHYLENE GLYCOL 6000:ORAL:TABLET, EXTENDED RELEASE:MG	ORAL	86.4MG ORAL TABLET, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
30IQX730WE	POLYETHYLENE GLYCOL 6000:ORAL:TABLET, FILM COATED:MG	ORAL	44MG ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
30IQX730WE	POLYETHYLENE GLYCOL 6000:ORAL:TABLET, MULTILAYER, EXTENDED RELEASE:MG	ORAL	10MG ORAL TABLET, MULTILAYER, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
30IQX730WE	POLYETHYLENE GLYCOL 6000:ORAL:TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE:mg	ORAL	11.53mg ORAL TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
30IQX730WE	POLYETHYLENE GLYCOL 6000:ORAL:TABLET, SUSTAINED ACTION:MG	ORAL	12.5MG ORAL TABLET, SUSTAINED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
30IQX730WE	POLYETHYLENE GLYCOL 6000:ORAL:TABLET, SUSTAINED ACTION, COATED:MG	ORAL	0.5MG ORAL TABLET, SUSTAINED ACTION, COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
30IQX730WE	POLYETHYLENE GLYCOL 6000:ORAL:TABLET, SUSTAINED ACTION, FILM COATED:MG	ORAL	0.32MG ORAL TABLET, SUSTAINED ACTION, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
30IQX730WE	POLYETHYLENE GLYCOL 6000:RECTAL:SUPPOSITORY:MG	RECTAL	128MG RECTAL SUPPOSITORY	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
30IQX730WE	POLYETHYLENE GLYCOL 6000:TOPICAL:EMULSION, CREAM:%W/W	TOPICAL	5%W/W TOPICAL EMULSION, CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
30IQX730WE	POLYETHYLENE GLYCOL 6000:TOPICAL:OINTMENT:NA	TOPICAL	TOPICAL OINTMENT	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
30IQX730WE	POLYETHYLENE GLYCOL 6000:VAGINAL:INSERT:MG	VAGINAL	0.1MG VAGINAL INSERT	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
30IQX730WE	POLYETHYLENE GLYCOL 6000:VAGINAL:TABLET:MG	VAGINAL	3MG VAGINAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
30IQX730WE	POLYETHYLENE GLYCOL 6000:VAGINAL:TABLET, FILM COATED:MG	VAGINAL	0.064MG VAGINAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
961TOZ5L7T	PENTASODIUM PENTETATE:INTRAVENOUS:INJECTION:%	INTRAVENOUS	0.5% INTRAVENOUS INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
Z2Z439864Y	ETHYL OLEATE:TOPICAL:PATCH, CONTROLLED RELEASE:NA	TOPICAL	TOPICAL PATCH, CONTROLLED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
Z2Z439864Y	ETHYL OLEATE:TRANSDERMAL:FILM, CONTROLLED RELEASE:MG	TRANSDERMAL	8.64MG TRANSDERMAL FILM, CONTROLLED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
P2Z71CIK5H	BETANAPHTHOL:ORAL:CAPSULE:MG	ORAL	0.3MG ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
9G2MAD7J6W	POLYACRYLIC ACID (250000 MW):TOPICAL:PATCH:MG	TOPICAL	196MG TOPICAL PATCH	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
9G2MAD7J6W	POLYACRYLIC ACID (250000 MW):TRANSDERMAL:FILM, CONTROLLED RELEASE:NA	TRANSDERMAL	TRANSDERMAL FILM, CONTROLLED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
593YOG76RN	SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE:IM - IV:INJECTABLE:%	IM - IV	0.18% IM - IV INJECTABLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
593YOG76RN	SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE:IM - IV:INJECTION:%	IM - IV	0.5% IM - IV INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
593YOG76RN	SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE:IM - IV:POWDER:%	IM - IV	1.56% IM - IV POWDER	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
593YOG76RN	SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE:IM - IV:POWDER, FOR INJECTION SOLUTION:%	IM - IV	0.18% IM - IV POWDER, FOR INJECTION SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
593YOG76RN	SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE:INTRA-ARTICULAR:INJECTABLE:%	INTRA-ARTICULAR	0.34% INTRA-ARTICULAR INJECTABLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
593YOG76RN	SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE:INTRALESIONAL:INJECTABLE:%	INTRALESIONAL	0.68% INTRALESIONAL INJECTABLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
593YOG76RN	SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE:INTRAMUSCULAR:INJECTABLE:%W/V	INTRAMUSCULAR	0.68%W/V INTRAMUSCULAR INJECTABLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
593YOG76RN	SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE:INTRAMUSCULAR:INJECTION:mg/1mL	INTRAMUSCULAR	5mg/1mL INTRAMUSCULAR INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
593YOG76RN	SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE:INTRAMUSCULAR:POWDER, FOR INJECTION SOLUTION, LYOPHILIZED:NA	INTRAMUSCULAR	INTRAMUSCULAR POWDER, FOR INJECTION SOLUTION, LYOPHILIZED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
593YOG76RN	SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE:INTRAMUSCULAR:POWDER, FOR INJECTION SOLUTION, LYOPHILIZED, WITH ADDITIVES:%	INTRAMUSCULAR	0.14% INTRAMUSCULAR POWDER, FOR INJECTION SOLUTION, LYOPHILIZED, WITH ADDITIVES	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
593YOG76RN	SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE:INTRAMUSCULAR:SUSPENSION, INJECTION:%W/V	INTRAMUSCULAR	0.38%W/V INTRAMUSCULAR SUSPENSION, INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
593YOG76RN	SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE:INTRASYNOVIAL:INJECTABLE:%	INTRASYNOVIAL	0.68% INTRASYNOVIAL INJECTABLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
593YOG76RN	SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE:INTRAVASCULAR:INJECTION:NA	INTRAVASCULAR	INTRAVASCULAR INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
593YOG76RN	SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE:INTRAVENOUS:INJECTABLE:mg/mL	INTRAVENOUS	1.8mg/mL INTRAVENOUS INJECTABLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
593YOG76RN	SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE:INTRAVENOUS:INJECTION:%	INTRAVENOUS	6.21% INTRAVENOUS INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
593YOG76RN	SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE:INTRAVENOUS:INJECTION:mg/1mL	INTRAVENOUS	5mg/1mL INTRAVENOUS INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
593YOG76RN	SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE:INTRAVENOUS:POWDER, FOR INJECTION SOLUTION:%	INTRAVENOUS	0.05% INTRAVENOUS POWDER, FOR INJECTION SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
593YOG76RN	SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE:INTRAVENOUS:POWDER, FOR INJECTION SOLUTION, LYOPHILIZED:%	INTRAVENOUS	0.05% INTRAVENOUS POWDER, FOR INJECTION SOLUTION, LYOPHILIZED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
593YOG76RN	SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE:INTRAVENOUS:SOLUTION, INJECTION:%	INTRAVENOUS	0.54% INTRAVENOUS SOLUTION, INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
593YOG76RN	SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE:INTRAVESICAL:SOLUTION:NA	INTRAVESICAL	INTRAVESICAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
593YOG76RN	SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE:INTRAVITREAL:INJECTABLE:%	INTRAVITREAL	0.86% INTRAVITREAL INJECTABLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
593YOG76RN	SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE:IV(INFUSION):INJECTION:%	IV(INFUSION)	0.5% IV(INFUSION) INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
593YOG76RN	SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE:IV(INFUSION):POWDER, FOR INJECTION SOLUTION:%	IV(INFUSION)	1.36% IV(INFUSION) POWDER, FOR INJECTION SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
593YOG76RN	SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE:IV(INFUSION):POWDER, FOR INJECTION SOLUTION, LYOPHILIZED:%	IV(INFUSION)	0.02% IV(INFUSION) POWDER, FOR INJECTION SOLUTION, LYOPHILIZED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
593YOG76RN	SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE:OPHTHALMIC:DROPS:%	OPHTHALMIC	0.041% OPHTHALMIC DROPS	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
593YOG76RN	SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE:OPHTHALMIC:SOLUTION:%	OPHTHALMIC	0.72% OPHTHALMIC SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
593YOG76RN	SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE:OPHTHALMIC:SOLUTION, DROPS:%	OPHTHALMIC	0.72% OPHTHALMIC SOLUTION, DROPS	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
593YOG76RN	SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE:OPHTHALMIC:SOLUTION/DROPS:%	OPHTHALMIC	1.3% OPHTHALMIC SOLUTION/DROPS	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
593YOG76RN	SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE:OPHTHALMIC:SUSPENSION:%	OPHTHALMIC	0.54% OPHTHALMIC SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
593YOG76RN	SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE:ORAL:CAPSULE:MG	ORAL	600MG ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
593YOG76RN	SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE:ORAL:ORAL SOLUTION DOSAGE FORM:mg/5mL	ORAL	30mg/5mL ORAL ORAL SOLUTION DOSAGE FORM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
593YOG76RN	SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE:ORAL:SOLUTION:MG/20ML	ORAL	258MG/20ML ORAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
593YOG76RN	SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE:ORAL:SUSPENSION:MG/5ML	ORAL	37.5MG/5ML ORAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
593YOG76RN	SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE:ORAL:SYRUP:MG/5ML	ORAL	20.6MG/5ML ORAL SYRUP	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
593YOG76RN	SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE:ORAL:TABLET:MG	ORAL	31.72MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
593YOG76RN	SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE:ORAL:TABLET, DELAYED ACTION, ENTERIC COATED:MG	ORAL	35MG ORAL TABLET, DELAYED ACTION, ENTERIC COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
593YOG76RN	SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE:ORAL:TABLET, FILM COATED:MG	ORAL	0.11MG ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
593YOG76RN	SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE:SUBCUTANEOUS:INJECTABLE:%	SUBCUTANEOUS	0.036% SUBCUTANEOUS INJECTABLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
593YOG76RN	SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE:SUBCUTANEOUS:INJECTION:%	SUBCUTANEOUS	0.12% SUBCUTANEOUS INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
593YOG76RN	SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE:SUBCUTANEOUS:POWDER, FOR INJECTION SOLUTION, LYOPHILIZED:%	SUBCUTANEOUS	0.064% SUBCUTANEOUS POWDER, FOR INJECTION SOLUTION, LYOPHILIZED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
593YOG76RN	SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE:TOPICAL:CREAM:%W/W 	TOPICAL	0.3%W/W  TOPICAL CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
593YOG76RN	SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE:TOPICAL:EMULSION, CREAM:%W/W	TOPICAL	0.3%W/W TOPICAL EMULSION, CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
593YOG76RN	SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE:TOPICAL:LOTION:%W/W	TOPICAL	0.27%W/W TOPICAL LOTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
593YOG76RN	SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE:TOPICAL:LOTION, AUGMENTED:%W/W	TOPICAL	0.15%W/W TOPICAL LOTION, AUGMENTED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
593YOG76RN	SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE:TOPICAL:SOLUTION:%W/V	TOPICAL	0.46%W/V TOPICAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
593YOG76RN	SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE:TOPICAL:SOLUTION, DROPS:%W/V	TOPICAL	0.46%W/V TOPICAL SOLUTION, DROPS	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
593YOG76RN	SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE:URETERAL:SOLUTION:NA	URETERAL	URETERAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
Q8Y7S3B85M	HYDROGENATED TALLOW ACID:ORAL:TABLET:MG	ORAL	1.81MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
Q8Y7S3B85M	HYDROGENATED TALLOW ACID:ORAL:TABLET, EXTENDED RELEASE:MG	ORAL	7.35MG ORAL TABLET, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
7H8VAM7778	CETETH-2:TOPICAL:EMULSION, CREAM:%W/W	TOPICAL	2.5%W/W TOPICAL EMULSION, CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
7H8VAM7778	CETETH-2:TOPICAL:LOTION:%W/W	TOPICAL	0.8%W/W TOPICAL LOTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
A752Q30A6X	SODIUM PHOSPHATE, TRIBASIC:BUCCAL:FILM, SOLUBLE:MG	BUCCAL	0.76MG BUCCAL FILM, SOLUBLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
A752Q30A6X	SODIUM PHOSPHATE, TRIBASIC:ORAL:GRANULE:MG	ORAL	1MG ORAL GRANULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
A752Q30A6X	SODIUM PHOSPHATE, TRIBASIC:ORAL:POWDER, FOR SUSPENSION:MG/5ML	ORAL	65MG/5ML ORAL POWDER, FOR SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
NL4J9F21N9	POLYETHYLENE GLYCOL 600:INTRAVENOUS:INJECTION:%	INTRAVENOUS	5% INTRAVENOUS INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
NL4J9F21N9	POLYETHYLENE GLYCOL 600:INTRAVENOUS:SOLUTION, INJECTION:%	INTRAVENOUS	5% INTRAVENOUS SOLUTION, INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
NL4J9F21N9	POLYETHYLENE GLYCOL 600:ORAL:CAPSULE:MG	ORAL	580.6MG ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
NL4J9F21N9	POLYETHYLENE GLYCOL 600:ORAL:CAPSULE, SOFT GELATIN:MG	ORAL	324MG ORAL CAPSULE, SOFT GELATIN	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
NL4J9F21N9	POLYETHYLENE GLYCOL 600:ORAL:CAPSULE, SOFT GELATIN LIQUID-FILLED:MG	ORAL	580.6MG ORAL CAPSULE, SOFT GELATIN LIQUID-FILLED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
NL4J9F21N9	POLYETHYLENE GLYCOL 600:ORAL:SOLUTION:MG/5ML	ORAL	650MG/5ML ORAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
NL4J9F21N9	POLYETHYLENE GLYCOL 600:ORAL:TABLET:MG	ORAL	6MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
NL4J9F21N9	POLYETHYLENE GLYCOL 600:ORAL:TABLET, DELAYED ACTION, ENTERIC COATED:NA	ORAL	ORAL TABLET, DELAYED ACTION, ENTERIC COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
NL4J9F21N9	POLYETHYLENE GLYCOL 600:ORAL:TABLET, EXTENDED RELEASE:MG	ORAL	2.5MG ORAL TABLET, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
NL4J9F21N9	POLYETHYLENE GLYCOL 600:ORAL:TABLET, SUSTAINED ACTION:MG	ORAL	1.2MG ORAL TABLET, SUSTAINED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
NL4J9F21N9	POLYETHYLENE GLYCOL 600:TOPICAL:SOLUTION:%W/W	TOPICAL	0.3%W/W TOPICAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
01YAE03M7J	.BETA.-CAROTENE:ORAL:EMULSION:NA	ORAL	ORAL EMULSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
C67IXB9Y7T	ISOPROPYL ISOSTEARATE:TOPICAL:CREAM, EMULSION, SUSTAINED RELEASE:%W/W	TOPICAL	3%W/W TOPICAL CREAM, EMULSION, SUSTAINED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=I
C67IXB9Y7T	ISOPROPYL ISOSTEARATE:TOPICAL:EMULSION, CREAM:%W/W	TOPICAL	3%W/W TOPICAL EMULSION, CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=I
258491E1RZ	GLYCERYL 1-STEARATE:ORAL:CAPSULE:MG	ORAL	0.53MG ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
258491E1RZ	GLYCERYL 1-STEARATE:ORAL:GRANULE, FOR ORAL SUSPENSION:MG	ORAL	0.7MG ORAL GRANULE, FOR ORAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
258491E1RZ	GLYCERYL 1-STEARATE:TOPICAL:LOTION:%W/W	TOPICAL	0.4%W/W TOPICAL LOTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
9T3UU8T0QK	SILODRATE:ORAL:TABLET:MG	ORAL	10.56MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
9T3UU8T0QK	SILODRATE:ORAL:TABLET, ORALLY DISINTEGRATING:MG	ORAL	6MG ORAL TABLET, ORALLY DISINTEGRATING	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
7V4MR24V5P	CETEARETH-12:TOPICAL:EMULSION, AEROSOL FOAM:%W/W	TOPICAL	5%W/W TOPICAL EMULSION, AEROSOL FOAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
7V4MR24V5P	CETEARETH-12:TOPICAL:EMULSION, CREAM:%W/W	TOPICAL	5%W/W TOPICAL EMULSION, CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
368GB5141J	SODIUM LAURYL SULFATE:BUCCAL:TABLET:MG	BUCCAL	5.18MG BUCCAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
368GB5141J	SODIUM LAURYL SULFATE:BUCCAL:TABLET, EXTENDED RELEASE:MG	BUCCAL	5.18MG BUCCAL TABLET, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
368GB5141J	SODIUM LAURYL SULFATE:BUCCAL/SUBLINGUAL:TABLET:MG	BUCCAL/SUBLINGUAL	1.1MG BUCCAL/SUBLINGUAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
368GB5141J	SODIUM LAURYL SULFATE:DENTAL:GEL:%	DENTAL	1.47% DENTAL GEL	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
368GB5141J	SODIUM LAURYL SULFATE:DENTAL:PASTE:NA	DENTAL	DENTAL PASTE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
368GB5141J	SODIUM LAURYL SULFATE:INHALATION:POWDER:NA	INHALATION	INHALATION POWDER	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
368GB5141J	SODIUM LAURYL SULFATE:ORAL:CAPSULE:MG	ORAL	25.8MG ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
368GB5141J	SODIUM LAURYL SULFATE:ORAL:CAPSULE (IMMED./COMP. RELEASE), HARD GELATIN:MG	ORAL	3.6MG ORAL CAPSULE (IMMED./COMP. RELEASE), HARD GELATIN	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
368GB5141J	SODIUM LAURYL SULFATE:ORAL:CAPSULE, DELAYED ACTION:MG	ORAL	5.98MG ORAL CAPSULE, DELAYED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
368GB5141J	SODIUM LAURYL SULFATE:ORAL:CAPSULE, DELAYED ACTION, COATED:mg	ORAL	1mg ORAL CAPSULE, DELAYED ACTION, COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
368GB5141J	SODIUM LAURYL SULFATE:ORAL:CAPSULE, DELAYED ACTION, COATED, HARD GELATIN:MG	ORAL	2MG ORAL CAPSULE, DELAYED ACTION, COATED, HARD GELATIN	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
368GB5141J	SODIUM LAURYL SULFATE:ORAL:CAPSULE, DELAYED ACTION, ENTERIC COATED:NA	ORAL	ORAL CAPSULE, DELAYED ACTION, ENTERIC COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
368GB5141J	SODIUM LAURYL SULFATE:ORAL:CAPSULE, DELAYED RELEASE:MG	ORAL	1MG ORAL CAPSULE, DELAYED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
368GB5141J	SODIUM LAURYL SULFATE:ORAL:CAPSULE, ENTERIC COATED PELLETS:MG	ORAL	0.6MG ORAL CAPSULE, ENTERIC COATED PELLETS	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
368GB5141J	SODIUM LAURYL SULFATE:ORAL:CAPSULE, EXTENDED RELEASE:MG	ORAL	16.67MG ORAL CAPSULE, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
368GB5141J	SODIUM LAURYL SULFATE:ORAL:CAPSULE, HARD GELATIN:MG	ORAL	16.2MG ORAL CAPSULE, HARD GELATIN	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
368GB5141J	SODIUM LAURYL SULFATE:ORAL:CAPSULE, SOFT GELATIN:MG	ORAL	96MG ORAL CAPSULE, SOFT GELATIN	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
368GB5141J	SODIUM LAURYL SULFATE:ORAL:CAPSULE, SUSTAINED ACTION:MG	ORAL	9.47MG ORAL CAPSULE, SUSTAINED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
368GB5141J	SODIUM LAURYL SULFATE:ORAL:CAPSULE, SUSTAINED ACTION, HARD GELATIN:MG	ORAL	3.75MG ORAL CAPSULE, SUSTAINED ACTION, HARD GELATIN	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
368GB5141J	SODIUM LAURYL SULFATE:ORAL:DISPERSIBLE TABLET:MG	ORAL	48MG ORAL DISPERSIBLE TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
368GB5141J	SODIUM LAURYL SULFATE:ORAL:DROPS:NA	ORAL	ORAL DROPS	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
368GB5141J	SODIUM LAURYL SULFATE:ORAL:GRANULE:mg	ORAL	6.2mg ORAL GRANULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
368GB5141J	SODIUM LAURYL SULFATE:ORAL:PELLET:MG	ORAL	0.264MG ORAL PELLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
368GB5141J	SODIUM LAURYL SULFATE:ORAL:POWDER, FOR ORAL SUSPENSION:MG/5ML	ORAL	0.48MG/5ML ORAL POWDER, FOR ORAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
368GB5141J	SODIUM LAURYL SULFATE:ORAL:POWDER, FOR SUSPENSION:MG/5ML	ORAL	3.3MG/5ML ORAL POWDER, FOR SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
368GB5141J	SODIUM LAURYL SULFATE:ORAL:SUSPENSION:MG/1ML	ORAL	1.5MG/1ML ORAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
368GB5141J	SODIUM LAURYL SULFATE:ORAL:SUSPENSION, EXTENDED RELEASE:MG/1ML	ORAL	0.02MG/1ML ORAL SUSPENSION, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
368GB5141J	SODIUM LAURYL SULFATE:ORAL:TABLET:MG	ORAL	51.69MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
368GB5141J	SODIUM LAURYL SULFATE:ORAL:TABLET (IMMED./COMP. RELEASE), COATED:MG	ORAL	1MG ORAL TABLET (IMMED./COMP. RELEASE), COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
368GB5141J	SODIUM LAURYL SULFATE:ORAL:TABLET (IMMED./COMP. RELEASE), FILM COATED:MG	ORAL	4.8MG ORAL TABLET (IMMED./COMP. RELEASE), FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
368GB5141J	SODIUM LAURYL SULFATE:ORAL:TABLET (IMMED./COMP. RELEASE), UNCOATED, CHEWABLE:MG	ORAL	5MG ORAL TABLET (IMMED./COMP. RELEASE), UNCOATED, CHEWABLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
368GB5141J	SODIUM LAURYL SULFATE:ORAL:TABLET, CHEWABLE:MG	ORAL	2MG ORAL TABLET, CHEWABLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
368GB5141J	SODIUM LAURYL SULFATE:ORAL:TABLET, COATED:MG	ORAL	5.2MG ORAL TABLET, COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
368GB5141J	SODIUM LAURYL SULFATE:ORAL:TABLET, CONTROLLED RELEASE:mg	ORAL	0.48mg ORAL TABLET, CONTROLLED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
368GB5141J	SODIUM LAURYL SULFATE:ORAL:TABLET, DELAYED ACTION:MG	ORAL	4MG ORAL TABLET, DELAYED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
368GB5141J	SODIUM LAURYL SULFATE:ORAL:TABLET, DELAYED ACTION, ENTERIC COATED:MG	ORAL	8.09MG ORAL TABLET, DELAYED ACTION, ENTERIC COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
368GB5141J	SODIUM LAURYL SULFATE:ORAL:TABLET, DELAYED RELEASE:MG	ORAL	3MG ORAL TABLET, DELAYED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
368GB5141J	SODIUM LAURYL SULFATE:ORAL:TABLET, EXTENDED RELEASE:MG	ORAL	51.69MG ORAL TABLET, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
368GB5141J	SODIUM LAURYL SULFATE:ORAL:TABLET, FILM COATED:MG	ORAL	20MG ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
368GB5141J	SODIUM LAURYL SULFATE:ORAL:TABLET, MULTILAYER, EXTENDED RELEASE:MG	ORAL	0.8MG ORAL TABLET, MULTILAYER, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
368GB5141J	SODIUM LAURYL SULFATE:ORAL:TABLET, ORALLY DISINTEGRATING:MG	ORAL	2MG ORAL TABLET, ORALLY DISINTEGRATING	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
368GB5141J	SODIUM LAURYL SULFATE:ORAL:TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE:mg	ORAL	0.5mg ORAL TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
368GB5141J	SODIUM LAURYL SULFATE:ORAL:TABLET, SUSTAINED ACTION:MG	ORAL	20.62MG ORAL TABLET, SUSTAINED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
368GB5141J	SODIUM LAURYL SULFATE:ORAL:TABLET, SUSTAINED ACTION, COATED:MG	ORAL	10.5MG ORAL TABLET, SUSTAINED ACTION, COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
368GB5141J	SODIUM LAURYL SULFATE:SUBLINGUAL:TABLET:MG	SUBLINGUAL	0.02MG SUBLINGUAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
368GB5141J	SODIUM LAURYL SULFATE:TOPICAL:CREAM:%W/W	TOPICAL	0.75%W/W TOPICAL CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
368GB5141J	SODIUM LAURYL SULFATE:TOPICAL:EMULSION, CREAM:%W/W	TOPICAL	2.5%W/W TOPICAL EMULSION, CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
368GB5141J	SODIUM LAURYL SULFATE:TOPICAL:GEL:%W/W	TOPICAL	0.05%W/W TOPICAL GEL	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
368GB5141J	SODIUM LAURYL SULFATE:TOPICAL:LOTION:%W/W	TOPICAL	0.5%W/W TOPICAL LOTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
368GB5141J	SODIUM LAURYL SULFATE:TOPICAL:OINTMENT:%W/W	TOPICAL	1%W/W TOPICAL OINTMENT	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
368GB5141J	SODIUM LAURYL SULFATE:TOPICAL:SHAMPOO:NA	TOPICAL	TOPICAL SHAMPOO	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
368GB5141J	SODIUM LAURYL SULFATE:TOPICAL:SHAMPOO, SUSPENSION:%W/V	TOPICAL	40%W/V TOPICAL SHAMPOO, SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
368GB5141J	SODIUM LAURYL SULFATE:TOPICAL:SPONGE:NA	TOPICAL	TOPICAL SPONGE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
368GB5141J	SODIUM LAURYL SULFATE:TOPICAL:SPRAY:%W/W	TOPICAL	0.1%W/W TOPICAL SPRAY	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
368GB5141J	SODIUM LAURYL SULFATE:TOPICAL:SPRAY:%W/V	TOPICAL	0.08%W/V TOPICAL SPRAY	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
368GB5141J	SODIUM LAURYL SULFATE:VAGINAL:CREAM:%W/W	VAGINAL	0.3%W/W VAGINAL CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
368GB5141J	SODIUM LAURYL SULFATE:VAGINAL:CREAM, EMULSION, SUSTAINED RELEASE:%W/W	VAGINAL	0.3%W/W VAGINAL CREAM, EMULSION, SUSTAINED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
368GB5141J	SODIUM LAURYL SULFATE:VAGINAL:EMULSION, CREAM:%W/W	VAGINAL	0.33%W/W VAGINAL EMULSION, CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
368GB5141J	SODIUM LAURYL SULFATE:VAGINAL:INSERT:MG	VAGINAL	5MG VAGINAL INSERT	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
368GB5141J	SODIUM LAURYL SULFATE:VAGINAL:TABLET:MG	VAGINAL	5MG VAGINAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
L6867H5FR4	ENTSUFON SODIUM:TOPICAL:EMULSION:%W/W	TOPICAL	40.3%W/W TOPICAL EMULSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
L6867H5FR4	ENTSUFON SODIUM:TOPICAL:SHAMPOO:%W/W	TOPICAL	54%W/W TOPICAL SHAMPOO	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
L6867H5FR4	ENTSUFON SODIUM:TOPICAL:SPONGE:NA	TOPICAL	TOPICAL SPONGE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
TE7660XO1C	GLYCINE:INTRAMUSCULAR:INJECTABLE:%W/V	INTRAMUSCULAR	3.22%W/V INTRAMUSCULAR INJECTABLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
TE7660XO1C	GLYCINE:INTRAVENOUS:INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION:MG/1ML	INTRAVENOUS	15MG/1ML INTRAVENOUS INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
TE7660XO1C	GLYCINE:IV(INFUSION):INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION:MG/1ML	IV(INFUSION)	12.5MG/1ML IV(INFUSION) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
TE7660XO1C	GLYCINE:ORAL:CAPSULE:MG	ORAL	3.5MG ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
TE7660XO1C	GLYCINE:ORAL:CAPSULE, SOFT GELATIN:MG	ORAL	6.22MG ORAL CAPSULE, SOFT GELATIN	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
TE7660XO1C	GLYCINE:ORAL:TABLET:MG	ORAL	20MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
C151H8M554	SUCROSE:BUCCAL:TABLET:MG	BUCCAL	16.6MG BUCCAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
C151H8M554	SUCROSE:BUCCAL/SUBLINGUAL:TABLET:MG	BUCCAL/SUBLINGUAL	91MG BUCCAL/SUBLINGUAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
C151H8M554	SUCROSE:INTRAMUSCULAR:POWDER, FOR INJECTION SOLUTION, LYOPHILIZED:%	INTRAMUSCULAR	6.84% INTRAMUSCULAR POWDER, FOR INJECTION SOLUTION, LYOPHILIZED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
C151H8M554	SUCROSE:INTRAMUSCULAR:SOLUTION, INJECTION:%W/V	INTRAMUSCULAR	7.29%W/V INTRAMUSCULAR SOLUTION, INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
C151H8M554	SUCROSE:INTRAVENOUS:INJECTION:%	INTRAVENOUS	19.5% INTRAVENOUS INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
C151H8M554	SUCROSE:INTRAVENOUS:INJECTION, EMULSION:MG/1ML	INTRAVENOUS	54MG/1ML INTRAVENOUS INJECTION, EMULSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
C151H8M554	SUCROSE:INTRAVENOUS:INJECTION, POWDER, LYOPHILIZED, FOR LIPOSOMAL SUSPENSION:%	INTRAVENOUS	90% INTRAVENOUS INJECTION, POWDER, LYOPHILIZED, FOR LIPOSOMAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
C151H8M554	SUCROSE:INTRAVENOUS:INJECTION, SUSPENSION, LIPOSOMAL:%	INTRAVENOUS	9.4% INTRAVENOUS INJECTION, SUSPENSION, LIPOSOMAL	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
C151H8M554	SUCROSE:INTRAVENOUS:POWDER, FOR INJECTION SOLUTION:%	INTRAVENOUS	20% INTRAVENOUS POWDER, FOR INJECTION SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
C151H8M554	SUCROSE:INTRAVENOUS:POWDER, FOR RECONSTITUTION:%	INTRAVENOUS	40% INTRAVENOUS POWDER, FOR RECONSTITUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
C151H8M554	SUCROSE:INTRAVENOUS:SOLUTION, INJECTION:NA	INTRAVENOUS	INTRAVENOUS SOLUTION, INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
C151H8M554	SUCROSE:INTRAVENOUS:SOLUTION, LIPOSOME, INJECTION:%	INTRAVENOUS	8.5% INTRAVENOUS SOLUTION, LIPOSOME, INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
C151H8M554	SUCROSE:IV(INFUSION):INJECTION, LIPOSOMAL:%	IV(INFUSION)	1% IV(INFUSION) INJECTION, LIPOSOMAL	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
C151H8M554	SUCROSE:IV(INFUSION):POWDER, FOR INJECTION SOLUTION, LYOPHILIZED:%W/W	IV(INFUSION)	30.59%W/W IV(INFUSION) POWDER, FOR INJECTION SOLUTION, LYOPHILIZED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
C151H8M554	SUCROSE:ORAL:CAPSULE:MG	ORAL	527.43MG ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
C151H8M554	SUCROSE:ORAL:CAPSULE, DELAYED ACTION:MG	ORAL	175.14MG ORAL CAPSULE, DELAYED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
C151H8M554	SUCROSE:ORAL:CAPSULE, DELAYED RELEASE:MG	ORAL	48MG ORAL CAPSULE, DELAYED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
C151H8M554	SUCROSE:ORAL:CAPSULE, ENTERIC COATED PELLETS:MG	ORAL	140.76MG ORAL CAPSULE, ENTERIC COATED PELLETS	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
C151H8M554	SUCROSE:ORAL:CAPSULE, EXTENDED RELEASE:MG	ORAL	396.14MG ORAL CAPSULE, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
C151H8M554	SUCROSE:ORAL:CAPSULE, HARD GELATIN:NA	ORAL	ORAL CAPSULE, HARD GELATIN	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
C151H8M554	SUCROSE:ORAL:CAPSULE, SUSTAINED ACTION:MG	ORAL	481.7MG ORAL CAPSULE, SUSTAINED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
C151H8M554	SUCROSE:ORAL:CONCENTRATE:MG/5ML	ORAL	4250MG/5ML ORAL CONCENTRATE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
C151H8M554	SUCROSE:ORAL:DROPS:MG/2.5ML	ORAL	755.5MG/2.5ML ORAL DROPS	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
C151H8M554	SUCROSE:ORAL:EMULSION:NA	ORAL	ORAL EMULSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
C151H8M554	SUCROSE:ORAL:FOR SUSPENSION:MG/5ML	ORAL	3041MG/5ML ORAL FOR SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
C151H8M554	SUCROSE:ORAL:GRANULE:MG	ORAL	3024.2MG ORAL GRANULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
C151H8M554	SUCROSE:ORAL:GRANULE, FOR ORAL SOLUTION:MG/5ML	ORAL	1774.84MG/5ML ORAL GRANULE, FOR ORAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
C151H8M554	SUCROSE:ORAL:GRANULE, FOR ORAL SUSPENSION:MG	ORAL	11MG ORAL GRANULE, FOR ORAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
C151H8M554	SUCROSE:ORAL:GRANULE, FOR RECONSTITUTION:MG	ORAL	2669.8MG ORAL GRANULE, FOR RECONSTITUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
C151H8M554	SUCROSE:ORAL:GRANULE, FOR SUSPENSION:MG	ORAL	2942.7MG ORAL GRANULE, FOR SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
C151H8M554	SUCROSE:ORAL:GRANULE, FOR SUSPENSION, EXTENDED RELEASE:NA	ORAL	ORAL GRANULE, FOR SUSPENSION, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
C151H8M554	SUCROSE:ORAL:LIQUID:MG/1ML	ORAL	720MG/1ML ORAL LIQUID	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
C151H8M554	SUCROSE:ORAL:LIQUID:g/10mL	ORAL	6.25g/10mL ORAL LIQUID	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
C151H8M554	SUCROSE:ORAL:PASTILLE:MG	ORAL	426MG ORAL PASTILLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
C151H8M554	SUCROSE:ORAL:POWDER:MG/1PKT	ORAL	4187MG/1PKT ORAL POWDER	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
C151H8M554	SUCROSE:ORAL:POWDER:MG/1SCP	ORAL	4187MG/1SCP ORAL POWDER	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
C151H8M554	SUCROSE:ORAL:POWDER, FOR ORAL SOLUTION:MG	ORAL	1933.3MG ORAL POWDER, FOR ORAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
C151H8M554	SUCROSE:ORAL:POWDER, FOR ORAL SUSPENSION:mg	ORAL	4636mg ORAL POWDER, FOR ORAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
C151H8M554	SUCROSE:ORAL:POWDER, FOR ORAL SUSPENSION:MG/1PKT	ORAL	3643MG/1PKT ORAL POWDER, FOR ORAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
C151H8M554	SUCROSE:ORAL:POWDER, FOR ORAL SUSPENSION:MG/1SCP	ORAL	3643MG/1SCP ORAL POWDER, FOR ORAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
C151H8M554	SUCROSE:ORAL:POWDER, FOR ORAL SUSPENSION:MG/5ML	ORAL	1195.44MG/5ML ORAL POWDER, FOR ORAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
C151H8M554	SUCROSE:ORAL:POWDER, FOR RECONSTITUTION:MG/5ML	ORAL	2322.79MG/5ML ORAL POWDER, FOR RECONSTITUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
C151H8M554	SUCROSE:ORAL:POWDER, FOR SOLUTION:MG/2GM	ORAL	1892.86MG/2GM ORAL POWDER, FOR SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
C151H8M554	SUCROSE:ORAL:POWDER, FOR SUSPENSION:MG	ORAL	9700MG ORAL POWDER, FOR SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
C151H8M554	SUCROSE:ORAL:POWDER, FOR SUSPENSION:MG/5ML	ORAL	166MG/5ML ORAL POWDER, FOR SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
C151H8M554	SUCROSE:ORAL:SOLUTION:MG/30ML	ORAL	21000MG/30ML ORAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
C151H8M554	SUCROSE:ORAL:SOLUTION:MG/5ML	ORAL	2255MG/5ML ORAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
C151H8M554	SUCROSE:ORAL:SOLUTION:%W/W	ORAL	30.51%W/W ORAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
C151H8M554	SUCROSE:ORAL:SOLUTION:NA	ORAL	ORAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
C151H8M554	SUCROSE:ORAL:SOLUTION, ELIXIR:MG/5ML	ORAL	2600MG/5ML ORAL SOLUTION, ELIXIR	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
C151H8M554	SUCROSE:ORAL:SOLUTION, SYRUP:MG/5ML	ORAL	2255MG/5ML ORAL SOLUTION, SYRUP	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
C151H8M554	SUCROSE:ORAL:SUSPENSION:MG/5ML	ORAL	8500MG/5ML ORAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
C151H8M554	SUCROSE:ORAL:SUSPENSION:MG/5 ML	ORAL	952.42MG/5 ML ORAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
C151H8M554	SUCROSE:ORAL:SUSPENSION:mg/1.25mL	ORAL	375mg/1.25mL ORAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
C151H8M554	SUCROSE:ORAL:SUSPENSION:%W/V	ORAL	44.44%W/V ORAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
C151H8M554	SUCROSE:ORAL:SUSPENSION, DROPS:MG/2.5ML	ORAL	1250MG/2.5ML ORAL SUSPENSION, DROPS	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
C151H8M554	SUCROSE:ORAL:SUSPENSION, EXTENDED RELEASE:MG/5ML	ORAL	1350MG/5ML ORAL SUSPENSION, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
C151H8M554	SUCROSE:ORAL:SUSPENSION, EXTENDED RELEASE:MG/ML	ORAL	0.8MG/ML ORAL SUSPENSION, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
C151H8M554	SUCROSE:ORAL:SUSPENSION, LIQUID:MG/5ML	ORAL	1750MG/5ML ORAL SUSPENSION, LIQUID	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
C151H8M554	SUCROSE:ORAL:SUSPENSION, SUSTAINED ACTION:MG/1PKT	ORAL	2323.3MG/1PKT ORAL SUSPENSION, SUSTAINED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
C151H8M554	SUCROSE:ORAL:SUSPENSION, SUSTAINED ACTION:MG/5ML	ORAL	600MG/5ML ORAL SUSPENSION, SUSTAINED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
C151H8M554	SUCROSE:ORAL:SUSPENSION, SYRUP, SUSTAINED ACTION:%	ORAL	10% ORAL SUSPENSION, SYRUP, SUSTAINED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
C151H8M554	SUCROSE:ORAL:SYRUP:%	ORAL	85.46% ORAL SYRUP	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
C151H8M554	SUCROSE:ORAL:SYRUP:g/5mL	ORAL	2.9g/5mL ORAL SYRUP	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
C151H8M554	SUCROSE:ORAL:TABLET:MG	ORAL	9700MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
C151H8M554	SUCROSE:ORAL:TABLET (IMMED./COMP. RELEASE), UNCOATED, CHEWABLE:MG	ORAL	2400MG ORAL TABLET (IMMED./COMP. RELEASE), UNCOATED, CHEWABLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
C151H8M554	SUCROSE:ORAL:TABLET, CHEWABLE:MG	ORAL	14.78MG ORAL TABLET, CHEWABLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
C151H8M554	SUCROSE:ORAL:TABLET, COATED:MG	ORAL	400MG ORAL TABLET, COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
C151H8M554	SUCROSE:ORAL:TABLET, DELAYED ACTION, ENTERIC COATED:MG	ORAL	279.5MG ORAL TABLET, DELAYED ACTION, ENTERIC COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
C151H8M554	SUCROSE:ORAL:TABLET, DELAYED RELEASE:MG	ORAL	33.5MG ORAL TABLET, DELAYED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
C151H8M554	SUCROSE:ORAL:TABLET, EXTENDED RELEASE:MG	ORAL	185.07MG ORAL TABLET, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
C151H8M554	SUCROSE:ORAL:TABLET, FILM COATED:MG	ORAL	200MG ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
C151H8M554	SUCROSE:ORAL:TABLET, REPEAT ACTION:MG	ORAL	129.55MG ORAL TABLET, REPEAT ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
C151H8M554	SUCROSE:ORAL:TABLET, SUGAR COATED:MG	ORAL	73.18MG ORAL TABLET, SUGAR COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
C151H8M554	SUCROSE:ORAL:TABLET, SUSTAINED ACTION:MG	ORAL	284.54MG ORAL TABLET, SUSTAINED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
C151H8M554	SUCROSE:ORAL:TABLET, SUSTAINED ACTION, FILM COATED:MG	ORAL	119.12MG ORAL TABLET, SUSTAINED ACTION, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
C151H8M554	SUCROSE:ORAL:TABLET, UNCOATED, LOZENGE:MG	ORAL	1255MG ORAL TABLET, UNCOATED, LOZENGE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
C151H8M554	SUCROSE:ORAL:TABLET, UNCOATED, TROCHE:NA	ORAL	ORAL TABLET, UNCOATED, TROCHE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
C151H8M554	SUCROSE:ORAL:WAFER:NA	ORAL	ORAL WAFER	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
C151H8M554	SUCROSE:RECTAL:LIQUID:NA	RECTAL	RECTAL LIQUID	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
C151H8M554	SUCROSE:RECTAL:SOLUTION:%	RECTAL	35.42% RECTAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
C151H8M554	SUCROSE:SUBCUTANEOUS:INJECTION:%	SUBCUTANEOUS	17% SUBCUTANEOUS INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
C151H8M554	SUCROSE:SUBCUTANEOUS:INJECTION, SUSPENSION, EXTENDED RELEASE:MG/0.85 ML	SUBCUTANEOUS	0.8MG/0.85 ML SUBCUTANEOUS INJECTION, SUSPENSION, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
C151H8M554	SUCROSE:SUBCUTANEOUS:MICROCAPSULES FOR INJECTION SUSPENSION, STERILE:%	SUBCUTANEOUS	0.08% SUBCUTANEOUS MICROCAPSULES FOR INJECTION SUSPENSION, STERILE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
C151H8M554	SUCROSE:SUBCUTANEOUS:POWDER, FOR INJECTION SOLUTION, LYOPHILIZED:%	SUBCUTANEOUS	8.21% SUBCUTANEOUS POWDER, FOR INJECTION SOLUTION, LYOPHILIZED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
C151H8M554	SUCROSE:SUBCUTANEOUS:POWDER, FOR INJECTION SOLUTION, LYOPHILIZED, WITH ADDITIVES:%	SUBCUTANEOUS	4.1% SUBCUTANEOUS POWDER, FOR INJECTION SOLUTION, LYOPHILIZED, WITH ADDITIVES	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
C151H8M554	SUCROSE:SUBCUTANEOUS:SOLUTION, INJECTION:%	SUBCUTANEOUS	7.29% SUBCUTANEOUS SOLUTION, INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
C151H8M554	SUCROSE:SUBLINGUAL:TABLET:MG	SUBLINGUAL	17MG SUBLINGUAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
C151H8M554	SUCROSE:TOPICAL:OINTMENT:%W/W	TOPICAL	20%W/W TOPICAL OINTMENT	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
C151H8M554	SUCROSE:TRANSMUCOSAL:TABLET, UNCOATED, LOZENGE:MG	TRANSMUCOSAL	100.35MG TRANSMUCOSAL TABLET, UNCOATED, LOZENGE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
E5GY4I6YCZ	CINNAMON OIL:ORAL:PASTILLE:MG	ORAL	4MG ORAL PASTILLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
E5GY4I6YCZ	CINNAMON OIL:ORAL:SOLUTION, ELIXIR:%	ORAL	11% ORAL SOLUTION, ELIXIR	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
E5GY4I6YCZ	CINNAMON OIL:ORAL:SUSPENSION:MG/5ML	ORAL	0.2MG/5ML ORAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
E5GY4I6YCZ	CINNAMON OIL:ORAL:SYRUP:MG/5ML	ORAL	0.05MG/5ML ORAL SYRUP	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
E5GY4I6YCZ	CINNAMON OIL:ORAL:TABLET (IMMED./COMP. RELEASE), UNCOATED, CHEWABLE:MG	ORAL	0.001MG ORAL TABLET (IMMED./COMP. RELEASE), UNCOATED, CHEWABLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
6P92858988	GLYCERYL TRICAPRYLATE:EPIDURAL:INJECTION, SUSPENSION, LIPOSOMAL:%	EPIDURAL	0.03% EPIDURAL INJECTION, SUSPENSION, LIPOSOMAL	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
6P92858988	GLYCERYL TRICAPRYLATE:INFILTRATION:INJECTION, LIPOSOMAL:%	INFILTRATION	0.2% INFILTRATION INJECTION, LIPOSOMAL	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
6P92858988	GLYCERYL TRICAPRYLATE:ORAL:TABLET, EXTENDED RELEASE:MG	ORAL	0.45MG ORAL TABLET, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
UTY7PDF93L	CARBOXYMETHYLCELLULOSE CALCIUM:ORAL:CAPSULE:MG	ORAL	70MG ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
UTY7PDF93L	CARBOXYMETHYLCELLULOSE CALCIUM:ORAL:CAPSULE, HARD GELATIN:MG	ORAL	36MG ORAL CAPSULE, HARD GELATIN	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
UTY7PDF93L	CARBOXYMETHYLCELLULOSE CALCIUM:ORAL:TABLET:MG	ORAL	125MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
UTY7PDF93L	CARBOXYMETHYLCELLULOSE CALCIUM:ORAL:TABLET (IMMED./COMP. RELEASE), FILM COATED:MG	ORAL	92.96MG ORAL TABLET (IMMED./COMP. RELEASE), FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
UTY7PDF93L	CARBOXYMETHYLCELLULOSE CALCIUM:ORAL:TABLET, DELAYED ACTION, ENTERIC COATED:MG	ORAL	13.3MG ORAL TABLET, DELAYED ACTION, ENTERIC COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
UTY7PDF93L	CARBOXYMETHYLCELLULOSE CALCIUM:ORAL:TABLET, FILM COATED:MG	ORAL	241.84MG ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
UTY7PDF93L	CARBOXYMETHYLCELLULOSE CALCIUM:ORAL:TABLET, ORALLY DISINTEGRATING:MG	ORAL	15MG ORAL TABLET, ORALLY DISINTEGRATING	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
8136Y38GY5	HYDROXYETHYL CELLULOSE (140 MPA.S AT 5%):ORAL:CAPSULE:MG	ORAL	20MG ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
8136Y38GY5	HYDROXYETHYL CELLULOSE (140 MPA.S AT 5%):ORAL:TABLET:MG	ORAL	10.7MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
8136Y38GY5	HYDROXYETHYL CELLULOSE (140 MPA.S AT 5%):ORAL:TABLET, FILM COATED:MG	ORAL	1MG ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
35SW5USQ3G	D&C YELLOW NO. 10:BUCCAL:GUM, CHEWING:MG	BUCCAL	1.01MG BUCCAL GUM, CHEWING	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
35SW5USQ3G	D&C YELLOW NO. 10:DENTAL:GEL:%	DENTAL	0.003% DENTAL GEL	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
35SW5USQ3G	D&C YELLOW NO. 10:DENTAL:PASTE:NA	DENTAL	DENTAL PASTE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
35SW5USQ3G	D&C YELLOW NO. 10:INHALATION:SOLUTION:NA	INHALATION	INHALATION SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
35SW5USQ3G	D&C YELLOW NO. 10:ORAL:CAPSULE:MG	ORAL	1.54MG ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
35SW5USQ3G	D&C YELLOW NO. 10:ORAL:CAPSULE (IMMED./COMP. RELEASE), SOFT GELATIN, PERLE:MG	ORAL	0.2MG ORAL CAPSULE (IMMED./COMP. RELEASE), SOFT GELATIN, PERLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
35SW5USQ3G	D&C YELLOW NO. 10:ORAL:CAPSULE, COATED PELLETS:MG	ORAL	0.015MG ORAL CAPSULE, COATED PELLETS	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
35SW5USQ3G	D&C YELLOW NO. 10:ORAL:CAPSULE, COATED, SOFT GELATIN:MG	ORAL	0.36MG ORAL CAPSULE, COATED, SOFT GELATIN	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
35SW5USQ3G	D&C YELLOW NO. 10:ORAL:CAPSULE, DELAYED ACTION:MG	ORAL	0.14MG ORAL CAPSULE, DELAYED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
35SW5USQ3G	D&C YELLOW NO. 10:ORAL:CAPSULE, DELAYED ACTION, COATED:mg	ORAL	0.127mg ORAL CAPSULE, DELAYED ACTION, COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
35SW5USQ3G	D&C YELLOW NO. 10:ORAL:CAPSULE, ENTERIC COATED PELLETS:MG	ORAL	0.053MG ORAL CAPSULE, ENTERIC COATED PELLETS	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
35SW5USQ3G	D&C YELLOW NO. 10:ORAL:CAPSULE, EXTENDED RELEASE:MG	ORAL	0.64MG ORAL CAPSULE, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
35SW5USQ3G	D&C YELLOW NO. 10:ORAL:CAPSULE, HARD GELATIN:MG	ORAL	0.05MG ORAL CAPSULE, HARD GELATIN	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
35SW5USQ3G	D&C YELLOW NO. 10:ORAL:CAPSULE, SOFT GELATIN:MG	ORAL	1.51MG ORAL CAPSULE, SOFT GELATIN	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
35SW5USQ3G	D&C YELLOW NO. 10:ORAL:CAPSULE, SUSTAINED ACTION:MG	ORAL	0.49MG ORAL CAPSULE, SUSTAINED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
35SW5USQ3G	D&C YELLOW NO. 10:ORAL:CONCENTRATE:MG/1ML	ORAL	0.025MG/1ML ORAL CONCENTRATE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
35SW5USQ3G	D&C YELLOW NO. 10:ORAL:GUM, CHEWING:MG	ORAL	0.1MG ORAL GUM, CHEWING	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
35SW5USQ3G	D&C YELLOW NO. 10:ORAL:LIQUID:MG/5ML	ORAL	0.005MG/5ML ORAL LIQUID	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
35SW5USQ3G	D&C YELLOW NO. 10:ORAL:POWDER:MG/1PKT	ORAL	6MG/1PKT ORAL POWDER	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
35SW5USQ3G	D&C YELLOW NO. 10:ORAL:POWDER, FOR ORAL SUSPENSION:MG/PKT	ORAL	12MG/PKT ORAL POWDER, FOR ORAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
35SW5USQ3G	D&C YELLOW NO. 10:ORAL:POWDER, FOR SOLUTION:NA	ORAL	ORAL POWDER, FOR SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
35SW5USQ3G	D&C YELLOW NO. 10:ORAL:SOLUTION:%	ORAL	0.33% ORAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
35SW5USQ3G	D&C YELLOW NO. 10:ORAL:SOLUTION:MG/1ML	ORAL	0.006MG/1ML ORAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
35SW5USQ3G	D&C YELLOW NO. 10:ORAL:SOLUTION, ELIXIR:MG/15ML	ORAL	0.3MG/15ML ORAL SOLUTION, ELIXIR	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
35SW5USQ3G	D&C YELLOW NO. 10:ORAL:SOLUTION, LIQUID:MG/1ML	ORAL	0.008MG/1ML ORAL SOLUTION, LIQUID	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
35SW5USQ3G	D&C YELLOW NO. 10:ORAL:SUSPENSION:MG/5ML	ORAL	20MG/5ML ORAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
35SW5USQ3G	D&C YELLOW NO. 10:ORAL:SUSPENSION, DROPS:NA	ORAL	ORAL SUSPENSION, DROPS	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
35SW5USQ3G	D&C YELLOW NO. 10:ORAL:SUSPENSION, EXTENDED RELEASE:MG/5ML	ORAL	0.3MG/5ML ORAL SUSPENSION, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
35SW5USQ3G	D&C YELLOW NO. 10:ORAL:SUSPENSION, LIQUID:MG/5ML	ORAL	0.04MG/5ML ORAL SUSPENSION, LIQUID	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
35SW5USQ3G	D&C YELLOW NO. 10:ORAL:SUSPENSION, SUSTAINED ACTION:NA	ORAL	ORAL SUSPENSION, SUSTAINED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
35SW5USQ3G	D&C YELLOW NO. 10:ORAL:SYRUP:MG/5ML	ORAL	1MG/5ML ORAL SYRUP	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
35SW5USQ3G	D&C YELLOW NO. 10:ORAL:TABLET:MG	ORAL	80MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
35SW5USQ3G	D&C YELLOW NO. 10:ORAL:TABLET (IMMED./COMP. RELEASE), COATED:MG	ORAL	0.1MG ORAL TABLET (IMMED./COMP. RELEASE), COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
35SW5USQ3G	D&C YELLOW NO. 10:ORAL:TABLET, CHEWABLE:MG	ORAL	0.3MG ORAL TABLET, CHEWABLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
35SW5USQ3G	D&C YELLOW NO. 10:ORAL:TABLET, COATED:MG	ORAL	2.5MG ORAL TABLET, COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
35SW5USQ3G	D&C YELLOW NO. 10:ORAL:TABLET, DELAYED ACTION:MG	ORAL	0.11MG ORAL TABLET, DELAYED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
35SW5USQ3G	D&C YELLOW NO. 10:ORAL:TABLET, DELAYED ACTION, ENTERIC COATED:MG	ORAL	1.9MG ORAL TABLET, DELAYED ACTION, ENTERIC COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
35SW5USQ3G	D&C YELLOW NO. 10:ORAL:TABLET, EXTENDED RELEASE:MG	ORAL	2.5MG ORAL TABLET, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
35SW5USQ3G	D&C YELLOW NO. 10:ORAL:TABLET, FILM COATED:MG	ORAL	120MG ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
35SW5USQ3G	D&C YELLOW NO. 10:ORAL:TABLET, SUSTAINED ACTION:MG	ORAL	2.01MG ORAL TABLET, SUSTAINED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
35SW5USQ3G	D&C YELLOW NO. 10:RECTAL:SOLUTION:%	RECTAL	0.001% RECTAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
35SW5USQ3G	D&C YELLOW NO. 10:RECTAL:SUPPOSITORY:MG	RECTAL	0.11MG RECTAL SUPPOSITORY	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
35SW5USQ3G	D&C YELLOW NO. 10:SUBLINGUAL:TABLET:MG	SUBLINGUAL	0.23MG SUBLINGUAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
35SW5USQ3G	D&C YELLOW NO. 10:TOPICAL:EMULSION, CREAM:NA	TOPICAL	TOPICAL EMULSION, CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
35SW5USQ3G	D&C YELLOW NO. 10:TOPICAL:GEL:%W/W	TOPICAL	0.001%W/W TOPICAL GEL	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
35SW5USQ3G	D&C YELLOW NO. 10:TOPICAL:LOTION:%W/W	TOPICAL	0.001%W/W TOPICAL LOTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
35SW5USQ3G	D&C YELLOW NO. 10:TOPICAL:SHAMPOO:%W/W	TOPICAL	0.001%W/W TOPICAL SHAMPOO	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
35SW5USQ3G	D&C YELLOW NO. 10:TOPICAL:SHAMPOO, SUSPENSION:NA	TOPICAL	TOPICAL SHAMPOO, SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
Q9L0O73W7L	COCONUT OIL:ORAL:CAPSULE:NA	ORAL	ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
Q9L0O73W7L	COCONUT OIL:ORAL:CAPSULE, SOFT GELATIN LIQUID-FILLED:NA	ORAL	ORAL CAPSULE, SOFT GELATIN LIQUID-FILLED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
Q9L0O73W7L	COCONUT OIL:ORAL:TABLET:NA	ORAL	ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
Q9L0O73W7L	COCONUT OIL:TOPICAL:EMULSION, CREAM:NA	TOPICAL	TOPICAL EMULSION, CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
Q9L0O73W7L	COCONUT OIL:TOPICAL:OINTMENT:%W/W	TOPICAL	14.75%W/W TOPICAL OINTMENT	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
Q9L0O73W7L	COCONUT OIL:TOPICAL:SOLUTION:%W/W	TOPICAL	15.5%W/W TOPICAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
IY9XDZ35W2	DEXTROSE, UNSPECIFIED FORM:AN,CNBLK INTRATHECAL:INJECTION:%	AN,CNBLK INTRATHECAL	7.5% AN,CNBLK INTRATHECAL INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
IY9XDZ35W2	DEXTROSE, UNSPECIFIED FORM:IM - IV:INJECTION:%	IM - IV	5% IM - IV INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
IY9XDZ35W2	DEXTROSE, UNSPECIFIED FORM:IM - IV - SC:INJECTION:NA	IM - IV - SC	IM - IV - SC INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
IY9XDZ35W2	DEXTROSE, UNSPECIFIED FORM:INTERSTITIAL:INJECTION:NA	INTERSTITIAL	INTERSTITIAL INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
IY9XDZ35W2	DEXTROSE, UNSPECIFIED FORM:INTRACAVITARY:INJECTION:NA	INTRACAVITARY	INTRACAVITARY INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
IY9XDZ35W2	DEXTROSE, UNSPECIFIED FORM:INTRAMUSCULAR:INJECTION:%W/V	INTRAMUSCULAR	4.4%W/V INTRAMUSCULAR INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
IY9XDZ35W2	DEXTROSE, UNSPECIFIED FORM:INTRAPERITONEAL:INJECTION:NA	INTRAPERITONEAL	INTRAPERITONEAL INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
IY9XDZ35W2	DEXTROSE, UNSPECIFIED FORM:INTRAPLEURAL:INJECTION:NA	INTRAPLEURAL	INTRAPLEURAL INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
IY9XDZ35W2	DEXTROSE, UNSPECIFIED FORM:INTRASPINAL:INJECTION:%	INTRASPINAL	5% INTRASPINAL INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
IY9XDZ35W2	DEXTROSE, UNSPECIFIED FORM:INTRAVENOUS:INJECTABLE:%	INTRAVENOUS	5% INTRAVENOUS INJECTABLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
IY9XDZ35W2	DEXTROSE, UNSPECIFIED FORM:INTRAVENOUS:INJECTION:NA	INTRAVENOUS	INTRAVENOUS INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
IY9XDZ35W2	DEXTROSE, UNSPECIFIED FORM:INTRAVENOUS:INJECTION, SOLUTION:%	INTRAVENOUS	5% INTRAVENOUS INJECTION, SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
IY9XDZ35W2	DEXTROSE, UNSPECIFIED FORM:INTRAVENOUS:POWDER, FOR INJECTION SOLUTION:%	INTRAVENOUS	5.02% INTRAVENOUS POWDER, FOR INJECTION SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
IY9XDZ35W2	DEXTROSE, UNSPECIFIED FORM:INTRAVENOUS:SOLUTION:%	INTRAVENOUS	0.05% INTRAVENOUS SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
IY9XDZ35W2	DEXTROSE, UNSPECIFIED FORM:INTRAVENOUS:SOLUTION, INJECTION:%	INTRAVENOUS	5% INTRAVENOUS SOLUTION, INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
IY9XDZ35W2	DEXTROSE, UNSPECIFIED FORM:IV(INFUSION):POWDER, FOR INJECTION SOLUTION:%	IV(INFUSION)	5% IV(INFUSION) POWDER, FOR INJECTION SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
IY9XDZ35W2	DEXTROSE, UNSPECIFIED FORM:NASAL:SPRAY:%W/W	NASAL	5%W/W NASAL SPRAY	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
IY9XDZ35W2	DEXTROSE, UNSPECIFIED FORM:NASAL:SPRAY, METERED:%	NASAL	5% NASAL SPRAY, METERED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
IY9XDZ35W2	DEXTROSE, UNSPECIFIED FORM:ORAL:CAPSULE, DELAYED ACTION:MG	ORAL	1.1MG ORAL CAPSULE, DELAYED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
IY9XDZ35W2	DEXTROSE, UNSPECIFIED FORM:ORAL:CONCENTRATE:MG/ML	ORAL	40MG/ML ORAL CONCENTRATE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
IY9XDZ35W2	DEXTROSE, UNSPECIFIED FORM:ORAL:GRANULE, FOR ORAL SUSPENSION:MG	ORAL	2813MG ORAL GRANULE, FOR ORAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
IY9XDZ35W2	DEXTROSE, UNSPECIFIED FORM:ORAL:LIQUID:MG/4ML	ORAL	160MG/4ML ORAL LIQUID	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
IY9XDZ35W2	DEXTROSE, UNSPECIFIED FORM:ORAL:PASTILLE:MG	ORAL	826MG ORAL PASTILLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
IY9XDZ35W2	DEXTROSE, UNSPECIFIED FORM:ORAL:PELLET:MG	ORAL	2813MG ORAL PELLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
IY9XDZ35W2	DEXTROSE, UNSPECIFIED FORM:ORAL:POWDER, FOR SOLUTION:NA	ORAL	ORAL POWDER, FOR SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
IY9XDZ35W2	DEXTROSE, UNSPECIFIED FORM:ORAL:SOLUTION:MG/5ML	ORAL	2489MG/5ML ORAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
IY9XDZ35W2	DEXTROSE, UNSPECIFIED FORM:ORAL:SOLUTION, ELIXIR:NA	ORAL	ORAL SOLUTION, ELIXIR	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
IY9XDZ35W2	DEXTROSE, UNSPECIFIED FORM:ORAL:SUSPENSION:MG/5ML	ORAL	500MG/5ML ORAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
IY9XDZ35W2	DEXTROSE, UNSPECIFIED FORM:ORAL:SYRUP:MG/5ML	ORAL	1350MG/5ML ORAL SYRUP	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
IY9XDZ35W2	DEXTROSE, UNSPECIFIED FORM:ORAL:TABLET:MG	ORAL	183.66MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
IY9XDZ35W2	DEXTROSE, UNSPECIFIED FORM:ORAL:TABLET (IMMED./COMP. RELEASE), UNCOATED, CHEWABLE:MG	ORAL	398MG ORAL TABLET (IMMED./COMP. RELEASE), UNCOATED, CHEWABLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
IY9XDZ35W2	DEXTROSE, UNSPECIFIED FORM:ORAL:TABLET, EXTENDED RELEASE:MG	ORAL	103.95MG ORAL TABLET, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
IY9XDZ35W2	DEXTROSE, UNSPECIFIED FORM:ORAL:TABLET, ORALLY DISINTEGRATING:MG	ORAL	1.2MG ORAL TABLET, ORALLY DISINTEGRATING	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
IY9XDZ35W2	DEXTROSE, UNSPECIFIED FORM:ORAL:TABLET, SUSTAINED ACTION:MG	ORAL	2MG ORAL TABLET, SUSTAINED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
IY9XDZ35W2	DEXTROSE, UNSPECIFIED FORM:ORAL:TABLET, UNCOATED, TROCHE:MG	ORAL	903.5MG ORAL TABLET, UNCOATED, TROCHE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
IY9XDZ35W2	DEXTROSE, UNSPECIFIED FORM:SPINAL:INJECTION:%	SPINAL	7.5% SPINAL INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
IY9XDZ35W2	DEXTROSE, UNSPECIFIED FORM:SUBLINGUAL:TABLET:MG	SUBLINGUAL	115.78MG SUBLINGUAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
I835H2IHHX	CETETH-20:TOPICAL:CREAM:%W/W	TOPICAL	15%W/W TOPICAL CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
I835H2IHHX	CETETH-20:TOPICAL:CREAM, AUGMENTED:%W/W	TOPICAL	6%W/W TOPICAL CREAM, AUGMENTED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
I835H2IHHX	CETETH-20:TOPICAL:CREAM, EMULSION, SUSTAINED RELEASE:%W/W	TOPICAL	3%W/W TOPICAL CREAM, EMULSION, SUSTAINED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
I835H2IHHX	CETETH-20:TOPICAL:EMULSION, CREAM:%W/W	TOPICAL	4.01%W/W TOPICAL EMULSION, CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
I835H2IHHX	CETETH-20:TOPICAL:EMULSION, LOTION:%W/W	TOPICAL	1%W/W TOPICAL EMULSION, LOTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
I835H2IHHX	CETETH-20:TOPICAL:LOTION:%W/W 	TOPICAL	2%W/W  TOPICAL LOTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
I835H2IHHX	CETETH-20:TOPICAL:SOLUTION:%W/W	TOPICAL	2%W/W TOPICAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
I835H2IHHX	CETETH-20:TOPICAL:SOLUTION, LIQUID:%W/W	TOPICAL	2%W/W TOPICAL SOLUTION, LIQUID	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
I835H2IHHX	CETETH-20:VAGINAL:TAMPON:NA	VAGINAL	VAGINAL TAMPON	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
K3R6ZDH4DU	DEXTRAN 40:INTRAVENOUS:POWDER, FOR INJECTION SOLUTION, LYOPHILIZED:%	INTRAVENOUS	30% INTRAVENOUS POWDER, FOR INJECTION SOLUTION, LYOPHILIZED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
N6K5787QVP	LIGHT MINERAL OIL:AURICULAR (OTIC):OIL:%V/V	AURICULAR (OTIC)	43.44%V/V AURICULAR (OTIC) OIL	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
N6K5787QVP	LIGHT MINERAL OIL:DENTAL:PASTE:NA	DENTAL	DENTAL PASTE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
N6K5787QVP	LIGHT MINERAL OIL:OPHTHALMIC:OINTMENT:NA	OPHTHALMIC	OPHTHALMIC OINTMENT	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
N6K5787QVP	LIGHT MINERAL OIL:OPHTHALMIC:SUSPENSION:NA	OPHTHALMIC	OPHTHALMIC SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
N6K5787QVP	LIGHT MINERAL OIL:ORAL:CAPSULE:MG	ORAL	0.8MG ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
N6K5787QVP	LIGHT MINERAL OIL:ORAL:CAPSULE, COATED, SOFT GELATIN:NA	ORAL	ORAL CAPSULE, COATED, SOFT GELATIN	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
N6K5787QVP	LIGHT MINERAL OIL:ORAL:CAPSULE, ENTERIC COATED PELLETS:MG	ORAL	14.1MG ORAL CAPSULE, ENTERIC COATED PELLETS	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
N6K5787QVP	LIGHT MINERAL OIL:ORAL:CAPSULE, SOFT GELATIN:NA	ORAL	ORAL CAPSULE, SOFT GELATIN	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
N6K5787QVP	LIGHT MINERAL OIL:ORAL:PASTILLE:MG	ORAL	3.6MG ORAL PASTILLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
N6K5787QVP	LIGHT MINERAL OIL:ORAL:TABLET:MG	ORAL	7.5MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
N6K5787QVP	LIGHT MINERAL OIL:ORAL:TABLET, COATED:MG	ORAL	4.8MG ORAL TABLET, COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
N6K5787QVP	LIGHT MINERAL OIL:ORAL:TABLET, FILM COATED:MG	ORAL	2.49MG ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
N6K5787QVP	LIGHT MINERAL OIL:ORAL:TABLET, SUSTAINED ACTION:MG	ORAL	0.2MG ORAL TABLET, SUSTAINED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
N6K5787QVP	LIGHT MINERAL OIL:RECTAL:SUSPENSION:NA	RECTAL	RECTAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
N6K5787QVP	LIGHT MINERAL OIL:TOPICAL:CREAM:%W/W	TOPICAL	10%W/W TOPICAL CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
N6K5787QVP	LIGHT MINERAL OIL:TOPICAL:CREAM, AUGMENTED:%W/W	TOPICAL	25%W/W TOPICAL CREAM, AUGMENTED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
N6K5787QVP	LIGHT MINERAL OIL:TOPICAL:DROPS:%W/V	TOPICAL	36.96%W/V TOPICAL DROPS	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
N6K5787QVP	LIGHT MINERAL OIL:TOPICAL:EMULSION:%W/W	TOPICAL	5%W/W TOPICAL EMULSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
N6K5787QVP	LIGHT MINERAL OIL:TOPICAL:EMULSION, AEROSOL FOAM:%W/W	TOPICAL	6%W/W TOPICAL EMULSION, AEROSOL FOAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
N6K5787QVP	LIGHT MINERAL OIL:TOPICAL:EMULSION, CREAM:%W/W	TOPICAL	20%W/W TOPICAL EMULSION, CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
N6K5787QVP	LIGHT MINERAL OIL:TOPICAL:LOTION:%W/W	TOPICAL	16%W/W TOPICAL LOTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
N6K5787QVP	LIGHT MINERAL OIL:TOPICAL:OIL:%W/W	TOPICAL	43.4%W/W TOPICAL OIL	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
N6K5787QVP	LIGHT MINERAL OIL:TOPICAL:OINTMENT:%W/W	TOPICAL	15%W/W TOPICAL OINTMENT	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
N6K5787QVP	LIGHT MINERAL OIL:TOPICAL:SUPPOSITORY, INSERT:NA	TOPICAL	TOPICAL SUPPOSITORY, INSERT	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
N6K5787QVP	LIGHT MINERAL OIL:TRANSDERMAL:FILM, CONTROLLED RELEASE:MG	TRANSDERMAL	162MG TRANSDERMAL FILM, CONTROLLED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
N6K5787QVP	LIGHT MINERAL OIL:TRANSDERMAL:FILM, EXTENDED RELEASE:MG	TRANSDERMAL	26.4MG TRANSDERMAL FILM, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
N6K5787QVP	LIGHT MINERAL OIL:TRANSDERMAL:PATCH:MG	TRANSDERMAL	74MG TRANSDERMAL PATCH	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
N6K5787QVP	LIGHT MINERAL OIL:VAGINAL:CREAM, EMULSION, SUSTAINED RELEASE:%	VAGINAL	7% VAGINAL CREAM, EMULSION, SUSTAINED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
N6K5787QVP	LIGHT MINERAL OIL:VAGINAL:INSERT:MG	VAGINAL	1465MG VAGINAL INSERT	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
N6K5787QVP	LIGHT MINERAL OIL:VAGINAL:SUPPOSITORY, INSERT:MG	VAGINAL	1464.9MG VAGINAL SUPPOSITORY, INSERT	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
7626GC95E5	CORIANDER OIL:ORAL:SOLUTION:NA	ORAL	ORAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
7626GC95E5	CORIANDER OIL:ORAL:SOLUTION, ELIXIR:%	ORAL	3% ORAL SOLUTION, ELIXIR	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
AE28F7PNPL	METHIONINE:INTRAMUSCULAR:SOLUTION, INJECTION:%W/V	INTRAMUSCULAR	0.073%W/V INTRAMUSCULAR SOLUTION, INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
AE28F7PNPL	METHIONINE:INTRATHECAL:INJECTABLE:%	INTRATHECAL	0.005% INTRATHECAL INJECTABLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
AE28F7PNPL	METHIONINE:INTRAVENOUS:INJECTABLE:%	INTRAVENOUS	0.004% INTRAVENOUS INJECTABLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
AE28F7PNPL	METHIONINE:INTRAVENOUS:INJECTION:%	INTRAVENOUS	0.3% INTRAVENOUS INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
AE28F7PNPL	METHIONINE:IV(INFUSION):INJECTABLE:%	IV(INFUSION)	0.15% IV(INFUSION) INJECTABLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
AE28F7PNPL	METHIONINE:IV(INFUSION):INJECTION:%	IV(INFUSION)	49.2% IV(INFUSION) INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
AE28F7PNPL	METHIONINE:IV(INFUSION):SOLUTION, INJECTION:%	IV(INFUSION)	0.16% IV(INFUSION) SOLUTION, INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
AE28F7PNPL	METHIONINE:ORAL:TABLET:NA	ORAL	ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
AE28F7PNPL	METHIONINE:SUBCUTANEOUS:INJECTABLE:%	SUBCUTANEOUS	0.15% SUBCUTANEOUS INJECTABLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
AE28F7PNPL	METHIONINE:SUBCUTANEOUS:INJECTION:%	SUBCUTANEOUS	0.01% SUBCUTANEOUS INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
AE28F7PNPL	METHIONINE:SUBCUTANEOUS:POWDER, FOR INJECTION SOLUTION, LYOPHILIZED:%	SUBCUTANEOUS	0.01% SUBCUTANEOUS POWDER, FOR INJECTION SOLUTION, LYOPHILIZED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
AE28F7PNPL	METHIONINE:SUBCUTANEOUS:SOLUTION, INJECTION:%	SUBCUTANEOUS	0.3% SUBCUTANEOUS SOLUTION, INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
AE28F7PNPL	METHIONINE:SUBCUTANEOUS:SUSPENSION, INJECTION:%	SUBCUTANEOUS	0.23% SUBCUTANEOUS SUSPENSION, INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
HX1032V43M	SODIUM THIOSULFATE:INTRAVENOUS:INJECTION:%	INTRAVENOUS	0.2% INTRAVENOUS INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
HX1032V43M	SODIUM THIOSULFATE:INTRAVENOUS:SOLUTION:NA	INTRAVENOUS	INTRAVENOUS SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
HX1032V43M	SODIUM THIOSULFATE:OPHTHALMIC:DROPS:%	OPHTHALMIC	0.2% OPHTHALMIC DROPS	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
HX1032V43M	SODIUM THIOSULFATE:OPHTHALMIC:OINTMENT:NA	OPHTHALMIC	OPHTHALMIC OINTMENT	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
HX1032V43M	SODIUM THIOSULFATE:OPHTHALMIC:SOLUTION:%	OPHTHALMIC	0.5% OPHTHALMIC SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
HX1032V43M	SODIUM THIOSULFATE:OPHTHALMIC:SOLUTION, DROPS:%	OPHTHALMIC	0.31% OPHTHALMIC SOLUTION, DROPS	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
HX1032V43M	SODIUM THIOSULFATE:OPHTHALMIC:SUSPENSION:%	OPHTHALMIC	0.32% OPHTHALMIC SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
HX1032V43M	SODIUM THIOSULFATE:OPHTHALMIC:SUSPENSION, DROPS:%	OPHTHALMIC	0.31% OPHTHALMIC SUSPENSION, DROPS	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
HX1032V43M	SODIUM THIOSULFATE:ORAL:CAPSULE:MG	ORAL	20MG ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
HX1032V43M	SODIUM THIOSULFATE:ORAL:SOLUTION:%	ORAL	0.2% ORAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
HX1032V43M	SODIUM THIOSULFATE:ORAL:TABLET:MG	ORAL	3MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
HX1032V43M	SODIUM THIOSULFATE:TOPICAL:CREAM:%W/W	TOPICAL	0.1%W/W TOPICAL CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
HX1032V43M	SODIUM THIOSULFATE:TOPICAL:CREAM, AUGMENTED:%W/V	TOPICAL	0.1%W/V TOPICAL CREAM, AUGMENTED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
HX1032V43M	SODIUM THIOSULFATE:TOPICAL:CREAM, EMULSION, SUSTAINED RELEASE:%W/V	TOPICAL	0.1%W/V TOPICAL CREAM, EMULSION, SUSTAINED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
HX1032V43M	SODIUM THIOSULFATE:TOPICAL:SOLUTION:%W/W	TOPICAL	0.3%W/W TOPICAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
1678RKX8RT	D&C RED NO. 22:ORAL:CAPSULE:MG	ORAL	0.022MG ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
1678RKX8RT	D&C RED NO. 22:ORAL:CAPSULE, SUSTAINED ACTION:NA	ORAL	ORAL CAPSULE, SUSTAINED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
1678RKX8RT	D&C RED NO. 22:ORAL:SUSPENSION:NA	ORAL	ORAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
1678RKX8RT	D&C RED NO. 22:ORAL:TABLET, COATED:NA	ORAL	ORAL TABLET, COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
4QD397987E	HISTIDINE:INTRAVENOUS:INJECTION, SUSPENSION, LIPOSOMAL:%	INTRAVENOUS	0.16% INTRAVENOUS INJECTION, SUSPENSION, LIPOSOMAL	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
4QD397987E	HISTIDINE:IV(INFUSION):INJECTION:%	IV(INFUSION)	37.2% IV(INFUSION) INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
4QD397987E	HISTIDINE:IV(INFUSION):INJECTION, LIPOSOMAL:%	IV(INFUSION)	0.015% IV(INFUSION) INJECTION, LIPOSOMAL	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
4QD397987E	HISTIDINE:IV(INFUSION):SOLUTION, INJECTION:%	IV(INFUSION)	0.085% IV(INFUSION) SOLUTION, INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
4QD397987E	HISTIDINE:ORAL:SUSPENSION:MG/1ML	ORAL	5MG/1ML ORAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
4QD397987E	HISTIDINE:SUBCUTANEOUS:POWDER, FOR INJECTION SOLUTION, LYOPHILIZED:%	SUBCUTANEOUS	0.39% SUBCUTANEOUS POWDER, FOR INJECTION SOLUTION, LYOPHILIZED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
4QD397987E	HISTIDINE:SUBCUTANEOUS:SOLUTION, INJECTION:%	SUBCUTANEOUS	0.073% SUBCUTANEOUS SOLUTION, INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
8Z96QXD6UM	TRIETHYL CITRATE:INTRAMUSCULAR:INJECTABLE:mg	INTRAMUSCULAR	2.4mg INTRAMUSCULAR INJECTABLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
8Z96QXD6UM	TRIETHYL CITRATE:INTRAMUSCULAR:INJECTION:mg	INTRAMUSCULAR	10.4mg INTRAMUSCULAR INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
8Z96QXD6UM	TRIETHYL CITRATE:ORAL:CAPSULE:MG	ORAL	16MG ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
8Z96QXD6UM	TRIETHYL CITRATE:ORAL:CAPSULE, COATED:MG	ORAL	2.18MG ORAL CAPSULE, COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
8Z96QXD6UM	TRIETHYL CITRATE:ORAL:CAPSULE, COATED PELLETS:MG	ORAL	0.59MG ORAL CAPSULE, COATED PELLETS	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
8Z96QXD6UM	TRIETHYL CITRATE:ORAL:CAPSULE, DELAYED ACTION:MG	ORAL	17.92MG ORAL CAPSULE, DELAYED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
8Z96QXD6UM	TRIETHYL CITRATE:ORAL:CAPSULE, DELAYED RELEASE:mg	ORAL	16.825mg ORAL CAPSULE, DELAYED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
8Z96QXD6UM	TRIETHYL CITRATE:ORAL:CAPSULE, ENTERIC COATED PELLETS:MG	ORAL	45MG ORAL CAPSULE, ENTERIC COATED PELLETS	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
8Z96QXD6UM	TRIETHYL CITRATE:ORAL:CAPSULE, EXTENDED RELEASE:MG	ORAL	22.23MG ORAL CAPSULE, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
8Z96QXD6UM	TRIETHYL CITRATE:ORAL:CAPSULE, FILM COATED, EXTENDED RELEASE:MG	ORAL	0.939MG ORAL CAPSULE, FILM COATED, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
8Z96QXD6UM	TRIETHYL CITRATE:ORAL:CAPSULE, HARD GELATIN:MG	ORAL	4MG ORAL CAPSULE, HARD GELATIN	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
8Z96QXD6UM	TRIETHYL CITRATE:ORAL:CAPSULE, SUSTAINED ACTION:MG	ORAL	7.5MG ORAL CAPSULE, SUSTAINED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
8Z96QXD6UM	TRIETHYL CITRATE:ORAL:CAPSULE, SUSTAINED ACTION, HARD GELATIN:MG	ORAL	3.3MG ORAL CAPSULE, SUSTAINED ACTION, HARD GELATIN	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
8Z96QXD6UM	TRIETHYL CITRATE:ORAL:GRANULE, FOR ORAL SUSPENSION:MG	ORAL	6.94MG ORAL GRANULE, FOR ORAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
8Z96QXD6UM	TRIETHYL CITRATE:ORAL:PELLET:MG	ORAL	3.8MG ORAL PELLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
8Z96QXD6UM	TRIETHYL CITRATE:ORAL:SUSPENSION:MG/15 ML	ORAL	8.27MG/15 ML ORAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
8Z96QXD6UM	TRIETHYL CITRATE:ORAL:SUSPENSION, EXTENDED RELEASE:MG/ML	ORAL	0.42MG/ML ORAL SUSPENSION, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
8Z96QXD6UM	TRIETHYL CITRATE:ORAL:SUSPENSION, SUSTAINED ACTION:MG/.20684GM	ORAL	6.94MG/.20684GM ORAL SUSPENSION, SUSTAINED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
8Z96QXD6UM	TRIETHYL CITRATE:ORAL:TABLET:mg	ORAL	2.3mg ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
8Z96QXD6UM	TRIETHYL CITRATE:ORAL:TABLET (IMMED./COMP. RELEASE), UNCOATED, CHEWABLE:MG	ORAL	2.8MG ORAL TABLET (IMMED./COMP. RELEASE), UNCOATED, CHEWABLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
8Z96QXD6UM	TRIETHYL CITRATE:ORAL:TABLET, CONTROLLED RELEASE:mg	ORAL	2.269mg ORAL TABLET, CONTROLLED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
8Z96QXD6UM	TRIETHYL CITRATE:ORAL:TABLET, DELAYED ACTION:MG	ORAL	15.1MG ORAL TABLET, DELAYED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
8Z96QXD6UM	TRIETHYL CITRATE:ORAL:TABLET, DELAYED ACTION, ENTERIC COATED:MG	ORAL	20.18MG ORAL TABLET, DELAYED ACTION, ENTERIC COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
8Z96QXD6UM	TRIETHYL CITRATE:ORAL:TABLET, DELAYED RELEASE:mg	ORAL	12.26mg ORAL TABLET, DELAYED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
8Z96QXD6UM	TRIETHYL CITRATE:ORAL:TABLET, EXTENDED RELEASE:MG	ORAL	14.3MG ORAL TABLET, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
8Z96QXD6UM	TRIETHYL CITRATE:ORAL:TABLET, FILM COATED:MG	ORAL	3.6MG ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
8Z96QXD6UM	TRIETHYL CITRATE:ORAL:TABLET, ORALLY DISINTEGRATING:MG	ORAL	4MG ORAL TABLET, ORALLY DISINTEGRATING	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
8Z96QXD6UM	TRIETHYL CITRATE:ORAL:TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE:MG	ORAL	18.7MG ORAL TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
8Z96QXD6UM	TRIETHYL CITRATE:ORAL:TABLET, SUSTAINED ACTION:MG	ORAL	2.28MG ORAL TABLET, SUSTAINED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
8Z96QXD6UM	TRIETHYL CITRATE:ORAL:TABLET, SUSTAINED ACTION, FILM COATED:MG	ORAL	0.5MG ORAL TABLET, SUSTAINED ACTION, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
71YMM1X75O	PEG-15 HYDROXYSTEARATES:INTRAVENOUS:INJECTION, EMULSION:MG/ML	INTRAVENOUS	44MG/ML INTRAVENOUS INJECTION, EMULSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
71YMM1X75O	PEG-15 HYDROXYSTEARATES:OPHTHALMIC:EMULSION:%W/V	OPHTHALMIC	0.25%W/V OPHTHALMIC EMULSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
A6R43525YO	METHYL CHLORIDE:ORAL:TABLET:MG	ORAL	69.82MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
A6R43525YO	METHYL CHLORIDE:ORAL:TABLET, COATED:NA	ORAL	ORAL TABLET, COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
D3741U8K7L	INDIGOTINDISULFONATE SODIUM:ORAL:CAPSULE:MG	ORAL	0.68MG ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=I
D3741U8K7L	INDIGOTINDISULFONATE SODIUM:ORAL:TABLET:MG	ORAL	2.87MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=I
D3741U8K7L	INDIGOTINDISULFONATE SODIUM:ORAL:TABLET, EXTENDED RELEASE:MG	ORAL	0.036MG ORAL TABLET, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=I
Z0D00IVA10	ETHYLPARABEN SODIUM:ORAL:CAPSULE, SOFT GELATIN:MG	ORAL	1MG ORAL CAPSULE, SOFT GELATIN	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
4PC054V79P	GLYCERYL OLEATE:ORAL:CAPSULE:NA	ORAL	ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
4PC054V79P	GLYCERYL OLEATE:ORAL:CAPSULE, HARD GELATIN:NA	ORAL	ORAL CAPSULE, HARD GELATIN	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
4PC054V79P	GLYCERYL OLEATE:ORAL:POWDER, FOR SUSPENSION:NA	ORAL	ORAL POWDER, FOR SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
4PC054V79P	GLYCERYL OLEATE:ORAL:TABLET:MG	ORAL	0.15MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
4PC054V79P	GLYCERYL OLEATE:ORAL:TABLET, COATED:NA	ORAL	ORAL TABLET, COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
4PC054V79P	GLYCERYL OLEATE:TOPICAL:CREAM, AUGMENTED:%W/W	TOPICAL	3.5%W/W TOPICAL CREAM, AUGMENTED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
4PC054V79P	GLYCERYL OLEATE:TOPICAL:GEL:%W/W	TOPICAL	1%W/W TOPICAL GEL	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
4PC054V79P	GLYCERYL OLEATE:TOPICAL:SPRAY:%W/W	TOPICAL	0.95%W/W TOPICAL SPRAY	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
4PC054V79P	GLYCERYL OLEATE:TRANSDERMAL:FILM, CONTROLLED RELEASE:MG	TRANSDERMAL	18.8MG TRANSDERMAL FILM, CONTROLLED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
SOI2LOH54Z	ZINC OXIDE:IM - SC:INJECTION:NA	IM - SC	IM - SC INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=Z
SOI2LOH54Z	ZINC OXIDE:RECTAL:SUPPOSITORY:MG	RECTAL	375MG RECTAL SUPPOSITORY	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=Z
SOI2LOH54Z	ZINC OXIDE:RESPIRATORY (INHALATION):SOLUTION, INJECTION:%	RESPIRATORY (INHALATION)	3.11% RESPIRATORY (INHALATION) SOLUTION, INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=Z
SOI2LOH54Z	ZINC OXIDE:SUBCUTANEOUS:INJECTABLE:%	SUBCUTANEOUS	0.002% SUBCUTANEOUS INJECTABLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=Z
SOI2LOH54Z	ZINC OXIDE:SUBCUTANEOUS:INJECTION:%	SUBCUTANEOUS	0.019% SUBCUTANEOUS INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=Z
SOI2LOH54Z	ZINC OXIDE:SUBCUTANEOUS:SUSPENSION, INJECTION:%	SUBCUTANEOUS	0.003% SUBCUTANEOUS SUSPENSION, INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=Z
3B8D35Y7S4	LACTIC ACID, DL-:IM - IV:INJECTION:ADJ PH	IM - IV	ADJ PH IM - IV INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
3B8D35Y7S4	LACTIC ACID, DL-:INTRAMUSCULAR:INJECTION:NA	INTRAMUSCULAR	INTRAMUSCULAR INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
3B8D35Y7S4	LACTIC ACID, DL-:INTRAVENOUS:INJECTION:%	INTRAVENOUS	0.13% INTRAVENOUS INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
3B8D35Y7S4	LACTIC ACID, DL-:IV(INFUSION):INJECTION:%	IV(INFUSION)	5.64% IV(INFUSION) INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
3B8D35Y7S4	LACTIC ACID, DL-:ORAL:LIQUID:MG/5ML	ORAL	10MG/5ML ORAL LIQUID	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
3B8D35Y7S4	LACTIC ACID, DL-:TOPICAL:SOLUTION:%W/W	TOPICAL	7.4%W/W TOPICAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
3B8D35Y7S4	LACTIC ACID, DL-:VAGINAL:SUPPOSITORY:NA	VAGINAL	VAGINAL SUPPOSITORY	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
288VBX44JC	HYPROMELLOSE 2910 (15000 MPA.S):NASAL:SPRAY, METERED:%	NASAL	0.1% NASAL SPRAY, METERED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
288VBX44JC	HYPROMELLOSE 2910 (15000 MPA.S):OPHTHALMIC:SOLUTION:%	OPHTHALMIC	0.5% OPHTHALMIC SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
288VBX44JC	HYPROMELLOSE 2910 (15000 MPA.S):OPHTHALMIC:SUSPENSION:%	OPHTHALMIC	0.5% OPHTHALMIC SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
288VBX44JC	HYPROMELLOSE 2910 (15000 MPA.S):OPHTHALMIC:SUSPENSION, DROPS:%	OPHTHALMIC	0.5% OPHTHALMIC SUSPENSION, DROPS	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
288VBX44JC	HYPROMELLOSE 2910 (15000 MPA.S):ORAL:CAPSULE:MG	ORAL	40.55MG ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
288VBX44JC	HYPROMELLOSE 2910 (15000 MPA.S):ORAL:CAPSULE, DELAYED ACTION:MG	ORAL	33.42MG ORAL CAPSULE, DELAYED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
288VBX44JC	HYPROMELLOSE 2910 (15000 MPA.S):ORAL:CAPSULE, ENTERIC COATED PELLETS:MG	ORAL	13.82MG ORAL CAPSULE, ENTERIC COATED PELLETS	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
288VBX44JC	HYPROMELLOSE 2910 (15000 MPA.S):ORAL:CAPSULE, EXTENDED RELEASE:MG	ORAL	10.6MG ORAL CAPSULE, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
288VBX44JC	HYPROMELLOSE 2910 (15000 MPA.S):ORAL:CAPSULE, HARD GELATIN:MG	ORAL	2MG ORAL CAPSULE, HARD GELATIN	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
288VBX44JC	HYPROMELLOSE 2910 (15000 MPA.S):ORAL:CAPSULE, SUSTAINED ACTION:MG	ORAL	21.1MG ORAL CAPSULE, SUSTAINED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
288VBX44JC	HYPROMELLOSE 2910 (15000 MPA.S):ORAL:CAPSULE, SUSTAINED ACTION, HARD GELATIN:MG	ORAL	4.77MG ORAL CAPSULE, SUSTAINED ACTION, HARD GELATIN	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
288VBX44JC	HYPROMELLOSE 2910 (15000 MPA.S):ORAL:GRANULE, FOR ORAL SUSPENSION:MG	ORAL	26.6MG ORAL GRANULE, FOR ORAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
288VBX44JC	HYPROMELLOSE 2910 (15000 MPA.S):ORAL:POWDER, FOR RECONSTITUTION:MG/5ML	ORAL	79.65MG/5ML ORAL POWDER, FOR RECONSTITUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
288VBX44JC	HYPROMELLOSE 2910 (15000 MPA.S):ORAL:POWDER, FOR SOLUTION:MG/1BOT	ORAL	2398.2MG/1BOT ORAL POWDER, FOR SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
288VBX44JC	HYPROMELLOSE 2910 (15000 MPA.S):ORAL:POWDER, FOR SUSPENSION:MG/1SCP	ORAL	30MG/1SCP ORAL POWDER, FOR SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
288VBX44JC	HYPROMELLOSE 2910 (15000 MPA.S):ORAL:SOLUTION, SYRUP:MG/1ML	ORAL	24MG/1ML ORAL SOLUTION, SYRUP	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
288VBX44JC	HYPROMELLOSE 2910 (15000 MPA.S):ORAL:SUSPENSION:MG/1ML	ORAL	5MG/1ML ORAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
288VBX44JC	HYPROMELLOSE 2910 (15000 MPA.S):ORAL:SUSPENSION, SUSTAINED ACTION:MG/.20684GM	ORAL	24.08MG/.20684GM ORAL SUSPENSION, SUSTAINED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
288VBX44JC	HYPROMELLOSE 2910 (15000 MPA.S):ORAL:SYRUP:MG/1ML	ORAL	5MG/1ML ORAL SYRUP	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
288VBX44JC	HYPROMELLOSE 2910 (15000 MPA.S):ORAL:TABLET:MG	ORAL	1943MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
288VBX44JC	HYPROMELLOSE 2910 (15000 MPA.S):ORAL:TABLET (IMMED./COMP. RELEASE), FILM COATED:MG	ORAL	214.5MG ORAL TABLET (IMMED./COMP. RELEASE), FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
288VBX44JC	HYPROMELLOSE 2910 (15000 MPA.S):ORAL:TABLET (IMMED./COMP. RELEASE), UNCOATED, CHEWABLE:MG	ORAL	11.8MG ORAL TABLET (IMMED./COMP. RELEASE), UNCOATED, CHEWABLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
288VBX44JC	HYPROMELLOSE 2910 (15000 MPA.S):ORAL:TABLET, COATED:MG	ORAL	29.25MG ORAL TABLET, COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
288VBX44JC	HYPROMELLOSE 2910 (15000 MPA.S):ORAL:TABLET, CONTROLLED RELEASE:MG	ORAL	20MG ORAL TABLET, CONTROLLED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
288VBX44JC	HYPROMELLOSE 2910 (15000 MPA.S):ORAL:TABLET, DELAYED ACTION:MG	ORAL	4.47MG ORAL TABLET, DELAYED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
288VBX44JC	HYPROMELLOSE 2910 (15000 MPA.S):ORAL:TABLET, DELAYED ACTION, ENTERIC COATED:MG	ORAL	19MG ORAL TABLET, DELAYED ACTION, ENTERIC COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
288VBX44JC	HYPROMELLOSE 2910 (15000 MPA.S):ORAL:TABLET, ENTERIC COATED PARTICLES:MG	ORAL	445MG ORAL TABLET, ENTERIC COATED PARTICLES	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
288VBX44JC	HYPROMELLOSE 2910 (15000 MPA.S):ORAL:TABLET, EXTENDED RELEASE:MG	ORAL	150MG ORAL TABLET, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
288VBX44JC	HYPROMELLOSE 2910 (15000 MPA.S):ORAL:TABLET, FILM COATED:MG	ORAL	60MG ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
288VBX44JC	HYPROMELLOSE 2910 (15000 MPA.S):ORAL:TABLET, MULTILAYER, COATED:MG	ORAL	22MG ORAL TABLET, MULTILAYER, COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
288VBX44JC	HYPROMELLOSE 2910 (15000 MPA.S):ORAL:TABLET, ORALLY DISINTEGRATING:MG	ORAL	25MG ORAL TABLET, ORALLY DISINTEGRATING	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
288VBX44JC	HYPROMELLOSE 2910 (15000 MPA.S):ORAL:TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE:MG	ORAL	7MG ORAL TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
288VBX44JC	HYPROMELLOSE 2910 (15000 MPA.S):ORAL:TABLET, SUSTAINED ACTION:MG	ORAL	250MG ORAL TABLET, SUSTAINED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
288VBX44JC	HYPROMELLOSE 2910 (15000 MPA.S):ORAL:TABLET, SUSTAINED ACTION, COATED:MG	ORAL	6.7MG ORAL TABLET, SUSTAINED ACTION, COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
288VBX44JC	HYPROMELLOSE 2910 (15000 MPA.S):ORAL:TABLET, SUSTAINED ACTION, FILM COATED:MG	ORAL	54MG ORAL TABLET, SUSTAINED ACTION, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
21334LVV8W	.ALPHA.-TERPINEOL:TOPICAL:LOTION:%V/V	TOPICAL	11%V/V TOPICAL LOTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
QU7E2XA9TG	SODIUM STEARATE:ORAL:TABLET:MG	ORAL	9.48MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
QU7E2XA9TG	SODIUM STEARATE:ORAL:TABLET (IMMED./COMP. RELEASE), UNCOATED, BUCCAL:MG	ORAL	3.2MG ORAL TABLET (IMMED./COMP. RELEASE), UNCOATED, BUCCAL	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
QU7E2XA9TG	SODIUM STEARATE:ORAL:TABLET, DELAYED ACTION:MG	ORAL	10MG ORAL TABLET, DELAYED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
QU7E2XA9TG	SODIUM STEARATE:ORAL:TABLET, DELAYED RELEASE:mg	ORAL	10mg ORAL TABLET, DELAYED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
QU7E2XA9TG	SODIUM STEARATE:ORAL:TABLET, ORALLY DISINTEGRATING:MG	ORAL	0.85MG ORAL TABLET, ORALLY DISINTEGRATING	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
BUC5I9595W	CHERRY:ORAL:SOLUTION:MG/1ML	ORAL	1MG/1ML ORAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
BUC5I9595W	CHERRY:ORAL:TABLET:MG	ORAL	0.45MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
BUC5I9595W	CHERRY:ORAL:TABLET (IMMED./COMP. RELEASE), UNCOATED, CHEWABLE:NA	ORAL	ORAL TABLET (IMMED./COMP. RELEASE), UNCOATED, CHEWABLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
0MGW7Q3QG4	HYMETELLOSE (50 MPA.S):ORAL:TABLET:MG	ORAL	24MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
6O92ICV9RU	SORBITAN:ORAL:CAPSULE:MG	ORAL	19.08MG ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
6O92ICV9RU	SORBITAN:ORAL:CONCENTRATE:NA	ORAL	ORAL CONCENTRATE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
6O92ICV9RU	SORBITAN:ORAL:SOLUTION, ELIXIR:%	ORAL	4% ORAL SOLUTION, ELIXIR	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
6O92ICV9RU	SORBITAN:ORAL:SUSPENSION:NA	ORAL	ORAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
6O92ICV9RU	SORBITAN:TOPICAL:EMULSION, CREAM:NA	TOPICAL	TOPICAL EMULSION, CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
W45XXM0XWE	1,2,6-HEXANETRIOL:TOPICAL:CREAM:%W/W	TOPICAL	0.5%W/W TOPICAL CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=1
VA9U6BR3SB	DIPALMITOYLPHOSPHATIDYLGLYCEROL, DL-:INFILTRATION:INJECTION, LIPOSOMAL:%	INFILTRATION	0.09% INFILTRATION INJECTION, LIPOSOMAL	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
VA9U6BR3SB	DIPALMITOYLPHOSPHATIDYLGLYCEROL, DL-:INTRAVENOUS:INJECTION, SUSPENSION:%	INTRAVENOUS	0.004% INTRAVENOUS INJECTION, SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
ZK64F7XSTX	D&C RED NO. 27 ALUMINUM LAKE:ORAL:CAPSULE:MG	ORAL	1.31MG ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
ZK64F7XSTX	D&C RED NO. 27 ALUMINUM LAKE:ORAL:TABLET:MG	ORAL	0.69MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
ZK64F7XSTX	D&C RED NO. 27 ALUMINUM LAKE:ORAL:TABLET (IMMED./COMP. RELEASE), UNCOATED, CHEWABLE:MG	ORAL	1.25MG ORAL TABLET (IMMED./COMP. RELEASE), UNCOATED, CHEWABLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
ZK64F7XSTX	D&C RED NO. 27 ALUMINUM LAKE:ORAL:TABLET, DELAYED RELEASE:MG	ORAL	0.6MG ORAL TABLET, DELAYED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
ZK64F7XSTX	D&C RED NO. 27 ALUMINUM LAKE:ORAL:TABLET, EXTENDED RELEASE:MG	ORAL	0.54MG ORAL TABLET, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
ZK64F7XSTX	D&C RED NO. 27 ALUMINUM LAKE:ORAL:TABLET, FILM COATED:MG	ORAL	0.33MG ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
ZK64F7XSTX	D&C RED NO. 27 ALUMINUM LAKE:ORAL:TABLET, SUSTAINED ACTION:NA	ORAL	ORAL TABLET, SUSTAINED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
ZK64F7XSTX	D&C RED NO. 27 ALUMINUM LAKE:ORAL:TABLET, SUSTAINED ACTION, COATED:NA	ORAL	ORAL TABLET, SUSTAINED ACTION, COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
1L24V9R23S	POTASSIUM ALUM:VAGINAL:SUPPOSITORY:MG	VAGINAL	17.2MG VAGINAL SUPPOSITORY	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
N2TH4S4KUD	MONTAN WAX:ORAL:TABLET:MG	ORAL	0.06MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
N2TH4S4KUD	MONTAN WAX:ORAL:TABLET, FILM COATED:MG	ORAL	0.03MG ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
27NA468985	SODIUM STARCH GLYCOLATE TYPE B POTATO:ORAL:CAPSULE:MG	ORAL	26.53MG ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
27NA468985	SODIUM STARCH GLYCOLATE TYPE B POTATO:ORAL:TABLET:MG	ORAL	36MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
27NA468985	SODIUM STARCH GLYCOLATE TYPE B POTATO:ORAL:TABLET, DELAYED ACTION, ENTERIC COATED:MG	ORAL	7.98MG ORAL TABLET, DELAYED ACTION, ENTERIC COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
27NA468985	SODIUM STARCH GLYCOLATE TYPE B POTATO:ORAL:TABLET, FILM COATED:MG	ORAL	12MG ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
HM5Z15LEBN	POTASSIUM BICARBONATE:ORAL:CAPSULE, SOFT GELATIN:MG	ORAL	29MG ORAL CAPSULE, SOFT GELATIN	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
HM5Z15LEBN	POTASSIUM BICARBONATE:ORAL:LOZENGE:mg	ORAL	4mg ORAL LOZENGE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
HM5Z15LEBN	POTASSIUM BICARBONATE:ORAL:POWDER, FOR ORAL SOLUTION:MG	ORAL	500MG ORAL POWDER, FOR ORAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
HM5Z15LEBN	POTASSIUM BICARBONATE:ORAL:SOLUTION:MG/5ML	ORAL	25MG/5ML ORAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
HM5Z15LEBN	POTASSIUM BICARBONATE:ORAL:TABLET:MG	ORAL	12.2MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
HM5Z15LEBN	POTASSIUM BICARBONATE:ORAL:TABLET, UNCOATED, LOZENGE:MG	ORAL	1.06MG ORAL TABLET, UNCOATED, LOZENGE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
HM5Z15LEBN	POTASSIUM BICARBONATE:ORAL:TROCHE:MG	ORAL	4MG ORAL TROCHE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
HM5Z15LEBN	POTASSIUM BICARBONATE:TRANSMUCOSAL:TABLET:MG	TRANSMUCOSAL	8MG TRANSMUCOSAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
RDH86HJV5Z	POVIDONE K90:AURICULAR (OTIC):SOLUTION, DROPS:%	AURICULAR (OTIC)	0.2% AURICULAR (OTIC) SOLUTION, DROPS	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
RDH86HJV5Z	POVIDONE K90:OPHTHALMIC:SOLUTION:%W/V	OPHTHALMIC	0.3%W/V OPHTHALMIC SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
RDH86HJV5Z	POVIDONE K90:OPHTHALMIC:SOLUTION, DROPS:%	OPHTHALMIC	1.2% OPHTHALMIC SOLUTION, DROPS	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
RDH86HJV5Z	POVIDONE K90:ORAL:CAPSULE:MG	ORAL	54.81MG ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
RDH86HJV5Z	POVIDONE K90:ORAL:CAPSULE, DELAYED ACTION:MG	ORAL	9.29MG ORAL CAPSULE, DELAYED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
RDH86HJV5Z	POVIDONE K90:ORAL:CAPSULE, DELAYED RELEASE:MG	ORAL	22.82MG ORAL CAPSULE, DELAYED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
RDH86HJV5Z	POVIDONE K90:ORAL:CAPSULE, EXTENDED RELEASE:MG	ORAL	18.8MG ORAL CAPSULE, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
RDH86HJV5Z	POVIDONE K90:ORAL:CAPSULE, HARD GELATIN:MG	ORAL	5.95MG ORAL CAPSULE, HARD GELATIN	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
RDH86HJV5Z	POVIDONE K90:ORAL:CAPSULE, SUSTAINED ACTION:NA	ORAL	ORAL CAPSULE, SUSTAINED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
RDH86HJV5Z	POVIDONE K90:ORAL:CAPSULE, SUSTAINED ACTION, HARD GELATIN:MG	ORAL	18.8MG ORAL CAPSULE, SUSTAINED ACTION, HARD GELATIN	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
RDH86HJV5Z	POVIDONE K90:ORAL:GRANULE, FOR SUSPENSION:MG	ORAL	32MG ORAL GRANULE, FOR SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
RDH86HJV5Z	POVIDONE K90:ORAL:SUSPENSION:MG/1ML	ORAL	0.1MG/1ML ORAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
RDH86HJV5Z	POVIDONE K90:ORAL:TABLET:MG	ORAL	78MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
RDH86HJV5Z	POVIDONE K90:ORAL:TABLET, COATED:MG	ORAL	9.77MG ORAL TABLET, COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
RDH86HJV5Z	POVIDONE K90:ORAL:TABLET, CONTROLLED RELEASE:MG	ORAL	35MG ORAL TABLET, CONTROLLED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
RDH86HJV5Z	POVIDONE K90:ORAL:TABLET, DELAYED ACTION:MG	ORAL	15MG ORAL TABLET, DELAYED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
RDH86HJV5Z	POVIDONE K90:ORAL:TABLET, DELAYED ACTION, ENTERIC COATED:MG	ORAL	4MG ORAL TABLET, DELAYED ACTION, ENTERIC COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
RDH86HJV5Z	POVIDONE K90:ORAL:TABLET, DELAYED RELEASE:MG	ORAL	48MG ORAL TABLET, DELAYED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
RDH86HJV5Z	POVIDONE K90:ORAL:TABLET, ENTERIC COATED PARTICLES:MG	ORAL	27.6MG ORAL TABLET, ENTERIC COATED PARTICLES	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
RDH86HJV5Z	POVIDONE K90:ORAL:TABLET, EXTENDED RELEASE:MG	ORAL	78MG ORAL TABLET, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
RDH86HJV5Z	POVIDONE K90:ORAL:TABLET, FILM COATED:MG	ORAL	44MG ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
RDH86HJV5Z	POVIDONE K90:ORAL:TABLET, SUSTAINED ACTION:MG	ORAL	40.8MG ORAL TABLET, SUSTAINED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
RDH86HJV5Z	POVIDONE K90:TOPICAL:SOLUTION:%W/V	TOPICAL	2%W/V TOPICAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
RDH86HJV5Z	POVIDONE K90:TRANSDERMAL:SOLUTION:%W/W	TRANSDERMAL	2.5%W/W TRANSDERMAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
2V16EO95H1	PALMITIC ACID:INTRAVENOUS:INJECTION, SUSPENSION:%	INTRAVENOUS	0.001% INTRAVENOUS INJECTION, SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
2V16EO95H1	PALMITIC ACID:ORAL:TABLET:MG	ORAL	6MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
5S29HWU6QB	CINNAMON:ORAL:SOLUTION, ELIXIR:MG/5ML	ORAL	10.5MG/5ML ORAL SOLUTION, ELIXIR	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
NX76LV5T8J	EUDRAGIT L 30:ORAL:CAPSULE, EXTENDED RELEASE:MG	ORAL	66.3MG ORAL CAPSULE, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
NX76LV5T8J	EUDRAGIT L 30 D:ORAL:CAPSULE:mg	ORAL	93.6mg ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
NX76LV5T8J	EUDRAGIT L 30 D:ORAL:CAPSULE, DELAYED ACTION:mg	ORAL	82.513mg ORAL CAPSULE, DELAYED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
NX76LV5T8J	EUDRAGIT L 30 D:ORAL:CAPSULE, DELAYED RELEASE:mg	ORAL	79.22mg ORAL CAPSULE, DELAYED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
NX76LV5T8J	EUDRAGIT L 30 D:ORAL:TABLET, CONTROLLED RELEASE:mg	ORAL	22.74mg ORAL TABLET, CONTROLLED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
NX76LV5T8J	EUDRAGIT L 30 D:ORAL:TABLET, EXTENDED RELEASE:mg	ORAL	9.2mg ORAL TABLET, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
NX76LV5T8J	METHACRYLIC ACID - ETHYL ACRYLATE COPOLYMER (1:1) TYPE A:ORAL:CAPSULE, COATED PELLETS:MG	ORAL	3.94MG ORAL CAPSULE, COATED PELLETS	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
NX76LV5T8J	METHACRYLIC ACID - ETHYL ACRYLATE COPOLYMER (1:1) TYPE A:ORAL:CAPSULE, DELAYED ACTION, COATED, HARD GELATIN:MG	ORAL	100.69MG ORAL CAPSULE, DELAYED ACTION, COATED, HARD GELATIN	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
NX76LV5T8J	METHACRYLIC ACID - ETHYL ACRYLATE COPOLYMER (1:1) TYPE A:ORAL:CAPSULE, DELAYED RELEASE:MG	ORAL	58.88MG ORAL CAPSULE, DELAYED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
NX76LV5T8J	METHACRYLIC ACID - ETHYL ACRYLATE COPOLYMER (1:1) TYPE A:ORAL:CAPSULE, ENTERIC COATED PELLETS:MG	ORAL	1500MG ORAL CAPSULE, ENTERIC COATED PELLETS	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
NX76LV5T8J	METHACRYLIC ACID - ETHYL ACRYLATE COPOLYMER (1:1) TYPE A:ORAL:CAPSULE, HARD GELATIN:MG	ORAL	2.2MG ORAL CAPSULE, HARD GELATIN	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
NX76LV5T8J	METHACRYLIC ACID - ETHYL ACRYLATE COPOLYMER (1:1) TYPE A:ORAL:CAPSULE, SUSTAINED ACTION:MG	ORAL	57.28MG ORAL CAPSULE, SUSTAINED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
NX76LV5T8J	METHACRYLIC ACID - ETHYL ACRYLATE COPOLYMER (1:1) TYPE A:ORAL:CAPSULE, SUSTAINED ACTION, HARD GELATIN:MG	ORAL	10.9MG ORAL CAPSULE, SUSTAINED ACTION, HARD GELATIN	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
NX76LV5T8J	METHACRYLIC ACID - ETHYL ACRYLATE COPOLYMER (1:1) TYPE A:ORAL:GRANULE, FOR ORAL SUSPENSION:MG	ORAL	38MG ORAL GRANULE, FOR ORAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
NX76LV5T8J	METHACRYLIC ACID - ETHYL ACRYLATE COPOLYMER (1:1) TYPE A:ORAL:PELLET:MG	ORAL	38MG ORAL PELLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
NX76LV5T8J	METHACRYLIC ACID - ETHYL ACRYLATE COPOLYMER (1:1) TYPE A:ORAL:SOLUTION:MG	ORAL	3.68MG ORAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
NX76LV5T8J	METHACRYLIC ACID - ETHYL ACRYLATE COPOLYMER (1:1) TYPE A:ORAL:TABLET:MG	ORAL	91MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
NX76LV5T8J	METHACRYLIC ACID - ETHYL ACRYLATE COPOLYMER (1:1) TYPE A:ORAL:TABLET, DELAYED ACTION, ENTERIC COATED:MG	ORAL	140MG ORAL TABLET, DELAYED ACTION, ENTERIC COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
NX76LV5T8J	METHACRYLIC ACID - ETHYL ACRYLATE COPOLYMER (1:1) TYPE A:ORAL:TABLET, ENTERIC COATED PARTICLES:MG	ORAL	27.9MG ORAL TABLET, ENTERIC COATED PARTICLES	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
NX76LV5T8J	METHACRYLIC ACID - ETHYL ACRYLATE COPOLYMER (1:1) TYPE A:ORAL:TABLET, EXTENDED RELEASE:MG	ORAL	133.34MG ORAL TABLET, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
NX76LV5T8J	METHACRYLIC ACID - ETHYL ACRYLATE COPOLYMER (1:1) TYPE A:ORAL:TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE:MG	ORAL	95MG ORAL TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
NX76LV5T8J	METHACRYLIC ACID - ETHYL ACRYLATE COPOLYMER (1:1) TYPE A:ORAL:TABLET, SUSTAINED ACTION:MG	ORAL	7.2MG ORAL TABLET, SUSTAINED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
NX76LV5T8J	METHACRYLIC ACID - ETHYL ACRYLATE COPOLYMER (1:1) TYPE A:ORAL:TABLET, SUSTAINED ACTION, COATED:MG	ORAL	15MG ORAL TABLET, SUSTAINED ACTION, COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
8ILA5X28VS	ETHYLENE-VINYL ACETATE COPOLYMER (28% VINYL ACETATE):IMPLANTATION:IMPLANT:MG	IMPLANTATION	43MG IMPLANTATION IMPLANT	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
8ILA5X28VS	ETHYLENE-VINYL ACETATE COPOLYMER (28% VINYL ACETATE):SUBCUTANEOUS:IMPLANT:MG	SUBCUTANEOUS	43MG SUBCUTANEOUS IMPLANT	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
8ILA5X28VS	ETHYLENE-VINYL ACETATE COPOLYMER (28% VINYL ACETATE):VAGINAL:INSERT:MG	VAGINAL	1677MG VAGINAL INSERT	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
459TN2L5F5	POLYLACTIDE:INTRAMUSCULAR:INJECTION:mg	INTRAMUSCULAR	188.4mg INTRAMUSCULAR INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
459TN2L5F5	POLYLACTIDE:INTRAMUSCULAR:POWDER, FOR INJECTION SUSPENSION, LYOPHILIZED:%	INTRAMUSCULAR	26.48% INTRAMUSCULAR POWDER, FOR INJECTION SUSPENSION, LYOPHILIZED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
459TN2L5F5	POLYLACTIDE:PERIODONTAL:DRUG DELIVERY SYSTEM:NA	PERIODONTAL	PERIODONTAL DRUG DELIVERY SYSTEM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
LKG8494WBH	BENZYL ALCOHOL:AN,INFILTRATION:INJECTION:NA	AN,INFILTRATION	AN,INFILTRATION INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
LKG8494WBH	BENZYL ALCOHOL:AURICULAR (OTIC):SUSPENSION:NA	AURICULAR (OTIC)	AURICULAR (OTIC) SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
LKG8494WBH	BENZYL ALCOHOL:AURICULAR (OTIC):SUSPENSION, LIQUID:%	AURICULAR (OTIC)	0.9% AURICULAR (OTIC) SUSPENSION, LIQUID	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
LKG8494WBH	BENZYL ALCOHOL:DENTAL:PASTE:MG	DENTAL	25MG DENTAL PASTE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
LKG8494WBH	BENZYL ALCOHOL:EPIDURAL:INJECTION:%	EPIDURAL	1% EPIDURAL INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
LKG8494WBH	BENZYL ALCOHOL:EXTRACORPOREAL:INJECTION:%	EXTRACORPOREAL	1% EXTRACORPOREAL INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
LKG8494WBH	BENZYL ALCOHOL:IM - IV:INJECTABLE:%	IM - IV	1% IM - IV INJECTABLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
LKG8494WBH	BENZYL ALCOHOL:IM - IV:INJECTION:%	IM - IV	5.21% IM - IV INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
LKG8494WBH	BENZYL ALCOHOL:IM - IV:LIQUID, WATER, STERILE, FOR INJECTION:%	IM - IV	1% IM - IV LIQUID, WATER, STERILE, FOR INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
LKG8494WBH	BENZYL ALCOHOL:IM - IV:POWDER, FOR INJECTION SOLUTION:%	IM - IV	6.69% IM - IV POWDER, FOR INJECTION SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
LKG8494WBH	BENZYL ALCOHOL:IM - IV:SOLUTION, INJECTION:%	IM - IV	2% IM - IV SOLUTION, INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
LKG8494WBH	BENZYL ALCOHOL:IM - IV - SC:INJECTION:%	IM - IV - SC	1.8% IM - IV - SC INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
LKG8494WBH	BENZYL ALCOHOL:IM - SC:INJECTABLE:%	IM - SC	1.2% IM - SC INJECTABLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
LKG8494WBH	BENZYL ALCOHOL:IM - SC:INJECTION:%	IM - SC	2% IM - SC INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
LKG8494WBH	BENZYL ALCOHOL:IM - SC:INJECTION, SUSTAINED ACTION:%	IM - SC	1.2% IM - SC INJECTION, SUSTAINED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
LKG8494WBH	BENZYL ALCOHOL:INTERSTITIAL:INJECTION:NA	INTERSTITIAL	INTERSTITIAL INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
LKG8494WBH	BENZYL ALCOHOL:INTRA-ARTERIAL:INJECTION:%	INTRA-ARTERIAL	0.9% INTRA-ARTERIAL INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
LKG8494WBH	BENZYL ALCOHOL:INTRA-ARTERIAL:SUSPENSION, INJECTION:mg/1mL	INTRA-ARTERIAL	9.16mg/1mL INTRA-ARTERIAL SUSPENSION, INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
LKG8494WBH	BENZYL ALCOHOL:INTRA-ARTICULAR:INJECTABLE:%	INTRA-ARTICULAR	0.94% INTRA-ARTICULAR INJECTABLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
LKG8494WBH	BENZYL ALCOHOL:INTRA-ARTICULAR:INJECTION:%	INTRA-ARTICULAR	1.5% INTRA-ARTICULAR INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
LKG8494WBH	BENZYL ALCOHOL:INTRA-ARTICULAR:INJECTION, SOLUTION:mg/1mL	INTRA-ARTICULAR	10mg/1mL INTRA-ARTICULAR INJECTION, SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
LKG8494WBH	BENZYL ALCOHOL:INTRA-ARTICULAR:INJECTION, SUSTAINED ACTION:NA	INTRA-ARTICULAR	INTRA-ARTICULAR INJECTION, SUSTAINED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
LKG8494WBH	BENZYL ALCOHOL:INTRABURSAL:INJECTION:%	INTRABURSAL	1% INTRABURSAL INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
LKG8494WBH	BENZYL ALCOHOL:INTRACAVITARY:INJECTION:NA	INTRACAVITARY	INTRACAVITARY INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
LKG8494WBH	BENZYL ALCOHOL:INTRACAVITARY:POWDER, FOR INJECTION SOLUTION, LYOPHILIZED:%	INTRACAVITARY	0.84% INTRACAVITARY POWDER, FOR INJECTION SOLUTION, LYOPHILIZED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
LKG8494WBH	BENZYL ALCOHOL:INTRADERMAL:INJECTION:%	INTRADERMAL	0.9% INTRADERMAL INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
LKG8494WBH	BENZYL ALCOHOL:INTRADERMAL:INJECTION, SUSTAINED ACTION:NA	INTRADERMAL	INTRADERMAL INJECTION, SUSTAINED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
LKG8494WBH	BENZYL ALCOHOL:INTRALESIONAL:INJECTABLE:%	INTRALESIONAL	0.94% INTRALESIONAL INJECTABLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
LKG8494WBH	BENZYL ALCOHOL:INTRALESIONAL:INJECTION:%	INTRALESIONAL	1% INTRALESIONAL INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
LKG8494WBH	BENZYL ALCOHOL:INTRALESIONAL:INJECTION, SOLUTION:MG/1ML	INTRALESIONAL	9MG/1ML INTRALESIONAL INJECTION, SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
LKG8494WBH	BENZYL ALCOHOL:INTRALESIONAL:INJECTION, SUSTAINED ACTION:NA	INTRALESIONAL	INTRALESIONAL INJECTION, SUSTAINED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
LKG8494WBH	BENZYL ALCOHOL:INTRALESIONAL:SUSPENSION, INJECTION:%	INTRALESIONAL	0.92% INTRALESIONAL SUSPENSION, INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
LKG8494WBH	BENZYL ALCOHOL:INTRAMUSCULAR:INJECTABLE:%W/V	INTRAMUSCULAR	5.71%W/V INTRAMUSCULAR INJECTABLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
LKG8494WBH	BENZYL ALCOHOL:INTRAMUSCULAR:INJECTION:%W/V	INTRAMUSCULAR	10.96%W/V INTRAMUSCULAR INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
LKG8494WBH	BENZYL ALCOHOL:INTRAMUSCULAR:INJECTION:%	INTRAMUSCULAR	10% INTRAMUSCULAR INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
LKG8494WBH	BENZYL ALCOHOL:INTRAMUSCULAR:INJECTION, MICROSPHERES:NA	INTRAMUSCULAR	INTRAMUSCULAR INJECTION, MICROSPHERES	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
LKG8494WBH	BENZYL ALCOHOL:INTRAMUSCULAR:INJECTION, SOLUTION:%V/V	INTRAMUSCULAR	2%V/V INTRAMUSCULAR INJECTION, SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
LKG8494WBH	BENZYL ALCOHOL:INTRAMUSCULAR:INJECTION, SUSTAINED ACTION:%	INTRAMUSCULAR	1% INTRAMUSCULAR INJECTION, SUSTAINED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
LKG8494WBH	BENZYL ALCOHOL:INTRAMUSCULAR:POWDER, FOR INJECTION SOLUTION:NA	INTRAMUSCULAR	INTRAMUSCULAR POWDER, FOR INJECTION SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
LKG8494WBH	BENZYL ALCOHOL:INTRAMUSCULAR:POWDER, FOR INJECTION SOLUTION, LYOPHILIZED:%	INTRAMUSCULAR	0.9% INTRAMUSCULAR POWDER, FOR INJECTION SOLUTION, LYOPHILIZED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
LKG8494WBH	BENZYL ALCOHOL:INTRAMUSCULAR:SOLUTION:%W/V	INTRAMUSCULAR	2%W/V INTRAMUSCULAR SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
LKG8494WBH	BENZYL ALCOHOL:INTRAMUSCULAR:SOLUTION, INJECTION:%	INTRAMUSCULAR	10% INTRAMUSCULAR SOLUTION, INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
LKG8494WBH	BENZYL ALCOHOL:INTRAMUSCULAR:SUSPENSION, INJECTION:%W/V	INTRAMUSCULAR	0.92%W/V INTRAMUSCULAR SUSPENSION, INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
LKG8494WBH	BENZYL ALCOHOL:INTRAPERITONEAL:INJECTION:NA	INTRAPERITONEAL	INTRAPERITONEAL INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
LKG8494WBH	BENZYL ALCOHOL:INTRAPLEURAL:INJECTION:NA	INTRAPLEURAL	INTRAPLEURAL INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
LKG8494WBH	BENZYL ALCOHOL:INTRASYNOVIAL:INJECTABLE:%	INTRASYNOVIAL	0.92% INTRASYNOVIAL INJECTABLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
LKG8494WBH	BENZYL ALCOHOL:INTRASYNOVIAL:INJECTION:%	INTRASYNOVIAL	1% INTRASYNOVIAL INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
LKG8494WBH	BENZYL ALCOHOL:INTRASYNOVIAL:INJECTION, SUSTAINED ACTION:NA	INTRASYNOVIAL	INTRASYNOVIAL INJECTION, SUSTAINED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
LKG8494WBH	BENZYL ALCOHOL:INTRASYNOVIAL:SUSPENSION, INJECTION:%	INTRASYNOVIAL	0.92% INTRASYNOVIAL SUSPENSION, INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
LKG8494WBH	BENZYL ALCOHOL:INTRA-SYNOVIAL:SUSPENSION, INJECTION:mg/1mL	INTRA-SYNOVIAL	9.16mg/1mL INTRA-SYNOVIAL SUSPENSION, INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
LKG8494WBH	BENZYL ALCOHOL:INTRATHECAL:INJECTION:%	INTRATHECAL	0.45% INTRATHECAL INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
LKG8494WBH	BENZYL ALCOHOL:INTRATRACHEAL:SUSPENSION:NA	INTRATRACHEAL	INTRATRACHEAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
LKG8494WBH	BENZYL ALCOHOL:INTRATUMOR:INJECTION:%	INTRATUMOR	0.9% INTRATUMOR INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
LKG8494WBH	BENZYL ALCOHOL:INTRAVENOUS:EMULSION, INJECTION:%	INTRAVENOUS	0.4% INTRAVENOUS EMULSION, INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
LKG8494WBH	BENZYL ALCOHOL:INTRAVENOUS:INFUSION:%	INTRAVENOUS	18% INTRAVENOUS INFUSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
LKG8494WBH	BENZYL ALCOHOL:INTRAVENOUS:INJECTABLE:%	INTRAVENOUS	2.02% INTRAVENOUS INJECTABLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
LKG8494WBH	BENZYL ALCOHOL:INTRAVENOUS:INJECTION:%	INTRAVENOUS	2% INTRAVENOUS INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
LKG8494WBH	BENZYL ALCOHOL:INTRAVENOUS:INJECTION, SOLUTION:mg/1mL	INTRAVENOUS	10mg/1mL INTRAVENOUS INJECTION, SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
LKG8494WBH	BENZYL ALCOHOL:INTRAVENOUS:LIQUID:%	INTRAVENOUS	10.4% INTRAVENOUS LIQUID	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
LKG8494WBH	BENZYL ALCOHOL:INTRAVENOUS:POWDER, FOR INJECTION SOLUTION:%	INTRAVENOUS	1.8% INTRAVENOUS POWDER, FOR INJECTION SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
LKG8494WBH	BENZYL ALCOHOL:INTRAVENOUS:POWDER, FOR INJECTION SOLUTION, LYOPHILIZED, WITH ADDITIVES:%	INTRAVENOUS	0.5% INTRAVENOUS POWDER, FOR INJECTION SOLUTION, LYOPHILIZED, WITH ADDITIVES	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
LKG8494WBH	BENZYL ALCOHOL:INTRAVENOUS:SOLUTION:%	INTRAVENOUS	0.9% INTRAVENOUS SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
LKG8494WBH	BENZYL ALCOHOL:INTRAVENOUS:SOLUTION, INJECTION:%	INTRAVENOUS	2.02% INTRAVENOUS SOLUTION, INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
LKG8494WBH	BENZYL ALCOHOL:IV - SC:SOLUTION, INJECTION:%	IV - SC	0.95% IV - SC SOLUTION, INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
LKG8494WBH	BENZYL ALCOHOL:IV(INFUSION):INJECTION:MG/1ML	IV(INFUSION)	30MG/1ML IV(INFUSION) INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
LKG8494WBH	BENZYL ALCOHOL:IV(INFUSION):POWDER, FOR INJECTION SOLUTION:%	IV(INFUSION)	6.69% IV(INFUSION) POWDER, FOR INJECTION SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
LKG8494WBH	BENZYL ALCOHOL:IV(INFUSION):POWDER, FOR INJECTION SOLUTION, LYOPHILIZED, WITH ADDITIVES:%	IV(INFUSION)	0.5% IV(INFUSION) POWDER, FOR INJECTION SOLUTION, LYOPHILIZED, WITH ADDITIVES	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
LKG8494WBH	BENZYL ALCOHOL:IV(INFUSION):SOLUTION:%	IV(INFUSION)	2.02% IV(INFUSION) SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
LKG8494WBH	BENZYL ALCOHOL:IV(INFUSION):SOLUTION, INJECTION:%	IV(INFUSION)	2.02% IV(INFUSION) SOLUTION, INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
LKG8494WBH	BENZYL ALCOHOL:NASAL:SPRAY:%	NASAL	0.9% NASAL SPRAY	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
LKG8494WBH	BENZYL ALCOHOL:NASAL:SPRAY, METERED:%	NASAL	0.5% NASAL SPRAY, METERED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
LKG8494WBH	BENZYL ALCOHOL:NERVE BLOCK:INJECTION:NA	NERVE BLOCK	NERVE BLOCK INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
LKG8494WBH	BENZYL ALCOHOL:OPHTHALMIC:SUSPENSION:NA	OPHTHALMIC	OPHTHALMIC SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
LKG8494WBH	BENZYL ALCOHOL:ORAL:CAPSULE:MG	ORAL	15MG ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
LKG8494WBH	BENZYL ALCOHOL:ORAL:CAPSULE, SOFT GELATIN:NA	ORAL	ORAL CAPSULE, SOFT GELATIN	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
LKG8494WBH	BENZYL ALCOHOL:ORAL:CAPSULE, SUSTAINED ACTION:MG	ORAL	1.23MG ORAL CAPSULE, SUSTAINED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
LKG8494WBH	BENZYL ALCOHOL:ORAL:CONCENTRATE:NA	ORAL	ORAL CONCENTRATE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
LKG8494WBH	BENZYL ALCOHOL:ORAL:SOLUTION:MG/1ML	ORAL	50MG/1ML ORAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
LKG8494WBH	BENZYL ALCOHOL:ORAL:SUSPENSION:MG/10ML	ORAL	1000MG/10ML ORAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
LKG8494WBH	BENZYL ALCOHOL:ORAL:TABLET:MG	ORAL	1.06MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
LKG8494WBH	BENZYL ALCOHOL:ORAL:TABLET, DELAYED ACTION, ENTERIC COATED:MG	ORAL	2.31MG ORAL TABLET, DELAYED ACTION, ENTERIC COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
LKG8494WBH	BENZYL ALCOHOL:ORAL:TABLET, SUSTAINED ACTION, COATED:MG	ORAL	1.25MG ORAL TABLET, SUSTAINED ACTION, COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
LKG8494WBH	BENZYL ALCOHOL:RECTAL:GEL:%	RECTAL	3.1% RECTAL GEL	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
LKG8494WBH	BENZYL ALCOHOL:SOFT TISSUE:INJECTABLE:%	SOFT TISSUE	0.94% SOFT TISSUE INJECTABLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
LKG8494WBH	BENZYL ALCOHOL:SOFT TISSUE:INJECTION:%	SOFT TISSUE	1% SOFT TISSUE INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
LKG8494WBH	BENZYL ALCOHOL:SOFT TISSUE:INJECTION, SUSTAINED ACTION:NA	SOFT TISSUE	SOFT TISSUE INJECTION, SUSTAINED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
LKG8494WBH	BENZYL ALCOHOL:SOFT TISSUE:SUSPENSION, INJECTION:%	SOFT TISSUE	0.92% SOFT TISSUE SUSPENSION, INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
LKG8494WBH	BENZYL ALCOHOL:SUBCONJUNCTIVAL:INJECTION:%	SUBCONJUNCTIVAL	0.95% SUBCONJUNCTIVAL INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
LKG8494WBH	BENZYL ALCOHOL:SUBCUTANEOUS:INJECTION:%	SUBCUTANEOUS	4.5% SUBCUTANEOUS INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
LKG8494WBH	BENZYL ALCOHOL:SUBCUTANEOUS:INJECTION, SOLUTION:%	SUBCUTANEOUS	0.23% SUBCUTANEOUS INJECTION, SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
LKG8494WBH	BENZYL ALCOHOL:SUBCUTANEOUS:SOLUTION, INJECTION:%	SUBCUTANEOUS	1.46% SUBCUTANEOUS SOLUTION, INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
LKG8494WBH	BENZYL ALCOHOL:TOPICAL:CREAM:%W/W	TOPICAL	2.7%W/W TOPICAL CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
LKG8494WBH	BENZYL ALCOHOL:TOPICAL:CREAM, AUGMENTED:%W/W	TOPICAL	1%W/W TOPICAL CREAM, AUGMENTED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
LKG8494WBH	BENZYL ALCOHOL:TOPICAL:CREAM, EMULSION, SUSTAINED RELEASE:%W/W	TOPICAL	2%W/W TOPICAL CREAM, EMULSION, SUSTAINED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
LKG8494WBH	BENZYL ALCOHOL:TOPICAL:EMULSION, CREAM:%W/W	TOPICAL	2.7%W/W TOPICAL EMULSION, CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
LKG8494WBH	BENZYL ALCOHOL:TOPICAL:GEL:%W/W	TOPICAL	2%W/W TOPICAL GEL	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
LKG8494WBH	BENZYL ALCOHOL:TOPICAL:LOTION:%W/W	TOPICAL	1.3%W/W TOPICAL LOTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
LKG8494WBH	BENZYL ALCOHOL:TOPICAL:OINTMENT:%W/W	TOPICAL	2.2%W/W TOPICAL OINTMENT	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
LKG8494WBH	BENZYL ALCOHOL:TOPICAL:SOLUTION:%W/W	TOPICAL	2%W/W TOPICAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
LKG8494WBH	BENZYL ALCOHOL:TOPICAL:SUPPOSITORY, INSERT:NA	TOPICAL	TOPICAL SUPPOSITORY, INSERT	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
LKG8494WBH	BENZYL ALCOHOL:TOPICAL:SUSPENSION:%W/W	TOPICAL	1%W/W TOPICAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
LKG8494WBH	BENZYL ALCOHOL:TOPICAL:TABLET:NA	TOPICAL	TOPICAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
LKG8494WBH	BENZYL ALCOHOL:URETERAL:SOLUTION:NA	URETERAL	URETERAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
LKG8494WBH	BENZYL ALCOHOL:VAGINAL:CREAM, AUGMENTED:%	VAGINAL	1% VAGINAL CREAM, AUGMENTED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
LKG8494WBH	BENZYL ALCOHOL:VAGINAL:CREAM, EMULSION, SUSTAINED RELEASE:%	VAGINAL	1% VAGINAL CREAM, EMULSION, SUSTAINED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
LKG8494WBH	BENZYL ALCOHOL:VAGINAL:EMULSION, CREAM:%	VAGINAL	1% VAGINAL EMULSION, CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
LKG8494WBH	BENZYL ALCOHOL:VAGINAL:SUPPOSITORY, INSERT:NA	VAGINAL	VAGINAL SUPPOSITORY, INSERT	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
LKG8494WBH	BENZYL ALCOHOL:VAGINAL:TABLET:NA	VAGINAL	VAGINAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
JX0HIX6OAG	POLOXAMER 182:TOPICAL:GEL:%W/W	TOPICAL	0.2%W/W TOPICAL GEL	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
7T1F30V5YH	POLYSORBATE 20:AURICULAR (OTIC):SUSPENSION, LIQUID:%	AURICULAR (OTIC)	0.1% AURICULAR (OTIC) SUSPENSION, LIQUID	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
7T1F30V5YH	POLYSORBATE 20:IM - SC:INJECTION:%	IM - SC	0.001% IM - SC INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
7T1F30V5YH	POLYSORBATE 20:INTRAMUSCULAR:INJECTABLE:mg/1mL	INTRAMUSCULAR	16.2mg/1mL INTRAMUSCULAR INJECTABLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
7T1F30V5YH	POLYSORBATE 20:INTRAMUSCULAR:INJECTION:NA	INTRAMUSCULAR	INTRAMUSCULAR INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
7T1F30V5YH	POLYSORBATE 20:INTRAMUSCULAR:INJECTION, SUSPENSION, EXTENDED RELEASE:%	INTRAMUSCULAR	0.5% INTRAMUSCULAR INJECTION, SUSPENSION, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
7T1F30V5YH	POLYSORBATE 20:INTRAMUSCULAR:POWDER, FOR INJECTION SOLUTION, LYOPHILIZED:%	INTRAMUSCULAR	0.01% INTRAMUSCULAR POWDER, FOR INJECTION SOLUTION, LYOPHILIZED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
7T1F30V5YH	POLYSORBATE 20:INTRAMUSCULAR:SOLUTION, INJECTION:%W/V	INTRAMUSCULAR	0.029%W/V INTRAMUSCULAR SOLUTION, INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
7T1F30V5YH	POLYSORBATE 20:INTRAMUSCULAR:SUSPENSION, EXTENDED RELEASE:%	INTRAMUSCULAR	1% INTRAMUSCULAR SUSPENSION, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
7T1F30V5YH	POLYSORBATE 20:INTRAMUSCULAR:SUSPENSION, INJECTION:%	INTRAMUSCULAR	1.8% INTRAMUSCULAR SUSPENSION, INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
7T1F30V5YH	POLYSORBATE 20:INTRAVENOUS:INJECTABLE:mg/mL	INTRAVENOUS	10mg/mL INTRAVENOUS INJECTABLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
7T1F30V5YH	POLYSORBATE 20:INTRAVENOUS:INJECTION:%	INTRAVENOUS	4.8% INTRAVENOUS INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
7T1F30V5YH	POLYSORBATE 20:INTRAVENOUS:POWDER, FOR INJECTION SOLUTION:%	INTRAVENOUS	0.044% INTRAVENOUS POWDER, FOR INJECTION SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
7T1F30V5YH	POLYSORBATE 20:INTRAVENOUS:SOLUTION, INJECTION:%	INTRAVENOUS	1% INTRAVENOUS SOLUTION, INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
7T1F30V5YH	POLYSORBATE 20:IV(INFUSION):INJECTABLE:%	IV(INFUSION)	0.003% IV(INFUSION) INJECTABLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
7T1F30V5YH	POLYSORBATE 20:IV(INFUSION):INJECTION:%	IV(INFUSION)	2.4% IV(INFUSION) INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
7T1F30V5YH	POLYSORBATE 20:IV(INFUSION):POWDER, FOR INJECTION SOLUTION:%	IV(INFUSION)	0.023% IV(INFUSION) POWDER, FOR INJECTION SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
7T1F30V5YH	POLYSORBATE 20:IV(INFUSION):SOLUTION, INJECTION:%	IV(INFUSION)	0.003% IV(INFUSION) SOLUTION, INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
7T1F30V5YH	POLYSORBATE 20:NASAL:SPRAY, METERED:%	NASAL	2.5% NASAL SPRAY, METERED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
7T1F30V5YH	POLYSORBATE 20:OPHTHALMIC:SUSPENSION:%	OPHTHALMIC	0.05% OPHTHALMIC SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
7T1F30V5YH	POLYSORBATE 20:OPHTHALMIC:SUSPENSION, DROPS:NA	OPHTHALMIC	OPHTHALMIC SUSPENSION, DROPS	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
7T1F30V5YH	POLYSORBATE 20:ORAL:CAPSULE:MG	ORAL	56.25MG ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
7T1F30V5YH	POLYSORBATE 20:ORAL:POWDER, FOR SUSPENSION:MG/5ML	ORAL	1.3MG/5ML ORAL POWDER, FOR SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
7T1F30V5YH	POLYSORBATE 20:ORAL:SOLUTION, ELIXIR:NA	ORAL	ORAL SOLUTION, ELIXIR	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
7T1F30V5YH	POLYSORBATE 20:ORAL:SUSPENSION:MG/1ML	ORAL	5MG/1ML ORAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
7T1F30V5YH	POLYSORBATE 20:ORAL:TABLET:MG	ORAL	6MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
7T1F30V5YH	POLYSORBATE 20:ORAL:TABLET (IMMED./COMP. RELEASE), FILM COATED:MG	ORAL	0.35MG ORAL TABLET (IMMED./COMP. RELEASE), FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
7T1F30V5YH	POLYSORBATE 20:ORAL:TABLET, COATED:NA	ORAL	ORAL TABLET, COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
7T1F30V5YH	POLYSORBATE 20:ORAL:TABLET, EXTENDED RELEASE:MG	ORAL	4.2MG ORAL TABLET, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
7T1F30V5YH	POLYSORBATE 20:ORAL:TABLET, FILM COATED:NA	ORAL	ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
7T1F30V5YH	POLYSORBATE 20:SUBCUTANEOUS:INJECTABLE:%	SUBCUTANEOUS	0.003% SUBCUTANEOUS INJECTABLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
7T1F30V5YH	POLYSORBATE 20:SUBCUTANEOUS:INJECTION:%	SUBCUTANEOUS	0.001% SUBCUTANEOUS INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
7T1F30V5YH	POLYSORBATE 20:SUBCUTANEOUS:INJECTION, SOLUTION:%	SUBCUTANEOUS	0.05% SUBCUTANEOUS INJECTION, SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
7T1F30V5YH	POLYSORBATE 20:SUBCUTANEOUS:POWDER, FOR INJECTION SOLUTION, LYOPHILIZED:%	SUBCUTANEOUS	0.01% SUBCUTANEOUS POWDER, FOR INJECTION SOLUTION, LYOPHILIZED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
7T1F30V5YH	POLYSORBATE 20:SUBCUTANEOUS:SOLUTION, INJECTION:%	SUBCUTANEOUS	0.2% SUBCUTANEOUS SOLUTION, INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
7T1F30V5YH	POLYSORBATE 20:TOPICAL:EMULSION:%W/W	TOPICAL	2%W/W TOPICAL EMULSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
7T1F30V5YH	POLYSORBATE 20:TOPICAL:EMULSION, AEROSOL FOAM:%W/W	TOPICAL	3.7%W/W TOPICAL EMULSION, AEROSOL FOAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
7T1F30V5YH	POLYSORBATE 20:TOPICAL:EMULSION, CREAM:%W/W	TOPICAL	0.8%W/W TOPICAL EMULSION, CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
7T1F30V5YH	POLYSORBATE 20:TOPICAL:GEL:%W/W	TOPICAL	5%W/W TOPICAL GEL	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
7T1F30V5YH	POLYSORBATE 20:TOPICAL:LOTION:%W/W	TOPICAL	7.8%W/W TOPICAL LOTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
7T1F30V5YH	POLYSORBATE 20:TOPICAL:SOLUTION:%W/W	TOPICAL	15%W/W TOPICAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
7T1F30V5YH	POLYSORBATE 20:VAGINAL:SUPPOSITORY:NA	VAGINAL	VAGINAL SUPPOSITORY	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
7T1F30V5YH	POLYSORBATE 20:VAGINAL:TAMPON:MG	VAGINAL	64.8MG VAGINAL TAMPON	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
8C3Z4148WZ	ALGINIC ACID:OPHTHALMIC:SUPPOSITORY, INSERT, CONTROLLED RELEASE:MG	OPHTHALMIC	1MG OPHTHALMIC SUPPOSITORY, INSERT, CONTROLLED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
8C3Z4148WZ	ALGINIC ACID:ORAL:CAPSULE:MG	ORAL	80MG ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
8C3Z4148WZ	ALGINIC ACID:ORAL:TABLET:MG	ORAL	32MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
8C3Z4148WZ	ALGINIC ACID:ORAL:TABLET (IMMED./COMP. RELEASE), UNCOATED, CHEWABLE:MG	ORAL	400MG ORAL TABLET (IMMED./COMP. RELEASE), UNCOATED, CHEWABLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
8C3Z4148WZ	ALGINIC ACID:ORAL:TABLET, COATED:MG	ORAL	60MG ORAL TABLET, COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
8C3Z4148WZ	ALGINIC ACID:ORAL:TABLET, EXTENDED RELEASE:MG	ORAL	20MG ORAL TABLET, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
8C3Z4148WZ	ALGINIC ACID:ORAL:TABLET, FILM COATED:MG	ORAL	52.8MG ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
8C3Z4148WZ	ALGINIC ACID:ORAL:TABLET, SUSTAINED ACTION:MG	ORAL	22.25MG ORAL TABLET, SUSTAINED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
DH9E53K1Y8	NORFLURANE:INHALATION:AEROSOL:ug	INHALATION	98.7ug INHALATION AEROSOL	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=N
DH9E53K1Y8	NORFLURANE:INHALATION:AEROSOL, METERED:%	INHALATION	7.5% INHALATION AEROSOL, METERED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=N
DH9E53K1Y8	NORFLURANE:INHALATIONAEROSOL, METERED:AEROSOL, METERED:MG/1INH	INHALATIONAEROSOL, METERED	75MG/1INH INHALATIONAEROSOL, METERED AEROSOL, METERED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=N
DH9E53K1Y8	NORFLURANE:NASAL:AEROSOL:%	NASAL	5.45% NASAL AEROSOL	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=N
DH9E53K1Y8	NORFLURANE:RESPIRATORY (INHALATION):AEROSOL, METERED:%	RESPIRATORY (INHALATION)	89.76% RESPIRATORY (INHALATION) AEROSOL, METERED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=N
WAT0DDB505	CALCIUM SULFATE, UNSPECIFIED FORM:ORAL:CAPSULE:MG	ORAL	74.68MG ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
WAT0DDB505	CALCIUM SULFATE, UNSPECIFIED FORM:ORAL:CAPSULE, SUSTAINED ACTION:MG	ORAL	1.54MG ORAL CAPSULE, SUSTAINED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
WAT0DDB505	CALCIUM SULFATE, UNSPECIFIED FORM:ORAL:SYRUP:NA	ORAL	ORAL SYRUP	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
WAT0DDB505	CALCIUM SULFATE, UNSPECIFIED FORM:ORAL:TABLET, COATED:MG	ORAL	170MG ORAL TABLET, COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
WAT0DDB505	CALCIUM SULFATE, UNSPECIFIED FORM:ORAL:TABLET, DELAYED ACTION, ENTERIC COATED:MG	ORAL	75MG ORAL TABLET, DELAYED ACTION, ENTERIC COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
WAT0DDB505	CALCIUM SULFATE, UNSPECIFIED FORM:ORAL:TABLET, EXTENDED RELEASE:MG	ORAL	8.4MG ORAL TABLET, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
WAT0DDB505	CALCIUM SULFATE, UNSPECIFIED FORM:ORAL:TABLET, FILM COATED:MG	ORAL	443MG ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
WAT0DDB505	CALCIUM SULFATE, UNSPECIFIED FORM:ORAL:TABLET, REPEAT ACTION:MG	ORAL	235MG ORAL TABLET, REPEAT ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
47VY054OXY	ACETONE SODIUM BISULFITE:AN,CNBLK INTRATHECAL:INJECTION:NA	AN,CNBLK INTRATHECAL	AN,CNBLK INTRATHECAL INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
47VY054OXY	ACETONE SODIUM BISULFITE:AN,INFILTRATION:INJECTION:%	AN,INFILTRATION	0.2% AN,INFILTRATION INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
47VY054OXY	ACETONE SODIUM BISULFITE:DENTAL:INJECTION:NA	DENTAL	DENTAL INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
47VY054OXY	ACETONE SODIUM BISULFITE:INHALATION:SOLUTION:%	INHALATION	0.5% INHALATION SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
47VY054OXY	ACETONE SODIUM BISULFITE:IV(INFUSION):INJECTION:NA	IV(INFUSION)	IV(INFUSION) INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
47VY054OXY	ACETONE SODIUM BISULFITE:NERVE BLOCK:INJECTION:%	NERVE BLOCK	0.2% NERVE BLOCK INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
C269C4G2ZQ	SODIUM ALGINATE:ORAL:CAPSULE:MG	ORAL	80MG ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
C269C4G2ZQ	SODIUM ALGINATE:ORAL:LOZENGE:mg	ORAL	25mg ORAL LOZENGE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
C269C4G2ZQ	SODIUM ALGINATE:ORAL:SUSPENSION:MG/5ML	ORAL	6.15MG/5ML ORAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
C269C4G2ZQ	SODIUM ALGINATE:ORAL:SYRUP:MG/1ML	ORAL	3MG/1ML ORAL SYRUP	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
C269C4G2ZQ	SODIUM ALGINATE:ORAL:TABLET:mg	ORAL	120mg ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
C269C4G2ZQ	SODIUM ALGINATE:ORAL:TABLET, CONTROLLED RELEASE:MG	ORAL	262MG ORAL TABLET, CONTROLLED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
C269C4G2ZQ	SODIUM ALGINATE:ORAL:TABLET, EXTENDED RELEASE:MG	ORAL	313.7MG ORAL TABLET, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
C269C4G2ZQ	SODIUM ALGINATE:ORAL:TABLET, SUSTAINED ACTION:MG	ORAL	350MG ORAL TABLET, SUSTAINED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
C269C4G2ZQ	SODIUM ALGINATE:ORAL:TABLET, SUSTAINED ACTION, FILM COATED:MG	ORAL	320MG ORAL TABLET, SUSTAINED ACTION, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
C269C4G2ZQ	SODIUM ALGINATE:ORAL:TABLET, UNCOATED, LOZENGE:MG	ORAL	12.1MG ORAL TABLET, UNCOATED, LOZENGE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
C269C4G2ZQ	SODIUM ALGINATE:ORAL:TROCHE:MG	ORAL	64.31MG ORAL TROCHE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
E939MCU4ID	SOLVENT ORANGE 2:ORAL:TABLET, COATED:MG	ORAL	0.07MG ORAL TABLET, COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
1DI56QDM62	LECITHIN, SOYBEAN:INHALATION:AEROSOL, METERED:%	INHALATION	0.1% INHALATION AEROSOL, METERED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
1DI56QDM62	LECITHIN, SOYBEAN:ORAL:CAPSULE:MG	ORAL	7MG ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
1DI56QDM62	LECITHIN, SOYBEAN:ORAL:CAPSULE, EXTENDED RELEASE:MG	ORAL	0.67MG ORAL CAPSULE, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
1DI56QDM62	LECITHIN, SOYBEAN:ORAL:CAPSULE, SOFT GELATIN:MG	ORAL	20MG ORAL CAPSULE, SOFT GELATIN	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
1DI56QDM62	LECITHIN, SOYBEAN:ORAL:SUSPENSION:MG/1ML	ORAL	2MG/1ML ORAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
1DI56QDM62	LECITHIN, SOYBEAN:ORAL:TABLET:MG	ORAL	3.8MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
1DI56QDM62	LECITHIN, SOYBEAN:ORAL:TABLET, EXTENDED RELEASE:mg	ORAL	20mg ORAL TABLET, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
1DI56QDM62	LECITHIN, SOYBEAN:ORAL:TABLET, FILM COATED:MG	ORAL	0.33MG ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
1DI56QDM62	LECITHIN, SOYBEAN:VAGINAL:EMULSION, CREAM:%	VAGINAL	1% VAGINAL EMULSION, CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
UKE75GEA7F	HYDROXYPROPYL CELLULOSE (90000 WAMW):ORAL:CAPSULE:mg	ORAL	9.81mg ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
UKE75GEA7F	HYDROXYPROPYL CELLULOSE (90000 WAMW):ORAL:CAPSULE, DELAYED ACTION:MG	ORAL	6.73MG ORAL CAPSULE, DELAYED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
UKE75GEA7F	HYDROXYPROPYL CELLULOSE (90000 WAMW):ORAL:CAPSULE, DELAYED RELEASE:MG	ORAL	25MG ORAL CAPSULE, DELAYED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
UKE75GEA7F	HYDROXYPROPYL CELLULOSE (90000 WAMW):ORAL:CAPSULE, DELAYED RELEASE:mg	ORAL	18.95mg ORAL CAPSULE, DELAYED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
UKE75GEA7F	HYDROXYPROPYL CELLULOSE (90000 WAMW):ORAL:GRANULE:mg	ORAL	2.5mg ORAL GRANULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
UKE75GEA7F	HYDROXYPROPYL CELLULOSE (90000 WAMW):ORAL:LOZENGE:mg	ORAL	25mg ORAL LOZENGE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
UKE75GEA7F	HYDROXYPROPYL CELLULOSE (90000 WAMW):ORAL:SUSPENSION:mg/5mL	ORAL	6.66mg/5mL ORAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
UKE75GEA7F	HYDROXYPROPYL CELLULOSE (90000 WAMW):ORAL:TABLET:MG	ORAL	54MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
UKE75GEA7F	HYDROXYPROPYL CELLULOSE (90000 WAMW):ORAL:TABLET (IMMED./COMP. RELEASE), FILM COATED:MG	ORAL	2.86MG ORAL TABLET (IMMED./COMP. RELEASE), FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
UKE75GEA7F	HYDROXYPROPYL CELLULOSE (90000 WAMW):ORAL:TABLET (IMMED./COMP. RELEASE), UNCOATED, CHEWABLE:MG	ORAL	5MG ORAL TABLET (IMMED./COMP. RELEASE), UNCOATED, CHEWABLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
UKE75GEA7F	HYDROXYPROPYL CELLULOSE (90000 WAMW):ORAL:TABLET, DELAYED ACTION:MG	ORAL	5.6MG ORAL TABLET, DELAYED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
UKE75GEA7F	HYDROXYPROPYL CELLULOSE (90000 WAMW):ORAL:TABLET, DELAYED RELEASE:MG	ORAL	5.46MG ORAL TABLET, DELAYED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
UKE75GEA7F	HYDROXYPROPYL CELLULOSE (90000 WAMW):ORAL:TABLET, EXTENDED RELEASE:mg	ORAL	182mg ORAL TABLET, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
UKE75GEA7F	HYDROXYPROPYL CELLULOSE (90000 WAMW):ORAL:TABLET, FILM COATED:MG	ORAL	8.4MG ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
WG4ID2U7FT	PEGAPAMODUTIDE:ORAL:CAPSULE:MG	ORAL	16.77MG ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
OJ245FE5EU	SODIUM BENZOATE:BUCCAL:FILM:MG	BUCCAL	0.96MG BUCCAL FILM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
OJ245FE5EU	SODIUM BENZOATE:BUCCAL:FILM, SOLUBLE:MG	BUCCAL	0.69MG BUCCAL FILM, SOLUBLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
OJ245FE5EU	SODIUM BENZOATE:DENTAL:GEL:%	DENTAL	0.08% DENTAL GEL	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
OJ245FE5EU	SODIUM BENZOATE:DENTAL:PASTE:%	DENTAL	0.08% DENTAL PASTE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
OJ245FE5EU	SODIUM BENZOATE:IM - IV:INJECTION:%	IM - IV	10% IM - IV INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
OJ245FE5EU	SODIUM BENZOATE:INTRAMUSCULAR:INJECTION:%	INTRAMUSCULAR	5% INTRAMUSCULAR INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
OJ245FE5EU	SODIUM BENZOATE:INTRAMUSCULAR:SOLUTION, INJECTION:%W/V	INTRAMUSCULAR	4.8%W/V INTRAMUSCULAR SOLUTION, INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
OJ245FE5EU	SODIUM BENZOATE:INTRAVENOUS:EMULSION, INJECTION:%	INTRAVENOUS	0.1% INTRAVENOUS EMULSION, INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
OJ245FE5EU	SODIUM BENZOATE:INTRAVENOUS:INJECTABLE:%	INTRAVENOUS	0.07% INTRAVENOUS INJECTABLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
OJ245FE5EU	SODIUM BENZOATE:IV(INFUSION):INJECTION:%	IV(INFUSION)	5% IV(INFUSION) INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
OJ245FE5EU	SODIUM BENZOATE:ORAL:CAPSULE:MG	ORAL	0.3MG ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
OJ245FE5EU	SODIUM BENZOATE:ORAL:CAPSULE, HARD GELATIN:MG	ORAL	0.11MG ORAL CAPSULE, HARD GELATIN	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
OJ245FE5EU	SODIUM BENZOATE:ORAL:CONCENTRATE:MG/1ML	ORAL	2MG/1ML ORAL CONCENTRATE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
OJ245FE5EU	SODIUM BENZOATE:ORAL:DROPS:MG/1ML	ORAL	3MG/1ML ORAL DROPS	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
OJ245FE5EU	SODIUM BENZOATE:ORAL:EMULSION:NA	ORAL	ORAL EMULSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
OJ245FE5EU	SODIUM BENZOATE:ORAL:FOR SUSPENSION:MG/5ML	ORAL	10MG/5ML ORAL FOR SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
OJ245FE5EU	SODIUM BENZOATE:ORAL:GRANULE, FOR RECONSTITUTION:MG	ORAL	10MG ORAL GRANULE, FOR RECONSTITUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
OJ245FE5EU	SODIUM BENZOATE:ORAL:GRANULE, FOR SUSPENSION:MG	ORAL	10MG ORAL GRANULE, FOR SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
OJ245FE5EU	SODIUM BENZOATE:ORAL:LIQUID:mg/10mL	ORAL	10.13mg/10mL ORAL LIQUID	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
OJ245FE5EU	SODIUM BENZOATE:ORAL:LIQUID:MG/1ML	ORAL	1MG/1ML ORAL LIQUID	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
OJ245FE5EU	SODIUM BENZOATE:ORAL:ORAL SOLUTION DOSAGE FORM:mg/5mL	ORAL	2.5mg/5mL ORAL ORAL SOLUTION DOSAGE FORM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
OJ245FE5EU	SODIUM BENZOATE:ORAL:POWDER:MG	ORAL	0.01MG ORAL POWDER	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
OJ245FE5EU	SODIUM BENZOATE:ORAL:POWDER, FOR ORAL SOLUTION:MG	ORAL	98MG ORAL POWDER, FOR ORAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
OJ245FE5EU	SODIUM BENZOATE:ORAL:POWDER, FOR ORAL SUSPENSION:MG/5ML	ORAL	20MG/5ML ORAL POWDER, FOR ORAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
OJ245FE5EU	SODIUM BENZOATE:ORAL:POWDER, FOR RECONSTITUTION:MG/5ML	ORAL	5MG/5ML ORAL POWDER, FOR RECONSTITUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
OJ245FE5EU	SODIUM BENZOATE:ORAL:POWDER, FOR SOLUTION:MG/5ML	ORAL	93.32MG/5ML ORAL POWDER, FOR SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
OJ245FE5EU	SODIUM BENZOATE:ORAL:POWDER, FOR SUSPENSION:MG/1ML	ORAL	20MG/1ML ORAL POWDER, FOR SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
OJ245FE5EU	SODIUM BENZOATE:ORAL:SOLUTION:MG/160ML	ORAL	90MG/160ML ORAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
OJ245FE5EU	SODIUM BENZOATE:ORAL:SOLUTION:MG/5ML	ORAL	15MG/5ML ORAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
OJ245FE5EU	SODIUM BENZOATE:ORAL:SOLUTION, ELIXIR:MG/5ML	ORAL	5.02MG/5ML ORAL SOLUTION, ELIXIR	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
OJ245FE5EU	SODIUM BENZOATE:ORAL:SOLUTION, LIQUID:MG/1ML	ORAL	1MG/1ML ORAL SOLUTION, LIQUID	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
OJ245FE5EU	SODIUM BENZOATE:ORAL:SOLUTION, SYRUP:MG/5ML	ORAL	5MG/5ML ORAL SOLUTION, SYRUP	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
OJ245FE5EU	SODIUM BENZOATE:ORAL:SUSPENSION:MG/5ML	ORAL	10MG/5ML ORAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
OJ245FE5EU	SODIUM BENZOATE:ORAL:SUSPENSION, DROPS:MG/1ML	ORAL	2.5MG/1ML ORAL SUSPENSION, DROPS	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
OJ245FE5EU	SODIUM BENZOATE:ORAL:SUSPENSION, EXTENDED RELEASE:MG/ML	ORAL	2MG/ML ORAL SUSPENSION, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
OJ245FE5EU	SODIUM BENZOATE:ORAL:SUSPENSION, LIQUID:MG/5ML	ORAL	10MG/5ML ORAL SUSPENSION, LIQUID	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
OJ245FE5EU	SODIUM BENZOATE:ORAL:SUSPENSION, SYRUP, SUSTAINED ACTION:%	ORAL	0.05% ORAL SUSPENSION, SYRUP, SUSTAINED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
OJ245FE5EU	SODIUM BENZOATE:ORAL:SYRUP:MG/1ML	ORAL	10MG/1ML ORAL SYRUP	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
OJ245FE5EU	SODIUM BENZOATE:ORAL:TABLET:MG	ORAL	5MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
OJ245FE5EU	SODIUM BENZOATE:ORAL:TABLET (IMMED./COMP. RELEASE), UNCOATED, EFFERVESCENT:MG	ORAL	60MG ORAL TABLET (IMMED./COMP. RELEASE), UNCOATED, EFFERVESCENT	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
OJ245FE5EU	SODIUM BENZOATE:ORAL:TABLET, COATED:MG	ORAL	9MG ORAL TABLET, COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
OJ245FE5EU	SODIUM BENZOATE:ORAL:TABLET, DELAYED ACTION, ENTERIC COATED:MG	ORAL	0.34MG ORAL TABLET, DELAYED ACTION, ENTERIC COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
OJ245FE5EU	SODIUM BENZOATE:ORAL:TABLET, FILM COATED:MG	ORAL	0.02MG ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
OJ245FE5EU	SODIUM BENZOATE:ORAL:TABLET, SUSTAINED ACTION:NA	ORAL	ORAL TABLET, SUSTAINED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
OJ245FE5EU	SODIUM BENZOATE:RECTAL:ENEMA:%	RECTAL	0.1% RECTAL ENEMA	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
OJ245FE5EU	SODIUM BENZOATE:RECTAL:GEL:%	RECTAL	2.54% RECTAL GEL	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
OJ245FE5EU	SODIUM BENZOATE:RECTAL:SUPPOSITORY:NA	RECTAL	RECTAL SUPPOSITORY	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
OJ245FE5EU	SODIUM BENZOATE:TOPICAL:EMULSION:NA	TOPICAL	TOPICAL EMULSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
OJ245FE5EU	SODIUM BENZOATE:TOPICAL:EMULSION, CREAM:%W/W	TOPICAL	0.2%W/W TOPICAL EMULSION, CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
OJ245FE5EU	SODIUM BENZOATE:TOPICAL:GEL:%W/W	TOPICAL	0.24%W/W TOPICAL GEL	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
OJ245FE5EU	SODIUM BENZOATE:TOPICAL:PATCH:NA	TOPICAL	TOPICAL PATCH	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
OJ245FE5EU	SODIUM BENZOATE:TOPICAL:SOLUTION:%W/V	TOPICAL	0.1%W/V TOPICAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
OJ245FE5EU	SODIUM BENZOATE:TOPICAL:SPONGE:NA	TOPICAL	TOPICAL SPONGE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
2968PHW8QP	ANHYDROUS CITRIC ACID:NASAL:SPRAY:MG/INH	NASAL	2.6MG/INH NASAL SPRAY	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
2968PHW8QP	CITRIC ACID MONOHYDRATE:AN,CNBLK INTRATHECAL:INJECTION:%	AN,CNBLK INTRATHECAL	0.02% AN,CNBLK INTRATHECAL INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
2968PHW8QP	CITRIC ACID MONOHYDRATE:AN,INFILTRATION:INJECTION:%	AN,INFILTRATION	0.16% AN,INFILTRATION INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
2968PHW8QP	CITRIC ACID MONOHYDRATE:AURICULAR (OTIC):SOLUTION:%	AURICULAR (OTIC)	1% AURICULAR (OTIC) SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
2968PHW8QP	CITRIC ACID MONOHYDRATE:AURICULAR (OTIC):SOLUTION, DROPS:%	AURICULAR (OTIC)	0.04% AURICULAR (OTIC) SOLUTION, DROPS	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
2968PHW8QP	CITRIC ACID MONOHYDRATE:BUCCAL:FILM, SOLUBLE:MG	BUCCAL	0.69MG BUCCAL FILM, SOLUBLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
2968PHW8QP	CITRIC ACID MONOHYDRATE:BUCCAL:TABLET:MG	BUCCAL	30MG BUCCAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
2968PHW8QP	CITRIC ACID MONOHYDRATE:CAUDAL BLOCK:INJECTION:%	CAUDAL BLOCK	20% CAUDAL BLOCK INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
2968PHW8QP	CITRIC ACID MONOHYDRATE:EPIDURAL:INJECTION:%	EPIDURAL	0.02% EPIDURAL INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
2968PHW8QP	CITRIC ACID MONOHYDRATE:IM - IV:INJECTABLE:%	IM - IV	0.05% IM - IV INJECTABLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
2968PHW8QP	CITRIC ACID MONOHYDRATE:IM - IV:INJECTION:%	IM - IV	0.36% IM - IV INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
2968PHW8QP	CITRIC ACID MONOHYDRATE:IM - IV:SOLUTION:%	IM - IV	0.05% IM - IV SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
2968PHW8QP	CITRIC ACID MONOHYDRATE:IM - IV:SOLUTION, INJECTION:%	IM - IV	0.088% IM - IV SOLUTION, INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
2968PHW8QP	CITRIC ACID MONOHYDRATE:IM - IV - SC:INJECTABLE:%	IM - IV - SC	0.2% IM - IV - SC INJECTABLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
2968PHW8QP	CITRIC ACID MONOHYDRATE:IM - IV - SC:INJECTION:%	IM - IV - SC	1.26% IM - IV - SC INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
2968PHW8QP	CITRIC ACID MONOHYDRATE:IM - IV - SC:SOLUTION, INJECTION:MG/1ML	IM - IV - SC	2.2MG/1ML IM - IV - SC SOLUTION, INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
2968PHW8QP	CITRIC ACID MONOHYDRATE:IM - SC:INJECTION:%	IM - SC	0.22% IM - SC INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
2968PHW8QP	CITRIC ACID MONOHYDRATE:INFILTRATION:INJECTION:%	INFILTRATION	0.02% INFILTRATION INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
2968PHW8QP	CITRIC ACID MONOHYDRATE:INHALATION:AEROSOL, METERED:MG/INH	INHALATION	0.002MG/INH INHALATION AEROSOL, METERED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
2968PHW8QP	CITRIC ACID MONOHYDRATE:INHALATION:INHALANT:NA	INHALATION	INHALATION INHALANT	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
2968PHW8QP	CITRIC ACID MONOHYDRATE:INHALATION:SOLUTION:MG/1ML	INHALATION	4.2MG/1ML INHALATION SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
2968PHW8QP	CITRIC ACID MONOHYDRATE:INHALATION:SOLUTION:MG/INH	INHALATION	4.04MG/INH INHALATION SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
2968PHW8QP	CITRIC ACID MONOHYDRATE:INHALATION:SUSPENSION, FOR INHALATION:%	INHALATION	0.028% INHALATION SUSPENSION, FOR INHALATION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
2968PHW8QP	CITRIC ACID MONOHYDRATE:INTRA-AMNIOTIC:INJECTION:%	INTRA-AMNIOTIC	0.1% INTRA-AMNIOTIC INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
2968PHW8QP	CITRIC ACID MONOHYDRATE:INTRA-ARTERIAL:SOLUTION, INJECTION:%	INTRA-ARTERIAL	0.05% INTRA-ARTERIAL SOLUTION, INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
2968PHW8QP	CITRIC ACID MONOHYDRATE:INTRA-ARTICULAR:INJECTION:ADJ PH	INTRA-ARTICULAR	ADJ PH INTRA-ARTICULAR INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
2968PHW8QP	CITRIC ACID MONOHYDRATE:INTRA-ARTICULAR:INJECTION, SOLUTION:ADJ PH	INTRA-ARTICULAR	ADJ PH INTRA-ARTICULAR INJECTION, SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
2968PHW8QP	CITRIC ACID MONOHYDRATE:INTRABURSAL:INJECTION:%	INTRABURSAL	0.21% INTRABURSAL INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
2968PHW8QP	CITRIC ACID MONOHYDRATE:INTRACARDIAC:INJECTION:mg/1mL	INTRACARDIAC	2.5mg/1mL INTRACARDIAC INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
2968PHW8QP	CITRIC ACID MONOHYDRATE:INTRALESIONAL:INJECTION:ADJ PH	INTRALESIONAL	ADJ PH INTRALESIONAL INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
2968PHW8QP	CITRIC ACID MONOHYDRATE:INTRAMUSCULAR:INJECTABLE:%W/V	INTRAMUSCULAR	0.5%W/V INTRAMUSCULAR INJECTABLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
2968PHW8QP	CITRIC ACID MONOHYDRATE:INTRAMUSCULAR:INJECTION:mg/1mL	INTRAMUSCULAR	4.67mg/1mL INTRAMUSCULAR INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
2968PHW8QP	CITRIC ACID MONOHYDRATE:INTRAMUSCULAR:INJECTION:%	INTRAMUSCULAR	2% INTRAMUSCULAR INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
2968PHW8QP	CITRIC ACID MONOHYDRATE:INTRAMUSCULAR:INJECTION, SOLUTION:%W/V	INTRAMUSCULAR	0.05%W/V INTRAMUSCULAR INJECTION, SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
2968PHW8QP	CITRIC ACID MONOHYDRATE:INTRAMUSCULAR:POWDER, FOR INJECTION SOLUTION:%	INTRAMUSCULAR	0.03% INTRAMUSCULAR POWDER, FOR INJECTION SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
2968PHW8QP	CITRIC ACID MONOHYDRATE:INTRAMUSCULAR:SOLUTION, INJECTION:%W/V	INTRAMUSCULAR	0.02%W/V INTRAMUSCULAR SOLUTION, INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
2968PHW8QP	CITRIC ACID MONOHYDRATE:INTRAMUSCULAR:SUSPENSION, EXTENDED RELEASE:%	INTRAMUSCULAR	0.75% INTRAMUSCULAR SUSPENSION, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
2968PHW8QP	CITRIC ACID MONOHYDRATE:INTRAMUSCULAR:SUSPENSION, INJECTION:%	INTRAMUSCULAR	0.75% INTRAMUSCULAR SUSPENSION, INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
2968PHW8QP	CITRIC ACID MONOHYDRATE:INTRAOCULAR:INJECTION, SOLUTION, CONCENTRATE:%	INTRAOCULAR	0.025% INTRAOCULAR INJECTION, SOLUTION, CONCENTRATE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
2968PHW8QP	CITRIC ACID MONOHYDRATE:INTRAOCULAR:SOLUTION:%	INTRAOCULAR	0.05% INTRAOCULAR SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
2968PHW8QP	CITRIC ACID MONOHYDRATE:INTRAPLEURAL:INJECTION:ADJ PH	INTRAPLEURAL	ADJ PH INTRAPLEURAL INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
2968PHW8QP	CITRIC ACID MONOHYDRATE:INTRAPLEURAL:POWDER, FOR INJECTION SOLUTION:%	INTRAPLEURAL	0.03% INTRAPLEURAL POWDER, FOR INJECTION SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
2968PHW8QP	CITRIC ACID MONOHYDRATE:INTRASYNOVIAL:INJECTION:ADJ PH	INTRASYNOVIAL	ADJ PH INTRASYNOVIAL INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
2968PHW8QP	CITRIC ACID MONOHYDRATE:INTRATHECAL:INJECTION:ADJ PH	INTRATHECAL	ADJ PH INTRATHECAL INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
2968PHW8QP	CITRIC ACID MONOHYDRATE:INTRATHECAL:POWDER, FOR INJECTION SOLUTION:%	INTRATHECAL	0.03% INTRATHECAL POWDER, FOR INJECTION SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
2968PHW8QP	CITRIC ACID MONOHYDRATE:INTRAVASCULAR:SOLUTION, INJECTION:%	INTRAVASCULAR	0.05% INTRAVASCULAR SOLUTION, INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
2968PHW8QP	CITRIC ACID MONOHYDRATE:INTRAVENOUS:INJECTABLE:%	INTRAVENOUS	38.46% INTRAVENOUS INJECTABLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
2968PHW8QP	CITRIC ACID MONOHYDRATE:INTRAVENOUS:INJECTION:%	INTRAVENOUS	1% INTRAVENOUS INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
2968PHW8QP	CITRIC ACID MONOHYDRATE:INTRAVENOUS:INJECTION, SOLUTION:%	INTRAVENOUS	0.05% INTRAVENOUS INJECTION, SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
2968PHW8QP	CITRIC ACID MONOHYDRATE:INTRAVENOUS:LIQUID:%	INTRAVENOUS	0.2% INTRAVENOUS LIQUID	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
2968PHW8QP	CITRIC ACID MONOHYDRATE:INTRAVENOUS:LIQUID, CONCENTRATE, INJECTION:%	INTRAVENOUS	0.053% INTRAVENOUS LIQUID, CONCENTRATE, INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
2968PHW8QP	CITRIC ACID MONOHYDRATE:INTRAVENOUS:POWDER, FOR INJECTION SOLUTION:%	INTRAVENOUS	50% INTRAVENOUS POWDER, FOR INJECTION SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
2968PHW8QP	CITRIC ACID MONOHYDRATE:INTRAVENOUS:POWDER, FOR INJECTION SOLUTION, LYOPHILIZED:mg	INTRAVENOUS	384.6mg INTRAVENOUS POWDER, FOR INJECTION SOLUTION, LYOPHILIZED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
2968PHW8QP	CITRIC ACID MONOHYDRATE:INTRAVENOUS:SOLUTION:%	INTRAVENOUS	0.5% INTRAVENOUS SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
2968PHW8QP	CITRIC ACID MONOHYDRATE:INTRAVENOUS:SOLUTION, CONCENTRATE:%	INTRAVENOUS	0.003% INTRAVENOUS SOLUTION, CONCENTRATE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
2968PHW8QP	CITRIC ACID MONOHYDRATE:INTRAVENOUS:SOLUTION, INJECTION:%	INTRAVENOUS	0.53% INTRAVENOUS SOLUTION, INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
2968PHW8QP	CITRIC ACID MONOHYDRATE:INTRAVENOUS INFUSION:INJECTION:mg/1mL	INTRAVENOUS INFUSION	1mg/1mL INTRAVENOUS INFUSION INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
2968PHW8QP	CITRIC ACID MONOHYDRATE:IONTOPHORESIS:DRUG DELIVERY SYSTEM:MG/PATCH	IONTOPHORESIS	1.4MG/PATCH IONTOPHORESIS DRUG DELIVERY SYSTEM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
2968PHW8QP	CITRIC ACID MONOHYDRATE:IONTOPHORESIS:PATCH, CONTROLLED RELEASE:MG/PATCH	IONTOPHORESIS	0.2MG/PATCH IONTOPHORESIS PATCH, CONTROLLED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
2968PHW8QP	CITRIC ACID MONOHYDRATE:IONTOPHORESIS:SOLUTION:%	IONTOPHORESIS	0.02% IONTOPHORESIS SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
2968PHW8QP	CITRIC ACID MONOHYDRATE:IRRIGATION:INJECTION, SOLUTION, CONCENTRATE:%	IRRIGATION	0.025% IRRIGATION INJECTION, SOLUTION, CONCENTRATE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
2968PHW8QP	CITRIC ACID MONOHYDRATE:IV(INFUSION):INJECTION:%	IV(INFUSION)	1.05% IV(INFUSION) INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
2968PHW8QP	CITRIC ACID MONOHYDRATE:IV(INFUSION):LIQUID:%	IV(INFUSION)	0.2% IV(INFUSION) LIQUID	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
2968PHW8QP	CITRIC ACID MONOHYDRATE:IV(INFUSION):POWDER, FOR INJECTION SOLUTION:%	IV(INFUSION)	6.92% IV(INFUSION) POWDER, FOR INJECTION SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
2968PHW8QP	CITRIC ACID MONOHYDRATE:IV(INFUSION):POWDER, FOR INJECTION SOLUTION, LYOPHILIZED:ADJ PH	IV(INFUSION)	ADJ PH IV(INFUSION) POWDER, FOR INJECTION SOLUTION, LYOPHILIZED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
2968PHW8QP	CITRIC ACID MONOHYDRATE:IV(INFUSION):SOLUTION, CONCENTRATE:ADJ PH	IV(INFUSION)	ADJ PH IV(INFUSION) SOLUTION, CONCENTRATE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
2968PHW8QP	CITRIC ACID MONOHYDRATE:IV(INFUSION):SOLUTION, INJECTION:%	IV(INFUSION)	0.38% IV(INFUSION) SOLUTION, INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
2968PHW8QP	CITRIC ACID MONOHYDRATE:NASAL:GEL:NA	NASAL	NASAL GEL	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
2968PHW8QP	CITRIC ACID MONOHYDRATE:NASAL:SOLUTION:%	NASAL	0.28% NASAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
2968PHW8QP	CITRIC ACID MONOHYDRATE:NASAL:SOLUTION, SPRAY, METERED, PUMP:%	NASAL	0.006% NASAL SOLUTION, SPRAY, METERED, PUMP	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
2968PHW8QP	CITRIC ACID MONOHYDRATE:NASAL:SPRAY:%W/W	NASAL	0.2%W/W NASAL SPRAY	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
2968PHW8QP	CITRIC ACID MONOHYDRATE:NASAL:SPRAY, METERED:MG/INH	NASAL	35MG/INH NASAL SPRAY, METERED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
2968PHW8QP	CITRIC ACID MONOHYDRATE:NASAL:SPRAY, METERED:%	NASAL	0.42% NASAL SPRAY, METERED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
2968PHW8QP	CITRIC ACID MONOHYDRATE:NERVE BLOCK:INJECTION:%	NERVE BLOCK	0.16% NERVE BLOCK INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
2968PHW8QP	CITRIC ACID MONOHYDRATE:OPHTHALMIC:SOLUTION:%	OPHTHALMIC	0.2% OPHTHALMIC SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
2968PHW8QP	CITRIC ACID MONOHYDRATE:OPHTHALMIC:SOLUTION, DROPS:%	OPHTHALMIC	0.05% OPHTHALMIC SOLUTION, DROPS	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
2968PHW8QP	CITRIC ACID MONOHYDRATE:OPHTHALMIC:SUSPENSION:ADJ PH	OPHTHALMIC	ADJ PH OPHTHALMIC SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
2968PHW8QP	CITRIC ACID MONOHYDRATE:ORAL:BAR, CHEWABLE:MG	ORAL	500MG ORAL BAR, CHEWABLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
2968PHW8QP	CITRIC ACID MONOHYDRATE:ORAL:CAPSULE:MG	ORAL	119MG ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
2968PHW8QP	CITRIC ACID MONOHYDRATE:ORAL:CAPSULE, EXTENDED RELEASE:MG	ORAL	18.8MG ORAL CAPSULE, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
2968PHW8QP	CITRIC ACID MONOHYDRATE:ORAL:CAPSULE, SOFT GELATIN:MG	ORAL	1MG ORAL CAPSULE, SOFT GELATIN	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
2968PHW8QP	CITRIC ACID MONOHYDRATE:ORAL:CAPSULE, SUSTAINED ACTION, HARD GELATIN:MG	ORAL	18.8MG ORAL CAPSULE, SUSTAINED ACTION, HARD GELATIN	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
2968PHW8QP	CITRIC ACID MONOHYDRATE:ORAL:CONCENTRATE:MG/1ML	ORAL	7MG/1ML ORAL CONCENTRATE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
2968PHW8QP	CITRIC ACID MONOHYDRATE:ORAL:DROPS:MG/1ML	ORAL	1.8MG/1ML ORAL DROPS	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
2968PHW8QP	CITRIC ACID MONOHYDRATE:ORAL:EMULSION:NA	ORAL	ORAL EMULSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
2968PHW8QP	CITRIC ACID MONOHYDRATE:ORAL:FOR SUSPENSION:MG/5ML	ORAL	5MG/5ML ORAL FOR SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
2968PHW8QP	CITRIC ACID MONOHYDRATE:ORAL:GRANULE:MG	ORAL	6.25MG ORAL GRANULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
2968PHW8QP	CITRIC ACID MONOHYDRATE:ORAL:GRANULE, FOR ORAL SUSPENSION:MG	ORAL	4.9MG ORAL GRANULE, FOR ORAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
2968PHW8QP	CITRIC ACID MONOHYDRATE:ORAL:GRANULE, FOR RECONSTITUTION:MG	ORAL	6MG ORAL GRANULE, FOR RECONSTITUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
2968PHW8QP	CITRIC ACID MONOHYDRATE:ORAL:GRANULE, FOR SUSPENSION:MG/5ML	ORAL	14.1MG/5ML ORAL GRANULE, FOR SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
2968PHW8QP	CITRIC ACID MONOHYDRATE:ORAL:GRANULE, FOR SUSPENSION:MG	ORAL	9.1MG ORAL GRANULE, FOR SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
2968PHW8QP	CITRIC ACID MONOHYDRATE:ORAL:LIQUID:MG/1ML	ORAL	13.5MG/1ML ORAL LIQUID	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
2968PHW8QP	CITRIC ACID MONOHYDRATE:ORAL:PELLET:MG	ORAL	4.9MG ORAL PELLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
2968PHW8QP	CITRIC ACID MONOHYDRATE:ORAL:POWDER:MG/1PKT	ORAL	95MG/1PKT ORAL POWDER	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
2968PHW8QP	CITRIC ACID MONOHYDRATE:ORAL:POWDER:MG/1SCP	ORAL	95MG/1SCP ORAL POWDER	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
2968PHW8QP	CITRIC ACID MONOHYDRATE:ORAL:POWDER, FOR ORAL SOLUTION:MG	ORAL	315MG ORAL POWDER, FOR ORAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
2968PHW8QP	CITRIC ACID MONOHYDRATE:ORAL:POWDER, FOR ORAL SOLUTION:G/16 OZ	ORAL	1.74G/16 OZ ORAL POWDER, FOR ORAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
2968PHW8QP	CITRIC ACID MONOHYDRATE:ORAL:POWDER, FOR ORAL SUSPENSION:MG/1PKT	ORAL	81MG/1PKT ORAL POWDER, FOR ORAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
2968PHW8QP	CITRIC ACID MONOHYDRATE:ORAL:POWDER, FOR ORAL SUSPENSION:MG/1SCP	ORAL	81MG/1SCP ORAL POWDER, FOR ORAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
2968PHW8QP	CITRIC ACID MONOHYDRATE:ORAL:POWDER, FOR RECONSTITUTION:MG/5ML	ORAL	2.5MG/5ML ORAL POWDER, FOR RECONSTITUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
2968PHW8QP	CITRIC ACID MONOHYDRATE:ORAL:POWDER, FOR SOLUTION:MG/PKT	ORAL	120MG/PKT ORAL POWDER, FOR SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
2968PHW8QP	CITRIC ACID MONOHYDRATE:ORAL:POWDER, FOR SUSPENSION:MG/1ML	ORAL	140MG/1ML ORAL POWDER, FOR SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
2968PHW8QP	CITRIC ACID MONOHYDRATE:ORAL:SOLUTION:mg	ORAL	53.1mg ORAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
2968PHW8QP	CITRIC ACID MONOHYDRATE:ORAL:SOLUTION:MG/1ML	ORAL	7MG/1ML ORAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
2968PHW8QP	CITRIC ACID MONOHYDRATE:ORAL:SOLUTION:ADJ PH	ORAL	ADJ PH ORAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
2968PHW8QP	CITRIC ACID MONOHYDRATE:ORAL:SOLUTION, ELIXIR:MG/5ML	ORAL	100MG/5ML ORAL SOLUTION, ELIXIR	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
2968PHW8QP	CITRIC ACID MONOHYDRATE:ORAL:SOLUTION, LIQUID:MG/1ML	ORAL	7MG/1ML ORAL SOLUTION, LIQUID	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
2968PHW8QP	CITRIC ACID MONOHYDRATE:ORAL:SOLUTION, SYRUP:MG	ORAL	22.15MG ORAL SOLUTION, SYRUP	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
2968PHW8QP	CITRIC ACID MONOHYDRATE:ORAL:SPRAY:MG/1SPR	ORAL	10.24MG/1SPR ORAL SPRAY	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
2968PHW8QP	CITRIC ACID MONOHYDRATE:ORAL:SUSPENSION:mg/1mL	ORAL	5.14mg/1mL ORAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
2968PHW8QP	CITRIC ACID MONOHYDRATE:ORAL:SUSPENSION, DROPS:MG/2.5ML	ORAL	6MG/2.5ML ORAL SUSPENSION, DROPS	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
2968PHW8QP	CITRIC ACID MONOHYDRATE:ORAL:SUSPENSION, FOR INHALATION:MG/2ML	ORAL	0.612MG/2ML ORAL SUSPENSION, FOR INHALATION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
2968PHW8QP	CITRIC ACID MONOHYDRATE:ORAL:SUSPENSION, LIQUID:MG/1ML	ORAL	8.98MG/1ML ORAL SUSPENSION, LIQUID	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
2968PHW8QP	CITRIC ACID MONOHYDRATE:ORAL:SUSPENSION, SUSTAINED ACTION:MG/1PKT	ORAL	140.8MG/1PKT ORAL SUSPENSION, SUSTAINED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
2968PHW8QP	CITRIC ACID MONOHYDRATE:ORAL:SUSPENSION, SUSTAINED ACTION:MG/5ML	ORAL	5MG/5ML ORAL SUSPENSION, SUSTAINED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
2968PHW8QP	CITRIC ACID MONOHYDRATE:ORAL:SUSPENSION, SYRUP, SUSTAINED ACTION:MG/5ML	ORAL	60MG/5ML ORAL SUSPENSION, SYRUP, SUSTAINED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
2968PHW8QP	CITRIC ACID MONOHYDRATE:ORAL:SYRUP:MG/5ML	ORAL	60MG/5ML ORAL SYRUP	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
2968PHW8QP	CITRIC ACID MONOHYDRATE:ORAL:TABLET:MG	ORAL	78MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
2968PHW8QP	CITRIC ACID MONOHYDRATE:ORAL:TABLET (IMMED./COMP. RELEASE), FILM COATED:MG	ORAL	2.56MG ORAL TABLET (IMMED./COMP. RELEASE), FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
2968PHW8QP	CITRIC ACID MONOHYDRATE:ORAL:TABLET (IMMED./COMP. RELEASE), UNCOATED, CHEWABLE:MG	ORAL	4.26MG ORAL TABLET (IMMED./COMP. RELEASE), UNCOATED, CHEWABLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
2968PHW8QP	CITRIC ACID MONOHYDRATE:ORAL:TABLET, CHEWABLE:MG	ORAL	1.2MG ORAL TABLET, CHEWABLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
2968PHW8QP	CITRIC ACID MONOHYDRATE:ORAL:TABLET, COATED:NA	ORAL	ORAL TABLET, COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
2968PHW8QP	CITRIC ACID MONOHYDRATE:ORAL:TABLET, DELAYED ACTION, ENTERIC COATED:MG	ORAL	1MG ORAL TABLET, DELAYED ACTION, ENTERIC COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
2968PHW8QP	CITRIC ACID MONOHYDRATE:ORAL:TABLET, EXTENDED RELEASE:MG	ORAL	24MG ORAL TABLET, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
2968PHW8QP	CITRIC ACID MONOHYDRATE:ORAL:TABLET, FILM COATED:MG	ORAL	42MG ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
2968PHW8QP	CITRIC ACID MONOHYDRATE:ORAL:TABLET, ORALLY DISINTEGRATING:MG	ORAL	63MG ORAL TABLET, ORALLY DISINTEGRATING	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
2968PHW8QP	CITRIC ACID MONOHYDRATE:ORAL:TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE:MG	ORAL	3.08MG ORAL TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
2968PHW8QP	CITRIC ACID MONOHYDRATE:ORAL:TABLET, SUSTAINED ACTION, FILM COATED:MG	ORAL	40MG ORAL TABLET, SUSTAINED ACTION, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
2968PHW8QP	CITRIC ACID MONOHYDRATE:ORAL:TABLET, UNCOATED, LOZENGE:MG	ORAL	9.8MG ORAL TABLET, UNCOATED, LOZENGE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
2968PHW8QP	CITRIC ACID MONOHYDRATE:ORAL:TABLET, UNCOATED, TROCHE:MG	ORAL	12MG ORAL TABLET, UNCOATED, TROCHE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
2968PHW8QP	CITRIC ACID MONOHYDRATE:PARENTERAL:INJECTION:%	PARENTERAL	0.05% PARENTERAL INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
2968PHW8QP	CITRIC ACID MONOHYDRATE:PERIDURAL:INJECTION:NA	PERIDURAL	PERIDURAL INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
2968PHW8QP	CITRIC ACID MONOHYDRATE:RECTAL:EMULSION, AEROSOL FOAM:%	RECTAL	0.29% RECTAL EMULSION, AEROSOL FOAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
2968PHW8QP	CITRIC ACID MONOHYDRATE:RESPIRATORY (INHALATION):SUSPENSION, FOR INHALATION:%W/V	RESPIRATORY (INHALATION)	0.85%W/V RESPIRATORY (INHALATION) SUSPENSION, FOR INHALATION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
2968PHW8QP	CITRIC ACID MONOHYDRATE:SOFT TISSUE:INJECTION:ADJ PH	SOFT TISSUE	ADJ PH SOFT TISSUE INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
2968PHW8QP	CITRIC ACID MONOHYDRATE:SUBCUTANEOUS:INJECTION:mg/1mL	SUBCUTANEOUS	2.5mg/1mL SUBCUTANEOUS INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
2968PHW8QP	CITRIC ACID MONOHYDRATE:SUBLINGUAL:TABLET:MG	SUBLINGUAL	12MG SUBLINGUAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
2968PHW8QP	CITRIC ACID MONOHYDRATE:TOPICAL:AEROSOL:%W/W	TOPICAL	0.11%W/W TOPICAL AEROSOL	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
2968PHW8QP	CITRIC ACID MONOHYDRATE:TOPICAL:AEROSOL, FOAM:%W/W	TOPICAL	0.1%W/W TOPICAL AEROSOL, FOAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
2968PHW8QP	CITRIC ACID MONOHYDRATE:TOPICAL:CREAM:%W/W	TOPICAL	0.055%W/W TOPICAL CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
2968PHW8QP	CITRIC ACID MONOHYDRATE:TOPICAL:CREAM, AUGMENTED:%W/W	TOPICAL	0.05%W/W TOPICAL CREAM, AUGMENTED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
2968PHW8QP	CITRIC ACID MONOHYDRATE:TOPICAL:CREAM, EMULSION, SUSTAINED RELEASE:%W/W	TOPICAL	0.1%W/W TOPICAL CREAM, EMULSION, SUSTAINED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
2968PHW8QP	CITRIC ACID MONOHYDRATE:TOPICAL:EMULSION:%W/W	TOPICAL	0.11%W/W TOPICAL EMULSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
2968PHW8QP	CITRIC ACID MONOHYDRATE:TOPICAL:EMULSION, AEROSOL FOAM:%W/W	TOPICAL	0.11%W/W TOPICAL EMULSION, AEROSOL FOAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
2968PHW8QP	CITRIC ACID MONOHYDRATE:TOPICAL:EMULSION, CREAM:%W/W	TOPICAL	0.44%W/W TOPICAL EMULSION, CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
2968PHW8QP	CITRIC ACID MONOHYDRATE:TOPICAL:EMULSION, LOTION:%W/W	TOPICAL	0.05%W/W TOPICAL EMULSION, LOTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
2968PHW8QP	CITRIC ACID MONOHYDRATE:TOPICAL:GEL:%W/W	TOPICAL	0.56%W/W TOPICAL GEL	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
2968PHW8QP	CITRIC ACID MONOHYDRATE:TOPICAL:LIQUID:NA	TOPICAL	TOPICAL LIQUID	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
2968PHW8QP	CITRIC ACID MONOHYDRATE:TOPICAL:LOTION:%W/W	TOPICAL	0.85%W/W TOPICAL LOTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
2968PHW8QP	CITRIC ACID MONOHYDRATE:TOPICAL:OINTMENT:%W/W	TOPICAL	0.012%W/W TOPICAL OINTMENT	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
2968PHW8QP	CITRIC ACID MONOHYDRATE:TOPICAL:PATCH, CONTROLLED RELEASE:MG/PATCH	TOPICAL	0.2MG/PATCH TOPICAL PATCH, CONTROLLED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
2968PHW8QP	CITRIC ACID MONOHYDRATE:TOPICAL:POWDER, FOR SOLUTION:NA	TOPICAL	TOPICAL POWDER, FOR SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
2968PHW8QP	CITRIC ACID MONOHYDRATE:TOPICAL:SHAMPOO:%W/W	TOPICAL	2.3%W/W TOPICAL SHAMPOO	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
2968PHW8QP	CITRIC ACID MONOHYDRATE:TOPICAL:SHAMPOO, SUSPENSION:%W/V	TOPICAL	0.25%W/V TOPICAL SHAMPOO, SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
2968PHW8QP	CITRIC ACID MONOHYDRATE:TOPICAL:SOLUTION:%W/W	TOPICAL	0.19%W/W TOPICAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
2968PHW8QP	CITRIC ACID MONOHYDRATE:TOPICAL:SOLUTION:%V/V	TOPICAL	0.01%V/V TOPICAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
2968PHW8QP	CITRIC ACID MONOHYDRATE:TOPICAL:SOLUTION, DROPS:%W/V	TOPICAL	0.014%W/V TOPICAL SOLUTION, DROPS	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
2968PHW8QP	CITRIC ACID MONOHYDRATE:TOPICAL:SWAB:NA	TOPICAL	TOPICAL SWAB	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
2968PHW8QP	CITRIC ACID MONOHYDRATE:TRANSDERMAL:DRUG DELIVERY SYSTEM:MG/PATCH	TRANSDERMAL	1.4MG/PATCH TRANSDERMAL DRUG DELIVERY SYSTEM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
2968PHW8QP	CITRIC ACID MONOHYDRATE:TRANSDERMAL:FILM, EXTENDED RELEASE:mg	TRANSDERMAL	1.38mg TRANSDERMAL FILM, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
2968PHW8QP	CITRIC ACID MONOHYDRATE:VAGINAL:EMULSION, CREAM:%	VAGINAL	0.49% VAGINAL EMULSION, CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
2968PHW8QP	CITRIC ACID MONOHYDRATE:VAGINAL:SPONGE:MG	VAGINAL	7.5MG VAGINAL SPONGE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
47MLB0F1MV	ETHYLCELLULOSE (100 MPA.S):ORAL:TABLET, EXTENDED RELEASE:MG	ORAL	176MG ORAL TABLET, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
274KW0O50M	SUCROSE STEARATE:ORAL:CAPSULE, EXTENDED RELEASE:MG	ORAL	31.84MG ORAL CAPSULE, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
274KW0O50M	SUCROSE STEARATE:ORAL:CAPSULE, SUSTAINED ACTION:MG	ORAL	44.57MG ORAL CAPSULE, SUSTAINED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
274KW0O50M	SUCROSE STEARATE:ORAL:TABLET, EXTENDED RELEASE:MG	ORAL	44.56MG ORAL TABLET, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
274KW0O50M	SUCROSE STEARATE:ORAL:TABLET, FILM COATED:MG	ORAL	10.89MG ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
274KW0O50M	SUCROSE STEARATE:TOPICAL:CREAM:%W/W	TOPICAL	5%W/W TOPICAL CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
9G5L16BK6N	CORN SYRUP:ORAL:SOLUTION:MG/5ML	ORAL	750MG/5ML ORAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
9G5L16BK6N	CORN SYRUP:ORAL:SOLUTION, ELIXIR:%	ORAL	30.4% ORAL SOLUTION, ELIXIR	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
9G5L16BK6N	CORN SYRUP:ORAL:SUSPENSION:%	ORAL	34.2% ORAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
9G5L16BK6N	CORN SYRUP:ORAL:SUSPENSION, LIQUID:MG/5ML	ORAL	2500MG/5ML ORAL SUSPENSION, LIQUID	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
9G5L16BK6N	CORN SYRUP:ORAL:SUSPENSION, SUSTAINED ACTION:MG/5ML	ORAL	1500MG/5ML ORAL SUSPENSION, SUSTAINED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
9G5L16BK6N	CORN SYRUP:ORAL:SYRUP:%	ORAL	65.78% ORAL SYRUP	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
9G5L16BK6N	CORN SYRUP:ORAL:TABLET:MG	ORAL	14.07MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
9G5L16BK6N	CORN SYRUP:ORAL:TABLET, UNCOATED, TROCHE:NA	ORAL	ORAL TABLET, UNCOATED, TROCHE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
8470G57WFM	CORN OIL:INTRAMUSCULAR:INJECTION:NA	INTRAMUSCULAR	INTRAMUSCULAR INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
8470G57WFM	CORN OIL:ORAL:CAPSULE:MG	ORAL	918MG ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
8470G57WFM	CORN OIL:ORAL:CAPSULE, SOFT GELATIN:MG	ORAL	416MG ORAL CAPSULE, SOFT GELATIN	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
8470G57WFM	CORN OIL:ORAL:EMULSION:NA	ORAL	ORAL EMULSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
8470G57WFM	CORN OIL:ORAL:SOLUTION:NA	ORAL	ORAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
8470G57WFM	CORN OIL:ORAL:SUSPENSION:%	ORAL	50% ORAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
8470G57WFM	CORN OIL:ORAL:SUSPENSION:MG/15ML	ORAL	33MG/15ML ORAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
8470G57WFM	CORN OIL:ORAL:SUSPENSION, EXTENDED RELEASE:MG/5ML	ORAL	2.56MG/5ML ORAL SUSPENSION, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
8470G57WFM	CORN OIL:ORAL:TABLET:MG	ORAL	20MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
8470G57WFM	CORN OIL:ORAL:TABLET (IMMED./COMP. RELEASE), UNCOATED, CHEWABLE:NA	ORAL	ORAL TABLET (IMMED./COMP. RELEASE), UNCOATED, CHEWABLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
8470G57WFM	CORN OIL:ORAL:TABLET, COATED:MG	ORAL	10MG ORAL TABLET, COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
8470G57WFM	CORN OIL:ORAL:TABLET, DELAYED ACTION, ENTERIC COATED:MG	ORAL	0.03MG ORAL TABLET, DELAYED ACTION, ENTERIC COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
8470G57WFM	CORN OIL:SUBLINGUAL:TABLET:MG	SUBLINGUAL	1.7MG SUBLINGUAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
VTK01UQK3G	SODIUM SULFITE:AURICULAR (OTIC):SOLUTION:%	AURICULAR (OTIC)	0.02% AURICULAR (OTIC) SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
VTK01UQK3G	SODIUM SULFITE:EPIDURAL:INJECTION:%	EPIDURAL	0.1% EPIDURAL INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
VTK01UQK3G	SODIUM SULFITE:IM - IV:INJECTION:%	IM - IV	0.2% IM - IV INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
VTK01UQK3G	SODIUM SULFITE:INHALATION:SOLUTION:%	INHALATION	0.1% INHALATION SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
VTK01UQK3G	SODIUM SULFITE:INTRA-ARTICULAR:INJECTION:%W/V	INTRA-ARTICULAR	0.1%W/V INTRA-ARTICULAR INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
VTK01UQK3G	SODIUM SULFITE:INTRA-ARTICULAR:INJECTION, SOLUTION:mg/1mL	INTRA-ARTICULAR	1mg/1mL INTRA-ARTICULAR INJECTION, SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
VTK01UQK3G	SODIUM SULFITE:INTRALESIONAL:INJECTION:%W/V	INTRALESIONAL	0.1%W/V INTRALESIONAL INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
VTK01UQK3G	SODIUM SULFITE:INTRAMUSCULAR:INJECTION:%W/V	INTRAMUSCULAR	0.1%W/V INTRAMUSCULAR INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
VTK01UQK3G	SODIUM SULFITE:INTRAMUSCULAR:INJECTION, SOLUTION:mg/1mL	INTRAMUSCULAR	1mg/1mL INTRAMUSCULAR INJECTION, SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
VTK01UQK3G	SODIUM SULFITE:INTRAVENOUS:INJECTION:%	INTRAVENOUS	0.2% INTRAVENOUS INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
VTK01UQK3G	SODIUM SULFITE:INTRAVENOUS:INJECTION, SOLUTION:mg/1mL	INTRAVENOUS	1mg/1mL INTRAVENOUS INJECTION, SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
VTK01UQK3G	SODIUM SULFITE:IV(INFUSION):INJECTION:NA	IV(INFUSION)	IV(INFUSION) INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
VTK01UQK3G	SODIUM SULFITE:OPHTHALMIC:SOLUTION:%	OPHTHALMIC	0.2% OPHTHALMIC SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
VTK01UQK3G	SODIUM SULFITE:OPHTHALMIC:SOLUTION, DROPS:%	OPHTHALMIC	0.2% OPHTHALMIC SOLUTION, DROPS	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
VTK01UQK3G	SODIUM SULFITE:ORAL:CONCENTRATE:MG/1ML	ORAL	0.3MG/1ML ORAL CONCENTRATE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
VTK01UQK3G	SODIUM SULFITE:ORAL:SUSPENSION:NA	ORAL	ORAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
VTK01UQK3G	SODIUM SULFITE:ORAL:SYRUP:NA	ORAL	ORAL SYRUP	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
VTK01UQK3G	SODIUM SULFITE:SOFT TISSUE:INJECTION:%W/V	SOFT TISSUE	0.1%W/V SOFT TISSUE INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
VTK01UQK3G	SODIUM SULFITE:SUBCUTANEOUS:INJECTION:%	SUBCUTANEOUS	0.15% SUBCUTANEOUS INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
VTK01UQK3G	SODIUM SULFITE:TOPICAL:EMULSION, CREAM:%W/W	TOPICAL	0.2%W/W TOPICAL EMULSION, CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
H92E6QA4FV	ZINC STEARATE:ORAL:CAPSULE:MG	ORAL	2.04MG ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=Z
H92E6QA4FV	ZINC STEARATE:ORAL:SYRUP:NA	ORAL	ORAL SYRUP	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=Z
H92E6QA4FV	ZINC STEARATE:ORAL:TABLET:MG	ORAL	10.2MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=Z
H92E6QA4FV	ZINC STEARATE:ORAL:TABLET, EXTENDED RELEASE:MG	ORAL	15MG ORAL TABLET, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=Z
H92E6QA4FV	ZINC STEARATE:ORAL:TABLET, FILM COATED:MG	ORAL	15.2MG ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=Z
H92E6QA4FV	ZINC STEARATE:ORAL:TABLET, SUSTAINED ACTION:MG	ORAL	36MG ORAL TABLET, SUSTAINED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=Z
H92E6QA4FV	ZINC STEARATE:TOPICAL:EMULSION, CREAM:%W/W	TOPICAL	6%W/W TOPICAL EMULSION, CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=Z
799C8VF17R	ALBUMIN AGGREGATED:INTRAVENOUS:INJECTION:%	INTRAVENOUS	0.15% INTRAVENOUS INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
06XEA2VD56	SORBITAN MONOOLEATE:ORAL:CAPSULE:MG	ORAL	40MG ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
06XEA2VD56	SORBITAN MONOOLEATE:ORAL:CAPSULE, SOFT GELATIN:MG	ORAL	153.9MG ORAL CAPSULE, SOFT GELATIN	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
06XEA2VD56	SORBITAN MONOOLEATE:ORAL:CAPSULE, SOFT GELATIN LIQUID-FILLED:MG	ORAL	10MG ORAL CAPSULE, SOFT GELATIN LIQUID-FILLED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
06XEA2VD56	SORBITAN MONOOLEATE:ORAL:CAPSULE, SUSTAINED ACTION:MG	ORAL	1.7MG ORAL CAPSULE, SUSTAINED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
06XEA2VD56	SORBITAN MONOOLEATE:ORAL:EMULSION:NA	ORAL	ORAL EMULSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
06XEA2VD56	SORBITAN MONOOLEATE:ORAL:SOLUTION:MG/1ML	ORAL	150MG/1ML ORAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
06XEA2VD56	SORBITAN MONOOLEATE:ORAL:SUSPENSION:NA	ORAL	ORAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
06XEA2VD56	SORBITAN MONOOLEATE:ORAL:TABLET:MG	ORAL	1.7MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
06XEA2VD56	SORBITAN MONOOLEATE:ORAL:TABLET, COATED:MG	ORAL	0.13MG ORAL TABLET, COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
06XEA2VD56	SORBITAN MONOOLEATE:ORAL:TABLET, DELAYED ACTION, ENTERIC COATED:MG	ORAL	1.89MG ORAL TABLET, DELAYED ACTION, ENTERIC COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
06XEA2VD56	SORBITAN MONOOLEATE:ORAL:TABLET, FILM COATED:MG	ORAL	0.69MG ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
06XEA2VD56	SORBITAN MONOOLEATE:ORAL:TABLET, SUSTAINED ACTION:MG	ORAL	7.8MG ORAL TABLET, SUSTAINED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
06XEA2VD56	SORBITAN MONOOLEATE:ORAL:TABLET, SUSTAINED ACTION, FILM COATED:MG	ORAL	1MG ORAL TABLET, SUSTAINED ACTION, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
06XEA2VD56	SORBITAN MONOOLEATE:RECTAL:SUPPOSITORY:MG	RECTAL	22MG RECTAL SUPPOSITORY	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
06XEA2VD56	SORBITAN MONOOLEATE:TOPICAL:CREAM:%W/W	TOPICAL	0.4%W/W TOPICAL CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
06XEA2VD56	SORBITAN MONOOLEATE:TOPICAL:CREAM, AUGMENTED:%W/V	TOPICAL	0.2%W/V TOPICAL CREAM, AUGMENTED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
06XEA2VD56	SORBITAN MONOOLEATE:TOPICAL:CREAM, EMULSION, SUSTAINED RELEASE:%W/W	TOPICAL	3.5%W/W TOPICAL CREAM, EMULSION, SUSTAINED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
06XEA2VD56	SORBITAN MONOOLEATE:TOPICAL:EMULSION:%W/W	TOPICAL	2.5%W/W TOPICAL EMULSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
06XEA2VD56	SORBITAN MONOOLEATE:TOPICAL:EMULSION, CREAM:%W/W	TOPICAL	3.5%W/W TOPICAL EMULSION, CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
06XEA2VD56	SORBITAN MONOOLEATE:TOPICAL:GEL:%W/W	TOPICAL	0.2%W/W TOPICAL GEL	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
06XEA2VD56	SORBITAN MONOOLEATE:TOPICAL:LOTION:%W/W	TOPICAL	7%W/W TOPICAL LOTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
06XEA2VD56	SORBITAN MONOOLEATE:TOPICAL:OINTMENT:NA	TOPICAL	TOPICAL OINTMENT	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
06XEA2VD56	SORBITAN MONOOLEATE:TOPICAL:SPRAY:%W/W	TOPICAL	0.25%W/W TOPICAL SPRAY	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
06XEA2VD56	SORBITAN MONOOLEATE:TRANSDERMAL:FILM, CONTROLLED RELEASE:NA	TRANSDERMAL	TRANSDERMAL FILM, CONTROLLED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
8M4L3H2ZVZ	SODIUM NITRATE:OPHTHALMIC:SOLUTION:%	OPHTHALMIC	1.18% OPHTHALMIC SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
8M4L3H2ZVZ	SODIUM NITRATE:ORAL:SYRUP:NA	ORAL	ORAL SYRUP	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
XHX3C3X673	TRIACETIN:ENDOCERVICAL:GEL:NA	ENDOCERVICAL	ENDOCERVICAL GEL	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
XHX3C3X673	TRIACETIN:ORAL:CAPSULE:MG	ORAL	6.42MG ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
XHX3C3X673	TRIACETIN:ORAL:CAPSULE, COATED PELLETS:MG	ORAL	1.21MG ORAL CAPSULE, COATED PELLETS	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
XHX3C3X673	TRIACETIN:ORAL:CAPSULE, ENTERIC COATED PELLETS:MG	ORAL	5.1MG ORAL CAPSULE, ENTERIC COATED PELLETS	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
XHX3C3X673	TRIACETIN:ORAL:CAPSULE, EXTENDED RELEASE:MG	ORAL	46.7MG ORAL CAPSULE, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
XHX3C3X673	TRIACETIN:ORAL:CAPSULE, SUSTAINED ACTION:MG	ORAL	2.76MG ORAL CAPSULE, SUSTAINED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
XHX3C3X673	TRIACETIN:ORAL:CONCENTRATE:MG/1ML	ORAL	50MG/1ML ORAL CONCENTRATE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
XHX3C3X673	TRIACETIN:ORAL:POWDER, FOR ORAL SUSPENSION:MG/5ML	ORAL	1.02MG/5ML ORAL POWDER, FOR ORAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
XHX3C3X673	TRIACETIN:ORAL:SUSPENSION:MG/1ML	ORAL	0.32MG/1ML ORAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
XHX3C3X673	TRIACETIN:ORAL:SUSPENSION, EXTENDED RELEASE:MG/5ML	ORAL	1.18MG/5ML ORAL SUSPENSION, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
XHX3C3X673	TRIACETIN:ORAL:TABLET:MG	ORAL	6MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
XHX3C3X673	TRIACETIN:ORAL:TABLET (IMMED./COMP. RELEASE), FILM COATED:MG	ORAL	0.72MG ORAL TABLET (IMMED./COMP. RELEASE), FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
XHX3C3X673	TRIACETIN:ORAL:TABLET, CHEWABLE:MG	ORAL	1.36MG ORAL TABLET, CHEWABLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
XHX3C3X673	TRIACETIN:ORAL:TABLET, COATED:MG	ORAL	1MG ORAL TABLET, COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
XHX3C3X673	TRIACETIN:ORAL:TABLET, DELAYED ACTION, ENTERIC COATED:MG	ORAL	6MG ORAL TABLET, DELAYED ACTION, ENTERIC COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
XHX3C3X673	TRIACETIN:ORAL:TABLET, DELAYED RELEASE:mg	ORAL	1.82mg ORAL TABLET, DELAYED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
XHX3C3X673	TRIACETIN:ORAL:TABLET, EXTENDED RELEASE:MG	ORAL	8MG ORAL TABLET, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
XHX3C3X673	TRIACETIN:ORAL:TABLET, FILM COATED:MG	ORAL	15.12MG ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
XHX3C3X673	TRIACETIN:ORAL:TABLET, SUSTAINED ACTION:MG	ORAL	1.96MG ORAL TABLET, SUSTAINED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
XHX3C3X673	TRIACETIN:TRANSDERMAL:PATCH:MG	TRANSDERMAL	22.1MG TRANSDERMAL PATCH	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
XHX3C3X673	TRIACETIN:TRANSDERMAL:PATCH, CONTROLLED RELEASE:MG	TRANSDERMAL	22.1MG TRANSDERMAL PATCH, CONTROLLED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
XM0M87F357	FERROSOFERRIC OXIDE:ORAL:CAPSULE:MG	ORAL	0.96MG ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
XM0M87F357	FERROSOFERRIC OXIDE:ORAL:CAPSULE (IMMED./COMP. RELEASE):MG	ORAL	0.17MG ORAL CAPSULE (IMMED./COMP. RELEASE)	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
XM0M87F357	FERROSOFERRIC OXIDE:ORAL:CAPSULE (IMMED./COMP. RELEASE), SOFT GELATIN:MG	ORAL	0.93MG ORAL CAPSULE (IMMED./COMP. RELEASE), SOFT GELATIN	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
XM0M87F357	FERROSOFERRIC OXIDE:ORAL:CAPSULE, COATED:MG	ORAL	0.058MG ORAL CAPSULE, COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
XM0M87F357	FERROSOFERRIC OXIDE:ORAL:CAPSULE, COATED, SOFT GELATIN:MG	ORAL	0.015MG ORAL CAPSULE, COATED, SOFT GELATIN	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
XM0M87F357	FERROSOFERRIC OXIDE:ORAL:CAPSULE, DELAYED ACTION:MG	ORAL	0.89MG ORAL CAPSULE, DELAYED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
XM0M87F357	FERROSOFERRIC OXIDE:ORAL:CAPSULE, DELAYED RELEASE:MG	ORAL	0.89MG ORAL CAPSULE, DELAYED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
XM0M87F357	FERROSOFERRIC OXIDE:ORAL:CAPSULE, ENTERIC COATED PELLETS:MG	ORAL	0.86MG ORAL CAPSULE, ENTERIC COATED PELLETS	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
XM0M87F357	FERROSOFERRIC OXIDE:ORAL:CAPSULE, EXTENDED RELEASE:MG	ORAL	0.19MG ORAL CAPSULE, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
XM0M87F357	FERROSOFERRIC OXIDE:ORAL:CAPSULE, FILM COATED, EXTENDED RELEASE:MG	ORAL	0.0093MG ORAL CAPSULE, FILM COATED, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
XM0M87F357	FERROSOFERRIC OXIDE:ORAL:CAPSULE, HARD GELATIN:MG	ORAL	0.02MG ORAL CAPSULE, HARD GELATIN	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
XM0M87F357	FERROSOFERRIC OXIDE:ORAL:CAPSULE, SOFT GELATIN:MG	ORAL	0.3MG ORAL CAPSULE, SOFT GELATIN	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
XM0M87F357	FERROSOFERRIC OXIDE:ORAL:CAPSULE, SUSTAINED ACTION:MG	ORAL	1.49MG ORAL CAPSULE, SUSTAINED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
XM0M87F357	FERROSOFERRIC OXIDE:ORAL:POWDER, FOR SUSPENSION:NA	ORAL	ORAL POWDER, FOR SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
XM0M87F357	FERROSOFERRIC OXIDE:ORAL:TABLET:mg	ORAL	0.3mg ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
XM0M87F357	FERROSOFERRIC OXIDE:ORAL:TABLET (IMMED./COMP. RELEASE), FILM COATED:MG	ORAL	0.024MG ORAL TABLET (IMMED./COMP. RELEASE), FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
XM0M87F357	FERROSOFERRIC OXIDE:ORAL:TABLET, COATED:NA	ORAL	ORAL TABLET, COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
XM0M87F357	FERROSOFERRIC OXIDE:ORAL:TABLET, CONTROLLED RELEASE:MG	ORAL	0.32MG ORAL TABLET, CONTROLLED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
XM0M87F357	FERROSOFERRIC OXIDE:ORAL:TABLET, DELAYED ACTION:MG	ORAL	0.12MG ORAL TABLET, DELAYED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
XM0M87F357	FERROSOFERRIC OXIDE:ORAL:TABLET, DELAYED ACTION, ENTERIC COATED:NA	ORAL	ORAL TABLET, DELAYED ACTION, ENTERIC COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
XM0M87F357	FERROSOFERRIC OXIDE:ORAL:TABLET, EXTENDED RELEASE:MG	ORAL	4MG ORAL TABLET, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
XM0M87F357	FERROSOFERRIC OXIDE:ORAL:TABLET, FILM COATED:MG	ORAL	0.2MG ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
XM0M87F357	FERROSOFERRIC OXIDE:ORAL:TABLET, FILM COATED, EXTENDED RELEASE:MG	ORAL	0.11MG ORAL TABLET, FILM COATED, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
XM0M87F357	FERROSOFERRIC OXIDE:ORAL:TABLET, SUSTAINED ACTION:MG	ORAL	0.62MG ORAL TABLET, SUSTAINED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
XM0M87F357	FERROSOFERRIC OXIDE:ORAL:TABLET, SUSTAINED ACTION, COATED:MG	ORAL	1.23MG ORAL TABLET, SUSTAINED ACTION, COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
XM0M87F357	FERROSOFERRIC OXIDE:ORAL:TABLET, SUSTAINED ACTION, FILM COATED:MG	ORAL	0.002MG ORAL TABLET, SUSTAINED ACTION, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
86Q357L16B	ZINC CHLORIDE:IM - SC:INJECTION:NA	IM - SC	IM - SC INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=Z
86Q357L16B	ZINC CHLORIDE:INTRADERMAL:INJECTION:%	INTRADERMAL	0.7% INTRADERMAL INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=Z
86Q357L16B	ZINC CHLORIDE:OPHTHALMIC:SOLUTION:%W/V	OPHTHALMIC	0.003%W/V OPHTHALMIC SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=Z
86Q357L16B	ZINC CHLORIDE:OPHTHALMIC:SOLUTION, DROPS:%W/V	OPHTHALMIC	0.003%W/V OPHTHALMIC SOLUTION, DROPS	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=Z
86Q357L16B	ZINC CHLORIDE:ORAL:TABLET:MG	ORAL	7MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=Z
86Q357L16B	ZINC CHLORIDE:SUBCUTANEOUS:INJECTABLE:%	SUBCUTANEOUS	0.006% SUBCUTANEOUS INJECTABLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=Z
86Q357L16B	ZINC CHLORIDE:SUBCUTANEOUS:INJECTION:%	SUBCUTANEOUS	0.015% SUBCUTANEOUS INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=Z
86Q357L16B	ZINC CHLORIDE:SUBCUTANEOUS:INJECTION, SOLUTION:%	SUBCUTANEOUS	0.019% SUBCUTANEOUS INJECTION, SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=Z
75E63I9H07	SODIUM BITARTRATE:ORAL:TABLET, SUSTAINED ACTION:MG	ORAL	306MG ORAL TABLET, SUSTAINED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
OJ4Z5Z32L4	POLYETHYLENE GLYCOL 1450:ORAL:CAPSULE, EXTENDED RELEASE:MG	ORAL	17MG ORAL CAPSULE, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
OJ4Z5Z32L4	POLYETHYLENE GLYCOL 1450:ORAL:SOLUTION:MG/5ML	ORAL	1160MG/5ML ORAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
OJ4Z5Z32L4	POLYETHYLENE GLYCOL 1450:ORAL:SUSPENSION:NA	ORAL	ORAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
OJ4Z5Z32L4	POLYETHYLENE GLYCOL 1450:ORAL:TABLET, EXTENDED RELEASE:mg	ORAL	4.7mg ORAL TABLET, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
OJ4Z5Z32L4	POLYETHYLENE GLYCOL 1450:ORAL:TABLET, FILM COATED:MG	ORAL	0.13MG ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
OJ4Z5Z32L4	POLYETHYLENE GLYCOL 1450:TOPICAL:OINTMENT:%W/W	TOPICAL	43%W/W TOPICAL OINTMENT	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
OJ4Z5Z32L4	POLYETHYLENE GLYCOL 1450:URETHRAL:SUPPOSITORY:MG	URETHRAL	9.75MG URETHRAL SUPPOSITORY	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
39J80LT57T	HYPROMELLOSE 2208 (4000 MPA.S):ORAL:CAPSULE, EXTENDED RELEASE:MG	ORAL	2.4MG ORAL CAPSULE, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
39J80LT57T	HYPROMELLOSE 2208 (4000 MPA.S):ORAL:SUSPENSION:MG/5ML	ORAL	15MG/5ML ORAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
39J80LT57T	HYPROMELLOSE 2208 (4000 MPA.S):ORAL:TABLET, EXTENDED RELEASE:MG	ORAL	297MG ORAL TABLET, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
39J80LT57T	HYPROMELLOSE 2208 (4000 MPA.S):ORAL:TABLET, FILM COATED:MG	ORAL	40MG ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
39J80LT57T	HYPROMELLOSE 2208 (4000 MPA.S):ORAL:TABLET, FILM COATED, EXTENDED RELEASE:MG	ORAL	48MG ORAL TABLET, FILM COATED, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
39J80LT57T	HYPROMELLOSE 2208 (4000 MPA.S):TOPICAL:LOTION:%W/W 	TOPICAL	0.1%W/W  TOPICAL LOTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
39J80LT57T	HYPROMELLOSE 2208 (4000 MPA.S):VAGINAL:CREAM:%W/W	VAGINAL	0.3%W/W VAGINAL CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
39J80LT57T	HYPROMELLOSE 2208 (4000 MPA.S):VAGINAL:EMULSION, CREAM:%	VAGINAL	0.3% VAGINAL EMULSION, CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
B22547B95K	TRISODIUM CITRATE DIHYDRATE:IM - IV:INJECTABLE:%	IM - IV	0.025% IM - IV INJECTABLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
B22547B95K	TRISODIUM CITRATE DIHYDRATE:IM - IV:INJECTION:%	IM - IV	2.5% IM - IV INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
B22547B95K	TRISODIUM CITRATE DIHYDRATE:IM - IV:SOLUTION:%	IM - IV	0.025% IM - IV SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
B22547B95K	TRISODIUM CITRATE DIHYDRATE:IM - IV - SC:INJECTION:%	IM - IV - SC	0.21% IM - IV - SC INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
B22547B95K	TRISODIUM CITRATE DIHYDRATE:IM - IV - SC:SOLUTION, INJECTION:MG/1ML	IM - IV - SC	2.3MG/1ML IM - IV - SC SOLUTION, INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
B22547B95K	TRISODIUM CITRATE DIHYDRATE:IM - SC:INJECTION:%	IM - SC	0.2% IM - SC INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
B22547B95K	TRISODIUM CITRATE DIHYDRATE:INHALATION:SOLUTION:mg/3 mL	INHALATION	6.2mg/3 mL INHALATION SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
B22547B95K	TRISODIUM CITRATE DIHYDRATE:INHALATION:SOLUTION:MG/INH	INHALATION	0.86MG/INH INHALATION SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
B22547B95K	TRISODIUM CITRATE DIHYDRATE:INHALATION:SOLUTION:MG/ML	INHALATION	0.5MG/ML INHALATION SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
B22547B95K	TRISODIUM CITRATE DIHYDRATE:INHALATION:SUSPENSION, FOR INHALATION:%	INHALATION	0.005% INHALATION SUSPENSION, FOR INHALATION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
B22547B95K	TRISODIUM CITRATE DIHYDRATE:INTRA-ARTICULAR:INJECTION, SOLUTION:mg/1mL	INTRA-ARTICULAR	11mg/1mL INTRA-ARTICULAR INJECTION, SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
B22547B95K	TRISODIUM CITRATE DIHYDRATE:INTRACARDIAC:INJECTION:mg/5mL	INTRACARDIAC	10.35mg/5mL INTRACARDIAC INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
B22547B95K	TRISODIUM CITRATE DIHYDRATE:INTRAMUSCULAR:INJECTABLE:%	INTRAMUSCULAR	4% INTRAMUSCULAR INJECTABLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
B22547B95K	TRISODIUM CITRATE DIHYDRATE:INTRAMUSCULAR:INJECTION:%	INTRAMUSCULAR	2.88% INTRAMUSCULAR INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
B22547B95K	TRISODIUM CITRATE DIHYDRATE:INTRAMUSCULAR:INJECTION, SOLUTION:%W/V	INTRAMUSCULAR	2.48%W/V INTRAMUSCULAR INJECTION, SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
B22547B95K	TRISODIUM CITRATE DIHYDRATE:INTRAMUSCULAR:SOLUTION, INJECTION:%W/V	INTRAMUSCULAR	2.5%W/V INTRAMUSCULAR SOLUTION, INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
B22547B95K	TRISODIUM CITRATE DIHYDRATE:INTRAOCULAR:INJECTION, SOLUTION, CONCENTRATE:%	INTRAOCULAR	0.55% INTRAOCULAR INJECTION, SOLUTION, CONCENTRATE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
B22547B95K	TRISODIUM CITRATE DIHYDRATE:INTRAVENOUS:INJECTABLE:%	INTRAVENOUS	4% INTRAVENOUS INJECTABLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
B22547B95K	TRISODIUM CITRATE DIHYDRATE:INTRAVENOUS:INJECTION:%	INTRAVENOUS	2.88% INTRAVENOUS INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
B22547B95K	TRISODIUM CITRATE DIHYDRATE:INTRAVENOUS:INJECTION, SOLUTION:%	INTRAVENOUS	2.48% INTRAVENOUS INJECTION, SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
B22547B95K	TRISODIUM CITRATE DIHYDRATE:INTRAVENOUS:LIQUID:%	INTRAVENOUS	0.36% INTRAVENOUS LIQUID	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
B22547B95K	TRISODIUM CITRATE DIHYDRATE:INTRAVENOUS:POWDER:%	INTRAVENOUS	2.4% INTRAVENOUS POWDER	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
B22547B95K	TRISODIUM CITRATE DIHYDRATE:INTRAVENOUS:POWDER, FOR INJECTION SOLUTION, LYOPHILIZED:%	INTRAVENOUS	23.52% INTRAVENOUS POWDER, FOR INJECTION SOLUTION, LYOPHILIZED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
B22547B95K	TRISODIUM CITRATE DIHYDRATE:INTRAVENOUS:SOLUTION:%	INTRAVENOUS	0.37% INTRAVENOUS SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
B22547B95K	TRISODIUM CITRATE DIHYDRATE:INTRAVENOUS:SOLUTION, INJECTION:%	INTRAVENOUS	2.5% INTRAVENOUS SOLUTION, INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
B22547B95K	TRISODIUM CITRATE DIHYDRATE:INTRAVENOUS INFUSION:INJECTION:mg/1mL	INTRAVENOUS INFUSION	4mg/1mL INTRAVENOUS INFUSION INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
B22547B95K	TRISODIUM CITRATE DIHYDRATE:INTRAVITREAL:SUSPENSION, INJECTION:%	INTRAVITREAL	0.17% INTRAVITREAL SUSPENSION, INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
B22547B95K	TRISODIUM CITRATE DIHYDRATE:IRRIGATION:INJECTION, SOLUTION, CONCENTRATE:%	IRRIGATION	0.55% IRRIGATION INJECTION, SOLUTION, CONCENTRATE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
B22547B95K	TRISODIUM CITRATE DIHYDRATE:IV(INFUSION):INJECTABLE:%	IV(INFUSION)	0.48% IV(INFUSION) INJECTABLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
B22547B95K	TRISODIUM CITRATE DIHYDRATE:IV(INFUSION):INJECTION:%	IV(INFUSION)	0.48% IV(INFUSION) INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
B22547B95K	TRISODIUM CITRATE DIHYDRATE:IV(INFUSION):SOLUTION, INJECTION:%	IV(INFUSION)	3.04% IV(INFUSION) SOLUTION, INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
B22547B95K	TRISODIUM CITRATE DIHYDRATE:NASAL:SPRAY:%	NASAL	1.44% NASAL SPRAY	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
B22547B95K	TRISODIUM CITRATE DIHYDRATE:NASAL:SPRAY, METERED:MG/INH	NASAL	680MG/INH NASAL SPRAY, METERED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
B22547B95K	TRISODIUM CITRATE DIHYDRATE:NASAL:SPRAY, METERED:%	NASAL	0.28% NASAL SPRAY, METERED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
B22547B95K	TRISODIUM CITRATE DIHYDRATE:OPHTHALMIC:SOLUTION:%W/W	OPHTHALMIC	0.45%W/W OPHTHALMIC SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
B22547B95K	TRISODIUM CITRATE DIHYDRATE:OPHTHALMIC:SOLUTION, DROPS:%	OPHTHALMIC	0.45% OPHTHALMIC SOLUTION, DROPS	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
B22547B95K	TRISODIUM CITRATE DIHYDRATE:ORAL:CAPSULE:MG	ORAL	17.415MG ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
B22547B95K	TRISODIUM CITRATE DIHYDRATE:ORAL:POWDER, FOR SUSPENSION:MG/140ML	ORAL	1100MG/140ML ORAL POWDER, FOR SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
B22547B95K	TRISODIUM CITRATE DIHYDRATE:ORAL:SOLUTION:MG/5ML	ORAL	28MG/5ML ORAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
B22547B95K	TRISODIUM CITRATE DIHYDRATE:ORAL:SOLUTION:MG/1ML	ORAL	15.75MG/1ML ORAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
B22547B95K	TRISODIUM CITRATE DIHYDRATE:ORAL:SOLUTION:mg/15 mL	ORAL	3.75mg/15 mL ORAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
B22547B95K	TRISODIUM CITRATE DIHYDRATE:ORAL:SOLUTION, ELIXIR:MG/5ML	ORAL	1.5MG/5ML ORAL SOLUTION, ELIXIR	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
B22547B95K	TRISODIUM CITRATE DIHYDRATE:ORAL:SOLUTION, ELIXIR:%W/V	ORAL	0.047%W/V ORAL SOLUTION, ELIXIR	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
B22547B95K	TRISODIUM CITRATE DIHYDRATE:ORAL:SOLUTION, FOR INHALATION:MG/.5ML	ORAL	1MG/.5ML ORAL SOLUTION, FOR INHALATION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
B22547B95K	TRISODIUM CITRATE DIHYDRATE:ORAL:SOLUTION, LIQUID:MG/1ML	ORAL	3.3MG/1ML ORAL SOLUTION, LIQUID	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
B22547B95K	TRISODIUM CITRATE DIHYDRATE:ORAL:SOLUTION, SYRUP:MG/5ML	ORAL	59MG/5ML ORAL SOLUTION, SYRUP	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
B22547B95K	TRISODIUM CITRATE DIHYDRATE:ORAL:SUSPENSION:MG/5ML	ORAL	90MG/5ML ORAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
B22547B95K	TRISODIUM CITRATE DIHYDRATE:ORAL:SUSPENSION, FOR INHALATION:MG/2ML	ORAL	1MG/2ML ORAL SUSPENSION, FOR INHALATION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
B22547B95K	TRISODIUM CITRATE DIHYDRATE:ORAL:SUSPENSION, LIQUID:MG/1ML	ORAL	2.13MG/1ML ORAL SUSPENSION, LIQUID	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
B22547B95K	TRISODIUM CITRATE DIHYDRATE:ORAL:SYRUP:MG/5ML	ORAL	55.24MG/5ML ORAL SYRUP	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
B22547B95K	TRISODIUM CITRATE DIHYDRATE:ORAL:SYRUP:%W/W	ORAL	0.95%W/W ORAL SYRUP	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
B22547B95K	TRISODIUM CITRATE DIHYDRATE:ORAL:TABLET:MG	ORAL	110MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
B22547B95K	TRISODIUM CITRATE DIHYDRATE:ORAL:TABLET, EXTENDED RELEASE:MG	ORAL	101MG ORAL TABLET, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
B22547B95K	TRISODIUM CITRATE DIHYDRATE:PARENTERAL:INJECTION:%	PARENTERAL	0.48% PARENTERAL INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
B22547B95K	TRISODIUM CITRATE DIHYDRATE:RESPIRATORY (INHALATION):INHALANT:%	RESPIRATORY (INHALATION)	0.2% RESPIRATORY (INHALATION) INHALANT	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
B22547B95K	TRISODIUM CITRATE DIHYDRATE:RESPIRATORY (INHALATION):SOLUTION, FOR INHALATION:%	RESPIRATORY (INHALATION)	1.83% RESPIRATORY (INHALATION) SOLUTION, FOR INHALATION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
B22547B95K	TRISODIUM CITRATE DIHYDRATE:RESPIRATORY (INHALATION):SUSPENSION, FOR INHALATION:%	RESPIRATORY (INHALATION)	0.1% RESPIRATORY (INHALATION) SUSPENSION, FOR INHALATION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
B22547B95K	TRISODIUM CITRATE DIHYDRATE:SUBCUTANEOUS:INJECTION:%	SUBCUTANEOUS	0.2% SUBCUTANEOUS INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
B22547B95K	TRISODIUM CITRATE DIHYDRATE:SUBCUTANEOUS:INJECTION, SOLUTION:%	SUBCUTANEOUS	0.2% SUBCUTANEOUS INJECTION, SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
B22547B95K	TRISODIUM CITRATE DIHYDRATE:SUBLINGUAL:FILM:mg	SUBLINGUAL	3.62mg SUBLINGUAL FILM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
B22547B95K	TRISODIUM CITRATE DIHYDRATE:SUBLINGUAL:TABLET:MG	SUBLINGUAL	17MG SUBLINGUAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
B22547B95K	TRISODIUM CITRATE DIHYDRATE:TOPICAL:CLOTH:%W/W	TOPICAL	0.06%W/W TOPICAL CLOTH	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
B22547B95K	TRISODIUM CITRATE DIHYDRATE:TOPICAL:CREAM:%W/W	TOPICAL	0.08%W/W TOPICAL CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
B22547B95K	TRISODIUM CITRATE DIHYDRATE:TOPICAL:EMULSION, CREAM:%W/W	TOPICAL	0.1%W/W TOPICAL EMULSION, CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
B22547B95K	TRISODIUM CITRATE DIHYDRATE:TOPICAL:GEL:%W/W	TOPICAL	0.183%W/W TOPICAL GEL	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
B22547B95K	TRISODIUM CITRATE DIHYDRATE:TOPICAL:LOTION:%W/W	TOPICAL	0.32%W/W TOPICAL LOTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
B22547B95K	TRISODIUM CITRATE DIHYDRATE:TOPICAL:OPHTHALMIC SUSPENSION DOSAGE FORM:%W/V	TOPICAL	0.5%W/V TOPICAL OPHTHALMIC SUSPENSION DOSAGE FORM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
B22547B95K	TRISODIUM CITRATE DIHYDRATE:TOPICAL:SHAMPOO:%W/V	TOPICAL	2.67%W/V TOPICAL SHAMPOO	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
55X04QC32I	SODIUM HYDROXIDE:AN,CNBLK INTRATHECAL:INJECTION:ADJ PH	AN,CNBLK INTRATHECAL	ADJ PH AN,CNBLK INTRATHECAL INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
55X04QC32I	SODIUM HYDROXIDE:AN,INFILTRATION:INJECTABLE:ADJ PH	AN,INFILTRATION	ADJ PH AN,INFILTRATION INJECTABLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
55X04QC32I	SODIUM HYDROXIDE:AN,INFILTRATION:INJECTION:%	AN,INFILTRATION	0.071% AN,INFILTRATION INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
55X04QC32I	SODIUM HYDROXIDE:AN,INFILTRATION:SOLUTION, INJECTION:ADJ PH	AN,INFILTRATION	ADJ PH AN,INFILTRATION SOLUTION, INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
55X04QC32I	SODIUM HYDROXIDE:AN,SYMPATHETIC NBLK:INJECTION:ADJ PH	AN,SYMPATHETIC NBLK	ADJ PH AN,SYMPATHETIC NBLK INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
55X04QC32I	SODIUM HYDROXIDE:AURICULAR (OTIC):SOLUTION:%	AURICULAR (OTIC)	0.8% AURICULAR (OTIC) SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
55X04QC32I	SODIUM HYDROXIDE:AURICULAR (OTIC):SOLUTION, DROPS:ADJ PH	AURICULAR (OTIC)	ADJ PH AURICULAR (OTIC) SOLUTION, DROPS	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
55X04QC32I	SODIUM HYDROXIDE:AURICULAR (OTIC):SUSPENSION:ADJ PH	AURICULAR (OTIC)	ADJ PH AURICULAR (OTIC) SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
55X04QC32I	SODIUM HYDROXIDE:BUCCAL:FILM:MG	BUCCAL	0.09MG BUCCAL FILM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
55X04QC32I	SODIUM HYDROXIDE:BUCCAL:FILM, SOLUBLE:MG	BUCCAL	1.18MG BUCCAL FILM, SOLUBLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
55X04QC32I	SODIUM HYDROXIDE:CAUDAL BLOCK:INJECTABLE:ADJ PH	CAUDAL BLOCK	ADJ PH CAUDAL BLOCK INJECTABLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
55X04QC32I	SODIUM HYDROXIDE:CAUDAL BLOCK:INJECTION:ADJ PH	CAUDAL BLOCK	ADJ PH CAUDAL BLOCK INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
55X04QC32I	SODIUM HYDROXIDE:DENTAL:INJECTABLE:ADJ PH	DENTAL	ADJ PH DENTAL INJECTABLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
55X04QC32I	SODIUM HYDROXIDE:DENTAL:INJECTION:ADJ PH	DENTAL	ADJ PH DENTAL INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
55X04QC32I	SODIUM HYDROXIDE:DENTAL:PASTE:NA	DENTAL	DENTAL PASTE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
55X04QC32I	SODIUM HYDROXIDE:DENTAL:SOLUTION:ADJ PH	DENTAL	ADJ PH DENTAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
55X04QC32I	SODIUM HYDROXIDE:EPIDURAL:INJECTION:ADJ PH	EPIDURAL	ADJ PH EPIDURAL INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
55X04QC32I	SODIUM HYDROXIDE:EPIDURAL:INJECTION, SOLUTION:ADJ PH	EPIDURAL	ADJ PH EPIDURAL INJECTION, SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
55X04QC32I	SODIUM HYDROXIDE:EPIDURAL:LIQUID, WATER, STERILE, FOR INJECTION:ADJ PH	EPIDURAL	ADJ PH EPIDURAL LIQUID, WATER, STERILE, FOR INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
55X04QC32I	SODIUM HYDROXIDE:EPIDURAL:SOLUTION:ADJ PH	EPIDURAL	ADJ PH EPIDURAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
55X04QC32I	SODIUM HYDROXIDE:EPIDURAL:SOLUTION, INJECTION:ADJ PH	EPIDURAL	ADJ PH EPIDURAL SOLUTION, INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
55X04QC32I	SODIUM HYDROXIDE:EXTRACORPOREAL:INJECTION:ADJ PH	EXTRACORPOREAL	ADJ PH EXTRACORPOREAL INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
55X04QC32I	SODIUM HYDROXIDE:EXTRACORPOREAL:SOLUTION:ADJ PH	EXTRACORPOREAL	ADJ PH EXTRACORPOREAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
55X04QC32I	SODIUM HYDROXIDE:IM - IV:INJECTABLE:ADJ PH	IM - IV	ADJ PH IM - IV INJECTABLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
55X04QC32I	SODIUM HYDROXIDE:IM - IV:INJECTION:mg/mL	IM - IV	4.2mg/mL IM - IV INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
55X04QC32I	SODIUM HYDROXIDE:IM - IV:INJECTION, SOLUTION:ADJ PH	IM - IV	ADJ PH IM - IV INJECTION, SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
55X04QC32I	SODIUM HYDROXIDE:IM - IV:LIQUID, WATER, STERILE, FOR INJECTION:ADJ PH	IM - IV	ADJ PH IM - IV LIQUID, WATER, STERILE, FOR INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
55X04QC32I	SODIUM HYDROXIDE:IM - IV:POWDER:ADJ PH	IM - IV	ADJ PH IM - IV POWDER	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
55X04QC32I	SODIUM HYDROXIDE:IM - IV:POWDER, FOR INJECTION SOLUTION:%	IM - IV	0.7% IM - IV POWDER, FOR INJECTION SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
55X04QC32I	SODIUM HYDROXIDE:IM - IV:POWDER, FOR INJECTION SOLUTION, LYOPHILIZED:ADJ PH	IM - IV	ADJ PH IM - IV POWDER, FOR INJECTION SOLUTION, LYOPHILIZED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
55X04QC32I	SODIUM HYDROXIDE:IM - IV:SOLUTION, INJECTION:%	IM - IV	0.13% IM - IV SOLUTION, INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
55X04QC32I	SODIUM HYDROXIDE:IM - IV - SC:INJECTION:ADJ PH	IM - IV - SC	ADJ PH IM - IV - SC INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
55X04QC32I	SODIUM HYDROXIDE:IM - IV - SC:POWDER, FOR INJECTION SOLUTION:ADJ PH	IM - IV - SC	ADJ PH IM - IV - SC POWDER, FOR INJECTION SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
55X04QC32I	SODIUM HYDROXIDE:IM - IV - SC:POWDER, FOR INJECTION SOLUTION, LYOPHILIZED:ADJ PH	IM - IV - SC	ADJ PH IM - IV - SC POWDER, FOR INJECTION SOLUTION, LYOPHILIZED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
55X04QC32I	SODIUM HYDROXIDE:IM - IV - SC:SOLUTION, INJECTION:ADJ PH	IM - IV - SC	ADJ PH IM - IV - SC SOLUTION, INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
55X04QC32I	SODIUM HYDROXIDE:IM - SC:INJECTION:ADJ PH	IM - SC	ADJ PH IM - SC INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
55X04QC32I	SODIUM HYDROXIDE:IM - SC:INJECTION, SUSTAINED ACTION:ADJ PH	IM - SC	ADJ PH IM - SC INJECTION, SUSTAINED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
55X04QC32I	SODIUM HYDROXIDE:IM - SC:POWDER, FOR INJECTION SOLUTION:ADJ PH	IM - SC	ADJ PH IM - SC POWDER, FOR INJECTION SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
55X04QC32I	SODIUM HYDROXIDE:IM, IV:INJECTION:ADJ PH	IM, IV	ADJ PH IM, IV INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
55X04QC32I	SODIUM HYDROXIDE:INFILTRATION:INJECTION:ADJ PH	INFILTRATION	ADJ PH INFILTRATION INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
55X04QC32I	SODIUM HYDROXIDE:INFILTRATION:INJECTION, SOLUTION:ADJ PH	INFILTRATION	ADJ PH INFILTRATION INJECTION, SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
55X04QC32I	SODIUM HYDROXIDE:INFILTRATION:SOLUTION, INJECTION:ADJ PH	INFILTRATION	ADJ PH INFILTRATION SOLUTION, INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
55X04QC32I	SODIUM HYDROXIDE:INHALATION:AEROSOL, METERED:ADJ PH	INHALATION	ADJ PH INHALATION AEROSOL, METERED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
55X04QC32I	SODIUM HYDROXIDE:INHALATION:INHALANT SOLUTION DOSAGE FORM:ADJ PH	INHALATION	ADJ PH INHALATION INHALANT SOLUTION DOSAGE FORM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
55X04QC32I	SODIUM HYDROXIDE:INHALATION:SOLUTION:%	INHALATION	8% INHALATION SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
55X04QC32I	SODIUM HYDROXIDE:INJECTION:INJECTABLE:ADJ PH	INJECTION	ADJ PH INJECTION INJECTABLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
55X04QC32I	SODIUM HYDROXIDE:INJECTION:INJECTION:ADJ PH	INJECTION	ADJ PH INJECTION INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
55X04QC32I	SODIUM HYDROXIDE:INJECTION:INJECTION, SOLUTION:ADJ PH	INJECTION	ADJ PH INJECTION INJECTION, SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
55X04QC32I	SODIUM HYDROXIDE:INTERSTITIAL:INJECTION:ADJ PH	INTERSTITIAL	ADJ PH INTERSTITIAL INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
55X04QC32I	SODIUM HYDROXIDE:INTRA-AMNIOTIC:INJECTION:ADJ PH	INTRA-AMNIOTIC	ADJ PH INTRA-AMNIOTIC INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
55X04QC32I	SODIUM HYDROXIDE:INTRA-ARTERIAL:INJECTABLE:%	INTRA-ARTERIAL	0.44% INTRA-ARTERIAL INJECTABLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
55X04QC32I	SODIUM HYDROXIDE:INTRA-ARTERIAL:INJECTION:%	INTRA-ARTERIAL	17.6% INTRA-ARTERIAL INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
55X04QC32I	SODIUM HYDROXIDE:INTRA-ARTERIAL:INJECTION:mg/mL	INTRA-ARTERIAL	4.2mg/mL INTRA-ARTERIAL INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
55X04QC32I	SODIUM HYDROXIDE:INTRA-ARTERIAL:POWDER, FOR INJECTION SOLUTION:ADJ PH	INTRA-ARTERIAL	ADJ PH INTRA-ARTERIAL POWDER, FOR INJECTION SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
55X04QC32I	SODIUM HYDROXIDE:INTRA-ARTERIAL:POWDER, FOR INJECTION SOLUTION, LYOPHILIZED:ADJ PH	INTRA-ARTERIAL	ADJ PH INTRA-ARTERIAL POWDER, FOR INJECTION SOLUTION, LYOPHILIZED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
55X04QC32I	SODIUM HYDROXIDE:INTRA-ARTERIAL:SOLUTION, INJECTION:ADJ PH	INTRA-ARTERIAL	ADJ PH INTRA-ARTERIAL SOLUTION, INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
55X04QC32I	SODIUM HYDROXIDE:INTRA-ARTERIAL:SUSPENSION, INJECTION:ADJ PH	INTRA-ARTERIAL	ADJ PH INTRA-ARTERIAL SUSPENSION, INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
55X04QC32I	SODIUM HYDROXIDE:INTRA-ARTICULAR:INJECTABLE:ADJ PH	INTRA-ARTICULAR	ADJ PH INTRA-ARTICULAR INJECTABLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
55X04QC32I	SODIUM HYDROXIDE:INTRA-ARTICULAR:INJECTION:ADJ PH	INTRA-ARTICULAR	ADJ PH INTRA-ARTICULAR INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
55X04QC32I	SODIUM HYDROXIDE:INTRA-ARTICULAR:INJECTION, SOLUTION:ADJ PH	INTRA-ARTICULAR	ADJ PH INTRA-ARTICULAR INJECTION, SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
55X04QC32I	SODIUM HYDROXIDE:INTRA-ARTICULAR:INJECTION, SUSTAINED ACTION:ADJ PH	INTRA-ARTICULAR	ADJ PH INTRA-ARTICULAR INJECTION, SUSTAINED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
55X04QC32I	SODIUM HYDROXIDE:INTRABURSAL:INJECTION:ADJ PH	INTRABURSAL	ADJ PH INTRABURSAL INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
55X04QC32I	SODIUM HYDROXIDE:INTRACARDIAC:INJECTION:ADJ PH	INTRACARDIAC	ADJ PH INTRACARDIAC INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
55X04QC32I	SODIUM HYDROXIDE:INTRACAUDAL:INJECTION:ADJ PH	INTRACAUDAL	ADJ PH INTRACAUDAL INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
55X04QC32I	SODIUM HYDROXIDE:INTRACAUDAL:INJECTION, SOLUTION:ADJ PH	INTRACAUDAL	ADJ PH INTRACAUDAL INJECTION, SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
55X04QC32I	SODIUM HYDROXIDE:INTRACAVITARY:INJECTION:ADJ PH	INTRACAVITARY	ADJ PH INTRACAVITARY INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
55X04QC32I	SODIUM HYDROXIDE:INTRACAVITARY:POWDER, FOR INJECTION SOLUTION, LYOPHILIZED:ADJ PH	INTRACAVITARY	ADJ PH INTRACAVITARY POWDER, FOR INJECTION SOLUTION, LYOPHILIZED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
55X04QC32I	SODIUM HYDROXIDE:INTRADERMAL:INJECTION:ADJ PH	INTRADERMAL	ADJ PH INTRADERMAL INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
55X04QC32I	SODIUM HYDROXIDE:INTRADERMAL:INJECTION, SUSTAINED ACTION:ADJ PH	INTRADERMAL	ADJ PH INTRADERMAL INJECTION, SUSTAINED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
55X04QC32I	SODIUM HYDROXIDE:INTRADERMAL:POWDER, FOR INJECTION SOLUTION:ADJ PH	INTRADERMAL	ADJ PH INTRADERMAL POWDER, FOR INJECTION SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
55X04QC32I	SODIUM HYDROXIDE:INTRADISCAL:POWDER, FOR INJECTION SOLUTION:ADJ PH	INTRADISCAL	ADJ PH INTRADISCAL POWDER, FOR INJECTION SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
55X04QC32I	SODIUM HYDROXIDE:INTRALESIONAL:INJECTABLE:ADJ PH	INTRALESIONAL	ADJ PH INTRALESIONAL INJECTABLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
55X04QC32I	SODIUM HYDROXIDE:INTRALESIONAL:INJECTION:ADJ PH	INTRALESIONAL	ADJ PH INTRALESIONAL INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
55X04QC32I	SODIUM HYDROXIDE:INTRALESIONAL:INJECTION, SUSTAINED ACTION:ADJ PH	INTRALESIONAL	ADJ PH INTRALESIONAL INJECTION, SUSTAINED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
55X04QC32I	SODIUM HYDROXIDE:INTRALESIONAL:SUSPENSION, INJECTION:ADJ PH	INTRALESIONAL	ADJ PH INTRALESIONAL SUSPENSION, INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
55X04QC32I	SODIUM HYDROXIDE:INTRAMUSCULAR:INJECTABLE:%W/V	INTRAMUSCULAR	0.44%W/V INTRAMUSCULAR INJECTABLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
55X04QC32I	SODIUM HYDROXIDE:INTRAMUSCULAR:INJECTABLE:ADJ PH	INTRAMUSCULAR	ADJ PH INTRAMUSCULAR INJECTABLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
55X04QC32I	SODIUM HYDROXIDE:INTRAMUSCULAR:INJECTION:%	INTRAMUSCULAR	17.6% INTRAMUSCULAR INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
55X04QC32I	SODIUM HYDROXIDE:INTRAMUSCULAR:INJECTION:mg/mL	INTRAMUSCULAR	4.2mg/mL INTRAMUSCULAR INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
55X04QC32I	SODIUM HYDROXIDE:INTRAMUSCULAR:INJECTION:ADJ PH	INTRAMUSCULAR	ADJ PH INTRAMUSCULAR INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
55X04QC32I	SODIUM HYDROXIDE:INTRAMUSCULAR:INJECTION, SOLUTION:ADJ PH	INTRAMUSCULAR	ADJ PH INTRAMUSCULAR INJECTION, SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
55X04QC32I	SODIUM HYDROXIDE:INTRAMUSCULAR:INJECTION, SUSPENSION:ADJ PH	INTRAMUSCULAR	ADJ PH INTRAMUSCULAR INJECTION, SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
55X04QC32I	SODIUM HYDROXIDE:INTRAMUSCULAR:INJECTION, SUSTAINED ACTION:ADJ PH	INTRAMUSCULAR	ADJ PH INTRAMUSCULAR INJECTION, SUSTAINED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
55X04QC32I	SODIUM HYDROXIDE:INTRAMUSCULAR:LIQUID:ADJ PH	INTRAMUSCULAR	ADJ PH INTRAMUSCULAR LIQUID	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
55X04QC32I	SODIUM HYDROXIDE:INTRAMUSCULAR:POWDER, FOR INJECTION SOLUTION:ADJ PH	INTRAMUSCULAR	ADJ PH INTRAMUSCULAR POWDER, FOR INJECTION SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
55X04QC32I	SODIUM HYDROXIDE:INTRAMUSCULAR:POWDER, FOR INJECTION SOLUTION, LYOPHILIZED:%W/V	INTRAMUSCULAR	0.35%W/V INTRAMUSCULAR POWDER, FOR INJECTION SOLUTION, LYOPHILIZED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
55X04QC32I	SODIUM HYDROXIDE:INTRAMUSCULAR:SOLUTION:ADJ PH	INTRAMUSCULAR	ADJ PH INTRAMUSCULAR SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
55X04QC32I	SODIUM HYDROXIDE:INTRAMUSCULAR:SOLUTION, INJECTION:%W/V	INTRAMUSCULAR	0.1%W/V INTRAMUSCULAR SOLUTION, INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
55X04QC32I	SODIUM HYDROXIDE:INTRAMUSCULAR:SUSPENSION, EXTENDED RELEASE:ADJ PH	INTRAMUSCULAR	ADJ PH INTRAMUSCULAR SUSPENSION, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
55X04QC32I	SODIUM HYDROXIDE:INTRAMUSCULAR:SUSPENSION, INJECTION:%	INTRAMUSCULAR	0.43% INTRAMUSCULAR SUSPENSION, INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
55X04QC32I	SODIUM HYDROXIDE:INTRAOCULAR:SOLUTION:ADJ PH	INTRAOCULAR	ADJ PH INTRAOCULAR SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
55X04QC32I	SODIUM HYDROXIDE:INTRAPERITONEAL:INJECTION:ADJ PH	INTRAPERITONEAL	ADJ PH INTRAPERITONEAL INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
55X04QC32I	SODIUM HYDROXIDE:INTRAPERITONEAL:SOLUTION:ADJ PH	INTRAPERITONEAL	ADJ PH INTRAPERITONEAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
55X04QC32I	SODIUM HYDROXIDE:INTRAPLEURAL:INJECTION:ADJ PH	INTRAPLEURAL	ADJ PH INTRAPLEURAL INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
55X04QC32I	SODIUM HYDROXIDE:INTRASPINAL:INJECTION:ADJ PH	INTRASPINAL	ADJ PH INTRASPINAL INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
55X04QC32I	SODIUM HYDROXIDE:INTRASYNOVIAL:INJECTABLE:ADJ PH	INTRASYNOVIAL	ADJ PH INTRASYNOVIAL INJECTABLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
55X04QC32I	SODIUM HYDROXIDE:INTRASYNOVIAL:INJECTION:ADJ PH	INTRASYNOVIAL	ADJ PH INTRASYNOVIAL INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
55X04QC32I	SODIUM HYDROXIDE:INTRASYNOVIAL:INJECTION, SUSTAINED ACTION:ADJ PH	INTRASYNOVIAL	ADJ PH INTRASYNOVIAL INJECTION, SUSTAINED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
55X04QC32I	SODIUM HYDROXIDE:INTRASYNOVIAL:SUSPENSION, INJECTION:ADJ PH	INTRASYNOVIAL	ADJ PH INTRASYNOVIAL SUSPENSION, INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
55X04QC32I	SODIUM HYDROXIDE:INTRATHECAL:INJECTABLE:%	INTRATHECAL	0.44% INTRATHECAL INJECTABLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
55X04QC32I	SODIUM HYDROXIDE:INTRATHECAL:INJECTION:%	INTRATHECAL	17.6% INTRATHECAL INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
55X04QC32I	SODIUM HYDROXIDE:INTRATHECAL:INJECTION:mg/mL	INTRATHECAL	4.2mg/mL INTRATHECAL INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
55X04QC32I	SODIUM HYDROXIDE:INTRATHECAL:INJECTION, SOLUTION:ADJ PH	INTRATHECAL	ADJ PH INTRATHECAL INJECTION, SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
55X04QC32I	SODIUM HYDROXIDE:INTRATHECAL:POWDER, FOR INJECTION SOLUTION:ADJ PH	INTRATHECAL	ADJ PH INTRATHECAL POWDER, FOR INJECTION SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
55X04QC32I	SODIUM HYDROXIDE:INTRATHECAL:POWDER, FOR INJECTION SOLUTION, LYOPHILIZED:ADJ PH	INTRATHECAL	ADJ PH INTRATHECAL POWDER, FOR INJECTION SOLUTION, LYOPHILIZED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
55X04QC32I	SODIUM HYDROXIDE:INTRATHECAL:SOLUTION:ADJ PH	INTRATHECAL	ADJ PH INTRATHECAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
55X04QC32I	SODIUM HYDROXIDE:INTRATHECAL:SOLUTION, INJECTION:ADJ PH	INTRATHECAL	ADJ PH INTRATHECAL SOLUTION, INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
55X04QC32I	SODIUM HYDROXIDE:INTRATRACHEAL:INJECTION:NA	INTRATRACHEAL	INTRATRACHEAL INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
55X04QC32I	SODIUM HYDROXIDE:INTRATRACHEAL:POWDER, FOR SUSPENSION:ADJ PH	INTRATRACHEAL	ADJ PH INTRATRACHEAL POWDER, FOR SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
55X04QC32I	SODIUM HYDROXIDE:INTRATRACHEAL:SUSPENSION:ADJ PH	INTRATRACHEAL	ADJ PH INTRATRACHEAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
55X04QC32I	SODIUM HYDROXIDE:INTRATUMOR:INJECTABLE:ADJ PH	INTRATUMOR	ADJ PH INTRATUMOR INJECTABLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
55X04QC32I	SODIUM HYDROXIDE:INTRATUMOR:INJECTION:ADJ PH	INTRATUMOR	ADJ PH INTRATUMOR INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
55X04QC32I	SODIUM HYDROXIDE:INTRATUMOR:POWDER, FOR INJECTION SOLUTION:ADJ PH	INTRATUMOR	ADJ PH INTRATUMOR POWDER, FOR INJECTION SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
55X04QC32I	SODIUM HYDROXIDE:INTRAUTERINE:INJECTION:ADJ PH	INTRAUTERINE	ADJ PH INTRAUTERINE INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
55X04QC32I	SODIUM HYDROXIDE:INTRAVASCULAR:INJECTION:ADJ PH	INTRAVASCULAR	ADJ PH INTRAVASCULAR INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
55X04QC32I	SODIUM HYDROXIDE:INTRAVASCULAR:SOLUTION:ADJ PH	INTRAVASCULAR	ADJ PH INTRAVASCULAR SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
55X04QC32I	SODIUM HYDROXIDE:INTRAVASCULAR:SOLUTION, INJECTION:ADJ PH	INTRAVASCULAR	ADJ PH INTRAVASCULAR SOLUTION, INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
55X04QC32I	SODIUM HYDROXIDE:INTRAVENOUS:EMULSION, INJECTION:ADJ PH	INTRAVENOUS	ADJ PH INTRAVENOUS EMULSION, INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
55X04QC32I	SODIUM HYDROXIDE:INTRAVENOUS:INJECTABLE:%	INTRAVENOUS	0.6% INTRAVENOUS INJECTABLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
55X04QC32I	SODIUM HYDROXIDE:INTRAVENOUS:INJECTABLE:ADJ PH	INTRAVENOUS	ADJ PH INTRAVENOUS INJECTABLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
55X04QC32I	SODIUM HYDROXIDE:INTRAVENOUS:INJECTION:MG/VIAL	INTRAVENOUS	11.6MG/VIAL INTRAVENOUS INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
55X04QC32I	SODIUM HYDROXIDE:INTRAVENOUS:INJECTION:%	INTRAVENOUS	9.6% INTRAVENOUS INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
55X04QC32I	SODIUM HYDROXIDE:INTRAVENOUS:INJECTION:mg/40mL	INTRAVENOUS	4.2mg/40mL INTRAVENOUS INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
55X04QC32I	SODIUM HYDROXIDE:INTRAVENOUS:INJECTION:MG/1ML	INTRAVENOUS	0.64MG/1ML INTRAVENOUS INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
55X04QC32I	SODIUM HYDROXIDE:INTRAVENOUS:INJECTION:ADJ PH	INTRAVENOUS	ADJ PH INTRAVENOUS INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
55X04QC32I	SODIUM HYDROXIDE:INTRAVENOUS:INJECTION, EMULSION:ADJ PH	INTRAVENOUS	ADJ PH INTRAVENOUS INJECTION, EMULSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
55X04QC32I	SODIUM HYDROXIDE:INTRAVENOUS:INJECTION, POWDER, LYOPHILIZED, FOR LIPOSOMAL SUSPENSION:ADJ PH	INTRAVENOUS	ADJ PH INTRAVENOUS INJECTION, POWDER, LYOPHILIZED, FOR LIPOSOMAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
55X04QC32I	SODIUM HYDROXIDE:INTRAVENOUS:INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION:ADJ PH	INTRAVENOUS	ADJ PH INTRAVENOUS INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
55X04QC32I	SODIUM HYDROXIDE:INTRAVENOUS:INJECTION, SOLUTION:mg/1mL	INTRAVENOUS	1.2mg/1mL INTRAVENOUS INJECTION, SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
55X04QC32I	SODIUM HYDROXIDE:INTRAVENOUS:INJECTION, SOLUTION:ADJ PH	INTRAVENOUS	ADJ PH INTRAVENOUS INJECTION, SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
55X04QC32I	SODIUM HYDROXIDE:INTRAVENOUS:INJECTION, SOLUTION:ADJ PH	INTRAVENOUS	ADJ PH INTRAVENOUS INJECTION, SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
55X04QC32I	SODIUM HYDROXIDE:INTRAVENOUS:INJECTION, SUSPENSION:ADJ PH	INTRAVENOUS	ADJ PH INTRAVENOUS INJECTION, SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
55X04QC32I	SODIUM HYDROXIDE:INTRAVENOUS:INJECTION, SUSPENSION, LIPOSOMAL:ADJ PH	INTRAVENOUS	ADJ PH INTRAVENOUS INJECTION, SUSPENSION, LIPOSOMAL	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
55X04QC32I	SODIUM HYDROXIDE:INTRAVENOUS:LIQUID:ADJ PH	INTRAVENOUS	ADJ PH INTRAVENOUS LIQUID	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
55X04QC32I	SODIUM HYDROXIDE:INTRAVENOUS:POWDER:ADJ PH	INTRAVENOUS	ADJ PH INTRAVENOUS POWDER	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
55X04QC32I	SODIUM HYDROXIDE:INTRAVENOUS:POWDER FOR INJECTION DOSAGE FORM:ADJ PH	INTRAVENOUS	ADJ PH INTRAVENOUS POWDER FOR INJECTION DOSAGE FORM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
55X04QC32I	SODIUM HYDROXIDE:INTRAVENOUS:POWDER, FOR INJECTION SOLUTION:mg/1VIAL	INTRAVENOUS	22mg/1VIAL INTRAVENOUS POWDER, FOR INJECTION SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
55X04QC32I	SODIUM HYDROXIDE:INTRAVENOUS:POWDER, FOR INJECTION SOLUTION:%	INTRAVENOUS	13.66% INTRAVENOUS POWDER, FOR INJECTION SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
55X04QC32I	SODIUM HYDROXIDE:INTRAVENOUS:POWDER, FOR INJECTION SOLUTION:ADJ PH	INTRAVENOUS	ADJ PH INTRAVENOUS POWDER, FOR INJECTION SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
55X04QC32I	SODIUM HYDROXIDE:INTRAVENOUS:POWDER, FOR INJECTION SOLUTION, LYOPHILIZED:MG/1VIAL	INTRAVENOUS	78.36MG/1VIAL INTRAVENOUS POWDER, FOR INJECTION SOLUTION, LYOPHILIZED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
55X04QC32I	SODIUM HYDROXIDE:INTRAVENOUS:POWDER, FOR INJECTION SOLUTION, LYOPHILIZED:%	INTRAVENOUS	19.27% INTRAVENOUS POWDER, FOR INJECTION SOLUTION, LYOPHILIZED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
55X04QC32I	SODIUM HYDROXIDE:INTRAVENOUS:POWDER, FOR INJECTION SOLUTION, LYOPHILIZED:ADJ PH	INTRAVENOUS	ADJ PH INTRAVENOUS POWDER, FOR INJECTION SOLUTION, LYOPHILIZED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
55X04QC32I	SODIUM HYDROXIDE:INTRAVENOUS:SOLUTION:ADJ PH	INTRAVENOUS	ADJ PH INTRAVENOUS SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
55X04QC32I	SODIUM HYDROXIDE:INTRAVENOUS:SOLUTION, CONCENTRATE:ADJ PH	INTRAVENOUS	ADJ PH INTRAVENOUS SOLUTION, CONCENTRATE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
55X04QC32I	SODIUM HYDROXIDE:INTRAVENOUS:SOLUTION, INJECTION:%	INTRAVENOUS	0.1% INTRAVENOUS SOLUTION, INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
55X04QC32I	SODIUM HYDROXIDE:INTRAVENOUS:SOLUTION, LIPOSOME, INJECTION:ADJ PH	INTRAVENOUS	ADJ PH INTRAVENOUS SOLUTION, LIPOSOME, INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
55X04QC32I	SODIUM HYDROXIDE:INTRAVENOUS:SOLUTION, LIQUID:ADJ PH	INTRAVENOUS	ADJ PH INTRAVENOUS SOLUTION, LIQUID	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
55X04QC32I	SODIUM HYDROXIDE:INTRAVENOUS INFUSION:INJECTABLE:ADJ PH	INTRAVENOUS INFUSION	ADJ PH INTRAVENOUS INFUSION INJECTABLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
55X04QC32I	SODIUM HYDROXIDE:INTRAVENOUS INFUSION:INJECTION:%	INTRAVENOUS INFUSION	0.12% INTRAVENOUS INFUSION INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
55X04QC32I	SODIUM HYDROXIDE:INTRAVENOUS INFUSION:POWDER:ADJ PH	INTRAVENOUS INFUSION	ADJ PH INTRAVENOUS INFUSION POWDER	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
55X04QC32I	SODIUM HYDROXIDE:INTRAVESICAL:SOLUTION, INJECTION:ADJ PH	INTRAVESICAL	ADJ PH INTRAVESICAL SOLUTION, INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
55X04QC32I	SODIUM HYDROXIDE:INTRAVITREAL:INJECTABLE:ADJ PH	INTRAVITREAL	ADJ PH INTRAVITREAL INJECTABLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
55X04QC32I	SODIUM HYDROXIDE:INTRAVITREAL:INJECTION:ADJ PH	INTRAVITREAL	ADJ PH INTRAVITREAL INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
55X04QC32I	SODIUM HYDROXIDE:INTRAVITREAL:SUSPENSION, INJECTION:ADJ PH	INTRAVITREAL	ADJ PH INTRAVITREAL SUSPENSION, INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
55X04QC32I	SODIUM HYDROXIDE:IONTOPHORESIS:DRUG DELIVERY SYSTEM:MG	IONTOPHORESIS	4.2MG IONTOPHORESIS DRUG DELIVERY SYSTEM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
55X04QC32I	SODIUM HYDROXIDE:IONTOPHORESIS:SOLUTION:ADJ PH	IONTOPHORESIS	ADJ PH IONTOPHORESIS SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
55X04QC32I	SODIUM HYDROXIDE:IRRIGATION:SOLUTION:ADJ PH	IRRIGATION	ADJ PH IRRIGATION SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
55X04QC32I	SODIUM HYDROXIDE:IRRIGATION:SOLUTION, IRRIGATION:ADJ PH	IRRIGATION	ADJ PH IRRIGATION SOLUTION, IRRIGATION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
55X04QC32I	SODIUM HYDROXIDE:IV - SC:INJECTION:ADJ PH	IV - SC	ADJ PH IV - SC INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
55X04QC32I	SODIUM HYDROXIDE:IV - SC:POWDER, FOR INJECTION SOLUTION:ADJ PH	IV - SC	ADJ PH IV - SC POWDER, FOR INJECTION SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
55X04QC32I	SODIUM HYDROXIDE:IV - SC:SOLUTION, INJECTION:ADJ PH	IV - SC	ADJ PH IV - SC SOLUTION, INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
55X04QC32I	SODIUM HYDROXIDE:IV(INFUSION):EMULSION, INJECTION:ADJ PH	IV(INFUSION)	ADJ PH IV(INFUSION) EMULSION, INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
55X04QC32I	SODIUM HYDROXIDE:IV(INFUSION):INFUSION:ADJ PH	IV(INFUSION)	ADJ PH IV(INFUSION) INFUSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
55X04QC32I	SODIUM HYDROXIDE:IV(INFUSION):INJECTABLE:ADJ PH	IV(INFUSION)	ADJ PH IV(INFUSION) INJECTABLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
55X04QC32I	SODIUM HYDROXIDE:IV(INFUSION):INJECTION:ADJ PH	IV(INFUSION)	ADJ PH IV(INFUSION) INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
55X04QC32I	SODIUM HYDROXIDE:IV(INFUSION):INJECTION, LIPOSOMAL:ADJ PH	IV(INFUSION)	ADJ PH IV(INFUSION) INJECTION, LIPOSOMAL	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
55X04QC32I	SODIUM HYDROXIDE:IV(INFUSION):LIQUID, WATER, STERILE, FOR INJECTION:ADJ PH	IV(INFUSION)	ADJ PH IV(INFUSION) LIQUID, WATER, STERILE, FOR INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
55X04QC32I	SODIUM HYDROXIDE:IV(INFUSION):POWDER, FOR INJECTION SOLUTION:%	IV(INFUSION)	9% IV(INFUSION) POWDER, FOR INJECTION SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
55X04QC32I	SODIUM HYDROXIDE:IV(INFUSION):POWDER, FOR INJECTION SOLUTION, LYOPHILIZED:%	IV(INFUSION)	1.57% IV(INFUSION) POWDER, FOR INJECTION SOLUTION, LYOPHILIZED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
55X04QC32I	SODIUM HYDROXIDE:IV(INFUSION):SOLUTION:%	IV(INFUSION)	2.78% IV(INFUSION) SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
55X04QC32I	SODIUM HYDROXIDE:IV(INFUSION):SOLUTION, INJECTION:%	IV(INFUSION)	2.83% IV(INFUSION) SOLUTION, INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
55X04QC32I	SODIUM HYDROXIDE:NASAL:SOLUTION:ADJ PH	NASAL	ADJ PH NASAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
55X04QC32I	SODIUM HYDROXIDE:NASAL:SOLUTION, FOR INHALATION:ADJ PH	NASAL	ADJ PH NASAL SOLUTION, FOR INHALATION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
55X04QC32I	SODIUM HYDROXIDE:NASAL:SOLUTION, SPRAY:ADJ PH	NASAL	ADJ PH NASAL SOLUTION, SPRAY	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
55X04QC32I	SODIUM HYDROXIDE:NASAL:SPRAY:ADJ PH	NASAL	ADJ PH NASAL SPRAY	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
55X04QC32I	SODIUM HYDROXIDE:NASAL:SPRAY, METERED:%	NASAL	0.004% NASAL SPRAY, METERED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
55X04QC32I	SODIUM HYDROXIDE:NERVE BLOCK:INJECTABLE:ADJ PH	NERVE BLOCK	ADJ PH NERVE BLOCK INJECTABLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
55X04QC32I	SODIUM HYDROXIDE:NERVE BLOCK:INJECTION:%	NERVE BLOCK	0.071% NERVE BLOCK INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
55X04QC32I	SODIUM HYDROXIDE:NERVE BLOCK:SOLUTION, INJECTION:ADJ PH	NERVE BLOCK	ADJ PH NERVE BLOCK SOLUTION, INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
55X04QC32I	SODIUM HYDROXIDE:OPHTHALMIC:DROPS:NA	OPHTHALMIC	OPHTHALMIC DROPS	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
55X04QC32I	SODIUM HYDROXIDE:OPHTHALMIC:EMULSION:%W/W	OPHTHALMIC	0.4%W/W OPHTHALMIC EMULSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
55X04QC32I	SODIUM HYDROXIDE:OPHTHALMIC:EMULSION:ADJ PH	OPHTHALMIC	ADJ PH OPHTHALMIC EMULSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
55X04QC32I	SODIUM HYDROXIDE:OPHTHALMIC:GEL:%	OPHTHALMIC	1.69% OPHTHALMIC GEL	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
55X04QC32I	SODIUM HYDROXIDE:OPHTHALMIC:POWDER, FOR SOLUTION:ADJ PH	OPHTHALMIC	ADJ PH OPHTHALMIC POWDER, FOR SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
55X04QC32I	SODIUM HYDROXIDE:OPHTHALMIC:SOLUTION:%	OPHTHALMIC	0.59% OPHTHALMIC SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
55X04QC32I	SODIUM HYDROXIDE:OPHTHALMIC:SOLUTION:ADJ PH	OPHTHALMIC	ADJ PH OPHTHALMIC SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
55X04QC32I	SODIUM HYDROXIDE:OPHTHALMIC:SOLUTION, DROPS:%	OPHTHALMIC	0.1% OPHTHALMIC SOLUTION, DROPS	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
55X04QC32I	SODIUM HYDROXIDE:OPHTHALMIC:SOLUTION, DROPS:ADJ PH	OPHTHALMIC	ADJ PH OPHTHALMIC SOLUTION, DROPS	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
55X04QC32I	SODIUM HYDROXIDE:OPHTHALMIC:SOLUTION, IRRIGATION:ADJ PH	OPHTHALMIC	ADJ PH OPHTHALMIC SOLUTION, IRRIGATION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
55X04QC32I	SODIUM HYDROXIDE:OPHTHALMIC:SOLUTION/ DROPS:ADJ PH	OPHTHALMIC	ADJ PH OPHTHALMIC SOLUTION/ DROPS	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
55X04QC32I	SODIUM HYDROXIDE:OPHTHALMIC:SOLUTION/DROPS:ADJ PH	OPHTHALMIC	ADJ PH OPHTHALMIC SOLUTION/DROPS	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
55X04QC32I	SODIUM HYDROXIDE:OPHTHALMIC:SUSPENSION:ADJ PH	OPHTHALMIC	ADJ PH OPHTHALMIC SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
55X04QC32I	SODIUM HYDROXIDE:OPHTHALMIC:SUSPENSION, DROPS:ADJ PH	OPHTHALMIC	ADJ PH OPHTHALMIC SUSPENSION, DROPS	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
55X04QC32I	SODIUM HYDROXIDE:ORAL:CAPSULE:MG	ORAL	9.88MG ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
55X04QC32I	SODIUM HYDROXIDE:ORAL:CAPSULE, COATED:MG	ORAL	0.08MG ORAL CAPSULE, COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
55X04QC32I	SODIUM HYDROXIDE:ORAL:CAPSULE, COATED PELLETS:MG	ORAL	0.013MG ORAL CAPSULE, COATED PELLETS	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
55X04QC32I	SODIUM HYDROXIDE:ORAL:CAPSULE, DELAYED ACTION:MG	ORAL	0.25MG ORAL CAPSULE, DELAYED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
55X04QC32I	SODIUM HYDROXIDE:ORAL:CAPSULE, ENTERIC COATED PELLETS:MG	ORAL	0.083MG ORAL CAPSULE, ENTERIC COATED PELLETS	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
55X04QC32I	SODIUM HYDROXIDE:ORAL:CAPSULE, SOFT GELATIN LIQUID-FILLED:MG	ORAL	1.5MG ORAL CAPSULE, SOFT GELATIN LIQUID-FILLED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
55X04QC32I	SODIUM HYDROXIDE:ORAL:CONCENTRATE:MG/5ML	ORAL	10MG/5ML ORAL CONCENTRATE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
55X04QC32I	SODIUM HYDROXIDE:ORAL:EMULSION:ADJ PH	ORAL	ADJ PH ORAL EMULSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
55X04QC32I	SODIUM HYDROXIDE:ORAL:FILM, SOLUBLE:MG	ORAL	1.84MG ORAL FILM, SOLUBLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
55X04QC32I	SODIUM HYDROXIDE:ORAL:GRANULE, FOR ORAL SUSPENSION:ADJ PH	ORAL	ADJ PH ORAL GRANULE, FOR ORAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
55X04QC32I	SODIUM HYDROXIDE:ORAL:LIQUID:MG/5ML	ORAL	2MG/5ML ORAL LIQUID	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
55X04QC32I	SODIUM HYDROXIDE:ORAL:LIQUID:ADJ PH	ORAL	ADJ PH ORAL LIQUID	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
55X04QC32I	SODIUM HYDROXIDE:ORAL:POWDER, FOR ORAL SUSPENSION:MG/50ML	ORAL	1.7MG/50ML ORAL POWDER, FOR ORAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
55X04QC32I	SODIUM HYDROXIDE:ORAL:POWDER, FOR SOLUTION:ADJ PH	ORAL	ADJ PH ORAL POWDER, FOR SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
55X04QC32I	SODIUM HYDROXIDE:ORAL:SOLUTION:MG/1ML	ORAL	80MG/1ML ORAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
55X04QC32I	SODIUM HYDROXIDE:ORAL:SOLUTION:G/160 mL	ORAL	4.56G/160 mL ORAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
55X04QC32I	SODIUM HYDROXIDE:ORAL:SOLUTION:MG/5ML	ORAL	4.5MG/5ML ORAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
55X04QC32I	SODIUM HYDROXIDE:ORAL:SOLUTION, ELIXIR:ADJ PH	ORAL	ADJ PH ORAL SOLUTION, ELIXIR	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
55X04QC32I	SODIUM HYDROXIDE:ORAL:SOLUTION, INJECTION:ADJ PH	ORAL	ADJ PH ORAL SOLUTION, INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
55X04QC32I	SODIUM HYDROXIDE:ORAL:SUSPENSION:%	ORAL	8% ORAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
55X04QC32I	SODIUM HYDROXIDE:ORAL:SYRUP:MG/5ML	ORAL	71MG/5ML ORAL SYRUP	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
55X04QC32I	SODIUM HYDROXIDE:ORAL:TABLET:MG	ORAL	7MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
55X04QC32I	SODIUM HYDROXIDE:ORAL:TABLET, COATED:NA	ORAL	ORAL TABLET, COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
55X04QC32I	SODIUM HYDROXIDE:ORAL:TABLET, DELAYED ACTION:MG	ORAL	1.24MG ORAL TABLET, DELAYED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
55X04QC32I	SODIUM HYDROXIDE:ORAL:TABLET, DELAYED ACTION, ENTERIC COATED:MG	ORAL	0.32MG ORAL TABLET, DELAYED ACTION, ENTERIC COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
55X04QC32I	SODIUM HYDROXIDE:ORAL:TABLET, DELAYED RELEASE:MG	ORAL	0.1MG ORAL TABLET, DELAYED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
55X04QC32I	SODIUM HYDROXIDE:ORAL:TABLET, EXTENDED RELEASE:MG	ORAL	5.33MG ORAL TABLET, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
55X04QC32I	SODIUM HYDROXIDE:ORAL:TABLET, ORALLY DISINTEGRATING:MG	ORAL	0.16MG ORAL TABLET, ORALLY DISINTEGRATING	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
55X04QC32I	SODIUM HYDROXIDE:ORAL:TABLET, SUSTAINED ACTION:MG	ORAL	0.4MG ORAL TABLET, SUSTAINED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
55X04QC32I	SODIUM HYDROXIDE:OTIC:SUSPENSION:ADJ PH	OTIC	ADJ PH OTIC SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
55X04QC32I	SODIUM HYDROXIDE:PARENTERAL:INJECTION:ADJ PH	PARENTERAL	ADJ PH PARENTERAL INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
55X04QC32I	SODIUM HYDROXIDE:PARENTERAL:LIQUID, WATER, STERILE, FOR INJECTION:ADJ PH	PARENTERAL	ADJ PH PARENTERAL LIQUID, WATER, STERILE, FOR INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
55X04QC32I	SODIUM HYDROXIDE:PARENTERAL:POWDER, FOR INJECTION SOLUTION:ADJ PH	PARENTERAL	ADJ PH PARENTERAL POWDER, FOR INJECTION SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
55X04QC32I	SODIUM HYDROXIDE:PERFUSION, CARDIAC:SOLUTION:ADJ PH	PERFUSION, CARDIAC	ADJ PH PERFUSION, CARDIAC SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
55X04QC32I	SODIUM HYDROXIDE:PERIDURAL:INJECTION:ADJ PH	PERIDURAL	ADJ PH PERIDURAL INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
55X04QC32I	SODIUM HYDROXIDE:PERINEURAL:INJECTION:ADJ PH	PERINEURAL	ADJ PH PERINEURAL INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
55X04QC32I	SODIUM HYDROXIDE:PHOTOPHERESIS:SOLUTION:ADJ PH	PHOTOPHERESIS	ADJ PH PHOTOPHERESIS SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
55X04QC32I	SODIUM HYDROXIDE:RECTAL:ENEMA:%	RECTAL	0.44% RECTAL ENEMA	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
55X04QC32I	SODIUM HYDROXIDE:RECTAL:POWDER, FOR INJECTION SOLUTION:ADJ PH	RECTAL	ADJ PH RECTAL POWDER, FOR INJECTION SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
55X04QC32I	SODIUM HYDROXIDE:RECTAL:SOLUTION:%	RECTAL	0.63% RECTAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
55X04QC32I	SODIUM HYDROXIDE:RESPIRATORY (INHALATION):POWDER, FOR INHALATION:ADJ PH	RESPIRATORY (INHALATION)	ADJ PH RESPIRATORY (INHALATION) POWDER, FOR INHALATION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
55X04QC32I	SODIUM HYDROXIDE:RESPIRATORY (INHALATION):SOLUTION:ADJ PH	RESPIRATORY (INHALATION)	ADJ PH RESPIRATORY (INHALATION) SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
55X04QC32I	SODIUM HYDROXIDE:RESPIRATORY (INHALATION):SOLUTION, AEROSOL, FOR INHALATION:ADJ PH	RESPIRATORY (INHALATION)	ADJ PH RESPIRATORY (INHALATION) SOLUTION, AEROSOL, FOR INHALATION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
55X04QC32I	SODIUM HYDROXIDE:RESPIRATORY (INHALATION):SOLUTION, FOR INHALATION:%	RESPIRATORY (INHALATION)	0.058% RESPIRATORY (INHALATION) SOLUTION, FOR INHALATION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
55X04QC32I	SODIUM HYDROXIDE:RESPIRATORY (INHALATION):SOLUTION, INJECTION:ADJ PH	RESPIRATORY (INHALATION)	ADJ PH RESPIRATORY (INHALATION) SOLUTION, INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
55X04QC32I	SODIUM HYDROXIDE:RETROBULBAR:INJECTION:ADJ PH	RETROBULBAR	ADJ PH RETROBULBAR INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
55X04QC32I	SODIUM HYDROXIDE:SOFT TISSUE:INJECTABLE:ADJ PH	SOFT TISSUE	ADJ PH SOFT TISSUE INJECTABLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
55X04QC32I	SODIUM HYDROXIDE:SOFT TISSUE:INJECTION:ADJ PH	SOFT TISSUE	ADJ PH SOFT TISSUE INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
55X04QC32I	SODIUM HYDROXIDE:SOFT TISSUE:INJECTION, SUSTAINED ACTION:ADJ PH	SOFT TISSUE	ADJ PH SOFT TISSUE INJECTION, SUSTAINED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
55X04QC32I	SODIUM HYDROXIDE:SOFT TISSUE:SUSPENSION, INJECTION:ADJ PH	SOFT TISSUE	ADJ PH SOFT TISSUE SUSPENSION, INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
55X04QC32I	SODIUM HYDROXIDE:SPINAL:INJECTABLE:ADJ PH	SPINAL	ADJ PH SPINAL INJECTABLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
55X04QC32I	SODIUM HYDROXIDE:SPINAL:INJECTION:ADJ PH	SPINAL	ADJ PH SPINAL INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
55X04QC32I	SODIUM HYDROXIDE:SUBARACHNOID:SOLUTION, INJECTION:ADJ PH	SUBARACHNOID	ADJ PH SUBARACHNOID SOLUTION, INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
55X04QC32I	SODIUM HYDROXIDE:SUBCONJUNCTIVAL:INJECTION:ADJ PH	SUBCONJUNCTIVAL	ADJ PH SUBCONJUNCTIVAL INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
55X04QC32I	SODIUM HYDROXIDE:SUBCUTANEOUS:INJECTABLE:%	SUBCUTANEOUS	0.42% SUBCUTANEOUS INJECTABLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
55X04QC32I	SODIUM HYDROXIDE:SUBCUTANEOUS:INJECTION:%	SUBCUTANEOUS	3.15% SUBCUTANEOUS INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
55X04QC32I	SODIUM HYDROXIDE:SUBCUTANEOUS:INJECTION:ADJ PH	SUBCUTANEOUS	ADJ PH SUBCUTANEOUS INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
55X04QC32I	SODIUM HYDROXIDE:SUBCUTANEOUS:INJECTION, SOLUTION:ADJ PH	SUBCUTANEOUS	ADJ PH SUBCUTANEOUS INJECTION, SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
55X04QC32I	SODIUM HYDROXIDE:SUBCUTANEOUS:POWDER, FOR INJECTION SOLUTION:ADJ PH	SUBCUTANEOUS	ADJ PH SUBCUTANEOUS POWDER, FOR INJECTION SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
55X04QC32I	SODIUM HYDROXIDE:SUBCUTANEOUS:POWDER, FOR INJECTION SOLUTION, LYOPHILIZED:ADJ PH	SUBCUTANEOUS	ADJ PH SUBCUTANEOUS POWDER, FOR INJECTION SOLUTION, LYOPHILIZED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
55X04QC32I	SODIUM HYDROXIDE:SUBCUTANEOUS:POWDER, FOR INJECTION SOLUTION, LYOPHILIZED, WITH ADDITIVES:ADJ PH	SUBCUTANEOUS	ADJ PH SUBCUTANEOUS POWDER, FOR INJECTION SOLUTION, LYOPHILIZED, WITH ADDITIVES	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
55X04QC32I	SODIUM HYDROXIDE:SUBCUTANEOUS:SOLUTION:ADJ PH	SUBCUTANEOUS	ADJ PH SUBCUTANEOUS SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
55X04QC32I	SODIUM HYDROXIDE:SUBCUTANEOUS:SOLUTION, INJECTION:%	SUBCUTANEOUS	1% SUBCUTANEOUS SOLUTION, INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
55X04QC32I	SODIUM HYDROXIDE:SUBCUTANEOUS:SUSPENSION:ADJ PH	SUBCUTANEOUS	ADJ PH SUBCUTANEOUS SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
55X04QC32I	SODIUM HYDROXIDE:SUBCUTANEOUS:SUSPENSION, INJECTION:%	SUBCUTANEOUS	0.073% SUBCUTANEOUS SUSPENSION, INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
55X04QC32I	SODIUM HYDROXIDE:SUBMUCOSAL:INJECTION:ADJ PH	SUBMUCOSAL	ADJ PH SUBMUCOSAL INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
55X04QC32I	SODIUM HYDROXIDE:SUBMUCOSAL:SOLUTION, INJECTION:ADJ PH	SUBMUCOSAL	ADJ PH SUBMUCOSAL SOLUTION, INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
55X04QC32I	SODIUM HYDROXIDE:TOPICAL:CREAM:%W/W	TOPICAL	0.55%W/W TOPICAL CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
55X04QC32I	SODIUM HYDROXIDE:TOPICAL:CREAM, AUGMENTED:%W/V	TOPICAL	2.72%W/V TOPICAL CREAM, AUGMENTED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
55X04QC32I	SODIUM HYDROXIDE:TOPICAL:CREAM, EMULSION, SUSTAINED RELEASE:%W/V	TOPICAL	2.72%W/V TOPICAL CREAM, EMULSION, SUSTAINED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
55X04QC32I	SODIUM HYDROXIDE:TOPICAL:DISC:NA	TOPICAL	TOPICAL DISC	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
55X04QC32I	SODIUM HYDROXIDE:TOPICAL:EMULSION:%W/W	TOPICAL	0.2%W/W TOPICAL EMULSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
55X04QC32I	SODIUM HYDROXIDE:TOPICAL:EMULSION, AEROSOL FOAM:ADJ PH	TOPICAL	ADJ PH TOPICAL EMULSION, AEROSOL FOAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
55X04QC32I	SODIUM HYDROXIDE:TOPICAL:EMULSION, CREAM:%W/W	TOPICAL	0.52%W/W TOPICAL EMULSION, CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
55X04QC32I	SODIUM HYDROXIDE:TOPICAL:EMULSION, LOTION:%W/W	TOPICAL	0.022%W/W TOPICAL EMULSION, LOTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
55X04QC32I	SODIUM HYDROXIDE:TOPICAL:GEL:%W/W	TOPICAL	3.2%W/W TOPICAL GEL	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
55X04QC32I	SODIUM HYDROXIDE:TOPICAL:JELLY:NA	TOPICAL	TOPICAL JELLY	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
55X04QC32I	SODIUM HYDROXIDE:TOPICAL:LOTION:%W/W	TOPICAL	2.6%W/W TOPICAL LOTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
55X04QC32I	SODIUM HYDROXIDE:TOPICAL:LOTION, AUGMENTED:NA	TOPICAL	TOPICAL LOTION, AUGMENTED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
55X04QC32I	SODIUM HYDROXIDE:TOPICAL:OINTMENT:NA	TOPICAL	TOPICAL OINTMENT	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
55X04QC32I	SODIUM HYDROXIDE:TOPICAL:OINTMENT, AUGMENTED:%W/W	TOPICAL	0.11%W/W TOPICAL OINTMENT, AUGMENTED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
55X04QC32I	SODIUM HYDROXIDE:TOPICAL:SHAMPOO:NA	TOPICAL	TOPICAL SHAMPOO	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
55X04QC32I	SODIUM HYDROXIDE:TOPICAL:SOLUTION:%W/V	TOPICAL	0.59%W/V TOPICAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
55X04QC32I	SODIUM HYDROXIDE:TOPICAL:SOLUTION:ADJ PH	TOPICAL	ADJ PH TOPICAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
55X04QC32I	SODIUM HYDROXIDE:TOPICAL:SOLUTION, DROPS:ADJ PH	TOPICAL	ADJ PH TOPICAL SOLUTION, DROPS	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
55X04QC32I	SODIUM HYDROXIDE:TOPICAL:SOLUTION/DROPS:NA	TOPICAL	TOPICAL SOLUTION/DROPS	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
55X04QC32I	SODIUM HYDROXIDE:TOPICAL:SPONGE:NA	TOPICAL	TOPICAL SPONGE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
55X04QC32I	SODIUM HYDROXIDE:TOPICAL:SUSPENSION:NA	TOPICAL	TOPICAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
55X04QC32I	SODIUM HYDROXIDE:TOPICAL:SUSPENSION, DROPS:NA	TOPICAL	TOPICAL SUSPENSION, DROPS	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
55X04QC32I	SODIUM HYDROXIDE:TOPICAL:SWAB:ADJ PH	TOPICAL	ADJ PH TOPICAL SWAB	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
55X04QC32I	SODIUM HYDROXIDE:TRANSDERMAL:DRUG DELIVERY SYSTEM:MG	TRANSDERMAL	4.2MG TRANSDERMAL DRUG DELIVERY SYSTEM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
55X04QC32I	SODIUM HYDROXIDE:TRANSDERMAL:FILM, CONTROLLED RELEASE:MG	TRANSDERMAL	0.85MG TRANSDERMAL FILM, CONTROLLED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
55X04QC32I	SODIUM HYDROXIDE:TRANSDERMAL:GEL:%	TRANSDERMAL	4.72% TRANSDERMAL GEL	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
55X04QC32I	SODIUM HYDROXIDE:TRANSDERMAL:GEL:ADJ PH	TRANSDERMAL	ADJ PH TRANSDERMAL GEL	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
55X04QC32I	SODIUM HYDROXIDE:TRANSDERMAL:GEL, METERED:%	TRANSDERMAL	7% TRANSDERMAL GEL, METERED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
55X04QC32I	SODIUM HYDROXIDE:URETERAL:SOLUTION:ADJ PH	URETERAL	ADJ PH URETERAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
55X04QC32I	SODIUM HYDROXIDE:URETHRAL:SOLUTION:ADJ PH	URETHRAL	ADJ PH URETHRAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
55X04QC32I	SODIUM HYDROXIDE:VAGINAL:CREAM, EMULSION, SUSTAINED RELEASE:%	VAGINAL	0.025% VAGINAL CREAM, EMULSION, SUSTAINED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
55X04QC32I	SODIUM HYDROXIDE:VAGINAL:EMULSION, CREAM:%	VAGINAL	0.19% VAGINAL EMULSION, CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
55X04QC32I	SODIUM HYDROXIDE:VAGINAL:GEL:%	VAGINAL	0.25% VAGINAL GEL	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
MD83SFE959	TERT-BUTYL ALCOHOL:INTRAVENOUS:INJECTABLE:mg/1mL	INTRAVENOUS	0.3mg/1mL INTRAVENOUS INJECTABLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
MD83SFE959	TERT-BUTYL ALCOHOL:SUBCUTANEOUS:INJECTABLE:mg/1mL	SUBCUTANEOUS	0.3mg/1mL SUBCUTANEOUS INJECTABLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
MD83SFE959	TERT-BUTYL ALCOHOL:TOPICAL:GEL:%W/W	TOPICAL	0.12%W/W TOPICAL GEL	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
2URQ2N32W3	CALCIUM LACTATE:VAGINAL:TABLET:MG	VAGINAL	30MG VAGINAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
56F9Z98TEM	ISOBUTYL ALCOHOL:ORAL:TABLET, COATED:NA	ORAL	ORAL TABLET, COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=I
IRY12B2TQ6	BENZODODECINIUM BROMIDE:OPHTHALMIC:SOLUTION:%	OPHTHALMIC	0.012% OPHTHALMIC SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
IRY12B2TQ6	BENZODODECINIUM BROMIDE:OPHTHALMIC:SOLUTION, GEL FORMING, EXTENDED RELEASE:%	OPHTHALMIC	0.012% OPHTHALMIC SOLUTION, GEL FORMING, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
E107L85C40	DIPROPYLENE GLYCOL:BUCCAL:PATCH, CONTROLLED RELEASE:MG	BUCCAL	29.9MG BUCCAL PATCH, CONTROLLED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
E107L85C40	DIPROPYLENE GLYCOL:TRANSDERMAL:FILM:MG	TRANSDERMAL	5.37MG TRANSDERMAL FILM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
E107L85C40	DIPROPYLENE GLYCOL:TRANSDERMAL:FILM, CONTROLLED RELEASE:MG	TRANSDERMAL	12MG TRANSDERMAL FILM, CONTROLLED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
E107L85C40	DIPROPYLENE GLYCOL:TRANSDERMAL:FILM, EXTENDED RELEASE:MG	TRANSDERMAL	1.58MG TRANSDERMAL FILM, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
E107L85C40	DIPROPYLENE GLYCOL:TRANSDERMAL:PATCH:MG	TRANSDERMAL	49.4MG TRANSDERMAL PATCH	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
E107L85C40	DIPROPYLENE GLYCOL:TRANSDERMAL:PATCH, CONTROLLED RELEASE:MG	TRANSDERMAL	0.22MG TRANSDERMAL PATCH, CONTROLLED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
5Z492UNF9O	PROPYLENE GLYCOL DIACETATE:AURICULAR (OTIC):SOLUTION:%	AURICULAR (OTIC)	65% AURICULAR (OTIC) SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
5Z492UNF9O	PROPYLENE GLYCOL DIACETATE:OPHTHALMIC:SOLUTION, DROPS:%	OPHTHALMIC	3% OPHTHALMIC SOLUTION, DROPS	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
5Z492UNF9O	PROPYLENE GLYCOL DIACETATE:TOPICAL:EMULSION, CREAM:%W/W	TOPICAL	10%W/W TOPICAL EMULSION, CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
X045WJ989B	SORBIC ACID:OPHTHALMIC:EMULSION:%	OPHTHALMIC	0.1% OPHTHALMIC EMULSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
X045WJ989B	SORBIC ACID:OPHTHALMIC:SOLUTION:%	OPHTHALMIC	0.2% OPHTHALMIC SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
X045WJ989B	SORBIC ACID:OPHTHALMIC:SOLUTION, DROPS:%	OPHTHALMIC	0.2% OPHTHALMIC SOLUTION, DROPS	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
X045WJ989B	SORBIC ACID:ORAL:CAPSULE:MG	ORAL	0.94MG ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
X045WJ989B	SORBIC ACID:ORAL:CAPSULE, SUSTAINED ACTION:MG	ORAL	0.94MG ORAL CAPSULE, SUSTAINED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
X045WJ989B	SORBIC ACID:ORAL:CONCENTRATE:MG/1ML	ORAL	0.1MG/1ML ORAL CONCENTRATE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
X045WJ989B	SORBIC ACID:ORAL:LIQUID:MG/5ML	ORAL	5MG/5ML ORAL LIQUID	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
X045WJ989B	SORBIC ACID:ORAL:SOLUTION:MG/1ML	ORAL	1MG/1ML ORAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
X045WJ989B	SORBIC ACID:ORAL:SOLUTION/DROPS:%W/V	ORAL	0.2%W/V ORAL SOLUTION/DROPS	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
X045WJ989B	SORBIC ACID:ORAL:SUSPENSION:MG/5ML	ORAL	5MG/5ML ORAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
X045WJ989B	SORBIC ACID:ORAL:SYRUP:MG/5ML	ORAL	5.01MG/5ML ORAL SYRUP	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
X045WJ989B	SORBIC ACID:ORAL:TABLET:MG	ORAL	0.94MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
X045WJ989B	SORBIC ACID:ORAL:TABLET (IMMED./COMP. RELEASE), UNCOATED, CHEWABLE:NA	ORAL	ORAL TABLET (IMMED./COMP. RELEASE), UNCOATED, CHEWABLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
X045WJ989B	SORBIC ACID:ORAL:TABLET, COATED:NA	ORAL	ORAL TABLET, COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
X045WJ989B	SORBIC ACID:ORAL:TABLET, DELAYED ACTION, ENTERIC COATED:MG	ORAL	0.028MG ORAL TABLET, DELAYED ACTION, ENTERIC COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
X045WJ989B	SORBIC ACID:ORAL:TABLET, FILM COATED:NA	ORAL	ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
X045WJ989B	SORBIC ACID:ORAL:TABLET, SUSTAINED ACTION, FILM COATED:MG	ORAL	0.4MG ORAL TABLET, SUSTAINED ACTION, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
X045WJ989B	SORBIC ACID:SUBLINGUAL:TABLET:MG	SUBLINGUAL	0.16MG SUBLINGUAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
X045WJ989B	SORBIC ACID:TOPICAL:CREAM:%W/W 	TOPICAL	0.2%W/W  TOPICAL CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
X045WJ989B	SORBIC ACID:TOPICAL:CREAM, EMULSION, SUSTAINED RELEASE:%W/W	TOPICAL	0.2%W/W TOPICAL CREAM, EMULSION, SUSTAINED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
X045WJ989B	SORBIC ACID:TOPICAL:EMULSION, AEROSOL FOAM:%W/W	TOPICAL	0.15%W/W TOPICAL EMULSION, AEROSOL FOAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
X045WJ989B	SORBIC ACID:TOPICAL:EMULSION, CREAM:%W/W	TOPICAL	0.75%W/W TOPICAL EMULSION, CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
X045WJ989B	SORBIC ACID:TOPICAL:GEL:%W/W	TOPICAL	0.18%W/W TOPICAL GEL	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
X045WJ989B	SORBIC ACID:TOPICAL:LOTION:%W/W	TOPICAL	0.2%W/W TOPICAL LOTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
X045WJ989B	SORBIC ACID:TOPICAL:OINTMENT:%W/W	TOPICAL	0.1%W/W TOPICAL OINTMENT	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
X045WJ989B	SORBIC ACID:TOPICAL:SOLUTION:%W/V	TOPICAL	0.2%W/V TOPICAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
X045WJ989B	SORBIC ACID:VAGINAL:GEL:%	VAGINAL	0.09% VAGINAL GEL	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
X045WJ989B	SORBIC ACID:VAGINAL:SPONGE:MG	VAGINAL	6MG VAGINAL SPONGE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
V56DFE46J5	STEARETH-2:TOPICAL:CREAM:%W/W 	TOPICAL	4.25%W/W  TOPICAL CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
V56DFE46J5	STEARETH-2:TOPICAL:CREAM, EMULSION, SUSTAINED RELEASE:%W/W	TOPICAL	0.85%W/W TOPICAL CREAM, EMULSION, SUSTAINED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
V56DFE46J5	STEARETH-2:TOPICAL:EMULSION, CREAM:%W/W	TOPICAL	4.5%W/W TOPICAL EMULSION, CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
V56DFE46J5	STEARETH-2:TOPICAL:LOTION:%W/W	TOPICAL	0.4%W/W TOPICAL LOTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
V56DFE46J5	STEARETH-2:TOPICAL:OINTMENT:%W/W	TOPICAL	5%W/W TOPICAL OINTMENT	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
V7AD894FAZ	ETHYLCELLULOSE (45 MPA.S):ORAL:CAPSULE, EXTENDED RELEASE:MG	ORAL	101.41MG ORAL CAPSULE, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
V7AD894FAZ	ETHYLCELLULOSE (45 MPA.S):ORAL:SUSPENSION, EXTENDED RELEASE:MG/5ML	ORAL	8.19MG/5ML ORAL SUSPENSION, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
V7AD894FAZ	ETHYLCELLULOSE (45 MPA.S):ORAL:TABLET, CONTROLLED RELEASE:MG	ORAL	24MG ORAL TABLET, CONTROLLED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
YGX74DKE74	CARBOXYMETHYLCELLULOSE SODIUM (0.7 CARBOXYMETHYL SUBSTITUTION PER SACCHARIDE; 38 MPA.S AT 2%):BUCCAL:FILM:MG	BUCCAL	17.64MG BUCCAL FILM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
YGX74DKE74	CARBOXYMETHYLCELLULOSE SODIUM (0.7 CARBOXYMETHYL SUBSTITUTION PER SACCHARIDE; 38 MPA.S AT 2%):ORAL:TABLET:MG	ORAL	7MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
O0GN6F9B2Y	METHYLCELLULOSE (400 MPA.S):ORAL:TABLET:MG	ORAL	33MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
X958PZJ9ON	PEG-20 SORBITAN ISOSTEARATE:INTRAMUSCULAR:INJECTION:NA	INTRAMUSCULAR	INTRAMUSCULAR INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
X958PZJ9ON	PEG-20 SORBITAN ISOSTEARATE:ORAL:EMULSION:NA	ORAL	ORAL EMULSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
NPU9M2E6L8	METHYLCELLULOSE (15 MPA.S):ORAL:TABLET:mg	ORAL	180mg ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
NPU9M2E6L8	METHYLCELLULOSE (15 MPA.S):ORAL:TABLET, DELAYED RELEASE:MG	ORAL	5MG ORAL TABLET, DELAYED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
NPU9M2E6L8	METHYLCELLULOSE (15 MPA.S):ORAL:TABLET, EXTENDED RELEASE:MG	ORAL	82.5MG ORAL TABLET, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
NPU9M2E6L8	METHYLCELLULOSE (15 MPA.S):ORAL:TABLET, FILM COATED:MG	ORAL	68MG ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
GW89575KF9	SQUALANE:ORAL:POWDER:%	ORAL	2% ORAL POWDER	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
GW89575KF9	SQUALANE:TOPICAL:CREAM, AUGMENTED:%W/W	TOPICAL	6%W/W TOPICAL CREAM, AUGMENTED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
GW89575KF9	SQUALANE:TOPICAL:EMULSION, CREAM:%W/W	TOPICAL	6%W/W TOPICAL EMULSION, CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
GW89575KF9	SQUALANE:TOPICAL:SOLUTION:%W/W	TOPICAL	1%W/W TOPICAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
U3JF91U133	HYDROXYPROPYL CELLULOSE (1200000 WAMW):BUCCAL:FILM:MG	BUCCAL	100.04MG BUCCAL FILM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
U3JF91U133	HYDROXYPROPYL CELLULOSE (1200000 WAMW):BUCCAL:FILM, SOLUBLE:MG	BUCCAL	72.91MG BUCCAL FILM, SOLUBLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
U3JF91U133	HYDROXYPROPYL CELLULOSE (1200000 WAMW):BUCCAL:GUM:MG	BUCCAL	13.92MG BUCCAL GUM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
U3JF91U133	HYDROXYPROPYL CELLULOSE (1200000 WAMW):BUCCAL:GUM, CHEWING:MG	BUCCAL	27.92MG BUCCAL GUM, CHEWING	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
U3JF91U133	HYDROXYPROPYL CELLULOSE (1200000 WAMW):ORAL:CAPSULE:MG	ORAL	41.5MG ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
U3JF91U133	HYDROXYPROPYL CELLULOSE (1200000 WAMW):ORAL:CAPSULE, COATED PELLETS:MG	ORAL	3.96MG ORAL CAPSULE, COATED PELLETS	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
U3JF91U133	HYDROXYPROPYL CELLULOSE (1200000 WAMW):ORAL:CAPSULE, DELAYED ACTION:MG	ORAL	12.96MG ORAL CAPSULE, DELAYED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
U3JF91U133	HYDROXYPROPYL CELLULOSE (1200000 WAMW):ORAL:CAPSULE, DELAYED RELEASE:MG	ORAL	16MG ORAL CAPSULE, DELAYED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
U3JF91U133	HYDROXYPROPYL CELLULOSE (1200000 WAMW):ORAL:CAPSULE, ENTERIC COATED PELLETS:MG	ORAL	41.4MG ORAL CAPSULE, ENTERIC COATED PELLETS	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
U3JF91U133	HYDROXYPROPYL CELLULOSE (1200000 WAMW):ORAL:CAPSULE, EXTENDED RELEASE:MG	ORAL	214.48MG ORAL CAPSULE, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
U3JF91U133	HYDROXYPROPYL CELLULOSE (1200000 WAMW):ORAL:CAPSULE, HARD GELATIN:MG	ORAL	71.3MG ORAL CAPSULE, HARD GELATIN	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
U3JF91U133	HYDROXYPROPYL CELLULOSE (1200000 WAMW):ORAL:CAPSULE, SUSTAINED ACTION:MG	ORAL	41.5MG ORAL CAPSULE, SUSTAINED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
U3JF91U133	HYDROXYPROPYL CELLULOSE (1200000 WAMW):ORAL:GRANULE:MG	ORAL	12.5MG ORAL GRANULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
U3JF91U133	HYDROXYPROPYL CELLULOSE (1200000 WAMW):ORAL:GRANULE, FOR ORAL SUSPENSION:MG	ORAL	39MG ORAL GRANULE, FOR ORAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
U3JF91U133	HYDROXYPROPYL CELLULOSE (1200000 WAMW):ORAL:GRANULE, FOR RECONSTITUTION:MG	ORAL	20MG ORAL GRANULE, FOR RECONSTITUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
U3JF91U133	HYDROXYPROPYL CELLULOSE (1200000 WAMW):ORAL:GRANULE, FOR SUSPENSION:MG	ORAL	31.4MG ORAL GRANULE, FOR SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
U3JF91U133	HYDROXYPROPYL CELLULOSE (1200000 WAMW):ORAL:PELLET:MG	ORAL	39MG ORAL PELLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
U3JF91U133	HYDROXYPROPYL CELLULOSE (1200000 WAMW):ORAL:POWDER, FOR ORAL SUSPENSION:MG/25.169GM	ORAL	67MG/25.169GM ORAL POWDER, FOR ORAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
U3JF91U133	HYDROXYPROPYL CELLULOSE (1200000 WAMW):ORAL:POWDER, FOR RECONSTITUTION:MG/5ML	ORAL	0.03MG/5ML ORAL POWDER, FOR RECONSTITUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
U3JF91U133	HYDROXYPROPYL CELLULOSE (1200000 WAMW):ORAL:POWDER, FOR SUSPENSION:MG/5ML	ORAL	12MG/5ML ORAL POWDER, FOR SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
U3JF91U133	HYDROXYPROPYL CELLULOSE (1200000 WAMW):ORAL:SUSPENSION:MG/1ML	ORAL	20MG/1ML ORAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
U3JF91U133	HYDROXYPROPYL CELLULOSE (1200000 WAMW):ORAL:TABLET:MG	ORAL	71MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
U3JF91U133	HYDROXYPROPYL CELLULOSE (1200000 WAMW):ORAL:TABLET (IMMED./COMP. RELEASE), FILM COATED:MG	ORAL	24MG ORAL TABLET (IMMED./COMP. RELEASE), FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
U3JF91U133	HYDROXYPROPYL CELLULOSE (1200000 WAMW):ORAL:TABLET (IMMED./COMP. RELEASE), UNCOATED, CHEWABLE:MG	ORAL	24MG ORAL TABLET (IMMED./COMP. RELEASE), UNCOATED, CHEWABLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
U3JF91U133	HYDROXYPROPYL CELLULOSE (1200000 WAMW):ORAL:TABLET, CHEWABLE:MG	ORAL	2.5MG ORAL TABLET, CHEWABLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
U3JF91U133	HYDROXYPROPYL CELLULOSE (1200000 WAMW):ORAL:TABLET, COATED:MG	ORAL	8.36MG ORAL TABLET, COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
U3JF91U133	HYDROXYPROPYL CELLULOSE (1200000 WAMW):ORAL:TABLET, CONTROLLED RELEASE:MG	ORAL	43.8MG ORAL TABLET, CONTROLLED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
U3JF91U133	HYDROXYPROPYL CELLULOSE (1200000 WAMW):ORAL:TABLET, DELAYED ACTION:MG	ORAL	8.5MG ORAL TABLET, DELAYED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
U3JF91U133	HYDROXYPROPYL CELLULOSE (1200000 WAMW):ORAL:TABLET, DELAYED ACTION, ENTERIC COATED:MG	ORAL	15MG ORAL TABLET, DELAYED ACTION, ENTERIC COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
U3JF91U133	HYDROXYPROPYL CELLULOSE (1200000 WAMW):ORAL:TABLET, DELAYED RELEASE:MG	ORAL	75MG ORAL TABLET, DELAYED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
U3JF91U133	HYDROXYPROPYL CELLULOSE (1200000 WAMW):ORAL:TABLET, ENTERIC COATED PARTICLES:MG	ORAL	9MG ORAL TABLET, ENTERIC COATED PARTICLES	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
U3JF91U133	HYDROXYPROPYL CELLULOSE (1200000 WAMW):ORAL:TABLET, EXTENDED RELEASE:MG	ORAL	228MG ORAL TABLET, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
U3JF91U133	HYDROXYPROPYL CELLULOSE (1200000 WAMW):ORAL:TABLET, FILM COATED:MG	ORAL	131.67MG ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
U3JF91U133	HYDROXYPROPYL CELLULOSE (1200000 WAMW):ORAL:TABLET, FILM COATED, EXTENDED RELEASE:MG	ORAL	2.03MG ORAL TABLET, FILM COATED, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
U3JF91U133	HYDROXYPROPYL CELLULOSE (1200000 WAMW):ORAL:TABLET, MULTILAYER, EXTENDED RELEASE:MG	ORAL	107MG ORAL TABLET, MULTILAYER, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
U3JF91U133	HYDROXYPROPYL CELLULOSE (1200000 WAMW):ORAL:TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE:MG	ORAL	10MG ORAL TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
U3JF91U133	HYDROXYPROPYL CELLULOSE (1200000 WAMW):ORAL:TABLET, SUSTAINED ACTION:MG	ORAL	240MG ORAL TABLET, SUSTAINED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
U3JF91U133	HYDROXYPROPYL CELLULOSE (1200000 WAMW):ORAL:TABLET, SUSTAINED ACTION, COATED:MG	ORAL	22.75MG ORAL TABLET, SUSTAINED ACTION, COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
U3JF91U133	HYDROXYPROPYL CELLULOSE (1200000 WAMW):ORAL:TABLET, SUSTAINED ACTION, FILM COATED:MG	ORAL	187.6MG ORAL TABLET, SUSTAINED ACTION, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
U3JF91U133	HYDROXYPROPYL CELLULOSE (1200000 WAMW):SUBLINGUAL:TABLET:MG	SUBLINGUAL	1MG SUBLINGUAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
U3JF91U133	HYDROXYPROPYL CELLULOSE (1200000 WAMW):TOPICAL:GEL:%W/W	TOPICAL	4%W/W TOPICAL GEL	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
U3JF91U133	HYDROXYPROPYL CELLULOSE (1200000 WAMW):TOPICAL:LOTION:%W/W	TOPICAL	0.5%W/W TOPICAL LOTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
U3JF91U133	HYDROXYPROPYL CELLULOSE (1200000 WAMW):TOPICAL:LOTION, AUGMENTED:%W/W	TOPICAL	0.54%W/W TOPICAL LOTION, AUGMENTED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
U3JF91U133	HYDROXYPROPYL CELLULOSE (1200000 WAMW):TOPICAL:PATCH:NA	TOPICAL	TOPICAL PATCH	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
U3JF91U133	HYDROXYPROPYL CELLULOSE (1200000 WAMW):TOPICAL:SOLUTION:%W/W	TOPICAL	2.5%W/W TOPICAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
U3JF91U133	HYDROXYPROPYL CELLULOSE (1200000 WAMW):TRANSDERMAL:FILM, CONTROLLED RELEASE:MG	TRANSDERMAL	19MG TRANSDERMAL FILM, CONTROLLED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
U3JF91U133	HYDROXYPROPYL CELLULOSE (1200000 WAMW):TRANSDERMAL:GEL:%	TRANSDERMAL	1.5% TRANSDERMAL GEL	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
U3JF91U133	HYDROXYPROPYL CELLULOSE (1200000 WAMW):TRANSDERMAL:PATCH:MG	TRANSDERMAL	1MG TRANSDERMAL PATCH	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
5ZA2S6B08X	CETYL PALMITATE:TOPICAL:CREAM:%W/W	TOPICAL	0.35%W/W TOPICAL CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
5ZA2S6B08X	CETYL PALMITATE:TOPICAL:EMULSION, CREAM:%W/W	TOPICAL	0.31%W/W TOPICAL EMULSION, CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
5ZA2S6B08X	CETYL PALMITATE:TOPICAL:OINTMENT:NA	TOPICAL	TOPICAL OINTMENT	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
5ZA2S6B08X	CETYL PALMITATE:TOPICAL:SOLUTION:%W/W	TOPICAL	0.05%W/W TOPICAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
5ZA2S6B08X	CETYL PALMITATE:VAGINAL:EMULSION, CREAM:%	VAGINAL	3.3% VAGINAL EMULSION, CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
656HXR6YXN	DOCUSATE SODIUM/SODIUM BENZOATE:ORAL:CAPSULE:MG	ORAL	85MG ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
656HXR6YXN	DOCUSATE SODIUM/SODIUM BENZOATE:ORAL:CAPSULE, EXTENDED RELEASE:MG	ORAL	0.14MG ORAL CAPSULE, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
656HXR6YXN	DOCUSATE SODIUM/SODIUM BENZOATE:ORAL:TABLET:MG	ORAL	8MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
656HXR6YXN	DOCUSATE SODIUM/SODIUM BENZOATE:ORAL:TABLET, FILM COATED:MG	ORAL	3MG ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
K304VI98I3	CANADA BALSAM:TOPICAL:LOTION:%W/W	TOPICAL	0.5%W/W TOPICAL LOTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
5UVC90J1LK	DIATRIZOIC ACID:INTRAMUSCULAR:INJECTION:ADJ PH	INTRAMUSCULAR	ADJ PH INTRAMUSCULAR INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
5UVC90J1LK	DIATRIZOIC ACID:INTRAVASCULAR:INJECTION:ADJ PH	INTRAVASCULAR	ADJ PH INTRAVASCULAR INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
5UVC90J1LK	DIATRIZOIC ACID:INTRAVENOUS:INJECTION:ADJ PH	INTRAVENOUS	ADJ PH INTRAVENOUS INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
5UVC90J1LK	DIATRIZOIC ACID:IV(INFUSION):INJECTION:ADJ PH	IV(INFUSION)	ADJ PH IV(INFUSION) INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
5UVC90J1LK	DIATRIZOIC ACID:URETERAL:SOLUTION:ADJ PH	URETERAL	ADJ PH URETERAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
K7G5SCF8IL	RHODAMINE B:ORAL:SUSPENSION:NA	ORAL	ORAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=R
K7G5SCF8IL	RHODAMINE B:ORAL:TABLET:MG	ORAL	0.005MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=R
K7G5SCF8IL	RHODAMINE B:TOPICAL:EMULSION:%W/W	TOPICAL	0.001%W/W TOPICAL EMULSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=R
9DBA0SBB0L	D&C RED NO. 33:DENTAL:SOLUTION:%	DENTAL	0.001% DENTAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
9DBA0SBB0L	D&C RED NO. 33:ORAL:CAPSULE:MG	ORAL	0.39MG ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
9DBA0SBB0L	D&C RED NO. 33:ORAL:CAPSULE, EXTENDED RELEASE:MG	ORAL	0.003MG ORAL CAPSULE, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
9DBA0SBB0L	D&C RED NO. 33:ORAL:CAPSULE, HARD GELATIN:NA	ORAL	ORAL CAPSULE, HARD GELATIN	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
9DBA0SBB0L	D&C RED NO. 33:ORAL:CAPSULE, SOFT GELATIN:NA	ORAL	ORAL CAPSULE, SOFT GELATIN	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
9DBA0SBB0L	D&C RED NO. 33:ORAL:CAPSULE, SOFT GELATIN LIQUID-FILLED:MG	ORAL	0.011MG ORAL CAPSULE, SOFT GELATIN LIQUID-FILLED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
9DBA0SBB0L	D&C RED NO. 33:ORAL:CAPSULE, SUSTAINED ACTION:MG	ORAL	0.001MG ORAL CAPSULE, SUSTAINED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
9DBA0SBB0L	D&C RED NO. 33:ORAL:CONCENTRATE:%	ORAL	0.002% ORAL CONCENTRATE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
9DBA0SBB0L	D&C RED NO. 33:ORAL:SOLUTION:MG/5ML	ORAL	0.33MG/5ML ORAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
9DBA0SBB0L	D&C RED NO. 33:ORAL:SOLUTION, ELIXIR:MG/5ML	ORAL	27.5MG/5ML ORAL SOLUTION, ELIXIR	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
9DBA0SBB0L	D&C RED NO. 33:ORAL:SUSPENSION:MG/5ML	ORAL	0.13MG/5ML ORAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
9DBA0SBB0L	D&C RED NO. 33:ORAL:SUSPENSION, LIQUID:MG/5ML	ORAL	0.065MG/5ML ORAL SUSPENSION, LIQUID	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
9DBA0SBB0L	D&C RED NO. 33:ORAL:SUSPENSION, SUSTAINED ACTION:NA	ORAL	ORAL SUSPENSION, SUSTAINED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
9DBA0SBB0L	D&C RED NO. 33:ORAL:SYRUP:MG	ORAL	0.097MG ORAL SYRUP	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
9DBA0SBB0L	D&C RED NO. 33:ORAL:TABLET:MG	ORAL	0.29MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
9DBA0SBB0L	D&C RED NO. 33:ORAL:TABLET, COATED:MG	ORAL	0.002MG ORAL TABLET, COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
9DBA0SBB0L	D&C RED NO. 33:ORAL:TABLET, FILM COATED:NA	ORAL	ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
9DBA0SBB0L	D&C RED NO. 33:TOPICAL:SHAMPOO:%W/W	TOPICAL	0.002%W/W TOPICAL SHAMPOO	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
RPF7Z41GAW	SODIUM DITHIONATE:INTRAMUSCULAR:SOLUTION, INJECTION:%W/V	INTRAMUSCULAR	0.32%W/V INTRAMUSCULAR SOLUTION, INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
RPF7Z41GAW	SODIUM DITHIONATE:INTRAVENOUS:SOLUTION, INJECTION:%	INTRAVENOUS	0.32% INTRAVENOUS SOLUTION, INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
7G1J5DA97F	WHITE WAX:ORAL:CAPSULE:MG	ORAL	15.86MG ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=W
7G1J5DA97F	WHITE WAX:ORAL:CAPSULE, SOFT GELATIN:MG	ORAL	18.36MG ORAL CAPSULE, SOFT GELATIN	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=W
7G1J5DA97F	WHITE WAX:ORAL:CAPSULE, SUSTAINED ACTION:MG	ORAL	15.3MG ORAL CAPSULE, SUSTAINED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=W
7G1J5DA97F	WHITE WAX:ORAL:TABLET:MG	ORAL	5MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=W
7G1J5DA97F	WHITE WAX:ORAL:TABLET, COATED:MG	ORAL	3MG ORAL TABLET, COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=W
7G1J5DA97F	WHITE WAX:ORAL:TABLET, DELAYED ACTION, ENTERIC COATED:NA	ORAL	ORAL TABLET, DELAYED ACTION, ENTERIC COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=W
7G1J5DA97F	WHITE WAX:ORAL:TABLET, EXTENDED RELEASE:NA	ORAL	ORAL TABLET, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=W
7G1J5DA97F	WHITE WAX:ORAL:TABLET, FILM COATED:MG	ORAL	0.2MG ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=W
7G1J5DA97F	WHITE WAX:ORAL:TABLET, REPEAT ACTION:MG	ORAL	0.037MG ORAL TABLET, REPEAT ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=W
7G1J5DA97F	WHITE WAX:ORAL:TABLET, SUSTAINED ACTION:MG	ORAL	14MG ORAL TABLET, SUSTAINED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=W
7G1J5DA97F	WHITE WAX:RECTAL:SUPPOSITORY:MG	RECTAL	265MG RECTAL SUPPOSITORY	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=W
7G1J5DA97F	WHITE WAX:TOPICAL:CREAM:%W/W 	TOPICAL	6%W/W  TOPICAL CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=W
7G1J5DA97F	WHITE WAX:TOPICAL:CREAM, AUGMENTED:%W/W	TOPICAL	10%W/W TOPICAL CREAM, AUGMENTED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=W
7G1J5DA97F	WHITE WAX:TOPICAL:EMULSION, CREAM:%W/W	TOPICAL	6%W/W TOPICAL EMULSION, CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=W
7G1J5DA97F	WHITE WAX:TOPICAL:LOTION:%W/W	TOPICAL	1%W/W TOPICAL LOTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=W
7G1J5DA97F	WHITE WAX:TOPICAL:OINTMENT:%W/W	TOPICAL	7.3%W/W TOPICAL OINTMENT	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=W
7G1J5DA97F	WHITE WAX:TOPICAL:OINTMENT, AUGMENTED:%W/W	TOPICAL	6.75%W/W TOPICAL OINTMENT, AUGMENTED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=W
7G1J5DA97F	WHITE WAX:VAGINAL:EMULSION, CREAM:%	VAGINAL	2% VAGINAL EMULSION, CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=W
D5340Y2I9G	CASTOR OIL:INTRAMUSCULAR:INJECTABLE:%W/V	INTRAMUSCULAR	27.78%W/V INTRAMUSCULAR INJECTABLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
D5340Y2I9G	CASTOR OIL:INTRAMUSCULAR:INJECTION:%	INTRAMUSCULAR	29.5% INTRAMUSCULAR INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
D5340Y2I9G	CASTOR OIL:INTRAMUSCULAR:INJECTION, SOLUTION:%V/V	INTRAMUSCULAR	28.6%V/V INTRAMUSCULAR INJECTION, SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
D5340Y2I9G	CASTOR OIL:NASAL:GEL:MG/SPR	NASAL	107MG/SPR NASAL GEL	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
D5340Y2I9G	CASTOR OIL:OPHTHALMIC:EMULSION:%	OPHTHALMIC	5% OPHTHALMIC EMULSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
D5340Y2I9G	CASTOR OIL:ORAL:CAPSULE:MG	ORAL	1.04MG ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
D5340Y2I9G	CASTOR OIL:ORAL:CAPSULE, SUSTAINED ACTION:MG	ORAL	1.76MG ORAL CAPSULE, SUSTAINED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
D5340Y2I9G	CASTOR OIL:ORAL:GRANULE, FOR SUSPENSION:MG	ORAL	32MG ORAL GRANULE, FOR SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
D5340Y2I9G	CASTOR OIL:ORAL:TABLET:MG	ORAL	2MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
D5340Y2I9G	CASTOR OIL:ORAL:TABLET, COATED:MG	ORAL	0.9MG ORAL TABLET, COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
D5340Y2I9G	CASTOR OIL:ORAL:TABLET, FILM COATED:MG	ORAL	3.06MG ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
D5340Y2I9G	CASTOR OIL:ORAL:TABLET, SUSTAINED ACTION:MG	ORAL	23.27MG ORAL TABLET, SUSTAINED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
D5340Y2I9G	CASTOR OIL:ORAL:TABLET, SUSTAINED ACTION, COATED:NA	ORAL	ORAL TABLET, SUSTAINED ACTION, COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
D5340Y2I9G	CASTOR OIL:SUBLINGUAL:TABLET:MG	SUBLINGUAL	1.6MG SUBLINGUAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
D5340Y2I9G	CASTOR OIL:TOPICAL:EMULSION, CREAM:NA	TOPICAL	TOPICAL EMULSION, CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
D5340Y2I9G	CASTOR OIL:TOPICAL:OINTMENT:%W/W	TOPICAL	14.9%W/W TOPICAL OINTMENT	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
D5340Y2I9G	CASTOR OIL:TOPICAL:SOLUTION:NA	TOPICAL	TOPICAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
0240V77G50	PEG-5 OLEATE:ORAL:SOLUTION:%	ORAL	31.9% ORAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
0240V77G50	PEG-5 OLEATE:TOPICAL:EMULSION, CREAM:%W/W	TOPICAL	3.05%W/W TOPICAL EMULSION, CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
0240V77G50	PEG-5 OLEATE:TOPICAL:LOTION:NA	TOPICAL	TOPICAL LOTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
0240V77G50	PEG-5 OLEATE:TOPICAL:SUPPOSITORY:NA	TOPICAL	TOPICAL SUPPOSITORY	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
0240V77G50	PEG-5 OLEATE:VAGINAL:EMULSION, CREAM:%	VAGINAL	3% VAGINAL EMULSION, CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
0240V77G50	PEG-5 OLEATE:VAGINAL:SUPPOSITORY:NA	VAGINAL	VAGINAL SUPPOSITORY	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
WZH3C48M4T	POTASSIUM HYDROXIDE:INTRAVASCULAR:SOLUTION:NA	INTRAVASCULAR	INTRAVASCULAR SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
WZH3C48M4T	POTASSIUM HYDROXIDE:INTRAVENOUS:INJECTION:ADJ PH	INTRAVENOUS	ADJ PH INTRAVENOUS INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
WZH3C48M4T	POTASSIUM HYDROXIDE:IV(INFUSION):INJECTION:ADJ PH	IV(INFUSION)	ADJ PH IV(INFUSION) INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
WZH3C48M4T	POTASSIUM HYDROXIDE:ORAL:CAPSULE:MG	ORAL	28.69MG ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
WZH3C48M4T	POTASSIUM HYDROXIDE:ORAL:CAPSULE, EXTENDED RELEASE:MG	ORAL	0.065MG ORAL CAPSULE, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
WZH3C48M4T	POTASSIUM HYDROXIDE:ORAL:CAPSULE, SOFT GELATIN:MG	ORAL	25.6MG ORAL CAPSULE, SOFT GELATIN	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
WZH3C48M4T	POTASSIUM HYDROXIDE:ORAL:CAPSULE, SOFT GELATIN LIQUID-FILLED:MG	ORAL	25.6MG ORAL CAPSULE, SOFT GELATIN LIQUID-FILLED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
WZH3C48M4T	POTASSIUM HYDROXIDE:ORAL:PASTILLE:ADJ PH	ORAL	ADJ PH ORAL PASTILLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
WZH3C48M4T	POTASSIUM HYDROXIDE:ORAL:SOLUTION:ADJ PH	ORAL	ADJ PH ORAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
WZH3C48M4T	POTASSIUM HYDROXIDE:TOPICAL:CREAM, EMULSION, SUSTAINED RELEASE:%W/W	TOPICAL	0.045%W/W TOPICAL CREAM, EMULSION, SUSTAINED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
WZH3C48M4T	POTASSIUM HYDROXIDE:TOPICAL:EMULSION, AEROSOL FOAM:NA	TOPICAL	TOPICAL EMULSION, AEROSOL FOAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
WZH3C48M4T	POTASSIUM HYDROXIDE:TOPICAL:EMULSION, CREAM:%W/W	TOPICAL	0.5%W/W TOPICAL EMULSION, CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
WZH3C48M4T	POTASSIUM HYDROXIDE:TOPICAL:GEL:%W/W	TOPICAL	0.5%W/W TOPICAL GEL	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
WZH3C48M4T	POTASSIUM HYDROXIDE:TOPICAL:SOLUTION:%W/W	TOPICAL	14.02%W/W TOPICAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
WZH3C48M4T	POTASSIUM HYDROXIDE:TOPICAL:SUPPOSITORY:NA	TOPICAL	TOPICAL SUPPOSITORY	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
WZH3C48M4T	POTASSIUM HYDROXIDE:TOPICAL:SUPPOSITORY, INSERT:%W/W	TOPICAL	0.06%W/W TOPICAL SUPPOSITORY, INSERT	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
WZH3C48M4T	POTASSIUM HYDROXIDE:VAGINAL:CREAM, EMULSION, SUSTAINED RELEASE:%	VAGINAL	0.045% VAGINAL CREAM, EMULSION, SUSTAINED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
WZH3C48M4T	POTASSIUM HYDROXIDE:VAGINAL:EMULSION, CREAM:%	VAGINAL	0.5% VAGINAL EMULSION, CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
AB6MNQ6J6L	SUCCINIC ACID:IM - IV:INJECTION:ADJ PH	IM - IV	ADJ PH IM - IV INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
AB6MNQ6J6L	SUCCINIC ACID:INTRAVENOUS:INJECTION:%	INTRAVENOUS	0.001% INTRAVENOUS INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
AB6MNQ6J6L	SUCCINIC ACID:INTRAVENOUS:POWDER, FOR INJECTION SOLUTION, LYOPHILIZED:mg/vial	INTRAVENOUS	2.693mg/vial INTRAVENOUS POWDER, FOR INJECTION SOLUTION, LYOPHILIZED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
AB6MNQ6J6L	SUCCINIC ACID:IV(INFUSION):INJECTION:%	IV(INFUSION)	0.001% IV(INFUSION) INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
AB6MNQ6J6L	SUCCINIC ACID:ORAL:CAPSULE:mg	ORAL	65mg ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
AB6MNQ6J6L	SUCCINIC ACID:ORAL:CONCENTRATE:MG/1ML	ORAL	6MG/1ML ORAL CONCENTRATE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
AB6MNQ6J6L	SUCCINIC ACID:ORAL:POWDER, FOR ORAL SUSPENSION:MG/5ML	ORAL	0.84MG/5ML ORAL POWDER, FOR ORAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
AB6MNQ6J6L	SUCCINIC ACID:ORAL:POWDER, FOR RECONSTITUTION:MG/5ML	ORAL	1.9MG/5ML ORAL POWDER, FOR RECONSTITUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
AB6MNQ6J6L	SUCCINIC ACID:ORAL:POWDER, FOR SUSPENSION:NA	ORAL	ORAL POWDER, FOR SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
AB6MNQ6J6L	SUCCINIC ACID:ORAL:SOLUTION:MG/1ML	ORAL	0.01MG/1ML ORAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
AB6MNQ6J6L	SUCCINIC ACID:ORAL:TABLET:MG	ORAL	65.1MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
AB6MNQ6J6L	SUCCINIC ACID:ORAL:TABLET (IMMED./COMP. RELEASE), UNCOATED, CHEWABLE:MG	ORAL	2.86MG ORAL TABLET (IMMED./COMP. RELEASE), UNCOATED, CHEWABLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
AB6MNQ6J6L	SUCCINIC ACID:ORAL:TABLET, CONTROLLED RELEASE:MG	ORAL	4MG ORAL TABLET, CONTROLLED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
AB6MNQ6J6L	SUCCINIC ACID:ORAL:TABLET, EXTENDED RELEASE:MG	ORAL	307.06MG ORAL TABLET, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
AB6MNQ6J6L	SUCCINIC ACID:TOPICAL:GEL:ADJ PH	TOPICAL	ADJ PH TOPICAL GEL	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
46N107B71O	SHELLAC:ORAL:CAPSULE:MG	ORAL	330.88MG ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
46N107B71O	SHELLAC:ORAL:CAPSULE, COATED PELLETS:MG	ORAL	0.43MG ORAL CAPSULE, COATED PELLETS	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
46N107B71O	SHELLAC:ORAL:CAPSULE, DELAYED ACTION:MG	ORAL	0.063MG ORAL CAPSULE, DELAYED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
46N107B71O	SHELLAC:ORAL:CAPSULE, DELAYED ACTION, ENTERIC COATED:NA	ORAL	ORAL CAPSULE, DELAYED ACTION, ENTERIC COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
46N107B71O	SHELLAC:ORAL:CAPSULE, DELAYED RELEASE:MG	ORAL	0.02MG ORAL CAPSULE, DELAYED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
46N107B71O	SHELLAC:ORAL:CAPSULE, ENTERIC COATED PELLETS:MG	ORAL	29MG ORAL CAPSULE, ENTERIC COATED PELLETS	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
46N107B71O	SHELLAC:ORAL:CAPSULE, EXTENDED RELEASE:MG	ORAL	0.0783MG ORAL CAPSULE, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
46N107B71O	SHELLAC:ORAL:CAPSULE, SOFT GELATIN:NA	ORAL	ORAL CAPSULE, SOFT GELATIN	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
46N107B71O	SHELLAC:ORAL:CAPSULE, SUSTAINED ACTION:MG	ORAL	75.01MG ORAL CAPSULE, SUSTAINED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
46N107B71O	SHELLAC:ORAL:TABLET:MG	ORAL	24.04MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
46N107B71O	SHELLAC:ORAL:TABLET, COATED:MG	ORAL	15.2MG ORAL TABLET, COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
46N107B71O	SHELLAC:ORAL:TABLET, DELAYED ACTION:MG	ORAL	0.22MG ORAL TABLET, DELAYED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
46N107B71O	SHELLAC:ORAL:TABLET, DELAYED ACTION, ENTERIC COATED:MG	ORAL	21.44MG ORAL TABLET, DELAYED ACTION, ENTERIC COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
46N107B71O	SHELLAC:ORAL:TABLET, EXTENDED RELEASE:MG	ORAL	1.24MG ORAL TABLET, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
46N107B71O	SHELLAC:ORAL:TABLET, FILM COATED:MG	ORAL	4.4MG ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
46N107B71O	SHELLAC:ORAL:TABLET, SUSTAINED ACTION:MG	ORAL	213.24MG ORAL TABLET, SUSTAINED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
46N107B71O	SHELLAC:ORAL:TABLET, SUSTAINED ACTION, COATED:NA	ORAL	ORAL TABLET, SUSTAINED ACTION, COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
46N107B71O	SHELLAC:SUBLINGUAL:FILM:QS	SUBLINGUAL	QS SUBLINGUAL FILM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
3QPI1U3FV8	BUTYLPARABEN:INTRAMUSCULAR:INJECTION:NA	INTRAMUSCULAR	INTRAMUSCULAR INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
3QPI1U3FV8	BUTYLPARABEN:ORAL:CAPSULE:MG	ORAL	0.002MG ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
3QPI1U3FV8	BUTYLPARABEN:ORAL:CAPSULE, SUSTAINED ACTION:NA	ORAL	ORAL CAPSULE, SUSTAINED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
3QPI1U3FV8	BUTYLPARABEN:ORAL:DROPS:MG/1ML	ORAL	1MG/1ML ORAL DROPS	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
3QPI1U3FV8	BUTYLPARABEN:ORAL:EMULSION:NA	ORAL	ORAL EMULSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
3QPI1U3FV8	BUTYLPARABEN:ORAL:LIQUID:MG/120ML	ORAL	6MG/120ML ORAL LIQUID	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
3QPI1U3FV8	BUTYLPARABEN:ORAL:SOLUTION:MG/1ML	ORAL	0.08MG/1ML ORAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
3QPI1U3FV8	BUTYLPARABEN:ORAL:SOLUTION, SYRUP:MG/1ML	ORAL	0.38MG/1ML ORAL SOLUTION, SYRUP	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
3QPI1U3FV8	BUTYLPARABEN:ORAL:SUSPENSION:MG/5ML	ORAL	8MG/5ML ORAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
3QPI1U3FV8	BUTYLPARABEN:ORAL:SYRUP:MG/1GM	ORAL	0.18MG/1GM ORAL SYRUP	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
3QPI1U3FV8	BUTYLPARABEN:ORAL:TABLET, COATED:MG	ORAL	0.004MG ORAL TABLET, COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
3QPI1U3FV8	BUTYLPARABEN:ORAL:TABLET, EXTENDED RELEASE:NA	ORAL	ORAL TABLET, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
3QPI1U3FV8	BUTYLPARABEN:ORAL:TABLET, REPEAT ACTION:MG	ORAL	0.006MG ORAL TABLET, REPEAT ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
3QPI1U3FV8	BUTYLPARABEN:ORAL:TABLET, SUSTAINED ACTION:MG	ORAL	0.04MG ORAL TABLET, SUSTAINED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
3QPI1U3FV8	BUTYLPARABEN:ORAL:TABLET, SUSTAINED ACTION, COATED:NA	ORAL	ORAL TABLET, SUSTAINED ACTION, COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
3QPI1U3FV8	BUTYLPARABEN:RECTAL:LIQUID:%	RECTAL	0.005% RECTAL LIQUID	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
3QPI1U3FV8	BUTYLPARABEN:RECTAL:SOLUTION:%	RECTAL	0.005% RECTAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
3QPI1U3FV8	BUTYLPARABEN:TOPICAL:CREAM, EMULSION, SUSTAINED RELEASE:%W/W	TOPICAL	0.05%W/W TOPICAL CREAM, EMULSION, SUSTAINED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
3QPI1U3FV8	BUTYLPARABEN:TOPICAL:EMULSION, CREAM:%W/W	TOPICAL	0.4%W/W TOPICAL EMULSION, CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
3QPI1U3FV8	BUTYLPARABEN:TOPICAL:LOTION:%W/W 	TOPICAL	0.05%W/W  TOPICAL LOTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
3QPI1U3FV8	BUTYLPARABEN:TOPICAL:OINTMENT:NA	TOPICAL	TOPICAL OINTMENT	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
FU2US082MT	D&C RED NO. 39:ORAL:EMULSION:NA	ORAL	ORAL EMULSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
FU2US082MT	D&C RED NO. 39:TOPICAL:LOTION:NA	TOPICAL	TOPICAL LOTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
936JST6JCN	CETYL ALCOHOL:AURICULAR (OTIC):SUSPENSION:%	AURICULAR (OTIC)	1% AURICULAR (OTIC) SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
936JST6JCN	CETYL ALCOHOL:OPHTHALMIC:SUSPENSION:%	OPHTHALMIC	0.5% OPHTHALMIC SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
936JST6JCN	CETYL ALCOHOL:ORAL:CAPSULE, DELAYED ACTION:MG	ORAL	12.5MG ORAL CAPSULE, DELAYED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
936JST6JCN	CETYL ALCOHOL:ORAL:CAPSULE, DELAYED ACTION, COATED:mg	ORAL	3.25mg ORAL CAPSULE, DELAYED ACTION, COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
936JST6JCN	CETYL ALCOHOL:ORAL:CAPSULE, DELAYED RELEASE:MG	ORAL	2.33MG ORAL CAPSULE, DELAYED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
936JST6JCN	CETYL ALCOHOL:ORAL:CAPSULE, ENTERIC COATED PELLETS:MG	ORAL	3.07MG ORAL CAPSULE, ENTERIC COATED PELLETS	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
936JST6JCN	CETYL ALCOHOL:ORAL:TABLET:NA	ORAL	ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
936JST6JCN	CETYL ALCOHOL:ORAL:TABLET, COATED:MG	ORAL	0.25MG ORAL TABLET, COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
936JST6JCN	CETYL ALCOHOL:ORAL:TABLET, FILM COATED:NA	ORAL	ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
936JST6JCN	CETYL ALCOHOL:ORAL:TABLET, ORALLY DISINTEGRATING:MG	ORAL	8.5MG ORAL TABLET, ORALLY DISINTEGRATING	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
936JST6JCN	CETYL ALCOHOL:ORAL:TABLET, SUSTAINED ACTION:MG	ORAL	44MG ORAL TABLET, SUSTAINED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
936JST6JCN	CETYL ALCOHOL:ORAL:TABLET, SUSTAINED ACTION, FILM COATED:MG	ORAL	59MG ORAL TABLET, SUSTAINED ACTION, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
936JST6JCN	CETYL ALCOHOL:RECTAL:AEROSOL, METERED:%	RECTAL	0.16% RECTAL AEROSOL, METERED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
936JST6JCN	CETYL ALCOHOL:RECTAL:EMULSION, AEROSOL FOAM:%	RECTAL	0.66% RECTAL EMULSION, AEROSOL FOAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
936JST6JCN	CETYL ALCOHOL:TOPICAL:AEROSOL:%W/W	TOPICAL	1.16%W/W TOPICAL AEROSOL	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
936JST6JCN	CETYL ALCOHOL:TOPICAL:AEROSOL, FOAM:%	TOPICAL	1.17% TOPICAL AEROSOL, FOAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
936JST6JCN	CETYL ALCOHOL:TOPICAL:AEROSOL, METERED:NA	TOPICAL	TOPICAL AEROSOL, METERED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
936JST6JCN	CETYL ALCOHOL:TOPICAL:CREAM:%W/W	TOPICAL	6.7%W/W TOPICAL CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
936JST6JCN	CETYL ALCOHOL:TOPICAL:CREAM, AUGMENTED:%W/W	TOPICAL	4%W/W TOPICAL CREAM, AUGMENTED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
936JST6JCN	CETYL ALCOHOL:TOPICAL:CREAM, EMULSION, SUSTAINED RELEASE:%W/W	TOPICAL	7.2%W/W TOPICAL CREAM, EMULSION, SUSTAINED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
936JST6JCN	CETYL ALCOHOL:TOPICAL:EMULSION, AEROSOL FOAM:%W/W	TOPICAL	3.23%W/W TOPICAL EMULSION, AEROSOL FOAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
936JST6JCN	CETYL ALCOHOL:TOPICAL:EMULSION, CREAM:%W/W	TOPICAL	12%W/W TOPICAL EMULSION, CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
936JST6JCN	CETYL ALCOHOL:TOPICAL:LOTION:%W/W	TOPICAL	4.5%W/W TOPICAL LOTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
936JST6JCN	CETYL ALCOHOL:TOPICAL:OINTMENT:%W/W	TOPICAL	7%W/W TOPICAL OINTMENT	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
936JST6JCN	CETYL ALCOHOL:TOPICAL:SUPPOSITORY:NA	TOPICAL	TOPICAL SUPPOSITORY	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
936JST6JCN	CETYL ALCOHOL:TOPICAL:SUPPOSITORY, INSERT:%W/W	TOPICAL	3%W/W TOPICAL SUPPOSITORY, INSERT	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
936JST6JCN	CETYL ALCOHOL:TOPICAL:SUSPENSION:%W/W	TOPICAL	2.01%W/W TOPICAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
936JST6JCN	CETYL ALCOHOL:VAGINAL:CREAM, EMULSION, SUSTAINED RELEASE:%	VAGINAL	5% VAGINAL CREAM, EMULSION, SUSTAINED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
936JST6JCN	CETYL ALCOHOL:VAGINAL:EMULSION, AEROSOL FOAM:%	VAGINAL	0.75% VAGINAL EMULSION, AEROSOL FOAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
936JST6JCN	CETYL ALCOHOL:VAGINAL:EMULSION, CREAM:%	VAGINAL	4% VAGINAL EMULSION, CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
R8WTH25YS2	GLYCERYL DIBEHENATE:ORAL:CAPSULE:MG	ORAL	5.7MG ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
R8WTH25YS2	GLYCERYL DIBEHENATE:ORAL:CAPSULE, ENTERIC COATED PELLETS:MG	ORAL	3.5MG ORAL CAPSULE, ENTERIC COATED PELLETS	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
R8WTH25YS2	GLYCERYL DIBEHENATE:ORAL:CAPSULE, HARD GELATIN:MG	ORAL	2.7MG ORAL CAPSULE, HARD GELATIN	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
R8WTH25YS2	GLYCERYL DIBEHENATE:ORAL:POWDER, FOR ORAL SOLUTION:MG	ORAL	2MG ORAL POWDER, FOR ORAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
R8WTH25YS2	GLYCERYL DIBEHENATE:ORAL:POWDER, FOR ORAL SUSPENSION:MG/25.169GM	ORAL	1971MG/25.169GM ORAL POWDER, FOR ORAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
R8WTH25YS2	GLYCERYL DIBEHENATE:ORAL:SOLUTION:MG	ORAL	3MG ORAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
R8WTH25YS2	GLYCERYL DIBEHENATE:ORAL:TABLET:MG	ORAL	14MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
R8WTH25YS2	GLYCERYL DIBEHENATE:ORAL:TABLET (IMMED./COMP. RELEASE), COATED:MG	ORAL	1.6MG ORAL TABLET (IMMED./COMP. RELEASE), COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
R8WTH25YS2	GLYCERYL DIBEHENATE:ORAL:TABLET, CONTROLLED RELEASE:MG	ORAL	15.04MG ORAL TABLET, CONTROLLED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
R8WTH25YS2	GLYCERYL DIBEHENATE:ORAL:TABLET, DELAYED RELEASE:MG	ORAL	12.5MG ORAL TABLET, DELAYED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
R8WTH25YS2	GLYCERYL DIBEHENATE:ORAL:TABLET, EXTENDED RELEASE:MG	ORAL	142.5MG ORAL TABLET, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
R8WTH25YS2	GLYCERYL DIBEHENATE:ORAL:TABLET, FILM COATED:MG	ORAL	5.25MG ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
R8WTH25YS2	GLYCERYL DIBEHENATE:ORAL:TABLET, ORALLY DISINTEGRATING:MG	ORAL	5.6MG ORAL TABLET, ORALLY DISINTEGRATING	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
R8WTH25YS2	GLYCERYL DIBEHENATE:ORAL:TABLET, SUSTAINED ACTION:MG	ORAL	50.6MG ORAL TABLET, SUSTAINED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
EX438O2MRT	FERRIC OXIDE YELLOW:BUCCAL:FILM:MG	BUCCAL	0.27MG BUCCAL FILM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
EX438O2MRT	FERRIC OXIDE YELLOW:BUCCAL:TABLET:MG	BUCCAL	1MG BUCCAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
EX438O2MRT	FERRIC OXIDE YELLOW:INHALATION:POWDER:MG	INHALATION	0.04MG INHALATION POWDER	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
EX438O2MRT	FERRIC OXIDE YELLOW:ORAL:CAPSULE:MG	ORAL	1.05MG ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
EX438O2MRT	FERRIC OXIDE YELLOW:ORAL:CAPSULE (IMMED./COMP. RELEASE):NA	ORAL	ORAL CAPSULE (IMMED./COMP. RELEASE)	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
EX438O2MRT	FERRIC OXIDE YELLOW:ORAL:CAPSULE (IMMED./COMP. RELEASE), HARD GELATIN:MG	ORAL	0.17MG ORAL CAPSULE (IMMED./COMP. RELEASE), HARD GELATIN	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
EX438O2MRT	FERRIC OXIDE YELLOW:ORAL:CAPSULE, COATED:MG	ORAL	0.012MG ORAL CAPSULE, COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
EX438O2MRT	FERRIC OXIDE YELLOW:ORAL:CAPSULE, DELAYED ACTION:MG	ORAL	0.68MG ORAL CAPSULE, DELAYED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
EX438O2MRT	FERRIC OXIDE YELLOW:ORAL:CAPSULE, DELAYED ACTION, ENTERIC COATED:NA	ORAL	ORAL CAPSULE, DELAYED ACTION, ENTERIC COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
EX438O2MRT	FERRIC OXIDE YELLOW:ORAL:CAPSULE, DELAYED RELEASE:MG	ORAL	0.42MG ORAL CAPSULE, DELAYED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
EX438O2MRT	FERRIC OXIDE YELLOW:ORAL:CAPSULE, ENTERIC COATED PELLETS:NA	ORAL	ORAL CAPSULE, ENTERIC COATED PELLETS	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
EX438O2MRT	FERRIC OXIDE YELLOW:ORAL:CAPSULE, EXTENDED RELEASE:MG	ORAL	1.67MG ORAL CAPSULE, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
EX438O2MRT	FERRIC OXIDE YELLOW:ORAL:CAPSULE, HARD GELATIN:MG	ORAL	0.41MG ORAL CAPSULE, HARD GELATIN	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
EX438O2MRT	FERRIC OXIDE YELLOW:ORAL:CAPSULE, SOFT GELATIN:MG	ORAL	1.23MG ORAL CAPSULE, SOFT GELATIN	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
EX438O2MRT	FERRIC OXIDE YELLOW:ORAL:CAPSULE, SOFT GELATIN LIQUID-FILLED:MG	ORAL	0.1MG ORAL CAPSULE, SOFT GELATIN LIQUID-FILLED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
EX438O2MRT	FERRIC OXIDE YELLOW:ORAL:CAPSULE, SUSTAINED ACTION:MG	ORAL	3.04MG ORAL CAPSULE, SUSTAINED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
EX438O2MRT	FERRIC OXIDE YELLOW:ORAL:GRANULE, FOR ORAL SUSPENSION:MG	ORAL	1.8MG ORAL GRANULE, FOR ORAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
EX438O2MRT	FERRIC OXIDE YELLOW:ORAL:GRANULE, FOR RECONSTITUTION:MG	ORAL	0.25MG ORAL GRANULE, FOR RECONSTITUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
EX438O2MRT	FERRIC OXIDE YELLOW:ORAL:PELLET:MG	ORAL	1.8MG ORAL PELLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
EX438O2MRT	FERRIC OXIDE YELLOW:ORAL:POWDER, FOR ORAL SOLUTION:MG	ORAL	0.38MG ORAL POWDER, FOR ORAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
EX438O2MRT	FERRIC OXIDE YELLOW:ORAL:POWDER, FOR SUSPENSION:mg	ORAL	0.45mg ORAL POWDER, FOR SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
EX438O2MRT	FERRIC OXIDE YELLOW:ORAL:SOFT CAPSULE DOSAGE FORM:mg	ORAL	0.123mg ORAL SOFT CAPSULE DOSAGE FORM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
EX438O2MRT	FERRIC OXIDE YELLOW:ORAL:SUSPENSION, SUSTAINED ACTION:MG/.20684GM	ORAL	0.04MG/.20684GM ORAL SUSPENSION, SUSTAINED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
EX438O2MRT	FERRIC OXIDE YELLOW:ORAL:TABLET:MG	ORAL	2.89MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
EX438O2MRT	FERRIC OXIDE YELLOW:ORAL:TABLET (IMMED./COMP. RELEASE), FILM COATED:MG	ORAL	2.02MG ORAL TABLET (IMMED./COMP. RELEASE), FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
EX438O2MRT	FERRIC OXIDE YELLOW:ORAL:TABLET, CHEWABLE:mg	ORAL	0.7mg ORAL TABLET, CHEWABLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
EX438O2MRT	FERRIC OXIDE YELLOW:ORAL:TABLET, COATED:MG	ORAL	0.38MG ORAL TABLET, COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
EX438O2MRT	FERRIC OXIDE YELLOW:ORAL:TABLET, CONTROLLED RELEASE:MG	ORAL	0.93MG ORAL TABLET, CONTROLLED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
EX438O2MRT	FERRIC OXIDE YELLOW:ORAL:TABLET, DELAYED ACTION:MG	ORAL	0.4MG ORAL TABLET, DELAYED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
EX438O2MRT	FERRIC OXIDE YELLOW:ORAL:TABLET, DELAYED ACTION, ENTERIC COATED:MG	ORAL	0.43MG ORAL TABLET, DELAYED ACTION, ENTERIC COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
EX438O2MRT	FERRIC OXIDE YELLOW:ORAL:TABLET, DELAYED RELEASE:MG	ORAL	0.27MG ORAL TABLET, DELAYED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
EX438O2MRT	FERRIC OXIDE YELLOW:ORAL:TABLET, EXTENDED RELEASE:MG	ORAL	3MG ORAL TABLET, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
EX438O2MRT	FERRIC OXIDE YELLOW:ORAL:TABLET, FILM COATED:MG	ORAL	11.5MG ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
EX438O2MRT	FERRIC OXIDE YELLOW:ORAL:TABLET, FILM COATED, EXTENDED RELEASE:MG	ORAL	2.42MG ORAL TABLET, FILM COATED, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
EX438O2MRT	FERRIC OXIDE YELLOW:ORAL:TABLET, MULTILAYER, EXTENDED RELEASE:MG	ORAL	1.96MG ORAL TABLET, MULTILAYER, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
EX438O2MRT	FERRIC OXIDE YELLOW:ORAL:TABLET, ORALLY DISINTEGRATING:MG	ORAL	1.5MG ORAL TABLET, ORALLY DISINTEGRATING	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
EX438O2MRT	FERRIC OXIDE YELLOW:ORAL:TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE:mg	ORAL	0.32mg ORAL TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
EX438O2MRT	FERRIC OXIDE YELLOW:ORAL:TABLET, SUSTAINED ACTION:MG	ORAL	3MG ORAL TABLET, SUSTAINED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
EX438O2MRT	FERRIC OXIDE YELLOW:ORAL:TABLET, SUSTAINED ACTION, FILM COATED:MG	ORAL	0.065MG ORAL TABLET, SUSTAINED ACTION, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
EX438O2MRT	FERRIC OXIDE YELLOW:ORAL-20:TABLET:mg	ORAL-20	2mg ORAL-20 TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
EX438O2MRT	FERRIC OXIDE YELLOW:SUBLINGUAL:TABLET:MG	SUBLINGUAL	1MG SUBLINGUAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
0RE8K4LNJS	ISOPROPYL MYRISTATE:AURICULAR (OTIC):OIL:%V/V	AURICULAR (OTIC)	3.85%V/V AURICULAR (OTIC) OIL	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=I
0RE8K4LNJS	ISOPROPYL MYRISTATE:AURICULAR (OTIC):SUSPENSION:%	AURICULAR (OTIC)	0.024% AURICULAR (OTIC) SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=I
0RE8K4LNJS	ISOPROPYL MYRISTATE:TOPICAL:AEROSOL:%W/W	TOPICAL	9.3%W/W TOPICAL AEROSOL	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=I
0RE8K4LNJS	ISOPROPYL MYRISTATE:TOPICAL:AEROSOL, SPRAY:NA	TOPICAL	TOPICAL AEROSOL, SPRAY	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=I
0RE8K4LNJS	ISOPROPYL MYRISTATE:TOPICAL:CREAM:%W/W	TOPICAL	10%W/W TOPICAL CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=I
0RE8K4LNJS	ISOPROPYL MYRISTATE:TOPICAL:CREAM, AUGMENTED:%W/W	TOPICAL	8%W/W TOPICAL CREAM, AUGMENTED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=I
0RE8K4LNJS	ISOPROPYL MYRISTATE:TOPICAL:CREAM, EMULSION, SUSTAINED RELEASE:%W/W	TOPICAL	10%W/W TOPICAL CREAM, EMULSION, SUSTAINED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=I
0RE8K4LNJS	ISOPROPYL MYRISTATE:TOPICAL:EMULSION, AEROSOL FOAM:%W/W	TOPICAL	7.9%W/W TOPICAL EMULSION, AEROSOL FOAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=I
0RE8K4LNJS	ISOPROPYL MYRISTATE:TOPICAL:EMULSION, CREAM:%W/W	TOPICAL	15%W/W TOPICAL EMULSION, CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=I
0RE8K4LNJS	ISOPROPYL MYRISTATE:TOPICAL:EMULSION, LOTION:%W/W	TOPICAL	1%W/W TOPICAL EMULSION, LOTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=I
0RE8K4LNJS	ISOPROPYL MYRISTATE:TOPICAL:GEL:%W/W	TOPICAL	10%W/W TOPICAL GEL	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=I
0RE8K4LNJS	ISOPROPYL MYRISTATE:TOPICAL:LOTION:%W/W	TOPICAL	5%W/W TOPICAL LOTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=I
0RE8K4LNJS	ISOPROPYL MYRISTATE:TOPICAL:OIL:%W/W	TOPICAL	13.5%W/W TOPICAL OIL	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=I
0RE8K4LNJS	ISOPROPYL MYRISTATE:TOPICAL:OINTMENT:%W/W	TOPICAL	35%W/W TOPICAL OINTMENT	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=I
0RE8K4LNJS	ISOPROPYL MYRISTATE:TOPICAL:PATCH, CONTROLLED RELEASE:NA	TOPICAL	TOPICAL PATCH, CONTROLLED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=I
0RE8K4LNJS	ISOPROPYL MYRISTATE:TOPICAL:SPRAY:%W/W	TOPICAL	50.3%W/W TOPICAL SPRAY	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=I
0RE8K4LNJS	ISOPROPYL MYRISTATE:TRANSDERMAL:FILM:MG	TRANSDERMAL	58.08MG TRANSDERMAL FILM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=I
0RE8K4LNJS	ISOPROPYL MYRISTATE:TRANSDERMAL:FILM, CONTROLLED RELEASE:MG	TRANSDERMAL	20.4MG TRANSDERMAL FILM, CONTROLLED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=I
0RE8K4LNJS	ISOPROPYL MYRISTATE:TRANSDERMAL:GEL:%W/W	TRANSDERMAL	1%W/W TRANSDERMAL GEL	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=I
0RE8K4LNJS	ISOPROPYL MYRISTATE:TRANSDERMAL:GEL, METERED:%	TRANSDERMAL	1% TRANSDERMAL GEL, METERED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=I
0RE8K4LNJS	ISOPROPYL MYRISTATE:VAGINAL:CREAM, EMULSION, SUPPOSITORY:NA	VAGINAL	VAGINAL CREAM, EMULSION, SUPPOSITORY	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=I
0RE8K4LNJS	ISOPROPYL MYRISTATE:VAGINAL:CREAM, EMULSION, SUSTAINED RELEASE:%	VAGINAL	1% VAGINAL CREAM, EMULSION, SUSTAINED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=I
0RE8K4LNJS	ISOPROPYL MYRISTATE:VAGINAL:EMULSION, CREAM:%	VAGINAL	1% VAGINAL EMULSION, CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=I
0RE8K4LNJS	ISOPROPYL MYRISTATE:VAGINAL:SUPPOSITORY, INSERT:%W/W	VAGINAL	1%W/W VAGINAL SUPPOSITORY, INSERT	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=I
80N308T1NN	ZEIN:ORAL:TABLET:NA	ORAL	ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=Z
80N308T1NN	ZEIN:ORAL:TABLET, COATED:MG	ORAL	3.23MG ORAL TABLET, COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=Z
80N308T1NN	ZEIN:ORAL:TABLET, DELAYED ACTION, ENTERIC COATED:MG	ORAL	1.87MG ORAL TABLET, DELAYED ACTION, ENTERIC COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=Z
80N308T1NN	ZEIN:ORAL:TABLET, EXTENDED RELEASE:MG	ORAL	135MG ORAL TABLET, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=Z
80N308T1NN	ZEIN:ORAL:TABLET, FILM COATED:MG	ORAL	5.75MG ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=Z
80N308T1NN	ZEIN:ORAL:TABLET, REPEAT ACTION:MG	ORAL	4.71MG ORAL TABLET, REPEAT ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=Z
80N308T1NN	ZEIN:ORAL:TABLET, SUSTAINED ACTION:MG	ORAL	135MG ORAL TABLET, SUSTAINED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=Z
92RU3N3Y1O	DIMETHICONE:ORAL:CAPSULE:MG	ORAL	2.2MG ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
92RU3N3Y1O	DIMETHICONE:TOPICAL:EMULSION, AEROSOL FOAM:%W/W	TOPICAL	0.95%W/W TOPICAL EMULSION, AEROSOL FOAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
92RU3N3Y1O	DIMETHICONE:TOPICAL:EMULSION, CREAM:%W/W	TOPICAL	5%W/W TOPICAL EMULSION, CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
92RU3N3Y1O	DIMETHICONE:TOPICAL:LOTION:%W/W	TOPICAL	1%W/W TOPICAL LOTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
92RU3N3Y1O	DIMETHICONE:TRANSDERMAL:FILM, CONTROLLED RELEASE:MG	TRANSDERMAL	564MG TRANSDERMAL FILM, CONTROLLED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
92RU3N3Y1O	DIMETHICONE:TRANSDERMAL:PATCH:mg	TRANSDERMAL	0.45mg TRANSDERMAL PATCH	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
YSE9PPT4TH	HYALURONATE SODIUM:INTRA-ARTICULAR:INJECTABLE:%W/W	INTRA-ARTICULAR	2.3%W/W INTRA-ARTICULAR INJECTABLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
YSE9PPT4TH	HYALURONATE SODIUM:INTRAMUSCULAR:INJECTABLE:%W/W	INTRAMUSCULAR	2.3%W/W INTRAMUSCULAR INJECTABLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
YSE9PPT4TH	HYALURONATE SODIUM:INTRAVITREAL:INJECTABLE:%W/W	INTRAVITREAL	2.3%W/W INTRAVITREAL INJECTABLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
YSE9PPT4TH	HYALURONATE SODIUM:TOPICAL:GEL:%W/W	TOPICAL	2.5%W/W TOPICAL GEL	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
YSE9PPT4TH	HYALURONATE SODIUM:TOPICAL:LOTION:%W/W	TOPICAL	0.011%W/W TOPICAL LOTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
P86KHA8V3K	SPERMACETI:TOPICAL:EMULSION, CREAM:%W/W	TOPICAL	11%W/W TOPICAL EMULSION, CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
P86KHA8V3K	SPERMACETI:VAGINAL:EMULSION, CREAM:%	VAGINAL	3% VAGINAL EMULSION, CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
3D6CWI0P23	MIRIPIRIUM CHLORIDE:INTRA-ARTICULAR:INJECTION:%	INTRA-ARTICULAR	0.019% INTRA-ARTICULAR INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
3D6CWI0P23	MIRIPIRIUM CHLORIDE:INTRALESIONAL:INJECTABLE:%	INTRALESIONAL	0.019% INTRALESIONAL INJECTABLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
3D6CWI0P23	MIRIPIRIUM CHLORIDE:INTRALESIONAL:INJECTION:%	INTRALESIONAL	0.019% INTRALESIONAL INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
3D6CWI0P23	MIRIPIRIUM CHLORIDE:INTRALESIONAL:INJECTION, SUSTAINED ACTION:%	INTRALESIONAL	0.02% INTRALESIONAL INJECTION, SUSTAINED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
3D6CWI0P23	MIRIPIRIUM CHLORIDE:INTRAMUSCULAR:INJECTABLE:%W/V	INTRAMUSCULAR	0.019%W/V INTRAMUSCULAR INJECTABLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
3D6CWI0P23	MIRIPIRIUM CHLORIDE:INTRAMUSCULAR:INJECTION:%W/V	INTRAMUSCULAR	0.019%W/V INTRAMUSCULAR INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
3D6CWI0P23	MIRIPIRIUM CHLORIDE:INTRAMUSCULAR:INJECTION, SUSTAINED ACTION:%W/V	INTRAMUSCULAR	0.02%W/V INTRAMUSCULAR INJECTION, SUSTAINED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
3D6CWI0P23	MIRIPIRIUM CHLORIDE:INTRASYNOVIAL:INJECTABLE:%	INTRASYNOVIAL	0.019% INTRASYNOVIAL INJECTABLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
3D6CWI0P23	MIRIPIRIUM CHLORIDE:INTRASYNOVIAL:INJECTION:NA	INTRASYNOVIAL	INTRASYNOVIAL INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
3D6CWI0P23	MIRIPIRIUM CHLORIDE:INTRASYNOVIAL:INJECTION, SUSTAINED ACTION:%	INTRASYNOVIAL	0.02% INTRASYNOVIAL INJECTION, SUSTAINED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
3D6CWI0P23	MIRIPIRIUM CHLORIDE:SOFT TISSUE:INJECTION:%	SOFT TISSUE	0.019% SOFT TISSUE INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
3D6CWI0P23	MIRIPIRIUM CHLORIDE:SOFT TISSUE:INJECTION, SUSTAINED ACTION:%	SOFT TISSUE	0.02% SOFT TISSUE INJECTION, SUSTAINED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
R40P36GDK6	APAFLURANE:INHALATION:AEROSOL, METERED:%	INHALATION	6.82% INHALATION AEROSOL, METERED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
R40P36GDK6	APAFLURANE:RESPIRATORY (INHALATION):AEROSOL, METERED:%	RESPIRATORY (INHALATION)	7.46% RESPIRATORY (INHALATION) AEROSOL, METERED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
UW86K581WY	CAPSICUM OLEORESIN:ORAL:SYRUP:MG/5ML	ORAL	0.053MG/5ML ORAL SYRUP	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
SY7Q814VUP	CALCIUM:INTRAMUSCULAR:INJECTION:%W/V	INTRAMUSCULAR	0.001%W/V INTRAMUSCULAR INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
SY7Q814VUP	CALCIUM:ORAL:TABLET:MG	ORAL	85.04MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
ETJ7Z6XBU4	SILICON DIOXIDE:BUCCAL:TABLET:MG	BUCCAL	1.25MG BUCCAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
ETJ7Z6XBU4	SILICON DIOXIDE:BUCCAL:TABLET, EXTENDED RELEASE:MG	BUCCAL	0.46MG BUCCAL TABLET, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
ETJ7Z6XBU4	SILICON DIOXIDE:DENTAL:GEL:%	DENTAL	19% DENTAL GEL	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
ETJ7Z6XBU4	SILICON DIOXIDE:DENTAL:PASTE:NA	DENTAL	DENTAL PASTE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
ETJ7Z6XBU4	SILICON DIOXIDE:ENDOCERVICAL:GEL:%	ENDOCERVICAL	8% ENDOCERVICAL GEL	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
ETJ7Z6XBU4	SILICON DIOXIDE:INHALATION:POWDER:NA	INHALATION	INHALATION POWDER	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
ETJ7Z6XBU4	SILICON DIOXIDE:NASAL:GEL:%	NASAL	4% NASAL GEL	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
ETJ7Z6XBU4	SILICON DIOXIDE:ORAL:CAPSULE:MG	ORAL	100MG ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
ETJ7Z6XBU4	SILICON DIOXIDE:ORAL:CAPSULE (IMMED./COMP. RELEASE):MG	ORAL	2.5MG ORAL CAPSULE (IMMED./COMP. RELEASE)	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
ETJ7Z6XBU4	SILICON DIOXIDE:ORAL:CAPSULE (IMMED./COMP. RELEASE), HARD GELATIN:NA	ORAL	ORAL CAPSULE (IMMED./COMP. RELEASE), HARD GELATIN	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
ETJ7Z6XBU4	SILICON DIOXIDE:ORAL:CAPSULE, COATED PELLETS:MG	ORAL	8.61MG ORAL CAPSULE, COATED PELLETS	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
ETJ7Z6XBU4	SILICON DIOXIDE:ORAL:CAPSULE, COATED, SOFT GELATIN:MG	ORAL	0.5MG ORAL CAPSULE, COATED, SOFT GELATIN	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
ETJ7Z6XBU4	SILICON DIOXIDE:ORAL:CAPSULE, DELAYED ACTION:MG	ORAL	13.69MG ORAL CAPSULE, DELAYED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
ETJ7Z6XBU4	SILICON DIOXIDE:ORAL:CAPSULE, DELAYED ACTION, COATED, HARD GELATIN:MG	ORAL	1.28MG ORAL CAPSULE, DELAYED ACTION, COATED, HARD GELATIN	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
ETJ7Z6XBU4	SILICON DIOXIDE:ORAL:CAPSULE, DELAYED ACTION, ENTERIC COATED:NA	ORAL	ORAL CAPSULE, DELAYED ACTION, ENTERIC COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
ETJ7Z6XBU4	SILICON DIOXIDE:ORAL:CAPSULE, DELAYED RELEASE:MG	ORAL	2.6MG ORAL CAPSULE, DELAYED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
ETJ7Z6XBU4	SILICON DIOXIDE:ORAL:CAPSULE, ENTERIC COATED PELLETS:MG	ORAL	9.64MG ORAL CAPSULE, ENTERIC COATED PELLETS	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
ETJ7Z6XBU4	SILICON DIOXIDE:ORAL:CAPSULE, EXTENDED RELEASE:MG	ORAL	15MG ORAL CAPSULE, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
ETJ7Z6XBU4	SILICON DIOXIDE:ORAL:CAPSULE, GELATIN COATED:MG	ORAL	9MG ORAL CAPSULE, GELATIN COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
ETJ7Z6XBU4	SILICON DIOXIDE:ORAL:CAPSULE, HARD GELATIN:MG	ORAL	6MG ORAL CAPSULE, HARD GELATIN	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
ETJ7Z6XBU4	SILICON DIOXIDE:ORAL:CAPSULE, SOFT GELATIN:MG	ORAL	1.73MG ORAL CAPSULE, SOFT GELATIN	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
ETJ7Z6XBU4	SILICON DIOXIDE:ORAL:CAPSULE, SOFT GELATIN LIQUID-FILLED:MG	ORAL	8.8MG ORAL CAPSULE, SOFT GELATIN LIQUID-FILLED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
ETJ7Z6XBU4	SILICON DIOXIDE:ORAL:CAPSULE, SUSTAINED ACTION:MG	ORAL	106MG ORAL CAPSULE, SUSTAINED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
ETJ7Z6XBU4	SILICON DIOXIDE:ORAL:CAPSULE, SUSTAINED ACTION, HARD GELATIN:MG	ORAL	1.7MG ORAL CAPSULE, SUSTAINED ACTION, HARD GELATIN	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
ETJ7Z6XBU4	SILICON DIOXIDE:ORAL:DISPERSIBLE TABLET:MG	ORAL	16MG ORAL DISPERSIBLE TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
ETJ7Z6XBU4	SILICON DIOXIDE:ORAL:DROPS:NA	ORAL	ORAL DROPS	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
ETJ7Z6XBU4	SILICON DIOXIDE:ORAL:FILM, SOLUBLE:MG	ORAL	0.6MG ORAL FILM, SOLUBLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
ETJ7Z6XBU4	SILICON DIOXIDE:ORAL:FOR SUSPENSION:MG/5ML	ORAL	15MG/5ML ORAL FOR SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
ETJ7Z6XBU4	SILICON DIOXIDE:ORAL:GRANULE:MG	ORAL	100MG ORAL GRANULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
ETJ7Z6XBU4	SILICON DIOXIDE:ORAL:GRANULE, ENTERIC COATED:MG	ORAL	3.2MG ORAL GRANULE, ENTERIC COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
ETJ7Z6XBU4	SILICON DIOXIDE:ORAL:GRANULE, for ORAL SOLUTION:MG/SACHET	ORAL	1.8MG/SACHET ORAL GRANULE, for ORAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
ETJ7Z6XBU4	SILICON DIOXIDE:ORAL:GRANULE, FOR RECONSTITUTION:MG	ORAL	16.25MG ORAL GRANULE, FOR RECONSTITUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
ETJ7Z6XBU4	SILICON DIOXIDE:ORAL:GRANULE, FOR SUSPENSION:MG	ORAL	25MG ORAL GRANULE, FOR SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
ETJ7Z6XBU4	SILICON DIOXIDE:ORAL:GRANULE, FOR SUSPENSION, EXTENDED RELEASE:NA	ORAL	ORAL GRANULE, FOR SUSPENSION, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
ETJ7Z6XBU4	SILICON DIOXIDE:ORAL:LOZENGE:mg	ORAL	2mg ORAL LOZENGE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
ETJ7Z6XBU4	SILICON DIOXIDE:ORAL:PELLET:MG	ORAL	0.088MG ORAL PELLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
ETJ7Z6XBU4	SILICON DIOXIDE:ORAL:POWDER:MG/1SCP	ORAL	100MG/1SCP ORAL POWDER	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
ETJ7Z6XBU4	SILICON DIOXIDE:ORAL:POWDER:MG/1GM	ORAL	30MG/1GM ORAL POWDER	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
ETJ7Z6XBU4	SILICON DIOXIDE:ORAL:POWDER:MG	ORAL	0.02MG ORAL POWDER	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
ETJ7Z6XBU4	SILICON DIOXIDE:ORAL:POWDER, FOR ORAL SOLUTION:MG	ORAL	0.75MG ORAL POWDER, FOR ORAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
ETJ7Z6XBU4	SILICON DIOXIDE:ORAL:POWDER, FOR ORAL SUSPENSION:MG/5ML	ORAL	102MG/5ML ORAL POWDER, FOR ORAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
ETJ7Z6XBU4	SILICON DIOXIDE:ORAL:POWDER, FOR ORAL SUSPENSION:MG/PKT	ORAL	30MG/PKT ORAL POWDER, FOR ORAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
ETJ7Z6XBU4	SILICON DIOXIDE:ORAL:POWDER, FOR RECONSTITUTION:MG/5ML	ORAL	200MG/5ML ORAL POWDER, FOR RECONSTITUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
ETJ7Z6XBU4	SILICON DIOXIDE:ORAL:POWDER, FOR SOLUTION:MG/1BOT	ORAL	129MG/1BOT ORAL POWDER, FOR SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
ETJ7Z6XBU4	SILICON DIOXIDE:ORAL:POWDER, FOR SOLUTION:MG/POUCH	ORAL	14.99MG/POUCH ORAL POWDER, FOR SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
ETJ7Z6XBU4	SILICON DIOXIDE:ORAL:POWDER, FOR SUSPENSION:MG/5ML	ORAL	125MG/5ML ORAL POWDER, FOR SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
ETJ7Z6XBU4	SILICON DIOXIDE:ORAL:POWDER, FOR SUSPENSION:MG	ORAL	55MG ORAL POWDER, FOR SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
ETJ7Z6XBU4	SILICON DIOXIDE:ORAL:SOLUTION:mg	ORAL	33.6mg ORAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
ETJ7Z6XBU4	SILICON DIOXIDE:ORAL:SUSPENSION:MG/5ML	ORAL	138MG/5ML ORAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
ETJ7Z6XBU4	SILICON DIOXIDE:ORAL:SUSPENSION, EXTENDED RELEASE:MG/ML	ORAL	2.03MG/ML ORAL SUSPENSION, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
ETJ7Z6XBU4	SILICON DIOXIDE:ORAL:SUSPENSION, SUSTAINED ACTION:MG/.00577GM	ORAL	21.6MG/.00577GM ORAL SUSPENSION, SUSTAINED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
ETJ7Z6XBU4	SILICON DIOXIDE:ORAL:TABLET:mg	ORAL	138.5mg ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
ETJ7Z6XBU4	SILICON DIOXIDE:ORAL:TABLET: MG	ORAL	35 MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
ETJ7Z6XBU4	SILICON DIOXIDE:ORAL:TABLET (IMMED./COMP. RELEASE), COATED:MG	ORAL	6MG ORAL TABLET (IMMED./COMP. RELEASE), COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
ETJ7Z6XBU4	SILICON DIOXIDE:ORAL:TABLET (IMMED./COMP. RELEASE), FILM COATED:MG	ORAL	138MG ORAL TABLET (IMMED./COMP. RELEASE), FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
ETJ7Z6XBU4	SILICON DIOXIDE:ORAL:TABLET (IMMED./COMP. RELEASE), UNCOATED, CHEWABLE:MG	ORAL	84.8MG ORAL TABLET (IMMED./COMP. RELEASE), UNCOATED, CHEWABLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
ETJ7Z6XBU4	SILICON DIOXIDE:ORAL:TABLET, CHEWABLE:MG	ORAL	25MG ORAL TABLET, CHEWABLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
ETJ7Z6XBU4	SILICON DIOXIDE:ORAL:TABLET, COATED:MG	ORAL	24MG ORAL TABLET, COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
ETJ7Z6XBU4	SILICON DIOXIDE:ORAL:TABLET, CONTROLLED RELEASE:MG	ORAL	5.2MG ORAL TABLET, CONTROLLED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
ETJ7Z6XBU4	SILICON DIOXIDE:ORAL:TABLET, DELAYED ACTION:MG	ORAL	170MG ORAL TABLET, DELAYED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
ETJ7Z6XBU4	SILICON DIOXIDE:ORAL:TABLET, DELAYED ACTION, COATED:MG	ORAL	85MG ORAL TABLET, DELAYED ACTION, COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
ETJ7Z6XBU4	SILICON DIOXIDE:ORAL:TABLET, DELAYED ACTION, ENTERIC COATED:MG	ORAL	85MG ORAL TABLET, DELAYED ACTION, ENTERIC COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
ETJ7Z6XBU4	SILICON DIOXIDE:ORAL:TABLET, DELAYED RELEASE:MG	ORAL	7MG ORAL TABLET, DELAYED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
ETJ7Z6XBU4	SILICON DIOXIDE:ORAL:TABLET, DISPERSIBLE:MG	ORAL	6MG ORAL TABLET, DISPERSIBLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
ETJ7Z6XBU4	SILICON DIOXIDE:ORAL:TABLET, ENTERIC COATED PARTICLES:MG	ORAL	3MG ORAL TABLET, ENTERIC COATED PARTICLES	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
ETJ7Z6XBU4	SILICON DIOXIDE:ORAL:TABLET, EXTENDED RELEASE:MG	ORAL	70MG ORAL TABLET, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
ETJ7Z6XBU4	SILICON DIOXIDE:ORAL:TABLET, FILM COATED:MG	ORAL	33MG ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
ETJ7Z6XBU4	SILICON DIOXIDE:ORAL:TABLET, FILM COATED, EXTENDED RELEASE:MG	ORAL	17.5MG ORAL TABLET, FILM COATED, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
ETJ7Z6XBU4	SILICON DIOXIDE:ORAL:TABLET, FOR SUSPENSION:MG	ORAL	6.25MG ORAL TABLET, FOR SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
ETJ7Z6XBU4	SILICON DIOXIDE:ORAL:TABLET, ORALLY DISINTEGRATING:MG	ORAL	20MG ORAL TABLET, ORALLY DISINTEGRATING	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
ETJ7Z6XBU4	SILICON DIOXIDE:ORAL:TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE:MG	ORAL	11.5MG ORAL TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
ETJ7Z6XBU4	SILICON DIOXIDE:ORAL:TABLET, SUGAR COATED:MG	ORAL	0.8MG ORAL TABLET, SUGAR COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
ETJ7Z6XBU4	SILICON DIOXIDE:ORAL:TABLET, SUSTAINED ACTION:MG	ORAL	48MG ORAL TABLET, SUSTAINED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
ETJ7Z6XBU4	SILICON DIOXIDE:ORAL:TABLET, SUSTAINED ACTION, COATED:MG	ORAL	7MG ORAL TABLET, SUSTAINED ACTION, COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
ETJ7Z6XBU4	SILICON DIOXIDE:ORAL:TABLET, SUSTAINED ACTION, FILM COATED:MG	ORAL	60MG ORAL TABLET, SUSTAINED ACTION, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
ETJ7Z6XBU4	SILICON DIOXIDE:ORAL:TABLET, SUSTAINED RELEASE, FILM COATED:MG	ORAL	30MG ORAL TABLET, SUSTAINED RELEASE, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
ETJ7Z6XBU4	SILICON DIOXIDE:RECTAL:SUPPOSITORY:MG	RECTAL	14MG RECTAL SUPPOSITORY	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
ETJ7Z6XBU4	SILICON DIOXIDE:SUBLINGUAL:TABLET:MG	SUBLINGUAL	10MG SUBLINGUAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
ETJ7Z6XBU4	SILICON DIOXIDE:TOPICAL:GEL:%W/W	TOPICAL	0.25%W/W TOPICAL GEL	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
ETJ7Z6XBU4	SILICON DIOXIDE:TRANSDERMAL:FILM, CONTROLLED RELEASE:MG	TRANSDERMAL	49MG TRANSDERMAL FILM, CONTROLLED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
ETJ7Z6XBU4	SILICON DIOXIDE:TRANSDERMAL:PATCH:MG	TRANSDERMAL	12.206MG TRANSDERMAL PATCH	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
ETJ7Z6XBU4	SILICON DIOXIDE:VAGINAL:CREAM, EMULSION, SUSTAINED RELEASE:%W/W	VAGINAL	0.75%W/W VAGINAL CREAM, EMULSION, SUSTAINED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
ETJ7Z6XBU4	SILICON DIOXIDE:VAGINAL:EMULSION, CREAM:%	VAGINAL	1.01% VAGINAL EMULSION, CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
ETJ7Z6XBU4	SILICON DIOXIDE:VAGINAL:INSERT:MG	VAGINAL	2.5MG VAGINAL INSERT	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
ETJ7Z6XBU4	SILICON DIOXIDE:VAGINAL:TABLET:MG	VAGINAL	8MG VAGINAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
ETJ7Z6XBU4	SILICON DIOXIDE:VAGINAL:TAMPON:NA	VAGINAL	VAGINAL TAMPON	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
ETJ7Z6XBU4	SILICON DIOXIDE, COLLOIDAL:ORAL:CAPSULE:mg	ORAL	7mg ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
ETJ7Z6XBU4	SILICON DIOXIDE, COLLOIDAL:ORAL:CAPSULE, DELAYED RELEASE:MG	ORAL	0.5MG ORAL CAPSULE, DELAYED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
ETJ7Z6XBU4	SILICON DIOXIDE, COLLOIDAL:ORAL:CAPSULE, EXTENDED RELEASE:mg	ORAL	9.48mg ORAL CAPSULE, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
ETJ7Z6XBU4	SILICON DIOXIDE, COLLOIDAL:ORAL:POWDER, FOR SUSPENSION:mg	ORAL	27.66mg ORAL POWDER, FOR SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
ETJ7Z6XBU4	SILICON DIOXIDE, COLLOIDAL:ORAL:SUSPENSION:MG/1ML	ORAL	5MG/1ML ORAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
ETJ7Z6XBU4	SILICON DIOXIDE, COLLOIDAL:ORAL:TABLET:MG	ORAL	30MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
ETJ7Z6XBU4	SILICON DIOXIDE, COLLOIDAL:ORAL:TABLET, DELAYED RELEASE:mg	ORAL	15mg ORAL TABLET, DELAYED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
ETJ7Z6XBU4	SILICON DIOXIDE, COLLOIDAL:ORAL:TABLET, EXTENDED RELEASE:mg	ORAL	54.6mg ORAL TABLET, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
ETJ7Z6XBU4	SILICON DIOXIDE, COLLOIDAL:ORAL:TABLET, FILM COATED:mg	ORAL	5mg ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
ETJ7Z6XBU4	SILICON DIOXIDE, COLLOIDAL:ORAL:TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE:mg	ORAL	7.8mg ORAL TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
ETJ7Z6XBU4	SILICON DIOXIDE, COLLOIDAL:ORAL-20:TABLET:mg	ORAL-20	4mg ORAL-20 TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
V42034O9PU	MYRISTYL ALCOHOL:ORAL:TABLET, SUSTAINED ACTION:MG	ORAL	2MG ORAL TABLET, SUSTAINED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
V42034O9PU	MYRISTYL ALCOHOL:TOPICAL:EMULSION, CREAM:%W/W	TOPICAL	3%W/W TOPICAL EMULSION, CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
V42034O9PU	MYRISTYL ALCOHOL:TOPICAL:LOTION:%W/W	TOPICAL	1%W/W TOPICAL LOTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
V42034O9PU	MYRISTYL ALCOHOL:TOPICAL:SUSPENSION:%W/W	TOPICAL	1.05%W/W TOPICAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
9B9691B2N9	MAGNESIUM SILICATE:ORAL:CAPSULE:MG	ORAL	40MG ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
9B9691B2N9	MAGNESIUM SILICATE:ORAL:TABLET:MG	ORAL	10MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
9B9691B2N9	MAGNESIUM SILICATE:ORAL:TABLET, COATED:MG	ORAL	29.03MG ORAL TABLET, COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
9B9691B2N9	MAGNESIUM SILICATE:ORAL:TABLET, ENTERIC COATED PARTICLES:MG	ORAL	30MG ORAL TABLET, ENTERIC COATED PARTICLES	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
9B9691B2N9	MAGNESIUM SILICATE:ORAL:TABLET, FILM COATED:MG	ORAL	14.3MG ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
9B9691B2N9	MAGNESIUM SILICATE:SUBLINGUAL:TABLET:MG	SUBLINGUAL	1.2MG SUBLINGUAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
H3E878020N	COTTONSEED OIL:INTRAMUSCULAR:INJECTABLE:NA	INTRAMUSCULAR	INTRAMUSCULAR INJECTABLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
H3E878020N	COTTONSEED OIL:INTRAMUSCULAR:INJECTION:%W/V	INTRAMUSCULAR	87.46%W/V INTRAMUSCULAR INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
H3E878020N	COTTONSEED OIL:ORAL:CAPSULE, SOFT GELATIN:NA	ORAL	ORAL CAPSULE, SOFT GELATIN	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
H3E878020N	COTTONSEED OIL:ORAL:TABLET:MG	ORAL	0.16MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
8PJ61P6TS3	BUTYL ALCOHOL:ORAL:CAPSULE, DELAYED ACTION, ENTERIC COATED:NA	ORAL	ORAL CAPSULE, DELAYED ACTION, ENTERIC COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
8PJ61P6TS3	BUTYL ALCOHOL:ORAL:TABLET, COATED:NA	ORAL	ORAL TABLET, COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
8PJ61P6TS3	BUTYL ALCOHOL:ORAL:TABLET, DELAYED ACTION:MG	ORAL	0.011MG ORAL TABLET, DELAYED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
8PJ61P6TS3	BUTYL ALCOHOL:ORAL:TABLET, DELAYED RELEASE:MG	ORAL	0.052MG ORAL TABLET, DELAYED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
8PJ61P6TS3	BUTYL ALCOHOL:ORAL:TABLET, EXTENDED RELEASE:MG	ORAL	0.2MG ORAL TABLET, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
8PJ61P6TS3	BUTYL ALCOHOL:TOPICAL:SOLUTION:%W/W	TOPICAL	0.079%W/W TOPICAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
8PJ61P6TS3	BUTYL ALCOHOL:TOPICAL:SWAB:NA	TOPICAL	TOPICAL SWAB	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
8TL7LH93FM	ERYTHROSINE SODIUM ANHYDROUS:ORAL:CAPSULE:MG	ORAL	0.42MG ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
52QK2NZ2T0	1,2-DIMYRISTOYL-SN-GLYCERO-3-PHOSPHOCHOLINE:INTRAVENOUS:POWDER, FOR INJECTION SOLUTION, LYOPHILIZED:%	INTRAVENOUS	7.05% INTRAVENOUS POWDER, FOR INJECTION SOLUTION, LYOPHILIZED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=1
52QK2NZ2T0	1,2-DIMYRISTOYL-SN-GLYCERO-3-PHOSPHOCHOLINE:IV(INFUSION):SUSPENSION, INJECTION:%	IV(INFUSION)	0.34% IV(INFUSION) SUSPENSION, INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=1
1BQV3749L5	STANNOUS CHLORIDE:INTRADERMAL:POWDER, FOR INJECTION SOLUTION:%	INTRADERMAL	0.008% INTRADERMAL POWDER, FOR INJECTION SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
1BQV3749L5	STANNOUS CHLORIDE:INTRAVENOUS:INJECTION:%	INTRAVENOUS	0.34% INTRAVENOUS INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
1BQV3749L5	STANNOUS CHLORIDE:INTRAVENOUS:POWDER, FOR INJECTION SOLUTION:%	INTRAVENOUS	0.025% INTRAVENOUS POWDER, FOR INJECTION SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
1BQV3749L5	STANNOUS CHLORIDE:INTRAVENOUS:POWDER, FOR INJECTION SOLUTION, LYOPHILIZED:UG/1VIAL	INTRAVENOUS	7.6UG/1VIAL INTRAVENOUS POWDER, FOR INJECTION SOLUTION, LYOPHILIZED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
1BQV3749L5	STANNOUS CHLORIDE:IV(INFUSION):INJECTION:%	IV(INFUSION)	0.05% IV(INFUSION) INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
1BQV3749L5	STANNOUS CHLORIDE:IV(INFUSION):POWDER, FOR INJECTION SOLUTION, LYOPHILIZED:%	IV(INFUSION)	0.003% IV(INFUSION) POWDER, FOR INJECTION SOLUTION, LYOPHILIZED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
1BQV3749L5	STANNOUS CHLORIDE:SUBCUTANEOUS:POWDER, FOR INJECTION SOLUTION:%	SUBCUTANEOUS	0.008% SUBCUTANEOUS POWDER, FOR INJECTION SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
4987GT719I	GLYCERYL MONOCITRATE:TOPICAL:EMULSION, CREAM:%W/W	TOPICAL	0.05%W/W TOPICAL EMULSION, CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
GMW67QNF9C	LEUCINE:IV(INFUSION):INJECTION:%	IV(INFUSION)	52.6% IV(INFUSION) INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
GMW67QNF9C	LEUCINE:IV(INFUSION):SOLUTION, INJECTION:%	IV(INFUSION)	0.27% IV(INFUSION) SOLUTION, INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
GMW67QNF9C	LEUCINE:ORAL:CAPSULE:MG	ORAL	0.78MG ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
GMW67QNF9C	LEUCINE:ORAL:TABLET:MG	ORAL	4.5MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
2DMT128M1S	CETOSTEARYL ALCOHOL:ORAL:CAPSULE, EXTENDED RELEASE:MG	ORAL	9.43MG ORAL CAPSULE, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
2DMT128M1S	CETOSTEARYL ALCOHOL:ORAL:TABLET, EXTENDED RELEASE:MG	ORAL	200MG ORAL TABLET, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
2DMT128M1S	CETOSTEARYL ALCOHOL:ORAL:TABLET, SUSTAINED ACTION:MG	ORAL	70MG ORAL TABLET, SUSTAINED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
2DMT128M1S	CETOSTEARYL ALCOHOL:ORAL:TABLET, SUSTAINED ACTION, FILM COATED:MG	ORAL	62MG ORAL TABLET, SUSTAINED ACTION, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
2DMT128M1S	CETOSTEARYL ALCOHOL:TOPICAL:AEROSOL, FOAM:%W/W	TOPICAL	0.26%W/W TOPICAL AEROSOL, FOAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
2DMT128M1S	CETOSTEARYL ALCOHOL:TOPICAL:CREAM:%W/W	TOPICAL	12%W/W TOPICAL CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
2DMT128M1S	CETOSTEARYL ALCOHOL:TOPICAL:CREAM, AUGMENTED:%W/W	TOPICAL	8%W/W TOPICAL CREAM, AUGMENTED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
2DMT128M1S	CETOSTEARYL ALCOHOL:TOPICAL:CREAM, EMULSION, SUSTAINED RELEASE:%W/W	TOPICAL	11.5%W/W TOPICAL CREAM, EMULSION, SUSTAINED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
2DMT128M1S	CETOSTEARYL ALCOHOL:TOPICAL:EMULSION, AEROSOL FOAM:%W/W	TOPICAL	1.09%W/W TOPICAL EMULSION, AEROSOL FOAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
2DMT128M1S	CETOSTEARYL ALCOHOL:TOPICAL:EMULSION, CREAM:%W/W	TOPICAL	11.4%W/W TOPICAL EMULSION, CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
2DMT128M1S	CETOSTEARYL ALCOHOL:TOPICAL:EMULSION, LOTION:%W/W	TOPICAL	5%W/W TOPICAL EMULSION, LOTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
2DMT128M1S	CETOSTEARYL ALCOHOL:TOPICAL:LOTION:%W/W	TOPICAL	5%W/W TOPICAL LOTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
2DMT128M1S	CETOSTEARYL ALCOHOL:TOPICAL:OINTMENT:%W/W	TOPICAL	1.2%W/W TOPICAL OINTMENT	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
2DMT128M1S	CETOSTEARYL ALCOHOL:TOPICAL:SPRAY:%W/W	TOPICAL	1%W/W TOPICAL SPRAY	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
2DMT128M1S	CETOSTEARYL ALCOHOL:TOPICAL:SUPPOSITORY, INSERT:NA	TOPICAL	TOPICAL SUPPOSITORY, INSERT	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
2DMT128M1S	CETOSTEARYL ALCOHOL:TOPICAL:SUSPENSION:%W/W	TOPICAL	2.5%W/W TOPICAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
2DMT128M1S	CETOSTEARYL ALCOHOL:TOPICAL:TABLET:NA	TOPICAL	TOPICAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
2DMT128M1S	CETOSTEARYL ALCOHOL:VAGINAL:CREAM, AUGMENTED:%	VAGINAL	10% VAGINAL CREAM, AUGMENTED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
2DMT128M1S	CETOSTEARYL ALCOHOL:VAGINAL:EMULSION, CREAM:%	VAGINAL	12% VAGINAL EMULSION, CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
2DMT128M1S	CETOSTEARYL ALCOHOL:VAGINAL:SUPPOSITORY, INSERT:NA	VAGINAL	VAGINAL SUPPOSITORY, INSERT	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
2DMT128M1S	CETOSTEARYL ALCOHOL:VAGINAL:TABLET:NA	VAGINAL	VAGINAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
J2B2A4N98G	LACTOSE, UNSPECIFIED FORM:BUCCAL:TABLET:MG	BUCCAL	183.3MG BUCCAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
J2B2A4N98G	LACTOSE, UNSPECIFIED FORM:BUCCAL/SUBLINGUAL:TABLET:MG	BUCCAL/SUBLINGUAL	296.7MG BUCCAL/SUBLINGUAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
J2B2A4N98G	LACTOSE, UNSPECIFIED FORM:IM - IV:INJECTION:%	IM - IV	20.35% IM - IV INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
J2B2A4N98G	LACTOSE, UNSPECIFIED FORM:IM - IV:POWDER, FOR INJECTION SOLUTION:NA	IM - IV	IM - IV POWDER, FOR INJECTION SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
J2B2A4N98G	LACTOSE, UNSPECIFIED FORM:IM - IV - SC:INJECTION:NA	IM - IV - SC	IM - IV - SC INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
J2B2A4N98G	LACTOSE, UNSPECIFIED FORM:IM - IV - SC:POWDER, FOR INJECTION SOLUTION:%	IM - IV - SC	13.3% IM - IV - SC POWDER, FOR INJECTION SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
J2B2A4N98G	LACTOSE, UNSPECIFIED FORM:INHALATION:CAPSULE:MG	INHALATION	20MG INHALATION CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
J2B2A4N98G	LACTOSE, UNSPECIFIED FORM:INHALATION:CAPSULE, HARD GELATIN:MG	INHALATION	25MG INHALATION CAPSULE, HARD GELATIN	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
J2B2A4N98G	LACTOSE, UNSPECIFIED FORM:INHALATION:POWDER:%	INHALATION	9% INHALATION POWDER	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
J2B2A4N98G	LACTOSE, UNSPECIFIED FORM:INHALATIONPOWDER, METERED:POWDER, METERED:MG/1GM	INHALATIONPOWDER, METERED	870MG/1GM INHALATIONPOWDER, METERED POWDER, METERED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
J2B2A4N98G	LACTOSE, UNSPECIFIED FORM:INTRACAVITARY:POWDER, FOR INJECTION SOLUTION, LYOPHILIZED:%	INTRACAVITARY	19.38% INTRACAVITARY POWDER, FOR INJECTION SOLUTION, LYOPHILIZED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
J2B2A4N98G	LACTOSE, UNSPECIFIED FORM:INTRAMUSCULAR:INJECTION:NA	INTRAMUSCULAR	INTRAMUSCULAR INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
J2B2A4N98G	LACTOSE, UNSPECIFIED FORM:INTRAMUSCULAR:POWDER, FOR INJECTION SOLUTION:%	INTRAMUSCULAR	2% INTRAMUSCULAR POWDER, FOR INJECTION SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
J2B2A4N98G	LACTOSE, UNSPECIFIED FORM:INTRAVENOUS:INJECTION:%	INTRAVENOUS	1% INTRAVENOUS INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
J2B2A4N98G	LACTOSE, UNSPECIFIED FORM:INTRAVENOUS:POWDER, FOR INJECTION SOLUTION:%	INTRAVENOUS	5% INTRAVENOUS POWDER, FOR INJECTION SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
J2B2A4N98G	LACTOSE, UNSPECIFIED FORM:IV(INFUSION):POWDER, FOR INJECTION SOLUTION, LYOPHILIZED:%	IV(INFUSION)	10% IV(INFUSION) POWDER, FOR INJECTION SOLUTION, LYOPHILIZED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
J2B2A4N98G	LACTOSE, UNSPECIFIED FORM:IV(INFUSION):SOLUTION, INJECTION:%	IV(INFUSION)	0.45% IV(INFUSION) SOLUTION, INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
J2B2A4N98G	LACTOSE, UNSPECIFIED FORM:ORAL:CAPSULE:MG	ORAL	530MG ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
J2B2A4N98G	LACTOSE, UNSPECIFIED FORM:ORAL:CAPSULE, COATED PELLETS:MG	ORAL	102.44MG ORAL CAPSULE, COATED PELLETS	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
J2B2A4N98G	LACTOSE, UNSPECIFIED FORM:ORAL:CAPSULE, DELAYED ACTION, ENTERIC COATED:NA	ORAL	ORAL CAPSULE, DELAYED ACTION, ENTERIC COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
J2B2A4N98G	LACTOSE, UNSPECIFIED FORM:ORAL:CAPSULE, ENTERIC COATED PELLETS:MG	ORAL	231.84MG ORAL CAPSULE, ENTERIC COATED PELLETS	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
J2B2A4N98G	LACTOSE, UNSPECIFIED FORM:ORAL:CAPSULE, HARD GELATIN:MG	ORAL	100MG ORAL CAPSULE, HARD GELATIN	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
J2B2A4N98G	LACTOSE, UNSPECIFIED FORM:ORAL:CAPSULE, SOFT GELATIN:MG	ORAL	115.75MG ORAL CAPSULE, SOFT GELATIN	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
J2B2A4N98G	LACTOSE, UNSPECIFIED FORM:ORAL:CAPSULE, SUSTAINED ACTION:MG	ORAL	120MG ORAL CAPSULE, SUSTAINED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
J2B2A4N98G	LACTOSE, UNSPECIFIED FORM:ORAL:CONCENTRATE:NA	ORAL	ORAL CONCENTRATE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
J2B2A4N98G	LACTOSE, UNSPECIFIED FORM:ORAL:GRANULE:MG/5ML	ORAL	650.75MG/5ML ORAL GRANULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
J2B2A4N98G	LACTOSE, UNSPECIFIED FORM:ORAL:GRANULE, FOR SUSPENSION:NA	ORAL	ORAL GRANULE, FOR SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
J2B2A4N98G	LACTOSE, UNSPECIFIED FORM:ORAL:POWDER, FOR SOLUTION:NA	ORAL	ORAL POWDER, FOR SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
J2B2A4N98G	LACTOSE, UNSPECIFIED FORM:ORAL:SOLUTION:MG/15ML	ORAL	1682MG/15ML ORAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
J2B2A4N98G	LACTOSE, UNSPECIFIED FORM:ORAL:TABLET:MG	ORAL	2217MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
J2B2A4N98G	LACTOSE, UNSPECIFIED FORM:ORAL:TABLET (IMMED./COMP. RELEASE), UNCOATED, CHEWABLE:MG	ORAL	117.7MG ORAL TABLET (IMMED./COMP. RELEASE), UNCOATED, CHEWABLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
J2B2A4N98G	LACTOSE, UNSPECIFIED FORM:ORAL:TABLET, COATED:MG	ORAL	332.05MG ORAL TABLET, COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
J2B2A4N98G	LACTOSE, UNSPECIFIED FORM:ORAL:TABLET, CONTROLLED RELEASE:MG	ORAL	0.017MG ORAL TABLET, CONTROLLED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
J2B2A4N98G	LACTOSE, UNSPECIFIED FORM:ORAL:TABLET, DELAYED ACTION:MG	ORAL	92.02MG ORAL TABLET, DELAYED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
J2B2A4N98G	LACTOSE, UNSPECIFIED FORM:ORAL:TABLET, DELAYED ACTION, ENTERIC COATED:MG	ORAL	209MG ORAL TABLET, DELAYED ACTION, ENTERIC COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
J2B2A4N98G	LACTOSE, UNSPECIFIED FORM:ORAL:TABLET, DELAYED RELEASE:NA	ORAL	ORAL TABLET, DELAYED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
J2B2A4N98G	LACTOSE, UNSPECIFIED FORM:ORAL:TABLET, EXTENDED RELEASE:MG	ORAL	122.99MG ORAL TABLET, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
J2B2A4N98G	LACTOSE, UNSPECIFIED FORM:ORAL:TABLET, FILM COATED:MG	ORAL	590MG ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
J2B2A4N98G	LACTOSE, UNSPECIFIED FORM:ORAL:TABLET, MULTILAYER, EXTENDED RELEASE:MG	ORAL	122MG ORAL TABLET, MULTILAYER, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
J2B2A4N98G	LACTOSE, UNSPECIFIED FORM:ORAL:TABLET, REPEAT ACTION:MG	ORAL	153.2MG ORAL TABLET, REPEAT ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
J2B2A4N98G	LACTOSE, UNSPECIFIED FORM:ORAL:TABLET, SUSTAINED ACTION:MG	ORAL	400MG ORAL TABLET, SUSTAINED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
J2B2A4N98G	LACTOSE, UNSPECIFIED FORM:ORAL:TABLET, SUSTAINED ACTION, FILM COATED:MG	ORAL	51.1MG ORAL TABLET, SUSTAINED ACTION, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
J2B2A4N98G	LACTOSE, UNSPECIFIED FORM:ORAL:TABLET, SUSTAINED RELEASE, FILM COATED:MG	ORAL	38.75MG ORAL TABLET, SUSTAINED RELEASE, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
J2B2A4N98G	LACTOSE, UNSPECIFIED FORM:RECTAL:SOLUTION:%	RECTAL	8% RECTAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
J2B2A4N98G	LACTOSE, UNSPECIFIED FORM:RECTAL:TABLET:MG	RECTAL	20MG RECTAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
J2B2A4N98G	LACTOSE, UNSPECIFIED FORM:SUBCUTANEOUS:POWDER, FOR INJECTION SOLUTION:%	SUBCUTANEOUS	2% SUBCUTANEOUS POWDER, FOR INJECTION SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
J2B2A4N98G	LACTOSE, UNSPECIFIED FORM:SUBCUTANEOUS:POWDER, FOR INJECTION SOLUTION, LYOPHILIZED:%	SUBCUTANEOUS	0.5% SUBCUTANEOUS POWDER, FOR INJECTION SOLUTION, LYOPHILIZED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
J2B2A4N98G	LACTOSE, UNSPECIFIED FORM:SUBLINGUAL:TABLET:MG	SUBLINGUAL	175.92MG SUBLINGUAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
J2B2A4N98G	LACTOSE, UNSPECIFIED FORM:TOPICAL:EMULSION, CREAM:NA	TOPICAL	TOPICAL EMULSION, CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
J2B2A4N98G	LACTOSE, UNSPECIFIED FORM:TRANSDERMAL:FILM, CONTROLLED RELEASE:MG	TRANSDERMAL	675MG TRANSDERMAL FILM, CONTROLLED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
J2B2A4N98G	LACTOSE, UNSPECIFIED FORM:TRANSDERMAL:OINTMENT:%	TRANSDERMAL	18.9% TRANSDERMAL OINTMENT	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
J2B2A4N98G	LACTOSE, UNSPECIFIED FORM:VAGINAL:EMULSION, CREAM:%	VAGINAL	3% VAGINAL EMULSION, CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
J2B2A4N98G	LACTOSE, UNSPECIFIED FORM:VAGINAL:SUPPOSITORY:NA	VAGINAL	VAGINAL SUPPOSITORY	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
J2B2A4N98G	LACTOSE, UNSPECIFIED FORM:VAGINAL:TABLET:MG	VAGINAL	1013MG VAGINAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
X3W0AM1JLX	FD&C RED NO. 4:TOPICAL:LOTION:%W/W	TOPICAL	0.001%W/W TOPICAL LOTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NVZ4I0H58X	SORBITAN MONOSTEARATE:ORAL:SUSPENSION:MG/5ML	ORAL	62.5MG/5ML ORAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
NVZ4I0H58X	SORBITAN MONOSTEARATE:TOPICAL:CREAM:%W/W	TOPICAL	8%W/W TOPICAL CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
NVZ4I0H58X	SORBITAN MONOSTEARATE:TOPICAL:CREAM, AUGMENTED:%W/W	TOPICAL	2%W/W TOPICAL CREAM, AUGMENTED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
NVZ4I0H58X	SORBITAN MONOSTEARATE:TOPICAL:CREAM, EMULSION, SUSTAINED RELEASE:%W/W	TOPICAL	5%W/W TOPICAL CREAM, EMULSION, SUSTAINED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
NVZ4I0H58X	SORBITAN MONOSTEARATE:TOPICAL:EMULSION, CREAM:%W/W	TOPICAL	6%W/W TOPICAL EMULSION, CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
NVZ4I0H58X	SORBITAN MONOSTEARATE:TOPICAL:LOTION:%W/W	TOPICAL	2.5%W/W TOPICAL LOTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
NVZ4I0H58X	SORBITAN MONOSTEARATE:TOPICAL:OINTMENT:NA	TOPICAL	TOPICAL OINTMENT	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
NVZ4I0H58X	SORBITAN MONOSTEARATE:TOPICAL:SOLUTION:NA	TOPICAL	TOPICAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
NVZ4I0H58X	SORBITAN MONOSTEARATE:TOPICAL:SPRAY:%W/W	TOPICAL	4.58%W/W TOPICAL SPRAY	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
NVZ4I0H58X	SORBITAN MONOSTEARATE:TOPICAL:SUPPOSITORY, INSERT:NA	TOPICAL	TOPICAL SUPPOSITORY, INSERT	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
NVZ4I0H58X	SORBITAN MONOSTEARATE:TOPICAL:SUSPENSION:%W/W	TOPICAL	2.15%W/W TOPICAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
NVZ4I0H58X	SORBITAN MONOSTEARATE:TOPICAL:TABLET:NA	TOPICAL	TOPICAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
NVZ4I0H58X	SORBITAN MONOSTEARATE:VAGINAL:CREAM, AUGMENTED:%	VAGINAL	2% VAGINAL CREAM, AUGMENTED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
NVZ4I0H58X	SORBITAN MONOSTEARATE:VAGINAL:EMULSION, CREAM:%	VAGINAL	5% VAGINAL EMULSION, CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
NVZ4I0H58X	SORBITAN MONOSTEARATE:VAGINAL:SUPPOSITORY, INSERT:NA	VAGINAL	VAGINAL SUPPOSITORY, INSERT	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
NVZ4I0H58X	SORBITAN MONOSTEARATE:VAGINAL:TABLET:NA	VAGINAL	VAGINAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
5HK03SA80J	SODIUM TRIPOLYPHOSPHATE, UNSPECIFIED FORM:ORAL:TABLET:MG	ORAL	8MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
5A9KE2L9L3	ORANGE JUICE:ORAL:POWDER:MG/1SCP	ORAL	12.5MG/1SCP ORAL POWDER	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
5A9KE2L9L3	ORANGE JUICE:ORAL:SOLUTION:%	ORAL	0.01% ORAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
5A9KE2L9L3	ORANGE JUICE:ORAL:SUSPENSION:NA	ORAL	ORAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
FD0913P475	STEARETH-10:RECTAL:AEROSOL, METERED:%	RECTAL	0.23% RECTAL AEROSOL, METERED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
FD0913P475	STEARETH-10:TOPICAL:AEROSOL, METERED:NA	TOPICAL	TOPICAL AEROSOL, METERED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
FD0913P475	STEARETH-10:TOPICAL:EMULSION, AEROSOL FOAM:NA	TOPICAL	TOPICAL EMULSION, AEROSOL FOAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
48Q180SH9T	NONOXYNOL-9:OPHTHALMIC:SOLUTION:%	OPHTHALMIC	0.13% OPHTHALMIC SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=N
48Q180SH9T	NONOXYNOL-9:TOPICAL:SOLUTION:%W/W	TOPICAL	0.01%W/W TOPICAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=N
H5RIZ3MPW4	DIAZOLIDINYL UREA:TOPICAL:CREAM, EMULSION, SUSTAINED RELEASE:%W/W	TOPICAL	0.2%W/W TOPICAL CREAM, EMULSION, SUSTAINED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
H5RIZ3MPW4	DIAZOLIDINYL UREA:TOPICAL:EMULSION, CREAM:%W/W	TOPICAL	0.2%W/W TOPICAL EMULSION, CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
H5RIZ3MPW4	DIAZOLIDINYL UREA:TOPICAL:LOTION:NA	TOPICAL	TOPICAL LOTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
H5RIZ3MPW4	DIAZOLIDINYL UREA:TOPICAL:OINTMENT:%W/W	TOPICAL	0.1%W/W TOPICAL OINTMENT	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
0ZBX0N59RZ	ACETYLTRIBUTYL CITRATE:ORAL:CAPSULE:MG	ORAL	6.57MG ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
0ZBX0N59RZ	ACETYLTRIBUTYL CITRATE:ORAL:CAPSULE, COATED:MG	ORAL	3.5MG ORAL CAPSULE, COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
0ZBX0N59RZ	ACETYLTRIBUTYL CITRATE:ORAL:CAPSULE, DELAYED RELEASE:MG	ORAL	4.72MG ORAL CAPSULE, DELAYED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
0ZBX0N59RZ	ACETYLTRIBUTYL CITRATE:ORAL:CAPSULE, ENTERIC COATED PELLETS:MG	ORAL	7.6MG ORAL CAPSULE, ENTERIC COATED PELLETS	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
0ZBX0N59RZ	ACETYLTRIBUTYL CITRATE:ORAL:CAPSULE, EXTENDED RELEASE:MG	ORAL	18.96MG ORAL CAPSULE, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
0ZBX0N59RZ	ACETYLTRIBUTYL CITRATE:ORAL:CAPSULE, SUSTAINED ACTION:MG	ORAL	18.98MG ORAL CAPSULE, SUSTAINED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
0ZBX0N59RZ	ACETYLTRIBUTYL CITRATE:ORAL:TABLET:MG	ORAL	0.56MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
0ZBX0N59RZ	ACETYLTRIBUTYL CITRATE:ORAL:TABLET, DELAYED RELEASE:MG	ORAL	11.54MG ORAL TABLET, DELAYED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
0ZBX0N59RZ	ACETYLTRIBUTYL CITRATE:ORAL:TABLET, ENTERIC COATED PARTICLES:MG	ORAL	18.7MG ORAL TABLET, ENTERIC COATED PARTICLES	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
0ZBX0N59RZ	ACETYLTRIBUTYL CITRATE:ORAL:TABLET, EXTENDED RELEASE:MG	ORAL	39MG ORAL TABLET, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
0ZBX0N59RZ	ACETYLTRIBUTYL CITRATE:ORAL:TABLET, SUSTAINED ACTION:MG	ORAL	57.35MG ORAL TABLET, SUSTAINED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
0ZBX0N59RZ	ACETYLTRIBUTYL CITRATE:TOPICAL:SPONGE:%W/W	TOPICAL	5.4%W/W TOPICAL SPONGE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
33X04XA5AT	LACTIC ACID:ORAL:SOLUTION:MG/5ML	ORAL	7.673MG/5ML ORAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
33X04XA5AT	LACTIC ACID:TOPICAL:AEROSOL, FOAM:%W/W	TOPICAL	1%W/W TOPICAL AEROSOL, FOAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
33X04XA5AT	LACTIC ACID:TOPICAL:CREAM:%W/W	TOPICAL	1%W/W TOPICAL CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
33X04XA5AT	LACTIC ACID, UNSPECIFIED FORM:AN,INFILTRATION:INJECTION:%	AN,INFILTRATION	0.12% AN,INFILTRATION INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
33X04XA5AT	LACTIC ACID, UNSPECIFIED FORM:AURICULAR (OTIC):SOLUTION, DROPS:ADJ PH	AURICULAR (OTIC)	ADJ PH AURICULAR (OTIC) SOLUTION, DROPS	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
33X04XA5AT	LACTIC ACID, UNSPECIFIED FORM:IM - IV:INJECTION:%	IM - IV	100% IM - IV INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
33X04XA5AT	LACTIC ACID, UNSPECIFIED FORM:IM - IV - SC:INJECTION:%	IM - IV - SC	0.012% IM - IV - SC INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
33X04XA5AT	LACTIC ACID, UNSPECIFIED FORM:IM - IV - SC:SOLUTION, INJECTION:NA	IM - IV - SC	IM - IV - SC SOLUTION, INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
33X04XA5AT	LACTIC ACID, UNSPECIFIED FORM:INTRACARDIAC:INJECTION:%	INTRACARDIAC	0.012% INTRACARDIAC INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
33X04XA5AT	LACTIC ACID, UNSPECIFIED FORM:INTRACARDIAC:SOLUTION, INJECTION:NA	INTRACARDIAC	INTRACARDIAC SOLUTION, INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
33X04XA5AT	LACTIC ACID, UNSPECIFIED FORM:INTRAMUSCULAR:INJECTABLE:NA	INTRAMUSCULAR	INTRAMUSCULAR INJECTABLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
33X04XA5AT	LACTIC ACID, UNSPECIFIED FORM:INTRAMUSCULAR:INJECTION:ADJ PH	INTRAMUSCULAR	ADJ PH INTRAMUSCULAR INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
33X04XA5AT	LACTIC ACID, UNSPECIFIED FORM:INTRAVENOUS:INJECTABLE:%	INTRAVENOUS	0.41% INTRAVENOUS INJECTABLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
33X04XA5AT	LACTIC ACID, UNSPECIFIED FORM:INTRAVENOUS:INJECTION:%	INTRAVENOUS	0.71% INTRAVENOUS INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
33X04XA5AT	LACTIC ACID, UNSPECIFIED FORM:INTRAVENOUS:SOLUTION, INJECTION:%	INTRAVENOUS	0.1% INTRAVENOUS SOLUTION, INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
33X04XA5AT	LACTIC ACID, UNSPECIFIED FORM:IV(INFUSION):INJECTION:%	IV(INFUSION)	1.86% IV(INFUSION) INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
33X04XA5AT	LACTIC ACID, UNSPECIFIED FORM:IV(INFUSION):SOLUTION, INJECTION:%	IV(INFUSION)	0.13% IV(INFUSION) SOLUTION, INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
33X04XA5AT	LACTIC ACID, UNSPECIFIED FORM:NERVE BLOCK:INJECTION:%	NERVE BLOCK	0.12% NERVE BLOCK INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
33X04XA5AT	LACTIC ACID, UNSPECIFIED FORM:ORAL:CAPSULE:MG	ORAL	1.6MG ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
33X04XA5AT	LACTIC ACID, UNSPECIFIED FORM:ORAL:CAPSULE, SOFT GELATIN LIQUID-FILLED:MG	ORAL	44MG ORAL CAPSULE, SOFT GELATIN LIQUID-FILLED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
33X04XA5AT	LACTIC ACID, UNSPECIFIED FORM:ORAL:CONCENTRATE:%W/W	ORAL	0.18%W/W ORAL CONCENTRATE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
33X04XA5AT	LACTIC ACID, UNSPECIFIED FORM:ORAL:SOLUTION:ADJ PH	ORAL	ADJ PH ORAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
33X04XA5AT	LACTIC ACID, UNSPECIFIED FORM:ORAL:SYRUP:NA	ORAL	ORAL SYRUP	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
33X04XA5AT	LACTIC ACID, UNSPECIFIED FORM:ORAL:TABLET:ADJ PH	ORAL	ADJ PH ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
33X04XA5AT	LACTIC ACID, UNSPECIFIED FORM:PARENTERAL:INJECTION:NA	PARENTERAL	PARENTERAL INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
33X04XA5AT	LACTIC ACID, UNSPECIFIED FORM:SUBCUTANEOUS:INJECTION:%	SUBCUTANEOUS	0.34% SUBCUTANEOUS INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
33X04XA5AT	LACTIC ACID, UNSPECIFIED FORM:TOPICAL:AEROSOL:%W/W	TOPICAL	1.05%W/W TOPICAL AEROSOL	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
33X04XA5AT	LACTIC ACID, UNSPECIFIED FORM:TOPICAL:AEROSOL, FOAM:%W/W	TOPICAL	1%W/W TOPICAL AEROSOL, FOAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
33X04XA5AT	LACTIC ACID, UNSPECIFIED FORM:TOPICAL:CREAM:%W/W	TOPICAL	0.05%W/W TOPICAL CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
33X04XA5AT	LACTIC ACID, UNSPECIFIED FORM:TOPICAL:EMULSION, AEROSOL FOAM:%W/W	TOPICAL	1.05%W/W TOPICAL EMULSION, AEROSOL FOAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
33X04XA5AT	LACTIC ACID, UNSPECIFIED FORM:TOPICAL:EMULSION, CREAM:%W/W	TOPICAL	1%W/W TOPICAL EMULSION, CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
33X04XA5AT	LACTIC ACID, UNSPECIFIED FORM:TOPICAL:GEL:%W/W	TOPICAL	6.07%W/W TOPICAL GEL	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
33X04XA5AT	LACTIC ACID, UNSPECIFIED FORM:TOPICAL:LOTION:%W/W	TOPICAL	5.7%W/W TOPICAL LOTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
33X04XA5AT	LACTIC ACID, UNSPECIFIED FORM:TOPICAL:OINTMENT:NA	TOPICAL	TOPICAL OINTMENT	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
33X04XA5AT	LACTIC ACID, UNSPECIFIED FORM:TOPICAL:SOLUTION:%W/W	TOPICAL	7.22%W/W TOPICAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
33X04XA5AT	LACTIC ACID, UNSPECIFIED FORM:TOPICAL:SUSPENSION:%W/W	TOPICAL	0.7%W/W TOPICAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
33X04XA5AT	LACTIC ACID, UNSPECIFIED FORM:VAGINAL:EMULSION, CREAM:%	VAGINAL	0.81% VAGINAL EMULSION, CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
33X04XA5AT	LACTIC ACID, UNSPECIFIED FORM:VAGINAL:SUPPOSITORY:NA	VAGINAL	VAGINAL SUPPOSITORY	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
33X04XA5AT	LACTIC ACID, UNSPECIFIED FORM:VAGINAL:TABLET:MG	VAGINAL	70MG VAGINAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
45P3261C7T	SODIUM CARBONATE:AN,INFILTRATION:INJECTION:ADJ PH	AN,INFILTRATION	ADJ PH AN,INFILTRATION INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
45P3261C7T	SODIUM CARBONATE:BUCCAL:GUM:MG	BUCCAL	14.4MG BUCCAL GUM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
45P3261C7T	SODIUM CARBONATE:BUCCAL:GUM, CHEWING:MG	BUCCAL	30MG BUCCAL GUM, CHEWING	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
45P3261C7T	SODIUM CARBONATE:BUCCAL:TABLET:MG	BUCCAL	20MG BUCCAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
45P3261C7T	SODIUM CARBONATE:IM - IV:INJECTION:%	IM - IV	1.64% IM - IV INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
45P3261C7T	SODIUM CARBONATE:IM - IV:POWDER, FOR INJECTION SOLUTION:%	IM - IV	63% IM - IV POWDER, FOR INJECTION SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
45P3261C7T	SODIUM CARBONATE:INTRA-ARTERIAL:SOLUTION, INJECTION:ADJ PH	INTRA-ARTERIAL	ADJ PH INTRA-ARTERIAL SOLUTION, INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
45P3261C7T	SODIUM CARBONATE:INTRAMUSCULAR:INJECTION:%	INTRAMUSCULAR	1% INTRAMUSCULAR INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
45P3261C7T	SODIUM CARBONATE:INTRAMUSCULAR:POWDER, FOR INJECTION SOLUTION:NA	INTRAMUSCULAR	INTRAMUSCULAR POWDER, FOR INJECTION SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
45P3261C7T	SODIUM CARBONATE:INTRAPERITONEAL:POWDER, FOR INJECTION SOLUTION:NA	INTRAPERITONEAL	INTRAPERITONEAL POWDER, FOR INJECTION SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
45P3261C7T	SODIUM CARBONATE:INTRAPLEURAL:POWDER, FOR INJECTION SOLUTION:NA	INTRAPLEURAL	INTRAPLEURAL POWDER, FOR INJECTION SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
45P3261C7T	SODIUM CARBONATE:INTRATUMOR:POWDER, FOR INJECTION SOLUTION:NA	INTRATUMOR	INTRATUMOR POWDER, FOR INJECTION SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
45P3261C7T	SODIUM CARBONATE:INTRAVASCULAR:INJECTION:ADJ PH	INTRAVASCULAR	ADJ PH INTRAVASCULAR INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
45P3261C7T	SODIUM CARBONATE:INTRAVASCULAR:SOLUTION, INJECTION:ADJ PH	INTRAVASCULAR	ADJ PH INTRAVASCULAR SOLUTION, INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
45P3261C7T	SODIUM CARBONATE:INTRAVENOUS:INJECTION:%W/W	INTRAVENOUS	15.4%W/W INTRAVENOUS INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
45P3261C7T	SODIUM CARBONATE:INTRAVENOUS:POWDER:MG	INTRAVENOUS	575MG INTRAVENOUS POWDER	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
45P3261C7T	SODIUM CARBONATE:INTRAVENOUS:POWDER, FOR INJECTION SOLUTION:%	INTRAVENOUS	20.8% INTRAVENOUS POWDER, FOR INJECTION SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
45P3261C7T	SODIUM CARBONATE:INTRAVENOUS:SOLUTION, INJECTION:ADJ PH	INTRAVENOUS	ADJ PH INTRAVENOUS SOLUTION, INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
45P3261C7T	SODIUM CARBONATE:IV - SC:INJECTION:ADJ PH	IV - SC	ADJ PH IV - SC INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
45P3261C7T	SODIUM CARBONATE:IV(INFUSION):INJECTION:%	IV(INFUSION)	24.1% IV(INFUSION) INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
45P3261C7T	SODIUM CARBONATE:IV(INFUSION):POWDER, FOR INJECTION SOLUTION, LYOPHILIZED:%	IV(INFUSION)	0.18% IV(INFUSION) POWDER, FOR INJECTION SOLUTION, LYOPHILIZED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
45P3261C7T	SODIUM CARBONATE:NERVE BLOCK:INJECTION:ADJ PH	NERVE BLOCK	ADJ PH NERVE BLOCK INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
45P3261C7T	SODIUM CARBONATE:OPHTHALMIC:SOLUTION:%	OPHTHALMIC	0.01% OPHTHALMIC SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
45P3261C7T	SODIUM CARBONATE:ORAL:CAPSULE:MG	ORAL	91.8MG ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
45P3261C7T	SODIUM CARBONATE:ORAL:CAPSULE, DELAYED ACTION:mg	ORAL	10mg ORAL CAPSULE, DELAYED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
45P3261C7T	SODIUM CARBONATE:ORAL:CAPSULE, SUSTAINED ACTION:MG	ORAL	6MG ORAL CAPSULE, SUSTAINED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
45P3261C7T	SODIUM CARBONATE:ORAL:GRANULE, FOR ORAL SUSPENSION:MG	ORAL	6.5MG ORAL GRANULE, FOR ORAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
45P3261C7T	SODIUM CARBONATE:ORAL:GUM, CHEWING:MG	ORAL	10MG ORAL GUM, CHEWING	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
45P3261C7T	SODIUM CARBONATE:ORAL:INJECTION:%W/V	ORAL	2.4%W/V ORAL INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
45P3261C7T	SODIUM CARBONATE:ORAL:LOZENGE:mg	ORAL	25mg ORAL LOZENGE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
45P3261C7T	SODIUM CARBONATE:ORAL:SUSPENSION, SUSTAINED ACTION:MG/206.84 MG	ORAL	6.5MG/206.84 MG ORAL SUSPENSION, SUSTAINED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
45P3261C7T	SODIUM CARBONATE:ORAL:TABLET:MG	ORAL	10.4MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
45P3261C7T	SODIUM CARBONATE:ORAL:TABLET (IMMED./COMP. RELEASE), FILM COATED:MG	ORAL	8MG ORAL TABLET (IMMED./COMP. RELEASE), FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
45P3261C7T	SODIUM CARBONATE:ORAL:TABLET, DELAYED ACTION:MG	ORAL	15MG ORAL TABLET, DELAYED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
45P3261C7T	SODIUM CARBONATE:ORAL:TABLET, DELAYED ACTION, ENTERIC COATED:MG	ORAL	10MG ORAL TABLET, DELAYED ACTION, ENTERIC COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
45P3261C7T	SODIUM CARBONATE:ORAL:TABLET, EFFERVESCENT, FOR SOLUTION:MG	ORAL	430MG ORAL TABLET, EFFERVESCENT, FOR SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
45P3261C7T	SODIUM CARBONATE:ORAL:TABLET, EXTENDED RELEASE:MG	ORAL	30MG ORAL TABLET, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
45P3261C7T	SODIUM CARBONATE:ORAL:TABLET, FILM COATED:MG	ORAL	30MG ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
45P3261C7T	SODIUM CARBONATE:ORAL:TABLET, UNCOATED, LOZENGE:MG	ORAL	8.55MG ORAL TABLET, UNCOATED, LOZENGE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
45P3261C7T	SODIUM CARBONATE:ORAL:TROCHE:MG	ORAL	25MG ORAL TROCHE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
45P3261C7T	SODIUM CARBONATE:RECTAL:POWDER, FOR INJECTION SOLUTION:NA	RECTAL	RECTAL POWDER, FOR INJECTION SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
45P3261C7T	SODIUM CARBONATE:RECTAL:SUSPENSION:NA	RECTAL	RECTAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
45P3261C7T	SODIUM CARBONATE:SUBLINGUAL:TABLET:MG	SUBLINGUAL	7.5MG SUBLINGUAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
GFD7C86Q1W	LIMONENE, (+)-:TOPICAL:GEL:%W/W	TOPICAL	0.5%W/W TOPICAL GEL	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
GFD7C86Q1W	LIMONENE, (+)-:TOPICAL:LOTION:%V/V	TOPICAL	10%V/V TOPICAL LOTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
GFD7C86Q1W	LIMONENE, (+)-:TOPICAL:SOLUTION:NA	TOPICAL	TOPICAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
T5L8T28FGP	MINERAL OIL:AURICULAR (OTIC):OINTMENT:NA	AURICULAR (OTIC)	AURICULAR (OTIC) OINTMENT	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
T5L8T28FGP	MINERAL OIL:AURICULAR (OTIC):SUSPENSION:%	AURICULAR (OTIC)	0.5% AURICULAR (OTIC) SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
T5L8T28FGP	MINERAL OIL:DENTAL:PASTE:MG	DENTAL	457.95MG DENTAL PASTE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
T5L8T28FGP	MINERAL OIL:OPHTHALMIC:OINTMENT:%	OPHTHALMIC	59.5% OPHTHALMIC OINTMENT	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
T5L8T28FGP	MINERAL OIL:OPHTHALMIC:SUSPENSION:%	OPHTHALMIC	0.1% OPHTHALMIC SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
T5L8T28FGP	MINERAL OIL:ORAL:CAPSULE:MG	ORAL	60.08MG ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
T5L8T28FGP	MINERAL OIL:ORAL:CAPSULE, SUSTAINED ACTION:MG	ORAL	50MG ORAL CAPSULE, SUSTAINED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
T5L8T28FGP	MINERAL OIL:ORAL:DROPS:NA	ORAL	ORAL DROPS	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
T5L8T28FGP	MINERAL OIL:ORAL:TABLET:MG	ORAL	50MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
T5L8T28FGP	MINERAL OIL:ORAL:TABLET, COATED:MG	ORAL	1.3MG ORAL TABLET, COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
T5L8T28FGP	MINERAL OIL:ORAL:TABLET, DELAYED ACTION, ENTERIC COATED:MG	ORAL	5.67MG ORAL TABLET, DELAYED ACTION, ENTERIC COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
T5L8T28FGP	MINERAL OIL:ORAL:TABLET, FILM COATED:NA	ORAL	ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
T5L8T28FGP	MINERAL OIL:ORAL:TABLET, SUSTAINED ACTION:NA	ORAL	ORAL TABLET, SUSTAINED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
T5L8T28FGP	MINERAL OIL:TOPICAL:AEROSOL, SPRAY:NA	TOPICAL	TOPICAL AEROSOL, SPRAY	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
T5L8T28FGP	MINERAL OIL:TOPICAL:CREAM:%W/W	TOPICAL	23.63%W/W TOPICAL CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
T5L8T28FGP	MINERAL OIL:TOPICAL:CREAM, AUGMENTED:%W/W	TOPICAL	50.62%W/W TOPICAL CREAM, AUGMENTED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
T5L8T28FGP	MINERAL OIL:TOPICAL:CREAM, EMULSION, SUSTAINED RELEASE:%W/W	TOPICAL	50.6%W/W TOPICAL CREAM, EMULSION, SUSTAINED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
T5L8T28FGP	MINERAL OIL:TOPICAL:EMULSION, CREAM:%W/W	TOPICAL	40%W/W TOPICAL EMULSION, CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
T5L8T28FGP	MINERAL OIL:TOPICAL:EMULSION, LOTION:%W/W	TOPICAL	20%W/W TOPICAL EMULSION, LOTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
T5L8T28FGP	MINERAL OIL:TOPICAL:GEL:%W/W	TOPICAL	2.5%W/W TOPICAL GEL	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
T5L8T28FGP	MINERAL OIL:TOPICAL:LOTION:%W/W	TOPICAL	20%W/W TOPICAL LOTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
T5L8T28FGP	MINERAL OIL:TOPICAL:OIL:%W/W	TOPICAL	42%W/W TOPICAL OIL	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
T5L8T28FGP	MINERAL OIL:TOPICAL:OINTMENT:%W/W	TOPICAL	97.95%W/W TOPICAL OINTMENT	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
T5L8T28FGP	MINERAL OIL:TOPICAL:PASTE:%W/W	TOPICAL	47.5%W/W TOPICAL PASTE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
T5L8T28FGP	MINERAL OIL:TOPICAL:PATCH:NA	TOPICAL	TOPICAL PATCH	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
T5L8T28FGP	MINERAL OIL:TOPICAL:SPRAY:%W/W	TOPICAL	45.95%W/W TOPICAL SPRAY	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
T5L8T28FGP	MINERAL OIL:TOPICAL:SUPPOSITORY:NA	TOPICAL	TOPICAL SUPPOSITORY	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
T5L8T28FGP	MINERAL OIL:TOPICAL:SUSPENSION:%W/W	TOPICAL	82%W/W TOPICAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
T5L8T28FGP	MINERAL OIL:TRANSDERMAL:FILM:MG	TRANSDERMAL	11.42MG TRANSDERMAL FILM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
T5L8T28FGP	MINERAL OIL:TRANSDERMAL:FILM, CONTROLLED RELEASE:MG	TRANSDERMAL	34MG TRANSDERMAL FILM, CONTROLLED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
T5L8T28FGP	MINERAL OIL:TRANSDERMAL:PATCH, CONTROLLED RELEASE:MG	TRANSDERMAL	1.52MG TRANSDERMAL PATCH, CONTROLLED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
T5L8T28FGP	MINERAL OIL:VAGINAL:CREAM, EMULSION, SUSTAINED RELEASE:%	VAGINAL	7% VAGINAL CREAM, EMULSION, SUSTAINED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
T5L8T28FGP	MINERAL OIL:VAGINAL:EMULSION, CREAM:%	VAGINAL	15% VAGINAL EMULSION, CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
T5L8T28FGP	MINERAL OIL:VAGINAL:GEL:%	VAGINAL	4.73% VAGINAL GEL	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
T5L8T28FGP	MINERAL OIL:VAGINAL:SUPPOSITORY:%W/W	VAGINAL	3%W/W VAGINAL SUPPOSITORY	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
4VON5FNS3C	SODIUM METABISULFITE:AN,CNBLK INTRATHECAL:INJECTION:NA	AN,CNBLK INTRATHECAL	AN,CNBLK INTRATHECAL INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
4VON5FNS3C	SODIUM METABISULFITE:AN,INFILTRATION:INJECTION:%	AN,INFILTRATION	0.5% AN,INFILTRATION INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
4VON5FNS3C	SODIUM METABISULFITE:CAUDAL BLOCK:INJECTION:%	CAUDAL BLOCK	0.18% CAUDAL BLOCK INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
4VON5FNS3C	SODIUM METABISULFITE:DENTAL:INJECTION:%	DENTAL	0.05% DENTAL INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
4VON5FNS3C	SODIUM METABISULFITE:EPIDURAL:INJECTION:%	EPIDURAL	0.18% EPIDURAL INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
4VON5FNS3C	SODIUM METABISULFITE:IM - IV - SC:INJECTION:%	IM - IV - SC	0.15% IM - IV - SC INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
4VON5FNS3C	SODIUM METABISULFITE:IM - IV - SC:SOLUTION, INJECTION:NA	IM - IV - SC	IM - IV - SC SOLUTION, INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
4VON5FNS3C	SODIUM METABISULFITE:INFILTRATION:INJECTION:%	INFILTRATION	0.05% INFILTRATION INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
4VON5FNS3C	SODIUM METABISULFITE:INHALATION:SOLUTION:%	INHALATION	1% INHALATION SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
4VON5FNS3C	SODIUM METABISULFITE:INTRA-ARTICULAR:INJECTION:%	INTRA-ARTICULAR	0.2% INTRA-ARTICULAR INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
4VON5FNS3C	SODIUM METABISULFITE:INTRABURSAL:INJECTION:%	INTRABURSAL	0.2% INTRABURSAL INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
4VON5FNS3C	SODIUM METABISULFITE:INTRACARDIAC:INJECTION:%	INTRACARDIAC	0.09% INTRACARDIAC INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
4VON5FNS3C	SODIUM METABISULFITE:INTRACARDIAC:SOLUTION, INJECTION:NA	INTRACARDIAC	INTRACARDIAC SOLUTION, INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
4VON5FNS3C	SODIUM METABISULFITE:INTRAMUSCULAR:INJECTION:%W/V	INTRAMUSCULAR	27.5%W/V INTRAMUSCULAR INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
4VON5FNS3C	SODIUM METABISULFITE:INTRAMUSCULAR:SOLUTION, INJECTION:%W/V	INTRAMUSCULAR	0.66%W/V INTRAMUSCULAR SOLUTION, INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
4VON5FNS3C	SODIUM METABISULFITE:INTRAPERITONEAL:INJECTION:%	INTRAPERITONEAL	0.33% INTRAPERITONEAL INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
4VON5FNS3C	SODIUM METABISULFITE:INTRAVENOUS:EMULSION, INJECTION:%	INTRAVENOUS	0.025% INTRAVENOUS EMULSION, INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
4VON5FNS3C	SODIUM METABISULFITE:INTRAVENOUS:INJECTION:%W/V	INTRAVENOUS	0.9%W/V INTRAVENOUS INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
4VON5FNS3C	SODIUM METABISULFITE:INTRAVENOUS:SOLUTION, INJECTION:%	INTRAVENOUS	0.66% INTRAVENOUS SOLUTION, INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
4VON5FNS3C	SODIUM METABISULFITE:INTRAVENOUS INFUSION:INJECTION:%W/V	INTRAVENOUS INFUSION	0.2%W/V INTRAVENOUS INFUSION INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
4VON5FNS3C	SODIUM METABISULFITE:IONTOPHORESIS:PATCH, CONTROLLED RELEASE:MG	IONTOPHORESIS	0.5MG IONTOPHORESIS PATCH, CONTROLLED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
4VON5FNS3C	SODIUM METABISULFITE:IONTOPHORESIS:SOLUTION:%	IONTOPHORESIS	0.05% IONTOPHORESIS SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
4VON5FNS3C	SODIUM METABISULFITE:IV(INFUSION):SOLUTION, INJECTION:%	IV(INFUSION)	0.22% IV(INFUSION) SOLUTION, INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
4VON5FNS3C	SODIUM METABISULFITE:NERVE BLOCK:INJECTION:%	NERVE BLOCK	0.5% NERVE BLOCK INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
4VON5FNS3C	SODIUM METABISULFITE:NERVE BLOCK:SOLUTION, INJECTION:%	NERVE BLOCK	0.05% NERVE BLOCK SOLUTION, INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
4VON5FNS3C	SODIUM METABISULFITE:OPHTHALMIC:SOLUTION:%	OPHTHALMIC	0.25% OPHTHALMIC SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
4VON5FNS3C	SODIUM METABISULFITE:OPHTHALMIC:SUSPENSION, DROPS:%	OPHTHALMIC	0.1% OPHTHALMIC SUSPENSION, DROPS	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
4VON5FNS3C	SODIUM METABISULFITE:ORAL:CAPSULE:MG	ORAL	0.36MG ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
4VON5FNS3C	SODIUM METABISULFITE:ORAL:CONCENTRATE:MG/1ML	ORAL	2MG/1ML ORAL CONCENTRATE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
4VON5FNS3C	SODIUM METABISULFITE:ORAL:LIQUID:MG/5ML	ORAL	1MG/5ML ORAL LIQUID	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
4VON5FNS3C	SODIUM METABISULFITE:ORAL:ORAL SOLUTION DOSAGE FORM:mg/5mL	ORAL	1mg/5mL ORAL ORAL SOLUTION DOSAGE FORM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
4VON5FNS3C	SODIUM METABISULFITE:ORAL:SOLUTION:MG/160ML	ORAL	320MG/160ML ORAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
4VON5FNS3C	SODIUM METABISULFITE:ORAL:SOLUTION:MG/5ML	ORAL	5MG/5ML ORAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
4VON5FNS3C	SODIUM METABISULFITE:ORAL:SUSPENSION:MG/5ML	ORAL	5MG/5ML ORAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
4VON5FNS3C	SODIUM METABISULFITE:ORAL:SUSPENSION, EXTENDED RELEASE:MG/5ML	ORAL	5MG/5ML ORAL SUSPENSION, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
4VON5FNS3C	SODIUM METABISULFITE:ORAL:SYRUP:MG/1ML	ORAL	1MG/1ML ORAL SYRUP	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
4VON5FNS3C	SODIUM METABISULFITE:ORAL:TABLET:MG	ORAL	8MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
4VON5FNS3C	SODIUM METABISULFITE:PERIDURAL:INJECTION:NA	PERIDURAL	PERIDURAL INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
4VON5FNS3C	SODIUM METABISULFITE:RECTAL:TABLET:MG	RECTAL	2MG RECTAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
4VON5FNS3C	SODIUM METABISULFITE:SUBCUTANEOUS:INJECTION:mg/1mL	SUBCUTANEOUS	1.2mg/1mL SUBCUTANEOUS INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
4VON5FNS3C	SODIUM METABISULFITE:SUBCUTANEOUS:INJECTION:%	SUBCUTANEOUS	0.3% SUBCUTANEOUS INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
4VON5FNS3C	SODIUM METABISULFITE:SUBCUTANEOUS:SOLUTION, INJECTION:%	SUBCUTANEOUS	0.05% SUBCUTANEOUS SOLUTION, INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
4VON5FNS3C	SODIUM METABISULFITE:SUBLINGUAL:TABLET:MG	SUBLINGUAL	2MG SUBLINGUAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
4VON5FNS3C	SODIUM METABISULFITE:SUBMUCOSAL:INJECTION:%	SUBMUCOSAL	0.05% SUBMUCOSAL INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
4VON5FNS3C	SODIUM METABISULFITE:SUBMUCOSAL:SOLUTION, INJECTION:%	SUBMUCOSAL	5% SUBMUCOSAL SOLUTION, INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
4VON5FNS3C	SODIUM METABISULFITE:TOPICAL:CREAM, AUGMENTED:%W/W	TOPICAL	0.2%W/W TOPICAL CREAM, AUGMENTED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
4VON5FNS3C	SODIUM METABISULFITE:TOPICAL:EMULSION, CREAM:NA	TOPICAL	TOPICAL EMULSION, CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
4VON5FNS3C	SODIUM METABISULFITE:TOPICAL:LOTION:%W/V	TOPICAL	0.2%W/V TOPICAL LOTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
4VON5FNS3C	SODIUM METABISULFITE:TOPICAL:PATCH:MG	TOPICAL	0.002MG TOPICAL PATCH	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
4VON5FNS3C	SODIUM METABISULFITE:TOPICAL:PATCH, CONTROLLED RELEASE:MG	TOPICAL	0.5MG TOPICAL PATCH, CONTROLLED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
4VON5FNS3C	SODIUM METABISULFITE:TOPICAL:POWDER, FOR SOLUTION:NA	TOPICAL	TOPICAL POWDER, FOR SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
4VON5FNS3C	SODIUM METABISULFITE:TOPICAL:SUSPENSION:%W/W	TOPICAL	0.3%W/W TOPICAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
4VON5FNS3C	SODIUM METABISULFITE:VAGINAL:SPONGE:MG	VAGINAL	1.5MG VAGINAL SPONGE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
273FM27VK1	HYDROXYMETHYL CELLULOSE:ORAL:CAPSULE, SUSTAINED ACTION:MG	ORAL	1.6MG ORAL CAPSULE, SUSTAINED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
273FM27VK1	HYDROXYMETHYL CELLULOSE:ORAL:POWDER, FOR RECONSTITUTION:MG/5ML	ORAL	75MG/5ML ORAL POWDER, FOR RECONSTITUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
273FM27VK1	HYDROXYMETHYL CELLULOSE:ORAL:TABLET:MG	ORAL	4MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
273FM27VK1	HYDROXYMETHYL CELLULOSE:ORAL:TABLET, FILM COATED:MG	ORAL	30MG ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
273FM27VK1	HYDROXYMETHYL CELLULOSE:TOPICAL:SOLUTION:NA	TOPICAL	TOPICAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
N78PI4C683	VERSETAMIDE:INTRAVENOUS:INJECTION:%	INTRAVENOUS	2.54% INTRAVENOUS INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=V
TZX5469Z6I	SODIUM BISULFITE:AN,INFILTRATION:INJECTION:%	AN,INFILTRATION	0.2% AN,INFILTRATION INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
TZX5469Z6I	SODIUM BISULFITE:AURICULAR (OTIC):SOLUTION:%	AURICULAR (OTIC)	0.1% AURICULAR (OTIC) SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
TZX5469Z6I	SODIUM BISULFITE:AURICULAR (OTIC):SUSPENSION:%	AURICULAR (OTIC)	0.001% AURICULAR (OTIC) SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
TZX5469Z6I	SODIUM BISULFITE:EPIDURAL:INJECTION:NA	EPIDURAL	EPIDURAL INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
TZX5469Z6I	SODIUM BISULFITE:IM - IV:INJECTION:%	IM - IV	0.66% IM - IV INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
TZX5469Z6I	SODIUM BISULFITE:IM - IV:POWDER, FOR INJECTION SOLUTION:%	IM - IV	5.18% IM - IV POWDER, FOR INJECTION SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
TZX5469Z6I	SODIUM BISULFITE:IM - IV:SOLUTION, INJECTION:NA	IM - IV	IM - IV SOLUTION, INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
TZX5469Z6I	SODIUM BISULFITE:IM - IV - SC:INJECTION:%	IM - IV - SC	0.5% IM - IV - SC INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
TZX5469Z6I	SODIUM BISULFITE:INHALATION:INHALANT:%	INHALATION	0.075% INHALATION INHALANT	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
TZX5469Z6I	SODIUM BISULFITE:INHALATION:SOLUTION:%	INHALATION	0.3% INHALATION SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
TZX5469Z6I	SODIUM BISULFITE:INTRA-ARTERIAL:INJECTION:NA	INTRA-ARTERIAL	INTRA-ARTERIAL INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
TZX5469Z6I	SODIUM BISULFITE:INTRA-ARTICULAR:INJECTION:%	INTRA-ARTICULAR	0.32% INTRA-ARTICULAR INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
TZX5469Z6I	SODIUM BISULFITE:INTRA-ARTICULAR:INJECTION, SUSTAINED ACTION:NA	INTRA-ARTICULAR	INTRA-ARTICULAR INJECTION, SUSTAINED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
TZX5469Z6I	SODIUM BISULFITE:INTRABURSAL:INJECTION:NA	INTRABURSAL	INTRABURSAL INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
TZX5469Z6I	SODIUM BISULFITE:INTRACARDIAC:INJECTION:%	INTRACARDIAC	0.1% INTRACARDIAC INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
TZX5469Z6I	SODIUM BISULFITE:INTRADERMAL:INJECTION, SUSTAINED ACTION:NA	INTRADERMAL	INTRADERMAL INJECTION, SUSTAINED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
TZX5469Z6I	SODIUM BISULFITE:INTRADISCAL:POWDER, FOR INJECTION SOLUTION:NA	INTRADISCAL	INTRADISCAL POWDER, FOR INJECTION SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
TZX5469Z6I	SODIUM BISULFITE:INTRALESIONAL:INJECTION:%	INTRALESIONAL	0.32% INTRALESIONAL INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
TZX5469Z6I	SODIUM BISULFITE:INTRALESIONAL:INJECTION, SUSTAINED ACTION:NA	INTRALESIONAL	INTRALESIONAL INJECTION, SUSTAINED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
TZX5469Z6I	SODIUM BISULFITE:INTRAMUSCULAR:INJECTION:%W/V	INTRAMUSCULAR	0.66%W/V INTRAMUSCULAR INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
TZX5469Z6I	SODIUM BISULFITE:INTRAMUSCULAR:INJECTION, SUSTAINED ACTION:NA	INTRAMUSCULAR	INTRAMUSCULAR INJECTION, SUSTAINED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
TZX5469Z6I	SODIUM BISULFITE:INTRAPERITONEAL:INJECTION:%	INTRAPERITONEAL	0.66% INTRAPERITONEAL INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
TZX5469Z6I	SODIUM BISULFITE:INTRAPERITONEAL:SOLUTION:NA	INTRAPERITONEAL	INTRAPERITONEAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
TZX5469Z6I	SODIUM BISULFITE:INTRASYNOVIAL:INJECTION:%	INTRASYNOVIAL	0.32% INTRASYNOVIAL INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
TZX5469Z6I	SODIUM BISULFITE:INTRASYNOVIAL:INJECTION, SUSTAINED ACTION:NA	INTRASYNOVIAL	INTRASYNOVIAL INJECTION, SUSTAINED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
TZX5469Z6I	SODIUM BISULFITE:INTRAVENOUS:INJECTION:%	INTRAVENOUS	1.6% INTRAVENOUS INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
TZX5469Z6I	SODIUM BISULFITE:INTRAVENOUS:SOLUTION, INJECTION:%	INTRAVENOUS	0.05% INTRAVENOUS SOLUTION, INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
TZX5469Z6I	SODIUM BISULFITE:IONTOPHORESIS:SOLUTION:%	IONTOPHORESIS	0.055% IONTOPHORESIS SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
TZX5469Z6I	SODIUM BISULFITE:IRRIGATION:INJECTION:%	IRRIGATION	0.33% IRRIGATION INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
TZX5469Z6I	SODIUM BISULFITE:IV(INFUSION):INJECTION:%	IV(INFUSION)	5% IV(INFUSION) INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
TZX5469Z6I	SODIUM BISULFITE:IV(INFUSION):SOLUTION, INJECTION:%	IV(INFUSION)	0.024% IV(INFUSION) SOLUTION, INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
TZX5469Z6I	SODIUM BISULFITE:NERVE BLOCK:INJECTION:%	NERVE BLOCK	2.2% NERVE BLOCK INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
TZX5469Z6I	SODIUM BISULFITE:OPHTHALMIC:SOLUTION:%	OPHTHALMIC	0.1% OPHTHALMIC SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
TZX5469Z6I	SODIUM BISULFITE:OPHTHALMIC:SOLUTION, DROPS:%	OPHTHALMIC	0.1% OPHTHALMIC SOLUTION, DROPS	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
TZX5469Z6I	SODIUM BISULFITE:OPHTHALMIC:SUSPENSION:%	OPHTHALMIC	0.06% OPHTHALMIC SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
TZX5469Z6I	SODIUM BISULFITE:ORAL:CAPSULE:MG	ORAL	0.36MG ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
TZX5469Z6I	SODIUM BISULFITE:ORAL:CONCENTRATE:MG/1ML	ORAL	0.5MG/1ML ORAL CONCENTRATE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
TZX5469Z6I	SODIUM BISULFITE:ORAL:SOLUTION:%	ORAL	0.1% ORAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
TZX5469Z6I	SODIUM BISULFITE:ORAL:SUSPENSION:MG/5ML	ORAL	2MG/5ML ORAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
TZX5469Z6I	SODIUM BISULFITE:ORAL:SYRUP:NA	ORAL	ORAL SYRUP	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
TZX5469Z6I	SODIUM BISULFITE:ORAL:TABLET:mg	ORAL	3mg ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
TZX5469Z6I	SODIUM BISULFITE:SOFT TISSUE:INJECTION:%	SOFT TISSUE	0.1% SOFT TISSUE INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
TZX5469Z6I	SODIUM BISULFITE:SUBCUTANEOUS:INJECTION:%	SUBCUTANEOUS	0.15% SUBCUTANEOUS INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
TZX5469Z6I	SODIUM BISULFITE:SUBLINGUAL:TABLET:MG	SUBLINGUAL	0.5MG SUBLINGUAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
TZX5469Z6I	SODIUM BISULFITE:TOPICAL:EMULSION, CREAM:%W/W	TOPICAL	0.3%W/W TOPICAL EMULSION, CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
TZX5469Z6I	SODIUM BISULFITE:TOPICAL:LOTION:NA	TOPICAL	TOPICAL LOTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
TZX5469Z6I	SODIUM BISULFITE:TOPICAL:POWDER, FOR SOLUTION:%W/V	TOPICAL	0.1%W/V TOPICAL POWDER, FOR SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
TZX5469Z6I	SODIUM BISULFITE:TOPICAL:SOLUTION:%W/V	TOPICAL	0.055%W/V TOPICAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
T75W9911L6	PROPANE:RECTAL:EMULSION, AEROSOL FOAM:%	RECTAL	0.34% RECTAL EMULSION, AEROSOL FOAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
T75W9911L6	PROPANE:TOPICAL:AEROSOL, SPRAY:NA	TOPICAL	TOPICAL AEROSOL, SPRAY	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
T75W9911L6	PROPANE:TOPICAL:EMULSION, AEROSOL FOAM:NA	TOPICAL	TOPICAL EMULSION, AEROSOL FOAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
4J9FJ0HL51	POTASSIUM PHOSPHATE, MONOBASIC:AN,INFILTRATION:INJECTION:%	AN,INFILTRATION	2.72% AN,INFILTRATION INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
4J9FJ0HL51	POTASSIUM PHOSPHATE, MONOBASIC:AURICULAR (OTIC):SOLUTION:%	AURICULAR (OTIC)	0.2% AURICULAR (OTIC) SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
4J9FJ0HL51	POTASSIUM PHOSPHATE, MONOBASIC:IM - IV:INJECTION:%	IM - IV	0.096% IM - IV INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
4J9FJ0HL51	POTASSIUM PHOSPHATE, MONOBASIC:INTRA-ARTICULAR:INJECTION:%	INTRA-ARTICULAR	0.3% INTRA-ARTICULAR INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
4J9FJ0HL51	POTASSIUM PHOSPHATE, MONOBASIC:INTRAMUSCULAR:INJECTABLE:%W/V	INTRAMUSCULAR	0.096%W/V INTRAMUSCULAR INJECTABLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
4J9FJ0HL51	POTASSIUM PHOSPHATE, MONOBASIC:INTRAMUSCULAR:INJECTION:%W/V	INTRAMUSCULAR	0.3%W/V INTRAMUSCULAR INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
4J9FJ0HL51	POTASSIUM PHOSPHATE, MONOBASIC:INTRAUTERINE:SOLUTION:NA	INTRAUTERINE	INTRAUTERINE SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
4J9FJ0HL51	POTASSIUM PHOSPHATE, MONOBASIC:INTRAVENOUS:INJECTABLE:%	INTRAVENOUS	0.096% INTRAVENOUS INJECTABLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
4J9FJ0HL51	POTASSIUM PHOSPHATE, MONOBASIC:INTRAVENOUS:INJECTION:%	INTRAVENOUS	0.68% INTRAVENOUS INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
4J9FJ0HL51	POTASSIUM PHOSPHATE, MONOBASIC:INTRAVENOUS:POWDER, FOR INJECTION SOLUTION, LYOPHILIZED:MG/VIAL	INTRAVENOUS	68MG/VIAL INTRAVENOUS POWDER, FOR INJECTION SOLUTION, LYOPHILIZED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
4J9FJ0HL51	POTASSIUM PHOSPHATE, MONOBASIC:INTRAVENOUS:POWDER, FOR RECONSTITUTION:%	INTRAVENOUS	2.72% INTRAVENOUS POWDER, FOR RECONSTITUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
4J9FJ0HL51	POTASSIUM PHOSPHATE, MONOBASIC:INTRAVENOUS:SOLUTION, INJECTION:%	INTRAVENOUS	0.085% INTRAVENOUS SOLUTION, INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
4J9FJ0HL51	POTASSIUM PHOSPHATE, MONOBASIC:INTRAVESICAL:SOLUTION, INJECTION:%	INTRAVESICAL	2.92% INTRAVESICAL SOLUTION, INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
4J9FJ0HL51	POTASSIUM PHOSPHATE, MONOBASIC:IV(INFUSION):INJECTION:MG/1VIAL	IV(INFUSION)	68MG/1VIAL IV(INFUSION) INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
4J9FJ0HL51	POTASSIUM PHOSPHATE, MONOBASIC:IV(INFUSION):SOLUTION, INJECTION:%	IV(INFUSION)	1.36% IV(INFUSION) SOLUTION, INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
4J9FJ0HL51	POTASSIUM PHOSPHATE, MONOBASIC:NASAL:SOLUTION:%	NASAL	0.071% NASAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
4J9FJ0HL51	POTASSIUM PHOSPHATE, MONOBASIC:NASAL:SPRAY:%	NASAL	0.14% NASAL SPRAY	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
4J9FJ0HL51	POTASSIUM PHOSPHATE, MONOBASIC:NERVE BLOCK:INJECTION:%	NERVE BLOCK	2.72% NERVE BLOCK INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
4J9FJ0HL51	POTASSIUM PHOSPHATE, MONOBASIC:OPHTHALMIC:SOLUTION:%	OPHTHALMIC	0.2% OPHTHALMIC SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
4J9FJ0HL51	POTASSIUM PHOSPHATE, MONOBASIC:OPHTHALMIC:SUSPENSION:%	OPHTHALMIC	0.44% OPHTHALMIC SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
4J9FJ0HL51	POTASSIUM PHOSPHATE, MONOBASIC:ORAL:CAPSULE, ENTERIC COATED PELLETS:MG	ORAL	17MG ORAL CAPSULE, ENTERIC COATED PELLETS	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
4J9FJ0HL51	POTASSIUM PHOSPHATE, MONOBASIC:ORAL:EMULSION:NA	ORAL	ORAL EMULSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
4J9FJ0HL51	POTASSIUM PHOSPHATE, MONOBASIC:ORAL:SOLUTION:MG/5ML	ORAL	25MG/5ML ORAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
4J9FJ0HL51	POTASSIUM PHOSPHATE, MONOBASIC:ORAL:SOLUTION, SYRUP:MG/1ML	ORAL	4.75MG/1ML ORAL SOLUTION, SYRUP	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
4J9FJ0HL51	POTASSIUM PHOSPHATE, MONOBASIC:ORAL:SUSPENSION:MG/5ML	ORAL	50MG/5ML ORAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
4J9FJ0HL51	POTASSIUM PHOSPHATE, MONOBASIC:ORAL:SYRUP:MG/5ML	ORAL	13.66MG/5ML ORAL SYRUP	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
4J9FJ0HL51	POTASSIUM PHOSPHATE, MONOBASIC:ORAL:TABLET:MG	ORAL	25MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
4J9FJ0HL51	POTASSIUM PHOSPHATE, MONOBASIC:ORAL:TABLET, SUSTAINED ACTION:MG	ORAL	4MG ORAL TABLET, SUSTAINED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
4J9FJ0HL51	POTASSIUM PHOSPHATE, MONOBASIC:SUBCUTANEOUS:INJECTABLE:%	SUBCUTANEOUS	0.27% SUBCUTANEOUS INJECTABLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
4J9FJ0HL51	POTASSIUM PHOSPHATE, MONOBASIC:SUBCUTANEOUS:INJECTION:%	SUBCUTANEOUS	0.27% SUBCUTANEOUS INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
4J9FJ0HL51	POTASSIUM PHOSPHATE, MONOBASIC:SUBCUTANEOUS:POWDER, FOR INJECTION SOLUTION, LYOPHILIZED:%	SUBCUTANEOUS	0.12% SUBCUTANEOUS POWDER, FOR INJECTION SOLUTION, LYOPHILIZED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
A2M91M918C	HYDROGENATED SOYBEAN OIL:ORAL:CAPSULE:MG	ORAL	19.03MG ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
A2M91M918C	HYDROGENATED SOYBEAN OIL:ORAL:CAPSULE, SOFT GELATIN:MG	ORAL	15.3MG ORAL CAPSULE, SOFT GELATIN	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
A2M91M918C	HYDROGENATED SOYBEAN OIL:ORAL:TABLET:MG	ORAL	13.5MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
A2M91M918C	HYDROGENATED SOYBEAN OIL:ORAL:TABLET, COATED:MG	ORAL	3MG ORAL TABLET, COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
A2M91M918C	HYDROGENATED SOYBEAN OIL:ORAL:TABLET, EXTENDED RELEASE:MG	ORAL	48MG ORAL TABLET, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
Q3JEK5DO4K	ANETHOLE:DENTAL:SOLUTION:NA	DENTAL	DENTAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
Q3JEK5DO4K	ANETHOLE:ORAL:SOLUTION:NA	ORAL	ORAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
Q3JEK5DO4K	ANETHOLE:ORAL:SOLUTION, ELIXIR:%	ORAL	0.003% ORAL SOLUTION, ELIXIR	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
Q3JEK5DO4K	ANETHOLE:ORAL:SYRUP:MG/5ML	ORAL	2.3MG/5ML ORAL SYRUP	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
EOL5G26Q9F	CAPTAN:TOPICAL:SHAMPOO, SUSPENSION:%W/W	TOPICAL	1%W/W TOPICAL SHAMPOO, SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
YOW8V9698H	DIMETHYL SULFOXIDE:IV(INFUSION):POWDER, FOR INJECTION SUSPENSION, LYOPHILIZED:NA	IV(INFUSION)	IV(INFUSION) POWDER, FOR INJECTION SUSPENSION, LYOPHILIZED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
YOW8V9698H	DIMETHYL SULFOXIDE:SUBCUTANEOUS:IMPLANT:MG	SUBCUTANEOUS	104MG SUBCUTANEOUS IMPLANT	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
YOW8V9698H	DIMETHYL SULFOXIDE:TOPICAL:DRESSING:NA	TOPICAL	TOPICAL DRESSING	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
YOW8V9698H	DIMETHYL SULFOXIDE:TOPICAL:LOTION:%W/W	TOPICAL	45.5%W/W TOPICAL LOTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
YOW8V9698H	DIMETHYL SULFOXIDE:TOPICAL:SOLUTION:%W/W	TOPICAL	45.5%W/W TOPICAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
UG00KM4WR7	HIGH DENSITY POLYETHYLENE:DENTAL:PASTE:MG	DENTAL	40MG DENTAL PASTE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
UG00KM4WR7	HIGH DENSITY POLYETHYLENE:INTRAUTERINE:INTRAUTERINE DEVICE:NA	INTRAUTERINE	INTRAUTERINE INTRAUTERINE DEVICE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
UG00KM4WR7	HIGH DENSITY POLYETHYLENE:OPHTHALMIC:OINTMENT:NA	OPHTHALMIC	OPHTHALMIC OINTMENT	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
UG00KM4WR7	HIGH DENSITY POLYETHYLENE:ORAL:CAPSULE:MG	ORAL	2MG ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
UG00KM4WR7	HIGH DENSITY POLYETHYLENE:ORAL:TABLET:MG	ORAL	10MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
UG00KM4WR7	HIGH DENSITY POLYETHYLENE:ORAL:TABLET, COATED:MG	ORAL	12MG ORAL TABLET, COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
UG00KM4WR7	HIGH DENSITY POLYETHYLENE:ORAL:TABLET, DELAYED ACTION, ENTERIC COATED:NA	ORAL	ORAL TABLET, DELAYED ACTION, ENTERIC COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
UG00KM4WR7	HIGH DENSITY POLYETHYLENE:ORAL:TABLET, SUSTAINED ACTION:MG	ORAL	0.64MG ORAL TABLET, SUSTAINED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
UG00KM4WR7	HIGH DENSITY POLYETHYLENE:TOPICAL:EMULSION, CREAM:%W/W	TOPICAL	54.5%W/W TOPICAL EMULSION, CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
UG00KM4WR7	HIGH DENSITY POLYETHYLENE:TOPICAL:GEL:%W/W	TOPICAL	26%W/W TOPICAL GEL	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
UG00KM4WR7	HIGH DENSITY POLYETHYLENE:TOPICAL:LOTION:%W/W	TOPICAL	1.5%W/W TOPICAL LOTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
UG00KM4WR7	HIGH DENSITY POLYETHYLENE:TOPICAL:OINTMENT:%W/W	TOPICAL	9%W/W TOPICAL OINTMENT	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
UG00KM4WR7	HIGH DENSITY POLYETHYLENE:TOPICAL:PASTE:NA	TOPICAL	TOPICAL PASTE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
UG00KM4WR7	HIGH DENSITY POLYETHYLENE:TOPICAL:TAPE:NA	TOPICAL	TOPICAL TAPE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
UG00KM4WR7	HIGH DENSITY POLYETHYLENE:TRANSDERMAL:FILM, CONTROLLED RELEASE:MG	TRANSDERMAL	85MG TRANSDERMAL FILM, CONTROLLED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
UG00KM4WR7	HIGH DENSITY POLYETHYLENE:VAGINAL:SUPPOSITORY:MG	VAGINAL	3321.2MG VAGINAL SUPPOSITORY	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
8D9H4QU99H	COCO-CAPRYLATE/CAPRATE:TOPICAL:GEL:%W/W	TOPICAL	2.5%W/W TOPICAL GEL	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
58QVG85GW3	POLYVINYL ACETATE PHTHALATE:ORAL:CAPSULE:NA	ORAL	ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
58QVG85GW3	POLYVINYL ACETATE PHTHALATE:ORAL:CAPSULE, DELAYED ACTION:MG	ORAL	32MG ORAL CAPSULE, DELAYED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
58QVG85GW3	POLYVINYL ACETATE PHTHALATE:ORAL:TABLET, DELAYED ACTION, ENTERIC COATED:NA	ORAL	ORAL TABLET, DELAYED ACTION, ENTERIC COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
58QVG85GW3	POLYVINYL ACETATE PHTHALATE:ORAL:TABLET, EXTENDED RELEASE:MG	ORAL	37.4MG ORAL TABLET, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
58QVG85GW3	POLYVINYL ACETATE PHTHALATE:ORAL:TABLET, SUSTAINED ACTION:NA	ORAL	ORAL TABLET, SUSTAINED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
L7J6A1NE81	BENZOIN, (+/-)-:ORAL:CAPSULE:NA	ORAL	ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
L7J6A1NE81	BENZOIN, (+/-)-:ORAL:CAPSULE, SUSTAINED ACTION:NA	ORAL	ORAL CAPSULE, SUSTAINED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
CHI530446X	VANILLIN:ORAL:CAPSULE:MG	ORAL	0.94MG ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=V
CHI530446X	VANILLIN:ORAL:CAPSULE, SUSTAINED ACTION:MG	ORAL	0.94MG ORAL CAPSULE, SUSTAINED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=V
CHI530446X	VANILLIN:ORAL:EMULSION:NA	ORAL	ORAL EMULSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=V
CHI530446X	VANILLIN:ORAL:POWDER:NA	ORAL	ORAL POWDER	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=V
CHI530446X	VANILLIN:ORAL:POWDER, FOR SUSPENSION:MG/1ML	ORAL	1.6MG/1ML ORAL POWDER, FOR SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=V
CHI530446X	VANILLIN:ORAL:SOLUTION:MG/5ML	ORAL	50MG/5ML ORAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=V
CHI530446X	VANILLIN:ORAL:SOLUTION, ELIXIR:MG/5ML	ORAL	0.014MG/5ML ORAL SOLUTION, ELIXIR	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=V
CHI530446X	VANILLIN:ORAL:SUSPENSION:MG/5ML	ORAL	5MG/5ML ORAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=V
CHI530446X	VANILLIN:ORAL:SUSPENSION:MG/10ML	ORAL	1MG/10ML ORAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=V
CHI530446X	VANILLIN:ORAL:SYRUP:NA	ORAL	ORAL SYRUP	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=V
CHI530446X	VANILLIN:ORAL:TABLET:MG	ORAL	1.5MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=V
CHI530446X	VANILLIN:ORAL:TABLET (IMMED./COMP. RELEASE), UNCOATED, CHEWABLE:MG	ORAL	2.5MG ORAL TABLET (IMMED./COMP. RELEASE), UNCOATED, CHEWABLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=V
CHI530446X	VANILLIN:ORAL:TABLET, COATED:MG	ORAL	65.5MG ORAL TABLET, COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=V
CHI530446X	VANILLIN:ORAL:TABLET, DELAYED ACTION:MG	ORAL	0.8MG ORAL TABLET, DELAYED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=V
CHI530446X	VANILLIN:ORAL:TABLET, DELAYED ACTION, ENTERIC COATED:MG	ORAL	1.16MG ORAL TABLET, DELAYED ACTION, ENTERIC COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=V
CHI530446X	VANILLIN:ORAL:TABLET, ENTERIC COATED PARTICLES:MG	ORAL	0.7MG ORAL TABLET, ENTERIC COATED PARTICLES	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=V
CHI530446X	VANILLIN:ORAL:TABLET, FILM COATED:MG	ORAL	0.78MG ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=V
CHI530446X	VANILLIN:ORAL:TABLET, SUSTAINED ACTION:MG	ORAL	3.4MG ORAL TABLET, SUSTAINED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=V
CHI530446X	VANILLIN:ORAL:TABLET, SUSTAINED ACTION, FILM COATED:MG	ORAL	0.8MG ORAL TABLET, SUSTAINED ACTION, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=V
L06K8R7DQK	FD&C BLUE NO. 2:BUCCAL:TABLET:MG	BUCCAL	0.008MG BUCCAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
L06K8R7DQK	FD&C BLUE NO. 2:ORAL:CAPSULE:MG	ORAL	0.34MG ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
L06K8R7DQK	FD&C BLUE NO. 2:ORAL:CAPSULE, DELAYED ACTION:MG	ORAL	0.15MG ORAL CAPSULE, DELAYED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
L06K8R7DQK	FD&C BLUE NO. 2:ORAL:CAPSULE, DELAYED RELEASE:MG	ORAL	0.21MG ORAL CAPSULE, DELAYED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
L06K8R7DQK	FD&C BLUE NO. 2:ORAL:CAPSULE, ENTERIC COATED PELLETS:NA	ORAL	ORAL CAPSULE, ENTERIC COATED PELLETS	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
L06K8R7DQK	FD&C BLUE NO. 2:ORAL:CAPSULE, EXTENDED RELEASE:MG	ORAL	0.44MG ORAL CAPSULE, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
L06K8R7DQK	FD&C BLUE NO. 2:ORAL:CAPSULE, HARD GELATIN:MG	ORAL	0.011MG ORAL CAPSULE, HARD GELATIN	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
L06K8R7DQK	FD&C BLUE NO. 2:ORAL:CAPSULE, SUSTAINED ACTION:MG	ORAL	0.03MG ORAL CAPSULE, SUSTAINED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
L06K8R7DQK	FD&C BLUE NO. 2:ORAL:TABLET:MG	ORAL	21MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
L06K8R7DQK	FD&C BLUE NO. 2:ORAL:TABLET (IMMED./COMP. RELEASE), FILM COATED:MG	ORAL	0.25MG ORAL TABLET (IMMED./COMP. RELEASE), FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
L06K8R7DQK	FD&C BLUE NO. 2:ORAL:TABLET, COATED:MG	ORAL	24.12MG ORAL TABLET, COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
L06K8R7DQK	FD&C BLUE NO. 2:ORAL:TABLET, DELAYED ACTION:MG	ORAL	0.4MG ORAL TABLET, DELAYED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
L06K8R7DQK	FD&C BLUE NO. 2:ORAL:TABLET, DELAYED ACTION, ENTERIC COATED:MG	ORAL	0.2MG ORAL TABLET, DELAYED ACTION, ENTERIC COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
L06K8R7DQK	FD&C BLUE NO. 2:ORAL:TABLET, EXTENDED RELEASE:MG	ORAL	2.78MG ORAL TABLET, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
L06K8R7DQK	FD&C BLUE NO. 2:ORAL:TABLET, FILM COATED:MG	ORAL	0.9MG ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
L06K8R7DQK	FD&C BLUE NO. 2:ORAL:TABLET, FILM COATED, EXTENDED RELEASE:MG	ORAL	0.57MG ORAL TABLET, FILM COATED, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
L06K8R7DQK	FD&C BLUE NO. 2:ORAL:TABLET, SUSTAINED ACTION:MG	ORAL	0.6MG ORAL TABLET, SUSTAINED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
L06K8R7DQK	FD&C BLUE NO. 2:ORAL:TABLET, SUSTAINED ACTION, COATED:NA	ORAL	ORAL TABLET, SUSTAINED ACTION, COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
YC9ST449YJ	ETHYL VANILLIN:ORAL:CAPSULE:MG	ORAL	0.34MG ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
YC9ST449YJ	ETHYL VANILLIN:ORAL:CAPSULE, COATED, SOFT GELATIN:MG	ORAL	0.27MG ORAL CAPSULE, COATED, SOFT GELATIN	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
YC9ST449YJ	ETHYL VANILLIN:ORAL:CAPSULE, SOFT GELATIN:MG	ORAL	0.64MG ORAL CAPSULE, SOFT GELATIN	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
YC9ST449YJ	ETHYL VANILLIN:ORAL:CAPSULE, SUSTAINED ACTION:NA	ORAL	ORAL CAPSULE, SUSTAINED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
YC9ST449YJ	ETHYL VANILLIN:ORAL:SUSPENSION:MG/5ML	ORAL	0.08MG/5ML ORAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
YC9ST449YJ	ETHYL VANILLIN:ORAL:SYRUP:NA	ORAL	ORAL SYRUP	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
YC9ST449YJ	ETHYL VANILLIN:ORAL:TABLET (IMMED./COMP. RELEASE), UNCOATED, CHEWABLE:MG	ORAL	0.14MG ORAL TABLET (IMMED./COMP. RELEASE), UNCOATED, CHEWABLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
8SKN0B0MIM	BENZOIC ACID:IM - IV:INJECTION:%	IM - IV	5% IM - IV INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
8SKN0B0MIM	BENZOIC ACID:INTRAMUSCULAR:INJECTION:ADJ PH	INTRAMUSCULAR	ADJ PH INTRAMUSCULAR INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
8SKN0B0MIM	BENZOIC ACID:INTRAMUSCULAR:SOLUTION, INJECTION:%W/V	INTRAMUSCULAR	0.2%W/V INTRAMUSCULAR SOLUTION, INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
8SKN0B0MIM	BENZOIC ACID:INTRAVENOUS:SOLUTION, INJECTION:%	INTRAVENOUS	0.003% INTRAVENOUS SOLUTION, INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
8SKN0B0MIM	BENZOIC ACID:IRRIGATION:SOLUTION:%	IRRIGATION	0.024% IRRIGATION SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
8SKN0B0MIM	BENZOIC ACID:IV(INFUSION):INJECTION:ADJ PH	IV(INFUSION)	ADJ PH IV(INFUSION) INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
8SKN0B0MIM	BENZOIC ACID:ORAL:CONCENTRATE:MG/5ML	ORAL	12.5MG/5ML ORAL CONCENTRATE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
8SKN0B0MIM	BENZOIC ACID:ORAL:EMULSION:NA	ORAL	ORAL EMULSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
8SKN0B0MIM	BENZOIC ACID:ORAL:LIQUID:%	ORAL	0.2% ORAL LIQUID	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
8SKN0B0MIM	BENZOIC ACID:ORAL:SOLUTION:MG/1ML	ORAL	2.07MG/1ML ORAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
8SKN0B0MIM	BENZOIC ACID:ORAL:SOLUTION, ELIXIR:%W/V	ORAL	0.1%W/V ORAL SOLUTION, ELIXIR	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
8SKN0B0MIM	BENZOIC ACID:ORAL:SOLUTION, LIQUID:MG/1ML	ORAL	2MG/1ML ORAL SOLUTION, LIQUID	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
8SKN0B0MIM	BENZOIC ACID:ORAL:SPRAY:MG/1SPR	ORAL	0.053MG/1SPR ORAL SPRAY	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
8SKN0B0MIM	BENZOIC ACID:ORAL:SUSPENSION:MG/5ML	ORAL	25MG/5ML ORAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
8SKN0B0MIM	BENZOIC ACID:ORAL:SYRUP:MG/5ML	ORAL	7.53MG/5ML ORAL SYRUP	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
8SKN0B0MIM	BENZOIC ACID:ORAL:TABLET, COATED:NA	ORAL	ORAL TABLET, COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
8SKN0B0MIM	BENZOIC ACID:ORAL:TABLET, FILM COATED:NA	ORAL	ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
8SKN0B0MIM	BENZOIC ACID:RECTAL:GEL:%	RECTAL	0.28% RECTAL GEL	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
8SKN0B0MIM	BENZOIC ACID:RECTAL:SUSPENSION:%	RECTAL	0.002% RECTAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
8SKN0B0MIM	BENZOIC ACID:TOPICAL:AEROSOL, FOAM:%W/W	TOPICAL	0.0004%W/W TOPICAL AEROSOL, FOAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
8SKN0B0MIM	BENZOIC ACID:TOPICAL:CREAM:%W/W	TOPICAL	0.2%W/W TOPICAL CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
8SKN0B0MIM	BENZOIC ACID:TOPICAL:CREAM, EMULSION, SUSTAINED RELEASE:%W/W	TOPICAL	0.19%W/W TOPICAL CREAM, EMULSION, SUSTAINED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
8SKN0B0MIM	BENZOIC ACID:TOPICAL:EMULSION, AEROSOL FOAM:%W/W	TOPICAL	0.1%W/W TOPICAL EMULSION, AEROSOL FOAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
8SKN0B0MIM	BENZOIC ACID:TOPICAL:EMULSION, CREAM:%W/W	TOPICAL	0.25%W/W TOPICAL EMULSION, CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
8SKN0B0MIM	BENZOIC ACID:TOPICAL:GEL:%W/W	TOPICAL	0.1%W/W TOPICAL GEL	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
8SKN0B0MIM	BENZOIC ACID:TOPICAL:LOTION:%W/W	TOPICAL	0.2%W/W TOPICAL LOTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
8SKN0B0MIM	BENZOIC ACID:TOPICAL:SOLUTION:%W/W	TOPICAL	0.1%W/W TOPICAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
8SKN0B0MIM	BENZOIC ACID:TOPICAL:SUPPOSITORY:NA	TOPICAL	TOPICAL SUPPOSITORY	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
8SKN0B0MIM	BENZOIC ACID:TOPICAL:SUPPOSITORY, INSERT:%W/W	TOPICAL	0.2%W/W TOPICAL SUPPOSITORY, INSERT	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
8SKN0B0MIM	BENZOIC ACID:VAGINAL:CREAM, EMULSION, SUSTAINED RELEASE:%	VAGINAL	0.19% VAGINAL CREAM, EMULSION, SUSTAINED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
8SKN0B0MIM	BENZOIC ACID:VAGINAL:EMULSION, AEROSOL FOAM:%	VAGINAL	0.1% VAGINAL EMULSION, AEROSOL FOAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
8SKN0B0MIM	BENZOIC ACID:VAGINAL:EMULSION, CREAM:%	VAGINAL	0.25% VAGINAL EMULSION, CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
8SKN0B0MIM	BENZOIC ACID:VAGINAL:SPONGE:MG	VAGINAL	3MG VAGINAL SPONGE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
8SKN0B0MIM	BENZOIC ACID:VAGINAL:SUPPOSITORY:NA	VAGINAL	VAGINAL SUPPOSITORY	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
03DH2IZ3FY	COCO-BETAINE:TOPICAL:SHAMPOO:%W/W 	TOPICAL	6%W/W  TOPICAL SHAMPOO	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
ENK4Y6S66X	PEG-7 METHYL ETHER:TOPICAL:GEL:%W/W	TOPICAL	20%W/W TOPICAL GEL	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
TJ904HH8SN	TETRACHLOROETHYLENE:ORAL:TABLET, DELAYED ACTION, ENTERIC COATED:MG	ORAL	702MG ORAL TABLET, DELAYED ACTION, ENTERIC COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
1K09F3G675	FERRIC OXIDE RED:BUCCAL:FILM, SOLUBLE:MG	BUCCAL	0.03MG BUCCAL FILM, SOLUBLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
1K09F3G675	FERRIC OXIDE RED:BUCCAL:TABLET:MG	BUCCAL	0.4MG BUCCAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
1K09F3G675	FERRIC OXIDE RED:ORAL:CAPSULE:MG	ORAL	2.64MG ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
1K09F3G675	FERRIC OXIDE RED:ORAL:CAPSULE (IMMED./COMP. RELEASE):NA	ORAL	ORAL CAPSULE (IMMED./COMP. RELEASE)	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
1K09F3G675	FERRIC OXIDE RED:ORAL:CAPSULE, COATED:MG	ORAL	0.11MG ORAL CAPSULE, COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
1K09F3G675	FERRIC OXIDE RED:ORAL:CAPSULE, DELAYED ACTION:MG	ORAL	0.55MG ORAL CAPSULE, DELAYED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
1K09F3G675	FERRIC OXIDE RED:ORAL:CAPSULE, DELAYED RELEASE:MG	ORAL	2.3MG ORAL CAPSULE, DELAYED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
1K09F3G675	FERRIC OXIDE RED:ORAL:CAPSULE, ENTERIC COATED PELLETS:MG	ORAL	2MG ORAL CAPSULE, ENTERIC COATED PELLETS	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
1K09F3G675	FERRIC OXIDE RED:ORAL:CAPSULE, EXTENDED RELEASE:mg	ORAL	0.6mg ORAL CAPSULE, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
1K09F3G675	FERRIC OXIDE RED:ORAL:CAPSULE, HARD GELATIN:MG	ORAL	0.3MG ORAL CAPSULE, HARD GELATIN	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
1K09F3G675	FERRIC OXIDE RED:ORAL:CAPSULE, SOFT GELATIN:MG	ORAL	2.28MG ORAL CAPSULE, SOFT GELATIN	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
1K09F3G675	FERRIC OXIDE RED:ORAL:CAPSULE, SUSTAINED ACTION:NA	ORAL	ORAL CAPSULE, SUSTAINED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
1K09F3G675	FERRIC OXIDE RED:ORAL:DROPS:NA	ORAL	ORAL DROPS	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
1K09F3G675	FERRIC OXIDE RED:ORAL:POWDER, FOR ORAL SUSPENSION:MG/5ML	ORAL	0.75MG/5ML ORAL POWDER, FOR ORAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
1K09F3G675	FERRIC OXIDE RED:ORAL:SUSPENSION, SUSTAINED ACTION:MG/1PKT	ORAL	2.7MG/1PKT ORAL SUSPENSION, SUSTAINED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
1K09F3G675	FERRIC OXIDE RED:ORAL:TABLET:MG	ORAL	13MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
1K09F3G675	FERRIC OXIDE RED:ORAL:TABLET (IMMED./COMP. RELEASE), FILM COATED:MG	ORAL	1MG ORAL TABLET (IMMED./COMP. RELEASE), FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
1K09F3G675	FERRIC OXIDE RED:ORAL:TABLET (IMMED./COMP. RELEASE), UNCOATED, CHEWABLE:MG	ORAL	1.5MG ORAL TABLET (IMMED./COMP. RELEASE), UNCOATED, CHEWABLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
1K09F3G675	FERRIC OXIDE RED:ORAL:TABLET, CHEWABLE:MG	ORAL	0.5MG ORAL TABLET, CHEWABLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
1K09F3G675	FERRIC OXIDE RED:ORAL:TABLET, COATED:NA	ORAL	ORAL TABLET, COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
1K09F3G675	FERRIC OXIDE RED:ORAL:TABLET, CONTROLLED RELEASE:MG	ORAL	5.24MG ORAL TABLET, CONTROLLED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
1K09F3G675	FERRIC OXIDE RED:ORAL:TABLET, DELAYED ACTION:MG	ORAL	3MG ORAL TABLET, DELAYED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
1K09F3G675	FERRIC OXIDE RED:ORAL:TABLET, DELAYED ACTION, ENTERIC COATED:MG	ORAL	2.3MG ORAL TABLET, DELAYED ACTION, ENTERIC COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
1K09F3G675	FERRIC OXIDE RED:ORAL:TABLET, DELAYED RELEASE:MG	ORAL	1.24MG ORAL TABLET, DELAYED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
1K09F3G675	FERRIC OXIDE RED:ORAL:TABLET, EXTENDED RELEASE:MG	ORAL	4.08MG ORAL TABLET, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
1K09F3G675	FERRIC OXIDE RED:ORAL:TABLET, FILM COATED:MG	ORAL	3MG ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
1K09F3G675	FERRIC OXIDE RED:ORAL:TABLET, FILM COATED, EXTENDED RELEASE:MG	ORAL	0.1MG ORAL TABLET, FILM COATED, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
1K09F3G675	FERRIC OXIDE RED:ORAL:TABLET, MULTILAYER, EXTENDED RELEASE:MG	ORAL	0.11MG ORAL TABLET, MULTILAYER, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
1K09F3G675	FERRIC OXIDE RED:ORAL:TABLET, ORALLY DISINTEGRATING:MG	ORAL	0.64MG ORAL TABLET, ORALLY DISINTEGRATING	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
1K09F3G675	FERRIC OXIDE RED:ORAL:TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE:MG	ORAL	0.15MG ORAL TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
1K09F3G675	FERRIC OXIDE RED:ORAL:TABLET, SUSTAINED ACTION:MG	ORAL	3MG ORAL TABLET, SUSTAINED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
1K09F3G675	FERRIC OXIDE RED:ORAL:TABLET, SUSTAINED ACTION, COATED:MG	ORAL	3.6MG ORAL TABLET, SUSTAINED ACTION, COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
1K09F3G675	FERRIC OXIDE RED:ORAL:TABLET, SUSTAINED ACTION, FILM COATED:MG	ORAL	1.8MG ORAL TABLET, SUSTAINED ACTION, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
1K09F3G675	FERRIC OXIDE RED:SUBLINGUAL:TABLET:MG	SUBLINGUAL	1MG SUBLINGUAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
1K09F3G675	FERRIC OXIDE RED:TOPICAL:LOTION:NA	TOPICAL	TOPICAL LOTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
U3J3635T4U	PONCEAU XYLIDINE:ORAL:CAPSULE:MG	ORAL	0.001MG ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
U3J3635T4U	PONCEAU XYLIDINE:ORAL:TABLET:MG	ORAL	0.18MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
U3J3635T4U	PONCEAU XYLIDINE:ORAL:TABLET, COATED:NA	ORAL	ORAL TABLET, COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
97Z1WI3NDX	CALCIUM PHOSPHATE, UNSPECIFIED FORM:ORAL:TABLET:MG	ORAL	160MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
97Z1WI3NDX	CALCIUM PHOSPHATE, UNSPECIFIED FORM:ORAL:TABLET, COATED:MG	ORAL	93.6MG ORAL TABLET, COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
97Z1WI3NDX	CALCIUM PHOSPHATE, UNSPECIFIED FORM:ORAL:TABLET, EXTENDED RELEASE:NA	ORAL	ORAL TABLET, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
97Z1WI3NDX	CALCIUM PHOSPHATE, UNSPECIFIED FORM:ORAL:TABLET, FILM COATED:MG	ORAL	362MG ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
DM477EE40D	MALTOSE MONOHYDRATE:ORAL:TABLET:MG	ORAL	380.5MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
PQ6CK8PD0R	ASCORBIC ACID:AN,INFILTRATION:INJECTION:NA	AN,INFILTRATION	AN,INFILTRATION INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
PQ6CK8PD0R	ASCORBIC ACID:CAUDAL BLOCK:INJECTION:NA	CAUDAL BLOCK	CAUDAL BLOCK INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
PQ6CK8PD0R	ASCORBIC ACID:EPIDURAL:INJECTION:NA	EPIDURAL	EPIDURAL INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
PQ6CK8PD0R	ASCORBIC ACID:IM - IV:INJECTION:%	IM - IV	0.2% IM - IV INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
PQ6CK8PD0R	ASCORBIC ACID:INHALATION:AEROSOL, METERED:MG/INH	INHALATION	959.5MG/INH INHALATION AEROSOL, METERED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
PQ6CK8PD0R	ASCORBIC ACID:INHALATION:AEROSOL, SPRAY:%	INHALATION	0.11% INHALATION AEROSOL, SPRAY	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
PQ6CK8PD0R	ASCORBIC ACID:INHALATION:SOLUTION:%	INHALATION	1.02% INHALATION SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
PQ6CK8PD0R	ASCORBIC ACID:INTRAMUSCULAR:INJECTION:%	INTRAMUSCULAR	1% INTRAMUSCULAR INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
PQ6CK8PD0R	ASCORBIC ACID:INTRAVENOUS:INJECTION:%	INTRAVENOUS	62.5% INTRAVENOUS INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
PQ6CK8PD0R	ASCORBIC ACID:INTRAVENOUS:POWDER, FOR INJECTION SOLUTION:%	INTRAVENOUS	0.2% INTRAVENOUS POWDER, FOR INJECTION SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
PQ6CK8PD0R	ASCORBIC ACID:INTRAVENOUS:POWDER, FOR INJECTION SOLUTION, LYOPHILIZED:%	INTRAVENOUS	0.088% INTRAVENOUS POWDER, FOR INJECTION SOLUTION, LYOPHILIZED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
PQ6CK8PD0R	ASCORBIC ACID:INTRAVENOUS:SOLUTION, INJECTION:%	INTRAVENOUS	0.2% INTRAVENOUS SOLUTION, INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
PQ6CK8PD0R	ASCORBIC ACID:IV(INFUSION):INJECTION:%	IV(INFUSION)	50.4% IV(INFUSION) INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
PQ6CK8PD0R	ASCORBIC ACID:IV(INFUSION):POWDER, FOR INJECTION SOLUTION:NA	IV(INFUSION)	IV(INFUSION) POWDER, FOR INJECTION SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
PQ6CK8PD0R	ASCORBIC ACID:IV(INFUSION):POWDER, FOR INJECTION SOLUTION, LYOPHILIZED:%	IV(INFUSION)	48% IV(INFUSION) POWDER, FOR INJECTION SOLUTION, LYOPHILIZED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
PQ6CK8PD0R	ASCORBIC ACID:NERVE BLOCK:INJECTION:NA	NERVE BLOCK	NERVE BLOCK INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
PQ6CK8PD0R	ASCORBIC ACID:NERVE BLOCK:SOLUTION, INJECTION:%	NERVE BLOCK	0.2% NERVE BLOCK SOLUTION, INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
PQ6CK8PD0R	ASCORBIC ACID:ORAL:CAPSULE:MG	ORAL	7MG ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
PQ6CK8PD0R	ASCORBIC ACID:ORAL:CAPSULE, EXTENDED RELEASE:MG	ORAL	0.4MG ORAL CAPSULE, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
PQ6CK8PD0R	ASCORBIC ACID:ORAL:CONCENTRATE:MG/1ML	ORAL	6MG/1ML ORAL CONCENTRATE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
PQ6CK8PD0R	ASCORBIC ACID:ORAL:POWDER, FOR ORAL SOLUTION:MG	ORAL	5MG ORAL POWDER, FOR ORAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
PQ6CK8PD0R	ASCORBIC ACID:ORAL:SOLUTION:MG/5ML	ORAL	30MG/5ML ORAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
PQ6CK8PD0R	ASCORBIC ACID:ORAL:SUSPENSION:MG/5ML	ORAL	50MG/5ML ORAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
PQ6CK8PD0R	ASCORBIC ACID:ORAL:SUSPENSION, EXTENDED RELEASE:MG/5ML	ORAL	2.93MG/5ML ORAL SUSPENSION, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
PQ6CK8PD0R	ASCORBIC ACID:ORAL:SUSPENSION, SUSTAINED ACTION:NA	ORAL	ORAL SUSPENSION, SUSTAINED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
PQ6CK8PD0R	ASCORBIC ACID:ORAL:SYRUP:MG/5ML	ORAL	29.97MG/5ML ORAL SYRUP	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
PQ6CK8PD0R	ASCORBIC ACID:ORAL:TABLET:MG	ORAL	28.44MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
PQ6CK8PD0R	ASCORBIC ACID:ORAL:TABLET, FILM COATED:MG	ORAL	20MG ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
PQ6CK8PD0R	ASCORBIC ACID:ORAL:TABLET, ORALLY DISINTEGRATING:MG	ORAL	2.35MG ORAL TABLET, ORALLY DISINTEGRATING	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
PQ6CK8PD0R	ASCORBIC ACID:RECTAL:SUPPOSITORY:MG	RECTAL	3MG RECTAL SUPPOSITORY	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
PQ6CK8PD0R	ASCORBIC ACID:SUBCUTANEOUS:INJECTION:%	SUBCUTANEOUS	1% SUBCUTANEOUS INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
PQ6CK8PD0R	ASCORBIC ACID:TOPICAL:GEL:%W/W	TOPICAL	0.3%W/W TOPICAL GEL	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
PQ6CK8PD0R	ASCORBIC ACID:TOPICAL:SOLUTION:%W/W	TOPICAL	0.044%W/W TOPICAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
4846Q921YM	CALCIUM SULFATE DIHYDRATE:ORAL:CAPSULE:MG	ORAL	370MG ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
4846Q921YM	CALCIUM SULFATE DIHYDRATE:ORAL:CAPSULE, SUSTAINED ACTION:MG	ORAL	26.68MG ORAL CAPSULE, SUSTAINED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
4846Q921YM	CALCIUM SULFATE DIHYDRATE:ORAL:TABLET:MG	ORAL	413MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
4846Q921YM	CALCIUM SULFATE DIHYDRATE:ORAL:TABLET, COATED:MG	ORAL	214.24MG ORAL TABLET, COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
4846Q921YM	CALCIUM SULFATE DIHYDRATE:ORAL:TABLET, DELAYED ACTION, ENTERIC COATED:MG	ORAL	87.2MG ORAL TABLET, DELAYED ACTION, ENTERIC COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
4846Q921YM	CALCIUM SULFATE DIHYDRATE:ORAL:TABLET, EXTENDED RELEASE:MG	ORAL	29.7MG ORAL TABLET, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
4846Q921YM	CALCIUM SULFATE DIHYDRATE:ORAL:TABLET, FILM COATED:MG	ORAL	341MG ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
4846Q921YM	CALCIUM SULFATE DIHYDRATE:ORAL:TABLET, REPEAT ACTION:MG	ORAL	242.95MG ORAL TABLET, REPEAT ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
4846Q921YM	CALCIUM SULFATE DIHYDRATE:ORAL:TABLET, SUSTAINED ACTION:NA	ORAL	ORAL TABLET, SUSTAINED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
WYQ7N0BPYC	ACETYLCYSTEINE:INHALATION:SOLUTION:%	INHALATION	0.5% INHALATION SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
7Z075S9991	GELATIN TYPE A PORCINE (160 BLOOM):ORAL:CAPSULE:MG	ORAL	270MG ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
7Z075S9991	GELATIN TYPE A PORCINE (160 BLOOM):ORAL:CAPSULE, SOFT GELATIN:NA	ORAL	ORAL CAPSULE, SOFT GELATIN	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
3980JIH2SW	SODIUM PHOSPHATE, MONOBASIC:TOPICAL:CREAM:%W/W	TOPICAL	0.3%W/W TOPICAL CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
3980JIH2SW	SODIUM PHOSPHATE, MONOBASIC, UNSPECIFIED FORM:BUCCAL:FILM:MG	BUCCAL	0.47MG BUCCAL FILM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
3980JIH2SW	SODIUM PHOSPHATE, MONOBASIC, UNSPECIFIED FORM:BUCCAL:FILM, SOLUBLE:MG	BUCCAL	0.76MG BUCCAL FILM, SOLUBLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
3980JIH2SW	SODIUM PHOSPHATE, MONOBASIC, UNSPECIFIED FORM:IM - IV:INJECTABLE:%	IM - IV	0.16% IM - IV INJECTABLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
3980JIH2SW	SODIUM PHOSPHATE, MONOBASIC, UNSPECIFIED FORM:IM - IV:INJECTION:%	IM - IV	1.47% IM - IV INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
3980JIH2SW	SODIUM PHOSPHATE, MONOBASIC, UNSPECIFIED FORM:INTRALESIONAL:SUSPENSION, INJECTION:%	INTRALESIONAL	0.68% INTRALESIONAL SUSPENSION, INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
3980JIH2SW	SODIUM PHOSPHATE, MONOBASIC, UNSPECIFIED FORM:INTRAMUSCULAR:INJECTION:%	INTRAMUSCULAR	2.56% INTRAMUSCULAR INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
3980JIH2SW	SODIUM PHOSPHATE, MONOBASIC, UNSPECIFIED FORM:INTRAMUSCULAR:POWDER, FOR INJECTION SOLUTION:%W/V	INTRAMUSCULAR	0.18%W/V INTRAMUSCULAR POWDER, FOR INJECTION SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
3980JIH2SW	SODIUM PHOSPHATE, MONOBASIC, UNSPECIFIED FORM:INTRAMUSCULAR:SUSPENSION, EXTENDED RELEASE:%	INTRAMUSCULAR	0.6% INTRAMUSCULAR SUSPENSION, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
3980JIH2SW	SODIUM PHOSPHATE, MONOBASIC, UNSPECIFIED FORM:INTRAMUSCULAR:SUSPENSION, INJECTION:%W/V	INTRAMUSCULAR	0.68%W/V INTRAMUSCULAR SUSPENSION, INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
3980JIH2SW	SODIUM PHOSPHATE, MONOBASIC, UNSPECIFIED FORM:INTRASYNOVIAL:SUSPENSION, INJECTION:%	INTRASYNOVIAL	0.68% INTRASYNOVIAL SUSPENSION, INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
3980JIH2SW	SODIUM PHOSPHATE, MONOBASIC, UNSPECIFIED FORM:INTRAVENOUS:INJECTION:%	INTRAVENOUS	2.56% INTRAVENOUS INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
3980JIH2SW	SODIUM PHOSPHATE, MONOBASIC, UNSPECIFIED FORM:INTRAVENOUS:POWDER, FOR INJECTION SOLUTION:%	INTRAVENOUS	0.18% INTRAVENOUS POWDER, FOR INJECTION SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
3980JIH2SW	SODIUM PHOSPHATE, MONOBASIC, UNSPECIFIED FORM:INTRAVENOUS:SOLUTION, INJECTION:%	INTRAVENOUS	0.35% INTRAVENOUS SOLUTION, INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
3980JIH2SW	SODIUM PHOSPHATE, MONOBASIC, UNSPECIFIED FORM:IONTOPHORESIS:PATCH, CONTROLLED RELEASE:MG	IONTOPHORESIS	14.2MG IONTOPHORESIS PATCH, CONTROLLED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
3980JIH2SW	SODIUM PHOSPHATE, MONOBASIC, UNSPECIFIED FORM:IV(INFUSION):POWDER, FOR INJECTION SOLUTION:%	IV(INFUSION)	1.32% IV(INFUSION) POWDER, FOR INJECTION SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
3980JIH2SW	SODIUM PHOSPHATE, MONOBASIC, UNSPECIFIED FORM:OPHTHALMIC:SOLUTION:%	OPHTHALMIC	0.19% OPHTHALMIC SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
3980JIH2SW	SODIUM PHOSPHATE, MONOBASIC, UNSPECIFIED FORM:ORAL:SOLUTION:MG/5ML	ORAL	25MG/5ML ORAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
3980JIH2SW	SODIUM PHOSPHATE, MONOBASIC, UNSPECIFIED FORM:ORAL:SOLUTION, LIQUID:ADJ PH	ORAL	ADJ PH ORAL SOLUTION, LIQUID	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
3980JIH2SW	SODIUM PHOSPHATE, MONOBASIC, UNSPECIFIED FORM:ORAL:SUSPENSION:MG/5ML	ORAL	32.5MG/5ML ORAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
3980JIH2SW	SODIUM PHOSPHATE, MONOBASIC, UNSPECIFIED FORM:ORAL:TABLET:MG	ORAL	1.38MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
3980JIH2SW	SODIUM PHOSPHATE, MONOBASIC, UNSPECIFIED FORM:SOFT TISSUE:SUSPENSION, INJECTION:%	SOFT TISSUE	0.68% SOFT TISSUE SUSPENSION, INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
3980JIH2SW	SODIUM PHOSPHATE, MONOBASIC, UNSPECIFIED FORM:SUBCUTANEOUS:POWDER, FOR INJECTION SOLUTION, LYOPHILIZED:%	SUBCUTANEOUS	0.022% SUBCUTANEOUS POWDER, FOR INJECTION SOLUTION, LYOPHILIZED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
3980JIH2SW	SODIUM PHOSPHATE, MONOBASIC, UNSPECIFIED FORM:SUBCUTANEOUS:SUSPENSION, INJECTION:%	SUBCUTANEOUS	0.11% SUBCUTANEOUS SUSPENSION, INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
3980JIH2SW	SODIUM PHOSPHATE, MONOBASIC, UNSPECIFIED FORM:TOPICAL:CREAM, AUGMENTED:%W/W	TOPICAL	0.2%W/W TOPICAL CREAM, AUGMENTED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
3980JIH2SW	SODIUM PHOSPHATE, MONOBASIC, UNSPECIFIED FORM:TOPICAL:CREAM, EMULSION, SUSTAINED RELEASE:%W/W	TOPICAL	0.27%W/W TOPICAL CREAM, EMULSION, SUSTAINED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
3980JIH2SW	SODIUM PHOSPHATE, MONOBASIC, UNSPECIFIED FORM:TOPICAL:EMULSION, CREAM:%W/W	TOPICAL	0.27%W/W TOPICAL EMULSION, CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
3980JIH2SW	SODIUM PHOSPHATE, MONOBASIC, UNSPECIFIED FORM:TOPICAL:LOTION:%W/W	TOPICAL	0.3%W/W TOPICAL LOTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
3980JIH2SW	SODIUM PHOSPHATE, MONOBASIC, UNSPECIFIED FORM:TOPICAL:LOTION, AUGMENTED:%W/W	TOPICAL	0.2%W/W TOPICAL LOTION, AUGMENTED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
3980JIH2SW	SODIUM PHOSPHATE, MONOBASIC, UNSPECIFIED FORM:TOPICAL:PATCH, CONTROLLED RELEASE:MG	TOPICAL	14.2MG TOPICAL PATCH, CONTROLLED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
3980JIH2SW	SODIUM PHOSPHATE, MONOBASIC, UNSPECIFIED FORM:TOPICAL:SHAMPOO, SUSPENSION:NA	TOPICAL	TOPICAL SHAMPOO, SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
3980JIH2SW	SODIUM PHOSPHATE, MONOBASIC, UNSPECIFIED FORM:TOPICAL:SOLUTION:%W/V	TOPICAL	0.1%W/V TOPICAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
6716Z5YR3G	POLIDRONIUM CHLORIDE:OPHTHALMIC:SOLUTION:%	OPHTHALMIC	0.001% OPHTHALMIC SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
6716Z5YR3G	POLIDRONIUM CHLORIDE:TOPICAL:SOLUTION:%W/V	TOPICAL	0.001%W/V TOPICAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
R67D5N7LRS	LOW-SUBSTITUTED HYDROXYPROPYL CELLULOSE (8% HYDROXYPROPYL; 120000 MW):ORAL:TABLET, FILM COATED:MG	ORAL	29MG ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
76845O8NMZ	ETHYL ACETATE:INTRAMUSCULAR:INJECTION, MICROSPHERES:NA	INTRAMUSCULAR	INTRAMUSCULAR INJECTION, MICROSPHERES	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
76845O8NMZ	ETHYL ACETATE:ORAL:CAPSULE, SUSTAINED ACTION:MG	ORAL	382.26MG ORAL CAPSULE, SUSTAINED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
76845O8NMZ	ETHYL ACETATE:ORAL:SOLUTION:MG/5ML	ORAL	50MG/5ML ORAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
76845O8NMZ	ETHYL ACETATE:ORAL:SUSPENSION:NA	ORAL	ORAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
76845O8NMZ	ETHYL ACETATE:ORAL:TABLET:NA	ORAL	ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
76845O8NMZ	ETHYL ACETATE:ORAL:TABLET, DELAYED RELEASE:NA	ORAL	ORAL TABLET, DELAYED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
76845O8NMZ	ETHYL ACETATE:ORAL:TABLET, SUSTAINED ACTION:NA	ORAL	ORAL TABLET, SUSTAINED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
76845O8NMZ	ETHYL ACETATE:TOPICAL:SOLUTION:%W/W	TOPICAL	31%W/W TOPICAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
76845O8NMZ	ETHYL ACETATE:TRANSDERMAL:FILM, CONTROLLED RELEASE:MG	TRANSDERMAL	36138MG TRANSDERMAL FILM, CONTROLLED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
H4N855PNZ1	.ALPHA.-TOCOPHEROL:BUCCAL:FILM, SOLUBLE:MG	BUCCAL	0.07MG BUCCAL FILM, SOLUBLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
H4N855PNZ1	.ALPHA.-TOCOPHEROL:INTRAVENOUS:INJECTION, POWDER, LYOPHILIZED, FOR LIPOSOMAL SUSPENSION:%	INTRAVENOUS	0.064% INTRAVENOUS INJECTION, POWDER, LYOPHILIZED, FOR LIPOSOMAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
H4N855PNZ1	.ALPHA.-TOCOPHEROL:ORAL:CAPSULE:MG	ORAL	1MG ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
H4N855PNZ1	.ALPHA.-TOCOPHEROL:ORAL:CAPSULE, SOFT GELATIN:MG	ORAL	5MG ORAL CAPSULE, SOFT GELATIN	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
H4N855PNZ1	.ALPHA.-TOCOPHEROL:ORAL:SOLUTION:MG/1ML	ORAL	1.05MG/1ML ORAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
H4N855PNZ1	.ALPHA.-TOCOPHEROL:ORAL:TABLET:MG	ORAL	0.2MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
H4N855PNZ1	.ALPHA.-TOCOPHEROL:ORAL:TABLET (IMMED./COMP. RELEASE), UNCOATED, CHEWABLE:MG	ORAL	0.1MG ORAL TABLET (IMMED./COMP. RELEASE), UNCOATED, CHEWABLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
H4N855PNZ1	.ALPHA.-TOCOPHEROL:ORAL:TABLET, EXTENDED RELEASE:MG	ORAL	0.2MG ORAL TABLET, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
H4N855PNZ1	.ALPHA.-TOCOPHEROL:ORAL:TABLET, SUSTAINED ACTION:MG	ORAL	1.34MG ORAL TABLET, SUSTAINED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
H4N855PNZ1	.ALPHA.-TOCOPHEROL:TOPICAL:OINTMENT:%W/W	TOPICAL	0.002%W/W TOPICAL OINTMENT	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
H4N855PNZ1	.ALPHA.-TOCOPHEROL:TOPICAL:PATCH:MG	TOPICAL	0.099MG TOPICAL PATCH	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
H4N855PNZ1	.ALPHA.-TOCOPHEROL:TRANSDERMAL:PATCH:MG	TRANSDERMAL	0.09MG TRANSDERMAL PATCH	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
5VBE2X0WG0	TRIMETHYLSILYL TREATED DIMETHICONOL/TRIMETHYLSILOXYSILICATE CROSSPOLYMER (45/55 W/W; 100000 PA.S):TOPICAL:PATCH:MG	TOPICAL	86.92MG TOPICAL PATCH	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
5VBE2X0WG0	TRIMETHYLSILYL TREATED DIMETHICONOL/TRIMETHYLSILOXYSILICATE CROSSPOLYMER (45/55 W/W; 100000 PA.S):TRANSDERMAL:PATCH:MG	TRANSDERMAL	470MG TRANSDERMAL PATCH	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
91WQV43244	ETHYLENEDIAMINE DIHYDROCHLORIDE:TOPICAL:EMULSION, CREAM:%W/W	TOPICAL	0.25%W/W TOPICAL EMULSION, CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
XRK36F13ZZ	ETHYL ACRYLATE AND METHYL METHACRYLATE COPOLYMER (2:1; 600000 MW):ORAL:TABLET, EXTENDED RELEASE:MG	ORAL	27.5MG ORAL TABLET, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
2LRS185U6K	D&C RED NO. 27:ORAL:POWDER, FOR ORAL SUSPENSION:MG/5ML	ORAL	1.67MG/5ML ORAL POWDER, FOR ORAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
2LRS185U6K	D&C RED NO. 27:ORAL:TABLET:MG	ORAL	1MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
2LRS185U6K	D&C RED NO. 27:ORAL:TABLET, DELAYED RELEASE:MG	ORAL	0.7MG ORAL TABLET, DELAYED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
2LRS185U6K	D&C RED NO. 27:ORAL:TABLET, EXTENDED RELEASE:MG	ORAL	1.43MG ORAL TABLET, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
9N5G1G3D3H	TRIMETHYLSILYL TREATED DIMETHICONOL/TRIMETHYLSILOXYSILICATE CROSSPOLYMER (40/60 W/W; 5000000 PA.S):TOPICAL:PATCH:MG	TOPICAL	86.92MG TOPICAL PATCH	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
9N5G1G3D3H	TRIMETHYLSILYL TREATED DIMETHICONOL/TRIMETHYLSILOXYSILICATE CROSSPOLYMER (40/60 W/W; 5000000 PA.S):TRANSDERMAL:FILM, CONTROLLED RELEASE:MG	TRANSDERMAL	228.23MG TRANSDERMAL FILM, CONTROLLED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
9N5G1G3D3H	TRIMETHYLSILYL TREATED DIMETHICONOL/TRIMETHYLSILOXYSILICATE CROSSPOLYMER (40/60 W/W; 5000000 PA.S):TRANSDERMAL:PATCH:MG	TRANSDERMAL	1098MG TRANSDERMAL PATCH	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
W25LM17A4W	POLYCARBOPHIL:BUCCAL:FILM:MG	BUCCAL	2.06MG BUCCAL FILM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
W25LM17A4W	POLYCARBOPHIL:BUCCAL:FILM, SOLUBLE:MG	BUCCAL	1.37MG BUCCAL FILM, SOLUBLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
W25LM17A4W	POLYCARBOPHIL:BUCCAL:TABLET:MG	BUCCAL	3.13MG BUCCAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
W25LM17A4W	POLYCARBOPHIL:OPHTHALMIC:GEL:%	OPHTHALMIC	0.38% OPHTHALMIC GEL	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
W25LM17A4W	POLYCARBOPHIL:OPHTHALMIC:SOLUTION:%	OPHTHALMIC	0.9% OPHTHALMIC SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
W25LM17A4W	POLYCARBOPHIL:OPHTHALMIC:SUSPENSION, DROPS:%	OPHTHALMIC	0.86% OPHTHALMIC SUSPENSION, DROPS	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
W25LM17A4W	POLYCARBOPHIL:TOPICAL:GEL:NA	TOPICAL	TOPICAL GEL	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
W25LM17A4W	POLYCARBOPHIL:TOPICAL:PATCH:NA	TOPICAL	TOPICAL PATCH	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
W25LM17A4W	POLYCARBOPHIL:TOPICAL:SOLUTION:%W/W	TOPICAL	0.88%W/W TOPICAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
W25LM17A4W	POLYCARBOPHIL:TOPICAL:SUSPENSION, DROPS:%W/W	TOPICAL	0.86%W/W TOPICAL SUSPENSION, DROPS	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
W25LM17A4W	POLYCARBOPHIL:VAGINAL:GEL:%	VAGINAL	2.25% VAGINAL GEL	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
CAL22UVI4M	POLYSORBATE 60:BUCCAL:GUM, CHEWING:MG	BUCCAL	0.23MG BUCCAL GUM, CHEWING	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
CAL22UVI4M	POLYSORBATE 60:OPHTHALMIC:OINTMENT:%	OPHTHALMIC	15% OPHTHALMIC OINTMENT	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
CAL22UVI4M	POLYSORBATE 60:ORAL:EMULSION:%	ORAL	2% ORAL EMULSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
CAL22UVI4M	POLYSORBATE 60:ORAL:SUSPENSION:MG/5ML	ORAL	25MG/5ML ORAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
CAL22UVI4M	POLYSORBATE 60:ORAL:TABLET, COATED:NA	ORAL	ORAL TABLET, COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
CAL22UVI4M	POLYSORBATE 60:RECTAL:SUPPOSITORY:NA	RECTAL	RECTAL SUPPOSITORY	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
CAL22UVI4M	POLYSORBATE 60:TOPICAL:AEROSOL:%W/W	TOPICAL	0.42%W/W TOPICAL AEROSOL	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
CAL22UVI4M	POLYSORBATE 60:TOPICAL:AEROSOL, FOAM:%W/W	TOPICAL	0.43%W/W TOPICAL AEROSOL, FOAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
CAL22UVI4M	POLYSORBATE 60:TOPICAL:CREAM:%W/W	TOPICAL	6%W/W TOPICAL CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
CAL22UVI4M	POLYSORBATE 60:TOPICAL:CREAM, AUGMENTED:%W/W	TOPICAL	3%W/W TOPICAL CREAM, AUGMENTED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
CAL22UVI4M	POLYSORBATE 60:TOPICAL:CREAM, EMULSION, SUSTAINED RELEASE:%W/W	TOPICAL	5%W/W TOPICAL CREAM, EMULSION, SUSTAINED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
CAL22UVI4M	POLYSORBATE 60:TOPICAL:EMULSION, AEROSOL FOAM:%W/W	TOPICAL	0.42%W/W TOPICAL EMULSION, AEROSOL FOAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
CAL22UVI4M	POLYSORBATE 60:TOPICAL:EMULSION, CREAM:%W/W	TOPICAL	6.1%W/W TOPICAL EMULSION, CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
CAL22UVI4M	POLYSORBATE 60:TOPICAL:LOTION:%W/W	TOPICAL	5%W/W TOPICAL LOTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
CAL22UVI4M	POLYSORBATE 60:TOPICAL:OINTMENT:%W/W	TOPICAL	2%W/W TOPICAL OINTMENT	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
CAL22UVI4M	POLYSORBATE 60:TOPICAL:SHAMPOO:%W/W	TOPICAL	14.55%W/W TOPICAL SHAMPOO	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
CAL22UVI4M	POLYSORBATE 60:TOPICAL:SUPPOSITORY:NA	TOPICAL	TOPICAL SUPPOSITORY	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
CAL22UVI4M	POLYSORBATE 60:TOPICAL:SUPPOSITORY, INSERT:%W/W	TOPICAL	3%W/W TOPICAL SUPPOSITORY, INSERT	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
CAL22UVI4M	POLYSORBATE 60:TOPICAL:SUSPENSION:%W/W	TOPICAL	2.85%W/W TOPICAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
CAL22UVI4M	POLYSORBATE 60:TOPICAL:TABLET:NA	TOPICAL	TOPICAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
CAL22UVI4M	POLYSORBATE 60:VAGINAL:CREAM, AUGMENTED:%	VAGINAL	1.5% VAGINAL CREAM, AUGMENTED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
CAL22UVI4M	POLYSORBATE 60:VAGINAL:CREAM, EMULSION, SUSTAINED RELEASE:%	VAGINAL	5% VAGINAL CREAM, EMULSION, SUSTAINED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
CAL22UVI4M	POLYSORBATE 60:VAGINAL:EMULSION, CREAM:%	VAGINAL	5% VAGINAL EMULSION, CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
CAL22UVI4M	POLYSORBATE 60:VAGINAL:SUPPOSITORY, INSERT:NA	VAGINAL	VAGINAL SUPPOSITORY, INSERT	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
CAL22UVI4M	POLYSORBATE 60:VAGINAL:TABLET:NA	VAGINAL	VAGINAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
3SY5LH9PMK	ANHYDROUS LACTOSE:BUCCAL:TABLET:MG	BUCCAL	23.75MG BUCCAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
3SY5LH9PMK	ANHYDROUS LACTOSE:IM - IV:INJECTABLE:%	IM - IV	2.5% IM - IV INJECTABLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
3SY5LH9PMK	ANHYDROUS LACTOSE:IM - IV:POWDER, FOR INJECTION SOLUTION:%	IM - IV	2.5% IM - IV POWDER, FOR INJECTION SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
3SY5LH9PMK	ANHYDROUS LACTOSE:INHALATION:POWDER:MG/1INH	INHALATION	1.16MG/1INH INHALATION POWDER	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
3SY5LH9PMK	ANHYDROUS LACTOSE:INTRACAVITARY:POWDER, FOR INJECTION SOLUTION, LYOPHILIZED:%	INTRACAVITARY	4.75% INTRACAVITARY POWDER, FOR INJECTION SOLUTION, LYOPHILIZED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
3SY5LH9PMK	ANHYDROUS LACTOSE:INTRAVENOUS:POWDER, FOR INJECTION SOLUTION, LYOPHILIZED:%W/V	INTRAVENOUS	5.7%W/V INTRAVENOUS POWDER, FOR INJECTION SOLUTION, LYOPHILIZED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
3SY5LH9PMK	ANHYDROUS LACTOSE:IV(INFUSION):POWDER, FOR INJECTION SOLUTION:%	IV(INFUSION)	2.5% IV(INFUSION) POWDER, FOR INJECTION SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
3SY5LH9PMK	ANHYDROUS LACTOSE:ORAL:CAPSULE:MG	ORAL	402.5MG ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
3SY5LH9PMK	ANHYDROUS LACTOSE:ORAL:CAPSULE (IMMED./COMP. RELEASE):MG	ORAL	46.06MG ORAL CAPSULE (IMMED./COMP. RELEASE)	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
3SY5LH9PMK	ANHYDROUS LACTOSE:ORAL:CAPSULE, COATED, SOFT GELATIN:MG	ORAL	71.91MG ORAL CAPSULE, COATED, SOFT GELATIN	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
3SY5LH9PMK	ANHYDROUS LACTOSE:ORAL:CAPSULE, DELAYED RELEASE:MG	ORAL	40MG ORAL CAPSULE, DELAYED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
3SY5LH9PMK	ANHYDROUS LACTOSE:ORAL:CAPSULE, ENTERIC COATED PELLETS:MG	ORAL	117MG ORAL CAPSULE, ENTERIC COATED PELLETS	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
3SY5LH9PMK	ANHYDROUS LACTOSE:ORAL:CAPSULE, EXTENDED RELEASE:MG	ORAL	53.8MG ORAL CAPSULE, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
3SY5LH9PMK	ANHYDROUS LACTOSE:ORAL:CAPSULE, HARD GELATIN:MG	ORAL	238.24MG ORAL CAPSULE, HARD GELATIN	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
3SY5LH9PMK	ANHYDROUS LACTOSE:ORAL:CAPSULE, SUSTAINED ACTION:MG	ORAL	300.8MG ORAL CAPSULE, SUSTAINED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
3SY5LH9PMK	ANHYDROUS LACTOSE:ORAL:GRANULE:MG	ORAL	433MG ORAL GRANULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
3SY5LH9PMK	ANHYDROUS LACTOSE:ORAL:GRANULE, FOR RECONSTITUTION:MG	ORAL	15.69MG ORAL GRANULE, FOR RECONSTITUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
3SY5LH9PMK	ANHYDROUS LACTOSE:ORAL:POWDER, FOR ORAL SUSPENSION:MG/5ML	ORAL	468.7MG/5ML ORAL POWDER, FOR ORAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
3SY5LH9PMK	ANHYDROUS LACTOSE:ORAL:TABLET:MG	ORAL	735.2MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
3SY5LH9PMK	ANHYDROUS LACTOSE:ORAL:TABLET (IMMED./COMP. RELEASE), COATED:MG	ORAL	93.3MG ORAL TABLET (IMMED./COMP. RELEASE), COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
3SY5LH9PMK	ANHYDROUS LACTOSE:ORAL:TABLET (IMMED./COMP. RELEASE), FILM COATED:MG	ORAL	204MG ORAL TABLET (IMMED./COMP. RELEASE), FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
3SY5LH9PMK	ANHYDROUS LACTOSE:ORAL:TABLET (IMMED./COMP. RELEASE), UNCOATED, BUCCAL:MG	ORAL	98.7MG ORAL TABLET (IMMED./COMP. RELEASE), UNCOATED, BUCCAL	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
3SY5LH9PMK	ANHYDROUS LACTOSE:ORAL:TABLET (IMMED./COMP. RELEASE), UNCOATED, CHEWABLE:MG	ORAL	108MG ORAL TABLET (IMMED./COMP. RELEASE), UNCOATED, CHEWABLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
3SY5LH9PMK	ANHYDROUS LACTOSE:ORAL:TABLET, CHEWABLE:MG	ORAL	475.5MG ORAL TABLET, CHEWABLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
3SY5LH9PMK	ANHYDROUS LACTOSE:ORAL:TABLET, COATED:MG	ORAL	144.19MG ORAL TABLET, COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
3SY5LH9PMK	ANHYDROUS LACTOSE:ORAL:TABLET, DELAYED ACTION:MG	ORAL	333MG ORAL TABLET, DELAYED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
3SY5LH9PMK	ANHYDROUS LACTOSE:ORAL:TABLET, DELAYED ACTION, ENTERIC COATED:MG	ORAL	90MG ORAL TABLET, DELAYED ACTION, ENTERIC COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
3SY5LH9PMK	ANHYDROUS LACTOSE:ORAL:TABLET, DELAYED RELEASE:MG	ORAL	812MG ORAL TABLET, DELAYED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
3SY5LH9PMK	ANHYDROUS LACTOSE:ORAL:TABLET, EXTENDED RELEASE:MG	ORAL	264.45MG ORAL TABLET, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
3SY5LH9PMK	ANHYDROUS LACTOSE:ORAL:TABLET, FILM COATED:MG	ORAL	453.6MG ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
3SY5LH9PMK	ANHYDROUS LACTOSE:ORAL:TABLET, FILM COATED, EXTENDED RELEASE:MG	ORAL	48MG ORAL TABLET, FILM COATED, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
3SY5LH9PMK	ANHYDROUS LACTOSE:ORAL:TABLET, ORALLY DISINTEGRATING:MG	ORAL	25MG ORAL TABLET, ORALLY DISINTEGRATING	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
3SY5LH9PMK	ANHYDROUS LACTOSE:ORAL:TABLET, SUSTAINED ACTION:MG	ORAL	180.9MG ORAL TABLET, SUSTAINED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
3SY5LH9PMK	ANHYDROUS LACTOSE:ORAL:TABLET, SUSTAINED ACTION, COATED:MG	ORAL	130.7MG ORAL TABLET, SUSTAINED ACTION, COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
3SY5LH9PMK	ANHYDROUS LACTOSE:ORAL:TABLET, SUSTAINED ACTION, FILM COATED:MG	ORAL	157.95MG ORAL TABLET, SUSTAINED ACTION, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
3SY5LH9PMK	ANHYDROUS LACTOSE:SUBLINGUAL:TABLET:MG	SUBLINGUAL	128MG SUBLINGUAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
3SY5LH9PMK	ANHYDROUS LACTOSE:VAGINAL:TABLET:MG	VAGINAL	605MG VAGINAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
8XK1039013	MAGNESIUM ALUMINOMETASILICATE TYPE IB:ORAL:TABLET:MG	ORAL	6.4MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
9755T40D11	BLACK CURRANT:ORAL:SOLUTION:MG/5ML	ORAL	7MG/5ML ORAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
AAO1P0WSXJ	MONOTHIOGLYCEROL:AN,INFILTRATION:INJECTION:NA	AN,INFILTRATION	AN,INFILTRATION INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
AAO1P0WSXJ	MONOTHIOGLYCEROL:CAUDAL BLOCK:INJECTION:NA	CAUDAL BLOCK	CAUDAL BLOCK INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
AAO1P0WSXJ	MONOTHIOGLYCEROL:EPIDURAL:INJECTION:NA	EPIDURAL	EPIDURAL INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
AAO1P0WSXJ	MONOTHIOGLYCEROL:IM - IV:INJECTION:%	IM - IV	0.5% IM - IV INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
AAO1P0WSXJ	MONOTHIOGLYCEROL:IM - IV - SC:INJECTION:NA	IM - IV - SC	IM - IV - SC INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
AAO1P0WSXJ	MONOTHIOGLYCEROL:INTRAMUSCULAR:INJECTION:%	INTRAMUSCULAR	1% INTRAMUSCULAR INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
AAO1P0WSXJ	MONOTHIOGLYCEROL:INTRAMUSCULAR:SOLUTION:%W/V	INTRAMUSCULAR	0.5%W/V INTRAMUSCULAR SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
AAO1P0WSXJ	MONOTHIOGLYCEROL:INTRAVENOUS:INJECTION:%	INTRAVENOUS	1% INTRAVENOUS INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
AAO1P0WSXJ	MONOTHIOGLYCEROL:INTRAVENOUS:SOLUTION:%	INTRAVENOUS	0.5% INTRAVENOUS SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
AAO1P0WSXJ	MONOTHIOGLYCEROL:IV(INFUSION):INJECTION:%	IV(INFUSION)	0.5% IV(INFUSION) INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
AAO1P0WSXJ	MONOTHIOGLYCEROL:IV(INFUSION):SOLUTION, INJECTION:%	IV(INFUSION)	0.008% IV(INFUSION) SOLUTION, INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
AAO1P0WSXJ	MONOTHIOGLYCEROL:NERVE BLOCK:INJECTION:NA	NERVE BLOCK	NERVE BLOCK INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
6AP9J91K4V	CALCIUM SACCHARATE:INTRAVENOUS:SOLUTION:%	INTRAVENOUS	0.09% INTRAVENOUS SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
389H2R62BD	BUTYL ESTER OF METHYL VINYL ETHER/MALEIC ANHYDRIDE COPOLYMER (125000 MW):TOPICAL:SOLUTION:%W/W	TOPICAL	30%W/W TOPICAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
2Y53S6ATLU	DIMETHICONE 350:ORAL:CAPSULE:MG	ORAL	3.7MG ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
2Y53S6ATLU	DIMETHICONE 350:ORAL:CAPSULE, SUSTAINED ACTION:MG	ORAL	0.11MG ORAL CAPSULE, SUSTAINED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
2Y53S6ATLU	DIMETHICONE 350:TOPICAL:CREAM:%W/W	TOPICAL	0.8%W/W TOPICAL CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
2Y53S6ATLU	DIMETHICONE 350:TOPICAL:EMULSION, CREAM:%W/W	TOPICAL	1%W/W TOPICAL EMULSION, CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
2Y53S6ATLU	DIMETHICONE 350:TOPICAL:LOTION:%W/W	TOPICAL	1%W/W TOPICAL LOTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
2Y53S6ATLU	DIMETHICONE 350:TOPICAL:SOLUTION:%W/W	TOPICAL	0.5%W/W TOPICAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
8IPS6BI6KW	METHYL LAURATE:TRANSDERMAL:FILM, CONTROLLED RELEASE:MG	TRANSDERMAL	17.6MG TRANSDERMAL FILM, CONTROLLED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
8IPS6BI6KW	METHYL LAURATE:TRANSDERMAL:GEL:%	TRANSDERMAL	0.25% TRANSDERMAL GEL	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
H7AGY1OJO8	POVIDONE K27:ORAL:TABLET:MG	ORAL	26.6MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
Pending	AEROTEX RESIN 3730:TRANSDERMAL:FILM, CONTROLLED RELEASE:MG	TRANSDERMAL	1.9MG TRANSDERMAL FILM, CONTROLLED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
Pending	ALUMINUM POLYESTER:TRANSDERMAL:FILM:MG	TRANSDERMAL	9.78MG TRANSDERMAL FILM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
Pending	ALUMINUM POLYESTER:TRANSDERMAL:FILM, CONTROLLED RELEASE:MG	TRANSDERMAL	81MG TRANSDERMAL FILM, CONTROLLED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
Pending	ALZAMER-50:ORAL:TABLET, CONTROLLED RELEASE:MG	ORAL	32MG ORAL TABLET, CONTROLLED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
Pending	ALZAMER-50:ORAL:TABLET, SUSTAINED ACTION:MG	ORAL	10MG ORAL TABLET, SUSTAINED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
Pending	AMBERLITE XE-88:ORAL:TABLET:MG	ORAL	10MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
Pending	AMBERLITE XE-88:ORAL:TABLET, COATED:MG	ORAL	11MG ORAL TABLET, COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
Pending	AMMONIUM CALCIUM ALGINATE:ORAL:TABLET:MG	ORAL	10.72MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
Pending	AMPHOTERIC-9:TOPICAL:EMULSION, CREAM:%W/W	TOPICAL	0.66%W/W TOPICAL EMULSION, CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
Pending	CALCIUM CARRAGEENAN SULFATE:ORAL:SYRUP:NA	ORAL	ORAL SYRUP	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
Pending	CALCIUM PHOSPHATE, DIBASIC MONOHYDRATE:ORAL:TABLET:MG	ORAL	109.3MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
Pending	CARBOMER 1382:TOPICAL:GEL:%W/W	TOPICAL	0.9%W/W TOPICAL GEL	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
Pending	CARBOXYMETHYL STARCH:ORAL:CAPSULE:MG	ORAL	15MG ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
Pending	CARBOXYMETHYL STARCH:ORAL:TABLET:MG	ORAL	25MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
Pending	CARMINE:ORAL:SUSPENSION:MG/5ML	ORAL	50.4MG/5ML ORAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
Pending	CARMINE:ORAL:TABLET:MG	ORAL	6.8MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
Pending	CARMINE:ORAL:TABLET, FILM COATED:MG	ORAL	0.38MG ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
Pending	CARMINE:ORAL:TABLET, UNCOATED, TROCHE:NA	ORAL	ORAL TABLET, UNCOATED, TROCHE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
Pending	CELLABURATE:ORAL:CAPSULE, EXTENDED RELEASE:MG	ORAL	5.5MG ORAL CAPSULE, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
Pending	CELLABURATE:ORAL:TABLET, EXTENDED RELEASE:MG	ORAL	88.4MG ORAL TABLET, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
Pending	CELLULOSE ACETATE CA-320S:ORAL:TABLET, EXTENDED RELEASE:MG	ORAL	36.02MG ORAL TABLET, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
Pending	CELLULOSE ACETATE CA-398-10:ORAL:TABLET:MG	ORAL	15.77MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
Pending	CELLULOSE ACETATE CA-398-10:ORAL:TABLET, CONTROLLED RELEASE:MG	ORAL	27.72MG ORAL TABLET, CONTROLLED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
Pending	CELLULOSE ACETATE CA-398-10:ORAL:TABLET, EXTENDED RELEASE:MG	ORAL	47.49MG ORAL TABLET, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
Pending	COCO-BETAINE:TOPICAL:SHAMPOO:%W/W	TOPICAL	6%W/W TOPICAL SHAMPOO	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
Pending	COCONUT OIL - LECITHIN:ORAL:CAPSULE, SOFT GELATIN:NA	ORAL	ORAL CAPSULE, SOFT GELATIN	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
Pending	CYCLOMETHICONE/DIMETHICONE COPOLYOL:TOPICAL:GEL:%W/W	TOPICAL	2.3%W/W TOPICAL GEL	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
Pending	DIASTASE, MALT:ORAL:SYRUP:NA	ORAL	ORAL SYRUP	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
Pending	EIDERDOWN SOAP:ORAL:TABLET, EXTENDED RELEASE:NA	ORAL	ORAL TABLET, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
Pending	EIDERDOWN SOAP:ORAL:TABLET, REPEAT ACTION:MG	ORAL	0.39MG ORAL TABLET, REPEAT ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
Pending	EIDERDOWN SOAP:ORAL:TABLET, SUSTAINED ACTION:MG	ORAL	0.23MG ORAL TABLET, SUSTAINED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
Pending	ESSENCE LEMON:ORAL:SYRUP:%	ORAL	0.05% ORAL SYRUP	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
Pending	ESSENCE ORANGE:ORAL:SYRUP:%	ORAL	0.2% ORAL SYRUP	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
Pending	ETHYLENE-PROPYLENE COPOLYMER:TRANSDERMAL:FILM, CONTROLLED RELEASE:MG	TRANSDERMAL	31.67MG TRANSDERMAL FILM, CONTROLLED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
Pending	FERRIC OXIDE BROWN:ORAL:CAPSULE:MG	ORAL	0.098MG ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
Pending	FERRIC OXIDE BROWN:ORAL:CAPSULE, SOFT GELATIN:MG	ORAL	0.7MG ORAL CAPSULE, SOFT GELATIN	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
Pending	FERRIC OXIDE BROWN:ORAL:TABLET:MG	ORAL	1.13MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
Pending	FERRIC OXIDE ORANGE:ORAL:TABLET:MG	ORAL	0.51MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
Pending	FERRIC OXIDE ORANGE:ORAL:TABLET, EXTENDED RELEASE:MG	ORAL	0.079MG ORAL TABLET, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
Pending	FLOUR:ORAL:CAPSULE:NA	ORAL	ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
Pending	FLOUR:ORAL:TABLET:MG	ORAL	1.16MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
Pending	FLOUR:ORAL:TABLET, COATED:MG	ORAL	11.25MG ORAL TABLET, COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
Pending	FLOUR:ORAL:TABLET, SUSTAINED ACTION:NA	ORAL	ORAL TABLET, SUSTAINED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
Pending	GLYCERIN POLYMER SOLUTION I-137:ORAL:TABLET:MG	ORAL	0.5MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
Pending	GLYCERIN POLYMER SOLUTION IM-137:ORAL:TABLET:NA	ORAL	ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
Pending	GUM BASE, CHEWING:BUCCAL:GUM:MG	BUCCAL	691.2MG BUCCAL GUM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
Pending	GUM BASE, CHEWING:BUCCAL:GUM, CHEWING:MG	BUCCAL	729.6MG BUCCAL GUM, CHEWING	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
Pending	HYDROGENATED POLYBUTENE 635-690:TRANSDERMAL:FILM:MG	TRANSDERMAL	142.99MG TRANSDERMAL FILM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
Pending	HYSTRENE:ORAL:CAPSULE:NA	ORAL	ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
Pending	HYSTRENE:ORAL:TABLET:MG	ORAL	3MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
Pending	ISOOCTYL ACRYLATE/ACRYLAMIDE/VINYL ACETATE COPOLYMER, KOLLIDON VA 64 POLYMER:ORAL:TABLET, FILM COATED:MG	ORAL	53MG ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=I
Pending	ISOOCTYL ACRYLATE/ACRYLAMIDE/VINYL ACETATE COPOLYMER, KOLLIDON VA 64 POLYMER:TOPICAL:SPONGE:%	TOPICAL	5.4% TOPICAL SPONGE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=I
Pending	LANOLIN CHOLESTEROLS:TOPICAL:EMULSION:NA	TOPICAL	TOPICAL EMULSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
Pending	LANOLIN CHOLESTEROLS:TOPICAL:SPONGE:NA	TOPICAL	TOPICAL SPONGE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
Pending	METHYLATED SPIRITS:ORAL:CAPSULE:MG	ORAL	0.1MG ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
Pending	METHYLATED SPIRITS:ORAL:TABLET, EXTENDED RELEASE:MG	ORAL	0.022MG ORAL TABLET, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
Pending	MISTRON SPRAY TALC:ORAL:TABLET:NA	ORAL	ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
Pending	NEUTRAL OIL:ORAL:CAPSULE, SUSTAINED ACTION:MG	ORAL	240MG ORAL CAPSULE, SUSTAINED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=N
Pending	NEUTRAL OIL:SUBLINGUAL:AEROSOL:NA	SUBLINGUAL	SUBLINGUAL AEROSOL	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=N
Pending	PLASACRYL:ORAL:TABLET:MG	ORAL	5.4MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
Pending	POLY(DIMETHYLSILOXANE/METHYLVINYLSILOXANE/METHYLHYDROGENSILOXANE) DIMETHYLVINYL OR DIMETHYLHYDROXY OR TRIMETHYL ENDBLOCKED:VAGINAL:INSERT, EXTENDED RELEASE:MG	VAGINAL	9980MG VAGINAL INSERT, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
Pending	POLYDEXTROSE K:ORAL:TABLET, FILM COATED:MG	ORAL	8.13MG ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
Pending	POLYESTER POLYAMINE COPOLYMER:TRANSDERMAL:FILM, CONTROLLED RELEASE:MG	TRANSDERMAL	6.67MG TRANSDERMAL FILM, CONTROLLED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
Pending	POLYGLACTIN:DENTAL:POWDER:NA	DENTAL	DENTAL POWDER	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
Pending	POLYGLACTIN:IMPLANTATION:PELLET, IMPLANT:MG	IMPLANTATION	25.2MG IMPLANTATION PELLET, IMPLANT	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
Pending	POLYGLACTIN:INTRA-ARTICULAR:INJECTION, SUSPENSION, EXTENDED RELEASE:MG	INTRA-ARTICULAR	96MG INTRA-ARTICULAR INJECTION, SUSPENSION, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
Pending	POLYGLACTIN:INTRAMUSCULAR:INJECTION:%	INTRAMUSCULAR	14.5% INTRAMUSCULAR INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
Pending	POLYGLACTIN:INTRAMUSCULAR:INJECTION, MICROSPHERES:%	INTRAMUSCULAR	56.64% INTRAMUSCULAR INJECTION, MICROSPHERES	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
Pending	POLYGLACTIN:INTRAMUSCULAR:POWDER, FOR INJECTION SOLUTION, LYOPHILIZED:%	INTRAMUSCULAR	17% INTRAMUSCULAR POWDER, FOR INJECTION SOLUTION, LYOPHILIZED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
Pending	POLYGLACTIN:INTRAMUSCULAR:POWDER, FOR INJECTION SUSPENSION:%	INTRAMUSCULAR	15.77% INTRAMUSCULAR POWDER, FOR INJECTION SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
Pending	POLYGLACTIN:SUBCUTANEOUS:INJECTION:%	SUBCUTANEOUS	21.15% SUBCUTANEOUS INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
Pending	POLYGLACTIN:SUBCUTANEOUS:INJECTION, SUSPENSION:mg	SUBCUTANEOUS	304mg SUBCUTANEOUS INJECTION, SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
Pending	POLYGLACTIN:SUBCUTANEOUS:MICROCAPSULES FOR INJECTION SUSPENSION, STERILE:%	SUBCUTANEOUS	3.72% SUBCUTANEOUS MICROCAPSULES FOR INJECTION SUSPENSION, STERILE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
Pending	POLYGLACTIN:SUBCUTANEOUS:PELLET, IMPLANT:MG	SUBCUTANEOUS	25.2MG SUBCUTANEOUS PELLET, IMPLANT	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
Pending	POLYGLACTIN:SUBCUTANEOUS:POWDER, FOR INJECTION SUSPENSION:%	SUBCUTANEOUS	13.26% SUBCUTANEOUS POWDER, FOR INJECTION SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
Pending	POLYISOBUTYLENE LOW MOLECULAR WEIGHT:TRANSDERMAL:PATCH, CONTROLLED RELEASE:MG	TRANSDERMAL	8.13MG TRANSDERMAL PATCH, CONTROLLED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
Pending	POLYISOBUTYLENE MEDIUM MOLECULAR WEIGHT:TRANSDERMAL:PATCH, CONTROLLED RELEASE:MG	TRANSDERMAL	1.63MG TRANSDERMAL PATCH, CONTROLLED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
Pending	POLYISOBUTYLENE/POLYBUTENE ADHESIVE:TRANSDERMAL:FILM, CONTROLLED RELEASE:MG	TRANSDERMAL	221.25MG TRANSDERMAL FILM, CONTROLLED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
Pending	POLYOXYETHYLENE - POLYOXYPROPYLENE 1800:OPHTHALMIC:SOLUTION:NA	OPHTHALMIC	OPHTHALMIC SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
Pending	POLYOXYETHYLENE - POLYOXYPROPYLENE 1800:TOPICAL:EMULSION, CREAM:NA	TOPICAL	TOPICAL EMULSION, CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
Pending	POLYPROPYLENE:INTRAUTERINE:INTRAUTERINE DEVICE:NA	INTRAUTERINE	INTRAUTERINE INTRAUTERINE DEVICE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
Pending	POLYPROPYLENE:TOPICAL:SPONGE:NA	TOPICAL	TOPICAL SPONGE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
Pending	POLYPROPYLENE:TRANSDERMAL:FILM, CONTROLLED RELEASE:MG	TRANSDERMAL	13.5MG TRANSDERMAL FILM, CONTROLLED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
Pending	POLYSACCHARIDES SOY:ORAL:TABLET:MG	ORAL	52MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
Pending	POLYSACCHARIDES SOY:ORAL:TABLET, DELAYED ACTION, ENTERIC COATED:MG	ORAL	53.5MG ORAL TABLET, DELAYED ACTION, ENTERIC COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
Pending	POLYVINYL CHLORIDE-POLYVINYL ACETATE COPOLYMER:TRANSDERMAL:FILM, CONTROLLED RELEASE:MG	TRANSDERMAL	899.88MG TRANSDERMAL FILM, CONTROLLED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
Pending	POLYVINYLACETAL:ORAL:CAPSULE, SUSTAINED ACTION:MG	ORAL	5MG ORAL CAPSULE, SUSTAINED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
Pending	POLYVINYLACETAL:ORAL:TABLET:MG	ORAL	41.85MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
Pending	POTASSIUM SOAP:TOPICAL:SOLUTION:%W/W	TOPICAL	32.8%W/W TOPICAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
Pending	POVIDONE/EICOSENE COPOLYMER:TOPICAL:EMULSION, CREAM:%W/W	TOPICAL	1%W/W TOPICAL EMULSION, CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
Pending	POVIDONE/EICOSENE COPOLYMER:TOPICAL:LOTION:%W/W	TOPICAL	1%W/W TOPICAL LOTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
Pending	RA-2397:TRANSDERMAL:FILM, CONTROLLED RELEASE:MG	TRANSDERMAL	142.2MG TRANSDERMAL FILM, CONTROLLED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=R
Pending	RA-3011:TRANSDERMAL:FILM, CONTROLLED RELEASE:MG	TRANSDERMAL	142.2MG TRANSDERMAL FILM, CONTROLLED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=R
Pending	SILICONE ADHESIVE 4302:TRANSDERMAL:PATCH:mg	TRANSDERMAL	44.55mg TRANSDERMAL PATCH	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
Pending	SODIUM CELLULOSE:ORAL:CAPSULE:MG	ORAL	150MG ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
Pending	STARCH 7150:ORAL:CAPSULE:MG	ORAL	0.44MG ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
Pending	STARCH 7150:ORAL:TABLET:MG	ORAL	50MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
Pending	STARCH 825:ORAL:CAPSULE:MG	ORAL	217MG ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
Pending	STARCH 826:ORAL:CAPSULE:MG	ORAL	237MG ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
Pending	STARCH 826:ORAL:TABLET:MG	ORAL	138MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
Pending	STARCH 826:ORAL:TABLET, FILM COATED:MG	ORAL	10MG ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
Pending	STARCH 826:SUBLINGUAL:TABLET:MG	SUBLINGUAL	12MG SUBLINGUAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
Pending	STYRENE/ISOPRENE/STYRENE BLOCK COPOLYMER:TOPICAL:PATCH:MG	TOPICAL	519.75MG TOPICAL PATCH	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
Pending	SURFACTOL QS:TOPICAL:SOLUTION:%W/W	TOPICAL	2%W/W TOPICAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
Pending	TALLOW GLYCERIDES:TOPICAL:EMULSION:%W/W	TOPICAL	2.55%W/W TOPICAL EMULSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
Pending	TALLOW GLYCERIDES:TOPICAL:EMULSION, CREAM:%W/W	TOPICAL	2.78%W/W TOPICAL EMULSION, CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
Pending	TRITON 720:OPHTHALMIC:SOLUTION:NA	OPHTHALMIC	OPHTHALMIC SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
Pending	VINYL ACETATE - CROTONIC ACID COPOLYMER:ORAL:CAPSULE, SUSTAINED ACTION:NA	ORAL	ORAL CAPSULE, SUSTAINED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=V
Pending	VISCOSE/COTTON:TRANSDERMAL:FILM, CONTROLLED RELEASE:MG	TRANSDERMAL	84MG TRANSDERMAL FILM, CONTROLLED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=V
Pending	WECOBEE FS:TOPICAL:EMULSION, CREAM:%W/W	TOPICAL	67.2%W/W TOPICAL EMULSION, CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=W
Pending	WECOBEE FS:VAGINAL:EMULSION, CREAM:MG	VAGINAL	1495MG VAGINAL EMULSION, CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=W
Pending	WECOBEE FS:VAGINAL:SUPPOSITORY:MG	VAGINAL	1700MG VAGINAL SUPPOSITORY	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=W
Pending	XYLITOL 300:ORAL:POWDER, FOR ORAL SUSPENSION:MG/PKT	ORAL	4223MG/PKT ORAL POWDER, FOR ORAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=X
Pending	XYLITOL 300:ORAL:TABLET, ORALLY DISINTEGRATING:MG	ORAL	10MG ORAL TABLET, ORALLY DISINTEGRATING	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=X
U466TXA0AK	LOW SUBSTITUTED HYDROXYPROPYL CELLULOSE (8% HYDROXYPROPYL: 135000 MW):ORAL:TABLET:MG	ORAL	53.76MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
0WZ8WG20P6	HYPROMELLOSE 2910 (6 MPA.S):ORAL:CAPSULE:MG	ORAL	150MG ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
0WZ8WG20P6	HYPROMELLOSE 2910 (6 MPA.S):ORAL:CAPSULE, DELAYED ACTION:MG	ORAL	57.5MG ORAL CAPSULE, DELAYED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
0WZ8WG20P6	HYPROMELLOSE 2910 (6 MPA.S):ORAL:CAPSULE, DELAYED RELEASE:MG	ORAL	60.7MG ORAL CAPSULE, DELAYED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
0WZ8WG20P6	HYPROMELLOSE 2910 (6 MPA.S):ORAL:CAPSULE, EXTENDED RELEASE:MG	ORAL	24.72MG ORAL CAPSULE, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
0WZ8WG20P6	HYPROMELLOSE 2910 (6 MPA.S):ORAL:CAPSULE, SOFT GELATIN LIQUID-FILLED:MG	ORAL	2.59MG ORAL CAPSULE, SOFT GELATIN LIQUID-FILLED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
0WZ8WG20P6	HYPROMELLOSE 2910 (6 MPA.S):ORAL:POWDER, FOR ORAL SUSPENSION:MG/5ML	ORAL	35MG/5ML ORAL POWDER, FOR ORAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
0WZ8WG20P6	HYPROMELLOSE 2910 (6 MPA.S):ORAL:TABLET:MG	ORAL	80.31MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
0WZ8WG20P6	HYPROMELLOSE 2910 (6 MPA.S):ORAL:TABLET (IMMED./COMP. RELEASE), FILM COATED:MG	ORAL	17.2MG ORAL TABLET (IMMED./COMP. RELEASE), FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
0WZ8WG20P6	HYPROMELLOSE 2910 (6 MPA.S):ORAL:TABLET, DELAYED ACTION:MG	ORAL	14.5MG ORAL TABLET, DELAYED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
0WZ8WG20P6	HYPROMELLOSE 2910 (6 MPA.S):ORAL:TABLET, DELAYED ACTION, ENTERIC COATED:MG	ORAL	5.25MG ORAL TABLET, DELAYED ACTION, ENTERIC COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
0WZ8WG20P6	HYPROMELLOSE 2910 (6 MPA.S):ORAL:TABLET, DELAYED RELEASE:mg	ORAL	25.48mg ORAL TABLET, DELAYED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
0WZ8WG20P6	HYPROMELLOSE 2910 (6 MPA.S):ORAL:TABLET, EXTENDED RELEASE:MG	ORAL	85MG ORAL TABLET, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
0WZ8WG20P6	HYPROMELLOSE 2910 (6 MPA.S):ORAL:TABLET, FILM COATED:MG	ORAL	19.84MG ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
0WZ8WG20P6	HYPROMELLOSE 2910 (6 MPA.S):ORAL:TABLET, FILM COATED, EXTENDED RELEASE:MG	ORAL	3.29MG ORAL TABLET, FILM COATED, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
0WZ8WG20P6	HYPROMELLOSE 2910 (6 MPA.S):ORAL:TABLET, ORALLY DISINTEGRATING:MG	ORAL	13MG ORAL TABLET, ORALLY DISINTEGRATING	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
0WZ8WG20P6	HYPROMELLOSE 2910 (6 MPA.S):ORAL:TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE:mg	ORAL	9.1mg ORAL TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
7JPC6Y25QS	OCTOXYNOL-9:TOPICAL:GEL:%W/W	TOPICAL	0.12%W/W TOPICAL GEL	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
7JPC6Y25QS	OCTOXYNOL-9:TOPICAL:LOTION:%W/W 	TOPICAL	0.12%W/W  TOPICAL LOTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
7JPC6Y25QS	OCTOXYNOL-9:TOPICAL:OINTMENT:NA	TOPICAL	TOPICAL OINTMENT	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
7JPC6Y25QS	OCTOXYNOL-9:TOPICAL:SOLUTION:NA	TOPICAL	TOPICAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
7JPC6Y25QS	OCTOXYNOL-9:TOPICAL:SPONGE:NA	TOPICAL	TOPICAL SPONGE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
Q40Q9N063P	ACETIC ACID:AN,INFILTRATION:INJECTION:NA	AN,INFILTRATION	AN,INFILTRATION INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
Q40Q9N063P	ACETIC ACID:AURICULAR (OTIC):SUSPENSION:ADJ PH	AURICULAR (OTIC)	ADJ PH AURICULAR (OTIC) SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
Q40Q9N063P	ACETIC ACID:AURICULAR (OTIC):SUSPENSION, LIQUID:%	AURICULAR (OTIC)	0.26% AURICULAR (OTIC) SUSPENSION, LIQUID	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
Q40Q9N063P	ACETIC ACID:EXTRACORPOREAL:SOLUTION:%	EXTRACORPOREAL	0.12% EXTRACORPOREAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
Q40Q9N063P	ACETIC ACID:IM - IV - SC:INJECTION:%	IM - IV - SC	0.35% IM - IV - SC INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
Q40Q9N063P	ACETIC ACID:IM - SC:INJECTION:%	IM - SC	0.2% IM - SC INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
Q40Q9N063P	ACETIC ACID:IM - SC:INJECTION, SUSTAINED ACTION:ADJ PH	IM - SC	ADJ PH IM - SC INJECTION, SUSTAINED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
Q40Q9N063P	ACETIC ACID:INTRA-ARTICULAR:INJECTION:ADJ PH	INTRA-ARTICULAR	ADJ PH INTRA-ARTICULAR INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
Q40Q9N063P	ACETIC ACID:INTRALESIONAL:INJECTION:ADJ PH	INTRALESIONAL	ADJ PH INTRALESIONAL INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
Q40Q9N063P	ACETIC ACID:INTRAMUSCULAR:INJECTION:%W/V	INTRAMUSCULAR	0.25%W/V INTRAMUSCULAR INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
Q40Q9N063P	ACETIC ACID:INTRAMUSCULAR:POWDER, FOR INJECTION SOLUTION, LYOPHILIZED:ADJ PH	INTRAMUSCULAR	ADJ PH INTRAMUSCULAR POWDER, FOR INJECTION SOLUTION, LYOPHILIZED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
Q40Q9N063P	ACETIC ACID:INTRASYNOVIAL:INJECTION:ADJ PH	INTRASYNOVIAL	ADJ PH INTRASYNOVIAL INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
Q40Q9N063P	ACETIC ACID:INTRATRACHEAL:SUSPENSION:ADJ PH	INTRATRACHEAL	ADJ PH INTRATRACHEAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
Q40Q9N063P	ACETIC ACID:INTRAVENOUS:INJECTABLE:%	INTRAVENOUS	0.1% INTRAVENOUS INJECTABLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
Q40Q9N063P	ACETIC ACID:INTRAVENOUS:INJECTION:%	INTRAVENOUS	0.27% INTRAVENOUS INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
Q40Q9N063P	ACETIC ACID:INTRAVENOUS:INJECTION:ADJ PH	INTRAVENOUS	ADJ PH INTRAVENOUS INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
Q40Q9N063P	ACETIC ACID:INTRAVENOUS:INJECTION, SOLUTION:ug/1mL	INTRAVENOUS	5.4ug/1mL INTRAVENOUS INJECTION, SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
Q40Q9N063P	ACETIC ACID:INTRAVENOUS:INJECTION, SOLUTION:%	INTRAVENOUS	0.01% INTRAVENOUS INJECTION, SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
Q40Q9N063P	ACETIC ACID:INTRAVENOUS:INJECTION, SOLUTION:%	INTRAVENOUS	0.009% INTRAVENOUS INJECTION, SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
Q40Q9N063P	ACETIC ACID:INTRAVENOUS:POWDER, FOR INJECTION SOLUTION, LYOPHILIZED:ADJ PH	INTRAVENOUS	ADJ PH INTRAVENOUS POWDER, FOR INJECTION SOLUTION, LYOPHILIZED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
Q40Q9N063P	ACETIC ACID:INTRAVENOUS:SOLUTION:ADJ PH	INTRAVENOUS	ADJ PH INTRAVENOUS SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
Q40Q9N063P	ACETIC ACID:INTRAVENOUS:SOLUTION, INJECTION:%W/V	INTRAVENOUS	0.4%W/V INTRAVENOUS SOLUTION, INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
Q40Q9N063P	ACETIC ACID:IRRIGATION:SOLUTION:ADJ PH	IRRIGATION	ADJ PH IRRIGATION SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
Q40Q9N063P	ACETIC ACID:IV - SC:INJECTION:%	IV - SC	0.2% IV - SC INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
Q40Q9N063P	ACETIC ACID:IV - SC:INJECTION, SOLUTION:%	IV - SC	0.2% IV - SC INJECTION, SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
Q40Q9N063P	ACETIC ACID:IV(INFUSION):INJECTABLE:%	IV(INFUSION)	0.14% IV(INFUSION) INJECTABLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
Q40Q9N063P	ACETIC ACID:IV(INFUSION):INJECTION:%	IV(INFUSION)	1% IV(INFUSION) INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
Q40Q9N063P	ACETIC ACID:IV(INFUSION):POWDER, FOR INJECTION SOLUTION, LYOPHILIZED:%	IV(INFUSION)	0.27% IV(INFUSION) POWDER, FOR INJECTION SOLUTION, LYOPHILIZED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
Q40Q9N063P	ACETIC ACID:IV(INFUSION):SOLUTION, INJECTION:%	IV(INFUSION)	0.055% IV(INFUSION) SOLUTION, INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
Q40Q9N063P	ACETIC ACID:NASAL:SOLUTION:NA	NASAL	NASAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
Q40Q9N063P	ACETIC ACID:NASAL:SPRAY, METERED:%W/V	NASAL	0.12%W/V NASAL SPRAY, METERED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
Q40Q9N063P	ACETIC ACID:NERVE BLOCK:INJECTION:NA	NERVE BLOCK	NERVE BLOCK INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
Q40Q9N063P	ACETIC ACID:OPHTHALMIC:POWDER, FOR SOLUTION:ADJ PH	OPHTHALMIC	ADJ PH OPHTHALMIC POWDER, FOR SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
Q40Q9N063P	ACETIC ACID:OPHTHALMIC:SOLUTION:%	OPHTHALMIC	0.08% OPHTHALMIC SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
Q40Q9N063P	ACETIC ACID:OPHTHALMIC:SOLUTION, DROPS:%	OPHTHALMIC	0.09% OPHTHALMIC SOLUTION, DROPS	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
Q40Q9N063P	ACETIC ACID:ORAL:CAPSULE:NA	ORAL	ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
Q40Q9N063P	ACETIC ACID:ORAL:CAPSULE, ENTERIC COATED PELLETS:MG	ORAL	0.36MG ORAL CAPSULE, ENTERIC COATED PELLETS	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
Q40Q9N063P	ACETIC ACID:ORAL:CAPSULE, HARD GELATIN:NA	ORAL	ORAL CAPSULE, HARD GELATIN	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
Q40Q9N063P	ACETIC ACID:ORAL:CONCENTRATE:NA	ORAL	ORAL CONCENTRATE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
Q40Q9N063P	ACETIC ACID:ORAL:SOLUTION:MG/5ML	ORAL	5MG/5ML ORAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
Q40Q9N063P	ACETIC ACID:ORAL:SOLUTION, ELIXIR:MG/5ML	ORAL	1.07MG/5ML ORAL SOLUTION, ELIXIR	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
Q40Q9N063P	ACETIC ACID:ORAL:SOLUTION, INJECTION:ADJ PH	ORAL	ADJ PH ORAL SOLUTION, INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
Q40Q9N063P	ACETIC ACID:ORAL:SOLUTION, SYRUP:MG/5ML	ORAL	13.2MG/5ML ORAL SOLUTION, SYRUP	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
Q40Q9N063P	ACETIC ACID:ORAL:SYRUP:%	ORAL	0.2% ORAL SYRUP	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
Q40Q9N063P	ACETIC ACID:ORAL:TABLET:MG	ORAL	0.002MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
Q40Q9N063P	ACETIC ACID:OTIC:SUSPENSION:%	OTIC	0.04% OTIC SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
Q40Q9N063P	ACETIC ACID:PARENTERAL:INJECTION:ADJ PH	PARENTERAL	ADJ PH PARENTERAL INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
Q40Q9N063P	ACETIC ACID:PHOTOPHERESIS:SOLUTION:%	PHOTOPHERESIS	0.12% PHOTOPHERESIS SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
Q40Q9N063P	ACETIC ACID:SOFT TISSUE:INJECTION:ADJ PH	SOFT TISSUE	ADJ PH SOFT TISSUE INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
Q40Q9N063P	ACETIC ACID:SUBCUTANEOUS:INJECTABLE:%	SUBCUTANEOUS	0.2% SUBCUTANEOUS INJECTABLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
Q40Q9N063P	ACETIC ACID:SUBCUTANEOUS:INJECTION:%	SUBCUTANEOUS	0.2% SUBCUTANEOUS INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
Q40Q9N063P	ACETIC ACID:SUBCUTANEOUS:INJECTION, SOLUTION:%	SUBCUTANEOUS	0.011% SUBCUTANEOUS INJECTION, SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
Q40Q9N063P	ACETIC ACID:SUBCUTANEOUS:POWDER, FOR INJECTION SOLUTION, LYOPHILIZED:%	SUBCUTANEOUS	0.041% SUBCUTANEOUS POWDER, FOR INJECTION SOLUTION, LYOPHILIZED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
Q40Q9N063P	ACETIC ACID:SUBCUTANEOUS:SOLUTION:%	SUBCUTANEOUS	0.15% SUBCUTANEOUS SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
Q40Q9N063P	ACETIC ACID:SUBCUTANEOUS:SOLUTION, INJECTION:%	SUBCUTANEOUS	0.11% SUBCUTANEOUS SOLUTION, INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
Q40Q9N063P	ACETIC ACID:SUBMUCOSAL:SOLUTION, INJECTION:ADJ PH	SUBMUCOSAL	ADJ PH SUBMUCOSAL SOLUTION, INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
Q40Q9N063P	ACETIC ACID:TOPICAL:EMULSION, CREAM:NA	TOPICAL	TOPICAL EMULSION, CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
Q40Q9N063P	ACETIC ACID:TOPICAL:SOLUTION:%	TOPICAL	0.043% TOPICAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
Q40Q9N063P	ACETIC ACID:TOPICAL:SPONGE:NA	TOPICAL	TOPICAL SPONGE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
Q40Q9N063P	ACETIC ACID:VAGINAL:EMULSION, AEROSOL FOAM:%	VAGINAL	0.025% VAGINAL EMULSION, AEROSOL FOAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
Z82Y2C65EA	HYDROGENATED COTTONSEED OIL:ORAL:CAPSULE:MG	ORAL	15MG ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
Z82Y2C65EA	HYDROGENATED COTTONSEED OIL:ORAL:CAPSULE:MG	ORAL	2.6MG ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
Z82Y2C65EA	HYDROGENATED COTTONSEED OIL:ORAL:CAPSULE, EXTENDED RELEASE:MG	ORAL	39.14MG ORAL CAPSULE, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
Z82Y2C65EA	HYDROGENATED COTTONSEED OIL:ORAL:CAPSULE, SUSTAINED ACTION:MG	ORAL	58MG ORAL CAPSULE, SUSTAINED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
Z82Y2C65EA	HYDROGENATED COTTONSEED OIL:ORAL:TABLET:MG	ORAL	34MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
Z82Y2C65EA	HYDROGENATED COTTONSEED OIL:ORAL:TABLET:MG	ORAL	10MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
Z82Y2C65EA	HYDROGENATED COTTONSEED OIL:ORAL:TABLET (IMMED./COMP. RELEASE), UNCOATED, CHEWABLE:NA	ORAL	ORAL TABLET (IMMED./COMP. RELEASE), UNCOATED, CHEWABLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
Z82Y2C65EA	HYDROGENATED COTTONSEED OIL:ORAL:TABLET, COATED:MG	ORAL	0.6MG ORAL TABLET, COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
Z82Y2C65EA	HYDROGENATED COTTONSEED OIL:ORAL:TABLET, DELAYED ACTION, ENTERIC COATED:MG	ORAL	4MG ORAL TABLET, DELAYED ACTION, ENTERIC COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
Z82Y2C65EA	HYDROGENATED COTTONSEED OIL:ORAL:TABLET, EXTENDED RELEASE:MG	ORAL	228MG ORAL TABLET, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
Z82Y2C65EA	HYDROGENATED COTTONSEED OIL:ORAL:TABLET, EXTENDED RELEASE:MG	ORAL	212.5MG ORAL TABLET, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
Z82Y2C65EA	HYDROGENATED COTTONSEED OIL:ORAL:TABLET, SUSTAINED ACTION:MG	ORAL	402MG ORAL TABLET, SUSTAINED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
Z82Y2C65EA	HYDROGENATED COTTONSEED OIL:ORAL:TABLET, SUSTAINED ACTION:MG	ORAL	35MG ORAL TABLET, SUSTAINED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
Z82Y2C65EA	HYDROGENATED COTTONSEED OIL:SUBLINGUAL:TABLET:MG	SUBLINGUAL	2MG SUBLINGUAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
6DC9Q167V3	PROPYLENE GLYCOL:AURICULAR (OTIC):DROPS:NA	AURICULAR (OTIC)	AURICULAR (OTIC) DROPS	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
6DC9Q167V3	PROPYLENE GLYCOL:AURICULAR (OTIC):SOLUTION:%	AURICULAR (OTIC)	94.93% AURICULAR (OTIC) SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
6DC9Q167V3	PROPYLENE GLYCOL:AURICULAR (OTIC):SOLUTION, DROPS:ADJ PH	AURICULAR (OTIC)	ADJ PH AURICULAR (OTIC) SOLUTION, DROPS	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
6DC9Q167V3	PROPYLENE GLYCOL:AURICULAR (OTIC):SUSPENSION:%	AURICULAR (OTIC)	10% AURICULAR (OTIC) SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
6DC9Q167V3	PROPYLENE GLYCOL:BUCCAL:FILM:MG	BUCCAL	1.48MG BUCCAL FILM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
6DC9Q167V3	PROPYLENE GLYCOL:BUCCAL:FILM, SOLUBLE:MG	BUCCAL	1.02MG BUCCAL FILM, SOLUBLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
6DC9Q167V3	PROPYLENE GLYCOL:DENTAL:OINTMENT:NA	DENTAL	DENTAL OINTMENT	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
6DC9Q167V3	PROPYLENE GLYCOL:DENTAL:PASTE:NA	DENTAL	DENTAL PASTE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
6DC9Q167V3	PROPYLENE GLYCOL:DENTAL:SOLUTION:%	DENTAL	2% DENTAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
6DC9Q167V3	PROPYLENE GLYCOL:EXTRACORPOREAL:SOLUTION:%	EXTRACORPOREAL	5% EXTRACORPOREAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
6DC9Q167V3	PROPYLENE GLYCOL:IM - IV:INJECTABLE:%	IM - IV	40% IM - IV INJECTABLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
6DC9Q167V3	PROPYLENE GLYCOL:IM - IV:INJECTION:%	IM - IV	82.04% IM - IV INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
6DC9Q167V3	PROPYLENE GLYCOL:IM - IV:SOLUTION, INJECTION:%	IM - IV	41.6% IM - IV SOLUTION, INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
6DC9Q167V3	PROPYLENE GLYCOL:INHALATION:SOLUTION:%	INHALATION	25% INHALATION SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
6DC9Q167V3	PROPYLENE GLYCOL:INTRAMUSCULAR:INJECTION:%W/V	INTRAMUSCULAR	41.3%W/V INTRAMUSCULAR INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
6DC9Q167V3	PROPYLENE GLYCOL:INTRAMUSCULAR:POWDER, FOR INJECTION SOLUTION:NA	INTRAMUSCULAR	INTRAMUSCULAR POWDER, FOR INJECTION SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
6DC9Q167V3	PROPYLENE GLYCOL:INTRAMUSCULAR:SOLUTION, INJECTION:%V/V	INTRAMUSCULAR	40%V/V INTRAMUSCULAR SOLUTION, INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
6DC9Q167V3	PROPYLENE GLYCOL:INTRAVENOUS:INFUSION:NA	INTRAVENOUS	INTRAVENOUS INFUSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
6DC9Q167V3	PROPYLENE GLYCOL:INTRAVENOUS:INJECTABLE:%	INTRAVENOUS	40% INTRAVENOUS INJECTABLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
6DC9Q167V3	PROPYLENE GLYCOL:INTRAVENOUS:INJECTION:%V/V	INTRAVENOUS	67%V/V INTRAVENOUS INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
6DC9Q167V3	PROPYLENE GLYCOL:INTRAVENOUS:SOLUTION, CONCENTRATE:%	INTRAVENOUS	50.33% INTRAVENOUS SOLUTION, CONCENTRATE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
6DC9Q167V3	PROPYLENE GLYCOL:INTRAVENOUS:SOLUTION, INJECTION:%	INTRAVENOUS	30.9% INTRAVENOUS SOLUTION, INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
6DC9Q167V3	PROPYLENE GLYCOL:INTRAVENOUS INFUSION:SOLUTION, INJECTION:mg/mL	INTRAVENOUS INFUSION	503mg/mL INTRAVENOUS INFUSION SOLUTION, INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
6DC9Q167V3	PROPYLENE GLYCOL:IV(INFUSION):INJECTABLE:%	IV(INFUSION)	20.8% IV(INFUSION) INJECTABLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
6DC9Q167V3	PROPYLENE GLYCOL:IV(INFUSION):INJECTION:MG/1ML	IV(INFUSION)	400MG/1ML IV(INFUSION) INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
6DC9Q167V3	PROPYLENE GLYCOL:IV(INFUSION):SOLUTION, INJECTION:%	IV(INFUSION)	30% IV(INFUSION) SOLUTION, INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
6DC9Q167V3	PROPYLENE GLYCOL:NASAL:SOLUTION:%	NASAL	12% NASAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
6DC9Q167V3	PROPYLENE GLYCOL:NASAL:SPRAY, METERED:%	NASAL	20% NASAL SPRAY, METERED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
6DC9Q167V3	PROPYLENE GLYCOL:OPHTHALMIC:EMULSION:%W/V	OPHTHALMIC	1.5%W/V OPHTHALMIC EMULSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
6DC9Q167V3	PROPYLENE GLYCOL:OPHTHALMIC:GEL:%	OPHTHALMIC	0.44% OPHTHALMIC GEL	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
6DC9Q167V3	PROPYLENE GLYCOL:OPHTHALMIC:SOLUTION:%	OPHTHALMIC	15% OPHTHALMIC SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
6DC9Q167V3	PROPYLENE GLYCOL:OPHTHALMIC:SOLUTION, DROPS:%	OPHTHALMIC	0.75% OPHTHALMIC SOLUTION, DROPS	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
6DC9Q167V3	PROPYLENE GLYCOL:OPHTHALMIC:SUSPENSION:%	OPHTHALMIC	5% OPHTHALMIC SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
6DC9Q167V3	PROPYLENE GLYCOL:OPHTHALMIC:SUSPENSION, DROPS:%	OPHTHALMIC	1% OPHTHALMIC SUSPENSION, DROPS	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
6DC9Q167V3	PROPYLENE GLYCOL:ORAL:CAPSULE:MG	ORAL	52MG ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
6DC9Q167V3	PROPYLENE GLYCOL:ORAL:CAPSULE, DELAYED ACTION:MG	ORAL	0.016MG ORAL CAPSULE, DELAYED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
6DC9Q167V3	PROPYLENE GLYCOL:ORAL:CAPSULE, DELAYED ACTION, ENTERIC COATED:NA	ORAL	ORAL CAPSULE, DELAYED ACTION, ENTERIC COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
6DC9Q167V3	PROPYLENE GLYCOL:ORAL:CAPSULE, ENTERIC COATED PELLETS:MG	ORAL	1.7MG ORAL CAPSULE, ENTERIC COATED PELLETS	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
6DC9Q167V3	PROPYLENE GLYCOL:ORAL:CAPSULE, EXTENDED RELEASE:MG	ORAL	0.019MG ORAL CAPSULE, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
6DC9Q167V3	PROPYLENE GLYCOL:ORAL:CAPSULE, SOFT GELATIN:MG	ORAL	148.31MG ORAL CAPSULE, SOFT GELATIN	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
6DC9Q167V3	PROPYLENE GLYCOL:ORAL:CAPSULE, SOFT GELATIN LIQUID-FILLED:MG	ORAL	17.7MG ORAL CAPSULE, SOFT GELATIN LIQUID-FILLED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
6DC9Q167V3	PROPYLENE GLYCOL:ORAL:CAPSULE, SUSTAINED ACTION:MG	ORAL	14.6MG ORAL CAPSULE, SUSTAINED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
6DC9Q167V3	PROPYLENE GLYCOL:ORAL:CONCENTRATE:MG/1ML	ORAL	700MG/1ML ORAL CONCENTRATE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
6DC9Q167V3	PROPYLENE GLYCOL:ORAL:DROPS:MG/1ML	ORAL	1.25MG/1ML ORAL DROPS	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
6DC9Q167V3	PROPYLENE GLYCOL:ORAL:LIQUID:mg/10mL	ORAL	975mg/10mL ORAL LIQUID	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
6DC9Q167V3	PROPYLENE GLYCOL:ORAL:LIQUID:MG/ML	ORAL	621.6MG/ML ORAL LIQUID	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
6DC9Q167V3	PROPYLENE GLYCOL:ORAL:LIQUID:ML/ML	ORAL	0.15ML/ML ORAL LIQUID	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
6DC9Q167V3	PROPYLENE GLYCOL:ORAL:LIQUID, CONCENTRATE:MG/1ML	ORAL	540MG/1ML ORAL LIQUID, CONCENTRATE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
6DC9Q167V3	PROPYLENE GLYCOL:ORAL:ORAL SOLUTION DOSAGE FORM:mg/5mL	ORAL	250mg/5mL ORAL ORAL SOLUTION DOSAGE FORM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
6DC9Q167V3	PROPYLENE GLYCOL:ORAL:POWDER:MG/1SCP	ORAL	55MG/1SCP ORAL POWDER	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
6DC9Q167V3	PROPYLENE GLYCOL:ORAL:SOLUTION:MG/15ML	ORAL	3767MG/15ML ORAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
6DC9Q167V3	PROPYLENE GLYCOL:ORAL:SOLUTION:mg/15 mL	ORAL	2475mg/15 mL ORAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
6DC9Q167V3	PROPYLENE GLYCOL:ORAL:SOLUTION:mg/5 mL	ORAL	1295mg/5 mL ORAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
6DC9Q167V3	PROPYLENE GLYCOL:ORAL:SOLUTION:MG/1ML	ORAL	1017.5MG/1ML ORAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
6DC9Q167V3	PROPYLENE GLYCOL:ORAL:SOLUTION:MG/5ML	ORAL	1000MG/5ML ORAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
6DC9Q167V3	PROPYLENE GLYCOL:ORAL:SOLUTION:MG/ML	ORAL	100MG/ML ORAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
6DC9Q167V3	PROPYLENE GLYCOL:ORAL:SOLUTION, CONCENTRATE:MG/1ML	ORAL	518MG/1ML ORAL SOLUTION, CONCENTRATE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
6DC9Q167V3	PROPYLENE GLYCOL:ORAL:SOLUTION, ELIXIR:MG/15ML	ORAL	3108MG/15ML ORAL SOLUTION, ELIXIR	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
6DC9Q167V3	PROPYLENE GLYCOL:ORAL:SOLUTION, LIQUID:%	ORAL	14% ORAL SOLUTION, LIQUID	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
6DC9Q167V3	PROPYLENE GLYCOL:ORAL:SOLUTION, SYRUP:MG/5ML	ORAL	610MG/5ML ORAL SOLUTION, SYRUP	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
6DC9Q167V3	PROPYLENE GLYCOL:ORAL:SPRAY:MG/1SPR	ORAL	37.45MG/1SPR ORAL SPRAY	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
6DC9Q167V3	PROPYLENE GLYCOL:ORAL:SUSPENSION:MG/5ML	ORAL	125MG/5ML ORAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
6DC9Q167V3	PROPYLENE GLYCOL:ORAL:SUSPENSION:mg/1mL	ORAL	43.46mg/1mL ORAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
6DC9Q167V3	PROPYLENE GLYCOL:ORAL:SUSPENSION, EXTENDED RELEASE:MG/5ML	ORAL	250MG/5ML ORAL SUSPENSION, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
6DC9Q167V3	PROPYLENE GLYCOL:ORAL:SUSPENSION, LIQUID:MG/5ML	ORAL	250MG/5ML ORAL SUSPENSION, LIQUID	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
6DC9Q167V3	PROPYLENE GLYCOL:ORAL:SUSPENSION, SUSTAINED ACTION:MG/5ML	ORAL	150MG/5ML ORAL SUSPENSION, SUSTAINED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
6DC9Q167V3	PROPYLENE GLYCOL:ORAL:TABLET:mg	ORAL	5.41mg ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
6DC9Q167V3	PROPYLENE GLYCOL:ORAL:TABLET (IMMED./COMP. RELEASE), FILM COATED:MG	ORAL	0.21MG ORAL TABLET (IMMED./COMP. RELEASE), FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
6DC9Q167V3	PROPYLENE GLYCOL:ORAL:TABLET, COATED:MG	ORAL	1.5MG ORAL TABLET, COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
6DC9Q167V3	PROPYLENE GLYCOL:ORAL:TABLET, CONTROLLED RELEASE:NA	ORAL	ORAL TABLET, CONTROLLED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
6DC9Q167V3	PROPYLENE GLYCOL:ORAL:TABLET, DELAYED ACTION:MG	ORAL	5.83MG ORAL TABLET, DELAYED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
6DC9Q167V3	PROPYLENE GLYCOL:ORAL:TABLET, DELAYED ACTION, ENTERIC COATED:MG	ORAL	6.95MG ORAL TABLET, DELAYED ACTION, ENTERIC COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
6DC9Q167V3	PROPYLENE GLYCOL:ORAL:TABLET, DELAYED RELEASE:MG	ORAL	5.97MG ORAL TABLET, DELAYED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
6DC9Q167V3	PROPYLENE GLYCOL:ORAL:TABLET, ENTERIC COATED PARTICLES:MG	ORAL	4.3MG ORAL TABLET, ENTERIC COATED PARTICLES	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
6DC9Q167V3	PROPYLENE GLYCOL:ORAL:TABLET, EXTENDED RELEASE:MG	ORAL	2.44MG ORAL TABLET, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
6DC9Q167V3	PROPYLENE GLYCOL:ORAL:TABLET, FILM COATED:MG	ORAL	14.4MG ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
6DC9Q167V3	PROPYLENE GLYCOL:ORAL:TABLET, SUSTAINED ACTION:MG	ORAL	9MG ORAL TABLET, SUSTAINED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
6DC9Q167V3	PROPYLENE GLYCOL:ORAL:TABLET, SUSTAINED ACTION, COATED:NA	ORAL	ORAL TABLET, SUSTAINED ACTION, COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
6DC9Q167V3	PROPYLENE GLYCOL:ORAL:TABLET, SUSTAINED ACTION, FILM COATED:MG	ORAL	12.8MG ORAL TABLET, SUSTAINED ACTION, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
6DC9Q167V3	PROPYLENE GLYCOL:PARENTERAL:INJECTION:ML/1ML	PARENTERAL	0.1ML/1ML PARENTERAL INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
6DC9Q167V3	PROPYLENE GLYCOL:PHOTOPHERESIS:SOLUTION:%	PHOTOPHERESIS	5% PHOTOPHERESIS SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
6DC9Q167V3	PROPYLENE GLYCOL:RECTAL:AEROSOL, METERED:%	RECTAL	18% RECTAL AEROSOL, METERED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
6DC9Q167V3	PROPYLENE GLYCOL:RECTAL:EMULSION, AEROSOL FOAM:%	RECTAL	47.04% RECTAL EMULSION, AEROSOL FOAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
6DC9Q167V3	PROPYLENE GLYCOL:RECTAL:GEL:%	RECTAL	82.88% RECTAL GEL	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
6DC9Q167V3	PROPYLENE GLYCOL:RECTAL:SUSPENSION:%	RECTAL	11.3% RECTAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
6DC9Q167V3	PROPYLENE GLYCOL:SUBCUTANEOUS:INJECTION:%	SUBCUTANEOUS	1.4% SUBCUTANEOUS INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
6DC9Q167V3	PROPYLENE GLYCOL:SUBCUTANEOUS:INJECTION, SOLUTION:MG/1ML	SUBCUTANEOUS	14MG/1ML SUBCUTANEOUS INJECTION, SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
6DC9Q167V3	PROPYLENE GLYCOL:SUBCUTANEOUS:SOLUTION, INJECTION:%	SUBCUTANEOUS	0.47% SUBCUTANEOUS SOLUTION, INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
6DC9Q167V3	PROPYLENE GLYCOL:SUBLINGUAL:FILM:QS	SUBLINGUAL	QS SUBLINGUAL FILM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
6DC9Q167V3	PROPYLENE GLYCOL:SUBLINGUAL:SPRAY:%	SUBLINGUAL	0.45% SUBLINGUAL SPRAY	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
6DC9Q167V3	PROPYLENE GLYCOL:TOPICAL:AEROSOL:%W/W	TOPICAL	19.2%W/W TOPICAL AEROSOL	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
6DC9Q167V3	PROPYLENE GLYCOL:TOPICAL:AEROSOL, FOAM:%W/W	TOPICAL	2.1%W/W TOPICAL AEROSOL, FOAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
6DC9Q167V3	PROPYLENE GLYCOL:TOPICAL:AEROSOL, METERED:NA	TOPICAL	TOPICAL AEROSOL, METERED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
6DC9Q167V3	PROPYLENE GLYCOL:TOPICAL:CREAM: %W/W	TOPICAL	71.08 %W/W TOPICAL CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
6DC9Q167V3	PROPYLENE GLYCOL:TOPICAL:CREAM, AUGMENTED:%W/W	TOPICAL	30%W/W TOPICAL CREAM, AUGMENTED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
6DC9Q167V3	PROPYLENE GLYCOL:TOPICAL:EMULSION:%W/W	TOPICAL	8%W/W TOPICAL EMULSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
6DC9Q167V3	PROPYLENE GLYCOL:TOPICAL:EMULSION, AEROSOL FOAM:%W/W	TOPICAL	21.05%W/W TOPICAL EMULSION, AEROSOL FOAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
6DC9Q167V3	PROPYLENE GLYCOL:TOPICAL:EMULSION, CREAM:%W/W	TOPICAL	71.08%W/W TOPICAL EMULSION, CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
6DC9Q167V3	PROPYLENE GLYCOL:TOPICAL:EMULSION, LOTION:%W/W	TOPICAL	47.5%W/W TOPICAL EMULSION, LOTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
6DC9Q167V3	PROPYLENE GLYCOL:TOPICAL:FILM, CONTROLLED RELEASE:MG	TOPICAL	700MG TOPICAL FILM, CONTROLLED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
6DC9Q167V3	PROPYLENE GLYCOL:TOPICAL:GEL:%W/W	TOPICAL	98.09%W/W TOPICAL GEL	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
6DC9Q167V3	PROPYLENE GLYCOL:TOPICAL:LOTION:%W/W	TOPICAL	47.6%W/W TOPICAL LOTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
6DC9Q167V3	PROPYLENE GLYCOL:TOPICAL:LOTION, AUGMENTED:%W/W	TOPICAL	30%W/W TOPICAL LOTION, AUGMENTED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
6DC9Q167V3	PROPYLENE GLYCOL:TOPICAL:OINTMENT:%W/W	TOPICAL	45%W/W TOPICAL OINTMENT	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
6DC9Q167V3	PROPYLENE GLYCOL:TOPICAL:OINTMENT, AUGMENTED:%W/W	TOPICAL	65%W/W TOPICAL OINTMENT, AUGMENTED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
6DC9Q167V3	PROPYLENE GLYCOL:TOPICAL:PATCH:NA	TOPICAL	TOPICAL PATCH	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
6DC9Q167V3	PROPYLENE GLYCOL:TOPICAL:PATCH, CONTROLLED RELEASE:NA	TOPICAL	TOPICAL PATCH, CONTROLLED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
6DC9Q167V3	PROPYLENE GLYCOL:TOPICAL:SHAMPOO:%W/W	TOPICAL	3.5%W/W TOPICAL SHAMPOO	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
6DC9Q167V3	PROPYLENE GLYCOL:TOPICAL:SHAMPOO, SUSPENSION:%W/W	TOPICAL	2%W/W TOPICAL SHAMPOO, SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
6DC9Q167V3	PROPYLENE GLYCOL:TOPICAL:SOLUTION:%W/W	TOPICAL	99.98%W/W TOPICAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
6DC9Q167V3	PROPYLENE GLYCOL:TOPICAL:SOLUTION, LIQUID:%W/W	TOPICAL	5%W/W TOPICAL SOLUTION, LIQUID	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
6DC9Q167V3	PROPYLENE GLYCOL:TOPICAL:SPONGE:NA	TOPICAL	TOPICAL SPONGE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
6DC9Q167V3	PROPYLENE GLYCOL:TOPICAL:SUPPOSITORY:NA	TOPICAL	TOPICAL SUPPOSITORY	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
6DC9Q167V3	PROPYLENE GLYCOL:TOPICAL:SUPPOSITORY, INSERT:%W/W	TOPICAL	20%W/W TOPICAL SUPPOSITORY, INSERT	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
6DC9Q167V3	PROPYLENE GLYCOL:TOPICAL:SUSPENSION:%W/W	TOPICAL	5.28%W/W TOPICAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
6DC9Q167V3	PROPYLENE GLYCOL:TOPICAL:SWAB:NA	TOPICAL	TOPICAL SWAB	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
6DC9Q167V3	PROPYLENE GLYCOL:TRANSDERMAL:FILM, CONTROLLED RELEASE:MG	TRANSDERMAL	58.13MG TRANSDERMAL FILM, CONTROLLED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
6DC9Q167V3	PROPYLENE GLYCOL:TRANSDERMAL:GEL:%	TRANSDERMAL	20% TRANSDERMAL GEL	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
6DC9Q167V3	PROPYLENE GLYCOL:VAGINAL:CREAM:%W/W	VAGINAL	10%W/W VAGINAL CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
6DC9Q167V3	PROPYLENE GLYCOL:VAGINAL:CREAM, EMULSION, SUSTAINED RELEASE:%	VAGINAL	20% VAGINAL CREAM, EMULSION, SUSTAINED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
6DC9Q167V3	PROPYLENE GLYCOL:VAGINAL:EMULSION, AEROSOL FOAM:%	VAGINAL	6.4% VAGINAL EMULSION, AEROSOL FOAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
6DC9Q167V3	PROPYLENE GLYCOL:VAGINAL:EMULSION, CREAM:%	VAGINAL	20% VAGINAL EMULSION, CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
6DC9Q167V3	PROPYLENE GLYCOL:VAGINAL:GEL:%	VAGINAL	3% VAGINAL GEL	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
6DC9Q167V3	PROPYLENE GLYCOL:VAGINAL:SUPPOSITORY:MG	VAGINAL	252MG VAGINAL SUPPOSITORY	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
6DC9Q167V3	PROPYLENE GLYCOL:VAGINAL:TAMPON:MG	VAGINAL	62.1MG VAGINAL TAMPON	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
PQM9SA369U	COLA NUT:ORAL:CONCENTRATE:MG/1ML	ORAL	247.2MG/1ML ORAL CONCENTRATE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
PQM9SA369U	COLA NUT:ORAL:SOLUTION:%	ORAL	2% ORAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
PQM9SA369U	COLA NUT:RECTAL:SOLUTION:%	RECTAL	2% RECTAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
DIA7C37AOW	SODIUM TARTRATE DIHYDRATE:INTRAMUSCULAR:INJECTION:mg/1mL	INTRAMUSCULAR	12mg/1mL INTRAMUSCULAR INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
DIA7C37AOW	SODIUM TARTRATE DIHYDRATE:INTRAVENOUS:INJECTION:mg/1mL	INTRAVENOUS	12mg/1mL INTRAVENOUS INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
DIA7C37AOW	SODIUM TARTRATE DIHYDRATE:SUBCUTANEOUS:INJECTION:mg/1mL	SUBCUTANEOUS	1.38mg/1mL SUBCUTANEOUS INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
5V4827GL2O	NONOXYNOL-15:TOPICAL:SOLUTION:NA	TOPICAL	TOPICAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=N
5V4827GL2O	NONOXYNOL-15:TOPICAL:SPONGE:NA	TOPICAL	TOPICAL SPONGE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=N
809Y72KV36	CARBOMER COPOLYMER TYPE B (ALLYL PENTAERYTHRITOL CROSSLINKED):TOPICAL:CREAM, AUGMENTED:%W/W	TOPICAL	0.2%W/W TOPICAL CREAM, AUGMENTED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
809Y72KV36	CARBOMER COPOLYMER TYPE B (ALLYL PENTAERYTHRITOL CROSSLINKED):TOPICAL:CREAM, EMULSION, SUSTAINED RELEASE:%W/V	TOPICAL	0.2%W/V TOPICAL CREAM, EMULSION, SUSTAINED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
809Y72KV36	CARBOMER COPOLYMER TYPE B (ALLYL PENTAERYTHRITOL CROSSLINKED):TOPICAL:EMULSION, CREAM:%W/W	TOPICAL	0.2%W/W TOPICAL EMULSION, CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
809Y72KV36	CARBOMER COPOLYMER TYPE B (ALLYL PENTAERYTHRITOL CROSSLINKED):TOPICAL:EMULSION, LOTION:%W/W	TOPICAL	0.3%W/W TOPICAL EMULSION, LOTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
809Y72KV36	CARBOMER COPOLYMER TYPE B (ALLYL PENTAERYTHRITOL CROSSLINKED):TOPICAL:GEL:%W/W	TOPICAL	0.8%W/W TOPICAL GEL	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
809Y72KV36	CARBOMER COPOLYMER TYPE B (ALLYL PENTAERYTHRITOL CROSSLINKED):TOPICAL:LOTION:%W/W	TOPICAL	0.4%W/W TOPICAL LOTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
809Y72KV36	CARBOMER COPOLYMER TYPE B (ALLYL PENTAERYTHRITOL CROSSLINKED):TRANSDERMAL:FILM, CONTROLLED RELEASE:MG	TRANSDERMAL	24.3MG TRANSDERMAL FILM, CONTROLLED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
809Y72KV36	CARBOMER COPOLYMER TYPE B (ALLYL PENTAERYTHRITOL CROSSLINKED):TRANSDERMAL:GEL:%W/W	TRANSDERMAL	0.3%W/W TRANSDERMAL GEL	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
V38JK4Z93O	ETHYL VANILLATE:ORAL:SOLUTION, ELIXIR:NA	ORAL	ORAL SOLUTION, ELIXIR	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
V38JK4Z93O	ETHYL VANILLATE:ORAL:SYRUP:NA	ORAL	ORAL SYRUP	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
66O7AQV0RT	HYDROXYPROPYL CELLULOSE (70000 WAMW):ORAL:CAPSULE, DELAYED RELEASE:MG	ORAL	13.9MG ORAL CAPSULE, DELAYED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
66O7AQV0RT	HYDROXYPROPYL CELLULOSE (70000 WAMW):ORAL:CAPSULE, EXTENDED RELEASE:MG	ORAL	22.58MG ORAL CAPSULE, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
66O7AQV0RT	HYDROXYPROPYL CELLULOSE (70000 WAMW):ORAL:TABLET, EXTENDED RELEASE:MG	ORAL	8MG ORAL TABLET, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
66O7AQV0RT	HYDROXYPROPYL CELLULOSE (70000 WAMW):ORAL:TABLET, FILM COATED:MG	ORAL	15MG ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
M0C2SP444T	GLUTAMIC ACID HYDROCHLORIDE:ORAL:CAPSULE:MG	ORAL	30MG ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
M0C2SP444T	GLUTAMIC ACID HYDROCHLORIDE:ORAL:TABLET:MG	ORAL	30MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
68538UP9SE	MONOSODIUM CITRATE:ORAL:GRANULE, EFFERVESCENT:NA	ORAL	ORAL GRANULE, EFFERVESCENT	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
68538UP9SE	MONOSODIUM CITRATE:ORAL:POWDER:MG	ORAL	0.14MG ORAL POWDER	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
68538UP9SE	MONOSODIUM CITRATE:ORAL:POWDER, FOR RECONSTITUTION:MG/5ML	ORAL	6MG/5ML ORAL POWDER, FOR RECONSTITUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
68538UP9SE	MONOSODIUM CITRATE:ORAL:POWDER, FOR SUSPENSION:MG/1ML	ORAL	22MG/1ML ORAL POWDER, FOR SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
68538UP9SE	MONOSODIUM CITRATE:ORAL:TABLET:MG	ORAL	50MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
68538UP9SE	MONOSODIUM CITRATE:ORAL:TABLET, EFFERVESCENT, FOR SOLUTION:MG	ORAL	1900MG ORAL TABLET, EFFERVESCENT, FOR SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
68538UP9SE	MONOSODIUM CITRATE:ORAL:TABLET, ORALLY DISINTEGRATING:MG	ORAL	7.5MG ORAL TABLET, ORALLY DISINTEGRATING	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
9T1C662FKS	OCTOXYNOL-40:OPHTHALMIC:SOLUTION:%	OPHTHALMIC	0.05% OPHTHALMIC SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
9T1C662FKS	OCTOXYNOL-40:OPHTHALMIC:SOLUTION, DROPS:%	OPHTHALMIC	0.01% OPHTHALMIC SOLUTION, DROPS	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
9T1C662FKS	OCTOXYNOL-40:OPHTHALMIC:SOLUTION/DROPS:%	OPHTHALMIC	0.003% OPHTHALMIC SOLUTION/DROPS	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
F2O5O2OI9F	CELLACEFATE:ORAL:CAPSULE:MG	ORAL	75.6MG ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
F2O5O2OI9F	CELLACEFATE:ORAL:CAPSULE, ENTERIC COATED PELLETS:MG	ORAL	28.2MG ORAL CAPSULE, ENTERIC COATED PELLETS	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
F2O5O2OI9F	CELLACEFATE:ORAL:CAPSULE, SUSTAINED ACTION:MG	ORAL	9.42MG ORAL CAPSULE, SUSTAINED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
F2O5O2OI9F	CELLACEFATE:ORAL:TABLET:MG	ORAL	45.37MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
F2O5O2OI9F	CELLACEFATE:ORAL:TABLET, COATED:NA	ORAL	ORAL TABLET, COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
F2O5O2OI9F	CELLACEFATE:ORAL:TABLET, DELAYED ACTION:MG	ORAL	59.8MG ORAL TABLET, DELAYED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
F2O5O2OI9F	CELLACEFATE:ORAL:TABLET, DELAYED ACTION, ENTERIC COATED:MG	ORAL	70MG ORAL TABLET, DELAYED ACTION, ENTERIC COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
F2O5O2OI9F	CELLACEFATE:ORAL:TABLET, FILM COATED:MG	ORAL	15.6MG ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
F2O5O2OI9F	CELLACEFATE:ORAL:TABLET, SUSTAINED ACTION:MG	ORAL	70MG ORAL TABLET, SUSTAINED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
X69NU20D19	CALCIUM PYROPHOSPHATE:ORAL:TABLET:MG	ORAL	298.04MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
PH41D05744	BENZETHONIUM CHLORIDE:AURICULAR (OTIC):SOLUTION:%	AURICULAR (OTIC)	0.1% AURICULAR (OTIC) SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
PH41D05744	BENZETHONIUM CHLORIDE:IM - IV:INJECTION:%	IM - IV	0.01% IM - IV INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
PH41D05744	BENZETHONIUM CHLORIDE:INTRAMUSCULAR:INJECTION:NA	INTRAMUSCULAR	INTRAMUSCULAR INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
PH41D05744	BENZETHONIUM CHLORIDE:INTRAVENOUS:POWDER, FOR INJECTION SOLUTION:%	INTRAVENOUS	0.05% INTRAVENOUS POWDER, FOR INJECTION SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
PH41D05744	BENZETHONIUM CHLORIDE:IV(INFUSION):INJECTION:%	IV(INFUSION)	0.012% IV(INFUSION) INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
PH41D05744	BENZETHONIUM CHLORIDE:NASAL:SPRAY, METERED:%	NASAL	0.02% NASAL SPRAY, METERED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
PH41D05744	BENZETHONIUM CHLORIDE:OPHTHALMIC:POWDER, FOR SUSPENSION:NA	OPHTHALMIC	OPHTHALMIC POWDER, FOR SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
PH41D05744	BENZETHONIUM CHLORIDE:OPHTHALMIC:SOLUTION, DROPS:%	OPHTHALMIC	0.02% OPHTHALMIC SOLUTION, DROPS	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
0OUO26BB88	STEARALKONIUM CHLORIDE:TOPICAL:LOTION:%W/W	TOPICAL	3.15%W/W TOPICAL LOTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
6D4M1DAL6O	POLYOXYL 35 CASTOR OIL:INTRAVENOUS:INJECTION:%	INTRAVENOUS	52.7% INTRAVENOUS INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
6D4M1DAL6O	POLYOXYL 35 CASTOR OIL:INTRAVENOUS:INJECTION, SOLUTION:mg/1mL	INTRAVENOUS	527mg/1mL INTRAVENOUS INJECTION, SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
6D4M1DAL6O	POLYOXYL 35 CASTOR OIL:INTRAVENOUS:SOLUTION, INJECTION:mg/1mL	INTRAVENOUS	527mg/1mL INTRAVENOUS SOLUTION, INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
6D4M1DAL6O	POLYOXYL 35 CASTOR OIL:INTRAVESICAL:SOLUTION:%	INTRAVESICAL	50% INTRAVESICAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
6D4M1DAL6O	POLYOXYL 35 CASTOR OIL:IV(INFUSION):INJECTION:%	IV(INFUSION)	65% IV(INFUSION) INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
6D4M1DAL6O	POLYOXYL 35 CASTOR OIL:IV(INFUSION):SOLUTION, INJECTION:%	IV(INFUSION)	52.75% IV(INFUSION) SOLUTION, INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
6D4M1DAL6O	POLYOXYL 35 CASTOR OIL:OPHTHALMIC:SOLUTION:%	OPHTHALMIC	5% OPHTHALMIC SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
6D4M1DAL6O	POLYOXYL 35 CASTOR OIL:OPHTHALMIC:SOLUTION, DROPS:%	OPHTHALMIC	5% OPHTHALMIC SOLUTION, DROPS	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
6D4M1DAL6O	POLYOXYL 35 CASTOR OIL:ORAL:CAPSULE:MG	ORAL	120MG ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
6D4M1DAL6O	POLYOXYL 35 CASTOR OIL:ORAL:CAPSULE, SOFT GELATIN:MG	ORAL	599.4MG ORAL CAPSULE, SOFT GELATIN	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
6D4M1DAL6O	POLYOXYL 35 CASTOR OIL:ORAL:SOLUTION:MG/1ML	ORAL	515MG/1ML ORAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
6D4M1DAL6O	POLYOXYL 35 CASTOR OIL:ORAL:SOLUTION/DROPS:%W/V	ORAL	5%W/V ORAL SOLUTION/DROPS	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
6D4M1DAL6O	POLYOXYL 35 CASTOR OIL:ORAL:SUSPENSION:MG/1ML	ORAL	0.4MG/1ML ORAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
6D4M1DAL6O	POLYOXYL 35 CASTOR OIL:ORAL:TABLET:MG	ORAL	2MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
6D4M1DAL6O	POLYOXYL 35 CASTOR OIL:ORAL:TABLET, EXTENDED RELEASE:NA	ORAL	ORAL TABLET, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
6D4M1DAL6O	POLYOXYL 35 CASTOR OIL:SUBLINGUAL:TABLET:mg	SUBLINGUAL	2mg SUBLINGUAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
6D4M1DAL6O	POLYOXYL 35 CASTOR OIL:TOPICAL:SOLUTION:%W/V	TOPICAL	4.86%W/V TOPICAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
5C4SQ0541D	CARRAGEENAN CALCIUM:ORAL:POWDER, FOR SUSPENSION:NA	ORAL	ORAL POWDER, FOR SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
TI9T76XD44	ORANGE PEEL:ORAL:SYRUP:%	ORAL	0.18% ORAL SYRUP	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
70WT22SF4B	SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE:AN,INFILTRATION:INJECTION:%	AN,INFILTRATION	0.02% AN,INFILTRATION INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
70WT22SF4B	SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE:AURICULAR (OTIC):SOLUTION:%	AURICULAR (OTIC)	0.5% AURICULAR (OTIC) SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
70WT22SF4B	SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE:AURICULAR (OTIC):SUSPENSION:NA	AURICULAR (OTIC)	AURICULAR (OTIC) SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
70WT22SF4B	SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE:IM - IV:INJECTION:%	IM - IV	20% IM - IV INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
70WT22SF4B	SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE:IM - IV:POWDER:%	IM - IV	27.93% IM - IV POWDER	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
70WT22SF4B	SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE:IM - IV:POWDER, FOR INJECTION SOLUTION:%	IM - IV	8% IM - IV POWDER, FOR INJECTION SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
70WT22SF4B	SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE:IM - IV:SOLUTION, INJECTION:%	IM - IV	0.57% IM - IV SOLUTION, INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
70WT22SF4B	SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE:IM - IV - SC:INJECTION:MG/ML	IM - IV - SC	1.35MG/ML IM - IV - SC INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
70WT22SF4B	SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE:IM - SC:INJECTION:%	IM - SC	0.027% IM - SC INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
70WT22SF4B	SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE:IM - SC:POWDER, FOR INJECTION SOLUTION:NA	IM - SC	IM - SC POWDER, FOR INJECTION SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
70WT22SF4B	SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE:INTRA-ARTICULAR:INJECTABLE:%W/W	INTRA-ARTICULAR	0.3%W/W INTRA-ARTICULAR INJECTABLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
70WT22SF4B	SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE:INTRA-ARTICULAR:INJECTION:ADJ PH	INTRA-ARTICULAR	ADJ PH INTRA-ARTICULAR INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
70WT22SF4B	SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE:INTRA-ARTICULAR:SUSPENSION:%	INTRA-ARTICULAR	0.35% INTRA-ARTICULAR SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
70WT22SF4B	SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE:INTRABURSAL:INJECTION:MG/ML	INTRABURSAL	1.35MG/ML INTRABURSAL INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
70WT22SF4B	SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE:INTRABURSAL:INJECTION:ADJ PH	INTRABURSAL	ADJ PH INTRABURSAL INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
70WT22SF4B	SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE:INTRADERMAL:INJECTION:NA	INTRADERMAL	INTRADERMAL INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
70WT22SF4B	SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE:INTRALESIONAL:INJECTABLE:%	INTRALESIONAL	0.14% INTRALESIONAL INJECTABLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
70WT22SF4B	SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE:INTRALESIONAL:INJECTION:MG/ML	INTRALESIONAL	1.35MG/ML INTRALESIONAL INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
70WT22SF4B	SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE:INTRALESIONAL:INJECTION, SUSTAINED ACTION:MG/ML	INTRALESIONAL	1.35MG/ML INTRALESIONAL INJECTION, SUSTAINED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
70WT22SF4B	SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE:INTRAMUSCULAR:INJECTABLE:%W/W	INTRAMUSCULAR	0.3%W/W INTRAMUSCULAR INJECTABLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
70WT22SF4B	SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE:INTRAMUSCULAR:INJECTION:NA	INTRAMUSCULAR	INTRAMUSCULAR INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
70WT22SF4B	SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE:INTRAMUSCULAR:INJECTION, SUSTAINED ACTION:%W/V	INTRAMUSCULAR	0.067%W/V INTRAMUSCULAR INJECTION, SUSTAINED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
70WT22SF4B	SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE:INTRAMUSCULAR:POWDER, FOR INJECTION SOLUTION:%	INTRAMUSCULAR	0.54% INTRAMUSCULAR POWDER, FOR INJECTION SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
70WT22SF4B	SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE:INTRAMUSCULAR:POWDER, FOR INJECTION SOLUTION, LYOPHILIZED:%	INTRAMUSCULAR	21.5% INTRAMUSCULAR POWDER, FOR INJECTION SOLUTION, LYOPHILIZED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
70WT22SF4B	SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE:INTRAMUSCULAR:POWDER, FOR INJECTION SOLUTION, LYOPHILIZED, WITH ADDITIVES:%	INTRAMUSCULAR	0.37% INTRAMUSCULAR POWDER, FOR INJECTION SOLUTION, LYOPHILIZED, WITH ADDITIVES	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
70WT22SF4B	SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE:INTRAMUSCULAR:SOLUTION, INJECTION:NA	INTRAMUSCULAR	INTRAMUSCULAR SOLUTION, INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
70WT22SF4B	SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE:INTRAMUSCULAR:SUSPENSION:%	INTRAMUSCULAR	0.35% INTRAMUSCULAR SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
70WT22SF4B	SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE:INTRASYNOVIAL:INJECTABLE:%	INTRASYNOVIAL	0.14% INTRASYNOVIAL INJECTABLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
70WT22SF4B	SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE:INTRASYNOVIAL:INJECTION, SUSTAINED ACTION:MG/ML	INTRASYNOVIAL	1.35MG/ML INTRASYNOVIAL INJECTION, SUSTAINED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
70WT22SF4B	SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE:INTRAVENOUS:INJECTABLE:mg/mL	INTRAVENOUS	14.4mg/mL INTRAVENOUS INJECTABLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
70WT22SF4B	SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE:INTRAVENOUS:INJECTABLE:%	INTRAVENOUS	0.094% INTRAVENOUS INJECTABLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
70WT22SF4B	SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE:INTRAVENOUS:INJECTION:%	INTRAVENOUS	1.44% INTRAVENOUS INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
70WT22SF4B	SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE:INTRAVENOUS:POWDER, FOR INJECTION SOLUTION:%	INTRAVENOUS	2.9% INTRAVENOUS POWDER, FOR INJECTION SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
70WT22SF4B	SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE:INTRAVENOUS:SOLUTION, INJECTION:%	INTRAVENOUS	1.44% INTRAVENOUS SOLUTION, INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
70WT22SF4B	SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE:INTRAVITREAL:INJECTABLE:%	INTRAVITREAL	1.33% INTRAVITREAL INJECTABLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
70WT22SF4B	SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE:IV(INFUSION):INJECTION:%	IV(INFUSION)	1.23% IV(INFUSION) INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
70WT22SF4B	SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE:IV(INFUSION):POWDER, FOR INJECTION SOLUTION:%	IV(INFUSION)	2% IV(INFUSION) POWDER, FOR INJECTION SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
70WT22SF4B	SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE:IV(INFUSION):POWDER, FOR INJECTION SOLUTION, LYOPHILIZED:%	IV(INFUSION)	21.5% IV(INFUSION) POWDER, FOR INJECTION SOLUTION, LYOPHILIZED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
70WT22SF4B	SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE:NASAL:SOLUTION:%	NASAL	0.045% NASAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
70WT22SF4B	SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE:NASAL:SOLUTION, SPRAY, METERED, PUMP:%	NASAL	0.066% NASAL SOLUTION, SPRAY, METERED, PUMP	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
70WT22SF4B	SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE:NASAL:SPRAY, METERED:%	NASAL	0.49% NASAL SPRAY, METERED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
70WT22SF4B	SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE:NERVE BLOCK:INJECTION:%	NERVE BLOCK	0.02% NERVE BLOCK INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
70WT22SF4B	SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE:OPHTHALMIC:DROPS:%	OPHTHALMIC	0.36% OPHTHALMIC DROPS	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
70WT22SF4B	SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE:OPHTHALMIC:SOLUTION:mg/1mL	OPHTHALMIC	2.76mg/1mL OPHTHALMIC SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
70WT22SF4B	SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE:OPHTHALMIC:SOLUTION:%	OPHTHALMIC	2.15% OPHTHALMIC SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
70WT22SF4B	SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE:OPHTHALMIC:SOLUTION, DROPS:%	OPHTHALMIC	2.5% OPHTHALMIC SOLUTION, DROPS	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
70WT22SF4B	SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE:OPHTHALMIC:SOLUTION/DROPS:%	OPHTHALMIC	0.55% OPHTHALMIC SOLUTION/DROPS	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
70WT22SF4B	SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE:OPHTHALMIC:SUSPENSION:%	OPHTHALMIC	0.87% OPHTHALMIC SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
70WT22SF4B	SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE:OPHTHALMIC:SUSPENSION, DROPS:%	OPHTHALMIC	0.43% OPHTHALMIC SUSPENSION, DROPS	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
70WT22SF4B	SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE:ORAL:CAPSULE:MG	ORAL	500MG ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
70WT22SF4B	SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE:ORAL:CAPSULE, SUSTAINED ACTION:MG	ORAL	92MG ORAL CAPSULE, SUSTAINED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
70WT22SF4B	SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE:ORAL:DROPS:NA	ORAL	ORAL DROPS	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
70WT22SF4B	SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE:ORAL:SOLUTION:MG/5ML	ORAL	70.5MG/5ML ORAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
70WT22SF4B	SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE:ORAL:SUSPENSION:MG/5ML	ORAL	62.5MG/5ML ORAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
70WT22SF4B	SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE:ORAL:SYRUP:MG/1ML	ORAL	0.65MG/1ML ORAL SYRUP	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
70WT22SF4B	SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE:ORAL:TABLET:MG	ORAL	80MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
70WT22SF4B	SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE:ORAL:TABLET, COATED:MG	ORAL	0.22MG ORAL TABLET, COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
70WT22SF4B	SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE:ORAL:TABLET, DELAYED ACTION, ENTERIC COATED:MG	ORAL	16.24MG ORAL TABLET, DELAYED ACTION, ENTERIC COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
70WT22SF4B	SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE:ORAL:TABLET, SUSTAINED ACTION:MG	ORAL	70MG ORAL TABLET, SUSTAINED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
70WT22SF4B	SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE:ORAL:TABLET, SUSTAINED ACTION, FILM COATED:MG	ORAL	105MG ORAL TABLET, SUSTAINED ACTION, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
70WT22SF4B	SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE:SOFT TISSUE:INJECTION:ADJ PH	SOFT TISSUE	ADJ PH SOFT TISSUE INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
70WT22SF4B	SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE:SOFT TISSUE:INJECTION, SUSTAINED ACTION:MG/ML	SOFT TISSUE	1.35MG/ML SOFT TISSUE INJECTION, SUSTAINED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
70WT22SF4B	SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE:SUBCUTANEOUS:INJECTABLE:%	SUBCUTANEOUS	0.19% SUBCUTANEOUS INJECTABLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
70WT22SF4B	SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE:SUBCUTANEOUS:INJECTION:%	SUBCUTANEOUS	0.38% SUBCUTANEOUS INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
70WT22SF4B	SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE:SUBCUTANEOUS:POWDER, FOR INJECTION SOLUTION:%	SUBCUTANEOUS	0.54% SUBCUTANEOUS POWDER, FOR INJECTION SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
70WT22SF4B	SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE:SUBCUTANEOUS:POWDER, FOR INJECTION SOLUTION, LYOPHILIZED:%	SUBCUTANEOUS	0.34% SUBCUTANEOUS POWDER, FOR INJECTION SOLUTION, LYOPHILIZED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
70WT22SF4B	SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE:SUBCUTANEOUS:SOLUTION, INJECTION:%	SUBCUTANEOUS	0.089% SUBCUTANEOUS SOLUTION, INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
70WT22SF4B	SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE:SUBCUTANEOUS:SUSPENSION:%	SUBCUTANEOUS	0.38% SUBCUTANEOUS SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
70WT22SF4B	SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE:SUBCUTANEOUS:SUSPENSION, INJECTION:%	SUBCUTANEOUS	0.38% SUBCUTANEOUS SUSPENSION, INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
70WT22SF4B	SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE:TOPICAL:CREAM, EMULSION, SUSTAINED RELEASE:%W/W	TOPICAL	0.2%W/W TOPICAL CREAM, EMULSION, SUSTAINED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
70WT22SF4B	SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE:TOPICAL:EMULSION, CREAM:%W/W	TOPICAL	0.34%W/W TOPICAL EMULSION, CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
70WT22SF4B	SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE:TOPICAL:LOTION:%W/W	TOPICAL	1.59%W/W TOPICAL LOTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
70WT22SF4B	SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE:TOPICAL:OINTMENT:%W/W	TOPICAL	0.15%W/W TOPICAL OINTMENT	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
70WT22SF4B	SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE:TOPICAL:SOLUTION:%W/W	TOPICAL	49.78%W/W TOPICAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
70WT22SF4B	SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE:TOPICAL:SOLUTION:mg/1mL	TOPICAL	2.76mg/1mL TOPICAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
70WT22SF4B	SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE:TOPICAL:SOLUTION, DROPS:%W/V	TOPICAL	0.27%W/V TOPICAL SOLUTION, DROPS	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
70WT22SF4B	SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE:TOPICAL:SPONGE:NA	TOPICAL	TOPICAL SPONGE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
70WT22SF4B	SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE:URETHRAL:INJECTION:%	URETHRAL	2% URETHRAL INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
P2Y1C6M9PS	SODIUM LACTATE, L-:EPIDURAL:INJECTION:NA	EPIDURAL	EPIDURAL INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
P2Y1C6M9PS	SODIUM LACTATE, L-:IM - IV:INJECTION:NA	IM - IV	IM - IV INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
P2Y1C6M9PS	SODIUM LACTATE, L-:IM - IV - SC:INJECTION:%	IM - IV - SC	0.18% IM - IV - SC INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
P2Y1C6M9PS	SODIUM LACTATE, L-:INTRACARDIAC:INJECTION:%	INTRACARDIAC	0.18% INTRACARDIAC INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
P2Y1C6M9PS	SODIUM LACTATE, L-:IV(INFUSION):INJECTION:%	IV(INFUSION)	0.18% IV(INFUSION) INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
P2Y1C6M9PS	SODIUM LACTATE, L-:NERVE BLOCK:INJECTION:NA	NERVE BLOCK	NERVE BLOCK INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
3FPU23BG52	TOLUENE:ORAL:CAPSULE, SOFT GELATIN:MG	ORAL	0.2MG ORAL CAPSULE, SOFT GELATIN	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
FZ989GH94E	POVIDONE K30:ORAL:TABLET:mg	ORAL	0.97mg ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
FZ989GH94E	POVIDONE, UNSPECIFIED:AURICULAR (OTIC):SUSPENSION:NA	AURICULAR (OTIC)	AURICULAR (OTIC) SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
FZ989GH94E	POVIDONE, UNSPECIFIED:INTRAMUSCULAR:INJECTION:%	INTRAMUSCULAR	0.9% INTRAMUSCULAR INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
FZ989GH94E	POVIDONE, UNSPECIFIED:INTRAVENOUS:INJECTABLE:%	INTRAVENOUS	2% INTRAVENOUS INJECTABLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
FZ989GH94E	POVIDONE, UNSPECIFIED:INTRAVENOUS:INJECTION:%	INTRAVENOUS	1% INTRAVENOUS INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
FZ989GH94E	POVIDONE, UNSPECIFIED:IV(INFUSION):INJECTION:NA	IV(INFUSION)	IV(INFUSION) INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
FZ989GH94E	POVIDONE, UNSPECIFIED:OPHTHALMIC:SOLUTION:%	OPHTHALMIC	2% OPHTHALMIC SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
FZ989GH94E	POVIDONE, UNSPECIFIED:OPHTHALMIC:SOLUTION, DROPS:%	OPHTHALMIC	1.8% OPHTHALMIC SOLUTION, DROPS	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
FZ989GH94E	POVIDONE, UNSPECIFIED:OPHTHALMIC:SUSPENSION:%	OPHTHALMIC	1.8% OPHTHALMIC SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
FZ989GH94E	POVIDONE, UNSPECIFIED:OPHTHALMIC:SUSPENSION, DROPS:%	OPHTHALMIC	1.5% OPHTHALMIC SUSPENSION, DROPS	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
FZ989GH94E	POVIDONE, UNSPECIFIED:ORAL:CAPSULE:MG	ORAL	130MG ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
FZ989GH94E	POVIDONE, UNSPECIFIED:ORAL:CAPSULE, COATED PELLETS:MG	ORAL	10.03MG ORAL CAPSULE, COATED PELLETS	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
FZ989GH94E	POVIDONE, UNSPECIFIED:ORAL:CAPSULE, COATED, SOFT GELATIN:MG	ORAL	6.9MG ORAL CAPSULE, COATED, SOFT GELATIN	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
FZ989GH94E	POVIDONE, UNSPECIFIED:ORAL:CAPSULE, DELAYED ACTION, ENTERIC COATED:NA	ORAL	ORAL CAPSULE, DELAYED ACTION, ENTERIC COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
FZ989GH94E	POVIDONE, UNSPECIFIED:ORAL:CAPSULE, DELAYED RELEASE:MG	ORAL	8.7MG ORAL CAPSULE, DELAYED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
FZ989GH94E	POVIDONE, UNSPECIFIED:ORAL:CAPSULE, ENTERIC COATED PELLETS:MG	ORAL	9.2MG ORAL CAPSULE, ENTERIC COATED PELLETS	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
FZ989GH94E	POVIDONE, UNSPECIFIED:ORAL:CAPSULE, EXTENDED RELEASE:MG	ORAL	102.73MG ORAL CAPSULE, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
FZ989GH94E	POVIDONE, UNSPECIFIED:ORAL:CAPSULE, HARD GELATIN:MG	ORAL	50MG ORAL CAPSULE, HARD GELATIN	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
FZ989GH94E	POVIDONE, UNSPECIFIED:ORAL:CAPSULE, SOFT GELATIN:NA	ORAL	ORAL CAPSULE, SOFT GELATIN	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
FZ989GH94E	POVIDONE, UNSPECIFIED:ORAL:CAPSULE, SUSTAINED ACTION:MG	ORAL	72MG ORAL CAPSULE, SUSTAINED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
FZ989GH94E	POVIDONE, UNSPECIFIED:ORAL:CAPSULE, SUSTAINED ACTION, HARD GELATIN:MG	ORAL	10.43MG ORAL CAPSULE, SUSTAINED ACTION, HARD GELATIN	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
FZ989GH94E	POVIDONE, UNSPECIFIED:ORAL:DISPERSIBLE TABLET:MG	ORAL	2MG ORAL DISPERSIBLE TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
FZ989GH94E	POVIDONE, UNSPECIFIED:ORAL:DROPS:NA	ORAL	ORAL DROPS	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
FZ989GH94E	POVIDONE, UNSPECIFIED:ORAL:GRANULE:MG	ORAL	100MG ORAL GRANULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
FZ989GH94E	POVIDONE, UNSPECIFIED:ORAL:GRANULE, EFFERVESCENT:NA	ORAL	ORAL GRANULE, EFFERVESCENT	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
FZ989GH94E	POVIDONE, UNSPECIFIED:ORAL:GRANULE, FOR ORAL SUSPENSION:MG	ORAL	75MG ORAL GRANULE, FOR ORAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
FZ989GH94E	POVIDONE, UNSPECIFIED:ORAL:GRANULE, FOR SUSPENSION:NA	ORAL	ORAL GRANULE, FOR SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
FZ989GH94E	POVIDONE, UNSPECIFIED:ORAL:GRANULE, FOR SUSPENSION, EXTENDED RELEASE:NA	ORAL	ORAL GRANULE, FOR SUSPENSION, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
FZ989GH94E	POVIDONE, UNSPECIFIED:ORAL:POWDER, FOR ORAL SOLUTION:MG	ORAL	4.5MG ORAL POWDER, FOR ORAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
FZ989GH94E	POVIDONE, UNSPECIFIED:ORAL:POWDER, FOR ORAL SUSPENSION:MG/5ML	ORAL	5.85MG/5ML ORAL POWDER, FOR ORAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
FZ989GH94E	POVIDONE, UNSPECIFIED:ORAL:POWDER, FOR RECONSTITUTION:NA	ORAL	ORAL POWDER, FOR RECONSTITUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
FZ989GH94E	POVIDONE, UNSPECIFIED:ORAL:POWDER, FOR SUSPENSION:MG/5ML	ORAL	35MG/5ML ORAL POWDER, FOR SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
FZ989GH94E	POVIDONE, UNSPECIFIED:ORAL:SOLUTION:MG/5ML	ORAL	250MG/5ML ORAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
FZ989GH94E	POVIDONE, UNSPECIFIED:ORAL:SUSPENSION:MG/1ML	ORAL	1.57MG/1ML ORAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
FZ989GH94E	POVIDONE, UNSPECIFIED:ORAL:SUSPENSION, EXTENDED RELEASE:MG/5ML	ORAL	5.21MG/5ML ORAL SUSPENSION, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
FZ989GH94E	POVIDONE, UNSPECIFIED:ORAL:TABLET (IMMED./COMP. RELEASE), COATED:MG	ORAL	3MG ORAL TABLET (IMMED./COMP. RELEASE), COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
FZ989GH94E	POVIDONE, UNSPECIFIED:ORAL:TABLET (IMMED./COMP. RELEASE), FILM COATED:MG	ORAL	240MG ORAL TABLET (IMMED./COMP. RELEASE), FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
FZ989GH94E	POVIDONE, UNSPECIFIED:ORAL:TABLET (IMMED./COMP. RELEASE), UNCOATED, BUCCAL:MG	ORAL	4MG ORAL TABLET (IMMED./COMP. RELEASE), UNCOATED, BUCCAL	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
FZ989GH94E	POVIDONE, UNSPECIFIED:ORAL:TABLET (IMMED./COMP. RELEASE), UNCOATED, CHEWABLE:MG	ORAL	18MG ORAL TABLET (IMMED./COMP. RELEASE), UNCOATED, CHEWABLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
FZ989GH94E	POVIDONE, UNSPECIFIED:ORAL:TABLET, CHEWABLE:MG	ORAL	21MG ORAL TABLET, CHEWABLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
FZ989GH94E	POVIDONE, UNSPECIFIED:ORAL:TABLET, COATED:MG	ORAL	49.2MG ORAL TABLET, COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
FZ989GH94E	POVIDONE, UNSPECIFIED:ORAL:TABLET, CONTROLLED RELEASE:MG	ORAL	219.03MG ORAL TABLET, CONTROLLED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
FZ989GH94E	POVIDONE, UNSPECIFIED:ORAL:TABLET, DELAYED ACTION:MG	ORAL	73.7MG ORAL TABLET, DELAYED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
FZ989GH94E	POVIDONE, UNSPECIFIED:ORAL:TABLET, DELAYED ACTION, ENTERIC COATED:MG	ORAL	35MG ORAL TABLET, DELAYED ACTION, ENTERIC COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
FZ989GH94E	POVIDONE, UNSPECIFIED:ORAL:TABLET, DISPERSIBLE:MG	ORAL	2MG ORAL TABLET, DISPERSIBLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
FZ989GH94E	POVIDONE, UNSPECIFIED:ORAL:TABLET, EXTENDED RELEASE:MG	ORAL	371.25MG ORAL TABLET, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
FZ989GH94E	POVIDONE, UNSPECIFIED:ORAL:TABLET, FILM COATED:MG	ORAL	116MG ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
FZ989GH94E	POVIDONE, UNSPECIFIED:ORAL:TABLET, ORALLY DISINTEGRATING:MG	ORAL	15.03MG ORAL TABLET, ORALLY DISINTEGRATING	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
FZ989GH94E	POVIDONE, UNSPECIFIED:ORAL:TABLET, REPEAT ACTION:MG	ORAL	10MG ORAL TABLET, REPEAT ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
FZ989GH94E	POVIDONE, UNSPECIFIED:ORAL:TABLET, SUSTAINED ACTION:MG	ORAL	300MG ORAL TABLET, SUSTAINED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
FZ989GH94E	POVIDONE, UNSPECIFIED:ORAL:TABLET, SUSTAINED ACTION, COATED:MG	ORAL	17MG ORAL TABLET, SUSTAINED ACTION, COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
FZ989GH94E	POVIDONE, UNSPECIFIED:ORAL:TABLET, SUSTAINED ACTION, FILM COATED:MG	ORAL	53.33MG ORAL TABLET, SUSTAINED ACTION, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
FZ989GH94E	POVIDONE, UNSPECIFIED:ORAL:TABLET, UNCOATED, TROCHE:MG	ORAL	35MG ORAL TABLET, UNCOATED, TROCHE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
FZ989GH94E	POVIDONE, UNSPECIFIED:SUBCUTANEOUS:IMPLANT:MG	SUBCUTANEOUS	6MG SUBCUTANEOUS IMPLANT	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
FZ989GH94E	POVIDONE, UNSPECIFIED:SUBLINGUAL:TABLET:MG	SUBLINGUAL	12MG SUBLINGUAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
FZ989GH94E	POVIDONE, UNSPECIFIED:TOPICAL:EMULSION, CREAM:NA	TOPICAL	TOPICAL EMULSION, CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
FZ989GH94E	POVIDONE, UNSPECIFIED:TOPICAL:LOTION:NA	TOPICAL	TOPICAL LOTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
FZ989GH94E	POVIDONE, UNSPECIFIED:TOPICAL:PATCH:NA	TOPICAL	TOPICAL PATCH	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
FZ989GH94E	POVIDONE, UNSPECIFIED:TOPICAL:SOLUTION:%W/W	TOPICAL	4%W/W TOPICAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
FZ989GH94E	POVIDONE, UNSPECIFIED:TRANSDERMAL:FILM, CONTROLLED RELEASE:MG	TRANSDERMAL	9.69MG TRANSDERMAL FILM, CONTROLLED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
FZ989GH94E	POVIDONE, UNSPECIFIED:TRANSDERMAL:PATCH, CONTROLLED RELEASE:MG	TRANSDERMAL	20MG TRANSDERMAL PATCH, CONTROLLED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
FZ989GH94E	POVIDONE, UNSPECIFIED:TRANSDERMAL:SOLUTION:%	TRANSDERMAL	2.44% TRANSDERMAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
FZ989GH94E	POVIDONE, UNSPECIFIED:VAGINAL:INSERT:MG	VAGINAL	49MG VAGINAL INSERT	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
FZ989GH94E	POVIDONE, UNSPECIFIED:VAGINAL:TABLET:MG	VAGINAL	50MG VAGINAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
I753WB2F1M	FD&C YELLOW NO. 5:BUCCAL/SUBLINGUAL:TABLET:MG	BUCCAL/SUBLINGUAL	0.11MG BUCCAL/SUBLINGUAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
I753WB2F1M	FD&C YELLOW NO. 5:ORAL:CAPSULE:MG	ORAL	652MG ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
I753WB2F1M	FD&C YELLOW NO. 5:ORAL:CAPSULE (IMMED./COMP. RELEASE):MG	ORAL	0.027MG ORAL CAPSULE (IMMED./COMP. RELEASE)	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
I753WB2F1M	FD&C YELLOW NO. 5:ORAL:CAPSULE (IMMED./COMP. RELEASE), COATED, SOFT GELATIN:MG	ORAL	0.26MG ORAL CAPSULE (IMMED./COMP. RELEASE), COATED, SOFT GELATIN	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
I753WB2F1M	FD&C YELLOW NO. 5:ORAL:CAPSULE, EXTENDED RELEASE:MG	ORAL	0.13MG ORAL CAPSULE, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
I753WB2F1M	FD&C YELLOW NO. 5:ORAL:CAPSULE, HARD GELATIN:NA	ORAL	ORAL CAPSULE, HARD GELATIN	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
I753WB2F1M	FD&C YELLOW NO. 5:ORAL:CAPSULE, SOFT GELATIN:NA	ORAL	ORAL CAPSULE, SOFT GELATIN	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
I753WB2F1M	FD&C YELLOW NO. 5:ORAL:CAPSULE, SUSTAINED ACTION:MG	ORAL	0.26MG ORAL CAPSULE, SUSTAINED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
I753WB2F1M	FD&C YELLOW NO. 5:ORAL:SOLUTION:MG/1ML	ORAL	1MG/1ML ORAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
I753WB2F1M	FD&C YELLOW NO. 5:ORAL:SOLUTION, ELIXIR:MG/5ML	ORAL	0.1MG/5ML ORAL SOLUTION, ELIXIR	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
I753WB2F1M	FD&C YELLOW NO. 5:ORAL:SUSPENSION:NA	ORAL	ORAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
I753WB2F1M	FD&C YELLOW NO. 5:ORAL:SYRUP:MG	ORAL	0.1MG ORAL SYRUP	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
I753WB2F1M	FD&C YELLOW NO. 5:ORAL:TABLET:MG	ORAL	180MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
I753WB2F1M	FD&C YELLOW NO. 5:ORAL:TABLET, COATED:MG	ORAL	7.93MG ORAL TABLET, COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
I753WB2F1M	FD&C YELLOW NO. 5:ORAL:TABLET, DELAYED ACTION, ENTERIC COATED:NA	ORAL	ORAL TABLET, DELAYED ACTION, ENTERIC COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
I753WB2F1M	FD&C YELLOW NO. 5:ORAL:TABLET, EXTENDED RELEASE:MG	ORAL	1.33MG ORAL TABLET, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
I753WB2F1M	FD&C YELLOW NO. 5:ORAL:TABLET, FILM COATED:MG	ORAL	1.68MG ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
I753WB2F1M	FD&C YELLOW NO. 5:ORAL:TABLET, SUSTAINED ACTION:MG	ORAL	0.11MG ORAL TABLET, SUSTAINED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
I753WB2F1M	FD&C YELLOW NO. 5:ORAL:TABLET, SUSTAINED ACTION, COATED:MG	ORAL	0.76MG ORAL TABLET, SUSTAINED ACTION, COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
I753WB2F1M	FD&C YELLOW NO. 5:SUBLINGUAL:TABLET:MG	SUBLINGUAL	0.1MG SUBLINGUAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
I753WB2F1M	FD&C YELLOW NO. 5:TOPICAL:EMULSION, CREAM:%W/W	TOPICAL	0.004%W/W TOPICAL EMULSION, CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
I753WB2F1M	FD&C YELLOW NO. 5:TOPICAL:POWDER:NA	TOPICAL	TOPICAL POWDER	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
I753WB2F1M	FD&C YELLOW NO. 5:TOPICAL:SHAMPOO, SUSPENSION:NA	TOPICAL	TOPICAL SHAMPOO, SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
I753WB2F1M	FD&C YELLOW NO. 5:TOPICAL:SOLUTION:%W/W	TOPICAL	0.006%W/W TOPICAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
I753WB2F1M	FD&C YELLOW NO. 5:TOPICAL:SPONGE:%W/W	TOPICAL	0.06%W/W TOPICAL SPONGE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
I753WB2F1M	FD&C YELLOW NO. 5:VAGINAL:EMULSION, CREAM:%	VAGINAL	0.004% VAGINAL EMULSION, CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
I753WB2F1M	FD&C YELLOW NO. 5:VAGINAL:SUPPOSITORY:NA	VAGINAL	VAGINAL SUPPOSITORY	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
14255EXE39	ETHYLPARABEN:ORAL:GRANULE, FOR ORAL SOLUTION:MG	ORAL	0.6MG ORAL GRANULE, FOR ORAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
14255EXE39	ETHYLPARABEN:ORAL:POWDER, FOR ORAL SOLUTION:MG	ORAL	0.66MG ORAL POWDER, FOR ORAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
14255EXE39	ETHYLPARABEN:ORAL:POWDER, FOR SOLUTION:MG/2GM	ORAL	0.6MG/2GM ORAL POWDER, FOR SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
14255EXE39	ETHYLPARABEN:ORAL:SOLUTION:MG/5ML	ORAL	0.6MG/5ML ORAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
14255EXE39	ETHYLPARABEN:ORAL:SOLUTION:MG/ML	ORAL	0.12MG/ML ORAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
14255EXE39	ETHYLPARABEN:ORAL:SUSPENSION:MG/5ML	ORAL	2MG/5ML ORAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
14255EXE39	ETHYLPARABEN:TOPICAL:EMULSION, CREAM:NA	TOPICAL	TOPICAL EMULSION, CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
EQR32Y7H0M	ZINC CARBONATE:SUBCUTANEOUS:POWDER, FOR INJECTION SUSPENSION:%	SUBCUTANEOUS	0.16% SUBCUTANEOUS POWDER, FOR INJECTION SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=Z
XV74C1N1AE	HYDROQUINONE:VAGINAL:CREAM:%W/W	VAGINAL	0.02%W/W VAGINAL CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
3FTR44B32Q	STANNOUS FLUORIDE:INTRAVENOUS:INJECTION:%	INTRAVENOUS	0.073% INTRAVENOUS INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
9H4L916OBU	HYPROMELLOSE 2208 (3 MPA.S):ORAL:CAPSULE:MG	ORAL	1.17MG ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
9H4L916OBU	HYPROMELLOSE 2208 (3 MPA.S):ORAL:CAPSULE, EXTENDED RELEASE:MG	ORAL	23.76MG ORAL CAPSULE, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
9H4L916OBU	HYPROMELLOSE 2208 (3 MPA.S):ORAL:CAPSULE, SUSTAINED ACTION:MG	ORAL	7MG ORAL CAPSULE, SUSTAINED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
9H4L916OBU	HYPROMELLOSE 2208 (3 MPA.S):ORAL:SUSPENSION:mg/5mL	ORAL	7.5mg/5mL ORAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
9H4L916OBU	HYPROMELLOSE 2208 (3 MPA.S):ORAL:TABLET:MG	ORAL	71.25MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
9H4L916OBU	HYPROMELLOSE 2208 (3 MPA.S):ORAL:TABLET, DELAYED RELEASE:MG	ORAL	6.85MG ORAL TABLET, DELAYED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
9H4L916OBU	HYPROMELLOSE 2208 (3 MPA.S):ORAL:TABLET, EXTENDED RELEASE:MG	ORAL	393MG ORAL TABLET, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
9H4L916OBU	HYPROMELLOSE 2208 (3 MPA.S):ORAL:TABLET, FILM COATED, EXTENDED RELEASE:MG	ORAL	357.9MG ORAL TABLET, FILM COATED, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
P160Q81342	DISODIUM LAURYL SULFOSUCCINATE:TOPICAL:GEL:%W/W	TOPICAL	0.04%W/W TOPICAL GEL	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
P160Q81342	DISODIUM LAURYL SULFOSUCCINATE:TOPICAL:SHAMPOO:%W/W	TOPICAL	15%W/W TOPICAL SHAMPOO	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
I29I2VHG38	LAURIC DIETHANOLAMIDE:TOPICAL:EMULSION:%W/W	TOPICAL	15%W/W TOPICAL EMULSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
I29I2VHG38	LAURIC DIETHANOLAMIDE:TOPICAL:LOTION:%W/V	TOPICAL	0.6%W/V TOPICAL LOTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
I29I2VHG38	LAURIC DIETHANOLAMIDE:TOPICAL:SHAMPOO:%W/W	TOPICAL	20%W/W TOPICAL SHAMPOO	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
I29I2VHG38	LAURIC DIETHANOLAMIDE:TOPICAL:SHAMPOO, SUSPENSION:%W/V	TOPICAL	4%W/V TOPICAL SHAMPOO, SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
I29I2VHG38	LAURIC DIETHANOLAMIDE:TOPICAL:SOLUTION:NA	TOPICAL	TOPICAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
I29I2VHG38	LAURIC DIETHANOLAMIDE:TOPICAL:SPONGE:NA	TOPICAL	TOPICAL SPONGE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
I29I2VHG38	LAURIC DIETHANOLAMIDE:TOPICAL:SUSPENSION:%W/W	TOPICAL	0.45%W/W TOPICAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
0057334FAB	PPG-20 METHYL GLUCOSE ETHER DISTEARATE:TOPICAL:GEL:%W/W	TOPICAL	4.75%W/W TOPICAL GEL	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
Y132ZOQ9H7	POLYISOBUTYLENE (800000 MW):TRANSDERMAL:FILM:MG	TRANSDERMAL	159MG TRANSDERMAL FILM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
1II18XLS1L	PPG-15 STEARYL ETHER:TOPICAL:GEL:%W/W	TOPICAL	2%W/W TOPICAL GEL	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
1II18XLS1L	PPG-15 STEARYL ETHER:TOPICAL:OINTMENT:%W/W	TOPICAL	15%W/W TOPICAL OINTMENT	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
1II18XLS1L	PPG-15 STEARYL ETHER:TOPICAL:SUSPENSION:%W/W	TOPICAL	16%W/W TOPICAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
44AIH82TSC	CELLULOSE, OXIDIZED:ORAL:TABLET:MG	ORAL	165.09MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
44AIH82TSC	CELLULOSE, OXIDIZED:ORAL:TABLET, COATED:MG	ORAL	20MG ORAL TABLET, COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
0A5MM307FC	CARBOXYPOLYMETHYLENE:ORAL:SUSPENSION:NA	ORAL	ORAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
0A5MM307FC	CARBOXYPOLYMETHYLENE:ORAL:TABLET, EXTENDED RELEASE:MG	ORAL	20MG ORAL TABLET, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
0A5MM307FC	CARBOXYPOLYMETHYLENE:ORAL:TABLET, SUSTAINED ACTION:MG	ORAL	195MG ORAL TABLET, SUSTAINED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
0A5MM307FC	CARBOXYPOLYMETHYLENE:RECTAL:ENEMA:NA	RECTAL	RECTAL ENEMA	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
0A5MM307FC	CARBOXYPOLYMETHYLENE:TOPICAL:DISC:NA	TOPICAL	TOPICAL DISC	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
0A5MM307FC	CARBOXYPOLYMETHYLENE:TOPICAL:GEL:%W/W	TOPICAL	1%W/W TOPICAL GEL	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
0A5MM307FC	CARBOXYPOLYMETHYLENE:TOPICAL:LOTION:%W/W	TOPICAL	0.15%W/W TOPICAL LOTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
P1BM4ZH95L	SODIUM POLYMETAPHOSPHATE:ORAL:SUSPENSION:MG/1ML	ORAL	1MG/1ML ORAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
3YQC9ZY4YB	GUANIDINE HYDROCHLORIDE:INTRAVENOUS:INJECTION:%	INTRAVENOUS	0.08% INTRAVENOUS INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
2UMI9U37CP	OLEIC ACID:INHALATION:AEROSOL, METERED:%	INHALATION	0.27% INHALATION AEROSOL, METERED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
2UMI9U37CP	OLEIC ACID:INTRAVENOUS:EMULSION, INJECTION:%	INTRAVENOUS	0.03% INTRAVENOUS EMULSION, INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
2UMI9U37CP	OLEIC ACID:NASAL:AEROSOL, METERED:%	NASAL	0.13% NASAL AEROSOL, METERED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
2UMI9U37CP	OLEIC ACID:ORAL:CAPSULE, SOFT GELATIN:MG	ORAL	598.6MG ORAL CAPSULE, SOFT GELATIN	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
2UMI9U37CP	OLEIC ACID:ORAL:TABLET, COATED:MG	ORAL	0.72MG ORAL TABLET, COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
2UMI9U37CP	OLEIC ACID:ORAL:TABLET, EXTENDED RELEASE:NA	ORAL	ORAL TABLET, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
2UMI9U37CP	OLEIC ACID:ORAL:TABLET, FILM COATED:NA	ORAL	ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
2UMI9U37CP	OLEIC ACID:ORAL:TABLET, REPEAT ACTION:MG	ORAL	1.85MG ORAL TABLET, REPEAT ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
2UMI9U37CP	OLEIC ACID:ORAL:TABLET, SUSTAINED ACTION:MG	ORAL	2MG ORAL TABLET, SUSTAINED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
2UMI9U37CP	OLEIC ACID:RESPIRATORY (INHALATION):AEROSOL, METERED:MG/INH	RESPIRATORY (INHALATION)	0.003MG/INH RESPIRATORY (INHALATION) AEROSOL, METERED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
2UMI9U37CP	OLEIC ACID:TOPICAL:EMULSION:NA	TOPICAL	TOPICAL EMULSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
2UMI9U37CP	OLEIC ACID:TOPICAL:EMULSION, CREAM:%W/W	TOPICAL	25%W/W TOPICAL EMULSION, CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
2UMI9U37CP	OLEIC ACID:TOPICAL:GEL:%W/W	TOPICAL	2.5%W/W TOPICAL GEL	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
2UMI9U37CP	OLEIC ACID:TOPICAL:SOLUTION:%W/W	TOPICAL	7.4%W/W TOPICAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
2UMI9U37CP	OLEIC ACID:TRANSDERMAL:FILM, CONTROLLED RELEASE:MG	TRANSDERMAL	22MG TRANSDERMAL FILM, CONTROLLED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
2UMI9U37CP	OLEIC ACID:TRANSDERMAL:PATCH, CONTROLLED RELEASE:MG	TRANSDERMAL	5.51MG TRANSDERMAL PATCH, CONTROLLED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
RWW266YE9I	HYDROXYETHYLPIPERAZINE ETHANE SULFONIC ACID:INTRAVENOUS:INJECTION:%	INTRAVENOUS	0.41% INTRAVENOUS INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
RWW266YE9I	HYDROXYETHYLPIPERAZINE ETHANE SULFONIC ACID:INTRAVENOUS:SOLUTION, LIQUID:mg/1mL	INTRAVENOUS	6mg/1mL INTRAVENOUS SOLUTION, LIQUID	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
66Y63L379N	MALTOSE ANHYDROUS:ORAL:TABLET:MG	ORAL	473MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
V8A1AW0880	MICA:ORAL:TABLET:MG	ORAL	0.26MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
T9D99G2B1R	CARAMEL:ORAL:BAR, CHEWABLE:NA	ORAL	ORAL BAR, CHEWABLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
T9D99G2B1R	CARAMEL:ORAL:CAPSULE:NA	ORAL	ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
T9D99G2B1R	CARAMEL:ORAL:CAPSULE, SOFT GELATIN:NA	ORAL	ORAL CAPSULE, SOFT GELATIN	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
T9D99G2B1R	CARAMEL:ORAL:GRANULE:MG	ORAL	2.5MG ORAL GRANULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
T9D99G2B1R	CARAMEL:ORAL:LIQUID:NA	ORAL	ORAL LIQUID	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
T9D99G2B1R	CARAMEL:ORAL:POWDER, FOR SOLUTION:NA	ORAL	ORAL POWDER, FOR SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
T9D99G2B1R	CARAMEL:ORAL:SOLUTION:MG/5ML	ORAL	4MG/5ML ORAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
T9D99G2B1R	CARAMEL:ORAL:SOLUTION, ELIXIR:NA	ORAL	ORAL SOLUTION, ELIXIR	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
T9D99G2B1R	CARAMEL:ORAL:SUSPENSION:MG/5ML	ORAL	111.12MG/5ML ORAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
T9D99G2B1R	CARAMEL:ORAL:SYRUP:MG/5ML	ORAL	207MG/5ML ORAL SYRUP	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
T9D99G2B1R	CARAMEL:RECTAL:LIQUID:NA	RECTAL	RECTAL LIQUID	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
T9D99G2B1R	CARAMEL:RECTAL:POWDER, FOR SOLUTION:NA	RECTAL	RECTAL POWDER, FOR SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
T9D99G2B1R	CARAMEL:TOPICAL:EMULSION, CREAM:%W/W	TOPICAL	0.26%W/W TOPICAL EMULSION, CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
6Y2XJ05B35	GLYCERYL PALMITATE:RECTAL:SUPPOSITORY:NA	RECTAL	RECTAL SUPPOSITORY	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
6Y2XJ05B35	GLYCERYL PALMITATE:TOPICAL:EMULSION, CREAM:NA	TOPICAL	TOPICAL EMULSION, CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
6Y2XJ05B35	GLYCERYL PALMITATE:TOPICAL:LOTION:NA	TOPICAL	TOPICAL LOTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
A9IO7TF4S0	SODIUM BISULFATE ACETONE:NERVE BLOCK:INJECTION:NA	NERVE BLOCK	NERVE BLOCK INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
T44ZYB1BAV	HORNSTEDTIA COSTATA SEED:ORAL:SOLUTION, ELIXIR:MG/5ML	ORAL	2.5MG/5ML ORAL SOLUTION, ELIXIR	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
H0G9379FGK	CALCIUM CARBONATE:AURICULAR (OTIC):SOLUTION:%	AURICULAR (OTIC)	0.38% AURICULAR (OTIC) SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
H0G9379FGK	CALCIUM CARBONATE:BUCCAL:GUM, CHEWING:MG	BUCCAL	145.7MG BUCCAL GUM, CHEWING	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
H0G9379FGK	CALCIUM CARBONATE:ORAL:CAPSULE:MG	ORAL	349.9MG ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
H0G9379FGK	CALCIUM CARBONATE:ORAL:CAPSULE, HARD GELATIN:MG	ORAL	62.84MG ORAL CAPSULE, HARD GELATIN	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
H0G9379FGK	CALCIUM CARBONATE:ORAL:CAPSULE, SUSTAINED ACTION:MG	ORAL	4MG ORAL CAPSULE, SUSTAINED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
H0G9379FGK	CALCIUM CARBONATE:ORAL:FILM, SOLUBLE:MG	ORAL	4.83MG ORAL FILM, SOLUBLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
H0G9379FGK	CALCIUM CARBONATE:ORAL:TABLET:MG	ORAL	292.2MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
H0G9379FGK	CALCIUM CARBONATE:ORAL:TABLET (IMMED./COMP. RELEASE), FILM COATED:MG	ORAL	132MG ORAL TABLET (IMMED./COMP. RELEASE), FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
H0G9379FGK	CALCIUM CARBONATE:ORAL:TABLET (IMMED./COMP. RELEASE), UNCOATED, CHEWABLE:MG	ORAL	550MG ORAL TABLET (IMMED./COMP. RELEASE), UNCOATED, CHEWABLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
H0G9379FGK	CALCIUM CARBONATE:ORAL:TABLET, COATED:MG	ORAL	64.8MG ORAL TABLET, COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
H0G9379FGK	CALCIUM CARBONATE:ORAL:TABLET, DELAYED ACTION, ENTERIC COATED:MG	ORAL	8.4MG ORAL TABLET, DELAYED ACTION, ENTERIC COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
H0G9379FGK	CALCIUM CARBONATE:ORAL:TABLET, FILM COATED:MG	ORAL	262.16MG ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
H0G9379FGK	CALCIUM CARBONATE:ORAL:TABLET, SUSTAINED ACTION:MG	ORAL	229.7MG ORAL TABLET, SUSTAINED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
H0G9379FGK	CALCIUM CARBONATE:RESPIRATORY (INHALATION):SOLUTION, INJECTION:%	RESPIRATORY (INHALATION)	4.02% RESPIRATORY (INHALATION) SOLUTION, INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
P9BC99461E	ALUMINUM MONOSTEARATE:TOPICAL:EMULSION, CREAM:%W/W	TOPICAL	0.01%W/W TOPICAL EMULSION, CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
32K497ZK2U	POLYVINYL ACETATE:ORAL:SUSPENSION:MG/1ML	ORAL	6.41MG/1ML ORAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
32K497ZK2U	POLYVINYL ACETATE:ORAL:SUSPENSION, EXTENDED RELEASE:MG/5ML	ORAL	25.08MG/5ML ORAL SUSPENSION, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
32K497ZK2U	POLYVINYL ACETATE:ORAL:TABLET:MG	ORAL	19.24MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
32K497ZK2U	POLYVINYL ACETATE:ORAL:TABLET, CHEWABLE:MG	ORAL	25.82MG ORAL TABLET, CHEWABLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
32K497ZK2U	POLYVINYL ACETATE:ORAL:TABLET, SUSTAINED ACTION:MG	ORAL	46MG ORAL TABLET, SUSTAINED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
32K497ZK2U	POLYVINYL ACETATE:SUBLINGUAL:TABLET:MG	SUBLINGUAL	8.07MG SUBLINGUAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
32K497ZK2U	POLYVINYL ACETATE:TRANSDERMAL:FILM, CONTROLLED RELEASE:MG	TRANSDERMAL	16MG TRANSDERMAL FILM, CONTROLLED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
32K497ZK2U	POLYVINYL ACETATE:TRANSDERMAL:PATCH, CONTROLLED RELEASE:MG	TRANSDERMAL	3.99MG TRANSDERMAL PATCH, CONTROLLED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
512OYT1CRR	COCOA BUTTER:ORAL:POWDER:NA	ORAL	ORAL POWDER	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
512OYT1CRR	COCOA BUTTER:RECTAL:SUPPOSITORY:MG	RECTAL	2070.6MG RECTAL SUPPOSITORY	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
512OYT1CRR	COCOA BUTTER:TOPICAL:LOTION:NA	TOPICAL	TOPICAL LOTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
D65DG142WK	MALTITOL:BUCCAL:GUM, CHEWING:MG	BUCCAL	209.2MG BUCCAL GUM, CHEWING	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
D65DG142WK	MALTITOL:ORAL:CAPSULE, SOFT GELATIN:MG	ORAL	38.7MG ORAL CAPSULE, SOFT GELATIN	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
D65DG142WK	MALTITOL:ORAL:ORAL SOLUTION DOSAGE FORM:mg/5mL	ORAL	2200mg/5mL ORAL ORAL SOLUTION DOSAGE FORM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
D65DG142WK	MALTITOL:ORAL:SOLUTION:MG/1ML	ORAL	750MG/1ML ORAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
D65DG142WK	MALTITOL:ORAL:SOLUTION, LIQUID:MG/1ML	ORAL	292MG/1ML ORAL SOLUTION, LIQUID	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
D65DG142WK	MALTITOL:ORAL:SUSPENSION:MG/5ML	ORAL	1350MG/5ML ORAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
D65DG142WK	MALTITOL:ORAL:SUSPENSION:MG/1ML	ORAL	300MG/1ML ORAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
D65DG142WK	MALTITOL:ORAL:SYRUP:MG/1ML	ORAL	500MG/1ML ORAL SYRUP	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
D65DG142WK	MALTITOL:ORAL:TABLET, ORALLY DISINTEGRATING:MG	ORAL	0.9MG ORAL TABLET, ORALLY DISINTEGRATING	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
D65DG142WK	MALTITOL:SUBLINGUAL:FILM:mg	SUBLINGUAL	7.33mg SUBLINGUAL FILM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
MZM1I680W0	PROPYLENE GLYCOL MONOSTEARATE:TOPICAL:EMULSION, CREAM:%W/W	TOPICAL	8%W/W TOPICAL EMULSION, CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
MZM1I680W0	PROPYLENE GLYCOL MONOSTEARATE:TOPICAL:LOTION:%W/W	TOPICAL	3%W/W TOPICAL LOTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
MZM1I680W0	PROPYLENE GLYCOL MONOSTEARATE:TOPICAL:OINTMENT:%W/W	TOPICAL	2%W/W TOPICAL OINTMENT	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
BJG0S321QY	ETHYLCELLULOSE (20 MPA.S):ORAL:CAPSULE, EXTENDED RELEASE:MG	ORAL	72.71MG ORAL CAPSULE, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
BJG0S321QY	ETHYLCELLULOSE (20 MPA.S):ORAL:CAPSULE, FILM COATED, EXTENDED RELEASE:MG	ORAL	31.97MG ORAL CAPSULE, FILM COATED, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
BJG0S321QY	ETHYLCELLULOSE (20 MPA.S):ORAL:TABLET, EXTENDED RELEASE:MG	ORAL	28.3MG ORAL TABLET, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
1NA5AO9GH7	POLYBUTENE (1400 MW):TRANSDERMAL:PATCH, CONTROLLED RELEASE:MG	TRANSDERMAL	3.25MG TRANSDERMAL PATCH, CONTROLLED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
OVV5IIJ58F	LANOLIN OIL:TOPICAL:CREAM:%W/W	TOPICAL	2%W/W TOPICAL CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
8D4NXF3ZH7	METHYL STEARATE:TOPICAL:EMULSION, CREAM:%W/W	TOPICAL	1%W/W TOPICAL EMULSION, CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
8D4NXF3ZH7	METHYL STEARATE:VAGINAL:CREAM, EMULSION, SUSTAINED RELEASE:%	VAGINAL	1.5% VAGINAL CREAM, EMULSION, SUSTAINED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
8D4NXF3ZH7	METHYL STEARATE:VAGINAL:EMULSION, CREAM:%	VAGINAL	1% VAGINAL EMULSION, CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
7Z8S9VYZ4B	ETHYLCELLULOSE, UNSPECIFIED:ORAL:CAPSULE:MG	ORAL	69.97MG ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
7Z8S9VYZ4B	ETHYLCELLULOSE, UNSPECIFIED:ORAL:CAPSULE, COATED:MG	ORAL	16.5MG ORAL CAPSULE, COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
7Z8S9VYZ4B	ETHYLCELLULOSE, UNSPECIFIED:ORAL:CAPSULE, DELAYED ACTION:MG	ORAL	88.06MG ORAL CAPSULE, DELAYED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
7Z8S9VYZ4B	ETHYLCELLULOSE, UNSPECIFIED:ORAL:CAPSULE, DELAYED RELEASE:MG	ORAL	1.42MG ORAL CAPSULE, DELAYED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
7Z8S9VYZ4B	ETHYLCELLULOSE, UNSPECIFIED:ORAL:CAPSULE, ENTERIC COATED PELLETS:MG	ORAL	18MG ORAL CAPSULE, ENTERIC COATED PELLETS	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
7Z8S9VYZ4B	ETHYLCELLULOSE, UNSPECIFIED:ORAL:CAPSULE, SUSTAINED ACTION:MG	ORAL	39.2MG ORAL CAPSULE, SUSTAINED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
7Z8S9VYZ4B	ETHYLCELLULOSE, UNSPECIFIED:ORAL:CAPSULE, SUSTAINED ACTION, HARD GELATIN:MG	ORAL	56.6MG ORAL CAPSULE, SUSTAINED ACTION, HARD GELATIN	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
7Z8S9VYZ4B	ETHYLCELLULOSE, UNSPECIFIED:ORAL:GRANULE, FOR SUSPENSION:MG	ORAL	85MG ORAL GRANULE, FOR SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
7Z8S9VYZ4B	ETHYLCELLULOSE, UNSPECIFIED:ORAL:GRANULE, FOR SUSPENSION, EXTENDED RELEASE:NA	ORAL	ORAL GRANULE, FOR SUSPENSION, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
7Z8S9VYZ4B	ETHYLCELLULOSE, UNSPECIFIED:ORAL:POWDER:MG/1SCP	ORAL	298.5MG/1SCP ORAL POWDER	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
7Z8S9VYZ4B	ETHYLCELLULOSE, UNSPECIFIED:ORAL:POWDER, FOR SUSPENSION:NA	ORAL	ORAL POWDER, FOR SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
7Z8S9VYZ4B	ETHYLCELLULOSE, UNSPECIFIED:ORAL:SUSPENSION, SUSTAINED ACTION:NA	ORAL	ORAL SUSPENSION, SUSTAINED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
7Z8S9VYZ4B	ETHYLCELLULOSE, UNSPECIFIED:ORAL:TABLET:MG	ORAL	120.8MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
7Z8S9VYZ4B	ETHYLCELLULOSE, UNSPECIFIED:ORAL:TABLET (IMMED./COMP. RELEASE), UNCOATED, CHEWABLE:MG	ORAL	8.8MG ORAL TABLET (IMMED./COMP. RELEASE), UNCOATED, CHEWABLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
7Z8S9VYZ4B	ETHYLCELLULOSE, UNSPECIFIED:ORAL:TABLET, COATED:MG	ORAL	20MG ORAL TABLET, COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
7Z8S9VYZ4B	ETHYLCELLULOSE, UNSPECIFIED:ORAL:TABLET, DELAYED ACTION, ENTERIC COATED:MG	ORAL	53.8MG ORAL TABLET, DELAYED ACTION, ENTERIC COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
7Z8S9VYZ4B	ETHYLCELLULOSE, UNSPECIFIED:ORAL:TABLET, EXTENDED RELEASE:MG	ORAL	300MG ORAL TABLET, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
7Z8S9VYZ4B	ETHYLCELLULOSE, UNSPECIFIED:ORAL:TABLET, FILM COATED:MG	ORAL	83MG ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
7Z8S9VYZ4B	ETHYLCELLULOSE, UNSPECIFIED:ORAL:TABLET, ORALLY DISINTEGRATING:MG	ORAL	35.28MG ORAL TABLET, ORALLY DISINTEGRATING	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
7Z8S9VYZ4B	ETHYLCELLULOSE, UNSPECIFIED:ORAL:TABLET, SUSTAINED ACTION:MG	ORAL	308.8MG ORAL TABLET, SUSTAINED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
7Z8S9VYZ4B	ETHYLCELLULOSE, UNSPECIFIED:ORAL:TABLET, SUSTAINED ACTION, COATED:MG	ORAL	15.15MG ORAL TABLET, SUSTAINED ACTION, COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
7Z8S9VYZ4B	ETHYLCELLULOSE, UNSPECIFIED:ORAL:TABLET, SUSTAINED ACTION, FILM COATED:MG	ORAL	52.5MG ORAL TABLET, SUSTAINED ACTION, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
7Z8S9VYZ4B	ETHYLCELLULOSE, UNSPECIFIED:TOPICAL:PATCH:NA	TOPICAL	TOPICAL PATCH	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
7Z8S9VYZ4B	ETHYLCELLULOSE, UNSPECIFIED:TRANSDERMAL:FILM, CONTROLLED RELEASE:MG	TRANSDERMAL	80.4MG TRANSDERMAL FILM, CONTROLLED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
7Z8S9VYZ4B	ETHYLCELLULOSE, UNSPECIFIED:TRANSDERMAL:PATCH:MG	TRANSDERMAL	18MG TRANSDERMAL PATCH	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
7Z8S9VYZ4B	ETHYLCELLULOSE, UNSPECIFIED:TRANSDERMAL:PATCH, ELECTRICALLY CONTROLLED:MG	TRANSDERMAL	35MG TRANSDERMAL PATCH, ELECTRICALLY CONTROLLED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
7Z8S9VYZ4B	ETHYLCELLULOSE, UNSPECIFIED:VAGINAL:TABLET:MG	VAGINAL	50MG VAGINAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
SR60A3XG0F	CINNAMALDEHYDE:ORAL:SUSPENSION:%	ORAL	0.01% ORAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
SR60A3XG0F	CINNAMALDEHYDE:ORAL:TABLET:MG	ORAL	2.1MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
83H19HW7K6	BENZYL CHLORIDE:INTRAVENOUS:INJECTION:%	INTRAVENOUS	0.001% INTRAVENOUS INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
2ZD004190S	THREONINE:INTRAVENOUS:POWDER, FOR INJECTION SOLUTION, LYOPHILIZED:%	INTRAVENOUS	16% INTRAVENOUS POWDER, FOR INJECTION SOLUTION, LYOPHILIZED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
2ZD004190S	THREONINE:IV(INFUSION):INJECTION:%	IV(INFUSION)	35.6% IV(INFUSION) INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
2ZD004190S	THREONINE:IV(INFUSION):SOLUTION, INJECTION:%	IV(INFUSION)	0.12% IV(INFUSION) SOLUTION, INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
0W8RRI5W5A	SORBITAN SESQUIOLEATE:RECTAL:OINTMENT:%	RECTAL	2% RECTAL OINTMENT	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
0W8RRI5W5A	SORBITAN SESQUIOLEATE:TOPICAL:OINTMENT:%W/W	TOPICAL	2%W/W TOPICAL OINTMENT	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
0THT5PCI0R	CYCLOMETHICONE 5:TOPICAL:AEROSOL:%W/W	TOPICAL	2.5%W/W TOPICAL AEROSOL	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
0THT5PCI0R	CYCLOMETHICONE 5:TOPICAL:CREAM, AUGMENTED:%W/W	TOPICAL	13%W/W TOPICAL CREAM, AUGMENTED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
D072FFP9GU	CETYL ESTERS WAX:ORAL:POWDER, FOR SUSPENSION:NA	ORAL	ORAL POWDER, FOR SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
D072FFP9GU	CETYL ESTERS WAX:TOPICAL:CREAM:%W/W	TOPICAL	2%W/W TOPICAL CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
D072FFP9GU	CETYL ESTERS WAX:TOPICAL:EMULSION, CREAM:%W/W	TOPICAL	10.3%W/W TOPICAL EMULSION, CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
D072FFP9GU	CETYL ESTERS WAX:TOPICAL:LOTION:NA	TOPICAL	TOPICAL LOTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
D072FFP9GU	CETYL ESTERS WAX:TOPICAL:SUPPOSITORY, INSERT:NA	TOPICAL	TOPICAL SUPPOSITORY, INSERT	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
D072FFP9GU	CETYL ESTERS WAX:TOPICAL:TABLET:NA	TOPICAL	TOPICAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
D072FFP9GU	CETYL ESTERS WAX:VAGINAL:CREAM, AUGMENTED:%	VAGINAL	3% VAGINAL CREAM, AUGMENTED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
D072FFP9GU	CETYL ESTERS WAX:VAGINAL:CREAM, EMULSION, SUSTAINED RELEASE:%	VAGINAL	9% VAGINAL CREAM, EMULSION, SUSTAINED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
D072FFP9GU	CETYL ESTERS WAX:VAGINAL:EMULSION, CREAM:%	VAGINAL	3% VAGINAL EMULSION, CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
D072FFP9GU	CETYL ESTERS WAX:VAGINAL:SUPPOSITORY, INSERT:NA	VAGINAL	VAGINAL SUPPOSITORY, INSERT	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
D072FFP9GU	CETYL ESTERS WAX:VAGINAL:TABLET:NA	VAGINAL	VAGINAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
S4255P4G5M	CALCIUM SILICATE:ORAL:CAPSULE:MG	ORAL	20MG ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
S4255P4G5M	CALCIUM SILICATE:ORAL:CAPSULE, SOFT GELATIN:MG	ORAL	1.03MG ORAL CAPSULE, SOFT GELATIN	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
S4255P4G5M	CALCIUM SILICATE:ORAL:TABLET:MG	ORAL	146.13MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
S4255P4G5M	CALCIUM SILICATE:ORAL:TABLET, COATED:MG	ORAL	155MG ORAL TABLET, COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
S4255P4G5M	CALCIUM SILICATE:ORAL:TABLET, FILM COATED:MG	ORAL	182.7MG ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
S4255P4G5M	CALCIUM SILICATE:ORAL:TABLET, ORALLY DISINTEGRATING:MG	ORAL	75MG ORAL TABLET, ORALLY DISINTEGRATING	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
S4255P4G5M	CALCIUM SILICATE:ORAL:TABLET, SUSTAINED ACTION:MG	ORAL	15MG ORAL TABLET, SUSTAINED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
5EXL5H740Y	PINE NEEDLE OIL (PINUS SYLVESTRIS):TOPICAL:LOTION:%V/V	TOPICAL	0.25%V/V TOPICAL LOTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
5EXL5H740Y	PINE NEEDLE OIL (PINUS SYLVESTRIS):TOPICAL:SOLUTION:NA	TOPICAL	TOPICAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
2A88ZO081O	PINEAPPLE:ORAL:CONCENTRATE:MG/1ML	ORAL	1MG/1ML ORAL CONCENTRATE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
2A88ZO081O	PINEAPPLE:ORAL:POWDER, FOR ORAL SUSPENSION:MG/5ML	ORAL	30MG/5ML ORAL POWDER, FOR ORAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
5KY68S2577	METHACRYLIC ACID - METHYL METHACRYLATE COPOLYMER (1:2):ORAL:CAPSULE:mg	ORAL	116.1mg ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
5KY68S2577	METHACRYLIC ACID - METHYL METHACRYLATE COPOLYMER (1:2):ORAL:CAPSULE, DELAYED ACTION:MG	ORAL	50.42MG ORAL CAPSULE, DELAYED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
5KY68S2577	METHACRYLIC ACID - METHYL METHACRYLATE COPOLYMER (1:2):ORAL:CAPSULE, DELAYED RELEASE:MG	ORAL	17.79MG ORAL CAPSULE, DELAYED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
5KY68S2577	METHACRYLIC ACID - METHYL METHACRYLATE COPOLYMER (1:2):ORAL:CAPSULE, EXTENDED RELEASE:MG	ORAL	47.31MG ORAL CAPSULE, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
5KY68S2577	METHACRYLIC ACID - METHYL METHACRYLATE COPOLYMER (1:2):ORAL:CAPSULE, SUSTAINED ACTION:MG	ORAL	28.38MG ORAL CAPSULE, SUSTAINED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
5KY68S2577	METHACRYLIC ACID - METHYL METHACRYLATE COPOLYMER (1:2):ORAL:TABLET:mg	ORAL	23mg ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
5KY68S2577	METHACRYLIC ACID - METHYL METHACRYLATE COPOLYMER (1:2):ORAL:TABLET, CONTROLLED RELEASE:MG	ORAL	35.24MG ORAL TABLET, CONTROLLED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
5KY68S2577	METHACRYLIC ACID - METHYL METHACRYLATE COPOLYMER (1:2):ORAL:TABLET, DELAYED ACTION:MG	ORAL	16MG ORAL TABLET, DELAYED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
5KY68S2577	METHACRYLIC ACID - METHYL METHACRYLATE COPOLYMER (1:2):ORAL:TABLET, DELAYED RELEASE:MG	ORAL	40.8MG ORAL TABLET, DELAYED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
5KY68S2577	METHACRYLIC ACID - METHYL METHACRYLATE COPOLYMER (1:2):ORAL:TABLET, EXTENDED RELEASE:mg	ORAL	9mg ORAL TABLET, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
5KY68S2577	METHACRYLIC ACID - METHYL METHACRYLATE COPOLYMER (1:2):ORAL:TABLET, FILM COATED:MG	ORAL	16MG ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
5KY68S2577	METHACRYLIC ACID - METHYL METHACRYLATE COPOLYMER (1:2):ORAL:TABLET, SUSTAINED ACTION:MG	ORAL	5.6MG ORAL TABLET, SUSTAINED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
5KY68S2577	METHACRYLIC ACID - METHYL METHACRYLATE COPOLYMER (1:2):ORAL:TABLET, SUSTAINED ACTION, COATED:MG	ORAL	4.32MG ORAL TABLET, SUSTAINED ACTION, COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
P0NTE48364	METHYLCELLULOSE (1500 MPA.S):ORAL:TABLET:MG	ORAL	2.75MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
F7625B974U	LYSINE MONOHYDRATE:INTRAVENOUS:INJECTION:%	INTRAVENOUS	0.8% INTRAVENOUS INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
F7625B974U	LYSINE MONOHYDRATE:RESPIRATORY (INHALATION):POWDER, FOR SOLUTION:%	RESPIRATORY (INHALATION)	5.25% RESPIRATORY (INHALATION) POWDER, FOR SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
2S7830E561	CROSPOVIDONE:IMPLANTATION:PELLET:MG	IMPLANTATION	2MG IMPLANTATION PELLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
2S7830E561	CROSPOVIDONE:INTRA-ARTICULAR:INJECTION:%	INTRA-ARTICULAR	0.02% INTRA-ARTICULAR INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
2S7830E561	CROSPOVIDONE:INTRAMUSCULAR:INJECTION:%	INTRAMUSCULAR	0.02% INTRAMUSCULAR INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
2S7830E561	CROSPOVIDONE:INTRAUTERINE:SOLUTION:NA	INTRAUTERINE	INTRAUTERINE SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
2S7830E561	CROSPOVIDONE:ORAL:CAPSULE:MG	ORAL	148MG ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
2S7830E561	CROSPOVIDONE:ORAL:CAPSULE (IMMED./COMP. RELEASE), HARD GELATIN:MG	ORAL	15.91MG ORAL CAPSULE (IMMED./COMP. RELEASE), HARD GELATIN	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
2S7830E561	CROSPOVIDONE:ORAL:CAPSULE, COATED, SOFT GELATIN:MG	ORAL	14MG ORAL CAPSULE, COATED, SOFT GELATIN	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
2S7830E561	CROSPOVIDONE:ORAL:CAPSULE, DELAYED ACTION:mg	ORAL	6mg ORAL CAPSULE, DELAYED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
2S7830E561	CROSPOVIDONE:ORAL:CAPSULE, DELAYED ACTION, ENTERIC COATED:NA	ORAL	ORAL CAPSULE, DELAYED ACTION, ENTERIC COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
2S7830E561	CROSPOVIDONE:ORAL:CAPSULE, DELAYED RELEASE:MG	ORAL	13.5MG ORAL CAPSULE, DELAYED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
2S7830E561	CROSPOVIDONE:ORAL:CAPSULE, ENTERIC COATED PELLETS:MG	ORAL	40.5MG ORAL CAPSULE, ENTERIC COATED PELLETS	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
2S7830E561	CROSPOVIDONE:ORAL:CAPSULE, EXTENDED RELEASE:MG	ORAL	20.54MG ORAL CAPSULE, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
2S7830E561	CROSPOVIDONE:ORAL:CAPSULE, HARD GELATIN:MG	ORAL	70MG ORAL CAPSULE, HARD GELATIN	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
2S7830E561	CROSPOVIDONE:ORAL:CAPSULE, SUSTAINED ACTION:MG	ORAL	10.71MG ORAL CAPSULE, SUSTAINED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
2S7830E561	CROSPOVIDONE:ORAL:DISPERSIBLE TABLET:MG	ORAL	340MG ORAL DISPERSIBLE TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
2S7830E561	CROSPOVIDONE:ORAL:GRANULE, FOR ORAL SUSPENSION:MG	ORAL	75MG ORAL GRANULE, FOR ORAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
2S7830E561	CROSPOVIDONE:ORAL:GRANULE, FOR ORAL SUSPENSION:MG/SACHET	ORAL	36.3MG/SACHET ORAL GRANULE, FOR ORAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
2S7830E561	CROSPOVIDONE:ORAL:PELLET:MG	ORAL	75MG ORAL PELLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
2S7830E561	CROSPOVIDONE:ORAL:POWDER, FOR SUSPENSION:MG/1SCP	ORAL	50MG/1SCP ORAL POWDER, FOR SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
2S7830E561	CROSPOVIDONE:ORAL:SUSPENSION:MG/5ML	ORAL	2.5MG/5ML ORAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
2S7830E561	CROSPOVIDONE:ORAL:SUSPENSION, SUSTAINED ACTION:MG/1PKT	ORAL	186.8MG/1PKT ORAL SUSPENSION, SUSTAINED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
2S7830E561	CROSPOVIDONE:ORAL:TABLET:mg	ORAL	394mg ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
2S7830E561	CROSPOVIDONE:ORAL:TABLET (IMMED./COMP. RELEASE), COATED:MG	ORAL	14MG ORAL TABLET (IMMED./COMP. RELEASE), COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
2S7830E561	CROSPOVIDONE:ORAL:TABLET (IMMED./COMP. RELEASE), FILM COATED:MG	ORAL	110MG ORAL TABLET (IMMED./COMP. RELEASE), FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
2S7830E561	CROSPOVIDONE:ORAL:TABLET (IMMED./COMP. RELEASE), UNCOATED, BUCCAL:MG	ORAL	9.6MG ORAL TABLET (IMMED./COMP. RELEASE), UNCOATED, BUCCAL	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
2S7830E561	CROSPOVIDONE:ORAL:TABLET (IMMED./COMP. RELEASE), UNCOATED, CHEWABLE:MG	ORAL	100MG ORAL TABLET (IMMED./COMP. RELEASE), UNCOATED, CHEWABLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
2S7830E561	CROSPOVIDONE:ORAL:TABLET, CHEWABLE:MG	ORAL	60MG ORAL TABLET, CHEWABLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
2S7830E561	CROSPOVIDONE:ORAL:TABLET, COATED:MG	ORAL	104MG ORAL TABLET, COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
2S7830E561	CROSPOVIDONE:ORAL:TABLET, CONTROLLED RELEASE:NA	ORAL	ORAL TABLET, CONTROLLED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
2S7830E561	CROSPOVIDONE:ORAL:TABLET, DELAYED ACTION:MG	ORAL	84MG ORAL TABLET, DELAYED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
2S7830E561	CROSPOVIDONE:ORAL:TABLET, DELAYED ACTION, ENTERIC COATED:MG	ORAL	50MG ORAL TABLET, DELAYED ACTION, ENTERIC COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
2S7830E561	CROSPOVIDONE:ORAL:TABLET, DELAYED RELEASE:MG	ORAL	49MG ORAL TABLET, DELAYED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
2S7830E561	CROSPOVIDONE:ORAL:TABLET, DISPERSIBLE:MG	ORAL	10MG ORAL TABLET, DISPERSIBLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
2S7830E561	CROSPOVIDONE:ORAL:TABLET, ENTERIC COATED PARTICLES:MG	ORAL	130MG ORAL TABLET, ENTERIC COATED PARTICLES	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
2S7830E561	CROSPOVIDONE:ORAL:TABLET, EXTENDED RELEASE:MG	ORAL	395.91MG ORAL TABLET, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
2S7830E561	CROSPOVIDONE:ORAL:TABLET, FILM COATED:MG	ORAL	196.7MG ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
2S7830E561	CROSPOVIDONE:ORAL:TABLET, FILM COATED, EXTENDED RELEASE:MG	ORAL	12MG ORAL TABLET, FILM COATED, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
2S7830E561	CROSPOVIDONE:ORAL:TABLET, FOR SUSPENSION:MG	ORAL	125MG ORAL TABLET, FOR SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
2S7830E561	CROSPOVIDONE:ORAL:TABLET, MULTILAYER, EXTENDED RELEASE:MG	ORAL	5MG ORAL TABLET, MULTILAYER, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
2S7830E561	CROSPOVIDONE:ORAL:TABLET, ORALLY DISINTEGRATING:MG	ORAL	280MG ORAL TABLET, ORALLY DISINTEGRATING	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
2S7830E561	CROSPOVIDONE:ORAL:TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE:mg	ORAL	110mg ORAL TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
2S7830E561	CROSPOVIDONE:ORAL:TABLET, REPEAT ACTION:MG	ORAL	10MG ORAL TABLET, REPEAT ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
2S7830E561	CROSPOVIDONE:ORAL:TABLET, SUSTAINED ACTION:MG	ORAL	144MG ORAL TABLET, SUSTAINED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
2S7830E561	CROSPOVIDONE:ORAL:TABLET, SUSTAINED ACTION, COATED:MG	ORAL	15.4MG ORAL TABLET, SUSTAINED ACTION, COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
2S7830E561	CROSPOVIDONE:ORAL:TABLET, SUSTAINED ACTION, FILM COATED:MG	ORAL	5MG ORAL TABLET, SUSTAINED ACTION, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
2S7830E561	CROSPOVIDONE:SUBLINGUAL:TABLET:MG	SUBLINGUAL	6MG SUBLINGUAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
2S7830E561	CROSPOVIDONE:SUBLINGUAL:TABLET (IMMED./COMP. RELEASE), UNCOATED, BUCCAL:MG	SUBLINGUAL	16MG SUBLINGUAL TABLET (IMMED./COMP. RELEASE), UNCOATED, BUCCAL	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
2S7830E561	CROSPOVIDONE:TOPICAL:EMULSION:%W/W	TOPICAL	1%W/W TOPICAL EMULSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
2S7830E561	CROSPOVIDONE:TOPICAL:LOTION:NA	TOPICAL	TOPICAL LOTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
2S7830E561	CROSPOVIDONE:TRANSDERMAL:FILM:MG	TRANSDERMAL	3.63MG TRANSDERMAL FILM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
2S7830E561	CROSPOVIDONE:TRANSDERMAL:FILM, CONTROLLED RELEASE:MG	TRANSDERMAL	60MG TRANSDERMAL FILM, CONTROLLED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
2S7830E561	CROSPOVIDONE:TRANSDERMAL:FILM, EXTENDED RELEASE:MG	TRANSDERMAL	47.5MG TRANSDERMAL FILM, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
2S7830E561	CROSPOVIDONE:TRANSDERMAL:PATCH, ELECTRICALLY CONTROLLED:MG	TRANSDERMAL	62MG TRANSDERMAL PATCH, ELECTRICALLY CONTROLLED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
2S7830E561	CROSPOVIDONE:VAGINAL:SUPPOSITORY:MG	VAGINAL	116.1MG VAGINAL SUPPOSITORY	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
2S7830E561	CROSPOVIDONE:VAGINAL:TABLET:MG	VAGINAL	50MG VAGINAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
6HG8UB2MUY	MEGLUMINE:INTRAMUSCULAR:INJECTION:%	INTRAMUSCULAR	14.48% INTRAMUSCULAR INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
6HG8UB2MUY	MEGLUMINE:INTRAVASCULAR:INJECTION:ADJ PH	INTRAVASCULAR	ADJ PH INTRAVASCULAR INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
6HG8UB2MUY	MEGLUMINE:INTRAVENOUS:INJECTION:%	INTRAVENOUS	15.4% INTRAVENOUS INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
6HG8UB2MUY	MEGLUMINE:IV(INFUSION):INJECTION:%	IV(INFUSION)	5.7% IV(INFUSION) INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
6HG8UB2MUY	MEGLUMINE:ORAL:CAPSULE, DELAYED ACTION:MG	ORAL	3.5MG ORAL CAPSULE, DELAYED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
6HG8UB2MUY	MEGLUMINE:ORAL:CAPSULE, DELAYED ACTION, ENTERIC COATED:NA	ORAL	ORAL CAPSULE, DELAYED ACTION, ENTERIC COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
6HG8UB2MUY	MEGLUMINE:ORAL:CAPSULE, DELAYED RELEASE:MG	ORAL	3.5MG ORAL CAPSULE, DELAYED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
6HG8UB2MUY	MEGLUMINE:ORAL:CAPSULE, ENTERIC COATED PELLETS:MG	ORAL	3MG ORAL CAPSULE, ENTERIC COATED PELLETS	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
6HG8UB2MUY	MEGLUMINE:ORAL:CAPSULE, EXTENDED RELEASE:MG	ORAL	5MG ORAL CAPSULE, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
6HG8UB2MUY	MEGLUMINE:ORAL:TABLET:MG	ORAL	24MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
6HG8UB2MUY	MEGLUMINE:ORAL:TABLET (IMMED./COMP. RELEASE), FILM COATED:MG	ORAL	1MG ORAL TABLET (IMMED./COMP. RELEASE), FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
6HG8UB2MUY	MEGLUMINE:ORAL:TABLET, DELAYED ACTION:MG	ORAL	0.5MG ORAL TABLET, DELAYED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
6HG8UB2MUY	MEGLUMINE:ORAL:TABLET, DELAYED RELEASE:MG	ORAL	10MG ORAL TABLET, DELAYED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
6HG8UB2MUY	MEGLUMINE:ORAL:TABLET, FILM COATED:NA	ORAL	ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
6HG8UB2MUY	MEGLUMINE:URETERAL:SOLUTION:%	URETERAL	7.24% URETERAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
I41B9FJK6V	DIETHYL SEBACATE:TOPICAL:EMULSION, CREAM:NA	TOPICAL	TOPICAL EMULSION, CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
I41B9FJK6V	DIETHYL SEBACATE:TOPICAL:LOTION:%W/W	TOPICAL	2.97%W/W TOPICAL LOTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
I41B9FJK6V	DIETHYL SEBACATE:TOPICAL:SOLUTION:%W/W	TOPICAL	24%W/W TOPICAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
172F2WN8DV	OLEYL ALCOHOL:TOPICAL:CREAM:%W/W	TOPICAL	10%W/W TOPICAL CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
172F2WN8DV	OLEYL ALCOHOL:TOPICAL:CREAM, AUGMENTED:%W/W	TOPICAL	10%W/W TOPICAL CREAM, AUGMENTED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
172F2WN8DV	OLEYL ALCOHOL:TOPICAL:EMULSION, CREAM:%W/W	TOPICAL	10%W/W TOPICAL EMULSION, CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
172F2WN8DV	OLEYL ALCOHOL:TOPICAL:OINTMENT:%W/W	TOPICAL	5%W/W TOPICAL OINTMENT	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
172F2WN8DV	OLEYL ALCOHOL:TRANSDERMAL:FILM:MG	TRANSDERMAL	6.11MG TRANSDERMAL FILM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
172F2WN8DV	OLEYL ALCOHOL:TRANSDERMAL:FILM, CONTROLLED RELEASE:MG	TRANSDERMAL	6.03MG TRANSDERMAL FILM, CONTROLLED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
172F2WN8DV	OLEYL ALCOHOL:TRANSDERMAL:FILM, EXTENDED RELEASE:MG	TRANSDERMAL	7.45MG TRANSDERMAL FILM, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
172F2WN8DV	OLEYL ALCOHOL:TRANSDERMAL:GEL:%	TRANSDERMAL	1.5% TRANSDERMAL GEL	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
172F2WN8DV	OLEYL ALCOHOL:TRANSDERMAL:PATCH:mg	TRANSDERMAL	5.32mg TRANSDERMAL PATCH	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
0I3V7S25AW	MYRISTIC ACID:ORAL:CAPSULE, EXTENDED RELEASE:MG	ORAL	215.13MG ORAL CAPSULE, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
0I3V7S25AW	MYRISTIC ACID:ORAL:CAPSULE, SUSTAINED ACTION:NA	ORAL	ORAL CAPSULE, SUSTAINED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
DE08037SAB	MAGNESIUM SULFATE, UNSPECIFIED FORM:ORAL:CAPSULE:NA	ORAL	ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
DE08037SAB	MAGNESIUM SULFATE, UNSPECIFIED FORM:ORAL:POWDER:MG/1PKT	ORAL	500MG/1PKT ORAL POWDER	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
DE08037SAB	MAGNESIUM SULFATE, UNSPECIFIED FORM:ORAL:POWDER:MG/1SCP	ORAL	500MG/1SCP ORAL POWDER	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
DE08037SAB	MAGNESIUM SULFATE, UNSPECIFIED FORM:ORAL:TABLET:MG	ORAL	2.9MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
DE08037SAB	MAGNESIUM SULFATE, UNSPECIFIED FORM:ORAL:TABLET, COATED:NA	ORAL	ORAL TABLET, COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
DE08037SAB	MAGNESIUM SULFATE, UNSPECIFIED FORM:ORAL:TABLET, EXTENDED RELEASE:MG	ORAL	4MG ORAL TABLET, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
DE08037SAB	MAGNESIUM SULFATE, UNSPECIFIED FORM:ORAL:TABLET, FILM COATED:MG	ORAL	14MG ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
96K6UQ3ZD4	SUCRALOSE:BUCCAL:GUM, CHEWING:MG	BUCCAL	3.5MG BUCCAL GUM, CHEWING	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
96K6UQ3ZD4	SUCRALOSE:NASAL:SPRAY:%	NASAL	0.15% NASAL SPRAY	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
96K6UQ3ZD4	SUCRALOSE:NASAL:SPRAY, METERED:%	NASAL	0.15% NASAL SPRAY, METERED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
96K6UQ3ZD4	SUCRALOSE:ORAL:FILM, SOLUBLE:MG	ORAL	5.5MG ORAL FILM, SOLUBLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
96K6UQ3ZD4	SUCRALOSE:ORAL:GRANULE:MG	ORAL	5.4MG ORAL GRANULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
96K6UQ3ZD4	SUCRALOSE:ORAL:GRANULE, FOR ORAL SUSPENSION:MG	ORAL	2.33MG ORAL GRANULE, FOR ORAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
96K6UQ3ZD4	SUCRALOSE:ORAL:LIQUID:MG/1ML	ORAL	3MG/1ML ORAL LIQUID	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
96K6UQ3ZD4	SUCRALOSE:ORAL:LOZENGE:mg	ORAL	4mg ORAL LOZENGE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
96K6UQ3ZD4	SUCRALOSE:ORAL:ORAL SOLUTION DOSAGE FORM:mg/5mL	ORAL	2.875mg/5mL ORAL ORAL SOLUTION DOSAGE FORM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
96K6UQ3ZD4	SUCRALOSE:ORAL:POWDER, FOR ORAL SOLUTION:MG	ORAL	1210MG ORAL POWDER, FOR ORAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
96K6UQ3ZD4	SUCRALOSE:ORAL:POWDER, FOR ORAL SOLUTION:G/16 OZ	ORAL	0.79G/16 OZ ORAL POWDER, FOR ORAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
96K6UQ3ZD4	SUCRALOSE:ORAL:POWDER, FOR ORAL SUSPENSION:MG	ORAL	90MG ORAL POWDER, FOR ORAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
96K6UQ3ZD4	SUCRALOSE:ORAL:POWDER, FOR SOLUTION:MG	ORAL	34.25MG ORAL POWDER, FOR SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
96K6UQ3ZD4	SUCRALOSE:ORAL:POWDER, FOR SUSPENSION:g/236mL	ORAL	0.0055g/236mL ORAL POWDER, FOR SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
96K6UQ3ZD4	SUCRALOSE:ORAL:SOLUTION:MG/160ML	ORAL	200MG/160ML ORAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
96K6UQ3ZD4	SUCRALOSE:ORAL:SOLUTION:MG/1ML	ORAL	40MG/1ML ORAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
96K6UQ3ZD4	SUCRALOSE:ORAL:SOLUTION:mg	ORAL	22.5mg ORAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
96K6UQ3ZD4	SUCRALOSE:ORAL:SOLUTION:mg/15 mL	ORAL	22.5mg/15 mL ORAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
96K6UQ3ZD4	SUCRALOSE:ORAL:SOLUTION, SYRUP:MG	ORAL	4.64MG ORAL SOLUTION, SYRUP	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
96K6UQ3ZD4	SUCRALOSE:ORAL:SUSPENSION:MG/5ML	ORAL	40MG/5ML ORAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
96K6UQ3ZD4	SUCRALOSE:ORAL:SUSPENSION:mg/1mL	ORAL	6mg/1mL ORAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
96K6UQ3ZD4	SUCRALOSE:ORAL:SUSPENSION, EXTENDED RELEASE:MG/1ML	ORAL	2MG/1ML ORAL SUSPENSION, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
96K6UQ3ZD4	SUCRALOSE:ORAL:SYRUP:MG/1ML	ORAL	1MG/1ML ORAL SYRUP	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
96K6UQ3ZD4	SUCRALOSE:ORAL:TABLET:MG	ORAL	15MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
96K6UQ3ZD4	SUCRALOSE:ORAL:TABLET (IMMED./COMP. RELEASE), UNCOATED, CHEWABLE:MG	ORAL	1.88MG ORAL TABLET (IMMED./COMP. RELEASE), UNCOATED, CHEWABLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
96K6UQ3ZD4	SUCRALOSE:ORAL:TABLET, CHEWABLE:MG	ORAL	4MG ORAL TABLET, CHEWABLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
96K6UQ3ZD4	SUCRALOSE:ORAL:TABLET, EFFERVESCENT, FOR SOLUTION:MG	ORAL	30MG ORAL TABLET, EFFERVESCENT, FOR SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
96K6UQ3ZD4	SUCRALOSE:ORAL:TABLET, ORALLY DISINTEGRATING:MG	ORAL	12MG ORAL TABLET, ORALLY DISINTEGRATING	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
96K6UQ3ZD4	SUCRALOSE:ORAL:TABLET, UNCOATED, LOZENGE:MG	ORAL	0.76MG ORAL TABLET, UNCOATED, LOZENGE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
96K6UQ3ZD4	SUCRALOSE:ORAL:TROCHE:MG	ORAL	4MG ORAL TROCHE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
96K6UQ3ZD4	SUCRALOSE:SUBLINGUAL:TABLET:MG	SUBLINGUAL	1.5MG SUBLINGUAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
96K6UQ3ZD4	SUCRALOSE:SUBLINGUAL:TABLET (IMMED./COMP. RELEASE), UNCOATED, BUCCAL:MG	SUBLINGUAL	0.52MG SUBLINGUAL TABLET (IMMED./COMP. RELEASE), UNCOATED, BUCCAL	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
C7X2M0VVNH	LIME (CALCIUM OXIDE):ORAL:CAPSULE:NA	ORAL	ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
C7X2M0VVNH	LIME (CALCIUM OXIDE):ORAL:SOLUTION, CONCENTRATE:%	ORAL	10% ORAL SOLUTION, CONCENTRATE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
C7X2M0VVNH	LIME (CALCIUM OXIDE):ORAL:SOLUTION, ELIXIR:NA	ORAL	ORAL SOLUTION, ELIXIR	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
1DAF35W3S2	CORN GLYCERIDES:ORAL:CAPSULE, SOFT GELATIN:MG	ORAL	344MG ORAL CAPSULE, SOFT GELATIN	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
1DAF35W3S2	CORN GLYCERIDES:ORAL:SOLUTION:MG/1ML	ORAL	318.85MG/1ML ORAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
C9H2L21V7U	MEDIUM-CHAIN TRIGLYCERIDES:INTRAVENOUS:INJECTION, EMULSION:MG/ML	INTRAVENOUS	11MG/ML INTRAVENOUS INJECTION, EMULSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
C9H2L21V7U	MEDIUM-CHAIN TRIGLYCERIDES:ORAL:CAPSULE:MG	ORAL	249.47MG ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
C9H2L21V7U	MEDIUM-CHAIN TRIGLYCERIDES:ORAL:CAPSULE (IMMED./COMP. RELEASE), COATED, SOFT GELATIN:NA	ORAL	ORAL CAPSULE (IMMED./COMP. RELEASE), COATED, SOFT GELATIN	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
C9H2L21V7U	MEDIUM-CHAIN TRIGLYCERIDES:ORAL:CAPSULE, EXTENDED RELEASE:MG	ORAL	3.08MG ORAL CAPSULE, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
C9H2L21V7U	MEDIUM-CHAIN TRIGLYCERIDES:ORAL:CAPSULE, SOFT GELATIN:MG	ORAL	250MG ORAL CAPSULE, SOFT GELATIN	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
C9H2L21V7U	MEDIUM-CHAIN TRIGLYCERIDES:ORAL:CAPSULE, SOFT GELATIN LIQUID-FILLED:MG	ORAL	72.2MG ORAL CAPSULE, SOFT GELATIN LIQUID-FILLED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
C9H2L21V7U	MEDIUM-CHAIN TRIGLYCERIDES:ORAL:POWDER, FOR ORAL SUSPENSION:MG/1PKT	ORAL	48MG/1PKT ORAL POWDER, FOR ORAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
C9H2L21V7U	MEDIUM-CHAIN TRIGLYCERIDES:ORAL:POWDER, FOR SUSPENSION:MG/5ML	ORAL	3390MG/5ML ORAL POWDER, FOR SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
C9H2L21V7U	MEDIUM-CHAIN TRIGLYCERIDES:ORAL:SOLUTION:MG/1ML	ORAL	944.6MG/1ML ORAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
C9H2L21V7U	MEDIUM-CHAIN TRIGLYCERIDES:ORAL:SOLUTION:g/1mL	ORAL	0.95g/1mL ORAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
C9H2L21V7U	MEDIUM-CHAIN TRIGLYCERIDES:ORAL:TABLET:MG	ORAL	0.34MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
C9H2L21V7U	MEDIUM-CHAIN TRIGLYCERIDES:ORAL:TABLET, EXTENDED RELEASE:mg	ORAL	0.37mg ORAL TABLET, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
C9H2L21V7U	MEDIUM-CHAIN TRIGLYCERIDES:SUBCUTANEOUS:INJECTION, SUSPENSION, EXTENDED RELEASE:MG/0.85 ML	SUBCUTANEOUS	774.4MG/0.85 ML SUBCUTANEOUS INJECTION, SUSPENSION, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
C9H2L21V7U	MEDIUM-CHAIN TRIGLYCERIDES:SUBLINGUAL:SPRAY:%	SUBLINGUAL	3.67% SUBLINGUAL SPRAY	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
C9H2L21V7U	MEDIUM-CHAIN TRIGLYCERIDES:SUBLINGUAL:SPRAY, METERED:%	SUBLINGUAL	3.67% SUBLINGUAL SPRAY, METERED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
C9H2L21V7U	MEDIUM-CHAIN TRIGLYCERIDES:TOPICAL:AEROSOL, SPRAY:NA	TOPICAL	TOPICAL AEROSOL, SPRAY	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
C9H2L21V7U	MEDIUM-CHAIN TRIGLYCERIDES:TOPICAL:CREAM:%W/W	TOPICAL	2.5%W/W TOPICAL CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
C9H2L21V7U	MEDIUM-CHAIN TRIGLYCERIDES:TOPICAL:CREAM, AUGMENTED:%W/W	TOPICAL	8%W/W TOPICAL CREAM, AUGMENTED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
C9H2L21V7U	MEDIUM-CHAIN TRIGLYCERIDES:TOPICAL:CREAM, EMULSION, SUSTAINED RELEASE:%W/W	TOPICAL	10%W/W TOPICAL CREAM, EMULSION, SUSTAINED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
C9H2L21V7U	MEDIUM-CHAIN TRIGLYCERIDES:TOPICAL:EMULSION, AEROSOL FOAM:%W/W	TOPICAL	10.87%W/W TOPICAL EMULSION, AEROSOL FOAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
C9H2L21V7U	MEDIUM-CHAIN TRIGLYCERIDES:TOPICAL:EMULSION, CREAM:%W/W	TOPICAL	10.8%W/W TOPICAL EMULSION, CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
C9H2L21V7U	MEDIUM-CHAIN TRIGLYCERIDES:TOPICAL:GEL:%W/W	TOPICAL	10%W/W TOPICAL GEL	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
C9H2L21V7U	MEDIUM-CHAIN TRIGLYCERIDES:TOPICAL:LOTION:%W/W	TOPICAL	7%W/W TOPICAL LOTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
C9H2L21V7U	MEDIUM-CHAIN TRIGLYCERIDES:TOPICAL:OINTMENT:%W/W	TOPICAL	20%W/W TOPICAL OINTMENT	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
C9H2L21V7U	MEDIUM-CHAIN TRIGLYCERIDES:TOPICAL:SOLUTION:NA	TOPICAL	TOPICAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
C9H2L21V7U	MEDIUM-CHAIN TRIGLYCERIDES:TOPICAL:SPRAY:%W/W	TOPICAL	18%W/W TOPICAL SPRAY	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
C9H2L21V7U	MEDIUM-CHAIN TRIGLYCERIDES:TOPICAL:SUPPOSITORY, INSERT:NA	TOPICAL	TOPICAL SUPPOSITORY, INSERT	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
C9H2L21V7U	MEDIUM-CHAIN TRIGLYCERIDES:TRANSDERMAL:FILM, CONTROLLED RELEASE:NA	TRANSDERMAL	TRANSDERMAL FILM, CONTROLLED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
C9H2L21V7U	TRIGLYCERIDES, MEDIUM CHAIN:TOPICAL:CREAM:%W/W	TOPICAL	15%W/W TOPICAL CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
C9H2L21V7U	TRIGLYCERIDES, MEDIUM CHAIN:TOPICAL:GEL:%W/W	TOPICAL	1%W/W TOPICAL GEL	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
36W53O7109	CHLOROCRESOL:TOPICAL:CREAM:%W/W	TOPICAL	0.1%W/W TOPICAL CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
36W53O7109	CHLOROCRESOL:TOPICAL:CREAM, AUGMENTED:%W/W	TOPICAL	0.1%W/W TOPICAL CREAM, AUGMENTED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
36W53O7109	CHLOROCRESOL:TOPICAL:EMULSION, CREAM:%W/W	TOPICAL	0.75%W/W TOPICAL EMULSION, CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
SA1B764746	POLYETHYLENE GLYCOL 3000:ORAL:TABLET:MG	ORAL	2.3MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
SA1B764746	POLYETHYLENE GLYCOL 3000:ORAL:TABLET, EXTENDED RELEASE:MG	ORAL	3MG ORAL TABLET, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
SA1B764746	POLYETHYLENE GLYCOL 3000:ORAL:TABLET, FILM COATED:MG	ORAL	0.56MG ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
R57ZHV85D4	BORIC ACID:AURICULAR (OTIC):SOLUTION:%	AURICULAR (OTIC)	0.049% AURICULAR (OTIC) SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
R57ZHV85D4	BORIC ACID:INTRAVENOUS:SOLUTION, INJECTION:%	INTRAVENOUS	0.32% INTRAVENOUS SOLUTION, INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
R57ZHV85D4	BORIC ACID:IV(INFUSION):INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION:MG/1ML	IV(INFUSION)	5.25MG/1ML IV(INFUSION) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
R57ZHV85D4	BORIC ACID:OPHTHALMIC:DROPS:%	OPHTHALMIC	1.8% OPHTHALMIC DROPS	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
R57ZHV85D4	BORIC ACID:OPHTHALMIC:EMULSION:%W/V	OPHTHALMIC	0.3%W/V OPHTHALMIC EMULSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
R57ZHV85D4	BORIC ACID:OPHTHALMIC:GEL:%	OPHTHALMIC	0.5% OPHTHALMIC GEL	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
R57ZHV85D4	BORIC ACID:OPHTHALMIC:POWDER, FOR SOLUTION:%	OPHTHALMIC	0.06% OPHTHALMIC POWDER, FOR SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
R57ZHV85D4	BORIC ACID:OPHTHALMIC:POWDER, FOR SUSPENSION:NA	OPHTHALMIC	OPHTHALMIC POWDER, FOR SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
R57ZHV85D4	BORIC ACID:OPHTHALMIC:SOLUTION:%	OPHTHALMIC	2.3% OPHTHALMIC SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
R57ZHV85D4	BORIC ACID:OPHTHALMIC:SOLUTION, DROPS:%	OPHTHALMIC	1.5% OPHTHALMIC SOLUTION, DROPS	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
R57ZHV85D4	BORIC ACID:OPHTHALMIC:SOLUTION, GEL FORMING, EXTENDED RELEASE:%	OPHTHALMIC	0.3% OPHTHALMIC SOLUTION, GEL FORMING, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
R57ZHV85D4	BORIC ACID:OPHTHALMIC:SUSPENSION:%	OPHTHALMIC	1% OPHTHALMIC SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
R57ZHV85D4	BORIC ACID:OPHTHALMIC:SUSPENSION, DROPS:%	OPHTHALMIC	0.6% OPHTHALMIC SUSPENSION, DROPS	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
R57ZHV85D4	BORIC ACID:ORAL:SOLUTION/DROPS:%W/V	ORAL	1.5%W/V ORAL SOLUTION/DROPS	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
R57ZHV85D4	BORIC ACID:OTIC:SUSPENSION:%	OTIC	0.6% OTIC SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
R57ZHV85D4	BORIC ACID:TOPICAL:EMULSION:%W/W	TOPICAL	1.3%W/W TOPICAL EMULSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
R57ZHV85D4	BORIC ACID:TOPICAL:SHAMPOO:%W/W	TOPICAL	2%W/W TOPICAL SHAMPOO	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
R57ZHV85D4	BORIC ACID:TOPICAL:SOLUTION:%W/W	TOPICAL	1.5%W/W TOPICAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
R57ZHV85D4	BORIC ACID:TOPICAL:SUSPENSION:%W/W	TOPICAL	0.3%W/W TOPICAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
Q7AO2R1M0B	AMMONIUM LAURYL SULFATE:TOPICAL:AEROSOL:NA	TOPICAL	TOPICAL AEROSOL	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
Q7AO2R1M0B	AMMONIUM LAURYL SULFATE:TOPICAL:EMULSION:%W/W	TOPICAL	39.75%W/W TOPICAL EMULSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
4YK5Z54AT2	DENATONIUM BENZOATE:TOPICAL:GEL:%W/W	TOPICAL	0.001%W/W TOPICAL GEL	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
4YK5Z54AT2	DENATONIUM BENZOATE:TOPICAL:SWAB:NA	TOPICAL	TOPICAL SWAB	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
PN2ZH5LOQY	FD&C RED NO. 3:ORAL:CAPSULE:MG	ORAL	1.69MG ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
PN2ZH5LOQY	FD&C RED NO. 3:ORAL:CAPSULE, EXTENDED RELEASE:MG	ORAL	0.3909MG ORAL CAPSULE, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
PN2ZH5LOQY	FD&C RED NO. 3:ORAL:CAPSULE, HARD GELATIN:NA	ORAL	ORAL CAPSULE, HARD GELATIN	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
PN2ZH5LOQY	FD&C RED NO. 3:ORAL:CAPSULE, SOFT GELATIN:MG	ORAL	0.22MG ORAL CAPSULE, SOFT GELATIN	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
PN2ZH5LOQY	FD&C RED NO. 3:ORAL:CAPSULE, SUSTAINED ACTION:MG	ORAL	0.3MG ORAL CAPSULE, SUSTAINED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
PN2ZH5LOQY	FD&C RED NO. 3:ORAL:DROPS:MG/2.5ML	ORAL	0.13MG/2.5ML ORAL DROPS	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
PN2ZH5LOQY	FD&C RED NO. 3:ORAL:GRANULE:MG	ORAL	0.25MG ORAL GRANULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
PN2ZH5LOQY	FD&C RED NO. 3:ORAL:POWDER, FOR ORAL SUSPENSION:MG/5ML	ORAL	0.4MG/5ML ORAL POWDER, FOR ORAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
PN2ZH5LOQY	FD&C RED NO. 3:ORAL:POWDER, FOR SOLUTION:NA	ORAL	ORAL POWDER, FOR SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
PN2ZH5LOQY	FD&C RED NO. 3:ORAL:POWDER, FOR SUSPENSION:MG/5ML	ORAL	2MG/5ML ORAL POWDER, FOR SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
PN2ZH5LOQY	FD&C RED NO. 3:ORAL:SOLUTION, ELIXIR:MG/5ML	ORAL	0.039MG/5ML ORAL SOLUTION, ELIXIR	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
PN2ZH5LOQY	FD&C RED NO. 3:ORAL:SUSPENSION:MG/5ML	ORAL	1MG/5ML ORAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
PN2ZH5LOQY	FD&C RED NO. 3:ORAL:SYRUP:MG/5ML	ORAL	0.15MG/5ML ORAL SYRUP	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
PN2ZH5LOQY	FD&C RED NO. 3:ORAL:TABLET:MG	ORAL	2.2MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
PN2ZH5LOQY	FD&C RED NO. 3:ORAL:TABLET (IMMED./COMP. RELEASE), UNCOATED, CHEWABLE:MG	ORAL	0.05MG ORAL TABLET (IMMED./COMP. RELEASE), UNCOATED, CHEWABLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
PN2ZH5LOQY	FD&C RED NO. 3:ORAL:TABLET, COATED:MG	ORAL	0.5MG ORAL TABLET, COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
PN2ZH5LOQY	FD&C RED NO. 3:ORAL:TABLET, DELAYED ACTION, ENTERIC COATED:MG	ORAL	0.005MG ORAL TABLET, DELAYED ACTION, ENTERIC COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
PN2ZH5LOQY	FD&C RED NO. 3:ORAL:TABLET, EXTENDED RELEASE:MG	ORAL	0.03MG ORAL TABLET, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
PN2ZH5LOQY	FD&C RED NO. 3:ORAL:TABLET, FILM COATED:MG	ORAL	0.004MG ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
PN2ZH5LOQY	FD&C RED NO. 3:ORAL:TABLET, SUSTAINED ACTION:NA	ORAL	ORAL TABLET, SUSTAINED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
PN2ZH5LOQY	FD&C RED NO. 3:ORAL:TABLET, SUSTAINED ACTION, COATED:NA	ORAL	ORAL TABLET, SUSTAINED ACTION, COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
1N032N7MFO	BROWN IRON OXIDE:ORAL:CAPSULE:NA	ORAL	ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
1N032N7MFO	BROWN IRON OXIDE:ORAL:TABLET:MG	ORAL	0.79MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
1N032N7MFO	BROWN IRON OXIDE:ORAL:TABLET, FILM COATED:MG	ORAL	0.2MG ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
0VUT3PMY82	HYPROMELLOSE 2910 (3 MPA.S):ORAL:CAPSULE:MG	ORAL	25.78MG ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
0VUT3PMY82	HYPROMELLOSE 2910 (3 MPA.S):ORAL:CAPSULE (IMMED./COMP. RELEASE):MG	ORAL	24.03MG ORAL CAPSULE (IMMED./COMP. RELEASE)	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
0VUT3PMY82	HYPROMELLOSE 2910 (3 MPA.S):ORAL:CAPSULE, DELAYED ACTION:MG	ORAL	80.14MG ORAL CAPSULE, DELAYED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
0VUT3PMY82	HYPROMELLOSE 2910 (3 MPA.S):ORAL:CAPSULE, DELAYED ACTION, COATED:mg	ORAL	32.728mg ORAL CAPSULE, DELAYED ACTION, COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
0VUT3PMY82	HYPROMELLOSE 2910 (3 MPA.S):ORAL:CAPSULE, DELAYED RELEASE:MG	ORAL	29MG ORAL CAPSULE, DELAYED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
0VUT3PMY82	HYPROMELLOSE 2910 (3 MPA.S):ORAL:CAPSULE, EXTENDED RELEASE:MG	ORAL	29.18MG ORAL CAPSULE, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
0VUT3PMY82	HYPROMELLOSE 2910 (3 MPA.S):ORAL:CAPSULE, HARD GELATIN:MG	ORAL	3.6MG ORAL CAPSULE, HARD GELATIN	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
0VUT3PMY82	HYPROMELLOSE 2910 (3 MPA.S):ORAL:CAPSULE, SOFT GELATIN:NA	ORAL	ORAL CAPSULE, SOFT GELATIN	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
0VUT3PMY82	HYPROMELLOSE 2910 (3 MPA.S):ORAL:GRANULE:MG	ORAL	10.4MG ORAL GRANULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
0VUT3PMY82	HYPROMELLOSE 2910 (3 MPA.S):ORAL:SUSPENSION:MG/1ML	ORAL	31.25MG/1ML ORAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
0VUT3PMY82	HYPROMELLOSE 2910 (3 MPA.S):ORAL:TABLET:mg	ORAL	29mg ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
0VUT3PMY82	HYPROMELLOSE 2910 (3 MPA.S):ORAL:TABLET (IMMED./COMP. RELEASE), FILM COATED:MG	ORAL	10.8MG ORAL TABLET (IMMED./COMP. RELEASE), FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
0VUT3PMY82	HYPROMELLOSE 2910 (3 MPA.S):ORAL:TABLET, DELAYED ACTION:MG	ORAL	24.55MG ORAL TABLET, DELAYED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
0VUT3PMY82	HYPROMELLOSE 2910 (3 MPA.S):ORAL:TABLET, DELAYED RELEASE:MG	ORAL	16.26MG ORAL TABLET, DELAYED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
0VUT3PMY82	HYPROMELLOSE 2910 (3 MPA.S):ORAL:TABLET, EXTENDED RELEASE:MG	ORAL	72.5MG ORAL TABLET, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
0VUT3PMY82	HYPROMELLOSE 2910 (3 MPA.S):ORAL:TABLET, FILM COATED:MG	ORAL	5.1MG ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
0VUT3PMY82	HYPROMELLOSE 2910 (3 MPA.S):ORAL:TABLET, ORALLY DISINTEGRATING:MG	ORAL	3.87MG ORAL TABLET, ORALLY DISINTEGRATING	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
0VUT3PMY82	HYPROMELLOSE 2910 (3 MPA.S):ORAL:TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE:mg	ORAL	6mg ORAL TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
I9O0E3H2ZE	PARAFFIN:ORAL:CAPSULE:MG	ORAL	34MG ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
I9O0E3H2ZE	PARAFFIN:ORAL:CAPSULE, SUSTAINED ACTION:MG	ORAL	50MG ORAL CAPSULE, SUSTAINED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
I9O0E3H2ZE	PARAFFIN:ORAL:TABLET:MG	ORAL	0.7MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
I9O0E3H2ZE	PARAFFIN:ORAL:TABLET, COATED:MG	ORAL	0.07MG ORAL TABLET, COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
I9O0E3H2ZE	PARAFFIN:ORAL:TABLET, DELAYED ACTION:MG	ORAL	0.2MG ORAL TABLET, DELAYED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
I9O0E3H2ZE	PARAFFIN:ORAL:TABLET, DELAYED RELEASE:MG	ORAL	0.2MG ORAL TABLET, DELAYED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
I9O0E3H2ZE	PARAFFIN:ORAL:TABLET, EXTENDED RELEASE:MG	ORAL	150.2MG ORAL TABLET, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
I9O0E3H2ZE	PARAFFIN:ORAL:TABLET, SUSTAINED ACTION:MG	ORAL	40MG ORAL TABLET, SUSTAINED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
I9O0E3H2ZE	PARAFFIN:RECTAL:OINTMENT:%	RECTAL	5% RECTAL OINTMENT	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
I9O0E3H2ZE	PARAFFIN:TOPICAL:AEROSOL, FOAM:%W/W	TOPICAL	94.93%W/W TOPICAL AEROSOL, FOAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
I9O0E3H2ZE	PARAFFIN:TOPICAL:CREAM:%W/W	TOPICAL	2.5%W/W TOPICAL CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
I9O0E3H2ZE	PARAFFIN:TOPICAL:EMULSION, CREAM:%W/W	TOPICAL	2%W/W TOPICAL EMULSION, CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
I9O0E3H2ZE	PARAFFIN:TOPICAL:OINTMENT:%W/W	TOPICAL	69%W/W TOPICAL OINTMENT	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
CR6K9C2NHK	METHYLPARABEN SODIUM:ORAL:CAPSULE:MG	ORAL	0.27MG ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
CR6K9C2NHK	METHYLPARABEN SODIUM:ORAL:POWDER, FOR ORAL SUSPENSION:MG/5ML	ORAL	5MG/5ML ORAL POWDER, FOR ORAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
CR6K9C2NHK	METHYLPARABEN SODIUM:ORAL:POWDER, FOR SUSPENSION:%	ORAL	0.02% ORAL POWDER, FOR SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
CR6K9C2NHK	METHYLPARABEN SODIUM:ORAL:SOLUTION:MG/1ML	ORAL	2.6MG/1ML ORAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
CR6K9C2NHK	METHYLPARABEN SODIUM:ORAL:SUSPENSION:MG/1ML	ORAL	3.43MG/1ML ORAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
CR6K9C2NHK	METHYLPARABEN SODIUM:ORAL:TABLET:MG	ORAL	0.19MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
CR6K9C2NHK	METHYLPARABEN SODIUM:ORAL:TABLET, ORALLY DISINTEGRATING:MG	ORAL	0.3MG ORAL TABLET, ORALLY DISINTEGRATING	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
06YD7896S3	TRIHYDROXYSTEARIN:TOPICAL:EMULSION, CREAM:NA	TOPICAL	TOPICAL EMULSION, CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
06YD7896S3	TRIHYDROXYSTEARIN:TOPICAL:OINTMENT:%W/W	TOPICAL	3%W/W TOPICAL OINTMENT	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
94YQ11Y95F	PEG-2 STEARATE:TOPICAL:EMULSION, AEROSOL FOAM:NA	TOPICAL	TOPICAL EMULSION, AEROSOL FOAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
94YQ11Y95F	PEG-2 STEARATE:TOPICAL:EMULSION, CREAM:%W/W	TOPICAL	1%W/W TOPICAL EMULSION, CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
94YQ11Y95F	PEG-2 STEARATE:VAGINAL:EMULSION, CREAM:NA	VAGINAL	VAGINAL EMULSION, CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
3OWL53L36A	MANNITOL:BUCCAL:GUM, CHEWING:MG	BUCCAL	37.11MG BUCCAL GUM, CHEWING	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
3OWL53L36A	MANNITOL:BUCCAL:TABLET:MG	BUCCAL	97.69MG BUCCAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
3OWL53L36A	MANNITOL:BUCCAL/SUBLINGUAL:TABLET:MG	BUCCAL/SUBLINGUAL	52.5MG BUCCAL/SUBLINGUAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
3OWL53L36A	MANNITOL:IM - IV:INJECTION:%	IM - IV	2.5% IM - IV INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
3OWL53L36A	MANNITOL:IM - IV:POWDER, FOR INJECTION SOLUTION:%	IM - IV	30% IM - IV POWDER, FOR INJECTION SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
3OWL53L36A	MANNITOL:IM - IV - SC:INJECTION:NA	IM - IV - SC	IM - IV - SC INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
3OWL53L36A	MANNITOL:IM - SC:INJECTION:NA	IM - SC	IM - SC INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
3OWL53L36A	MANNITOL:IM - SC:POWDER, FOR INJECTION SOLUTION:%	IM - SC	2% IM - SC POWDER, FOR INJECTION SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
3OWL53L36A	MANNITOL:INJECTION:INJECTABLE:MG/VIAL	INJECTION	125MG/VIAL INJECTION INJECTABLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
3OWL53L36A	MANNITOL:INTRAMUSCULAR:INJECTABLE:%	INTRAMUSCULAR	5% INTRAMUSCULAR INJECTABLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
3OWL53L36A	MANNITOL:INTRAMUSCULAR:INJECTION:mg	INTRAMUSCULAR	88.4mg INTRAMUSCULAR INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
3OWL53L36A	MANNITOL:INTRAMUSCULAR:INJECTION:%	INTRAMUSCULAR	10.66% INTRAMUSCULAR INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
3OWL53L36A	MANNITOL:INTRAMUSCULAR:INJECTION, MICROSPHERES:%	INTRAMUSCULAR	13.49% INTRAMUSCULAR INJECTION, MICROSPHERES	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
3OWL53L36A	MANNITOL:INTRAMUSCULAR:POWDER, FOR INJECTION SOLUTION:%	INTRAMUSCULAR	11.93% INTRAMUSCULAR POWDER, FOR INJECTION SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
3OWL53L36A	MANNITOL:INTRAMUSCULAR:POWDER, FOR INJECTION SOLUTION, LYOPHILIZED:%	INTRAMUSCULAR	8.5% INTRAMUSCULAR POWDER, FOR INJECTION SOLUTION, LYOPHILIZED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
3OWL53L36A	MANNITOL:INTRAMUSCULAR:POWDER, FOR INJECTION SOLUTION, LYOPHILIZED, WITH ADDITIVES:%	INTRAMUSCULAR	3.6% INTRAMUSCULAR POWDER, FOR INJECTION SOLUTION, LYOPHILIZED, WITH ADDITIVES	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
3OWL53L36A	MANNITOL:INTRAMUSCULAR:POWDER, FOR INJECTION SUSPENSION:%W/V	INTRAMUSCULAR	4.5%W/V INTRAMUSCULAR POWDER, FOR INJECTION SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
3OWL53L36A	MANNITOL:INTRAMUSCULAR:POWDER, FOR INJECTION SUSPENSION, LYOPHILIZED:%	INTRAMUSCULAR	5.19% INTRAMUSCULAR POWDER, FOR INJECTION SUSPENSION, LYOPHILIZED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
3OWL53L36A	MANNITOL:INTRAVENOUS:INFUSION:%	INTRAVENOUS	17% INTRAVENOUS INFUSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
3OWL53L36A	MANNITOL:INTRAVENOUS:INJECTABLE:%	INTRAVENOUS	45% INTRAVENOUS INJECTABLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
3OWL53L36A	MANNITOL:INTRAVENOUS:INJECTION:%	INTRAVENOUS	33.9% INTRAVENOUS INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
3OWL53L36A	MANNITOL:INTRAVENOUS:INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION:%W/W	INTRAVENOUS	50%W/W INTRAVENOUS INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
3OWL53L36A	MANNITOL:INTRAVENOUS:INJECTION, SUSPENSION:%	INTRAVENOUS	2.5% INTRAVENOUS INJECTION, SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
3OWL53L36A	MANNITOL:INTRAVENOUS:LIQUID:%	INTRAVENOUS	4.1% INTRAVENOUS LIQUID	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
3OWL53L36A	MANNITOL:INTRAVENOUS:LIQUID, CONCENTRATE, INJECTION:%	INTRAVENOUS	6.13% INTRAVENOUS LIQUID, CONCENTRATE, INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
3OWL53L36A	MANNITOL:INTRAVENOUS:POWDER:%	INTRAVENOUS	45% INTRAVENOUS POWDER	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
3OWL53L36A	MANNITOL:INTRAVENOUS:POWDER FOR INJECTION DOSAGE FORM:mg/1VIAL	INTRAVENOUS	150mg/1VIAL INTRAVENOUS POWDER FOR INJECTION DOSAGE FORM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
3OWL53L36A	MANNITOL:INTRAVENOUS:POWDER, FOR INJECTION SOLUTION:%	INTRAVENOUS	34% INTRAVENOUS POWDER, FOR INJECTION SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
3OWL53L36A	MANNITOL:INTRAVENOUS:POWDER, FOR INJECTION SOLUTION:%W/V	INTRAVENOUS	3.8%W/V INTRAVENOUS POWDER, FOR INJECTION SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
3OWL53L36A	MANNITOL:INTRAVENOUS:POWDER, FOR INJECTION SOLUTION, LYOPHILIZED:%	INTRAVENOUS	66.6% INTRAVENOUS POWDER, FOR INJECTION SOLUTION, LYOPHILIZED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
3OWL53L36A	MANNITOL:INTRAVENOUS:POWDER, FOR INJECTION SOLUTION, LYOPHILIZED, WITH ADDITIVES:%	INTRAVENOUS	3.94% INTRAVENOUS POWDER, FOR INJECTION SOLUTION, LYOPHILIZED, WITH ADDITIVES	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
3OWL53L36A	MANNITOL:INTRAVENOUS:SOLUTION:%	INTRAVENOUS	4.15% INTRAVENOUS SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
3OWL53L36A	MANNITOL:INTRAVENOUS:SOLUTION, INJECTION:%	INTRAVENOUS	6.25% INTRAVENOUS SOLUTION, INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
3OWL53L36A	MANNITOL:INTRAVENOUS:SOLUTION, LIPOSOME, INJECTION:%	INTRAVENOUS	10% INTRAVENOUS SOLUTION, LIPOSOME, INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
3OWL53L36A	MANNITOL:INTRAVENOUS INFUSION:INJECTABLE:MG/VIAL	INTRAVENOUS INFUSION	125MG/VIAL INTRAVENOUS INFUSION INJECTABLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
3OWL53L36A	MANNITOL:INTRAVENOUS INFUSION:INJECTION:%	INTRAVENOUS INFUSION	5.1% INTRAVENOUS INFUSION INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
3OWL53L36A	MANNITOL:IV(INFUSION):CONCENTRATE:%	IV(INFUSION)	22% IV(INFUSION) CONCENTRATE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
3OWL53L36A	MANNITOL:IV(INFUSION):INFUSION:%	IV(INFUSION)	3.85% IV(INFUSION) INFUSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
3OWL53L36A	MANNITOL:IV(INFUSION):INJECTABLE:%	IV(INFUSION)	4.4% IV(INFUSION) INJECTABLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
3OWL53L36A	MANNITOL:IV(INFUSION):POWDER, FOR INJECTION SOLUTION:%	IV(INFUSION)	75% IV(INFUSION) POWDER, FOR INJECTION SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
3OWL53L36A	MANNITOL:IV(INFUSION):POWDER, FOR INJECTION SOLUTION, LYOPHILIZED:%	IV(INFUSION)	4% IV(INFUSION) POWDER, FOR INJECTION SOLUTION, LYOPHILIZED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
3OWL53L36A	MANNITOL:IV(INFUSION):POWDER, FOR INJECTION SOLUTION, LYOPHILIZED, WITH ADDITIVES:%	IV(INFUSION)	7.5% IV(INFUSION) POWDER, FOR INJECTION SOLUTION, LYOPHILIZED, WITH ADDITIVES	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
3OWL53L36A	MANNITOL:IV(INFUSION):SOLUTION:%	IV(INFUSION)	3.85% IV(INFUSION) SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
3OWL53L36A	MANNITOL:IV(INFUSION):SOLUTION, CONCENTRATE:%	IV(INFUSION)	4.4% IV(INFUSION) SOLUTION, CONCENTRATE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
3OWL53L36A	MANNITOL:IV(INFUSION):SOLUTION, INJECTION:%	IV(INFUSION)	20.67% IV(INFUSION) SOLUTION, INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
3OWL53L36A	MANNITOL:NASAL:SOLUTION, SPRAY:%	NASAL	4.15% NASAL SOLUTION, SPRAY	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
3OWL53L36A	MANNITOL:OPHTHALMIC:GEL:%	OPHTHALMIC	5% OPHTHALMIC GEL	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
3OWL53L36A	MANNITOL:OPHTHALMIC:POWDER, FOR SOLUTION:%	OPHTHALMIC	5.6% OPHTHALMIC POWDER, FOR SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
3OWL53L36A	MANNITOL:OPHTHALMIC:SOLUTION:%w/v	OPHTHALMIC	4.7%w/v OPHTHALMIC SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
3OWL53L36A	MANNITOL:OPHTHALMIC:SOLUTION, DROPS:%	OPHTHALMIC	4.6% OPHTHALMIC SOLUTION, DROPS	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
3OWL53L36A	MANNITOL:OPHTHALMIC:SOLUTION, GEL FORMING, EXTENDED RELEASE:%	OPHTHALMIC	4.35% OPHTHALMIC SOLUTION, GEL FORMING, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
3OWL53L36A	MANNITOL:OPHTHALMIC:SUSPENSION:%	OPHTHALMIC	2.4% OPHTHALMIC SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
3OWL53L36A	MANNITOL:OPHTHALMIC:SUSPENSION, DROPS:%	OPHTHALMIC	4% OPHTHALMIC SUSPENSION, DROPS	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
3OWL53L36A	MANNITOL:ORAL:CAPSULE:MG	ORAL	297.2MG ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
3OWL53L36A	MANNITOL:ORAL:CAPSULE (IMMED./COMP. RELEASE), HARD GELATIN:MG	ORAL	264.8MG ORAL CAPSULE (IMMED./COMP. RELEASE), HARD GELATIN	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
3OWL53L36A	MANNITOL:ORAL:CAPSULE, COATED PELLETS:MG	ORAL	1.75MG ORAL CAPSULE, COATED PELLETS	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
3OWL53L36A	MANNITOL:ORAL:CAPSULE, DELAYED ACTION:MG	ORAL	227MG ORAL CAPSULE, DELAYED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
3OWL53L36A	MANNITOL:ORAL:CAPSULE, DELAYED ACTION, ENTERIC COATED:NA	ORAL	ORAL CAPSULE, DELAYED ACTION, ENTERIC COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
3OWL53L36A	MANNITOL:ORAL:CAPSULE, DELAYED RELEASE:MG	ORAL	39.1MG ORAL CAPSULE, DELAYED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
3OWL53L36A	MANNITOL:ORAL:CAPSULE, ENTERIC COATED PELLETS:MG	ORAL	236MG ORAL CAPSULE, ENTERIC COATED PELLETS	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
3OWL53L36A	MANNITOL:ORAL:CAPSULE, EXTENDED RELEASE:MG	ORAL	6.42MG ORAL CAPSULE, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
3OWL53L36A	MANNITOL:ORAL:CAPSULE, HARD GELATIN:MG	ORAL	92MG ORAL CAPSULE, HARD GELATIN	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
3OWL53L36A	MANNITOL:ORAL:CAPSULE, SUSTAINED ACTION:MG	ORAL	56.1MG ORAL CAPSULE, SUSTAINED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
3OWL53L36A	MANNITOL:ORAL:DISPERSIBLE TABLET:MG	ORAL	58.3MG ORAL DISPERSIBLE TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
3OWL53L36A	MANNITOL:ORAL:GRANULE:mg	ORAL	487.09mg ORAL GRANULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
3OWL53L36A	MANNITOL:ORAL:GRANULE, EFFERVESCENT:NA	ORAL	ORAL GRANULE, EFFERVESCENT	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
3OWL53L36A	MANNITOL:ORAL:GRANULE, FOR ORAL SUSPENSION:MG	ORAL	193.2MG ORAL GRANULE, FOR ORAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
3OWL53L36A	MANNITOL:ORAL:GRANULE, FOR SUSPENSION:MG	ORAL	500MG ORAL GRANULE, FOR SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
3OWL53L36A	MANNITOL:ORAL:LOZENGE:mg	ORAL	972mg ORAL LOZENGE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
3OWL53L36A	MANNITOL:ORAL:POWDER:MG/1PKT	ORAL	1100MG/1PKT ORAL POWDER	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
3OWL53L36A	MANNITOL:ORAL:POWDER:MG/1SCP	ORAL	1100MG/1SCP ORAL POWDER	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
3OWL53L36A	MANNITOL:ORAL:POWDER, FOR ORAL SOLUTION:MG	ORAL	755MG ORAL POWDER, FOR ORAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
3OWL53L36A	MANNITOL:ORAL:POWDER, FOR RECONSTITUTION:MG/5ML	ORAL	293.62MG/5ML ORAL POWDER, FOR RECONSTITUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
3OWL53L36A	MANNITOL:ORAL:POWDER, FOR SOLUTION:MG/1ML	ORAL	45.86MG/1ML ORAL POWDER, FOR SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
3OWL53L36A	MANNITOL:ORAL:POWDER, FOR SUSPENSION:mg	ORAL	1196.75mg ORAL POWDER, FOR SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
3OWL53L36A	MANNITOL:ORAL:POWDER, FOR SUSPENSION:MG/5ML	ORAL	200MG/5ML ORAL POWDER, FOR SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
3OWL53L36A	MANNITOL:ORAL:POWDER, FOR SUSPENSION:g/236mL	ORAL	0.339g/236mL ORAL POWDER, FOR SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
3OWL53L36A	MANNITOL:ORAL:SOLUTION:MG	ORAL	747MG ORAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
3OWL53L36A	MANNITOL:ORAL:SOLUTION, INJECTION:MG/1.7ML	ORAL	50MG/1.7ML ORAL SOLUTION, INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
3OWL53L36A	MANNITOL:ORAL:SUSPENSION:MG/5ML	ORAL	500MG/5ML ORAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
3OWL53L36A	MANNITOL:ORAL:SUSPENSION, SUSTAINED ACTION:MG/1PKT	ORAL	2464.6MG/1PKT ORAL SUSPENSION, SUSTAINED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
3OWL53L36A	MANNITOL:ORAL:TABLET:MG	ORAL	681.65MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
3OWL53L36A	MANNITOL:ORAL:TABLET (IMMED./COMP. RELEASE), FILM COATED:MG	ORAL	181.5MG ORAL TABLET (IMMED./COMP. RELEASE), FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
3OWL53L36A	MANNITOL:ORAL:TABLET (IMMED./COMP. RELEASE), UNCOATED, CHEWABLE:MG	ORAL	630MG ORAL TABLET (IMMED./COMP. RELEASE), UNCOATED, CHEWABLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
3OWL53L36A	MANNITOL:ORAL:TABLET, CHEWABLE:MG	ORAL	410.6MG ORAL TABLET, CHEWABLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
3OWL53L36A	MANNITOL:ORAL:TABLET, COATED:MG	ORAL	177.7MG ORAL TABLET, COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
3OWL53L36A	MANNITOL:ORAL:TABLET, CONTROLLED RELEASE:NA	ORAL	ORAL TABLET, CONTROLLED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
3OWL53L36A	MANNITOL:ORAL:TABLET, DELAYED ACTION:MG	ORAL	110.08MG ORAL TABLET, DELAYED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
3OWL53L36A	MANNITOL:ORAL:TABLET, DELAYED ACTION, ENTERIC COATED:MG	ORAL	77.9MG ORAL TABLET, DELAYED ACTION, ENTERIC COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
3OWL53L36A	MANNITOL:ORAL:TABLET, DELAYED RELEASE:MG	ORAL	213MG ORAL TABLET, DELAYED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
3OWL53L36A	MANNITOL:ORAL:TABLET, DISPERSIBLE:MG	ORAL	104MG ORAL TABLET, DISPERSIBLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
3OWL53L36A	MANNITOL:ORAL:TABLET, EXTENDED RELEASE:MG	ORAL	384.75MG ORAL TABLET, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
3OWL53L36A	MANNITOL:ORAL:TABLET, FILM COATED:MG	ORAL	241.21MG ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
3OWL53L36A	MANNITOL:ORAL:TABLET, FOR SUSPENSION:MG	ORAL	270MG ORAL TABLET, FOR SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
3OWL53L36A	MANNITOL:ORAL:TABLET, ORALLY DISINTEGRATING:MG	ORAL	606.72MG ORAL TABLET, ORALLY DISINTEGRATING	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
3OWL53L36A	MANNITOL:ORAL:TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE:mg	ORAL	261.33mg ORAL TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
3OWL53L36A	MANNITOL:ORAL:TABLET, SUSTAINED ACTION:MG	ORAL	392.2MG ORAL TABLET, SUSTAINED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
3OWL53L36A	MANNITOL:ORAL:TABLET, SUSTAINED ACTION, FILM COATED:MG	ORAL	274.97MG ORAL TABLET, SUSTAINED ACTION, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
3OWL53L36A	MANNITOL:ORAL:TABLET, UNCOATED, LOZENGE:MG	ORAL	187.6MG ORAL TABLET, UNCOATED, LOZENGE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
3OWL53L36A	MANNITOL:ORAL:TROCHE:MG	ORAL	1035.18MG ORAL TROCHE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
3OWL53L36A	MANNITOL:ORAL:WAFER:MG	ORAL	500MG ORAL WAFER	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
3OWL53L36A	MANNITOL:PARENTERAL:INJECTION:%	PARENTERAL	4.4% PARENTERAL INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
3OWL53L36A	MANNITOL:PARENTERAL:POWDER, FOR INJECTION SOLUTION:%	PARENTERAL	20% PARENTERAL POWDER, FOR INJECTION SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
3OWL53L36A	MANNITOL:RESPIRATORY (INHALATION):POWDER, FOR INHALATION:%	RESPIRATORY (INHALATION)	0.051% RESPIRATORY (INHALATION) POWDER, FOR INHALATION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
3OWL53L36A	MANNITOL:SUBCUTANEOUS:INJECTABLE:%	SUBCUTANEOUS	50% SUBCUTANEOUS INJECTABLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
3OWL53L36A	MANNITOL:SUBCUTANEOUS:INJECTION:%	SUBCUTANEOUS	4% SUBCUTANEOUS INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
3OWL53L36A	MANNITOL:SUBCUTANEOUS:INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION:MG/1VIAL	SUBCUTANEOUS	100MG/1VIAL SUBCUTANEOUS INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
3OWL53L36A	MANNITOL:SUBCUTANEOUS:POWDER, FOR INJECTION SOLUTION:%	SUBCUTANEOUS	9% SUBCUTANEOUS POWDER, FOR INJECTION SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
3OWL53L36A	MANNITOL:SUBCUTANEOUS:POWDER, FOR INJECTION SOLUTION, LYOPHILIZED:%	SUBCUTANEOUS	22.05% SUBCUTANEOUS POWDER, FOR INJECTION SOLUTION, LYOPHILIZED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
3OWL53L36A	MANNITOL:SUBCUTANEOUS:POWDER, FOR INJECTION SOLUTION, LYOPHILIZED, WITH ADDITIVES:%	SUBCUTANEOUS	4% SUBCUTANEOUS POWDER, FOR INJECTION SOLUTION, LYOPHILIZED, WITH ADDITIVES	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
3OWL53L36A	MANNITOL:SUBCUTANEOUS:POWDER, FOR INJECTION SUSPENSION, LYOPHILIZED:%	SUBCUTANEOUS	10% SUBCUTANEOUS POWDER, FOR INJECTION SUSPENSION, LYOPHILIZED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
3OWL53L36A	MANNITOL:SUBCUTANEOUS:SOLUTION:%	SUBCUTANEOUS	1.59% SUBCUTANEOUS SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
3OWL53L36A	MANNITOL:SUBCUTANEOUS:SOLUTION, INJECTION:%	SUBCUTANEOUS	4.95% SUBCUTANEOUS SOLUTION, INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
3OWL53L36A	MANNITOL:SUBCUTANEOUS:SUSPENSION, INJECTION:%	SUBCUTANEOUS	1.21% SUBCUTANEOUS SUSPENSION, INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
3OWL53L36A	MANNITOL:SUBLINGUAL:TABLET:MG	SUBLINGUAL	204MG SUBLINGUAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
3OWL53L36A	MANNITOL:SUBLINGUAL:TABLET (IMMED./COMP. RELEASE), UNCOATED, BUCCAL:MG	SUBLINGUAL	157.48MG SUBLINGUAL TABLET (IMMED./COMP. RELEASE), UNCOATED, BUCCAL	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
3OWL53L36A	MANNITOL:SUBLINGUAL:TABLET, ORALLY DISINTEGRATING:mg	SUBLINGUAL	10.25mg SUBLINGUAL TABLET, ORALLY DISINTEGRATING	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
3OWL53L36A	MANNITOL:SUBMUCOSAL:SOLUTION, INJECTION:%	SUBMUCOSAL	2.94% SUBMUCOSAL SOLUTION, INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
3OWL53L36A	MANNITOL:TOPICAL:SOLUTION:%W/V	TOPICAL	2.39%W/V TOPICAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
3OWL53L36A	MANNITOL:TOPICAL:SOLUTION, DROPS:%W/V	TOPICAL	1.6%W/V TOPICAL SOLUTION, DROPS	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
3OWL53L36A	MANNITOL:TOPICAL:SUSPENSION:%W/W	TOPICAL	0.3%W/W TOPICAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
3OWL53L36A	MANNITOL:TOPICAL:SUSPENSION, DROPS:%W/W	TOPICAL	1.01%W/W TOPICAL SUSPENSION, DROPS	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
3OWL53L36A	MANNITOL:TRANSDERMAL:PATCH, ELECTRICALLY CONTROLLED:MG	TRANSDERMAL	342.35MG TRANSDERMAL PATCH, ELECTRICALLY CONTROLLED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
3OWL53L36A	MANNITOL:TRANSMUCOSAL:TABLET:MG	TRANSMUCOSAL	180.19MG TRANSMUCOSAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
3OWL53L36A	MANNITOL :ORAL:CAPSULE:mg	ORAL	336.6mg ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
3OWL53L36A	MANNITOL :ORAL:CAPSULE:mg	ORAL	266.7mg ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
3OWL53L36A	MANNITOL :ORAL:CAPSULE:mg	ORAL	258mg ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
3OWL53L36A	MANNITOL :ORAL:TABLET:mg	ORAL	97.93mg ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
4J2TY8Y81V	STRAWBERRY:ORAL:LIQUID:%	ORAL	0.02% ORAL LIQUID	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
4J2TY8Y81V	STRAWBERRY:ORAL:POWDER, FOR ORAL SUSPENSION:MG	ORAL	20MG ORAL POWDER, FOR ORAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
4J2TY8Y81V	STRAWBERRY:ORAL:SUSPENSION, LIQUID:MG/1ML	ORAL	0.7MG/1ML ORAL SUSPENSION, LIQUID	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
4J2TY8Y81V	STRAWBERRY:ORAL:SYRUP:MG/5ML	ORAL	2.5MG/5ML ORAL SYRUP	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
4J2TY8Y81V	STRAWBERRY:ORAL:TABLET, ORALLY DISINTEGRATING:MG	ORAL	1MG ORAL TABLET, ORALLY DISINTEGRATING	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
4J2TY8Y81V	STRAWBERRY:ORAL:TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE:MG	ORAL	3MG ORAL TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
3XUS85K0RA	BUTYLENE GLYCOL:TOPICAL:PATCH, CONTROLLED RELEASE:NA	TOPICAL	TOPICAL PATCH, CONTROLLED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
3XUS85K0RA	BUTYLENE GLYCOL:TRANSDERMAL:FILM, CONTROLLED RELEASE:MG	TRANSDERMAL	8.12MG TRANSDERMAL FILM, CONTROLLED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
3XUS85K0RA	BUTYLENE GLYCOL:TRANSDERMAL:PATCH, CONTROLLED RELEASE:MG	TRANSDERMAL	2.03MG TRANSDERMAL PATCH, CONTROLLED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
24H4NWX5CO	KAOLIN:ORAL:CAPSULE:MG	ORAL	90.83MG ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=K
24H4NWX5CO	KAOLIN:ORAL:CAPSULE, ENTERIC COATED PELLETS:MG	ORAL	14.61MG ORAL CAPSULE, ENTERIC COATED PELLETS	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=K
24H4NWX5CO	KAOLIN:ORAL:POWDER, FOR SUSPENSION:NA	ORAL	ORAL POWDER, FOR SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=K
24H4NWX5CO	KAOLIN:ORAL:SOLUTION:NA	ORAL	ORAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=K
24H4NWX5CO	KAOLIN:ORAL:SYRUP:%	ORAL	1% ORAL SYRUP	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=K
24H4NWX5CO	KAOLIN:ORAL:TABLET:MG	ORAL	32.13MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=K
24H4NWX5CO	KAOLIN:ORAL:TABLET, COATED:MG	ORAL	8MG ORAL TABLET, COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=K
24H4NWX5CO	KAOLIN:ORAL:TABLET, DELAYED ACTION, ENTERIC COATED:MG	ORAL	18.5MG ORAL TABLET, DELAYED ACTION, ENTERIC COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=K
24H4NWX5CO	KAOLIN:ORAL:TABLET, DELAYED RELEASE:MG	ORAL	16.75MG ORAL TABLET, DELAYED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=K
24H4NWX5CO	KAOLIN:ORAL:TABLET, EXTENDED RELEASE:MG	ORAL	10MG ORAL TABLET, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=K
24H4NWX5CO	KAOLIN:ORAL:TABLET, SUSTAINED ACTION:MG	ORAL	66MG ORAL TABLET, SUSTAINED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=K
24H4NWX5CO	KAOLIN:TOPICAL:FILM, CONTROLLED RELEASE:NA	TOPICAL	TOPICAL FILM, CONTROLLED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=K
24H4NWX5CO	KAOLIN:TOPICAL:PATCH:MG	TOPICAL	140MG TOPICAL PATCH	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=K
24H4NWX5CO	KAOLIN:TOPICAL:PATCH, CONTROLLED RELEASE:NA	TOPICAL	TOPICAL PATCH, CONTROLLED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=K
QE535CBH7S	YELLOW OB:ORAL:TABLET:NA	ORAL	ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=Y
ML30MJ2U7I	MAGNESIUM SULFATE ANHYDROUS:ORAL:CAPSULE:MG	ORAL	29.8MG ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
632GS99618	SODIUM LAUROYL SARCOSINATE:TOPICAL:LOTION:%W/W	TOPICAL	0.75%W/W TOPICAL LOTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
632GS99618	SODIUM LAUROYL SARCOSINATE:TOPICAL:SUSPENSION:%W/W	TOPICAL	0.75%W/W TOPICAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
Q74T35078H	VANILLA:ORAL:TABLET:mg	ORAL	0.8mg ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=V
Q74T35078H	VANILLA:ORAL:TABLET, ORALLY DISINTEGRATING:MG	ORAL	0.41MG ORAL TABLET, ORALLY DISINTEGRATING	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=V
5EVU04N5QU	ORANGE:ORAL:SUSPENSION:MG/15 ML	ORAL	0.69MG/15 ML ORAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
5EVU04N5QU	ORANGE EXTRACT:ORAL:SUSPENSION:MG/15 ML	ORAL	60MG/15 ML ORAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
47E5O17Y3R	PHENYLALANINE:IV(INFUSION):INJECTION:%	IV(INFUSION)	52.6% IV(INFUSION) INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
47E5O17Y3R	PHENYLALANINE:IV(INFUSION):SOLUTION, INJECTION:%	IV(INFUSION)	0.17% IV(INFUSION) SOLUTION, INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
TTV12P4NEE	XANTHAN GUM:OPHTHALMIC:SOLUTION:%	OPHTHALMIC	0.6% OPHTHALMIC SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=X
TTV12P4NEE	XANTHAN GUM:OPHTHALMIC:SOLUTION, GEL FORMING, EXTENDED RELEASE:%	OPHTHALMIC	0.6% OPHTHALMIC SOLUTION, GEL FORMING, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=X
TTV12P4NEE	XANTHAN GUM:OPHTHALMIC:SUSPENSION:%W/V	OPHTHALMIC	0.6%W/V OPHTHALMIC SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=X
TTV12P4NEE	XANTHAN GUM:ORAL:CAPSULE:mg	ORAL	0.007mg ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=X
TTV12P4NEE	XANTHAN GUM:ORAL:DROPS:MG/1ML	ORAL	2.9MG/1ML ORAL DROPS	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=X
TTV12P4NEE	XANTHAN GUM:ORAL:FILM, SOLUBLE:MG	ORAL	0.3MG ORAL FILM, SOLUBLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=X
TTV12P4NEE	XANTHAN GUM:ORAL:FOR SUSPENSION:MG/5ML	ORAL	3.75MG/5ML ORAL FOR SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=X
TTV12P4NEE	XANTHAN GUM:ORAL:GRANULE:MG/5ML	ORAL	10MG/5ML ORAL GRANULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=X
TTV12P4NEE	XANTHAN GUM:ORAL:GRANULE, FOR ORAL SUSPENSION:MG	ORAL	75MG ORAL GRANULE, FOR ORAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=X
TTV12P4NEE	XANTHAN GUM:ORAL:LOZENGE:mg	ORAL	50mg ORAL LOZENGE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=X
TTV12P4NEE	XANTHAN GUM:ORAL:PELLET:MG	ORAL	75MG ORAL PELLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=X
TTV12P4NEE	XANTHAN GUM:ORAL:POWDER:MG/1PKT	ORAL	275MG/1PKT ORAL POWDER	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=X
TTV12P4NEE	XANTHAN GUM:ORAL:POWDER:MG/1SCP	ORAL	275MG/1SCP ORAL POWDER	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=X
TTV12P4NEE	XANTHAN GUM:ORAL:POWDER:MG/BOTTLE	ORAL	0.06MG/BOTTLE ORAL POWDER	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=X
TTV12P4NEE	XANTHAN GUM:ORAL:POWDER, FOR ORAL SUSPENSION:MG	ORAL	360MG ORAL POWDER, FOR ORAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=X
TTV12P4NEE	XANTHAN GUM:ORAL:POWDER, FOR ORAL SUSPENSION:MG/5ML	ORAL	10MG/5ML ORAL POWDER, FOR ORAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=X
TTV12P4NEE	XANTHAN GUM:ORAL:POWDER, FOR RECONSTITUTION:MG/5ML	ORAL	25MG/5ML ORAL POWDER, FOR RECONSTITUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=X
TTV12P4NEE	XANTHAN GUM:ORAL:POWDER, FOR SOLUTION:MG/1GM	ORAL	41MG/1GM ORAL POWDER, FOR SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=X
TTV12P4NEE	XANTHAN GUM:ORAL:POWDER, FOR SUSPENSION:MG/5ML	ORAL	80MG/5ML ORAL POWDER, FOR SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=X
TTV12P4NEE	XANTHAN GUM:ORAL:SOLUTION:MG/1ML	ORAL	1.5MG/1ML ORAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=X
TTV12P4NEE	XANTHAN GUM:ORAL:SUSPENSION:mg/5mL	ORAL	40mg/5mL ORAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=X
TTV12P4NEE	XANTHAN GUM:ORAL:SUSPENSION:MG	ORAL	13.75MG ORAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=X
TTV12P4NEE	XANTHAN GUM:ORAL:SUSPENSION:mg/1.25mL	ORAL	2.5mg/1.25mL ORAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=X
TTV12P4NEE	XANTHAN GUM:ORAL:SUSPENSION:MG/1ML	ORAL	2.18MG/1ML ORAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=X
TTV12P4NEE	XANTHAN GUM:ORAL:SUSPENSION, DROPS:MG/1ML	ORAL	2.19MG/1ML ORAL SUSPENSION, DROPS	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=X
TTV12P4NEE	XANTHAN GUM:ORAL:SUSPENSION, EXTENDED RELEASE:MG/ML	ORAL	4.17MG/ML ORAL SUSPENSION, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=X
TTV12P4NEE	XANTHAN GUM:ORAL:SUSPENSION, EXTENDED RELEASE:MG/1ML	ORAL	2.5MG/1ML ORAL SUSPENSION, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=X
TTV12P4NEE	XANTHAN GUM:ORAL:SUSPENSION, LIQUID:MG/5ML	ORAL	11.5MG/5ML ORAL SUSPENSION, LIQUID	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=X
TTV12P4NEE	XANTHAN GUM:ORAL:SUSPENSION, SUSTAINED ACTION:MG/1PKT	ORAL	186.8MG/1PKT ORAL SUSPENSION, SUSTAINED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=X
TTV12P4NEE	XANTHAN GUM:ORAL:SUSPENSION, SYRUP, SUSTAINED ACTION:%	ORAL	0.03% ORAL SUSPENSION, SYRUP, SUSTAINED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=X
TTV12P4NEE	XANTHAN GUM:ORAL:TABLET:MG	ORAL	14MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=X
TTV12P4NEE	XANTHAN GUM:ORAL:TABLET, CHEWABLE:MG	ORAL	4MG ORAL TABLET, CHEWABLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=X
TTV12P4NEE	XANTHAN GUM:ORAL:TABLET, CONTROLLED RELEASE:MG	ORAL	109.52MG ORAL TABLET, CONTROLLED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=X
TTV12P4NEE	XANTHAN GUM:ORAL:TABLET, EXTENDED RELEASE:MG	ORAL	154MG ORAL TABLET, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=X
TTV12P4NEE	XANTHAN GUM:ORAL:TABLET, FILM COATED:MG	ORAL	0.079MG ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=X
TTV12P4NEE	XANTHAN GUM:ORAL:TABLET, ORALLY DISINTEGRATING:MG	ORAL	0.15MG ORAL TABLET, ORALLY DISINTEGRATING	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=X
TTV12P4NEE	XANTHAN GUM:ORAL:TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE:mg	ORAL	6mg ORAL TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=X
TTV12P4NEE	XANTHAN GUM:ORAL:TABLET, SUSTAINED ACTION:MG	ORAL	50MG ORAL TABLET, SUSTAINED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=X
TTV12P4NEE	XANTHAN GUM:ORAL:TABLET, UNCOATED, LOZENGE:MG	ORAL	2.12MG ORAL TABLET, UNCOATED, LOZENGE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=X
TTV12P4NEE	XANTHAN GUM:ORAL:TROCHE:MG	ORAL	63.2MG ORAL TROCHE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=X
TTV12P4NEE	XANTHAN GUM:RECTAL:ENEMA:%	RECTAL	0.25% RECTAL ENEMA	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=X
TTV12P4NEE	XANTHAN GUM:RECTAL:SUSPENSION:%	RECTAL	0.057% RECTAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=X
TTV12P4NEE	XANTHAN GUM:TOPICAL:CREAM:%W/W 	TOPICAL	0.3%W/W  TOPICAL CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=X
TTV12P4NEE	XANTHAN GUM:TOPICAL:CREAM, AUGMENTED:%W/W	TOPICAL	0.22%W/W TOPICAL CREAM, AUGMENTED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=X
TTV12P4NEE	XANTHAN GUM:TOPICAL:CREAM, EMULSION, SUSTAINED RELEASE:%W/W	TOPICAL	0.75%W/W TOPICAL CREAM, EMULSION, SUSTAINED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=X
TTV12P4NEE	XANTHAN GUM:TOPICAL:EMULSION, AEROSOL FOAM:%W/W	TOPICAL	0.27%W/W TOPICAL EMULSION, AEROSOL FOAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=X
TTV12P4NEE	XANTHAN GUM:TOPICAL:EMULSION, CREAM:%W/W	TOPICAL	0.75%W/W TOPICAL EMULSION, CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=X
TTV12P4NEE	XANTHAN GUM:TOPICAL:GEL:%W/W	TOPICAL	2.85%W/W TOPICAL GEL	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=X
TTV12P4NEE	XANTHAN GUM:TOPICAL:LOTION:%W/V	TOPICAL	0.3%W/V TOPICAL LOTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=X
TTV12P4NEE	XANTHAN GUM:TOPICAL:SUSPENSION:%W/W	TOPICAL	0.11%W/W TOPICAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=X
1534K8653J	WHEAT GLUTEN:ORAL:TABLET:NA	ORAL	ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=W
1CS02G8656	METHACRYLIC ACID:ORAL:CAPSULE, DELAYED RELEASE:MG	ORAL	34.5MG ORAL CAPSULE, DELAYED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
T3CHA1B51H	ANTIPYRINE:OPHTHALMIC:SOLUTION:%	OPHTHALMIC	0.1% OPHTHALMIC SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
36KCS0R750	SODIUM SULFATE ANHYDROUS:INHALATION:SOLUTION:%	INHALATION	0.025% INHALATION SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
36KCS0R750	SODIUM SULFATE ANHYDROUS:INTRAMUSCULAR:INJECTION:NA	INTRAMUSCULAR	INTRAMUSCULAR INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
36KCS0R750	SODIUM SULFATE ANHYDROUS:IV(INFUSION):SOLUTION, INJECTION:%	IV(INFUSION)	1.14% IV(INFUSION) SOLUTION, INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
36KCS0R750	SODIUM SULFATE ANHYDROUS:OPHTHALMIC:SOLUTION:%	OPHTHALMIC	0.15% OPHTHALMIC SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
36KCS0R750	SODIUM SULFATE ANHYDROUS:OPHTHALMIC:SOLUTION, DROPS:%	OPHTHALMIC	0.17% OPHTHALMIC SOLUTION, DROPS	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
36KCS0R750	SODIUM SULFATE ANHYDROUS:OPHTHALMIC:SUSPENSION:%	OPHTHALMIC	1.2% OPHTHALMIC SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
36KCS0R750	SODIUM SULFATE ANHYDROUS:ORAL:TABLET:MG	ORAL	105.1MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
OFM06SG1KO	DICHLORODIFLUOROMETHANE:INHALATION:AEROSOL, METERED:MG/INH	INHALATION	14700MG/INH INHALATION AEROSOL, METERED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
OFM06SG1KO	DICHLORODIFLUOROMETHANE:INHALATION:AEROSOL, SPRAY:%	INHALATION	25% INHALATION AEROSOL, SPRAY	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
OFM06SG1KO	DICHLORODIFLUOROMETHANE:INTRAPLEURAL:AEROSOL, METERED:%	INTRAPLEURAL	26% INTRAPLEURAL AEROSOL, METERED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
OFM06SG1KO	DICHLORODIFLUOROMETHANE:NASAL:AEROSOL:NA	NASAL	NASAL AEROSOL	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
OFM06SG1KO	DICHLORODIFLUOROMETHANE:NASAL:AEROSOL, METERED:%	NASAL	6.12% NASAL AEROSOL, METERED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
OFM06SG1KO	DICHLORODIFLUOROMETHANE:RECTAL:AEROSOL, METERED:%	RECTAL	13.5% RECTAL AEROSOL, METERED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
OFM06SG1KO	DICHLORODIFLUOROMETHANE:SUBLINGUAL:AEROSOL:NA	SUBLINGUAL	SUBLINGUAL AEROSOL	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
OFM06SG1KO	DICHLORODIFLUOROMETHANE:TOPICAL:AEROSOL:NA	TOPICAL	TOPICAL AEROSOL	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
OFM06SG1KO	DICHLORODIFLUOROMETHANE:TOPICAL:AEROSOL, METERED:NA	TOPICAL	TOPICAL AEROSOL, METERED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
OFM06SG1KO	DICHLORODIFLUOROMETHANE:TOPICAL:AEROSOL, SPRAY:NA	TOPICAL	TOPICAL AEROSOL, SPRAY	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
OFM06SG1KO	DICHLORODIFLUOROMETHANE:TOPICAL:EMULSION, AEROSOL FOAM:%W/W	TOPICAL	8%W/W TOPICAL EMULSION, AEROSOL FOAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
OFM06SG1KO	DICHLORODIFLUOROMETHANE:VAGINAL:EMULSION, AEROSOL FOAM:%	VAGINAL	20% VAGINAL EMULSION, AEROSOL FOAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
RRE756S6Q2	AMMONIUM ACETATE:IV(INFUSION):INJECTION:%	IV(INFUSION)	0.4% IV(INFUSION) INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
ZUE0CEL42O	GLYCERYL RICINOLEATE:TOPICAL:SHAMPOO, SUSPENSION:%W/W	TOPICAL	2%W/W TOPICAL SHAMPOO, SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
U725QWY32X	POVIDONE K30:AURICULAR (OTIC):SOLUTION, DROPS:%	AURICULAR (OTIC)	0.2% AURICULAR (OTIC) SOLUTION, DROPS	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
U725QWY32X	POVIDONE K30:BUCCAL:TABLET, EXTENDED RELEASE:MG	BUCCAL	0.5MG BUCCAL TABLET, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
U725QWY32X	POVIDONE K30:OPHTHALMIC:SOLUTION:%	OPHTHALMIC	15% OPHTHALMIC SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
U725QWY32X	POVIDONE K30:OPHTHALMIC:SOLUTION, DROPS:%	OPHTHALMIC	2% OPHTHALMIC SOLUTION, DROPS	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
U725QWY32X	POVIDONE K30:OPHTHALMIC:SUSPENSION:%	OPHTHALMIC	0.6% OPHTHALMIC SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
U725QWY32X	POVIDONE K30:ORAL:CAPSULE:MG	ORAL	61.5MG ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
U725QWY32X	POVIDONE K30:ORAL:CAPSULE (IMMED./COMP. RELEASE), HARD GELATIN:MG	ORAL	16MG ORAL CAPSULE (IMMED./COMP. RELEASE), HARD GELATIN	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
U725QWY32X	POVIDONE K30:ORAL:CAPSULE, COATED, SOFT GELATIN:MG	ORAL	5MG ORAL CAPSULE, COATED, SOFT GELATIN	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
U725QWY32X	POVIDONE K30:ORAL:CAPSULE, DELAYED ACTION:MG	ORAL	12.38MG ORAL CAPSULE, DELAYED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
U725QWY32X	POVIDONE K30:ORAL:CAPSULE, DELAYED RELEASE:MG	ORAL	8.06MG ORAL CAPSULE, DELAYED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
U725QWY32X	POVIDONE K30:ORAL:CAPSULE, EXTENDED RELEASE:MG	ORAL	82.18MG ORAL CAPSULE, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
U725QWY32X	POVIDONE K30:ORAL:CAPSULE, SOFT GELATIN:MG	ORAL	30MG ORAL CAPSULE, SOFT GELATIN	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
U725QWY32X	POVIDONE K30:ORAL:CAPSULE, SOFT GELATIN LIQUID-FILLED:MG	ORAL	25.2MG ORAL CAPSULE, SOFT GELATIN LIQUID-FILLED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
U725QWY32X	POVIDONE K30:ORAL:CAPSULE, SUSTAINED ACTION:MG	ORAL	10.05MG ORAL CAPSULE, SUSTAINED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
U725QWY32X	POVIDONE K30:ORAL:CAPSULE, SUSTAINED ACTION, HARD GELATIN:MG	ORAL	41.7MG ORAL CAPSULE, SUSTAINED ACTION, HARD GELATIN	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
U725QWY32X	POVIDONE K30:ORAL:DISPERSIBLE TABLET:MG	ORAL	84MG ORAL DISPERSIBLE TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
U725QWY32X	POVIDONE K30:ORAL:GRANULE:MG/1PKT	ORAL	201.63MG/1PKT ORAL GRANULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
U725QWY32X	POVIDONE K30:ORAL:GRANULE:mg	ORAL	16.4mg ORAL GRANULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
U725QWY32X	POVIDONE K30:ORAL:GRANULE, EFFERVESCENT:NA	ORAL	ORAL GRANULE, EFFERVESCENT	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
U725QWY32X	POVIDONE K30:ORAL:LIQUID:MG/1ML	ORAL	30MG/1ML ORAL LIQUID	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
U725QWY32X	POVIDONE K30:ORAL:LOZENGE:mg	ORAL	35mg ORAL LOZENGE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
U725QWY32X	POVIDONE K30:ORAL:PELLET:MG	ORAL	3MG ORAL PELLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
U725QWY32X	POVIDONE K30:ORAL:POWDER:MG/SACHET	ORAL	18MG/SACHET ORAL POWDER	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
U725QWY32X	POVIDONE K30:ORAL:POWDER FOR ORAL SOLUTION DOSAGE FORM:mg	ORAL	5mg ORAL POWDER FOR ORAL SOLUTION DOSAGE FORM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
U725QWY32X	POVIDONE K30:ORAL:POWDER, FOR ORAL SOLUTION:MG	ORAL	5MG ORAL POWDER, FOR ORAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
U725QWY32X	POVIDONE K30:ORAL:POWDER, FOR SUSPENSION:MG/5ML	ORAL	13MG/5ML ORAL POWDER, FOR SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
U725QWY32X	POVIDONE K30:ORAL:SOLUTION:MG/1ML	ORAL	30.5MG/1ML ORAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
U725QWY32X	POVIDONE K30:ORAL:SOLUTION:MG/SACHET	ORAL	5MG/SACHET ORAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
U725QWY32X	POVIDONE K30:ORAL:SUSPENSION:MG/5ML	ORAL	18.5MG/5ML ORAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
U725QWY32X	POVIDONE K30:ORAL:SUSPENSION, EXTENDED RELEASE:MG/ML	ORAL	1.03MG/ML ORAL SUSPENSION, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
U725QWY32X	POVIDONE K30:ORAL:TABLET:mg	ORAL	94mg ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
U725QWY32X	POVIDONE K30:ORAL:TABLET (IMMED./COMP. RELEASE), COATED:MG	ORAL	8MG ORAL TABLET (IMMED./COMP. RELEASE), COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
U725QWY32X	POVIDONE K30:ORAL:TABLET (IMMED./COMP. RELEASE), FILM COATED:MG	ORAL	12.5MG ORAL TABLET (IMMED./COMP. RELEASE), FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
U725QWY32X	POVIDONE K30:ORAL:TABLET (IMMED./COMP. RELEASE), UNCOATED, CHEWABLE:MG	ORAL	10MG ORAL TABLET (IMMED./COMP. RELEASE), UNCOATED, CHEWABLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
U725QWY32X	POVIDONE K30:ORAL:TABLET (IMMED./COMP. RELEASE), UNCOATED, EFFERVESCENT:MG	ORAL	40MG ORAL TABLET (IMMED./COMP. RELEASE), UNCOATED, EFFERVESCENT	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
U725QWY32X	POVIDONE K30:ORAL:TABLET, CHEWABLE:MG	ORAL	8.18MG ORAL TABLET, CHEWABLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
U725QWY32X	POVIDONE K30:ORAL:TABLET, COATED:MG	ORAL	21MG ORAL TABLET, COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
U725QWY32X	POVIDONE K30:ORAL:TABLET, CONTROLLED RELEASE:MG	ORAL	20.5MG ORAL TABLET, CONTROLLED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
U725QWY32X	POVIDONE K30:ORAL:TABLET, DELAYED ACTION:MG	ORAL	50MG ORAL TABLET, DELAYED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
U725QWY32X	POVIDONE K30:ORAL:TABLET, DELAYED ACTION, COATED:MG	ORAL	35MG ORAL TABLET, DELAYED ACTION, COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
U725QWY32X	POVIDONE K30:ORAL:TABLET, DELAYED ACTION, ENTERIC COATED:MG	ORAL	27.2MG ORAL TABLET, DELAYED ACTION, ENTERIC COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
U725QWY32X	POVIDONE K30:ORAL:TABLET, DELAYED RELEASE:MG	ORAL	40.11MG ORAL TABLET, DELAYED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
U725QWY32X	POVIDONE K30:ORAL:TABLET, DISPERSIBLE:MG	ORAL	3MG ORAL TABLET, DISPERSIBLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
U725QWY32X	POVIDONE K30:ORAL:TABLET, ENTERIC COATED PARTICLES:MG	ORAL	18.6MG ORAL TABLET, ENTERIC COATED PARTICLES	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
U725QWY32X	POVIDONE K30:ORAL:TABLET, EXTENDED RELEASE:mg	ORAL	90mg ORAL TABLET, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
U725QWY32X	POVIDONE K30:ORAL:TABLET, FILM COATED:MG	ORAL	75MG ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
U725QWY32X	POVIDONE K30:ORAL:TABLET, MULTILAYER, COATED:MG	ORAL	15MG ORAL TABLET, MULTILAYER, COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
U725QWY32X	POVIDONE K30:ORAL:TABLET, ORALLY DISINTEGRATING:MG	ORAL	35.71MG ORAL TABLET, ORALLY DISINTEGRATING	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
U725QWY32X	POVIDONE K30:ORAL:TABLET, SUSTAINED ACTION:MG	ORAL	60MG ORAL TABLET, SUSTAINED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
U725QWY32X	POVIDONE K30:ORAL:TABLET, SUSTAINED ACTION, COATED:MG	ORAL	16MG ORAL TABLET, SUSTAINED ACTION, COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
U725QWY32X	POVIDONE K30:SUBLINGUAL:FILM:mg	SUBLINGUAL	2.3mg SUBLINGUAL FILM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
U725QWY32X	POVIDONE K30:SUBLINGUAL:TABLET:MG	SUBLINGUAL	10MG SUBLINGUAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
U725QWY32X	POVIDONE K30:SUBLINGUAL:TABLET (IMMED./COMP. RELEASE), UNCOATED, BUCCAL:MG	SUBLINGUAL	8MG SUBLINGUAL TABLET (IMMED./COMP. RELEASE), UNCOATED, BUCCAL	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
U725QWY32X	POVIDONE K30:TOPICAL:EMULSION, AEROSOL FOAM:%W/W	TOPICAL	1.9%W/W TOPICAL EMULSION, AEROSOL FOAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
U725QWY32X	POVIDONE K30:TOPICAL:PATCH, CONTROLLED RELEASE:NA	TOPICAL	TOPICAL PATCH, CONTROLLED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
U725QWY32X	POVIDONE K30:TRANSDERMAL:FILM:MG	TRANSDERMAL	5.11MG TRANSDERMAL FILM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
U725QWY32X	POVIDONE K30:TRANSDERMAL:FILM, CONTROLLED RELEASE:MG	TRANSDERMAL	7.27MG TRANSDERMAL FILM, CONTROLLED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
U725QWY32X	POVIDONE K30:TRANSDERMAL:PATCH:MG	TRANSDERMAL	5.695MG TRANSDERMAL PATCH	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
U725QWY32X	POVIDONE K30:VAGINAL:TABLET:MG	VAGINAL	50MG VAGINAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
58779NIC8P	HYPROMELLOSE 2208 (4 MPA.S):ORAL:TABLET, EXTENDED RELEASE:mg	ORAL	130mg ORAL TABLET, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
58779NIC8P	HYPROMELLOSE 2208 (4 MPA.S):SUBLINGUAL:TABLET:mg	SUBLINGUAL	0.22mg SUBLINGUAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
Z0H242BBR1	ASPARTAME:BUCCAL:PATCH, CONTROLLED RELEASE:MG	BUCCAL	1.1MG BUCCAL PATCH, CONTROLLED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
Z0H242BBR1	ASPARTAME:ORAL:CAPSULE:MG	ORAL	0.8MG ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
Z0H242BBR1	ASPARTAME:ORAL:GRANULE, EFFERVESCENT:NA	ORAL	ORAL GRANULE, EFFERVESCENT	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
Z0H242BBR1	ASPARTAME:ORAL:GRANULE, FOR SUSPENSION:MG	ORAL	35MG ORAL GRANULE, FOR SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
Z0H242BBR1	ASPARTAME:ORAL:POWDER:MG/1PKT	ORAL	450MG/1PKT ORAL POWDER	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
Z0H242BBR1	ASPARTAME:ORAL:POWDER, FOR ORAL SOLUTION:MG	ORAL	233MG ORAL POWDER, FOR ORAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
Z0H242BBR1	ASPARTAME:ORAL:POWDER, FOR ORAL SOLUTION:G/16 OZ	ORAL	0.875G/16 OZ ORAL POWDER, FOR ORAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
Z0H242BBR1	ASPARTAME:ORAL:POWDER, FOR ORAL SUSPENSION:MG/PKT	ORAL	50MG/PKT ORAL POWDER, FOR ORAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
Z0H242BBR1	ASPARTAME:ORAL:POWDER, FOR RECONSTITUTION:MG/5ML	ORAL	12.5MG/5ML ORAL POWDER, FOR RECONSTITUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
Z0H242BBR1	ASPARTAME:ORAL:POWDER, FOR SOLUTION:MG/100ML	ORAL	47MG/100ML ORAL POWDER, FOR SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
Z0H242BBR1	ASPARTAME:ORAL:POWDER, FOR SUSPENSION:MG/1SCP	ORAL	20MG/1SCP ORAL POWDER, FOR SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
Z0H242BBR1	ASPARTAME:ORAL:SOLUTION:MG	ORAL	40MG ORAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
Z0H242BBR1	ASPARTAME:ORAL:SUSPENSION:MG/5ML	ORAL	50MG/5ML ORAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
Z0H242BBR1	ASPARTAME:ORAL:SYRUP:MG/5ML	ORAL	0.63MG/5ML ORAL SYRUP	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
Z0H242BBR1	ASPARTAME:ORAL:TABLET:MG	ORAL	20MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
Z0H242BBR1	ASPARTAME:ORAL:TABLET (IMMED./COMP. RELEASE), FILM COATED:MG	ORAL	5.1MG ORAL TABLET (IMMED./COMP. RELEASE), FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
Z0H242BBR1	ASPARTAME:ORAL:TABLET (IMMED./COMP. RELEASE), UNCOATED, CHEWABLE:MG	ORAL	65MG ORAL TABLET (IMMED./COMP. RELEASE), UNCOATED, CHEWABLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
Z0H242BBR1	ASPARTAME:ORAL:TABLET (IMMED./COMP. RELEASE), UNCOATED, EFFERVESCENT:MG	ORAL	30MG ORAL TABLET (IMMED./COMP. RELEASE), UNCOATED, EFFERVESCENT	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
Z0H242BBR1	ASPARTAME:ORAL:TABLET, CHEWABLE:MG	ORAL	12MG ORAL TABLET, CHEWABLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
Z0H242BBR1	ASPARTAME:ORAL:TABLET, DISPERSIBLE:MG	ORAL	2.5MG ORAL TABLET, DISPERSIBLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
Z0H242BBR1	ASPARTAME:ORAL:TABLET, FILM COATED:MG	ORAL	20MG ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
Z0H242BBR1	ASPARTAME:ORAL:TABLET, FOR SUSPENSION:MG	ORAL	3.7MG ORAL TABLET, FOR SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
Z0H242BBR1	ASPARTAME:ORAL:TABLET, ORALLY DISINTEGRATING:MG	ORAL	40MG ORAL TABLET, ORALLY DISINTEGRATING	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
Z0H242BBR1	ASPARTAME:ORAL:TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE:MG	ORAL	13MG ORAL TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
Z0H242BBR1	ASPARTAME:ORAL:TROCHE:MG	ORAL	6.1MG ORAL TROCHE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
Z0H242BBR1	ASPARTAME:SUBLINGUAL:TABLET:MG	SUBLINGUAL	8MG SUBLINGUAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
Z0H242BBR1	ASPARTAME:TRANSDERMAL:PATCH, ELECTRICALLY CONTROLLED:MG	TRANSDERMAL	9.5MG TRANSDERMAL PATCH, ELECTRICALLY CONTROLLED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
1364PS73AF	ACETONE:IMPLANTATION:PELLET:NA	IMPLANTATION	IMPLANTATION PELLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
1364PS73AF	ACETONE:TOPICAL:LOTION:%W/W	TOPICAL	10%W/W TOPICAL LOTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
1364PS73AF	ACETONE:TOPICAL:SHAMPOO:%W/W	TOPICAL	12%W/W TOPICAL SHAMPOO	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
1364PS73AF	ACETONE:TOPICAL:SOLUTION:%W/W	TOPICAL	12.69%W/W TOPICAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
0DE9724IHC	PROTAMINE SULFATE:IM - SC:INJECTION:NA	IM - SC	IM - SC INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
0DE9724IHC	PROTAMINE SULFATE:INTRADERMAL:INJECTION:%	INTRADERMAL	0.13% INTRADERMAL INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
0DE9724IHC	PROTAMINE SULFATE:SUBCUTANEOUS:INJECTION:%	SUBCUTANEOUS	0.036% SUBCUTANEOUS INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
0DE9724IHC	PROTAMINE SULFATE:SUBCUTANEOUS:SUSPENSION:%	SUBCUTANEOUS	0.028% SUBCUTANEOUS SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
0DE9724IHC	PROTAMINE SULFATE:SUBCUTANEOUS:SUSPENSION, INJECTION:%	SUBCUTANEOUS	0.028% SUBCUTANEOUS SUSPENSION, INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
MTK99R3UV0	METAPHOSPHORIC ACID:IV(INFUSION):INJECTION:%	IV(INFUSION)	0.13% IV(INFUSION) INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
MTK99R3UV0	METAPHOSPHORIC ACID:ORAL:CAPSULE:NA	ORAL	ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
7FLD91C86K	EDETATE DISODIUM:AN,INFILTRATION:INJECTION:%	AN,INFILTRATION	0.011% AN,INFILTRATION INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
7FLD91C86K	EDETATE DISODIUM:AN,INFILTRATION:SOLUTION, INJECTION:NA	AN,INFILTRATION	AN,INFILTRATION SOLUTION, INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
7FLD91C86K	EDETATE DISODIUM:AURICULAR (OTIC):SOLUTION:%	AURICULAR (OTIC)	0.1% AURICULAR (OTIC) SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
7FLD91C86K	EDETATE DISODIUM:AURICULAR (OTIC):SUSPENSION:NA	AURICULAR (OTIC)	AURICULAR (OTIC) SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
7FLD91C86K	EDETATE DISODIUM:CAUDAL BLOCK:INJECTION:NA	CAUDAL BLOCK	CAUDAL BLOCK INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
7FLD91C86K	EDETATE DISODIUM:EPIDURAL:INJECTION:%	EPIDURAL	0.011% EPIDURAL INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
7FLD91C86K	EDETATE DISODIUM:IM - IV:INJECTABLE:%	IM - IV	0.05% IM - IV INJECTABLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
7FLD91C86K	EDETATE DISODIUM:IM - IV:INJECTION:%	IM - IV	0.05% IM - IV INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
7FLD91C86K	EDETATE DISODIUM:IM - IV:LIQUID, WATER, STERILE, FOR INJECTION:%	IM - IV	0.01% IM - IV LIQUID, WATER, STERILE, FOR INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
7FLD91C86K	EDETATE DISODIUM:IM - IV:SOLUTION, INJECTION:%	IM - IV	0.05% IM - IV SOLUTION, INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
7FLD91C86K	EDETATE DISODIUM:IM - IV - SC:INJECTION:%	IM - IV - SC	0.2% IM - IV - SC INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
7FLD91C86K	EDETATE DISODIUM:IM - SC:INJECTION:%	IM - SC	0.2% IM - SC INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
7FLD91C86K	EDETATE DISODIUM:INHALATION:SOLUTION:%W/V	INHALATION	0.05%W/V INHALATION SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
7FLD91C86K	EDETATE DISODIUM:INHALATION:SOLUTION, FOR INHALATION:%	INHALATION	0.005% INHALATION SOLUTION, FOR INHALATION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
7FLD91C86K	EDETATE DISODIUM:INHALATION:SUSPENSION:mg/2mL	INHALATION	0.19mg/2mL INHALATION SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
7FLD91C86K	EDETATE DISODIUM:INHALATION:SUSPENSION, FOR INHALATION:%	INHALATION	0.01% INHALATION SUSPENSION, FOR INHALATION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
7FLD91C86K	EDETATE DISODIUM:INTRA-ARTERIAL:INJECTION:NA	INTRA-ARTERIAL	INTRA-ARTERIAL INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
7FLD91C86K	EDETATE DISODIUM:INTRA-ARTICULAR:INJECTABLE:%	INTRA-ARTICULAR	0.01% INTRA-ARTICULAR INJECTABLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
7FLD91C86K	EDETATE DISODIUM:INTRA-ARTICULAR:INJECTION:%	INTRA-ARTICULAR	0.05% INTRA-ARTICULAR INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
7FLD91C86K	EDETATE DISODIUM:INTRA-ARTICULAR:INJECTION, SUSTAINED ACTION:NA	INTRA-ARTICULAR	INTRA-ARTICULAR INJECTION, SUSTAINED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
7FLD91C86K	EDETATE DISODIUM:INTRABURSAL:INJECTION:%	INTRABURSAL	0.01% INTRABURSAL INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
7FLD91C86K	EDETATE DISODIUM:INTRACARDIAC:INJECTION:mg/1mL	INTRACARDIAC	0.2mg/1mL INTRACARDIAC INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
7FLD91C86K	EDETATE DISODIUM:INTRACAVITARY:INJECTION:NA	INTRACAVITARY	INTRACAVITARY INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
7FLD91C86K	EDETATE DISODIUM:INTRADERMAL:INJECTION:NA	INTRADERMAL	INTRADERMAL INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
7FLD91C86K	EDETATE DISODIUM:INTRADERMAL:INJECTION, SUSTAINED ACTION:NA	INTRADERMAL	INTRADERMAL INJECTION, SUSTAINED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
7FLD91C86K	EDETATE DISODIUM:INTRADISCAL:POWDER, FOR INJECTION SOLUTION:NA	INTRADISCAL	INTRADISCAL POWDER, FOR INJECTION SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
7FLD91C86K	EDETATE DISODIUM:INTRALESIONAL:INJECTABLE:%	INTRALESIONAL	0.01% INTRALESIONAL INJECTABLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
7FLD91C86K	EDETATE DISODIUM:INTRALESIONAL:INJECTION:%	INTRALESIONAL	0.05% INTRALESIONAL INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
7FLD91C86K	EDETATE DISODIUM:INTRALESIONAL:INJECTION, SUSTAINED ACTION:NA	INTRALESIONAL	INTRALESIONAL INJECTION, SUSTAINED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
7FLD91C86K	EDETATE DISODIUM:INTRAMUSCULAR:INJECTABLE:%W/V	INTRAMUSCULAR	0.01%W/V INTRAMUSCULAR INJECTABLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
7FLD91C86K	EDETATE DISODIUM:INTRAMUSCULAR:INJECTION:%W/V	INTRAMUSCULAR	10%W/V INTRAMUSCULAR INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
7FLD91C86K	EDETATE DISODIUM:INTRAMUSCULAR:INJECTION, SOLUTION:%	INTRAMUSCULAR	0.02% INTRAMUSCULAR INJECTION, SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
7FLD91C86K	EDETATE DISODIUM:INTRAMUSCULAR:INJECTION, SUSTAINED ACTION:NA	INTRAMUSCULAR	INTRAMUSCULAR INJECTION, SUSTAINED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
7FLD91C86K	EDETATE DISODIUM:INTRAMUSCULAR:SOLUTION, INJECTION:%W/V	INTRAMUSCULAR	0.1%W/V INTRAMUSCULAR SOLUTION, INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
7FLD91C86K	EDETATE DISODIUM:INTRASYNOVIAL:INJECTION:NA	INTRASYNOVIAL	INTRASYNOVIAL INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
7FLD91C86K	EDETATE DISODIUM:INTRASYNOVIAL:INJECTION, SUSTAINED ACTION:NA	INTRASYNOVIAL	INTRASYNOVIAL INJECTION, SUSTAINED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
7FLD91C86K	EDETATE DISODIUM:INTRAUTERINE:SOLUTION:NA	INTRAUTERINE	INTRAUTERINE SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
7FLD91C86K	EDETATE DISODIUM:INTRAVASCULAR:INJECTION:%	INTRAVASCULAR	0.04% INTRAVASCULAR INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
7FLD91C86K	EDETATE DISODIUM:INTRAVENOUS:EMULSION, INJECTION:%	INTRAVENOUS	0.005% INTRAVENOUS EMULSION, INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
7FLD91C86K	EDETATE DISODIUM:INTRAVENOUS:INFUSION:%	INTRAVENOUS	0.01% INTRAVENOUS INFUSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
7FLD91C86K	EDETATE DISODIUM:INTRAVENOUS:INJECTABLE:mg/mL	INTRAVENOUS	1.1mg/mL INTRAVENOUS INJECTABLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
7FLD91C86K	EDETATE DISODIUM:INTRAVENOUS:INJECTION:%	INTRAVENOUS	10% INTRAVENOUS INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
7FLD91C86K	EDETATE DISODIUM:INTRAVENOUS:INJECTION, SOLUTION:MG/1ML	INTRAVENOUS	0.25MG/1ML INTRAVENOUS INJECTION, SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
7FLD91C86K	EDETATE DISODIUM:INTRAVENOUS:INJECTION, SOLUTION:%	INTRAVENOUS	0.01% INTRAVENOUS INJECTION, SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
7FLD91C86K	EDETATE DISODIUM:INTRAVENOUS:LIQUID, WATER, STERILE, FOR INJECTION:MG/1ML	INTRAVENOUS	0.5MG/1ML INTRAVENOUS LIQUID, WATER, STERILE, FOR INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
7FLD91C86K	EDETATE DISODIUM:INTRAVENOUS:POWDER, FOR INJECTION SOLUTION:%	INTRAVENOUS	0.1% INTRAVENOUS POWDER, FOR INJECTION SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
7FLD91C86K	EDETATE DISODIUM:INTRAVENOUS:POWDER, FOR INJECTION SOLUTION, LYOPHILIZED:%	INTRAVENOUS	1.88% INTRAVENOUS POWDER, FOR INJECTION SOLUTION, LYOPHILIZED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
7FLD91C86K	EDETATE DISODIUM:INTRAVENOUS:SOLUTION:%	INTRAVENOUS	0.05% INTRAVENOUS SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
7FLD91C86K	EDETATE DISODIUM:INTRAVENOUS:SOLUTION, INJECTION:%	INTRAVENOUS	0.11% INTRAVENOUS SOLUTION, INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
7FLD91C86K	EDETATE DISODIUM:IONTOPHORESIS:PATCH, CONTROLLED RELEASE:MG	IONTOPHORESIS	0.1MG IONTOPHORESIS PATCH, CONTROLLED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
7FLD91C86K	EDETATE DISODIUM:IV - SC:SOLUTION, INJECTION:%	IV - SC	0.02% IV - SC SOLUTION, INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
7FLD91C86K	EDETATE DISODIUM:IV(INFUSION):EMULSION, INJECTION:%	IV(INFUSION)	0.05% IV(INFUSION) EMULSION, INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
7FLD91C86K	EDETATE DISODIUM:IV(INFUSION):INJECTABLE:%	IV(INFUSION)	0.02% IV(INFUSION) INJECTABLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
7FLD91C86K	EDETATE DISODIUM:IV(INFUSION):INJECTION:%	IV(INFUSION)	1% IV(INFUSION) INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
7FLD91C86K	EDETATE DISODIUM:IV(INFUSION):POWDER, FOR INJECTION SOLUTION, LYOPHILIZED:%	IV(INFUSION)	1.88% IV(INFUSION) POWDER, FOR INJECTION SOLUTION, LYOPHILIZED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
7FLD91C86K	EDETATE DISODIUM:IV(INFUSION):POWDER, FOR INJECTION SUSPENSION, LYOPHILIZED:%	IV(INFUSION)	0.04% IV(INFUSION) POWDER, FOR INJECTION SUSPENSION, LYOPHILIZED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
7FLD91C86K	EDETATE DISODIUM:IV(INFUSION):SOLUTION, INJECTION:%	IV(INFUSION)	0.04% IV(INFUSION) SOLUTION, INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
7FLD91C86K	EDETATE DISODIUM:NASAL:SOLUTION:%	NASAL	0.1% NASAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
7FLD91C86K	EDETATE DISODIUM:NASAL:SOLUTION, SPRAY:%	NASAL	0.05% NASAL SOLUTION, SPRAY	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
7FLD91C86K	EDETATE DISODIUM:NASAL:SOLUTION, SPRAY, METERED, PUMP:%	NASAL	0.007% NASAL SOLUTION, SPRAY, METERED, PUMP	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
7FLD91C86K	EDETATE DISODIUM:NASAL:SPRAY:%	NASAL	0.1% NASAL SPRAY	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
7FLD91C86K	EDETATE DISODIUM:NASAL:SPRAY, METERED:%	NASAL	0.5% NASAL SPRAY, METERED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
7FLD91C86K	EDETATE DISODIUM:NERVE BLOCK:INJECTION:%	NERVE BLOCK	0.011% NERVE BLOCK INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
7FLD91C86K	EDETATE DISODIUM:NERVE BLOCK:SOLUTION, INJECTION:NA	NERVE BLOCK	NERVE BLOCK SOLUTION, INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
7FLD91C86K	EDETATE DISODIUM:OPHTHALMIC:DROPS:%	OPHTHALMIC	0.05% OPHTHALMIC DROPS	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
7FLD91C86K	EDETATE DISODIUM:OPHTHALMIC:EMULSION:%W/V	OPHTHALMIC	0.3%W/V OPHTHALMIC EMULSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
7FLD91C86K	EDETATE DISODIUM:OPHTHALMIC:GEL:%	OPHTHALMIC	0.055% OPHTHALMIC GEL	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
7FLD91C86K	EDETATE DISODIUM:OPHTHALMIC:SOLUTION:%	OPHTHALMIC	0.5% OPHTHALMIC SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
7FLD91C86K	EDETATE DISODIUM:OPHTHALMIC:SOLUTION, DROPS:%W/W	OPHTHALMIC	0.02%W/W OPHTHALMIC SOLUTION, DROPS	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
7FLD91C86K	EDETATE DISODIUM:OPHTHALMIC:SOLUTION/ DROPS:MG/1ML	OPHTHALMIC	0.1MG/1ML OPHTHALMIC SOLUTION/ DROPS	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
7FLD91C86K	EDETATE DISODIUM:OPHTHALMIC:SOLUTION/DROPS:%	OPHTHALMIC	0.015% OPHTHALMIC SOLUTION/DROPS	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
7FLD91C86K	EDETATE DISODIUM:OPHTHALMIC:SUSPENSION:%	OPHTHALMIC	0.13% OPHTHALMIC SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
7FLD91C86K	EDETATE DISODIUM:OPHTHALMIC:SUSPENSION, DROPS:%	OPHTHALMIC	0.1% OPHTHALMIC SUSPENSION, DROPS	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
7FLD91C86K	EDETATE DISODIUM:ORAL:CAPSULE:MG	ORAL	1MG ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
7FLD91C86K	EDETATE DISODIUM:ORAL:CAPSULE (IMMED./COMP. RELEASE):MG	ORAL	1MG ORAL CAPSULE (IMMED./COMP. RELEASE)	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
7FLD91C86K	EDETATE DISODIUM:ORAL:CAPSULE, SOFT GELATIN:MG	ORAL	1MG ORAL CAPSULE, SOFT GELATIN	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
7FLD91C86K	EDETATE DISODIUM:ORAL:CONCENTRATE:MG/1ML	ORAL	3MG/1ML ORAL CONCENTRATE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
7FLD91C86K	EDETATE DISODIUM:ORAL:EMULSION:NA	ORAL	ORAL EMULSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
7FLD91C86K	EDETATE DISODIUM:ORAL:LIQUID:MG/1ML	ORAL	0.5MG/1ML ORAL LIQUID	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
7FLD91C86K	EDETATE DISODIUM:ORAL:POWDER, FOR SOLUTION:NA	ORAL	ORAL POWDER, FOR SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
7FLD91C86K	EDETATE DISODIUM:ORAL:POWDER, FOR SUSPENSION:MG/5ML	ORAL	3MG/5ML ORAL POWDER, FOR SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
7FLD91C86K	EDETATE DISODIUM:ORAL:SOLUTION:MG/160ML	ORAL	210MG/160ML ORAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
7FLD91C86K	EDETATE DISODIUM:ORAL:SOLUTION:MG/5ML	ORAL	5.53MG/5ML ORAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
7FLD91C86K	EDETATE DISODIUM:ORAL:SOLUTION, ELIXIR:%	ORAL	0.005% ORAL SOLUTION, ELIXIR	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
7FLD91C86K	EDETATE DISODIUM:ORAL:SOLUTION, FOR INHALATION:MG/.5ML	ORAL	0.055MG/.5ML ORAL SOLUTION, FOR INHALATION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
7FLD91C86K	EDETATE DISODIUM:ORAL:SOLUTION/DROPS:%W/V	ORAL	0.1%W/V ORAL SOLUTION/DROPS	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
7FLD91C86K	EDETATE DISODIUM:ORAL:SUSPENSION:MG/5ML	ORAL	7.5MG/5ML ORAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
7FLD91C86K	EDETATE DISODIUM:ORAL:SUSPENSION, DROPS:MG/2.5ML	ORAL	1MG/2.5ML ORAL SUSPENSION, DROPS	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
7FLD91C86K	EDETATE DISODIUM:ORAL:SUSPENSION, EXTENDED RELEASE:MG/5ML	ORAL	10MG/5ML ORAL SUSPENSION, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
7FLD91C86K	EDETATE DISODIUM:ORAL:SUSPENSION, FOR INHALATION:MG/2ML	ORAL	0.2MG/2ML ORAL SUSPENSION, FOR INHALATION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
7FLD91C86K	EDETATE DISODIUM:ORAL:SUSPENSION, SYRUP, SUSTAINED ACTION:%	ORAL	0.01% ORAL SUSPENSION, SYRUP, SUSTAINED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
7FLD91C86K	EDETATE DISODIUM:ORAL:SYRUP:MG/5ML	ORAL	25MG/5ML ORAL SYRUP	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
7FLD91C86K	EDETATE DISODIUM:ORAL:TABLET:MG	ORAL	4MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
7FLD91C86K	EDETATE DISODIUM:ORAL:TABLET (IMMED./COMP. RELEASE), UNCOATED, CHEWABLE:MG	ORAL	0.25MG ORAL TABLET (IMMED./COMP. RELEASE), UNCOATED, CHEWABLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
7FLD91C86K	EDETATE DISODIUM:ORAL:TABLET, COATED:MG	ORAL	0.21MG ORAL TABLET, COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
7FLD91C86K	EDETATE DISODIUM:ORAL:TABLET, DELAYED ACTION:MG	ORAL	100MG ORAL TABLET, DELAYED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
7FLD91C86K	EDETATE DISODIUM:ORAL:TABLET, DELAYED ACTION, ENTERIC COATED:MG	ORAL	100MG ORAL TABLET, DELAYED ACTION, ENTERIC COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
7FLD91C86K	EDETATE DISODIUM:ORAL:TABLET, EFFERVESCENT, FOR SOLUTION:MG	ORAL	0.9MG ORAL TABLET, EFFERVESCENT, FOR SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
7FLD91C86K	EDETATE DISODIUM:ORAL:TABLET, EXTENDED RELEASE:MG	ORAL	5MG ORAL TABLET, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
7FLD91C86K	EDETATE DISODIUM:ORAL:TABLET, FILM COATED:MG	ORAL	4MG ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
7FLD91C86K	EDETATE DISODIUM:ORAL:TABLET, ORALLY DISINTEGRATING:MG	ORAL	3MG ORAL TABLET, ORALLY DISINTEGRATING	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
7FLD91C86K	EDETATE DISODIUM:OTIC:SUSPENSION:%	OTIC	0.01% OTIC SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
7FLD91C86K	EDETATE DISODIUM:RECTAL:EMULSION, AEROSOL FOAM:%	RECTAL	0.085% RECTAL EMULSION, AEROSOL FOAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
7FLD91C86K	EDETATE DISODIUM:RECTAL:ENEMA:%	RECTAL	0.1% RECTAL ENEMA	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
7FLD91C86K	EDETATE DISODIUM:RECTAL:SOLUTION:%	RECTAL	0.04% RECTAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
7FLD91C86K	EDETATE DISODIUM:RESPIRATORY (INHALATION):INHALANT:%	RESPIRATORY (INHALATION)	0.011% RESPIRATORY (INHALATION) INHALANT	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
7FLD91C86K	EDETATE DISODIUM:RESPIRATORY (INHALATION):SOLUTION:%	RESPIRATORY (INHALATION)	0.05% RESPIRATORY (INHALATION) SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
7FLD91C86K	EDETATE DISODIUM:RESPIRATORY (INHALATION):SOLUTION, FOR INHALATION:%	RESPIRATORY (INHALATION)	0.03% RESPIRATORY (INHALATION) SOLUTION, FOR INHALATION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
7FLD91C86K	EDETATE DISODIUM:RESPIRATORY (INHALATION):SPRAY:%	RESPIRATORY (INHALATION)	0.05% RESPIRATORY (INHALATION) SPRAY	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
7FLD91C86K	EDETATE DISODIUM:RESPIRATORY (INHALATION):SUSPENSION, FOR INHALATION:%	RESPIRATORY (INHALATION)	0.02% RESPIRATORY (INHALATION) SUSPENSION, FOR INHALATION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
7FLD91C86K	EDETATE DISODIUM:SOFT TISSUE:INJECTION:%	SOFT TISSUE	0.05% SOFT TISSUE INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
7FLD91C86K	EDETATE DISODIUM:SUBCUTANEOUS:INJECTABLE:%	SUBCUTANEOUS	0.1% SUBCUTANEOUS INJECTABLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
7FLD91C86K	EDETATE DISODIUM:SUBCUTANEOUS:INJECTION:%	SUBCUTANEOUS	0.2% SUBCUTANEOUS INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
7FLD91C86K	EDETATE DISODIUM:SUBCUTANEOUS:INJECTION, SOLUTION:%	SUBCUTANEOUS	0.02% SUBCUTANEOUS INJECTION, SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
7FLD91C86K	EDETATE DISODIUM:SUBCUTANEOUS:SOLUTION, INJECTION:%	SUBCUTANEOUS	0.11% SUBCUTANEOUS SOLUTION, INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
7FLD91C86K	EDETATE DISODIUM:TOPICAL:CREAM:%W/W	TOPICAL	0.05%W/W TOPICAL CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
7FLD91C86K	EDETATE DISODIUM:TOPICAL:CREAM, AUGMENTED:%W/W	TOPICAL	0.1%W/W TOPICAL CREAM, AUGMENTED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
7FLD91C86K	EDETATE DISODIUM:TOPICAL:CREAM, EMULSION, SUSTAINED RELEASE:%W/W	TOPICAL	0.05%W/W TOPICAL CREAM, EMULSION, SUSTAINED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
7FLD91C86K	EDETATE DISODIUM:TOPICAL:DROPS:%W/V	TOPICAL	0.05%W/V TOPICAL DROPS	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
7FLD91C86K	EDETATE DISODIUM:TOPICAL:EMULSION:%W/W	TOPICAL	0.11%W/W TOPICAL EMULSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
7FLD91C86K	EDETATE DISODIUM:TOPICAL:EMULSION, AEROSOL FOAM:%W/W	TOPICAL	0.05%W/W TOPICAL EMULSION, AEROSOL FOAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
7FLD91C86K	EDETATE DISODIUM:TOPICAL:EMULSION, CREAM:%W/W	TOPICAL	0.1%W/W TOPICAL EMULSION, CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
7FLD91C86K	EDETATE DISODIUM:TOPICAL:FILM, CONTROLLED RELEASE:MG	TOPICAL	14MG TOPICAL FILM, CONTROLLED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
7FLD91C86K	EDETATE DISODIUM:TOPICAL:GEL:%W/W	TOPICAL	0.17%W/W TOPICAL GEL	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
7FLD91C86K	EDETATE DISODIUM:TOPICAL:LOTION:%W/V	TOPICAL	0.12%W/V TOPICAL LOTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
7FLD91C86K	EDETATE DISODIUM:TOPICAL:OINTMENT:%W/W	TOPICAL	0.007%W/W TOPICAL OINTMENT	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
7FLD91C86K	EDETATE DISODIUM:TOPICAL:OPHTHALMIC SUSPENSION DOSAGE FORM:%W/V	TOPICAL	0.06%W/V TOPICAL OPHTHALMIC SUSPENSION DOSAGE FORM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
7FLD91C86K	EDETATE DISODIUM:TOPICAL:PATCH:MG	TOPICAL	7MG TOPICAL PATCH	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
7FLD91C86K	EDETATE DISODIUM:TOPICAL:PATCH, CONTROLLED RELEASE:NA	TOPICAL	TOPICAL PATCH, CONTROLLED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
7FLD91C86K	EDETATE DISODIUM:TOPICAL:POWDER, FOR SOLUTION:NA	TOPICAL	TOPICAL POWDER, FOR SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
7FLD91C86K	EDETATE DISODIUM:TOPICAL:SOLUTION, DROPS:%W/V	TOPICAL	0.05%W/V TOPICAL SOLUTION, DROPS	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
7FLD91C86K	EDETATE DISODIUM:TOPICAL:SOLUTION/DROPS:%W/V	TOPICAL	0.01%W/V TOPICAL SOLUTION/DROPS	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
7FLD91C86K	EDETATE DISODIUM:TOPICAL:SUSPENSION:NA	TOPICAL	TOPICAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
7FLD91C86K	EDETATE DISODIUM:TOPICAL:SUSPENSION, DROPS:%W/W	TOPICAL	0.1%W/W TOPICAL SUSPENSION, DROPS	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
7FLD91C86K	EDETATE DISODIUM:TRANSDERMAL:GEL:%	TRANSDERMAL	0.06% TRANSDERMAL GEL	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
7FLD91C86K	EDETATE DISODIUM:URETERAL:SOLUTION:NA	URETERAL	URETERAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
7FLD91C86K	EDETATE DISODIUM:URETHRAL:SOLUTION:NA	URETHRAL	URETHRAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
7FLD91C86K	EDETATE DISODIUM:VAGINAL:CREAM:%W/W	VAGINAL	0.05%W/W VAGINAL CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
7FLD91C86K	EDETATE DISODIUM:VAGINAL:CREAM, EMULSION, SUSTAINED RELEASE:%	VAGINAL	0.05% VAGINAL CREAM, EMULSION, SUSTAINED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
7FLD91C86K	EDETATE DISODIUM:VAGINAL:EMULSION, CREAM:%	VAGINAL	0.05% VAGINAL EMULSION, CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
7FLD91C86K	EDETATE DISODIUM:VAGINAL:GEL:%	VAGINAL	0.05% VAGINAL GEL	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
113C650IR1	TRICHLOROETHANE:ORAL:TABLET:NA	ORAL	ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
113C650IR1	TRICHLOROETHANE:ORAL:TABLET, COATED:NA	ORAL	ORAL TABLET, COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
K679OBS311	CARBOXYMETHYLCELLULOSE SODIUM:INTRA-ARTICULAR:INJECTION:%	INTRA-ARTICULAR	0.75% INTRA-ARTICULAR INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
K679OBS311	CARBOXYMETHYLCELLULOSE SODIUM:INTRAMUSCULAR:INJECTION:%	INTRAMUSCULAR	0.75% INTRAMUSCULAR INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
K679OBS311	CARBOXYMETHYLCELLULOSE SODIUM:ORAL:TABLET, DELAYED RELEASE:mg	ORAL	36mg ORAL TABLET, DELAYED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
K679OBS311	CARBOXYMETHYLCELLULOSE SODIUM:ORAL:TABLET, EXTENDED RELEASE:mg	ORAL	40mg ORAL TABLET, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
K679OBS311	CARBOXYMETHYLCELLULOSE SODIUM :ORAL:TABLET:mg	ORAL	105mg ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
K679OBS311	CARBOXYMETHYLCELLULOSE SODIUM, UNSPECIFIED FORM:DENTAL:GEL:%	DENTAL	0.4% DENTAL GEL	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
K679OBS311	CARBOXYMETHYLCELLULOSE SODIUM, UNSPECIFIED FORM:DENTAL:PASTE:MG	DENTAL	174MG DENTAL PASTE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
K679OBS311	CARBOXYMETHYLCELLULOSE SODIUM, UNSPECIFIED FORM:ENTERAL:SUSPENSION:MG/ML	ENTERAL	29.2MG/ML ENTERAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
K679OBS311	CARBOXYMETHYLCELLULOSE SODIUM, UNSPECIFIED FORM:IM - IV:INJECTION:NA	IM - IV	IM - IV INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
K679OBS311	CARBOXYMETHYLCELLULOSE SODIUM, UNSPECIFIED FORM:INTRA-ARTICULAR:INJECTABLE:%	INTRA-ARTICULAR	0.75% INTRA-ARTICULAR INJECTABLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
K679OBS311	CARBOXYMETHYLCELLULOSE SODIUM, UNSPECIFIED FORM:INTRA-ARTICULAR:INJECTION:%	INTRA-ARTICULAR	0.76% INTRA-ARTICULAR INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
K679OBS311	CARBOXYMETHYLCELLULOSE SODIUM, UNSPECIFIED FORM:INTRA-ARTICULAR:INJECTION, SUSPENSION, EXTENDED RELEASE:MG	INTRA-ARTICULAR	25MG INTRA-ARTICULAR INJECTION, SUSPENSION, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
K679OBS311	CARBOXYMETHYLCELLULOSE SODIUM, UNSPECIFIED FORM:INTRA-ARTICULAR:INJECTION, SUSTAINED ACTION:NA	INTRA-ARTICULAR	INTRA-ARTICULAR INJECTION, SUSTAINED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
K679OBS311	CARBOXYMETHYLCELLULOSE SODIUM, UNSPECIFIED FORM:INTRABURSAL:INJECTION:%	INTRABURSAL	0.76% INTRABURSAL INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
K679OBS311	CARBOXYMETHYLCELLULOSE SODIUM, UNSPECIFIED FORM:INTRADERMAL:INJECTION:NA	INTRADERMAL	INTRADERMAL INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
K679OBS311	CARBOXYMETHYLCELLULOSE SODIUM, UNSPECIFIED FORM:INTRADERMAL:INJECTION, SUSTAINED ACTION:NA	INTRADERMAL	INTRADERMAL INJECTION, SUSTAINED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
K679OBS311	CARBOXYMETHYLCELLULOSE SODIUM, UNSPECIFIED FORM:INTRALESIONAL:INJECTION:NA	INTRALESIONAL	INTRALESIONAL INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
K679OBS311	CARBOXYMETHYLCELLULOSE SODIUM, UNSPECIFIED FORM:INTRALESIONAL:INJECTION, SUSTAINED ACTION:NA	INTRALESIONAL	INTRALESIONAL INJECTION, SUSTAINED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
K679OBS311	CARBOXYMETHYLCELLULOSE SODIUM, UNSPECIFIED FORM:INTRAMUSCULAR:INJECTABLE:mg	INTRAMUSCULAR	15mg INTRAMUSCULAR INJECTABLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
K679OBS311	CARBOXYMETHYLCELLULOSE SODIUM, UNSPECIFIED FORM:INTRAMUSCULAR:INJECTABLE:%W/V	INTRAMUSCULAR	0.75%W/V INTRAMUSCULAR INJECTABLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
K679OBS311	CARBOXYMETHYLCELLULOSE SODIUM, UNSPECIFIED FORM:INTRAMUSCULAR:INJECTION:mg	INTRAMUSCULAR	25mg INTRAMUSCULAR INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
K679OBS311	CARBOXYMETHYLCELLULOSE SODIUM, UNSPECIFIED FORM:INTRAMUSCULAR:INJECTION:%	INTRAMUSCULAR	3% INTRAMUSCULAR INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
K679OBS311	CARBOXYMETHYLCELLULOSE SODIUM, UNSPECIFIED FORM:INTRAMUSCULAR:INJECTION, MICROSPHERES:%	INTRAMUSCULAR	1% INTRAMUSCULAR INJECTION, MICROSPHERES	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
K679OBS311	CARBOXYMETHYLCELLULOSE SODIUM, UNSPECIFIED FORM:INTRAMUSCULAR:INJECTION, SUSTAINED ACTION:NA	INTRAMUSCULAR	INTRAMUSCULAR INJECTION, SUSTAINED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
K679OBS311	CARBOXYMETHYLCELLULOSE SODIUM, UNSPECIFIED FORM:INTRAMUSCULAR:POWDER, FOR INJECTION SOLUTION, LYOPHILIZED:%	INTRAMUSCULAR	3% INTRAMUSCULAR POWDER, FOR INJECTION SOLUTION, LYOPHILIZED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
K679OBS311	CARBOXYMETHYLCELLULOSE SODIUM, UNSPECIFIED FORM:INTRAMUSCULAR:POWDER, FOR INJECTION SUSPENSION:%W/V	INTRAMUSCULAR	0.7%W/V INTRAMUSCULAR POWDER, FOR INJECTION SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
K679OBS311	CARBOXYMETHYLCELLULOSE SODIUM, UNSPECIFIED FORM:INTRASYNOVIAL:INJECTION:%	INTRASYNOVIAL	0.1% INTRASYNOVIAL INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
K679OBS311	CARBOXYMETHYLCELLULOSE SODIUM, UNSPECIFIED FORM:INTRASYNOVIAL:INJECTION, SUSTAINED ACTION:NA	INTRASYNOVIAL	INTRASYNOVIAL INJECTION, SUSTAINED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
K679OBS311	CARBOXYMETHYLCELLULOSE SODIUM, UNSPECIFIED FORM:INTRATRACHEAL:SUSPENSION:NA	INTRATRACHEAL	INTRATRACHEAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
K679OBS311	CARBOXYMETHYLCELLULOSE SODIUM, UNSPECIFIED FORM:INTRAVITREAL:SUSPENSION, INJECTION:%	INTRAVITREAL	0.5% INTRAVITREAL SUSPENSION, INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
K679OBS311	CARBOXYMETHYLCELLULOSE SODIUM, UNSPECIFIED FORM:NASAL:SPRAY, METERED:%	NASAL	0.15% NASAL SPRAY, METERED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
K679OBS311	CARBOXYMETHYLCELLULOSE SODIUM, UNSPECIFIED FORM:OPHTHALMIC:SOLUTION:%	OPHTHALMIC	0.5% OPHTHALMIC SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
K679OBS311	CARBOXYMETHYLCELLULOSE SODIUM, UNSPECIFIED FORM:OPHTHALMIC:SOLUTION, DROPS:%	OPHTHALMIC	0.5% OPHTHALMIC SOLUTION, DROPS	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
K679OBS311	CARBOXYMETHYLCELLULOSE SODIUM, UNSPECIFIED FORM:ORAL:CAPSULE:MG	ORAL	160MG ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
K679OBS311	CARBOXYMETHYLCELLULOSE SODIUM, UNSPECIFIED FORM:ORAL:CAPSULE, DELAYED ACTION, COATED, HARD GELATIN:MG	ORAL	4MG ORAL CAPSULE, DELAYED ACTION, COATED, HARD GELATIN	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
K679OBS311	CARBOXYMETHYLCELLULOSE SODIUM, UNSPECIFIED FORM:ORAL:CAPSULE, ENTERIC COATED PELLETS:MG	ORAL	4.2MG ORAL CAPSULE, ENTERIC COATED PELLETS	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
K679OBS311	CARBOXYMETHYLCELLULOSE SODIUM, UNSPECIFIED FORM:ORAL:CAPSULE, HARD GELATIN:NA	ORAL	ORAL CAPSULE, HARD GELATIN	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
K679OBS311	CARBOXYMETHYLCELLULOSE SODIUM, UNSPECIFIED FORM:ORAL:CAPSULE, SUSTAINED ACTION:MG	ORAL	0.47MG ORAL CAPSULE, SUSTAINED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
K679OBS311	CARBOXYMETHYLCELLULOSE SODIUM, UNSPECIFIED FORM:ORAL:DROPS:MG/2.5ML	ORAL	12.85MG/2.5ML ORAL DROPS	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
K679OBS311	CARBOXYMETHYLCELLULOSE SODIUM, UNSPECIFIED FORM:ORAL:GRANULE:MG	ORAL	25.7MG ORAL GRANULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
K679OBS311	CARBOXYMETHYLCELLULOSE SODIUM, UNSPECIFIED FORM:ORAL:GRANULE, FOR SUSPENSION:NA	ORAL	ORAL GRANULE, FOR SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
K679OBS311	CARBOXYMETHYLCELLULOSE SODIUM, UNSPECIFIED FORM:ORAL:POWDER, FOR ORAL SOLUTION:MG	ORAL	4.2MG ORAL POWDER, FOR ORAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
K679OBS311	CARBOXYMETHYLCELLULOSE SODIUM, UNSPECIFIED FORM:ORAL:POWDER, FOR SOLUTION:MG/1ML	ORAL	2.63MG/1ML ORAL POWDER, FOR SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
K679OBS311	CARBOXYMETHYLCELLULOSE SODIUM, UNSPECIFIED FORM:ORAL:POWDER, FOR SUSPENSION:%	ORAL	1% ORAL POWDER, FOR SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
K679OBS311	CARBOXYMETHYLCELLULOSE SODIUM, UNSPECIFIED FORM:ORAL:SOLUTION:MG	ORAL	35MG ORAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
K679OBS311	CARBOXYMETHYLCELLULOSE SODIUM, UNSPECIFIED FORM:ORAL:SUSPENSION:MG/5ML	ORAL	2000MG/5ML ORAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
K679OBS311	CARBOXYMETHYLCELLULOSE SODIUM, UNSPECIFIED FORM:ORAL:SUSPENSION, DROPS:MG/2.5ML	ORAL	2.5MG/2.5ML ORAL SUSPENSION, DROPS	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
K679OBS311	CARBOXYMETHYLCELLULOSE SODIUM, UNSPECIFIED FORM:ORAL:SUSPENSION, SYRUP, SUSTAINED ACTION:%	ORAL	0.02% ORAL SUSPENSION, SYRUP, SUSTAINED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
K679OBS311	CARBOXYMETHYLCELLULOSE SODIUM, UNSPECIFIED FORM:ORAL:SYRUP:MG/5ML	ORAL	50MG/5ML ORAL SYRUP	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
K679OBS311	CARBOXYMETHYLCELLULOSE SODIUM, UNSPECIFIED FORM:ORAL:TABLET:MG	ORAL	48MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
K679OBS311	CARBOXYMETHYLCELLULOSE SODIUM, UNSPECIFIED FORM:ORAL:TABLET (IMMED./COMP. RELEASE), UNCOATED, CHEWABLE:MG	ORAL	24.75MG ORAL TABLET (IMMED./COMP. RELEASE), UNCOATED, CHEWABLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
K679OBS311	CARBOXYMETHYLCELLULOSE SODIUM, UNSPECIFIED FORM:ORAL:TABLET, COATED:MG	ORAL	3.2MG ORAL TABLET, COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
K679OBS311	CARBOXYMETHYLCELLULOSE SODIUM, UNSPECIFIED FORM:ORAL:TABLET, CONTROLLED RELEASE:mg	ORAL	0.04mg ORAL TABLET, CONTROLLED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
K679OBS311	CARBOXYMETHYLCELLULOSE SODIUM, UNSPECIFIED FORM:ORAL:TABLET, DELAYED ACTION:MG	ORAL	50MG ORAL TABLET, DELAYED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
K679OBS311	CARBOXYMETHYLCELLULOSE SODIUM, UNSPECIFIED FORM:ORAL:TABLET, EXTENDED RELEASE:MG	ORAL	233.3MG ORAL TABLET, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
K679OBS311	CARBOXYMETHYLCELLULOSE SODIUM, UNSPECIFIED FORM:ORAL:TABLET, FILM COATED:MG	ORAL	50MG ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
K679OBS311	CARBOXYMETHYLCELLULOSE SODIUM, UNSPECIFIED FORM:ORAL:TABLET, FILM COATED, EXTENDED RELEASE:MG	ORAL	50.02MG ORAL TABLET, FILM COATED, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
K679OBS311	CARBOXYMETHYLCELLULOSE SODIUM, UNSPECIFIED FORM:ORAL:TABLET, SUSTAINED ACTION:MG	ORAL	155MG ORAL TABLET, SUSTAINED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
K679OBS311	CARBOXYMETHYLCELLULOSE SODIUM, UNSPECIFIED FORM:SOFT TISSUE:INJECTION:%	SOFT TISSUE	0.5% SOFT TISSUE INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
K679OBS311	CARBOXYMETHYLCELLULOSE SODIUM, UNSPECIFIED FORM:SUBCUTANEOUS:IMPLANT:MG	SUBCUTANEOUS	16MG SUBCUTANEOUS IMPLANT	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
K679OBS311	CARBOXYMETHYLCELLULOSE SODIUM, UNSPECIFIED FORM:SUBCUTANEOUS:INJECTION:NA	SUBCUTANEOUS	SUBCUTANEOUS INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
K679OBS311	CARBOXYMETHYLCELLULOSE SODIUM, UNSPECIFIED FORM:TOPICAL:FILM, CONTROLLED RELEASE:MG	TOPICAL	700MG TOPICAL FILM, CONTROLLED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
K679OBS311	CARBOXYMETHYLCELLULOSE SODIUM, UNSPECIFIED FORM:TOPICAL:JELLY:NA	TOPICAL	TOPICAL JELLY	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
K679OBS311	CARBOXYMETHYLCELLULOSE SODIUM, UNSPECIFIED FORM:TOPICAL:LOTION:NA	TOPICAL	TOPICAL LOTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
K679OBS311	CARBOXYMETHYLCELLULOSE SODIUM, UNSPECIFIED FORM:TOPICAL:PASTE:NA	TOPICAL	TOPICAL PASTE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
K679OBS311	CARBOXYMETHYLCELLULOSE SODIUM, UNSPECIFIED FORM:TOPICAL:PASTE, DENTIFRICE:NA	TOPICAL	TOPICAL PASTE, DENTIFRICE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
K679OBS311	CARBOXYMETHYLCELLULOSE SODIUM, UNSPECIFIED FORM:TOPICAL:PATCH:MG	TOPICAL	210MG TOPICAL PATCH	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
K679OBS311	CARBOXYMETHYLCELLULOSE SODIUM, UNSPECIFIED FORM:TOPICAL:PATCH, CONTROLLED RELEASE:NA	TOPICAL	TOPICAL PATCH, CONTROLLED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
K679OBS311	CARBOXYMETHYLCELLULOSE SODIUM, UNSPECIFIED FORM:TOPICAL:SOLUTION:%W/W	TOPICAL	0.5%W/W TOPICAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
K679OBS311	CARBOXYMETHYLCELLULOSE SODIUM, UNSPECIFIED FORM:VAGINAL:EMULSION, AEROSOL FOAM:%	VAGINAL	0.2% VAGINAL EMULSION, AEROSOL FOAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
8D4SNN7V92	PROPYL GALLATE:INTRAMUSCULAR:INJECTION:NA	INTRAMUSCULAR	INTRAMUSCULAR INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
8D4SNN7V92	PROPYL GALLATE:ORAL:CAPSULE:MG	ORAL	0.16MG ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
8D4SNN7V92	PROPYL GALLATE:ORAL:CAPSULE, SOFT GELATIN:MG	ORAL	2MG ORAL CAPSULE, SOFT GELATIN	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
8D4SNN7V92	PROPYL GALLATE:ORAL:CONCENTRATE:MG/1ML	ORAL	0.2MG/1ML ORAL CONCENTRATE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
8D4SNN7V92	PROPYL GALLATE:ORAL:SUSPENSION, EXTENDED RELEASE:MG/5ML	ORAL	1MG/5ML ORAL SUSPENSION, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
8D4SNN7V92	PROPYL GALLATE:ORAL:TABLET:MG	ORAL	1.36MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
8D4SNN7V92	PROPYL GALLATE:ORAL:TABLET, EXTENDED RELEASE:MG	ORAL	0.067MG ORAL TABLET, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
8D4SNN7V92	PROPYL GALLATE:ORAL:TABLET, FILM COATED:MG	ORAL	0.04MG ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
8D4SNN7V92	PROPYL GALLATE:ORAL:TABLET, SUSTAINED ACTION:MG	ORAL	0.06MG ORAL TABLET, SUSTAINED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
8D4SNN7V92	PROPYL GALLATE:ORAL:TABLET, SUSTAINED ACTION, COATED:MG	ORAL	0.04MG ORAL TABLET, SUSTAINED ACTION, COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
8D4SNN7V92	PROPYL GALLATE:TOPICAL:EMULSION, CREAM:NA	TOPICAL	TOPICAL EMULSION, CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
8D4SNN7V92	PROPYL GALLATE:TOPICAL:GEL:%W/W	TOPICAL	0.05%W/W TOPICAL GEL	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
8D4SNN7V92	PROPYL GALLATE:TOPICAL:OINTMENT:NA	TOPICAL	TOPICAL OINTMENT	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
94255I6E2T	SODIUM PHOSPHATE, DIBASIC, DIHYDRATE:IM - IV:INJECTION:NA	IM - IV	IM - IV INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
94255I6E2T	SODIUM PHOSPHATE, DIBASIC, DIHYDRATE:INTRAVENOUS:INJECTABLE:%	INTRAVENOUS	0.24% INTRAVENOUS INJECTABLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
94255I6E2T	SODIUM PHOSPHATE, DIBASIC, DIHYDRATE:INTRAVENOUS:INJECTION:%	INTRAVENOUS	0.15% INTRAVENOUS INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
94255I6E2T	SODIUM PHOSPHATE, DIBASIC, DIHYDRATE:INTRAVENOUS:SOLUTION, INJECTION:%	INTRAVENOUS	1.09% INTRAVENOUS SOLUTION, INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
94255I6E2T	SODIUM PHOSPHATE, DIBASIC, DIHYDRATE:IV - SC:INJECTION, SOLUTION:MG/1ML	IV - SC	0.53MG/1ML IV - SC INJECTION, SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
94255I6E2T	SODIUM PHOSPHATE, DIBASIC, DIHYDRATE:IV(INFUSION):INJECTION:%	IV(INFUSION)	0.013% IV(INFUSION) INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
94255I6E2T	SODIUM PHOSPHATE, DIBASIC, DIHYDRATE:NASAL:SPRAY:MG/1ML	NASAL	3MG/1ML NASAL SPRAY	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
94255I6E2T	SODIUM PHOSPHATE, DIBASIC, DIHYDRATE:NASAL:SPRAY, METERED:%	NASAL	0.3% NASAL SPRAY, METERED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
94255I6E2T	SODIUM PHOSPHATE, DIBASIC, DIHYDRATE:OPHTHALMIC:SOLUTION:%	OPHTHALMIC	1.2% OPHTHALMIC SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
94255I6E2T	SODIUM PHOSPHATE, DIBASIC, DIHYDRATE:OPHTHALMIC:SOLUTION, DROPS:%	OPHTHALMIC	1.2% OPHTHALMIC SOLUTION, DROPS	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
94255I6E2T	SODIUM PHOSPHATE, DIBASIC, DIHYDRATE:OPHTHALMIC:SOLUTION/DROPS:%	OPHTHALMIC	0.095% OPHTHALMIC SOLUTION/DROPS	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
94255I6E2T	SODIUM PHOSPHATE, DIBASIC, DIHYDRATE:ORAL:CAPSULE:MG	ORAL	0.9MG ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
94255I6E2T	SODIUM PHOSPHATE, DIBASIC, DIHYDRATE:ORAL:CAPSULE, DELAYED ACTION:MG	ORAL	2MG ORAL CAPSULE, DELAYED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
94255I6E2T	SODIUM PHOSPHATE, DIBASIC, DIHYDRATE:ORAL:CAPSULE, ENTERIC COATED PELLETS:MG	ORAL	0.9MG ORAL CAPSULE, ENTERIC COATED PELLETS	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
94255I6E2T	SODIUM PHOSPHATE, DIBASIC, DIHYDRATE:ORAL:POWDER, FOR SOLUTION:NA	ORAL	ORAL POWDER, FOR SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
94255I6E2T	SODIUM PHOSPHATE, DIBASIC, DIHYDRATE:ORAL:SOLUTION:MG/1ML	ORAL	2.5MG/1ML ORAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
94255I6E2T	SODIUM PHOSPHATE, DIBASIC, DIHYDRATE:ORAL:SUSPENSION:MG/1ML	ORAL	8MG/1ML ORAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
94255I6E2T	SODIUM PHOSPHATE, DIBASIC, DIHYDRATE:SUBCUTANEOUS:INJECTABLE:%	SUBCUTANEOUS	0.18% SUBCUTANEOUS INJECTABLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
94255I6E2T	SODIUM PHOSPHATE, DIBASIC, DIHYDRATE:SUBCUTANEOUS:INJECTION:%	SUBCUTANEOUS	0.15% SUBCUTANEOUS INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
94255I6E2T	SODIUM PHOSPHATE, DIBASIC, DIHYDRATE:SUBCUTANEOUS:INJECTION, SOLUTION:MG/1ML	SUBCUTANEOUS	1.42MG/1ML SUBCUTANEOUS INJECTION, SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
94255I6E2T	SODIUM PHOSPHATE, DIBASIC, DIHYDRATE:SUBCUTANEOUS:POWDER, FOR INJECTION SOLUTION, LYOPHILIZED:%	SUBCUTANEOUS	0.11% SUBCUTANEOUS POWDER, FOR INJECTION SOLUTION, LYOPHILIZED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
94255I6E2T	SODIUM PHOSPHATE, DIBASIC, DIHYDRATE:SUBCUTANEOUS:SOLUTION, INJECTION:%	SUBCUTANEOUS	0.047% SUBCUTANEOUS SOLUTION, INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
94255I6E2T	SODIUM PHOSPHATE, DIBASIC, DIHYDRATE:SUBCUTANEOUS:SUSPENSION, INJECTION:%	SUBCUTANEOUS	0.13% SUBCUTANEOUS SUSPENSION, INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
94255I6E2T	SODIUM PHOSPHATE, DIBASIC, DIHYDRATE:TOPICAL:EMULSION, CREAM:%W/W	TOPICAL	0.25%W/W TOPICAL EMULSION, CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
94255I6E2T	SODIUM PHOSPHATE, DIBASIC, DIHYDRATE:TOPICAL:GEL:%W/W	TOPICAL	0.003%W/W TOPICAL GEL	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
L0IYT1O31N	SODIUM THIOSULFATE ANHYDROUS:INTRAVENOUS:SOLUTION:%	INTRAVENOUS	0.19% INTRAVENOUS SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
L0IYT1O31N	SODIUM THIOSULFATE ANHYDROUS:ORAL:SOLUTION:%	ORAL	0.2% ORAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
L0IYT1O31N	SODIUM THIOSULFATE ANHYDROUS:ORAL:TABLET:MG	ORAL	0.6MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
K6MOM3T5YL	CARBOMER HOMOPOLYMER TYPE B (ALLYL PENTAERYTHRITOL OR ALLYL SUCROSE CROSSLINKED):BUCCAL:TABLET:MG	BUCCAL	9.38MG BUCCAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
K6MOM3T5YL	CARBOMER HOMOPOLYMER TYPE B (ALLYL PENTAERYTHRITOL OR ALLYL SUCROSE CROSSLINKED):OPHTHALMIC:SUSPENSION:%	OPHTHALMIC	0.45% OPHTHALMIC SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
K6MOM3T5YL	CARBOMER HOMOPOLYMER TYPE B (ALLYL PENTAERYTHRITOL OR ALLYL SUCROSE CROSSLINKED):OPHTHALMIC:SUSPENSION, DROPS:%	OPHTHALMIC	0.4% OPHTHALMIC SUSPENSION, DROPS	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
K6MOM3T5YL	CARBOMER HOMOPOLYMER TYPE B (ALLYL PENTAERYTHRITOL OR ALLYL SUCROSE CROSSLINKED):ORAL:CAPSULE:MG	ORAL	14.2MG ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
K6MOM3T5YL	CARBOMER HOMOPOLYMER TYPE B (ALLYL PENTAERYTHRITOL OR ALLYL SUCROSE CROSSLINKED):ORAL:SUSPENSION:MG/5ML	ORAL	50MG/5ML ORAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
K6MOM3T5YL	CARBOMER HOMOPOLYMER TYPE B (ALLYL PENTAERYTHRITOL OR ALLYL SUCROSE CROSSLINKED):ORAL:TABLET, EXTENDED RELEASE:mg	ORAL	30mg ORAL TABLET, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
K6MOM3T5YL	CARBOMER HOMOPOLYMER TYPE B (ALLYL PENTAERYTHRITOL OR ALLYL SUCROSE CROSSLINKED):ORAL:TABLET, ORALLY DISINTEGRATING:MG	ORAL	0.3MG ORAL TABLET, ORALLY DISINTEGRATING	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
K6MOM3T5YL	CARBOMER HOMOPOLYMER TYPE B (ALLYL PENTAERYTHRITOL OR ALLYL SUCROSE CROSSLINKED):ORAL:TABLET, SUSTAINED ACTION:MG	ORAL	90MG ORAL TABLET, SUSTAINED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
K6MOM3T5YL	CARBOMER HOMOPOLYMER TYPE B (ALLYL PENTAERYTHRITOL OR ALLYL SUCROSE CROSSLINKED):ORAL:TABLET, SUSTAINED ACTION, COATED:MG	ORAL	3MG ORAL TABLET, SUSTAINED ACTION, COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
K6MOM3T5YL	CARBOMER HOMOPOLYMER TYPE B (ALLYL PENTAERYTHRITOL OR ALLYL SUCROSE CROSSLINKED):RECTAL:ENEMA:%	RECTAL	0.24% RECTAL ENEMA	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
K6MOM3T5YL	CARBOMER HOMOPOLYMER TYPE B (ALLYL PENTAERYTHRITOL OR ALLYL SUCROSE CROSSLINKED):TOPICAL:CREAM, AUGMENTED:%W/V	TOPICAL	1%W/V TOPICAL CREAM, AUGMENTED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
K6MOM3T5YL	CARBOMER HOMOPOLYMER TYPE B (ALLYL PENTAERYTHRITOL OR ALLYL SUCROSE CROSSLINKED):TOPICAL:CREAM, EMULSION, SUSTAINED RELEASE:%W/V	TOPICAL	1%W/V TOPICAL CREAM, EMULSION, SUSTAINED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
K6MOM3T5YL	CARBOMER HOMOPOLYMER TYPE B (ALLYL PENTAERYTHRITOL OR ALLYL SUCROSE CROSSLINKED):TOPICAL:EMULSION:%W/W	TOPICAL	0.5%W/W TOPICAL EMULSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
K6MOM3T5YL	CARBOMER HOMOPOLYMER TYPE B (ALLYL PENTAERYTHRITOL OR ALLYL SUCROSE CROSSLINKED):TOPICAL:EMULSION, CREAM:%W/W	TOPICAL	1%W/W TOPICAL EMULSION, CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
K6MOM3T5YL	CARBOMER HOMOPOLYMER TYPE B (ALLYL PENTAERYTHRITOL OR ALLYL SUCROSE CROSSLINKED):TOPICAL:GEL:%W/W	TOPICAL	1.51%W/W TOPICAL GEL	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
K6MOM3T5YL	CARBOMER HOMOPOLYMER TYPE B (ALLYL PENTAERYTHRITOL OR ALLYL SUCROSE CROSSLINKED):TOPICAL:LOTION:%W/W	TOPICAL	0.5%W/W TOPICAL LOTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
K6MOM3T5YL	CARBOMER HOMOPOLYMER TYPE B (ALLYL PENTAERYTHRITOL OR ALLYL SUCROSE CROSSLINKED):TOPICAL:OINTMENT:%W/W	TOPICAL	0.5%W/W TOPICAL OINTMENT	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
K6MOM3T5YL	CARBOMER HOMOPOLYMER TYPE B (ALLYL PENTAERYTHRITOL OR ALLYL SUCROSE CROSSLINKED):TOPICAL:SOLUTION:%W/W	TOPICAL	0.18%W/W TOPICAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
K6MOM3T5YL	CARBOMER HOMOPOLYMER TYPE B (ALLYL PENTAERYTHRITOL OR ALLYL SUCROSE CROSSLINKED):VAGINAL:GEL:%W/W	VAGINAL	2%W/W VAGINAL GEL	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
6W9PS8B71J	SORBITAN MONOLAURATE:INTRAMUSCULAR:INJECTION, SUSPENSION, EXTENDED RELEASE:%	INTRAMUSCULAR	1.23% INTRAMUSCULAR INJECTION, SUSPENSION, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
6W9PS8B71J	SORBITAN MONOLAURATE:OPHTHALMIC:OINTMENT:NA	OPHTHALMIC	OPHTHALMIC OINTMENT	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
6W9PS8B71J	SORBITAN MONOLAURATE:ORAL:CAPSULE:MG	ORAL	0.08MG ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
6W9PS8B71J	SORBITAN MONOLAURATE:ORAL:GRANULE, EFFERVESCENT:NA	ORAL	ORAL GRANULE, EFFERVESCENT	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
6W9PS8B71J	SORBITAN MONOLAURATE:ORAL:SUSPENSION:MG/5ML	ORAL	2.5MG/5ML ORAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
6W9PS8B71J	SORBITAN MONOLAURATE:ORAL:SYRUP:NA	ORAL	ORAL SYRUP	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
6W9PS8B71J	SORBITAN MONOLAURATE:ORAL:TABLET:MG	ORAL	66.7MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
6W9PS8B71J	SORBITAN MONOLAURATE:ORAL:TABLET, FILM COATED:MG	ORAL	83.9MG ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
6W9PS8B71J	SORBITAN MONOLAURATE:TOPICAL:AEROSOL:%W/W	TOPICAL	4.74%W/W TOPICAL AEROSOL	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
6W9PS8B71J	SORBITAN MONOLAURATE:TOPICAL:EMULSION, AEROSOL FOAM:%W/W	TOPICAL	4.74%W/W TOPICAL EMULSION, AEROSOL FOAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
6W9PS8B71J	SORBITAN MONOLAURATE:TOPICAL:GEL:%W/W	TOPICAL	1%W/W TOPICAL GEL	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
TD2LE91MBE	TOLU BALSAM:ORAL:SUSPENSION:NA	ORAL	ORAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
TD2LE91MBE	TOLU BALSAM:ORAL:TABLET:NA	ORAL	ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
NZ94SDL6WR	LOW-SUBSTITUTED HYDROXYPROPYL CELLULOSE (11% HYDROXYPROPYL; 120000 MW):ORAL:TABLET:MG	ORAL	60MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
776XM7047L	CALCIUM STEARATE:BUCCAL/SUBLINGUAL:TABLET:MG	BUCCAL/SUBLINGUAL	1.42MG BUCCAL/SUBLINGUAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
776XM7047L	CALCIUM STEARATE:ORAL:CAPSULE:MG	ORAL	21.1MG ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
776XM7047L	CALCIUM STEARATE:ORAL:CAPSULE, EXTENDED RELEASE:MG	ORAL	3.2MG ORAL CAPSULE, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
776XM7047L	CALCIUM STEARATE:ORAL:CAPSULE, HARD GELATIN:MG	ORAL	1MG ORAL CAPSULE, HARD GELATIN	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
776XM7047L	CALCIUM STEARATE:ORAL:CAPSULE, SUSTAINED ACTION:MG	ORAL	91.9MG ORAL CAPSULE, SUSTAINED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
776XM7047L	CALCIUM STEARATE:ORAL:POWDER:MG/1GM	ORAL	30MG/1GM ORAL POWDER	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
776XM7047L	CALCIUM STEARATE:ORAL:TABLET:MG	ORAL	42.9MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
776XM7047L	CALCIUM STEARATE:ORAL:TABLET (IMMED./COMP. RELEASE), UNCOATED, CHEWABLE:MG	ORAL	47.5MG ORAL TABLET (IMMED./COMP. RELEASE), UNCOATED, CHEWABLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
776XM7047L	CALCIUM STEARATE:ORAL:TABLET, COATED:MG	ORAL	1MG ORAL TABLET, COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
776XM7047L	CALCIUM STEARATE:ORAL:TABLET, DELAYED ACTION:MG	ORAL	4.8MG ORAL TABLET, DELAYED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
776XM7047L	CALCIUM STEARATE:ORAL:TABLET, DELAYED ACTION, ENTERIC COATED:MG	ORAL	3.2MG ORAL TABLET, DELAYED ACTION, ENTERIC COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
776XM7047L	CALCIUM STEARATE:ORAL:TABLET, DELAYED RELEASE:MG	ORAL	3.4MG ORAL TABLET, DELAYED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
776XM7047L	CALCIUM STEARATE:ORAL:TABLET, EXTENDED RELEASE:MG	ORAL	15MG ORAL TABLET, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
776XM7047L	CALCIUM STEARATE:ORAL:TABLET, FILM COATED:MG	ORAL	16MG ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
776XM7047L	CALCIUM STEARATE:ORAL:TABLET, ORALLY DISINTEGRATING:MG	ORAL	14MG ORAL TABLET, ORALLY DISINTEGRATING	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
776XM7047L	CALCIUM STEARATE:ORAL:TABLET, SUSTAINED ACTION:MG	ORAL	24MG ORAL TABLET, SUSTAINED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
776XM7047L	CALCIUM STEARATE:SUBLINGUAL:TABLET:MG	SUBLINGUAL	2MG SUBLINGUAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
7LVU907546	MAGNESIUM ALUMINOMETASILICATE TYPE 1A:ORAL:TABLET:mg	ORAL	11.5mg ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
7LVU907546	MAGNESIUM ALUMINOMETASILICATE TYPE IA:ORAL:TABLET, ORALLY DISINTEGRATING:MG	ORAL	6MG ORAL TABLET, ORALLY DISINTEGRATING	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
H5ZC52369M	LAUROYL PEG-32 GLYCERIDES:ORAL:CAPSULE:mg	ORAL	3mg ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
H5ZC52369M	LAUROYL PEG-32 GLYCERIDES:ORAL:TABLET:MG	ORAL	0.15MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
3L6NN8ZZKU	SODIUM N-(CARBONYL-METHOXYPOLYETHYLENE GLYCOL 2000)-1,2-DISTEAROYL-SN-GLYCERO-3-PHOSPHOETHANOLAMINE:INTRAVENOUS:INJECTION:%	INTRAVENOUS	0.012% INTRAVENOUS INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
5856J3G2A2	SODIUM STARCH GLYCOLATE:ORAL:TABLET:mg	ORAL	70mg ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
5856J3G2A2	SODIUM STARCH GLYCOLATE:ORAL:TABLET, DELAYED RELEASE:mg	ORAL	36mg ORAL TABLET, DELAYED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
5856J3G2A2	SODIUM STARCH GLYCOLATE:ORAL:TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE:mg	ORAL	19.88mg ORAL TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
5856J3G2A2	SODIUM STARCH GLYCOLATE TYPE A POTATO:BUCCAL:TABLET:MG	BUCCAL	8.3MG BUCCAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
5856J3G2A2	SODIUM STARCH GLYCOLATE TYPE A POTATO:ORAL:CAPSULE:MG	ORAL	180MG ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
5856J3G2A2	SODIUM STARCH GLYCOLATE TYPE A POTATO:ORAL:CAPSULE, COATED PELLETS:MG	ORAL	16.71MG ORAL CAPSULE, COATED PELLETS	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
5856J3G2A2	SODIUM STARCH GLYCOLATE TYPE A POTATO:ORAL:CAPSULE, DELAYED ACTION:MG	ORAL	15MG ORAL CAPSULE, DELAYED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
5856J3G2A2	SODIUM STARCH GLYCOLATE TYPE A POTATO:ORAL:CAPSULE, DELAYED ACTION, COATED, HARD GELATIN:MG	ORAL	16MG ORAL CAPSULE, DELAYED ACTION, COATED, HARD GELATIN	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
5856J3G2A2	SODIUM STARCH GLYCOLATE TYPE A POTATO:ORAL:CAPSULE, DELAYED RELEASE:MG	ORAL	18.3MG ORAL CAPSULE, DELAYED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
5856J3G2A2	SODIUM STARCH GLYCOLATE TYPE A POTATO:ORAL:CAPSULE, ENTERIC COATED PELLETS:MG	ORAL	16.8MG ORAL CAPSULE, ENTERIC COATED PELLETS	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
5856J3G2A2	SODIUM STARCH GLYCOLATE TYPE A POTATO:ORAL:CAPSULE, EXTENDED RELEASE:MG	ORAL	30MG ORAL CAPSULE, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
5856J3G2A2	SODIUM STARCH GLYCOLATE TYPE A POTATO:ORAL:CAPSULE, HARD GELATIN:MG	ORAL	20MG ORAL CAPSULE, HARD GELATIN	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
5856J3G2A2	SODIUM STARCH GLYCOLATE TYPE A POTATO:ORAL:CAPSULE, SOFT GELATIN:MG	ORAL	7.75MG ORAL CAPSULE, SOFT GELATIN	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
5856J3G2A2	SODIUM STARCH GLYCOLATE TYPE A POTATO:ORAL:CAPSULE, SUSTAINED ACTION:MG	ORAL	18.6MG ORAL CAPSULE, SUSTAINED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
5856J3G2A2	SODIUM STARCH GLYCOLATE TYPE A POTATO:ORAL:DISPERSIBLE TABLET:MG	ORAL	2.4MG ORAL DISPERSIBLE TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
5856J3G2A2	SODIUM STARCH GLYCOLATE TYPE A POTATO:ORAL:TABLET:MG	ORAL	876MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
5856J3G2A2	SODIUM STARCH GLYCOLATE TYPE A POTATO:ORAL:TABLET (IMMED./COMP. RELEASE), COATED:MG	ORAL	17MG ORAL TABLET (IMMED./COMP. RELEASE), COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
5856J3G2A2	SODIUM STARCH GLYCOLATE TYPE A POTATO:ORAL:TABLET (IMMED./COMP. RELEASE), FILM COATED:MG	ORAL	20MG ORAL TABLET (IMMED./COMP. RELEASE), FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
5856J3G2A2	SODIUM STARCH GLYCOLATE TYPE A POTATO:ORAL:TABLET (IMMED./COMP. RELEASE), UNCOATED, CHEWABLE:MG	ORAL	50MG ORAL TABLET (IMMED./COMP. RELEASE), UNCOATED, CHEWABLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
5856J3G2A2	SODIUM STARCH GLYCOLATE TYPE A POTATO:ORAL:TABLET, CHEWABLE:MG	ORAL	75MG ORAL TABLET, CHEWABLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
5856J3G2A2	SODIUM STARCH GLYCOLATE TYPE A POTATO:ORAL:TABLET, COATED:MG	ORAL	73MG ORAL TABLET, COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
5856J3G2A2	SODIUM STARCH GLYCOLATE TYPE A POTATO:ORAL:TABLET, CONTROLLED RELEASE:MG	ORAL	25.86MG ORAL TABLET, CONTROLLED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
5856J3G2A2	SODIUM STARCH GLYCOLATE TYPE A POTATO:ORAL:TABLET, DELAYED ACTION:MG	ORAL	34MG ORAL TABLET, DELAYED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
5856J3G2A2	SODIUM STARCH GLYCOLATE TYPE A POTATO:ORAL:TABLET, DELAYED ACTION, ENTERIC COATED:MG	ORAL	21MG ORAL TABLET, DELAYED ACTION, ENTERIC COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
5856J3G2A2	SODIUM STARCH GLYCOLATE TYPE A POTATO:ORAL:TABLET, DELAYED RELEASE:MG	ORAL	60.5MG ORAL TABLET, DELAYED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
5856J3G2A2	SODIUM STARCH GLYCOLATE TYPE A POTATO:ORAL:TABLET, ENTERIC COATED PARTICLES:MG	ORAL	12MG ORAL TABLET, ENTERIC COATED PARTICLES	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
5856J3G2A2	SODIUM STARCH GLYCOLATE TYPE A POTATO:ORAL:TABLET, EXTENDED RELEASE:MG	ORAL	48MG ORAL TABLET, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
5856J3G2A2	SODIUM STARCH GLYCOLATE TYPE A POTATO:ORAL:TABLET, FILM COATED:MG	ORAL	90MG ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
5856J3G2A2	SODIUM STARCH GLYCOLATE TYPE A POTATO:ORAL:TABLET, MULTILAYER, COATED:MG	ORAL	2MG ORAL TABLET, MULTILAYER, COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
5856J3G2A2	SODIUM STARCH GLYCOLATE TYPE A POTATO:ORAL:TABLET, ORALLY DISINTEGRATING:MG	ORAL	71.43MG ORAL TABLET, ORALLY DISINTEGRATING	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
5856J3G2A2	SODIUM STARCH GLYCOLATE TYPE A POTATO:ORAL:TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE:mg	ORAL	3mg ORAL TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
5856J3G2A2	SODIUM STARCH GLYCOLATE TYPE A POTATO:ORAL:TABLET, SUSTAINED ACTION:MG	ORAL	15MG ORAL TABLET, SUSTAINED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
5856J3G2A2	SODIUM STARCH GLYCOLATE TYPE A POTATO:ORAL:TABLET, SUSTAINED ACTION, COATED:NA	ORAL	ORAL TABLET, SUSTAINED ACTION, COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
5856J3G2A2	SODIUM STARCH GLYCOLATE TYPE A POTATO:ORAL:TABLET, SUSTAINED ACTION, FILM COATED:MG	ORAL	10MG ORAL TABLET, SUSTAINED ACTION, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
5856J3G2A2	SODIUM STARCH GLYCOLATE TYPE A POTATO:SUBLINGUAL:TABLET:MG	SUBLINGUAL	5.5MG SUBLINGUAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
5856J3G2A2	SODIUM STARCH GLYCOLATE TYPE A POTATO:TRANSMUCOSAL:TABLET:MG	TRANSMUCOSAL	10MG TRANSMUCOSAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
2R04ONI662	EUCALYPTUS OIL:ORAL:SYRUP:%	ORAL	0.014% ORAL SYRUP	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
73071MW2KM	GLYCERYL DISTEARATE:ORAL:CAPSULE, EXTENDED RELEASE:MG	ORAL	25.48MG ORAL CAPSULE, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
73071MW2KM	GLYCERYL DISTEARATE:ORAL:CAPSULE, SUSTAINED ACTION:MG	ORAL	39.2MG ORAL CAPSULE, SUSTAINED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
73071MW2KM	GLYCERYL DISTEARATE:ORAL:TABLET:mg	ORAL	20mg ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
73071MW2KM	GLYCERYL DISTEARATE:ORAL:TABLET, EXTENDED RELEASE:MG	ORAL	8.5MG ORAL TABLET, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
73071MW2KM	GLYCERYL DISTEARATE:ORAL:TABLET, ORALLY DISINTEGRATING:MG	ORAL	4MG ORAL TABLET, ORALLY DISINTEGRATING	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
ND2M416302	ISOPROPYL ALCOHOL:AURICULAR (OTIC):OIL:%V/V	AURICULAR (OTIC)	1.6%V/V AURICULAR (OTIC) OIL	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=I
ND2M416302	ISOPROPYL ALCOHOL:TOPICAL:AEROSOL, METERED:%W/W	TOPICAL	4%W/W TOPICAL AEROSOL, METERED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=I
ND2M416302	ISOPROPYL ALCOHOL:TOPICAL:AEROSOL, SPRAY:%W/W	TOPICAL	10%W/W TOPICAL AEROSOL, SPRAY	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=I
ND2M416302	ISOPROPYL ALCOHOL:TOPICAL:CREAM:%W/W	TOPICAL	6.5%W/W TOPICAL CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=I
ND2M416302	ISOPROPYL ALCOHOL:TOPICAL:GEL:%W/W	TOPICAL	30%W/W TOPICAL GEL	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=I
ND2M416302	ISOPROPYL ALCOHOL:TOPICAL:LOTION:%V/V	TOPICAL	78.34%V/V TOPICAL LOTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=I
ND2M416302	ISOPROPYL ALCOHOL:TOPICAL:LOTION, AUGMENTED:%W/W	TOPICAL	30%W/W TOPICAL LOTION, AUGMENTED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=I
ND2M416302	ISOPROPYL ALCOHOL:TOPICAL:OIL:%W/W	TOPICAL	3.75%W/W TOPICAL OIL	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=I
ND2M416302	ISOPROPYL ALCOHOL:TOPICAL:OINTMENT:NA	TOPICAL	TOPICAL OINTMENT	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=I
ND2M416302	ISOPROPYL ALCOHOL:TOPICAL:SOLUTION:%V/V 	TOPICAL	51.5%V/V  TOPICAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=I
ND2M416302	ISOPROPYL ALCOHOL:TOPICAL:SPONGE:NA	TOPICAL	TOPICAL SPONGE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=I
ND2M416302	ISOPROPYL ALCOHOL:TOPICAL:SPRAY:%W/W	TOPICAL	23.4%W/W TOPICAL SPRAY	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=I
ND2M416302	ISOPROPYL ALCOHOL:TOPICAL:SWAB:NA	TOPICAL	TOPICAL SWAB	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=I
ND2M416302	ISOPROPYL ALCOHOL:TRANSDERMAL:FILM, CONTROLLED RELEASE:NA	TRANSDERMAL	TRANSDERMAL FILM, CONTROLLED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=I
ND2M416302	ISOPROPYL ALCOHOL:TRANSDERMAL:PATCH, ELECTRICALLY CONTROLLED:NA	TRANSDERMAL	TRANSDERMAL PATCH, ELECTRICALLY CONTROLLED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=I
ND2M416302	ISOPROPYL ALCOHOL:TRANSDERMAL:SOLUTION:%	TRANSDERMAL	28.76% TRANSDERMAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=I
79QS2MG2LP	STARCH, WHEAT:ORAL:CAPSULE, SUSTAINED ACTION:MG	ORAL	0.75MG ORAL CAPSULE, SUSTAINED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
79QS2MG2LP	STARCH, WHEAT:ORAL:TABLET:MG	ORAL	65.59MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
79QS2MG2LP	STARCH, WHEAT:ORAL:TABLET, COATED:NA	ORAL	ORAL TABLET, COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
79QS2MG2LP	STARCH, WHEAT:ORAL:TABLET, FILM COATED:MG	ORAL	49MG ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
451W47IQ8X	HYPERTONIC SODIUM CHLORIDE SOLUTION:IV(INFUSION):INJECTION:%	IV(INFUSION)	0.59% IV(INFUSION) INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
451W47IQ8X	HYPERTONIC SODIUM CHLORIDE SOLUTION:OPHTHALMIC:SOLUTION:%	OPHTHALMIC	0.81% OPHTHALMIC SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
451W47IQ8X	ISOTONIC SODIUM CHLORIDE SOLUTION:INTRAVENOUS:INJECTION:%	INTRAVENOUS	0.9% INTRAVENOUS INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=I
451W47IQ8X	ISOTONIC SODIUM CHLORIDE SOLUTION:INTRAVENOUS:SOLUTION:%	INTRAVENOUS	0.9% INTRAVENOUS SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=I
451W47IQ8X	SODIUM CHLORIDE:AN,CNBLK INTRATHECAL:INJECTION:%	AN,CNBLK INTRATHECAL	0.8% AN,CNBLK INTRATHECAL INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
451W47IQ8X	SODIUM CHLORIDE:AN,INFILTRATION:INJECTABLE:NA	AN,INFILTRATION	AN,INFILTRATION INJECTABLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
451W47IQ8X	SODIUM CHLORIDE:AN,INFILTRATION:INJECTION:%	AN,INFILTRATION	0.9% AN,INFILTRATION INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
451W47IQ8X	SODIUM CHLORIDE:AN,INFILTRATION:SOLUTION, INJECTION:%	AN,INFILTRATION	0.65% AN,INFILTRATION SOLUTION, INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
451W47IQ8X	SODIUM CHLORIDE:AN,SYMPATHETIC NBLK:INJECTION:%	AN,SYMPATHETIC NBLK	0.3% AN,SYMPATHETIC NBLK INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
451W47IQ8X	SODIUM CHLORIDE:AURICULAR (OTIC):SOLUTION:%	AURICULAR (OTIC)	9% AURICULAR (OTIC) SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
451W47IQ8X	SODIUM CHLORIDE:AURICULAR (OTIC):SUSPENSION:%	AURICULAR (OTIC)	0.86% AURICULAR (OTIC) SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
451W47IQ8X	SODIUM CHLORIDE:AURICULAR (OTIC):SUSPENSION, LIQUID:%	AURICULAR (OTIC)	0.9% AURICULAR (OTIC) SUSPENSION, LIQUID	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
451W47IQ8X	SODIUM CHLORIDE:CAUDAL BLOCK:INJECTABLE:NA	CAUDAL BLOCK	CAUDAL BLOCK INJECTABLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
451W47IQ8X	SODIUM CHLORIDE:CAUDAL BLOCK:INJECTION:%	CAUDAL BLOCK	0.9% CAUDAL BLOCK INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
451W47IQ8X	SODIUM CHLORIDE:DENTAL:INJECTABLE:%	DENTAL	0.3% DENTAL INJECTABLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
451W47IQ8X	SODIUM CHLORIDE:DENTAL:INJECTION:%	DENTAL	0.6% DENTAL INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
451W47IQ8X	SODIUM CHLORIDE:EPIDURAL:INJECTION:%W/V	EPIDURAL	0.8%W/V EPIDURAL INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
451W47IQ8X	SODIUM CHLORIDE:EPIDURAL:INJECTION, SOLUTION:mg/1mL	EPIDURAL	8mg/1mL EPIDURAL INJECTION, SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
451W47IQ8X	SODIUM CHLORIDE:EPIDURAL:LIQUID, WATER, STERILE, FOR INJECTION:%	EPIDURAL	0.8% EPIDURAL LIQUID, WATER, STERILE, FOR INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
451W47IQ8X	SODIUM CHLORIDE:EPIDURAL:SOLUTION:%	EPIDURAL	0.9% EPIDURAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
451W47IQ8X	SODIUM CHLORIDE:EPIDURAL:SOLUTION, INJECTION:%	EPIDURAL	0.9% EPIDURAL SOLUTION, INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
451W47IQ8X	SODIUM CHLORIDE:EPIDURAL, INFILTRATION, NERVE BLOCK:INJECTION:MG/ML	EPIDURAL, INFILTRATION, NERVE BLOCK	8.6MG/ML EPIDURAL, INFILTRATION, NERVE BLOCK INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
451W47IQ8X	SODIUM CHLORIDE:EXTRACORPOREAL:INJECTION:%	EXTRACORPOREAL	0.9% EXTRACORPOREAL INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
451W47IQ8X	SODIUM CHLORIDE:EXTRACORPOREAL:SOLUTION:%	EXTRACORPOREAL	0.8% EXTRACORPOREAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
451W47IQ8X	SODIUM CHLORIDE:IM - IV:INJECTABLE:%	IM - IV	0.9% IM - IV INJECTABLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
451W47IQ8X	SODIUM CHLORIDE:IM - IV:INJECTION:%	IM - IV	14% IM - IV INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
451W47IQ8X	SODIUM CHLORIDE:IM - IV:INJECTION:mg/mL	IM - IV	4.9mg/mL IM - IV INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
451W47IQ8X	SODIUM CHLORIDE:IM - IV:LIQUID, WATER, STERILE, FOR INJECTION:%	IM - IV	0.8% IM - IV LIQUID, WATER, STERILE, FOR INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
451W47IQ8X	SODIUM CHLORIDE:IM - IV:POWDER, FOR INJECTION SOLUTION:%	IM - IV	9% IM - IV POWDER, FOR INJECTION SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
451W47IQ8X	SODIUM CHLORIDE:IM - IV:POWDER, FOR INJECTION SOLUTION, LYOPHILIZED:%	IM - IV	18% IM - IV POWDER, FOR INJECTION SOLUTION, LYOPHILIZED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
451W47IQ8X	SODIUM CHLORIDE:IM - IV:SOLUTION:%	IM - IV	0.9% IM - IV SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
451W47IQ8X	SODIUM CHLORIDE:IM - IV:SOLUTION, INJECTION:%	IM - IV	0.9% IM - IV SOLUTION, INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
451W47IQ8X	SODIUM CHLORIDE:IM - IV - SC:INJECTION:%	IM - IV - SC	0.9% IM - IV - SC INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
451W47IQ8X	SODIUM CHLORIDE:IM - IV - SC:SOLUTION, INJECTION:NA	IM - IV - SC	IM - IV - SC SOLUTION, INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
451W47IQ8X	SODIUM CHLORIDE:IM - SC:INJECTION:%	IM - SC	0.9% IM - SC INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
451W47IQ8X	SODIUM CHLORIDE:INFILTRATION:INJECTION:%	INFILTRATION	0.86% INFILTRATION INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
451W47IQ8X	SODIUM CHLORIDE:INFILTRATION:INJECTION, LIPOSOMAL:%	INFILTRATION	0.54% INFILTRATION INJECTION, LIPOSOMAL	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
451W47IQ8X	SODIUM CHLORIDE:INFILTRATION:INJECTION, SOLUTION:MG/1ML	INFILTRATION	7MG/1ML INFILTRATION INJECTION, SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
451W47IQ8X	SODIUM CHLORIDE:INFILTRATION:SOLUTION, INJECTION:%	INFILTRATION	0.85% INFILTRATION SOLUTION, INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
451W47IQ8X	SODIUM CHLORIDE:INHALATION:INHALANT:NA	INHALATION	INHALATION INHALANT	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
451W47IQ8X	SODIUM CHLORIDE:INHALATION:INHALANT SOLUTION DOSAGE FORM:mg/5mL	INHALATION	11.25mg/5mL INHALATION INHALANT SOLUTION DOSAGE FORM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
451W47IQ8X	SODIUM CHLORIDE:INHALATION:SOLUTION:mg/3 mL	INHALATION	27mg/3 mL INHALATION SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
451W47IQ8X	SODIUM CHLORIDE:INHALATION:SOLUTION:mg/3mL	INHALATION	9mg/3mL INHALATION SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
451W47IQ8X	SODIUM CHLORIDE:INHALATION:SOLUTION:MG/1ML	INHALATION	8MG/1ML INHALATION SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
451W47IQ8X	SODIUM CHLORIDE:INHALATION:SOLUTION:%W/V	INHALATION	0.9%W/V INHALATION SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
451W47IQ8X	SODIUM CHLORIDE:INHALATION:SOLUTION, FOR INHALATION:%	INHALATION	1.13% INHALATION SOLUTION, FOR INHALATION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
451W47IQ8X	SODIUM CHLORIDE:INHALATION:SUSPENSION:mg/2mL	INHALATION	17.2mg/2mL INHALATION SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
451W47IQ8X	SODIUM CHLORIDE:INHALATION:SUSPENSION, FOR INHALATION:%	INHALATION	0.85% INHALATION SUSPENSION, FOR INHALATION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
451W47IQ8X	SODIUM CHLORIDE:INJECTION:INJECTION:mg/1mL	INJECTION	8.5mg/1mL INJECTION INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
451W47IQ8X	SODIUM CHLORIDE:INJECTION:INJECTION, SOLUTION:mg/1mL	INJECTION	7mg/1mL INJECTION INJECTION, SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
451W47IQ8X	SODIUM CHLORIDE:INTRA-ARTERIAL:INJECTABLE:%	INTRA-ARTERIAL	0.49% INTRA-ARTERIAL INJECTABLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
451W47IQ8X	SODIUM CHLORIDE:INTRA-ARTERIAL:INJECTION:%	INTRA-ARTERIAL	19.6% INTRA-ARTERIAL INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
451W47IQ8X	SODIUM CHLORIDE:INTRA-ARTERIAL:INJECTION:mg/mL	INTRA-ARTERIAL	4.9mg/mL INTRA-ARTERIAL INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
451W47IQ8X	SODIUM CHLORIDE:INTRA-ARTERIAL:POWDER, FOR INJECTION SOLUTION:%	INTRA-ARTERIAL	0.14% INTRA-ARTERIAL POWDER, FOR INJECTION SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
451W47IQ8X	SODIUM CHLORIDE:INTRA-ARTERIAL:SOLUTION:%	INTRA-ARTERIAL	0.9% INTRA-ARTERIAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
451W47IQ8X	SODIUM CHLORIDE:INTRA-ARTERIAL:SOLUTION, INJECTION:%	INTRA-ARTERIAL	0.05% INTRA-ARTERIAL SOLUTION, INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
451W47IQ8X	SODIUM CHLORIDE:INTRA-ARTERIAL:SUSPENSION, INJECTION:mg/1mL	INTRA-ARTERIAL	1.5mg/1mL INTRA-ARTERIAL SUSPENSION, INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
451W47IQ8X	SODIUM CHLORIDE:INTRA-ARTICULAR:INJECTABLE:%	INTRA-ARTICULAR	0.67% INTRA-ARTICULAR INJECTABLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
451W47IQ8X	SODIUM CHLORIDE:INTRA-ARTICULAR:INJECTION:MG/1ML	INTRA-ARTICULAR	6.5MG/1ML INTRA-ARTICULAR INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
451W47IQ8X	SODIUM CHLORIDE:INTRA-ARTICULAR:INJECTION:%	INTRA-ARTICULAR	0.9% INTRA-ARTICULAR INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
451W47IQ8X	SODIUM CHLORIDE:INTRA-ARTICULAR:INJECTION, SUSPENSION, EXTENDED RELEASE:MG	INTRA-ARTICULAR	45MG INTRA-ARTICULAR INJECTION, SUSPENSION, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
451W47IQ8X	SODIUM CHLORIDE:INTRA-ARTICULAR:INJECTION, SUSTAINED ACTION:NA	INTRA-ARTICULAR	INTRA-ARTICULAR INJECTION, SUSTAINED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
451W47IQ8X	SODIUM CHLORIDE:INTRA-ARTICULAR:SUSPENSION:%	INTRA-ARTICULAR	0.48% INTRA-ARTICULAR SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
451W47IQ8X	SODIUM CHLORIDE:INTRABURSAL:INJECTION:%	INTRABURSAL	0.9% INTRABURSAL INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
451W47IQ8X	SODIUM CHLORIDE:INTRACARDIAC:INJECTION:%	INTRACARDIAC	0.7% INTRACARDIAC INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
451W47IQ8X	SODIUM CHLORIDE:INTRACARDIAC:SOLUTION, INJECTION:NA	INTRACARDIAC	INTRACARDIAC SOLUTION, INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
451W47IQ8X	SODIUM CHLORIDE:INTRACAUDAL:INJECTION:%	INTRACAUDAL	0.86% INTRACAUDAL INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
451W47IQ8X	SODIUM CHLORIDE:INTRACAUDAL:INJECTION, SOLUTION:MG/1ML	INTRACAUDAL	7MG/1ML INTRACAUDAL INJECTION, SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
451W47IQ8X	SODIUM CHLORIDE:INTRACAVITARY:INJECTION:%	INTRACAVITARY	0.82% INTRACAVITARY INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
451W47IQ8X	SODIUM CHLORIDE:INTRACAVITARY:POWDER, FOR INJECTION SOLUTION:NA	INTRACAVITARY	INTRACAVITARY POWDER, FOR INJECTION SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
451W47IQ8X	SODIUM CHLORIDE:INTRADERMAL:INJECTION:%	INTRADERMAL	0.7% INTRADERMAL INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
451W47IQ8X	SODIUM CHLORIDE:INTRADERMAL:INJECTION, SUSTAINED ACTION:NA	INTRADERMAL	INTRADERMAL INJECTION, SUSTAINED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
451W47IQ8X	SODIUM CHLORIDE:INTRALESIONAL:INJECTABLE:%	INTRALESIONAL	0.87% INTRALESIONAL INJECTABLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
451W47IQ8X	SODIUM CHLORIDE:INTRALESIONAL:INJECTION:%	INTRALESIONAL	0.85% INTRALESIONAL INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
451W47IQ8X	SODIUM CHLORIDE:INTRALESIONAL:INJECTION, SUSTAINED ACTION:%	INTRALESIONAL	0.9% INTRALESIONAL INJECTION, SUSTAINED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
451W47IQ8X	SODIUM CHLORIDE:INTRALESIONAL:SUSPENSION, INJECTION:%	INTRALESIONAL	0.22% INTRALESIONAL SUSPENSION, INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
451W47IQ8X	SODIUM CHLORIDE:INTRAMUSCULAR:INJECTABLE:mg/1mL	INTRAMUSCULAR	3.3mg/1mL INTRAMUSCULAR INJECTABLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
451W47IQ8X	SODIUM CHLORIDE:INTRAMUSCULAR:INJECTABLE:%W/V	INTRAMUSCULAR	0.87%W/V INTRAMUSCULAR INJECTABLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
451W47IQ8X	SODIUM CHLORIDE:INTRAMUSCULAR:INJECTION:%W/V	INTRAMUSCULAR	0.9%W/V INTRAMUSCULAR INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
451W47IQ8X	SODIUM CHLORIDE:INTRAMUSCULAR:INJECTION, SOLUTION:%W/V	INTRAMUSCULAR	0.9%W/V INTRAMUSCULAR INJECTION, SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
451W47IQ8X	SODIUM CHLORIDE:INTRAMUSCULAR:INJECTION, SUSPENSION, EXTENDED RELEASE:%	INTRAMUSCULAR	1.96% INTRAMUSCULAR INJECTION, SUSPENSION, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
451W47IQ8X	SODIUM CHLORIDE:INTRAMUSCULAR:INJECTION, SUSTAINED ACTION:%W/V	INTRAMUSCULAR	0.9%W/V INTRAMUSCULAR INJECTION, SUSTAINED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
451W47IQ8X	SODIUM CHLORIDE:INTRAMUSCULAR:LIQUID:%W/V	INTRAMUSCULAR	0.67%W/V INTRAMUSCULAR LIQUID	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
451W47IQ8X	SODIUM CHLORIDE:INTRAMUSCULAR:POWDER, FOR INJECTION SOLUTION:%	INTRAMUSCULAR	22.6% INTRAMUSCULAR POWDER, FOR INJECTION SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
451W47IQ8X	SODIUM CHLORIDE:INTRAMUSCULAR:POWDER, FOR INJECTION SOLUTION, LYOPHILIZED, WITH ADDITIVES:%	INTRAMUSCULAR	0.24% INTRAMUSCULAR POWDER, FOR INJECTION SOLUTION, LYOPHILIZED, WITH ADDITIVES	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
451W47IQ8X	SODIUM CHLORIDE:INTRAMUSCULAR:SOLUTION:mg/1mL	INTRAMUSCULAR	9mg/1mL INTRAMUSCULAR SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
451W47IQ8X	SODIUM CHLORIDE:INTRAMUSCULAR:SOLUTION, INJECTION:%W/V	INTRAMUSCULAR	0.9%W/V INTRAMUSCULAR SOLUTION, INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
451W47IQ8X	SODIUM CHLORIDE:INTRAMUSCULAR:SUSPENSION:%	INTRAMUSCULAR	0.9% INTRAMUSCULAR SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
451W47IQ8X	SODIUM CHLORIDE:INTRAMUSCULAR:SUSPENSION, INJECTION:%W/V	INTRAMUSCULAR	0.87%W/V INTRAMUSCULAR SUSPENSION, INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
451W47IQ8X	SODIUM CHLORIDE:INTRAOCULAR:SOLUTION:%W/V	INTRAOCULAR	0.9%W/V INTRAOCULAR SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
451W47IQ8X	SODIUM CHLORIDE:INTRAPERITONEAL:POWDER, FOR INJECTION SOLUTION:%	INTRAPERITONEAL	22.6% INTRAPERITONEAL POWDER, FOR INJECTION SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
451W47IQ8X	SODIUM CHLORIDE:INTRAPERITONEAL:SOLUTION:%	INTRAPERITONEAL	0.54% INTRAPERITONEAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
451W47IQ8X	SODIUM CHLORIDE:INTRAPLEURAL:POWDER, FOR INJECTION SOLUTION:%	INTRAPLEURAL	22.6% INTRAPLEURAL POWDER, FOR INJECTION SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
451W47IQ8X	SODIUM CHLORIDE:INTRASYNOVIAL:INJECTABLE:%	INTRASYNOVIAL	0.87% INTRASYNOVIAL INJECTABLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
451W47IQ8X	SODIUM CHLORIDE:INTRASYNOVIAL:INJECTION:%	INTRASYNOVIAL	0.9% INTRASYNOVIAL INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
451W47IQ8X	SODIUM CHLORIDE:INTRASYNOVIAL:INJECTION, SUSTAINED ACTION:%	INTRASYNOVIAL	0.9% INTRASYNOVIAL INJECTION, SUSTAINED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
451W47IQ8X	SODIUM CHLORIDE:INTRASYNOVIAL:SUSPENSION, INJECTION:%	INTRASYNOVIAL	0.22% INTRASYNOVIAL SUSPENSION, INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
451W47IQ8X	SODIUM CHLORIDE:INTRA-SYNOVIAL:SUSPENSION, INJECTION:mg/1mL	INTRA-SYNOVIAL	1.5mg/1mL INTRA-SYNOVIAL SUSPENSION, INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
451W47IQ8X	SODIUM CHLORIDE:INTRATHECAL:INJECTABLE:%	INTRATHECAL	0.9% INTRATHECAL INJECTABLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
451W47IQ8X	SODIUM CHLORIDE:INTRATHECAL:INJECTION:%	INTRATHECAL	19.6% INTRATHECAL INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
451W47IQ8X	SODIUM CHLORIDE:INTRATHECAL:INJECTION:MG/ML	INTRATHECAL	9MG/ML INTRATHECAL INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
451W47IQ8X	SODIUM CHLORIDE:INTRATHECAL:INJECTION, SOLUTION:mg/1mL	INTRATHECAL	8mg/1mL INTRATHECAL INJECTION, SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
451W47IQ8X	SODIUM CHLORIDE:INTRATHECAL:INJECTION, SUSPENSION, LIPOSOMAL:%	INTRATHECAL	9% INTRATHECAL INJECTION, SUSPENSION, LIPOSOMAL	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
451W47IQ8X	SODIUM CHLORIDE:INTRATHECAL:POWDER, FOR INJECTION SOLUTION:%	INTRATHECAL	0.14% INTRATHECAL POWDER, FOR INJECTION SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
451W47IQ8X	SODIUM CHLORIDE:INTRATHECAL:SOLUTION, INJECTION:%	INTRATHECAL	0.9% INTRATHECAL SOLUTION, INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
451W47IQ8X	SODIUM CHLORIDE:INTRATRACHEAL:INJECTION:%	INTRATRACHEAL	1.2% INTRATRACHEAL INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
451W47IQ8X	SODIUM CHLORIDE:INTRATRACHEAL:POWDER, FOR SUSPENSION:%	INTRATRACHEAL	4.68% INTRATRACHEAL POWDER, FOR SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
451W47IQ8X	SODIUM CHLORIDE:INTRATRACHEAL:SUSPENSION:%	INTRATRACHEAL	0.76% INTRATRACHEAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
451W47IQ8X	SODIUM CHLORIDE:INTRATUMOR:INJECTABLE:NA	INTRATUMOR	INTRATUMOR INJECTABLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
451W47IQ8X	SODIUM CHLORIDE:INTRATUMOR:INJECTION:%	INTRATUMOR	1.2% INTRATUMOR INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
451W47IQ8X	SODIUM CHLORIDE:INTRATUMOR:POWDER, FOR INJECTION SOLUTION:NA	INTRATUMOR	INTRATUMOR POWDER, FOR INJECTION SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
451W47IQ8X	SODIUM CHLORIDE:INTRATYMPANIC:SUSPENSION:%W/W	INTRATYMPANIC	0.43%W/W INTRATYMPANIC SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
451W47IQ8X	SODIUM CHLORIDE:INTRAVASCULAR:INJECTION:mg/1mL	INTRAVASCULAR	8.6mg/1mL INTRAVASCULAR INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
451W47IQ8X	SODIUM CHLORIDE:INTRAVASCULAR:SOLUTION:NA	INTRAVASCULAR	INTRAVASCULAR SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
451W47IQ8X	SODIUM CHLORIDE:INTRAVENOUS:INJECTABLE:%	INTRAVENOUS	90% INTRAVENOUS INJECTABLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
451W47IQ8X	SODIUM CHLORIDE:INTRAVENOUS:INJECTABLE:MG/1ML	INTRAVENOUS	9MG/1ML INTRAVENOUS INJECTABLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
451W47IQ8X	SODIUM CHLORIDE:INTRAVENOUS:INJECTION:MG/1ML	INTRAVENOUS	18MG/1ML INTRAVENOUS INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
451W47IQ8X	SODIUM CHLORIDE:INTRAVENOUS:INJECTION:%	INTRAVENOUS	9.14% INTRAVENOUS INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
451W47IQ8X	SODIUM CHLORIDE:INTRAVENOUS:INJECTION:MG/ML	INTRAVENOUS	9MG/ML INTRAVENOUS INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
451W47IQ8X	SODIUM CHLORIDE:INTRAVENOUS:INJECTION:%	INTRAVENOUS	0.9% INTRAVENOUS INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
451W47IQ8X	SODIUM CHLORIDE:INTRAVENOUS:INJECTION:%W/V	INTRAVENOUS	0.9%W/V INTRAVENOUS INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
451W47IQ8X	SODIUM CHLORIDE:INTRAVENOUS:INJECTION, EMULSION:MG/ML	INTRAVENOUS	6.2MG/ML INTRAVENOUS INJECTION, EMULSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
451W47IQ8X	SODIUM CHLORIDE:INTRAVENOUS:INJECTION, SOLUTION:%	INTRAVENOUS	0.9% INTRAVENOUS INJECTION, SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
451W47IQ8X	SODIUM CHLORIDE:INTRAVENOUS:LIQUID:%	INTRAVENOUS	0.9% INTRAVENOUS LIQUID	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
451W47IQ8X	SODIUM CHLORIDE:INTRAVENOUS:LIQUID, WATER, STERILE, FOR INJECTION:%	INTRAVENOUS	0.9% INTRAVENOUS LIQUID, WATER, STERILE, FOR INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
451W47IQ8X	SODIUM CHLORIDE:INTRAVENOUS:POWDER, FOR INJECTION SOLUTION:%	INTRAVENOUS	48.7% INTRAVENOUS POWDER, FOR INJECTION SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
451W47IQ8X	SODIUM CHLORIDE:INTRAVENOUS:POWDER, FOR INJECTION SOLUTION, LYOPHILIZED:%	INTRAVENOUS	13.7% INTRAVENOUS POWDER, FOR INJECTION SOLUTION, LYOPHILIZED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
451W47IQ8X	SODIUM CHLORIDE:INTRAVENOUS:POWDER, FOR INJECTION SOLUTION, LYOPHILIZED:MG/1VIAL	INTRAVENOUS	4.5MG/1VIAL INTRAVENOUS POWDER, FOR INJECTION SOLUTION, LYOPHILIZED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
451W47IQ8X	SODIUM CHLORIDE:INTRAVENOUS:POWDER, FOR INJECTION SOLUTION, LYOPHILIZED, WITH ADDITIVES:%	INTRAVENOUS	3.15% INTRAVENOUS POWDER, FOR INJECTION SOLUTION, LYOPHILIZED, WITH ADDITIVES	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
451W47IQ8X	SODIUM CHLORIDE:INTRAVENOUS:SOLUTION:%	INTRAVENOUS	0.9% INTRAVENOUS SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
451W47IQ8X	SODIUM CHLORIDE:INTRAVENOUS:SOLUTION, INJECTION:MG/ML	INTRAVENOUS	9MG/ML INTRAVENOUS SOLUTION, INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
451W47IQ8X	SODIUM CHLORIDE:INTRAVENOUS:SOLUTION, INJECTION:%	INTRAVENOUS	8.9% INTRAVENOUS SOLUTION, INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
451W47IQ8X	SODIUM CHLORIDE:INTRAVENOUS:SOLUTION, INJECTION:%	INTRAVENOUS	0.8% INTRAVENOUS SOLUTION, INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
451W47IQ8X	SODIUM CHLORIDE:INTRAVENOUS:SOLUTION, LIQUID:uL/1mL	INTRAVENOUS	801.1uL/1mL INTRAVENOUS SOLUTION, LIQUID	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
451W47IQ8X	SODIUM CHLORIDE:INTRAVENOUS BOLUS:INJECTABLE:%	INTRAVENOUS BOLUS	0.9% INTRAVENOUS BOLUS INJECTABLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
451W47IQ8X	SODIUM CHLORIDE:INTRAVENOUS BOLUS:SOLUTION, INJECTION:%	INTRAVENOUS BOLUS	0.9% INTRAVENOUS BOLUS SOLUTION, INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
451W47IQ8X	SODIUM CHLORIDE:INTRAVENOUS INFUSION:INJECTABLE:MG/1ML	INTRAVENOUS INFUSION	9MG/1ML INTRAVENOUS INFUSION INJECTABLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
451W47IQ8X	SODIUM CHLORIDE:INTRAVENOUS INFUSION:INJECTION:MG/1ML	INTRAVENOUS INFUSION	4.8MG/1ML INTRAVENOUS INFUSION INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
451W47IQ8X	SODIUM CHLORIDE:INTRAVENOUS INFUSION:INJECTION, SOLUTION:%	INTRAVENOUS INFUSION	0.9% INTRAVENOUS INFUSION INJECTION, SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
451W47IQ8X	SODIUM CHLORIDE:INTRAVESICAL:SOLUTION, INJECTION:%	INTRAVESICAL	35.1% INTRAVESICAL SOLUTION, INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
451W47IQ8X	SODIUM CHLORIDE:INTRAVITREAL:INJECTABLE:%	INTRAVITREAL	10% INTRAVITREAL INJECTABLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
451W47IQ8X	SODIUM CHLORIDE:INTRAVITREAL:INJECTION:%	INTRAVITREAL	0.77% INTRAVITREAL INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
451W47IQ8X	SODIUM CHLORIDE:INTRAVITREAL:SUSPENSION, INJECTION:%	INTRAVITREAL	0.55% INTRAVITREAL SUSPENSION, INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
451W47IQ8X	SODIUM CHLORIDE:IONTOPHORESIS:DRUG DELIVERY SYSTEM:MG	IONTOPHORESIS	0.6MG IONTOPHORESIS DRUG DELIVERY SYSTEM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
451W47IQ8X	SODIUM CHLORIDE:IONTOPHORESIS:PATCH, CONTROLLED RELEASE:MG	IONTOPHORESIS	3.1MG IONTOPHORESIS PATCH, CONTROLLED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
451W47IQ8X	SODIUM CHLORIDE:IONTOPHORESIS:SOLUTION:%	IONTOPHORESIS	0.6% IONTOPHORESIS SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
451W47IQ8X	SODIUM CHLORIDE:IV - SC:INJECTION:MG/1ML	IV - SC	8.6MG/1ML IV - SC INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
451W47IQ8X	SODIUM CHLORIDE:IV - SC:INJECTION:%	IV - SC	1.8% IV - SC INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
451W47IQ8X	SODIUM CHLORIDE:IV - SC:INJECTION, SOLUTION:%	IV - SC	0.7% IV - SC INJECTION, SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
451W47IQ8X	SODIUM CHLORIDE:IV - SC:POWDER, FOR INJECTION SOLUTION:%	IV - SC	0.68% IV - SC POWDER, FOR INJECTION SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
451W47IQ8X	SODIUM CHLORIDE:IV - SC:SOLUTION, INJECTION:%	IV - SC	0.9% IV - SC SOLUTION, INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
451W47IQ8X	SODIUM CHLORIDE:IV (INFUSION):SOLUTION:MG/1ML	IV (INFUSION)	9MG/1ML IV (INFUSION) SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
451W47IQ8X	SODIUM CHLORIDE:IV(INFUSION):INJECTABLE:%	IV(INFUSION)	0.9% IV(INFUSION) INJECTABLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
451W47IQ8X	SODIUM CHLORIDE:IV(INFUSION):INJECTION:mg/1mL	IV(INFUSION)	8.5mg/1mL IV(INFUSION) INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
451W47IQ8X	SODIUM CHLORIDE:IV(INFUSION):LIQUID:%	IV(INFUSION)	0.9% IV(INFUSION) LIQUID	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
451W47IQ8X	SODIUM CHLORIDE:IV(INFUSION):LIQUID, WATER, STERILE, FOR INJECTION:%	IV(INFUSION)	0.8% IV(INFUSION) LIQUID, WATER, STERILE, FOR INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
451W47IQ8X	SODIUM CHLORIDE:IV(INFUSION):POWDER, FOR INJECTION SOLUTION:%	IV(INFUSION)	45% IV(INFUSION) POWDER, FOR INJECTION SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
451W47IQ8X	SODIUM CHLORIDE:IV(INFUSION):POWDER, FOR INJECTION SOLUTION, LYOPHILIZED, WITH ADDITIVES:%	IV(INFUSION)	3.15% IV(INFUSION) POWDER, FOR INJECTION SOLUTION, LYOPHILIZED, WITH ADDITIVES	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
451W47IQ8X	SODIUM CHLORIDE:IV(INFUSION):SUSPENSION, INJECTION:%	IV(INFUSION)	0.9% IV(INFUSION) SUSPENSION, INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
451W47IQ8X	SODIUM CHLORIDE:NASAL:SOLUTION:%	NASAL	0.9% NASAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
451W47IQ8X	SODIUM CHLORIDE:NASAL:SOLUTION, FOR INHALATION:%	NASAL	1.13% NASAL SOLUTION, FOR INHALATION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
451W47IQ8X	SODIUM CHLORIDE:NASAL:SOLUTION, SPRAY:%	NASAL	0.68% NASAL SOLUTION, SPRAY	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
451W47IQ8X	SODIUM CHLORIDE:NASAL:SOLUTION, SPRAY, METERED, PUMP:%	NASAL	0.093% NASAL SOLUTION, SPRAY, METERED, PUMP	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
451W47IQ8X	SODIUM CHLORIDE:NASAL:SPRAY:MG/1ML	NASAL	7.5MG/1ML NASAL SPRAY	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
451W47IQ8X	SODIUM CHLORIDE:NASAL:SPRAY:%	NASAL	0.7% NASAL SPRAY	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
451W47IQ8X	SODIUM CHLORIDE:NASAL:SPRAY, METERED:MCG/SPRAY	NASAL	931.6MCG/SPRAY NASAL SPRAY, METERED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
451W47IQ8X	SODIUM CHLORIDE:NASAL:SPRAY, METERED:%	NASAL	1.9% NASAL SPRAY, METERED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
451W47IQ8X	SODIUM CHLORIDE:NERVE BLOCK:INJECTABLE:NA	NERVE BLOCK	NERVE BLOCK INJECTABLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
451W47IQ8X	SODIUM CHLORIDE:NERVE BLOCK:INJECTION:%	NERVE BLOCK	0.9% NERVE BLOCK INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
451W47IQ8X	SODIUM CHLORIDE:NERVE BLOCK:SOLUTION, INJECTION:%	NERVE BLOCK	0.9% NERVE BLOCK SOLUTION, INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
451W47IQ8X	SODIUM CHLORIDE:OPHTHALMIC:DROPS:%	OPHTHALMIC	0.65% OPHTHALMIC DROPS	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
451W47IQ8X	SODIUM CHLORIDE:OPHTHALMIC:GEL:%	OPHTHALMIC	0.9% OPHTHALMIC GEL	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
451W47IQ8X	SODIUM CHLORIDE:OPHTHALMIC:POWDER, FOR SOLUTION:%	OPHTHALMIC	0.9% OPHTHALMIC POWDER, FOR SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
451W47IQ8X	SODIUM CHLORIDE:OPHTHALMIC:POWDER, FOR SUSPENSION:NA	OPHTHALMIC	OPHTHALMIC POWDER, FOR SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
451W47IQ8X	SODIUM CHLORIDE:OPHTHALMIC:SOLUTION:mg/1mL	OPHTHALMIC	8mg/1mL OPHTHALMIC SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
451W47IQ8X	SODIUM CHLORIDE:OPHTHALMIC:SOLUTION:%	OPHTHALMIC	4% OPHTHALMIC SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
451W47IQ8X	SODIUM CHLORIDE:OPHTHALMIC:SOLUTION:%W/V	OPHTHALMIC	0.05%W/V OPHTHALMIC SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
451W47IQ8X	SODIUM CHLORIDE:OPHTHALMIC:SOLUTION, DROPS:%	OPHTHALMIC	0.9% OPHTHALMIC SOLUTION, DROPS	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
451W47IQ8X	SODIUM CHLORIDE:OPHTHALMIC:SOLUTION/ DROPS:MG/1ML	OPHTHALMIC	8.3MG/1ML OPHTHALMIC SOLUTION/ DROPS	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
451W47IQ8X	SODIUM CHLORIDE:OPHTHALMIC:SOLUTION/DROPS:%	OPHTHALMIC	0.82% OPHTHALMIC SOLUTION/DROPS	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
451W47IQ8X	SODIUM CHLORIDE:OPHTHALMIC:SUSPENSION:%	OPHTHALMIC	0.85% OPHTHALMIC SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
451W47IQ8X	SODIUM CHLORIDE:OPHTHALMIC:SUSPENSION, DROPS:%	OPHTHALMIC	0.68% OPHTHALMIC SUSPENSION, DROPS	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
451W47IQ8X	SODIUM CHLORIDE:ORAL:CAPSULE:MG	ORAL	6MG ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
451W47IQ8X	SODIUM CHLORIDE:ORAL:CAPSULE, EXTENDED RELEASE:MG	ORAL	20.72MG ORAL CAPSULE, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
451W47IQ8X	SODIUM CHLORIDE:ORAL:DROPS:NA	ORAL	ORAL DROPS	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
451W47IQ8X	SODIUM CHLORIDE:ORAL:GRANULE, FOR SUSPENSION:MG	ORAL	13.5MG ORAL GRANULE, FOR SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
451W47IQ8X	SODIUM CHLORIDE:ORAL:POWDER, FOR ORAL SOLUTION:MG	ORAL	25.27MG ORAL POWDER, FOR ORAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
451W47IQ8X	SODIUM CHLORIDE:ORAL:POWDER, FOR ORAL SUSPENSION:MG/5ML	ORAL	5MG/5ML ORAL POWDER, FOR ORAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
451W47IQ8X	SODIUM CHLORIDE:ORAL:POWDER, FOR SOLUTION:NA	ORAL	ORAL POWDER, FOR SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
451W47IQ8X	SODIUM CHLORIDE:ORAL:POWDER, FOR SUSPENSION:MG/5ML	ORAL	12.5MG/5ML ORAL POWDER, FOR SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
451W47IQ8X	SODIUM CHLORIDE:ORAL:SOLUTION:%	ORAL	0.9% ORAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
451W47IQ8X	SODIUM CHLORIDE:ORAL:SOLUTION, ELIXIR:MG/5ML	ORAL	2MG/5ML ORAL SOLUTION, ELIXIR	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
451W47IQ8X	SODIUM CHLORIDE:ORAL:SOLUTION, FOR INHALATION:MG	ORAL	27MG ORAL SOLUTION, FOR INHALATION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
451W47IQ8X	SODIUM CHLORIDE:ORAL:SOLUTION, SYRUP:MG/1ML	ORAL	0.4MG/1ML ORAL SOLUTION, SYRUP	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
451W47IQ8X	SODIUM CHLORIDE:ORAL:SUSPENSION:MG/1ML	ORAL	20MG/1ML ORAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
451W47IQ8X	SODIUM CHLORIDE:ORAL:SUSPENSION, FOR INHALATION:MG/2ML	ORAL	17MG/2ML ORAL SUSPENSION, FOR INHALATION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
451W47IQ8X	SODIUM CHLORIDE:ORAL:SYRUP:MG/1ML	ORAL	3MG/1ML ORAL SYRUP	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
451W47IQ8X	SODIUM CHLORIDE:ORAL:TABLET:MG	ORAL	150MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
451W47IQ8X	SODIUM CHLORIDE:ORAL:TABLET (IMMED./COMP. RELEASE), UNCOATED, CHEWABLE:MG	ORAL	7.5MG ORAL TABLET (IMMED./COMP. RELEASE), UNCOATED, CHEWABLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
451W47IQ8X	SODIUM CHLORIDE:ORAL:TABLET, CONTROLLED RELEASE:MG	ORAL	36MG ORAL TABLET, CONTROLLED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
451W47IQ8X	SODIUM CHLORIDE:ORAL:TABLET, DELAYED ACTION:MG	ORAL	24MG ORAL TABLET, DELAYED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
451W47IQ8X	SODIUM CHLORIDE:ORAL:TABLET, DELAYED RELEASE:MG	ORAL	30MG ORAL TABLET, DELAYED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
451W47IQ8X	SODIUM CHLORIDE:ORAL:TABLET, EXTENDED RELEASE:MG	ORAL	335.1MG ORAL TABLET, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
451W47IQ8X	SODIUM CHLORIDE:ORAL:TABLET, FILM COATED:MG	ORAL	100MG ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
451W47IQ8X	SODIUM CHLORIDE:ORAL:TABLET, ORALLY DISINTEGRATING:MG	ORAL	10MG ORAL TABLET, ORALLY DISINTEGRATING	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
451W47IQ8X	SODIUM CHLORIDE:ORAL:TABLET, SUSTAINED ACTION:MG	ORAL	143.26MG ORAL TABLET, SUSTAINED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
451W47IQ8X	SODIUM CHLORIDE:ORAL:TABLET, SUSTAINED ACTION, COATED:MG	ORAL	46.8MG ORAL TABLET, SUSTAINED ACTION, COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
451W47IQ8X	SODIUM CHLORIDE:OTIC:SUSPENSION:%	OTIC	0.53% OTIC SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
451W47IQ8X	SODIUM CHLORIDE:PARENTERAL:INJECTABLE:%	PARENTERAL	C% PARENTERAL INJECTABLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
451W47IQ8X	SODIUM CHLORIDE:PARENTERAL:INJECTION:%	PARENTERAL	24% PARENTERAL INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
451W47IQ8X	SODIUM CHLORIDE:PARENTERAL:LIQUID, WATER, STERILE, FOR INJECTION:%	PARENTERAL	0.8% PARENTERAL LIQUID, WATER, STERILE, FOR INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
451W47IQ8X	SODIUM CHLORIDE:PERIDURAL:INJECTION:%	PERIDURAL	0.81% PERIDURAL INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
451W47IQ8X	SODIUM CHLORIDE:PERINEURAL:INJECTION:mg/1mL	PERINEURAL	8.6mg/1mL PERINEURAL INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
451W47IQ8X	SODIUM CHLORIDE:PERINEURAL:INJECTION:%	PERINEURAL	0.7% PERINEURAL INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
451W47IQ8X	SODIUM CHLORIDE:PHOTOPHERESIS:SOLUTION:%	PHOTOPHERESIS	0.8% PHOTOPHERESIS SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
451W47IQ8X	SODIUM CHLORIDE:RECTAL:ENEMA:%	RECTAL	0.7% RECTAL ENEMA	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
451W47IQ8X	SODIUM CHLORIDE:RECTAL:SOLUTION:NA	RECTAL	RECTAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
451W47IQ8X	SODIUM CHLORIDE:RECTAL:SUPPOSITORY:MG	RECTAL	52.5MG RECTAL SUPPOSITORY	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
451W47IQ8X	SODIUM CHLORIDE:RESPIRATORY (INHALATION):INHALANT:%	RESPIRATORY (INHALATION)	0.86% RESPIRATORY (INHALATION) INHALANT	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
451W47IQ8X	SODIUM CHLORIDE:RESPIRATORY (INHALATION):SOLUTION:%W/V	RESPIRATORY (INHALATION)	0.9%W/V RESPIRATORY (INHALATION) SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
451W47IQ8X	SODIUM CHLORIDE:RESPIRATORY (INHALATION):SOLUTION, AEROSOL, FOR INHALATION:%	RESPIRATORY (INHALATION)	0.23% RESPIRATORY (INHALATION) SOLUTION, AEROSOL, FOR INHALATION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
451W47IQ8X	SODIUM CHLORIDE:RESPIRATORY (INHALATION):SOLUTION, FOR INHALATION:%W/V	RESPIRATORY (INHALATION)	0.9%W/V RESPIRATORY (INHALATION) SOLUTION, FOR INHALATION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
451W47IQ8X	SODIUM CHLORIDE:RESPIRATORY (INHALATION):SUSPENSION, FOR INHALATION:%W/V	RESPIRATORY (INHALATION)	0.85%W/V RESPIRATORY (INHALATION) SUSPENSION, FOR INHALATION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
451W47IQ8X	SODIUM CHLORIDE:RETROBULBAR:INJECTION:%	RETROBULBAR	0.86% RETROBULBAR INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
451W47IQ8X	SODIUM CHLORIDE:SOFT TISSUE:INJECTABLE:%	SOFT TISSUE	0.66% SOFT TISSUE INJECTABLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
451W47IQ8X	SODIUM CHLORIDE:SOFT TISSUE:INJECTION:%	SOFT TISSUE	0.85% SOFT TISSUE INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
451W47IQ8X	SODIUM CHLORIDE:SOFT TISSUE:INJECTION, SUSTAINED ACTION:%	SOFT TISSUE	0.9% SOFT TISSUE INJECTION, SUSTAINED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
451W47IQ8X	SODIUM CHLORIDE:SOFT TISSUE:SUSPENSION, INJECTION:%	SOFT TISSUE	0.22% SOFT TISSUE SUSPENSION, INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
451W47IQ8X	SODIUM CHLORIDE:SUBARACHNOID:SOLUTION, INJECTION:%	SUBARACHNOID	0.9% SUBARACHNOID SOLUTION, INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
451W47IQ8X	SODIUM CHLORIDE:SUBCUTANEOUS:IMPLANT:MG	SUBCUTANEOUS	77MG SUBCUTANEOUS IMPLANT	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
451W47IQ8X	SODIUM CHLORIDE:SUBCUTANEOUS:INJECTABLE:%	SUBCUTANEOUS	0.89% SUBCUTANEOUS INJECTABLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
451W47IQ8X	SODIUM CHLORIDE:SUBCUTANEOUS:INJECTION:MG/1ML	SUBCUTANEOUS	9MG/1ML SUBCUTANEOUS INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
451W47IQ8X	SODIUM CHLORIDE:SUBCUTANEOUS:INJECTION, SOLUTION:%W/V	SUBCUTANEOUS	0.9%W/V SUBCUTANEOUS INJECTION, SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
451W47IQ8X	SODIUM CHLORIDE:SUBCUTANEOUS:INJECTION, SOLUTION:%	SUBCUTANEOUS	0.15% SUBCUTANEOUS INJECTION, SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
451W47IQ8X	SODIUM CHLORIDE:SUBCUTANEOUS:SOLUTION:mg/1mL	SUBCUTANEOUS	9mg/1mL SUBCUTANEOUS SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
451W47IQ8X	SODIUM CHLORIDE:SUBCUTANEOUS:SOLUTION, INJECTION:%	SUBCUTANEOUS	2.25% SUBCUTANEOUS SOLUTION, INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
451W47IQ8X	SODIUM CHLORIDE:SUBCUTANEOUS:SUSPENSION, INJECTION:%	SUBCUTANEOUS	1.23% SUBCUTANEOUS SUSPENSION, INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
451W47IQ8X	SODIUM CHLORIDE:SUBMUCOSAL:INJECTION:%	SUBMUCOSAL	0.16% SUBMUCOSAL INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
451W47IQ8X	SODIUM CHLORIDE:SUBMUCOSAL:SOLUTION, INJECTION:%	SUBMUCOSAL	16% SUBMUCOSAL SOLUTION, INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
451W47IQ8X	SODIUM CHLORIDE:TOPICAL:EMULSION, CREAM:NA	TOPICAL	TOPICAL EMULSION, CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
451W47IQ8X	SODIUM CHLORIDE:TOPICAL:GEL:%W/W	TOPICAL	0.18%W/W TOPICAL GEL	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
451W47IQ8X	SODIUM CHLORIDE:TOPICAL:JELLY:NA	TOPICAL	TOPICAL JELLY	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
451W47IQ8X	SODIUM CHLORIDE:TOPICAL:LOTION:%W/V	TOPICAL	0.3%W/V TOPICAL LOTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
451W47IQ8X	SODIUM CHLORIDE:TOPICAL:OINTMENT:NA	TOPICAL	TOPICAL OINTMENT	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
451W47IQ8X	SODIUM CHLORIDE:TOPICAL:OPHTHALMIC SUSPENSION DOSAGE FORM:%W/V	TOPICAL	0.5%W/V TOPICAL OPHTHALMIC SUSPENSION DOSAGE FORM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
451W47IQ8X	SODIUM CHLORIDE:TOPICAL:PATCH, CONTROLLED RELEASE:MG	TOPICAL	3.1MG TOPICAL PATCH, CONTROLLED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
451W47IQ8X	SODIUM CHLORIDE:TOPICAL:SHAMPOO:%W/W	TOPICAL	2.25%W/W TOPICAL SHAMPOO	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
451W47IQ8X	SODIUM CHLORIDE:TOPICAL:SOLUTION:%W/V	TOPICAL	0.9%W/V TOPICAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
451W47IQ8X	SODIUM CHLORIDE:TOPICAL:SOLUTION, DROPS:%W/V	TOPICAL	0.86%W/V TOPICAL SOLUTION, DROPS	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
451W47IQ8X	SODIUM CHLORIDE:TOPICAL:SOLUTION/DROPS:%W/V	TOPICAL	0.82%W/V TOPICAL SOLUTION/DROPS	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
451W47IQ8X	SODIUM CHLORIDE:TOPICAL:SUSPENSION:%W/W	TOPICAL	0.3%W/W TOPICAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
451W47IQ8X	SODIUM CHLORIDE:TOPICAL:SUSPENSION, DROPS:MG/ML	TOPICAL	5.05MG/ML TOPICAL SUSPENSION, DROPS	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
451W47IQ8X	SODIUM CHLORIDE:TRANSDERMAL:DRUG DELIVERY SYSTEM:MG	TRANSDERMAL	0.6MG TRANSDERMAL DRUG DELIVERY SYSTEM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
SX01TZO3QZ	SODIUM PHOSPHATE, TRIBASIC, ANHYDROUS:ORAL:POWDER, FOR ORAL SUSPENSION:MG/25.169GM	ORAL	353MG/25.169GM ORAL POWDER, FOR ORAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
SX01TZO3QZ	SODIUM PHOSPHATE, TRIBASIC, ANHYDROUS:ORAL:SUSPENSION:mg/5mL	ORAL	52.8mg/5mL ORAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
B5TNV5E10B	DINOSEB-AMMONIUM:TOPICAL:SOLUTION:NA	TOPICAL	TOPICAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
B5TNV5E10B	DINOSEB-AMMONIUM:TOPICAL:SPONGE:NA	TOPICAL	TOPICAL SPONGE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
Z4152N8IUI	SILICON:ORAL:DROPS:NA	ORAL	ORAL DROPS	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
Z4152N8IUI	SILICON:ORAL:POWDER, FOR SUSPENSION:NA	ORAL	ORAL POWDER, FOR SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
Z4152N8IUI	SILICON:ORAL:SUSPENSION:NA	ORAL	ORAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
Z4152N8IUI	SILICON:TOPICAL:EMULSION, CREAM:%W/W	TOPICAL	0.4%W/W TOPICAL EMULSION, CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
Z4152N8IUI	SILICON:TOPICAL:LOTION:NA	TOPICAL	TOPICAL LOTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
Z4152N8IUI	SILICON:TRANSDERMAL:FILM, CONTROLLED RELEASE:NA	TRANSDERMAL	TRANSDERMAL FILM, CONTROLLED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
0E2639OTJY	PEG-6 ISOSTEARATE:TOPICAL:EMULSION, LOTION:%W/W	TOPICAL	2%W/W TOPICAL EMULSION, LOTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
0E2639OTJY	PEG-6 ISOSTEARATE:TOPICAL:LOTION:%W/W	TOPICAL	2%W/W TOPICAL LOTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
8GQS4E66YY	AMMONIO METHACRYLATE COPOLYMER TYPE A:ORAL:CAPSULE, DELAYED ACTION:MG	ORAL	15.36MG ORAL CAPSULE, DELAYED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
8GQS4E66YY	AMMONIO METHACRYLATE COPOLYMER TYPE A:ORAL:CAPSULE, EXTENDED RELEASE:MG	ORAL	42.4MG ORAL CAPSULE, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
8GQS4E66YY	AMMONIO METHACRYLATE COPOLYMER TYPE A:ORAL:CAPSULE, SUSTAINED ACTION:MG	ORAL	25.59MG ORAL CAPSULE, SUSTAINED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
8GQS4E66YY	AMMONIO METHACRYLATE COPOLYMER TYPE A:ORAL:CAPSULE, SUSTAINED ACTION, HARD GELATIN:MG	ORAL	4.2MG ORAL CAPSULE, SUSTAINED ACTION, HARD GELATIN	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
8GQS4E66YY	AMMONIO METHACRYLATE COPOLYMER TYPE A:ORAL:POWDER, FOR SUSPENSION:MG/5ML	ORAL	161MG/5ML ORAL POWDER, FOR SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
8GQS4E66YY	AMMONIO METHACRYLATE COPOLYMER TYPE A:ORAL:TABLET, CONTROLLED RELEASE:NA	ORAL	ORAL TABLET, CONTROLLED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
8GQS4E66YY	AMMONIO METHACRYLATE COPOLYMER TYPE A:ORAL:TABLET, EXTENDED RELEASE:MG	ORAL	8.72MG ORAL TABLET, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
8GQS4E66YY	AMMONIO METHACRYLATE COPOLYMER TYPE A:ORAL:TABLET, SUSTAINED ACTION, COATED:MG	ORAL	25MG ORAL TABLET, SUSTAINED ACTION, COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
S870P55O2W	ISOMALT:ORAL:TABLET:MG	ORAL	522MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=I
S870P55O2W	ISOMALT:ORAL:TABLET, UNCOATED, TROCHE:MG	ORAL	1718.71MG ORAL TABLET, UNCOATED, TROCHE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=I
6941286E4I	PEG-120 GLYCERYL STEARATE:TOPICAL:EMULSION, CREAM:%W/W	TOPICAL	5%W/W TOPICAL EMULSION, CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
6941286E4I	PEG-120 GLYCERYL STEARATE:VAGINAL:EMULSION, CREAM:%	VAGINAL	2% VAGINAL EMULSION, CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
RWP5GA015D	POTASSIUM:ORAL:SOLUTION:MG	ORAL	35MG ORAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
RWP5GA015D	POTASSIUM:ORAL:TABLET:MG	ORAL	1MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
S38J6RZN16	HYDROXYETHYL CELLULOSE (2000 MPA.S AT 1%):ORAL:TABLET, EXTENDED RELEASE:mg	ORAL	19mg ORAL TABLET, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
DRG3KJZ1TJ	APRICOT KERNEL OIL PEG-6 ESTERS:TOPICAL:EMULSION, CREAM:%W/W	TOPICAL	2.94%W/W TOPICAL EMULSION, CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
DRG3KJZ1TJ	APRICOT KERNEL OIL PEG-6 ESTERS:VAGINAL:EMULSION, CREAM:%	VAGINAL	2.94% VAGINAL EMULSION, CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
0BZ5A00FQU	POLACRILIN POTASSIUM:ORAL:CAPSULE:MG	ORAL	23MG ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
0BZ5A00FQU	POLACRILIN POTASSIUM:ORAL:CAPSULE (IMMED./COMP. RELEASE), HARD GELATIN:MG	ORAL	45.28MG ORAL CAPSULE (IMMED./COMP. RELEASE), HARD GELATIN	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
0BZ5A00FQU	POLACRILIN POTASSIUM:ORAL:SUSPENSION, LIQUID:MG/5ML	ORAL	20MG/5ML ORAL SUSPENSION, LIQUID	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
0BZ5A00FQU	POLACRILIN POTASSIUM:ORAL:TABLET:MG	ORAL	45.8MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
0BZ5A00FQU	POLACRILIN POTASSIUM:ORAL:TABLET (IMMED./COMP. RELEASE), FILM COATED:MG	ORAL	4MG ORAL TABLET (IMMED./COMP. RELEASE), FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
0BZ5A00FQU	POLACRILIN POTASSIUM:ORAL:TABLET (IMMED./COMP. RELEASE), UNCOATED, CHEWABLE:MG	ORAL	21MG ORAL TABLET (IMMED./COMP. RELEASE), UNCOATED, CHEWABLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
0BZ5A00FQU	POLACRILIN POTASSIUM:ORAL:TABLET, COATED:MG	ORAL	5MG ORAL TABLET, COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
0BZ5A00FQU	POLACRILIN POTASSIUM:ORAL:TABLET, FILM COATED:MG	ORAL	40MG ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
0BZ5A00FQU	POLACRILIN POTASSIUM:ORAL:TABLET, ORALLY DISINTEGRATING:MG	ORAL	40MG ORAL TABLET, ORALLY DISINTEGRATING	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
0BZ5A00FQU	POLACRILIN POTASSIUM:ORAL:TABLET, SUSTAINED ACTION:MG	ORAL	10MG ORAL TABLET, SUSTAINED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
G4U024CQK6	HYPROMELLOSE PHTHALATE (31% PHTHALATE, 40 CST):ORAL:CAPSULE:mg	ORAL	5.16mg ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
G4U024CQK6	HYPROMELLOSE PHTHALATE (31% PHTHALATE, 40 CST):ORAL:CAPSULE, DELAYED RELEASE:MG	ORAL	18.1MG ORAL CAPSULE, DELAYED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
G4U024CQK6	HYPROMELLOSE PHTHALATE (31% PHTHALATE, 40 CST):ORAL:TABLET, DELAYED RELEASE:MG	ORAL	16.42MG ORAL TABLET, DELAYED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
12EH9M7279	METHANESULFONIC ACID:IM - IV - SC:INJECTION:ADJ PH	IM - IV - SC	ADJ PH IM - IV - SC INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
12EH9M7279	METHANESULFONIC ACID:INTRAMUSCULAR:INJECTION, SOLUTION:ADJ PH	INTRAMUSCULAR	ADJ PH INTRAMUSCULAR INJECTION, SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
12EH9M7279	METHANESULFONIC ACID:INTRAVENOUS:INJECTION, SOLUTION:ADJ PH	INTRAVENOUS	ADJ PH INTRAVENOUS INJECTION, SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
12EH9M7279	METHANESULFONIC ACID:IV(INFUSION):POWDER, FOR INJECTION SOLUTION, LYOPHILIZED:%	IV(INFUSION)	8.07% IV(INFUSION) POWDER, FOR INJECTION SOLUTION, LYOPHILIZED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
12EH9M7279	METHANESULFONIC ACID:SUBCUTANEOUS:INJECTION:ADJ PH	SUBCUTANEOUS	ADJ PH SUBCUTANEOUS INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
12EH9M7279	METHANESULFONIC ACID:SUBCUTANEOUS:INJECTION, SOLUTION:ADJ PH	SUBCUTANEOUS	ADJ PH SUBCUTANEOUS INJECTION, SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
VP36V95O3T	GENTISIC ACID:INTRAVENOUS:INJECTION:MG/1ML	INTRAVENOUS	0.63MG/1ML INTRAVENOUS INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
IS93EQR73R	POLOXAMER 331:ORAL:POWDER, FOR SOLUTION:MG/5ML	ORAL	1000MG/5ML ORAL POWDER, FOR SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
IS93EQR73R	POLOXAMER 331:ORAL:POWDER, FOR SUSPENSION:MG/5ML	ORAL	26.43MG/5ML ORAL POWDER, FOR SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
FCZ5MH785I	GLYCERYL STEARATE SE:RECTAL:SUPPOSITORY:MG	RECTAL	35MG RECTAL SUPPOSITORY	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
FCZ5MH785I	GLYCERYL STEARATE SE:TOPICAL:EMULSION, CREAM:%W/W 	TOPICAL	4%W/W  TOPICAL EMULSION, CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
FCZ5MH785I	GLYCERYL STEARATE SE:TOPICAL:LOTION:%W/W	TOPICAL	1.15%W/W TOPICAL LOTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
3NXW29V3WO	HYPROMELLOSE 2208 (100000 MPA.S):ORAL:CAPSULE:MG	ORAL	113.7MG ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
3NXW29V3WO	HYPROMELLOSE, UNSPECIFIED:BUCCAL:TABLET:MG	BUCCAL	24MG BUCCAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
3NXW29V3WO	HYPROMELLOSE, UNSPECIFIED:INHALATION:POWDER:MG	INHALATION	45.67MG INHALATION POWDER	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
3NXW29V3WO	HYPROMELLOSE, UNSPECIFIED:IRRIGATION:SOLUTION:NA	IRRIGATION	IRRIGATION SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
3NXW29V3WO	HYPROMELLOSE, UNSPECIFIED:NASAL:POWDER, FOR INHALATION:NA	NASAL	NASAL POWDER, FOR INHALATION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
3NXW29V3WO	HYPROMELLOSE, UNSPECIFIED:NASAL:SOLUTION, SPRAY:%	NASAL	0.1% NASAL SOLUTION, SPRAY	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
3NXW29V3WO	HYPROMELLOSE, UNSPECIFIED:NASAL:SOLUTION, SPRAY, METERED, PUMP:%	NASAL	0.014% NASAL SOLUTION, SPRAY, METERED, PUMP	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
3NXW29V3WO	HYPROMELLOSE, UNSPECIFIED:NASAL:SPRAY:%	NASAL	0.1% NASAL SPRAY	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
3NXW29V3WO	HYPROMELLOSE, UNSPECIFIED:NASAL:SPRAY, METERED:%	NASAL	0.1% NASAL SPRAY, METERED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
3NXW29V3WO	HYPROMELLOSE, UNSPECIFIED:OPHTHALMIC:GEL:%	OPHTHALMIC	2.25% OPHTHALMIC GEL	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
3NXW29V3WO	HYPROMELLOSE, UNSPECIFIED:OPHTHALMIC:SOLUTION:%	OPHTHALMIC	0.5% OPHTHALMIC SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
3NXW29V3WO	HYPROMELLOSE, UNSPECIFIED:OPHTHALMIC:SOLUTION, DROPS:%	OPHTHALMIC	0.5% OPHTHALMIC SOLUTION, DROPS	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
3NXW29V3WO	HYPROMELLOSE, UNSPECIFIED:OPHTHALMIC:SOLUTION/DROPS:%	OPHTHALMIC	0.5% OPHTHALMIC SOLUTION/DROPS	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
3NXW29V3WO	HYPROMELLOSE, UNSPECIFIED:OPHTHALMIC:SUSPENSION:%	OPHTHALMIC	0.5% OPHTHALMIC SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
3NXW29V3WO	HYPROMELLOSE, UNSPECIFIED:OPHTHALMIC:SUSPENSION, DROPS:%	OPHTHALMIC	0.6% OPHTHALMIC SUSPENSION, DROPS	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
3NXW29V3WO	HYPROMELLOSE, UNSPECIFIED:ORAL:CAPSULE:MG	ORAL	155MG ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
3NXW29V3WO	HYPROMELLOSE, UNSPECIFIED:ORAL:CAPSULE, COATED PELLETS:MG	ORAL	3.32MG ORAL CAPSULE, COATED PELLETS	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
3NXW29V3WO	HYPROMELLOSE, UNSPECIFIED:ORAL:CAPSULE, DELAYED ACTION:MG	ORAL	67.87MG ORAL CAPSULE, DELAYED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
3NXW29V3WO	HYPROMELLOSE, UNSPECIFIED:ORAL:CAPSULE, DELAYED ACTION, COATED, HARD GELATIN:MG	ORAL	20MG ORAL CAPSULE, DELAYED ACTION, COATED, HARD GELATIN	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
3NXW29V3WO	HYPROMELLOSE, UNSPECIFIED:ORAL:CAPSULE, DELAYED ACTION, ENTERIC COATED:NA	ORAL	ORAL CAPSULE, DELAYED ACTION, ENTERIC COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
3NXW29V3WO	HYPROMELLOSE, UNSPECIFIED:ORAL:CAPSULE, DELAYED RELEASE:MG	ORAL	96MG ORAL CAPSULE, DELAYED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
3NXW29V3WO	HYPROMELLOSE, UNSPECIFIED:ORAL:CAPSULE, ENTERIC COATED PELLETS:MG	ORAL	64.43MG ORAL CAPSULE, ENTERIC COATED PELLETS	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
3NXW29V3WO	HYPROMELLOSE, UNSPECIFIED:ORAL:CAPSULE, EXTENDED RELEASE:MG	ORAL	118MG ORAL CAPSULE, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
3NXW29V3WO	HYPROMELLOSE, UNSPECIFIED:ORAL:CAPSULE, HARD GELATIN:MG	ORAL	73.9MG ORAL CAPSULE, HARD GELATIN	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
3NXW29V3WO	HYPROMELLOSE, UNSPECIFIED:ORAL:CAPSULE, SOFT GELATIN LIQUID-FILLED:MG	ORAL	118MG ORAL CAPSULE, SOFT GELATIN LIQUID-FILLED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
3NXW29V3WO	HYPROMELLOSE, UNSPECIFIED:ORAL:CAPSULE, SUSTAINED ACTION:MG	ORAL	670.04MG ORAL CAPSULE, SUSTAINED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
3NXW29V3WO	HYPROMELLOSE, UNSPECIFIED:ORAL:CONCENTRATE:NA	ORAL	ORAL CONCENTRATE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
3NXW29V3WO	HYPROMELLOSE, UNSPECIFIED:ORAL:DROPS:MG/1ML	ORAL	1.3MG/1ML ORAL DROPS	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
3NXW29V3WO	HYPROMELLOSE, UNSPECIFIED:ORAL:FILM, SOLUBLE:MG	ORAL	33.5MG ORAL FILM, SOLUBLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
3NXW29V3WO	HYPROMELLOSE, UNSPECIFIED:ORAL:GRANULE:NA	ORAL	ORAL GRANULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
3NXW29V3WO	HYPROMELLOSE, UNSPECIFIED:ORAL:GRANULE, ENTERIC COATED:MG	ORAL	17.2MG ORAL GRANULE, ENTERIC COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
3NXW29V3WO	HYPROMELLOSE, UNSPECIFIED:ORAL:GRANULE, FOR ORAL SUSPENSION:MG	ORAL	10.6MG ORAL GRANULE, FOR ORAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
3NXW29V3WO	HYPROMELLOSE, UNSPECIFIED:ORAL:PELLET:MG	ORAL	6.7MG ORAL PELLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
3NXW29V3WO	HYPROMELLOSE, UNSPECIFIED:ORAL:POWDER, FOR ORAL SUSPENSION:MG/5ML	ORAL	75MG/5ML ORAL POWDER, FOR ORAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
3NXW29V3WO	HYPROMELLOSE, UNSPECIFIED:ORAL:POWDER, FOR RECONSTITUTION:MG/5ML	ORAL	150MG/5ML ORAL POWDER, FOR RECONSTITUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
3NXW29V3WO	HYPROMELLOSE, UNSPECIFIED:ORAL:POWDER, FOR SUSPENSION:MG/5ML	ORAL	65MG/5ML ORAL POWDER, FOR SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
3NXW29V3WO	HYPROMELLOSE, UNSPECIFIED:ORAL:SOLUTION:MG/1ML	ORAL	4.5MG/1ML ORAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
3NXW29V3WO	HYPROMELLOSE, UNSPECIFIED:ORAL:SUSPENSION:MG/5ML	ORAL	325MG/5ML ORAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
3NXW29V3WO	HYPROMELLOSE, UNSPECIFIED:ORAL:SUSPENSION, LIQUID:MG/1ML	ORAL	5MG/1ML ORAL SUSPENSION, LIQUID	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
3NXW29V3WO	HYPROMELLOSE, UNSPECIFIED:ORAL:SYRUP:MG/5ML	ORAL	180MG/5ML ORAL SYRUP	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
3NXW29V3WO	HYPROMELLOSE, UNSPECIFIED:ORAL:TABLET:mg	ORAL	16.68mg ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
3NXW29V3WO	HYPROMELLOSE, UNSPECIFIED:ORAL:TABLET (IMMED./COMP. RELEASE), COATED:MG	ORAL	19.2MG ORAL TABLET (IMMED./COMP. RELEASE), COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
3NXW29V3WO	HYPROMELLOSE, UNSPECIFIED:ORAL:TABLET (IMMED./COMP. RELEASE), FILM COATED:MG	ORAL	24MG ORAL TABLET (IMMED./COMP. RELEASE), FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
3NXW29V3WO	HYPROMELLOSE, UNSPECIFIED:ORAL:TABLET (IMMED./COMP. RELEASE), UNCOATED, CHEWABLE:MG	ORAL	10MG ORAL TABLET (IMMED./COMP. RELEASE), UNCOATED, CHEWABLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
3NXW29V3WO	HYPROMELLOSE, UNSPECIFIED:ORAL:TABLET, CHEWABLE:MG	ORAL	22MG ORAL TABLET, CHEWABLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
3NXW29V3WO	HYPROMELLOSE, UNSPECIFIED:ORAL:TABLET, COATED:MG	ORAL	245MG ORAL TABLET, COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
3NXW29V3WO	HYPROMELLOSE, UNSPECIFIED:ORAL:TABLET, CONTROLLED RELEASE:MG	ORAL	65.7MG ORAL TABLET, CONTROLLED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
3NXW29V3WO	HYPROMELLOSE, UNSPECIFIED:ORAL:TABLET, DELAYED ACTION:MG	ORAL	19.62MG ORAL TABLET, DELAYED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
3NXW29V3WO	HYPROMELLOSE, UNSPECIFIED:ORAL:TABLET, DELAYED ACTION, ENTERIC COATED:MG	ORAL	127.29MG ORAL TABLET, DELAYED ACTION, ENTERIC COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
3NXW29V3WO	HYPROMELLOSE, UNSPECIFIED:ORAL:TABLET, DELAYED RELEASE:MG	ORAL	16.4MG ORAL TABLET, DELAYED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
3NXW29V3WO	HYPROMELLOSE, UNSPECIFIED:ORAL:TABLET, EXTENDED RELEASE:MG	ORAL	450MG ORAL TABLET, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
3NXW29V3WO	HYPROMELLOSE, UNSPECIFIED:ORAL:TABLET, FILM COATED:MG	ORAL	536.8MG ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
3NXW29V3WO	HYPROMELLOSE, UNSPECIFIED:ORAL:TABLET, FILM COATED, EXTENDED RELEASE:MG	ORAL	48.01MG ORAL TABLET, FILM COATED, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
3NXW29V3WO	HYPROMELLOSE, UNSPECIFIED:ORAL:TABLET, FOR SUSPENSION:MG	ORAL	45MG ORAL TABLET, FOR SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
3NXW29V3WO	HYPROMELLOSE, UNSPECIFIED:ORAL:TABLET, MULTILAYER, EXTENDED RELEASE:MG	ORAL	125.5MG ORAL TABLET, MULTILAYER, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
3NXW29V3WO	HYPROMELLOSE, UNSPECIFIED:ORAL:TABLET, ORALLY DISINTEGRATING:MG	ORAL	18MG ORAL TABLET, ORALLY DISINTEGRATING	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
3NXW29V3WO	HYPROMELLOSE, UNSPECIFIED:ORAL:TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE:MG	ORAL	29MG ORAL TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
3NXW29V3WO	HYPROMELLOSE, UNSPECIFIED:ORAL:TABLET, SUSTAINED ACTION:MG	ORAL	400MG ORAL TABLET, SUSTAINED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
3NXW29V3WO	HYPROMELLOSE, UNSPECIFIED:ORAL:TABLET, SUSTAINED ACTION, COATED:MG	ORAL	221MG ORAL TABLET, SUSTAINED ACTION, COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
3NXW29V3WO	HYPROMELLOSE, UNSPECIFIED:ORAL:TABLET, SUSTAINED ACTION, FILM COATED:MG	ORAL	58.33MG ORAL TABLET, SUSTAINED ACTION, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
3NXW29V3WO	HYPROMELLOSE, UNSPECIFIED:ORAL:TABLET, SUSTAINED RELEASE, FILM COATED:MG	ORAL	300MG ORAL TABLET, SUSTAINED RELEASE, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
3NXW29V3WO	HYPROMELLOSE, UNSPECIFIED:RECTAL:GEL:%	RECTAL	8.7% RECTAL GEL	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
3NXW29V3WO	HYPROMELLOSE, UNSPECIFIED:TOPICAL:EMULSION, CREAM:%W/W	TOPICAL	0.1%W/W TOPICAL EMULSION, CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
3NXW29V3WO	HYPROMELLOSE, UNSPECIFIED:TOPICAL:EMULSION, LOTION:%W/W	TOPICAL	0.1%W/W TOPICAL EMULSION, LOTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
3NXW29V3WO	HYPROMELLOSE, UNSPECIFIED:TOPICAL:JELLY:%W/W	TOPICAL	2.5%W/W TOPICAL JELLY	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
3NXW29V3WO	HYPROMELLOSE, UNSPECIFIED:TOPICAL:LOTION:%W/W	TOPICAL	0.1%W/W TOPICAL LOTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
3NXW29V3WO	HYPROMELLOSE, UNSPECIFIED:TOPICAL:PATCH:NA	TOPICAL	TOPICAL PATCH	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
3NXW29V3WO	HYPROMELLOSE, UNSPECIFIED:TOPICAL:SOLUTION:%W/V	TOPICAL	4%W/V TOPICAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
3NXW29V3WO	HYPROMELLOSE, UNSPECIFIED:TOPICAL:SOLUTION, DROPS:%W/V	TOPICAL	0.11%W/V TOPICAL SOLUTION, DROPS	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
3NXW29V3WO	HYPROMELLOSE, UNSPECIFIED:URETHRAL:JELLY:%	URETHRAL	2.3% URETHRAL JELLY	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
3NXW29V3WO	HYPROMELLOSE, UNSPECIFIED:VAGINAL:GEL:%	VAGINAL	3.5% VAGINAL GEL	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
3NXW29V3WO	HYPROMELLOSE, UNSPECIFIED:VAGINAL:INSERT:MG	VAGINAL	52.6MG VAGINAL INSERT	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
3NXW29V3WO	HYPROMELLOSE, UNSPECIFIED:VAGINAL:TABLET:MG	VAGINAL	5MG VAGINAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
3NXW29V3WO	HYPROMELLOSE, UNSPECIFIED:VAGINAL:TABLET, FILM COATED:MG	VAGINAL	54.21MG VAGINAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
F5UM2KM3W7	BENZALKONIUM CHLORIDE:AURICULAR (OTIC):SOLUTION:%	AURICULAR (OTIC)	0.028% AURICULAR (OTIC) SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
F5UM2KM3W7	BENZALKONIUM CHLORIDE:AURICULAR (OTIC):SUSPENSION:%	AURICULAR (OTIC)	0.02% AURICULAR (OTIC) SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
F5UM2KM3W7	BENZALKONIUM CHLORIDE:IM - SC:INJECTION:NA	IM - SC	IM - SC INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
F5UM2KM3W7	BENZALKONIUM CHLORIDE:INHALATION:SOLUTION:%	INHALATION	20% INHALATION SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
F5UM2KM3W7	BENZALKONIUM CHLORIDE:INTRA-ARTICULAR:INJECTABLE:%	INTRA-ARTICULAR	0.02% INTRA-ARTICULAR INJECTABLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
F5UM2KM3W7	BENZALKONIUM CHLORIDE:INTRA-ARTICULAR:INJECTION:%	INTRA-ARTICULAR	0.01% INTRA-ARTICULAR INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
F5UM2KM3W7	BENZALKONIUM CHLORIDE:INTRA-ARTICULAR:SUSPENSION:%	INTRA-ARTICULAR	0.01% INTRA-ARTICULAR SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
F5UM2KM3W7	BENZALKONIUM CHLORIDE:INTRABURSAL:INJECTION:NA	INTRABURSAL	INTRABURSAL INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
F5UM2KM3W7	BENZALKONIUM CHLORIDE:INTRADERMAL:INJECTION:NA	INTRADERMAL	INTRADERMAL INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
F5UM2KM3W7	BENZALKONIUM CHLORIDE:INTRALESIONAL:INJECTABLE:%	INTRALESIONAL	0.02% INTRALESIONAL INJECTABLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
F5UM2KM3W7	BENZALKONIUM CHLORIDE:INTRALESIONAL:INJECTION:NA	INTRALESIONAL	INTRALESIONAL INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
F5UM2KM3W7	BENZALKONIUM CHLORIDE:INTRAMUSCULAR:INJECTABLE:%	INTRAMUSCULAR	0.02% INTRAMUSCULAR INJECTABLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
F5UM2KM3W7	BENZALKONIUM CHLORIDE:INTRAMUSCULAR:INJECTION:%	INTRAMUSCULAR	0.01% INTRAMUSCULAR INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
F5UM2KM3W7	BENZALKONIUM CHLORIDE:INTRAMUSCULAR:SUSPENSION:%	INTRAMUSCULAR	0.01% INTRAMUSCULAR SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
F5UM2KM3W7	BENZALKONIUM CHLORIDE:INTRAOCULAR:SOLUTION:%	INTRAOCULAR	0.005% INTRAOCULAR SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
F5UM2KM3W7	BENZALKONIUM CHLORIDE:INTRASYNOVIAL:INJECTION:%	INTRASYNOVIAL	0.01% INTRASYNOVIAL INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
F5UM2KM3W7	BENZALKONIUM CHLORIDE:NASAL:GEL:NA	NASAL	NASAL GEL	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
F5UM2KM3W7	BENZALKONIUM CHLORIDE:NASAL:SOLUTION:%	NASAL	0.12% NASAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
F5UM2KM3W7	BENZALKONIUM CHLORIDE:NASAL:SOLUTION, SPRAY:%	NASAL	0.03% NASAL SOLUTION, SPRAY	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
F5UM2KM3W7	BENZALKONIUM CHLORIDE:NASAL:SOLUTION, SPRAY, METERED, PUMP:%	NASAL	0.003% NASAL SOLUTION, SPRAY, METERED, PUMP	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
F5UM2KM3W7	BENZALKONIUM CHLORIDE:NASAL:SPRAY:%	NASAL	0.12% NASAL SPRAY	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
F5UM2KM3W7	BENZALKONIUM CHLORIDE:NASAL:SPRAY, METERED:%	NASAL	0.12% NASAL SPRAY, METERED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
F5UM2KM3W7	BENZALKONIUM CHLORIDE:OPHTHALMIC:GEL:%	OPHTHALMIC	0.008% OPHTHALMIC GEL	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
F5UM2KM3W7	BENZALKONIUM CHLORIDE:OPHTHALMIC:OINTMENT:%	OPHTHALMIC	0.025% OPHTHALMIC OINTMENT	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
F5UM2KM3W7	BENZALKONIUM CHLORIDE:OPHTHALMIC:SOLUTION:%	OPHTHALMIC	12.6% OPHTHALMIC SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
F5UM2KM3W7	BENZALKONIUM CHLORIDE:OPHTHALMIC:SOLUTION, DROPS:%	OPHTHALMIC	10% OPHTHALMIC SOLUTION, DROPS	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
F5UM2KM3W7	BENZALKONIUM CHLORIDE:OPHTHALMIC:SOLUTION/ DROPS:MG/1ML	OPHTHALMIC	0.05MG/1ML OPHTHALMIC SOLUTION/ DROPS	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
F5UM2KM3W7	BENZALKONIUM CHLORIDE:OPHTHALMIC:SOLUTION/DROPS:%	OPHTHALMIC	0.012% OPHTHALMIC SOLUTION/DROPS	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
F5UM2KM3W7	BENZALKONIUM CHLORIDE:OPHTHALMIC:SUSPENSION:%	OPHTHALMIC	0.025% OPHTHALMIC SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
F5UM2KM3W7	BENZALKONIUM CHLORIDE:OPHTHALMIC:SUSPENSION, DROPS:%	OPHTHALMIC	0.025% OPHTHALMIC SUSPENSION, DROPS	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
F5UM2KM3W7	BENZALKONIUM CHLORIDE:ORAL:SOLUTION:MG/1ML	ORAL	0.2MG/1ML ORAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
F5UM2KM3W7	BENZALKONIUM CHLORIDE:OTIC:SUSPENSION:%	OTIC	0.01% OTIC SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
F5UM2KM3W7	BENZALKONIUM CHLORIDE:RESPIRATORY (INHALATION):SPRAY:%	RESPIRATORY (INHALATION)	0.01% RESPIRATORY (INHALATION) SPRAY	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
F5UM2KM3W7	BENZALKONIUM CHLORIDE:TOPICAL:JELLY:NA	TOPICAL	TOPICAL JELLY	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
F5UM2KM3W7	BENZALKONIUM CHLORIDE:TOPICAL:LOTION:%W/W	TOPICAL	0.1%W/W TOPICAL LOTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
F5UM2KM3W7	BENZALKONIUM CHLORIDE:TOPICAL:OPHTHALMIC SUSPENSION DOSAGE FORM:%W/V	TOPICAL	0.01%W/V TOPICAL OPHTHALMIC SUSPENSION DOSAGE FORM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
F5UM2KM3W7	BENZALKONIUM CHLORIDE:TOPICAL:SHAMPOO:%W/W	TOPICAL	0.2%W/W TOPICAL SHAMPOO	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
F5UM2KM3W7	BENZALKONIUM CHLORIDE:TOPICAL:SOLUTION:%W/V	TOPICAL	0.02%W/V TOPICAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
F5UM2KM3W7	BENZALKONIUM CHLORIDE:TOPICAL:SOLUTION, DROPS:%W/V	TOPICAL	0.02%W/V TOPICAL SOLUTION, DROPS	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
F5UM2KM3W7	BENZALKONIUM CHLORIDE:TOPICAL:SOLUTION/DROPS:%W/V	TOPICAL	0.01%W/V TOPICAL SOLUTION/DROPS	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
F5UM2KM3W7	BENZALKONIUM CHLORIDE:TOPICAL:SUSPENSION:%W/W	TOPICAL	0.003%W/W TOPICAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
F5UM2KM3W7	BENZALKONIUM CHLORIDE:TOPICAL:SUSPENSION, DROPS:%W/W	TOPICAL	0.01%W/W TOPICAL SUSPENSION, DROPS	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
E934B3V59H	CALCIUM SULFATE ANHYDROUS:ORAL:CAPSULE:MG	ORAL	50MG ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
E934B3V59H	CALCIUM SULFATE ANHYDROUS:ORAL:SOLUTION:NA	ORAL	ORAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
E934B3V59H	CALCIUM SULFATE ANHYDROUS:ORAL:TABLET:MG	ORAL	174.5MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
E934B3V59H	CALCIUM SULFATE ANHYDROUS:ORAL:TABLET, COATED:NA	ORAL	ORAL TABLET, COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
E934B3V59H	CALCIUM SULFATE ANHYDROUS:ORAL:TABLET, DELAYED RELEASE:MG	ORAL	67MG ORAL TABLET, DELAYED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
E934B3V59H	CALCIUM SULFATE ANHYDROUS:ORAL:TABLET, EXTENDED RELEASE:MG	ORAL	234.05MG ORAL TABLET, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
E934B3V59H	CALCIUM SULFATE ANHYDROUS:ORAL:TABLET, SUSTAINED ACTION:NA	ORAL	ORAL TABLET, SUSTAINED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
25BB7EKE2E	BARIUM SULFATE:IMPLANTATION:IMPLANT:MG	IMPLANTATION	15MG IMPLANTATION IMPLANT	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
25BB7EKE2E	BARIUM SULFATE:INTRAUTERINE:INTRAUTERINE DEVICE:NA	INTRAUTERINE	INTRAUTERINE INTRAUTERINE DEVICE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
25BB7EKE2E	BARIUM SULFATE:INTRAUTERINE:SUPPOSITORY, INSERT, CONTROLLED RELEASE:MG	INTRAUTERINE	10MG INTRAUTERINE SUPPOSITORY, INSERT, CONTROLLED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
25BB7EKE2E	BARIUM SULFATE:SUBCUTANEOUS:IMPLANT:MG	SUBCUTANEOUS	15MG SUBCUTANEOUS IMPLANT	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
25BB7EKE2E	BARIUM SULFATE:VAGINAL:INSERT:MG	VAGINAL	1.42MG VAGINAL INSERT	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
25BB7EKE2E	BARIUM SULFATE:VAGINAL:INSERT, EXTENDED RELEASE:MG	VAGINAL	5.9MG VAGINAL INSERT, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
3P3ONR6O1S	FD&C GREEN NO. 3:DENTAL:GEL:%	DENTAL	0.003% DENTAL GEL	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
3P3ONR6O1S	FD&C GREEN NO. 3:ORAL:CAPSULE:MG	ORAL	40MG ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
3P3ONR6O1S	FD&C GREEN NO. 3:ORAL:CAPSULE, COATED, SOFT GELATIN:NA	ORAL	ORAL CAPSULE, COATED, SOFT GELATIN	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
3P3ONR6O1S	FD&C GREEN NO. 3:ORAL:CAPSULE, DELAYED ACTION:mg	ORAL	0.53mg ORAL CAPSULE, DELAYED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
3P3ONR6O1S	FD&C GREEN NO. 3:ORAL:CAPSULE, ENTERIC COATED PELLETS:MG	ORAL	0.22MG ORAL CAPSULE, ENTERIC COATED PELLETS	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
3P3ONR6O1S	FD&C GREEN NO. 3:ORAL:CAPSULE, EXTENDED RELEASE:MG	ORAL	0.16MG ORAL CAPSULE, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
3P3ONR6O1S	FD&C GREEN NO. 3:ORAL:CAPSULE, SOFT GELATIN:MG	ORAL	0.17MG ORAL CAPSULE, SOFT GELATIN	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
3P3ONR6O1S	FD&C GREEN NO. 3:ORAL:CAPSULE, SOFT GELATIN LIQUID-FILLED:MG	ORAL	0.018MG ORAL CAPSULE, SOFT GELATIN LIQUID-FILLED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
3P3ONR6O1S	FD&C GREEN NO. 3:ORAL:CAPSULE, SUSTAINED ACTION:MG	ORAL	0.067MG ORAL CAPSULE, SUSTAINED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
3P3ONR6O1S	FD&C GREEN NO. 3:ORAL:SOLUTION:MG/5ML	ORAL	0.25MG/5ML ORAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
3P3ONR6O1S	FD&C GREEN NO. 3:ORAL:SOLUTION, ELIXIR:NA	ORAL	ORAL SOLUTION, ELIXIR	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
3P3ONR6O1S	FD&C GREEN NO. 3:ORAL:SYRUP:MG/5ML	ORAL	3.75MG/5ML ORAL SYRUP	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
3P3ONR6O1S	FD&C GREEN NO. 3:ORAL:TABLET:MG	ORAL	10MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
3P3ONR6O1S	FD&C GREEN NO. 3:ORAL:TABLET, COATED:MG	ORAL	0.005MG ORAL TABLET, COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
3P3ONR6O1S	FD&C GREEN NO. 3:ORAL:TABLET, DELAYED ACTION, ENTERIC COATED:NA	ORAL	ORAL TABLET, DELAYED ACTION, ENTERIC COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
3P3ONR6O1S	FD&C GREEN NO. 3:RECTAL:SUPPOSITORY:MG	RECTAL	0.015MG RECTAL SUPPOSITORY	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
YD01N1999R	PEG-100 STEARATE:TOPICAL:CREAM, AUGMENTED:%W/W	TOPICAL	0.5%W/W TOPICAL CREAM, AUGMENTED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
YD01N1999R	PEG-100 STEARATE:TOPICAL:EMULSION, CREAM:%W/W	TOPICAL	2.1%W/W TOPICAL EMULSION, CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
YD01N1999R	PEG-100 STEARATE:TOPICAL:LOTION:%W/W	TOPICAL	1%W/W TOPICAL LOTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
YD01N1999R	PEG-100 STEARATE:VAGINAL:EMULSION, CREAM:NA	VAGINAL	VAGINAL EMULSION, CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
E40U03LEM0	QUATERNIUM-15:TOPICAL:CREAM, AUGMENTED:%W/W	TOPICAL	0.1%W/W TOPICAL CREAM, AUGMENTED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=Q
E40U03LEM0	QUATERNIUM-15:TOPICAL:EMULSION, CREAM:%W/W	TOPICAL	0.02%W/W TOPICAL EMULSION, CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=Q
E40U03LEM0	QUATERNIUM-15:TOPICAL:LOTION:NA	TOPICAL	TOPICAL LOTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=Q
E40U03LEM0	QUATERNIUM-15:TOPICAL:SHAMPOO:NA	TOPICAL	TOPICAL SHAMPOO	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=Q
H4E039OIGX	GENTISIC ACID ETHANOLAMIDE:IV(INFUSION):INJECTION:%	IV(INFUSION)	2% IV(INFUSION) INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
0YIW783RG1	FORMIC ACID:INTRAVENOUS:INJECTION:%	INTRAVENOUS	6% INTRAVENOUS INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
X33R8U0062	ISOSTEARIC ACID:TOPICAL:CREAM, EMULSION, SUSTAINED RELEASE:%W/W	TOPICAL	25%W/W TOPICAL CREAM, EMULSION, SUSTAINED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=I
X33R8U0062	ISOSTEARIC ACID:TOPICAL:EMULSION, CREAM:%W/W	TOPICAL	25%W/W TOPICAL EMULSION, CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=I
X33R8U0062	ISOSTEARIC ACID:TOPICAL:OINTMENT:NA	TOPICAL	TOPICAL OINTMENT	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=I
X33R8U0062	ISOSTEARIC ACID:TRANSDERMAL:GEL:%	TRANSDERMAL	0.2% TRANSDERMAL GEL	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=I
EAG959U971	DISTEAROYLPHOSPHATIDYLCHOLINE, DL-:INTRAVENOUS:INJECTION:%	INTRAVENOUS	0.68% INTRAVENOUS INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
EAG959U971	DISTEAROYLPHOSPHATIDYLCHOLINE, DL-:INTRAVENOUS:INJECTION, SUSPENSION:%	INTRAVENOUS	0.004% INTRAVENOUS INJECTION, SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
01DMT14Z63	POTASSIUM METAPHOSPHATE:ORAL:SUSPENSION:NA	ORAL	ORAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
HHT01ZNK31	CARBOMER HOMOPOLYMER TYPE B (ALLYL PENTAERYTHRITOL CROSSLINKED):OPHTHALMIC:GEL:%	OPHTHALMIC	0.48% OPHTHALMIC GEL	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
HHT01ZNK31	CARBOMER HOMOPOLYMER TYPE B (ALLYL PENTAERYTHRITOL CROSSLINKED):OPHTHALMIC:SUSPENSION:%	OPHTHALMIC	0.5% OPHTHALMIC SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
HHT01ZNK31	CARBOMER HOMOPOLYMER TYPE B (ALLYL PENTAERYTHRITOL CROSSLINKED):OPHTHALMIC:SUSPENSION, DROPS:%	OPHTHALMIC	0.45% OPHTHALMIC SUSPENSION, DROPS	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
HHT01ZNK31	CARBOMER HOMOPOLYMER TYPE B (ALLYL PENTAERYTHRITOL CROSSLINKED):ORAL:CAPSULE:MG	ORAL	20MG ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
HHT01ZNK31	CARBOMER HOMOPOLYMER TYPE B (ALLYL PENTAERYTHRITOL CROSSLINKED):ORAL:GEL:%W/W	ORAL	1.25%W/W ORAL GEL	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
HHT01ZNK31	CARBOMER HOMOPOLYMER TYPE B (ALLYL PENTAERYTHRITOL CROSSLINKED):ORAL:GRANULE, FOR SUSPENSION:MG	ORAL	150MG ORAL GRANULE, FOR SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
HHT01ZNK31	CARBOMER HOMOPOLYMER TYPE B (ALLYL PENTAERYTHRITOL CROSSLINKED):ORAL:SOLUTION:%W/W	ORAL	0.13%W/W ORAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
HHT01ZNK31	CARBOMER HOMOPOLYMER TYPE B (ALLYL PENTAERYTHRITOL CROSSLINKED):ORAL:SUSPENSION:MG/5ML	ORAL	8MG/5ML ORAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
HHT01ZNK31	CARBOMER HOMOPOLYMER TYPE B (ALLYL PENTAERYTHRITOL CROSSLINKED):ORAL:TABLET:MG	ORAL	4MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
HHT01ZNK31	CARBOMER HOMOPOLYMER TYPE B (ALLYL PENTAERYTHRITOL CROSSLINKED):ORAL:TABLET, EXTENDED RELEASE:MG	ORAL	56.14MG ORAL TABLET, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
HHT01ZNK31	CARBOMER HOMOPOLYMER TYPE B (ALLYL PENTAERYTHRITOL CROSSLINKED):TOPICAL:CREAM:%W/W	TOPICAL	1.2%W/W TOPICAL CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
HHT01ZNK31	CARBOMER HOMOPOLYMER TYPE B (ALLYL PENTAERYTHRITOL CROSSLINKED):TOPICAL:EMULSION, CREAM:%W/W	TOPICAL	1%W/W TOPICAL EMULSION, CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
HHT01ZNK31	CARBOMER HOMOPOLYMER TYPE B (ALLYL PENTAERYTHRITOL CROSSLINKED):TOPICAL:SOLUTION:%W/W	TOPICAL	0.15%W/W TOPICAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
AV0YTZ4E6J	1,4-SORBITAN:ORAL:CAPSULE:MG	ORAL	24.15MG ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=1
X2RN3Q8DNE	GALACTOSE:ORAL:POWDER, FOR SOLUTION:NA	ORAL	ORAL POWDER, FOR SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
X2RN3Q8DNE	GALACTOSE:ORAL:SOLUTION:MG/15ML	ORAL	2200MG/15ML ORAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
X2RN3Q8DNE	GALACTOSE:ORAL:TABLET:MG	ORAL	0.67MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
X2RN3Q8DNE	GALACTOSE:RECTAL:SOLUTION:%	RECTAL	14.67% RECTAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
70097M6I30	MAGNESIUM PALMITOSTEARATE:ORAL:CAPSULE, EXTENDED RELEASE:MG	ORAL	0.31MG ORAL CAPSULE, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
70097M6I30	MAGNESIUM STEARATE:BUCCAL:TABLET:MG	BUCCAL	4MG BUCCAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
70097M6I30	MAGNESIUM STEARATE:BUCCAL:TABLET, EXTENDED RELEASE:MG	BUCCAL	0.58MG BUCCAL TABLET, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
70097M6I30	MAGNESIUM STEARATE:BUCCAL/SUBLINGUAL:TABLET:MG	BUCCAL/SUBLINGUAL	17.5MG BUCCAL/SUBLINGUAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
70097M6I30	MAGNESIUM STEARATE:IMPLANTATION:DRUG DELIVERY SYSTEM:MG	IMPLANTATION	0.015MG IMPLANTATION DRUG DELIVERY SYSTEM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
70097M6I30	MAGNESIUM STEARATE:IMPLANTATION:IMPLANT:MG	IMPLANTATION	0.1MG IMPLANTATION IMPLANT	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
70097M6I30	MAGNESIUM STEARATE:INHALATION:INHALANT:UG	INHALATION	75UG INHALATION INHALANT	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
70097M6I30	MAGNESIUM STEARATE:INHALATION:POWDER:MG	INHALATION	0.13MG INHALATION POWDER	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
70097M6I30	MAGNESIUM STEARATE:INHALATION:POWDER, FOR INHALATION:%	INHALATION	0.008% INHALATION POWDER, FOR INHALATION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
70097M6I30	MAGNESIUM STEARATE:INTRAVITREAL:DRUG DELIVERY SYSTEM:MG	INTRAVITREAL	0.015MG INTRAVITREAL DRUG DELIVERY SYSTEM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
70097M6I30	MAGNESIUM STEARATE:INTRAVITREAL:IMPLANT:MG	INTRAVITREAL	0.005MG INTRAVITREAL IMPLANT	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
70097M6I30	MAGNESIUM STEARATE:ORAL:CAPSULE:mg	ORAL	28mg ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
70097M6I30	MAGNESIUM STEARATE:ORAL:CAPSULE (IMMED./COMP. RELEASE):MG	ORAL	2.5MG ORAL CAPSULE (IMMED./COMP. RELEASE)	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
70097M6I30	MAGNESIUM STEARATE:ORAL:CAPSULE (IMMED./COMP. RELEASE), HARD GELATIN:MG	ORAL	10MG ORAL CAPSULE (IMMED./COMP. RELEASE), HARD GELATIN	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
70097M6I30	MAGNESIUM STEARATE:ORAL:CAPSULE, COATED PELLETS:MG	ORAL	0.15MG ORAL CAPSULE, COATED PELLETS	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
70097M6I30	MAGNESIUM STEARATE:ORAL:CAPSULE, COATED, SOFT GELATIN:MG	ORAL	3MG ORAL CAPSULE, COATED, SOFT GELATIN	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
70097M6I30	MAGNESIUM STEARATE:ORAL:CAPSULE, DELAYED ACTION:MG	ORAL	41.1MG ORAL CAPSULE, DELAYED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
70097M6I30	MAGNESIUM STEARATE:ORAL:CAPSULE, DELAYED ACTION, ENTERIC COATED:NA	ORAL	ORAL CAPSULE, DELAYED ACTION, ENTERIC COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
70097M6I30	MAGNESIUM STEARATE:ORAL:CAPSULE, DELAYED RELEASE:MG	ORAL	10.69MG ORAL CAPSULE, DELAYED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
70097M6I30	MAGNESIUM STEARATE:ORAL:CAPSULE, ENTERIC COATED PELLETS:MG	ORAL	34.87MG ORAL CAPSULE, ENTERIC COATED PELLETS	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
70097M6I30	MAGNESIUM STEARATE:ORAL:CAPSULE, EXTENDED RELEASE:MG	ORAL	31.8MG ORAL CAPSULE, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
70097M6I30	MAGNESIUM STEARATE:ORAL:CAPSULE, GELATIN COATED:MG	ORAL	1.5MG ORAL CAPSULE, GELATIN COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
70097M6I30	MAGNESIUM STEARATE:ORAL:CAPSULE, HARD GELATIN:MG	ORAL	79.4MG ORAL CAPSULE, HARD GELATIN	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
70097M6I30	MAGNESIUM STEARATE:ORAL:CAPSULE, SOFT GELATIN:MG	ORAL	9MG ORAL CAPSULE, SOFT GELATIN	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
70097M6I30	MAGNESIUM STEARATE:ORAL:CAPSULE, SUSTAINED ACTION:MG	ORAL	100MG ORAL CAPSULE, SUSTAINED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
70097M6I30	MAGNESIUM STEARATE:ORAL:CONCENTRATE:NA	ORAL	ORAL CONCENTRATE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
70097M6I30	MAGNESIUM STEARATE:ORAL:DISPERSIBLE TABLET:MG	ORAL	16MG ORAL DISPERSIBLE TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
70097M6I30	MAGNESIUM STEARATE:ORAL:DROPS:NA	ORAL	ORAL DROPS	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
70097M6I30	MAGNESIUM STEARATE:ORAL:GRANULE:MG	ORAL	4MG ORAL GRANULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
70097M6I30	MAGNESIUM STEARATE:ORAL:GRANULE, FOR ORAL SUSPENSION:MG	ORAL	7MG ORAL GRANULE, FOR ORAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
70097M6I30	MAGNESIUM STEARATE:ORAL:LOZENGE:mg	ORAL	12mg ORAL LOZENGE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
70097M6I30	MAGNESIUM STEARATE:ORAL:PELLET:MG	ORAL	2.628MG ORAL PELLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
70097M6I30	MAGNESIUM STEARATE:ORAL:POWDER:MG	ORAL	8.4MG ORAL POWDER	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
70097M6I30	MAGNESIUM STEARATE:ORAL:POWDER, FOR ORAL SUSPENSION:MG/5ML	ORAL	15MG/5ML ORAL POWDER, FOR ORAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
70097M6I30	MAGNESIUM STEARATE:ORAL:POWDER, FOR SUSPENSION:MG/5ML	ORAL	32.5MG/5ML ORAL POWDER, FOR SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
70097M6I30	MAGNESIUM STEARATE:ORAL:SOLUTION:NA	ORAL	ORAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
70097M6I30	MAGNESIUM STEARATE:ORAL:SUSPENSION:MG/5ML	ORAL	57.56MG/5ML ORAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
70097M6I30	MAGNESIUM STEARATE:ORAL:SUSPENSION, SUSTAINED ACTION:MG/1PKT	ORAL	27MG/1PKT ORAL SUSPENSION, SUSTAINED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
70097M6I30	MAGNESIUM STEARATE:ORAL:TABLET:MG	ORAL	35MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
70097M6I30	MAGNESIUM STEARATE:ORAL:TABLET (IMMED./COMP. RELEASE), COATED:MG	ORAL	6.4MG ORAL TABLET (IMMED./COMP. RELEASE), COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
70097M6I30	MAGNESIUM STEARATE:ORAL:TABLET (IMMED./COMP. RELEASE), FILM COATED:MG	ORAL	20.5MG ORAL TABLET (IMMED./COMP. RELEASE), FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
70097M6I30	MAGNESIUM STEARATE:ORAL:TABLET (IMMED./COMP. RELEASE), UNCOATED, CHEWABLE:MG	ORAL	50MG ORAL TABLET (IMMED./COMP. RELEASE), UNCOATED, CHEWABLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
70097M6I30	MAGNESIUM STEARATE:ORAL:TABLET, CHEWABLE:MG	ORAL	40MG ORAL TABLET, CHEWABLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
70097M6I30	MAGNESIUM STEARATE:ORAL:TABLET, COATED:MG	ORAL	40MG ORAL TABLET, COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
70097M6I30	MAGNESIUM STEARATE:ORAL:TABLET, CONTROLLED RELEASE:MG	ORAL	12.4MG ORAL TABLET, CONTROLLED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
70097M6I30	MAGNESIUM STEARATE:ORAL:TABLET, DELAYED ACTION:MG	ORAL	14MG ORAL TABLET, DELAYED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
70097M6I30	MAGNESIUM STEARATE:ORAL:TABLET, DELAYED ACTION, ENTERIC COATED:MG	ORAL	53.8MG ORAL TABLET, DELAYED ACTION, ENTERIC COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
70097M6I30	MAGNESIUM STEARATE:ORAL:TABLET, DELAYED RELEASE:MG	ORAL	10MG ORAL TABLET, DELAYED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
70097M6I30	MAGNESIUM STEARATE:ORAL:TABLET, DISPERSIBLE:MG	ORAL	4.5MG ORAL TABLET, DISPERSIBLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
70097M6I30	MAGNESIUM STEARATE:ORAL:TABLET, ENTERIC COATED PARTICLES:MG	ORAL	7MG ORAL TABLET, ENTERIC COATED PARTICLES	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
70097M6I30	MAGNESIUM STEARATE:ORAL:TABLET, EXTENDED RELEASE:MG	ORAL	26.66MG ORAL TABLET, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
70097M6I30	MAGNESIUM STEARATE:ORAL:TABLET, FILM COATED:MG	ORAL	28.31MG ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
70097M6I30	MAGNESIUM STEARATE:ORAL:TABLET, FILM COATED, EXTENDED RELEASE:MG	ORAL	17.5MG ORAL TABLET, FILM COATED, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
70097M6I30	MAGNESIUM STEARATE:ORAL:TABLET, FOR SUSPENSION:MG	ORAL	12.5MG ORAL TABLET, FOR SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
70097M6I30	MAGNESIUM STEARATE:ORAL:TABLET, MULTILAYER, COATED:MG	ORAL	3MG ORAL TABLET, MULTILAYER, COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
70097M6I30	MAGNESIUM STEARATE:ORAL:TABLET, MULTILAYER, EXTENDED RELEASE:MG	ORAL	15MG ORAL TABLET, MULTILAYER, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
70097M6I30	MAGNESIUM STEARATE:ORAL:TABLET, ORALLY DISINTEGRATING:MG	ORAL	71.43MG ORAL TABLET, ORALLY DISINTEGRATING	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
70097M6I30	MAGNESIUM STEARATE:ORAL:TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE:mg	ORAL	7.8mg ORAL TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
70097M6I30	MAGNESIUM STEARATE:ORAL:TABLET, REPEAT ACTION:MG	ORAL	1.2MG ORAL TABLET, REPEAT ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
70097M6I30	MAGNESIUM STEARATE:ORAL:TABLET, SUSTAINED ACTION:MG	ORAL	150MG ORAL TABLET, SUSTAINED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
70097M6I30	MAGNESIUM STEARATE:ORAL:TABLET, SUSTAINED ACTION, COATED:MG	ORAL	10MG ORAL TABLET, SUSTAINED ACTION, COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
70097M6I30	MAGNESIUM STEARATE:ORAL:TABLET, SUSTAINED ACTION, FILM COATED:MG	ORAL	15.8MG ORAL TABLET, SUSTAINED ACTION, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
70097M6I30	MAGNESIUM STEARATE:ORAL:TABLET, SUSTAINED RELEASE, FILM COATED:MG	ORAL	17.5MG ORAL TABLET, SUSTAINED RELEASE, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
70097M6I30	MAGNESIUM STEARATE:ORAL:TABLET, UNCOATED, LOZENGE:MG	ORAL	15MG ORAL TABLET, UNCOATED, LOZENGE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
70097M6I30	MAGNESIUM STEARATE:ORAL:TABLET, UNCOATED, TROCHE:MG	ORAL	20MG ORAL TABLET, UNCOATED, TROCHE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
70097M6I30	MAGNESIUM STEARATE:ORAL:TROCHE:MG	ORAL	21MG ORAL TROCHE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
70097M6I30	MAGNESIUM STEARATE:ORAL:WAFER:MG	ORAL	15MG ORAL WAFER	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
70097M6I30	MAGNESIUM STEARATE:ORAL-20:TABLET:mg	ORAL-20	8mg ORAL-20 TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
70097M6I30	MAGNESIUM STEARATE:SUBCUTANEOUS:IMPLANT:MG	SUBCUTANEOUS	0.5MG SUBCUTANEOUS IMPLANT	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
70097M6I30	MAGNESIUM STEARATE:SUBLINGUAL:TABLET:MG	SUBLINGUAL	6MG SUBLINGUAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
70097M6I30	MAGNESIUM STEARATE:SUBLINGUAL:TABLET (IMMED./COMP. RELEASE), UNCOATED, BUCCAL:MG	SUBLINGUAL	3MG SUBLINGUAL TABLET (IMMED./COMP. RELEASE), UNCOATED, BUCCAL	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
70097M6I30	MAGNESIUM STEARATE:TOPICAL:EMULSION, CREAM:%W/W	TOPICAL	0.001%W/W TOPICAL EMULSION, CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
70097M6I30	MAGNESIUM STEARATE:TRANSDERMAL:PATCH, ELECTRICALLY CONTROLLED:MG	TRANSDERMAL	9.65MG TRANSDERMAL PATCH, ELECTRICALLY CONTROLLED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
70097M6I30	MAGNESIUM STEARATE:TRANSMUCOSAL:TABLET:MG	TRANSMUCOSAL	1.5MG TRANSMUCOSAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
70097M6I30	MAGNESIUM STEARATE:TRANSMUCOSAL:TABLET, UNCOATED, LOZENGE:MG	TRANSMUCOSAL	25MG TRANSMUCOSAL TABLET, UNCOATED, LOZENGE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
70097M6I30	MAGNESIUM STEARATE:VAGINAL:INSERT:MG	VAGINAL	23MG VAGINAL INSERT	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
70097M6I30	MAGNESIUM STEARATE:VAGINAL:TABLET:MG	VAGINAL	23MG VAGINAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
70097M6I30	MAGNESIUM STEARATE:VAGINAL:TABLET, FILM COATED:MG	VAGINAL	0.4MG VAGINAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
8P5F881OCY	BALSAM PERU:RECTAL:SUPPOSITORY:MG	RECTAL	100MG RECTAL SUPPOSITORY	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
A3N5ZCN45C	BENTONITE:ORAL:CAPSULE:ADJ PH	ORAL	ADJ PH ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
A3N5ZCN45C	BENTONITE:ORAL:SUSPENSION:MG/5ML	ORAL	65MG/5ML ORAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
A3N5ZCN45C	BENTONITE:ORAL:TABLET:MG	ORAL	23MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
A3N5ZCN45C	BENTONITE:ORAL:TABLET, COATED:MG	ORAL	1.8MG ORAL TABLET, COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
A3N5ZCN45C	BENTONITE:TOPICAL:LOTION:%W/W	TOPICAL	5%W/W TOPICAL LOTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
A3N5ZCN45C	BENTONITE:TOPICAL:POWDER:%W/W	TOPICAL	66.64%W/W TOPICAL POWDER	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
A3N5ZCN45C	BENTONITE:TOPICAL:SHAMPOO, SUSPENSION:%W/V	TOPICAL	3.25%W/V TOPICAL SHAMPOO, SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
A3N5ZCN45C	BENTONITE:TRANSDERMAL:FILM, CONTROLLED RELEASE:MG	TRANSDERMAL	9.86MG TRANSDERMAL FILM, CONTROLLED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
A3N5ZCN45C	BENTONITE:TRANSDERMAL:PATCH, CONTROLLED RELEASE:MG	TRANSDERMAL	2.47MG TRANSDERMAL PATCH, CONTROLLED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
A3N5ZCN45C	BENTONITE:VAGINAL:SUPPOSITORY:MG	VAGINAL	288.1MG VAGINAL SUPPOSITORY	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
89NA02M4RX	PECTIN:DENTAL:PASTE:MG	DENTAL	180MG DENTAL PASTE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
89NA02M4RX	PECTIN:NASAL:SOLUTION, SPRAY:%	NASAL	1% NASAL SOLUTION, SPRAY	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
89NA02M4RX	PECTIN:ORAL:BAR, CHEWABLE:NA	ORAL	ORAL BAR, CHEWABLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
89NA02M4RX	PECTIN:ORAL:CAPSULE, EXTENDED RELEASE:MG	ORAL	5.45MG ORAL CAPSULE, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
89NA02M4RX	PECTIN:ORAL:POWDER:MG/1PKT	ORAL	255MG/1PKT ORAL POWDER	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
89NA02M4RX	PECTIN:ORAL:POWDER:MG/1SCP	ORAL	255MG/1SCP ORAL POWDER	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
89NA02M4RX	PECTIN:ORAL:TABLET:MG	ORAL	0.7MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
89NA02M4RX	PECTIN:TOPICAL:PASTE:NA	TOPICAL	TOPICAL PASTE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
89NA02M4RX	PECTIN:TOPICAL:PASTE, DENTIFRICE:NA	TOPICAL	TOPICAL PASTE, DENTIFRICE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
2165RE0K14	LOW SUBSTITUTED HYDROXYPROPYL CELLULOSE (11% HYDROXYPROPYL: 120000 MW):ORAL:TABLET, EXTENDED RELEASE:mg	ORAL	6.25mg ORAL TABLET, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
2165RE0K14	LOW-SUBSTITUTED HYDROXYPROPYL CELLULOSE (11% HYDROXYPROPYL: 130000 MW):ORAL:CAPSULE:mg	ORAL	5.3mg ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
2165RE0K14	LOW-SUBSTITUTED HYDROXYPROPYL CELLULOSE, UNSPECIFIED:ORAL:CAPSULE:MG	ORAL	35.63MG ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
2165RE0K14	LOW-SUBSTITUTED HYDROXYPROPYL CELLULOSE, UNSPECIFIED:ORAL:CAPSULE, DELAYED ACTION:MG	ORAL	40MG ORAL CAPSULE, DELAYED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
2165RE0K14	LOW-SUBSTITUTED HYDROXYPROPYL CELLULOSE, UNSPECIFIED:ORAL:CAPSULE, ENTERIC COATED PELLETS:MG	ORAL	20MG ORAL CAPSULE, ENTERIC COATED PELLETS	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
2165RE0K14	LOW-SUBSTITUTED HYDROXYPROPYL CELLULOSE, UNSPECIFIED:ORAL:CAPSULE, EXTENDED RELEASE:MG	ORAL	20MG ORAL CAPSULE, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
2165RE0K14	LOW-SUBSTITUTED HYDROXYPROPYL CELLULOSE, UNSPECIFIED:ORAL:CAPSULE, HARD GELATIN:MG	ORAL	6MG ORAL CAPSULE, HARD GELATIN	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
2165RE0K14	LOW-SUBSTITUTED HYDROXYPROPYL CELLULOSE, UNSPECIFIED:ORAL:TABLET:MG	ORAL	100MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
2165RE0K14	LOW-SUBSTITUTED HYDROXYPROPYL CELLULOSE, UNSPECIFIED:ORAL:TABLET (IMMED./COMP. RELEASE), FILM COATED:MG	ORAL	50MG ORAL TABLET (IMMED./COMP. RELEASE), FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
2165RE0K14	LOW-SUBSTITUTED HYDROXYPROPYL CELLULOSE, UNSPECIFIED:ORAL:TABLET (IMMED./COMP. RELEASE), UNCOATED, CHEWABLE:MG	ORAL	35MG ORAL TABLET (IMMED./COMP. RELEASE), UNCOATED, CHEWABLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
2165RE0K14	LOW-SUBSTITUTED HYDROXYPROPYL CELLULOSE, UNSPECIFIED:ORAL:TABLET, DELAYED ACTION, COATED:MG	ORAL	15MG ORAL TABLET, DELAYED ACTION, COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
2165RE0K14	LOW-SUBSTITUTED HYDROXYPROPYL CELLULOSE, UNSPECIFIED:ORAL:TABLET, DELAYED ACTION, ENTERIC COATED:MG	ORAL	19.5MG ORAL TABLET, DELAYED ACTION, ENTERIC COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
2165RE0K14	LOW-SUBSTITUTED HYDROXYPROPYL CELLULOSE, UNSPECIFIED:ORAL:TABLET, DELAYED RELEASE:MG	ORAL	26.3MG ORAL TABLET, DELAYED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
2165RE0K14	LOW-SUBSTITUTED HYDROXYPROPYL CELLULOSE, UNSPECIFIED:ORAL:TABLET, MULTILAYER, EXTENDED RELEASE:MG	ORAL	63MG ORAL TABLET, MULTILAYER, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
2165RE0K14	LOW-SUBSTITUTED HYDROXYPROPYL CELLULOSE, UNSPECIFIED:ORAL:TABLET, ORALLY DISINTEGRATING:MG	ORAL	42MG ORAL TABLET, ORALLY DISINTEGRATING	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
2165RE0K14	LOW-SUBSTITUTED HYDROXYPROPYL CELLULOSE, UNSPECIFIED:ORAL:TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE:MG	ORAL	40MG ORAL TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
2165RE0K14	LOW-SUBSTITUTED HYDROXYPROPYL CELLULOSE, UNSPECIFIED:ORAL:TABLET, SUSTAINED ACTION:MG	ORAL	11.66MG ORAL TABLET, SUSTAINED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
F5WR8N145C	SODIUM IODIDE:INTRAVENOUS:INJECTION:%	INTRAVENOUS	1% INTRAVENOUS INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
F5WR8N145C	SODIUM IODIDE:INTRAVENOUS:POWDER, FOR INJECTION SOLUTION:%	INTRAVENOUS	5% INTRAVENOUS POWDER, FOR INJECTION SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
F5WR8N145C	SODIUM IODIDE:TOPICAL:SPONGE:NA	TOPICAL	TOPICAL SPONGE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
LIT014L4RH	QUATERNIUM-15 CIS-FORM:TOPICAL:EMULSION, CREAM:%W/W	TOPICAL	0.1%W/W TOPICAL EMULSION, CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=Q
LIT014L4RH	QUATERNIUM-15 CIS-FORM:TOPICAL:LOTION:NA	TOPICAL	TOPICAL LOTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=Q
LIT014L4RH	QUATERNIUM-15 CIS-FORM:VAGINAL:EMULSION, CREAM:NA	VAGINAL	VAGINAL EMULSION, CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=Q
O181101B5G	SODIUM PHOSPHATE P-32:IM - IV:INJECTION:NA	IM - IV	IM - IV INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
R4OXA9G5BV	MAGNESIUM PALMITOSTEARATE:ORAL:TABLET:MG	ORAL	10MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
3LH1P5MUK0	DIISOPROPYLBENZOTHIAZYL-2-SULFENAMIDE:ORAL:TABLET:MG	ORAL	77MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
X21KPH4633	PEG-25 PROPYLENE GLYCOL STEARATE:TOPICAL:EMULSION, CREAM:NA	TOPICAL	TOPICAL EMULSION, CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
1IVH67816N	HYPROMELLOSE 2910 (50 MPA.S):ORAL:CAPSULE:mg	ORAL	155mg ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
1IVH67816N	HYPROMELLOSE 2910 (50 MPA.S):ORAL:CAPSULE, EXTENDED RELEASE:MG	ORAL	54MG ORAL CAPSULE, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
1IVH67816N	HYPROMELLOSE 2910 (50 MPA.S):ORAL:TABLET:MG	ORAL	48.26MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
1IVH67816N	HYPROMELLOSE 2910 (50 MPA.S):ORAL:TABLET, DELAYED RELEASE:mg	ORAL	35mg ORAL TABLET, DELAYED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
1IVH67816N	HYPROMELLOSE 2910 (50 MPA.S):ORAL:TABLET, EXTENDED RELEASE:MG	ORAL	180MG ORAL TABLET, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
1IVH67816N	HYPROMELLOSE 2910 (50 MPA.S):ORAL:TABLET, FILM COATED:MG	ORAL	16.875MG ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
1IVH67816N	HYPROMELLOSE 2910 (50 MPA.S):ORAL:TABLET, FILM COATED, EXTENDED RELEASE:MG	ORAL	0.56MG ORAL TABLET, FILM COATED, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
1Z74184RGV	EGG PHOSPHOLIPIDS:INTRAVENOUS:EMULSION, INJECTION:%	INTRAVENOUS	1.2% INTRAVENOUS EMULSION, INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
1Z74184RGV	EGG PHOSPHOLIPIDS:INTRAVENOUS:INJECTABLE:%	INTRAVENOUS	1.2% INTRAVENOUS INJECTABLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
1Z74184RGV	EGG PHOSPHOLIPIDS:INTRAVENOUS:INJECTION:%	INTRAVENOUS	1.2% INTRAVENOUS INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
1Z74184RGV	EGG PHOSPHOLIPIDS:INTRAVENOUS:INJECTION, EMULSION:MG/1ML	INTRAVENOUS	144.6MG/1ML INTRAVENOUS INJECTION, EMULSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
1Z74184RGV	EGG PHOSPHOLIPIDS:INTRAVENOUS:POWDER, FOR INJECTION SOLUTION, LYOPHILIZED:%	INTRAVENOUS	4.88% INTRAVENOUS POWDER, FOR INJECTION SOLUTION, LYOPHILIZED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
1Z74184RGV	EGG PHOSPHOLIPIDS:IV(INFUSION):EMULSION:NA	IV(INFUSION)	IV(INFUSION) EMULSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
1Z74184RGV	EGG PHOSPHOLIPIDS:IV(INFUSION):INJECTION:%	IV(INFUSION)	1.2% IV(INFUSION) INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
1Z74184RGV	EGG PHOSPHOLIPIDS:ORAL:TABLET:MG	ORAL	48MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
817L1N4CKP	MALIC ACID:ORAL:LIQUID:ADJ PH	ORAL	ADJ PH ORAL LIQUID	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
817L1N4CKP	MALIC ACID:ORAL:POWDER:MG/1PKT	ORAL	232MG/1PKT ORAL POWDER	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
817L1N4CKP	MALIC ACID:ORAL:POWDER, FOR ORAL SOLUTION:MG	ORAL	315MG ORAL POWDER, FOR ORAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
817L1N4CKP	MALIC ACID:ORAL:POWDER, FOR SOLUTION:MG/1PKT	ORAL	123MG/1PKT ORAL POWDER, FOR SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
817L1N4CKP	MALIC ACID:ORAL:SOLUTION:G/160ML	ORAL	8.38G/160ML ORAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
817L1N4CKP	MALIC ACID:ORAL:SUSPENSION:MG/5ML	ORAL	21MG/5ML ORAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
817L1N4CKP	MALIC ACID:ORAL:TABLET:MG	ORAL	2.8MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
2C22T7DYYR	GALACTOSE MONOHYDRATE:ORAL:CAPSULE:MG	ORAL	163.61MG ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
2C22T7DYYR	GALACTOSE MONOHYDRATE:ORAL:TABLET:MG	ORAL	147.6MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
230OU9XXE4	GLYCERYL MONOSTEARATE:AURICULAR (OTIC):SUSPENSION:%	AURICULAR (OTIC)	0.5% AURICULAR (OTIC) SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
230OU9XXE4	GLYCERYL MONOSTEARATE:DENTAL:PASTE:MG	DENTAL	64MG DENTAL PASTE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
230OU9XXE4	GLYCERYL MONOSTEARATE:OPHTHALMIC:SUSPENSION:%	OPHTHALMIC	0.5% OPHTHALMIC SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
230OU9XXE4	GLYCERYL MONOSTEARATE:ORAL:CAPSULE, DELAYED ACTION:MG	ORAL	2.04MG ORAL CAPSULE, DELAYED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
230OU9XXE4	GLYCERYL MONOSTEARATE:ORAL:CAPSULE, DELAYED RELEASE:MG	ORAL	1.745MG ORAL CAPSULE, DELAYED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
230OU9XXE4	GLYCERYL MONOSTEARATE:ORAL:CAPSULE, EXTENDED RELEASE:MG	ORAL	18.38MG ORAL CAPSULE, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
230OU9XXE4	GLYCERYL MONOSTEARATE:ORAL:CAPSULE, HARD GELATIN:MG	ORAL	13.75MG ORAL CAPSULE, HARD GELATIN	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
230OU9XXE4	GLYCERYL MONOSTEARATE:ORAL:CAPSULE, SUSTAINED ACTION:MG	ORAL	27MG ORAL CAPSULE, SUSTAINED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
230OU9XXE4	GLYCERYL MONOSTEARATE:ORAL:GRANULE, FOR ORAL SUSPENSION:MG	ORAL	1.9MG ORAL GRANULE, FOR ORAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
230OU9XXE4	GLYCERYL MONOSTEARATE:ORAL:PELLET:MG	ORAL	1.9MG ORAL PELLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
230OU9XXE4	GLYCERYL MONOSTEARATE:ORAL:TABLET:MG	ORAL	8.75MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
230OU9XXE4	GLYCERYL MONOSTEARATE:ORAL:TABLET (IMMED./COMP. RELEASE), UNCOATED, CHEWABLE:MG	ORAL	0.25MG ORAL TABLET (IMMED./COMP. RELEASE), UNCOATED, CHEWABLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
230OU9XXE4	GLYCERYL MONOSTEARATE:ORAL:TABLET, CONTROLLED RELEASE:mg	ORAL	1.14mg ORAL TABLET, CONTROLLED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
230OU9XXE4	GLYCERYL MONOSTEARATE:ORAL:TABLET, DELAYED ACTION:MG	ORAL	1.4MG ORAL TABLET, DELAYED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
230OU9XXE4	GLYCERYL MONOSTEARATE:ORAL:TABLET, DELAYED ACTION, ENTERIC COATED:MG	ORAL	0.005MG ORAL TABLET, DELAYED ACTION, ENTERIC COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
230OU9XXE4	GLYCERYL MONOSTEARATE:ORAL:TABLET, DELAYED RELEASE:MG	ORAL	1.32MG ORAL TABLET, DELAYED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
230OU9XXE4	GLYCERYL MONOSTEARATE:ORAL:TABLET, EXTENDED RELEASE:MG	ORAL	17MG ORAL TABLET, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
230OU9XXE4	GLYCERYL MONOSTEARATE:ORAL:TABLET, FILM COATED:MG	ORAL	2.36MG ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
230OU9XXE4	GLYCERYL MONOSTEARATE:ORAL:TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE:MG	ORAL	7.5MG ORAL TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
230OU9XXE4	GLYCERYL MONOSTEARATE:ORAL:TABLET, SUSTAINED ACTION:MG	ORAL	154MG ORAL TABLET, SUSTAINED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
230OU9XXE4	GLYCERYL MONOSTEARATE:ORAL:TABLET, SUSTAINED ACTION, FILM COATED:MG	ORAL	264.3MG ORAL TABLET, SUSTAINED ACTION, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
230OU9XXE4	GLYCERYL MONOSTEARATE:RECTAL:SUPPOSITORY:MG	RECTAL	32.3MG RECTAL SUPPOSITORY	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
230OU9XXE4	GLYCERYL MONOSTEARATE:SUBLINGUAL:TABLET:MG	SUBLINGUAL	1.23MG SUBLINGUAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
230OU9XXE4	GLYCERYL MONOSTEARATE:TOPICAL:CREAM:%W/W	TOPICAL	7%W/W TOPICAL CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
230OU9XXE4	GLYCERYL MONOSTEARATE:TOPICAL:CREAM, EMULSION, SUSTAINED RELEASE:%W/W	TOPICAL	8.5%W/W TOPICAL CREAM, EMULSION, SUSTAINED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
230OU9XXE4	GLYCERYL MONOSTEARATE:TOPICAL:EMULSION, AEROSOL FOAM:NA	TOPICAL	TOPICAL EMULSION, AEROSOL FOAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
230OU9XXE4	GLYCERYL MONOSTEARATE:TOPICAL:EMULSION, CREAM:%W/W	TOPICAL	20%W/W TOPICAL EMULSION, CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
230OU9XXE4	GLYCERYL MONOSTEARATE:TOPICAL:LOTION:%W/W	TOPICAL	9%W/W TOPICAL LOTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
230OU9XXE4	GLYCERYL MONOSTEARATE:TOPICAL:OINTMENT:%W/W	TOPICAL	5%W/W TOPICAL OINTMENT	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
230OU9XXE4	GLYCERYL MONOSTEARATE:TOPICAL:SUPPOSITORY:NA	TOPICAL	TOPICAL SUPPOSITORY	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
230OU9XXE4	GLYCERYL MONOSTEARATE:TOPICAL:SUSPENSION:%W/W	TOPICAL	1.25%W/W TOPICAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
230OU9XXE4	GLYCERYL MONOSTEARATE:VAGINAL:CREAM, EMULSION, SUSTAINED RELEASE:%W/W	VAGINAL	1%W/W VAGINAL CREAM, EMULSION, SUSTAINED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
230OU9XXE4	GLYCERYL MONOSTEARATE:VAGINAL:EMULSION, CREAM:%	VAGINAL	17% VAGINAL EMULSION, CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
EU2PSP0G0W	SILICA DIMETHYL SILYLATE:ORAL:CAPSULE:MG	ORAL	0.5MG ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
EU2PSP0G0W	SILICA DIMETHYL SILYLATE:ORAL:TABLET:MG	ORAL	8MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
EU2PSP0G0W	SILICA DIMETHYL SILYLATE:ORAL:TABLET (IMMED./COMP. RELEASE), FILM COATED:MG	ORAL	0.5MG ORAL TABLET (IMMED./COMP. RELEASE), FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
EU2PSP0G0W	SILICA DIMETHYL SILYLATE:ORAL:TABLET, EXTENDED RELEASE:MG	ORAL	10MG ORAL TABLET, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
EU2PSP0G0W	SILICA DIMETHYL SILYLATE:ORAL:TABLET, FILM COATED:mg	ORAL	2.5mg ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
EU2PSP0G0W	SILICA DIMETHYL SILYLATE:SUBLINGUAL:TABLET:MG	SUBLINGUAL	0.8MG SUBLINGUAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
OSX88361UX	PHENYLMERCURIC ACETATE:OPHTHALMIC:OINTMENT:%	OPHTHALMIC	0.001% OPHTHALMIC OINTMENT	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
OSX88361UX	PHENYLMERCURIC ACETATE:OPHTHALMIC:SOLUTION:%	OPHTHALMIC	0.002% OPHTHALMIC SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
OSX88361UX	PHENYLMERCURIC ACETATE:TOPICAL:EMULSION, CREAM:%W/W	TOPICAL	0.01%W/W TOPICAL EMULSION, CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
OSX88361UX	PHENYLMERCURIC ACETATE:VAGINAL:EMULSION, CREAM:%	VAGINAL	0.01% VAGINAL EMULSION, CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
3WJQ0SDW1A	POLYETHYLENE GLYCOL, UNSPECIFIED:DENTAL:OINTMENT:NA	DENTAL	DENTAL OINTMENT	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
3WJQ0SDW1A	POLYETHYLENE GLYCOL, UNSPECIFIED:ORAL:CAPSULE:mg	ORAL	4.8mg ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
3WJQ0SDW1A	POLYETHYLENE GLYCOL, UNSPECIFIED:ORAL:TABLET:MG	ORAL	4.85MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
3WJQ0SDW1A	POLYETHYLENE GLYCOL, UNSPECIFIED:ORAL:TABLET, DELAYED ACTION, ENTERIC COATED:NA	ORAL	ORAL TABLET, DELAYED ACTION, ENTERIC COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
3WJQ0SDW1A	POLYETHYLENE GLYCOL, UNSPECIFIED:ORAL:TABLET, FILM COATED:mg	ORAL	5.69mg ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
3WJQ0SDW1A	POLYETHYLENE GLYCOL, UNSPECIFIED:SUBLINGUAL:FILM:mg	SUBLINGUAL	43.96mg SUBLINGUAL FILM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
3WJQ0SDW1A	POLYETHYLENE GLYCOL, UNSPECIFIED:TOPICAL:OINTMENT:NA	TOPICAL	TOPICAL OINTMENT	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
871QYF3I7B	MILK PROTEIN CONCENTRATE:BUCCAL:TABLET:MG	BUCCAL	27.43MG BUCCAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
871QYF3I7B	MILK PROTEIN CONCENTRATE:BUCCAL:TABLET, EXTENDED RELEASE:MG	BUCCAL	23MG BUCCAL TABLET, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
RO266O364U	DIMETHICONE 100:ORAL:TABLET, FILM COATED:MG	ORAL	2.5MG ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
RO266O364U	DIMETHICONE 100:TOPICAL:GEL:%W/W	TOPICAL	0.1%W/W TOPICAL GEL	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
6ZAE7X688J	LIQUID PETROLEUM:TOPICAL:OINTMENT:%W/W	TOPICAL	92.95%W/W TOPICAL OINTMENT	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
1394NXB9L6	HYDROLYZED SOY PROTEIN (ENZYMATIC; 2000 MW):IV(INFUSION):INJECTION, LIPOSOMAL:%	IV(INFUSION)	0.096% IV(INFUSION) INJECTION, LIPOSOMAL	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
3D49LE7HM2	GLUCEPTATE SODIUM:INTRAVENOUS:INJECTION:%	INTRAVENOUS	7.5% INTRAVENOUS INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
3D49LE7HM2	GLUCEPTATE SODIUM:INTRAVENOUS:POWDER, FOR INJECTION SOLUTION:%	INTRAVENOUS	20% INTRAVENOUS POWDER, FOR INJECTION SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
3VSI4D701X	1-(PHENYLAZO)-2-NAPHTHYLAMINE:ORAL:CAPSULE:MG	ORAL	0.13MG ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=1
3VSI4D701X	1-(PHENYLAZO)-2-NAPHTHYLAMINE:ORAL:TABLET:MG	ORAL	0.2MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=1
74G4R6TH13	METHACRYLIC ACID - METHYL METHACRYLATE COPOLYMER (1:1):ORAL:CAPSULE:MG	ORAL	57.6MG ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
74G4R6TH13	METHACRYLIC ACID - METHYL METHACRYLATE COPOLYMER (1:1):ORAL:CAPSULE, DELAYED ACTION:MG	ORAL	6.8MG ORAL CAPSULE, DELAYED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
74G4R6TH13	METHACRYLIC ACID - METHYL METHACRYLATE COPOLYMER (1:1):ORAL:CAPSULE, ENTERIC COATED PELLETS:MG	ORAL	93.36MG ORAL CAPSULE, ENTERIC COATED PELLETS	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
74G4R6TH13	METHACRYLIC ACID - METHYL METHACRYLATE COPOLYMER (1:1):ORAL:CAPSULE, EXTENDED RELEASE:MG	ORAL	55.58MG ORAL CAPSULE, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
74G4R6TH13	METHACRYLIC ACID - METHYL METHACRYLATE COPOLYMER (1:1):ORAL:CAPSULE, SUSTAINED ACTION:MG	ORAL	22.08MG ORAL CAPSULE, SUSTAINED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
74G4R6TH13	METHACRYLIC ACID - METHYL METHACRYLATE COPOLYMER (1:1):ORAL:SUSPENSION:MG/15 ML	ORAL	55.74MG/15 ML ORAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
74G4R6TH13	METHACRYLIC ACID - METHYL METHACRYLATE COPOLYMER (1:1):ORAL:TABLET:MG	ORAL	13.65MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
74G4R6TH13	METHACRYLIC ACID - METHYL METHACRYLATE COPOLYMER (1:1):ORAL:TABLET, CONTROLLED RELEASE:MG	ORAL	4.9MG ORAL TABLET, CONTROLLED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
74G4R6TH13	METHACRYLIC ACID - METHYL METHACRYLATE COPOLYMER (1:1):ORAL:TABLET, DELAYED ACTION:MG	ORAL	16MG ORAL TABLET, DELAYED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
74G4R6TH13	METHACRYLIC ACID - METHYL METHACRYLATE COPOLYMER (1:1):ORAL:TABLET, DELAYED RELEASE:mg	ORAL	42.9mg ORAL TABLET, DELAYED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
74G4R6TH13	METHACRYLIC ACID - METHYL METHACRYLATE COPOLYMER (1:1):ORAL:TABLET, EXTENDED RELEASE:mg	ORAL	10.5mg ORAL TABLET, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
74G4R6TH13	METHACRYLIC ACID - METHYL METHACRYLATE COPOLYMER (1:1):ORAL:TABLET, FILM COATED:MG	ORAL	16MG ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
74G4R6TH13	METHACRYLIC ACID - METHYL METHACRYLATE COPOLYMER (1:1):ORAL:TABLET, SUSTAINED ACTION, COATED:MG	ORAL	10.08MG ORAL TABLET, SUSTAINED ACTION, COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
9G34HU7RV0	EDETIC ACID:AURICULAR (OTIC):SUSPENSION:%	AURICULAR (OTIC)	0.001% AURICULAR (OTIC) SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
9G34HU7RV0	EDETIC ACID:INTRAMUSCULAR:SOLUTION, INJECTION:%W/V	INTRAMUSCULAR	0.02%W/V INTRAMUSCULAR SOLUTION, INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
9G34HU7RV0	EDETIC ACID:INTRAVENOUS:SOLUTION, INJECTION:%	INTRAVENOUS	0.02% INTRAVENOUS SOLUTION, INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
9G34HU7RV0	EDETIC ACID:ORAL:SOLUTION, INJECTION:MG/1.7ML	ORAL	0.5MG/1.7ML ORAL SOLUTION, INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
9G34HU7RV0	EDETIC ACID:ORAL:TABLET:MG	ORAL	4MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
9G34HU7RV0	EDETIC ACID:ORAL:TABLET, FILM COATED:MG	ORAL	0.2MG ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
9G34HU7RV0	EDETIC ACID:RECTAL:SUPPOSITORY:MG	RECTAL	1.7MG RECTAL SUPPOSITORY	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
9G34HU7RV0	EDETIC ACID:SUBCUTANEOUS:SOLUTION, INJECTION:%	SUBCUTANEOUS	0.02% SUBCUTANEOUS SOLUTION, INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
9G34HU7RV0	EDETIC ACID:SUBMUCOSAL:SOLUTION, INJECTION:%	SUBMUCOSAL	0.029% SUBMUCOSAL SOLUTION, INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
9G34HU7RV0	EDETIC ACID:TOPICAL:LOTION:NA	TOPICAL	TOPICAL LOTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
9G34HU7RV0	EDETIC ACID:TOPICAL:SHAMPOO:%W/W	TOPICAL	0.2%W/W TOPICAL SHAMPOO	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
9G34HU7RV0	EDETIC ACID:TOPICAL:SOLUTION:%W/W	TOPICAL	0.5%W/W TOPICAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
9G34HU7RV0	EDETIC ACID:TOPICAL:SUSPENSION:%W/W	TOPICAL	0.06%W/W TOPICAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
4ERD2076EF	PEG-40 CASTOR OIL:ORAL:TABLET:MG	ORAL	9MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
KC98RO82HJ	GLYCERYL MONO AND DIPALMITOSTEARATE:ORAL:CAPSULE:mg	ORAL	11.7mg ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
KC98RO82HJ	GLYCERYL MONO AND DIPALMITOSTEARATE:ORAL:CAPSULE, DELAYED RELEASE:mg	ORAL	5.61mg ORAL CAPSULE, DELAYED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
KC98RO82HJ	GLYCERYL MONO AND DIPALMITOSTEARATE:ORAL:TABLET, DELAYED RELEASE:MG	ORAL	2.02MG ORAL TABLET, DELAYED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
KC98RO82HJ	GLYCERYL MONO AND DIPALMITOSTEARATE:ORAL:TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE:mg	ORAL	4.62mg ORAL TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
KC98RO82HJ	GLYCERYL MONO AND DIPALMITOSTEARATE:TOPICAL:CREAM:%W/W	TOPICAL	13.5%W/W TOPICAL CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
KC98RO82HJ	GLYCERYL MONO AND DIPALMITOSTEARATE:VAGINAL:CREAM:%W/W	VAGINAL	4%W/W VAGINAL CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
02F3473H9O	MAGNESIUM CHLORIDE:AURICULAR (OTIC):SUSPENSION:%	AURICULAR (OTIC)	0.06% AURICULAR (OTIC) SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
02F3473H9O	MAGNESIUM CHLORIDE:INTRAMUSCULAR:INJECTION:NA	INTRAMUSCULAR	INTRAMUSCULAR INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
02F3473H9O	MAGNESIUM CHLORIDE:INTRAOCULAR:SOLUTION:%	INTRAOCULAR	0.03% INTRAOCULAR SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
02F3473H9O	MAGNESIUM CHLORIDE:INTRAPERITONEAL:SOLUTION:%	INTRAPERITONEAL	0.005% INTRAPERITONEAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
02F3473H9O	MAGNESIUM CHLORIDE:INTRAVITREAL:SUSPENSION, INJECTION:%	INTRAVITREAL	0.03% INTRAVITREAL SUSPENSION, INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
02F3473H9O	MAGNESIUM CHLORIDE:IV(INFUSION):INJECTION:%	IV(INFUSION)	10.2% IV(INFUSION) INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
02F3473H9O	MAGNESIUM CHLORIDE:OPHTHALMIC:POWDER, FOR SOLUTION:%	OPHTHALMIC	0.03% OPHTHALMIC POWDER, FOR SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
02F3473H9O	MAGNESIUM CHLORIDE:OPHTHALMIC:SOLUTION, DROPS:%	OPHTHALMIC	0.007% OPHTHALMIC SOLUTION, DROPS	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
02F3473H9O	MAGNESIUM CHLORIDE:SUBCUTANEOUS:POWDER, FOR INJECTION SOLUTION, LYOPHILIZED:%	SUBCUTANEOUS	0.13% SUBCUTANEOUS POWDER, FOR INJECTION SOLUTION, LYOPHILIZED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
Z1CLM48948	NUTMEG OIL:ORAL:SOLUTION, ELIXIR:MG/5ML	ORAL	4.5MG/5ML ORAL SOLUTION, ELIXIR	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=N
5TL50QU0W4	PEANUT OIL:AURICULAR (OTIC):OIL:%V/V	AURICULAR (OTIC)	48.3%V/V AURICULAR (OTIC) OIL	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
5TL50QU0W4	PEANUT OIL:INTRAMUSCULAR:INJECTION:NA	INTRAMUSCULAR	INTRAMUSCULAR INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
5TL50QU0W4	PEANUT OIL:INTRAMUSCULAR:INJECTION, SUSTAINED ACTION:NA	INTRAMUSCULAR	INTRAMUSCULAR INJECTION, SUSTAINED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
5TL50QU0W4	PEANUT OIL:INTRATRACHEAL:SUSPENSION:NA	INTRATRACHEAL	INTRATRACHEAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
5TL50QU0W4	PEANUT OIL:ORAL:CAPSULE:MG	ORAL	313.8MG ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
5TL50QU0W4	PEANUT OIL:ORAL:CAPSULE, COATED, SOFT GELATIN:MG	ORAL	149MG ORAL CAPSULE, COATED, SOFT GELATIN	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
5TL50QU0W4	PEANUT OIL:TOPICAL:CREAM, AUGMENTED:%W/W	TOPICAL	10%W/W TOPICAL CREAM, AUGMENTED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
5TL50QU0W4	PEANUT OIL:TOPICAL:EMULSION, CREAM:NA	TOPICAL	TOPICAL EMULSION, CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
5TL50QU0W4	PEANUT OIL:TOPICAL:OIL:%W/W	TOPICAL	50.5%W/W TOPICAL OIL	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
5TL50QU0W4	PEANUT OIL:VAGINAL:EMULSION, CREAM:%	VAGINAL	9% VAGINAL EMULSION, CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
5TL50QU0W4	PEANUT OIL, REFINED:TOPICAL:OIL:%W/W 	TOPICAL	50%W/W  TOPICAL OIL	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
XY6UN3QB6S	HIGH FRUCTOSE CORN SYRUP:ORAL:LIQUID:MG/1ML	ORAL	17MG/1ML ORAL LIQUID	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
XY6UN3QB6S	HIGH FRUCTOSE CORN SYRUP:ORAL:SOLUTION:MG/5ML	ORAL	1250MG/5ML ORAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
XY6UN3QB6S	HIGH FRUCTOSE CORN SYRUP:ORAL:SUSPENSION:MG/5ML	ORAL	1500MG/5ML ORAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
XY6UN3QB6S	HIGH FRUCTOSE CORN SYRUP:ORAL:SUSPENSION, EXTENDED RELEASE:MG/5ML	ORAL	1500MG/5ML ORAL SUSPENSION, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
XY6UN3QB6S	HIGH FRUCTOSE CORN SYRUP:ORAL:SUSPENSION, SUSTAINED ACTION:NA	ORAL	ORAL SUSPENSION, SUSTAINED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
7SPF5O5BW8	METANIL YELLOW:ORAL:TABLET:NA	ORAL	ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
K3Z4F929H6	LYSINE:IM - IV:INJECTION:NA	IM - IV	IM - IV INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
K3Z4F929H6	LYSINE:IV(INFUSION):INJECTION:%	IV(INFUSION)	49.2% IV(INFUSION) INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
K3Z4F929H6	LYSINE:IV(INFUSION):SOLUTION, INJECTION:%	IV(INFUSION)	0.22% IV(INFUSION) SOLUTION, INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
RYX5QG61EI	LEVULINIC ACID:TRANSDERMAL:FILM, EXTENDED RELEASE:mg	TRANSDERMAL	16.5mg TRANSDERMAL FILM, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
RYX5QG61EI	LEVULINIC ACID:TRANSDERMAL:PATCH, CONTROLLED RELEASE:MG	TRANSDERMAL	20MG TRANSDERMAL PATCH, CONTROLLED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
1699G8679Z	SODIUM POLYSTYRENE SULFONATE:ORAL:SUSPENSION:MG/15 ML	ORAL	42.071MG/15 ML ORAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
1699G8679Z	SODIUM POLYSTYRENE SULFONATE:ORAL:TABLET, SUSTAINED RELEASE, FILM COATED:MG	ORAL	18MG ORAL TABLET, SUSTAINED RELEASE, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
ZIF514RVZR	ALBUMIN HUMAN:INTRAVENOUS:INJECTION:%	INTRAVENOUS	2% INTRAVENOUS INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
ZIF514RVZR	ALBUMIN HUMAN:INTRAVENOUS:POWDER, FOR INJECTION SOLUTION:%	INTRAVENOUS	1% INTRAVENOUS POWDER, FOR INJECTION SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
ZIF514RVZR	ALBUMIN HUMAN:IV(INFUSION):INJECTION:%	IV(INFUSION)	1% IV(INFUSION) INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
ZIF514RVZR	ALBUMIN HUMAN:IV(INFUSION):POWDER, FOR INJECTION SOLUTION, LYOPHILIZED:%	IV(INFUSION)	80% IV(INFUSION) POWDER, FOR INJECTION SOLUTION, LYOPHILIZED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
ZIF514RVZR	ALBUMIN HUMAN:SUBCUTANEOUS:INJECTABLE:%	SUBCUTANEOUS	0.1% SUBCUTANEOUS INJECTABLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
MP1J8420LU	EDETATE SODIUM:IM - IV:INJECTION:%	IM - IV	0.01% IM - IV INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
MP1J8420LU	EDETATE SODIUM:IM - IV - SC:INJECTION:%	IM - IV - SC	0.2% IM - IV - SC INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
MP1J8420LU	EDETATE SODIUM:INHALATION:SOLUTION:%	INHALATION	0.02% INHALATION SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
MP1J8420LU	EDETATE SODIUM:INTRAMUSCULAR:INJECTION:%	INTRAMUSCULAR	0.01% INTRAMUSCULAR INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
MP1J8420LU	EDETATE SODIUM:IV(INFUSION):SOLUTION, INJECTION:%	IV(INFUSION)	0.04% IV(INFUSION) SOLUTION, INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
MP1J8420LU	EDETATE SODIUM:OPHTHALMIC:EMULSION:%	OPHTHALMIC	0.02% OPHTHALMIC EMULSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
MP1J8420LU	EDETATE SODIUM:OPHTHALMIC:SOLUTION:%	OPHTHALMIC	0.1% OPHTHALMIC SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
MP1J8420LU	EDETATE SODIUM:OPHTHALMIC:SUSPENSION:%	OPHTHALMIC	0.02% OPHTHALMIC SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
MP1J8420LU	EDETATE SODIUM:ORAL:CAPSULE, SOFT GELATIN:MG	ORAL	1MG ORAL CAPSULE, SOFT GELATIN	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
MP1J8420LU	EDETATE SODIUM:ORAL:TABLET:MG	ORAL	5MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
MP1J8420LU	EDETATE SODIUM:TOPICAL:EMULSION, CREAM:NA	TOPICAL	TOPICAL EMULSION, CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
MP1J8420LU	EDETATE SODIUM:TOPICAL:LOTION:%W/W	TOPICAL	0.17%W/W TOPICAL LOTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
MP1J8420LU	EDETATE SODIUM:TOPICAL:SHAMPOO:NA	TOPICAL	TOPICAL SHAMPOO	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
MP1J8420LU	EDETATE SODIUM:TOPICAL:SPONGE:%W/W	TOPICAL	0.14%W/W TOPICAL SPONGE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
87Y6436BKR	HYPROMELLOSE PHTHALATE (24% PHTHALATE, 55 CST):ORAL:CAPSULE:MG	ORAL	97.5MG ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
87Y6436BKR	HYPROMELLOSE PHTHALATE (24% PHTHALATE, 55 CST):ORAL:CAPSULE, DELAYED ACTION:MG	ORAL	27.51MG ORAL CAPSULE, DELAYED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
6UYK2W1W1E	OLIVE OIL:ORAL:CAPSULE:NA	ORAL	ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
6UYK2W1W1E	OLIVE OIL:ORAL:SOLUTION:MG/1ML	ORAL	425MG/1ML ORAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
6UYK2W1W1E	OLIVE OIL:TOPICAL:CREAM, AUGMENTED:%W/W	TOPICAL	27.75%W/W TOPICAL CREAM, AUGMENTED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
6UYK2W1W1E	OLIVE OIL:TOPICAL:SOLUTION:%W/W	TOPICAL	0.6%W/W TOPICAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
532B59J990	POLYVINYL ALCOHOL:INTRAVITREAL:IMPLANT:%	INTRAVITREAL	0.002% INTRAVITREAL IMPLANT	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
532B59J990	POLYVINYL ALCOHOL:ORAL:CAPSULE:mg	ORAL	0.68mg ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
532B59J990	POLYVINYL ALCOHOL:ORAL:TABLET:mg	ORAL	21.52mg ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
532B59J990	POLYVINYL ALCOHOL:ORAL:TABLET, DELAYED RELEASE:mg	ORAL	3.6mg ORAL TABLET, DELAYED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
532B59J990	POLYVINYL ALCOHOL:ORAL:TABLET, EXTENDED RELEASE:MG	ORAL	11.852MG ORAL TABLET, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
532B59J990	POLYVINYL ALCOHOL:ORAL:TABLET, FILM COATED:MG	ORAL	9.44MG ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
532B59J990	POLYVINYL ALCOHOL, UNSPECIFIED:AURICULAR (OTIC):SUSPENSION, LIQUID:%	AURICULAR (OTIC)	0.05% AURICULAR (OTIC) SUSPENSION, LIQUID	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
532B59J990	POLYVINYL ALCOHOL, UNSPECIFIED:INTRAMUSCULAR:INJECTION, MICROSPHERES:NA	INTRAMUSCULAR	INTRAMUSCULAR INJECTION, MICROSPHERES	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
532B59J990	POLYVINYL ALCOHOL, UNSPECIFIED:INTRAOCULAR:SOLUTION:%	INTRAOCULAR	1.4% INTRAOCULAR SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
532B59J990	POLYVINYL ALCOHOL, UNSPECIFIED:INTRAVITREAL:IMPLANT:MG	INTRAVITREAL	0.12MG INTRAVITREAL IMPLANT	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
532B59J990	POLYVINYL ALCOHOL, UNSPECIFIED:IONTOPHORESIS:DRUG DELIVERY SYSTEM:MG	IONTOPHORESIS	119MG IONTOPHORESIS DRUG DELIVERY SYSTEM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
532B59J990	POLYVINYL ALCOHOL, UNSPECIFIED:OPHTHALMIC:DROPS:%	OPHTHALMIC	1.4% OPHTHALMIC DROPS	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
532B59J990	POLYVINYL ALCOHOL, UNSPECIFIED:OPHTHALMIC:SOLUTION:%	OPHTHALMIC	1.4% OPHTHALMIC SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
532B59J990	POLYVINYL ALCOHOL, UNSPECIFIED:OPHTHALMIC:SOLUTION, DROPS:%	OPHTHALMIC	1.4% OPHTHALMIC SOLUTION, DROPS	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
532B59J990	POLYVINYL ALCOHOL, UNSPECIFIED:OPHTHALMIC:SUSPENSION:%	OPHTHALMIC	1.4% OPHTHALMIC SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
532B59J990	POLYVINYL ALCOHOL, UNSPECIFIED:OPHTHALMIC:SUSPENSION, DROPS:%	OPHTHALMIC	1.4% OPHTHALMIC SUSPENSION, DROPS	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
532B59J990	POLYVINYL ALCOHOL, UNSPECIFIED:ORAL:CAPSULE, EXTENDED RELEASE:NA	ORAL	ORAL CAPSULE, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
532B59J990	POLYVINYL ALCOHOL, UNSPECIFIED:ORAL:TABLET:mg	ORAL	18.6mg ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
532B59J990	POLYVINYL ALCOHOL, UNSPECIFIED:ORAL:TABLET (IMMED./COMP. RELEASE), FILM COATED:MG	ORAL	19.2MG ORAL TABLET (IMMED./COMP. RELEASE), FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
532B59J990	POLYVINYL ALCOHOL, UNSPECIFIED:ORAL:TABLET, COATED:MG	ORAL	0.7MG ORAL TABLET, COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
532B59J990	POLYVINYL ALCOHOL, UNSPECIFIED:ORAL:TABLET, CONTROLLED RELEASE:MG	ORAL	3.32MG ORAL TABLET, CONTROLLED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
532B59J990	POLYVINYL ALCOHOL, UNSPECIFIED:ORAL:TABLET, DELAYED ACTION:MG	ORAL	8.8MG ORAL TABLET, DELAYED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
532B59J990	POLYVINYL ALCOHOL, UNSPECIFIED:ORAL:TABLET, DELAYED RELEASE:MG	ORAL	4.64MG ORAL TABLET, DELAYED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
532B59J990	POLYVINYL ALCOHOL, UNSPECIFIED:ORAL:TABLET, EXTENDED RELEASE:MG	ORAL	79.4MG ORAL TABLET, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
532B59J990	POLYVINYL ALCOHOL, UNSPECIFIED:ORAL:TABLET, FILM COATED:MG	ORAL	20MG ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
532B59J990	POLYVINYL ALCOHOL, UNSPECIFIED:ORAL:TABLET, ORALLY DISINTEGRATING:MG	ORAL	2MG ORAL TABLET, ORALLY DISINTEGRATING	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
532B59J990	POLYVINYL ALCOHOL, UNSPECIFIED:TOPICAL:FILM, CONTROLLED RELEASE:NA	TOPICAL	TOPICAL FILM, CONTROLLED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
532B59J990	POLYVINYL ALCOHOL, UNSPECIFIED:TOPICAL:LOTION:NA	TOPICAL	TOPICAL LOTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
532B59J990	POLYVINYL ALCOHOL, UNSPECIFIED:TOPICAL:PATCH:NA	TOPICAL	TOPICAL PATCH	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
532B59J990	POLYVINYL ALCOHOL, UNSPECIFIED:TRANSDERMAL:DRUG DELIVERY SYSTEM:MG	TRANSDERMAL	119MG TRANSDERMAL DRUG DELIVERY SYSTEM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
532B59J990	POLYVINYL ALCOHOL, UNSPECIFIED:VAGINAL:EMULSION, AEROSOL FOAM:%	VAGINAL	0.5% VAGINAL EMULSION, AEROSOL FOAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
532B59J990	POLYVINYL ALCOHOL, UNSPECIFIED:VAGINAL:TABLET:MG	VAGINAL	20.6MG VAGINAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
I9PJ0O6294	ALUMINUM STARCH OCTENYLSUCCINATE:TOPICAL:EMULSION, CREAM:%W/W	TOPICAL	10%W/W TOPICAL EMULSION, CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
I9PJ0O6294	ALUMINUM STARCH OCTENYLSUCCINATE:TOPICAL:OINTMENT:%W/W	TOPICAL	11%W/W TOPICAL OINTMENT	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
JL4CCU7I1G	PEG-40 SORBITAN DIISOSTEARATE:DENTAL:SOLUTION:%	DENTAL	2.4% DENTAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
JL4CCU7I1G	PEG-40 SORBITAN DIISOSTEARATE:ORAL:LIQUID:MG/15ML	ORAL	100MG/15ML ORAL LIQUID	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
5C5403N26O	ACACIA:BUCCAL:GUM:MG	BUCCAL	7.07MG BUCCAL GUM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
5C5403N26O	ACACIA:BUCCAL:GUM, CHEWING:MG	BUCCAL	14MG BUCCAL GUM, CHEWING	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
5C5403N26O	ACACIA:BUCCAL/SUBLINGUAL:TABLET:MG	BUCCAL/SUBLINGUAL	9.1MG BUCCAL/SUBLINGUAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
5C5403N26O	ACACIA:ORAL:CAPSULE:mg	ORAL	32mg ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
5C5403N26O	ACACIA:ORAL:CAPSULE, EXTENDED RELEASE:mg	ORAL	16.05mg ORAL CAPSULE, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
5C5403N26O	ACACIA:ORAL:CAPSULE, SUSTAINED ACTION:MG	ORAL	11.77MG ORAL CAPSULE, SUSTAINED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
5C5403N26O	ACACIA:ORAL:POWDER:MG/1PKT	ORAL	1231MG/1PKT ORAL POWDER	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
5C5403N26O	ACACIA:ORAL:POWDER:MG/1SCP	ORAL	1231MG/1SCP ORAL POWDER	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
5C5403N26O	ACACIA:ORAL:POWDER, FOR ORAL SUSPENSION:MG/1PKT	ORAL	648MG/1PKT ORAL POWDER, FOR ORAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
5C5403N26O	ACACIA:ORAL:POWDER, FOR ORAL SUSPENSION:MG/1SCP	ORAL	648MG/1SCP ORAL POWDER, FOR ORAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
5C5403N26O	ACACIA:ORAL:POWDER, FOR SOLUTION:MG/5 ML	ORAL	41.67MG/5 ML ORAL POWDER, FOR SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
5C5403N26O	ACACIA:ORAL:POWDER, FOR SUSPENSION:MG/140ML	ORAL	1640MG/140ML ORAL POWDER, FOR SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
5C5403N26O	ACACIA:ORAL:SUSPENSION:MG/5ML	ORAL	1MG/5ML ORAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
5C5403N26O	ACACIA:ORAL:SYRUP:NA	ORAL	ORAL SYRUP	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
5C5403N26O	ACACIA:ORAL:TABLET:MG	ORAL	70MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
5C5403N26O	ACACIA:ORAL:TABLET (IMMED./COMP. RELEASE), UNCOATED, CHEWABLE:MG	ORAL	80MG ORAL TABLET (IMMED./COMP. RELEASE), UNCOATED, CHEWABLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
5C5403N26O	ACACIA:ORAL:TABLET, CHEWABLE:MG	ORAL	10MG ORAL TABLET, CHEWABLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
5C5403N26O	ACACIA:ORAL:TABLET, COATED:MG	ORAL	156MG ORAL TABLET, COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
5C5403N26O	ACACIA:ORAL:TABLET, DELAYED ACTION, ENTERIC COATED:MG	ORAL	10MG ORAL TABLET, DELAYED ACTION, ENTERIC COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
5C5403N26O	ACACIA:ORAL:TABLET, EXTENDED RELEASE:NA	ORAL	ORAL TABLET, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
5C5403N26O	ACACIA:ORAL:TABLET, FILM COATED:MG	ORAL	14.9MG ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
5C5403N26O	ACACIA:ORAL:TABLET, REPEAT ACTION:MG	ORAL	11.54MG ORAL TABLET, REPEAT ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
5C5403N26O	ACACIA:ORAL:TABLET, SUSTAINED ACTION:MG	ORAL	34.4MG ORAL TABLET, SUSTAINED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
T1FAD4SS2M	ALUMINUM SILICATE:ORAL:TABLET:MG	ORAL	19.25MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
T1FAD4SS2M	ALUMINUM SILICATE:ORAL:TABLET, COATED:MG	ORAL	50MG ORAL TABLET, COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
T1FAD4SS2M	ALUMINUM SILICATE:ORAL:TABLET, EXTENDED RELEASE:MG	ORAL	94MG ORAL TABLET, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
T1FAD4SS2M	ALUMINUM SILICATE:ORAL:TABLET, SUSTAINED ACTION:MG	ORAL	94MG ORAL TABLET, SUSTAINED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
T1FAD4SS2M	ALUMINUM SILICATE:ORAL:TABLET, SUSTAINED ACTION, COATED:MG	ORAL	47MG ORAL TABLET, SUSTAINED ACTION, COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
T1FAD4SS2M	ALUMINUM SILICATE:TOPICAL:PATCH:NA	TOPICAL	TOPICAL PATCH	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
T1FAD4SS2M	ALUMINUM SILICATE:TOPICAL:SHAMPOO, SUSPENSION:NA	TOPICAL	TOPICAL SHAMPOO, SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
AKN3KSD11B	ORANGE OIL:ORAL:GRANULE, EFFERVESCENT:NA	ORAL	ORAL GRANULE, EFFERVESCENT	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
AKN3KSD11B	ORANGE OIL:ORAL:SOLUTION:NA	ORAL	ORAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
AKN3KSD11B	ORANGE OIL:ORAL:SOLUTION, ELIXIR:%	ORAL	0.024% ORAL SOLUTION, ELIXIR	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
AKN3KSD11B	ORANGE OIL:ORAL:SUSPENSION:MG/1ML	ORAL	0.54MG/1ML ORAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
AKN3KSD11B	ORANGE OIL:ORAL:TABLET (IMMED./COMP. RELEASE), UNCOATED, CHEWABLE:MG	ORAL	0.002MG ORAL TABLET (IMMED./COMP. RELEASE), UNCOATED, CHEWABLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
AKN3KSD11B	ORANGE OIL:SUBLINGUAL:TABLET:MG	SUBLINGUAL	0.002MG SUBLINGUAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
4L2574620F	GUINEA GREEN B:ORAL:SOLUTION, ELIXIR:NA	ORAL	ORAL SOLUTION, ELIXIR	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
4L2574620F	GUINEA GREEN B:ORAL:TABLET:MG	ORAL	0.12MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
333AG72FWJ	POVIDONE K12:INTRAVENOUS:INJECTABLE:%	INTRAVENOUS	2% INTRAVENOUS INJECTABLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
333AG72FWJ	POVIDONE K12:INTRAVENOUS:INJECTION:MG/1VIAL	INTRAVENOUS	20MG/1VIAL INTRAVENOUS INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
333AG72FWJ	POVIDONE K12:INTRAVENOUS:INJECTION, SUSPENSION:%	INTRAVENOUS	0.08% INTRAVENOUS INJECTION, SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
333AG72FWJ	POVIDONE K12:INTRAVENOUS:POWDER, FOR INJECTION SOLUTION, LYOPHILIZED:%	INTRAVENOUS	2% INTRAVENOUS POWDER, FOR INJECTION SOLUTION, LYOPHILIZED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
333AG72FWJ	POVIDONE K12:IV - SC:INJECTION:%	IV - SC	2% IV - SC INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
333AG72FWJ	POVIDONE K12:IV(INFUSION):SOLUTION, CONCENTRATE:%	IV(INFUSION)	10% IV(INFUSION) SOLUTION, CONCENTRATE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
333AG72FWJ	POVIDONE K12:ORAL:TABLETS:MG	ORAL	40MG ORAL TABLETS	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
RN3152OP35	HYPROMELLOSE 2910 (4000 MPA.S):NASAL:SPRAY:%	NASAL	0.1% NASAL SPRAY	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
RN3152OP35	HYPROMELLOSE 2910 (4000 MPA.S):NASAL:SPRAY, METERED:MCG/SPRAY	NASAL	137MCG/SPRAY NASAL SPRAY, METERED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
RN3152OP35	HYPROMELLOSE 2910 (4000 MPA.S):OPHTHALMIC:SOLUTION:MG/1ML	OPHTHALMIC	5MG/1ML OPHTHALMIC SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
RN3152OP35	HYPROMELLOSE 2910 (4000 MPA.S):ORAL:CAPSULE, EXTENDED RELEASE:MG	ORAL	27MG ORAL CAPSULE, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
RN3152OP35	HYPROMELLOSE 2910 (4000 MPA.S):ORAL:TABLET:MG	ORAL	48MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
RN3152OP35	HYPROMELLOSE 2910 (4000 MPA.S):ORAL:TABLET, EXTENDED RELEASE:MG	ORAL	86.32MG ORAL TABLET, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
RN3152OP35	HYPROMELLOSE 2910 (4000 MPA.S):TOPICAL:JELLY:%W/W	TOPICAL	2.28%W/W TOPICAL JELLY	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
J9EQA3S2JM	FD&C BLUE NO. 1--ALUMINUM LAKE:INTRAUTERINE:INTRAUTERINE DEVICE:NA	INTRAUTERINE	INTRAUTERINE INTRAUTERINE DEVICE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
J9EQA3S2JM	FD&C BLUE NO. 1--ALUMINUM LAKE:ORAL:CAPSULE:MG	ORAL	0.041MG ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
J9EQA3S2JM	FD&C BLUE NO. 1--ALUMINUM LAKE:ORAL:CAPSULE, DELAYED ACTION, ENTERIC COATED:NA	ORAL	ORAL CAPSULE, DELAYED ACTION, ENTERIC COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
J9EQA3S2JM	FD&C BLUE NO. 1--ALUMINUM LAKE:ORAL:CAPSULE, ENTERIC COATED PELLETS:MG	ORAL	4MG ORAL CAPSULE, ENTERIC COATED PELLETS	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
J9EQA3S2JM	FD&C BLUE NO. 1--ALUMINUM LAKE:ORAL:CAPSULE, HARD GELATIN:NA	ORAL	ORAL CAPSULE, HARD GELATIN	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
J9EQA3S2JM	FD&C BLUE NO. 1--ALUMINUM LAKE:ORAL:CAPSULE, SOFT GELATIN:mg	ORAL	0.05mg ORAL CAPSULE, SOFT GELATIN	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
J9EQA3S2JM	FD&C BLUE NO. 1--ALUMINUM LAKE:ORAL:CAPSULE, SUSTAINED ACTION:MG	ORAL	0.022MG ORAL CAPSULE, SUSTAINED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
J9EQA3S2JM	FD&C BLUE NO. 1--ALUMINUM LAKE:ORAL:POWDER, FOR SOLUTION:NA	ORAL	ORAL POWDER, FOR SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
J9EQA3S2JM	FD&C BLUE NO. 1--ALUMINUM LAKE:ORAL:TABLET:mg	ORAL	1.5mg ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
J9EQA3S2JM	FD&C BLUE NO. 1--ALUMINUM LAKE:ORAL:TABLET:mg	ORAL	0.27mg ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
J9EQA3S2JM	FD&C BLUE NO. 1--ALUMINUM LAKE:ORAL:TABLET (IMMED./COMP. RELEASE), UNCOATED, CHEWABLE:MG	ORAL	0.18MG ORAL TABLET (IMMED./COMP. RELEASE), UNCOATED, CHEWABLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
J9EQA3S2JM	FD&C BLUE NO. 1--ALUMINUM LAKE:ORAL:TABLET, COATED:MG	ORAL	0.14MG ORAL TABLET, COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
J9EQA3S2JM	FD&C BLUE NO. 1--ALUMINUM LAKE:ORAL:TABLET, DELAYED ACTION, ENTERIC COATED:MG	ORAL	0.03MG ORAL TABLET, DELAYED ACTION, ENTERIC COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
J9EQA3S2JM	FD&C BLUE NO. 1--ALUMINUM LAKE:ORAL:TABLET, EXTENDED RELEASE:mg	ORAL	2mg ORAL TABLET, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
J9EQA3S2JM	FD&C BLUE NO. 1--ALUMINUM LAKE:ORAL:TABLET, EXTENDED RELEASE:MG	ORAL	0.563MG ORAL TABLET, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
J9EQA3S2JM	FD&C BLUE NO. 1--ALUMINUM LAKE:ORAL:TABLET, FILM COATED:MG	ORAL	8MG ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
J9EQA3S2JM	FD&C BLUE NO. 1--ALUMINUM LAKE:ORAL:TABLET, ORALLY DISINTEGRATING:MG	ORAL	0.8MG ORAL TABLET, ORALLY DISINTEGRATING	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
J9EQA3S2JM	FD&C BLUE NO. 1--ALUMINUM LAKE:ORAL:TABLET, SUSTAINED ACTION:MG	ORAL	2MG ORAL TABLET, SUSTAINED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
J9EQA3S2JM	FD&C BLUE NO. 1--ALUMINUM LAKE:ORAL:TABLET, SUSTAINED ACTION, FILM COATED:NA	ORAL	ORAL TABLET, SUSTAINED ACTION, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
T7A20Y888Y	TAGATOSE:ORAL:SOLUTION:MG/15ML	ORAL	200MG/15ML ORAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
T7A20Y888Y	TAGATOSE:RECTAL:SOLUTION:%	RECTAL	1.33% RECTAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
0E53J927NA	MAGNESIUM CARBONATE:ORAL:CAPSULE:MG	ORAL	22.4MG ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
0E53J927NA	MAGNESIUM CARBONATE:ORAL:CAPSULE, DELAYED ACTION:MG	ORAL	30MG ORAL CAPSULE, DELAYED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
0E53J927NA	MAGNESIUM CARBONATE:ORAL:CAPSULE, DELAYED RELEASE:MG	ORAL	20MG ORAL CAPSULE, DELAYED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
0E53J927NA	MAGNESIUM CARBONATE:ORAL:CAPSULE, ENTERIC COATED PELLETS:MG	ORAL	22.4MG ORAL CAPSULE, ENTERIC COATED PELLETS	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
0E53J927NA	MAGNESIUM CARBONATE:ORAL:CAPSULE, EXTENDED RELEASE:MG	ORAL	22.4MG ORAL CAPSULE, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
0E53J927NA	MAGNESIUM CARBONATE:ORAL:CAPSULE, SUSTAINED ACTION:MG	ORAL	22.4MG ORAL CAPSULE, SUSTAINED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
0E53J927NA	MAGNESIUM CARBONATE:ORAL:TABLET:MG	ORAL	250MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
0E53J927NA	MAGNESIUM CARBONATE:ORAL:TABLET (IMMED./COMP. RELEASE), UNCOATED, CHEWABLE:MG	ORAL	100MG ORAL TABLET (IMMED./COMP. RELEASE), UNCOATED, CHEWABLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
0E53J927NA	MAGNESIUM CARBONATE:ORAL:TABLET, COATED:MG	ORAL	28.5MG ORAL TABLET, COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
0E53J927NA	MAGNESIUM CARBONATE:ORAL:TABLET, DELAYED ACTION, ENTERIC COATED:MG	ORAL	250MG ORAL TABLET, DELAYED ACTION, ENTERIC COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
0E53J927NA	MAGNESIUM CARBONATE:ORAL:TABLET, FILM COATED:MG	ORAL	250MG ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
0E53J927NA	MAGNESIUM CARBONATE:ORAL:TABLET, ORALLY DISINTEGRATING:MG	ORAL	30MG ORAL TABLET, ORALLY DISINTEGRATING	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
0E53J927NA	MAGNESIUM CARBONATE:ORAL:TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE:mg	ORAL	13.98mg ORAL TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
DY38VHM5OD	SODIUM HYPOCHLORITE:IV(INFUSION):INJECTION:%	IV(INFUSION)	1% IV(INFUSION) INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
DY38VHM5OD	SODIUM HYPOCHLORITE:ORAL:SUSPENSION:MG/1ML	ORAL	3MG/1ML ORAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
76A0JE0FKJ	ADIPIC ACID:INTRAMUSCULAR:INJECTION:%W/V	INTRAMUSCULAR	1%W/V INTRAMUSCULAR INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
76A0JE0FKJ	ADIPIC ACID:VAGINAL:INSERT:MG	VAGINAL	57MG VAGINAL INSERT	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
76A0JE0FKJ	ADIPIC ACID:VAGINAL:TABLET:MG	VAGINAL	57MG VAGINAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
TM2TZD4G4A	GLYCERYL MONOCAPRYLATE:ORAL:CAPSULE:MG	ORAL	38.34MG ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
TM2TZD4G4A	GLYCERYL MONOCAPRYLATE:ORAL:CAPSULE, GELATIN COATED:MG	ORAL	62.2MG ORAL CAPSULE, GELATIN COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
TM2TZD4G4A	GLYCERYL MONOCAPRYLATE:ORAL:CAPSULE, SOFT GELATIN:MG	ORAL	400MG ORAL CAPSULE, SOFT GELATIN	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
TM2TZD4G4A	GLYCERYL MONOCAPRYLATE:ORAL:SOLUTION:MG/1ML	ORAL	349.1MG/1ML ORAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
TM2TZD4G4A	GLYCERYL MONOCAPRYLATE:ORAL:TABLET:MG	ORAL	1.3MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
UE856F2T78	CHONDRUS CRISPUS CARRAGEENAN:TOPICAL:LOTION:NA	TOPICAL	TOPICAL LOTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
3A9RD92BS4	MALTOL:ORAL:CONCENTRATE:MG/1ML	ORAL	0.1MG/1ML ORAL CONCENTRATE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
3A9RD92BS4	MALTOL:ORAL:SOLUTION:MG/5ML	ORAL	0.5MG/5ML ORAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
3A9RD92BS4	MALTOL:ORAL:SYRUP:NA	ORAL	ORAL SYRUP	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
NA	ACACIA SYRUP:ORAL:CAPSULE, SUSTAINED ACTION:MG	ORAL	69.64MG ORAL CAPSULE, SUSTAINED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
NA	ACRYLATES COPOLYMER:ORAL:TABLET:MG	ORAL	9.88MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
NA	ACRYLATES COPOLYMER:ORAL:TABLET (IMMED./COMP. RELEASE), UNCOATED, CHEWABLE:MG	ORAL	5.05MG ORAL TABLET (IMMED./COMP. RELEASE), UNCOATED, CHEWABLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
NA	ACRYLATES COPOLYMER:ORAL:TABLET, EXTENDED RELEASE:MG	ORAL	117.65MG ORAL TABLET, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
NA	ACRYLATES COPOLYMER:ORAL:TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE:MG	ORAL	11.88MG ORAL TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
NA	ACRYLATES COPOLYMER:ORAL:TABLET, SUSTAINED ACTION, COATED:MG	ORAL	25.18MG ORAL TABLET, SUSTAINED ACTION, COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
NA	ACRYLATES COPOLYMER:TOPICAL:CREAM, EMULSION, SUSTAINED RELEASE:%W/W	TOPICAL	13.6%W/W TOPICAL CREAM, EMULSION, SUSTAINED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
NA	ACRYLATES COPOLYMER:TOPICAL:GEL:%W/W	TOPICAL	0.8%W/W TOPICAL GEL	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
NA	ACRYLATES COPOLYMER:TRANSDERMAL:FILM, CONTROLLED RELEASE:MG	TRANSDERMAL	382.22MG TRANSDERMAL FILM, CONTROLLED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
NA	ACRYLATES COPOLYMER:TRANSDERMAL:PATCH:MG	TRANSDERMAL	62.1MG TRANSDERMAL PATCH	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
NA	ACRYLATES COPOLYMER:TRANSDERMAL:PATCH, CONTROLLED RELEASE:MG	TRANSDERMAL	677.68MG TRANSDERMAL PATCH, CONTROLLED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
NA	ACRYL-EZE 93018509 WHITE:ORAL:TABLET:MG	ORAL	76.68MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
NA	ACRYL-EZE 93018509 WHITE:ORAL:TABLET, EXTENDED RELEASE:MG	ORAL	47.5MG ORAL TABLET, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
NA	ACRYL-EZE 93084720 PINK:ORAL:TABLET, DELAYED RELEASE:MG	ORAL	58.5MG ORAL TABLET, DELAYED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
NA	ACRYL-EZE 93O91240 GREEN:ORAL:TABLET, DELAYED RELEASE:MG	ORAL	29.25MG ORAL TABLET, DELAYED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
NA	ACRYLIC ACID-ISOOCTYL ACRYLATE COPOLYMER:TRANSDERMAL:FILM, CONTROLLED RELEASE:MG	TRANSDERMAL	56.4MG TRANSDERMAL FILM, CONTROLLED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
NA	ADCOTE 72A103:TRANSDERMAL:PATCH, CONTROLLED RELEASE:MG	TRANSDERMAL	3.99MG TRANSDERMAL PATCH, CONTROLLED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
NA	ADHESIVE TAPE:TOPICAL:DISC:NA	TOPICAL	TOPICAL DISC	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
NA	ADHESIVE TAPE:TRANSDERMAL:FILM, CONTROLLED RELEASE:NA	TRANSDERMAL	TRANSDERMAL FILM, CONTROLLED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
NA	ADVANTIA PRIME 190100BA01 WHITE:ORAL:TABLET:MG	ORAL	3MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
NA	ADVANTIA PRIME 190100BA01 WHITE:ORAL:TABLET (IMMED./COMP. RELEASE), COATED:MG	ORAL	3MG ORAL TABLET (IMMED./COMP. RELEASE), COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
NA	ALBUMINS:ORAL:TABLET, FILM COATED:MG	ORAL	4.5MG ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
NA	ALKYL ARYL SODIUM SULFONATE:TOPICAL:SHAMPOO, SUSPENSION:%W/W	TOPICAL	2.5%W/W TOPICAL SHAMPOO, SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
NA	ALUMINUM SILICATE PENTAHYDRATE:ORAL:TABLET, COATED:NA	ORAL	ORAL TABLET, COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
NA	AMBERLITE:ORAL:CAPSULE:MG	ORAL	4.86MG ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
NA	AMBERLITE:ORAL:TABLET:MG	ORAL	20MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
NA	AMBERLITE:ORAL:TABLET, COATED:NA	ORAL	ORAL TABLET, COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
NA	AMBERLITE:ORAL:TABLET, FILM COATED:MG	ORAL	25MG ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
NA	AMERCHOL-CAB:OPHTHALMIC:OINTMENT:%	OPHTHALMIC	0.002% OPHTHALMIC OINTMENT	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
NA	AMERCHOL-CAB:TOPICAL:OINTMENT:%W/W	TOPICAL	10%W/W TOPICAL OINTMENT	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
NA	AMMONIO METHACRYLATE COPOLYMER:ORAL:CAPSULE, EXTENDED RELEASE:MG	ORAL	48.91MG ORAL CAPSULE, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
NA	AMMONIO METHACRYLATE COPOLYMER:ORAL:TABLET:NA	ORAL	ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
NA	ANIDRISORB 85/70:ORAL:CAPSULE:MG	ORAL	44MG ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
NA	ANIDRISORB 85/70:ORAL:CAPSULE, SOFT GELATIN:MG	ORAL	123MG ORAL CAPSULE, SOFT GELATIN	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
NA	ANIDRISORB 85/70:ORAL:CAPSULE, SOFT GELATIN LIQUID-FILLED:MG	ORAL	93.4MG ORAL CAPSULE, SOFT GELATIN LIQUID-FILLED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
NA	ANOXID SBN:TOPICAL:EMULSION, CREAM:%W/W	TOPICAL	0.16%W/W TOPICAL EMULSION, CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
NA	ANTIFOAM:ORAL:CAPSULE, SUSTAINED ACTION:MG	ORAL	0.16MG ORAL CAPSULE, SUSTAINED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
NA	ANTIFOAM:ORAL:POWDER, FOR SUSPENSION:NA	ORAL	ORAL POWDER, FOR SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
NA	ANTIFOAM:ORAL:SUSPENSION:NA	ORAL	ORAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
NA	ANTIFOAM:ORAL:TABLET, COATED:MG	ORAL	0.003MG ORAL TABLET, COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
NA	ANTIFOAM:ORAL:TABLET, DELAYED ACTION:MG	ORAL	0.12MG ORAL TABLET, DELAYED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
NA	ANTIFOAM:TOPICAL:LOTION:NA	TOPICAL	TOPICAL LOTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
NA	AQUACOAT:ORAL:CAPSULE:MG	ORAL	3.6MG ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
NA	AQUACOAT:ORAL:TABLET:MG	ORAL	2.25MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
NA	AQUACOAT:ORAL:TABLET (IMMED./COMP. RELEASE), UNCOATED, CHEWABLE:MG	ORAL	13.5MG ORAL TABLET (IMMED./COMP. RELEASE), UNCOATED, CHEWABLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
NA	AQUACOAT ECD:ORAL:CAPSULE:MG	ORAL	9MG ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
NA	AQUACOAT ECD:ORAL:TABLET:MG	ORAL	3.45MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
NA	AQUACOAT ECD:ORAL:TABLET, FILM COATED:NA	ORAL	ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
NA	AQUACOAT ECD:ORAL:TABLET, SUSTAINED ACTION:MG	ORAL	27.4MG ORAL TABLET, SUSTAINED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
NA	AQUACOAT ECD-30:ORAL:CAPSULE:MG	ORAL	13.33MG ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
NA	AQUACOAT ECD-30:ORAL:CAPSULE, EXTENDED RELEASE:MG	ORAL	32.5MG ORAL CAPSULE, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
NA	AQUACOAT ECD-30:ORAL:TABLET, EXTENDED RELEASE:MG	ORAL	76MG ORAL TABLET, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
NA	AQUAPHOR:TOPICAL:EMULSION, CREAM:%W/W	TOPICAL	1%W/W TOPICAL EMULSION, CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
NA	AQUAPHOR:TOPICAL:LOTION:NA	TOPICAL	TOPICAL LOTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
NA	AQUAPHOR:TOPICAL:OINTMENT:NA	TOPICAL	TOPICAL OINTMENT	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
NA	ARLACEL:TOPICAL:EMULSION:%W/W	TOPICAL	5.5%W/W TOPICAL EMULSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
NA	ARLACEL:TOPICAL:EMULSION, CREAM:%W/W	TOPICAL	1.5%W/W TOPICAL EMULSION, CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
NA	BEESWAX, SYNTHETIC:TOPICAL:CREAM:%W/W	TOPICAL	3.5%W/W TOPICAL CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
NA	BEESWAX, SYNTHETIC:TOPICAL:EMULSION, CREAM:%W/W	TOPICAL	3.5%W/W TOPICAL EMULSION, CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
NA	BLACK INK:INHALATION:POWDER:NA	INHALATION	INHALATION POWDER	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
NA	BLACK INK:ORAL:CAPSULE, DELAYED ACTION:NA	ORAL	ORAL CAPSULE, DELAYED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
NA	BLACK INK:ORAL:CAPSULE, DELAYED RELEASE:MG	ORAL	0.57MG ORAL CAPSULE, DELAYED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
NA	BLACK INK:ORAL:CAPSULE, EXTENDED RELEASE:NA	ORAL	ORAL CAPSULE, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
NA	BLACK INK:ORAL:CAPSULE, SOFT GELATIN LIQUID-FILLED:NA	ORAL	ORAL CAPSULE, SOFT GELATIN LIQUID-FILLED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
NA	BLACK INK:ORAL:CAPSULE, SUSTAINED ACTION:MG	ORAL	0.019MG ORAL CAPSULE, SUSTAINED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
NA	BLACK INK:ORAL:SOLUTION:NA	ORAL	ORAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
NA	BLACK INK:ORAL:TABLET:MG	ORAL	0.14MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
NA	BLACK INK:ORAL:TABLET, CONTROLLED RELEASE:NA	ORAL	ORAL TABLET, CONTROLLED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
NA	BLACK INK:ORAL:TABLET, DELAYED ACTION, ENTERIC COATED:MG	ORAL	1MG ORAL TABLET, DELAYED ACTION, ENTERIC COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
NA	BLACK INK:ORAL:TABLET, DELAYED RELEASE:NA	ORAL	ORAL TABLET, DELAYED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
NA	BLACK INK:ORAL:TABLET, EXTENDED RELEASE:MG	ORAL	0.019MG ORAL TABLET, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
NA	BLACK INK:ORAL:TABLET, FILM COATED:MG	ORAL	0.15MG ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
NA	BLACK INK:ORAL:TABLET, SUSTAINED ACTION:MG	ORAL	1MG ORAL TABLET, SUSTAINED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
NA	BLACK INK:ORAL:TABLET, SUSTAINED ACTION, COATED:NA	ORAL	ORAL TABLET, SUSTAINED ACTION, COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
NA	BLACK INK:ORAL:TABLET, SUSTAINED ACTION, FILM COATED:NA	ORAL	ORAL TABLET, SUSTAINED ACTION, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
NA	C13-14 ISOPARAFFIN/LAURETH-7/POLYACRYLAMIDE:TOPICAL:GEL:%W/W	TOPICAL	5%W/W TOPICAL GEL	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
NA	CARMINE 50:ORAL:SUSPENSION:NA	ORAL	ORAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
NA	CARMINE 50:ORAL:SYRUP:NA	ORAL	ORAL SYRUP	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
NA	CELLULOSIC POLYMERS:ORAL:CAPSULE, ENTERIC COATED PELLETS:NA	ORAL	ORAL CAPSULE, ENTERIC COATED PELLETS	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
NA	CELLULOSIC POLYMERS:ORAL:TABLET, DELAYED ACTION:NA	ORAL	ORAL TABLET, DELAYED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
NA	CELLULOSIC POLYMERS:ORAL:TABLET, DELAYED ACTION, ENTERIC COATED:NA	ORAL	ORAL TABLET, DELAYED ACTION, ENTERIC COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
NA	CELLULOSIC POLYMERS:ORAL:TABLET, FILM COATED:NA	ORAL	ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
NA	CELLULOSIC POLYMERS:ORAL:TABLET, SUSTAINED ACTION:NA	ORAL	ORAL TABLET, SUSTAINED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
NA	CHOLETH:VAGINAL:EMULSION, CREAM:%	VAGINAL	1% VAGINAL EMULSION, CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
NA	CHROMA-KOTE T2956-Y YELLOW:ORAL:TABLET:MG	ORAL	2.75MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
NA	CHROMA-KOTE T2956-Y YELLOW:ORAL:TABLET, FILM COATED:MG	ORAL	0.91MG ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
NA	COLLAGEN:TOPICAL:GEL:%W/W	TOPICAL	0.024%W/W TOPICAL GEL	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
NA	COLLAGEN:TOPICAL:LOTION:%W/W 	TOPICAL	8%W/W  TOPICAL LOTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
NA	COLORING SUSPENSION:TOPICAL:EMULSION, CREAM:NA	TOPICAL	TOPICAL EMULSION, CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
NA	COMPRESSIBLE SUGAR:ORAL:CAPSULE:MG	ORAL	270MG ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
NA	COMPRESSIBLE SUGAR:ORAL:CAPSULE, SUSTAINED ACTION:MG	ORAL	75MG ORAL CAPSULE, SUSTAINED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
NA	COMPRESSIBLE SUGAR:ORAL:POWDER, FOR ORAL SOLUTION:NA	ORAL	ORAL POWDER, FOR ORAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
NA	COMPRESSIBLE SUGAR:ORAL:POWDER, FOR ORAL SUSPENSION:MG/5ML	ORAL	2400MG/5ML ORAL POWDER, FOR ORAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
NA	COMPRESSIBLE SUGAR:ORAL:SOLUTION:MG/5ML	ORAL	1781.41MG/5ML ORAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
NA	COMPRESSIBLE SUGAR:ORAL:SUSPENSION, EXTENDED RELEASE:MG/ML	ORAL	145.5MG/ML ORAL SUSPENSION, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
NA	COMPRESSIBLE SUGAR:ORAL:TABLET:MG	ORAL	392.2MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
NA	COMPRESSIBLE SUGAR:ORAL:TABLET (IMMED./COMP. RELEASE), FILM COATED:MG	ORAL	50MG ORAL TABLET (IMMED./COMP. RELEASE), FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
NA	COMPRESSIBLE SUGAR:ORAL:TABLET (IMMED./COMP. RELEASE), UNCOATED, CHEWABLE:MG	ORAL	623.5MG ORAL TABLET (IMMED./COMP. RELEASE), UNCOATED, CHEWABLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
NA	COMPRESSIBLE SUGAR:ORAL:TABLET, CHEWABLE:MG	ORAL	330MG ORAL TABLET, CHEWABLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
NA	COMPRESSIBLE SUGAR:ORAL:TABLET, COATED:MG	ORAL	120MG ORAL TABLET, COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
NA	COMPRESSIBLE SUGAR:ORAL:TABLET, EXTENDED RELEASE:MG	ORAL	159.15MG ORAL TABLET, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
NA	COMPRESSIBLE SUGAR:ORAL:TABLET, SUSTAINED ACTION:MG	ORAL	253MG ORAL TABLET, SUSTAINED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
NA	COMPRESSIBLE SUGAR:ORAL:TABLET, SUSTAINED ACTION, FILM COATED:MG	ORAL	354MG ORAL TABLET, SUSTAINED ACTION, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
NA	COMPRESSIBLE SUGAR:SUBLINGUAL:TABLET:MG	SUBLINGUAL	136MG SUBLINGUAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
NA	CORN STARCH, PARTIALLY HYDROLYZED:ORAL:TABLET:MG	ORAL	5.28MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
NA	CORN STARCH, PARTIALLY HYDROLYZED:VAGINAL:TABLET:mg	VAGINAL	8mg VAGINAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
NA	CUTINA:ORAL:TABLET, EXTENDED RELEASE:MG	ORAL	50MG ORAL TABLET, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
NA	CUTINA:SUBLINGUAL:TABLET:MG	SUBLINGUAL	1.6MG SUBLINGUAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
NA	D&C BLUE NO. 1 LAKE:ORAL:TABLET:MG	ORAL	15.4MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
NA	D&C BLUE NO. 1 LAKE:ORAL:TABLET, COATED:NA	ORAL	ORAL TABLET, COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
NA	D&C BLUE NO. 2 LAKE:ORAL:CAPSULE:NA	ORAL	ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
NA	D&C BLUE NO. 2 LAKE:ORAL:TABLET:MG	ORAL	0.24MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
NA	D&C BLUE NO. 2 LAKE:ORAL:TABLET, COATED:MG	ORAL	0.008MG ORAL TABLET, COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
NA	D&C GREEN NO. 3 LAKE:ORAL:CAPSULE:NA	ORAL	ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
NA	D&C GREEN NO. 3 LAKE:ORAL:TABLET, COATED:NA	ORAL	ORAL TABLET, COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
NA	D&C RED NO. 27 LAKE:ORAL:CAPSULE, SUSTAINED ACTION:NA	ORAL	ORAL CAPSULE, SUSTAINED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
NA	D&C RED NO. 27 LAKE:ORAL:TABLET:MG	ORAL	0.4MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
NA	D&C RED NO. 3 LAKE (DELISTED):ORAL:CAPSULE:MG	ORAL	0.005MG ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
NA	D&C RED NO. 3 LAKE (DELISTED):ORAL:TABLET:MG	ORAL	0.5MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
NA	D&C RED NO. 3 LAKE (DELISTED):ORAL:TABLET, FILM COATED:NA	ORAL	ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
NA	D&C RED NO. 3 LAKE (DELISTED):SUBLINGUAL:TABLET:MG	SUBLINGUAL	0.005MG SUBLINGUAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
NA	D&C RED NO. 30 LAKE:ORAL:CAPSULE:NA	ORAL	ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
NA	D&C RED NO. 30 LAKE:ORAL:CAPSULE, ENTERIC COATED PELLETS:MG	ORAL	0.3MG ORAL CAPSULE, ENTERIC COATED PELLETS	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
NA	D&C RED NO. 30 LAKE:ORAL:GRANULE, FOR SUSPENSION:MG	ORAL	0.85MG ORAL GRANULE, FOR SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
NA	D&C RED NO. 30 LAKE:ORAL:POWDER:MG/1PKT	ORAL	3MG/1PKT ORAL POWDER	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
NA	D&C RED NO. 30 LAKE:ORAL:POWDER:MG/1SCP	ORAL	3MG/1SCP ORAL POWDER	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
NA	D&C RED NO. 30 LAKE:ORAL:SUSPENSION:MG/5ML	ORAL	0.3MG/5ML ORAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
NA	D&C RED NO. 30 LAKE:ORAL:TABLET:MG	ORAL	2.5MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
NA	D&C RED NO. 30 LAKE:ORAL:TABLET (IMMED./COMP. RELEASE), UNCOATED, CHEWABLE:MG	ORAL	5MG ORAL TABLET (IMMED./COMP. RELEASE), UNCOATED, CHEWABLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
NA	D&C RED NO. 30 LAKE:ORAL:TABLET, COATED:MG	ORAL	0.34MG ORAL TABLET, COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
NA	D&C RED NO. 30 LAKE:ORAL:TABLET, DELAYED ACTION, ENTERIC COATED:MG	ORAL	0.04MG ORAL TABLET, DELAYED ACTION, ENTERIC COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
NA	D&C RED NO. 30 LAKE:ORAL:TABLET, ENTERIC COATED PARTICLES:MG	ORAL	0.8MG ORAL TABLET, ENTERIC COATED PARTICLES	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
NA	D&C RED NO. 30 LAKE:ORAL:TABLET, EXTENDED RELEASE:MG	ORAL	0.1MG ORAL TABLET, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
NA	D&C RED NO. 30 LAKE:ORAL:TABLET, FILM COATED:MG	ORAL	0.064MG ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
NA	D&C RED NO. 30 LAKE:ORAL:TABLET, SUSTAINED ACTION:MG	ORAL	0.025MG ORAL TABLET, SUSTAINED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
NA	D&C RED NO. 33 LAKE:ORAL:CAPSULE:MG	ORAL	0.005MG ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
NA	D&C RED NO. 33 LAKE:ORAL:SYRUP:NA	ORAL	ORAL SYRUP	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
NA	D&C RED NO. 33 LAKE:ORAL:TABLET:MG	ORAL	0.3MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
NA	D&C RED NO. 40 LAKE:ORAL:CAPSULE:NA	ORAL	ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
NA	D&C RED NO. 40 LAKE:ORAL:CAPSULE, SUSTAINED ACTION:NA	ORAL	ORAL CAPSULE, SUSTAINED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
NA	D&C RED NO. 40 LAKE:ORAL:TABLET:MG	ORAL	0.2MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
NA	D&C RED NO. 40 LAKE:ORAL:TABLET, COATED:NA	ORAL	ORAL TABLET, COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
NA	D&C RED NO. 40 LAKE:RECTAL:SUPPOSITORY:NA	RECTAL	RECTAL SUPPOSITORY	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
NA	D&C RED NO. 6 LAKE:ORAL:TABLET:MG	ORAL	1.5MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
NA	D&C RED NO. 7 LAKE:ORAL:CAPSULE:NA	ORAL	ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
NA	D&C RED NO. 7 LAKE:ORAL:POWDER, FOR SUSPENSION:NA	ORAL	ORAL POWDER, FOR SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
NA	D&C RED NO. 7 LAKE:ORAL:TABLET:MG	ORAL	0.6MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
NA	D&C RED NO. 7 LAKE:ORAL:TABLET, DELAYED ACTION, ENTERIC COATED:MG	ORAL	0.5MG ORAL TABLET, DELAYED ACTION, ENTERIC COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
NA	D&C RED NO. 7 LAKE:ORAL:TABLET, FILM COATED:NA	ORAL	ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
NA	D&C YELLOW NO. 10 ALUMINUM LAKE:ORAL:POWDER, FOR ORAL SUSPENSION:mg	ORAL	28mg ORAL POWDER, FOR ORAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
NA	D&C YELLOW NO. 10 ALUMINUM LAKE:ORAL:TABLET:mg	ORAL	1.5mg ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
NA	D&C YELLOW NO. 10 LAKE:ORAL:CAPSULE:mg	ORAL	0.2mg ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
NA	D&C YELLOW NO. 10 LAKE:ORAL:CAPSULE, SUSTAINED ACTION:MG	ORAL	0.28MG ORAL CAPSULE, SUSTAINED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
NA	D&C YELLOW NO. 10 LAKE:ORAL:SOLUTION, ELIXIR:NA	ORAL	ORAL SOLUTION, ELIXIR	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
NA	D&C YELLOW NO. 10 LAKE:ORAL:TABLET:MG	ORAL	6.52MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
NA	D&C YELLOW NO. 10 LAKE:ORAL:TABLET (IMMED./COMP. RELEASE), FILM COATED:MG	ORAL	0.1MG ORAL TABLET (IMMED./COMP. RELEASE), FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
NA	D&C YELLOW NO. 10 LAKE:ORAL:TABLET (IMMED./COMP. RELEASE), UNCOATED, CHEWABLE:MG	ORAL	3MG ORAL TABLET (IMMED./COMP. RELEASE), UNCOATED, CHEWABLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
NA	D&C YELLOW NO. 10 LAKE:ORAL:TABLET, COATED:MG	ORAL	3.68MG ORAL TABLET, COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
NA	D&C YELLOW NO. 10 LAKE:ORAL:TABLET, EXTENDED RELEASE:MG	ORAL	0.44MG ORAL TABLET, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
NA	D&C YELLOW NO. 10 LAKE:ORAL:TABLET, FILM COATED:NA	ORAL	ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
NA	D&C YELLOW NO. 10 LAKE:ORAL:TABLET, ORALLY DISINTEGRATING:MG	ORAL	0.84MG ORAL TABLET, ORALLY DISINTEGRATING	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
NA	D&C YELLOW NO. 10 LAKE:ORAL:TABLET, SUSTAINED ACTION:MG	ORAL	1.32MG ORAL TABLET, SUSTAINED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
NA	D&C YELLOW NO. 10 LAKE:SUBLINGUAL:TABLET:MG	SUBLINGUAL	0.15MG SUBLINGUAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
NA	D&C YELLOW NO. 6 LAKE:ORAL:CAPSULE:NA	ORAL	ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
NA	D&C YELLOW NO. 6 LAKE:ORAL:CAPSULE, ENTERIC COATED PELLETS:MG	ORAL	0.5MG ORAL CAPSULE, ENTERIC COATED PELLETS	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
NA	D&C YELLOW NO. 6 LAKE:ORAL:SOLUTION:MG/5ML	ORAL	0.25MG/5ML ORAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
NA	D&C YELLOW NO. 6 LAKE:ORAL:TABLET:MG	ORAL	0.5MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
NA	D&C YELLOW NO. 6 LAKE:ORAL:TABLET, COATED:NA	ORAL	ORAL TABLET, COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
NA	D&C YELLOW NO. 6 LAKE:ORAL:TABLET, FILM COATED:NA	ORAL	ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
NA	D&C YELLOW NO. 6 LAKE:SUBLINGUAL:TABLET:MG	SUBLINGUAL	0.01MG SUBLINGUAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
NA	DAUBERT 1-5 PESTR (MATTE) 164Z:TRANSDERMAL:FILM, CONTROLLED RELEASE:MG	TRANSDERMAL	507.5MG TRANSDERMAL FILM, CONTROLLED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
NA	DC ANTIFOAM AF TRITURATION 1% ON SUCROSE:ORAL:POWDER, FOR SOLUTION:MG/1ML	ORAL	2.63MG/1ML ORAL POWDER, FOR SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
NA	DC ANTIFOAM AF TRITURATION 1% ON SUCROSE:ORAL:POWDER, FOR SUSPENSION:NA	ORAL	ORAL POWDER, FOR SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
NA	DEHYMULS E:TOPICAL:OINTMENT:%W/W	TOPICAL	7.5%W/W TOPICAL OINTMENT	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
NA	DEXTRAN:INTRAVENOUS:LIQUID, CONCENTRATE, INJECTION:%	INTRAVENOUS	0.91% INTRAVENOUS LIQUID, CONCENTRATE, INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
NA	DEXTRAN:TOPICAL:SOLUTION:NA	TOPICAL	TOPICAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
NA	DEXTRIN:ORAL:GRANULE, FOR ORAL SOLUTION:MG	ORAL	22MG ORAL GRANULE, FOR ORAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
NA	DEXTRIN:ORAL:POWDER, FOR ORAL SOLUTION:MG	ORAL	12.5MG ORAL POWDER, FOR ORAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
NA	DEXTRIN:ORAL:SOLUTION:MG/5ML	ORAL	2MG/5ML ORAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
NA	DEXTRIN:ORAL:TABLET:MG	ORAL	5.2MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
NA	DEXTRIN:ORAL:TABLET, COATED:NA	ORAL	ORAL TABLET, COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
NA	DEXTRIN:ORAL:TABLET, DELAYED ACTION, ENTERIC COATED:MG	ORAL	9.25MG ORAL TABLET, DELAYED ACTION, ENTERIC COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
NA	DEXTRIN:TOPICAL:CREAM:%W/W	TOPICAL	0.03%W/W TOPICAL CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
NA	DEXTRIN:TOPICAL:EMULSION, CREAM:%W/W	TOPICAL	0.029%W/W TOPICAL EMULSION, CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
NA	DEXTRIN:TOPICAL:LOTION:NA	TOPICAL	TOPICAL LOTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
NA	DEXTRIN:TOPICAL:SHAMPOO:%W/W	TOPICAL	5%W/W TOPICAL SHAMPOO	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
NA	DRI KLEAR 042:ORAL:TABLET:MG	ORAL	18MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
NA	DRI KLEAR 042:ORAL:TABLET, COATED:MG	ORAL	10MG ORAL TABLET, COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
NA	DRI KLEAR 042:ORAL:TABLET, FILM COATED:MG	ORAL	5.67MG ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
NA	DRI KLEAR LV 609527:ORAL:TABLET, FILM COATED:MG	ORAL	2.26MG ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
NA	DURO-TAK 280-2516:TRANSDERMAL:FILM, CONTROLLED RELEASE:NA	TRANSDERMAL	TRANSDERMAL FILM, CONTROLLED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
NA	DURO-TAK 387-2516:TRANSDERMAL:FILM, CONTROLLED RELEASE:MG	TRANSDERMAL	37.4MG TRANSDERMAL FILM, CONTROLLED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
NA	DURO-TAK 87-2070:TRANSDERMAL:FILM, CONTROLLED RELEASE:NA	TRANSDERMAL	TRANSDERMAL FILM, CONTROLLED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
NA	DURO-TAK 87-2194:TRANSDERMAL:FILM, CONTROLLED RELEASE:MG	TRANSDERMAL	208.28MG TRANSDERMAL FILM, CONTROLLED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
NA	DURO-TAK 87-2296:TRANSDERMAL:PATCH, CONTROLLED RELEASE:MG	TRANSDERMAL	43MG TRANSDERMAL PATCH, CONTROLLED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
NA	DURO-TAK 87-2979:TRANSDERMAL:FILM, CONTROLLED RELEASE:NA	TRANSDERMAL	TRANSDERMAL FILM, CONTROLLED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
NA	DUSTING POWDER:ORAL:TABLET:NA	ORAL	ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
NA	DUSTING POWDER:ORAL:TABLET, COATED:MG	ORAL	22MG ORAL TABLET, COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
NA	DYE BLACK LB-1171:ORAL:TABLET:MG	ORAL	1.55MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
NA	DYE BLACK LB-442:ORAL:TABLET:MG	ORAL	0.33MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
NA	DYE BLACK LB-9972:ORAL:TABLET:MG	ORAL	0.19MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
NA	DYE BLUE LAKE BLEND LB-332:ORAL:CAPSULE:MG	ORAL	0.56MG ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
NA	DYE BLUE LAKE BLEND LB-332:ORAL:TABLET:MG	ORAL	0.11MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
NA	DYE BLUE LAKOLENE:ORAL:TABLET:MG	ORAL	0.12MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
NA	DYE BROWN LAKE BLEND:BUCCAL:GUM, CHEWING:MG	BUCCAL	0.17MG BUCCAL GUM, CHEWING	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
NA	DYE BROWN LAKE BLEND:ORAL:TABLET:MG	ORAL	0.26MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
NA	DYE BROWN LAKE BLEND:ORAL:TABLET:MG	ORAL	0.16MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
NA	DYE BROWN LB-464:ORAL:TABLET:MG	ORAL	1.3MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
NA	DYE BURNT UMBER:ORAL:TABLET, FILM COATED:MG	ORAL	0.06MG ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
NA	DYE CARAMEL ACID PROOF 100:ORAL:SOLUTION, ELIXIR:MG/5ML	ORAL	0.05MG/5ML ORAL SOLUTION, ELIXIR	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
NA	DYE CARAMEL ACID PROOF 100:ORAL:SYRUP:%	ORAL	0.048% ORAL SYRUP	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
NA	DYE CHROMA-TONE:ORAL:CAPSULE:MG	ORAL	29.6MG ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
NA	DYE CHROMA-TONE:ORAL:TABLET, FILM COATED:MG	ORAL	1.53MG ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
NA	DYE DC RED LAKE:ORAL:TABLET:MG	ORAL	2.4MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
NA	DYE DC RED LB NO. 9570:ORAL:TABLET:MG	ORAL	0.85MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
NA	DYE FDC BLUE NO. 10:ORAL:SYRUP:MG/5ML	ORAL	0.004MG/5ML ORAL SYRUP	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
NA	DYE FDC BLUE NO. 10:ORAL:TABLET:NA	ORAL	ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
NA	DYE FDC BLUE NO. 40 HT LAKE:ORAL:CAPSULE:MG	ORAL	0.16MG ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
NA	DYE FDC BLUE NO. 40 HT LAKE:ORAL:TABLET:MG	ORAL	0.23MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
NA	DYE FDC BROWN R LB-56069:BUCCAL:GUM, CHEWING:MG	BUCCAL	0.14MG BUCCAL GUM, CHEWING	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
NA	DYE FDC BROWN R LB-56069:ORAL:TABLET:MG	ORAL	0.2MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
NA	DYE FDC GREEN LB-3323:ORAL:TABLET:MG	ORAL	1.65MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
NA	DYE GRAY NO. 2982:ORAL:CAPSULE:NA	ORAL	ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
NA	DYE GREEN AL LB-265:ORAL:TABLET:MG	ORAL	0.64MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
NA	DYE GREEN ALUMINUM LB:ORAL:TABLET:MG	ORAL	8MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
NA	DYE GREEN LAKE BLEND LB-333:ORAL:CAPSULE:MG	ORAL	0.73MG ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
NA	DYE GREEN LAKE BLEND LB-333:ORAL:TABLET:MG	ORAL	0.11MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
NA	DYE GREEN LB:ORAL:TABLET:MG	ORAL	0.4MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
NA	DYE GREEN LB-279:ORAL:TABLET:MG	ORAL	2MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
NA	DYE GREEN LB-482:ORAL:TABLET:MG	ORAL	1.27MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
NA	DYE GREEN LB-555:ORAL:TABLET:MG	ORAL	0.44MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
NA	DYE GREEN LB-820:ORAL:TABLET:MG	ORAL	0.6MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
NA	DYE GREEN LB-883:ORAL:TABLET:MG	ORAL	0.6MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
NA	DYE GREEN PB-1543:ORAL:TABLET:MG	ORAL	0.02MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
NA	DYE GREEN PR-1339:ORAL:TABLET:NA	ORAL	ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
NA	DYE MINT GREEN:ORAL:TABLET:MG	ORAL	0.006MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
NA	DYE MINT GREEN:ORAL:TABLET (IMMED./COMP. RELEASE), UNCOATED, CHEWABLE:MG	ORAL	0.075MG ORAL TABLET (IMMED./COMP. RELEASE), UNCOATED, CHEWABLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
NA	DYE OCHRE 3506:ORAL:TABLET:MG	ORAL	0.76MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
NA	DYE OCHRE 3506:ORAL:TABLET, COATED:MG	ORAL	0.29MG ORAL TABLET, COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
NA	DYE ORANGE LB-1387:ORAL:TABLET:MG	ORAL	0.5MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
NA	DYE ORANGE LB-1387:ORAL:TABLET, SUSTAINED ACTION:MG	ORAL	0.4MG ORAL TABLET, SUSTAINED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
NA	DYE ORANGE LB-715:ORAL:TABLET:MG	ORAL	4.8MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
NA	DYE ORANGE PB-2148:ORAL:TABLET:MG	ORAL	0.16MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
NA	DYE PINK:ORAL:CAPSULE:NA	ORAL	ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
NA	DYE PINK:ORAL:TABLET:MG	ORAL	0.3MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
NA	DYE PINK:ORAL:TABLET, DELAYED ACTION:MG	ORAL	7.93MG ORAL TABLET, DELAYED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
NA	DYE PURPLE LB-1902:ORAL:TABLET, SUSTAINED ACTION:MG	ORAL	0.8MG ORAL TABLET, SUSTAINED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
NA	DYE PURPLE LB-562:ORAL:TABLET:MG	ORAL	0.81MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
NA	DYE RED PB-1595:ORAL:TABLET:MG	ORAL	0.8MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
NA	DYE RED R07058:ORAL:POWDER:MG/1PKT	ORAL	2MG/1PKT ORAL POWDER	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
NA	DYE RED R07058:ORAL:POWDER:MG/1SCP	ORAL	2MG/1SCP ORAL POWDER	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
NA	DYE SWEDISH ORANGE NO. 2191:ORAL:CAPSULE:NA	ORAL	ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
NA	DYE TAN PB-1388:ORAL:TABLET:MG	ORAL	0.05MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
NA	DYE TAN PB-1388:ORAL:TABLET, FILM COATED:MG	ORAL	0.75MG ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
NA	DYE WHITE COATERIC YPA-6-7089:ORAL:TABLET, DELAYED ACTION, ENTERIC COATED:NA	ORAL	ORAL TABLET, DELAYED ACTION, ENTERIC COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
NA	DYE WILD CHERRY 7598:ORAL:SYRUP:MG/5ML	ORAL	0.18MG/5ML ORAL SYRUP	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
NA	DYE YELLOW LB 9706:ORAL:TABLET:MG	ORAL	0.44MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
NA	DYE YELLOW PB-1381:ORAL:TABLET:MG	ORAL	0.2MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
NA	ETHYLCELLULOSE DISPERSION TYPE B:ORAL:TABLET, EXTENDED RELEASE:MG	ORAL	26.4MG ORAL TABLET, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
NA	ETHYLENE-VINYL ACETATE COPOLYMERS:IMPLANTATION:IMPLANT:MG	IMPLANTATION	32.5MG IMPLANTATION IMPLANT	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
NA	ETHYLENE-VINYL ACETATE COPOLYMERS:IMPLANTATION:ROD:MG	IMPLANTATION	61MG IMPLANTATION ROD	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
NA	ETHYLENE-VINYL ACETATE COPOLYMERS:INTRAUTERINE:SUPPOSITORY, INSERT, CONTROLLED RELEASE:MG	INTRAUTERINE	160MG INTRAUTERINE SUPPOSITORY, INSERT, CONTROLLED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
NA	ETHYLENE-VINYL ACETATE COPOLYMERS:OPHTHALMIC:SUPPOSITORY, INSERT, CONTROLLED RELEASE:MG	OPHTHALMIC	14MG OPHTHALMIC SUPPOSITORY, INSERT, CONTROLLED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
NA	ETHYLENE-VINYL ACETATE COPOLYMERS:PERIODONTAL:FILM, CONTROLLED RELEASE:NA	PERIODONTAL	PERIODONTAL FILM, CONTROLLED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
NA	ETHYLENE-VINYL ACETATE COPOLYMERS:SUBCUTANEOUS:ROD:MG	SUBCUTANEOUS	61MG SUBCUTANEOUS ROD	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
NA	ETHYLENE-VINYL ACETATE COPOLYMERS:TRANSDERMAL:FILM:MG	TRANSDERMAL	11.65MG TRANSDERMAL FILM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
NA	ETHYLENE-VINYL ACETATE COPOLYMERS:TRANSDERMAL:FILM, CONTROLLED RELEASE:MG	TRANSDERMAL	735MG TRANSDERMAL FILM, CONTROLLED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
NA	FATTY ACID ESTERS:TRANSDERMAL:FILM, CONTROLLED RELEASE:NA	TRANSDERMAL	TRANSDERMAL FILM, CONTROLLED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FATTY ACID ESTERS, SATURATED:ORAL:CAPSULE, ENTERIC COATED PELLETS:MG	ORAL	0.2MG ORAL CAPSULE, ENTERIC COATED PELLETS	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FATTY ACID GLYCERIDES:ORAL:CAPSULE:MG	ORAL	1.8MG ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FATTY ACID GLYCERIDES:SUBLINGUAL:SPRAY:%	SUBLINGUAL	0.096% SUBLINGUAL SPRAY	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FATTY ACID GLYCERIDES:SUBLINGUAL:SPRAY, METERED:%	SUBLINGUAL	0.096% SUBLINGUAL SPRAY, METERED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FATTY ACID PENTAERYTHRIOL ESTER:TOPICAL:OINTMENT:%W/W	TOPICAL	1%W/W TOPICAL OINTMENT	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FATTY ACIDS:TOPICAL:SOLUTION:%W/W	TOPICAL	13.58%W/W TOPICAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FILM COATING SOLUTION, AQUEOUS IM-163:ORAL:TABLET:MG	ORAL	20MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FILM COATING SOLUTION, AQUEOUS IM-163:ORAL:TABLET, FILM COATED:MG	ORAL	6.3MG ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLAVOR 57000 IU:ORAL:GRANULE, FOR SUSPENSION:NA	ORAL	ORAL GRANULE, FOR SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLAVOR 57000 IU:ORAL:POWDER, FOR SUSPENSION:NA	ORAL	ORAL POWDER, FOR SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLAVOR 57820/A:ORAL:POWDER:NA	ORAL	ORAL POWDER	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLAVOR 57820/A:ORAL:SUSPENSION:NA	ORAL	ORAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLAVOR APRICOT 24829:ORAL:SOLUTION:%	ORAL	0.2% ORAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLAVOR APRICOT PEACH:ORAL:SYRUP:%	ORAL	0.3% ORAL SYRUP	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLAVOR BANANA 11090:ORAL:SOLUTION:%W/V	ORAL	1%W/V ORAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLAVOR BANANA 59256C:ORAL:SOLUTION:MG/5ML	ORAL	1.03MG/5ML ORAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLAVOR BANANA 59256C:ORAL:SYRUP:MG/5ML	ORAL	1.03MG/5ML ORAL SYRUP	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLAVOR BANANA 8763:ORAL:SOLUTION:%	ORAL	0.05% ORAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLAVOR BANANA FN-6713:ORAL:SOLUTION:MG/5ML	ORAL	20MG/5ML ORAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLAVOR BANANA SA84:ORAL:POWDER, FOR SUSPENSION:NA	ORAL	ORAL POWDER, FOR SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLAVOR BANANA SA84:ORAL:SUSPENSION:mg/5mL	ORAL	25mg/5mL ORAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLAVOR BANANA SA84:ORAL:TABLET:MG	ORAL	2.5MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLAVOR BANANA SA84:ORAL:TABLET, CHEWABLE:MG	ORAL	2.5MG ORAL TABLET, CHEWABLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLAVOR BERRY CITRUS BLEND 8409:ORAL:CONCENTRATE:%	ORAL	0.8% ORAL CONCENTRATE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLAVOR BERRY CITRUS BLEND 8409:ORAL:SOLUTION:%	ORAL	1% ORAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLAVOR BITTER MASK 9885:ORAL:SOLUTION:MG/5ML	ORAL	35MG/5ML ORAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLAVOR BITTERNESS MODIFIER 15555:ORAL:SOLUTION:MG/5ML	ORAL	10MG/5ML ORAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLAVOR BITTERNESS MODIFIER 36734:ORAL:SYRUP:MG/1ML	ORAL	1MG/1ML ORAL SYRUP	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLAVOR BLACK CHERRY 501027 AP0551:ORAL:TABLET:MG	ORAL	0.6MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLAVOR BLACK CHERRY 501027 AP0551:ORAL:TABLET, CHEWABLE:mg	ORAL	1mg ORAL TABLET, CHEWABLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLAVOR BLACKBERRY:ORAL:TABLET:mg	ORAL	0.843mg ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLAVOR BUBBLE GUM 15864:ORAL:SYRUP:MG/1ML	ORAL	1MG/1ML ORAL SYRUP	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLAVOR BUBBLE GUM MC-4938:ORAL:SUSPENSION:MG/5ML	ORAL	18MG/5ML ORAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLAVOR BUBBLE GUM MC-4938:ORAL:SYRUP:MG/1ML	ORAL	0.5MG/1ML ORAL SYRUP	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLAVOR BUTTERMINT 24020:ORAL:CONCENTRATE:NA	ORAL	ORAL CONCENTRATE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLAVOR CHERI-BERI PFC-8573:ORAL:POWDER, FOR SUSPENSION:MG/5ML	ORAL	25MG/5ML ORAL POWDER, FOR SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLAVOR CHERI-BERI PFC-8580:ORAL:SOLUTION:%	ORAL	0.05% ORAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLAVOR CHERI-BERI PFC-8580:ORAL:SYRUP:%	ORAL	1% ORAL SYRUP	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLAVOR CHERRY:ORAL:SOLUTION:mg/5mL	ORAL	2mg/5mL ORAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLAVOR CHERRY 181612:ORAL:POWDER, FOR SUSPENSION:NA	ORAL	ORAL POWDER, FOR SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLAVOR CHERRY 349:ORAL:SOLUTION:MG/5ML	ORAL	16.45MG/5ML ORAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLAVOR CHERRY 349:ORAL:SOLUTION, ELIXIR:NA	ORAL	ORAL SOLUTION, ELIXIR	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLAVOR CHERRY 349:ORAL:SUSPENSION:MG/5ML	ORAL	5MG/5ML ORAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLAVOR CHERRY 461566:ORAL:LIQUID:MG/5ML	ORAL	5MG/5ML ORAL LIQUID	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLAVOR CHERRY 461566:ORAL:SOLUTION:MG/1ML	ORAL	1.25MG/1ML ORAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLAVOR CHERRY 461566:ORAL:TABLET:mg	ORAL	0.5mg ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLAVOR CHERRY 461566:ORAL:TABLET, CHEWABLE:MG	ORAL	1.25MG ORAL TABLET, CHEWABLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLAVOR CHERRY 461566:SUBLINGUAL:TABLET:mg	SUBLINGUAL	0.5mg SUBLINGUAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLAVOR CHERRY 57.679/A:ORAL:SUSPENSION:MG/1ML	ORAL	50MG/1ML ORAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLAVOR CHERRY 594 S.D.:ORAL:GRANULE, FOR RECONSTITUTION:MG	ORAL	7.5MG ORAL GRANULE, FOR RECONSTITUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLAVOR CHERRY 594 S.D.:ORAL:POWDER, FOR ORAL SOLUTION:MG	ORAL	0.13MG ORAL POWDER, FOR ORAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLAVOR CHERRY 594 S.D.:ORAL:POWDER, FOR SUSPENSION:MG/5ML	ORAL	7.5MG/5ML ORAL POWDER, FOR SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLAVOR CHERRY 594 S.D.:ORAL:SOLUTION:MG/5ML	ORAL	2MG/5ML ORAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLAVOR CHERRY 594 S.D.:ORAL:SUSPENSION:mg/5mL	ORAL	5mg/5mL ORAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLAVOR CHERRY 594 S.D.:ORAL:TABLET:MG	ORAL	0.4MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLAVOR CHERRY 594 S.D.:ORAL:TABLET (IMMED./COMP. RELEASE), UNCOATED, CHEWABLE:MG	ORAL	5MG ORAL TABLET (IMMED./COMP. RELEASE), UNCOATED, CHEWABLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLAVOR CHERRY 842:ORAL:SOLUTION:%W/V	ORAL	0.49%W/V ORAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLAVOR CHERRY 842:ORAL:SYRUP:MG/5ML	ORAL	5MG/5ML ORAL SYRUP	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLAVOR CHERRY 8513:ORAL:SOLUTION:MG/5ML	ORAL	3.03MG/5ML ORAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLAVOR CHERRY 8513:ORAL:SYRUP:%	ORAL	0.022% ORAL SYRUP	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLAVOR CHERRY BURGUNDY 11650:ORAL:CONCENTRATE:NA	ORAL	ORAL CONCENTRATE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLAVOR CHERRY BURGUNDY 11650:ORAL:SOLUTION:%	ORAL	0.06% ORAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLAVOR CHERRY BURGUNDY 11650:ORAL:SYRUP:NA	ORAL	ORAL SYRUP	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLAVOR CHERRY F-232:ORAL:CONCENTRATE:%	ORAL	0.1% ORAL CONCENTRATE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLAVOR CHERRY F-232:ORAL:SOLUTION:MG/5ML	ORAL	15MG/5ML ORAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLAVOR CHERRY F-232:ORAL:SUSPENSION:%	ORAL	0.1% ORAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLAVOR CHERRY FMC 8513:ORAL:SOLUTION:%	ORAL	0.05% ORAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLAVOR CHERRY FMC 8513:ORAL:SYRUP:%	ORAL	0.08% ORAL SYRUP	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLAVOR CHERRY NV-1489:ORAL:TABLET:MG	ORAL	9MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLAVOR CHERRY PFC-9768:ORAL:CONCENTRATE:%	ORAL	0.7% ORAL CONCENTRATE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLAVOR CHERRY PFC-9768:ORAL:SOLUTION:%	ORAL	2% ORAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLAVOR CHERRY PFC-9768:ORAL:SYRUP:%	ORAL	2% ORAL SYRUP	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLAVOR CHERRY R-6556:ORAL:POWDER, FOR SUSPENSION:MG/5ML	ORAL	2.5MG/5ML ORAL POWDER, FOR SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLAVOR CHERRY VANILLA COMPOUND A77487:ORAL:SYRUP:%	ORAL	0.11% ORAL SYRUP	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLAVOR CHERRY WIXON 3566:ORAL:SYRUP:MG/5ML	ORAL	10MG/5ML ORAL SYRUP	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLAVOR CINNAMON:BUCCAL:GUM, CHEWING:MG	BUCCAL	26MG BUCCAL GUM, CHEWING	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLAVOR CINNAMON:ORAL:TROCHE:MG	ORAL	21MG ORAL TROCHE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLAVOR CINNAMON SD 516:BUCCAL:GUM, CHEWING:MG	BUCCAL	9.6MG BUCCAL GUM, CHEWING	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLAVOR CINNAMON VEKO 3726:BUCCAL:GUM, CHEWING:MG	BUCCAL	27MG BUCCAL GUM, CHEWING	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLAVOR CITRUS FN-7176:ORAL:SOLUTION:MG/5ML	ORAL	7.5MG/5ML ORAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLAVOR CITRUS FN-7176:ORAL:SUSPENSION:MG/5 ML	ORAL	5MG/5 ML ORAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLAVOR CITRUS/FRUIT FREEZE 1100609500:BUCCAL:GUM, CHEWING:MG	BUCCAL	2.25MG BUCCAL GUM, CHEWING	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLAVOR COCONUT 41:ORAL:CAPSULE:MG	ORAL	0.79MG ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLAVOR COLA FMC 15740:ORAL:SOLUTION, ELIXIR:%	ORAL	0.3% ORAL SOLUTION, ELIXIR	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLAVOR COLA FMC 15740:ORAL:SYRUP:NA	ORAL	ORAL SYRUP	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLAVOR COOL VANILLA BP18114:ORAL:TABLET:MG	ORAL	20.5MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLAVOR COOL VANILLA BP18257:ORAL:TABLET:MG	ORAL	22.23MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLAVOR COUGH SYRUP 134681:ORAL:SYRUP:MG/1ML	ORAL	6MG/1ML ORAL SYRUP	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLAVOR CREAMY VANILLA 16345:ORAL:SOLUTION:%	ORAL	0.2% ORAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLAVOR CREME 46971:ORAL:TABLET (IMMED./COMP. RELEASE), UNCOATED, CHEWABLE:MG	ORAL	2.5MG ORAL TABLET (IMMED./COMP. RELEASE), UNCOATED, CHEWABLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLAVOR CREME DE MENTHE 14677:ORAL:SOLUTION:%	ORAL	0.3% ORAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLAVOR CREME DE MENTHE 14677:ORAL:SUSPENSION:MG/5ML	ORAL	0.015MG/5ML ORAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLAVOR CREME DE VANILLA 28156:ORAL:DROPS:MG/1ML	ORAL	1.6MG/1ML ORAL DROPS	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLAVOR CREME DE VANILLA 28156:ORAL:POWDER, FOR RECONSTITUTION:MG/5ML	ORAL	1.5MG/5ML ORAL POWDER, FOR RECONSTITUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLAVOR CREME DE VANILLA 28156:ORAL:POWDER, FOR SUSPENSION:MG/5ML	ORAL	0.1MG/5ML ORAL POWDER, FOR SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLAVOR CREME DE VANILLA 28156:ORAL:SUSPENSION:MG/5ML	ORAL	4MG/5ML ORAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLAVOR F-5397A:ORAL:CONCENTRATE:%	ORAL	8% ORAL CONCENTRATE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLAVOR F-9843:ORAL:SUSPENSION:%	ORAL	0.05% ORAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLAVOR FRUIT 01-10428:ORAL:CONCENTRATE:%	ORAL	0.025% ORAL CONCENTRATE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLAVOR FRUIT FN-6714:ORAL:SOLUTION:MG/5ML	ORAL	2.5MG/5ML ORAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLAVOR FRUIT GUM 912:ORAL:GRANULE, FOR RECONSTITUTION:MG	ORAL	20MG ORAL GRANULE, FOR RECONSTITUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLAVOR FRUIT GUM 912:ORAL:POWDER, FOR ORAL SUSPENSION:MG/5ML	ORAL	18MG/5ML ORAL POWDER, FOR ORAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLAVOR FRUIT GUM 912:ORAL:POWDER, FOR SUSPENSION:MG/5ML	ORAL	20MG/5ML ORAL POWDER, FOR SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLAVOR FRUIT GUM 912:ORAL:SUSPENSION:MG/5ML	ORAL	2.69MG/5ML ORAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLAVOR FRUIT GUM 912:ORAL:TABLET (IMMED./COMP. RELEASE), UNCOATED, CHEWABLE:MG	ORAL	25MG ORAL TABLET (IMMED./COMP. RELEASE), UNCOATED, CHEWABLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLAVOR FRUIT TAK 20008:ORAL:CONCENTRATE:%	ORAL	0.1% ORAL CONCENTRATE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLAVOR GOLDEN PUNCH:ORAL:POWDER:MG/1PKT	ORAL	150MG/1PKT ORAL POWDER	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLAVOR GOLDEN PUNCH:ORAL:POWDER:MG/1SCP	ORAL	150MG/1SCP ORAL POWDER	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLAVOR GRAPE 501417C:ORAL:ORAL SOLUTION DOSAGE FORM:mg/5mL	ORAL	5mg/5mL ORAL ORAL SOLUTION DOSAGE FORM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLAVOR GRAPE 501417C:ORAL:SOLUTION:%W/V	ORAL	0.1%W/V ORAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLAVOR GRAPE 59.145/APO5.51:ORAL:POWDER, FOR SUSPENSION:MG/5ML	ORAL	5MG/5ML ORAL POWDER, FOR SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLAVOR GRAPE 59.145/APO5.51:ORAL:TABLET (IMMED./COMP. RELEASE), UNCOATED, CHEWABLE:MG	ORAL	1.25MG ORAL TABLET (IMMED./COMP. RELEASE), UNCOATED, CHEWABLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLAVOR GRAPE 59.266/APO5.51:ORAL:POWDER, FOR SUSPENSION:MG/5ML	ORAL	5MG/5ML ORAL POWDER, FOR SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLAVOR GRAPE 61.13252:ORAL:SOLUTION:MG/5ML	ORAL	1MG/5ML ORAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLAVOR GRAPE 6175:ORAL:SOLUTION:MG/5ML	ORAL	10MG/5ML ORAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLAVOR GRAPE 6175:ORAL:SUSPENSION:MG/5ML	ORAL	10MG/5ML ORAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLAVOR GRAPE 6175:ORAL:SUSPENSION, SYRUP, SUSTAINED ACTION:%	ORAL	0.04% ORAL SUSPENSION, SYRUP, SUSTAINED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLAVOR GRAPE 6175:ORAL:SYRUP:MG/5ML	ORAL	59.7MG/5ML ORAL SYRUP	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLAVOR GRAPE MANHEIMER 522463:ORAL:SOLUTION:MG/1ML	ORAL	4.38MG/1ML ORAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLAVOR GRAPE MANHEIMER 522463:ORAL:SUSPENSION:MG/5ML	ORAL	25MG/5ML ORAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLAVOR GRAPE NECTOR PFC-8599:ORAL:SYRUP:MG/5ML	ORAL	10MG/5ML ORAL SYRUP	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLAVOR GRAPE PFC-9924:ORAL:SOLUTION:%	ORAL	0.48% ORAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLAVOR GRAPE PFC-9924:ORAL:SYRUP:MG/5ML	ORAL	9.97MG/5ML ORAL SYRUP	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLAVOR GRAPE S120:ORAL:TABLET:MG	ORAL	2MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLAVOR GRAPE ST6835/09:ORAL:SOLUTION:MG/5ML	ORAL	3.11MG/5ML ORAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLAVOR GRAPE ST6835/09:ORAL:SYRUP:MG/5ML	ORAL	3.11MG/5ML ORAL SYRUP	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLAVOR GUARANA FMC-15417:ORAL:POWDER, FOR SUSPENSION:NA	ORAL	ORAL POWDER, FOR SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLAVOR KIWI S-718:ORAL:POWDER:MG/1PKT	ORAL	6.3MG/1PKT ORAL POWDER	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLAVOR KIWI S-718:ORAL:POWDER:MG/1SCP	ORAL	6.3MG/1SCP ORAL POWDER	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLAVOR LEMON:ORAL:SUSPENSION:mg/5mL	ORAL	15mg/5mL ORAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLAVOR LEMON 812:ORAL:SUSPENSION:MG/1ML	ORAL	1.76MG/1ML ORAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLAVOR LEMON 812:ORAL:SYRUP:NA	ORAL	ORAL SYRUP	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLAVOR LEMON LIME:SUBLINGUAL:FILM:mg	SUBLINGUAL	6mg SUBLINGUAL FILM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLAVOR LEMON LIME SD 935:ORAL:TABLET, ORALLY DISINTEGRATING:MG	ORAL	2.85MG ORAL TABLET, ORALLY DISINTEGRATING	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLAVOR LEMON LIME SD 935:SUBLINGUAL:FILM:mg	SUBLINGUAL	4.5mg SUBLINGUAL FILM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLAVOR LEMON LIME SD 935:SUBLINGUAL:TABLET:MG	SUBLINGUAL	1.18MG SUBLINGUAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLAVOR LEMON MINT 862.547:ORAL:SOLUTION:MG/5ML	ORAL	7.5MG/5ML ORAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLAVOR LEMON N&A 397:ORAL:POWDER, FOR SUSPENSION:g/236mL	ORAL	0.035g/236mL ORAL POWDER, FOR SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLAVOR LEMON N&A 397:SUBLINGUAL:TABLET (IMMED./COMP. RELEASE), UNCOATED, BUCCAL:MG	SUBLINGUAL	2MG SUBLINGUAL TABLET (IMMED./COMP. RELEASE), UNCOATED, BUCCAL	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLAVOR LEMON SPRAY V3938-1N1:ORAL:POWDER, FOR ORAL SOLUTION:MG	ORAL	340MG ORAL POWDER, FOR ORAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLAVOR LEMON SPRAY V3938-1N1:ORAL:POWDER, FOR SUSPENSION:mg	ORAL	55.5mg ORAL POWDER, FOR SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLAVOR MAGNASWEET 110:ORAL:LIQUID:MG/ML	ORAL	9MG/ML ORAL LIQUID	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLAVOR MANDARIN 15228-71:ORAL:GRANULE, FOR SUSPENSION:MG	ORAL	70MG ORAL GRANULE, FOR SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLAVOR MANGO:ORAL:POWDER, FOR ORAL SOLUTION:G/16 OZ	ORAL	1.43G/16 OZ ORAL POWDER, FOR ORAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLAVOR MENTHOL MINT PFC-9926:ORAL:TABLET, ORALLY DISINTEGRATING:MG	ORAL	7MG ORAL TABLET, ORALLY DISINTEGRATING	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLAVOR MENTHOL MINT PFC-9926:ORAL:TROCHE:MG	ORAL	1.2MG ORAL TROCHE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLAVOR MENTHOL VERALOCK:BUCCAL:GUM, CHEWING:MG	BUCCAL	3.84MG BUCCAL GUM, CHEWING	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLAVOR MINT 287:BUCCAL:GUM:MG	BUCCAL	27.03MG BUCCAL GUM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLAVOR MINT 287:BUCCAL:GUM, CHEWING:MG	BUCCAL	28MG BUCCAL GUM, CHEWING	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLAVOR MINT 51296 TP0551:ORAL:TABLET, ORALLY DISINTEGRATING:MG	ORAL	2.5MG ORAL TABLET, ORALLY DISINTEGRATING	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLAVOR MINT SN027513:ORAL:TABLET:MG	ORAL	1.5MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLAVOR MINT SN027513:ORAL:TABLET, ORALLY DISINTEGRATING:MG	ORAL	9.31MG ORAL TABLET, ORALLY DISINTEGRATING	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLAVOR MIXED BERRY 807.0246U:ORAL:SOLUTION:MG/5 ML	ORAL	10MG/5 ML ORAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLAVOR MIXED BERRY 807.0246U:ORAL:SUSPENSION:mg/5mL	ORAL	21.5mg/5mL ORAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLAVOR ORANGE:ORAL:SOLUTION:mg/15 mL	ORAL	30mg/15 mL ORAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLAVOR ORANGE 501071 AP0551:ORAL:POWDER, FOR ORAL SUSPENSION:mg	ORAL	50mg ORAL POWDER, FOR ORAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLAVOR ORANGE 501071 AP0551:ORAL:POWDER, FOR ORAL SUSPENSION:MG/PKT	ORAL	50MG/PKT ORAL POWDER, FOR ORAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLAVOR ORANGE 501071 AP0551:ORAL:POWDER, FOR ORAL SUSPENSION:MG/5ML	ORAL	25MG/5ML ORAL POWDER, FOR ORAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLAVOR ORANGE 501071 AP0551:ORAL:SUSPENSION:MG/1ML	ORAL	2.4MG/1ML ORAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLAVOR ORANGE 501071 AP0551:ORAL:TABLET:mg	ORAL	1.5mg ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLAVOR ORANGE 501071 AP0551:ORAL:TABLET (IMMED./COMP. RELEASE), UNCOATED, CHEWABLE:MG	ORAL	50MG ORAL TABLET (IMMED./COMP. RELEASE), UNCOATED, CHEWABLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLAVOR ORANGE 501071 AP0551:ORAL:TABLET, ORALLY DISINTEGRATING:MG	ORAL	5MG ORAL TABLET, ORALLY DISINTEGRATING	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLAVOR ORANGE 57.458/AP05.51:ORAL:POWDER, FOR ORAL SUSPENSION:MG/5ML	ORAL	20MG/5ML ORAL POWDER, FOR ORAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLAVOR ORANGE 57.458/AP05.51:ORAL:SUSPENSION:%W/W	ORAL	1.4%W/W ORAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLAVOR ORANGE 739K (PB82):ORAL:POWDER, FOR RECONSTITUTION:MG/5ML	ORAL	6.25MG/5ML ORAL POWDER, FOR RECONSTITUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLAVOR ORANGE 739K (PB82):ORAL:POWDER, FOR SUSPENSION:g/236mL	ORAL	0.04g/236mL ORAL POWDER, FOR SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLAVOR ORANGE 74016-71:ORAL:GRANULE, FOR SUSPENSION:MG	ORAL	70MG ORAL GRANULE, FOR SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLAVOR ORANGE NATURAL & ARTIFICIAL:ORAL:SOLUTION:mg/15mL	ORAL	0.6mg/15mL ORAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLAVOR ORANGE NO. 7679:ORAL:SOLUTION:%	ORAL	0.027% ORAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLAVOR ORANGE NO. 7679:ORAL:SYRUP:%	ORAL	0.25% ORAL SYRUP	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLAVOR ORANGE P-5614:ORAL:SUSPENSION:NA	ORAL	ORAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLAVOR PEACH 13503584:ORAL:SOLUTION:%	ORAL	0.042% ORAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLAVOR PEACH 13503584:ORAL:SYRUP:%	ORAL	0.31% ORAL SYRUP	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLAVOR PEACH 23070:ORAL:POWDER, FOR ORAL SUSPENSION:MG/1PKT	ORAL	60MG/1PKT ORAL POWDER, FOR ORAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLAVOR PEACH MINT FRITZSCHE 106109:ORAL:SYRUP:%	ORAL	0.1% ORAL SYRUP	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLAVOR PEACH PINEAPPLE FMC 14258:ORAL:SOLUTION:MG/5ML	ORAL	0.015MG/5ML ORAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLAVOR PEACH PINEAPPLE FMC 14258:ORAL:SUSPENSION:MG/5ML	ORAL	0.015MG/5ML ORAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLAVOR PEPPERMINT:ORAL:TABLET, ORALLY DISINTEGRATING:mg	ORAL	2.55mg ORAL TABLET, ORALLY DISINTEGRATING	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLAVOR PEPPERMINT 104:ORAL:SOLUTION:MG/5ML	ORAL	7MG/5ML ORAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLAVOR PEPPERMINT 104:ORAL:SYRUP:mg/5mL	ORAL	2.5mg/5mL ORAL SYRUP	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLAVOR PEPPERMINT 501500:ORAL:LIQUID:MG/5ML	ORAL	1.03MG/5ML ORAL LIQUID	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLAVOR PEPPERMINT 501500:ORAL:SOLUTION:MG	ORAL	5MG ORAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLAVOR PEPPERMINT 501500:ORAL:TABLET:mg	ORAL	1mg ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLAVOR PEPPERMINT 501500:ORAL:TABLET, ORALLY DISINTEGRATING:MG	ORAL	3.5MG ORAL TABLET, ORALLY DISINTEGRATING	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLAVOR PEPPERMINT 517:ORAL:LOZENGE:mg	ORAL	30mg ORAL LOZENGE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLAVOR PEPPERMINT 517:ORAL:POWDER, FOR SUSPENSION:NA	ORAL	ORAL POWDER, FOR SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLAVOR PEPPERMINT 517:ORAL:TABLET (IMMED./COMP. RELEASE), UNCOATED, CHEWABLE:MG	ORAL	2MG ORAL TABLET (IMMED./COMP. RELEASE), UNCOATED, CHEWABLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLAVOR PEPPERMINT 517:ORAL:TABLET, ORALLY DISINTEGRATING:MG	ORAL	2.5MG ORAL TABLET, ORALLY DISINTEGRATING	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLAVOR PEPPERMINT 894.115:ORAL:POWDER, FOR ORAL SUSPENSION:MG/1PKT	ORAL	10MG/1PKT ORAL POWDER, FOR ORAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLAVOR PEPPERMINT EXTRACT FN-2356:ORAL:SOLUTION:MG/1ML	ORAL	5MG/1ML ORAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLAVOR PEPPERMINT PFC 9927:ORAL:SOLUTION:%	ORAL	0.07% ORAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLAVOR PEPPERMINT SEELOCK 34907:ORAL:TABLET (IMMED./COMP. RELEASE), UNCOATED, CHEWABLE:MG	ORAL	11MG ORAL TABLET (IMMED./COMP. RELEASE), UNCOATED, CHEWABLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLAVOR PEPPERMINT SN583865:ORAL:SOLUTION:%	ORAL	0.1% ORAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLAVOR PEPPERMINT STICK FMC 16170:DENTAL:SOLUTION:%	DENTAL	4.5% DENTAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLAVOR PEPPERMINT STICK FMC 16170:ORAL:CONCENTRATE:NA	ORAL	ORAL CONCENTRATE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLAVOR PEPPERMINT WL-6167:ORAL:TABLET:MG	ORAL	5MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLAVOR PEPPERMINT, NATURAL SPRAYLENE:ORAL:TABLET:MG	ORAL	4MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLAVOR PINEAPPLE 501085:ORAL:POWDER, FOR ORAL SUSPENSION:MG/5ML	ORAL	40MG/5ML ORAL POWDER, FOR ORAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLAVOR PINEAPPLE N-2566:ORAL:SUSPENSION:NA	ORAL	ORAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLAVOR PROSWEET 694:ORAL:POWDER, FOR SUSPENSION:MG/1SCP	ORAL	5MG/1SCP ORAL POWDER, FOR SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLAVOR RASPBERRY:ORAL:SUSPENSION:MG/5ML	ORAL	10MG/5ML ORAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLAVOR RASPBERRY 21028D:ORAL:SOLUTION:%	ORAL	0.044% ORAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLAVOR RASPBERRY 21028D:ORAL:SYRUP:%	ORAL	0.1% ORAL SYRUP	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLAVOR RASPBERRY 28106:ORAL:DROPS:MG/1ML	ORAL	5MG/1ML ORAL DROPS	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLAVOR RASPBERRY 28106:ORAL:SUSPENSION:MG/5ML	ORAL	12.5MG/5ML ORAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLAVOR RASPBERRY 954:ORAL:SUSPENSION:MG/1ML	ORAL	2.5MG/1ML ORAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLAVOR RASPBERRY 954:ORAL:TABLET (IMMED./COMP. RELEASE), UNCOATED, CHEWABLE:MG	ORAL	5MG ORAL TABLET (IMMED./COMP. RELEASE), UNCOATED, CHEWABLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLAVOR RASPBERRY 954K (BK77):ORAL:POWDER, FOR ORAL SOLUTION:NA	ORAL	ORAL POWDER, FOR ORAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLAVOR RASPBERRY 954K (BK77):ORAL:POWDER, FOR RECONSTITUTION:MG/5ML	ORAL	12.5MG/5ML ORAL POWDER, FOR RECONSTITUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLAVOR RASPBERRY 954K (BK77):ORAL:SOLUTION:MG/5ML	ORAL	1MG/5ML ORAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLAVOR RASPBERRY 998:ORAL:SOLUTION:MG/5ML	ORAL	7.5MG/5ML ORAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLAVOR RASPBERRY 998:ORAL:SUSPENSION:MG/5ML	ORAL	10MG/5ML ORAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLAVOR RASPBERRY 998:ORAL:SYRUP:MG/5ML	ORAL	10MG/5ML ORAL SYRUP	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLAVOR RASPBERRY AROME PFC-9908:ORAL:SYRUP:%	ORAL	0.1% ORAL SYRUP	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLAVOR RASPBERRY F-1784:ORAL:SOLUTION:%	ORAL	1% ORAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLAVOR RASPBERRY F-1784:ORAL:SYRUP:%	ORAL	1.4% ORAL SYRUP	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLAVOR RASPBERRY F-1840:ORAL:SOLUTION:%	ORAL	0.25% ORAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLAVOR RASPBERRY F-1840:ORAL:SYRUP:%	ORAL	0.05% ORAL SYRUP	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLAVOR RASPBERRY PFC-8407:ORAL:CONCENTRATE:NA	ORAL	ORAL CONCENTRATE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLAVOR RASPBERRY PFC-8407:ORAL:SOLUTION:MG/75ML	ORAL	150MG/75ML ORAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLAVOR RASPBERRY PFC-8407:ORAL:SOLUTION, ELIXIR:%	ORAL	0.025% ORAL SOLUTION, ELIXIR	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLAVOR RASPBERRY PFC-8407:ORAL:SUSPENSION:MG/60ML	ORAL	20MG/60ML ORAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLAVOR RASPBERRY PFC-8407:RECTAL:SUSPENSION:%	RECTAL	0.033% RECTAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLAVOR STRAWBERRY:ORAL:SOLUTION:mg/1mL	ORAL	0.2mg/1mL ORAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLAVOR STRAWBERRY 052311 AP0551:ORAL:FOR SUSPENSION:MG/5ML	ORAL	25MG/5ML ORAL FOR SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLAVOR STRAWBERRY 052311 AP0551:ORAL:POWDER, FOR ORAL SUSPENSION:MG/5ML	ORAL	35MG/5ML ORAL POWDER, FOR ORAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLAVOR STRAWBERRY 052311 AP0551:ORAL:TABLET, ORALLY DISINTEGRATING:MG	ORAL	2.8MG ORAL TABLET, ORALLY DISINTEGRATING	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLAVOR STRAWBERRY 052311 AP0551:ORAL:TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE:mg	ORAL	5.86mg ORAL TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLAVOR STRAWBERRY 14953:ORAL:SOLUTION:%	ORAL	0.3% ORAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLAVOR STRAWBERRY 17.36.8509:ORAL:TABLET, ORALLY DISINTEGRATING:MG	ORAL	12MG ORAL TABLET, ORALLY DISINTEGRATING	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLAVOR STRAWBERRY 17.36.8509:ORAL:TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE:MG	ORAL	11MG ORAL TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLAVOR STRAWBERRY 17C56217:ORAL:SOLUTION:MG/5ML	ORAL	15MG/5ML ORAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLAVOR STRAWBERRY 17C56217:ORAL:TABLET, ORALLY DISINTEGRATING:MG	ORAL	0.25MG ORAL TABLET, ORALLY DISINTEGRATING	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLAVOR STRAWBERRY 52.311AP:ORAL:POWDER, FOR RECONSTITUTION:MG/5ML	ORAL	10MG/5ML ORAL POWDER, FOR RECONSTITUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLAVOR STRAWBERRY 52.311AP:ORAL:POWDER, FOR SUSPENSION:MG/5ML	ORAL	25MG/5ML ORAL POWDER, FOR SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLAVOR STRAWBERRY 52312/AP0551:ORAL:POWDER, FOR ORAL SUSPENSION:MG/5ML	ORAL	2.25MG/5ML ORAL POWDER, FOR ORAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLAVOR STRAWBERRY 52312/AP0551:ORAL:POWDER, FOR SUSPENSION:MG/5ML	ORAL	15MG/5ML ORAL POWDER, FOR SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLAVOR STRAWBERRY 55058:ORAL:CONCENTRATE:%	ORAL	0.1% ORAL CONCENTRATE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLAVOR STRAWBERRY 55058:ORAL:SYRUP:%	ORAL	0.1% ORAL SYRUP	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLAVOR STRAWBERRY 5951:ORAL:DROPS:MG/1ML	ORAL	2MG/1ML ORAL DROPS	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLAVOR STRAWBERRY 5951:ORAL:SUSPENSION:MG/5ML	ORAL	5MG/5ML ORAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLAVOR STRAWBERRY BANANA 24020:ORAL:SOLUTION:MG/5ML	ORAL	25MG/5ML ORAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLAVOR STRAWBERRY BANANA 24020:ORAL:SUSPENSION:MG/5ML	ORAL	56.1MG/5ML ORAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLAVOR STRAWBERRY GUARANA 586.997/APO5.51:ORAL:POWDER, FOR ORAL SUSPENSION:MG/5ML	ORAL	16.25MG/5ML ORAL POWDER, FOR ORAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLAVOR STRAWBERRY GUARANA 586.997/APO5.51:ORAL:POWDER, FOR RECONSTITUTION:MG/5ML	ORAL	10MG/5ML ORAL POWDER, FOR RECONSTITUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLAVOR STRAWBERRY GUARANA 586.997/APO5.51:ORAL:POWDER, FOR SUSPENSION:MG/5ML	ORAL	20MG/5ML ORAL POWDER, FOR SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLAVOR STRAWBERRY GUARANA 586.997/APO5.51:ORAL:TABLET:MG	ORAL	20MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLAVOR STRAWBERRY GUARANA 586.997/APO5.51:ORAL:TABLET (IMMED./COMP. RELEASE), UNCOATED, CHEWABLE:MG	ORAL	14.42MG ORAL TABLET (IMMED./COMP. RELEASE), UNCOATED, CHEWABLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLAVOR STRAWBERRY GUARANA 586.997/APO5.51:ORAL:TABLET, ORALLY DISINTEGRATING:MG	ORAL	2MG ORAL TABLET, ORALLY DISINTEGRATING	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLAVOR SWEET TONE 28837:ORAL:POWDER, FOR SUSPENSION:NA	ORAL	ORAL POWDER, FOR SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLAVOR SWEET TONE 28837:ORAL:SOLUTION:MG/5ML	ORAL	0.5MG/5ML ORAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLAVOR SWEET-AM 918.005:ORAL:GRANULE, FOR SUSPENSION:MG	ORAL	30MG ORAL GRANULE, FOR SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLAVOR SWEET-AM 918.005:ORAL:SOLUTION:MG/5ML	ORAL	2MG/5ML ORAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLAVOR TM 313298:ORAL:SUSPENSION:MG/5ML	ORAL	3.75MG/5ML ORAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLAVOR TROPICAL FRUIT PUNCH N&A 50432:ORAL:SOLUTION:%	ORAL	18.2% ORAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLAVOR TROPICAL FRUIT PUNCH N&A 50432:ORAL:SYRUP:MG/1ML	ORAL	5.2MG/1ML ORAL SYRUP	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLAVOR TUTTI FRUTTI:ORAL:SUSPENSION:MG/1ML	ORAL	0.46MG/1ML ORAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLAVOR TUTTI FRUTTI 51.880/AP05.51:ORAL:POWDER, FOR SUSPENSION:MG/5ML	ORAL	102MG/5ML ORAL POWDER, FOR SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLAVOR TUTTI FRUTTI 51.880/AP05.51:ORAL:SUSPENSION:MG/5ML	ORAL	2.5MG/5ML ORAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLAVOR TUTTI FRUTTI 51.880/AP05.51:ORAL:TABLET:MG	ORAL	10MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLAVOR TUTTI FRUTTI 51.880/AP05.51:ORAL:TABLET, ORALLY DISINTEGRATING:MG	ORAL	1.25MG ORAL TABLET, ORALLY DISINTEGRATING	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLAVOR TUTTI FRUTTI P-5400:ORAL:SUSPENSION:NA	ORAL	ORAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLAVOR TUTTI FRUTTI WL-18481:ORAL:POWDER, FOR SUSPENSION:MG/1ML	ORAL	6MG/1ML ORAL POWDER, FOR SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLAVOR VANILLA 501328 AP0551:ORAL:POWDER, FOR ORAL SUSPENSION:mg	ORAL	120mg ORAL POWDER, FOR ORAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLAVOR VANILLA C7984:ORAL:SYRUP:MG/5ML	ORAL	6MG/5ML ORAL SYRUP	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLAVOR VANILLA F-6257:ORAL:SOLUTION:%	ORAL	0.12% ORAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLAVOR VANILLA F-6257:ORAL:SYRUP:NA	ORAL	ORAL SYRUP	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLAVOR VANILLA P-1160:ORAL:SUSPENSION:NA	ORAL	ORAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLAVOR VANILLA PFC-9772:ORAL:CONCENTRATE:%	ORAL	1% ORAL CONCENTRATE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLAVOR WILD CHERRY 695047U:ORAL:CONCENTRATE:MG/1ML	ORAL	10MG/1ML ORAL CONCENTRATE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLAVOR WILD CHERRY GIVAUDAN F-1813:ORAL:POWDER, FOR SUSPENSION:MG/5ML	ORAL	68.2MG/5ML ORAL POWDER, FOR SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLAVOR WILD CHERRY K-321:ORAL:SUSPENSION:NA	ORAL	ORAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLAVOR WILD CHERRY NV-101-1489:ORAL:POWDER, FOR SUSPENSION:MG/5ML	ORAL	2.5MG/5ML ORAL POWDER, FOR SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLAVOR WILD CHERRY PFC-14783:ORAL:SUSPENSION:MG/1ML	ORAL	0.37MG/1ML ORAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLAVOR WILD CHERRY PFC-14783:ORAL:SYRUP:%	ORAL	0.4% ORAL SYRUP	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLUOROCHLOROHYDROCARBONS:INHALATION:AEROSOL, METERED:NA	INHALATION	INHALATION AEROSOL, METERED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FLUOROCHLOROHYDROCARBONS:INHALATION:AEROSOL, SPRAY:NA	INHALATION	INHALATION AEROSOL, SPRAY	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FRAGRANCE 91-122:TOPICAL:SHAMPOO, SUSPENSION:%W/W	TOPICAL	3%W/W TOPICAL SHAMPOO, SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FRAGRANCE 9128-Y:TOPICAL:EMULSION, CREAM:%W/W	TOPICAL	0.07%W/W TOPICAL EMULSION, CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FRAGRANCE BALSAM PINE NO. 5124:TOPICAL:OIL:%W/W	TOPICAL	0.03%W/W TOPICAL OIL	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FRAGRANCE CREAM NO. 73457:TOPICAL:OIL:%W/W	TOPICAL	1.15%W/W TOPICAL OIL	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FRAGRANCE CS-28197:TOPICAL:EMULSION, CREAM:NA	TOPICAL	TOPICAL EMULSION, CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FRAGRANCE GIVAUDAN ESS 9090/1C:TOPICAL:SOLUTION:NA	TOPICAL	TOPICAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FRAGRANCE GIVAUDAN ESS 9090/1C:TOPICAL:SPONGE:NA	TOPICAL	TOPICAL SPONGE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FRAGRANCE P O FL-147:TOPICAL:AEROSOL:%W/W	TOPICAL	0.27%W/W TOPICAL AEROSOL	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FRAGRANCE P O FL-147:TOPICAL:EMULSION:%W/W	TOPICAL	0.27%W/W TOPICAL EMULSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FRAGRANCE P O FL-147:TOPICAL:SOLUTION:%W/W	TOPICAL	0.13%W/W TOPICAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FRAGRANCE PA 52805:TOPICAL:SOLUTION:NA	TOPICAL	TOPICAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FRAGRANCE PA 52805:TOPICAL:SWAB:NA	TOPICAL	TOPICAL SWAB	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FRAGRANCE PERA DERM D:TOPICAL:LOTION:NA	TOPICAL	TOPICAL LOTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FRAGRANCE PERA DERM D:TOPICAL:SOLUTION:NA	TOPICAL	TOPICAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FRAGRANCE PERA DERM D:TOPICAL:SWAB:NA	TOPICAL	TOPICAL SWAB	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FRAGRANCE RBD-9819:TOPICAL:EMULSION, AEROSOL FOAM:%W/W	TOPICAL	0.1%W/W TOPICAL EMULSION, AEROSOL FOAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FRAGRANCE RBD-9819:TOPICAL:EMULSION, CREAM:%W/W	TOPICAL	0.06%W/W TOPICAL EMULSION, CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FRAGRANCE RBD-9819:TOPICAL:SOLUTION:%W/W	TOPICAL	0.025%W/W TOPICAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	FRAGRANCE UNGERER N5195:TOPICAL:LOTION:%W/W	TOPICAL	0.07%W/W TOPICAL LOTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
NA	GELATIN CAPSULE, HARD:ORAL:CAPSULE:MG	ORAL	118MG ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
NA	GELATIN CAPSULE, HARD:ORAL:CAPSULE, DELAYED ACTION:MG	ORAL	96MG ORAL CAPSULE, DELAYED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
NA	GELATIN CAPSULE, HARD:ORAL:CAPSULE, EXTENDED RELEASE:MG	ORAL	125MG ORAL CAPSULE, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
NA	GELATIN CAPSULE, HARD:ORAL:CAPSULE, HARD GELATIN:MG	ORAL	107MG ORAL CAPSULE, HARD GELATIN	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
NA	GELATIN HYDROLYSATE:ORAL:CAPSULE:MG	ORAL	17.25MG ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
NA	GLUCOSE SYRUP, HYDROGENATED:ORAL:SOLUTION:MG/5ML	ORAL	2000MG/5ML ORAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
NA	GLYCERYL STEARATE/PEG STEARATE:ORAL:TABLET:MG	ORAL	1.8MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
NA	GLYCERYL STEARATE/PEG STEARATE:ORAL:TABLET, COATED:MG	ORAL	1.8MG ORAL TABLET, COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
NA	GLYCERYL STEARATE/PEG STEARATE:RECTAL:SUPPOSITORY:MG	RECTAL	36.85MG RECTAL SUPPOSITORY	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
NA	GLYCERYL STEARATE/PEG STEARATE:TOPICAL:CREAM:%W/W	TOPICAL	6%W/W TOPICAL CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
NA	HYDROCARBON:RECTAL:AEROSOL, METERED:%	RECTAL	5.21% RECTAL AEROSOL, METERED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
NA	HYDROCARBON GEL, PLASTICIZED:DENTAL:PASTE:NA	DENTAL	DENTAL PASTE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
NA	HYDROCARBON GEL, PLASTICIZED:OPHTHALMIC:OINTMENT:NA	OPHTHALMIC	OPHTHALMIC OINTMENT	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
NA	HYDROCARBON GEL, PLASTICIZED:OPHTHALMIC:SUSPENSION:NA	OPHTHALMIC	OPHTHALMIC SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
NA	HYDROCARBON GEL, PLASTICIZED:TOPICAL:OINTMENT:%W/W	TOPICAL	97.7%W/W TOPICAL OINTMENT	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
NA	HYDROCARBON GEL, PLASTICIZED:TOPICAL:PASTE, DENTIFRICE:NA	TOPICAL	TOPICAL PASTE, DENTIFRICE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
NA	HYDROXYETHYL CELLULOSE:AURICULAR (OTIC):SOLUTION:%	AURICULAR (OTIC)	0.25% AURICULAR (OTIC) SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
NA	HYDROXYETHYL CELLULOSE:AURICULAR (OTIC):SUSPENSION:%	AURICULAR (OTIC)	0.2% AURICULAR (OTIC) SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
NA	HYDROXYETHYL CELLULOSE:BUCCAL:FILM:MG	BUCCAL	54.92MG BUCCAL FILM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
NA	HYDROXYETHYL CELLULOSE:BUCCAL:FILM, SOLUBLE:MG	BUCCAL	39.88MG BUCCAL FILM, SOLUBLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
NA	HYDROXYETHYL CELLULOSE:NASAL:SPRAY:%	NASAL	0.05% NASAL SPRAY	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
NA	HYDROXYETHYL CELLULOSE:OPHTHALMIC:SOLUTION:%	OPHTHALMIC	1.6% OPHTHALMIC SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
NA	HYDROXYETHYL CELLULOSE:OPHTHALMIC:SOLUTION, DROPS:%	OPHTHALMIC	0.5% OPHTHALMIC SOLUTION, DROPS	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
NA	HYDROXYETHYL CELLULOSE:OPHTHALMIC:SUSPENSION:%	OPHTHALMIC	0.25% OPHTHALMIC SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
NA	HYDROXYETHYL CELLULOSE:OPHTHALMIC:SUSPENSION, DROPS:%	OPHTHALMIC	0.35% OPHTHALMIC SUSPENSION, DROPS	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
NA	HYDROXYETHYL CELLULOSE:ORAL:CAPSULE:MG	ORAL	2.98MG ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
NA	HYDROXYETHYL CELLULOSE:ORAL:SOLUTION:MG/5ML	ORAL	25MG/5ML ORAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
NA	HYDROXYETHYL CELLULOSE:ORAL:SUSPENSION:MG/5ML	ORAL	150MG/5ML ORAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
NA	HYDROXYETHYL CELLULOSE:ORAL:SYRUP:MG/5ML	ORAL	100MG/5ML ORAL SYRUP	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
NA	HYDROXYETHYL CELLULOSE:ORAL:TABLET:MG	ORAL	22.96MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
NA	HYDROXYETHYL CELLULOSE:ORAL:TABLET (IMMED./COMP. RELEASE), UNCOATED, CHEWABLE:MG	ORAL	11.8MG ORAL TABLET (IMMED./COMP. RELEASE), UNCOATED, CHEWABLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
NA	HYDROXYETHYL CELLULOSE:ORAL:TABLET, COATED:NA	ORAL	ORAL TABLET, COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
NA	HYDROXYETHYL CELLULOSE:ORAL:TABLET, EXTENDED RELEASE:MG	ORAL	400MG ORAL TABLET, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
NA	HYDROXYETHYL CELLULOSE:ORAL:TABLET, SUSTAINED ACTION:MG	ORAL	150MG ORAL TABLET, SUSTAINED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
NA	HYDROXYETHYL CELLULOSE:ORAL:TABLET, SUSTAINED ACTION, COATED:MG	ORAL	140MG ORAL TABLET, SUSTAINED ACTION, COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
NA	HYDROXYETHYL CELLULOSE:ORAL:TABLET, SUSTAINED ACTION, FILM COATED:MG	ORAL	47.99MG ORAL TABLET, SUSTAINED ACTION, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
NA	HYDROXYETHYL CELLULOSE:OTIC:SUSPENSION:%	OTIC	0.2% OTIC SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
NA	HYDROXYETHYL CELLULOSE:TOPICAL:GEL:%W/W	TOPICAL	1.75%W/W TOPICAL GEL	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
NA	HYDROXYETHYL CELLULOSE:TOPICAL:LOTION:%W/W	TOPICAL	0.8%W/W TOPICAL LOTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
NA	HYDROXYETHYL CELLULOSE:TOPICAL:SOLUTION, DROPS:%W/V	TOPICAL	0.48%W/V TOPICAL SOLUTION, DROPS	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
NA	HYDROXYETHYL CELLULOSE:TOPICAL:SPONGE:NA	TOPICAL	TOPICAL SPONGE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
NA	HYDROXYETHYL CELLULOSE:TOPICAL:SPRAY:%W/W	TOPICAL	0.05%W/W TOPICAL SPRAY	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
NA	HYDROXYETHYL CELLULOSE:TOPICAL:SUSPENSION:%W/W	TOPICAL	0.69%W/W TOPICAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
NA	HYDROXYETHYL CELLULOSE:TRANSDERMAL:FILM, CONTROLLED RELEASE:MG	TRANSDERMAL	20MG TRANSDERMAL FILM, CONTROLLED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
NA	HYPROMELLOSE ACETATE SUCCINATE:ORAL:CAPSULE:MG	ORAL	44.6MG ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
NA	HYPROMELLOSE ACETATE SUCCINATE:ORAL:CAPSULE, DELAYED ACTION:MG	ORAL	66.78MG ORAL CAPSULE, DELAYED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
NA	HYPROMELLOSE ACETATE SUCCINATE:ORAL:CAPSULE, DELAYED RELEASE:mg	ORAL	51.8mg ORAL CAPSULE, DELAYED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
NA	HYPROMELLOSE ACETATE SUCCINATE:ORAL:CAPSULE, EXTENDED RELEASE:mg	ORAL	49.36mg ORAL CAPSULE, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
NA	HYPROMELLOSE ACETATE SUCCINATE:ORAL:GRANULE:mg	ORAL	45.8mg ORAL GRANULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
NA	HYPROMELLOSE ACETATE SUCCINATE:ORAL:TABLET:MG	ORAL	560MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
NA	HYPROMELLOSE ACETATE SUCCINATE:ORAL:TABLET, DELAYED ACTION:MG	ORAL	50.4MG ORAL TABLET, DELAYED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
NA	HYPROMELLOSE ACETATE SUCCINATE:ORAL:TABLET, DELAYED RELEASE:MG	ORAL	325MG ORAL TABLET, DELAYED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
NA	HYPROMELLOSE ACETATE SUCCINATE:ORAL:TABLET, EXTENDED RELEASE:NA	ORAL	ORAL TABLET, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
NA	HYPROMELLOSE PHTHALATE:ORAL:CAPSULE:MG	ORAL	69.3MG ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
NA	HYPROMELLOSE PHTHALATE:ORAL:CAPSULE, COATED PELLETS:MG	ORAL	13.26MG ORAL CAPSULE, COATED PELLETS	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
NA	HYPROMELLOSE PHTHALATE:ORAL:CAPSULE, DELAYED ACTION:mg	ORAL	65.1mg ORAL CAPSULE, DELAYED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
NA	HYPROMELLOSE PHTHALATE:ORAL:CAPSULE, DELAYED RELEASE:MG	ORAL	30MG ORAL CAPSULE, DELAYED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
NA	HYPROMELLOSE PHTHALATE:ORAL:CAPSULE, ENTERIC COATED PELLETS:MG	ORAL	144.51MG ORAL CAPSULE, ENTERIC COATED PELLETS	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
NA	HYPROMELLOSE PHTHALATE:ORAL:CAPSULE, EXTENDED RELEASE:MG	ORAL	46.66MG ORAL CAPSULE, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
NA	HYPROMELLOSE PHTHALATE:ORAL:CAPSULE, SUSTAINED ACTION:MG	ORAL	19.63MG ORAL CAPSULE, SUSTAINED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
NA	HYPROMELLOSE PHTHALATE:ORAL:GRANULE, FOR SUSPENSION:MG	ORAL	302.4MG ORAL GRANULE, FOR SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
NA	HYPROMELLOSE PHTHALATE:ORAL:TABLET:MG	ORAL	104.4MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
NA	HYPROMELLOSE PHTHALATE:ORAL:TABLET, DELAYED ACTION:MG	ORAL	45.36MG ORAL TABLET, DELAYED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
NA	HYPROMELLOSE PHTHALATE:ORAL:TABLET, DELAYED ACTION, ENTERIC COATED:MG	ORAL	44.57MG ORAL TABLET, DELAYED ACTION, ENTERIC COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
NA	HYPROMELLOSE PHTHALATE:ORAL:TABLET, DELAYED RELEASE:MG	ORAL	70.71MG ORAL TABLET, DELAYED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
NA	HYPROMELLOSE PHTHALATE:ORAL:TABLET, ENTERIC COATED PARTICLES:MG	ORAL	119.4MG ORAL TABLET, ENTERIC COATED PARTICLES	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
NA	HYPROMELLOSE PHTHALATE:ORAL:TABLET, EXTENDED RELEASE:MG	ORAL	25.68MG ORAL TABLET, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
NA	HYPROMELLOSE PHTHALATE:ORAL:TABLET, ORALLY DISINTEGRATING:MG	ORAL	47MG ORAL TABLET, ORALLY DISINTEGRATING	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
NA	INK BLACK 2271:ORAL:CAPSULE:NA	ORAL	ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=I
NA	INK BLACK 2271:ORAL:TABLET, SUSTAINED ACTION:NA	ORAL	ORAL TABLET, SUSTAINED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=I
NA	INK BLACK A-10464:ORAL:TABLET, SUSTAINED ACTION:NA	ORAL	ORAL TABLET, SUSTAINED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=I
NA	INK BLACK A-10527:ORAL:TABLET, REPEAT ACTION:MG	ORAL	0.19MG ORAL TABLET, REPEAT ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=I
NA	INK BLACK A-10527:ORAL:TABLET, SUSTAINED ACTION:NA	ORAL	ORAL TABLET, SUSTAINED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=I
NA	INK BLACK FGE-1386:ORAL:CAPSULE:NA	ORAL	ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=I
NA	INK BLACK FGE-1386:ORAL:TABLET:NA	ORAL	ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=I
NA	INK BLACK SW-9007:ORAL:TABLET:MG	ORAL	0.09MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=I
NA	INK BLACK SW-9007:ORAL:TABLET, ENTERIC COATED PARTICLES:NA	ORAL	ORAL TABLET, ENTERIC COATED PARTICLES	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=I
NA	INK BLACK SW-9007:ORAL:TABLET, FILM COATED:MG	ORAL	0.09MG ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=I
NA	INK BLACK SW-9008:NASAL:POWDER, FOR INHALATION:NA	NASAL	NASAL POWDER, FOR INHALATION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=I
NA	INK BLACK SW-9008:ORAL:CAPSULE, DELAYED ACTION:NA	ORAL	ORAL CAPSULE, DELAYED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=I
NA	INK BLACK SW-9008:ORAL:CAPSULE, DELAYED RELEASE:NA	ORAL	ORAL CAPSULE, DELAYED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=I
NA	INK BLACK SW-9008:ORAL:CAPSULE, EXTENDED RELEASE:MG	ORAL	0.1MG ORAL CAPSULE, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=I
NA	INK BLACK SW-9008:ORAL:CAPSULE, HARD GELATIN:NA	ORAL	ORAL CAPSULE, HARD GELATIN	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=I
NA	INK BLACK SW-9008:ORAL:CAPSULE, SUSTAINED ACTION:NA	ORAL	ORAL CAPSULE, SUSTAINED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=I
NA	INK BLACK SW-9008:ORAL:TABLET, SUSTAINED ACTION, FILM COATED:NA	ORAL	ORAL TABLET, SUSTAINED ACTION, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=I
NA	INK BLACK SW-9009:ORAL:CAPSULE:NA	ORAL	ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=I
NA	INK BLACK SW-9009:ORAL:CAPSULE, EXTENDED RELEASE:NA	ORAL	ORAL CAPSULE, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=I
NA	INK BLACK SW-9009:ORAL:CAPSULE, HARD GELATIN:NA	ORAL	ORAL CAPSULE, HARD GELATIN	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=I
NA	INK BLACK SW-9009:ORAL:CAPSULE, SUSTAINED ACTION:NA	ORAL	ORAL CAPSULE, SUSTAINED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=I
NA	INK BLUE AND YELLOW IMPRINT GG-823:ORAL:CAPSULE:NA	ORAL	ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=I
NA	INK BLUE TEK PRINT SB-6029:ORAL:CAPSULE:NA	ORAL	ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=I
NA	INK BLUE TEK PRINT SB-6029:ORAL:TABLET, SUSTAINED ACTION:MG	ORAL	0.2MG ORAL TABLET, SUSTAINED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=I
NA	INK BLUE TEKPRINT SB-6018:ORAL:CAPSULE:MG	ORAL	63.31MG ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=I
NA	INK BLUE VIDEOJET V496-D:BUCCAL:FILM:NA	BUCCAL	BUCCAL FILM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=I
NA	INK DARK YELLOW AND YELLOW IMPRINT GG-824:ORAL:CAPSULE:NA	ORAL	ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=I
NA	INK EDIBLE BLACK:ORAL:CAPSULE:MG	ORAL	0.25MG ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=I
NA	INK EDIBLE BLACK:ORAL:TABLET:NA	ORAL	ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=I
NA	INK EDIBLE BLACK:ORAL:TABLET, COATED:MG	ORAL	0.4MG ORAL TABLET, COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=I
NA	INK EDIBLE BLACK:ORAL:TABLET, EXTENDED RELEASE:NA	ORAL	ORAL TABLET, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=I
NA	INK EDIBLE BLACK:ORAL:TABLET, SUSTAINED ACTION:MG	ORAL	1MG ORAL TABLET, SUSTAINED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=I
NA	INK EDIBLE BLUE:ORAL:CAPSULE:MG	ORAL	1MG ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=I
NA	INK EDIBLE BLUE:ORAL:TABLET:NA	ORAL	ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=I
NA	INK EDIBLE BLUE:ORAL:TABLET, COATED:MG	ORAL	0.036MG ORAL TABLET, COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=I
NA	INK EDIBLE BLUE:ORAL:TABLET, FILM COATED:NA	ORAL	ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=I
NA	INK EDIBLE BROWN:ORAL:TABLET, COATED:MG	ORAL	0.036MG ORAL TABLET, COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=I
NA	INK EDIBLE BROWN:ORAL:TABLET, FILM COATED:NA	ORAL	ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=I
NA	INK EDIBLE BROWN:ORAL:TABLET, SUSTAINED ACTION:NA	ORAL	ORAL TABLET, SUSTAINED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=I
NA	INK EDIBLE GRAY:ORAL:CAPSULE:NA	ORAL	ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=I
NA	INK EDIBLE ORANGE:ORAL:TABLET, SUSTAINED ACTION:NA	ORAL	ORAL TABLET, SUSTAINED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=I
NA	INK EDIBLE PINK:ORAL:TABLET, SUSTAINED ACTION:NA	ORAL	ORAL TABLET, SUSTAINED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=I
NA	INK EDIBLE RED:ORAL:CAPSULE:NA	ORAL	ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=I
NA	INK EDIBLE RED:ORAL:CAPSULE, SOFT GELATIN:NA	ORAL	ORAL CAPSULE, SOFT GELATIN	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=I
NA	INK EDIBLE RED:ORAL:TABLET, COATED:NA	ORAL	ORAL TABLET, COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=I
NA	INK EDIBLE RED:ORAL:TABLET, DELAYED ACTION, ENTERIC COATED:NA	ORAL	ORAL TABLET, DELAYED ACTION, ENTERIC COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=I
NA	INK EDIBLE RED A-8032:ORAL:TABLET, SUSTAINED ACTION:NA	ORAL	ORAL TABLET, SUSTAINED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=I
NA	INK EDIBLE WHITE:ORAL:CAPSULE:MG	ORAL	0.001MG ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=I
NA	INK EDIBLE WHITE:ORAL:TABLET:NA	ORAL	ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=I
NA	INK EDIBLE WHITE:ORAL:TABLET, COATED:NA	ORAL	ORAL TABLET, COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=I
NA	INK EDIBLE WHITE:ORAL:TABLET, FILM COATED:NA	ORAL	ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=I
NA	INK EDIBLE WHITE:ORAL:TABLET, REPEAT ACTION:MG	ORAL	0.19MG ORAL TABLET, REPEAT ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=I
NA	INK FINE BLACK 2202C:ORAL:TABLET:NA	ORAL	ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=I
NA	INK FINE BLACK 2212:ORAL:TABLET:NA	ORAL	ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=I
NA	INK FINE BLACK 2212:ORAL:TABLET, EXTENDED RELEASE:NA	ORAL	ORAL TABLET, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=I
NA	INK FINE BLACK 2212:ORAL:TABLET, SUSTAINED ACTION:NA	ORAL	ORAL TABLET, SUSTAINED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=I
NA	INK GREEN A-10629:ORAL:TABLET, SUSTAINED ACTION:NA	ORAL	ORAL TABLET, SUSTAINED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=I
NA	INK ORANGE AND YELLOW IMPRINT GG-822:ORAL:CAPSULE:NA	ORAL	ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=I
NA	INK RED A-8032:ORAL:CAPSULE:NA	ORAL	ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=I
NA	INK RED A-8032:ORAL:CAPSULE, SUSTAINED ACTION:NA	ORAL	ORAL CAPSULE, SUSTAINED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=I
NA	INK RED A-8032:ORAL:TABLET, COATED:NA	ORAL	ORAL TABLET, COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=I
NA	INK S-1-7085:ORAL:CAPSULE:NA	ORAL	ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=I
NA	INK THINNER:ORAL:TABLET, EXTENDED RELEASE:MG	ORAL	0.018MG ORAL TABLET, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=I
NA	INK WHITE A-8154:ORAL:CAPSULE:MG	ORAL	0.8MG ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=I
NA	INK WHITE A-8154:ORAL:TABLET:NA	ORAL	ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=I
NA	INK WHITE A-8154:ORAL:TABLET, FILM COATED:NA	ORAL	ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=I
NA	INK WHITE SB-0007P:ORAL:CAPSULE:NA	ORAL	ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=I
NA	INK WHITE SB-0007P:ORAL:CAPSULE, SUSTAINED ACTION:NA	ORAL	ORAL CAPSULE, SUSTAINED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=I
NA	INK WHITE SW-0012:ORAL:CAPSULE, DELAYED RELEASE:	ORAL	ORAL CAPSULE, DELAYED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=I
NA	INK WHITE SW-0012:ORAL:CAPSULE, HARD GELATIN:NA	ORAL	ORAL CAPSULE, HARD GELATIN	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=I
NA	INK/POLYETHYLENE TEREPHTHALATE/ALUMINUM/POLYETHYLENE/SODIUM POLYMETHACRYLATE/ETHYLENE VINYLACETATE COPOLYMER:TRANSDERMAL:FILM, CONTROLLED RELEASE:MG/PATCH	TRANSDERMAL	264MG/PATCH TRANSDERMAL FILM, CONTROLLED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=I
NA	LANETH:TOPICAL:SOLUTION:%W/W	TOPICAL	0.5%W/W TOPICAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
NA	LANOLIN NONIONIC DERIVATIVES:OPHTHALMIC:OINTMENT:NA	OPHTHALMIC	OPHTHALMIC OINTMENT	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
NA	LANOLIN, ETHOXYLATED:TOPICAL:SOLUTION:%W/W	TOPICAL	1.5%W/W TOPICAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
NA	LAURETH SULFATE:TOPICAL:SPONGE:NA	TOPICAL	TOPICAL SPONGE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
NA	LAUROYL POLYOXYLGLYCERIDES:ORAL:CAPSULE:MG	ORAL	16.58MG ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
NA	LAUROYL POLYOXYLGLYCERIDES:ORAL:CAPSULE, HARD GELATIN:MG	ORAL	218MG ORAL CAPSULE, HARD GELATIN	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
NA	LAUROYL POLYOXYLGLYCERIDES:ORAL:TABLET:MG	ORAL	0.15MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
NA	LAUROYL POLYOXYLGLYCERIDES:ORAL:TABLET, FILM COATED:MG	ORAL	0.15MG ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
NA	LECITHIN:INTRAMUSCULAR:INJECTION:%	INTRAMUSCULAR	1.92% INTRAMUSCULAR INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
NA	LECITHIN:INTRAMUSCULAR:POWDER, FOR INJECTION SOLUTION:NA	INTRAMUSCULAR	INTRAMUSCULAR POWDER, FOR INJECTION SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
NA	LECITHIN:ORAL:BAR, CHEWABLE:NA	ORAL	ORAL BAR, CHEWABLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
NA	LECITHIN:ORAL:CAPSULE:MG	ORAL	15MG ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
NA	LECITHIN:ORAL:CAPSULE, COATED, SOFT GELATIN:MG	ORAL	1MG ORAL CAPSULE, COATED, SOFT GELATIN	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
NA	LECITHIN:ORAL:CAPSULE, SOFT GELATIN:MG	ORAL	1.8MG ORAL CAPSULE, SOFT GELATIN	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
NA	LECITHIN:ORAL:CAPSULE, SOFT GELATIN LIQUID-FILLED:MG	ORAL	325MG ORAL CAPSULE, SOFT GELATIN LIQUID-FILLED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
NA	LECITHIN:ORAL:CAPSULE, SUSTAINED ACTION:NA	ORAL	ORAL CAPSULE, SUSTAINED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
NA	LECITHIN:ORAL:POWDER, FOR SUSPENSION:MG/5ML	ORAL	167MG/5ML ORAL POWDER, FOR SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
NA	LECITHIN:ORAL:SUSPENSION:MG/1ML	ORAL	110MG/1ML ORAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
NA	LECITHIN:ORAL:TABLET:mg	ORAL	10mg ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
NA	LECITHIN:ORAL:TABLET, DELAYED RELEASE:MG	ORAL	0.16MG ORAL TABLET, DELAYED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
NA	LECITHIN:ORAL:TABLET, EXTENDED RELEASE:MG	ORAL	10MG ORAL TABLET, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
NA	LECITHIN:RECTAL:SUPPOSITORY:MG	RECTAL	6.5MG RECTAL SUPPOSITORY	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
NA	LECITHIN:TOPICAL:GEL:%W/W	TOPICAL	1%W/W TOPICAL GEL	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
NA	LECITHIN:TOPICAL:SOLUTION:%W/W	TOPICAL	1.4%W/W TOPICAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
NA	LECITHIN:VAGINAL:EMULSION, CREAM:%	VAGINAL	1% VAGINAL EMULSION, CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
NA	LECITHIN, DISATURATED:ORAL:TABLET, EXTENDED RELEASE:MG	ORAL	1.05MG ORAL TABLET, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
NA	LUDIPRESS:ORAL:TABLET:MG	ORAL	80MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
NA	LUDIPRESS:ORAL:TABLET, EXTENDED RELEASE:MG	ORAL	57.69MG ORAL TABLET, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
NA	MEDICAL ANTIFOAM EMULSION C:ORAL:SUSPENSION:%	ORAL	0.016% ORAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
NA	MEDICAL ANTIFOAM EMULSION C:ORAL:TABLET:MG	ORAL	1MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
NA	MEDICAL ANTIFORM A-F EMULSION:TOPICAL:EMULSION, CREAM:%W/W	TOPICAL	0.1%W/W TOPICAL EMULSION, CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
NA	METHACRYLIC ACID COPOLYMER:ORAL:CAPSULE:MG	ORAL	81.75MG ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
NA	METHACRYLIC ACID COPOLYMER:ORAL:CAPSULE, COATED:MG	ORAL	62.1MG ORAL CAPSULE, COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
NA	METHACRYLIC ACID COPOLYMER:ORAL:CAPSULE, DELAYED ACTION:MG	ORAL	158.69MG ORAL CAPSULE, DELAYED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
NA	METHACRYLIC ACID COPOLYMER:ORAL:CAPSULE, DELAYED ACTION, ENTERIC COATED:NA	ORAL	ORAL CAPSULE, DELAYED ACTION, ENTERIC COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
NA	METHACRYLIC ACID COPOLYMER:ORAL:CAPSULE, DELAYED RELEASE:MG	ORAL	180.046MG ORAL CAPSULE, DELAYED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
NA	METHACRYLIC ACID COPOLYMER:ORAL:CAPSULE, ENTERIC COATED PELLETS:MG	ORAL	95.88MG ORAL CAPSULE, ENTERIC COATED PELLETS	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
NA	METHACRYLIC ACID COPOLYMER:ORAL:CAPSULE, EXTENDED RELEASE:MG	ORAL	27.35MG ORAL CAPSULE, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
NA	METHACRYLIC ACID COPOLYMER:ORAL:CAPSULE, SUSTAINED ACTION:MG	ORAL	44.6MG ORAL CAPSULE, SUSTAINED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
NA	METHACRYLIC ACID COPOLYMER:ORAL:GRANULE, ENTERIC COATED:MG	ORAL	430.8MG ORAL GRANULE, ENTERIC COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
NA	METHACRYLIC ACID COPOLYMER:ORAL:SUSPENSION, SUSTAINED ACTION:MG/206.84 MG	ORAL	69.48MG/206.84 MG ORAL SUSPENSION, SUSTAINED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
NA	METHACRYLIC ACID COPOLYMER:ORAL:TABLET:MG	ORAL	86.7MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
NA	METHACRYLIC ACID COPOLYMER:ORAL:TABLET, DELAYED ACTION:MG	ORAL	160MG ORAL TABLET, DELAYED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
NA	METHACRYLIC ACID COPOLYMER:ORAL:TABLET, DELAYED ACTION, ENTERIC COATED:MG	ORAL	54MG ORAL TABLET, DELAYED ACTION, ENTERIC COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
NA	METHACRYLIC ACID COPOLYMER:ORAL:TABLET, EXTENDED RELEASE:MG	ORAL	105MG ORAL TABLET, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
NA	METHACRYLIC ACID COPOLYMER:ORAL:TABLET, ORALLY DISINTEGRATING:MG	ORAL	4MG ORAL TABLET, ORALLY DISINTEGRATING	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
NA	METHACRYLIC ACID COPOLYMER:ORAL:TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE:MG	ORAL	106.89MG ORAL TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
NA	METHACRYLIC ACID COPOLYMER:ORAL:TABLET, SUSTAINED ACTION:MG	ORAL	35MG ORAL TABLET, SUSTAINED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
NA	METHACRYLIC ACID COPOLYMER:ORAL:TABLET, SUSTAINED ACTION, COATED:MG	ORAL	24.6MG ORAL TABLET, SUSTAINED ACTION, COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
NA	METHYL ACRYLATE - METHYL METHACRYLATE:ORAL:TABLET, SUSTAINED ACTION:NA	ORAL	ORAL TABLET, SUSTAINED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
NA	METHYLCELLULOSE, UNSPECIFIED:BUCCAL/SUBLINGUAL:TABLET:MG	BUCCAL/SUBLINGUAL	4MG BUCCAL/SUBLINGUAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
NA	METHYLCELLULOSE, UNSPECIFIED:INTRA-ARTICULAR:INJECTION:%	INTRA-ARTICULAR	0.1% INTRA-ARTICULAR INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
NA	METHYLCELLULOSE, UNSPECIFIED:INTRALESIONAL:INJECTION:NA	INTRALESIONAL	INTRALESIONAL INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
NA	METHYLCELLULOSE, UNSPECIFIED:INTRAMUSCULAR:INJECTION:%W/V	INTRAMUSCULAR	0.1%W/V INTRAMUSCULAR INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
NA	METHYLCELLULOSE, UNSPECIFIED:INTRAMUSCULAR:INJECTION, SUSTAINED ACTION:NA	INTRAMUSCULAR	INTRAMUSCULAR INJECTION, SUSTAINED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
NA	METHYLCELLULOSE, UNSPECIFIED:INTRASYNOVIAL:INJECTION:NA	INTRASYNOVIAL	INTRASYNOVIAL INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
NA	METHYLCELLULOSE, UNSPECIFIED:NASAL:GEL:NA	NASAL	NASAL GEL	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
NA	METHYLCELLULOSE, UNSPECIFIED:OPHTHALMIC:DROPS:%	OPHTHALMIC	0.05% OPHTHALMIC DROPS	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
NA	METHYLCELLULOSE, UNSPECIFIED:OPHTHALMIC:POWDER, FOR SUSPENSION:NA	OPHTHALMIC	OPHTHALMIC POWDER, FOR SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
NA	METHYLCELLULOSE, UNSPECIFIED:OPHTHALMIC:SOLUTION:%	OPHTHALMIC	0.16% OPHTHALMIC SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
NA	METHYLCELLULOSE, UNSPECIFIED:OPHTHALMIC:SOLUTION, DROPS:%	OPHTHALMIC	0.5% OPHTHALMIC SOLUTION, DROPS	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
NA	METHYLCELLULOSE, UNSPECIFIED:OPHTHALMIC:SUSPENSION:NA	OPHTHALMIC	OPHTHALMIC SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
NA	METHYLCELLULOSE, UNSPECIFIED:ORAL:CAPSULE:MG	ORAL	13.5MG ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
NA	METHYLCELLULOSE, UNSPECIFIED:ORAL:CAPSULE, DELAYED ACTION:MG	ORAL	92.6MG ORAL CAPSULE, DELAYED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
NA	METHYLCELLULOSE, UNSPECIFIED:ORAL:CAPSULE, EXTENDED RELEASE:MG	ORAL	18.2MG ORAL CAPSULE, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
NA	METHYLCELLULOSE, UNSPECIFIED:ORAL:CAPSULE, SUSTAINED ACTION:MG	ORAL	3.2MG ORAL CAPSULE, SUSTAINED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
NA	METHYLCELLULOSE, UNSPECIFIED:ORAL:EMULSION:NA	ORAL	ORAL EMULSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
NA	METHYLCELLULOSE, UNSPECIFIED:ORAL:POWDER, FOR SUSPENSION:MG/5ML	ORAL	59.5MG/5ML ORAL POWDER, FOR SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
NA	METHYLCELLULOSE, UNSPECIFIED:ORAL:SYRUP:NA	ORAL	ORAL SYRUP	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
NA	METHYLCELLULOSE, UNSPECIFIED:ORAL:TABLET:MG	ORAL	183.6MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
NA	METHYLCELLULOSE, UNSPECIFIED:ORAL:TABLET (IMMED./COMP. RELEASE), UNCOATED, CHEWABLE:MG	ORAL	50MG ORAL TABLET (IMMED./COMP. RELEASE), UNCOATED, CHEWABLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
NA	METHYLCELLULOSE, UNSPECIFIED:ORAL:TABLET, COATED:MG	ORAL	138.3MG ORAL TABLET, COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
NA	METHYLCELLULOSE, UNSPECIFIED:ORAL:TABLET, FILM COATED:MG	ORAL	21MG ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
NA	METHYLCELLULOSE, UNSPECIFIED:ORAL:TABLET, SUSTAINED ACTION:MG	ORAL	96MG ORAL TABLET, SUSTAINED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
NA	METHYLCELLULOSE, UNSPECIFIED:SOFT TISSUE:INJECTION:NA	SOFT TISSUE	SOFT TISSUE INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
NA	METHYLCELLULOSE, UNSPECIFIED:SUBLINGUAL:TABLET:NA	SUBLINGUAL	SUBLINGUAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
NA	METHYLCELLULOSE, UNSPECIFIED:TOPICAL:EMULSION:NA	TOPICAL	TOPICAL EMULSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
NA	METHYLCELLULOSE, UNSPECIFIED:TOPICAL:EMULSION, AEROSOL FOAM:%W/W	TOPICAL	0.11%W/W TOPICAL EMULSION, AEROSOL FOAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
NA	METHYLCELLULOSE, UNSPECIFIED:TOPICAL:EMULSION, CREAM:%W/W	TOPICAL	1.3%W/W TOPICAL EMULSION, CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
NA	METHYLCELLULOSE, UNSPECIFIED:TOPICAL:LOTION:%W/W	TOPICAL	1.5%W/W TOPICAL LOTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
NA	METHYLCELLULOSE, UNSPECIFIED:TOPICAL:SPONGE:NA	TOPICAL	TOPICAL SPONGE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
NA	METHYLCELLULOSE, UNSPECIFIED:VAGINAL:TABLET:MG	VAGINAL	102MG VAGINAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
NA	MONO AND DIGLYCERIDE:ORAL:CAPSULE:MG	ORAL	369.47MG ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
NA	MONO AND DIGLYCERIDE:ORAL:CAPSULE, DELAYED ACTION:MG	ORAL	4MG ORAL CAPSULE, DELAYED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
NA	MONO AND DIGLYCERIDE:ORAL:CAPSULE, DELAYED RELEASE:MG	ORAL	11.4MG ORAL CAPSULE, DELAYED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
NA	MONO AND DIGLYCERIDE:TOPICAL:CREAM:%W/W	TOPICAL	13%W/W TOPICAL CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
NA	MONO AND DIGLYCERIDE:TOPICAL:CREAM, AUGMENTED:%W/W	TOPICAL	1%W/W TOPICAL CREAM, AUGMENTED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
NA	MONO AND DIGLYCERIDE:TOPICAL:EMULSION, AEROSOL FOAM:%W/W	TOPICAL	0.54%W/W TOPICAL EMULSION, AEROSOL FOAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
NA	MONOGLYCERIDES:ORAL:CAPSULE, SUSTAINED ACTION:NA	ORAL	ORAL CAPSULE, SUSTAINED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
NA	MONOGLYCERIDES:ORAL:TABLET:MG	ORAL	56.66MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
NA	MONOGLYCERIDES:ORAL:TABLET, EXTENDED RELEASE:MG	ORAL	16.4MG ORAL TABLET, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
NA	MULTISTEROL EXTRACT:TOPICAL:EMULSION, CREAM:NA	TOPICAL	TOPICAL EMULSION, CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
NA	MYVACET TYPE 5-00:ORAL:TABLET, COATED:MG	ORAL	0.31MG ORAL TABLET, COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
NA	MYVACET TYPE 5-00:ORAL:TABLET, SUSTAINED ACTION:MG	ORAL	0.04MG ORAL TABLET, SUSTAINED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
NA	OIL, HYDROGENATED:ORAL:TABLET, CONTROLLED RELEASE:MG	ORAL	6.65MG ORAL TABLET, CONTROLLED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPACOAT NA4108 BLUE:ORAL:TABLET, FILM COATED:NA	ORAL	ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPACOAT NA4711 LAVENDER:ORAL:TABLET, FILM COATED:NA	ORAL	ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPACOAT NA7013 CLEAR:ORAL:TABLET, SUSTAINED ACTION:MG	ORAL	4MG ORAL TABLET, SUSTAINED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPACODE A-10450 BLACK:ORAL:CAPSULE:NA	ORAL	ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPACODE A-10450 BLACK:ORAL:TABLET:NA	ORAL	ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPACODE A-10450 BLACK:ORAL:TABLET, FILM COATED:NA	ORAL	ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPACODE A-10509 BLACK:ORAL:CAPSULE:NA	ORAL	ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPACODE NS-78-17502 GRAY:ORAL:TABLET, FILM COATED:NA	ORAL	ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPACODE NS-78-17821 WB BLACK:ORAL:CAPSULE:NA	ORAL	ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPACODE NS-78-17821 WB BLACK:ORAL:TABLET, CONTROLLED RELEASE:MG	ORAL	0.02MG ORAL TABLET, CONTROLLED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPACODE NS-78-17821 WB BLACK:ORAL:TABLET, EXTENDED RELEASE:NA	ORAL	ORAL TABLET, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPACODE NS-78-8000 BLACK:ORAL:TABLET:MG	ORAL	0.3MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPACODE NS-78-8000 BLACK:ORAL:TABLET, COATED:MG	ORAL	0.1MG ORAL TABLET, COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPACODE NS-78-8000 BLACK:ORAL:TABLET, FILM COATED:MG	ORAL	0.1MG ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPACODE NS-78-8000 BLACK:ORAL:TABLET, SUSTAINED ACTION:MG	ORAL	0.2MG ORAL TABLET, SUSTAINED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPACODE NS-78-8001:ORAL:CAPSULE, SOFT GELATIN:NA	ORAL	ORAL CAPSULE, SOFT GELATIN	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPACODE NS-78-8001:ORAL:TABLET, EXTENDED RELEASE:NA	ORAL	ORAL TABLET, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPACODE NS-78-8001:ORAL:TABLET, SUSTAINED ACTION:NA	ORAL	ORAL TABLET, SUSTAINED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPACODE NS-78-8001:ORAL:TABLET, SUSTAINED ACTION, FILM COATED:NA	ORAL	ORAL TABLET, SUSTAINED ACTION, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPACODE NSP-78-17734 BLACK:ORAL:CAPSULE, SOFT GELATIN:NA	ORAL	ORAL CAPSULE, SOFT GELATIN	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPACODE S-1-13001 ORANGE:ORAL:TABLET:MG	ORAL	0.03MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPACODE S-1-16507:ORAL:TABLET, DELAYED ACTION, ENTERIC COATED:NA	ORAL	ORAL TABLET, DELAYED ACTION, ENTERIC COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPACODE S-1-1666 RED:ORAL:CAPSULE:MG	ORAL	1MG ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPACODE S-1-1666 RED:ORAL:TABLET, DELAYED ACTION, ENTERIC COATED:NA	ORAL	ORAL TABLET, DELAYED ACTION, ENTERIC COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPACODE S-1-1666 RED:ORAL:TABLET, FILM COATED:NA	ORAL	ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPACODE S-1-1666 RED:ORAL:TABLET, SUSTAINED ACTION, COATED:NA	ORAL	ORAL TABLET, SUSTAINED ACTION, COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPACODE S-1-1666-M RED:ORAL:TABLET, FILM COATED:NA	ORAL	ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPACODE S-1-17734 BLACK:ORAL:TABLET:NA	ORAL	ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPACODE S-1-17734 BLACK:ORAL:TABLET, FILM COATED:NA	ORAL	ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPACODE S-1-17762 BLACK:ORAL:CAPSULE:NA	ORAL	ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPACODE S-1-17762 BLACK:ORAL:CAPSULE, HARD GELATIN:NA	ORAL	ORAL CAPSULE, HARD GELATIN	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPACODE S-1-17822 BLACK:ORAL:CAPSULE:MG	ORAL	0.003MG ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPACODE S-1-17822 BLACK:ORAL:CAPSULE, DELAYED ACTION:MG	ORAL	0.042MG ORAL CAPSULE, DELAYED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPACODE S-1-17822 BLACK:ORAL:CAPSULE, EXTENDED RELEASE:MG	ORAL	0.023MG ORAL CAPSULE, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPACODE S-1-17822 BLACK:ORAL:TABLET, EXTENDED RELEASE:NA	ORAL	ORAL TABLET, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPACODE S-1-17823 BLACK:ORAL:CAPSULE:MG	ORAL	0.97MG ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPACODE S-1-17823 BLACK:ORAL:CAPSULE, EXTENDED RELEASE:NA	ORAL	ORAL CAPSULE, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPACODE S-1-17823 BLACK:ORAL:CAPSULE, SOFT GELATIN LIQUID-FILLED:NA	ORAL	ORAL CAPSULE, SOFT GELATIN LIQUID-FILLED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPACODE S-1-17823 BLACK:ORAL:TABLET, DELAYED ACTION:NA	ORAL	ORAL TABLET, DELAYED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPACODE S-1-17823 BLACK:ORAL:TABLET, DELAYED RELEASE:NA	ORAL	ORAL TABLET, DELAYED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPACODE S-1-17823 BLACK:ORAL:TABLET, EXTENDED RELEASE:NA	ORAL	ORAL TABLET, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPACODE S-1-27794 BLACK:ORAL:TABLET:NA	ORAL	ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPACODE S-1-27794 BLACK:ORAL:TABLET, EXTENDED RELEASE:NA	ORAL	ORAL TABLET, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPACODE S-1-3110 GREEN:ORAL:TABLET:NA	ORAL	ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPACODE S-1-4160 BLUE:ORAL:CAPSULE:NA	ORAL	ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPACODE S-1-4160 BLUE:ORAL:CAPSULE, SUSTAINED ACTION:NA	ORAL	ORAL CAPSULE, SUSTAINED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPACODE S-1-4160 BLUE:ORAL:TABLET:NA	ORAL	ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPACODE S-1-4160 BLUE:ORAL:TABLET, SUSTAINED ACTION:NA	ORAL	ORAL TABLET, SUSTAINED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPACODE S-1-4160 BLUE:ORAL:TABLET, SUSTAINED RELEASE, FILM COATED:NA	ORAL	ORAL TABLET, SUSTAINED RELEASE, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPACODE S-1-7020:ORAL:CAPSULE:NA	ORAL	ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPACODE S-1-7077:ORAL:CAPSULE:NA	ORAL	ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPACODE S-1-7078:ORAL:CAPSULE:NA	ORAL	ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPACODE S-1-7085 WHITE:ORAL:CAPSULE:MG	ORAL	0.033MG ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPACODE S-1-7085 WHITE:ORAL:CAPSULE, EXTENDED RELEASE:NA	ORAL	ORAL CAPSULE, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPACODE S-1-7085 WHITE:ORAL:CAPSULE, SUSTAINED ACTION:MG	ORAL	0.028MG ORAL CAPSULE, SUSTAINED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPACODE S-1-800HV BLACK:ORAL:CAPSULE:NA	ORAL	ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPACODE S-1-800HV BLACK:ORAL:TABLET, CONTROLLED RELEASE:NA	ORAL	ORAL TABLET, CONTROLLED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPACODE S-1-8025 BLACK:ORAL:CAPSULE:NA	ORAL	ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPACODE S-1-8025 BLACK:ORAL:CAPSULE, COATED, SOFT GELATIN:NA	ORAL	ORAL CAPSULE, COATED, SOFT GELATIN	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPACODE S-1-8025 BLACK:ORAL:TABLET:NA	ORAL	ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPACODE S-1-8081 BLACK:ORAL:TABLET:NA	ORAL	ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPACODE S-1-8090 BLACK:ORAL:CAPSULE:MG	ORAL	0.05MG ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPACODE S-1-8090 BLACK:ORAL:CAPSULE, SOFT GELATIN:NA	ORAL	ORAL CAPSULE, SOFT GELATIN	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPACODE S-1-8090 BLACK:ORAL:TABLET:MG	ORAL	0.6MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPACODE S-1-8090 BLACK:ORAL:TABLET, COATED:MG	ORAL	2.4MG ORAL TABLET, COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPACODE S-1-8090 BLACK:ORAL:TABLET, EXTENDED RELEASE:NA	ORAL	ORAL TABLET, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPACODE S-1-8090 BLACK:ORAL:TABLET, FILM COATED:MG	ORAL	0.7MG ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPACODE S-1-8090 BLACK:ORAL:TABLET, SUSTAINED ACTION, FILM COATED:NA	ORAL	ORAL TABLET, SUSTAINED ACTION, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPACODE S-1-8092 BLACK:ORAL:CAPSULE:NA	ORAL	ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPACODE S-1-8093 BLACK:ORAL:TABLET:NA	ORAL	ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPACODE S-1-8093 BLACK:ORAL:TABLET, FILM COATED:NA	ORAL	ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPACODE S-1-8095:ORAL:TABLET, FILM COATED:MG	ORAL	0.7MG ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPACODE S-1-8100-HV BLACK:ORAL:CAPSULE:NA	ORAL	ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPACODE S-1-8100-HV BLACK:ORAL:TABLET:MG	ORAL	0.09MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPACODE S-1-8100-HV BLACK:ORAL:TABLET, SUGAR COATED:MG	ORAL	0.09MG ORAL TABLET, SUGAR COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPACODE S-1-8100-HV BLACK:ORAL:TABLET, SUSTAINED ACTION:NA	ORAL	ORAL TABLET, SUSTAINED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPACODE S-1-8105 BLACK:ORAL:TABLET:NA	ORAL	ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPACODE S-1-8105 BLACK:ORAL:TABLET, FILM COATED:NA	ORAL	ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPACODE S-1-8106 BLACK:ORAL:TABLET:NA	ORAL	ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPACODE S-1-8106 BLACK:ORAL:TABLET, COATED:NA	ORAL	ORAL TABLET, COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPACODE S-1-8106 BLACK:ORAL:TABLET, SUSTAINED ACTION:NA	ORAL	ORAL TABLET, SUSTAINED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPACODE S-1-8109 BLACK:ORAL:TABLET, SUSTAINED ACTION, COATED:NA	ORAL	ORAL TABLET, SUSTAINED ACTION, COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPACODE S-1-8110 BLACK:ORAL:CAPSULE:NA	ORAL	ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPACODE S-1-8114 BLACK:ORAL:CAPSULE:MG	ORAL	0.033MG ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPACODE S-1-8114 BLACK:ORAL:CAPSULE, ENTERIC COATED PELLETS:NA	ORAL	ORAL CAPSULE, ENTERIC COATED PELLETS	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPACODE S-1-8114 BLACK:ORAL:CAPSULE, EXTENDED RELEASE:MG	ORAL	0.13MG ORAL CAPSULE, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPACODE S-1-8114 BLACK:ORAL:CAPSULE, HARD GELATIN:NA	ORAL	ORAL CAPSULE, HARD GELATIN	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPACODE S-1-8114 BLACK:ORAL:CAPSULE, SUSTAINED ACTION:MG	ORAL	0.033MG ORAL CAPSULE, SUSTAINED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPACODE S-1-8115 BLACK:ORAL:CAPSULE:MG	ORAL	0.041MG ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPACODE S-1-8115 BLACK:ORAL:CAPSULE, EXTENDED RELEASE:MG	ORAL	0.042MG ORAL CAPSULE, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPACODE S-1-8115 BLACK:ORAL:CAPSULE, HARD GELATIN:NA	ORAL	ORAL CAPSULE, HARD GELATIN	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPACODE S-1-8115 BLACK:ORAL:CAPSULE, SUSTAINED ACTION:MG	ORAL	0.023MG ORAL CAPSULE, SUSTAINED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPACODE S-1-8152HV BLACK:ORAL:CAPSULE:NA	ORAL	ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPACODE S-1-8152HV BLACK:ORAL:TABLET:NA	ORAL	ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPACODE S-1-8152HV BLACK:ORAL:TABLET, DELAYED ACTION, ENTERIC COATED:NA	ORAL	ORAL TABLET, DELAYED ACTION, ENTERIC COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPACODE S-1-8152HV BLACK:ORAL:TABLET, DELAYED RELEASE:NA	ORAL	ORAL TABLET, DELAYED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPACODE S-1-8152HV BLACK:ORAL:TABLET, EXTENDED RELEASE:NA	ORAL	ORAL TABLET, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPACODE S-1-9032:ORAL:TABLET:MG	ORAL	9MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPACODE S-19-7014 WHITE:ORAL:CAPSULE, SUSTAINED ACTION:MG	ORAL	0.5MG ORAL CAPSULE, SUSTAINED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPACODE SB-4028 GREEN:ORAL:CAPSULE:NA	ORAL	ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPACODE WB NS-78-17715 BLACK:ORAL:TABLET:MG	ORAL	0.09MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPACODE WB NS-78-17715 BLACK:ORAL:TABLET, CONTROLLED RELEASE:NA	ORAL	ORAL TABLET, CONTROLLED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPACODE WB NS-78-17715 BLACK:ORAL:TABLET, EXTENDED RELEASE:NA	ORAL	ORAL TABLET, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPACODE WB NS-78-17715 BLACK:ORAL:TABLET, SUSTAINED ACTION:NA	ORAL	ORAL TABLET, SUSTAINED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPACODE WB NSP-78-18022 WHITE:ORAL:CAPSULE, SOFT GELATIN LIQUID-FILLED:NA	ORAL	ORAL CAPSULE, SOFT GELATIN LIQUID-FILLED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY 00B57513 GREY:ORAL:TABLET:MG	ORAL	15MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY 00B57513 GREY:ORAL:TABLET, EXTENDED RELEASE:MG	ORAL	4.5MG ORAL TABLET, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY 00F17713 BLACK:ORAL:TABLET, DELAYED ACTION:NA	ORAL	ORAL TABLET, DELAYED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY 00F17713 BLACK:ORAL:TABLET, DELAYED RELEASE:NA	ORAL	ORAL TABLET, DELAYED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY 02B14941 PINK:ORAL:TABLET:MG	ORAL	6MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY 02G22555 YELLOW:ORAL:TABLET, FILM COATED:MG	ORAL	5MG ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY 02G24523 PINK:ORAL:TABLET, FILM COATED:MG	ORAL	8MG ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY 02G28619 WHITE:ORAL:TABLET:MG	ORAL	3MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY 02G28619 WHITE:ORAL:TABLET, FILM COATED:MG	ORAL	20MG ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY 02G59011 CLEAR:ORAL:CAPSULE, DELAYED ACTION:MG	ORAL	30MG ORAL CAPSULE, DELAYED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY 03B11434 GREEN:ORAL:TABLET:MG	ORAL	32.38MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY 03B12878 YELLOW:ORAL:TABLET, CONTROLLED RELEASE:MG	ORAL	13MG ORAL TABLET, CONTROLLED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY 03B12878 YELLOW:ORAL:TABLET, EXTENDED RELEASE:MG	ORAL	12MG ORAL TABLET, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY 03B14424 PINK:ORAL:TABLET, EXTENDED RELEASE:MG	ORAL	15MG ORAL TABLET, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY 03B14436 PINK:ORAL:TABLET:MG	ORAL	12MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY 03B17426 BEIGE:ORAL:TABLET, EXTENDED RELEASE:MG	ORAL	18MG ORAL TABLET, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY 03B17495 BEIGE:ORAL:TABLET:MG	ORAL	18MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY 03B17495 BEIGE:ORAL:TABLET (IMMED./COMP. RELEASE), FILM COATED:MG	ORAL	2.4MG ORAL TABLET (IMMED./COMP. RELEASE), FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY 03B20024 PURPLE:ORAL:TABLET, EXTENDED RELEASE:MG	ORAL	12.8MG ORAL TABLET, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY 03B20024 PURPLE:ORAL:TABLET, FILM COATED:MG	ORAL	3MG ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY 03B20556 BLUE:ORAL:TABLET, EXTENDED RELEASE:MG	ORAL	10.2MG ORAL TABLET, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY 03B21517 GREEN:ORAL:TABLET, EXTENDED RELEASE:MG	ORAL	7.7MG ORAL TABLET, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY 03B23523 ORANGE:ORAL:TABLET, EXTENDED RELEASE:MG	ORAL	10.2MG ORAL TABLET, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY 03B28796 WHITE:ORAL:TABLET:MG	ORAL	21MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY 03B28796 WHITE:ORAL:TABLET, EXTENDED RELEASE:MG	ORAL	32MG ORAL TABLET, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY 03B32034 YELLOW:ORAL:TABLET, EXTENDED RELEASE:MG	ORAL	7.7MG ORAL TABLET, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY 03B54955 PINK:ORAL:TABLET:MG	ORAL	18.5MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY 03B56518 BROWN:ORAL:TABLET:MG	ORAL	3MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY 03B56518 BROWN:ORAL:TABLET, FILM COATED:MG	ORAL	4MG ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY 03B57519 GREY:ORAL:TABLET:MG	ORAL	6.6MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY 03B57519 GREY:ORAL:TABLET, EXTENDED RELEASE:MG	ORAL	12.07MG ORAL TABLET, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY 03B58902 WHITE:ORAL:TABLET:MG	ORAL	10.5MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY 03B68903 WHITE:ORAL:TABLET:MG	ORAL	6MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY 03B80829 BLUE:ORAL:TABLET:MG	ORAL	3MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY 03B80829 BLUE:ORAL:TABLET, EXTENDED RELEASE:MG	ORAL	4.5MG ORAL TABLET, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY 03B82849 YELLOW:ORAL:TABLET:MG	ORAL	20MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY 03B86636 BROWN:ORAL:TABLET, DELAYED ACTION:MG	ORAL	9MG ORAL TABLET, DELAYED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY 03B86636 BROWN:ORAL:TABLET, DELAYED ACTION, ENTERIC COATED:MG	ORAL	6MG ORAL TABLET, DELAYED ACTION, ENTERIC COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY 03B93363 ORANGE:ORAL:TABLET:MG	ORAL	3.3MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY 03F51681 GREEN:ORAL:TABLET, EXTENDED RELEASE:MG	ORAL	6.83MG ORAL TABLET, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY 03F58741 WHITE:ORAL:TABLET, EXTENDED RELEASE:MG	ORAL	6.83MG ORAL TABLET, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY 03F58991 WHITE:ORAL:TABLET:MG	ORAL	21.3MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY 03F59016 CLEAR:ORAL:TABLET:MG	ORAL	24MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY 03F59016 CLEAR:ORAL:TABLET, EXTENDED RELEASE:MG	ORAL	4MG ORAL TABLET, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY 03F82726 YELLOW:ORAL:TABLET:MG	ORAL	7MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY 03F82726 YELLOW:ORAL:TABLET, FILM COATED:MG	ORAL	7MG ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY 03F86776 BROWN:ORAL:TABLET, EXTENDED RELEASE:MG	ORAL	6.83MG ORAL TABLET, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY 03F86990 BROWN:ORAL:TABLET, EXTENDED RELEASE:MG	ORAL	6.83MG ORAL TABLET, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY 03G24389 PINK:ORAL:TABLET:MG	ORAL	20MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY 03G24389 PINK:ORAL:TABLET, FILM COATED:MG	ORAL	9MG ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY 03K19229 CLEAR:ORAL:TABLET:MG	ORAL	4.3MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY 03K19229 CLEAR:ORAL:TABLET, DELAYED ACTION:MG	ORAL	8.4MG ORAL TABLET, DELAYED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY 04F58804 WHITE:ORAL:TABLET:MG	ORAL	16MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY 04F58804 WHITE:ORAL:TABLET, FILM COATED:MG	ORAL	10MG ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY 05B10446 PURPLE:ORAL:TABLET:MG	ORAL	16MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY 05B10446 PURPLE:ORAL:TABLET, COATED:MG	ORAL	23MG ORAL TABLET, COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY 05B10457 PURPLE:ORAL:TABLET:MG	ORAL	16MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY 05B10457 PURPLE:ORAL:TABLET, EXTENDED RELEASE:MG	ORAL	4.5MG ORAL TABLET, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY 05B11552 GREEN:ORAL:TABLET, EXTENDED RELEASE:MG	ORAL	3.64MG ORAL TABLET, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY 05B17055 TAN:ORAL:TABLET:MG	ORAL	4MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY 05B17055 TAN:ORAL:TABLET, FILM COATED:MG	ORAL	5MG ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY 12B58900 WHITE:ORAL:TABLET:MG	ORAL	20MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY 13B58802 WHITE:ORAL:TABLET:MG	ORAL	30MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY 13B58802 WHITE:ORAL:TABLET, FILM COATED:MG	ORAL	7.5MG ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY 13F58866 WHITE:ORAL:TABLET:MG	ORAL	3MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY 15B50612 BLUE:ORAL:TABLET:MG	ORAL	3.5MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY 20A54901 PINK:ORAL:TABLET:MG	ORAL	24MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY 20A58806 WHITE:ORAL:TABLET:MG	ORAL	11.25MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY 20A59015 CLEAR:ORAL:TABLET, FILM COATED:MG	ORAL	30MG ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY 20B50135 PURPLE:ORAL:TABLET, FILM COATED:MG	ORAL	25MG ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY 20H52619 YELLOW:ORAL:TABLET:NA	ORAL	ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY 32K14834 PINK:ORAL:TABLET, FILM COATED:MG	ORAL	16.8MG ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY 33G24690 PINK:ORAL:TABLET, FILM COATED:MG	ORAL	20MG ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY 40L14278 PINK:ORAL:TABLET, FILM COATED:MG	ORAL	33.6MG ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY 85F19250 CLEAR:ORAL:CAPSULE, EXTENDED RELEASE:MG	ORAL	7.65MG ORAL CAPSULE, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY 85F19250 CLEAR:ORAL:TABLET, EXTENDED RELEASE:MG	ORAL	29.1MG ORAL TABLET, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY 85G93096 ORANGE:ORAL:TABLET:MG	ORAL	4.53MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY AMB 80W68912 WHITE:ORAL:TABLET:MG	ORAL	16.24MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY AMB 80W68912 WHITE:ORAL:TABLET, EXTENDED RELEASE:MG	ORAL	36MG ORAL TABLET, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY AMB OY-B-28920 WHITE:ORAL:TABLET:MG	ORAL	21.74MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY AMB OY-B-28920 WHITE:ORAL:TABLET, FILM COATED:MG	ORAL	24MG ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY II 31F22071 YELLOW:ORAL:TABLET, DELAYED RELEASE:MG	ORAL	2MG ORAL TABLET, DELAYED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY II 31F23111 ORANGE:ORAL:TABLET:MG	ORAL	8MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY II 31F24128 PINK:ORAL:TABLET:MG	ORAL	16MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY II 31F58914 WHITE:ORAL:TABLET:MG	ORAL	23MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY II 31K84972 PINK:ORAL:TABLET:MG	ORAL	29.1MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY II 32B10817 BLUE:ORAL:TABLET:MG	ORAL	6MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY II 32K12968 YELLOW:ORAL:TABLET, CONTROLLED RELEASE:MG	ORAL	8.88MG ORAL TABLET, CONTROLLED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY II 32K13357 ORANGE:ORAL:TABLET:MG	ORAL	5MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY II 32K14833 PINK:ORAL:TABLET:MG	ORAL	21MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY II 32K14833 PINK:ORAL:TABLET, FILM COATED:MG	ORAL	5MG ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY II 33G28707 WHITE:ORAL:TABLET:MG	ORAL	31.25MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY II 33G28707 WHITE:ORAL:TABLET, EXTENDED RELEASE:MG	ORAL	30MG ORAL TABLET, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY II 39B18529 WHITE:ORAL:TABLET, EXTENDED RELEASE:MG	ORAL	11.6MG ORAL TABLET, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY II 40014876 PINK:ORAL:TABLET, FILM COATED:MG	ORAL	4.93MG ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY II 40C10881 BLUE:ORAL:TABLET:NA	ORAL	ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY II 40C10881 BLUE:ORAL:TABLET, FILM COATED:MG	ORAL	6MG ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY II 40C13396 ORANGE:ORAL:TABLET, FILM COATED:MG	ORAL	6MG ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY II 40C18303 WHITE:ORAL:TABLET:NA	ORAL	ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY II 40C18303 WHITE:ORAL:TABLET, FILM COATED:MG	ORAL	6MG ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY II 40L11438 GREEN:ORAL:TABLET, EXTENDED RELEASE:MG	ORAL	24MG ORAL TABLET, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY II 40L11438 GREEN:ORAL:TABLET, SUSTAINED ACTION:MG	ORAL	40MG ORAL TABLET, SUSTAINED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY II 40L11588 GREEN:ORAL:TABLET:MG	ORAL	26.25MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY II 40L12979 YELLOW:ORAL:TABLET, EXTENDED RELEASE:MG	ORAL	14.32MG ORAL TABLET, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY II 40L12979 YELLOW:ORAL:TABLET, SUSTAINED ACTION, COATED:MG	ORAL	30MG ORAL TABLET, SUSTAINED ACTION, COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY II 40L13950 ORANGE:ORAL:TABLET:MG	ORAL	9MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY II 40L14190 PINK:ORAL:TABLET:MG	ORAL	24.5MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY II 40L17427 BEIGE:ORAL:TABLET:MG	ORAL	9MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY II 49B13460 ORANGE:ORAL:TABLET:MG	ORAL	19MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY II 85F10919 BLUE:ORAL:TABLET:MG	ORAL	24MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY II 85F10919 BLUE:ORAL:TABLET (IMMED./COMP. RELEASE), FILM COATED:MG	ORAL	1.65MG ORAL TABLET (IMMED./COMP. RELEASE), FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY II 85F13980 ORANGE:ORAL:TABLET:MG	ORAL	18MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY II 85F140024 PINK:ORAL:TABLET (IMMED./COMP. RELEASE), FILM COATED:MG	ORAL	13.2MG ORAL TABLET (IMMED./COMP. RELEASE), FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY II 85F14452 PINK:ORAL:TABLET:MG	ORAL	9MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY II 85F15642 RED:ORAL:TABLET:MG	ORAL	16.8MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY II 85F15642 RED:ORAL:TABLET, EXTENDED RELEASE:MG	ORAL	10.5MG ORAL TABLET, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY II 85F18378 WHITE:ORAL:CAPSULE:MG	ORAL	25.31MG ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY II 85F18378 WHITE:ORAL:TABLET:MG	ORAL	50MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY II 85F18378 WHITE:ORAL:TABLET, EXTENDED RELEASE:MG	ORAL	31.6MG ORAL TABLET, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY II 85F18422 WHITE:ORAL:TABLET:MG	ORAL	40MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY II 85F18422 WHITE:ORAL:TABLET (IMMED./COMP. RELEASE), FILM COATED:MG	ORAL	8MG ORAL TABLET (IMMED./COMP. RELEASE), FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY II 85F18422 WHITE:ORAL:TABLET, CONTROLLED RELEASE:MG	ORAL	7.85MG ORAL TABLET, CONTROLLED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY II 85F18422 WHITE:ORAL:TABLET, EXTENDED RELEASE:MG	ORAL	36MG ORAL TABLET, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY II 85F18422 WHITE:ORAL:TABLET, FILM COATED:MG	ORAL	55MG ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY II 85F18442 WHITE:ORAL:TABLET:MG	ORAL	33MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY II 85F18442 WHITE:ORAL:TABLET, EXTENDED RELEASE:MG	ORAL	25MG ORAL TABLET, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY II 85F22055 YELLOW:ORAL:TABLET:MG	ORAL	18MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY II 85F23470 PINK:ORAL:TABLET:MG	ORAL	7.5MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY II 85F24033 PINK:ORAL:TABLET:MG	ORAL	7.5MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY II 85F24307 PINK:ORAL:TABLET:MG	ORAL	35MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY II 85F28751 WHITE:ORAL:TABLET:MG	ORAL	24MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY II 85F32782 YELLOW:ORAL:TABLET:MG	ORAL	15MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY II 85F34610 PINK:ORAL:TABLET:MG	ORAL	4MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY II 85F92008 YELLOW:ORAL:TABLET, SUSTAINED ACTION, FILM COATED:MG	ORAL	35.55MG ORAL TABLET, SUSTAINED ACTION, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY II 85F92716 YELLOW:ORAL:TABLET, EXTENDED RELEASE:MG	ORAL	9MG ORAL TABLET, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY II 85F93042 ORANGE:ORAL:TABLET:MG	ORAL	5.4MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY II 85F93042 ORANGE:ORAL:TABLET, FILM COATED, EXTENDED RELEASE:MG	ORAL	33.34MG ORAL TABLET, FILM COATED, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY II 85F94552 PINK:ORAL:TABLET, EXTENDED RELEASE:MG	ORAL	10.5MG ORAL TABLET, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY II 85F99126 BLUE:ORAL:TABLET, EXTENDED RELEASE:MG	ORAL	12MG ORAL TABLET, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY II OY-L-28900 WHITE:ORAL:TABLET:MG	ORAL	16MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY II OY-L-28900 WHITE:ORAL:TABLET, FILM COATED:MG	ORAL	5.55MG ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY II Y-19-19054 CLEAR:ORAL:CAPSULE, COATED PELLETS:MG	ORAL	1.23MG ORAL CAPSULE, COATED PELLETS	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY II Y-19-19054 CLEAR:ORAL:CAPSULE, SUSTAINED ACTION:MG	ORAL	45.14MG ORAL CAPSULE, SUSTAINED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY II Y-19-7483 CLEAR:ORAL:CAPSULE, SUSTAINED ACTION:MG	ORAL	5.74MG ORAL CAPSULE, SUSTAINED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY II Y-19-7483 CLEAR:ORAL:TABLET:MG	ORAL	5.6MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY II Y-19-7483 CLEAR:ORAL:TABLET, DELAYED ACTION:MG	ORAL	12MG ORAL TABLET, DELAYED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY II Y-19-7483 CLEAR:ORAL:TABLET, EXTENDED RELEASE:MG	ORAL	10.6MG ORAL TABLET, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY II Y-19-7483 CLEAR:ORAL:TABLET, FILM COATED:MG	ORAL	34MG ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY II Y-19-7483 CLEAR:ORAL:TABLET, SUSTAINED ACTION:MG	ORAL	35MG ORAL TABLET, SUSTAINED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY II Y-22-10274 LAVENDER:ORAL:TABLET, FILM COATED:MG	ORAL	8MG ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY II Y-22-10274 LAVENDER:ORAL:TABLET, SUSTAINED ACTION:MG	ORAL	14.95MG ORAL TABLET, SUSTAINED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY II Y-22-10508 BLUE:ORAL:TABLET:MG	ORAL	14.83MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY II Y-22-10519 BLUE:ORAL:TABLET:MG	ORAL	29.66MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY II Y-22-10538 BLUE:ORAL:TABLET:MG	ORAL	90MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY II Y-22-10764 BLUE:ORAL:TABLET:MG	ORAL	15MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY II Y-22-12553 YELLOW:ORAL:TABLET:MG	ORAL	40.36MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY II Y-22-12664 YELLOW:ORAL:TABLET:MG	ORAL	86.4MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY II Y-22-12664 YELLOW:ORAL:TABLET, EXTENDED RELEASE:MG	ORAL	12MG ORAL TABLET, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY II Y-22-12718 YELLOW:ORAL:TABLET, SUSTAINED ACTION:MG	ORAL	15MG ORAL TABLET, SUSTAINED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY II Y-22-12720 PALE YELLOW:ORAL:TABLET, EXTENDED RELEASE:MG	ORAL	14MG ORAL TABLET, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY II Y-22-12720 PALE YELLOW:ORAL:TABLET, FILM COATED:MG	ORAL	4.2MG ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY II Y-22-12780 YELLOW:ORAL:TABLET, FILM COATED:MG	ORAL	10.85MG ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY II Y-22-13061 ORANGE:ORAL:TABLET:MG	ORAL	24MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY II Y-22-13061 ORANGE:ORAL:TABLET, COATED:MG	ORAL	13MG ORAL TABLET, COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY II Y-22-13061 ORANGE:ORAL:TABLET, EXTENDED RELEASE:MG	ORAL	13MG ORAL TABLET, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY II Y-22-13061 ORANGE:ORAL:TABLET, FILM COATED:MG	ORAL	6.5MG ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY II Y-22-13061 ORANGE:ORAL:TABLET, SUSTAINED ACTION:MG	ORAL	40MG ORAL TABLET, SUSTAINED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY II Y-22-13083 ORANGE:ORAL:TABLET:MG	ORAL	15MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY II Y-22-13167 ORANGE:ORAL:TABLET:MG	ORAL	25MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY II Y-22-13167 ORANGE:ORAL:TABLET, SUSTAINED ACTION, FILM COATED:MG	ORAL	17.19MG ORAL TABLET, SUSTAINED ACTION, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY II Y-22-13577 FLESH:ORAL:TABLET, FILM COATED:MG	ORAL	9.3MG ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY II Y-22-13577 FLESH:ORAL:TABLET, SUSTAINED ACTION:MG	ORAL	15MG ORAL TABLET, SUSTAINED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY II Y-22-13603 ORANGE:ORAL:TABLET:MG	ORAL	67.5MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY II Y-22-13603 ORANGE:ORAL:TABLET, EXTENDED RELEASE:MG	ORAL	23.7MG ORAL TABLET, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY II Y-22-15061:ORAL:TABLET, SUSTAINED ACTION, COATED:MG	ORAL	17.1MG ORAL TABLET, SUSTAINED ACTION, COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY II Y-22-17025 BEIGE:ORAL:TABLET:MG	ORAL	30MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY II Y-22-17025 BEIGE:ORAL:TABLET, DELAYED ACTION, ENTERIC COATED:MG	ORAL	5MG ORAL TABLET, DELAYED ACTION, ENTERIC COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY II Y-22-17025 BEIGE:ORAL:TABLET, EXTENDED RELEASE:MG	ORAL	12MG ORAL TABLET, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY II Y-22-17025 BEIGE:ORAL:TABLET, FILM COATED:MG	ORAL	15MG ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY II Y-22-17515 GRAY:ORAL:TABLET, SUSTAINED RELEASE, FILM COATED:MG	ORAL	40MG ORAL TABLET, SUSTAINED RELEASE, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY II Y-22-7719 WHITE:ORAL:CAPSULE:MG	ORAL	4.44MG ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY II Y-22-7719 WHITE:ORAL:TABLET:MG	ORAL	113.3MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY II Y-22-7719 WHITE:ORAL:TABLET (IMMED./COMP. RELEASE), FILM COATED:MG	ORAL	5MG ORAL TABLET (IMMED./COMP. RELEASE), FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY II Y-22-7719 WHITE:ORAL:TABLET, COATED:NA	ORAL	ORAL TABLET, COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY II Y-22-7719 WHITE:ORAL:TABLET, EXTENDED RELEASE:MG	ORAL	32MG ORAL TABLET, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY II Y-22-7719 WHITE:ORAL:TABLET, FILM COATED:MG	ORAL	40MG ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY II Y-22-7719 WHITE:ORAL:TABLET, SUSTAINED ACTION:MG	ORAL	9MG ORAL TABLET, SUSTAINED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY II Y-22-7719 WHITE:ORAL:TABLET, SUSTAINED ACTION, COATED:MG	ORAL	18.15MG ORAL TABLET, SUSTAINED ACTION, COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY II Y-30-10671A BLUE:ORAL:TABLET:NA	ORAL	ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY II Y-30-12736A YELLOW:ORAL:TABLET:MG	ORAL	21MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY II Y-30-12736A YELLOW:ORAL:TABLET, FILM COATED:MG	ORAL	18MG ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY II Y-30-12736A YELLOW:ORAL:TABLET, SUSTAINED ACTION, FILM COATED:MG	ORAL	7MG ORAL TABLET, SUSTAINED ACTION, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY II Y-30-12737A YELLOW:ORAL:TABLET:MG	ORAL	6MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY II Y-30-12737A YELLOW:ORAL:TABLET, FILM COATED:MG	ORAL	5MG ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY II Y-30-14758 PINK:ORAL:TABLET, SUSTAINED ACTION, FILM COATED:MG	ORAL	7.99MG ORAL TABLET, SUSTAINED ACTION, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY II Y-30-17295A TAN:ORAL:TABLET:MG	ORAL	6MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY II Y-30-17296A BEIGE:ORAL:TABLET:MG	ORAL	6MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY II Y-30-17528 GRAY:ORAL:TABLET:MG	ORAL	25MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY II Y-30-18037 WHITE:ORAL:TABLET, CONTROLLED RELEASE:MG	ORAL	38MG ORAL TABLET, CONTROLLED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY II Y-30-18037 WHITE:ORAL:TABLET, EXTENDED RELEASE:MG	ORAL	33MG ORAL TABLET, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY II Y-30-18037 WHITE:ORAL:TABLET, FILM COATED:MG	ORAL	43.2MG ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY II Y-30-18037 WHITE:ORAL:TABLET, SUSTAINED RELEASE, FILM COATED:MG	ORAL	26MG ORAL TABLET, SUSTAINED RELEASE, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY II YS-1-19025A CLEAR:ORAL:CAPSULE, EXTENDED RELEASE:MG	ORAL	23.89MG ORAL CAPSULE, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY II YS-1-19025A CLEAR:ORAL:GRANULE, FOR ORAL SUSPENSION:MG	ORAL	7.08MG ORAL GRANULE, FOR ORAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY II YS-1-19025A CLEAR:ORAL:TABLET, COATED:MG	ORAL	9.9MG ORAL TABLET, COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY II YS-1-19025A CLEAR:ORAL:TABLET, EXTENDED RELEASE:MG	ORAL	42.8MG ORAL TABLET, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY II YS-1-7006 CLEAR:ORAL:CAPSULE, EXTENDED RELEASE:MG	ORAL	2.6MG ORAL CAPSULE, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY II YS-1-7006 CLEAR:ORAL:TABLET, COATED:MG	ORAL	4.8MG ORAL TABLET, COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY II YS-1-7006 CLEAR:ORAL:TABLET, EXTENDED RELEASE:MG	ORAL	2.25MG ORAL TABLET, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY II YS-1-7006 CLEAR:ORAL:TABLET, FILM COATED:MG	ORAL	1.5MG ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY II YS-1-7006 CLEAR:ORAL:TABLET, SUSTAINED ACTION:MG	ORAL	13MG ORAL TABLET, SUSTAINED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY II YS-22-18096 WHITE:ORAL:TABLET:MG	ORAL	28.5MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY II YS-30-12788A YELLOW:ORAL:TABLET, CONTROLLED RELEASE:MG	ORAL	18MG ORAL TABLET, CONTROLLED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY II YS-30-17265A BEIGE:ORAL:TABLET:MG	ORAL	6MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY II YS-30-17265A BEIGE:ORAL:TABLET, SUSTAINED ACTION:MG	ORAL	9MG ORAL TABLET, SUSTAINED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY II YS-30-18105 WHITE:ORAL:TABLET:MG	ORAL	36MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY II YS-30-18105 WHITE:ORAL:TABLET, EXTENDED RELEASE:MG	ORAL	24MG ORAL TABLET, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY II YS-30-18105 WHITE:ORAL:TABLET, FILM COATED:MG	ORAL	13.2MG ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY II YS-30-18105 WHITE:ORAL:TABLET, SUSTAINED ACTION:MG	ORAL	9MG ORAL TABLET, SUSTAINED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY OY-27301 BUTTERSCOTCH:ORAL:TABLET, DELAYED ACTION, ENTERIC COATED:MG	ORAL	6MG ORAL TABLET, DELAYED ACTION, ENTERIC COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY OY-29020 CLEAR:ORAL:CAPSULE:MG	ORAL	2.08MG ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY OY-29020 CLEAR:ORAL:TABLET, EXTENDED RELEASE:MG	ORAL	2.25MG ORAL TABLET, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY OY-52945 YELLOW:ORAL:TABLET:MG	ORAL	33.75MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY OY-52945 YELLOW:ORAL:TABLET, DELAYED ACTION, ENTERIC COATED:MG	ORAL	4.38MG ORAL TABLET, DELAYED ACTION, ENTERIC COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY OY-58900 WHITE:ORAL:TABLET:MG	ORAL	31.8MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY OY-58900 WHITE:ORAL:TABLET, FILM COATED:MG	ORAL	16.25MG ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY OY-7300 WHITE:ORAL:TABLET:MG	ORAL	35MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY OY-B-28920 WHITE:ORAL:TABLET:MG	ORAL	28MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY OY-B-28920 WHITE:ORAL:TABLET, FILM COATED:MG	ORAL	14MG ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY OY-B-32830:ORAL:TABLET:MG	ORAL	28MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY OY-GM-28900:ORAL:TABLET:MG	ORAL	3MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY OY-GM-28900:ORAL:TABLET, FILM COATED:MG	ORAL	26MG ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY OY-L-34836 PINK:ORAL:TABLET:MG	ORAL	24MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY OY-LS-23018 ORANGE:ORAL:TABLET, DELAYED ACTION, ENTERIC COATED:MG	ORAL	6MG ORAL TABLET, DELAYED ACTION, ENTERIC COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY OY-LS-23018 ORANGE:ORAL:TABLET, EXTENDED RELEASE:MG	ORAL	4.5MG ORAL TABLET, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY OY-LS-28908 WHITE:ORAL:TABLET:MG	ORAL	7.5MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY OY-LS-28914 WHITE:ORAL:TABLET, FILM COATED:MG	ORAL	15MG ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY OY-LS-37200 BUFF:ORAL:TABLET:MG	ORAL	10.05MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY OY-S-22815 YELLOW:ORAL:TABLET:NA	ORAL	ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY OY-S-26529 RED:ORAL:TABLET:NA	ORAL	ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY OY-S-28833 WHITE:ORAL:TABLET:NA	ORAL	ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY OY-S-28849 WHITE:ORAL:TABLET:MG	ORAL	5MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY OY-S-28924 WHITE:ORAL:TABLET:MG	ORAL	13MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY OY-S-28924 WHITE:ORAL:TABLET, FILM COATED:MG	ORAL	16.52MG ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY OY-S-29019 CLEAR:ORAL:TABLET, SUSTAINED ACTION:MG	ORAL	30MG ORAL TABLET, SUSTAINED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY OY-S-30913 BLUE:ORAL:TABLET, COATED:MG	ORAL	6.6MG ORAL TABLET, COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY OY-S-30913 BLUE:ORAL:TABLET, FILM COATED:MG	ORAL	35.4MG ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY OY-S-33016 ORANGE:ORAL:TABLET, COATED:MG	ORAL	3.3MG ORAL TABLET, COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY OY-S-54902 PINK:ORAL:TABLET, FILM COATED:MG	ORAL	5.24MG ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY OY-S-7322 WHITE:ORAL:TABLET, FILM COATED:MG	ORAL	9MG ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY OY-S-7399 WHITE:ORAL:TABLET:MG	ORAL	19MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY OY-S-7399 WHITE:ORAL:TABLET, FILM COATED:MG	ORAL	10MG ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY OY-S-9476 BROWN:ORAL:TABLET, SUSTAINED ACTION:MG	ORAL	28.26MG ORAL TABLET, SUSTAINED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY OY-SR-34907:ORAL:TABLET:MG	ORAL	12.25MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY Y-1-3211 GREEN:ORAL:TABLET:NA	ORAL	ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY Y-1-3211 GREEN:ORAL:TABLET, SUSTAINED ACTION:NA	ORAL	ORAL TABLET, SUSTAINED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY Y-1-4205 BLUE:ORAL:TABLET, FILM COATED:MG	ORAL	12.2MG ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY Y-1-4234 BLUE:ORAL:TABLET:MG	ORAL	3.06MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY Y-1-7000 WHITE:ORAL:TABLET:MG	ORAL	36.27MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY Y-1-7000 WHITE:ORAL:TABLET (IMMED./COMP. RELEASE), FILM COATED:NA	ORAL	ORAL TABLET (IMMED./COMP. RELEASE), FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY Y-1-7000 WHITE:ORAL:TABLET, COATED:MG	ORAL	3MG ORAL TABLET, COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY Y-1-7000 WHITE:ORAL:TABLET, CONTROLLED RELEASE:NA	ORAL	ORAL TABLET, CONTROLLED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY Y-1-7000 WHITE:ORAL:TABLET, EXTENDED RELEASE:MG	ORAL	11.1MG ORAL TABLET, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY Y-1-7000 WHITE:ORAL:TABLET, FILM COATED:MG	ORAL	27MG ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY Y-1-7000B WHITE:ORAL:TABLET:MG	ORAL	10MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY Y-1-7000H WHITE:ORAL:TABLET:MG	ORAL	39MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY Y-1-7000H WHITE:ORAL:TABLET (IMMED./COMP. RELEASE), FILM COATED:MG	ORAL	19.5MG ORAL TABLET (IMMED./COMP. RELEASE), FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY Y-1-7000H WHITE:ORAL:TABLET, FILM COATED:MG	ORAL	28MG ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY Y-1-7006 BLUE:ORAL:TABLET:MG	ORAL	3.23MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY Y-30-14565 PINK:ORAL:TABLET (IMMED./COMP. RELEASE), FILM COATED:MG	ORAL	18MG ORAL TABLET (IMMED./COMP. RELEASE), FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY Y-30-14565 PINK:ORAL:TABLET, FILM COATED:MG	ORAL	36MG ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY Y-30-17267 BEIGE:ORAL:TABLET, FILM COATED:NA	ORAL	ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY Y-5-10272A LAVENDER:ORAL:TABLET:NA	ORAL	ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY Y-5-1727 RED:ORAL:TABLET:MG	ORAL	7MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY Y-5-2028 YELLOW:ORAL:TABLET:NA	ORAL	ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY Y-5-2042 YELLOW:ORAL:TABLET:NA	ORAL	ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY Y-5-2042 YELLOW:ORAL:TABLET, SUSTAINED ACTION:MG	ORAL	18.3MG ORAL TABLET, SUSTAINED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY Y-5-2394 ORANGE:ORAL:TABLET:MG	ORAL	31.5MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY Y-5-2450 ORANGE:ORAL:TABLET:MG	ORAL	20.9MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY Y-5-2450 ORANGE:ORAL:TABLET, FILM COATED:MG	ORAL	7.88MG ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY Y-5-2646 BEIGE:ORAL:TABLET:MG	ORAL	14MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY Y-5-4270 BLUE:ORAL:TABLET:MG	ORAL	14MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY Y-5-4295 BLUE:ORAL:TABLET, SUSTAINED ACTION, COATED:MG	ORAL	17.11MG ORAL TABLET, SUSTAINED ACTION, COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY Y-5-6308:ORAL:TABLET:NA	ORAL	ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY Y-5-7058 WHITE:ORAL:TABLET:MG	ORAL	6MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY Y-5-7058 WHITE:ORAL:TABLET, COATED:MG	ORAL	3MG ORAL TABLET, COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY Y-5-7068 WHITE:ORAL:TABLET:MG	ORAL	120MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY Y-5-7068 WHITE:ORAL:TABLET, COATED:MG	ORAL	21MG ORAL TABLET, COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY Y-5-7068 WHITE:ORAL:TABLET, FILM COATED:MG	ORAL	22.5MG ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY Y-5-7068 WHITE:ORAL:TABLET, SUSTAINED ACTION:MG	ORAL	6MG ORAL TABLET, SUSTAINED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY Y-5-8050 BLACK:ORAL:TABLET:MG	ORAL	7MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY Y-5-9006 BROWN:ORAL:TABLET:NA	ORAL	ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY Y-5-9006 BROWN:ORAL:TABLET, EXTENDED RELEASE:MG	ORAL	15MG ORAL TABLET, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY Y-5-9006 BROWN:ORAL:TABLET, SUSTAINED ACTION:MG	ORAL	15MG ORAL TABLET, SUSTAINED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY Y-5-9020 BROWN:ORAL:TABLET:MG	ORAL	10MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY YELLOW:ORAL:TABLET:MG	ORAL	27MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY YELLOW:ORAL:TABLET (IMMED./COMP. RELEASE), FILM COATED:MG	ORAL	21MG ORAL TABLET (IMMED./COMP. RELEASE), FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY YELLOW:ORAL:TABLET, DELAYED RELEASE:MG	ORAL	4.31MG ORAL TABLET, DELAYED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY YELLOW:ORAL:TABLET, EXTENDED RELEASE:MG	ORAL	14MG ORAL TABLET, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY YELLOW:ORAL:TABLET, FILM COATED:MG	ORAL	8.4MG ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY YS-1-003 WHITE:ORAL:TABLET:MG	ORAL	8MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY YS-1-10525 BLUE:ORAL:TABLET:MG	ORAL	23MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY YS-1-10533A:ORAL:TABLET:MG	ORAL	8.16MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY YS-1-10547A BLUE:ORAL:TABLET:MG	ORAL	44MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY YS-1-10547A BLUE:ORAL:TABLET, FILM COATED:MG	ORAL	35MG ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY YS-1-10690A BLUE:ORAL:TABLET:NA	ORAL	ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY YS-1-11051 GREEN:ORAL:TABLET:MG	ORAL	17.56MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY YS-1-11051 GREEN:ORAL:TABLET, COATED:MG	ORAL	16MG ORAL TABLET, COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY YS-1-11060 GREEN:ORAL:TABLET, FILM COATED:MG	ORAL	10MG ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY YS-1-11234 GREEN:ORAL:TABLET:MG	ORAL	5.89MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY YS-1-1246 PINK:ORAL:TABLET:MG	ORAL	4.3MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY YS-1-1252 PINK:ORAL:TABLET, FILM COATED:MG	ORAL	4.5MG ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY YS-1-12525A YELLOW:ORAL:TABLET:MG	ORAL	19.2MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY YS-1-12525A YELLOW:ORAL:TABLET, FILM COATED:MG	ORAL	5MG ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY YS-1-12526A YELLOW:ORAL:TABLET:MG	ORAL	15MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY YS-1-12526A YELLOW:ORAL:TABLET, COATED:MG	ORAL	7.2MG ORAL TABLET, COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY YS-1-12526A YELLOW:ORAL:TABLET, FILM COATED:MG	ORAL	5MG ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY YS-1-12541 YELLOW:ORAL:TABLET:MG	ORAL	22MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY YS-1-12541 YELLOW:ORAL:TABLET, COATED:MG	ORAL	12MG ORAL TABLET, COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY YS-1-12625 YELLOW:ORAL:TABLET:MG	ORAL	10MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY YS-1-12702A YELLOW:ORAL:TABLET (IMMED./COMP. RELEASE), FILM COATED:MG	ORAL	12.5MG ORAL TABLET (IMMED./COMP. RELEASE), FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY YS-1-12726A YELLOW:ORAL:TABLET:MG	ORAL	4MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY YS-1-12726A YELLOW:ORAL:TABLET (IMMED./COMP. RELEASE), FILM COATED:MG	ORAL	4.8MG ORAL TABLET (IMMED./COMP. RELEASE), FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY YS-1-12732 YELLOW:ORAL:TABLET, FILM COATED:MG	ORAL	20.96MG ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY YS-1-12826 YELLOW:ORAL:TABLET:MG	ORAL	8.1MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY YS-1-13065A ORANGE:ORAL:TABLET:MG	ORAL	41MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY YS-1-13148A ORANGE:ORAL:TABLET:MG	ORAL	10MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY YS-1-13148A ORANGE:ORAL:TABLET, FILM COATED:MG	ORAL	5MG ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY YS-1-13214 ORANGE:ORAL:TABLET, CONTROLLED RELEASE:MG	ORAL	7.68MG ORAL TABLET, CONTROLLED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY YS-1-13591A ORANGE:ORAL:TABLET, FILM COATED:MG	ORAL	9MG ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY YS-1-13664A ORANGE:ORAL:TABLET:MG	ORAL	10.11MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY YS-1-13673A ORANGE:ORAL:TABLET:MG	ORAL	5.09MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY YS-1-13675A ORANGE:ORAL:TABLET:MG	ORAL	5.09MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY YS-1-14012 PINK:ORAL:TABLET:MG	ORAL	5MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY YS-1-14129 PINK:ORAL:CAPSULE, SUSTAINED ACTION:MG	ORAL	9MG ORAL CAPSULE, SUSTAINED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY YS-1-14129 PINK:ORAL:TABLET, FILM COATED:MG	ORAL	19MG ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY YS-1-14142 PINK:ORAL:TABLET, EXTENDED RELEASE:MG	ORAL	16MG ORAL TABLET, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY YS-1-14142 PINK:ORAL:TABLET, SUSTAINED ACTION, FILM COATED:MG	ORAL	16MG ORAL TABLET, SUSTAINED ACTION, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY YS-1-1441G:ORAL:TABLET, FILM COATED:MG	ORAL	8MG ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY YS-1-14518A PINK:ORAL:TABLET:MG	ORAL	4.5MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY YS-1-14518A PINK:ORAL:TABLET, FILM COATED:MG	ORAL	8MG ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY YS-1-14555A PINK:ORAL:TABLET, FILM COATED:MG	ORAL	4MG ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY YS-1-1456G PINK:ORAL:TABLET, COATED:MG	ORAL	10.9MG ORAL TABLET, COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY YS-1-14725 PINK:ORAL:TABLET:MG	ORAL	39MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY YS-1-14779A PINK:ORAL:TABLET:MG	ORAL	18MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY YS-1-14779A PINK:ORAL:TABLET, CONTROLLED RELEASE:MG	ORAL	7.48MG ORAL TABLET, CONTROLLED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY YS-1-15050 RED:ORAL:TABLET:MG	ORAL	6MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY YS-1-1510 PINK:ORAL:TABLET:MG	ORAL	4.2MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY YS-1-1543 PINK:ORAL:TABLET:MG	ORAL	6MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY YS-1-1543 PINK:ORAL:TABLET, FILM COATED:MG	ORAL	4.8MG ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY YS-1-16518A BROWN:ORAL:TABLET:MG	ORAL	16.2MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY YS-1-17169A:ORAL:TABLET:NA	ORAL	ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY YS-1-17180A BEIGE:ORAL:TABLET:MG	ORAL	15MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY YS-1-17209 BEIGE:ORAL:TABLET:MG	ORAL	30MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY YS-1-17222A TAN:ORAL:TABLET (IMMED./COMP. RELEASE), FILM COATED:MG	ORAL	20MG ORAL TABLET (IMMED./COMP. RELEASE), FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY YS-1-1724 RED:ORAL:TABLET:MG	ORAL	18.57MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY YS-1-17274A BEIGE:ORAL:CAPSULE, DELAYED ACTION:MG	ORAL	1.49MG ORAL CAPSULE, DELAYED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY YS-1-17274A BEIGE:ORAL:CAPSULE, SUSTAINED ACTION:MG	ORAL	9.1MG ORAL CAPSULE, SUSTAINED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY YS-1-17307A BUTTERSCOTCH:ORAL:TABLET:MG	ORAL	5.6MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY YS-1-17506A GRAY:ORAL:TABLET:MG	ORAL	15.75MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY YS-1-17506A GRAY:ORAL:TABLET, FILM COATED:MG	ORAL	15MG ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY YS-1-1751G RED:ORAL:TABLET, COATED:MG	ORAL	13.6MG ORAL TABLET, COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY YS-1-1755 GRAY:ORAL:TABLET:MG	ORAL	4.5MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY YS-1-18005 WHITE:ORAL:TABLET:MG	ORAL	5.89MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY YS-1-18027 WHITE:ORAL:TABLET:MG	ORAL	12.6MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY YS-1-18027 WHITE:ORAL:TABLET, FILM COATED:MG	ORAL	16.32MG ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY YS-1-18027A WHITE:ORAL:TABLET:MG	ORAL	21MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY YS-1-18027A WHITE:ORAL:TABLET, FILM COATED:MG	ORAL	5.5MG ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY YS-1-18111 WHITE:ORAL:TABLET:MG	ORAL	20MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY YS-1-18111 WHITE:ORAL:TABLET, FILM COATED:MG	ORAL	32MG ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY YS-1-18177A WHITE:ORAL:TABLET, FILM COATED:MG	ORAL	8.4MG ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY YS-1-18202A WHITE:ORAL:CAPSULE, DELAYED ACTION:MG	ORAL	6.25MG ORAL CAPSULE, DELAYED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY YS-1-18202A WHITE:ORAL:TABLET:MG	ORAL	21MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY YS-1-18229 WHITE:ORAL:TABLET, SUSTAINED ACTION:MG	ORAL	18.09MG ORAL TABLET, SUSTAINED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY YS-1-19025-A CLEAR:ORAL:CAPSULE, SUSTAINED ACTION:MG	ORAL	2.76MG ORAL CAPSULE, SUSTAINED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY YS-1-19025-A CLEAR:ORAL:TABLET:MG	ORAL	7.09MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY YS-1-19025-A CLEAR:ORAL:TABLET, COATED:MG	ORAL	4.45MG ORAL TABLET, COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY YS-1-19025-A CLEAR:ORAL:TABLET, CONTROLLED RELEASE:MG	ORAL	6MG ORAL TABLET, CONTROLLED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY YS-1-19025-A CLEAR:ORAL:TABLET, EXTENDED RELEASE:MG	ORAL	44.7MG ORAL TABLET, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY YS-1-19025-A CLEAR:ORAL:TABLET, FILM COATED:MG	ORAL	1.1MG ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY YS-1-19025-A CLEAR:ORAL:TABLET, SUSTAINED ACTION, FILM COATED:MG	ORAL	0.8MG ORAL TABLET, SUSTAINED ACTION, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY YS-1-19025-A CLEAR:ORAL:TABLET, SUSTAINED RELEASE, FILM COATED:MG	ORAL	10MG ORAL TABLET, SUSTAINED RELEASE, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY YS-1-2013 YELLOW:ORAL:TABLET:MG	ORAL	8MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY YS-1-2074 YELLOW:ORAL:TABLET:MG	ORAL	19.25MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY YS-1-2074 YELLOW:ORAL:TABLET, FILM COATED:MG	ORAL	4.8MG ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY YS-1-2122 YELLOW:ORAL:TABLET:NA	ORAL	ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY YS-1-2134 YELLOW:ORAL:TABLET:MG	ORAL	147.8MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY YS-1-2152 YELLOW:ORAL:TABLET:NA	ORAL	ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY YS-1-2398 ORANGE:ORAL:TABLET:MG	ORAL	25.3MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY YS-1-2449 ORANGE:ORAL:TABLET, EXTENDED RELEASE:MG	ORAL	15MG ORAL TABLET, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY YS-1-2465:ORAL:TABLET:NA	ORAL	ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY YS-1-2527 ORANGE:ORAL:TABLET:MG	ORAL	20MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY YS-1-2527 ORANGE:ORAL:TABLET, SUSTAINED ACTION:NA	ORAL	ORAL TABLET, SUSTAINED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY YS-1-2534:ORAL:TABLET:MG	ORAL	147.8MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY YS-1-2534:ORAL:TABLET, FILM COATED:MG	ORAL	20MG ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY YS-1-2546 ORANGE:ORAL:TABLET:MG	ORAL	11.7MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY YS-1-2546 ORANGE:ORAL:TABLET, FILM COATED:MG	ORAL	14MG ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY YS-1-2548 ORANGE:ORAL:TABLET:MG	ORAL	6.9MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY YS-1-2548 ORANGE:ORAL:TABLET, FILM COATED:MG	ORAL	13MG ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY YS-1-2549 ORANGE:ORAL:TABLET:MG	ORAL	120MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY YS-1-2558 ORANGE:ORAL:TABLET:MG	ORAL	25MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY YS-1-2558 ORANGE:ORAL:TABLET, FILM COATED:MG	ORAL	14MG ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY YS-1-2563 ORANGE:ORAL:TABLET:MG	ORAL	11.25MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY YS-1-2578 ORANGE:ORAL:TABLET, SUSTAINED ACTION:MG	ORAL	21MG ORAL TABLET, SUSTAINED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY YS-1-2596 ORANGE:ORAL:TABLET, FILM COATED:MG	ORAL	20MG ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY YS-1-2604 BEIGE:ORAL:TABLET:MG	ORAL	7.5MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY YS-1-2604 BEIGE:ORAL:TABLET, FILM COATED:NA	ORAL	ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY YS-1-2621 RUST:ORAL:TABLET:MG	ORAL	20MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY YS-1-2621 RUST:ORAL:TABLET, FILM COATED:MG	ORAL	17MG ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY YS-1-2623 BROWN:ORAL:TABLET, FILM COATED:MG	ORAL	34MG ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY YS-1-3105 GREEN:ORAL:TABLET:MG	ORAL	15MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY YS-1-3130 GREEN:ORAL:TABLET:MG	ORAL	36MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY YS-1-3130 GREEN:ORAL:TABLET, COATED:MG	ORAL	20MG ORAL TABLET, COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY YS-1-3130 GREEN:ORAL:TABLET, CONTROLLED RELEASE:MG	ORAL	8.08MG ORAL TABLET, CONTROLLED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY YS-1-3166 GREEN:ORAL:TABLET:MG	ORAL	12MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY YS-1-4018 BLUE:ORAL:TABLET:MG	ORAL	28MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY YS-1-4112 BLUE:ORAL:TABLET:MG	ORAL	147.8MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY YS-1-4137 BLUE:ORAL:TABLET:MG	ORAL	11.5MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY YS-1-4215:ORAL:TABLET:MG	ORAL	10MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY YS-1-4216:ORAL:TABLET:MG	ORAL	20MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY YS-1-4221 BLUE:ORAL:TABLET:NA	ORAL	ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY YS-1-4228 BLUE:ORAL:TABLET:MG	ORAL	19.94MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY YS-1-4235 BLUE:ORAL:TABLET:MG	ORAL	20.25MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY YS-1-4236 BLUE:ORAL:TABLET, FILM COATED:MG	ORAL	12.5MG ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY YS-1-4241 BLUE:ORAL:TABLET:MG	ORAL	5MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY YS-1-4241 BLUE:ORAL:TABLET, FILM COATED:MG	ORAL	6MG ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY YS-1-4251 BLUE:ORAL:TABLET, FILM COATED:MG	ORAL	2.52MG ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY YS-1-4256 BLUE:ORAL:TABLET, SUSTAINED ACTION, COATED:MG	ORAL	35.4MG ORAL TABLET, SUSTAINED ACTION, COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY YS-1-4282 BLUE:ORAL:TABLET, FILM COATED, EXTENDED RELEASE:MG	ORAL	8MG ORAL TABLET, FILM COATED, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY YS-1-4282 BLUE:ORAL:TABLET, SUSTAINED ACTION, FILM COATED:MG	ORAL	10MG ORAL TABLET, SUSTAINED ACTION, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY YS-1-4298 BLUE:ORAL:TABLET, FILM COATED:MG	ORAL	20MG ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY YS-1-4700 PURPLE:ORAL:TABLET:MG	ORAL	0.006MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY YS-1-4710:ORAL:TABLET:MG	ORAL	4MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY YS-1-4845 PURPLE:ORAL:TABLET, SUSTAINED ACTION, FILM COATED:MG	ORAL	16MG ORAL TABLET, SUSTAINED ACTION, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY YS-1-6318 YELLOW:ORAL:TABLET:MG	ORAL	6MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY YS-1-6370G YELLOW:ORAL:TABLET, COATED:MG	ORAL	10MG ORAL TABLET, COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY YS-1-6378G YELLOW:ORAL:TABLET:MG	ORAL	13.4MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY YS-1-6382G YELLOW:ORAL:TABLET:MG	ORAL	11MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY YS-1-7003 WHITE:ORAL:CAPSULE:MG	ORAL	7MG ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY YS-1-7003 WHITE:ORAL:CAPSULE, DELAYED ACTION:MG	ORAL	10MG ORAL CAPSULE, DELAYED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY YS-1-7003 WHITE:ORAL:CAPSULE, EXTENDED RELEASE:MG	ORAL	10.7MG ORAL CAPSULE, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY YS-1-7003 WHITE:ORAL:CAPSULE, SUSTAINED ACTION:MG	ORAL	1.5MG ORAL CAPSULE, SUSTAINED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY YS-1-7003 WHITE:ORAL:TABLET:MG	ORAL	147.8MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY YS-1-7003 WHITE:ORAL:TABLET, COATED:MG	ORAL	14MG ORAL TABLET, COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY YS-1-7003 WHITE:ORAL:TABLET, CONTROLLED RELEASE:MG	ORAL	23.7MG ORAL TABLET, CONTROLLED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY YS-1-7003 WHITE:ORAL:TABLET, DELAYED ACTION:MG	ORAL	4.94MG ORAL TABLET, DELAYED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY YS-1-7003 WHITE:ORAL:TABLET, EXTENDED RELEASE:MG	ORAL	27MG ORAL TABLET, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY YS-1-7003 WHITE:ORAL:TABLET, FILM COATED:MG	ORAL	36MG ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY YS-1-7003 WHITE:ORAL:TABLET, SUSTAINED ACTION:MG	ORAL	42.97MG ORAL TABLET, SUSTAINED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY YS-1-7003 WHITE:ORAL:TABLET, SUSTAINED ACTION, COATED:MG	ORAL	6.24MG ORAL TABLET, SUSTAINED ACTION, COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY YS-1-7003H WHITE:ORAL:TABLET:MG	ORAL	5MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY YS-1-7006 CLEAR:ORAL:CAPSULE:MG	ORAL	6.25MG ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY YS-1-7006 CLEAR:ORAL:CAPSULE, COATED PELLETS:MG	ORAL	4MG ORAL CAPSULE, COATED PELLETS	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY YS-1-7006 CLEAR:ORAL:CAPSULE, SUSTAINED ACTION:MG	ORAL	12.16MG ORAL CAPSULE, SUSTAINED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY YS-1-7006 CLEAR:ORAL:CAPSULE, SUSTAINED ACTION, HARD GELATIN:MG	ORAL	11.25MG ORAL CAPSULE, SUSTAINED ACTION, HARD GELATIN	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY YS-1-7006 CLEAR:ORAL:GRANULE:MG	ORAL	7.3MG ORAL GRANULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY YS-1-7006 CLEAR:ORAL:TABLET, COATED:MG	ORAL	11.16MG ORAL TABLET, COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY YS-1-7006 CLEAR:ORAL:TABLET, CONTROLLED RELEASE:MG	ORAL	14.9MG ORAL TABLET, CONTROLLED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY YS-1-7006 CLEAR:ORAL:TABLET, DELAYED ACTION:MG	ORAL	16MG ORAL TABLET, DELAYED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY YS-1-7006 CLEAR:ORAL:TABLET, EXTENDED RELEASE:MG	ORAL	47.05MG ORAL TABLET, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY YS-1-7006 CLEAR:ORAL:TABLET, FILM COATED:MG	ORAL	11MG ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY YS-1-7006 CLEAR:ORAL:TABLET, SUSTAINED ACTION:MG	ORAL	38.4MG ORAL TABLET, SUSTAINED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY YS-1-7006 CLEAR:ORAL:TABLET, SUSTAINED ACTION, FILM COATED:MG	ORAL	2.63MG ORAL TABLET, SUSTAINED ACTION, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY YS-1-7022 OFF-WHITE:ORAL:TABLET:MG	ORAL	4MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY YS-1-7027 WHITE:ORAL:TABLET:MG	ORAL	37MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY YS-1-7027 WHITE:ORAL:TABLET, SUSTAINED ACTION, COATED:MG	ORAL	16MG ORAL TABLET, SUSTAINED ACTION, COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY YS-1-7040 WHITE:ORAL:TABLET:MG	ORAL	35.76MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY YS-1-7040 WHITE:ORAL:TABLET (IMMED./COMP. RELEASE), FILM COATED:MG	ORAL	17.88MG ORAL TABLET (IMMED./COMP. RELEASE), FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY YS-1-7040 WHITE:ORAL:TABLET, FILM COATED:MG	ORAL	36MG ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY YS-1-7059 WHITE:ORAL:TABLET, SUSTAINED ACTION:MG	ORAL	30MG ORAL TABLET, SUSTAINED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY YS-1-7059 WHITE:ORAL:TABLET, SUSTAINED ACTION, FILM COATED:MG	ORAL	5MG ORAL TABLET, SUSTAINED ACTION, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY YS-1-7086 WHITE:ORAL:TABLET:MG	ORAL	12MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY YS-1-7086 WHITE:ORAL:TABLET, SUSTAINED ACTION, COATED:MG	ORAL	10MG ORAL TABLET, SUSTAINED ACTION, COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY YS-1-7444G WHITE:ORAL:TABLET, COATED:MG	ORAL	22MG ORAL TABLET, COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY YS-1-7472 CLEAR:ORAL:CAPSULE, EXTENDED RELEASE:MG	ORAL	50.76MG ORAL CAPSULE, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY YS-1-7472 CLEAR:ORAL:TABLET:MG	ORAL	2.25MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY YS-1-7472 CLEAR:ORAL:TABLET, DELAYED ACTION:MG	ORAL	4.35MG ORAL TABLET, DELAYED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY YS-1-7472 CLEAR:ORAL:TABLET, SUSTAINED ACTION, COATED:MG	ORAL	2.9MG ORAL TABLET, SUSTAINED ACTION, COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY YS-1-7507 GREY:ORAL:TABLET:MG	ORAL	19.06MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY YS-1-7507 GREY:ORAL:TABLET, FILM COATED:MG	ORAL	6MG ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY YS-1-7507 GREY:ORAL:TABLET, SUSTAINED ACTION, COATED:MG	ORAL	34.23MG ORAL TABLET, SUSTAINED ACTION, COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY YS-1-7552 GREY:ORAL:CAPSULE:MG	ORAL	7.3MG ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY YS-1-7552 GREY:ORAL:TABLET:MG	ORAL	7.5MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY YS-1-7700 WHITE:ORAL:TABLET:MG	ORAL	35.2MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY YS-1-7700 WHITE:ORAL:TABLET, EXTENDED RELEASE:MG	ORAL	35MG ORAL TABLET, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY YS-1-7706 CLEAR:ORAL:CAPSULE:MG	ORAL	3.6MG ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY YS-1-7706 CLEAR:ORAL:TABLET:MG	ORAL	2MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY YS-1-7706 CLEAR:ORAL:TABLET, FILM COATED:MG	ORAL	21MG ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY YS-1-7706G WHITE:ORAL:TABLET:MG	ORAL	22.5MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY YS-1-7706G WHITE:ORAL:TABLET, COATED:MG	ORAL	18.1MG ORAL TABLET, COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY YS-1-7706G WHITE:ORAL:TABLET, FILM COATED:MG	ORAL	20.63MG ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY YS-1-8325 BEIGE:ORAL:TABLET:MG	ORAL	15MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY YS-1-8345G BEIGE:ORAL:TABLET, FILM COATED:MG	ORAL	6MG ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY YS-1-8608 ORANGE:ORAL:TABLET, FILM COATED:MG	ORAL	10MG ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY YS-1-9012 BROWN:ORAL:TABLET:MG	ORAL	13.4MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY YS-1-9012 BROWN:ORAL:TABLET, SUSTAINED ACTION, FILM COATED:MG	ORAL	15.5MG ORAL TABLET, SUSTAINED ACTION, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY YS-1R-7006 CLEAR:ORAL:TABLET:MG	ORAL	26.25MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY YS-1R-7006 CLEAR:ORAL:TABLET, DELAYED RELEASE:MG	ORAL	17.4MG ORAL TABLET, DELAYED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY YS-1R-7006 CLEAR:ORAL:TABLET, EXTENDED RELEASE:MG	ORAL	37.05MG ORAL TABLET, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY YS-2-19114A CLEAR:ORAL:TABLET, CONTROLLED RELEASE:MG	ORAL	1.11MG ORAL TABLET, CONTROLLED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY YS-2-19114A CLEAR:ORAL:TABLET, FILM COATED:MG	ORAL	23.5MG ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY YS-22-18119 WHITE:ORAL:TABLET:MG	ORAL	10MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY YS-2-7013 CLEAR:ORAL:TABLET:MG	ORAL	4.44MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY YS-2-7013 CLEAR:ORAL:TABLET, COATED:MG	ORAL	2.7MG ORAL TABLET, COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY YS-2-7013 CLEAR:ORAL:TABLET, FILM COATED:MG	ORAL	1.2MG ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY YS-2-7063 WHITE:ORAL:TABLET, SUSTAINED ACTION:MG	ORAL	24MG ORAL TABLET, SUSTAINED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY YS-3-7011 CLEAR:ORAL:TABLET:MG	ORAL	18MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY YS-3-7011 CLEAR:ORAL:TABLET, FILM COATED:MG	ORAL	1MG ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY YS-3-7413 CLEAR:ORAL:TABLET:MG	ORAL	4MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY YS-3-7413 CLEAR:ORAL:TABLET, COATED:MG	ORAL	2.4MG ORAL TABLET, COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY YS-3-7413 CLEAR:ORAL:TABLET, EXTENDED RELEASE:MG	ORAL	4MG ORAL TABLET, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY YS-3-7413 CLEAR:ORAL:TABLET, FILM COATED:MG	ORAL	1.5MG ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY YS-5-1296 PINK:ORAL:TABLET:MG	ORAL	7.46MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY YS-5-2370 ORANGE:ORAL:TABLET:NA	ORAL	ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY YS-5-2370 ORANGE:ORAL:TABLET, FILM COATED:NA	ORAL	ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY YS-5-4277 BLUE:ORAL:TABLET, FILM COATED:MG	ORAL	0.9MG ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY YS-5-4278 BLUE:ORAL:TABLET, FILM COATED:MG	ORAL	2.16MG ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPADRY YS-5-7068:ORAL:TABLET:MG	ORAL	1.5MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPAGLOS GS 2-0300:ORAL:TABLET, COATED:NA	ORAL	ORAL TABLET, COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPAGLOS GS 2-0310:ORAL:TABLET:MG	ORAL	3.5MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPAGLOS GS 2-0310:ORAL:TABLET, SUGAR COATED:MG	ORAL	0.76MG ORAL TABLET, SUGAR COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPAGLOS S 0750:ORAL:TABLET:MG	ORAL	0.028MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPALUX AS 1459 PINK:ORAL:TABLET, COATED:MG	ORAL	5.31MG ORAL TABLET, COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPALUX AS 1589 PINK:ORAL:TABLET, COATED:MG	ORAL	0.07MG ORAL TABLET, COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPALUX AS 2006 YELLOW:ORAL:TABLET:MG	ORAL	0.6MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPALUX AS 2236:ORAL:TABLET:MG	ORAL	10.2MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPALUX AS 2236:ORAL:TABLET, COATED:MG	ORAL	22.13MG ORAL TABLET, COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPALUX AS 2236:ORAL:TABLET, DELAYED ACTION, ENTERIC COATED:NA	ORAL	ORAL TABLET, DELAYED ACTION, ENTERIC COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPALUX AS 2236:ORAL:TABLET, SUSTAINED ACTION:MG	ORAL	11.8MG ORAL TABLET, SUSTAINED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPALUX AS 2269 YELLOW:ORAL:TABLET:MG	ORAL	1.42MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPALUX AS 2413:ORAL:TABLET, COATED:NA	ORAL	ORAL TABLET, COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPALUX AS 2490 CORAL:ORAL:TABLET, SUSTAINED ACTION:NA	ORAL	ORAL TABLET, SUSTAINED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPALUX AS 2498 ORANGE:ORAL:TABLET:MG	ORAL	0.27MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPALUX AS 2498 ORANGE:ORAL:TABLET, COATED:MG	ORAL	3MG ORAL TABLET, COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPALUX AS 2613 TAN:ORAL:TABLET, SUGAR COATED:MG	ORAL	2.18MG ORAL TABLET, SUGAR COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPALUX AS 2676 SALMON JASPER RED:ORAL:TABLET:MG	ORAL	1.4MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPALUX AS 2787 BUTTERSCOTCH:ORAL:TABLET:MG	ORAL	4.47MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPALUX AS 3288 GREEN:ORAL:TABLET, REPEAT ACTION:MG	ORAL	8.61MG ORAL TABLET, REPEAT ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPALUX AS 3389 GREEN:ORAL:TABLET:NA	ORAL	ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPALUX AS 3391 GREEN:ORAL:TABLET:MG	ORAL	0.2MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPALUX AS 3391 GREEN:ORAL:TABLET, COATED:MG	ORAL	1.18MG ORAL TABLET, COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPALUX AS 3942 MAROON:ORAL:TABLET:MG	ORAL	17.6MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPALUX AS 4151 BLUE:ORAL:CAPSULE:MG	ORAL	2.76MG ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPALUX AS 4151 BLUE:ORAL:TABLET, REPEAT ACTION:MG	ORAL	8.43MG ORAL TABLET, REPEAT ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPALUX AS 4258 BLUE:ORAL:TABLET:NA	ORAL	ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPALUX AS 4270 BLUE:ORAL:TABLET, COATED:MG	ORAL	12.63MG ORAL TABLET, COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPALUX AS 5034 RED:ORAL:TABLET, COATED:MG	ORAL	0.02MG ORAL TABLET, COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPALUX AS 5107:ORAL:TABLET, SUSTAINED ACTION:MG	ORAL	17.6MG ORAL TABLET, SUSTAINED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPALUX AS 5162 GREEN:ORAL:TABLET:MG	ORAL	4.4MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPALUX AS 5212 GREEN:ORAL:TABLET, COATED:NA	ORAL	ORAL TABLET, COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPALUX AS 7000-B:ORAL:TABLET, COATED:MG	ORAL	4.95MG ORAL TABLET, COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPALUX AS 7000-P WHITE:ORAL:TABLET:MG	ORAL	3.81MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPALUX AS 7535 GRAY:ORAL:TABLET, COATED:NA	ORAL	ORAL TABLET, COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPALUX AS 9010 BROWN:ORAL:TABLET:MG	ORAL	0.003MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPALUX AS 9010 BROWN:ORAL:TABLET, COATED:MG	ORAL	0.45MG ORAL TABLET, COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPALUX AS-1475 PINK:ORAL:SOLUTION:NA	ORAL	ORAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPALUX AS-1475 PINK:ORAL:TABLET, DELAYED RELEASE:MG	ORAL	7.5MG ORAL TABLET, DELAYED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPALUX BLUE:ORAL:TABLET:NA	ORAL	ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPAQUE BLUE 100:ORAL:CAPSULE:NA	ORAL	ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPAQUE BLUE 147:ORAL:CAPSULE:NA	ORAL	ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPAQUE BLUE 605:ORAL:CAPSULE:NA	ORAL	ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPAQUE GREEN 97:ORAL:CAPSULE:NA	ORAL	ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPAQUE MAROON 6 DAR:ORAL:CAPSULE:NA	ORAL	ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPAQUE WHITE 001:ORAL:CAPSULE:MG	ORAL	78MG ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPAQUE WHITE 002:ORAL:CAPSULE:MG	ORAL	62MG ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPAQUE WHITE 8:ORAL:CAPSULE:NA	ORAL	ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPASPRAY IM-176:ORAL:TABLET:MG	ORAL	23.5MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPASPRAY K-1-1279:ORAL:TABLET:MG	ORAL	21.13MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPASPRAY K-1-1289 PINK:ORAL:TABLET:MG	ORAL	21.13MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPASPRAY K-1-14016 PINK:ORAL:TABLET, FILM COATED:MG	ORAL	3.75MG ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPASPRAY K-1-1414 PINK:ORAL:TABLET:MG	ORAL	11.4MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPASPRAY K-1-1573 LAVENDER:ORAL:TABLET:MG	ORAL	12MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPASPRAY K-1-2013 YELLOW:ORAL:TABLET:MG	ORAL	8MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPASPRAY K-1-2182 YELLOW:ORAL:TABLET:MG	ORAL	3MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPASPRAY K-1-2182 YELLOW:ORAL:TABLET, FILM COATED:MG	ORAL	1MG ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPASPRAY K-1-2216-A YELLOW:ORAL:TABLET:MG	ORAL	3MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPASPRAY K-1-2216-A YELLOW:ORAL:TABLET, COATED:MG	ORAL	0.5MG ORAL TABLET, COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPASPRAY K-1-2216-A YELLOW:ORAL:TABLET, FILM COATED:MG	ORAL	3MG ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPASPRAY K-1-2216-A YELLOW:ORAL:TABLET, SUSTAINED ACTION:MG	ORAL	6.8MG ORAL TABLET, SUSTAINED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPASPRAY K-1-2227 YELLOW:ORAL:TABLET:MG	ORAL	6MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPASPRAY K-1-2227 YELLOW:ORAL:TABLET, FILM COATED:MG	ORAL	1.69MG ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPASPRAY K-1-2228 YELLOW:ORAL:TABLET, SUSTAINED ACTION:MG	ORAL	17.8MG ORAL TABLET, SUSTAINED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPASPRAY K-1-2301 PEACH:ORAL:TABLET:MG	ORAL	4.7MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPASPRAY K-1-2303 ORANGE:ORAL:TABLET:MG	ORAL	0.35MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPASPRAY K-1-2304 ORANGE:ORAL:TABLET:MG	ORAL	1.8MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPASPRAY K-1-2314 ORANGE:ORAL:TABLET:MG	ORAL	3.74MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPASPRAY K-1-2327 ORANGE:ORAL:TABLET, SUSTAINED ACTION:MG	ORAL	6MG ORAL TABLET, SUSTAINED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPASPRAY K-1-2406 ORANGE:ORAL:TABLET:MG	ORAL	4.42MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPASPRAY K-1-2406 ORANGE:ORAL:TABLET, FILM COATED:MG	ORAL	2.1MG ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPASPRAY K-1-2430:ORAL:TABLET:MG	ORAL	13.5MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPASPRAY K-1-2441 ORANGE:ORAL:TABLET:MG	ORAL	5.95MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPASPRAY K-1-2473:ORAL:TABLET:MG	ORAL	22.5MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPASPRAY K-1-2473:ORAL:TABLET, FILM COATED:MG	ORAL	2.5MG ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPASPRAY K-1-2492:ORAL:TABLET:MG	ORAL	36MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPASPRAY K-1-2554:ORAL:TABLET, COATED:MG	ORAL	1.8MG ORAL TABLET, COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPASPRAY K-1-2570 ORANGE:ORAL:TABLET:MG	ORAL	5.25MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPASPRAY K-1-2570 ORANGE:ORAL:TABLET, FILM COATED:NA	ORAL	ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPASPRAY K-1-2614 BEIGE:ORAL:TABLET:MG	ORAL	6MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPASPRAY K-1-2614 BEIGE:ORAL:TABLET, FILM COATED:MG	ORAL	6MG ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPASPRAY K-1-2656 BEIGE:ORAL:TABLET, FILM COATED:MG	ORAL	9.08MG ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPASPRAY K-1-2711:ORAL:TABLET:MG	ORAL	12.6MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPASPRAY K-1-2711:ORAL:TABLET, COATED:NA	ORAL	ORAL TABLET, COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPASPRAY K-1-3000:ORAL:TABLET:MG	ORAL	0.6MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPASPRAY K-1-3000:ORAL:TABLET, COATED:MG	ORAL	0.6MG ORAL TABLET, COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPASPRAY K-1-3142 GREEN:ORAL:TABLET, SUSTAINED ACTION:MG	ORAL	5.1MG ORAL TABLET, SUSTAINED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPASPRAY K-1-3147:ORAL:TABLET:MG	ORAL	1.9MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPASPRAY K-1-3147:ORAL:TABLET, FILM COATED:MG	ORAL	0.6MG ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPASPRAY K-1-3147:ORAL:TABLET, SUSTAINED ACTION:MG	ORAL	2MG ORAL TABLET, SUSTAINED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPASPRAY K-1-3148 GREEN:ORAL:TABLET:MG	ORAL	1.35MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPASPRAY K-1-3148 GREEN:ORAL:TABLET, FILM COATED:MG	ORAL	0.74MG ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPASPRAY K-1-3178 GREEN:ORAL:TABLET:MG	ORAL	1.6MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPASPRAY K-1-3220 GREEN:ORAL:TABLET:MG	ORAL	1.8MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPASPRAY K-1-3227:ORAL:TABLET:MG	ORAL	4MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPASPRAY K-1-3227:ORAL:TABLET, COATED:MG	ORAL	3.2MG ORAL TABLET, COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPASPRAY K-1-3300-C GREEN:ORAL:TABLET:MG	ORAL	2.1MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPASPRAY K-1-3843:ORAL:TABLET, COATED:MG	ORAL	0.8MG ORAL TABLET, COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPASPRAY K-1-4108 BLUE:ORAL:TABLET:MG	ORAL	1.5MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPASPRAY K-1-4108 BLUE:ORAL:TABLET, FILM COATED:MG	ORAL	1.5MG ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPASPRAY K-1-4119:ORAL:TABLET:MG	ORAL	0.6MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPASPRAY K-1-4119:ORAL:TABLET, COATED:MG	ORAL	0.6MG ORAL TABLET, COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPASPRAY K-1-4122 BLUE:ORAL:TABLET:MG	ORAL	2.2MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPASPRAY K-1-4122 BLUE:ORAL:TABLET, FILM COATED:MG	ORAL	4.5MG ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPASPRAY K-1-4136 BLUE:ORAL:TABLET:NA	ORAL	ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPASPRAY K-1-4136 BLUE:ORAL:TABLET, COATED:MG	ORAL	0.6MG ORAL TABLET, COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPASPRAY K-1-4136 BLUE:ORAL:TABLET, FILM COATED:MG	ORAL	3MG ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPASPRAY K-1-4214:ORAL:TABLET:MG	ORAL	2.7MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPASPRAY K-1-4214:ORAL:TABLET, COATED:MG	ORAL	2.7MG ORAL TABLET, COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPASPRAY K-1-4234 BLUE:ORAL:TABLET:MG	ORAL	1.53MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPASPRAY K-1-4235 BLUE:ORAL:TABLET:MG	ORAL	15.57MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPASPRAY K-1-4728:ORAL:TABLET:MG	ORAL	4.68MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPASPRAY K-1-4731 PURPLE:ORAL:TABLET:NA	ORAL	ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPASPRAY K-1-4743 LAVENDER:ORAL:TABLET:MG	ORAL	2.2MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPASPRAY K-1-4786:ORAL:TABLET:MG	ORAL	2.1MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPASPRAY K-1-4786:ORAL:TABLET, COATED:MG	ORAL	2.1MG ORAL TABLET, COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPASPRAY K-1-7000 WHITE:ORAL:TABLET:MG	ORAL	22.5MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPASPRAY K-1-7000 WHITE:ORAL:TABLET, COATED:MG	ORAL	0.9MG ORAL TABLET, COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPASPRAY K-1-7000 WHITE:ORAL:TABLET, SUSTAINED ACTION:MG	ORAL	6.25MG ORAL TABLET, SUSTAINED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPASPRAY K-1-70008 WHITE:ORAL:TABLET:MG	ORAL	22.4MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPASPRAY K-1-9027 BROWN:ORAL:TABLET:MG	ORAL	1.2MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPASPRAY K-1-9039-L BROWN:ORAL:TABLET:MG	ORAL	12.2MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPASPRAY K-1-9039-L BROWN:ORAL:TABLET, FILM COATED:MG	ORAL	4.65MG ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPASPRAY K-1-9060 RED:ORAL:TABLET:MG	ORAL	2.9MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPASPRAY K-1-9080 BROWN:ORAL:TABLET:MG	ORAL	3.28MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPASPRAY M-1-3459 B ORANGE:ORAL:TABLET:MG	ORAL	4MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPASPRAY M-1-7111-B:ORAL:TABLET:MG	ORAL	40MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPASPRAY M-1-7111-B:ORAL:TABLET, FILM COATED:MG	ORAL	2.9MG ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPASPRAY M-1-711B WHITE:ORAL:TABLET:MG	ORAL	27.78MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPASPRAY M-1-7120 WHITE:ORAL:TABLET, FILM COATED:MG	ORAL	1.52MG ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPASPRAY WD-1270 PINK:ORAL:TABLET, DELAYED ACTION, ENTERIC COATED:MG	ORAL	6.7MG ORAL TABLET, DELAYED ACTION, ENTERIC COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPATINT DD-14000 PINK:ORAL:TABLET, FILM COATED:MG	ORAL	0.94MG ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	OPATINT DD-18000 WHITE:ORAL:TABLET, FILM COATED:MG	ORAL	0.68MG ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
NA	PARABENS:ORAL:CAPSULE:MG	ORAL	0.16MG ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
NA	PARABENS:ORAL:CAPSULE, SUSTAINED ACTION:NA	ORAL	ORAL CAPSULE, SUSTAINED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
NA	PARABENS:ORAL:DROPS:NA	ORAL	ORAL DROPS	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
NA	PARABENS:ORAL:POWDER, FOR SUSPENSION:NA	ORAL	ORAL POWDER, FOR SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
NA	PARABENS:ORAL:SOLUTION:NA	ORAL	ORAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
NA	PARABENS:ORAL:SUSPENSION:NA	ORAL	ORAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
NA	PARABENS:ORAL:TABLET:NA	ORAL	ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
NA	PARABENS:ORAL:TABLET, SUSTAINED ACTION:NA	ORAL	ORAL TABLET, SUSTAINED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
NA	PARABENS:TOPICAL:AEROSOL, METERED:NA	TOPICAL	TOPICAL AEROSOL, METERED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
NA	PEG 6-32 STEARATE/GLYCOL STEARATE:TOPICAL:EMULSION, CREAM:%W/W	TOPICAL	19.6%W/W TOPICAL EMULSION, CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
NA	PEG 6-32 STEARATE/GLYCOL STEARATE:VAGINAL:EMULSION, CREAM:%	VAGINAL	19.6% VAGINAL EMULSION, CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
NA	PEG VEGETABLE OIL:IM - SC:INJECTION:%	IM - SC	7% IM - SC INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
NA	PEG VEGETABLE OIL:IV(INFUSION):INJECTION:%	IV(INFUSION)	5% IV(INFUSION) INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
NA	PERFUME GD 5604:TOPICAL:EMULSION, CREAM:%W/W	TOPICAL	0.12%W/W TOPICAL EMULSION, CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
NA	PHARMABURST B1:ORAL:TABLET, ORALLY DISINTEGRATING:MG	ORAL	671.13MG ORAL TABLET, ORALLY DISINTEGRATING	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
NA	PHARMABURST B2:ORAL:TABLET, ORALLY DISINTEGRATING:MG	ORAL	792MG ORAL TABLET, ORALLY DISINTEGRATING	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
NA	PHARMABURST C1:ORAL:TABLET, ORALLY DISINTEGRATING:MG	ORAL	272.47MG ORAL TABLET, ORALLY DISINTEGRATING	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
NA	PHENONIP:IONTOPHORESIS:PATCH, CONTROLLED RELEASE:MG	IONTOPHORESIS	0.23MG IONTOPHORESIS PATCH, CONTROLLED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
NA	PHENONIP:TOPICAL:GEL:%W/W	TOPICAL	0.035%W/W TOPICAL GEL	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
NA	PHENONIP:TOPICAL:PATCH, CONTROLLED RELEASE:MG	TOPICAL	0.23MG TOPICAL PATCH, CONTROLLED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
NA	PHOSPHOLIPID:IV(INFUSION):EMULSION, INJECTION:%	IV(INFUSION)	12% IV(INFUSION) EMULSION, INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
NA	PHOSPHOLIPID:IV(INFUSION):POWDER, FOR INJECTION SOLUTION, LYOPHILIZED:%	IV(INFUSION)	12% IV(INFUSION) POWDER, FOR INJECTION SOLUTION, LYOPHILIZED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
NA	PIGMENT BLEND PB-2417 PINK:ORAL:TABLET, EXTENDED RELEASE:MG	ORAL	1.75MG ORAL TABLET, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
NA	PLASTIBASE-50W:DENTAL:PASTE:MG	DENTAL	549MG DENTAL PASTE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
NA	PLASTIBASE-50W:TOPICAL:OINTMENT:%W/W	TOPICAL	99.95%W/W TOPICAL OINTMENT	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
NA	POLISHING SOLUTION IM-182:ORAL:TABLET:MG	ORAL	0.7MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
NA	POLYESTER:BUCCAL:PATCH, CONTROLLED RELEASE:NA	BUCCAL	BUCCAL PATCH, CONTROLLED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
NA	POLYESTER:TRANSDERMAL:PATCH:MG	TRANSDERMAL	96MG TRANSDERMAL PATCH	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
NA	POLYESTER:TRANSDERMAL:PATCH, CONTROLLED RELEASE:MG	TRANSDERMAL	3.61MG TRANSDERMAL PATCH, CONTROLLED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
NA	POLYETHYLENE GLYCOL 540:TOPICAL:OINTMENT:%W/W	TOPICAL	76.5%W/W TOPICAL OINTMENT	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
NA	POLYISOBUTYLENE:TOPICAL:PATCH:MG	TOPICAL	2660MG TOPICAL PATCH	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
NA	POLYISOBUTYLENE:TRANSDERMAL:FILM:MG	TRANSDERMAL	16.83MG TRANSDERMAL FILM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
NA	POLYISOBUTYLENE:TRANSDERMAL:FILM, CONTROLLED RELEASE:MG	TRANSDERMAL	615.4MG TRANSDERMAL FILM, CONTROLLED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
NA	POLYISOBUTYLENE:TRANSDERMAL:PATCH:MG	TRANSDERMAL	26.7MG TRANSDERMAL PATCH	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
NA	POLYISOBUTYLENE:TRANSDERMAL:PATCH, CONTROLLED RELEASE:MG	TRANSDERMAL	10.5MG TRANSDERMAL PATCH, CONTROLLED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
NA	POLYOXYETHYLENE ALCOHOLS:TOPICAL:EMULSION, CREAM:%W/W	TOPICAL	7.5%W/W TOPICAL EMULSION, CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
NA	POLYOXYETHYLENE ALCOHOLS:TOPICAL:OINTMENT:NA	TOPICAL	TOPICAL OINTMENT	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
NA	POLYOXYETHYLENE FATTY ACID ESTERS:IM - IV - SC:INJECTION:NA	IM - IV - SC	IM - IV - SC INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
NA	POLYOXYETHYLENE FATTY ACID ESTERS:IM - SC:INJECTION:%	IM - SC	14% IM - SC INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
NA	POLYOXYETHYLENE FATTY ACID ESTERS:TOPICAL:DISC:NA	TOPICAL	TOPICAL DISC	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
NA	POLYOXYETHYLENE FATTY ACID ESTERS:TOPICAL:EMULSION, CREAM:%W/W	TOPICAL	1.9%W/W TOPICAL EMULSION, CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
NA	POLYOXYL DISTEARATE:TOPICAL:OINTMENT:NA	TOPICAL	TOPICAL OINTMENT	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
NA	POLYOXYL GLYCERYL STEARATE:ORAL:TABLET:MG	ORAL	23.33MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
NA	POLYOXYL GLYCERYL STEARATE:TOPICAL:EMULSION, CREAM:%W/W	TOPICAL	5%W/W TOPICAL EMULSION, CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
NA	POLYOXYL GLYCERYL STEARATE:TOPICAL:LOTION:%W/W	TOPICAL	1.5%W/W TOPICAL LOTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
NA	POLYOXYL LANOLIN:TOPICAL:SOLUTION:NA	TOPICAL	TOPICAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
NA	POLYOXYL STEARATE:AURICULAR (OTIC):SUSPENSION:%	AURICULAR (OTIC)	0.006% AURICULAR (OTIC) SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
NA	POLYOXYL STEARATE:ORAL:TABLET, COATED:MG	ORAL	2MG ORAL TABLET, COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
NA	POLYOXYL STEARATE:RECTAL:EMULSION, AEROSOL FOAM:%	RECTAL	1.32% RECTAL EMULSION, AEROSOL FOAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
NA	POLYOXYL STEARATE:TOPICAL:CREAM:%W/W 	TOPICAL	7%W/W  TOPICAL CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
NA	POLYOXYL STEARATE:TOPICAL:CREAM:%W/W	TOPICAL	1.4%W/W TOPICAL CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
NA	POLYOXYL STEARATE:TOPICAL:EMULSION:NA	TOPICAL	TOPICAL EMULSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
NA	POLYOXYL STEARATE:TOPICAL:EMULSION, CREAM:%W/W	TOPICAL	20%W/W TOPICAL EMULSION, CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
NA	POLYOXYL STEARATE:TOPICAL:LOTION:%W/W	TOPICAL	2%W/W TOPICAL LOTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
NA	POLYOXYL STEARATE:VAGINAL:EMULSION, CREAM:NA	VAGINAL	VAGINAL EMULSION, CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
NA	POLYOXYLETHYLENE ISONONYLPHENYL ESTER:ORAL:TABLET, SUSTAINED ACTION, COATED:MG	ORAL	1.54MG ORAL TABLET, SUSTAINED ACTION, COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
NA	POLYQUATERNIUM-10:TOPICAL:SHAMPOO:%W/V	TOPICAL	2.06%W/V TOPICAL SHAMPOO	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
NA	POLYQUATERNIUM-10:TOPICAL:SHAMPOO:%W/W 	TOPICAL	2%W/W  TOPICAL SHAMPOO	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
NA	POLYSACCHARIDES:ORAL:TABLET, DELAYED ACTION, ENTERIC COATED:MG	ORAL	80.4MG ORAL TABLET, DELAYED ACTION, ENTERIC COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
NA	POLYSILOXANE:INTRAVENOUS:INJECTABLE:NA	INTRAVENOUS	INTRAVENOUS INJECTABLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
NA	POLYSILOXANE:ORAL:CAPSULE:NA	ORAL	ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
NA	PRIMARY TASTE MODIFIER NO. 29275:ORAL:SYRUP:%	ORAL	0.2% ORAL SYRUP	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
NA	PRODUCT WAT:TOPICAL:AEROSOL:%W/W	TOPICAL	10.78%W/W TOPICAL AEROSOL	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
NA	PROMULGEN G:TOPICAL:EMULSION, CREAM:%W/W	TOPICAL	7%W/W TOPICAL EMULSION, CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
NA	PROMULGEN G:TOPICAL:LOTION:%W/W	TOPICAL	2.16%W/W TOPICAL LOTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
NA	PROMULGEN G:TOPICAL:SHAMPOO:%W/W	TOPICAL	4%W/W TOPICAL SHAMPOO	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
NA	PROSOLV:ORAL:TABLET:MG	ORAL	350.4MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
NA	PROSOLV:ORAL:TABLET, ORALLY DISINTEGRATING:MG	ORAL	240.07MG ORAL TABLET, ORALLY DISINTEGRATING	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
NA	PROSOLV 50:ORAL:CAPSULE:mg	ORAL	33.86mg ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
NA	PROSOLV 50:ORAL:CAPSULE, SUSTAINED ACTION, HARD GELATIN:MG	ORAL	82.5MG ORAL CAPSULE, SUSTAINED ACTION, HARD GELATIN	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
NA	PROSOLV 50:ORAL:TABLET:MG	ORAL	203.4MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
NA	PROSOLV 50:ORAL:TABLET, EXTENDED RELEASE:MG	ORAL	315MG ORAL TABLET, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
NA	PROSOLV 50:ORAL:TABLET, SUSTAINED ACTION:MG	ORAL	217.5MG ORAL TABLET, SUSTAINED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
NA	PROSOLV 90:ORAL:TABLET:MG	ORAL	104.31MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
NA	PROSOLV 90:ORAL:TABLET, EXTENDED RELEASE:MG	ORAL	25MG ORAL TABLET, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
NA	PROSOLV 90:SUBLINGUAL:TABLET:MG	SUBLINGUAL	18.7MG SUBLINGUAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
NA	PROSOLV HD 90:ORAL:CAPSULE:MG	ORAL	199.11MG ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
NA	PROSOLV HD 90:ORAL:TABLET:MG	ORAL	351.3MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
NA	PROSOLV HD 90:ORAL:TABLET (IMMED./COMP. RELEASE), FILM COATED:MG	ORAL	375.52MG ORAL TABLET (IMMED./COMP. RELEASE), FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
NA	PROSOLV HD 90:ORAL:TABLET, DELAYED ACTION:mg	ORAL	148.734mg ORAL TABLET, DELAYED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
NA	PROSOLV HD 90:ORAL:TABLET, DELAYED RELEASE:MG	ORAL	117.26MG ORAL TABLET, DELAYED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
NA	PROSOLV HD 90:ORAL:TABLET, EXTENDED RELEASE:MG	ORAL	352MG ORAL TABLET, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
NA	PROSOLV HD 90:ORAL:TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE:mg	ORAL	37.62mg ORAL TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
NA	PROSOLV SMCC 50:ORAL:TABLET:MG	ORAL	194MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
NA	PROSOLV SMCC 50:ORAL:TABLET, EXTENDED RELEASE:MG	ORAL	162MG ORAL TABLET, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
NA	PROSOLV SMCC 50:ORAL:TABLET, FILM COATED:MG	ORAL	100MG ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
NA	PROSOLV SMCC 50:ORAL:TABLET, ORALLY DISINTEGRATING:MG	ORAL	119.6MG ORAL TABLET, ORALLY DISINTEGRATING	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
NA	PROSOLV SMCC 90:ORAL:CAPSULE:mg	ORAL	141.3mg ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
NA	PROSOLV SMCC 90:ORAL:TABLET:MG	ORAL	568MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
NA	PROSOLV SMCC 90:ORAL:TABLET (IMMED./COMP. RELEASE), UNCOATED, CHEWABLE:MG	ORAL	28.4MG ORAL TABLET (IMMED./COMP. RELEASE), UNCOATED, CHEWABLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
NA	PROSOLV SMCC 90:ORAL:TABLET, CONTROLLED RELEASE:MG	ORAL	20MG ORAL TABLET, CONTROLLED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
NA	PROSOLV SMCC 90:ORAL:TABLET, DELAYED ACTION:mg	ORAL	146.2mg ORAL TABLET, DELAYED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
NA	PROSOLV SMCC 90:ORAL:TABLET, DELAYED ACTION, ENTERIC COATED:MG	ORAL	158.5MG ORAL TABLET, DELAYED ACTION, ENTERIC COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
NA	PROSOLV SMCC 90:ORAL:TABLET, EXTENDED RELEASE:MG	ORAL	536.35MG ORAL TABLET, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
NA	PROSOLV SMCC 90:ORAL:TABLET, EXTENDED RELEASE:MG	ORAL	180MG ORAL TABLET, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
NA	PROSOLV SMCC 90:ORAL:TABLET, FILM COATED:MG	ORAL	183MG ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
NA	PROSOLV SMCC 90:ORAL:TABLET, ORALLY DISINTEGRATING:MG	ORAL	70MG ORAL TABLET, ORALLY DISINTEGRATING	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
NA	PROSWEET:ORAL:TABLET (IMMED./COMP. RELEASE), UNCOATED, CHEWABLE:MG	ORAL	5MG ORAL TABLET (IMMED./COMP. RELEASE), UNCOATED, CHEWABLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
NA	PROSWEET K:ORAL:SYRUP:MG/1ML	ORAL	4MG/1ML ORAL SYRUP	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
NA	PROTEIN HYDROLYSATE:ORAL:TABLET, FILM COATED:MG	ORAL	15MG ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
NA	SCOTCHPAK 1022:TRANSDERMAL:FILM, CONTROLLED RELEASE:MG	TRANSDERMAL	904.92MG TRANSDERMAL FILM, CONTROLLED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
NA	SD ALCOHOL 3A:ORAL:CAPSULE, DELAYED ACTION, ENTERIC COATED:NA	ORAL	ORAL CAPSULE, DELAYED ACTION, ENTERIC COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
NA	SD ALCOHOL 3A:ORAL:TABLET:NA	ORAL	ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
NA	SD ALCOHOL 3A:TOPICAL:SPONGE:NA	TOPICAL	TOPICAL SPONGE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
NA	SD ALCOHOL 40:TOPICAL:EMULSION, AEROSOL FOAM:%W/W	TOPICAL	46%W/W TOPICAL EMULSION, AEROSOL FOAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
NA	SD ALCOHOL 40-2:TOPICAL:AEROSOL:%W/W	TOPICAL	57.65%W/W TOPICAL AEROSOL	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
NA	SD ALCOHOL 40-2:TOPICAL:GEL:%W/W	TOPICAL	97.5%W/W TOPICAL GEL	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
NA	SD ALCOHOL 40B:TOPICAL:AEROSOL:%W/W	TOPICAL	56.09%W/W TOPICAL AEROSOL	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
NA	SD ALCOHOL 40B:TOPICAL:EMULSION, AEROSOL FOAM:%W/W	TOPICAL	56.09%W/W TOPICAL EMULSION, AEROSOL FOAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
NA	SD ALCOHOL 40B:TOPICAL:SOLUTION:%W/W	TOPICAL	54.2%W/W TOPICAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
NA	SEPIFILM LP-761 BLANC:ORAL:TABLET, DELAYED RELEASE:MG	ORAL	10MG ORAL TABLET, DELAYED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
NA	SEPINEO P 600:TOPICAL:CREAM:%W/W 	TOPICAL	0.45%W/W  TOPICAL CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
NA	SEPINEO P 600:TOPICAL:GEL:%W/W	TOPICAL	4%W/W TOPICAL GEL	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
NA	SEPINEO P 600:TOPICAL:OINTMENT:%W/W 	TOPICAL	0.3%W/W  TOPICAL OINTMENT	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
NA	SHELLAC P.V.P. SOLUTION NO. 4:ORAL:CAPSULE, SUSTAINED ACTION:MG	ORAL	87MG ORAL CAPSULE, SUSTAINED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
NA	SILICONE:IM - IV:INJECTION:NA	IM - IV	IM - IV INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
NA	SILICONE:INTRAUTERINE:INTRAUTERINE DEVICE:MG	INTRAUTERINE	50.44MG INTRAUTERINE INTRAUTERINE DEVICE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
NA	SILICONE:INTRAUTERINE:SUPPOSITORY, INSERT, CONTROLLED RELEASE:MG	INTRAUTERINE	60MG INTRAUTERINE SUPPOSITORY, INSERT, CONTROLLED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
NA	SILICONE:ORAL:CAPSULE:MG	ORAL	15MG ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
NA	SILICONE:ORAL:CAPSULE, HARD GELATIN:MG	ORAL	0.42MG ORAL CAPSULE, HARD GELATIN	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
NA	SILICONE:ORAL:CAPSULE, SUSTAINED ACTION:MG	ORAL	0.14MG ORAL CAPSULE, SUSTAINED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
NA	SILICONE:ORAL:POWDER, FOR SUSPENSION:MG/5ML	ORAL	5MG/5ML ORAL POWDER, FOR SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
NA	SILICONE:ORAL:SUSPENSION:NA	ORAL	ORAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
NA	SILICONE:ORAL:TABLET:NA	ORAL	ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
NA	SILICONE:TOPICAL:LOTION:%W/W	TOPICAL	0.093%W/W TOPICAL LOTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
NA	SILICONE:TOPICAL:SHAMPOO, SUSPENSION:NA	TOPICAL	TOPICAL SHAMPOO, SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
NA	SILICONE:TRANSDERMAL:FILM, CONTROLLED RELEASE:MG	TRANSDERMAL	353.51MG TRANSDERMAL FILM, CONTROLLED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
NA	SILICONE:TRANSDERMAL:PATCH:MG	TRANSDERMAL	1098MG TRANSDERMAL PATCH	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
NA	SILICONE:VAGINAL:INSERT:MG	VAGINAL	27.48MG VAGINAL INSERT	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
NA	SILICONE:VAGINAL:INSERT, EXTENDED RELEASE:MG	VAGINAL	8.7MG VAGINAL INSERT, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
NA	SILICONE:VAGINAL:RING:mg	VAGINAL	8714.6mg VAGINAL RING	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
NA	SILICONE EMULSION:ORAL:CAPSULE:NA	ORAL	ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
NA	SILICONE EMULSION:ORAL:CAPSULE, SUSTAINED ACTION:MG	ORAL	0.078MG ORAL CAPSULE, SUSTAINED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
NA	SILICONE EMULSION:ORAL:CONCENTRATE:NA	ORAL	ORAL CONCENTRATE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
NA	SILICONE EMULSION:ORAL:POWDER, FOR SUSPENSION:MG/5ML	ORAL	62MG/5ML ORAL POWDER, FOR SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
NA	SILICONE EMULSION:TOPICAL:LOTION:%W/W	TOPICAL	0.5%W/W TOPICAL LOTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
NA	SILICONE/POLYESTER FILM STRIP:TRANSDERMAL:PATCH:MG	TRANSDERMAL	485.2MG TRANSDERMAL PATCH	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
NA	SIPON LS 20NP:TOPICAL:EMULSION:%W/W	TOPICAL	38%W/W TOPICAL EMULSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
NA	SODIUM ALKYL SULFATE:TOPICAL:SHAMPOO, SUSPENSION:NA	TOPICAL	TOPICAL SHAMPOO, SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
NA	SODIUM POLYACRYLATE:TOPICAL:PATCH:MG	TOPICAL	210MG TOPICAL PATCH	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
NA	SODIUM POLYACRYLATE:TOPICAL:PATCH, CONTROLLED RELEASE:NA	TOPICAL	TOPICAL PATCH, CONTROLLED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
NA	SOMAY 44:TOPICAL:SOLUTION:%W/W	TOPICAL	0.1%W/W TOPICAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
NA	SORBITOL SPECIAL POLYOL SOLUTION:ORAL:CAPSULE:MG	ORAL	83.52MG ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
NA	SORBITOL SPECIAL POLYOL SOLUTION:ORAL:CAPSULE, SOFT GELATIN:MG	ORAL	28.39MG ORAL CAPSULE, SOFT GELATIN	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
NA	SORBITOL SPECIAL POLYOL SOLUTION:ORAL:CAPSULE, SOFT GELATIN LIQUID-FILLED:NA	ORAL	ORAL CAPSULE, SOFT GELATIN LIQUID-FILLED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
NA	SORBITOL-GLYCERIN BLEND:ORAL:CAPSULE:MG	ORAL	163.58MG ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
NA	STARCH:BUCCAL:TABLET:MG	BUCCAL	22.5MG BUCCAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
NA	STARCH:BUCCAL/SUBLINGUAL:TABLET:MG	BUCCAL/SUBLINGUAL	14.19MG BUCCAL/SUBLINGUAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
NA	STARCH:INTRAMUSCULAR:INJECTION:%	INTRAMUSCULAR	0.6% INTRAMUSCULAR INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
NA	STARCH:ORAL:CAPSULE:MG	ORAL	605MG ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
NA	STARCH:ORAL:CAPSULE, COATED, HARD GELATIN:MG	ORAL	25MG ORAL CAPSULE, COATED, HARD GELATIN	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
NA	STARCH:ORAL:CAPSULE, DELAYED ACTION:MG	ORAL	43.5MG ORAL CAPSULE, DELAYED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
NA	STARCH:ORAL:CAPSULE, ENTERIC COATED PELLETS:MG	ORAL	36.4MG ORAL CAPSULE, ENTERIC COATED PELLETS	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
NA	STARCH:ORAL:CAPSULE, HARD GELATIN:MG	ORAL	33.5MG ORAL CAPSULE, HARD GELATIN	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
NA	STARCH:ORAL:CAPSULE, SOFT GELATIN:MG	ORAL	15.5MG ORAL CAPSULE, SOFT GELATIN	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
NA	STARCH:ORAL:CAPSULE, SUSTAINED ACTION:MG	ORAL	65.2MG ORAL CAPSULE, SUSTAINED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
NA	STARCH:ORAL:GRANULE, FOR SUSPENSION:NA	ORAL	ORAL GRANULE, FOR SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
NA	STARCH:ORAL:SUSPENSION:NA	ORAL	ORAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
NA	STARCH:ORAL:SUSPENSION, EXTENDED RELEASE:MG/5ML	ORAL	100MG/5ML ORAL SUSPENSION, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
NA	STARCH:ORAL:SYRUP:NA	ORAL	ORAL SYRUP	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
NA	STARCH:ORAL:TABLET:MG	ORAL	615.6MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
NA	STARCH:ORAL:TABLET (IMMED./COMP. RELEASE), FILM COATED:MG	ORAL	64.8MG ORAL TABLET (IMMED./COMP. RELEASE), FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
NA	STARCH:ORAL:TABLET (IMMED./COMP. RELEASE), UNCOATED, CHEWABLE:MG	ORAL	25.75MG ORAL TABLET (IMMED./COMP. RELEASE), UNCOATED, CHEWABLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
NA	STARCH:ORAL:TABLET, DELAYED ACTION:MG	ORAL	95MG ORAL TABLET, DELAYED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
NA	STARCH:ORAL:TABLET, DELAYED ACTION, ENTERIC COATED:MG	ORAL	100MG ORAL TABLET, DELAYED ACTION, ENTERIC COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
NA	STARCH:ORAL:TABLET, DELAYED RELEASE:MG	ORAL	71.5MG ORAL TABLET, DELAYED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
NA	STARCH:ORAL:TABLET, SUGAR COATED:MG	ORAL	43.25MG ORAL TABLET, SUGAR COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
NA	STARCH:ORAL:TABLET, SUSTAINED ACTION:MG	ORAL	50.39MG ORAL TABLET, SUSTAINED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
NA	STARCH:ORAL:TABLET, SUSTAINED ACTION, COATED:MG	ORAL	27MG ORAL TABLET, SUSTAINED ACTION, COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
NA	STARCH:ORAL:TABLET, SUSTAINED ACTION, FILM COATED:MG	ORAL	74.3MG ORAL TABLET, SUSTAINED ACTION, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
NA	STARCH:RECTAL:TABLET:MG	RECTAL	55MG RECTAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
NA	STARCH:SUBLINGUAL:TABLET:MG	SUBLINGUAL	75MG SUBLINGUAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
NA	STARCH:TOPICAL:EMULSION, CREAM:NA	TOPICAL	TOPICAL EMULSION, CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
NA	STARCH:VAGINAL:TABLET:MG	VAGINAL	305MG VAGINAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
NA	STARCH, MODIFIED:ORAL:CAPSULE:MG	ORAL	23MG ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
NA	STARCH, MODIFIED:ORAL:POWDER, FOR SUSPENSION:MG/5ML	ORAL	10MG/5ML ORAL POWDER, FOR SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
NA	STARCH, MODIFIED:ORAL:TABLET:MG	ORAL	50MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
NA	STARCH, PREGELATINIZED:ORAL:CAPSULE:MG	ORAL	452.79MG ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
NA	STARCH, PREGELATINIZED:ORAL:CAPSULE (IMMED./COMP. RELEASE), HARD GELATIN:MG	ORAL	70MG ORAL CAPSULE (IMMED./COMP. RELEASE), HARD GELATIN	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
NA	STARCH, PREGELATINIZED:ORAL:CAPSULE, COATED, SOFT GELATIN:MG	ORAL	15MG ORAL CAPSULE, COATED, SOFT GELATIN	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
NA	STARCH, PREGELATINIZED:ORAL:CAPSULE, EXTENDED RELEASE:MG	ORAL	6.56MG ORAL CAPSULE, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
NA	STARCH, PREGELATINIZED:ORAL:CAPSULE, HARD GELATIN:MG	ORAL	128.75MG ORAL CAPSULE, HARD GELATIN	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
NA	STARCH, PREGELATINIZED:ORAL:CAPSULE, SUSTAINED ACTION:MG	ORAL	141.75MG ORAL CAPSULE, SUSTAINED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
NA	STARCH, PREGELATINIZED:ORAL:DROPS:MG/1ML	ORAL	12MG/1ML ORAL DROPS	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
NA	STARCH, PREGELATINIZED:ORAL:SUSPENSION:MG/5ML	ORAL	75MG/5ML ORAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
NA	STARCH, PREGELATINIZED:ORAL:SUSPENSION, SUSTAINED ACTION:NA	ORAL	ORAL SUSPENSION, SUSTAINED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
NA	STARCH, PREGELATINIZED:ORAL:TABLET:MG	ORAL	345.95MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
NA	STARCH, PREGELATINIZED:ORAL:TABLET (IMMED./COMP. RELEASE), COATED:MG	ORAL	125MG ORAL TABLET (IMMED./COMP. RELEASE), COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
NA	STARCH, PREGELATINIZED:ORAL:TABLET (IMMED./COMP. RELEASE), FILM COATED:MG	ORAL	71.35MG ORAL TABLET (IMMED./COMP. RELEASE), FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
NA	STARCH, PREGELATINIZED:ORAL:TABLET (IMMED./COMP. RELEASE), UNCOATED, CHEWABLE:MG	ORAL	32MG ORAL TABLET (IMMED./COMP. RELEASE), UNCOATED, CHEWABLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
NA	STARCH, PREGELATINIZED:ORAL:TABLET, COATED:MG	ORAL	73MG ORAL TABLET, COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
NA	STARCH, PREGELATINIZED:ORAL:TABLET, CONTROLLED RELEASE:MG	ORAL	86.94MG ORAL TABLET, CONTROLLED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
NA	STARCH, PREGELATINIZED:ORAL:TABLET, DELAYED ACTION, ENTERIC COATED:MG	ORAL	64.8MG ORAL TABLET, DELAYED ACTION, ENTERIC COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
NA	STARCH, PREGELATINIZED:ORAL:TABLET, DELAYED RELEASE:MG	ORAL	22.5MG ORAL TABLET, DELAYED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
NA	STARCH, PREGELATINIZED:ORAL:TABLET, EXTENDED RELEASE:MG	ORAL	252.8MG ORAL TABLET, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
NA	STARCH, PREGELATINIZED:ORAL:TABLET, FILM COATED:MG	ORAL	240MG ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
NA	STARCH, PREGELATINIZED:ORAL:TABLET, ORALLY DISINTEGRATING:MG	ORAL	80MG ORAL TABLET, ORALLY DISINTEGRATING	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
NA	STARCH, PREGELATINIZED:ORAL:TABLET, SUGAR COATED:MG	ORAL	9.4MG ORAL TABLET, SUGAR COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
NA	STARCH, PREGELATINIZED:ORAL:TABLET, SUSTAINED ACTION:MG	ORAL	60MG ORAL TABLET, SUSTAINED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
NA	STARCH, PREGELATINIZED:ORAL:TABLET, SUSTAINED ACTION, COATED:MG	ORAL	33.75MG ORAL TABLET, SUSTAINED ACTION, COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
NA	STARCH, PREGELATINIZED:ORAL:TABLET, UNCOATED, LOZENGE:MG	ORAL	80MG ORAL TABLET, UNCOATED, LOZENGE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
NA	STARCH, PREGELATINIZED:SUBLINGUAL:TABLET:MG	SUBLINGUAL	60MG SUBLINGUAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
NA	STEARATES:ORAL:TABLET:MG	ORAL	4.5MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
NA	STEAR-O-WET C:ORAL:TABLET:MG	ORAL	12MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
NA	STEAR-O-WET M:ORAL:CAPSULE:MG	ORAL	14MG ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
NA	STEAR-O-WET M:ORAL:CAPSULE, COATED, SOFT GELATIN:MG	ORAL	1.5MG ORAL CAPSULE, COATED, SOFT GELATIN	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
NA	STEAR-O-WET M:ORAL:CAPSULE, HARD GELATIN:MG	ORAL	0.25MG ORAL CAPSULE, HARD GELATIN	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
NA	STEAR-O-WET M:ORAL:CAPSULE, SUSTAINED ACTION:MG	ORAL	6MG ORAL CAPSULE, SUSTAINED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
NA	STEAR-O-WET M:ORAL:TABLET:MG	ORAL	860MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
NA	STEAR-O-WET M:ORAL:TABLET (IMMED./COMP. RELEASE), FILM COATED:MG	ORAL	13.11MG ORAL TABLET (IMMED./COMP. RELEASE), FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
NA	STEAR-O-WET M:ORAL:TABLET, COATED:MG	ORAL	5.5MG ORAL TABLET, COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
NA	STEAR-O-WET M:ORAL:TABLET, DELAYED ACTION, ENTERIC COATED:MG	ORAL	1.2MG ORAL TABLET, DELAYED ACTION, ENTERIC COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
NA	STEAR-O-WET M:ORAL:TABLET, EXTENDED RELEASE:MG	ORAL	4MG ORAL TABLET, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
NA	STEAR-O-WET M:ORAL:TABLET, FILM COATED:MG	ORAL	18MG ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
NA	STEAROYL POLYOXYLGLYCERIDES:ORAL:CAPSULE:MG	ORAL	480MG ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
NA	STEAROYL POLYOXYLGLYCERIDES:ORAL:TABLET:MG	ORAL	2.6MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
NA	STEAROYL POLYOXYLGLYCERIDES:TOPICAL:CREAM:%W/W	TOPICAL	7.5%W/W TOPICAL CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
NA	SURELEASE E-719010 CLEAR:ORAL:CAPSULE:MG	ORAL	11.1MG ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
NA	SURELEASE E-719010 CLEAR:ORAL:CAPSULE, EXTENDED RELEASE:MG	ORAL	46.55MG ORAL CAPSULE, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
NA	SURELEASE E-719010 CLEAR:ORAL:CAPSULE, SUSTAINED ACTION:MG	ORAL	37.44MG ORAL CAPSULE, SUSTAINED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
NA	SURELEASE E-719010 CLEAR:ORAL:GRANULE:MG	ORAL	29.4MG ORAL GRANULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
NA	SURELEASE E-719010 CLEAR:ORAL:TABLET, DELAYED ACTION, ENTERIC COATED:MG	ORAL	2.5MG ORAL TABLET, DELAYED ACTION, ENTERIC COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
NA	SURELEASE E-719010 CLEAR:ORAL:TABLET, EXTENDED RELEASE:MG	ORAL	167.46MG ORAL TABLET, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
NA	SURELEASE E-7-7050:ORAL:CAPSULE, COATED PELLETS:MG	ORAL	39.8MG ORAL CAPSULE, COATED PELLETS	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
NA	SURELEASE E-7-7050:ORAL:CAPSULE, ENTERIC COATED PELLETS:MG	ORAL	28.33MG ORAL CAPSULE, ENTERIC COATED PELLETS	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
NA	SURELEASE E-7-7050:ORAL:TABLET, EXTENDED RELEASE:MG	ORAL	200MG ORAL TABLET, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
NA	SYNCHRON ORAL CARRIER:ORAL:TABLET, SUSTAINED ACTION:MG	ORAL	475MG ORAL TABLET, SUSTAINED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
NA	SYNTHETIC IRON OXIDES:ORAL:CAPSULE, DELAYED ACTION, ENTERIC COATED:NA	ORAL	ORAL CAPSULE, DELAYED ACTION, ENTERIC COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
NA	SYNTHETIC IRON OXIDES:ORAL:TABLET, ORALLY DISINTEGRATING:MG	ORAL	0.1MG ORAL TABLET, ORALLY DISINTEGRATING	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
NA	TEGACID:TOPICAL:EMULSION, CREAM:%W/W	TOPICAL	16%W/W TOPICAL EMULSION, CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
NA	TENOX:TOPICAL:EMULSION, CREAM:%W/W	TOPICAL	0.025%W/W TOPICAL EMULSION, CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
NA	TENOX:TOPICAL:OINTMENT:%W/W	TOPICAL	0.025%W/W TOPICAL OINTMENT	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
NA	TENOX-2:TOPICAL:OINTMENT:%W/W	TOPICAL	0.025%W/W TOPICAL OINTMENT	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
NA	TERPENE RESIN:ORAL:CAPSULE, SUSTAINED ACTION:NA	ORAL	ORAL CAPSULE, SUSTAINED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
NA	TIMING SOLUTION CLEAR N-7:ORAL:CAPSULE, SUSTAINED ACTION:MG	ORAL	26.2MG ORAL CAPSULE, SUSTAINED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
NA	UNION 76 AMSCO-RES 6038:TRANSDERMAL:FILM, CONTROLLED RELEASE:MG	TRANSDERMAL	5.7MG TRANSDERMAL FILM, CONTROLLED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=U
NA	VEGETABLE OIL:BUCCAL:GUM, CHEWING:MG	BUCCAL	14.4MG BUCCAL GUM, CHEWING	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=V
NA	VEGETABLE OIL:ORAL:CAPSULE:MG	ORAL	2MG ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=V
NA	VEGETABLE OIL:ORAL:GRANULE, FOR SUSPENSION:NA	ORAL	ORAL GRANULE, FOR SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=V
NA	VEGETABLE OIL:ORAL:SUSPENSION, SUSTAINED ACTION:NA	ORAL	ORAL SUSPENSION, SUSTAINED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=V
NA	VEGETABLE OIL:ORAL:TABLET:MG	ORAL	25MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=V
NA	VEGETABLE OIL:TOPICAL:EMULSION, CREAM:%W/W	TOPICAL	3.5%W/W TOPICAL EMULSION, CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=V
NA	VEGETABLE OIL:TOPICAL:SOLUTION:NA	TOPICAL	TOPICAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=V
NA	VEGETABLE OIL GLYCERIDE, HYDROGENATED:ORAL:TABLET, SUSTAINED ACTION:MG	ORAL	35MG ORAL TABLET, SUSTAINED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=V
NA	VEGETABLE OIL GLYCERIDE, HYDROGENATED:RECTAL:SUPPOSITORY:MG	RECTAL	870MG RECTAL SUPPOSITORY	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=V
NA	VEGETABLE OIL, HYDROGENATED:ORAL:CAPSULE:MG	ORAL	82MG ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=V
NA	VEGETABLE OIL, HYDROGENATED:ORAL:CAPSULE, EXTENDED RELEASE:MG	ORAL	9MG ORAL CAPSULE, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=V
NA	VEGETABLE OIL, HYDROGENATED:ORAL:CAPSULE, HARD GELATIN:MG	ORAL	261MG ORAL CAPSULE, HARD GELATIN	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=V
NA	VEGETABLE OIL, HYDROGENATED:ORAL:CAPSULE, SOFT GELATIN:MG	ORAL	82.8MG ORAL CAPSULE, SOFT GELATIN	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=V
NA	VEGETABLE OIL, HYDROGENATED:ORAL:CAPSULE, SOFT GELATIN LIQUID-FILLED:MG	ORAL	2.09MG ORAL CAPSULE, SOFT GELATIN LIQUID-FILLED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=V
NA	VEGETABLE OIL, HYDROGENATED:ORAL:TABLET:MG	ORAL	40MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=V
NA	VEGETABLE OIL, HYDROGENATED:ORAL:TABLET (IMMED./COMP. RELEASE), UNCOATED, CHEWABLE:MG	ORAL	8MG ORAL TABLET (IMMED./COMP. RELEASE), UNCOATED, CHEWABLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=V
NA	VEGETABLE OIL, HYDROGENATED:ORAL:TABLET, EXTENDED RELEASE:MG	ORAL	240MG ORAL TABLET, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=V
NA	VEGETABLE OIL, HYDROGENATED:ORAL:TABLET, FILM COATED:MG	ORAL	33MG ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=V
NA	VEGETABLE OIL, HYDROGENATED:ORAL:TABLET, SUSTAINED ACTION:MG	ORAL	228.5MG ORAL TABLET, SUSTAINED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=V
NA	VEGETABLE OIL, HYDROGENATED:RECTAL:SUPPOSITORY:MG	RECTAL	2026.5MG RECTAL SUPPOSITORY	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=V
NA	VEGETABLE OIL, HYDROGENATED:SUBLINGUAL:TABLET:MG	SUBLINGUAL	0.9MG SUBLINGUAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=V
NA	VEGETABLE OIL, HYDROGENATED:TOPICAL:EMULSION, CREAM:NA	TOPICAL	TOPICAL EMULSION, CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=V
NA	VEGETABLE OIL, HYDROGENATED:VAGINAL:SUPPOSITORY:MG	VAGINAL	2400MG VAGINAL SUPPOSITORY	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=V
NA	VEGETABLE OIL, HYDROGENATED:VAGINAL:SUPPOSITORY, INSERT:NA	VAGINAL	VAGINAL SUPPOSITORY, INSERT	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=V
NA	VEGETABLE SHORTENING:ORAL:CAPSULE:MG	ORAL	66.59MG ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=V
NA	VEGETABLE SHORTENING:ORAL:CAPSULE, SOFT GELATIN:NA	ORAL	ORAL CAPSULE, SOFT GELATIN	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=V
NA	VEGETABLE SHORTENING:ORAL:CAPSULE, SOFT GELATIN LIQUID-FILLED:MG	ORAL	8.34MG ORAL CAPSULE, SOFT GELATIN LIQUID-FILLED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=V
NA	WAX BLEND:ORAL:TABLET:NA	ORAL	ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=W
NA	WAX, VEGETABLE:ORAL:TABLET, ENTERIC COATED PARTICLES:MG	ORAL	2.5MG ORAL TABLET, ENTERIC COATED PARTICLES	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=W
058TS43PSM	SODIUM ALUMINOSILICATE:ORAL:TABLET:MG	ORAL	94MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
058TS43PSM	SODIUM ALUMINOSILICATE:ORAL:TABLET, EXTENDED RELEASE:MG	ORAL	94MG ORAL TABLET, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
058TS43PSM	SODIUM ALUMINOSILICATE:ORAL:TABLET, SUSTAINED ACTION:MG	ORAL	2MG ORAL TABLET, SUSTAINED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
SMD1X3XO9M	POWDERED CELLULOSE:BUCCAL/SUBLINGUAL:TABLET:MG	BUCCAL/SUBLINGUAL	4.5MG BUCCAL/SUBLINGUAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
SMD1X3XO9M	POWDERED CELLULOSE:ORAL:CAPSULE:MG	ORAL	405MG ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
SMD1X3XO9M	POWDERED CELLULOSE:ORAL:CAPSULE, DELAYED ACTION:MG	ORAL	8.5MG ORAL CAPSULE, DELAYED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
SMD1X3XO9M	POWDERED CELLULOSE:ORAL:CAPSULE, HARD GELATIN:MG	ORAL	140MG ORAL CAPSULE, HARD GELATIN	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
SMD1X3XO9M	POWDERED CELLULOSE:ORAL:DROPS:NA	ORAL	ORAL DROPS	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
SMD1X3XO9M	POWDERED CELLULOSE:ORAL:LIQUID:NA	ORAL	ORAL LIQUID	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
SMD1X3XO9M	POWDERED CELLULOSE:ORAL:POWDER, FOR SUSPENSION:NA	ORAL	ORAL POWDER, FOR SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
SMD1X3XO9M	POWDERED CELLULOSE:ORAL:SUSPENSION:MG/5ML	ORAL	100MG/5ML ORAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
SMD1X3XO9M	POWDERED CELLULOSE:ORAL:TABLET:MG	ORAL	560MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
SMD1X3XO9M	POWDERED CELLULOSE:ORAL:TABLET (IMMED./COMP. RELEASE), UNCOATED, CHEWABLE:NA	ORAL	ORAL TABLET (IMMED./COMP. RELEASE), UNCOATED, CHEWABLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
SMD1X3XO9M	POWDERED CELLULOSE:ORAL:TABLET, COATED:MG	ORAL	40.2MG ORAL TABLET, COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
SMD1X3XO9M	POWDERED CELLULOSE:ORAL:TABLET, DELAYED ACTION, ENTERIC COATED:MG	ORAL	16MG ORAL TABLET, DELAYED ACTION, ENTERIC COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
SMD1X3XO9M	POWDERED CELLULOSE:ORAL:TABLET, FILM COATED:MG	ORAL	391.7MG ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
SMD1X3XO9M	POWDERED CELLULOSE:ORAL:TABLET, SUSTAINED ACTION:MG	ORAL	110.6MG ORAL TABLET, SUSTAINED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
SMD1X3XO9M	POWDERED CELLULOSE:ORAL:TABLET, SUSTAINED ACTION, COATED:MG	ORAL	42.25MG ORAL TABLET, SUSTAINED ACTION, COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
SMD1X3XO9M	POWDERED CELLULOSE:ORAL-20:TABLET:mg	ORAL-20	96.25mg ORAL-20 TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
SMD1X3XO9M	POWDERED CELLULOSE:SUBLINGUAL:TABLET:MG	SUBLINGUAL	2MG SUBLINGUAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
SMD1X3XO9M	POWDERED CELLULOSE:TOPICAL:DISC:NA	TOPICAL	TOPICAL DISC	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
BPV390UAP0	SODIUM LAURETH-3 SULFATE:ORAL:CAPSULE:MG	ORAL	3.5MG ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
BPV390UAP0	SODIUM LAURETH-3 SULFATE:ORAL:TABLET:MG	ORAL	0.91MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
BPV390UAP0	SODIUM LAURETH-3 SULFATE:TOPICAL:EMULSION, CREAM:NA	TOPICAL	TOPICAL EMULSION, CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
BPV390UAP0	SODIUM LAURETH-3 SULFATE:TOPICAL:SHAMPOO:%W/W	TOPICAL	36%W/W TOPICAL SHAMPOO	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
BPV390UAP0	SODIUM LAURETH-3 SULFATE:TOPICAL:SPRAY:%W/W	TOPICAL	0.1%W/W TOPICAL SPRAY	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
2225PI3MOV	THIMEROSAL:AURICULAR (OTIC):SUSPENSION:%	AURICULAR (OTIC)	0.01% AURICULAR (OTIC) SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
2225PI3MOV	THIMEROSAL:IM - IV:INJECTION:%	IM - IV	0.03% IM - IV INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
2225PI3MOV	THIMEROSAL:IM - IV - SC:INJECTION:NA	IM - IV - SC	IM - IV - SC INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
2225PI3MOV	THIMEROSAL:IM - SC:INJECTION:NA	IM - SC	IM - SC INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
2225PI3MOV	THIMEROSAL:INTRAMUSCULAR:INJECTION:%W/V	INTRAMUSCULAR	0.008%W/V INTRAMUSCULAR INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
2225PI3MOV	THIMEROSAL:INTRAMUSCULAR:INJECTION, SUSTAINED ACTION:%	INTRAMUSCULAR	0.002% INTRAMUSCULAR INJECTION, SUSTAINED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
2225PI3MOV	THIMEROSAL:INTRAVENOUS:POWDER, FOR INJECTION SOLUTION:NA	INTRAVENOUS	INTRAVENOUS POWDER, FOR INJECTION SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
2225PI3MOV	THIMEROSAL:OPHTHALMIC:SOLUTION:%	OPHTHALMIC	0.01% OPHTHALMIC SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
2225PI3MOV	THIMEROSAL:OPHTHALMIC:SOLUTION, DROPS:%	OPHTHALMIC	0.001% OPHTHALMIC SOLUTION, DROPS	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
2225PI3MOV	THIMEROSAL:OPHTHALMIC:SUSPENSION:%	OPHTHALMIC	1% OPHTHALMIC SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
2225PI3MOV	THIMEROSAL:OPHTHALMIC:SUSPENSION, DROPS:%	OPHTHALMIC	1% OPHTHALMIC SUSPENSION, DROPS	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
2225PI3MOV	THIMEROSAL:SUBCUTANEOUS:INJECTION:%	SUBCUTANEOUS	0.001% SUBCUTANEOUS INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
2225PI3MOV	THIMEROSAL:SUBCUTANEOUS:POWDER, FOR INJECTION SOLUTION:NA	SUBCUTANEOUS	SUBCUTANEOUS POWDER, FOR INJECTION SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
2225PI3MOV	THIMEROSAL:SUBCUTANEOUS:SOLUTION, INJECTION:%	SUBCUTANEOUS	0.01% SUBCUTANEOUS SOLUTION, INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
2225PI3MOV	THIMEROSAL:TOPICAL:EMULSION, CREAM:NA	TOPICAL	TOPICAL EMULSION, CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
2225PI3MOV	THIMEROSAL:TOPICAL:LOTION:NA	TOPICAL	TOPICAL LOTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
2225PI3MOV	THIMEROSAL:TOPICAL:OINTMENT:%W/W	TOPICAL	0.04%W/W TOPICAL OINTMENT	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
4F6FC4MI8W	LAURAMINE OXIDE:TOPICAL:SOLUTION:%W/W	TOPICAL	4.8%W/W TOPICAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
4F6FC4MI8W	LAURAMINE OXIDE:TOPICAL:SPONGE:NA	TOPICAL	TOPICAL SPONGE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
9DLQ4CIU6V	PROLINE:IV(INFUSION):INJECTION:%	IV(INFUSION)	35.6% IV(INFUSION) INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
9DLQ4CIU6V	PROLINE:IV(INFUSION):SOLUTION, INJECTION:%	IV(INFUSION)	0.34% IV(INFUSION) SOLUTION, INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
01Q9PC255D	AMMONIUM CHLORIDE:ORAL:SYRUP:MG/5ML	ORAL	131.68MG/5ML ORAL SYRUP	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
01Q9PC255D	AMMONIUM CHLORIDE:ORAL:TABLET:MG	ORAL	4.2MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
01Q9PC255D	AMMONIUM CHLORIDE:ORAL:TABLET, EXTENDED RELEASE:MG	ORAL	10.67MG ORAL TABLET, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
01Q9PC255D	AMMONIUM CHLORIDE:ORAL:TABLET, FILM COATED:MG	ORAL	8MG ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
SB8ZUX40TY	SACCHARIN SODIUM:BUCCAL:FILM:MG	BUCCAL	2.99MG BUCCAL FILM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
SB8ZUX40TY	SACCHARIN SODIUM:BUCCAL:FILM, SOLUBLE:MG	BUCCAL	0.57MG BUCCAL FILM, SOLUBLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
SB8ZUX40TY	SACCHARIN SODIUM:BUCCAL/SUBLINGUAL:TABLET:MG	BUCCAL/SUBLINGUAL	0.4MG BUCCAL/SUBLINGUAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
SB8ZUX40TY	SACCHARIN SODIUM:DENTAL:GEL:%	DENTAL	0.3% DENTAL GEL	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
SB8ZUX40TY	SACCHARIN SODIUM:DENTAL:OINTMENT:NA	DENTAL	DENTAL OINTMENT	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
SB8ZUX40TY	SACCHARIN SODIUM:DENTAL:PASTE:NA	DENTAL	DENTAL PASTE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
SB8ZUX40TY	SACCHARIN SODIUM:DENTAL:SOLUTION:%	DENTAL	0.15% DENTAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
SB8ZUX40TY	SACCHARIN SODIUM:IM - IV:INJECTION:%	IM - IV	0.09% IM - IV INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
SB8ZUX40TY	SACCHARIN SODIUM:INHALATION:AEROSOL, METERED:%	INHALATION	0.045% INHALATION AEROSOL, METERED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
SB8ZUX40TY	SACCHARIN SODIUM:INHALATION:SOLUTION:NA	INHALATION	INHALATION SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
SB8ZUX40TY	SACCHARIN SODIUM:INTRAMUSCULAR:INJECTION:%W/V	INTRAMUSCULAR	0.09%W/V INTRAMUSCULAR INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
SB8ZUX40TY	SACCHARIN SODIUM:INTRAVENOUS:INJECTION:%	INTRAVENOUS	0.09% INTRAVENOUS INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
SB8ZUX40TY	SACCHARIN SODIUM:IV(INFUSION):INJECTION:%	IV(INFUSION)	0.09% IV(INFUSION) INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
SB8ZUX40TY	SACCHARIN SODIUM:ORAL:CAPSULE:MG	ORAL	2.02MG ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
SB8ZUX40TY	SACCHARIN SODIUM:ORAL:CAPSULE, SOFT GELATIN:MG	ORAL	0.51MG ORAL CAPSULE, SOFT GELATIN	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
SB8ZUX40TY	SACCHARIN SODIUM:ORAL:CONCENTRATE:MG/1ML	ORAL	1.5MG/1ML ORAL CONCENTRATE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
SB8ZUX40TY	SACCHARIN SODIUM:ORAL:DISPERSIBLE TABLET:MG	ORAL	0.5MG ORAL DISPERSIBLE TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
SB8ZUX40TY	SACCHARIN SODIUM:ORAL:EMULSION:NA	ORAL	ORAL EMULSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
SB8ZUX40TY	SACCHARIN SODIUM:ORAL:GRANULE, for ORAL SOLUTION:MG/SACHET	ORAL	5.5MG/SACHET ORAL GRANULE, for ORAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
SB8ZUX40TY	SACCHARIN SODIUM:ORAL:LIQUID:MG/ML	ORAL	6MG/ML ORAL LIQUID	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
SB8ZUX40TY	SACCHARIN SODIUM:ORAL:POWDER:MG	ORAL	0.003MG ORAL POWDER	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
SB8ZUX40TY	SACCHARIN SODIUM:ORAL:POWDER, FOR ORAL SOLUTION:MG	ORAL	60MG ORAL POWDER, FOR ORAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
SB8ZUX40TY	SACCHARIN SODIUM:ORAL:POWDER, FOR ORAL SUSPENSION:MG/5ML	ORAL	5MG/5ML ORAL POWDER, FOR ORAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
SB8ZUX40TY	SACCHARIN SODIUM:ORAL:POWDER, FOR RECONSTITUTION:MG/1BOT	ORAL	290MG/1BOT ORAL POWDER, FOR RECONSTITUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
SB8ZUX40TY	SACCHARIN SODIUM:ORAL:POWDER, FOR SOLUTION:MG/1BOT	ORAL	391.9MG/1BOT ORAL POWDER, FOR SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
SB8ZUX40TY	SACCHARIN SODIUM:ORAL:POWDER, FOR SUSPENSION:MG/5ML	ORAL	32.5MG/5ML ORAL POWDER, FOR SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
SB8ZUX40TY	SACCHARIN SODIUM:ORAL:SOLUTION:MG/15ML	ORAL	75MG/15ML ORAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
SB8ZUX40TY	SACCHARIN SODIUM:ORAL:SOLUTION:MG	ORAL	15MG ORAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
SB8ZUX40TY	SACCHARIN SODIUM:ORAL:SOLUTION, ELIXIR:MG/5ML	ORAL	15MG/5ML ORAL SOLUTION, ELIXIR	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
SB8ZUX40TY	SACCHARIN SODIUM:ORAL:SOLUTION, LIQUID:MG/1ML	ORAL	3MG/1ML ORAL SOLUTION, LIQUID	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
SB8ZUX40TY	SACCHARIN SODIUM:ORAL:SOLUTION, SYRUP:MG/1ML	ORAL	6MG/1ML ORAL SOLUTION, SYRUP	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
SB8ZUX40TY	SACCHARIN SODIUM:ORAL:SUSPENSION:mg/5mL	ORAL	20mg/5mL ORAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
SB8ZUX40TY	SACCHARIN SODIUM:ORAL:SUSPENSION, LIQUID:MG/5ML	ORAL	2.5MG/5ML ORAL SUSPENSION, LIQUID	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
SB8ZUX40TY	SACCHARIN SODIUM:ORAL:SYRUP:MG/5ML	ORAL	50MG/5ML ORAL SYRUP	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
SB8ZUX40TY	SACCHARIN SODIUM:ORAL:TABLET:MG	ORAL	20MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
SB8ZUX40TY	SACCHARIN SODIUM:ORAL:TABLET (IMMED./COMP. RELEASE), UNCOATED, CHEWABLE:MG	ORAL	9MG ORAL TABLET (IMMED./COMP. RELEASE), UNCOATED, CHEWABLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
SB8ZUX40TY	SACCHARIN SODIUM:ORAL:TABLET, CHEWABLE:MG	ORAL	5MG ORAL TABLET, CHEWABLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
SB8ZUX40TY	SACCHARIN SODIUM:ORAL:TABLET, FILM COATED:MG	ORAL	2MG ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
SB8ZUX40TY	SACCHARIN SODIUM:ORAL:TABLET, ORALLY DISINTEGRATING:MG	ORAL	2.5MG ORAL TABLET, ORALLY DISINTEGRATING	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
SB8ZUX40TY	SACCHARIN SODIUM:RECTAL:SOLUTION:%	RECTAL	0.085% RECTAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
SB8ZUX40TY	SACCHARIN SODIUM:RECTAL:SUSPENSION:%	RECTAL	0.036% RECTAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
SB8ZUX40TY	SACCHARIN SODIUM:RECTAL:TABLET:MG	RECTAL	0.6MG RECTAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
SB8ZUX40TY	SACCHARIN SODIUM:SUBLINGUAL:TABLET:MG	SUBLINGUAL	6.5MG SUBLINGUAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
SB8ZUX40TY	SACCHARIN SODIUM:TOPICAL:OINTMENT:NA	TOPICAL	TOPICAL OINTMENT	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
LMI26O6933	ALUMINUM OXIDE:ORAL:TABLET:NA	ORAL	ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
LMI26O6933	ALUMINUM OXIDE:TOPICAL:SPONGE:NA	TOPICAL	TOPICAL SPONGE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
LU49E6626Q	AMINOMETHYLPROPANOL:TOPICAL:EMULSION, CREAM:%W/W	TOPICAL	1%W/W TOPICAL EMULSION, CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
LU49E6626Q	AMINOMETHYLPROPANOL:TOPICAL:LOTION:%W/W	TOPICAL	0.1%W/W TOPICAL LOTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
W9Q9OB858O	ACID ORANGE 20:ORAL:TABLET:NA	ORAL	ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
3J2P07GVB6	CELLULOSE ACETATE:ORAL:CAPSULE:MG	ORAL	22.15MG ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
3J2P07GVB6	CELLULOSE ACETATE:ORAL:TABLET:mg	ORAL	25.2mg ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
3J2P07GVB6	CELLULOSE ACETATE:ORAL:TABLET (IMMED./COMP. RELEASE), UNCOATED, CHEWABLE:MG	ORAL	6.86MG ORAL TABLET (IMMED./COMP. RELEASE), UNCOATED, CHEWABLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
3J2P07GVB6	CELLULOSE ACETATE:ORAL:TABLET, CONTROLLED RELEASE:MG	ORAL	27.72MG ORAL TABLET, CONTROLLED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
3J2P07GVB6	CELLULOSE ACETATE:ORAL:TABLET, EXTENDED RELEASE:MG	ORAL	50.16MG ORAL TABLET, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
3J2P07GVB6	CELLULOSE ACETATE:ORAL:TABLET, SUSTAINED ACTION:MG	ORAL	37.32MG ORAL TABLET, SUSTAINED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
3J2P07GVB6	CELLULOSE ACETATE:ORAL:TABLET, SUSTAINED ACTION, COATED:MG	ORAL	44.6MG ORAL TABLET, SUSTAINED ACTION, COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
ECW0LZ41X8	D&C RED NO. 7:ORAL:CAPSULE:NA	ORAL	ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
ECW0LZ41X8	D&C RED NO. 7:ORAL:CAPSULE, ENTERIC COATED PELLETS:NA	ORAL	ORAL CAPSULE, ENTERIC COATED PELLETS	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
ECW0LZ41X8	D&C RED NO. 7:ORAL:CAPSULE, HARD GELATIN:NA	ORAL	ORAL CAPSULE, HARD GELATIN	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
ECW0LZ41X8	D&C RED NO. 7:ORAL:TABLET:MG	ORAL	0.5MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
ECW0LZ41X8	D&C RED NO. 7:ORAL:TABLET, CHEWABLE:MG	ORAL	0.4MG ORAL TABLET, CHEWABLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
ECW0LZ41X8	D&C RED NO. 7:ORAL:TABLET, COATED:NA	ORAL	ORAL TABLET, COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
ECW0LZ41X8	D&C RED NO. 7:ORAL:TABLET, FILM COATED:MG	ORAL	0.16MG ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
ECW0LZ41X8	D&C RED NO. 7:ORAL:TABLET, SUSTAINED ACTION:NA	ORAL	ORAL TABLET, SUSTAINED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
ECW0LZ41X8	D&C RED NO. 7:SUBLINGUAL:TABLET:MG	SUBLINGUAL	0.005MG SUBLINGUAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
5T9Z06LCV4	O-TOLYL BIGUANIDE:TOPICAL:SOLUTION:%W/W	TOPICAL	0.013%W/W TOPICAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
65OE787Q7W	POTASSIUM METABISULFITE:AN,INFILTRATION:INJECTION:NA	AN,INFILTRATION	AN,INFILTRATION INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
65OE787Q7W	POTASSIUM METABISULFITE:AN,INFILTRATION:SOLUTION, INJECTION:NA	AN,INFILTRATION	AN,INFILTRATION SOLUTION, INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
65OE787Q7W	POTASSIUM METABISULFITE:AURICULAR (OTIC):SOLUTION:%	AURICULAR (OTIC)	0.11% AURICULAR (OTIC) SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
65OE787Q7W	POTASSIUM METABISULFITE:AURICULAR (OTIC):SUSPENSION:NA	AURICULAR (OTIC)	AURICULAR (OTIC) SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
65OE787Q7W	POTASSIUM METABISULFITE:IM - IV:INJECTION:%	IM - IV	0.1% IM - IV INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
65OE787Q7W	POTASSIUM METABISULFITE:INTRAVENOUS:INJECTION:NA	INTRAVENOUS	INTRAVENOUS INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
65OE787Q7W	POTASSIUM METABISULFITE:IV(INFUSION):INJECTION:%	IV(INFUSION)	0.06% IV(INFUSION) INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
65OE787Q7W	POTASSIUM METABISULFITE:IV(INFUSION):SOLUTION, INJECTION:%	IV(INFUSION)	0.05% IV(INFUSION) SOLUTION, INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
65OE787Q7W	POTASSIUM METABISULFITE:NERVE BLOCK:INJECTION:NA	NERVE BLOCK	NERVE BLOCK INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
65OE787Q7W	POTASSIUM METABISULFITE:NERVE BLOCK:SOLUTION, INJECTION:NA	NERVE BLOCK	NERVE BLOCK SOLUTION, INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
65OE787Q7W	POTASSIUM METABISULFITE:RECTAL:ENEMA:%	RECTAL	0.47% RECTAL ENEMA	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
U076Q6Q621	POLYETHYLENE GLYCOL 1000:ORAL:CONCENTRATE:MG/1ML	ORAL	100MG/1ML ORAL CONCENTRATE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
U076Q6Q621	POLYETHYLENE GLYCOL 1000:ORAL:SOLUTION:MG/5ML	ORAL	1000MG/5ML ORAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
U076Q6Q621	POLYETHYLENE GLYCOL 1000:ORAL:TABLET, FILM COATED:MG	ORAL	1.52MG ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
U076Q6Q621	POLYETHYLENE GLYCOL 1000:RECTAL:SUPPOSITORY:MG	RECTAL	1658MG RECTAL SUPPOSITORY	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
U076Q6Q621	POLYETHYLENE GLYCOL 1000:RESPIRATORY (INHALATION):AEROSOL, METERED:%	RESPIRATORY (INHALATION)	0.022% RESPIRATORY (INHALATION) AEROSOL, METERED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
U076Q6Q621	POLYETHYLENE GLYCOL 1000:TOPICAL:EMULSION, AEROSOL FOAM:NA	TOPICAL	TOPICAL EMULSION, AEROSOL FOAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
U076Q6Q621	POLYETHYLENE GLYCOL 1000:TOPICAL:EMULSION, CREAM:%W/W	TOPICAL	0.5%W/W TOPICAL EMULSION, CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
U076Q6Q621	POLYETHYLENE GLYCOL 1000:TRANSDERMAL:GEL:%	TRANSDERMAL	0.5% TRANSDERMAL GEL	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
U076Q6Q621	POLYETHYLENE GLYCOL 1000:VAGINAL:SUPPOSITORY:NA	VAGINAL	VAGINAL SUPPOSITORY	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
BXR49TP611	ISOBUTANE:RECTAL:EMULSION, AEROSOL FOAM:%	RECTAL	5.52% RECTAL EMULSION, AEROSOL FOAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=I
BXR49TP611	ISOBUTANE:TOPICAL:AEROSOL:%W/W	TOPICAL	82.4%W/W TOPICAL AEROSOL	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=I
BXR49TP611	ISOBUTANE:TOPICAL:AEROSOL, SPRAY:%W/W	TOPICAL	82.39%W/W TOPICAL AEROSOL, SPRAY	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=I
BXR49TP611	ISOBUTANE:TOPICAL:SPRAY:%W/W	TOPICAL	82.4%W/W TOPICAL SPRAY	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=I
8CRQ2TH63M	ISOPROPYL PALMITATE:TOPICAL:AEROSOL:%W/W	TOPICAL	7.3%W/W TOPICAL AEROSOL	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=I
8CRQ2TH63M	ISOPROPYL PALMITATE:TOPICAL:AEROSOL, SPRAY:%W/W	TOPICAL	7.3%W/W TOPICAL AEROSOL, SPRAY	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=I
8CRQ2TH63M	ISOPROPYL PALMITATE:TOPICAL:CREAM:%W/W	TOPICAL	4.5%W/W TOPICAL CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=I
8CRQ2TH63M	ISOPROPYL PALMITATE:TOPICAL:CREAM, AUGMENTED:%W/W	TOPICAL	4%W/W TOPICAL CREAM, AUGMENTED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=I
8CRQ2TH63M	ISOPROPYL PALMITATE:TOPICAL:CREAM, EMULSION, SUSTAINED RELEASE:%W/W	TOPICAL	1.8%W/W TOPICAL CREAM, EMULSION, SUSTAINED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=I
8CRQ2TH63M	ISOPROPYL PALMITATE:TOPICAL:EMULSION, CREAM:%W/W	TOPICAL	5%W/W TOPICAL EMULSION, CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=I
8CRQ2TH63M	ISOPROPYL PALMITATE:TOPICAL:GEL:%W/W	TOPICAL	0.001%W/W TOPICAL GEL	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=I
8CRQ2TH63M	ISOPROPYL PALMITATE:TOPICAL:LOTION:%W/W	TOPICAL	5%W/W TOPICAL LOTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=I
8CRQ2TH63M	ISOPROPYL PALMITATE:TOPICAL:OINTMENT:NA	TOPICAL	TOPICAL OINTMENT	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=I
8CRQ2TH63M	ISOPROPYL PALMITATE:TOPICAL:SPRAY:%W/W	TOPICAL	7.3%W/W TOPICAL SPRAY	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=I
8CRQ2TH63M	ISOPROPYL PALMITATE:TRANSDERMAL:FILM:MG	TRANSDERMAL	1.81MG TRANSDERMAL FILM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=I
8CRQ2TH63M	ISOPROPYL PALMITATE:TRANSDERMAL:FILM, CONTROLLED RELEASE:MG	TRANSDERMAL	187.5MG TRANSDERMAL FILM, CONTROLLED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=I
37RBV3X49K	AMARANTH:ORAL:CAPSULE:MG	ORAL	0.1MG ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
37RBV3X49K	AMARANTH:ORAL:CAPSULE (IMMED./COMP. RELEASE), SOFT GELATIN, PERLE:MG	ORAL	0.18MG ORAL CAPSULE (IMMED./COMP. RELEASE), SOFT GELATIN, PERLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
37RBV3X49K	AMARANTH:ORAL:CAPSULE, EXTENDED RELEASE:MG	ORAL	2.9MG ORAL CAPSULE, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
37RBV3X49K	AMARANTH:ORAL:CAPSULE, SOFT GELATIN:MG	ORAL	0.092MG ORAL CAPSULE, SOFT GELATIN	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
37RBV3X49K	AMARANTH:ORAL:CAPSULE, SUSTAINED ACTION:MG	ORAL	0.1MG ORAL CAPSULE, SUSTAINED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
37RBV3X49K	AMARANTH:ORAL:CONCENTRATE:MG	ORAL	0.1MG ORAL CONCENTRATE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
37RBV3X49K	AMARANTH:ORAL:DROPS:NA	ORAL	ORAL DROPS	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
37RBV3X49K	AMARANTH:ORAL:LIQUID:MG/5ML	ORAL	0.008MG/5ML ORAL LIQUID	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
37RBV3X49K	AMARANTH:ORAL:POWDER, FOR SUSPENSION:NA	ORAL	ORAL POWDER, FOR SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
37RBV3X49K	AMARANTH:ORAL:SOLUTION, ELIXIR:MG/5ML	ORAL	0.1MG/5ML ORAL SOLUTION, ELIXIR	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
37RBV3X49K	AMARANTH:ORAL:SUSPENSION:NA	ORAL	ORAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
37RBV3X49K	AMARANTH:ORAL:SYRUP:%	ORAL	0.003% ORAL SYRUP	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
37RBV3X49K	AMARANTH:ORAL:TABLET:MG	ORAL	0.57MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
37RBV3X49K	AMARANTH:ORAL:TABLET, COATED:MG	ORAL	0.02MG ORAL TABLET, COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
37RBV3X49K	AMARANTH:ORAL:TABLET, FILM COATED:MG	ORAL	0.003MG ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
37RBV3X49K	AMARANTH:TOPICAL:EMULSION, CREAM:NA	TOPICAL	TOPICAL EMULSION, CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
JR9CE63FPM	METHYLPYRROLIDONE:PERIODONTAL:DRUG DELIVERY SYSTEM:NA	PERIODONTAL	PERIODONTAL DRUG DELIVERY SYSTEM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
JR9CE63FPM	METHYLPYRROLIDONE:SUBCUTANEOUS:INJECTION:%	SUBCUTANEOUS	25.85% SUBCUTANEOUS INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
JR9CE63FPM	METHYLPYRROLIDONE:SUBCUTANEOUS:INJECTION, SUSPENSION:mg	SUBCUTANEOUS	376mg SUBCUTANEOUS INJECTION, SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
023C2WHX2V	TROMETHAMINE:IM - IV:INJECTABLE:%	IM - IV	1.1% IM - IV INJECTABLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
023C2WHX2V	TROMETHAMINE:IM - IV:INJECTION, SOLUTION:%	IM - IV	1.21% IM - IV INJECTION, SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
023C2WHX2V	TROMETHAMINE:INTRA-ARTERIAL:INJECTION:%	INTRA-ARTERIAL	0.24% INTRA-ARTERIAL INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
023C2WHX2V	TROMETHAMINE:INTRAMUSCULAR:INJECTION:%W/V	INTRAMUSCULAR	0.1%W/V INTRAMUSCULAR INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
023C2WHX2V	TROMETHAMINE:INTRATHECAL:INJECTION:NA	INTRATHECAL	INTRATHECAL INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
023C2WHX2V	TROMETHAMINE:INTRATHECAL:SOLUTION:MG/ML	INTRATHECAL	1.21MG/ML INTRATHECAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
023C2WHX2V	TROMETHAMINE:INTRATRACHEAL:SUSPENSION:%	INTRATRACHEAL	0.24% INTRATRACHEAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
023C2WHX2V	TROMETHAMINE:INTRATYMPANIC:SUSPENSION:%W/W	INTRATYMPANIC	0.56%W/W INTRATYMPANIC SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
023C2WHX2V	TROMETHAMINE:INTRAVASCULAR:INJECTION:%	INTRAVASCULAR	1% INTRAVASCULAR INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
023C2WHX2V	TROMETHAMINE:INTRAVASCULAR:SOLUTION:MG/ML	INTRAVASCULAR	1.21MG/ML INTRAVASCULAR SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
023C2WHX2V	TROMETHAMINE:INTRAVASCULAR:SOLUTION, INJECTION:%	INTRAVASCULAR	0.1% INTRAVASCULAR SOLUTION, INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
023C2WHX2V	TROMETHAMINE:INTRAVENOUS:INJECTABLE:%	INTRAVENOUS	1.2% INTRAVENOUS INJECTABLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
023C2WHX2V	TROMETHAMINE:INTRAVENOUS:INJECTION:%	INTRAVENOUS	1.2% INTRAVENOUS INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
023C2WHX2V	TROMETHAMINE:INTRAVENOUS:SOLUTION:NA	INTRAVENOUS	INTRAVENOUS SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
023C2WHX2V	TROMETHAMINE:INTRAVENOUS:SOLUTION, INJECTION:%W/V	INTRAVENOUS	0.12%W/V INTRAVENOUS SOLUTION, INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
023C2WHX2V	TROMETHAMINE:IV(INFUSION):INJECTION:%	IV(INFUSION)	0.005% IV(INFUSION) INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
023C2WHX2V	TROMETHAMINE:IV(INFUSION):POWDER, FOR INJECTION SUSPENSION, LYOPHILIZED:%	IV(INFUSION)	0.61% IV(INFUSION) POWDER, FOR INJECTION SUSPENSION, LYOPHILIZED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
023C2WHX2V	TROMETHAMINE:IV(INFUSION):SOLUTION:MG/ML	IV(INFUSION)	1.21MG/ML IV(INFUSION) SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
023C2WHX2V	TROMETHAMINE:IV(INFUSION):SOLUTION, INJECTION:%	IV(INFUSION)	0.004% IV(INFUSION) SOLUTION, INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
023C2WHX2V	TROMETHAMINE:OPHTHALMIC:SOLUTION:%	OPHTHALMIC	0.94% OPHTHALMIC SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
023C2WHX2V	TROMETHAMINE:OPHTHALMIC:SOLUTION, DROPS:%	OPHTHALMIC	0.75% OPHTHALMIC SOLUTION, DROPS	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
023C2WHX2V	TROMETHAMINE:OPHTHALMIC:SOLUTION, GEL FORMING, EXTENDED RELEASE:%	OPHTHALMIC	0.8% OPHTHALMIC SOLUTION, GEL FORMING, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
023C2WHX2V	TROMETHAMINE:OPHTHALMIC:SUSPENSION, DROPS:ADJ PH	OPHTHALMIC	ADJ PH OPHTHALMIC SUSPENSION, DROPS	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
023C2WHX2V	TROMETHAMINE:ORAL:CAPSULE, SOFT GELATIN:MG	ORAL	15MG ORAL CAPSULE, SOFT GELATIN	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
023C2WHX2V	TROMETHAMINE:ORAL:SOLUTION:MG/ML	ORAL	1.21MG/ML ORAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
023C2WHX2V	TROMETHAMINE:ORAL:SOLUTION/DROPS:%W/V	ORAL	0.76%W/V ORAL SOLUTION/DROPS	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
023C2WHX2V	TROMETHAMINE:ORAL:TABLET:MG	ORAL	14.01MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
023C2WHX2V	TROMETHAMINE:RECTAL:SOLUTION:MG/ML	RECTAL	1.21MG/ML RECTAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
023C2WHX2V	TROMETHAMINE:RESPIRATORY (INHALATION):SOLUTION, FOR INHALATION:%	RESPIRATORY (INHALATION)	0.012% RESPIRATORY (INHALATION) SOLUTION, FOR INHALATION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
023C2WHX2V	TROMETHAMINE:SUBCUTANEOUS:INJECTION:%	SUBCUTANEOUS	0.6% SUBCUTANEOUS INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
023C2WHX2V	TROMETHAMINE:TOPICAL:GEL:%W/W	TOPICAL	0.8%W/W TOPICAL GEL	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
023C2WHX2V	TROMETHAMINE:TOPICAL:SOLUTION:%W/W	TOPICAL	8.4%W/W TOPICAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
023C2WHX2V	TROMETHAMINE:TRANSDERMAL:GEL:%W/W	TRANSDERMAL	0.1%W/W TRANSDERMAL GEL	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
023C2WHX2V	TROMETHAMINE:URETHRAL:SOLUTION:%	URETHRAL	0.12% URETHRAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
2T6YOF5WQT	METHOXY PEG-22/DODECYL GLYCOL COPOLYMER:TOPICAL:CREAM, AUGMENTED:%W/W	TOPICAL	5%W/W TOPICAL CREAM, AUGMENTED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
EE90ONI6FF	POTASSIUM CITRATE:ORAL:POWDER, FOR ORAL SOLUTION:MG	ORAL	32.5MG ORAL POWDER, FOR ORAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
EE90ONI6FF	POTASSIUM CITRATE:ORAL:SOLUTION:MG/5ML	ORAL	76.1MG/5ML ORAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
EE90ONI6FF	POTASSIUM CITRATE:ORAL:SUSPENSION:NA	ORAL	ORAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
EE90ONI6FF	POTASSIUM CITRATE:TOPICAL:AEROSOL:%W/W	TOPICAL	0.26%W/W TOPICAL AEROSOL	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
EE90ONI6FF	POTASSIUM CITRATE:TOPICAL:AEROSOL, FOAM:%W/W	TOPICAL	0.133%W/W TOPICAL AEROSOL, FOAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
EE90ONI6FF	POTASSIUM CITRATE:TOPICAL:EMULSION, AEROSOL FOAM:%W/W	TOPICAL	0.17%W/W TOPICAL EMULSION, AEROSOL FOAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
F68VH75CJC	CARBOMER HOMOPOLYMER TYPE A (ALLYL PENTAERYTHRITOL CROSSLINKED):ORAL:CAPSULE:MG	ORAL	8MG ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
F68VH75CJC	CARBOMER HOMOPOLYMER TYPE A (ALLYL PENTAERYTHRITOL CROSSLINKED):ORAL:TABLET, EXTENDED RELEASE:MG	ORAL	175MG ORAL TABLET, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
F68VH75CJC	CARBOMER HOMOPOLYMER TYPE A (ALLYL PENTAERYTHRITOL CROSSLINKED):TOPICAL:GEL:%W/W	TOPICAL	0.85%W/W TOPICAL GEL	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
F68VH75CJC	CARBOMER HOMOPOLYMER TYPE A (ALLYL PENTAERYTHRITOL CROSSLINKED):TOPICAL:LOTION:%W/W 	TOPICAL	0.7%W/W  TOPICAL LOTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
F68VH75CJC	CARBOMER HOMOPOLYMER TYPE A (ALLYL PENTAERYTHRITOL CROSSLINKED):TOPICAL:LOTION:%W/W	TOPICAL	0.2%W/W TOPICAL LOTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
9YT4B71U8P	LAVANDULA ANGUSTIFOLIA SUBSP. ANGUSTIFOLIA FLOWERING TOP:TOPICAL:EMULSION, CREAM:NA	TOPICAL	TOPICAL EMULSION, CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
9YT4B71U8P	LAVANDULA ANGUSTIFOLIA SUBSP. ANGUSTIFOLIA FLOWERING TOP:TOPICAL:SOLUTION:NA	TOPICAL	TOPICAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
581437HWX2	PROPYLENE GLYCOL DICAPRYLATE:TOPICAL:EMULSION, CREAM:%W/W	TOPICAL	10%W/W TOPICAL EMULSION, CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
1BK9DDD24E	PPG-12/SMDI COPOLYMER:TOPICAL:EMULSION, CREAM:%W/W	TOPICAL	1%W/W TOPICAL EMULSION, CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
1BK9DDD24E	PPG-12/SMDI COPOLYMER:TOPICAL:GEL:NA	TOPICAL	TOPICAL GEL	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
1BK9DDD24E	PPG-12/SMDI COPOLYMER:TOPICAL:LOTION:%W/W	TOPICAL	3%W/W TOPICAL LOTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
A7JR5F8DLH	GELATIN TYPE B BOVINE (200 BLOOM):ORAL:CAPSULE:mg	ORAL	112mg ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
A7JR5F8DLH	GELATIN TYPE B BOVINE (200 BLOOM):ORAL:TABLET:MG	ORAL	18MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
A7JR5F8DLH	GELATIN TYPE B BOVINE (200 BLOOM):ORAL:TABLET, FILM COATED:MG	ORAL	12MG ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
G2M7P15E5P	POLYETHYLENE GLYCOL 3350:INTRA-ARTERIAL:SUSPENSION, INJECTION:mg/1mL	INTRA-ARTERIAL	29.1mg/1mL INTRA-ARTERIAL SUSPENSION, INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
G2M7P15E5P	POLYETHYLENE GLYCOL 3350:INTRA-ARTICULAR:INJECTION:%	INTRA-ARTICULAR	3% INTRA-ARTICULAR INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
G2M7P15E5P	POLYETHYLENE GLYCOL 3350:INTRALESIONAL:INJECTABLE:%	INTRALESIONAL	2.91% INTRALESIONAL INJECTABLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
G2M7P15E5P	POLYETHYLENE GLYCOL 3350:INTRALESIONAL:INJECTION:%	INTRALESIONAL	3% INTRALESIONAL INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
G2M7P15E5P	POLYETHYLENE GLYCOL 3350:INTRALESIONAL:INJECTION, SUSTAINED ACTION:%	INTRALESIONAL	2.9% INTRALESIONAL INJECTION, SUSTAINED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
G2M7P15E5P	POLYETHYLENE GLYCOL 3350:INTRALESIONAL:SUSPENSION, INJECTION:%	INTRALESIONAL	2.91% INTRALESIONAL SUSPENSION, INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
G2M7P15E5P	POLYETHYLENE GLYCOL 3350:INTRAMUSCULAR:INJECTABLE:%W/V	INTRAMUSCULAR	2.91%W/V INTRAMUSCULAR INJECTABLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
G2M7P15E5P	POLYETHYLENE GLYCOL 3350:INTRAMUSCULAR:INJECTION:%W/V	INTRAMUSCULAR	6%W/V INTRAMUSCULAR INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
G2M7P15E5P	POLYETHYLENE GLYCOL 3350:INTRAMUSCULAR:INJECTION, SUSTAINED ACTION:%W/V	INTRAMUSCULAR	2.9%W/V INTRAMUSCULAR INJECTION, SUSTAINED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
G2M7P15E5P	POLYETHYLENE GLYCOL 3350:INTRASYNOVIAL:INJECTABLE:%	INTRASYNOVIAL	2.91% INTRASYNOVIAL INJECTABLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
G2M7P15E5P	POLYETHYLENE GLYCOL 3350:INTRASYNOVIAL:INJECTION:%	INTRASYNOVIAL	3% INTRASYNOVIAL INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
G2M7P15E5P	POLYETHYLENE GLYCOL 3350:INTRASYNOVIAL:INJECTION, SUSTAINED ACTION:%	INTRASYNOVIAL	2.9% INTRASYNOVIAL INJECTION, SUSTAINED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
G2M7P15E5P	POLYETHYLENE GLYCOL 3350:INTRASYNOVIAL:SUSPENSION, INJECTION:%	INTRASYNOVIAL	2.91% INTRASYNOVIAL SUSPENSION, INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
G2M7P15E5P	POLYETHYLENE GLYCOL 3350:INTRA-SYNOVIAL:SUSPENSION, INJECTION:mg/1mL	INTRA-SYNOVIAL	29.1mg/1mL INTRA-SYNOVIAL SUSPENSION, INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
G2M7P15E5P	POLYETHYLENE GLYCOL 3350:NASAL:SOLUTION:%	NASAL	40% NASAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
G2M7P15E5P	POLYETHYLENE GLYCOL 3350:NASAL:SPRAY, METERED:%	NASAL	1.5% NASAL SPRAY, METERED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
G2M7P15E5P	POLYETHYLENE GLYCOL 3350:ORAL:CAPSULE:MG	ORAL	27.2MG ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
G2M7P15E5P	POLYETHYLENE GLYCOL 3350:ORAL:CAPSULE, EXTENDED RELEASE:MG	ORAL	0.67MG ORAL CAPSULE, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
G2M7P15E5P	POLYETHYLENE GLYCOL 3350:ORAL:CAPSULE, HARD GELATIN:MG	ORAL	288MG ORAL CAPSULE, HARD GELATIN	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
G2M7P15E5P	POLYETHYLENE GLYCOL 3350:ORAL:CAPSULE, SOFT GELATIN:MG	ORAL	76.92MG ORAL CAPSULE, SOFT GELATIN	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
G2M7P15E5P	POLYETHYLENE GLYCOL 3350:ORAL:SUSPENSION:MG/1ML	ORAL	45MG/1ML ORAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
G2M7P15E5P	POLYETHYLENE GLYCOL 3350:ORAL:SUSPENSION, EXTENDED RELEASE:MG/5ML	ORAL	9.31MG/5ML ORAL SUSPENSION, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
G2M7P15E5P	POLYETHYLENE GLYCOL 3350:ORAL:SUSPENSION, SUSTAINED ACTION:NA	ORAL	ORAL SUSPENSION, SUSTAINED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
G2M7P15E5P	POLYETHYLENE GLYCOL 3350:ORAL:TABLET:MG	ORAL	25MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
G2M7P15E5P	POLYETHYLENE GLYCOL 3350:ORAL:TABLET (IMMED./COMP. RELEASE), FILM COATED:MG	ORAL	9.7MG ORAL TABLET (IMMED./COMP. RELEASE), FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
G2M7P15E5P	POLYETHYLENE GLYCOL 3350:ORAL:TABLET (IMMED./COMP. RELEASE), UNCOATED, CHEWABLE:MG	ORAL	15MG ORAL TABLET (IMMED./COMP. RELEASE), UNCOATED, CHEWABLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
G2M7P15E5P	POLYETHYLENE GLYCOL 3350:ORAL:TABLET, COATED:MG	ORAL	0.5MG ORAL TABLET, COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
G2M7P15E5P	POLYETHYLENE GLYCOL 3350:ORAL:TABLET, CONTROLLED RELEASE:MG	ORAL	1.67MG ORAL TABLET, CONTROLLED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
G2M7P15E5P	POLYETHYLENE GLYCOL 3350:ORAL:TABLET, DELAYED ACTION:MG	ORAL	4.4MG ORAL TABLET, DELAYED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
G2M7P15E5P	POLYETHYLENE GLYCOL 3350:ORAL:TABLET, DELAYED RELEASE:mg	ORAL	2.43mg ORAL TABLET, DELAYED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
G2M7P15E5P	POLYETHYLENE GLYCOL 3350:ORAL:TABLET, EXTENDED RELEASE:MG	ORAL	20.2MG ORAL TABLET, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
G2M7P15E5P	POLYETHYLENE GLYCOL 3350:ORAL:TABLET, FILM COATED:MG	ORAL	20MG ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
G2M7P15E5P	POLYETHYLENE GLYCOL 3350:ORAL:TABLET, SUSTAINED ACTION:MG	ORAL	6.75MG ORAL TABLET, SUSTAINED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
G2M7P15E5P	POLYETHYLENE GLYCOL 3350:ORAL:TABLET, SUSTAINED ACTION, COATED:MG	ORAL	8.5MG ORAL TABLET, SUSTAINED ACTION, COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
G2M7P15E5P	POLYETHYLENE GLYCOL 3350:RECTAL:SUPPOSITORY:MG	RECTAL	1425.96MG RECTAL SUPPOSITORY	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
G2M7P15E5P	POLYETHYLENE GLYCOL 3350:SOFT TISSUE:INJECTION:%	SOFT TISSUE	3% SOFT TISSUE INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
G2M7P15E5P	POLYETHYLENE GLYCOL 3350:SOFT TISSUE:INJECTION, SUSTAINED ACTION:%	SOFT TISSUE	2.9% SOFT TISSUE INJECTION, SUSTAINED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
G2M7P15E5P	POLYETHYLENE GLYCOL 3350:SOFT TISSUE:SUSPENSION, INJECTION:%	SOFT TISSUE	2.91% SOFT TISSUE SUSPENSION, INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
G2M7P15E5P	POLYETHYLENE GLYCOL 3350:SUBCUTANEOUS:SUSPENSION, INJECTION:%	SUBCUTANEOUS	4.42% SUBCUTANEOUS SUSPENSION, INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
G2M7P15E5P	POLYETHYLENE GLYCOL 3350:TOPICAL:CREAM:%W/W	TOPICAL	4.6%W/W TOPICAL CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
G2M7P15E5P	POLYETHYLENE GLYCOL 3350:TOPICAL:OINTMENT:%W/W	TOPICAL	40%W/W TOPICAL OINTMENT	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
G2M7P15E5P	POLYETHYLENE GLYCOL 3350:VAGINAL:SUPPOSITORY:NA	VAGINAL	VAGINAL SUPPOSITORY	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
D9C330MD8B	COPOVIDONE K25-31:ORAL:CAPSULE:mg	ORAL	224.4mg ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
D9C330MD8B	COPOVIDONE K25-31:ORAL:CAPSULE, COATED PELLETS:MG	ORAL	11.03MG ORAL CAPSULE, COATED PELLETS	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
D9C330MD8B	COPOVIDONE K25-31:ORAL:CAPSULE, DELAYED RELEASE:MG	ORAL	33.2MG ORAL CAPSULE, DELAYED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
D9C330MD8B	COPOVIDONE K25-31:ORAL:CAPSULE, EXTENDED RELEASE:MG	ORAL	85.55MG ORAL CAPSULE, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
D9C330MD8B	COPOVIDONE K25-31:ORAL:SUSPENSION:MG/5ML	ORAL	21.5MG/5ML ORAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
D9C330MD8B	COPOVIDONE K25-31:ORAL:TABLET:MG	ORAL	849.2MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
D9C330MD8B	COPOVIDONE K25-31:ORAL:TABLET (IMMED./COMP. RELEASE), UNCOATED, CHEWABLE:MG	ORAL	2.5MG ORAL TABLET (IMMED./COMP. RELEASE), UNCOATED, CHEWABLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
D9C330MD8B	COPOVIDONE K25-31:ORAL:TABLET, CONTROLLED RELEASE:mg	ORAL	5mg ORAL TABLET, CONTROLLED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
D9C330MD8B	COPOVIDONE K25-31:ORAL:TABLET, DELAYED RELEASE:MG	ORAL	42MG ORAL TABLET, DELAYED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
D9C330MD8B	COPOVIDONE K25-31:ORAL:TABLET, EXTENDED RELEASE:MG	ORAL	75MG ORAL TABLET, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
D9C330MD8B	COPOVIDONE K25-31:ORAL:TABLET, FILM COATED:MG	ORAL	853.8MG ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
D9C330MD8B	COPOVIDONE K25-31:ORAL:TABLET, FILM COATED, EXTENDED RELEASE:MG	ORAL	20MG ORAL TABLET, FILM COATED, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
D9C330MD8B	COPOVIDONE K25-31:ORAL:TABLET, ORALLY DISINTEGRATING:MG	ORAL	4.38MG ORAL TABLET, ORALLY DISINTEGRATING	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
D9C330MD8B	COPOVIDONE K25-31:ORAL:TABLET, SUSTAINED ACTION, FILM COATED:MG	ORAL	6.1MG ORAL TABLET, SUSTAINED ACTION, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
043IPI2M0K	1,2-DISTEAROYL-SN-GLYCERO-3-PHOSPHOCHOLINE:INTRAVENOUS:INJECTION:%	INTRAVENOUS	0.33% INTRAVENOUS INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=1
043IPI2M0K	1,2-DISTEAROYL-SN-GLYCERO-3-PHOSPHOCHOLINE:INTRAVENOUS:SOLUTION, LIPOSOME, INJECTION:%	INTRAVENOUS	2.8% INTRAVENOUS SOLUTION, LIPOSOME, INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=1
043IPI2M0K	1,2-DISTEAROYL-SN-GLYCERO-3-PHOSPHOCHOLINE:RESPIRATORY (INHALATION):POWDER, FOR INHALATION:MG/INH	RESPIRATORY (INHALATION)	6.4MG/INH RESPIRATORY (INHALATION) POWDER, FOR INHALATION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=1
23ZQ42JZZH	POLYVINYL ALCOHOL GRAFT POLYETHYLENE GLYCOL COPOLYMER (3:1; 45000 MW):ORAL:TABLET:MG	ORAL	5.37MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
23ZQ42JZZH	POLYVINYL ALCOHOL GRAFT POLYETHYLENE GLYCOL COPOLYMER (3:1; 45000 MW):ORAL:TABLET, EXTENDED RELEASE:MG	ORAL	19MG ORAL TABLET, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
3X3L452Y85	OLEYL OLEATE:TOPICAL:OINTMENT:%W/W	TOPICAL	2.55%W/W TOPICAL OINTMENT	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
3X3L452Y85	OLEYL OLEATE:TRANSDERMAL:PATCH, CONTROLLED RELEASE:MG	TRANSDERMAL	30MG TRANSDERMAL PATCH, CONTROLLED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O
B697894SGQ	POLYETHYLENE GLYCOL 400:IM - IV:INJECTION:%	IM - IV	20.3% IM - IV INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
B697894SGQ	POLYETHYLENE GLYCOL 400:IM - IV:SOLUTION, INJECTION:%	IM - IV	18% IM - IV SOLUTION, INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
B697894SGQ	POLYETHYLENE GLYCOL 400:INTRAVENOUS:INJECTABLE:%V/V	INTRAVENOUS	67%V/V INTRAVENOUS INJECTABLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
B697894SGQ	POLYETHYLENE GLYCOL 400:INTRAVENOUS:SOLUTION, INJECTION:%	INTRAVENOUS	75.58% INTRAVENOUS SOLUTION, INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
B697894SGQ	POLYETHYLENE GLYCOL 400:INTRAVENOUS INFUSION:INJECTION:%V/V	INTRAVENOUS INFUSION	67%V/V INTRAVENOUS INFUSION INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
B697894SGQ	POLYETHYLENE GLYCOL 400:INTRAVENOUS INFUSION:SOLUTION, INJECTION:MG/ML	INTRAVENOUS INFUSION	0.67MG/ML INTRAVENOUS INFUSION SOLUTION, INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
B697894SGQ	POLYETHYLENE GLYCOL 400:NASAL:SPRAY, METERED:%	NASAL	20% NASAL SPRAY, METERED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
B697894SGQ	POLYETHYLENE GLYCOL 400:OPHTHALMIC:OINTMENT:%	OPHTHALMIC	5% OPHTHALMIC OINTMENT	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
B697894SGQ	POLYETHYLENE GLYCOL 400:ORAL:AEROSOL:NA	ORAL	ORAL AEROSOL	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
B697894SGQ	POLYETHYLENE GLYCOL 400:ORAL:CAPSULE:MG	ORAL	960MG ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
B697894SGQ	POLYETHYLENE GLYCOL 400:ORAL:CAPSULE (IMMED./COMP. RELEASE), SOFT GELATIN:MG	ORAL	950MG ORAL CAPSULE (IMMED./COMP. RELEASE), SOFT GELATIN	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
B697894SGQ	POLYETHYLENE GLYCOL 400:ORAL:CAPSULE (IMMED./COMP. RELEASE), SOFT GELATIN, PERLE:MG	ORAL	50MG ORAL CAPSULE (IMMED./COMP. RELEASE), SOFT GELATIN, PERLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
B697894SGQ	POLYETHYLENE GLYCOL 400:ORAL:CAPSULE, COATED, SOFT GELATIN:MG	ORAL	103.55MG ORAL CAPSULE, COATED, SOFT GELATIN	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
B697894SGQ	POLYETHYLENE GLYCOL 400:ORAL:CAPSULE, DELAYED ACTION:MG	ORAL	2.74MG ORAL CAPSULE, DELAYED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
B697894SGQ	POLYETHYLENE GLYCOL 400:ORAL:CAPSULE, DELAYED RELEASE:MG	ORAL	2.74MG ORAL CAPSULE, DELAYED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
B697894SGQ	POLYETHYLENE GLYCOL 400:ORAL:CAPSULE, EXTENDED RELEASE:MG	ORAL	1.7MG ORAL CAPSULE, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
B697894SGQ	POLYETHYLENE GLYCOL 400:ORAL:CAPSULE, SOFT GELATIN:MG	ORAL	1057MG ORAL CAPSULE, SOFT GELATIN	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
B697894SGQ	POLYETHYLENE GLYCOL 400:ORAL:CAPSULE, SOFT GELATIN LIQUID-FILLED:MG	ORAL	324.5MG ORAL CAPSULE, SOFT GELATIN LIQUID-FILLED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
B697894SGQ	POLYETHYLENE GLYCOL 400:ORAL:CAPSULE, SUSTAINED ACTION, HARD GELATIN:MG	ORAL	11.32MG ORAL CAPSULE, SUSTAINED ACTION, HARD GELATIN	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
B697894SGQ	POLYETHYLENE GLYCOL 400:ORAL:CONCENTRATE:MG/1ML	ORAL	600MG/1ML ORAL CONCENTRATE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
B697894SGQ	POLYETHYLENE GLYCOL 400:ORAL:FILM, SOLUBLE:MG	ORAL	4.76MG ORAL FILM, SOLUBLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
B697894SGQ	POLYETHYLENE GLYCOL 400:ORAL:SOLUTION:MG/20ML	ORAL	8549MG/20ML ORAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
B697894SGQ	POLYETHYLENE GLYCOL 400:ORAL:SOLUTION:mg/5 mL	ORAL	563.5mg/5 mL ORAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
B697894SGQ	POLYETHYLENE GLYCOL 400:ORAL:SOLUTION, CONCENTRATE:%	ORAL	60% ORAL SOLUTION, CONCENTRATE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
B697894SGQ	POLYETHYLENE GLYCOL 400:ORAL:SUSPENSION:MG/5ML	ORAL	250MG/5ML ORAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
B697894SGQ	POLYETHYLENE GLYCOL 400:ORAL:SYRUP:MG/1ML	ORAL	74MG/1ML ORAL SYRUP	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
B697894SGQ	POLYETHYLENE GLYCOL 400:ORAL:TABLET:MG	ORAL	105.07MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
B697894SGQ	POLYETHYLENE GLYCOL 400:ORAL:TABLET (IMMED./COMP. RELEASE), FILM COATED:MG	ORAL	20MG ORAL TABLET (IMMED./COMP. RELEASE), FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
B697894SGQ	POLYETHYLENE GLYCOL 400:ORAL:TABLET, COATED:MG	ORAL	3.15MG ORAL TABLET, COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
B697894SGQ	POLYETHYLENE GLYCOL 400:ORAL:TABLET, DELAYED ACTION:MG	ORAL	4.57MG ORAL TABLET, DELAYED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
B697894SGQ	POLYETHYLENE GLYCOL 400:ORAL:TABLET, DELAYED RELEASE:MG	ORAL	2MG ORAL TABLET, DELAYED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
B697894SGQ	POLYETHYLENE GLYCOL 400:ORAL:TABLET, ENTERIC COATED PARTICLES:MG	ORAL	12.5MG ORAL TABLET, ENTERIC COATED PARTICLES	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
B697894SGQ	POLYETHYLENE GLYCOL 400:ORAL:TABLET, EXTENDED RELEASE:MG	ORAL	45MG ORAL TABLET, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
B697894SGQ	POLYETHYLENE GLYCOL 400:ORAL:TABLET, FILM COATED:MG	ORAL	5.91MG ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
B697894SGQ	POLYETHYLENE GLYCOL 400:ORAL:TABLET, FILM COATED, EXTENDED RELEASE:MG	ORAL	1.13MG ORAL TABLET, FILM COATED, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
B697894SGQ	POLYETHYLENE GLYCOL 400:ORAL:TABLET, SUSTAINED ACTION:MG	ORAL	45MG ORAL TABLET, SUSTAINED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
B697894SGQ	POLYETHYLENE GLYCOL 400:ORAL:TABLET, SUSTAINED ACTION, FILM COATED:MG	ORAL	1.8MG ORAL TABLET, SUSTAINED ACTION, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
B697894SGQ	POLYETHYLENE GLYCOL 400:ORAL:TABLET, SUSTAINED RELEASE, FILM COATED:MG	ORAL	1.28MG ORAL TABLET, SUSTAINED RELEASE, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
B697894SGQ	POLYETHYLENE GLYCOL 400:RECTAL:SUPPOSITORY:NA	RECTAL	RECTAL SUPPOSITORY	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
B697894SGQ	POLYETHYLENE GLYCOL 400:TOPICAL:CREAM:%W/W	TOPICAL	1.5%W/W TOPICAL CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
B697894SGQ	POLYETHYLENE GLYCOL 400:TOPICAL:CREAM, EMULSION, SUSTAINED RELEASE:%W/W	TOPICAL	7.5%W/W TOPICAL CREAM, EMULSION, SUSTAINED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
B697894SGQ	POLYETHYLENE GLYCOL 400:TOPICAL:DRESSING:NA	TOPICAL	TOPICAL DRESSING	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
B697894SGQ	POLYETHYLENE GLYCOL 400:TOPICAL:EMULSION, CREAM:%W/W	TOPICAL	7.5%W/W TOPICAL EMULSION, CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
B697894SGQ	POLYETHYLENE GLYCOL 400:TOPICAL:GEL:%W/W	TOPICAL	45%W/W TOPICAL GEL	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
B697894SGQ	POLYETHYLENE GLYCOL 400:TOPICAL:LOTION:%W/W	TOPICAL	5%W/W TOPICAL LOTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
B697894SGQ	POLYETHYLENE GLYCOL 400:TOPICAL:OINTMENT:%W/W	TOPICAL	65%W/W TOPICAL OINTMENT	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
B697894SGQ	POLYETHYLENE GLYCOL 400:TOPICAL:SOLUTION:%W/W	TOPICAL	69.9%W/W TOPICAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
B697894SGQ	POLYETHYLENE GLYCOL 400:TOPICAL:SPONGE:NA	TOPICAL	TOPICAL SPONGE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
B697894SGQ	POLYETHYLENE GLYCOL 400:TOPICAL:SWAB:NA	TOPICAL	TOPICAL SWAB	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
B697894SGQ	POLYETHYLENE GLYCOL 400:VAGINAL:SUPPOSITORY:NA	VAGINAL	VAGINAL SUPPOSITORY	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
25X51I8RD4	NIACINAMIDE:IM - IV:INJECTION:%	IM - IV	2.5% IM - IV INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=N
25X51I8RD4	NIACINAMIDE:INTRA-ARTICULAR:INJECTION:%	INTRA-ARTICULAR	2.5% INTRA-ARTICULAR INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=N
25X51I8RD4	NIACINAMIDE:INTRALESIONAL:INJECTION:%	INTRALESIONAL	2.5% INTRALESIONAL INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=N
25X51I8RD4	NIACINAMIDE:INTRAMUSCULAR:POWDER, FOR INJECTION SOLUTION:%	INTRAMUSCULAR	2.5% INTRAMUSCULAR POWDER, FOR INJECTION SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=N
25X51I8RD4	NIACINAMIDE:INTRASYNOVIAL:INJECTION:%	INTRASYNOVIAL	2.5% INTRASYNOVIAL INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=N
25X51I8RD4	NIACINAMIDE:IV - SC:INJECTION, SOLUTION:MG/1ML	IV - SC	20.76MG/1ML IV - SC INJECTION, SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=N
25X51I8RD4	NIACINAMIDE:TOPICAL:GEL:%W/W	TOPICAL	1.25%W/W TOPICAL GEL	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=N
G3MS6M810Y	POLYETHYLENE GLYCOL 7000000:ORAL:TABLET:mg	ORAL	132.66mg ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
G3MS6M810Y	POLYETHYLENE OXIDE 7000000:ORAL:TABLET, EXTENDED RELEASE:MG	ORAL	393.46MG ORAL TABLET, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
Y98611C087	GLYCERYL LAURATE:TOPICAL:PATCH, CONTROLLED RELEASE:NA	TOPICAL	TOPICAL PATCH, CONTROLLED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
Y98611C087	GLYCERYL LAURATE:TRANSDERMAL:FILM, CONTROLLED RELEASE:MG	TRANSDERMAL	0.83MG TRANSDERMAL FILM, CONTROLLED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
WQ29KQ9POT	GLUCONOLACTONE:IM - IV:INJECTION:ADJ PH	IM - IV	ADJ PH IM - IV INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
WQ29KQ9POT	GLUCONOLACTONE:INTRAVENOUS:INJECTION:ADJ PH	INTRAVENOUS	ADJ PH INTRAVENOUS INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
WQ29KQ9POT	GLUCONOLACTONE:TOPICAL:AEROSOL, METERED:%W/W	TOPICAL	0.25%W/W TOPICAL AEROSOL, METERED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
WQ29KQ9POT	GLUCONOLACTONE:TOPICAL:SOLUTION:%W/W	TOPICAL	0.25%W/W TOPICAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
WQ29KQ9POT	GLUCONOLACTONE:TOPICAL:SPONGE:NA	TOPICAL	TOPICAL SPONGE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
A2I8C7HI9T	METHYLPARABEN:AN,INFILTRATION:INJECTION:%	AN,INFILTRATION	0.1% AN,INFILTRATION INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
A2I8C7HI9T	METHYLPARABEN:AURICULAR (OTIC):SUSPENSION:%	AURICULAR (OTIC)	0.001% AURICULAR (OTIC) SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
A2I8C7HI9T	METHYLPARABEN:BUCCAL:FILM:MG	BUCCAL	1MG BUCCAL FILM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
A2I8C7HI9T	METHYLPARABEN:BUCCAL:FILM, SOLUBLE:MG	BUCCAL	0.71MG BUCCAL FILM, SOLUBLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
A2I8C7HI9T	METHYLPARABEN:CAUDAL BLOCK:INJECTION:%	CAUDAL BLOCK	0.1% CAUDAL BLOCK INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
A2I8C7HI9T	METHYLPARABEN:EPIDURAL:INJECTION:%	EPIDURAL	0.1% EPIDURAL INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
A2I8C7HI9T	METHYLPARABEN:EPIDURAL:LIQUID, WATER, STERILE, FOR INJECTION:%	EPIDURAL	5% EPIDURAL LIQUID, WATER, STERILE, FOR INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
A2I8C7HI9T	METHYLPARABEN:IM - IV:INJECTABLE:%	IM - IV	0.12% IM - IV INJECTABLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
A2I8C7HI9T	METHYLPARABEN:IM - IV:INJECTION:%	IM - IV	0.75% IM - IV INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
A2I8C7HI9T	METHYLPARABEN:IM - IV:POWDER, FOR INJECTION SOLUTION:%	IM - IV	0.36% IM - IV POWDER, FOR INJECTION SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
A2I8C7HI9T	METHYLPARABEN:IM - IV:SOLUTION:%	IM - IV	0.13% IM - IV SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
A2I8C7HI9T	METHYLPARABEN:IM - IV - SC:INJECTION:%	IM - IV - SC	0.44% IM - IV - SC INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
A2I8C7HI9T	METHYLPARABEN:IM - SC:INJECTION:%	IM - SC	0.18% IM - SC INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
A2I8C7HI9T	METHYLPARABEN:INFILTRATION:INJECTION:%	INFILTRATION	0.1% INFILTRATION INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
A2I8C7HI9T	METHYLPARABEN:INHALATION:SOLUTION:MG/INH	INHALATION	2750MG/INH INHALATION SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
A2I8C7HI9T	METHYLPARABEN:INTRA-ARTERIAL:INJECTION:NA	INTRA-ARTERIAL	INTRA-ARTERIAL INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
A2I8C7HI9T	METHYLPARABEN:INTRA-ARTICULAR:INJECTION:%	INTRA-ARTICULAR	0.24% INTRA-ARTICULAR INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
A2I8C7HI9T	METHYLPARABEN:INTRABURSAL:INJECTION:%	INTRABURSAL	0.18% INTRABURSAL INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
A2I8C7HI9T	METHYLPARABEN:INTRADERMAL:INJECTION:%	INTRADERMAL	0.1% INTRADERMAL INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
A2I8C7HI9T	METHYLPARABEN:INTRALESIONAL:INJECTION:%	INTRALESIONAL	0.15% INTRALESIONAL INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
A2I8C7HI9T	METHYLPARABEN:INTRAMUSCULAR:INJECTABLE:%W/V	INTRAMUSCULAR	0.18%W/V INTRAMUSCULAR INJECTABLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
A2I8C7HI9T	METHYLPARABEN:INTRAMUSCULAR:INJECTION:%W/V	INTRAMUSCULAR	0.38%W/V INTRAMUSCULAR INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
A2I8C7HI9T	METHYLPARABEN:INTRAMUSCULAR:INJECTION, SOLUTION:MG/1ML	INTRAMUSCULAR	1.8MG/1ML INTRAMUSCULAR INJECTION, SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
A2I8C7HI9T	METHYLPARABEN:INTRAMUSCULAR:INJECTION, SUSPENSION:%	INTRAMUSCULAR	0.14% INTRAMUSCULAR INJECTION, SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
A2I8C7HI9T	METHYLPARABEN:INTRAMUSCULAR:SOLUTION, INJECTION:NA	INTRAMUSCULAR	INTRAMUSCULAR SOLUTION, INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
A2I8C7HI9T	METHYLPARABEN:INTRAMUSCULAR:SUSPENSION:%	INTRAMUSCULAR	0.18% INTRAMUSCULAR SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
A2I8C7HI9T	METHYLPARABEN:INTRAMUSCULAR:SUSPENSION, INJECTION:%W/V	INTRAMUSCULAR	0.14%W/V INTRAMUSCULAR SUSPENSION, INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
A2I8C7HI9T	METHYLPARABEN:INTRASYNOVIAL:INJECTION:NA	INTRASYNOVIAL	INTRASYNOVIAL INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
A2I8C7HI9T	METHYLPARABEN:INTRATUMOR:INJECTION:%	INTRATUMOR	0.08% INTRATUMOR INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
A2I8C7HI9T	METHYLPARABEN:INTRAVASCULAR:INJECTION:%	INTRAVASCULAR	0.1% INTRAVASCULAR INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
A2I8C7HI9T	METHYLPARABEN:INTRAVENOUS:INJECTABLE:%	INTRAVENOUS	0.72% INTRAVENOUS INJECTABLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
A2I8C7HI9T	METHYLPARABEN:INTRAVENOUS:INJECTION:%	INTRAVENOUS	0.75% INTRAVENOUS INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
A2I8C7HI9T	METHYLPARABEN:INTRAVENOUS:INJECTION, SOLUTION:MG/1ML	INTRAVENOUS	1.8MG/1ML INTRAVENOUS INJECTION, SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
A2I8C7HI9T	METHYLPARABEN:INTRAVENOUS:INJECTION, SOLUTION:%	INTRAVENOUS	0.18% INTRAVENOUS INJECTION, SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
A2I8C7HI9T	METHYLPARABEN:INTRAVENOUS:POWDER, FOR INJECTION SOLUTION:%	INTRAVENOUS	1.5% INTRAVENOUS POWDER, FOR INJECTION SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
A2I8C7HI9T	METHYLPARABEN:INTRAVENOUS:SOLUTION, INJECTION:%	INTRAVENOUS	0.18% INTRAVENOUS SOLUTION, INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
A2I8C7HI9T	METHYLPARABEN:INTRAVENOUS INFUSION:INJECTION:MG/1ML	INTRAVENOUS INFUSION	1.8MG/1ML INTRAVENOUS INFUSION INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
A2I8C7HI9T	METHYLPARABEN:IONTOPHORESIS:SOLUTION:%	IONTOPHORESIS	0.1% IONTOPHORESIS SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
A2I8C7HI9T	METHYLPARABEN:IRRIGATION:SOLUTION:%	IRRIGATION	2% IRRIGATION SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
A2I8C7HI9T	METHYLPARABEN:IV - SC:INJECTION:%	IV - SC	0.18% IV - SC INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
A2I8C7HI9T	METHYLPARABEN:IV(INFUSION):INJECTION:%	IV(INFUSION)	0.44% IV(INFUSION) INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
A2I8C7HI9T	METHYLPARABEN:IV(INFUSION):LIQUID, WATER, STERILE, FOR INJECTION:%	IV(INFUSION)	5% IV(INFUSION) LIQUID, WATER, STERILE, FOR INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
A2I8C7HI9T	METHYLPARABEN:IV(INFUSION):POWDER, FOR INJECTION SOLUTION:%	IV(INFUSION)	0.36% IV(INFUSION) POWDER, FOR INJECTION SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
A2I8C7HI9T	METHYLPARABEN:NASAL:SOLUTION:%	NASAL	0.033% NASAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
A2I8C7HI9T	METHYLPARABEN:NASAL:SPRAY, METERED:%	NASAL	0.7% NASAL SPRAY, METERED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
A2I8C7HI9T	METHYLPARABEN:NERVE BLOCK:INJECTION:%	NERVE BLOCK	0.1% NERVE BLOCK INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
A2I8C7HI9T	METHYLPARABEN:OPHTHALMIC:OINTMENT:%	OPHTHALMIC	0.05% OPHTHALMIC OINTMENT	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
A2I8C7HI9T	METHYLPARABEN:OPHTHALMIC:SOLUTION:%	OPHTHALMIC	0.05% OPHTHALMIC SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
A2I8C7HI9T	METHYLPARABEN:OPHTHALMIC:SOLUTION, DROPS:%	OPHTHALMIC	0.053% OPHTHALMIC SOLUTION, DROPS	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
A2I8C7HI9T	METHYLPARABEN:OPHTHALMIC:SUSPENSION:%	OPHTHALMIC	0.05% OPHTHALMIC SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
A2I8C7HI9T	METHYLPARABEN:OPHTHALMIC:SUSPENSION, DROPS:%	OPHTHALMIC	0.05% OPHTHALMIC SUSPENSION, DROPS	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
A2I8C7HI9T	METHYLPARABEN:ORAL:CAPSULE:MG	ORAL	1MG ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
A2I8C7HI9T	METHYLPARABEN:ORAL:CAPSULE (IMMED./COMP. RELEASE), SOFT GELATIN, PERLE:MG	ORAL	0.32MG ORAL CAPSULE (IMMED./COMP. RELEASE), SOFT GELATIN, PERLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
A2I8C7HI9T	METHYLPARABEN:ORAL:CAPSULE, COATED, SOFT GELATIN:MG	ORAL	0.21MG ORAL CAPSULE, COATED, SOFT GELATIN	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
A2I8C7HI9T	METHYLPARABEN:ORAL:CAPSULE, HARD GELATIN:NA	ORAL	ORAL CAPSULE, HARD GELATIN	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
A2I8C7HI9T	METHYLPARABEN:ORAL:CAPSULE, SOFT GELATIN:MG	ORAL	0.68MG ORAL CAPSULE, SOFT GELATIN	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
A2I8C7HI9T	METHYLPARABEN:ORAL:CAPSULE, SUSTAINED ACTION:MG	ORAL	0.86MG ORAL CAPSULE, SUSTAINED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
A2I8C7HI9T	METHYLPARABEN:ORAL:CONCENTRATE:MG/1ML	ORAL	2MG/1ML ORAL CONCENTRATE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
A2I8C7HI9T	METHYLPARABEN:ORAL:DROPS:NA	ORAL	ORAL DROPS	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
A2I8C7HI9T	METHYLPARABEN:ORAL:EMULSION:NA	ORAL	ORAL EMULSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
A2I8C7HI9T	METHYLPARABEN:ORAL:GRANULE:MG	ORAL	50MG ORAL GRANULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
A2I8C7HI9T	METHYLPARABEN:ORAL:LIQUID:mg/10mL	ORAL	10.13mg/10mL ORAL LIQUID	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
A2I8C7HI9T	METHYLPARABEN:ORAL:LIQUID:MG	ORAL	2MG ORAL LIQUID	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
A2I8C7HI9T	METHYLPARABEN:ORAL:POWDER:%	ORAL	0.16% ORAL POWDER	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
A2I8C7HI9T	METHYLPARABEN:ORAL:POWDER, FOR ORAL SOLUTION:MG	ORAL	1.51MG ORAL POWDER, FOR ORAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
A2I8C7HI9T	METHYLPARABEN:ORAL:POWDER, FOR ORAL SUSPENSION:%W/W	ORAL	0.38%W/W ORAL POWDER, FOR ORAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
A2I8C7HI9T	METHYLPARABEN:ORAL:POWDER, FOR SOLUTION:MG/1ML	ORAL	1.58MG/1ML ORAL POWDER, FOR SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
A2I8C7HI9T	METHYLPARABEN:ORAL:POWDER, FOR SUSPENSION:MG/5ML	ORAL	5MG/5ML ORAL POWDER, FOR SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
A2I8C7HI9T	METHYLPARABEN:ORAL:SOLUTION:MG	ORAL	15MG ORAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
A2I8C7HI9T	METHYLPARABEN:ORAL:SOLUTION:mg/15 mL	ORAL	12mg/15 mL ORAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
A2I8C7HI9T	METHYLPARABEN:ORAL:SOLUTION:MG/ML	ORAL	2MG/ML ORAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
A2I8C7HI9T	METHYLPARABEN:ORAL:SOLUTION, CONCENTRATE:MG/1ML	ORAL	1MG/1ML ORAL SOLUTION, CONCENTRATE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
A2I8C7HI9T	METHYLPARABEN:ORAL:SOLUTION, ELIXIR:MG/5ML	ORAL	9MG/5ML ORAL SOLUTION, ELIXIR	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
A2I8C7HI9T	METHYLPARABEN:ORAL:SOLUTION, LIQUID:MG/1ML	ORAL	2MG/1ML ORAL SOLUTION, LIQUID	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
A2I8C7HI9T	METHYLPARABEN:ORAL:SOLUTION, SYRUP:MG/5ML	ORAL	9MG/5ML ORAL SOLUTION, SYRUP	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
A2I8C7HI9T	METHYLPARABEN:ORAL:SUSPENSION:MG/5ML	ORAL	1000MG/5ML ORAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
A2I8C7HI9T	METHYLPARABEN:ORAL:SUSPENSION:MG/15ML	ORAL	6.6MG/15ML ORAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
A2I8C7HI9T	METHYLPARABEN:ORAL:SUSPENSION:mg/1mL	ORAL	2.12mg/1mL ORAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
A2I8C7HI9T	METHYLPARABEN:ORAL:SUSPENSION, EXTENDED RELEASE:MG/5ML	ORAL	10MG/5ML ORAL SUSPENSION, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
A2I8C7HI9T	METHYLPARABEN:ORAL:SUSPENSION, LIQUID:MG/5ML	ORAL	10MG/5ML ORAL SUSPENSION, LIQUID	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
A2I8C7HI9T	METHYLPARABEN:ORAL:SUSPENSION, SUSTAINED ACTION:MG/5ML	ORAL	7.5MG/5ML ORAL SUSPENSION, SUSTAINED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
A2I8C7HI9T	METHYLPARABEN:ORAL:TABLET:MG	ORAL	1.8MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
A2I8C7HI9T	METHYLPARABEN:ORAL:TABLET (IMMED./COMP. RELEASE), UNCOATED, CHEWABLE:MG	ORAL	1.27MG ORAL TABLET (IMMED./COMP. RELEASE), UNCOATED, CHEWABLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
A2I8C7HI9T	METHYLPARABEN:ORAL:TABLET, COATED:MG	ORAL	0.016MG ORAL TABLET, COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
A2I8C7HI9T	METHYLPARABEN:ORAL:TABLET, CONTROLLED RELEASE:MG	ORAL	0.081MG ORAL TABLET, CONTROLLED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
A2I8C7HI9T	METHYLPARABEN:ORAL:TABLET, FILM COATED:MG	ORAL	0.23MG ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
A2I8C7HI9T	METHYLPARABEN:ORAL:TABLET, SUSTAINED ACTION:MG	ORAL	0.17MG ORAL TABLET, SUSTAINED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
A2I8C7HI9T	METHYLPARABEN:ORAL:TABLET, SUSTAINED ACTION, COATED:NA	ORAL	ORAL TABLET, SUSTAINED ACTION, COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
A2I8C7HI9T	METHYLPARABEN:PARENTERAL:INJECTION:%	PARENTERAL	0.18% PARENTERAL INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
A2I8C7HI9T	METHYLPARABEN:PARENTERAL:LIQUID, WATER, STERILE, FOR INJECTION:%	PARENTERAL	5% PARENTERAL LIQUID, WATER, STERILE, FOR INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
A2I8C7HI9T	METHYLPARABEN:PERIDURAL:INJECTION:%	PERIDURAL	0.1% PERIDURAL INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
A2I8C7HI9T	METHYLPARABEN:RECTAL:AEROSOL, METERED:%	RECTAL	0.09% RECTAL AEROSOL, METERED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
A2I8C7HI9T	METHYLPARABEN:RECTAL:ENEMA:%	RECTAL	0.18% RECTAL ENEMA	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
A2I8C7HI9T	METHYLPARABEN:RECTAL:LIQUID:%	RECTAL	0.13% RECTAL LIQUID	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
A2I8C7HI9T	METHYLPARABEN:RECTAL:SOLUTION:%	RECTAL	0.13% RECTAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
A2I8C7HI9T	METHYLPARABEN:RECTAL:SUSPENSION:%	RECTAL	0.23% RECTAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
A2I8C7HI9T	METHYLPARABEN:SOFT TISSUE:INJECTION:%	SOFT TISSUE	0.15% SOFT TISSUE INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
A2I8C7HI9T	METHYLPARABEN:SUBCUTANEOUS:INJECTION:%	SUBCUTANEOUS	0.3% SUBCUTANEOUS INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
A2I8C7HI9T	METHYLPARABEN:SUBCUTANEOUS:SUSPENSION, INJECTION:%	SUBCUTANEOUS	0.25% SUBCUTANEOUS SUSPENSION, INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
A2I8C7HI9T	METHYLPARABEN:TOPICAL:CREAM:%W/W	TOPICAL	0.2%W/W TOPICAL CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
A2I8C7HI9T	METHYLPARABEN:TOPICAL:CREAM, AUGMENTED:%W/W	TOPICAL	0.2%W/W TOPICAL CREAM, AUGMENTED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
A2I8C7HI9T	METHYLPARABEN:TOPICAL:CREAM, EMULSION, SUSTAINED RELEASE:%W/W	TOPICAL	0.2%W/W TOPICAL CREAM, EMULSION, SUSTAINED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
A2I8C7HI9T	METHYLPARABEN:TOPICAL:EMULSION:%W/W	TOPICAL	0.2%W/W TOPICAL EMULSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
A2I8C7HI9T	METHYLPARABEN:TOPICAL:EMULSION, AEROSOL FOAM:%W/W	TOPICAL	0.11%W/W TOPICAL EMULSION, AEROSOL FOAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
A2I8C7HI9T	METHYLPARABEN:TOPICAL:EMULSION, CREAM:%W/W	TOPICAL	0.5%W/W TOPICAL EMULSION, CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
A2I8C7HI9T	METHYLPARABEN:TOPICAL:EMULSION, LOTION:%W/W	TOPICAL	0.17%W/W TOPICAL EMULSION, LOTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
A2I8C7HI9T	METHYLPARABEN:TOPICAL:FILM, CONTROLLED RELEASE:MG	TOPICAL	14MG TOPICAL FILM, CONTROLLED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
A2I8C7HI9T	METHYLPARABEN:TOPICAL:GEL:%W/W	TOPICAL	0.3%W/W TOPICAL GEL	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
A2I8C7HI9T	METHYLPARABEN:TOPICAL:JELLY:%W/V	TOPICAL	0.07%W/V TOPICAL JELLY	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
A2I8C7HI9T	METHYLPARABEN:TOPICAL:LOTION:%W/W	TOPICAL	0.3%W/W TOPICAL LOTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
A2I8C7HI9T	METHYLPARABEN:TOPICAL:OINTMENT:%W/W	TOPICAL	0.2%W/W TOPICAL OINTMENT	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
A2I8C7HI9T	METHYLPARABEN:TOPICAL:PATCH:NA	TOPICAL	TOPICAL PATCH	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
A2I8C7HI9T	METHYLPARABEN:TOPICAL:PATCH, CONTROLLED RELEASE:NA	TOPICAL	TOPICAL PATCH, CONTROLLED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
A2I8C7HI9T	METHYLPARABEN:TOPICAL:SHAMPOO:%W/W	TOPICAL	0.15%W/W TOPICAL SHAMPOO	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
A2I8C7HI9T	METHYLPARABEN:TOPICAL:SHAMPOO, SUSPENSION:%W/W	TOPICAL	0.15%W/W TOPICAL SHAMPOO, SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
A2I8C7HI9T	METHYLPARABEN:TOPICAL:SOLUTION:%W/W	TOPICAL	0.1%W/W TOPICAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
A2I8C7HI9T	METHYLPARABEN:TOPICAL:SPRAY:%W/W	TOPICAL	0.2%W/W TOPICAL SPRAY	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
A2I8C7HI9T	METHYLPARABEN:TOPICAL:SUSPENSION:%W/W	TOPICAL	0.3%W/W TOPICAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
A2I8C7HI9T	METHYLPARABEN:URETERAL:SOLUTION:NA	URETERAL	URETERAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
A2I8C7HI9T	METHYLPARABEN:URETHRAL:INJECTION:%	URETHRAL	0.18% URETHRAL INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
A2I8C7HI9T	METHYLPARABEN:URETHRAL:JELLY:%	URETHRAL	0.07% URETHRAL JELLY	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
A2I8C7HI9T	METHYLPARABEN:VAGINAL:CREAM:%W/W	VAGINAL	0.2%W/W VAGINAL CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
A2I8C7HI9T	METHYLPARABEN:VAGINAL:CREAM, EMULSION, SUSTAINED RELEASE:%	VAGINAL	0.18% VAGINAL CREAM, EMULSION, SUSTAINED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
A2I8C7HI9T	METHYLPARABEN:VAGINAL:EMULSION, AEROSOL FOAM:%	VAGINAL	0.1% VAGINAL EMULSION, AEROSOL FOAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
A2I8C7HI9T	METHYLPARABEN:VAGINAL:EMULSION, CREAM:%	VAGINAL	0.2% VAGINAL EMULSION, CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
A2I8C7HI9T	METHYLPARABEN:VAGINAL:GEL:%	VAGINAL	0.08% VAGINAL GEL	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
A2I8C7HI9T	METHYLPARABEN:VAGINAL:SUPPOSITORY:NA	VAGINAL	VAGINAL SUPPOSITORY	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
8F049NKY49	CALCIUM POLYCARBOPHIL:ORAL:TABLET, UNCOATED, LOZENGE:MG	ORAL	5.49MG ORAL TABLET, UNCOATED, LOZENGE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
8F049NKY49	CALCIUM POLYCARBOPHIL:ORAL:TROCHE:MG	ORAL	32.04MG ORAL TROCHE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
REK4960K2U	BUTYLATED HYDROXYANISOLE:INTRAMUSCULAR:INJECTION:%	INTRAMUSCULAR	0.03% INTRAMUSCULAR INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
REK4960K2U	BUTYLATED HYDROXYANISOLE:INTRAVENOUS INFUSION:SOLUTION, INJECTION:mg	INTRAVENOUS INFUSION	0.003mg INTRAVENOUS INFUSION SOLUTION, INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
REK4960K2U	BUTYLATED HYDROXYANISOLE:IV(INFUSION):INJECTION:%	IV(INFUSION)	0.002% IV(INFUSION) INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
REK4960K2U	BUTYLATED HYDROXYANISOLE:IV(INFUSION):POWDER, FOR INJECTION SOLUTION:NA	IV(INFUSION)	IV(INFUSION) POWDER, FOR INJECTION SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
REK4960K2U	BUTYLATED HYDROXYANISOLE:NASAL:SOLUTION:%	NASAL	0.02% NASAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
REK4960K2U	BUTYLATED HYDROXYANISOLE:ORAL:CAPSULE:MG	ORAL	1MG ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
REK4960K2U	BUTYLATED HYDROXYANISOLE:ORAL:CAPSULE, GELATIN COATED:MG	ORAL	0.07MG ORAL CAPSULE, GELATIN COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
REK4960K2U	BUTYLATED HYDROXYANISOLE:ORAL:CAPSULE, SOFT GELATIN:MG	ORAL	1MG ORAL CAPSULE, SOFT GELATIN	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
REK4960K2U	BUTYLATED HYDROXYANISOLE:ORAL:CONCENTRATE:MG/1ML	ORAL	0.075MG/1ML ORAL CONCENTRATE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
REK4960K2U	BUTYLATED HYDROXYANISOLE:ORAL:EMULSION:NA	ORAL	ORAL EMULSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
REK4960K2U	BUTYLATED HYDROXYANISOLE:ORAL:GRANULE, FOR SUSPENSION:NA	ORAL	ORAL GRANULE, FOR SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
REK4960K2U	BUTYLATED HYDROXYANISOLE:ORAL:LIQUID:MG/1ML	ORAL	0.1MG/1ML ORAL LIQUID	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
REK4960K2U	BUTYLATED HYDROXYANISOLE:ORAL:SOLUTION:%W/V	ORAL	0.02%W/V ORAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
REK4960K2U	BUTYLATED HYDROXYANISOLE:ORAL:SUSPENSION:MG/5ML	ORAL	2.5MG/5ML ORAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
REK4960K2U	BUTYLATED HYDROXYANISOLE:ORAL:SYRUP:MG/5ML	ORAL	0.5MG/5ML ORAL SYRUP	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
REK4960K2U	BUTYLATED HYDROXYANISOLE:ORAL:TABLET:MG	ORAL	0.86MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
REK4960K2U	BUTYLATED HYDROXYANISOLE:ORAL:TABLET, EXTENDED RELEASE:MG	ORAL	0.5MG ORAL TABLET, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
REK4960K2U	BUTYLATED HYDROXYANISOLE:ORAL:TABLET, FILM COATED:MG	ORAL	0.4MG ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
REK4960K2U	BUTYLATED HYDROXYANISOLE:ORAL:TABLET, ORALLY DISINTEGRATING:MG	ORAL	0.6MG ORAL TABLET, ORALLY DISINTEGRATING	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
REK4960K2U	BUTYLATED HYDROXYANISOLE:RECTAL:SUPPOSITORY:MG	RECTAL	0.21MG RECTAL SUPPOSITORY	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
REK4960K2U	BUTYLATED HYDROXYANISOLE:SUBLINGUAL:FILM:mg	SUBLINGUAL	0.08mg SUBLINGUAL FILM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
REK4960K2U	BUTYLATED HYDROXYANISOLE:SUBLINGUAL:TABLET:MG	SUBLINGUAL	1MG SUBLINGUAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
REK4960K2U	BUTYLATED HYDROXYANISOLE:TOPICAL:CREAM:%W/W	TOPICAL	0.0052%W/W TOPICAL CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
REK4960K2U	BUTYLATED HYDROXYANISOLE:TOPICAL:EMULSION, CREAM:%W/W	TOPICAL	5.2%W/W TOPICAL EMULSION, CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
REK4960K2U	BUTYLATED HYDROXYANISOLE:TOPICAL:GEL:%W/W	TOPICAL	0.05%W/W TOPICAL GEL	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
REK4960K2U	BUTYLATED HYDROXYANISOLE:TOPICAL:LOTION:NA	TOPICAL	TOPICAL LOTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
REK4960K2U	BUTYLATED HYDROXYANISOLE:TOPICAL:OINTMENT:%W/W	TOPICAL	0.005%W/W TOPICAL OINTMENT	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
REK4960K2U	BUTYLATED HYDROXYANISOLE:TOPICAL:SOLUTION:NA	TOPICAL	TOPICAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
REK4960K2U	BUTYLATED HYDROXYANISOLE:TOPICAL:SUPPOSITORY:NA	TOPICAL	TOPICAL SUPPOSITORY	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
REK4960K2U	BUTYLATED HYDROXYANISOLE:VAGINAL:EMULSION, CREAM:%	VAGINAL	0.03% VAGINAL EMULSION, CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
REK4960K2U	BUTYLATED HYDROXYANISOLE:VAGINAL:OINTMENT:%	VAGINAL	0.02% VAGINAL OINTMENT	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
REK4960K2U	BUTYLATED HYDROXYANISOLE:VAGINAL:SUPPOSITORY:MG	VAGINAL	1MG VAGINAL SUPPOSITORY	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
A9U1687S1S	CYSTEINE HYDROCHLORIDE ANHYDROUS:INTRADISCAL:POWDER, FOR INJECTION SOLUTION:NA	INTRADISCAL	INTRADISCAL POWDER, FOR INJECTION SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
A9U1687S1S	CYSTEINE HYDROCHLORIDE ANHYDROUS:ORAL:TABLET, EXTENDED RELEASE:MG	ORAL	12.5MG ORAL TABLET, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
S033EH8359	SODIUM ASCORBATE:INTRADERMAL:POWDER, FOR INJECTION SOLUTION:%	INTRADERMAL	0.05% INTRADERMAL POWDER, FOR INJECTION SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
S033EH8359	SODIUM ASCORBATE:INTRAVENOUS:INJECTABLE:%	INTRAVENOUS	0.45% INTRAVENOUS INJECTABLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
S033EH8359	SODIUM ASCORBATE:INTRAVENOUS:INJECTION:%	INTRAVENOUS	1% INTRAVENOUS INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
S033EH8359	SODIUM ASCORBATE:INTRAVENOUS:SOLUTION, INJECTION:%	INTRAVENOUS	2.88% INTRAVENOUS SOLUTION, INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
S033EH8359	SODIUM ASCORBATE:ORAL:CAPSULE:MG	ORAL	3MG ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
S033EH8359	SODIUM ASCORBATE:ORAL:CAPSULE (IMMED./COMP. RELEASE):MG	ORAL	2MG ORAL CAPSULE (IMMED./COMP. RELEASE)	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
S033EH8359	SODIUM ASCORBATE:ORAL:SUSPENSION, EXTENDED RELEASE:MG/5ML	ORAL	16.4MG/5ML ORAL SUSPENSION, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
S033EH8359	SODIUM ASCORBATE:ORAL:TABLET:MG	ORAL	5MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
S033EH8359	SODIUM ASCORBATE:SUBCUTANEOUS:POWDER, FOR INJECTION SOLUTION:%	SUBCUTANEOUS	0.05% SUBCUTANEOUS POWDER, FOR INJECTION SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
767IP0Y5NH	D&C RED NO. 28:ORAL:CAPSULE:MG	ORAL	0.22MG ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
767IP0Y5NH	D&C RED NO. 28:ORAL:CAPSULE (IMMED./COMP. RELEASE):MG	ORAL	0.011MG ORAL CAPSULE (IMMED./COMP. RELEASE)	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
767IP0Y5NH	D&C RED NO. 28:ORAL:CAPSULE, COATED, SOFT GELATIN:MG	ORAL	0.057MG ORAL CAPSULE, COATED, SOFT GELATIN	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
767IP0Y5NH	D&C RED NO. 28:ORAL:CAPSULE, DELAYED ACTION:MG	ORAL	0.21MG ORAL CAPSULE, DELAYED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
767IP0Y5NH	D&C RED NO. 28:ORAL:CAPSULE, DELAYED ACTION, ENTERIC COATED:NA	ORAL	ORAL CAPSULE, DELAYED ACTION, ENTERIC COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
767IP0Y5NH	D&C RED NO. 28:ORAL:CAPSULE, DELAYED RELEASE:MG	ORAL	0.11MG ORAL CAPSULE, DELAYED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
767IP0Y5NH	D&C RED NO. 28:ORAL:CAPSULE, ENTERIC COATED PELLETS:NA	ORAL	ORAL CAPSULE, ENTERIC COATED PELLETS	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
767IP0Y5NH	D&C RED NO. 28:ORAL:CAPSULE, EXTENDED RELEASE:MG	ORAL	0.06MG ORAL CAPSULE, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
767IP0Y5NH	D&C RED NO. 28:ORAL:CAPSULE, HARD GELATIN:MG	ORAL	0.008MG ORAL CAPSULE, HARD GELATIN	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
767IP0Y5NH	D&C RED NO. 28:ORAL:CAPSULE, SUSTAINED ACTION:NA	ORAL	ORAL CAPSULE, SUSTAINED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
767IP0Y5NH	D&C RED NO. 28:ORAL:POWDER, FOR ORAL SOLUTION:NA	ORAL	ORAL POWDER, FOR ORAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
767IP0Y5NH	D&C RED NO. 28:ORAL:POWDER, FOR SUSPENSION:MG/5ML	ORAL	0.7MG/5ML ORAL POWDER, FOR SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
767IP0Y5NH	D&C RED NO. 28:ORAL:SUSPENSION:MG/5ML	ORAL	2.5MG/5ML ORAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
767IP0Y5NH	D&C RED NO. 28:ORAL:TABLET:NA	ORAL	ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
767IP0Y5NH	D&C RED NO. 28:TOPICAL:AEROSOL:%W/W	TOPICAL	0.001%W/W TOPICAL AEROSOL	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
V1YW10H14D	METHYL GLUCOSE SESQUISTEARATE:TOPICAL:CREAM, AUGMENTED:%W/W	TOPICAL	3.5%W/W TOPICAL CREAM, AUGMENTED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
V1YW10H14D	METHYL GLUCOSE SESQUISTEARATE:TOPICAL:EMULSION, CREAM:%W/W	TOPICAL	3.5%W/W TOPICAL EMULSION, CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
029TFK992N	CROSCARMELLOSE:ORAL:TABLET:MG	ORAL	80MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
J3TZF807X5	MALIC ACID, L-:ORAL:SOLUTION:MG/10ML	ORAL	34MG/10ML ORAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
J3TZF807X5	MALIC ACID, L-:ORAL:TABLET:NA	ORAL	ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=M
3X4P6271OX	CHLOROBUTANOL HEMIHYDRATE:INTRAMUSCULAR:INJECTION:%W/V	INTRAMUSCULAR	0.53%W/V INTRAMUSCULAR INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
3X4P6271OX	CHLOROBUTANOL HEMIHYDRATE:INTRAVENOUS:SOLUTION, INJECTION:%	INTRAVENOUS	0.53% INTRAVENOUS SOLUTION, INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
3X4P6271OX	CHLOROBUTANOL HEMIHYDRATE:TOPICAL:SOLUTION:%W/V	TOPICAL	0.3%W/V TOPICAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
27F77DSJ5V	HYDROGENATED STARCH HYDROLYSATE:ORAL:SOLUTION:MG/1ML	ORAL	300MG/1ML ORAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
27F77DSJ5V	HYDROGENATED STARCH HYDROLYSATE:SUBLINGUAL:FILM:MG	SUBLINGUAL	6.02MG SUBLINGUAL FILM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
KB1BQB7R06	LAURIC/MYRISTIC DIETHANOLOLAMIDE:TOPICAL:EMULSION:NA	TOPICAL	TOPICAL EMULSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
KB1BQB7R06	LAURIC/MYRISTIC DIETHANOLOLAMIDE:TOPICAL:LOTION:NA	TOPICAL	TOPICAL LOTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
KB1BQB7R06	LAURIC/MYRISTIC DIETHANOLOLAMIDE:TOPICAL:SPONGE:NA	TOPICAL	TOPICAL SPONGE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
26CD3J2R0C	PROPYLENE GLYCOL ALGINATE:ORAL:EMULSION:%	ORAL	0.015% ORAL EMULSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
26CD3J2R0C	PROPYLENE GLYCOL ALGINATE:ORAL:GRANULE, FOR SUSPENSION:NA	ORAL	ORAL GRANULE, FOR SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
26CD3J2R0C	PROPYLENE GLYCOL ALGINATE:ORAL:POWDER:MG/1PKT	ORAL	718MG/1PKT ORAL POWDER	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
26CD3J2R0C	PROPYLENE GLYCOL ALGINATE:ORAL:POWDER, FOR ORAL SOLUTION:MG	ORAL	25.27MG ORAL POWDER, FOR ORAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
26CD3J2R0C	PROPYLENE GLYCOL ALGINATE:ORAL:POWDER, FOR ORAL SUSPENSION:MG/1PKT	ORAL	189MG/1PKT ORAL POWDER, FOR ORAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
26CD3J2R0C	PROPYLENE GLYCOL ALGINATE:ORAL:POWDER, FOR SUSPENSION:mg	ORAL	50mg ORAL POWDER, FOR SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
26CD3J2R0C	PROPYLENE GLYCOL ALGINATE:ORAL:SUSPENSION:%	ORAL	0.015% ORAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
26CD3J2R0C	PROPYLENE GLYCOL ALGINATE:ORAL:TABLET:MG	ORAL	10MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
13A4J4NH9I	POLYOXYL 40 STEARATE:AURICULAR (OTIC):SUSPENSION:%	AURICULAR (OTIC)	1% AURICULAR (OTIC) SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
13A4J4NH9I	POLYOXYL 40 STEARATE:DENTAL:SOLUTION:NA	DENTAL	DENTAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
13A4J4NH9I	POLYOXYL 40 STEARATE:OPHTHALMIC:OINTMENT:NA	OPHTHALMIC	OPHTHALMIC OINTMENT	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
13A4J4NH9I	POLYOXYL 40 STEARATE:OPHTHALMIC:SOLUTION:%	OPHTHALMIC	7% OPHTHALMIC SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
13A4J4NH9I	POLYOXYL 40 STEARATE:OPHTHALMIC:SUSPENSION:%	OPHTHALMIC	0.5% OPHTHALMIC SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
13A4J4NH9I	POLYOXYL 40 STEARATE:ORAL:CAPSULE:MG	ORAL	7MG ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
13A4J4NH9I	POLYOXYL 40 STEARATE:ORAL:CAPSULE, HARD GELATIN:MG	ORAL	0.6MG ORAL CAPSULE, HARD GELATIN	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
13A4J4NH9I	POLYOXYL 40 STEARATE:ORAL:CONCENTRATE:MG	ORAL	4MG ORAL CONCENTRATE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
13A4J4NH9I	POLYOXYL 40 STEARATE:ORAL:GRANULE:NA	ORAL	ORAL GRANULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
13A4J4NH9I	POLYOXYL 40 STEARATE:ORAL:POWDER:NA	ORAL	ORAL POWDER	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
13A4J4NH9I	POLYOXYL 40 STEARATE:ORAL:SUSPENSION:NA	ORAL	ORAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
13A4J4NH9I	POLYOXYL 40 STEARATE:ORAL:TABLET:MG	ORAL	8.48MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
13A4J4NH9I	POLYOXYL 40 STEARATE:ORAL:TABLET, FILM COATED:MG	ORAL	2MG ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
13A4J4NH9I	POLYOXYL 40 STEARATE:TOPICAL:CREAM:%W/W	TOPICAL	8%W/W TOPICAL CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
13A4J4NH9I	POLYOXYL 40 STEARATE:TOPICAL:CREAM, EMULSION, SUSTAINED RELEASE:%W/W	TOPICAL	5.25%W/W TOPICAL CREAM, EMULSION, SUSTAINED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
13A4J4NH9I	POLYOXYL 40 STEARATE:TOPICAL:EMULSION, AEROSOL FOAM:%W/W	TOPICAL	1.08%W/W TOPICAL EMULSION, AEROSOL FOAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
13A4J4NH9I	POLYOXYL 40 STEARATE:TOPICAL:EMULSION, CREAM:%W/W	TOPICAL	8.8%W/W TOPICAL EMULSION, CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
13A4J4NH9I	POLYOXYL 40 STEARATE:TOPICAL:LOTION:%W/W	TOPICAL	3%W/W TOPICAL LOTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
13A4J4NH9I	POLYOXYL 40 STEARATE:TOPICAL:OINTMENT:NA	TOPICAL	TOPICAL OINTMENT	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
13A4J4NH9I	POLYOXYL 40 STEARATE:TOPICAL:SPONGE:NA	TOPICAL	TOPICAL SPONGE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
A1A1I8X02B	DIETHYLENE GLYCOL MONOETHYL ETHER:TOPICAL:CREAM:%W/W	TOPICAL	15%W/W TOPICAL CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
A1A1I8X02B	DIETHYLENE GLYCOL MONOETHYL ETHER:TOPICAL:CREAM, EMULSION, SUSTAINED RELEASE:%W/W	TOPICAL	15%W/W TOPICAL CREAM, EMULSION, SUSTAINED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
A1A1I8X02B	DIETHYLENE GLYCOL MONOETHYL ETHER:TOPICAL:EMULSION, CREAM:%W/W	TOPICAL	15%W/W TOPICAL EMULSION, CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
A1A1I8X02B	DIETHYLENE GLYCOL MONOETHYL ETHER:TOPICAL:GEL:%W/W	TOPICAL	49.91%W/W TOPICAL GEL	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
A1A1I8X02B	DIETHYLENE GLYCOL MONOETHYL ETHER:TOPICAL:LOTION:%W/W	TOPICAL	1%W/W TOPICAL LOTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
A1A1I8X02B	DIETHYLENE GLYCOL MONOETHYL ETHER:TRANSDERMAL:GEL:%	TRANSDERMAL	5% TRANSDERMAL GEL	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
A1A1I8X02B	DIETHYLENE GLYCOL MONOETHYL ETHER:TRANSDERMAL:PATCH:MG	TRANSDERMAL	430MG TRANSDERMAL PATCH	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D
4OH5W9UM87	STEARETH-100:TOPICAL:CREAM:%W/W 	TOPICAL	0.35%W/W  TOPICAL CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
4OH5W9UM87	STEARETH-100:TOPICAL:EMULSION, CREAM:%W/W	TOPICAL	0.35%W/W TOPICAL EMULSION, CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
4OH5W9UM87	STEARETH-100:TOPICAL:OINTMENT:%W/W	TOPICAL	0.6%W/W TOPICAL OINTMENT	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
75UI7QUZ5J	AMINOBENZOATE SODIUM:ORAL:CAPSULE:MG	ORAL	0.002MG ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
75UI7QUZ5J	AMINOBENZOATE SODIUM:ORAL:TABLET:MG	ORAL	0.001MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
K3E0U7O8KI	TRISODIUM HEDTA:TOPICAL:SOLUTION:%W/W	TOPICAL	0.4%W/W TOPICAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
K3E0U7O8KI	TRISODIUM HEDTA:TOPICAL:SPONGE:%W/W	TOPICAL	0.009%W/W TOPICAL SPONGE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
SU46BAM238	AMMONIUM SULFATE:INTRAVENOUS:INJECTION, SUSPENSION, LIPOSOMAL:%	INTRAVENOUS	0.2% INTRAVENOUS INJECTION, SUSPENSION, LIPOSOMAL	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
SU46BAM238	AMMONIUM SULFATE:IV(INFUSION):INJECTION, LIPOSOMAL:%	IV(INFUSION)	0.02% IV(INFUSION) INJECTION, LIPOSOMAL	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
BU8V88OWIQ	SODIUM BISULFATE:IM - IV:INJECTION:%	IM - IV	0.32% IM - IV INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
BU8V88OWIQ	SODIUM BISULFATE:IM - IV - SC:INJECTION:%	IM - IV - SC	0.1% IM - IV - SC INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
BU8V88OWIQ	SODIUM BISULFATE:INHALATION:SOLUTION:%	INHALATION	0.011% INHALATION SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
BU8V88OWIQ	SODIUM BISULFATE:OPHTHALMIC:SOLUTION:NA	OPHTHALMIC	OPHTHALMIC SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
BU8V88OWIQ	SODIUM BISULFATE:ORAL:CONCENTRATE:MG/1ML	ORAL	0.95MG/1ML ORAL CONCENTRATE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
A7NRR1HLH6	.BETA.-IONONE:NASAL:SPRAY, METERED:%	NASAL	1% NASAL SPRAY, METERED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=B
6Y89129C8H	ANISE OIL:ORAL:PASTILLE:MG	ORAL	16MG ORAL PASTILLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
6Y89129C8H	ANISE OIL:ORAL:SOLUTION:MG	ORAL	1.4MG ORAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
6Y89129C8H	ANISE OIL:ORAL:SOLUTION, ELIXIR:%	ORAL	3% ORAL SOLUTION, ELIXIR	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
6Y89129C8H	ANISE OIL:ORAL:SUSPENSION:%	ORAL	20% ORAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
6Y89129C8H	ANISE OIL:RECTAL:SOLUTION:%	RECTAL	0.14% RECTAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
BZ1R15MTK7	LEVOMENTHOL:BUCCAL:GUM:MG	BUCCAL	9.2MG BUCCAL GUM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
BZ1R15MTK7	LEVOMENTHOL:BUCCAL:GUM, CHEWING:MG	BUCCAL	4.4MG BUCCAL GUM, CHEWING	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
BZ1R15MTK7	LEVOMENTHOL:BUCCAL:INHALATION:%	BUCCAL	0.1% BUCCAL INHALATION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
BZ1R15MTK7	LEVOMENTHOL:ORAL:SOLUTION:mg/5mL	ORAL	2.5mg/5mL ORAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
BZ1R15MTK7	LEVOMENTHOL:SUBLINGUAL:AEROSOL, METERED:%	SUBLINGUAL	0.002% SUBLINGUAL AEROSOL, METERED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
BZ1R15MTK7	LEVOMENTHOL:SUBLINGUAL:SPRAY:%	SUBLINGUAL	0.005% SUBLINGUAL SPRAY	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
BZ1R15MTK7	LEVOMENTHOL:TOPICAL:LOTION:%W/W	TOPICAL	0.08%W/W TOPICAL LOTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
BZ1R15MTK7	LEVOMENTHOL:TOPICAL:SPRAY:%W/W	TOPICAL	0.05%W/W TOPICAL SPRAY	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
ZZQ59TY3KG	SODIUM LAURETH-2 SULFATE:TOPICAL:SHAMPOO:%W/W	TOPICAL	47.6%W/W TOPICAL SHAMPOO	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
P2OM2Q86BI	ETHYL ACRYLATE AND METHYL METHACRYLATE COPOLYMER (2:1; 750000 MW):ORAL:CAPSULE:MG	ORAL	33.8MG ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
P2OM2Q86BI	ETHYL ACRYLATE AND METHYL METHACRYLATE COPOLYMER (2:1; 750000 MW):ORAL:CAPSULE, ENTERIC COATED PELLETS:MG	ORAL	93.36MG ORAL CAPSULE, ENTERIC COATED PELLETS	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
P2OM2Q86BI	ETHYL ACRYLATE AND METHYL METHACRYLATE COPOLYMER (2:1; 750000 MW):ORAL:CAPSULE, EXTENDED RELEASE:MG	ORAL	36.72MG ORAL CAPSULE, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
P2OM2Q86BI	ETHYL ACRYLATE AND METHYL METHACRYLATE COPOLYMER (2:1; 750000 MW):ORAL:CAPSULE, SUSTAINED ACTION:MG	ORAL	187.3MG ORAL CAPSULE, SUSTAINED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
P2OM2Q86BI	ETHYL ACRYLATE AND METHYL METHACRYLATE COPOLYMER (2:1; 750000 MW):ORAL:GRANULE:MG/1PKT	ORAL	273.6MG/1PKT ORAL GRANULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
P2OM2Q86BI	ETHYL ACRYLATE AND METHYL METHACRYLATE COPOLYMER (2:1; 750000 MW):ORAL:TABLET:MG	ORAL	25MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
P2OM2Q86BI	ETHYL ACRYLATE AND METHYL METHACRYLATE COPOLYMER (2:1; 750000 MW):ORAL:TABLET, COATED:MG	ORAL	66MG ORAL TABLET, COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
P2OM2Q86BI	ETHYL ACRYLATE AND METHYL METHACRYLATE COPOLYMER (2:1; 750000 MW):ORAL:TABLET, CONTROLLED RELEASE:MG	ORAL	56.2MG ORAL TABLET, CONTROLLED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
P2OM2Q86BI	ETHYL ACRYLATE AND METHYL METHACRYLATE COPOLYMER (2:1; 750000 MW):ORAL:TABLET, SUSTAINED ACTION:MG	ORAL	0.35MG ORAL TABLET, SUSTAINED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
P2OM2Q86BI	ETHYL ACRYLATE AND METHYL METHACRYLATE COPOLYMER (2:1; 750000 MW):ORAL:TABLET, SUSTAINED ACTION, COATED:MG	ORAL	30MG ORAL TABLET, SUSTAINED ACTION, COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
P2OM2Q86BI	ETHYL ACRYLATE AND METHYL METHACRYLATE COPOLYMER (2:1; 750000 MW):ORAL:TABLET, SUSTAINED ACTION, FILM COATED:MG	ORAL	10MG ORAL TABLET, SUSTAINED ACTION, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
P2OM2Q86BI	ETHYL ACRYLATE AND METHYL METHACRYLATE COPOLYMER (2:1; 750000 MW):ORAL                            :TABLET, EXTENDED RELEASE        :MG	ORAL                            	96.5MG ORAL                             TABLET, EXTENDED RELEASE        	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
P2OM2Q86BI	EUDRAGIT NE 40 D:ORAL:CAPSULE, EXTENDED RELEASE:mg	ORAL	60mg ORAL CAPSULE, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=E
5K616HU99V	LIQUEFIED PETROLEUM GAS:TOPICAL:EMULSION, AEROSOL FOAM:NA	TOPICAL	TOPICAL EMULSION, AEROSOL FOAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
XKC1657P78	STAR ANISE:ORAL:TABLET:MG	ORAL	50MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
FA32R9S74X	PONCEAU 3R:ORAL:CAPSULE:NA	ORAL	ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
FA32R9S74X	PONCEAU 3R:ORAL:CAPSULE, SUSTAINED ACTION:MG	ORAL	0.035MG ORAL CAPSULE, SUSTAINED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
FA32R9S74X	PONCEAU 3R:ORAL:SYRUP:%	ORAL	0.001% ORAL SYRUP	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
FA32R9S74X	PONCEAU 3R:ORAL:TABLET:MG	ORAL	93.83MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
FA32R9S74X	PONCEAU 3R:ORAL:TABLET, COATED:MG	ORAL	0.1MG ORAL TABLET, COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
FA32R9S74X	PONCEAU 3R:ORAL:WAFER:MG	ORAL	0.05MG ORAL WAFER	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
LF9X1PN3XJ	CETETH-10:TOPICAL:LOTION:%W/W	TOPICAL	2.5%W/W TOPICAL LOTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
R95B8J264J	POLYETHYLENE GLYCOL 200:INTRAMUSCULAR:INJECTION:%	INTRAMUSCULAR	30% INTRAMUSCULAR INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
R95B8J264J	POLYETHYLENE GLYCOL 200:ORAL:CAPSULE:NA	ORAL	ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
R95B8J264J	POLYETHYLENE GLYCOL 200:ORAL:SOLUTION:MG/1ML	ORAL	200MG/1ML ORAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
R95B8J264J	POLYETHYLENE GLYCOL 200:ORAL:TABLET, EXTENDED RELEASE:NA	ORAL	ORAL TABLET, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
R95B8J264J	POLYETHYLENE GLYCOL 200:TOPICAL:OINTMENT:%W/W	TOPICAL	39%W/W TOPICAL OINTMENT	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
E8458C1KAA	TRIETHANOLAMINE LAURYL SULFATE:TOPICAL:EMULSION:%W/W	TOPICAL	10.78%W/W TOPICAL EMULSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
E8458C1KAA	TRIETHANOLAMINE LAURYL SULFATE:TOPICAL:EMULSION, CREAM:%W/W	TOPICAL	0.13%W/W TOPICAL EMULSION, CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
E8458C1KAA	TRIETHANOLAMINE LAURYL SULFATE:TOPICAL:SHAMPOO:%W/V	TOPICAL	75.3%W/V TOPICAL SHAMPOO	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=T
YM0K64F20V	PEG-120 METHYL GLUCOSE DIOLEATE:TOPICAL:SHAMPOO:%W/W	TOPICAL	1.8%W/W TOPICAL SHAMPOO	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
NVG71ZZ7P0	SODIUM ACETATE ANHYDROUS:IM - IV:INJECTION:NA	IM - IV	IM - IV INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
NVG71ZZ7P0	SODIUM ACETATE ANHYDROUS:IM - SC:INJECTION:%	IM - SC	0.07% IM - SC INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
NVG71ZZ7P0	SODIUM ACETATE ANHYDROUS:INTRAMUSCULAR:INJECTION:%W/V	INTRAMUSCULAR	0.47%W/V INTRAMUSCULAR INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
NVG71ZZ7P0	SODIUM ACETATE ANHYDROUS:INTRAVENOUS:INJECTABLE:%	INTRAVENOUS	0.005% INTRAVENOUS INJECTABLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
NVG71ZZ7P0	SODIUM ACETATE ANHYDROUS:INTRAVENOUS:INJECTION:%	INTRAVENOUS	6.25% INTRAVENOUS INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
NVG71ZZ7P0	SODIUM ACETATE ANHYDROUS:INTRAVENOUS:SOLUTION:%	INTRAVENOUS	17.7% INTRAVENOUS SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
NVG71ZZ7P0	SODIUM ACETATE ANHYDROUS:INTRAVENOUS:SOLUTION, INJECTION:%	INTRAVENOUS	0.085% INTRAVENOUS SOLUTION, INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
NVG71ZZ7P0	SODIUM ACETATE ANHYDROUS:IV(INFUSION):INJECTION:%	IV(INFUSION)	0.15% IV(INFUSION) INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
NVG71ZZ7P0	SODIUM ACETATE ANHYDROUS:IV(INFUSION):POWDER, FOR INJECTION SOLUTION, LYOPHILIZED:%	IV(INFUSION)	6.25% IV(INFUSION) POWDER, FOR INJECTION SOLUTION, LYOPHILIZED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
NVG71ZZ7P0	SODIUM ACETATE ANHYDROUS:OPHTHALMIC:SOLUTION:%	OPHTHALMIC	0.09% OPHTHALMIC SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
NVG71ZZ7P0	SODIUM ACETATE ANHYDROUS:ORAL:SOLUTION:MG	ORAL	177MG ORAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
NVG71ZZ7P0	SODIUM ACETATE ANHYDROUS:ORAL:SYRUP:MG/1ML	ORAL	4.1MG/1ML ORAL SYRUP	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
NVG71ZZ7P0	SODIUM ACETATE ANHYDROUS:SUBCUTANEOUS:INJECTION:%	SUBCUTANEOUS	0.16% SUBCUTANEOUS INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
NVG71ZZ7P0	SODIUM ACETATE ANHYDROUS:SUBCUTANEOUS:POWDER, FOR INJECTION SOLUTION, LYOPHILIZED:%	SUBCUTANEOUS	0.01% SUBCUTANEOUS POWDER, FOR INJECTION SOLUTION, LYOPHILIZED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
D4D38LT1L5	LAURETH-2:TOPICAL:SHAMPOO:%W/W	TOPICAL	2%W/W TOPICAL SHAMPOO	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
2KR89I4H1Y	STEARYL ALCOHOL:ORAL:CAPSULE, SUSTAINED ACTION:MG	ORAL	72MG ORAL CAPSULE, SUSTAINED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
2KR89I4H1Y	STEARYL ALCOHOL:ORAL:POWDER:%	ORAL	11% ORAL POWDER	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
2KR89I4H1Y	STEARYL ALCOHOL:ORAL:TABLET, CONTROLLED RELEASE:MG	ORAL	59MG ORAL TABLET, CONTROLLED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
2KR89I4H1Y	STEARYL ALCOHOL:ORAL:TABLET, EXTENDED RELEASE:MG	ORAL	20MG ORAL TABLET, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
2KR89I4H1Y	STEARYL ALCOHOL:ORAL:TABLET, SUSTAINED ACTION:MG	ORAL	244MG ORAL TABLET, SUSTAINED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
2KR89I4H1Y	STEARYL ALCOHOL:ORAL:TABLET, SUSTAINED ACTION, FILM COATED:MG	ORAL	60MG ORAL TABLET, SUSTAINED ACTION, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
2KR89I4H1Y	STEARYL ALCOHOL:TOPICAL:AEROSOL:%W/W	TOPICAL	0.53%W/W TOPICAL AEROSOL	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
2KR89I4H1Y	STEARYL ALCOHOL:TOPICAL:AEROSOL, FOAM:%W/W	TOPICAL	0.53%W/W TOPICAL AEROSOL, FOAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
2KR89I4H1Y	STEARYL ALCOHOL:TOPICAL:CREAM:%W/W 	TOPICAL	16%W/W  TOPICAL CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
2KR89I4H1Y	STEARYL ALCOHOL:TOPICAL:CREAM, AUGMENTED:%W/W	TOPICAL	4%W/W TOPICAL CREAM, AUGMENTED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
2KR89I4H1Y	STEARYL ALCOHOL:TOPICAL:CREAM, EMULSION, SUSTAINED RELEASE:%W/W	TOPICAL	15%W/W TOPICAL CREAM, EMULSION, SUSTAINED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
2KR89I4H1Y	STEARYL ALCOHOL:TOPICAL:EMULSION, AEROSOL FOAM:%W/W	TOPICAL	1%W/W TOPICAL EMULSION, AEROSOL FOAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
2KR89I4H1Y	STEARYL ALCOHOL:TOPICAL:EMULSION, CREAM:%W/W	TOPICAL	30%W/W TOPICAL EMULSION, CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
2KR89I4H1Y	STEARYL ALCOHOL:TOPICAL:LOTION:%W/W	TOPICAL	12%W/W TOPICAL LOTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
2KR89I4H1Y	STEARYL ALCOHOL:TOPICAL:OINTMENT:%W/W	TOPICAL	8%W/W TOPICAL OINTMENT	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
2KR89I4H1Y	STEARYL ALCOHOL:TOPICAL:SUPPOSITORY:NA	TOPICAL	TOPICAL SUPPOSITORY	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
2KR89I4H1Y	STEARYL ALCOHOL:TOPICAL:SUPPOSITORY, INSERT:%W/W	TOPICAL	8.5%W/W TOPICAL SUPPOSITORY, INSERT	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
2KR89I4H1Y	STEARYL ALCOHOL:TOPICAL:SUSPENSION:%W/W	TOPICAL	2.01%W/W TOPICAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
2KR89I4H1Y	STEARYL ALCOHOL:VAGINAL:CREAM:%W/W	VAGINAL	7%W/W VAGINAL CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
2KR89I4H1Y	STEARYL ALCOHOL:VAGINAL:CREAM, EMULSION, SUSTAINED RELEASE:%W/W	VAGINAL	8.4%W/W VAGINAL CREAM, EMULSION, SUSTAINED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
2KR89I4H1Y	STEARYL ALCOHOL:VAGINAL:EMULSION, CREAM:%W/W	VAGINAL	42.5%W/W VAGINAL EMULSION, CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
506T60A25R	SORBITOL:BUCCAL:GUM, CHEWING:MG	BUCCAL	257MG BUCCAL GUM, CHEWING	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
506T60A25R	SORBITOL:DENTAL:PASTE:NA	DENTAL	DENTAL PASTE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
506T60A25R	SORBITOL:INTRA-ARTICULAR:INJECTION:%	INTRA-ARTICULAR	84.83% INTRA-ARTICULAR INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
506T60A25R	SORBITOL:INTRALESIONAL:INJECTION:%	INTRALESIONAL	45% INTRALESIONAL INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
506T60A25R	SORBITOL:INTRAMUSCULAR:INJECTION:%	INTRAMUSCULAR	84.83% INTRAMUSCULAR INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
506T60A25R	SORBITOL:INTRASYNOVIAL:INJECTION:%	INTRASYNOVIAL	84.83% INTRASYNOVIAL INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
506T60A25R	SORBITOL:INTRAVENOUS:INJECTION:%	INTRAVENOUS	30% INTRAVENOUS INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
506T60A25R	SORBITOL:INTRAVENOUS:POWDER, FOR INJECTION SOLUTION, LYOPHILIZED:%	INTRAVENOUS	5.43% INTRAVENOUS POWDER, FOR INJECTION SOLUTION, LYOPHILIZED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
506T60A25R	SORBITOL:INTRAVENOUS:SOLUTION, INJECTION:%	INTRAVENOUS	48% INTRAVENOUS SOLUTION, INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
506T60A25R	SORBITOL:IV(INFUSION):INJECTABLE:%	IV(INFUSION)	4.7% IV(INFUSION) INJECTABLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
506T60A25R	SORBITOL:IV(INFUSION):INJECTION:%	IV(INFUSION)	30% IV(INFUSION) INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
506T60A25R	SORBITOL:IV(INFUSION):SOLUTION, INJECTION:%	IV(INFUSION)	7.14% IV(INFUSION) SOLUTION, INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
506T60A25R	SORBITOL:NASAL:SOLUTION:%	NASAL	2.5% NASAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
506T60A25R	SORBITOL:NASAL:SPRAY:%	NASAL	4.55% NASAL SPRAY	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
506T60A25R	SORBITOL:NASAL:SPRAY, METERED:%	NASAL	6.45% NASAL SPRAY, METERED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
506T60A25R	SORBITOL:OPHTHALMIC:SOLUTION:%	OPHTHALMIC	4.6% OPHTHALMIC SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
506T60A25R	SORBITOL:OPHTHALMIC:SOLUTION, DROPS:%	OPHTHALMIC	0.25% OPHTHALMIC SOLUTION, DROPS	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
506T60A25R	SORBITOL:ORAL:BAR, CHEWABLE:NA	ORAL	ORAL BAR, CHEWABLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
506T60A25R	SORBITOL:ORAL:CAPSULE:MG	ORAL	185.18MG ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
506T60A25R	SORBITOL:ORAL:CAPSULE, SOFT GELATIN:MG	ORAL	113.6MG ORAL CAPSULE, SOFT GELATIN	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
506T60A25R	SORBITOL:ORAL:CAPSULE, SOFT GELATIN LIQUID-FILLED:NA	ORAL	ORAL CAPSULE, SOFT GELATIN LIQUID-FILLED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
506T60A25R	SORBITOL:ORAL:CONCENTRATE:MG/1ML	ORAL	400MG/1ML ORAL CONCENTRATE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
506T60A25R	SORBITOL:ORAL:DROPS:MG/1ML	ORAL	30MG/1ML ORAL DROPS	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
506T60A25R	SORBITOL:ORAL:GRANULE, FOR SUSPENSION:MG	ORAL	28MG ORAL GRANULE, FOR SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
506T60A25R	SORBITOL:ORAL:GUM, CHEWING:MG	ORAL	257MG ORAL GUM, CHEWING	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
506T60A25R	SORBITOL:ORAL:LIQUID:MG/5ML	ORAL	286MG/5ML ORAL LIQUID	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
506T60A25R	SORBITOL:ORAL:POWDER:MG/BOTTLE	ORAL	11.147MG/BOTTLE ORAL POWDER	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
506T60A25R	SORBITOL:ORAL:POWDER:%	ORAL	5% ORAL POWDER	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
506T60A25R	SORBITOL:ORAL:POWDER, FOR SUSPENSION:MG/1ML	ORAL	342.84MG/1ML ORAL POWDER, FOR SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
506T60A25R	SORBITOL:ORAL:POWDER, FOR SUSPENSION:g/236mL	ORAL	0.15g/236mL ORAL POWDER, FOR SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
506T60A25R	SORBITOL:ORAL:SOLUTION:MG/5ML	ORAL	335MG/5ML ORAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
506T60A25R	SORBITOL:ORAL:SOLUTION, ELIXIR:%	ORAL	33% ORAL SOLUTION, ELIXIR	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
506T60A25R	SORBITOL:ORAL:SOLUTION, LIQUID:%V/V	ORAL	0.005%V/V ORAL SOLUTION, LIQUID	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
506T60A25R	SORBITOL:ORAL:SUSPENSION:MG/1ML	ORAL	409.5MG/1ML ORAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
506T60A25R	SORBITOL:ORAL:SUSPENSION, LIQUID:MG/5ML	ORAL	2000MG/5ML ORAL SUSPENSION, LIQUID	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
506T60A25R	SORBITOL:ORAL:SYRUP:%	ORAL	71.2% ORAL SYRUP	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
506T60A25R	SORBITOL:ORAL:TABLET:MG	ORAL	337.28MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
506T60A25R	SORBITOL:ORAL:TABLET (IMMED./COMP. RELEASE), UNCOATED, CHEWABLE:MG	ORAL	316MG ORAL TABLET (IMMED./COMP. RELEASE), UNCOATED, CHEWABLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
506T60A25R	SORBITOL:ORAL:TABLET, COATED:MG	ORAL	12.96MG ORAL TABLET, COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
506T60A25R	SORBITOL:ORAL:TABLET, DELAYED ACTION, ENTERIC COATED:NA	ORAL	ORAL TABLET, DELAYED ACTION, ENTERIC COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
506T60A25R	SORBITOL:ORAL:TABLET, EXTENDED RELEASE:MG	ORAL	47.4MG ORAL TABLET, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
506T60A25R	SORBITOL:ORAL:TABLET, FILM COATED:MG	ORAL	5MG ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
506T60A25R	SORBITOL:ORAL:TABLET, ORALLY DISINTEGRATING:MG	ORAL	7MG ORAL TABLET, ORALLY DISINTEGRATING	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
506T60A25R	SORBITOL:ORAL:TABLET, SUSTAINED ACTION:MG	ORAL	53.75MG ORAL TABLET, SUSTAINED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
506T60A25R	SORBITOL:RECTAL:SUSPENSION:%	RECTAL	33.33% RECTAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
506T60A25R	SORBITOL:SUBCUTANEOUS:INJECTABLE:%	SUBCUTANEOUS	4.7% SUBCUTANEOUS INJECTABLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
506T60A25R	SORBITOL:SUBCUTANEOUS:SOLUTION, INJECTION:%	SUBCUTANEOUS	4.7% SUBCUTANEOUS SOLUTION, INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
506T60A25R	SORBITOL:SUBLINGUAL:TABLET:MG	SUBLINGUAL	50.5MG SUBLINGUAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
506T60A25R	SORBITOL:TOPICAL:CREAM:%W/W	TOPICAL	10%W/W TOPICAL CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
506T60A25R	SORBITOL:TOPICAL:EMULSION:%W/W	TOPICAL	7%W/W TOPICAL EMULSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
506T60A25R	SORBITOL:TOPICAL:EMULSION, CREAM:%W/W	TOPICAL	5%W/W TOPICAL EMULSION, CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
506T60A25R	SORBITOL:TOPICAL:LIQUID:%W/W	TOPICAL	9.6%W/W TOPICAL LIQUID	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
506T60A25R	SORBITOL:TOPICAL:LOTION:NA	TOPICAL	TOPICAL LOTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
506T60A25R	SORBITOL:TOPICAL:OINTMENT:%W/W	TOPICAL	10%W/W TOPICAL OINTMENT	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
506T60A25R	SORBITOL:TOPICAL:SOLUTION:%W/V	TOPICAL	4.6%W/V TOPICAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
506T60A25R	SORBITOL:VAGINAL:TABLET:NA	VAGINAL	VAGINAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
506T60A25R	SORBITOL SOLUTION:BUCCAL:GUM, CHEWING:MG	BUCCAL	45MG BUCCAL GUM, CHEWING	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
506T60A25R	SORBITOL SOLUTION:INTRA-ARTICULAR:INJECTION:%	INTRA-ARTICULAR	84.83% INTRA-ARTICULAR INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
506T60A25R	SORBITOL SOLUTION:INTRALESIONAL:INJECTION:NA	INTRALESIONAL	INTRALESIONAL INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
506T60A25R	SORBITOL SOLUTION:INTRAMUSCULAR:INJECTION:%	INTRAMUSCULAR	84.83% INTRAMUSCULAR INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
506T60A25R	SORBITOL SOLUTION:INTRASYNOVIAL:INJECTION:%	INTRASYNOVIAL	84.83% INTRASYNOVIAL INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
506T60A25R	SORBITOL SOLUTION:INTRAVENOUS:INJECTION:%	INTRAVENOUS	7.14% INTRAVENOUS INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
506T60A25R	SORBITOL SOLUTION:INTRAVENOUS:SOLUTION, INJECTION:%	INTRAVENOUS	7.14% INTRAVENOUS SOLUTION, INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
506T60A25R	SORBITOL SOLUTION:IV(INFUSION):SOLUTION, INJECTION:%	IV(INFUSION)	7.14% IV(INFUSION) SOLUTION, INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
506T60A25R	SORBITOL SOLUTION:NASAL:SPRAY, METERED:MCG/SPRAY	NASAL	8836.5MCG/SPRAY NASAL SPRAY, METERED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
506T60A25R	SORBITOL SOLUTION:NASAL:SPRAY, METERED:%	NASAL	0.006% NASAL SPRAY, METERED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
506T60A25R	SORBITOL SOLUTION:OPHTHALMIC:SOLUTION:%	OPHTHALMIC	6.7% OPHTHALMIC SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
506T60A25R	SORBITOL SOLUTION:ORAL:CAPSULE:MG	ORAL	95MG ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
506T60A25R	SORBITOL SOLUTION:ORAL:CAPSULE, COATED, SOFT GELATIN:MG	ORAL	3.11MG ORAL CAPSULE, COATED, SOFT GELATIN	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
506T60A25R	SORBITOL SOLUTION:ORAL:CAPSULE, SOFT GELATIN:MG	ORAL	80MG ORAL CAPSULE, SOFT GELATIN	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
506T60A25R	SORBITOL SOLUTION:ORAL:CAPSULE, SOFT GELATIN LIQUID-FILLED:MG	ORAL	97MG ORAL CAPSULE, SOFT GELATIN LIQUID-FILLED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
506T60A25R	SORBITOL SOLUTION:ORAL:CONCENTRATE:MG/1ML	ORAL	600MG/1ML ORAL CONCENTRATE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
506T60A25R	SORBITOL SOLUTION:ORAL:DROPS:MG/1ML	ORAL	50MG/1ML ORAL DROPS	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
506T60A25R	SORBITOL SOLUTION:ORAL:GUM, CHEWING:MG	ORAL	45MG ORAL GUM, CHEWING	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
506T60A25R	SORBITOL SOLUTION:ORAL:LIQUID:MG/5ML	ORAL	2970MG/5ML ORAL LIQUID	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
506T60A25R	SORBITOL SOLUTION:ORAL:ORAL SOLUTION DOSAGE FORM:mg/5mL	ORAL	1350mg/5mL ORAL ORAL SOLUTION DOSAGE FORM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
506T60A25R	SORBITOL SOLUTION:ORAL:SOLUTION:MG/5ML	ORAL	2700MG/5ML ORAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
506T60A25R	SORBITOL SOLUTION:ORAL:SOLUTION, CONCENTRATE:MG/1ML	ORAL	300MG/1ML ORAL SOLUTION, CONCENTRATE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
506T60A25R	SORBITOL SOLUTION:ORAL:SOLUTION, ELIXIR:%	ORAL	75% ORAL SOLUTION, ELIXIR	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
506T60A25R	SORBITOL SOLUTION:ORAL:SOLUTION, SYRUP:MG/1ML	ORAL	500MG/1ML ORAL SOLUTION, SYRUP	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
506T60A25R	SORBITOL SOLUTION:ORAL:SUSPENSION:MG/15ML	ORAL	4012.5MG/15ML ORAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
506T60A25R	SORBITOL SOLUTION:ORAL:SUSPENSION:MG/5ML	ORAL	3570MG/5ML ORAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
506T60A25R	SORBITOL SOLUTION:ORAL:SUSPENSION:mg/1mL	ORAL	571.43mg/1mL ORAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
506T60A25R	SORBITOL SOLUTION:ORAL:SUSPENSION:mg/1.25mL	ORAL	62.5mg/1.25mL ORAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
506T60A25R	SORBITOL SOLUTION:ORAL:SUSPENSION, DROPS:MG/1ML	ORAL	250MG/1ML ORAL SUSPENSION, DROPS	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
506T60A25R	SORBITOL SOLUTION:ORAL:SUSPENSION, LIQUID:MG/5ML	ORAL	2000MG/5ML ORAL SUSPENSION, LIQUID	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
506T60A25R	SORBITOL SOLUTION:ORAL:SUSPENSION, SYRUP, SUSTAINED ACTION:%	ORAL	2% ORAL SUSPENSION, SYRUP, SUSTAINED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
506T60A25R	SORBITOL SOLUTION:ORAL:SYRUP:MG/5ML	ORAL	4370MG/5ML ORAL SYRUP	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
506T60A25R	SORBITOL SOLUTION:ORAL:TABLET:MG	ORAL	14MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
506T60A25R	SORBITOL SOLUTION:RECTAL:SUSPENSION:%	RECTAL	46.18% RECTAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
506T60A25R	SORBITOL SOLUTION:TOPICAL:CREAM:%W/W	TOPICAL	17.5%W/W TOPICAL CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
506T60A25R	SORBITOL SOLUTION:TOPICAL:CREAM, AUGMENTED:%W/W	TOPICAL	15%W/W TOPICAL CREAM, AUGMENTED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
506T60A25R	SORBITOL SOLUTION:TOPICAL:CREAM, EMULSION, SUSTAINED RELEASE:%W/W	TOPICAL	36.8%W/W TOPICAL CREAM, EMULSION, SUSTAINED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
506T60A25R	SORBITOL SOLUTION:TOPICAL:EMULSION, CREAM:%W/W	TOPICAL	25%W/W TOPICAL EMULSION, CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
506T60A25R	SORBITOL SOLUTION:TOPICAL:FILM, CONTROLLED RELEASE:MG	TOPICAL	2800MG TOPICAL FILM, CONTROLLED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
506T60A25R	SORBITOL SOLUTION:TOPICAL:LOTION:%W/W	TOPICAL	10.7%W/W TOPICAL LOTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
506T60A25R	SORBITOL SOLUTION:TOPICAL:LOTION:%W/W	TOPICAL	5%W/W TOPICAL LOTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
506T60A25R	SORBITOL SOLUTION:TOPICAL:OINTMENT:%W/W	TOPICAL	1.5%W/W TOPICAL OINTMENT	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
506T60A25R	SORBITOL SOLUTION:TOPICAL:PATCH:MG	TOPICAL	2240MG TOPICAL PATCH	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
506T60A25R	SORBITOL SOLUTION:TOPICAL:PATCH, CONTROLLED RELEASE:NA	TOPICAL	TOPICAL PATCH, CONTROLLED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
506T60A25R	SORBITOL SOLUTION:TOPICAL:SOLUTION, DROPS:%W/V	TOPICAL	6.9%W/V TOPICAL SOLUTION, DROPS	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
506T60A25R	SORBITOL SOLUTION:VAGINAL:CREAM, EMULSION, SUSTAINED RELEASE:%W/W	VAGINAL	36.8%W/W VAGINAL CREAM, EMULSION, SUSTAINED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
506T60A25R	SORBITOL SOLUTION:VAGINAL:EMULSION, CREAM:%	VAGINAL	36.8% VAGINAL EMULSION, CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
53J3F32P58	STEARETH-21:TOPICAL:CREAM, EMULSION, SUSTAINED RELEASE:%W/W	TOPICAL	2.5%W/W TOPICAL CREAM, EMULSION, SUSTAINED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
53J3F32P58	STEARETH-21:TOPICAL:EMULSION, CREAM:%W/W	TOPICAL	3%W/W TOPICAL EMULSION, CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
53J3F32P58	STEARETH-21:TOPICAL:LOTION:%W/W	TOPICAL	3%W/W TOPICAL LOTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
73CJJ317SR	GLYCERYL BEHENATE/EICOSADIOATE:ORAL:TABLET:MG	ORAL	6MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
73CJJ317SR	GLYCERYL BEHENATE/EICOSADIOATE:ORAL:TABLET, DELAYED ACTION:MG	ORAL	4.95MG ORAL TABLET, DELAYED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
73CJJ317SR	GLYCERYL BEHENATE/EICOSADIOATE:ORAL:TABLET, EXTENDED RELEASE:MG	ORAL	11MG ORAL TABLET, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=G
8MDF5V39QO	SODIUM BICARBONATE:BUCCAL:GUM:MG	BUCCAL	7.2MG BUCCAL GUM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
8MDF5V39QO	SODIUM BICARBONATE:BUCCAL:GUM, CHEWING:MG	BUCCAL	25MG BUCCAL GUM, CHEWING	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
8MDF5V39QO	SODIUM BICARBONATE:BUCCAL:TABLET:MG	BUCCAL	42MG BUCCAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
8MDF5V39QO	SODIUM BICARBONATE:IM - IV:INJECTION:MG/VIAL	IM - IV	175MG/VIAL IM - IV INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
8MDF5V39QO	SODIUM BICARBONATE:IM - IV:POWDER, FOR INJECTION SOLUTION, LYOPHILIZED:ADJ PH	IM - IV	ADJ PH IM - IV POWDER, FOR INJECTION SOLUTION, LYOPHILIZED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
8MDF5V39QO	SODIUM BICARBONATE:IM - IV:POWDER, FOR RECONSTITUTION:ADJ PH	IM - IV	ADJ PH IM - IV POWDER, FOR RECONSTITUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
8MDF5V39QO	SODIUM BICARBONATE:INTRAMUSCULAR:INJECTABLE:mg/1VIAL	INTRAMUSCULAR	175mg/1VIAL INTRAMUSCULAR INJECTABLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
8MDF5V39QO	SODIUM BICARBONATE:INTRAMUSCULAR:INJECTION:%	INTRAMUSCULAR	3.5% INTRAMUSCULAR INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
8MDF5V39QO	SODIUM BICARBONATE:INTRAMUSCULAR:POWDER, FOR INJECTION SOLUTION:ADJ PH	INTRAMUSCULAR	ADJ PH INTRAMUSCULAR POWDER, FOR INJECTION SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
8MDF5V39QO	SODIUM BICARBONATE:INTRAPERITONEAL:POWDER, FOR INJECTION SOLUTION:ADJ PH	INTRAPERITONEAL	ADJ PH INTRAPERITONEAL POWDER, FOR INJECTION SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
8MDF5V39QO	SODIUM BICARBONATE:INTRATHECAL:INJECTABLE:NA	INTRATHECAL	INTRATHECAL INJECTABLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
8MDF5V39QO	SODIUM BICARBONATE:INTRATHECAL:INJECTION:%	INTRATHECAL	0.005% INTRATHECAL INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
8MDF5V39QO	SODIUM BICARBONATE:INTRATRACHEAL:SUSPENSION:ADJ PH	INTRATRACHEAL	ADJ PH INTRATRACHEAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
8MDF5V39QO	SODIUM BICARBONATE:INTRAVENOUS:INJECTABLE:mg/1VIAL	INTRAVENOUS	175mg/1VIAL INTRAVENOUS INJECTABLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
8MDF5V39QO	SODIUM BICARBONATE:INTRAVENOUS:INJECTION:mg/1VIAL	INTRAVENOUS	764.66mg/1VIAL INTRAVENOUS INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
8MDF5V39QO	SODIUM BICARBONATE:INTRAVENOUS:INJECTION:ADJ PH	INTRAVENOUS	ADJ PH INTRAVENOUS INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
8MDF5V39QO	SODIUM BICARBONATE:INTRAVENOUS:INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION:mg/1VIAL	INTRAVENOUS	573.5mg/1VIAL INTRAVENOUS INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
8MDF5V39QO	SODIUM BICARBONATE:INTRAVENOUS:POWDER, FOR INJECTION SOLUTION:%	INTRAVENOUS	2.1% INTRAVENOUS POWDER, FOR INJECTION SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
8MDF5V39QO	SODIUM BICARBONATE:INTRAVENOUS:SOLUTION, INJECTION:ADJ PH	INTRAVENOUS	ADJ PH INTRAVENOUS SOLUTION, INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
8MDF5V39QO	SODIUM BICARBONATE:INTRAVITREAL:INJECTION:%	INTRAVITREAL	0.18% INTRAVITREAL INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
8MDF5V39QO	SODIUM BICARBONATE:IV(INFUSION):INJECTION:%	IV(INFUSION)	3.5% IV(INFUSION) INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
8MDF5V39QO	SODIUM BICARBONATE:IV(INFUSION):POWDER, FOR INJECTION SOLUTION:%	IV(INFUSION)	6% IV(INFUSION) POWDER, FOR INJECTION SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
8MDF5V39QO	SODIUM BICARBONATE:IV(INFUSION):POWDER, FOR INJECTION SOLUTION, LYOPHILIZED:%	IV(INFUSION)	0.18% IV(INFUSION) POWDER, FOR INJECTION SOLUTION, LYOPHILIZED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
8MDF5V39QO	SODIUM BICARBONATE:ORAL:CAPSULE:MG	ORAL	108MG ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
8MDF5V39QO	SODIUM BICARBONATE:ORAL:CAPSULE, DELAYED ACTION:MG	ORAL	0.36MG ORAL CAPSULE, DELAYED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
8MDF5V39QO	SODIUM BICARBONATE:ORAL:CAPSULE, HARD GELATIN:MG	ORAL	2MG ORAL CAPSULE, HARD GELATIN	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
8MDF5V39QO	SODIUM BICARBONATE:ORAL:FILM, SOLUBLE:MG	ORAL	0.6MG ORAL FILM, SOLUBLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
8MDF5V39QO	SODIUM BICARBONATE:ORAL:GRANULE, EFFERVESCENT:NA	ORAL	ORAL GRANULE, EFFERVESCENT	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
8MDF5V39QO	SODIUM BICARBONATE:ORAL:GUM, CHEWING:MG	ORAL	15MG ORAL GUM, CHEWING	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
8MDF5V39QO	SODIUM BICARBONATE:ORAL:POWDER, FOR SOLUTION:MG/1GM	ORAL	87.2MG/1GM ORAL POWDER, FOR SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
8MDF5V39QO	SODIUM BICARBONATE:ORAL:POWDER, FOR SUSPENSION:NA	ORAL	ORAL POWDER, FOR SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
8MDF5V39QO	SODIUM BICARBONATE:ORAL:SOLUTION:NA	ORAL	ORAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
8MDF5V39QO	SODIUM BICARBONATE:ORAL:SUSPENSION:MG/5ML	ORAL	5MG/5ML ORAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
8MDF5V39QO	SODIUM BICARBONATE:ORAL:TABLET:MG	ORAL	125MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
8MDF5V39QO	SODIUM BICARBONATE:ORAL:TABLET (IMMED./COMP. RELEASE), FILM COATED:MG	ORAL	4.24MG ORAL TABLET (IMMED./COMP. RELEASE), FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
8MDF5V39QO	SODIUM BICARBONATE:ORAL:TABLET (IMMED./COMP. RELEASE), UNCOATED, CHEWABLE:MG	ORAL	140MG ORAL TABLET (IMMED./COMP. RELEASE), UNCOATED, CHEWABLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
8MDF5V39QO	SODIUM BICARBONATE:ORAL:TABLET (IMMED./COMP. RELEASE), UNCOATED, EFFERVESCENT:MG	ORAL	267MG ORAL TABLET (IMMED./COMP. RELEASE), UNCOATED, EFFERVESCENT	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
8MDF5V39QO	SODIUM BICARBONATE:ORAL:TABLET, COATED:MG	ORAL	9MG ORAL TABLET, COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
8MDF5V39QO	SODIUM BICARBONATE:ORAL:TABLET, DELAYED ACTION, ENTERIC COATED:MG	ORAL	30MG ORAL TABLET, DELAYED ACTION, ENTERIC COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
8MDF5V39QO	SODIUM BICARBONATE:ORAL:TABLET, DELAYED RELEASE:MG	ORAL	0.43MG ORAL TABLET, DELAYED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
8MDF5V39QO	SODIUM BICARBONATE:ORAL:TABLET, EFFERVESCENT, FOR SOLUTION:MG	ORAL	1600MG ORAL TABLET, EFFERVESCENT, FOR SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
8MDF5V39QO	SODIUM BICARBONATE:ORAL:TABLET, EXTENDED RELEASE:MG	ORAL	40.4MG ORAL TABLET, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
8MDF5V39QO	SODIUM BICARBONATE:ORAL:TABLET, FILM COATED:MG	ORAL	40MG ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
8MDF5V39QO	SODIUM BICARBONATE:ORAL:TABLET, ORALLY DISINTEGRATING:MG	ORAL	30MG ORAL TABLET, ORALLY DISINTEGRATING	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
8MDF5V39QO	SODIUM BICARBONATE:ORAL:TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE:mg	ORAL	1mg ORAL TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
8MDF5V39QO	SODIUM BICARBONATE:ORAL:TABLET, SUSTAINED ACTION:MG	ORAL	2.56MG ORAL TABLET, SUSTAINED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
8MDF5V39QO	SODIUM BICARBONATE:ORAL:TABLET, SUSTAINED ACTION, COATED:MG	ORAL	2.56MG ORAL TABLET, SUSTAINED ACTION, COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
8MDF5V39QO	SODIUM BICARBONATE:SUBCUTANEOUS:INJECTION:ADJ PH	SUBCUTANEOUS	ADJ PH SUBCUTANEOUS INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
8MDF5V39QO	SODIUM BICARBONATE:SUBCUTANEOUS:POWDER, FOR INJECTION SOLUTION:%	SUBCUTANEOUS	0.016% SUBCUTANEOUS POWDER, FOR INJECTION SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
8MDF5V39QO	SODIUM BICARBONATE:SUBCUTANEOUS:POWDER, FOR INJECTION SOLUTION, LYOPHILIZED:NA	SUBCUTANEOUS	SUBCUTANEOUS POWDER, FOR INJECTION SOLUTION, LYOPHILIZED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
8MDF5V39QO	SODIUM BICARBONATE:SUBLINGUAL:TABLET:MG	SUBLINGUAL	3.25MG SUBLINGUAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
8MDF5V39QO	SODIUM BICARBONATE:TRANSDERMAL:PATCH, ELECTRICALLY CONTROLLED:MG	TRANSDERMAL	10MG TRANSDERMAL PATCH, ELECTRICALLY CONTROLLED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
8MDF5V39QO	SODIUM BICARBONATE:VAGINAL:INSERT:MG	VAGINAL	43MG VAGINAL INSERT	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
8MDF5V39QO	SODIUM BICARBONATE:VAGINAL:TABLET:MG	VAGINAL	43MG VAGINAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
97C5T2UQ7J	CHOLESTEROL:EPIDURAL:INJECTION, SUSPENSION, LIPOSOMAL:%	EPIDURAL	0.33% EPIDURAL INJECTION, SUSPENSION, LIPOSOMAL	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
97C5T2UQ7J	CHOLESTEROL:INFILTRATION:INJECTION, LIPOSOMAL:%	INFILTRATION	0.47% INFILTRATION INJECTION, LIPOSOMAL	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
97C5T2UQ7J	CHOLESTEROL:INTRAVENOUS:INJECTION:%	INTRAVENOUS	0.62% INTRAVENOUS INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
97C5T2UQ7J	CHOLESTEROL:INTRAVENOUS:INJECTION, POWDER, LYOPHILIZED, FOR LIPOSOMAL SUSPENSION:%	INTRAVENOUS	5.2% INTRAVENOUS INJECTION, POWDER, LYOPHILIZED, FOR LIPOSOMAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
97C5T2UQ7J	CHOLESTEROL:INTRAVENOUS:INJECTION, SUSPENSION, LIPOSOMAL:%	INTRAVENOUS	0.32% INTRAVENOUS INJECTION, SUSPENSION, LIPOSOMAL	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
97C5T2UQ7J	CHOLESTEROL:INTRAVENOUS:SOLUTION, LIPOSOME, INJECTION:%	INTRAVENOUS	0.68% INTRAVENOUS SOLUTION, LIPOSOME, INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
97C5T2UQ7J	CHOLESTEROL:IV(INFUSION):INJECTION, LIPOSOMAL:%	IV(INFUSION)	0.032% IV(INFUSION) INJECTION, LIPOSOMAL	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
97C5T2UQ7J	CHOLESTEROL:OPHTHALMIC:POWDER, FOR SUSPENSION:NA	OPHTHALMIC	OPHTHALMIC POWDER, FOR SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
97C5T2UQ7J	CHOLESTEROL:TOPICAL:EMULSION, CREAM:%W/W	TOPICAL	1%W/W TOPICAL EMULSION, CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
97C5T2UQ7J	CHOLESTEROL:TOPICAL:LOTION:%W/W	TOPICAL	1.5%W/W TOPICAL LOTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
97C5T2UQ7J	CHOLESTEROL:TOPICAL:OINTMENT:%W/W	TOPICAL	5%W/W TOPICAL OINTMENT	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
97C5T2UQ7J	CHOLESTEROL:VAGINAL:EMULSION, CREAM:%	VAGINAL	0.5% VAGINAL EMULSION, CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
RS7A450LGA	ANHYDROUS TRISODIUM CITRATE:IM - IV:INJECTION:%	IM - IV	16% IM - IV INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
RS7A450LGA	ANHYDROUS TRISODIUM CITRATE:INHALATION:SUSPENSION:mg/2mL	INHALATION	0.9mg/2mL INHALATION SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
RS7A450LGA	ANHYDROUS TRISODIUM CITRATE:INTRA-ARTERIAL:INJECTION:NA	INTRA-ARTERIAL	INTRA-ARTERIAL INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
RS7A450LGA	ANHYDROUS TRISODIUM CITRATE:INTRA-ARTICULAR:INJECTION:%	INTRA-ARTICULAR	1% INTRA-ARTICULAR INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
RS7A450LGA	ANHYDROUS TRISODIUM CITRATE:INTRABURSAL:INJECTION:%	INTRABURSAL	1% INTRABURSAL INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
RS7A450LGA	ANHYDROUS TRISODIUM CITRATE:INTRALESIONAL:INJECTION:%W/V	INTRALESIONAL	0.96%W/V INTRALESIONAL INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
RS7A450LGA	ANHYDROUS TRISODIUM CITRATE:INTRAMUSCULAR:INJECTION:%W/V	INTRAMUSCULAR	0.96%W/V INTRAMUSCULAR INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
RS7A450LGA	ANHYDROUS TRISODIUM CITRATE:INTRAVENOUS:INJECTION:%W/V	INTRAVENOUS	0.96%W/V INTRAVENOUS INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
RS7A450LGA	ANHYDROUS TRISODIUM CITRATE:INTRAVENOUS:POWDER, FOR INJECTION SOLUTION:%	INTRAVENOUS	6.99% INTRAVENOUS POWDER, FOR INJECTION SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
RS7A450LGA	ANHYDROUS TRISODIUM CITRATE:IV(INFUSION):CONCENTRATE:%	IV(INFUSION)	2.4% IV(INFUSION) CONCENTRATE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
RS7A450LGA	ANHYDROUS TRISODIUM CITRATE:IV(INFUSION):INJECTION:%	IV(INFUSION)	16% IV(INFUSION) INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
RS7A450LGA	ANHYDROUS TRISODIUM CITRATE:NASAL:SPRAY:%	NASAL	1.27% NASAL SPRAY	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
RS7A450LGA	ANHYDROUS TRISODIUM CITRATE:NASAL:SPRAY, METERED:%	NASAL	0.001% NASAL SPRAY, METERED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
RS7A450LGA	ANHYDROUS TRISODIUM CITRATE:OPHTHALMIC:SOLUTION:NA	OPHTHALMIC	OPHTHALMIC SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
RS7A450LGA	ANHYDROUS TRISODIUM CITRATE:ORAL:FOR SUSPENSION:MG/5ML	ORAL	9MG/5ML ORAL FOR SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
RS7A450LGA	ANHYDROUS TRISODIUM CITRATE:ORAL:GRANULE:NA	ORAL	ORAL GRANULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
RS7A450LGA	ANHYDROUS TRISODIUM CITRATE:ORAL:GRANULE, EFFERVESCENT:NA	ORAL	ORAL GRANULE, EFFERVESCENT	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
RS7A450LGA	ANHYDROUS TRISODIUM CITRATE:ORAL:LIQUID,EXTENDED RELEASE:MG/ML	ORAL	3.9MG/ML ORAL LIQUID,EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
RS7A450LGA	ANHYDROUS TRISODIUM CITRATE:ORAL:POWDER, FOR ORAL SUSPENSION:MG/5ML	ORAL	19.31MG/5ML ORAL POWDER, FOR ORAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
RS7A450LGA	ANHYDROUS TRISODIUM CITRATE:ORAL:POWDER, FOR RECONSTITUTION:MG/5ML	ORAL	7.5MG/5ML ORAL POWDER, FOR RECONSTITUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
RS7A450LGA	ANHYDROUS TRISODIUM CITRATE:ORAL:POWDER, FOR SOLUTION:MG/5ML	ORAL	48MG/5ML ORAL POWDER, FOR SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
RS7A450LGA	ANHYDROUS TRISODIUM CITRATE:ORAL:POWDER, FOR SUSPENSION:MG/5ML	ORAL	66.7MG/5ML ORAL POWDER, FOR SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
RS7A450LGA	ANHYDROUS TRISODIUM CITRATE:ORAL:SOLUTION:MG/5ML	ORAL	30MG/5ML ORAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
RS7A450LGA	ANHYDROUS TRISODIUM CITRATE:ORAL:SUSPENSION:MG/5ML	ORAL	7.5MG/5ML ORAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
RS7A450LGA	ANHYDROUS TRISODIUM CITRATE:ORAL:SYRUP:MG/5ML	ORAL	7.95MG/5ML ORAL SYRUP	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
RS7A450LGA	ANHYDROUS TRISODIUM CITRATE:ORAL:TABLET:MG	ORAL	28MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
RS7A450LGA	ANHYDROUS TRISODIUM CITRATE:ORAL:TABLET (IMMED./COMP. RELEASE), UNCOATED, EFFERVESCENT:MG	ORAL	935MG ORAL TABLET (IMMED./COMP. RELEASE), UNCOATED, EFFERVESCENT	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
RS7A450LGA	ANHYDROUS TRISODIUM CITRATE:ORAL:TABLET, DELAYED ACTION, ENTERIC COATED:MG	ORAL	15MG ORAL TABLET, DELAYED ACTION, ENTERIC COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
RS7A450LGA	ANHYDROUS TRISODIUM CITRATE:SOFT TISSUE:INJECTION:%W/V	SOFT TISSUE	0.96%W/V SOFT TISSUE INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
RS7A450LGA	ANHYDROUS TRISODIUM CITRATE:SUBLINGUAL:FILM:MG	SUBLINGUAL	1.34MG SUBLINGUAL FILM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
RS7A450LGA	ANHYDROUS TRISODIUM CITRATE:SUBLINGUAL:TABLET:MG	SUBLINGUAL	2.68MG SUBLINGUAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
RS7A450LGA	ANHYDROUS TRISODIUM CITRATE:TOPICAL:CREAM:%W/W	TOPICAL	0.05%W/W TOPICAL CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
RS7A450LGA	ANHYDROUS TRISODIUM CITRATE:TOPICAL:CREAM, EMULSION, SUSTAINED RELEASE:%W/W	TOPICAL	0.12%W/W TOPICAL CREAM, EMULSION, SUSTAINED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
RS7A450LGA	ANHYDROUS TRISODIUM CITRATE:TOPICAL:EMULSION, CREAM:%W/W	TOPICAL	0.28%W/W TOPICAL EMULSION, CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
RS7A450LGA	ANHYDROUS TRISODIUM CITRATE:TOPICAL:LOTION:%W/W	TOPICAL	0.075%W/W TOPICAL LOTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
KCR71CW036	PEG-4 DILAURATE:TOPICAL:LOTION:NA	TOPICAL	TOPICAL LOTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
10LGE70FSU	AMMONIUM PHOSPHATE, DIBASIC:ORAL:TABLET:MG	ORAL	0.4MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
10LGE70FSU	AMMONIUM PHOSPHATE, DIBASIC:ORAL:TABLET, SUSTAINED ACTION:MG	ORAL	0.4MG ORAL TABLET, SUSTAINED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
10LGE70FSU	AMMONIUM PHOSPHATE, DIBASIC:SUBLINGUAL:TABLET:MG	SUBLINGUAL	0.2MG SUBLINGUAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
UH6KR4953D	POLYETHYLENE GLYCOL 800:ORAL:TABLET:MG	ORAL	3.48MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
7773C1ROEU	LOW-SUBSTITUTED HYDROXYPROPYL CELLULOSE (11% HYDROXYPROPYL; 130000 MW):ORAL:TABLET:MG	ORAL	54MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
7773C1ROEU	LOW-SUBSTITUTED HYDROXYPROPYL CELLULOSE (11% HYDROXYPROPYL; 130000 MW):ORAL:TABLET, FILM COATED:mg	ORAL	6mg ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=L
X65D416703	SODIUM PHOSPHITE:INTRAMUSCULAR:POWDER, FOR INJECTION SOLUTION:%	INTRAMUSCULAR	2% INTRAMUSCULAR POWDER, FOR INJECTION SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
X65D416703	SODIUM PHOSPHITE:INTRAVENOUS:POWDER, FOR INJECTION SOLUTION:%	INTRAVENOUS	2% INTRAVENOUS POWDER, FOR INJECTION SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
91MBZ8H3QO	SODIUM BORATE:AURICULAR (OTIC):SOLUTION:%	AURICULAR (OTIC)	0.3% AURICULAR (OTIC) SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
91MBZ8H3QO	SODIUM BORATE:OPHTHALMIC:EMULSION:%W/V	OPHTHALMIC	0.11%W/V OPHTHALMIC EMULSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
91MBZ8H3QO	SODIUM BORATE:OPHTHALMIC:POWDER, FOR SOLUTION:NA	OPHTHALMIC	OPHTHALMIC POWDER, FOR SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
91MBZ8H3QO	SODIUM BORATE:OPHTHALMIC:POWDER, FOR SUSPENSION:NA	OPHTHALMIC	OPHTHALMIC POWDER, FOR SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
91MBZ8H3QO	SODIUM BORATE:OPHTHALMIC:SOLUTION:%	OPHTHALMIC	1.1% OPHTHALMIC SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
91MBZ8H3QO	SODIUM BORATE:OPHTHALMIC:SOLUTION, DROPS:%	OPHTHALMIC	1.1% OPHTHALMIC SOLUTION, DROPS	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
91MBZ8H3QO	SODIUM BORATE:OPHTHALMIC:SUSPENSION:NA	OPHTHALMIC	OPHTHALMIC SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
91MBZ8H3QO	SODIUM BORATE:OPHTHALMIC:SUSPENSION, DROPS:%	OPHTHALMIC	0.029% OPHTHALMIC SUSPENSION, DROPS	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
91MBZ8H3QO	SODIUM BORATE:TOPICAL:SOLUTION:%W/W	TOPICAL	0.51%W/W TOPICAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S
G6ZWA1Q43P	PPG-26 OLEATE:TOPICAL:EMULSION, CREAM:%W/W	TOPICAL	4%W/W TOPICAL EMULSION, CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P
3K9958V90M	ALCOHOL:DENTAL:SOLUTION:%	DENTAL	11.6% DENTAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
3K9958V90M	ALCOHOL:EXTRACORPOREAL:SOLUTION:%	EXTRACORPOREAL	5% EXTRACORPOREAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
3K9958V90M	ALCOHOL:IM - IV:INJECTABLE:%	IM - IV	10% IM - IV INJECTABLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
3K9958V90M	ALCOHOL:IM - IV:INJECTION:%	IM - IV	20% IM - IV INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
3K9958V90M	ALCOHOL:IM - IV:SOLUTION, INJECTION:%	IM - IV	10% IM - IV SOLUTION, INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
3K9958V90M	ALCOHOL:IM - IV - SC:INJECTION:%	IM - IV - SC	6.1% IM - IV - SC INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
3K9958V90M	ALCOHOL:INHALATION:AEROSOL, METERED:%	INHALATION	95.89% INHALATION AEROSOL, METERED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
3K9958V90M	ALCOHOL:INHALATION:AEROSOL, SPRAY:%	INHALATION	33% INHALATION AEROSOL, SPRAY	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
3K9958V90M	ALCOHOL:INHALATION:SOLUTION:%	INHALATION	25% INHALATION SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
3K9958V90M	ALCOHOL:INTRACAVITARY:INJECTION:NA	INTRACAVITARY	INTRACAVITARY INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
3K9958V90M	ALCOHOL:INTRAMUSCULAR:INJECTION:%V/V	INTRAMUSCULAR	12%V/V INTRAMUSCULAR INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
3K9958V90M	ALCOHOL:INTRAMUSCULAR:INJECTION, SOLUTION:%	INTRAMUSCULAR	6.1% INTRAMUSCULAR INJECTION, SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
3K9958V90M	ALCOHOL:INTRAMUSCULAR:LIQUID:%W/V	INTRAMUSCULAR	10%W/V INTRAMUSCULAR LIQUID	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
3K9958V90M	ALCOHOL:INTRAMUSCULAR:SOLUTION, INJECTION:%W/V	INTRAMUSCULAR	10%W/V INTRAMUSCULAR SOLUTION, INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
3K9958V90M	ALCOHOL:INTRAVENOUS:INJECTABLE:%	INTRAVENOUS	34.5% INTRAVENOUS INJECTABLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
3K9958V90M	ALCOHOL:INTRAVENOUS:INJECTION:%	INTRAVENOUS	92% INTRAVENOUS INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
3K9958V90M	ALCOHOL:INTRAVENOUS:INJECTION, EMULSION:MG/1ML	INTRAVENOUS	28.5MG/1ML INTRAVENOUS INJECTION, EMULSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
3K9958V90M	ALCOHOL:INTRAVENOUS:INJECTION, SOLUTION:%	INTRAVENOUS	6.1% INTRAVENOUS INJECTION, SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
3K9958V90M	ALCOHOL:INTRAVENOUS:LIQUID:%	INTRAVENOUS	10% INTRAVENOUS LIQUID	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
3K9958V90M	ALCOHOL:INTRAVENOUS:SOLUTION, CONCENTRATE:%	INTRAVENOUS	39.46% INTRAVENOUS SOLUTION, CONCENTRATE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
3K9958V90M	ALCOHOL:INTRAVENOUS:SOLUTION, INJECTION:mg/1mL	INTRAVENOUS	391mg/1mL INTRAVENOUS SOLUTION, INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
3K9958V90M	ALCOHOL:INTRAVENOUS:SOLUTION, INJECTION:%	INTRAVENOUS	39.5% INTRAVENOUS SOLUTION, INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
3K9958V90M	ALCOHOL:INTRAVENOUS INFUSION:INJECTION:%V/V	INTRAVENOUS INFUSION	23%V/V INTRAVENOUS INFUSION INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
3K9958V90M	ALCOHOL:INTRAVENOUS INFUSION:SOLUTION, INJECTION:mg/mL	INTRAVENOUS INFUSION	395mg/mL INTRAVENOUS INFUSION SOLUTION, INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
3K9958V90M	ALCOHOL:INTRAVESICAL:SOLUTION:%	INTRAVESICAL	50% INTRAVESICAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
3K9958V90M	ALCOHOL:IV - SC:INJECTION:%	IV - SC	0.95% IV - SC INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
3K9958V90M	ALCOHOL:IV(INFUSION):INJECTION:%	IV(INFUSION)	49% IV(INFUSION) INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
3K9958V90M	ALCOHOL:IV(INFUSION):POWDER, FOR INJECTION SOLUTION, LYOPHILIZED:%	IV(INFUSION)	0.027% IV(INFUSION) POWDER, FOR INJECTION SOLUTION, LYOPHILIZED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
3K9958V90M	ALCOHOL:IV(INFUSION):SOLUTION, INJECTION:%	IV(INFUSION)	49.7% IV(INFUSION) SOLUTION, INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
3K9958V90M	ALCOHOL:NASAL:AEROSOL:%	NASAL	2% NASAL AEROSOL	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
3K9958V90M	ALCOHOL:NASAL:AEROSOL, METERED:%	NASAL	0.7% NASAL AEROSOL, METERED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
3K9958V90M	ALCOHOL:OPHTHALMIC:SOLUTION:%	OPHTHALMIC	1.4% OPHTHALMIC SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
3K9958V90M	ALCOHOL:ORAL:SOLUTION:MG/ML	ORAL	356.3MG/ML ORAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
3K9958V90M	ALCOHOL:ORAL:SOLUTION:ML/ML	ORAL	0.05ML/ML ORAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
3K9958V90M	ALCOHOL:ORAL:SYRUP:MG/5 ML	ORAL	290MG/5 ML ORAL SYRUP	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
3K9958V90M	ALCOHOL:ORAL:SYRUP:mL/5mL	ORAL	0.25mL/5mL ORAL SYRUP	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
3K9958V90M	ALCOHOL:PHOTOPHERESIS:SOLUTION:%	PHOTOPHERESIS	5% PHOTOPHERESIS SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
3K9958V90M	ALCOHOL:RECTAL:GEL:%	RECTAL	22.45% RECTAL GEL	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
3K9958V90M	ALCOHOL:RECTAL:SUSPENSION:%	RECTAL	0.35% RECTAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
3K9958V90M	ALCOHOL:RESPIRATORY (INHALATION):AEROSOL, METERED:%	RESPIRATORY (INHALATION)	10% RESPIRATORY (INHALATION) AEROSOL, METERED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
3K9958V90M	ALCOHOL:RESPIRATORY (INHALATION):SOLUTION, FOR INHALATION:%	RESPIRATORY (INHALATION)	0.081% RESPIRATORY (INHALATION) SOLUTION, FOR INHALATION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
3K9958V90M	ALCOHOL:SUBCUTANEOUS:INJECTION, SOLUTION:%	SUBCUTANEOUS	6.1% SUBCUTANEOUS INJECTION, SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
3K9958V90M	ALCOHOL:SUBLINGUAL:SPRAY:%	SUBLINGUAL	4.96% SUBLINGUAL SPRAY	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
3K9958V90M	ALCOHOL:SUBLINGUAL:SPRAY, METERED:%	SUBLINGUAL	0.95% SUBLINGUAL SPRAY, METERED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
3K9958V90M	ALCOHOL:SUBLINGUAL:TABLET:MG	SUBLINGUAL	0.001MG SUBLINGUAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
3K9958V90M	ALCOHOL:TOPICAL:AEROSOL, SPRAY:%W/W	TOPICAL	10.3%W/W TOPICAL AEROSOL, SPRAY	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
3K9958V90M	ALCOHOL:TOPICAL:CLOTH:%W/W	TOPICAL	57.62%W/W TOPICAL CLOTH	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
3K9958V90M	ALCOHOL:TOPICAL:EMULSION, AEROSOL FOAM:%W/W	TOPICAL	60.43%W/W TOPICAL EMULSION, AEROSOL FOAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
3K9958V90M	ALCOHOL:TOPICAL:EMULSION, CREAM:NA	TOPICAL	TOPICAL EMULSION, CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
3K9958V90M	ALCOHOL:TOPICAL:GEL:%W/W	TOPICAL	94.78%W/W TOPICAL GEL	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
3K9958V90M	ALCOHOL:TOPICAL:LOTION:%W/W	TOPICAL	11.79%W/W TOPICAL LOTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
3K9958V90M	ALCOHOL:TOPICAL:PATCH:NA	TOPICAL	TOPICAL PATCH	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
3K9958V90M	ALCOHOL:TOPICAL:POWDER, FOR SOLUTION:NA	TOPICAL	TOPICAL POWDER, FOR SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
3K9958V90M	ALCOHOL:TOPICAL:SHAMPOO:%W/V	TOPICAL	10.28%W/V TOPICAL SHAMPOO	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
3K9958V90M	ALCOHOL:TOPICAL:SOLUTION:%W/W	TOPICAL	91.26%W/W TOPICAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
3K9958V90M	ALCOHOL:TOPICAL:SOLUTION, LIQUID:%W/W	TOPICAL	25%W/W TOPICAL SOLUTION, LIQUID	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
3K9958V90M	ALCOHOL:TOPICAL:SPRAY:%W/W	TOPICAL	49.3%W/W TOPICAL SPRAY	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
3K9958V90M	ALCOHOL:TOPICAL:SWAB:%W/V	TOPICAL	30%W/V TOPICAL SWAB	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
3K9958V90M	ALCOHOL:TRANSDERMAL:FILM, CONTROLLED RELEASE:MG	TRANSDERMAL	358.7MG TRANSDERMAL FILM, CONTROLLED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
3K9958V90M	ALCOHOL:TRANSDERMAL:GEL:%	TRANSDERMAL	74.1% TRANSDERMAL GEL	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
3K9958V90M	ALCOHOL:TRANSDERMAL:GEL, METERED:%	TRANSDERMAL	73.5% TRANSDERMAL GEL, METERED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
3K9958V90M	ALCOHOL:TRANSDERMAL:PATCH, CONTROLLED RELEASE:NA	TRANSDERMAL	TRANSDERMAL PATCH, CONTROLLED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
3K9958V90M	ALCOHOL:TRANSDERMAL:SOLUTION:%	TRANSDERMAL	60.25% TRANSDERMAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
3K9958V90M	ALCOHOL:TRANSDERMAL:SPRAY:%W/V	TRANSDERMAL	90%W/V TRANSDERMAL SPRAY	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
3K9958V90M	ALCOHOL, DEHYDRATED:INHALATION:AEROSOL:ug	INHALATION	1ug INHALATION AEROSOL	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
3K9958V90M	ALCOHOL, DEHYDRATED:INTRAVENOUS:INJECTION:mL/1mL	INTRAVENOUS	0.2mL/1mL INTRAVENOUS INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
3K9958V90M	ALCOHOL, DEHYDRATED:ORAL:LIQUID:mg/10mL	ORAL	75mg/10mL ORAL LIQUID	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
3K9958V90M	ALCOHOL, DEHYDRATED:TOPICAL:AEROSOL, FOAM:%W/W	TOPICAL	60%W/W TOPICAL AEROSOL, FOAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
3K9958V90M	ALCOHOL, DEHYDRATED:TOPICAL:SOLUTION:%W/W	TOPICAL	28.42%W/W TOPICAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
3K9958V90M	ALCOHOL, DILUTED:IM - IV:INJECTION:%	IM - IV	10% IM - IV INJECTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
3K9958V90M	ALCOHOL, DILUTED:TOPICAL:AEROSOL:%W/W	TOPICAL	68.5%W/W TOPICAL AEROSOL	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
3K9958V90M	ALCOHOL, DILUTED:TOPICAL:POWDER, FOR SOLUTION:%W/W	TOPICAL	40%W/W TOPICAL POWDER, FOR SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
3K9958V90M	ALCOHOL, DILUTED:TOPICAL:SHAMPOO:%W/W 	TOPICAL	10%W/W  TOPICAL SHAMPOO	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=A
RFW2ET671P	HYDROXYPROPYL CELLULOSE (1600000 WAMW):ORAL:CAPSULE, DELAYED ACTION:MG	ORAL	36.23MG ORAL CAPSULE, DELAYED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
RFW2ET671P	HYDROXYPROPYL CELLULOSE (1600000 WAMW):ORAL:POWDER, FOR SUSPENSION:g/236mL	ORAL	0.2g/236mL ORAL POWDER, FOR SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
RFW2ET671P	HYDROXYPROPYL CELLULOSE (1600000 WAMW):ORAL:SUSPENSION:MG/1G	ORAL	10MG/1G ORAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
RFW2ET671P	HYDROXYPROPYL CELLULOSE (1600000 WAMW):ORAL:TABLET:MG	ORAL	35MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
RFW2ET671P	HYDROXYPROPYL CELLULOSE (1600000 WAMW):ORAL:TABLET, CHEWABLE:mg	ORAL	4.5mg ORAL TABLET, CHEWABLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
RFW2ET671P	HYDROXYPROPYL CELLULOSE (1600000 WAMW):ORAL:TABLET, EXTENDED RELEASE:mg	ORAL	70mg ORAL TABLET, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
RFW2ET671P	HYDROXYPROPYL CELLULOSE (1600000 WAMW):TOPICAL:GEL:%W/W	TOPICAL	2.5%W/W TOPICAL GEL	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
RFW2ET671P	HYDROXYPROPYL CELLULOSE (1600000 WAMW):TOPICAL:SOLUTION:MG/1ML	TOPICAL	1MG/1ML TOPICAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
RFW2ET671P	HYDROXYPROPYL CELLULOSE (1600000 WAMW):TRANSDERMAL:GEL:%W/W	TRANSDERMAL	2%W/W TRANSDERMAL GEL	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=H
WZB9127XOA	FD&C RED NO. 40:BUCCAL:GUM, CHEWING:MG	BUCCAL	2MG BUCCAL GUM, CHEWING	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
WZB9127XOA	FD&C RED NO. 40:BUCCAL:TABLET:MG	BUCCAL	0.006MG BUCCAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
WZB9127XOA	FD&C RED NO. 40:DENTAL:SOLUTION:%	DENTAL	0.001% DENTAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
WZB9127XOA	FD&C RED NO. 40:ORAL:BAR, CHEWABLE:NA	ORAL	ORAL BAR, CHEWABLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
WZB9127XOA	FD&C RED NO. 40:ORAL:CAPSULE:mg	ORAL	1.5mg ORAL CAPSULE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
WZB9127XOA	FD&C RED NO. 40:ORAL:CAPSULE, COATED, SOFT GELATIN:MG	ORAL	0.046MG ORAL CAPSULE, COATED, SOFT GELATIN	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
WZB9127XOA	FD&C RED NO. 40:ORAL:CAPSULE, DELAYED ACTION:MG	ORAL	0.15MG ORAL CAPSULE, DELAYED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
WZB9127XOA	FD&C RED NO. 40:ORAL:CAPSULE, DELAYED ACTION, ENTERIC COATED:NA	ORAL	ORAL CAPSULE, DELAYED ACTION, ENTERIC COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
WZB9127XOA	FD&C RED NO. 40:ORAL:CAPSULE, DELAYED RELEASE:MG	ORAL	0.26MG ORAL CAPSULE, DELAYED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
WZB9127XOA	FD&C RED NO. 40:ORAL:CAPSULE, ENTERIC COATED PELLETS:MG	ORAL	0.001MG ORAL CAPSULE, ENTERIC COATED PELLETS	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
WZB9127XOA	FD&C RED NO. 40:ORAL:CAPSULE, EXTENDED RELEASE:MG	ORAL	0.27MG ORAL CAPSULE, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
WZB9127XOA	FD&C RED NO. 40:ORAL:CAPSULE, HARD GELATIN:MG	ORAL	0.15MG ORAL CAPSULE, HARD GELATIN	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
WZB9127XOA	FD&C RED NO. 40:ORAL:CAPSULE, SOFT GELATIN:MG	ORAL	0.52MG ORAL CAPSULE, SOFT GELATIN	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
WZB9127XOA	FD&C RED NO. 40:ORAL:CAPSULE, SOFT GELATIN LIQUID-FILLED:MG	ORAL	0.05MG ORAL CAPSULE, SOFT GELATIN LIQUID-FILLED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
WZB9127XOA	FD&C RED NO. 40:ORAL:CAPSULE, SUSTAINED ACTION:MG	ORAL	0.2MG ORAL CAPSULE, SUSTAINED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
WZB9127XOA	FD&C RED NO. 40:ORAL:CONCENTRATE:%	ORAL	0.004% ORAL CONCENTRATE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
WZB9127XOA	FD&C RED NO. 40:ORAL:DROPS:MG/1ML	ORAL	0.01MG/1ML ORAL DROPS	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
WZB9127XOA	FD&C RED NO. 40:ORAL:LIQUID:mg/10mL	ORAL	0.06mg/10mL ORAL LIQUID	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
WZB9127XOA	FD&C RED NO. 40:ORAL:POWDER:MG/1PKT	ORAL	0.5MG/1PKT ORAL POWDER	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
WZB9127XOA	FD&C RED NO. 40:ORAL:POWDER, FOR ORAL SUSPENSION:MG/5ML	ORAL	0.8MG/5ML ORAL POWDER, FOR ORAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
WZB9127XOA	FD&C RED NO. 40:ORAL:POWDER, FOR RECONSTITUTION:MG/5ML	ORAL	1.46MG/5ML ORAL POWDER, FOR RECONSTITUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
WZB9127XOA	FD&C RED NO. 40:ORAL:POWDER, FOR SOLUTION:MG/5ML	ORAL	0.33MG/5ML ORAL POWDER, FOR SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
WZB9127XOA	FD&C RED NO. 40:ORAL:POWDER, FOR SUSPENSION:MG/5ML	ORAL	1.88MG/5ML ORAL POWDER, FOR SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
WZB9127XOA	FD&C RED NO. 40:ORAL:SOLUTION:MG/5ML	ORAL	2.3MG/5ML ORAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
WZB9127XOA	FD&C RED NO. 40:ORAL:SOLUTION, ELIXIR:%	ORAL	2.5% ORAL SOLUTION, ELIXIR	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
WZB9127XOA	FD&C RED NO. 40:ORAL:SOLUTION, SYRUP:MG	ORAL	0.03MG ORAL SOLUTION, SYRUP	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
WZB9127XOA	FD&C RED NO. 40:ORAL:SUSPENSION:mg/5mL	ORAL	0.25mg/5mL ORAL SUSPENSION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
WZB9127XOA	FD&C RED NO. 40:ORAL:SUSPENSION, DROPS:MG/2.5ML	ORAL	0.4MG/2.5ML ORAL SUSPENSION, DROPS	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
WZB9127XOA	FD&C RED NO. 40:ORAL:SUSPENSION, LIQUID:MG/5ML	ORAL	0.25MG/5ML ORAL SUSPENSION, LIQUID	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
WZB9127XOA	FD&C RED NO. 40:ORAL:SUSPENSION, SYRUP, SUSTAINED ACTION:%	ORAL	0.001% ORAL SUSPENSION, SYRUP, SUSTAINED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
WZB9127XOA	FD&C RED NO. 40:ORAL:SYRUP:%	ORAL	0.4% ORAL SYRUP	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
WZB9127XOA	FD&C RED NO. 40:ORAL:SYRUP:MG/5ML	ORAL	0.23MG/5ML ORAL SYRUP	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
WZB9127XOA	FD&C RED NO. 40:ORAL:TABLET:MG	ORAL	2.22MG ORAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
WZB9127XOA	FD&C RED NO. 40:ORAL:TABLET (IMMED./COMP. RELEASE), COATED:MG	ORAL	0.1MG ORAL TABLET (IMMED./COMP. RELEASE), COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
WZB9127XOA	FD&C RED NO. 40:ORAL:TABLET (IMMED./COMP. RELEASE), FILM COATED:NA	ORAL	ORAL TABLET (IMMED./COMP. RELEASE), FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
WZB9127XOA	FD&C RED NO. 40:ORAL:TABLET (IMMED./COMP. RELEASE), UNCOATED, CHEWABLE:MG	ORAL	40MG ORAL TABLET (IMMED./COMP. RELEASE), UNCOATED, CHEWABLE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
WZB9127XOA	FD&C RED NO. 40:ORAL:TABLET, COATED:NA	ORAL	ORAL TABLET, COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
WZB9127XOA	FD&C RED NO. 40:ORAL:TABLET, DELAYED ACTION:MG	ORAL	0.45MG ORAL TABLET, DELAYED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
WZB9127XOA	FD&C RED NO. 40:ORAL:TABLET, DELAYED ACTION, ENTERIC COATED:MG	ORAL	0.043MG ORAL TABLET, DELAYED ACTION, ENTERIC COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
WZB9127XOA	FD&C RED NO. 40:ORAL:TABLET, DELAYED RELEASE:MG	ORAL	0.09MG ORAL TABLET, DELAYED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
WZB9127XOA	FD&C RED NO. 40:ORAL:TABLET, EXTENDED RELEASE:MG	ORAL	2.34MG ORAL TABLET, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
WZB9127XOA	FD&C RED NO. 40:ORAL:TABLET, FILM COATED:MG	ORAL	0.028MG ORAL TABLET, FILM COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
WZB9127XOA	FD&C RED NO. 40:ORAL:TABLET, FILM COATED, EXTENDED RELEASE:MG	ORAL	0.19MG ORAL TABLET, FILM COATED, EXTENDED RELEASE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
WZB9127XOA	FD&C RED NO. 40:ORAL:TABLET, SUSTAINED ACTION:NA	ORAL	ORAL TABLET, SUSTAINED ACTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
WZB9127XOA	FD&C RED NO. 40:ORAL:TABLET, SUSTAINED ACTION, COATED:NA	ORAL	ORAL TABLET, SUSTAINED ACTION, COATED	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
WZB9127XOA	FD&C RED NO. 40:SUBLINGUAL:TABLET:MG	SUBLINGUAL	0.004MG SUBLINGUAL TABLET	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
WZB9127XOA	FD&C RED NO. 40:TOPICAL:SHAMPOO:%W/W	TOPICAL	0.004%W/W TOPICAL SHAMPOO	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
WZB9127XOA	FD&C RED NO. 40:TOPICAL:SOLUTION:NA	TOPICAL	TOPICAL SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
WZB9127XOA	FD&C RED NO. 40:TOPICAL:SPONGE:NA	TOPICAL	TOPICAL SPONGE	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=F
0F32U78V2Q	CHLOROXYLENOL:AURICULAR (OTIC):SOLUTION:%	AURICULAR (OTIC)	0.1% AURICULAR (OTIC) SOLUTION	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
0F32U78V2Q	CHLOROXYLENOL:TOPICAL:EMULSION, CREAM:%W/W	TOPICAL	0.15%W/W TOPICAL EMULSION, CREAM	https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=C
